PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mathys, A; Semal, P; Brecko, J; Van den Spiegel, D				Mathys, Aurore; Semal, Patrick; Brecko, Jonathan; Van den Spiegel, Didier			Improving 3D photogrammetry models through spectral imaging: Tooth enamel as a case study	PLOS ONE			English	Article								Reflective or translucent materials are a challenge to digitize in 3D. Results are better with a matt coating although objects from museum collections are often too fragile or too valuable to be treated in this way. It is therefore essential that alternative solutions are found. This study analyzed spectral photogrammetry as a possible solution. Spectral photogrammetry is an emerging technique which uses images at different wavelengths to create 3D models. Tooth enamel is a challenging material to digitize. Six sets of teeth were photographed at different wavelengths. The results showed that the quality of the models enamels parts improved when taken with ultraviolet wavelengths whilst models were less accurate when photogrammetry was performed with the red and infrared spectrum. This can be explained by the optical properties of enamel. This study demonstrates that knowing the optical properties of a material beforehand could help future photogrammetric digitization of challenging materials.	[Mathys, Aurore; Brecko, Jonathan; Van den Spiegel, Didier] Royal Museum Cent Africa, Biol Collect & Data Management, Tervuren, Belgium; [Mathys, Aurore; Semal, Patrick; Brecko, Jonathan] Royal Belgian Inst Nat Sci, Sci Heritage Serv, Brussels, Belgium	Royal Museum for Central Africa; Royal Belgian Institute of Natural Sciences	Mathys, A (corresponding author), Royal Museum Cent Africa, Biol Collect & Data Management, Tervuren, Belgium.; Mathys, A (corresponding author), Royal Belgian Inst Nat Sci, Sci Heritage Serv, Brussels, Belgium.	aurore.mathys@africamuseum.be	Mathys, Aurore/AAA-3835-2022	Mathys, Aurore/0000-0002-3884-4853; Semal, Patrick/0000-0002-4048-7728	Belgian Scientific Policy [BR/175/PI/3DSPECTRAL]	Belgian Scientific Policy	The study is part of the research project BR/175/PI/3DSPECTRAL funded by the Belgian Scientific Policy (http://belspo.be/).Project leader is DV.	Aggarwal Charu C., 2016, OUTLIER ANAL; Arbace L, 2013, J CULT HERIT, V14, P332, DOI 10.1016/j.culher.2012.06.008; Bade R, 2006, PROC 17 SIMULATION V, V6, P289; Bertacchini E, 2013, INT J ARTS MANAG, V15, P60; Betts MW, 2011, J ARCHAEOL SCI, V38, P755, DOI 10.1016/j.jas.2010.06.021; BRODBELT RHW, 1981, J DENT RES, V60, P1749, DOI 10.1177/00220345810600100401; Brusco N, 2006, MACH VISION APPL, V17, P373, DOI 10.1007/s00138-006-0026-2; Bucking TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178540; Busby J., 2016, 3D SCANNING REFLECTI; Callieri M, 2004, IEEE COMPUT GRAPH, V24, P16, DOI 10.1109/MCG.2004.1274056; Chane CS, 2013, IMAGE VISION COMPUT, V31, P91, DOI 10.1016/j.imavis.2012.10.006; Chen HF, 2014, ADVANCED CERAMICS FOR DENTISTRY, P5, DOI 10.1016/B978-0-12-394619-5.00002-X; Chieruzzi M, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6070134; Curson MEJ, 2003, ENCY FOOD SCI NUTR, P1743; Davies A, 2018, APPL SCI PHOTOGR, P1; Delcourt J, 2010, THESIS; Delvaux L, 2017, CONSERVATION IR UV 3, DOI [10.13140/RG.2.2.10989.28649, DOI 10.13140/RG.2.2.10989.28649]; Evin A, 2016, J ARCHAEOL SCI-REP, V9, P87, DOI 10.1016/j.jasrep.2016.06.028; Gonizzi Barsanti S, 2013, ISPRS ANN PHOTOGRAMM, P151; Granero-Montagud L, 2013, PROC SPIE, V8790, DOI 10.1117/12.2020333; Hassett BR, 2017, ARCHAEOMETRY, V59, P191, DOI 10.1111/arcm.12229; Hess M, 2015, STUD CONSERV, V60, pS126, DOI 10.1179/0039363015Z.000000000217; Horak R., 2008, WEBSTERS NEW WORLD T; Kim MH, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185534; Liang HD, 2014, ISPRS J PHOTOGRAMM, V95, P13, DOI 10.1016/j.isprsjprs.2014.05.011; Lopez-Martinez T, 2018, J CULT HERIT, V30, P117, DOI 10.1016/j.culher.2017.09.019; Mallison H., 2014, J PALEONTOL TECHN, V12, P1; Mathys A, 2015, 2015 DIGITAL HERITAGE INTERNATIONAL CONGRESS, VOL 1: DIGITIZATION & ACQUISITION, COMPUTER GRAPHICS & INTERACTION, P19, DOI 10.1109/DigitalHeritage.2015.7413827; Mathys Aurore, 2013, 2013 Digital Heritage International Congress (DigitalHeritage). Federating the 19th Int'I VSMM, 10th Eurographics GCH, & 2nd UNESCO Memory of the World Conferences, plus special sessions from CAA, Arqueologico 2.0, Space2Place, ICOMOS ICIP & CIPA, EU projects, et al. Proceedings, P201; Mathys A, 2014, EUROMED 2014 DIGITAL, P17; Mitchell H. L., 2008, INT ARCH PHOTOGRAMME, VXXXVII, P779; de Almeida VM, 2017, COL DEVEL CULT HERIT, P3; Munoz-Munoz F, 2016, J ZOOL SYST EVOL RES, V54, P318, DOI 10.1111/jzs.12137; Nikonenko NA, 2015, OPTICAL PROPERTIES S; Nocerino E., 2018, INT ARCH PHOTOGRAMME, V42, P773, DOI [10.5194/isprs, DOI 10.5194/ISPRS]; Orban R, 2006, B ARCHEOLOGIQUE PROV, V2006, P79; Pamart A, 2017, INT ARCH PHOTOGRAMM, V42-2, P559, DOI 10.5194/isprs-archives-XLII-2-W3-559-2017; Porter S., 2016, COMPUTER APPL QUANTI; Rougier H, 2012, SPY CAVE 125 YEARS M, V1, P123; Salgado C.M., 2016, SECONDARY ANAL ELECT, P163, DOI [10.1007/978-3-319-43742-2_14.2, DOI 10.1007/978-3-319-43742-2_14.2, DOI 10.1007/978-3-319-43742-2_14]; Tsiafaki D, 2016, VIRTUAL ARCHAEOL REV, V7, P67, DOI 10.4995/var.2016.5910; Tucci G, 2011, INT ARCH PHOTOGRAMM, V38-5, P413; VALINASAB B., 2015, J KOREAN SOC MANUF T, V24, P23, DOI [DOI 10.7735/KSMTE.2015.24.1.023, 10.7735/ksmte.2015.24.1.023]; Vautherin J, 2016, ISPRS ANN PHOTO REM, V3, P139, DOI 10.5194/isprsannals-III-3-139-2016; Wachowiak MJ, 2009, J AM INST CONSERV, V48, P141, DOI 10.1179/019713609804516992; Webb EK, 2017, J AM INST CONSERV, V56, P211, DOI 10.1080/01971360.2017.1359463; Weyrich T, 2004, SPBG 04 S POINT BAS, P85, DOI [10.2312/SPBG/SPBG04/085-094, DOI 10.2312/SPBG/SPBG04/085-094]; Zijp J.R., 2001, OPTICAL PROPERTIES D	48	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220949	10.1371/journal.pone.0220949	http://dx.doi.org/10.1371/journal.pone.0220949			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408481	Green Submitted, Green Published, gold			2022-12-27	WOS:000485009500028
J	Buunk, AM; Spikman, JM; Metzemaekers, JDM; van Dijk, JMC; Groen, RJM				Buunk, Anne M.; Spikman, Jacoba M.; Metzemaekers, Jan D. M.; van Dijk, J. Marc C.; Groen, Rob J. M.			Return to work after subarachnoid hemorrhage: The influence of cognitive deficits	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; TRAUMATIC BRAIN-INJURY; LONG-TERM OUTCOMES; QUALITY-OF-LIFE; REINTEGRATION; SATISFACTION; IMPAIRMENTS; DEPRESSION	Introduction Cognitive deficits are frequently found after subarachnoid hemorrhage (SAH), but their influence on return to work is largely unknown. To improve identification of those patients at-risk for long-term return to work problems, we aimed to examine the value of cognitive deficits in the prediction of long-term return to work after subarachnoid hemorrhage. Methods SAH patients (N = 71) who were employed before SAH and were able to undergo neuropsychological assessment, were included. Demographic characteristics and acute SAH-related variables (SAH-type and external cerebrospinal fluid drainage) were taken into account. Neuropsychological tests for memory, speed, attention, executive function, and emotion recognition and a questionnaire for executive functions were used. Return to work was assessed using the Role Resumption List. Results Results showed that patients with incomplete return to work had significantly lower scores on neuropsychological measures for complex attention and executive functions (p < 0.05) compared to patients with complete return to work. Return to work could not be significantly predicted using only demographic characteristics and acute SAH-related variables, but adding measures of complex attention and executive functions resulted in a prognostic model that could reliably distinguish between complete and incomplete return to work. Statistically significant predictors in the final model were cerebrospinal fluid drainage and scores on a questionnaire for executive functions: patients with cerebrospinal fluid drainage and higher scores on the a questionnaire for executive functions were less likely to return to work. Discussion Together, these findings show that neuropsychological measures, especially for complex attention and executive functions, have added value to acute SAH-related and demographic variables in the prediction of long-term return to work after SAH.	[Buunk, Anne M.; Spikman, Jacoba M.] Univ Groningen, Subdept Neuropsychol, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands; [Metzemaekers, Jan D. M.; van Dijk, J. Marc C.; Groen, Rob J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands	University of Groningen; University of Groningen	Buunk, AM (corresponding author), Univ Groningen, Subdept Neuropsychol, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands.	a.m.buunk@umcg.nl	van Dijk, J. Marc C./C-1078-2013	van Dijk, J. Marc C./0000-0002-0814-5680; Spikman, Jacoba/0000-0002-6477-0763; Groen, Rob J.M./0000-0003-3067-763X	charitable foundation Catharina Heerdt	charitable foundation Catharina Heerdt	This study was funded by the charitable foundation Catharina Heerdt to JMS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Alfieri A, 2011, J CLIN NEUROSCI, V18, P1478, DOI 10.1016/j.jocn.2011.02.036; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Blonder LX, 2012, J CLIN EXP NEUROPSYC, V34, P634, DOI 10.1080/13803395.2012.667069; Boerboom W, 2014, J REHABIL MED, V46, P28, DOI 10.2340/16501977-1236; Buunk AM, 2016, NEUROPSYCHOLOGY; Buunk AM, 2017, NEUROPSYCHOLOGIA, V103, P131, DOI 10.1016/j.neuropsychologia.2017.07.015; CANHAO P, 1995, ACTA NEUROCHIR, V132, P14, DOI 10.1007/BF01404842; Carter BS, 2000, NEUROSURGERY, V46, P1326, DOI 10.1097/00006123-200006000-00008; Deelman B.G., 1980, NEUROPSYCHOLOGIE NED; Degos V, 2012, ANESTHESIOLOGY, V117, P1289, DOI 10.1097/ALN.0b013e318267395b; Doerfler S, 2018, WORLD NEUROSURG, V114, pE483, DOI 10.1016/j.wneu.2018.02.195; Dupont S, 2013, NEUROL RES, V35, P107, DOI 10.1179/1743132812Y.0000000122; Edwards JD, 2018, INT J STROKE, V13, P243, DOI 10.1177/1747493017743059; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Golden C.J., 1978, STROOP COLOR WORD TE; Hedlund M, 2011, BRIT J NEUROSURG, V25, P693, DOI 10.3109/02688697.2011.578769; HUTTER BO, 1993, NEUROSURGERY, V33, P999; HUTTER BO, 1994, ACTA NEUROCHIR, V127, P129, DOI 10.1007/BF01808755; HUTTER BO, 1995, J CLIN EXP NEUROPSYC, V17, P499, DOI 10.1080/01688639508405141; Kauranen T, 2013, J NEUROL NEUROSUR PS, V84, P316, DOI 10.1136/jnnp-2012-302629; Kollegger H, 1989, Int Disabil Stud, V11, P57; Konczalla J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-140; Lago A, 2016, NEUROL RES, V38, P692, DOI 10.1080/01616412.2016.1200306; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Mani K, 2017, WORK, V58, P51, DOI 10.3233/WOR-172597; Morris PG, 2004, NEUROSURGERY, V54, P47, DOI 10.1227/01.NEU.0000097198.94828.E1; Passier PECA, 2011, J STROKE CEREBROVASC, V20, P324, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.001; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Sonesson B, 2018, J NEUROSURG, V128, P785, DOI 10.3171/2016.11.JNS16805; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2010, J NEUROTRAUM, V27, P1195, DOI 10.1089/neu.2010.1277; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stienen MN, 2014, WORLD NEUROSURG; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taufique Z, 2016, NEUROSURGERY, V78, P256, DOI 10.1227/NEU.0000000000001042; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; van der Kemp J, 2019, NEUROPSYCHOL REHABIL, V29, P638, DOI 10.1080/09602011.2017.1313746; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Verhage F., 1964, INTELLIGENTIE LEEFTI; Vilkki JS, 2004, NEUROSURGERY, V55, P790, DOI 10.1227/01.NEU.0000137629.17424.6D; Vilkki J, 2012, ACTA NEUROCHIR, V154, P1437, DOI 10.1007/s00701-012-1417-y; Wallmark S, 2016, ACTA NEUROCHIR, V158, P233, DOI 10.1007/s00701-015-2665-4; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; Young AW, 2002, FACIAL EXPRESSIONS E	49	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220972	10.1371/journal.pone.0220972	http://dx.doi.org/10.1371/journal.pone.0220972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398223	Green Published, gold, Green Submitted			2022-12-27	WOS:000485004000033
J	Li, J; Zhu, XD; Wang, HS; Lee, CP; Chen, SJ; Qian, YY; Han, M; Bunney, R; Beiser, DG; Hoek, TLV				Li, Jing; Zhu, Xiangdong; Wang, Huashan; Lee, Chunpei; Chen, Sy-Jou; Qian, Yuanyu; Han, Mei; Bunney, Ryan; Beiser, David G.; Hoek, Terry L. Vanden			Akt1-mediated CPR cooling protection targets regulators of metabolism, inflammation and contractile function in mouse cardiac arrest	PLOS ONE			English	Article							FACTOR-KAPPA-B; THERAPEUTIC HYPOTHERMIA CARDIOPROTECTION; PYRUVATE-DEHYDROGENASE COMPLEX; MILD HYPOTHERMIA; AKT; RESUSCITATION; ACTIVATION; INHIBITION; HEART; PHOSPHOLAMBAN	Therapeutic hypothermia initiated during cardiopulmonary resuscitation (CPR) in pre-clinical studies appears to be highly protective against sudden cardiac arrest injury. Given the challenges to implementing CPR cooling clinically, insights into its critical mechanisms of protection could guide development of new CPR drugs that mimic hypothermia effects without the need for physical cooling. Here, we used Akt1-deficient mice that lose CPR hypothermia protection to identify hypothermia targets. Adult female C57BL/6 mice (Akt1(+/+) and Akt1(+/-)) underwent 8 min of KCl-induced asystolic arrest and were randomized to receive hypothermia (30 +/- 0.5 degrees C) or normothermia. Hypothermia was initiated during CPR and extended for 1 h after resuscitation. Neurologically scored survival was measured at 72 h. Other outcomes included mean arterial pressure and target measures in heart and brain related to contractile function, glucose utilization and inflammation. Compared to northothermia, hypothermia improved both 2h mean arterial pressure and 72h neurologically intact survival in Akt1(+/+) mice but not in Akt1(+/-) mice. In Akt1(+/+) mice, hypothermia increased Akt and GSK3 beta phosphorylation, pyruvate dehydrogenase activation, and NAD(+) and ATP production while decreasing I kappa B alpha degradation and NF-kappa B activity in both heart and brain at 30 min after CPR. It also increased phospholamban phosphorylation in heart tissue. Further, hypothermia reduced metabolic and inflammatory blood markers lactate and Pre-B cell Colony Enhancing Factor. Despite hypothermia treatment, all these effects were reversed in Akt1(+/-) mice. Taken together, drugs that target Akt1 and its effectors may have the potential to mimic hypothermia-like protection to improve sudden cardiac arrest survival when administered during CPR.	[Li, Jing; Zhu, Xiangdong; Wang, Huashan; Lee, Chunpei; Chen, Sy-Jou; Qian, Yuanyu; Bunney, Ryan; Hoek, Terry L. Vanden] Univ Illinois Hosp & Hlth Sci Syst, Ctr Adv Resuscitat Med, Ctr Cardiovasc Res, Chicago, IL 60612 USA; [Li, Jing; Zhu, Xiangdong; Wang, Huashan; Lee, Chunpei; Chen, Sy-Jou; Qian, Yuanyu; Bunney, Ryan; Hoek, Terry L. Vanden] Univ Illinois Hosp & Hlth Sci Syst, Dept Emergency Med, Chicago, IL 60612 USA; [Chen, Sy-Jou] Triserv Gen Hosp, Dept Emergency Med, Natl Def Med Ctr, Taipei, Taiwan; [Qian, Yuanyu] Chinese Peoples Liberat Army Gen Hosp, Emergency Dept, Beijing, Peoples R China; [Han, Mei; Beiser, David G.] Univ Chicago, Dept Med, Sect Emergency Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	National Defense Medical Center; Tri-Service General Hospital; Chinese People's Liberation Army General Hospital; University of Chicago	Hoek, TLV (corresponding author), Univ Illinois Hosp & Hlth Sci Syst, Ctr Adv Resuscitat Med, Ctr Cardiovasc Res, Chicago, IL 60612 USA.; Hoek, TLV (corresponding author), Univ Illinois Hosp & Hlth Sci Syst, Dept Emergency Med, Chicago, IL 60612 USA.	tvh@uic.edu		wang, huashan/0000-0002-3662-1576; Beiser, David/0000-0001-9676-087X	National Institute of General Medical Sciences [1R01 GM120485]; National Heart, Lung, and Blood Institute [K08-HL-091184, 1R01HL147031-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL147031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120485] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences, http://dx.doi.org/10.13039/100000057, 1R01 GM120485, to Dr Terry L. Vanden Hoek; National Heart, Lung, and Blood Institute, http://dx.doi.org/10.13039/100000050, K08-HL-091184, to Dr. David G. Beiser; and National Heart, Lung and Blood Institute, 1R01HL147031-01, to Dr Terry L. Vanden Hoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella BS, 2004, CIRCULATION, V109, P2786, DOI 10.1161/01.CIR.0000131940.19833.85; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; ALOIA RC, 1989, BIOCHIM BIOPHYS ACTA, V988, P123, DOI 10.1016/0304-4157(89)90007-5; Anthonsen MW, 2001, J BIOL CHEM, V276, P35344, DOI 10.1074/jbc.M105264200; Beeson CC, 2012, J VASC RES, V49, P89, DOI 10.1159/000332326; Beiser DG, 2011, RESUSCITATION, V82, P115, DOI 10.1016/j.resuscitation.2010.08.038; Beiser DG, 2010, AM J PHYSIOL-HEART C, V298, pH1761, DOI 10.1152/ajpheart.00187.2010; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Cai LP, 2016, J NEUROSCI RES, V94, P749, DOI 10.1002/jnr.23740; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; Catalucci D, 2009, J BIOL CHEM, V284, P28180, DOI 10.1074/jbc.M109.036566; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Diestel A, 2008, CRYOBIOLOGY, V57, P216, DOI 10.1016/j.cryobiol.2008.08.005; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; HENDRICKX HHL, 1984, RESUSCITATION, V12, P117, DOI 10.1016/0300-9572(84)90063-7; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; Jones AE, 2004, SHOCK, V22, P410, DOI 10.1097/01.shk.0000142186.95718.82; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Katome T, 2003, J BIOL CHEM, V278, P28312, DOI 10.1074/jbc.M302094200; Ketzer LA, 2009, AM J PHYSIOL-HEART C, V297, pH556, DOI 10.1152/ajpheart.00302.2009; Kilgannon JH, 2008, RESUSCITATION, V79, P410, DOI 10.1016/j.resuscitation.2008.07.019; Kloner RA, 2001, CIRCULATION, V104, P2981, DOI 10.1161/hc4801.100038; KUSUOKA H, 1991, AM J PHYSIOL, V261, pH1005, DOI 10.1152/ajpheart.1991.261.4.H1005; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; LEWANDOWSKI ED, 1995, CIRCULATION, V91, P2071, DOI 10.1161/01.CIR.91.7.2071; Li J, 2015, AM J PHYSIOL-HEART C, V308, pH1414, DOI 10.1152/ajpheart.00748.2014; Li J, 2014, CRIT CARE MED, V42, pE734, DOI 10.1097/CCM.0000000000000656; Li J, 2011, J TRAUMA, V71, P1262, DOI 10.1097/TA.0b013e31821280c5; Li J, 2011, J NEUROTRAUM, V28, P1281, DOI 10.1089/neu.2011.1751; Lim CM, 2004, INTENS CARE MED, V30, P1638, DOI 10.1007/s00134-004-2336-z; Luthra P, 2008, J VIROL, V82, P10887, DOI 10.1128/JVI.00806-08; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Ning XH, 1998, AM J PHYSIOL-HEART C, V274, pH786, DOI 10.1152/ajpheart.1998.274.3.H786; NISHIJIMA MK, 1989, AM J PHYSIOL, V257, pH1860, DOI 10.1152/ajpheart.1989.257.6.H1860; Nishimura Yoshiharu, 2005, Interact Cardiovasc Thorac Surg, V4, P101, DOI 10.1510/icvts.2004.097188; Piao L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185046; Post H, 2010, ACTA PHYSIOL, V199, P43, DOI 10.1111/j.1748-1716.2010.02083.x; Randle P J, 1981, Curr Top Cell Regul, V18, P107; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Shao ZH, 2010, AM J PHYSIOL-HEART C, V298, pH2164, DOI 10.1152/ajpheart.00994.2009; Sharp WW, 2014, FASEB J, V28, P316, DOI 10.1096/fj.12-226225; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Stowe DF, 1999, AM J PHYSIOL-HEART C, V277, pH2321, DOI 10.1152/ajpheart.1999.277.6.H2321; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; TANI M, 1989, CIRC RES, V65, P1045, DOI 10.1161/01.RES.65.4.1045; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Webster CM, 2009, NEUROBIOL DIS, V33, P301, DOI 10.1016/j.nbd.2008.11.001; Yannopoulos D, 2009, CIRCULATION, V120, P1426, DOI 10.1161/CIRCULATIONAHA.109.848424; YATVIN MB, 1980, INT J RADIAT BIOL, V37, P513, DOI 10.1080/09553008014550641; Zhao TC, 2001, CIRC RES, V89, P915, DOI 10.1161/hh2201.099452; Zhu XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095622	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220604	10.1371/journal.pone.0220604	http://dx.doi.org/10.1371/journal.pone.0220604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398213	Green Published, gold, Green Submitted			2022-12-27	WOS:000485004000011
J	Ogawa, Y; Takahashi, N; Takemoto, T; Nishiume, T; Suzuki, M; Ishiguro, N; Kojima, T				Ogawa, Yoshikazu; Takahashi, Nobunori; Takemoto, Toki; Nishiume, Tsuyoshi; Suzuki, Mochihito; Ishiguro, Naoki; Kojima, Toshihisa			Hyaluronan promotes TRPV4-induced chondrogenesis in ATDC5 cells	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; NF-KAPPA-B; DOWN-REGULATION; ACID INCREASES; TRPV4; CHONDROCYTES; EXPRESSION; ACTIVATION; RECEPTOR; KINASE	Hyaluronan (HA) is an extracellular matrix glycosaminoglycan essential for the homeostasis of cartilage-related tissues. Intracellular adhesion molecule-1 (ICAM-1) and CD44 have been identified as receptors for HA. Recently, transient receptor potential vanilloid 4 (TRPV4) has emerged as a potential research target in several areas of physiology. TRPV4 is a Ca2+-permeable, non-selective cation channel that appears to have mechanosensory or osmosensory roles in several musculoskeletal tissues. HA and TRPV4 play key roles in chondrogenesis; however, it has remained unclear whether they have interactive effects on chondrogenesis and, if so, how do they interact with each other? This study investigated the relationship between HA, its receptors ICAM-1 and CD44, and TRPV4 in the chondrogenic pathway using the ATDC5 cell line. It was found that the presence of HA is required for TRPV4-induced chondrogenesis. Loss of HA suppressed TRPV4-induced expression of the chondrogenic markers, SOX9 and Aggrecan. Moreover, HA affects TRPV4-induced chondrogenic development via each of ICAM-1 and CD44 partially. In conclusion, for the first time, the existence of an interaction between HA, its receptor ICAM-1 and CD44, and TRPV4-activity in chondrogenesis in the ATDC5 cell line was reported. TRPV4 is known to function as a mechanosensory channel in several musculoskeletal tissues. Therefore, findings of this study may suggest the existence of a molecular mechanism that underlies the interactive effects of HA and mechanical loading on joint chondrogenesis.	[Ogawa, Yoshikazu; Takahashi, Nobunori; Takemoto, Toki; Nishiume, Tsuyoshi; Suzuki, Mochihito; Ishiguro, Naoki; Kojima, Toshihisa] Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi, Japan	Nagoya University	Takahashi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Orthopaed Surg, Showa Ku, Nagoya, Aichi, Japan.	nobunori@med.nagoya-u.ac.jp			JSPS KAKENHI [16K10897]; Seikagaku Corporation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Seikagaku Corporation	This work was supported by JSPS KAKENHI Grant Number 16K10897. Seikagaku Corporation has provided research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala RK, 2016, ONCOGENE, V35, P314, DOI 10.1038/onc.2015.83; Addison MP, 2016, PHARMACOL REP, V68, P620, DOI 10.1016/j.pharep.2016.01.003; Ariyoshi W, 2014, OSTEOARTHR CARTILAGE, V22, P111, DOI 10.1016/j.joca.2013.10.013; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; Chan DD, 2015, OSTEOARTHR CARTILAGE, V23, P1879, DOI 10.1016/j.joca.2015.06.021; DAVIES ME, 1991, CONNECT TISSUE RES, V26, P207, DOI 10.3109/03008209109152439; Fukui T, 2014, J MATER SCI-MATER M, V25, P1173, DOI 10.1007/s10856-013-5139-3; Guilak F, 2010, ANN NY ACAD SCI, V1192, P404, DOI 10.1111/j.1749-6632.2010.05389.x; Hirabara S, 2013, BIOCHEM BIOPH RES CO, V430, P519, DOI 10.1016/j.bbrc.2012.12.003; Hiramitsu T, 2006, RHEUMATOLOGY, V45, P824, DOI 10.1093/rheumatology/kel026; JIAO Q, 2015, BIOMARKERS, P1, DOI DOI 10.3109/1354750X.2015.1118547.PMID:26634947; Jin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016713; Lessey-Morillon EC, 2014, J IMMUNOL, V192, P3390, DOI 10.4049/jimmunol.1302525; LEV R, 1964, J HISTOCHEM CYTOCHEM, V12, P309, DOI 10.1177/12.4.309; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Lo WC, 2013, BIOMATERIALS, V34, P4739, DOI 10.1016/j.biomaterials.2013.03.016; Lu XW, 2015, GLYCOCONJUGATE J, V32, P549, DOI 10.1007/s10719-015-9597-3; MCCOURT PAG, 1994, J BIOL CHEM, V269, P30081; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Mongkhon JM, 2014, INFLAMM RES, V63, P691, DOI 10.1007/s00011-014-0742-4; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; O'Conor CJ, 2014, P NATL ACAD SCI USA, V111, P1316, DOI 10.1073/pnas.1319569111; Onodera Y, 2015, FEBS OPEN BIO, V5, P476, DOI 10.1016/j.fob.2015.05.007; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Sanchez JC, 2014, CELL CALCIUM, V56, P493, DOI 10.1016/j.ceca.2014.10.006; Sato E, 2014, J ORTHOP RES, V32, P1619, DOI 10.1002/jor.22691; Scheraga RG, 2016, J IMMUNOL, V196, P428, DOI 10.4049/jimmunol.1501688; Takahashi N, 2015, RHEUMATOL INT, V35, P1707, DOI 10.1007/s00296-015-3283-4; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xu T, 2012, INT J MOL MED, V30, P1119, DOI 10.3892/ijmm.2012.1107; Yasuda T, 2007, INFLAMM RES, V56, P246, DOI 10.1007/s00011-007-6168-5; Yasuda T, 2012, J PHARMACOL SCI, V118, P25, DOI 10.1254/jphs.11044FP; Yasuda T, 2010, CLIN RHEUMATOL, V29, P1259, DOI 10.1007/s10067-010-1512-5; Yatabe T, 2009, ANN RHEUM DIS, V68, P1051, DOI 10.1136/ard.2007.086884; Zhang LP, 2015, NEUROSCIENCE, V311, P166, DOI 10.1016/j.neuroscience.2015.10.028	37	6	8	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219492	10.1371/journal.pone.0219492	http://dx.doi.org/10.1371/journal.pone.0219492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393869	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500011
J	Vaccani, AC; Freret-Meurer, NV; Bertoncini, AA; Santos, LN				Vaccani, Amanda C.; Freret-Meurer, Natalie V.; Bertoncini, Athila A.; Santos, Luciano N.			Shining in the dark: First record of biofluorescence in the seahorse Hippocampus reidi	PLOS ONE			English	Article							FLUORESCENCE	Marine environments are visual domains restricted regarding light characteristics. Overall, blue monochromatic spectrum prevails in offshore areas especially below 15m depth, since long wavelengths are quickly attenuated. Light intensity is even more constrained in coastal waters, particularly those of tropical estuaries and bays, because further scattering through dissolved and suspended materials. Biofluorescence, which is the ability of organisms to absorb light and reflect it in a different wavelength, has been reported for many marine fish. In this paper, biofluorescence was recorded for the first time for the longsnout seahorse Hippocampus reidi, under natural conditions at Ilha Grande bay, Brazil, and both adult, juvenile and fry individuals kept in captivity. Although displaying the same colour emissions, sea-horses differed in relation to body lighting, colour patterns, and age wherein fluorescence occurs. Newborn seahorses exhibit green biofluorescence only in the eyes and stomach. Further experiments are necessary to address whether H. reidi can change the patterns of biofluorescence emission for sensorial and social purposes.	[Vaccani, Amanda C.; Bertoncini, Athila A.; Santos, Luciano N.] Univ Fed Estado Rio de Janeiro, Dept Ecol & Recursos Marinhos, Rio De Janeiro, RJ, Brazil; [Vaccani, Amanda C.; Freret-Meurer, Natalie V.] Univ Santa Ursula, Inst Biol, Rio De Janeiro, RJ, Brazil; [Vaccani, Amanda C.; Freret-Meurer, Natalie V.] Univ Santa Ursula, Lab Comportamento Anim & Conservacao, Rio De Janeiro, RJ, Brazil; [Bertoncini, Athila A.; Santos, Luciano N.] Univ Fed Estado Rio de Janeiro, Lab Ictiol Teor & Aplicada, Rio De Janeiro, RJ, Brazil	Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro	Santos, LN (corresponding author), Univ Fed Estado Rio de Janeiro, Dept Ecol & Recursos Marinhos, Rio De Janeiro, RJ, Brazil.; Santos, LN (corresponding author), Univ Fed Estado Rio de Janeiro, Lab Ictiol Teor & Aplicada, Rio De Janeiro, RJ, Brazil.	luciano.santos@unirio.br	Santos, Luciano/M-4377-2015; Bertoncini, Athila/B-3640-2013	Santos, Luciano/0000-0002-5279-5672; Vaccani, Amanda/0000-0001-7900-575X; Bertoncini, Athila/0000-0002-6310-0127	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/202.840/2015, E-26/202.755/2018]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [314379/2018-5]; CAPES - Coordenacao de aperfeicoamento de pessoal de nivel superior	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES - Coordenacao de aperfeicoamento de pessoal de nivel superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Research Grant to LNS, E-26/202.840/2015; E-26/202.755/2018) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Research Grant to LNS, ref. 314379/2018-5). This work was also supported by CAPES - Coordenacao de aperfeicoamento de pessoal de nivel superior (https://www.capes.gov.br/) to AV. The funder had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, LIST THREATENED SPEC; Anthes N, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00126; Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92; De Brauwer M, 2018, CONSERV BIOL, V32, P706, DOI 10.1111/cobi.13033; Gerlach T, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0145-1; Gruber DF, 2016, SCI REPORTS, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Haddock SHD, 2005, SCI BLUE WATER DIVIN; Haddock SHD, 2010, P ROY SOC B-BIOL SCI, V277, P1155, DOI 10.1098/rspb.2009.1774; IUCN, 2010, RED LIST THREATENED; Kalb N, 2015, ETHOLOGY, V121, P566, DOI 10.1111/eth.12367; Kirk J.T.O., 2011, LIGHT PHOTOSYNTHESIS; Lourie S. A., 1999, SEAHORSES IDENTIFICA; Lourie SA, 2016, ZOOTAXA, V4146, P1, DOI 10.11646/zootaxa.4146.1.1; Mazel CH, 2004, SCIENCE, V303, P51, DOI 10.1126/science.1089803; Meadows MG, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1211; Michiels Nico K., 2008, BMC Ecology, V8, P16, DOI 10.1186/1472-6785-8-16; Sparks JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083259; Wucherer MF, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-1; Wucherer MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037913; Zhang YH, 2016, ZOOTAXA, V4170, P384, DOI 10.11646/zootaxa.4170.2.11	20	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220561	10.1371/journal.pone.0220561	http://dx.doi.org/10.1371/journal.pone.0220561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393893	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500040
J	Wang, H; Snapp, SS; Fisher, M; Viens, F				Wang, Han; Snapp, Sieglinde S.; Fisher, Monica; Viens, Frederi			A Bayesian analysis of longitudinal farm surveys in Central Malawi reveals yield determinants and site-specific management strategies	PLOS ONE			English	Article							SOIL FERTILITY; MAIZE YIELD; GAPS; INTENSIFICATION; INFESTATION; CLIMATE; SYSTEMS; WHEAT; FIELD	Understanding the challenges to increasing maize productivity in sub-Saharan Africa, especially agronomic factors that reduce on-farm crop yield, has important implications for policies to reduce national and global food insecurity. Previous research on the maize yield gap has tended to emphasize the size of the gap (theoretical vs. achievable yields), rather than what determines maize yield in specific contexts. As a result, there is insufficient evidence on the key agronomic and environmental factors that influence maize yield in a smallholder farm environment. In this study, we implemented a Bayesian analysis with plot-level longitudinal household survey data covering 1,197 plots and 320 farms in Central Malawi. Households were interviewed and monitored three times per year, in 2015 and 2016, to document farmer management practices and seasonal rainfall, and direct measurements were taken of plant and soil characteristics to quantify impact on plot-level maize yield stability. The results revealed a high positive association between a leaf chlorophyll indicator and maize yield, with significance levels exceeding 95% Bayesian credibility at all sites and a regression coefficient posterior mean from 28% to 42% on a relative scale. A parasitic weed, Striga asiatica, was the variable most consistently negatively associated with maize yield, exceeding 95% credibility in most cases, of high intensity, with regression means ranging from 23% to 38% on a relative scale. The influence of rainfall, either directly or indirectly, varied by site and season. We conclude that the factors preventing Striga infestation and enhancing nitrogen fertility will lead to higher maize yield in Malawi. To improve plant nitrogen status, fertilizer was effective at higher productivity sites, whereas soil carbon and organic inputs were important at marginal sites. Uniquely, a Bayesian approach allowed differentiation of response by site for a relatively modest sample size study (given the complexity of farm environments and management practices). Considering the biophysical constraints, our findings highlight management strategies for crop yields, and point towards area-specific recommendations for nitrogen management and crop yield.	[Wang, Han; Viens, Frederi] Michigan State Univ, Dept Stat & Probabil, E Lansing, MI 48824 USA; [Snapp, Sieglinde S.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Fisher, Monica] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya	Michigan State University; Michigan State University; International Centre of Insect Physiology & Ecology (ICIPE)	Snapp, SS (corresponding author), Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA.	snapp@msu.edu	Snapp, Sieglinde/AAU-8121-2020; Snapp, Sieg/GWQ-5774-2022	Snapp, Sieglinde/0000-0002-9738-0649; Fisher, Monica/0000-0002-6669-6261; Viens, Frederi/0000-0001-9162-8212	International Institute for Tropical Agriculture [AID-OAA-A-13-00006]; Michigan State University	International Institute for Tropical Agriculture; Michigan State University	This work originates from United States Agency for International Development (USAID) Grant AID-OAA-A-13-00006 entitled Africa RISING (Research In Sustainable Intensification for the Next Generation, https://africa-rising.net/category/partners/iita/), supported by the International Institute for Tropical Agriculture through a grant to SS, with support from Michigan State University. The funders had no role in study design, data collection, data analysis, decision to publish or manuscript preparation.	[Anonymous], 2012, MAL GOV GUID AGR PRO; Atera E. A., 2012, Journal of Agricultural Science (Toronto), V4, P41, DOI 10.5539/jas.v4n5p41; Baldos ULC, 2018, AM J AGR EC; Barboza L, 2014, ANN APPL STAT, V8, P1966, DOI 10.1214/14-AOAS785; Batie S.S, 2008, WICKED PROBLEMS APPL; BERNER DK, 1995, PLANT DIS, V79, P652, DOI 10.1094/PD-79-0652; Beukes I, 2017, S AFR J SCI, V113, DOI 10.17159/sajs.2017/20160121; Clarke DJM, 2012, INDEX BASED CROP INS; Culman SW, 2012, SOIL SCI SOC AM J, V76, P494, DOI 10.2136/sssaj2011.0286; DIACONIS P, 1979, ANN STAT, V7, P269, DOI 10.1214/aos/1176344611; Dunson DB, 2001, AM J EPIDEMIOL, V153, P1222, DOI 10.1093/aje/153.12.1222; Fermont AM, 2009, FIELD CROP RES, V112, P24, DOI 10.1016/j.fcr.2009.01.009; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gine X, 2007, STAT ANAL RAINFALL I; Haller H., 2002, METHODS PSYCHOL RES, V7, P1, DOI DOI 10.1119/1.2343497; Hoffmann MP, 2018, AGR SYST, V159, P199, DOI 10.1016/j.agsy.2017.03.012; Jamil M, 2012, FIELD CROP RES, V134, P1, DOI 10.1016/j.fcr.2012.03.015; Kabambe V. H., 2008, Bunda Journal of Agriculture, Environmental Science and Technology, V3, P35; Kamara AY, 2014, AGR ECOSYST ENVIRON, V188, P111, DOI 10.1016/j.agee.2014.02.027; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Liu ZJ, 2012, GLOBAL CHANGE BIOL, V18, P3441, DOI 10.1111/j.1365-2486.2012.02774.x; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2005, AGRON J, V97, P241; Loh CE, 2018, R CRIT STUD ASIAN ED, P1; Lowole M., 1983, SOIL MAP MALAWI; Marenya PP, 2009, AM J AGR ECON, V91, P991, DOI 10.1111/j.1467-8276.2009.01313.x; McShane BB, 2017, J AM STAT ASSOC, V112, P885, DOI 10.1080/01621459.2017.1289846; Michler JD, 2015, 2015 AGR APPL EC ASS; Mungai LM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01720; Musumba M., 2017, SUSTAINABLE INTENSIF; Prost L, 2008, ECOL MODEL, V219, P66, DOI 10.1016/j.ecolmodel.2008.07.026; Sauer J, 2009, REV AGR ECON, V31, P535, DOI 10.1111/j.1467-9353.2009.01452.x; Sauerborn J, 2003, APPL SOIL ECOL, V23, P181, DOI 10.1016/S0929-1393(03)00023-4; Scharf PC, 2002, AGRON J, V94, P435; Shaxson L, 1998, OUTLOOK AGR, V27, P101, DOI 10.1177/003072709802700207; Smith A, 2016, AGR SYST, V145, P139, DOI 10.1016/j.agsy.2016.03.008; Snapp SS, 2018, AGR SYST, V162, P77, DOI 10.1016/j.agsy.2018.01.012; Snapp SS, 2003, FOOD POLICY, V28, P349, DOI 10.1016/j.foodpol.2003.08.002; Snapp SS, 1998, COMMUN SOIL SCI PLAN, V29, P2571, DOI 10.1080/00103629809370135; Stuart AM, 2016, FIELD CROP RES, V194, P43, DOI 10.1016/j.fcr.2016.04.039; Tamene L, 2016, NUTR CYCL AGROECOSYS, V105, P291, DOI 10.1007/s10705-015-9692-7; Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007; van Bussel LGJ, 2015, FIELD CROP RES, V177, P98, DOI 10.1016/j.fcr.2015.03.005; van Dijk M, 2017, AGR SYST, V154, P90, DOI 10.1016/j.agsy.2017.03.004; van Ittersum MK, 2013, FIELD CROP RES, V143, P4, DOI 10.1016/j.fcr.2012.09.009; van Vugt D, 2018, FIELD CROP RES, V221, P245, DOI 10.1016/j.fcr.2017.11.028; Wooldridge JM, 2013, INTRO ECONOMETRICS M, V5th; Zhang ZY, 2007, INT J BEHAV DEV, V31, P374, DOI 10.1177/0165025407077764	49	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219296	10.1371/journal.pone.0219296	http://dx.doi.org/10.1371/journal.pone.0219296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393872	gold, Green Submitted, Green Published			2022-12-27	WOS:000485002500009
J	Rajamaki, ML; Lemmetty, A; Laamanen, J; Roininen, E; Vishwakarma, A; Streng, J; Latvala, S; Valkonen, JPT				Rajamaki, Minna-Liisa; Lemmetty, Anne; Laamanen, Jaana; Roininen, Elina; Vishwakarma, Archana; Streng, Janne; Latvala, Satu; Valkonen, Jari P. T.			Small-RNA analysis of pre-basic mother plants and conserved accessions of plant genetic resources for the presence of viruses	PLOS ONE			English	Article							YELLOW-NET-VIRUS; BUSHY-DWARF-VIRUS; BLACK-CURRANT; RT-PCR; MOTTLE-VIRUS; RUBUS-IDAEUS; HOST-RANGE; 1ST REPORT; RASPBERRY; SEQUENCE	Pathogen-free stocks of vegetatively propagated plants are crucial in certified plant production. They require regular monitoring of the plant germplasm for pathogens, especially of the stocks maintained in the field. Here we tested pre-basic mother plants of Fragaria, Rubus and Ribes spp., and conserved accessions of the plant genetic resources of Rubus spp. maintained at research stations in Finland, for the presence of viruses using small interfering RNA (siRNA) -based diagnostics (VirusDetect). The advance of the method is that unrelated viruses can be detected simultaneously without resumptions of the viruses present. While no virus was detected in pre-basic mother plants of Fragaria and Ribes species, rubus yellow net virus (RYNV) was detected in pre-basic mother plants of Rubus. Raspberry bushy dwarf virus (RBDV), black raspberry necrosis virus (BRNV), raspberry vein chlorosis virus (RVCV) and RYNV were detected in the Rubus genetic resource collection. The L polymerase encoding sequence characterized from seven RVCV isolates showed considerable genetic variation. The data provide the first molecular biological evidence for the presence of RYNV in Finland. RYNV was not revealed in virus indexing by indicator plants, which suggests that it may be endogenously present in some raspberry cultivars. In addition, a putative new RYNV-like badnavirus was detected in Rubus spp. Blackcurrant reversion virus (BRV) and gooseberry vein banding associated virus (GVBaV) were detected in symptomatic Ribes plants grown in the field. Results were consistent with those obtained using PCR or reverse transcription PCR and suggest that the current virus indexing methods of prebasic mother plants work as expected. Furthermore, many new viruses were identified in the collections of plant genetic resources not previously tested for viruses. In the future, siRNA-based diagnostics could be a useful supplement for the currently used virus detection methods in certified plant production and thus rationalize and simplify the current testing system.	[Rajamaki, Minna-Liisa; Roininen, Elina; Vishwakarma, Archana; Streng, Janne; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Lemmetty, Anne; Latvala, Satu] Nat Resources Inst Finland Luke, Jokioinen, Finland; [Laamanen, Jaana] Nat Resources Inst Finland Luke, Jyvaskyla, Finland	University of Helsinki; Natural Resources Institute Finland (Luke); Natural Resources Institute Finland (Luke)	Valkonen, JPT (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.; Laamanen, J (corresponding author), Nat Resources Inst Finland Luke, Jyvaskyla, Finland.	jaana.laamanen@luke.fi; jari.valkonen@helsinki.fi	Rajamäki, Minna-Liisa/AAY-5758-2020	Rajamäki, Minna-Liisa/0000-0002-7952-0433; Valkonen, Jari/0000-0002-3704-9911; Vishwakarma, Archana/0000-0002-4820-6468	Ministry of Agriculture and Forestry, Finland [1872/312/2012, 2221/03.01.02/2015]	Ministry of Agriculture and Forestry, Finland	This study was supported by Ministry of Agriculture and Forestry, Finland (grants 1872/312/2012 and 2221/03.01.02/2015 to JPTV); https://mmm.fi/en/about-the-site.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiewsakun P, 2015, VIROLOGY, V479, P26, DOI 10.1016/j.virol.2015.02.011; Anonymous, 2008, Bulletin OEPP, V38, P430, DOI 10.1111/j.1365-2338.2008.01259.x; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; BHAT AI, 2016, VIRUSES-BASEL, V8, DOI DOI 10.1111/J.1364-3703.2004.00217.X; Chang S., 1993, FRONT MICROBIOL, V11, P113, DOI 10.1007/BF02670468; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Diaz-Lara A, 2015, VIRUS GENES, V50, P104, DOI 10.1007/s11262-014-1149-6; DIAZLARA A, 2016, APS ANNUAL MEETING, V30, P3; Halgren A, 2007, PHYTOPATHOLOGY, V97, P44, DOI 10.1094/PHYTO-97-0044; HOHN T, 2008, SPRINGER, P54, DOI DOI 10.1016/J.VIROL.2015.02.011; HTTPS, DA; Isogai M, 2012, J GEN PLANT PATHOL, V78, P360, DOI 10.1007/s10327-012-0392-8; Jaakola L, 2010, PLANT CELL ENVIRON, V33, P1239, DOI 10.1111/j.1365-3040.2010.02154.x; Jones AT, 2000, EUR J PLANT PATHOL, V106, P623, DOI 10.1023/A:1008765819284; JONES AT, 1986, ANN APPL BIOL, V109, P323, DOI 10.1111/j.1744-7348.1986.tb05324.x; Jones AT, 2002, ANN APPL BIOL, V141, P1, DOI 10.1111/j.1744-7348.2002.tb00189.x; JONES AT, 1991, ANN APPL BIOL, V118, P331, DOI 10.1111/j.1744-7348.1991.tb05633.x; Kalischuk ML, 2008, PLANT DIS, V92, P974, DOI 10.1094/PDIS-92-6-0974A; Kalischuka ML, 2013, VIRUS RES, V178, P306, DOI 10.1016/j.virusres.2013.09.026; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kokko H, 1996, EUR J PLANT PATHOL, V102, P713, DOI 10.1007/BF01877253; Kokko HI, 1996, BIOTECHNIQUES, V20, P842; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LANGMEAD B, GENOME BIOL, P10, DOI DOI 10.1016/J.VIROL.2016.10.017; Latvala S, 1997, ANN APPL BIOL, V131, P283, DOI 10.1111/j.1744-7348.1997.tb05157.x; Lemmetty A, 2004, ACTA HORTIC, P115, DOI 10.17660/ActaHortic.2004.656.17; Lemmetty A, 1997, PHYTOPATHOLOGY, V87, P404, DOI 10.1094/PHYTO.1997.87.4.404; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Manduric S., 2017, NJF REPORT, V493; Maree HJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01082; Martin RR, 2013, PLANT DIS, V97, P168, DOI 10.1094/PDIS-04-12-0362-FE; Martin RR, 2004, ISHS ACTA HORT, V656, P199; McGavin WJ, 2011, PLANT PATHOL, V60, P462, DOI 10.1111/j.1365-3059.2010.02387.x; McGavin WJ, 2010, ARCH VIROL, V155, P1897, DOI 10.1007/s00705-010-0807-9; McMenemy LS, 2009, AGR FOREST ENTOMOL, V11, P61, DOI 10.1111/j.1461-9563.2008.00409.x; Nukari A, 2009, AGR FOOD SCI, V18, P117, DOI 10.2137/145960609789267506; OEPP/EPPO, 2009, B OEPP EPPO B, V39, P271; OEPP/EPPO, 2008, BULLETIN, V38, P14; Official Statistics of Finland (OSF), 2018, HORTICULTURAL STATIS; Olmos A., 2018, Bulletin OEPP, V48, P219, DOI 10.1111/epp.12472; Quito-Avila DF, 2012, J VIROL METHODS, V179, P38, DOI 10.1016/j.jviromet.2011.09.016; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith GR, 2017, AUSTRALAS PLANT PATH, V46, P277, DOI 10.1007/s13313-017-0489-9; SUSI H, 2018, ANN APPL BIOL; Susi P, 2004, MOL PLANT PATHOL, V5, P167, DOI 10.1111/J.1364-3703.2004.00217.X; TAPIO E, 1961, PUBLICATIONS OF THE, V184, P1, DOI DOI 10.1094/PDIS-92-6-0974A; Tapio E, 1961, THESIS, V184, P1; UOSUKAINEN M, 1988, ANN AGR FENN, V27, P209; Valasevich N, 2011, ARCH VIROL, V156, P369, DOI 10.1007/s00705-010-0912-9; Vappula N., 1962, ANN AGR FENN, V1, P124; Wang QC, 2005, PLANT CELL REP, V24, P280, DOI 10.1007/s00299-005-0936-x; Wang QC, 2008, MOL PLANT PATHOL, V9, P237, DOI [10.1111/j.1364-3703.2007.00456.x, 10.1111/J.1364-3703.2007.00456.X]; Xu DL, 2011, VIRUS GENES, V43, P130, DOI 10.1007/s11262-011-0614-8; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng Yanyan, VIROLOGY, V342, P150, DOI [10.1016/j.virol.2005.07.030, DOI 10.1016/J.VIROL.2005.07.030, DOI 10.1016/J.VIROL.2009.03.024]; Zheng Y, 2017, VIROLOGY, V500, P130, DOI 10.1016/j.virol.2016.10.017; ZIEGLER A, 1992, J GEN VIROL, V73, P3213, DOI 10.1099/0022-1317-73-12-3213	60	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220621	10.1371/journal.pone.0220621	http://dx.doi.org/10.1371/journal.pone.0220621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390343	Green Published, gold, Green Submitted			2022-12-27	WOS:000484999400022
J	Takacs, L; Smolik, F; Putnam, S				Takacs, Lea; Smolik, Filip; Putnam, Samuel			Assessing longitudinal pathways between maternal depressive symptoms, parenting self-esteem and infant temperament	PLOS ONE			English	Article							PERINATAL DEPRESSION; SOCIAL SUPPORT; POSTNATAL DEPRESSION; CHILDRENS BEHAVIOR; PERSONALITY-TRAITS; ANTENATAL ANXIETY; MOTHERS; EFFICACY; STRESS; POSTPARTUM	Background Previous studies of relations between parenting self-concepts, parental adjustment and child temperament have been ambiguous regarding the direction of influence; and have rarely followed families from pregnancy through the first year of life. The current study examines change and stability in maternal depressive symptoms, parenting competences and child temperament through the perinatal period until nine months postpartum. Methods Czech mothers (N = 282) participated at three time points: the third trimester of pregnancy (Time 1), six weeks (Time 2) and nine months postpartum (Time 3). Questionnaire data concerned depressive symptoms (T1, T2, T3), maternal parenting self-esteem (T1, T2) and sense of competence (T3), and child temperament (T2, T3). A path model was used to examine concurrent and longitudinal relations between these variables. Results The analyses indicated longitudinal stability of all constructs, as well as concurrent relations between them. Longitudinal relations supported child-to-parent, rather than parent-to-child, effects: child difficult temperament predicted decreases in perceived maternal parenting competences, but maternal variables did not predict change in infant temperament. In addition, we observed weak mutual relations between maternal depression levels and parenting competences, such that maternal depression diminished perceived parenting competences that in turn contributed to higher levels of depression. Conclusion Mothers' confidence in their ability to parent is influenced by their experience with a difficult infant and by their depressive symptoms during the child's first year of life. Depressive symptoms are, in turn, aggravated by mothers' low perceived competences in the parenting role.	[Takacs, Lea] Charles Univ Prague, Fac Arts, Dept Psychol, Prague, Czech Republic; [Smolik, Filip] Czech Acad Sci, Inst Psychol, Prague, Czech Republic; [Putnam, Samuel] Bowdoin Coll, Dept Psychol, Brunswick, ME 04011 USA	Charles University Prague; Czech Academy of Sciences; Institute of Psychology of the Czech Academy of Sciences; Bowdoin College	Takacs, L (corresponding author), Charles Univ Prague, Fac Arts, Dept Psychol, Prague, Czech Republic.	lea.takacs@ff.cuni.cz	Smolík, Filip/B-6342-2013; Takács, Lea/AAL-4968-2020	Smolík, Filip/0000-0003-4160-6124; Takács, Lea/0000-0002-8137-026X	Czech Science Foundation [17-10464S]; European Regional Development Fund-Project "Creativity and Adaptability as Conditions of the Success of Europe in an Interrelated World" [CZ.02.1.01/0.0/0.0/16_019/0000734]	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund-Project "Creativity and Adaptability as Conditions of the Success of Europe in an Interrelated World"	This study was supported by the Czech Science Foundation (project GA CR No. 17-10464S, Perinatal risk factors, maternal competences and child development - A prospective study from prenatal period to preschool age), the grant was awarded to LT. LT was funded by the European Regional Development Fund-Project "Creativity and Adaptability as Conditions of the Success of Europe in an Interrelated World" (No. CZ.02.1.01/0.0/0.0/16_019/0000734). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann AES, 2016, J ABNORM CHILD PSYCH, V44, P421, DOI 10.1007/s10802-015-0058-z; Austin MP, 2005, EARLY HUM DEV, V81, P183, DOI 10.1016/j.earlhumdev.2004.07.001; Bagner DM, 2010, J AM ACAD CHILD PSY, V49, P699, DOI 10.1016/j.jaac.2010.03.012; BATES JE, 1979, CHILD DEV, V50, P794, DOI 10.1111/j.1467-8624.1979.tb02428.x; Bauer A, 2015, PSYCHOL MED, V45, P51, DOI 10.1017/S0033291714001044; Beck CT, 1996, NURS RES, V45, P225, DOI 10.1097/00006199-199607000-00006; BELL RQ, 1968, PSYCHOL REV, V75, P81, DOI 10.1037/h0025583; Bhat A, 2015, INFANT BEHAV DEV, V39, P35, DOI 10.1016/j.infbeh.2014.12.002; Braithwaite EC, 2013, J AM ACAD CHILD PSY, V52, P519, DOI 10.1016/j.jaac.2013.02.010; Breedlove G, 2011, J MIDWIFERY WOM HEAL, V56, P18, DOI 10.1111/j.1542-2011.2010.00002.x; Bridgett DJ, 2009, INFANT BEHAV DEV, V32, P103, DOI 10.1016/j.infbeh.2008.10.007; Britton JR, 2011, WOMEN HEALTH, V51, P55, DOI 10.1080/03630242.2011.540741; Chong SC, 2016, INFANT MENT HEALTH J, V37, P584, DOI 10.1002/imhj.21582; Coleman PK, 2003, INF MENTAL HLTH J, V24, P126, DOI 10.1002/imhj.10048; Cornish AM, 2006, J REPROD INFANT PSYC, V24, P121, DOI 10.1080/02646830600644021; Cornish AM, 2005, INFANT BEHAV DEV, V28, P407, DOI 10.1016/j.infbeh.2005.03.004; Cox J., 2003, PERINATAL MENTAL HLT; CUTRONA CE, 1986, CHILD DEV, V57, P1507, DOI 10.1111/j.1467-8624.1986.tb00475.x; Davis EP, 2007, J AM ACAD CHILD PSY, V46, P737, DOI 10.1097/chi.0b013e318047b775; Dennis C.-L, 2013, PSYCHOSOCIAL PSYCHOL; Eastwood JG, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-148; Edhborg M, 2000, J REPROD INFANT PSYC, V18, P225, DOI 10.1080/713683036; Erickson NL, 2017, JOGNN-J OBST GYN NEO, V46, P588, DOI 10.1016/j.jogn.2017.03.008; Farrow C, 2007, INFANT MENT HEALTH J, V28, P517, DOI 10.1002/imhj.20151; Feldman R, 2009, J AM ACAD CHILD PSY, V48, P919, DOI 10.1097/CHI.0b013e3181b21651; Fiala A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1261-y; Field T, 2011, INFANT BEHAV DEV, V34, P1, DOI 10.1016/j.infbeh.2010.09.008; Forbes EE, 2008, J ABNORM CHILD PSYCH, V36, P207, DOI 10.1007/s10802-007-9171-y; Fox NA, 2001, CHILD DEV, V72, P1, DOI 10.1111/1467-8624.00262; Gao LL, 2014, MIDWIFERY, V30, P532, DOI 10.1016/j.midw.2013.06.007; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Gartstein MA, 2009, J APPL DEV PSYCHOL, V30, P149, DOI 10.1016/j.appdev.2008.12.001; Grace S L, 2003, Arch Womens Ment Health, V6, P263, DOI 10.1007/s00737-003-0024-6; Gray PH, 2013, EARLY HUM DEV, V89, P625, DOI 10.1016/j.earlhumdev.2013.04.005; GROSS D, 1994, RES NURS HEALTH, V17, P207, DOI 10.1002/nur.4770170308; Hanington L, 2010, INFANT BEHAV DEV, V33, P88, DOI 10.1016/j.infbeh.2009.11.004; Hummel AC, 2015, CHILD PSYCHIAT HUM D, V46, P21, DOI 10.1007/s10578-014-0448-4; Jover M, 2014, SPAN J PSYCHOL, V17, DOI 10.1017/sjp.2014.87; Keller H, 2009, J CROSS CULT PSYCHOL, V40, P996, DOI 10.1177/0022022109348576; Kerstis B, 2013, SCAND J PUBLIC HEALT, V41, P233, DOI 10.1177/1403494812472006; Koutra K, 2017, J AFFECT DISORDERS, V217, P89, DOI 10.1016/j.jad.2017.04.002; Leahy-Warren P, 2012, J CLIN NURS, V21, P388, DOI 10.1111/j.1365-2702.2011.03701.x; Letourneau NL, 2017, DEPRESS ANXIETY, V34, P928, DOI 10.1002/da.22687; Lin YF, 2017, J AFFECT DISORDERS, V207, P9, DOI 10.1016/j.jad.2016.09.010; Lusby CM, 2014, DEV PSYCHOBIOL, V56, P459, DOI 10.1002/dev.21112; McMahon C, 2001, AUST NZ J PSYCHIAT, V35, P581, DOI 10.1046/j.1440-1614.2001.00942.x; Melchior M, 2012, J AFFECT DISORDERS, V137, P165, DOI 10.1016/j.jad.2011.09.018; Misri S, 2006, AM J ORTHOPSYCHIAT, V76, P115, DOI 10.1037/0002-9432.76.1.115; Norcross PL, 2017, INFANT BEHAV DEV, V49, P238, DOI 10.1016/j.infbeh.2017.09.009; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; Ohan JL, 2000, CAN J BEHAV SCI, V32, P251, DOI 10.1037/h0087122; Pauli-Pott U, 2004, DEV PSYCHOPATHOL, V16, P19, DOI 10.1017/S0954579404040398; Porter CL, 2003, J FAM PSYCHOL, V17, P54, DOI 10.1037/0893-3200.17.1.54; Putnam SP, 2017, J RES PERS, V67, P157, DOI 10.1016/j.jrp.2016.07.009; Razurel C, 2017, WOMEN HEALTH, V57, P154, DOI 10.1080/03630242.2016.1157125; Rode JL, 2016, ARCH WOMEN MENT HLTH, V19, P133, DOI 10.1007/s00737-015-0540-1; Rosseel Y, 2012, LAVAAN; Rothbart M.K., 1998, HDB CHILD PSYCHOL, P105, DOI DOI 10.1002/9780470147658.CHPSY0303; ROTHBART MK, 1981, CHILD DEV, V52, P569, DOI 10.1111/j.1467-8624.1981.tb03082.x; Rouse MH, 2014, INFANT BEHAV DEV, V37, P739, DOI 10.1016/j.infbeh.2014.09.001; Shea E., 1988, THEORY RES BEHAVIORA, V4, P101; Skipstein A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1120; SUPER CM, 1986, INT J BEHAV DEV, V9, P545, DOI 10.1177/016502548600900409; Thomason E, 2014, INFANT BEHAV DEV, V37, P406, DOI 10.1016/j.infbeh.2014.05.009; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; van der Waerden J, 2015, J PEDIATR-US, V166, P1440, DOI 10.1016/j.jpeds.2015.03.002; Verhage ML, 2013, J FAM PSYCHOL, V27, P844, DOI 10.1037/a0034263; Woolhouse H, 2016, ARCH WOMEN MENT HLTH, V19, P141, DOI 10.1007/s00737-015-0562-8	68	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220633	10.1371/journal.pone.0220633	http://dx.doi.org/10.1371/journal.pone.0220633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381596	Green Submitted, Green Published, gold			2022-12-27	WOS:000484993600025
J	Choi, BKA; D'Onofrio, PM; Shabanzadeh, AP; Koeberle, PD				Choi, Brian K. A.; D'Onofrio, Philippe M.; Shabanzadeh, Alireza P.; Koeberle, Paulo D.			Stabilization of primary cilia reduces abortive cell cycle re-entry to protect injured adult CNS neurons from apoptosis	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; ALZHEIMERS-DISEASE; PROVIDES NEUROPROTECTION; SCAR FORMATION; OPTIC-NERVE; INHIBITION; EXPRESSION; AURORA; PROGRESSION; ACTIVATION	Abortive cell cycle (ACC) re-entry of apoptotic neurons is a recently characterized phenomenon that occurs after central nervous system (CNS) injury or over the course of CNS disease. Consequently, inhibiting cell cycle progression is neuroprotective in numerous CNS pathology models. Primary cilia are ubiquitous, centriole-based cellular organelles that prevent cell cycling, but their ability to modulate abortive cell cycle has not been described. Here, we show that neuronal cilia are ablated in-vitro and in-vivo following injury by hypoxia or optic nerve transection (ONT), respectively. Furthermore, forced cilia resorption sensitized neurons to these injuries and enhanced cell death. In contrast, pharmacological inhibition or shRNA knockdown of the proteins that disassemble the cilia increased neuron survival and decreased the phosphorylation of retinoblastoma (Rb), a master switch for cell cycle re-entry. Our findings show that the stabilization of neuronal primary cilia inhibits, at least transiently, apoptotic cell cycling, which has implications for future therapeutic strategies that halt or slow the progression of neurodegenerative diseases and acute CNS injuries.	[Choi, Brian K. A.; D'Onofrio, Philippe M.; Shabanzadeh, Alireza P.; Koeberle, Paulo D.] Univ Toronto, Dept Surg, Div Anat, Toronto, ON, Canada; [Choi, Brian K. A.; D'Onofrio, Philippe M.; Koeberle, Paulo D.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Shabanzadeh, Alireza P.] Univ Toronto, Krembil Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; Krembil Research Institute; University of Toronto	Koeberle, PD (corresponding author), Univ Toronto, Dept Surg, Div Anat, Toronto, ON, Canada.; Koeberle, PD (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada.	paulo.koeberle@utoronto.ca		Choi, Kyung An Brian/0000-0002-4607-3833	Canadian Institutes of Health Research [MOP 119309]; University of Toronto Division of Anatomy, Department of Surgery	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Division of Anatomy, Department of Surgery	This research was supported by the Canadian Institutes of Health Research Operating Grant (MOP 119309 to PDK) and the University of Toronto Division of Anatomy, Department of Surgery Bridge funding awarded to PDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2013, J NEUROSCI, V33, P14645, DOI 10.1523/JNEUROSCI.1327-13.2013; Aliagas-Martin I, 2009, J MED CHEM, V52, P3300, DOI 10.1021/jm9000314; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Cao Muqing, 2015, Cilia, V5, P4, DOI 10.1186/s13630-016-0027-3; Carlen B, 2005, ULTRASTRUCT PATHOL, V29, P217, DOI 10.1080/01913120590951220; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dai Yun, 2004, Curr Oncol Rep, V6, P123, DOI 10.1007/s11912-004-0024-3; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Folch J, 2012, NEUROTOX RES, V22, P195, DOI 10.1007/s12640-011-9277-4; Galan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101349; Gendron TF, 2001, J NEUROCHEM, V78, P316, DOI 10.1046/j.1471-4159.2001.00423.x; Goto H, 2013, CELL MOL LIFE SCI, V70, P3893, DOI 10.1007/s00018-013-1302-8; Gradilone SA, 2013, CANCER RES, V73, P2259, DOI 10.1158/0008-5472.CAN-12-2938; Hassounah NB, 2012, CLIN CANCER RES, V18, P2429, DOI 10.1158/1078-0432.CCR-11-0755; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Hu W, 2014, CANC RES S, V65, P1350; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Imai H, 2002, EUR J NEUROSCI, V15, P1929, DOI 10.1046/j.1460-9568.2002.02025.x; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Inoko A, 2012, J CELL BIOL, V197, P391, DOI 10.1083/jcb.201106101; Izawa Ichiro, 2015, Cilia, V4, P12, DOI 10.1186/s13630-015-0021-1; Jordan-Sciutto KL, 2003, J NEUROPATH EXP NEUR, V62, P68, DOI 10.1093/jnen/62.1.68; Kabadi SV, 2012, NEUROTHERAPEUTICS, V9, P405, DOI 10.1007/s13311-011-0095-4; Kasper M, 2017, EUR J CANCER, V42, P437; Kim S, 2011, CELL CYCLE, V10, P2683, DOI 10.4161/cc.10.16.17009; Kim S, 2011, NAT CELL BIOL, V13, P351, DOI 10.1038/ncb2183; Kinzel D, 2010, DEV CELL, V19, P66, DOI 10.1016/j.devcel.2010.06.005; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lee KH, 2012, EMBO J, V31, P3104, DOI 10.1038/emboj.2012.144; Magharious Mark M, 2011, J Vis Exp, DOI 10.3791/2241; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; Miyamoto T, 2015, CELL REP, V10, P664, DOI 10.1016/j.celrep.2015.01.003; Mori D, 2009, NAT CELL BIOL, V11, P1057, DOI 10.1038/ncb1919; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pazour GJ, 2000, J CELL BIOL, V151; Pelegri C, 2008, INT J DEV NEUROSCI, V26, P665, DOI 10.1016/j.ijdevneu.2008.07.016; Plotnikova OV, 2009, METHOD CELL BIOL, V94, P137, DOI 10.1016/S0091-679X(08)94007-3; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Ran J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12917; Ranganathan S, 2003, AM J PATHOL, V162, P823, DOI 10.1016/S0002-9440(10)63879-5; Rashidian J, 2007, BBA-MOL BASIS DIS, V1772, P484, DOI 10.1016/j.bbadis.2006.11.009; Rosenbaum T, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-4; Saito M, 2017, EMBO REP, V18, P1460, DOI 10.15252/embr.201744204; Sasaki H, 1999, DEVELOPMENT, V126, P3915; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schafer KA, 1998, VET PATHOL, V35, P461, DOI 10.1177/030098589803500601; SMITH TW, 1995, J NEUROPATH EXP NEUR, V54, P297, DOI 10.1097/00005072-199505000-00002; Tian DS, 2006, J NEUROSCI RES, V84, P1053, DOI 10.1002/jnr.20999; Tian H, 2017, HUM MOL GENET, V26, P860, DOI 10.1093/hmg/ddx002; Varvel NH, 2008, J NEUROSCI, V28, P10786, DOI 10.1523/JNEUROSCI.2441-08.2008; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang FH, 2002, J CEREBR BLOOD F MET, V22, P171, DOI 10.1097/00004647-200202000-00005; Wang G, 2013, J CELL SCI, V126, P1355, DOI 10.1242/jcs.114918; Yi ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38574; Yu Y, 2012, NEUROCHEM RES, V37, P503, DOI 10.1007/s11064-011-0636-6; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; ZHANG WH, 2011, NAT CELL BIOL, P1013; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	70	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220056	10.1371/journal.pone.0220056	http://dx.doi.org/10.1371/journal.pone.0220056			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369591	gold, Green Published, Green Submitted			2022-12-27	WOS:000484987900022
J	Kawahara, T; Kojima, T; Kandori, S; Kurobe, M; Yoshino, T; Kimura, T; Nagumo, Y; Ishituka, R; Mitsuzuka, K; Narita, S; Kobayashi, T; Matsui, Y; Ogawa, O; Sugimoto, M; Miyazaki, J; Nishiyama, H				Kawahara, Takashi; Kojima, Takahiro; Kandori, Shuya; Kurobe, Masahiro; Yoshino, Takayuki; Kimura, Tomokazu; Nagumo, Yoshiyuki; Ishituka, Ryutaro; Mitsuzuka, Koji; Narita, Shintaro; Kobayashi, Takashi; Matsui, Yoshiyuki; Ogawa, Osamu; Sugimoto, Mikio; Miyazaki, Jun; Nishiyama, Hiroyuki			TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer	PLOS ONE			English	Article							FACTOR RECEPTOR GENE; CELL LUNG-CANCER; P53; VARIANTS; EPIDEMIOLOGY; RISK; ADENOCARCINOMAS; SUSCEPTIBILITY; ACTIVATION; EXPRESSION	Objective TP53, a well-known tumor-suppressor gene in bladder carcinogenesis, has a functional single-nucleotide polymorphism on codon 72. The aim of this study was to elucidate the association between TP53 codon 72 polymorphism and somatic mutations in bladder cancer. Material and methods Germline TP53 codon 72 polymorphism and somatic mutations of 50 cancer-associated genes were analyzed in 103 bladder cancer patients (59 non-muscle-invasive and 44 muscle-invasive), using Taqman genotyping assay and target sequencing, respectively. The expression of FGF-FGFR signaling pathway genes was analyzed by RNA sequencing of frozen tissue. Results The allele frequency of TP53 codon 72 in our cohort was 37, 42, and 21% for Arg/Arg, Arg/Pro, and Pro/Pro, respectively. Interestingly, the prevalence of FGFR3 mutation was higher in patients with the Arg allele, whereas that of the RAS mutation was higher in patients without the Arg allele. The same association was seen in non-muscle-invasive bladder cancer (NMIBC) patients and no differences were observed in muscle-invasive bladder cancer patients. In NMIBC, FGFR1 expression was higher in patients without the Arg allele and FGFR3 expression was higher in patients with the Arg allele. Conclusion The germline TP53 codon 72 polymorphism was associated with mutations of FGFR3 or RAS and expression of FGFR1 and FGFR3 in NMIBC. These findings provide new insight into the molecular mechanisms underlying the influence of the genetic background on carcinogenesis in bladder cancer.	[Kawahara, Takashi; Kojima, Takahiro; Kandori, Shuya; Kurobe, Masahiro; Yoshino, Takayuki; Kimura, Tomokazu; Nagumo, Yoshiyuki; Ishituka, Ryutaro; Nishiyama, Hiroyuki] Univ Tsukuba, Fac Med, Dept Urol, Tsukuba, Ibaraki, Japan; [Mitsuzuka, Koji] Tohoku Univ, Grad Sch Med, Dept Urol, Sendai, Miyagi, Japan; [Narita, Shintaro] Akita Univ, Grad Sch Med, Dept Urol, Akita, Japan; [Kobayashi, Takashi; Matsui, Yoshiyuki; Ogawa, Osamu] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto, Japan; [Sugimoto, Mikio] Kagawa Univ, Fac Med, Dept Urol, Takamatsu, Kagawa, Japan; [Miyazaki, Jun] Int Univ Hlth & Welf, Sch Med, Dept Urol, Narita, Japan	University of Tsukuba; Tohoku University; Akita University; Kyoto University; Kagawa University; International University of Health & Welfare	Kojima, T (corresponding author), Univ Tsukuba, Fac Med, Dept Urol, Tsukuba, Ibaraki, Japan.	tkojima@md.tsukuba.ac.jp	Miyazaki, Jun/HFZ-7703-2022; KUROBE, MASAHIRO/AAE-7786-2021	Kandori, Shuya/0000-0003-4621-8470; KUROBE, MASAHIRO/0000-0002-5819-523X	Japan Society for the Promotion of Science (JSPS) [26670696, 26293349, 18K09158]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research (H.N.) (grant number 26670696), a Grant-in-Aid for Scientific Research B (H.N.) (grant number 26293349) and a Grant-in-Aid for Scientific Research C (T. Kojima) (grant number 18K09158) from the Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/english/). JSPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkar AA, 2003, CANCER RES, V63, P8108; Billerey C, 2001, AM J PATHOL, V158, P1955, DOI 10.1016/S0002-9440(10)64665-2; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Buttitta F, 2006, INT J CANCER, V119, P2586, DOI 10.1002/ijc.22143; Chang DW, 2012, UROL ONCOL-SEMIN ORI, V30, P524, DOI 10.1016/j.urolonc.2012.04.003; Cheng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057284; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fargnoli MC, 2008, J INVEST DERMATOL, V128, P2485, DOI 10.1038/jid.2008.67; FUJIMOTO K, 1992, CANCER RES, V52, P1393; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Horikawa Y, 2008, ONCOL REP, V20, P49; Hu YC, 2005, CLIN CANCER RES, V11, P2502, DOI 10.1158/1078-0432.CCR-04-1913; Jang JH, 2005, ONCOGENE, V24, P945, DOI 10.1038/sj.onc.1208254; Jebar AH, 2005, ONCOGENE, V24, P5218, DOI 10.1038/sj.onc.1208705; Juanpere N, 2012, HUM PATHOL, V43, P1573, DOI 10.1016/j.humpath.2011.10.026; Kiemeney LA, 2010, NAT GENET, V42, P415, DOI 10.1038/ng.558; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Kurobe M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165109; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; Liu YL, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3760-0; Negri E, 2001, EUR J CANCER PREV, V10, P7, DOI 10.1097/00008469-200102000-00002; Olumi AF, 2000, UROL CLIN N AM, V27, P75, DOI 10.1016/S0094-0143(05)70236-6; Pandith Arshad A, 2016, Asian Pac J Cancer Prev, V17, P2787; Pelucchi C, 2006, NAT CLIN PRACT UROL, V3, P327, DOI 10.1038/ncpuro0510; Pim D, 2004, INT J CANCER, V108, P196, DOI 10.1002/ijc.11548; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Siddique M, 2006, ONCOGENE, V25, P3489, DOI 10.1038/sj.onc.1209405; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Suzuki M, 2006, CANCER-AM CANCER SOC, V106, P2200, DOI 10.1002/cncr.21853; Szymanowska A, 2006, LUNG CANCER, V52, P9, DOI 10.1016/j.lungcan.2005.12.007; Tanaka S, 2018, JS STAR VERSION 9; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tomlinson DC, 2009, CANCER RES, V69, P4613, DOI 10.1158/0008-5472.CAN-08-2816; Trifa AP, 2016, BRIT J HAEMATOL, V174, P218, DOI 10.1111/bjh.14041; Vivenza D, 2016, INT J BIOL MARKER, V31, pE183, DOI 10.5301/jbm.5000192; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yang ZL, 2013, GENE, V512, P408, DOI 10.1016/j.gene.2012.09.085	40	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220173	10.1371/journal.pone.0220173	http://dx.doi.org/10.1371/journal.pone.0220173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369573	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900033
J	Mizuno, H; Yuasa, N; Takeuchi, E; Miyake, H; Nagai, H; Yoshioka, Y; Miyata, K				Mizuno, Hironori; Yuasa, Norihiro; Takeuchi, Eiji; Miyake, Hideo; Nagai, Hidemasa; Yoshioka, Yuichiro; Miyata, Kanji			Blood cell markers that can predict the long-term outcomes of patients with colorectal cancer	PLOS ONE			English	Article							MEAN CORPUSCULAR VOLUME; TO-LYMPHOCYTE RATIO; PROGNOSTIC SCORE GPS; MONOCYTE RATIO; PREOPERATIVE LYMPHOCYTE; ENDOTHELIAL DYSFUNCTION; PLATELET COUNT; NEUTROPHIL; COLON; SURVIVAL	Objectives To identify blood cell markers that predict the long-term outcomes of patients with colorectal cancer. Methods Data from 892 stage II and III colorectal cancer patients who underwent R0 resection were included. We analyzed the correlations of the preoperative blood data, previously reported prognostic indices, and clinicopathologic factors with the long-term outcomes, such as relapse-free survival and overall survival, using univariate and multivariate analyses. Results Multivariate analysis showed that tumor location, stage, mean corpuscular volume, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio were significantly correlated with relapse-free survival. A mean corpuscular volume >= 80.5 fL, neutrophil-to-lymphocyte ratio >= 5.5, and lymphocyte-to-monocyte ratio <3.4 had hazard ratios for disease relapse between 1.39 and 1.93. The cumulative scores of these three factors were aggregated into a laboratory prognostic score, with a maximum score at 6. The relapse-free survival and overall survival were well stratified by a laboratory prognostic score between 0-3 and 4-6, respectively, independent of the stage. Conclusion The mean corpuscular volume, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio can serve as blood cell markers to predict the long-term outcomes of patients who underwent R0 resection for stage II/III colorectal cancer.	[Mizuno, Hironori; Yuasa, Norihiro; Takeuchi, Eiji; Miyake, Hideo; Nagai, Hidemasa; Yoshioka, Yuichiro; Miyata, Kanji] Japanese Red Cross Nagoya First Hosp, Dept Gastrointestinal Surg, Nakamura Ku, Michishita Cho, Nagoya, Aichi, Japan	Red Cross Nagoya Daiichi Hospital	Mizuno, H (corresponding author), Japanese Red Cross Nagoya First Hosp, Dept Gastrointestinal Surg, Nakamura Ku, Michishita Cho, Nagoya, Aichi, Japan.	hironori.miz@gmail.com			Japanese Red Cross Nagoya First Hospital Research Grant [NFRCH 18-0016]	Japanese Red Cross Nagoya First Hospital Research Grant	This work was supported by the Japanese Red Cross Nagoya First Hospital Research Grant (NFRCH 18-0016) to HM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balde AI, 2017, J SURG RES, V219, P244, DOI 10.1016/j.jss.2017.05.109; Chan JCY, 2017, ANN SURG, V265, P539, DOI 10.1097/SLA.0000000000001743; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Evani SJ, 2013, FASEB J, V27, P3017, DOI 10.1096/fj.12-224824; Feliciano EMC, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.2319; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo YH, 2017, ONCOTARGET, V8, P20011, DOI 10.18632/oncotarget.15311; Han FY, 2018, ONCOL LETT, V15, P3339, DOI 10.3892/ol.2017.7697; Haram A, 2017, J SURG ONCOL, V115, P470, DOI 10.1002/jso.24523; He WZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0439-x; Huang XZ, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/1053125; Iseki Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132488; Ishizuka M, 2013, BRIT J CANCER, V109, P401, DOI 10.1038/bjc.2013.350; Li M, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/132642; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Lin EY, 2004, BRIT J CANCER, V90, P2053, DOI 10.1038/sj.bjc.6601705; Mahmoud MY, 1996, AGE AGEING, V25, P310, DOI 10.1093/ageing/25.4.310; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McMillan DC, 2007, INT J COLORECTAL DIS, V22, P881, DOI 10.1007/s00384-006-0259-6; Mohanty JG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00084; Mohri Y, 2013, WORLD J SURG, V37, P2688, DOI 10.1007/s00268-013-2156-9; Monreal M, 1998, THROMB HAEMOSTASIS, V79, P916; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Moritani K, 2014, SURG TODAY, V44, P1685, DOI 10.1007/s00595-013-0748-5; Nagai H, 2018, SURG TODAY, V48, P186, DOI 10.1007/s00595-017-1575-x; Nozoe T, 2014, INT SURG, V99, P512, DOI 10.9738/INTSURG-D-13-00118.1; Pectasides D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1406-7; Pine JK, 2015, BRIT J CANCER, V113, P204, DOI 10.1038/bjc.2015.87; PORATHFUREDI A, 1983, CYTOMETRY, V4, P263, DOI 10.1002/cyto.990040312; SATOMI A, 1995, ACTA ONCOL, V34, P69, DOI 10.3109/02841869509093641; Schneider C, 2018, EUR J CANCER PREV, V27, P530, DOI 10.1097/CEJ.0000000000000397; Shibutani M, 2017, ONCOL LETT, V13, P1000, DOI 10.3892/ol.2016.5487; Skjelbakken T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001109; Sobin LH., 2010, TNM CLASSIFICATION M; Solak Y, 2013, NEPHROLOGY, V18, P728, DOI 10.1111/nep.12130; Son HJ, 2013, ANN SURG ONCOL, V20, P2908, DOI 10.1245/s10434-013-2968-8; Song W, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005540; Song YX, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3752-0; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Stotz M, 2014, BRIT J CANCER, V110, P435, DOI 10.1038/bjc.2013.785; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tsantes AE, 2006, ANTIOXID REDOX SIGN, V8, P1205, DOI 10.1089/ars.2006.8.1205; Ueda T, 2013, CIRC J, V77, P2766, DOI 10.1253/circj.CJ-13-0718; Vayrynen JP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19572-y; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Warschkow R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2412-0; Watanabe T, 2018, INT J CLIN ONCOL, V23, P1, DOI 10.1007/s10147-017-1101-6; Wu QB, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007051; Yoon HJ, 2016, CLIN CHEM LAB MED, V54, P1247, DOI 10.1515/cclm-2015-0786; Yoshida N, 2018, ANN SURG; Zheng YZ, 2013, WORLD J GASTROENTERO, V19, P2811, DOI 10.3748/wjg.v19.i18.2811	52	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220579	10.1371/journal.pone.0220579	http://dx.doi.org/10.1371/journal.pone.0220579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369651	Green Submitted, gold, Green Published			2022-12-27	WOS:000484987900066
J	Wong, RJ; Tran, T; Kaufman, H; Niles, J; Gish, R				Wong, Robert J.; Tran, Tram; Kaufman, Harvey; Niles, Justin; Gish, Robert			Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; LONG-TERM OUTCOMES; NATIONAL-HEALTH; UNITED-STATES; PREVALENCE; TRANSPLANTATION; MORTALITY; DIAGNOSIS; CIRRHOSIS; SEVERITY	Hepatic fibrosis and advanced fibrosis in particular is the strongest predictor of liver-related outcomes and mortality among nonalcoholic steatohepatitis (NASH) patients. Understanding prevalence and predictors of NASH with advanced fibrosis is critical for healthcare resource planning. Using a large U.S. clinical laboratory database from 10/1/2017-9/30/2018, adults negative for hepatitis B and hepatitis C and after excluding for alcoholic liver disease and pregnancy were evaluated for prevalence of F3 and F4 fibrosis using a systematic algorithm of five fibrosis-4 (FIB-4) criteria: Criteria 1 (>= F3: > 2.67), Criteria 2 (2.67 < F3 <= 4.12 and F4 > 4.12), Criteria 3 (2.67 < F3 <= 3.15, F4 > 3.15), Criteria 4 (3.25 < F3 <= 3.5,F4 > 3.5),Criteria 5 (3.25 < F3 <= 4.12, F4 > 4.12). Metabolic co-morbidities evaluated included decreased high density lipoprotein (< 40 mg/dL men, < 50 mg/dL women), high triglycerides (>= 150 mg/dL), elevated hemoglobin A1C (>= 6.5%). Parallel analyses of patients with specific NAFLD/NASH ICD-9/10 codes from 10/1/2013-9/30/2018 were performed. Multivariate logistic regression models evaluated for predictors of >= F3 fibrosis. Among patients with NAFLD/NASH ICD-9/10 codes, >= F3 prevalence ranged from 4.35%-6.90%, and F4 prevalence ranged from 2.52%-3.67%. Increasing metabolic co-morbidities was associated with higher risk of. F3 fibrosis. Compared to NASH patients without metabolic co-morbidities, NASH with four concurrent metabolic co-morbidities had higher risk of >= F3 (OR 1.56, 95% CI 1.40-1.73, p < 0.001). In summary, prevalence of NASH with advanced fibrosis among U.S. adults was as high as 6.90% and prevalence of NASH with cirrhosis was as high as 3.67%, representing 5.18 million and 2.75 million, respectively, when using an estimate of 75 million U.S. adults with NAFLD. Co-morbid metabolic abnormalities were associated with higher risk of advanced fibrosis among NASH patients.	[Wong, Robert J.] Alameda Hlth Syst Highland Hosp, Div Gastroenterol & Hepatol, Oakland, CA 94602 USA; [Tran, Tram] Gilead Sci, Foster City, CA USA; [Kaufman, Harvey; Niles, Justin] Quest Diagnost, Secaucus, NJ USA; [Gish, Robert] Stanford Hlth Care, Div Gastroenterol & Hepatol, Palo Alto, CA USA	Gilead Sciences; Stanford University	Wong, RJ (corresponding author), Alameda Hlth Syst Highland Hosp, Div Gastroenterol & Hepatol, Oakland, CA 94602 USA.	Rowong@alamedahealthsystem.org	Gish, Robert/B-3605-2018	Gish, Robert/0000-0001-6306-3189; Wong, Robert/0000-0002-8923-2806	Gilead Sciences	Gilead Sciences(Gilead Sciences)	This study was supported by a research grant from Gilead Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Fujii H, 2019, J GASTROEN HEPATOL, V34, P1390, DOI 10.1111/jgh.14595; Goldberg D, 2017, GASTROENTEROLOGY, V152, P1090, DOI 10.1053/j.gastro.2017.01.003; Gordon SC, 2018, HEPATOLOGY, V68, p617A; Holmberg SD, 2013, CLIN INFECT DIS, V57, P240, DOI 10.1093/cid/cit245; Kabbany MN, 2017, AM J GASTROENTEROL, V112, P581, DOI 10.1038/ajg.2017.5; Le MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173499; McPherson S, 2017, AM J GASTROENTEROL, V112, P740, DOI 10.1038/ajg.2016.453; Nakahara T, 2014, J GASTROENTEROL, V49, P1477, DOI 10.1007/s00535-013-0911-1; Patel PJ, 2018, INTERN MED J, V48, P144, DOI 10.1111/imj.13667; Petta S, 2012, ALIMENT PHARM THER, V35, P238, DOI 10.1111/j.1365-2036.2011.04929.x; Petta S, 2017, LIVER INT, V37, P1389, DOI 10.1111/liv.13397; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Sanyal AJ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1149-9; Stepanova M, 2010, GUT, V59, P1410, DOI 10.1136/gut.2010.213553; Vilar-Gomez E, 2018, GASTROENTEROLOGY, V155, P443, DOI 10.1053/j.gastro.2018.04.034; Wong RJ, 2017, ALIMENT PHARM THER, V46, P974, DOI 10.1111/apt.14327; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Younossi ZM, 2013, METABOLISM, V62, P352, DOI 10.1016/j.metabol.2012.08.005	27	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220612	10.1371/journal.pone.0220612	http://dx.doi.org/10.1371/journal.pone.0220612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369606	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900067
J	Zhao, J; Wang, C; Totton, SC; Cullen, JN; O'Connor, AM				Zhao, Jing; Wang, Chong; Totton, Sarah C.; Cullen, Jonah N.; O'Connor, Annette M.			Reporting and analysis of repeated measurements in preclinical animals experiments	PLOS ONE			English	Article							BIOMEDICAL-RESEARCH; DESIGN	A common feature of preclinical animal experiments is repeated measurement of the outcome, e.g., body weight measured in mice pups weekly for 20 weeks. Separate time point analysis or repeated measures analysis approaches can be used to analyze such data. Each approach requires assumptions about the underlying data and violations of these assumptions have implications for estimation of precision, and type I and type II error rates. Given the ethical responsibilities to maximize valid results obtained from animals used in research, our objective was to evaluate approaches to reporting repeated measures design used by investigators and to assess how assumptions about variation in the outcome over time impact type I and II error rates and precision of estimates. We assessed the reporting of repeated measures designs of 58 studies in preclinical animal experiments. We used simulation modelling to evaluate three approaches to statistical analysis of repeated measurement data. In particular, we assessed the impact of (a) repeated measure analysis assuming that the outcome had non-constant variation at all time points (heterogeneous variance) (b) repeated measure analysis assuming constant variation in the outcome (homogeneous variance), (c) separate ANOVA at individual time point in repeated measures designs. The evaluation of the three model fitting was based on comparing the p-values distributions, the type I and type II error rates and by implication, the shrinkage or inflation of standard error estimates from 1000 simulated dataset. Of 58 studies with repeated measures design, three provided a rationale for repeated measurement and 23 studies reported using a repeated-measures analysis approach. Of the 35 studies that did not use repeated-measures analysis, fourteen studies used only two time points to calculate weight change which potentially means collected data was not fully utilized. Other studies reported only select time points (n = 12) raising the issue of selective reporting. Simulation studies showed that an incorrect assumption about the variance structure resulted in modified error rates and precision estimates. The reporting of the validity of assumptions for repeated measurement data is very poor. The homogeneous variation assumption, which is often invalid for body weight measurements, should be confirmed prior to conducting the repeated-measures analysis using homogeneous covariance structure and adjusting the analysis using corrections or model specifications if this is not met.	[Zhao, Jing; Wang, Chong] Iowa State Univ, Dept Stat, Coll Stat, Ames, IA USA; [Wang, Chong; Cullen, Jonah N.; O'Connor, Annette M.] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA	Iowa State University; Iowa State University	O'Connor, AM (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	oconnor@iastate.edu	O'Connor, A/AFK-8069-2022; O'Connor, A/E-5591-2010; Wang, Chong/AAI-3796-2020; O'Connor, Annette/GRX-1453-2022	O'Connor, A/0000-0003-0604-7822; O'Connor, A/0000-0003-0604-7822; Wang, Chong/0000-0003-4489-4344; O'Connor, Annette/0000-0003-0604-7822	Iowa State University Presidential Initiative for Data Driven Science; Iowa State University Presidential Initiative For Data Driven Science	Iowa State University Presidential Initiative for Data Driven Science; Iowa State University Presidential Initiative For Data Driven Science	This project was supported by funds from the Iowa State University Presidential Initiative for Data Driven Science. There was no additional external funding received for this study.; This project was supported by funds from the Iowa State University Presidential Initiative For Data Driven Science. There was no additional external funding received for this study.	Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Basha PM, 2011, BIOL TRACE ELEM RES, V144, P1083, DOI 10.1007/s12011-011-9137-3; Cho CE, 2013, EPIGENETICS-US, V8, P710, DOI 10.4161/epi.24948; Dong GH, 2009, ARCH TOXICOL, V83, P805, DOI 10.1007/s00204-009-0424-0; El-lethey H.S., 2010, J AM SCI, V6, P54; Farina M, 2003, TOXICOL LETT, V144, P351, DOI 10.1016/S0378-4274(03)00242-X; Festing Michael F W, 2002, ILAR J, V43, P244; Ghosal S, 2015, PHYSIOL BEHAV, V150, P31, DOI 10.1016/j.physbeh.2015.06.021; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Holson RR, 2008, NEUROTOXICOL TERATOL, V30, P326, DOI 10.1016/j.ntt.2007.06.001; Hunter P, 2017, EMBO REP, V18, P1493, DOI 10.15252/embr.201744876; Huwaldt JA., 2012, PLOT DIGITIZER 2 6 2; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; Knight KL, 2010, J ATHL TRAINING, V45, P98, DOI 10.4085/1062-6050-45.1.98; Li GW, 2017, INT J EPIDEMIOL, V46, P746, DOI 10.1093/ije/dyw320; Liu F, 2014, PHYSIOL BEHAV, V124, P1, DOI 10.1016/j.physbeh.2013.10.027; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; O'Connor AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199441; Oberfeld D, 2013, BEHAV RES METHODS, V45, P792, DOI 10.3758/s13428-012-0281-2; Pan J, 2007, STAT MODEL, V7, P49, DOI 10.1177/1471082x0600700104; Pinheiro J., 2006, MIXED EFFECTS MODELS; Reinhardt V, 2004, LAB ANIM-UK, V38, P213, DOI 10.1258/002367704323133600; Sable P, 2011, NEUROSCIENCE, V190, P127, DOI 10.1016/j.neuroscience.2011.05.010; Salama AF, 2013, TOXICOL IND HEALTH, V29, P600, DOI 10.1177/0748233711432577; Samsa G, 2018, ACAD MED J ASS AM ME; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Siddiqui O, 2011, J BIOPHARM STAT, V21, P423, DOI 10.1080/10543401003777995; Smith AJ, 2018, LAB ANIM-UK, V52, P135, DOI 10.1177/0023677217724823; Sullivan LM, 2008, CIRCULATION, V117, P1238, DOI 10.1161/CIRCULATIONAHA.107.654350; van der Steen JT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188247; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Whitford GM, 2009, NEUROTOXICOL TERATOL, V31, P210, DOI 10.1016/j.ntt.2009.02.003	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220879	10.1371/journal.pone.0220879	http://dx.doi.org/10.1371/journal.pone.0220879			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404099	Green Published, gold			2022-12-27	WOS:000485006800039
J	Adam, AC; Lie, KK; Whatmore, P; Jakt, LM; Moren, M; Skjaerven, KH				Adam, Anne-Catrin; Lie, Kai Kristoffer; Whatmore, Paul; Jakt, Lars Martin; Moren, Mari; Skjaerven, Kaja Helvik			Profiling DNA methylation patterns of zebrafish liver associated with parental high dietary arachidonic acid	PLOS ONE			English	Article							GENE BODY METHYLATION; DEVELOPMENTAL PLASTICITY; EPIGENETIC MODIFICATION; PROTEIN RESTRICTION; PREGNANT RATS; EXPRESSION; METABOLISM; NUTRITION; DISEASE; CONSEQUENCES	Diet has been shown to influence epigenetic key players, such as DNA methylation, which can regulate the gene expression potential in both parents and offspring. Diets enriched in omega-6 and deficient in omega-3 PUFAs (low dietary omega-3/omega-6 PUFA ratio), have been associated with the promotion of pathogenesis of diseases in humans and other mammals. In this study, we investigated the impact of increased dietary intake of arachidonic acid (ARA), a physiologically important omega-6 PUFA, on 2 generations of zebrafish. Parental fish were fed either a low or a high ARA diet, while the progeny of both groups were fed the low ARA diet. We screened for DNA methylation on single base-pair resolution using reduced representation bisulfite sequencing (RRBS). The DNA methylation profiling revealed significant differences between the dietary groups in both parents and offspring. The majority of differentially methylated loci associated with high dietary ARA were found in introns and intergenic regions for both generations. Common loci between the identified differentially methylated loci in F-0 and F-1 livers were reported. We described overlapping gene annotations of identified methylation changes with differential expression, but based on a small number of overlaps. The present study describes the diet-associated methylation profiles across genomic regions, and it demonstrates that parental high dietary ARA modulates DNA methylation patterns in zebrafish liver.	[Adam, Anne-Catrin; Lie, Kai Kristoffer; Whatmore, Paul; Moren, Mari; Skjaerven, Kaja Helvik] Inst Marine Res, Bergen, Norway; [Jakt, Lars Martin] Nord Univ, Fac Biosci & Aquaculture, Bodo, Norway; [Moren, Mari] Nofima AS, Bergen, Norway	Institute of Marine Research - Norway; Nord University; Nofima	Adam, AC (corresponding author), Inst Marine Res, Bergen, Norway.	aad@hi.no	Lie, Kai Kristoffer/AAM-8809-2020	Jakt, Lars Martin/0000-0002-3787-8138; Skjaerven, Kaja Helvik/0000-0003-4185-390X; Adam, Anne-Catrin/0000-0001-9713-4512	Research Council of Norway [EpiSip 228877, EpiFeedFish 225250/E40]	Research Council of Norway(Research Council of Norway)	This research was financed through The Research Council of Norway (www.forskningsradet.no): EpiSip 228877 (KHS) and EpiFeedFish 225250/E40 (KHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AC, 2017, BR J NUTR, V09, P1; Adam AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201278; Akalin A, 2015, BIOINFORMATICS, V31, P1127, DOI 10.1093/bioinformatics/btu775; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Alswat KA, 2013, SAUDI J GASTROENTERO, V19, P144, DOI 10.4103/1319-3767.114505; Amarasinghe HE, 2015, PEERJ, V3, DOI 10.7717/peerj.1079; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Andrews S., 2017, FASTQC QUALITY CONTR; [Anonymous], 2013, R LANG ENV STAT COMP; Asil SM, 2017, AQUACULTURE, V476, P8, DOI 10.1016/j.aquaculture.2017.03.048; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bogdanovic O, 2017, CURR OPIN GENET DEV, V46, P9, DOI 10.1016/j.gde.2017.06.007; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Burdge GC, 2007, BRIT J NUTR, V97, P435, DOI 10.1017/S0007114507352392; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Cannon MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090335; Ciano M, 2016, BIOCHEM BIOPH RES CO, V479, P325, DOI 10.1016/j.bbrc.2016.09.071; Clermont PL, 2016, FRONT BIOSCI-LANDMRK, V21, P430, DOI 10.2741/4399; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; de Vrieze E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089347; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Gluckman PD, 2011, BIRTH DEFECTS RES C, V93, P12, DOI 10.1002/bdrc.20198; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Goodman RH, 2000, GENE DEV, V14, P1553; Heard E, 2014, CELL, V157, P95, DOI 10.1016/j.cell.2014.02.045; Hoile SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021668; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hore TA, 2017, EPIGENOMICS-UK, V9, P863, DOI 10.2217/epi-2017-0021; Huang K, 2010, REGEN MED, V5, P531, DOI [10.2217/rme.10.35, 10.2217/RME.10.35]; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Klughammer J, 2015, CELL REP, V13, P2621, DOI 10.1016/j.celrep.2015.11.024; Lands B, 2012, NUTRIENTS, V4, P1338, DOI 10.3390/nu4091338; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lie KK, 2016, COMP BIOCHEM PHYS A, V191, P80, DOI 10.1016/j.cbpa.2015.10.011; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McGaughey DM, 2014, G3-GENES GENOM GENET, V4, P861, DOI 10.1534/g3.113.009514; McGregor K, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0935-y; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Moody L, 2017, EPIGENOMICS-UK, V9, P1387, DOI 10.2217/epi-2017-0066; Newman T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166394; Norberg B, 2017, GEN COMP ENDOCR, V250, P21, DOI 10.1016/j.ygcen.2017.05.020; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Park LK, 2012, P NUTR SOC, V71, P75, DOI 10.1017/S0029665111003302; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Polak M, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1492; Sabet JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154979; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Seiliez I, 2017, AQUACULTURE, V471, P80, DOI 10.1016/j.aquaculture.2017.01.010; Sharma U, 2017, CELL METAB, V25, P544, DOI 10.1016/j.cmet.2017.02.003; Sheffield NC, 2017, NAT MED, V23, P386, DOI 10.1038/nm.4273; Silva-Martinez GA, 2016, EPIGENETICS-US, V11, P321, DOI 10.1080/15592294.2016.1161873; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Skjaerven KH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21211-5; Skjaerven KH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34535; Szyf M, 2007, TOXICOL SCI, V100, P7, DOI 10.1093/toxsci/kfm177; Thomas MH, 2016, BIOCHIMIE; Triggs AM, 2012, FUNCT ECOL, V26, P1409, DOI 10.1111/j.1365-2435.2012.02051.x; Veron V, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5048-4; Voisin S, 2015, EUR J HUM GENET, V23, P654, DOI 10.1038/ejhg.2014.139; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Waterland RA, 2009, HORM RES, V71, P13, DOI 10.1159/000178030; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Xue SS, 2015, BBA-MOL CELL BIOL L, V1851, P1317, DOI 10.1016/j.bbalip.2015.07.001; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu HL, 2015, BRIT J NUTR, V113, P1032, DOI 10.1017/S0007114515000252; Yuan T, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004996; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zenk F, 2017, SCIENCE, V357, P212, DOI 10.1126/science.aam5339; Zhang CS, 2016, FORESTS, V7, DOI 10.3390/f7100222; Zhang NF, 2018, ANIM NUTR, V4, P11, DOI 10.1016/j.aninu.2017.08.009; Zhang Y, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00505; Zilberman D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1230-2	89	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220934	10.1371/journal.pone.0220934	http://dx.doi.org/10.1371/journal.pone.0220934			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398226	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000028
J	Golestanirad, L; Kazemivalipour, E; Keil, B; Downs, S; Kirsch, J; Elahi, B; Pilitsis, J; Wald, LL				Golestanirad, Laleh; Kazemivalipour, Ehsan; Keil, Boris; Downs, Sean; Kirsch, John; Elahi, Behzad; Pilitsis, Julie; Wald, Lawrence L.			Reconfigurable MRI coil technology can substantially reduce RF heating of deep brain stimulation implants: First in-vitro study of RF heating reduction in bilateral DBS leads at 1.5 T	PLOS ONE			English	Article							CARDIAC-PACEMAKERS; SAFETY; WIRES; TESLA; SAR	Patients with deep brain stimulation (DBS) implants can significantly benefit from magnetic resonance imaging (MRI), however access to MRI is restricted in these patients because of safety concerns due to RF heating of the leads. Recently we introduced a patient-adjustable reconfigurable transmit coil for low-SAR imaging of DBS at 1.5T. A previous simulation study demonstrated a substantial reduction in the local SAR around single DBS leads in 9 unilateral lead models. This work reports the first experimental results of temperature measurement at the tips of bilateral DBS leads with realistic trajectories extracted from postoperative CT images of 10 patients (20 leads in total). A total of 200 measurements were performed to record temperature rise at the tips of the leads during 2 minutes of scanning with the coil rotated to cover all accessible rotation angles. In all patients, we were able to find an optimum coil rotation angle and reduced the heating of both left and right leads to a level below the heating produced by the body coil. An average heat reduction of 65% was achieved for bilateral leads. When considering each lead alone, an average heat reduction of 80% was achieved. Our results suggest that reconfigurable coil technology introduces a promising approach for imaging of patients with DBS implants.	[Golestanirad, Laleh] Northwestern Univ, Dept Biomed Engn, McCormick Sch Engn, Evanston, IL 60208 USA; [Golestanirad, Laleh] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; [Kazemivalipour, Ehsan] Bilkent Univ, Dept Elect & Elect Engn, Ankara, Turkey; [Keil, Boris] Inst Med Phys & Radiat Protect, Dept Life Sci Engn, Giessen, Germany; [Downs, Sean; Kirsch, John; Wald, Lawrence L.] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Elahi, Behzad] Bryan Hlth, Dept Neurol, Lincoln, NE USA; [Pilitsis, Julie] Albany Med Ctr, Dept Neurosurg, Albany, NY USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Ihsan Dogramaci Bilkent University; Harvard University; Massachusetts General Hospital; Albany Medical College	Golestanirad, L (corresponding author), Northwestern Univ, Dept Biomed Engn, McCormick Sch Engn, Evanston, IL 60208 USA.; Golestanirad, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA.	Laleh.rad1@northwestern.edu	Wald, Lawrence L/D-4151-2009; Keil, Boris/AAX-9557-2020; Golestanirad, Laleh/P-7096-2018	Wald, Lawrence L/0000-0001-8278-6307; Golestani Rad, Laleh/0000-0003-3869-6114; Keil, Boris/0000-0003-0805-8330; Kazemivalipour, Ehsan/0000-0003-4221-2397; Elahi, Behzad/0000-0002-4397-4935	National Institute of Health (NIH) [R03EB024705, R00EB021320]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB024705, R00EB021320] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	LG has received awards R03EB024705 and R00EB021320 from National Institute of Health (NIH).	Ackermans L, 2008, NEUROTHERAPEUTICS, V5, P339, DOI 10.1016/j.nurt.2008.01.009; Baker KB, 2005, NEUROSURGERY, V57, P392, DOI 10.1227/01.NEU.0000176877.26994.0C; Calcagnini G, 2008, J MAGN RESON IMAGING, V28, P879, DOI 10.1002/jmri.21536; Corripio I, 2016, BIOL PSYCHIAT, V80, pE69, DOI 10.1016/j.biopsych.2016.03.1049; Elwassif MM, 2006, J NEURAL ENG, V3, P306, DOI 10.1088/1741-2560/3/4/008; Eryaman Y., 2012, MAGNETIC RESONANCE M; Eryaman Y, 2019, NEUROIMAGE, V184, P658, DOI 10.1016/j.neuroimage.2018.09.072; Eryaman Y, 2015, MAGN RESON MED, V73, P1896, DOI 10.1002/mrm.25324; Eryaman Y, 2011, MAGN RESON MED, V65, P1305, DOI 10.1002/mrm.22724; Finelli DA, 2002, AM J NEURORADIOL, V23, P1795; Golestanirad L, 2018, MAGNETIC RESONANCE M; Golestanirad L, 2017, 25 ANN M INT SOSC MA; Golestanirad L, 2019, IEEE T MICROW THEORY, V67, P1265, DOI 10.1109/TMTT.2018.2885517; Golestanirad L, 2019, NEUROIMAGE, V184, P566, DOI 10.1016/j.neuroimage.2018.09.034; Golestanirad L, 2017, MAGN RESON MED, V78, P1558, DOI 10.1002/mrm.26535; Golestanirad L, 2017, MAGN RESON MED, V77, P1701, DOI 10.1002/mrm.26220; Golestanirad L, 2017, NEUROIMAGE, V147, P577, DOI 10.1016/j.neuroimage.2016.12.056; Golestanirad L, 2016, CAN J NEUROL SCI, V43, P120, DOI 10.1017/cjn.2015.318; Holtzheimer PE, 2012, ARCH GEN PSYCHIAT, V69, P150, DOI 10.1001/archgenpsychiatry.2011.1456; Hoult DI, 2000, CONCEPT MAGNETIC RES, V12, P173, DOI 10.1002/1099-0534(2000)12:4<173::AID-CMR1>3.0.CO;2-Q; Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029; Mattei E, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-11; McElcheran CE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38099-w; McElcheran Clare, 2014, JOINT ANN M INT SOC; McElcheran CE, 2017, MAGN RESON MED, V78, P2406, DOI 10.1002/mrm.26622; McElcheran CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134379; Moeschler SM, 2015, NEUROMODULATION, V18, P285, DOI 10.1111/ner.12254; Nitz WR, 2001, J MAGN RESON IMAGING, V13, P105, DOI 10.1002/1522-2586(200101)13:1<105::AID-JMRI1016>3.0.CO;2-0; Nordbeck P, 2011, MAGN RESON MED, V65, P44, DOI 10.1002/mrm.22592; Ondo W, 2001, ARCH NEUROL-CHICAGO, V58, P218, DOI 10.1001/archneur.58.2.218; Park SM, 2007, J MAGN RESON IMAGING, V26, P1278, DOI 10.1002/jmri.21159; Rezai AR, 2004, INVEST RADIOL, V39, P300, DOI 10.1097/01.rli.0000124940.02340.ab; Rezai AR, 2002, J MAGN RESON IMAGING, V15, P241, DOI 10.1002/jmri.10069; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Schrock LE, 2015, MOVEMENT DISORD, V30, P448, DOI 10.1002/mds.26094; Shellock FG, 2007, J CARDIOVASC MAGN R, V9, P21, DOI 10.1080/10976640600897237; Sommer T, 2006, CIRCULATION, V114, P1285, DOI 10.1161/CIRCULATIONAHA.105.597013; Taba HA, 2010, J NEUROSURG, V113, P1224, DOI 10.3171/2010.8.JNS10312; Tagliati M, 2009, NEUROIMAGE, V47, pT53, DOI 10.1016/j.neuroimage.2009.04.044; US Food and Drug Administration, 2017, FDA EX SUMM MEDTR AC; US Food and Drug Administration (FDA), 2018, MEDTR DBS SYST EP; US Food and Drug Administration (FDA), 2009, MEDTR ACTIVA DEEP BR; Yeung CJ, 2002, MAGNET RESON MED, V48, P1096, DOI 10.1002/mrm.10310	43	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220043	10.1371/journal.pone.0220043	http://dx.doi.org/10.1371/journal.pone.0220043			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390346	Green Submitted, Green Published, gold			2022-12-27	WOS:000484999400010
J	Hatano, M; Tokuda, K; Kobayashi, Y; Yamashiro, C; Uchi, SH; Kobayashi, M; Kimura, K				Hatano, Makoto; Tokuda, Kazuhiro; Kobayashi, Yuka; Yamashiro, Chiemi; Uchi, Sho-Hei; Kobayashi, Masaaki; Kimura, Kazuhiro			Inhibitory effect of nintedanib on VEGF secretion in retinal pigment epithelial cells induced by exposure to a necrotic cell lysate	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCED CHOROIDAL NEOVASCULARIZATION; TRIPLE ANGIOKINASE INHIBITOR; MACULAR DEGENERATION; INFLAMMATION; KINASE; PROGRESSION; ACTIVATION; PI3K/AKT; THERAPY	Necrosis is a form of cell death that results in rupture of the plasma membrane and the release of cellular contents, and it can give rise to sterile inflammation in the retina and other tissues. The secretion of vascular endothelial growth factor (VEGF) by retinal pigment epithelial (RPE) cells contributes to retinal homeostasis as well as to pathological angiogenesis. We have now examined the effect of a necrotic cell lysate prepared from human RPE cells (NLR) on the release of VEGF by healthy RPE cells. We found that NLR markedly increased the release of VEGF from RPE cells and that this effect was attenuated by nintedanib, a multiple receptor tyrosine kinase inhibitor, whereas it was unaffected by inhibitors of NF-kappa B signaling or of caspase-1. NLR also induced the phosphorylation of extracellular signal-regulated kinase (Erk) and signal transducer and activator of transcription 3 (Stat3) in a manner sensitive to inhibition by nintedanib, although inhibitors of Erk and Stat3 signaling pathways did not affect NLR-induced VEGF secretion. In addition, nintedanib attenuated the development of choroidal neovascularization in mice. Our results have thus shown that a necrotic lysate of RPE cells induced VEGF secretion from healthy RPE cells and that this effect was mediated by receptor tyrosine kinase signaling. They therefore suggest that VEGF secretion by healthy RPE cells is a potential therapeutic target for retinal diseases associated with sterile inflammation and pathological angiogenesis.	[Hatano, Makoto; Tokuda, Kazuhiro; Kobayashi, Yuka; Yamashiro, Chiemi; Uchi, Sho-Hei; Kobayashi, Masaaki; Kimura, Kazuhiro] Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Ube, Yamaguchi, Japan	Yamaguchi University	Kimura, K (corresponding author), Yamaguchi Univ, Dept Ophthalmol, Grad Sch Med, Ube, Yamaguchi, Japan.	kimura@yamaguchi-u.ac.jp						Ambati J, 2011, INVEST OPHTH VIS SCI, V52, P2166, DOI 10.1167/iovs.11-7328; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Chan-Ling T, 2006, AM J PATHOL, V168, P1031, DOI 10.2353/ajpath.2006.050697; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Feenstra Derrick J, 2013, J Clin Exp Ophthalmol, V4, P298; Fleshner M, 2017, NEUROPSYCHOPHARMACOL, V42, P36, DOI 10.1038/npp.2016.125; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; GJNRI, 2010, STERILE INFLAMMATION, V10, P826; Hanus J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.478; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Kang S, 2013, CURR EYE RES, V38, P119, DOI 10.3109/02713683.2012.727520; Kent D, 2003, MOL VIS, V9, P747; Kimura K, 2015, J MOL MED, V93, P749, DOI 10.1007/s00109-015-1289-8; Kobayashi M, 2019, INVEST OPHTH VIS SCI, V60, P528, DOI 10.1167/iovs.18-25678; Kobayashi Y, 2016, LAB INVEST, V96, P1178, DOI 10.1038/labinvest.2016.99; Krause TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094313; Krysko O, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.156; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kutikhin AG, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00343; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Ledermann JA, 2011, J CLIN ONCOL, V29, P3798, DOI 10.1200/JCO.2010.33.5208; Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125001; Murakami Y, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.58; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Pandolfi F, 2016, CLIN THER, V38, P1017, DOI 10.1016/j.clinthera.2016.02.028; Park GB, 2018, MOL MED REP, V17, P3563, DOI 10.3892/mmr.2017.8355; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Qin SF, 2011, EXP EYE RES, V93, P889, DOI 10.1016/j.exer.2011.10.002; Qiu YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep14362; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Salvi V, 2016, ONCOTARGET, V7, P39256, DOI 10.18632/oncotarget.9684; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Seo MS, 1999, AM J PATHOL, V154, P1743, DOI 10.1016/S0002-9440(10)65430-2; Simo R, 2010, RETINAL PIGMENT EPIT, V2010; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Szade A, 2015, IUBMB LIFE, V67, P145, DOI 10.1002/iub.1358; Yan YJ, 2017, BIOL PHARM BULL, V40, P2088, DOI 10.1248/bpb.b17-00319; Yi XJ, 1997, GRAEF ARCH CLIN EXP, V235, P313, DOI 10.1007/BF01739641; Zeisel MB, 2005, J IMMUNOL, V174, P7393, DOI 10.4049/jimmunol.174.11.7393; Zhou QB, 2014, MOL THER, V22, P378, DOI 10.1038/mt.2013.243; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034; Zhuang Z, 2015, MOL VIS, V21, P1173	51	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0218632	10.1371/journal.pone.0218632	http://dx.doi.org/10.1371/journal.pone.0218632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386668	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100004
J	Blanco-Rayon, E; Ivanina, AV; Sokolova, IM; Marigomez, I; Izagirre, U				Blanco-Rayon, Esther; Ivanina, Anna, V; Sokolova, Inna M.; Marigomez, Ionan; Izagirre, Urtzi			Food-type may jeopardize biomarker interpretation in mussels used in aquatic toxicological experimentation	PLOS ONE			English	Article							WATER-ACCOMMODATED FRACTION; MYTILUS-GALLOPROVINCIALIS; DIGESTIVE GLAND; MARINE MUSSEL; LYSOSOMAL RESPONSES; HEAVY-METALS; DNA-DAMAGE; TRANSCRIPTIONAL RESPONSES; QUANTITATIVE ALTERATIONS; MEDITERRANEAN MUSSEL	To assess the influence of food type on biomarkers, mussels (Mytilus galloprovincialis) were maintained under laboratory conditions and fed using 4 different microalgae diets ad libitum for 1 week: (a) Isochrysis galbana; (b) Tetraselmis chuii; (c) a mixture of I. galbana and T. chuii; and (d) a commercial food (Microalgae Composed Diet, Acuinuga). Different microalgae were shown to present different distribution and fate in the midgut. I. galbana (approximate to 4 mu m empty set) readily reached digestive cells to be intracellularly digested. T. chuii (approximate to 10 mu m empty set and hardly digestible) was retained in stomach and digestive ducts for long times and extracellularly digested. Based on these findings, it appeared likely that the presence of large amounts of microalgal enzymes and metabolites might interfere with biochemical determinations of mussel's biomarkers and/or that the diet-induced alterations of mussels' digestion could modulate lysosomal and tissue-level biomarkers. To test these hypotheses, a battery of common biochemical, cytological and tissue-level biomarkers were determined in the gills (including activities of pyruvate kinase, phosphoenolpyruvate carboxykinase and cytochrome c oxidase) and the digestive gland of the mussels (including protein, lipid, free glucose and glycogen total content, lysosomal structural changes and membrane stability, intracellular accumulation of neutral lipids and lipofuscins, changes in cell type composition and epithelial thinning, as well as altered tissue integrity). The type of food was concluded to be a major factor influencing biomarkers in short-term experiments though not all the microalgae affected biomarkers and their responsiveness in the same way. T. chuii seemed to alter the nutritional status, oxidative stress and digestion processes, thus interfering with a variety of biomarkers. On the other hand, the massive presence of I. galbana within digestive cells hampered the measurement of cytochemical biomarkers and rendered less reliable the results of biochemical biomarkers (as these could be attributed to both the mussel and the microalgae). Research to optimize dietary food type, composition, regime and rations for toxicological experimentation is urgently needed. Meanwhile, a detailed description of the food type and feeding conditions should be always provided when reporting aquatic toxicological experiments with mussels, as a necessary prerequisite to compare and interpret the biological responses elicited by pollutants.	[Blanco-Rayon, Esther; Marigomez, Ionan; Izagirre, Urtzi] Univ Basque Country, UPV EHU, Dept Zool & Anim Cell Biol, CBET Res Grp, Leioa, Basque Country, Spain; [Blanco-Rayon, Esther; Marigomez, Ionan; Izagirre, Urtzi] Univ Basque Country, PiE UPV EHU, Plentzia Marine Stn, Res Ctr Expt Marine Biol & Biotechnol, Plentzia, Basque Country, Spain; [Ivanina, Anna, V; Sokolova, Inna M.] Univ N Carolina, Dept Biol Sci, Charlotte, NC USA; [Sokolova, Inna M.] Univ Rostock, Interdisciplinary Fac, Dept Marine Biol, Inst Biosci, Rostock, Germany; [Sokolova, Inna M.] Univ Rostock, Interdisciplinary Fac, Dept Maritime Syst, Rostock, Germany	University of Basque Country; University of Basque Country; University of North Carolina; University of North Carolina Charlotte; University of Rostock; University of Rostock	Marigomez, I (corresponding author), Univ Basque Country, UPV EHU, Dept Zool & Anim Cell Biol, CBET Res Grp, Leioa, Basque Country, Spain.; Marigomez, I (corresponding author), Univ Basque Country, PiE UPV EHU, Plentzia Marine Stn, Res Ctr Expt Marine Biol & Biotechnol, Plentzia, Basque Country, Spain.	ionan.marigomez@ehu.eus	Sokolova, Inna M./B-4955-2009; MARIGOMEZ, Ionan/C-3909-2017; Sokolova, Inna/AAE-4150-2019; Izagirre, Urtzi/C-3848-2017	Sokolova, Inna M./0000-0002-2068-4302; MARIGOMEZ, Ionan/0000-0001-6274-541X; Sokolova, Inna/0000-0002-2068-4302; Izagirre, Urtzi/0000-0002-3477-4974	Spanish Ministry of Economy and Finance [BMW-CTM2012-40203-C02-01]; University of the Basque Country UPV/EHU [UFI 11/37]; Basque Government [IT810-B]; Department of Education of the Basque Government [PRE2013 1 640]	Spanish Ministry of Economy and Finance(Spanish Government); University of the Basque Country UPV/EHU; Basque Government(Basque Government); Department of Education of the Basque Government	This work was funded by the Spanish Ministry of Economy and Finance (BMW-CTM2012-40203-C02-01), the University of the Basque Country UPV/EHU (UFI 11/37) and the Basque Government (Consolidated Research Groups Grant IT810-B). EB-R was recipient of a doctoral fellowship (PRE2013 1 640) financed by the Department of Education of the Basque Government (Eusko Jaurlaritza).	Albentosa M, 1997, AQUACULTURE, V154, P305, DOI 10.1016/S0044-8486(97)00057-4; ARANDA DA, 1994, AQUACULTURE, V126, P151, DOI 10.1016/0044-8486(94)90256-9; Attig H, 2010, ECOTOX ENVIRON SAFE, V73, P1712, DOI 10.1016/j.ecoenv.2010.08.007; Banni M, 2010, ECOTOX ENVIRON SAFE, V73, P842, DOI 10.1016/j.ecoenv.2009.12.032; Barmo C, 2012, COMP BIOCHEM PHYS A, V163, pS11, DOI 10.1016/j.cbpa.2012.05.037; Barmo C, 2011, CHEMOSPHERE, V83, P1087, DOI 10.1016/j.chemosphere.2011.01.037; Baussant T, 2011, MAR POLLUT BULL, V62, P1437, DOI 10.1016/j.marpolbul.2011.04.029; Bebianno MJ, 1998, SCI TOTAL ENVIRON, V214, P123, DOI 10.1016/S0048-9697(98)00059-X; Becker B, 1998, J PHYCOL, V34, P779, DOI 10.1046/j.1529-8817.1998.340779.x; Bergmeyer H., 1985, METHODS ENZYMATIC AN, VVI; Bergmeyer H.U., 1985, METHODS ENZYMATIC AN, VVIII; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Blanco-Rayon E, 2019, J INVERTEBR PATHOL, V161, P29, DOI 10.1016/j.jip.2019.01.001; Blanco-Rayon E, 2019, AQUAT TOXICOL, V206, P164, DOI 10.1016/j.aquatox.2018.11.016; Brate ILN, 2018, SCI TOTAL ENVIRON, V626, P1310, DOI 10.1016/j.scitotenv.2018.01.141; BRICELJ VM, 1984, MAR ECOL PROG SER, V17, P57, DOI 10.3354/meps017057; Brooks SPJ, 1997, COMP BIOCHEM PHYS A, V118, P1103, DOI 10.1016/S0300-9629(97)00237-5; Brooks S, 2011, MAR POLLUT BULL, V62, P327, DOI 10.1016/j.marpolbul.2010.10.007; Brooks SJ, 2015, AQUAT TOXICOL, V160, P1, DOI 10.1016/j.aquatox.2014.12.018; CAJARAVILLE MP, 1991, ARCH ENVIRON CON TOX, V21, P395, DOI 10.1007/BF01060362; CAJARAVILLE MP, 1995, ENVIRON TOXIC WATER, V10, P1, DOI 10.1002/tox.2530100102; Cajaraville MP, 1997, COMP BIOCHEM PHYS C, V117, P233, DOI 10.1016/S0742-8413(97)00057-1; CAJARAVILLE MP, 1990, DIS AQUAT ORGAN, V9, P221, DOI 10.3354/dao009221; CAJARAVILLE MP, 1992, COMP BIOCHEM PHYS C, V102, P113; CAJARAVILLE MP, 1992, COMP BIOCHEM PHYS C, V102, P103, DOI 10.1016/0742-8413(92)90051-8; Cancio I, 1999, COMP BIOCHEM PHYS C, V123, P135, DOI 10.1016/S0742-8413(99)00019-5; Cancio I, 1998, TOXICOL APPL PHARM, V149, P64, DOI 10.1006/taap.1997.8358; Canesi L, 1998, COMP BIOCHEM PHYS C, V120, P261, DOI 10.1016/S0742-8413(98)10004-X; Canesi L, 1999, AQUAT TOXICOL, V46, P67, DOI 10.1016/S0166-445X(98)00116-7; Cappello T, 2017, ECOTOX ENVIRON SAFE, V143, P166, DOI 10.1016/j.ecoenv.2017.05.031; Cavaletto M, 2002, COMP BIOCHEM PHYS C, V131, P447, DOI 10.1016/S1532-0456(02)00030-3; Chandurvelan R, 2013, COMP BIOCHEM PHYS A, V164, P84, DOI 10.1016/j.cbpa.2012.10.011; Chandurvelan R, 2012, AQUAT TOXICOL, V124, P114, DOI 10.1016/j.aquatox.2012.07.013; Chaparro OR, 2001, MAR ECOL PROG SER, V222, P119, DOI 10.3354/meps222119; COUCH JA, 1984, MAR ENVIRON RES, V14, P525, DOI 10.1016/0141-1136(84)90145-4; CROSBY ND, 1971, CAN J ZOOLOG, V49, P617, DOI 10.1139/z71-099; Culling CFA, 1974, HDB HISTOPATHOLOGICA, V3rd; Dallas LJ, 2018, CHEMOSPHERE, V196, P531, DOI 10.1016/j.chemosphere.2017.12.144; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Davies IM, 2012, ICES COOPERATIVE RES; Dimitriadis VK, 2012, MAR ENVIRON RES, V73, P70, DOI 10.1016/j.marenvres.2011.11.004; Domouhtsidou GP, 2000, ARCH ENVIRON CON TOX, V38, P472, DOI 10.1007/s002449910062; Dondero F, 2010, SCI TOTAL ENVIRON, V408, P3775, DOI 10.1016/j.scitotenv.2010.03.040; Faria M, 2018, SCI TOTAL ENVIRON, V625, P1467, DOI 10.1016/j.scitotenv.2017.12.274; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fontes MK, 2018, WATER RES, V132, P361, DOI 10.1016/j.watres.2017.12.077; Franzellitti S, 2012, AQUAT TOXICOL, V124, P125, DOI 10.1016/j.aquatox.2012.07.011; Garmendia L, 2011, J ENVIRON MONITOR, V13, P915, DOI 10.1039/c0em00410c; Giuliani ME, 2013, AQUAT TOXICOL, V134, P120, DOI 10.1016/j.aquatox.2013.03.012; Gonzalez-Fernandez C, 2016, AQUAT TOXICOL, V177, P211, DOI 10.1016/j.aquatox.2016.05.027; Gonzalez-Fernandez C, 2015, AQUAT TOXICOL, V167, P90, DOI 10.1016/j.aquatox.2015.07.007; Gonzalez-Rey M, 2012, ENVIRON TOXICOL PHAR, V33, P361, DOI 10.1016/j.etap.2011.12.017; Gueguen M, 2008, AQUAT LIVING RESOUR, V21, P21, DOI 10.1051/alr:2008018; Guerra-Rivas G, 2002, COMP BIOCHEM PHYS C, V132, P171, DOI 10.1016/S1532-0456(02)00061-3; HARRISON FL, 1982, MAR BIOL, V68, P109, DOI 10.1007/BF00397598; HAWKINS AJS, 1984, MAR BIOL, V82, P233, DOI 10.1007/BF00392404; HOLWERDA DA, 1981, MOL PHYSIOL, V1, P165; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Ibarrola I, 2017, AQUACULTURE, V479, P544, DOI 10.1016/j.aquaculture.2017.06.031; Ivanina AV, 2016, J EXP BIOL, V219, P1659, DOI 10.1242/jeb.134700; Ivanina AV, 2010, AQUAT TOXICOL, V99, P330, DOI 10.1016/j.aquatox.2010.05.013; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Izagirre U., 2007, THESIS; Izagirre U, 2014, AQUAT TOXICOL, V149, P145, DOI 10.1016/j.aquatox.2014.01.013; Izagirre U, 2008, MAR ECOL PROG SER, V372, P105, DOI 10.3354/meps07656; Izagirre U, 2009, COMP BIOCHEM PHYS C, V149, P587, DOI 10.1016/j.cbpc.2009.01.004; Jimeno-Romero A, 2016, NANOTOXICOLOGY, V10, P1168, DOI 10.1080/17435390.2016.1196250; Fernandez-Reiriz MJ, 2015, AQUACULTURE, V446, P42, DOI 10.1016/j.aquaculture.2015.04.025; Keppler D., 1984, METHOD ENZYMAT AN, V6, P11; KRISHNAKUMAR PK, 1994, MAR ECOL PROG SER, V106, P249, DOI 10.3354/meps106249; Lacroix C, 2015, AQUAT TOXICOL, V162, P126, DOI 10.1016/j.aquatox.2015.03.008; Lima I, 2008, MAR POLLUT BULL, V56, P633, DOI 10.1016/j.marpolbul.2008.01.018; Lucassen M, 2003, AM J PHYSIOL-REG I, V285, pR1410, DOI 10.1152/ajpregu.00111.2003; Maria VL, 2011, COMP BIOCHEM PHYS C, V154, P56, DOI 10.1016/j.cbpc.2011.02.004; Marigomez I, 2005, COMP BIOCHEM PHYS C, V141, P188, DOI 10.1016/j.cca.2005.06.005; Marigomez I, 2003, AQUAT TOXICOL, V64, P235, DOI 10.1016/S0166-445X(03)00056-0; Marigomez I, 2006, MAR POLLUT BULL, V53, P287, DOI 10.1016/j.marpolbul.2005.09.026; Martinez-Fernandeza E, 2004, AQUACULTURE, V230, P417, DOI 10.1016/S0044-8486(03)00416-2; Mezzelani M, 2016, AQUAT TOXICOL, V180, P306, DOI 10.1016/j.aquatox.2016.10.006; Milan M, 2018, ENVIRON POLLUT, V237, P442, DOI 10.1016/j.envpol.2018.02.049; Moore MN, 2007, AQUAT TOXICOL, V84, P80, DOI 10.1016/j.aquatox.2007.06.007; Moore MN, 2004, MAR ENVIRON RES, V58, P603, DOI 10.1016/j.marenvres.2004.03.049; Moore MN, 2004, 36 ICES TIMES, P31; Morley SA, 2009, COMP BIOCHEM PHYS A, V152, P423, DOI 10.1016/j.cbpa.2008.11.015; Mugica M, 2015, AQUAT TOXICOL, V164, P99, DOI 10.1016/j.aquatox.2015.04.020; Mugica M, 2015, MAR ENVIRON RES, V103, P1, DOI 10.1016/j.marenvres.2014.10.005; Nardi A, 2017, CHEMOSPHERE, V169, P493, DOI 10.1016/j.chemosphere.2016.11.093; Okay OS, 2006, ENVIRON INT, V32, P538, DOI 10.1016/j.envint.2005.12.005; Oliveira P, 2017, WATER RES, V117, P102, DOI 10.1016/j.watres.2017.03.052; Ortiz-Zarragoitia M, 2006, ARCH ENVIRON CON TOX, V50, P361, DOI 10.1007/s00244-005-1082-8; Ortiz-Zarragoitia M, 2011, J ENVIRON MONITOR, V13, P84, DOI 10.1039/c0em00102c; Patetsini E, 2012, COMP BIOCHEM PHYS A, V163, pS26, DOI 10.1016/j.cbpa.2012.05.082; Paul-Pont I, 2016, ENVIRON POLLUT, V216, P724, DOI 10.1016/j.envpol.2016.06.039; Pearse A. G. E., 1972, HISTOCHEMISTRY THEOR, V2, P761; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; PIPE RK, 1985, MAR BIOL, V87, P157, DOI 10.1007/BF00539423; REGOLI F, 1992, MAR ECOL PROG SER, V84, P63, DOI 10.3354/meps084063; Ricciardi F, 2008, MAR POLLUT BULL, V57, P365, DOI 10.1016/j.marpolbul.2008.02.023; Rocha TL, 2016, AQUAT TOXICOL, V177, P306, DOI 10.1016/j.aquatox.2016.06.003; Rouillon G, 2003, ACTA OECOL, V24, pS299, DOI 10.1016/S1146-609X(03)00029-8; Ruiz P, 2015, MAR ENVIRON RES, V111, P107, DOI 10.1016/j.marenvres.2015.07.018; Satoh A, 2005, ENVIRON INT, V31, P713, DOI 10.1016/j.envint.2005.01.001; Serafim MA, 2002, MAR ENVIRON RES, V54, P361, DOI 10.1016/S0141-1136(02)00121-6; Shaw JP, 2011, MAR ENVIRON RES, V72, P13, DOI 10.1016/j.marenvres.2011.05.003; SIDELL BD, 1987, PHYSIOL ZOOL, V60, P221, DOI 10.1086/physzool.60.2.30158646; SIMON LM, 1971, INT J BIOCHEM, V2, P569, DOI 10.1016/0020-711X(71)90026-7; Sokolova IM, 2000, J COMP PHYSIOL B, V170, P91, DOI 10.1007/s003600050264; Sokolova IM, 2001, MAR ECOL PROG SER, V224, P171, DOI 10.3354/meps224171; Sokolova I, 2018, INTEGR COMP BIOL, V58, P519, DOI 10.1093/icb/icy017; Sole M, 2007, SCI MAR, V71, P373, DOI 10.3989/scimar.2007.71n2373; Sole M, 2010, ANAL BIOANAL CHEM, V396, P649, DOI 10.1007/s00216-009-3182-1; Soto M, 1996, TISSUE CELL, V28, P557, DOI 10.1016/S0040-8166(96)80058-9; Southgate PC, 2017, AQUACULTURE, V473, P443, DOI 10.1016/j.aquaculture.2017.02.032; Speciale A, 2018, ECOTOX ENVIRON SAFE, V150, P96, DOI 10.1016/j.ecoenv.2017.12.038; STOREY KB, 1995, J EXP MAR BIOL ECOL, V188, P99, DOI 10.1016/0022-0981(94)00191-F; Taban IC, 2004, MAR ENVIRON RES, V58, P701, DOI 10.1016/j.marenvres.2004.03.018; Tizon RU, 2013, ISR J AQUAC, V890, P1; Torre A, 2013, TOXICOL IN VITRO, V27, P1260, DOI 10.1016/j.tiv.2013.02.017; UNEP/RAMOGE, 1999, MAN BIOM REC MED POL; VEGA MM, 1989, MAR BIOL, V103, P547, DOI 10.1007/BF00399587; VIARENGO A, 1991, COMP BIOCHEM PHYS C, V100, P187, DOI 10.1016/0742-8413(91)90151-I; Vidal-Linan L, 2016, ENVIRON POLLUT, V214, P885, DOI 10.1016/j.envpol.2016.04.083; Vidal-Linan L, 2013, SCI TOTAL ENVIRON, V461, P56, DOI 10.1016/j.scitotenv.2013.04.079; WIDDOWS J, 1982, MAR BIOL, V67, P15, DOI 10.1007/BF00397090; Woo S, 2011, COMP BIOCHEM PHYS D, V6, P348, DOI 10.1016/j.cbd.2011.07.003; You LP, 2013, FISH SHELLFISH IMMUN, V35, P343, DOI 10.1016/j.fsi.2013.04.021; Zaldibar B, 2007, AQUAT TOXICOL, V81, P183, DOI 10.1016/j.aquatox.2006.12.007	127	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220661	10.1371/journal.pone.0220661	http://dx.doi.org/10.1371/journal.pone.0220661			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381612	Green Submitted, Green Published, gold			2022-12-27	WOS:000484993600027
J	Boggett, S; Ou-Young, J; Heiberg, J; De Steiger, R; Richardson, M; Williams, Z; Royse, C				Boggett, Stuart; Ou-Young, Jared; Heiberg, Johan; De Steiger, Richard; Richardson, Martin; Williams, Zelda; Royse, Colin			A randomized trial of desflurane or sevoflurane on postoperative quality of recovery after knee arthroscopy	PLOS ONE			English	Article							MORRIS WATER MAZE; OUTPATIENT ANESTHESIA; COGNITIVE FUNCTION; AIRWAY REFLEXES; SURGERY; MAINTENANCE; ISOFLURANE; MEMORY; DURATION; DEFICITS	Background Studies have described different recovery profiles of sevoflurane and desflurane typically early after surgery. Methods We conducted a randomized superiority trial to determine whether Overall Recovery 3 days after knee arthroscopy would be superior with desflurane. Adult participants undergoing knee arthroscopic surgery with general anesthesia were randomized to either desflurane or sevoflurane general anesthesia. Intraoperative and postoperative drugs and analgesics were administered at the discretion of the anesthesiologist. Postoperative quality of recovery was assessed using the "Postoperative Quality of Recovery Scale". The primary outcome was Overall Recovery 3 days after surgery and secondary outcomes were individual recovery domains at 15 minutes, 40 minutes, 1 day, 3 days, 1 month, and 3 months. Patients and researchers were blinded. Results 300 patients were randomized to sevoflurane or desflurane (age 51.7 +/- 14.1 vs. 47.3 +/- 13.5 years; duration of anesthesia 24.9 +/- 11.1 vs. 23.3 +/- 8.3 minutes). The proportion achieving baseline or better scores in all domains increased over the follow-up period in both groups but was not different at day 3 (sevoflurane 43% vs. desflurane 37%, p = 0.314). Similarly, rates of recovery increased over time in the five subdomains, with no differences between groups for physiological, p = 0.222; nociceptive, p = 0.391; emotive, p = 0.30; Activities-of-daily-living, p = 0.593; and cognitive recovery, p = 0.877. Conclusion No significant difference in the quality of recovery scale could be shown using sevoflurane or desflurane general anesthesia after knee arthroscopy in adult participants.	[Boggett, Stuart; Ou-Young, Jared; Williams, Zelda; Royse, Colin] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia; [Heiberg, Johan] Aarhus Univ, Dept Cardiothorac & Vasc Surg, Aarhaus, Denmark; [De Steiger, Richard; Richardson, Martin] Univ Melbourne, Epworth Healthcare Campus, Melbourne, Vic, Australia; [Royse, Colin] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Melbourne, Vic, Australia; [Royse, Colin] Cleveland Clin, Outcomes Res Consortium, Cleveland, OH 44106 USA	University of Melbourne; Aarhus University; University of Melbourne; Royal Melbourne Hospital; Cleveland Clinic Foundation	Royse, C (corresponding author), Univ Melbourne, Dept Surg, Melbourne, Vic, Australia.; Royse, C (corresponding author), Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Melbourne, Vic, Australia.; Royse, C (corresponding author), Cleveland Clin, Outcomes Res Consortium, Cleveland, OH 44106 USA.	colin.royse@unimelb.edu.au	Richardson, Martin/H-2272-2018	Richardson, Martin/0000-0002-1280-3834; Ou-Young, Jared/0000-0002-3110-350X; Boggett, Stuart/0000-0002-0117-6425				Callaway JK, 2016, BEHAV BRAIN RES, V303, P44, DOI 10.1016/j.bbr.2016.01.032; Callaway JK, 2015, J ALZHEIMERS DIS, V44, P995, DOI 10.3233/JAD-132444; Callaway JK, 2012, ANESTHESIOLOGY, V117, P1091, DOI 10.1097/ALN.0b013e31826cb228; Callaway JK, 2012, EUR J ANAESTH, V29, P239, DOI 10.1097/EJA.0b013e32835103c1; Chen XG, 2001, ANESTH ANALG, V93, P1489, DOI 10.1097/00000539-200112000-00029; Dogru K, 2003, CURR THER RES CLIN E, V64, P301, DOI 10.1016/S0011-393X(03)00086-9; EGER EI, 1987, ANESTH ANALG, V66, P977; Ergonenc Jalan, 2014, Anesth Essays Res, V8, P367, DOI 10.4103/0259-1162.143151; Green Michael S, 2015, Anesth Pain Med, V5, pe22271, DOI 10.5812/aapm.22271; Heiberg J, 2017, ARCH PSYCHOL, V1, P1; Jindal R, 2011, INDIAN J ANAESTH, V55, P36, DOI 10.4103/0019-5049.76604; Mahmoud NA, 2001, ANAESTHESIA, V56, P171, DOI 10.1046/j.1365-2044.2001.01528.x; McKay RE, 2010, BRIT J ANAESTH, V104, P175, DOI 10.1093/bja/aep374; Mckay RE, 2005, ANESTH ANALG, V100, P697, DOI 10.1213/01.ANE.0000146514.65070.AE; NATHANSON MH, 1995, ANESTH ANALG, V81, P1186, DOI 10.1097/00000539-199512000-00012; Newman S, 2014, ACTA ANAESTH SCAND, V58, P185, DOI 10.1111/aas.12234; Rortgen D, 2010, BRIT J ANAESTH, V104, P167, DOI 10.1093/bja/aep369; Royse CF, 2014, ACTA ANAESTH SCAND, V58, P660, DOI 10.1111/aas.12273; Royse CF, 2014, ACTA ANAESTH SCAND, V58, P345, DOI 10.1111/aas.12264; Royse CF, 2011, ANAESTHESIA, V66, P455, DOI 10.1111/j.1365-2044.2011.06704.x; Royse CF, 2013, ANESTHESIOLOGY, V119, P576, DOI 10.1097/ALN.0b013e318299f72b; Royse CF, 2010, ANESTHESIOLOGY, V113, P892, DOI 10.1097/ALN.0b013e3181d960a9; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Tarazi EM, 1998, J CLIN ANESTH, V10, P272, DOI 10.1016/S0952-8180(98)00027-0; White PF, 2009, ANESTH ANALG, V109, P387, DOI 10.1213/ane.0b013e3181adc21a	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220733	10.1371/journal.pone.0220733	http://dx.doi.org/10.1371/journal.pone.0220733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381593	Green Published, gold			2022-12-27	WOS:000484993600034
J	Ah, YM; Han, E; Jun, K; Yu, YM; Lee, JY				Ah, Young-Mi; Han, Euna; Jun, Kwanghee; Yu, Yun Mi; Lee, Ju-Yeun			Change in sedative burden after dementia onset using difference-in-difference estimations	PLOS ONE			English	Article							MEDICATION USE; OLDER-PEOPLE; DRUG-USE; LOAD; MORTALITY; RISK; CARE; POPULATION; PREVALENCE; RESIDENTS	Background Sedative agents are avoided in older adults because of potential risks including cognitive impairment, fall, frailty, and mortality. However, no studies addressing both prediagnostic and postdiagnostic period of dementia have evaluated sedative agent usage over an extended period. Objectives To describe a longitudinal change in sedative medication use before and after the diagnosis with dementia over 10 years compared to patients without dementia. Methods We conducted a retrospective cohort study using longitudinal claims data for senior national health insurance beneficiaries. After 1:4 propensity score matching, 54,165 older patients (>= 60 years) were included. Difference-in-difference (DID) of sedative burden and use of sedative agents pre- and post-dementia diagnosis were estimated, and compared to those of patients without dementia. The yearly average daily sedative load (adSL) for each individual was calculated after applying duration, dose, and sedative score of medications from the sedative load model. The medication use for each sedative category was calculated using the defined daily dose (DDD) per 1000 patient-days. Results The adSL in patients with dementia was consistently high before and after diagnosis and significantly increased after diagnosis, compared to those of patients without dementia (DID 0.123 unit/day, 95% confidence interval 0.117-0.129). DID of medication use was the highest for antidepressants (64.764 DDD/1000 patient-days) followed by Z-drugs and antipsychotics. Atypical antipsychotic and antidepressant usage steeply increased after dementia diagnosis. Conclusion Sedative burden in patients with dementia before and after dementia diagnosis was higher than that in patients without dementia, and was further increased after dementia diagnosis.	[Ah, Young-Mi] Yeungnam Univ, Coll Pharm, Gyeongsangbuk Do, South Korea; [Han, Euna; Yu, Yun Mi] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Res, Incheon, South Korea; [Jun, Kwanghee; Lee, Ju-Yeun] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Jun, Kwanghee; Lee, Ju-Yeun] Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea	Yeungnam University; Yonsei University; Seoul National University (SNU); Seoul National University (SNU)	Lee, JY (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.; Lee, JY (corresponding author), Seoul Natl Univ, Res Inst Pharmaceut Sci, Seoul, South Korea.	jypham@snu.ac.kr		Yu, Yun Mi/0000-0002-8267-9453; Han, Euna/0000-0003-2656-7059; Lee, Ju-Yeun/0000-0002-2261-7330	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03029528]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03029528). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; de Mauleon A, 2014, J AM MED DIR ASSOC, V15, P812, DOI 10.1016/j.jamda.2014.06.015; Gadzhanova Svetla, 2015, Drugs Real World Outcomes, V2, P53; Gnjidic D, 2014, FUND CLIN PHARMACOL, V28, P10, DOI 10.1111/j.1472-8206.2012.01063.x; Herrmann N, 2007, ALZHEIMERS DEMENT, V3, P385, DOI 10.1016/j.jalz.2007.07.007; Hilmer SN, 2007, ARCH INTERN MED, V167, P781, DOI 10.1001/archinte.167.8.781; Hwang SH, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1467-z; Islam MM, 2016, NEUROEPIDEMIOLOGY, V47, P181, DOI 10.1159/000454881; Jean-Bart E, 2017, INT J CLIN PHARM-NET, V39, P1237, DOI 10.1007/s11096-017-0533-4; Ko SJ, 2016, THE SOCIAL BURDEN AN; Kripke DF, 1998, BIOL PSYCHIAT, V43, P687, DOI 10.1016/S0006-3223(97)00292-8; Lapeyre-Mestre M, 2016, DRUG AGING, V33, P865, DOI 10.1007/s40266-016-0414-x; Linjakumpu T, 2003, INT J GERIATR PSYCH, V18, P542, DOI 10.1002/gps.846; Linjakumpu T, 2002, INT J GERIATR PSYCH, V17, P874, DOI 10.1002/gps.712; Linjakumpu TA, 2004, ANN PHARMACOTHER, V38, P2017, DOI 10.1345/aph.1E067; Nair NP, 2016, CLIN INTERV AGING, V11, P497, DOI 10.2147/CIA.S99097; Ni Chroinin D, 2016, AUSTRALAS J AGEING, V35, P262, DOI 10.1111/ajag.12312; Norgaard A, 2017, J ALZHEIMERS DIS, V56, P707, DOI 10.3233/JAD-160828; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Parsons C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-56; Peklar J, 2015, J AM MED DIR ASSOC, V16, P282, DOI 10.1016/j.jamda.2014.10.010; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Reus VI, 2016, AM J PSYCHIAT, V173, P543, DOI 10.1176/appi.ajp.2015.173501; Schwertner E, 2019, J AM MED DIR ASSOC, V20, P323, DOI 10.1016/j.jamda.2018.12.019; Taipale HT, 2010, AM J GERIATR PHARMAC, V8, P460, DOI 10.1016/j.amjopharm.2010.10.004; Taipale HT, 2009, DRUG AGING, V26, P871, DOI 10.2165/11317080-000000000-00000; Wilson NM, 2010, AGE AGEING, V39, P503, DOI 10.1093/ageing/afq053; Wimo A, 2017, ALZHEIMERS DEMENT, V13, P1, DOI 10.1016/j.jalz.2016.07.150; Wright RM, 2009, J AM GERIATR SOC, V57, P243, DOI 10.1111/j.1532-5415.2008.02127.x; Yu NW, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0530-4; Zerah L, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.02.001	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220582	10.1371/journal.pone.0220582	http://dx.doi.org/10.1371/journal.pone.0220582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374112	Green Submitted, Green Published, gold			2022-12-27	WOS:000484991500022
J	Chiazzari, B; Magalon, H; Gelin, P; Macdonald, A				Chiazzari, Brent; Magalon, Helene; Gelin, Pauline; Macdonald, Angus			Living on the edge: Assessing the diversity of South African Pocillopora on the margins of the Southwestern Indian Ocean	PLOS ONE			English	Article							CORAL GENUS POCILLOPORA; SPECIES DELIMITATION; SODWANA BAY; REEF CORAL; CONNECTIVITY; PATTERNS; SCLERACTINIA; POLYMORPHISM; INDIVIDUALS; POPULATIONS	Scleractinia of the Maputaland reef complex (MRC) in South Africa exist at the margins of the Western Indian Ocean (WIO) coral distribution and are the only substantial hermatypic coral communities in South Africa. Pocillopora species occupy a conspicuous component of the MRC, and previous investigations identified three species of Pocillopora utilizing conventional taxonomy. Thus, our aims were four-fold: to elucidate Pocillopora species diversity using genetic techniques, primarily using species delimitation methods based on the ORF gene; to test for the presence of hybridisation within the Pocillopora community on the South-West margin of distribution in the Indian Ocean using two nuclear and two mitochondrial markers; to test the presence of cryptic species, using 13 microsatellite markers, finally, to elucidate the degree of genetic diversity within each Pocillopora species found and compare this to communities in lower latitudes. We illustrate taxonomic inconsistencies between these inventories and our phylogenetic data. The MRC harbours unique populations of Pocillopora, consisting of three species hypothetically co-occurring throughout the south WIO, namely: P. meandrina/P. eydouxi, commonly misidentified as P. verrucosa, P. verrucosa, sometimes correctly identified, but also commonly misidentified as P. damicornis sensu lato, and P. villosa, almost always misidentified as P. eydouxi. The hypothesis that hybrid swarms of Pocillopora occur in marginal environments such as the MRC was not supported, with low levels of introgressive hybridization reported instead. Analyses illustrate low genetic diversity at the species and population resolutions, suggesting a small founder population for each species. Nevertheless, these populations are demographically unique, exhibiting high levels of ITS2 haplotype endemism compared to higher latitude populations and the rest of the WIO. Pocillopora diversity on the MRC represents a unique assemblage and warrants further protection.	[Chiazzari, Brent; Macdonald, Angus] Univ KwaZulu Natal, Sch Life Sci, Westville, Kwazulu Natal, South Africa; [Magalon, Helene; Gelin, Pauline] Univ La Reunion, Fac Sci & Technol, CNRS, IRD,Lab Excellence CORAIL,UMR ENTROPIE, St Denis, Reunion, France	University of Kwazulu Natal; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); University of La Reunion	Chiazzari, B (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Westville, Kwazulu Natal, South Africa.	brent.chiazzari@gmail.com	Magalon, Helene/ABH-1252-2020	Magalon, Helene/0000-0002-7061-955X	National Research Foundation of South Africa; SANBI as part of the SeaKeys project (FBI Marine grant); SANBI	National Research Foundation of South Africa(National Research Foundation - South Africa); SANBI as part of the SeaKeys project (FBI Marine grant); SANBI	This work was supported by a personal grant to BC from the National Research Foundation of South Africa, and a portion of the laboratory work was funded by SANBI as part of the SeaKeys project (FBI Marine grant). HM funded the microsatellite laboratory work through personal university stipend. AM funded the bulk of laboratory work and field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to members of the Marine Evolution Lab (MAREVOL) that assisted in sampling: Kerry Etsebeth, Carolina Barausse, Kirsty Wiggill, and Jessica Chiazzari. We are also thankful to David Obura, and Louis Celliers who aided in identifying species in the field, and Louis Celliers for aiding in confirming previous information on species identification. Thanks go to Kerry Sink, Mari-Lise Franken and Prideel Madjiet and SANBI for logistical and funding support. We acknowledge the Plateforme Gentyane of the Institut National de la Recherche Agronomique (INRA, Clermont-Ferrand, France) for genotyping and technical support. Lastly, thanks to the three anonymous reviewers, their advice and comments have greatly improved the overall quality of this manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baums IB, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00059; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Budd AF, 2010, SCIENCE, V328, P1558, DOI 10.1126/science.1188947; Celliers L, 2008, BIODIVERS CONSERV, V17, P3097, DOI 10.1007/s10531-007-9271-6; Chiazzari B, 2013, AFR J MAR SCI, V35, P233, DOI 10.2989/1814232X.2013.795915; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Combosch DJ, 2015, MOL PHYLOGENET EVOL, V88, P154, DOI 10.1016/j.ympev.2015.03.022; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; FLOT JF, 2006, P 10 INT COR REEF S, V1, P24, DOI DOI 10.1016/J.AUTREV.2006.09.014; FLOT JF, 2010, BMC EVOL BIOL, V10; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gelin P, 2017, MOL PHYLOGENET EVOL, V109, P430, DOI 10.1016/j.ympev.2017.01.018; Gelin P, 2018, ECOL EVOL, V8, P1411, DOI 10.1002/ece3.3747; Glassom D, 2006, CORAL REEFS, V25, P485, DOI 10.1007/s00338-006-0117-6; Gorospe KD, 2013, MOL ECOL, V22, P3721, DOI 10.1111/mec.12335; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hsu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107366; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnston EC, 2018, PEERJ, V6, DOI 10.7717/peerj.4355; Johnston EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06085-3; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitahara MV, 2016, CNIDARIA PRESENT FUT, P41; Lamarck JB, 1816, IRE PARTIE, V1, P1; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lutjeharms JRE, 2007, OCEAN SCI, V3, P129, DOI 10.5194/os-3-129-2007; Macdonald AHH, 2011, MAR BIOL, V158, P613, DOI 10.1007/s00227-010-1585-3; Magalon H, 2004, MOL ECOL NOTES, V4, P206, DOI 10.1111/j.1471-8286.2004.00618.x; Marti-Puig P, 2014, B MAR SCI, V90, P211, DOI 10.5343/bms.2012.1080; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Nylander J. A. A., 2004, MRMODELTEST V2; Pante E, 2015, MOL ECOL, V24, P525, DOI 10.1111/mec.13048; Paz DA, 2015, MORPHOLOGICAL VARIAT, DOI [10.1007/s00442-014-3199-9, DOI 10.1007/S00442-014-3199-9]; Pinzon JH, 2013, J BIOGEOGR, V40, P1595, DOI 10.1111/jbi.12110; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Porter SN, 2017, CORAL REEFS, V36, P369, DOI 10.1007/s00338-016-1531-z; Pritchard JK, 2000, GENETICS, V155, P945; Puillandre N, 2011, MOL ECOL; Rambaut A., 2014, TRACER V1 6 1; Rambaut A, 2013, TREEANNOTATOR V1 7 0; Ridgway T, 2008, MAR ECOL PROG SER, V354, P161, DOI 10.3354/meps07245; RIEGL B, 1995, B MAR SCI, V56, P676; Riegl Bernard, 1996, Pacific Science, V50, P404; Schleyer M.H., 2003, Zoologische Verhandelingen (Leiden), V345, P387; Schleyer Michael H., 2000, P83; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Schmidt-Roach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050847; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schweigger AF., 1820, HDB NATURGESCHICHTE; Smit K, 2017, HELGOLAND MAR RES, V71, DOI 10.1186/s10152-017-0482-2; Soto D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202586; Souter P, 2010, MAR BIOL, V157, P875, DOI 10.1007/s00227-009-1370-3; Starger CJ, 2008, MOL ECOL RESOUR, V8, P619, DOI 10.1111/j.1471-8286.2007.02017.x; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Teske PR, 2015, MAR ECOL PROG SER, V539, P153, DOI 10.3354/meps11516; Torda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058447; Torres AF, 2018, CORAL REEFS, V37, P1209, DOI 10.1007/s00338-018-1729-3; Veron JEN, 1978, J MAR BIOL ASSOC UK, V58, P544, DOI [10.1017/S0025315400028289, DOI 10.1017/S0025315400028289]; Veron JEN, 2000, CORALS WORLD, DOI [10.1126/Science.1061936, DOI 10.1126/SCIENCE.1061936]; WILGENBUSCH JC, 2004, AWTY SYSTEM GRAPHICA; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	73	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220477	10.1371/journal.pone.0220477	http://dx.doi.org/10.1371/journal.pone.0220477			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374077	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500014
J	Sati, HF; Bruinsma, N; Galas, M; Hsieh, J; Sanhueza, A; Pardo, PR; Espinal, MA				Sati, Hatim F.; Bruinsma, Nienke; Galas, Marcelo; Hsieh, Jenny; Sanhueza, Antonio; Pardo, Pilar Ramon; Espinal, Marcos A.			Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000-2015	PLOS ONE			English	Article							EUROPE-AMERICA; ASIA-AFRICA; RESISTANCE; COUNTRIES; STRAINS; ENTEROBACTERIACEAE; BANGLADESH	Background Shigellosis is the second leading cause of diarrheal death globally. The global burden has been complicated by the emergence of Shigella strains resistant to first line antibiotic treatments such as ciprofloxacin. This study aims to describe the epidemiologic distribution of the most common Shigella species, and their antimicrobial susceptibility patterns to ciprofloxacin and nalidixic acid (NA) in Latin America. Methods Laboratory data from 19 countries were obtained through the Latin American Network for Antimicrobial Resistance Surveillance (ReLAVRA) from 2000-2015. The Clinical Laboratory Standards Institute reduced susceptibility breakpoints for Enterobacteriaceae was used to interpret the disc diffusion tests for Shigella susceptibility to ciprofloxacin and NA. Negative binominal regression was used to analyze longitudinal trends of Shigella isolates antimicrobial susceptibility. Results 79,548 Shigella isolates were tested and reported between 2000-2015. The most common isolated species were S. flexneri (49%), and S. sonnei (28%). There was a steady increase in the proportion of S. sonnei isolates within the region(p<0.001). The average annual percentage increase (AAPI) in nonsusceptibility was 18.4% (p<0.001) for ciprofloxacin (baseline = 0.3); and 13.2%(p<0.001) for NA (baseline = 3). AAPI nonsusceptibility to ciprofloxacin was 13.3% for S. flexneri (p<0.04); and 39.9% for S. sonnei (p<0.001). Honduras, Dominican Republic, Venezuela, and Chile reported the highest increase in nonsusceptibility to ciprofloxacin among all Shigella isolates. Conclusion There is an increasing trend in Shigella nonsusceptibility to ciprofloxacin and NA, including among the most common shigella species, in Latin America. This rise of nonsusceptibility among Shigella species to commonly used treatments such as ciprofloxacin is alarming and threatens the control and management of this currently treatable infection. Improved data quality, collection and reporting is needed in Latin America to respond effectively to the rising trends observed. This includes the need for quality isolate level epidemiological data; molecular data, and data on antibiotic consumption and use.	[Sati, Hatim F.; Bruinsma, Nienke; Galas, Marcelo; Hsieh, Jenny; Pardo, Pilar Ramon; Espinal, Marcos A.] Pan Amer Hlth Org, Communicable Dis & Environm Determinants Hlth, Antimicrobial Resistance Special Program, Washington, DC 20037 USA; [Sanhueza, Antonio] Pan Amer Hlth Org, Evidence & Intelligence Act Hlth EIH, Hlth Anal Metr & Evidence EIH HA, Washington, DC USA	Pan American Health Organization; Pan American Health Organization	Sati, HF (corresponding author), Pan Amer Hlth Org, Communicable Dis & Environm Determinants Hlth, Antimicrobial Resistance Special Program, Washington, DC 20037 USA.	satihat@paho.org		Sati, Hatim/0000-0003-2358-0522				Ahmed AM, 2006, J MED MICROBIOL, V55, P1685, DOI 10.1099/jmm.0.46725-0; Anderson M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00045; Arcilla MS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-410; Avdic E, 2014, INFECT DIS CLIN N AM, V28, P215, DOI 10.1016/j.idc.2014.01.002; BENNISH ML, 1992, CLIN INFECT DIS, V14, P1055, DOI 10.1093/clinids/14.5.1055; Byarugaba DK, 2004, INT J ANTIMICROB AG, V24, P105, DOI 10.1016/j.ijantimicag.2004.02.015; CDCP enters for Disease Control and Prevention, 2017, CDCHAN 0040; CLSI, 2019, 15 INF SUPPL CLIN LA, V29th; Collignon P, 2018, LANCET PLANET HEALTH, V2, pE398, DOI 10.1016/S2542-5196(18)30186-4; Gu B, 2015, EPIDEMIOL INFECT, V143, P2687, DOI 10.1017/S0950268814003446; Gu B, 2012, INT J ANTIMICROB AG, V40, P9, DOI 10.1016/j.ijantimicag.2012.02.005; Hakanen A, 1999, J CLIN MICROBIOL, V37, P3572, DOI 10.1128/JCM.37.11.3572-3577.1999; The HC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002055; Holt KE, 2013, P NATL ACAD SCI USA, V110, P17522, DOI 10.1073/pnas.1308632110; HOOPER DC, 1985, ANTIMICROB AGENTS CH, V28, P716, DOI 10.1128/AAC.28.5.716; Jacoby GA, 2014, MICROBIOL SPECTR, V2, DOI [10.1128/microbiolspec.PLAS-0006-2013, 10.1128/microbiolspec.PLAS-0006.2013]; Kahsay Atsebaha Gebrekidan, 2016, BMC Res Notes, V9, P422, DOI 10.1186/s13104-016-2236-7; Ke X, 2011, ARCH MICROBIOL, V193, P767, DOI 10.1007/s00203-011-0744-3; Kerneis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004494; Khalil IA, 2018, LANCET INFECT DIS, V18, P1229, DOI [10.1016/S1473-3099(18)30475-4, 10.1016/s1473-3099(18)30475-4]; Kotloff KL, 2018, LANCET, V391, P801, DOI 10.1016/S0140-6736(17)33296-8; Kuo CY, 2008, J MICROBIOL IMMUNOL, V41, P107; Lawless J, 1987, CANADIAN J STAT, V15; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Lluque A, 2015, INT J MED MICROBIOL, V305, P480, DOI 10.1016/j.ijmm.2015.04.005; O'Hara CM, 2005, CLIN MICROBIOL REV, V18, P147, DOI 10.1128/CMR.18.1.147-162.2005; Octavia SLR, 2015, SHIGELLA SHIGELLOSIS; Puzari M, 2018, J INFECT PUBLIC HEAL, V11, P451, DOI 10.1016/j.jiph.2017.09.025; Rahman M, 2007, J HEALTH POPUL NUTR, V25, P158; Ram PK, 2008, EPIDEMIOL INFECT, V136, P577, DOI 10.1017/S0950268807009351; Rossotti R, 2012, EUR J CLIN MICROBIOL, V31, P1517, DOI 10.1007/s10096-011-1472-y; SACK DA, 1994, LANCET, V343, P1413, DOI 10.1016/S0140-6736(94)92531-3; Sader HS, 2007, DIAGN MICR INFEC DIS, V58, P27, DOI 10.1016/j.diagmicrobio.2006.12.006; Strockbine NA BC, 2015, ESCHERICHIA SHIGELLA; Taylor DN, 2017, J TRAVEL MED, V24, pS17, DOI 10.1093/jtm/taw097; Thompson CN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003708; Troeger C, 2017, LANCET INFECT DIS, V17, P909, DOI 10.1016/S1473-3099(17)30276-1; van der Bij AK, 2012, J ANTIMICROB CHEMOTH, V67, P2090, DOI 10.1093/jac/dks214; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; WHO, 2015, GLOB ANT RES SURV SY; Williams PCM, 2018, PAEDIATR INT CHILD H, V38, pS50, DOI 10.1080/20469047.2017.1409454; World Health Organization, 2005, GUIDELINES CONTROL S; World Health Organization, 2016, ANTIMICROBIAL RESIST	43	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220445	10.1371/journal.pone.0220445	http://dx.doi.org/10.1371/journal.pone.0220445			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374081	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500012
J	Ayub, M; Ghazanfar, MA; Mehmood, Z; Saba, T; Alharbey, R; Munshi, AM; Alrige, MA				Ayub, Mubbashir; Ghazanfar, Mustansar Ali; Mehmood, Zahid; Saba, Tanzila; Alharbey, Riad; Munshi, Asmaa Mandi; Alrige, Mayda Abdullateef			Modeling user rating preference behavior to improve the performance of the collaborative filtering based recommender systems	PLOS ONE			English	Article							SIMILARITY MEASURE; IMAGE RETRIEVAL; TRUST; ALLEVIATE	One of the main concerns for online shopping websites is to provide efficient and customized recommendations to a very large number of users based on their preferences. Collaborative filtering (CF) is the most famous type of recommender system method to provide personalized recommendations to users. CF generates recommendations by identifying clusters of similar users or items from the user-item rating matrix. This cluster of similar users or items is generally identified by using some similarity measurement method. Among numerous proposed similarity measure methods by researchers, the Pearson correlation coefficient (PCC) is a commonly used similarity measure method for CF-based recommender systems. The standard PCC suffers some inherent limitations and ignores user rating preference behavior (RPB). Typically, users have different RPB, where some users may give the same rating to various items without liking the items and some users may tend to give average rating albeit liking the items. Traditional similarity measure methods (including PCC) do not consider this rating pattern of users. In this article, we present a novel similarity measure method to consider user RPB while calculating similarity among users. The proposed similarity measure method state user RPB as a function of user average rating value, and variance or standard deviation. The user RPB is then combined with an improved model of standard PCC to form an improved similarity measure method for CF-based recommender systems. The proposed similarity measure is named as improved PCC weighted with RPB (IPWR). The qualitative and quantitative analysis of the IPWR similarity measure method is performed using five state-of-the-art datasets (i.e. Epinions, MovieLens-100K, MovieLens-1M, CiaoDVD, and MovieTweetings). The IPWR similarity measure method performs better than state-of-the-art similarity measure methods in terms of mean absolute error (MAE), root mean square error (RMSE), precision, recall, and F-measure.	[Ayub, Mubbashir; Ghazanfar, Mustansar Ali] Univ Engn & Technol, Dept Software Engn, Taxila, Pakistan; [Mehmood, Zahid] Univ Engn & Technol, Dept Comp Engn, Taxila, Pakistan; [Saba, Tanzila] Prince Sultan Univ, Coll Comp & Informat Sci, Riyadh, Saudi Arabia; [Alharbey, Riad; Munshi, Asmaa Mandi] Univ Jeddah, Coll Comp Sci & Engn, Jeddah, Saudi Arabia; [Alrige, Mayda Abdullateef] King Abdulaziz Univ, Fac Comp & Informat Technol, Informat Syst Dept, Jeddah, Saudi Arabia	University of Engineering & Technology Taxila; University of Engineering & Technology Taxila; Prince Sultan University; University of Jeddah; King Abdulaziz University	Mehmood, Z (corresponding author), Univ Engn & Technol, Dept Comp Engn, Taxila, Pakistan.	zahid.mehmood@uettaxila.edu.pk	Ayub, Mubbashir/AAK-8982-2020; Ghazanfar, Mustansar/ABA-3929-2020; Mehmood, Dr. Zahid/S-1709-2018; Saba, Tanzila/D-4593-2018; Alrige, Mayada/AAS-5593-2021	Ghazanfar, Mustansar/0000-0003-1967-6273; Mehmood, Dr. Zahid/0000-0003-4888-2594; Saba, Tanzila/0000-0003-3138-3801; Alrige, Mayada/0000-0002-1315-7053				Adomavicius G, 2005, IEEE T KNOWL DATA EN, V17, P734, DOI 10.1109/TKDE.2005.99; Ahn HJ, 2008, INFORM SCIENCES, V178, P37, DOI 10.1016/j.ins.2007.07.024; Al-Oufi S, 2012, EXPERT SYST APPL, V39, P13173, DOI 10.1016/j.eswa.2012.05.084; Alahmadi DH, 2015, 2015 IEEE 27 INT C T; Ayub M, 2018, 32 INT C INF NETW IC; Ayub M, 2018, 2018 INT C INF NETW; Baluja S., 2008, P 17 INT C WORLD WID, P895; Bobadilla J, 2013, KNOWL-BASED SYST, V46, P109, DOI 10.1016/j.knosys.2013.03.012; Bobadilla J, 2012, KNOWL-BASED SYST, V26, P225, DOI 10.1016/j.knosys.2011.07.021; Bobadilla J, 2012, INFORM SCIENCES, V185, P1, DOI 10.1016/j.ins.2011.09.014; Bobadilla J, 2012, INFORM PROCESS MANAG, V48, P204, DOI 10.1016/j.ipm.2011.03.007; Boratto L, 2017, INFORM SCIENCES, V378, P424, DOI 10.1016/j.ins.2016.07.060; Ghazanfar M.A., 2010, 2010 3 INT C KNOWL D; Ghazanfar MA, 2013, PROC SPIE, V9067, DOI 10.1117/12.2051416; Ghazanfar MA, 2010, THIRD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING: WKDD 2010, PROCEEDINGS, P94, DOI 10.1109/WKDD.2010.117; Golbeck J., 2006, P IEEE CONS COMM NET; Gong S, 2009, 2009 2 INT WORKSH KN; Guo G., 2013, P 7 ACM C RECOMMENDE, P451; Guo G., 2014, P 2014 IEEE ACM INT; Guo GB, 2014, KNOWL-BASED SYST, V57, P57, DOI 10.1016/j.knosys.2013.12.007; Harper FM, 2016, ACM T INTERACT INTEL, V5, DOI 10.1145/2827872; Jabeen S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194526; Jamali M., 2009, P 3 ACM C REC SYST; Janasiewicz T., 2011, INT C COMP COLL INT; Lee WP, 2016, KNOWL-BASED SYST, V106, P125, DOI 10.1016/j.knosys.2016.05.037; Li YM, 2013, DECIS SUPPORT SYST, V55, P740, DOI 10.1016/j.dss.2013.02.009; Liu B.Y.Y.L.D., P 23 INT JOINT C ART; Liu HF, 2014, KNOWL-BASED SYST, V56, P156, DOI 10.1016/j.knosys.2013.11.006; Ma H, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961201; Mehmood A, 2018, 2018 14TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL INTELLIGENCE AND SECURITY (CIS), P1, DOI 10.1109/CIS2018.2018.00009; Mehmood Z, 2018, ARAB J SCI ENG, V43, P7265, DOI 10.1007/s13369-018-3062-0; Mehmood Z, 2018, KUWAIT J SCI, V45, P54; Mehmood Z, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/8217250; Patra BK, 2015, KNOWL-BASED SYST, V82, P163, DOI 10.1016/j.knosys.2015.03.001; Polatidis N, 2016, EXPERT SYST APPL, V48, P100, DOI 10.1016/j.eswa.2015.11.023; Qazi KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194151; Ricci F., 2011, INTRO RECOMMENDER SY; Safoury Laila, 2013, Lecture Notes on Software Engineering, V1, P303, DOI 10.7763/LNSE.2013.V1.66; Saranya KG, 2017, APPL MATH INFORM SCI, V11, P317, DOI [DOI 10.18576/AMIS/110137, 10.18576/amis/110137]; Sarwar A, 2019, J INF SCI, V45, P117, DOI 10.1177/0165551518782825; Sun S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002527; Tan ZH, 2017, IEEE ACCESS, V5, P27211, DOI 10.1109/ACCESS.2017.2778424; XIONG L, 2010, P 2010 SIAM INT C DA; Zahra S, 2015, INFORM SCIENCES, V320, P156, DOI 10.1016/j.ins.2015.03.062	44	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220129	10.1371/journal.pone.0220129	http://dx.doi.org/10.1371/journal.pone.0220129			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369585	Green Published, gold			2022-12-27	WOS:000484987900027
J	Ehling, R; Bsteh, G; Muehlbacher, A; Hermann, K; Brenneis, C				Ehling, Rainer; Bsteh, Gabriel; Muehlbacher, Andreas; Hermann, Kay; Brenneis, Christian			Ecological validity of walking capacity tests following rehabilitation in people with multiple sclerosis	PLOS ONE			English	Article							TIMED 25-FOOT WALK; LOWER PHYSICAL-ACTIVITY; CLINICALLY MEANINGFUL; ACTIVITY MONITORS; 6-MINUTE WALK; DISABILITY; ACCELEROMETRY; RELIABILITY; PERFORMANCE; IMPACT	Background Walking capacity tests are commonly used to evaluate interventions aiming at reducing walking impairment in people with multiple sclerosis (pwMS). However, their ecological validity has recently been questioned. The aim of the present study was to investigate the ecological validity of the 2- and 6-minutes walking tests (2MWT and 6MWT) and the timed 25-foot walk (T25FW) after 28 days of multidisciplinary inpatient rehabilitation (MIR) in pwMS using accelerometry. Methods PwMS wore an accelerometer on 7 consecutive days within a 14-day period prior to MIR, performed 2/6MWT and T25FW at the beginning and at the end of MIR, followed by another 7 consecutive days of accelerometry. Results Significant improvements in 2/6MWT and T25FW after MIR in a cohort of 76 pwMS (mean age = 47.9, SD 8.3 years) were overall correlated to a significant gain in everyday life mobility (total steps/day). However, the correlation was strongly dependent on pre-existing walking disability defined by EDSS and only pwMS with "mild" walking impairment (EDSS 2-3.5) were able to transfer benefits measurable by walking capacity tests into improved everyday life mobility, while pwMS with "moderate to severe" walking disability (EDSS 4-6.5) were not. Conclusion Ecological validity of changes in walking capacity tests following MIR is strongly dependent on pre-existing walking impairment.	[Ehling, Rainer; Muehlbacher, Andreas; Hermann, Kay; Brenneis, Christian] Clin Rehabil Munster, Dept Neurol, Munster, Austria; [Ehling, Rainer; Brenneis, Christian] Karl Landsteiner Inst Interdisziplinare Forsch, Reha Zentrum Munster, Munster, Austria; [Bsteh, Gabriel] Med Univ Innsbruck, Clin Dept Neurol, Innsbruck, Austria	Medical University of Innsbruck	Ehling, R (corresponding author), Clin Rehabil Munster, Dept Neurol, Munster, Austria.; Ehling, R (corresponding author), Karl Landsteiner Inst Interdisziplinare Forsch, Reha Zentrum Munster, Munster, Austria.	rainer.ehling@reha-muenster.at			Austrian Multiple Sclerosis Research Foundation	Austrian Multiple Sclerosis Research Foundation	This work was supported by a research grant of the Austrian Multiple Sclerosis Research Foundation (no grant number). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Auty A, 1998, CAN J NEUROL SCI, V25, P31; Baert I, 2014, NEUROREHAB NEURAL RE, V28, P621, DOI 10.1177/1545968314521010; Bradshaw MJ, 2017, NEUROL-CLIN PRACT, V7, P354, DOI 10.1212/CPJ.0000000000000382; Engelhard MM, 2018, GAIT POSTURE, V59, P211, DOI 10.1016/j.gaitpost.2017.10.015; Feys P, 2013, NEUROREHABILITATION, V33, P439, DOI 10.3233/NRE-130975; Gijbels D, 2011, MULT SCLER J, V17, P1269, DOI 10.1177/1352458511408475; Gijbels D, 2010, MULT SCLER J, V16, P618, DOI 10.1177/1352458510361357; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Goldman MD, 2013, NEUROLOGY, V81, P1856, DOI 10.1212/01.wnl.0000436065.97642.d2; Goldman Myla D, 2010, Ther Adv Neurol Disord, V3, P229, DOI 10.1177/1756285610374117; GOODKIN DE, 1991, NEUROLOGY, V41, P332, DOI 10.1212/WNL.41.2_Part_1.332; Hobart J, 2000, BRAIN, V123, P1027, DOI 10.1093/brain/123.5.1027; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Hobart J, 2013, NEUROLOGY, V80, P1509, DOI 10.1212/WNL.0b013e31828cf7f3; Kieseier BC, 2012, MULT SCLER J, V18, P914, DOI 10.1177/1352458512444498; Kragt JJ, 2006, MULT SCLER J, V12, P594, DOI 10.1177/1352458506070768; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LaRocca NG, 2011, PATIENT, V4, P189, DOI 10.2165/11591150-000000000-00000; Learmonth YC, 2013, MULT SCLER J, V19, P1784, DOI 10.1177/1352458513483890; Motl RW, 2008, MULT SCLER J, V14, P140, DOI 10.1177/1352458507079126; Motl RW, 2013, ACTA NEUROL SCAND, V127, P384, DOI 10.1111/ane.12036; Motl RW, 2007, ADAPT PHYS ACT Q, V24, P245, DOI 10.1123/apaq.24.3.245; Motl RW, 2017, MULT SCLER J, V23, P704, DOI 10.1177/1352458517690823; Motl RW, 2014, BEHAV MED, V40, P29, DOI 10.1080/08964289.2013.821966; Motl RW, 2012, EXPERT REV NEUROTHER, V12, P1079, DOI [10.1586/ern.12.74, 10.1586/ERN.12.74]; Motl RW, 2011, BEHAV MED, V37, P125, DOI 10.1080/08964289.2011.636769; Neven A, 2016, NEUROL SCI, V37, P1483, DOI 10.1007/s10072-016-2609-7; Ng AV, 1997, MED SCI SPORT EXER, V29, P517, DOI 10.1097/00005768-199704000-00014; Paltamaa J, 2008, PHYS THER, V88, P176, DOI 10.2522/ptj.20070064; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Riemenschneider M, 2018, MULT SCLER J, V24, P886, DOI 10.1177/1352458518777377; Sandroff BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093511; Sandroff BM, 2013, DISABIL REHABIL, V35, P725, DOI 10.3109/09638288.2012.707745; Sasaki JE, 2017, EXPERT REV MED DEVIC, V14, P891, DOI 10.1080/17434440.2017.1386550; Stellmann JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123822; Weikert M, 2010, J NEUROL SCI, V290, P6, DOI 10.1016/j.jns.2009.12.021; Wens I, 2013, MULT SCLER J, V19, P1556, DOI 10.1177/1352458513504252; WHO, 2001, WHO INT CLASS FUNCT	39	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220613	10.1371/journal.pone.0220613	http://dx.doi.org/10.1371/journal.pone.0220613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369622	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900068
J	Howe, C; Moparthi, VK; Ho, FM; Persson, K; Stensjo, K				Howe, Christoph; Moparthi, Vamsi K.; Ho, Felix M.; Persson, Karina; Stensjo, Karin			The Dps4 from Nostoc punctiforme ATCC 29133 is a member of His-type FOC containing Dps protein class that can be broadly found among cyanobacteria	PLOS ONE			English	Article							DNA-BINDING PROTEIN; MYCOBACTERIUM-SMEGMATIS DPS; FERROXIDASE CENTER; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; IRON-BINDING; THERMOSYNECHOCOCCUS-ELONGATUS; ESCHERICHIA-COLI; FERRITIN HOMOLOG; RESISTANCE	Dps proteins (DNA-binding proteins from starved cells) have been found to detoxify H2O2. At their catalytic centers, the ferroxidase center (FOC), Dps proteins utilize Fe2+ to reduce H2O2 and therefore play an essential role in the protection against oxidative stress and maintaining iron homeostasis. Whereas most bacteria accommodate one or two Dps, there are five different Dps proteins in Nostoc punctiforme, a phototrophic and filamentous cyanobacterium. This uncommonly high number of Dps proteins implies a sophisticated machinery for maintaining complex iron homeostasis and for protection against oxidative stress. Functional analyses and structural information on cyanobacterial Dps proteins are rare, but essential for understanding the function of each of the NpDps proteins. In this study, we present the crystal structure of NpDps4 in its metal-free, iron-and zinc-bound forms. The FOC coordinates either two iron atoms or one zinc atom. Spectroscopic analyses revealed that NpDps4 could oxidize Fe2+ utilizing O-2, but no evidence for its use of the oxidant H2O2 could be found. We identified Zn2+ to be an effective inhibitor of the O-2-mediated Fe2+ oxidation in NpDps4. NpDps4 exhibits a FOC that is very different from canonical Dps, but structurally similar to the atypical one from DpsA of Thermosynechococcus elongatus. Sequence comparisons among Dps protein homologs to NpDps4 within the cyanobacterial phylum led us to classify a novel FOC class: the His-type FOC. The features of this special FOC have not been identified in Dps proteins from other bacterial phyla and it might be unique to cyanobacterial Dps proteins.	[Howe, Christoph; Moparthi, Vamsi K.; Ho, Felix M.; Stensjo, Karin] Uppsala Univ, Angstrom Lab, Dept Chem, Uppsala, Sweden; [Persson, Karina] Umea Univ, Dept Chem, Umea, Sweden; [Moparthi, Vamsi K.] Linkoping Univ, Dept Phys Chem & Biol, Div Chem, Linkoping, Sweden	Uppsala University; Umea University; Linkoping University	Howe, C; Stensjo, K (corresponding author), Uppsala Univ, Angstrom Lab, Dept Chem, Uppsala, Sweden.; Persson, K (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	karina.persson@umu.se; karin.stensjo@kemi.uu.se	Stensjo, Karin/E-3801-2017	Stensjo, Karin/0000-0001-6993-8476; Ho, Felix/0000-0001-7731-3396	NordForsk [82845]; NCoE program "NordAqua"; Swedish Energy Agency [11674-5]; Sven and Lilly Lawski foundation; Stiftelsen Lars Hiertas Minne	NordForsk; NCoE program "NordAqua"; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Sven and Lilly Lawski foundation; Stiftelsen Lars Hiertas Minne	This work was supported by KS: NordForsk (project 82845) (https://www.nordforsk.org/en), the NCoE program "NordAqua", KS: Swedish Energy Agency (https://www.energimyndigheten.se/en/), (project 11674-5); VKM: Post Doc scholarship, Sven and Lilly Lawski foundation, CH: Stiftelsen Lars Hiertas Minne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alaleona F, 2010, FEBS J, V277, P903, DOI 10.1111/j.1742-4658.2009.07532.x; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Antelmann H, 1997, J BACTERIOL, V179, P7251, DOI 10.1128/jb.179.23.7251-7256.1997; Ardini M, 2013, BBA-GEN SUBJECTS, V1830, P3745, DOI 10.1016/j.bbagen.2013.02.003; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Ceci P, 2011, J BIOL INORG CHEM, V16, P869, DOI 10.1007/s00775-011-0784-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury RP, 2010, IUBMB LIFE, V62, P67, DOI 10.1002/iub.285; Ebrahimi KH, 2015, CHEM REV, V115, P295, DOI 10.1021/cr5004908; Ebrahimi KH, 2010, J BIOL INORG CHEM, V15, P1243, DOI 10.1007/s00775-010-0682-6; Ekman M, 2014, ENVIRON MICROBIOL, V16, P829, DOI 10.1111/1462-2920.12233; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franceschini S, 2006, FEBS J, V273, P4913, DOI 10.1111/j.1742-4658.2006.05490.x; Fujisawa T, 2017, NUCLEIC ACIDS RES, V45, pD551, DOI 10.1093/nar/gkw1131; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Grove A, 2005, J MOL BIOL, V347, P495, DOI 10.1016/j.jmb.2005.01.055; Haikarainen T, 2010, BIOCHEM BIOPH RES CO, V398, P361, DOI 10.1016/j.bbrc.2010.06.071; Haikarainen T, 2010, J BIOL INORG CHEM, V15, P183, DOI 10.1007/s00775-009-0582-9; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Havukainen H, 2008, PROTEIN SCI, V17, P1513, DOI 10.1110/ps.036236.108; Howe C, 2018, J BIOL CHEM, V293, P16635, DOI 10.1074/jbc.RA118.002425; Hudek L, 2012, BIOMETALS, V25, P893, DOI 10.1007/s10534-012-9556-4; Hudek L, 2013, FEMS MICROBIOL ECOL, V86, P149, DOI 10.1111/1574-6941.12153; Huergo LF, 2013, J BACTERIOL, V195, P1970, DOI 10.1128/JB.00059-13; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kauko A, 2004, J MOL BIOL, V338, P547, DOI 10.1016/j.jmb.2004.03.009; Kauko A, 2006, J MOL BIOL, V364, P97, DOI 10.1016/j.jmb.2006.08.061; Kim SG, 2006, J MOL BIOL, V361, P105, DOI 10.1016/j.jmb.2006.06.010; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Latifi A, 2009, FEMS MICROBIOL REV, V33, P258, DOI 10.1111/j.1574-6976.2008.00134.x; Li X, 2007, MOL MICROBIOL, V63, P694, DOI 10.1111/j.1365-2958.2006.05550.x; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; Miyamoto T, 2011, ACTA CRYSTALLOGR F, V67, P17, DOI 10.1107/S1744309110043113; Moparthi VK, 2016, BBA-BIOENERGETICS, V1857, P1766, DOI 10.1016/j.bbabio.2016.08.003; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Ow SY, 2009, J PROTEOME RES, V8, P187, DOI 10.1021/pr800285v; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Papinutto E, 2002, J BIOL CHEM, V277, P15093, DOI 10.1074/jbc.M112378200; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Pospisil P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01950; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; PRICE D, 1982, P NATL ACAD SCI-BIOL, V79, P3116, DOI 10.1073/pnas.79.10.3116; Ren B, 2003, J MOL BIOL, V329, P467, DOI 10.1016/S0022-2836(03)00466-2; Roy S, 2004, J MOL BIOL, V339, P1103, DOI 10.1016/j.jmb.2004.04.042; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Santos SP, 2015, FEBS J, V282, P4307, DOI 10.1111/febs.13420; Stefanini S, 1999, BIOCHEM J, V338, P71, DOI 10.1042/0264-6021:3380071; Stillman TJ, 2005, MOL MICROBIOL, V57, P1101, DOI 10.1111/j.1365-2958.2005.04757.x; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Uyeda JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162539; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; Williams SM, 2017, STRUCTURE, V25, P1449, DOI 10.1016/j.str.2017.07.006; Williams SM, 2014, J BIOL CHEM, V289, P11042, DOI 10.1074/jbc.M113.524421; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang XO, 2000, BIOCHEMISTRY-US, V39, P4915, DOI 10.1021/bi992631f; Zanotti G, 2002, J MOL BIOL, V323, P125, DOI 10.1016/S0022-2836(02)00879-3; Zeth K, 2004, P NATL ACAD SCI USA, V101, P13780, DOI 10.1073/pnas.0401821101; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	72	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218300	10.1371/journal.pone.0218300	http://dx.doi.org/10.1371/journal.pone.0218300			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369577	gold, Green Published, Green Submitted			2022-12-27	WOS:000484987900009
J	Parundekar, A; Kalantre, G; Khadpekar, A; Viswanathan, GA				Parundekar, Akshay; Kalantre, Girija; Khadpekar, Akshada; Viswanathan, Ganesh A.			Operating regimes in a single enzymatic cascade at ensemble-level	PLOS ONE			English	Article							COVALENT MODIFICATION; FLOW-CYTOMETRY; PROTEIN-KINASE; ZERO-ORDER; ULTRASENSITIVITY; FLUCTUATIONS; CANCER; CELLS	Single enzymatic cascade, ubiquitously found in cellular signaling networks, is a phosphorylation-dephosphorylation reaction cycle causing a transition between inactive and active states of a protein catalysed by kinase and phosphatase, respectively. Steady-state information processing ability of such a cycle (e.g., MAPK cascade) has been classified into four qualitatively different operating regimes, viz., hyperbolic (H), signal-transducing (ST), threshold-hyperbolic (TH) and ultrasensitive (U). These four regimes represent qualitatively different dose-response curves, that is, relationship between concentrations of input kinase (e.g., pMEK) and response activated protein (e.g., pERK). Regimes were identified using a deterministic model accounting for population-averaged behavior only. Operating regimes can be strongly influenced by the inherently present cell-to-cell variability in an ensemble of cells which is captured in the form of pMEK and pERK distributions using reporter-based single-cell experimentation. In this study, we show that such experimentally acquired snapshot pMEK and pERK distribution data of a single MAPK cascade can be directly used to infer the underlying operating regime even in the absence of a dose-response curve. This deduction is possible primarily due to the presence of a monotonic relationship between experimental observables RIQR, ratio of the inter-quartile range of the pERK and pMEK distribution pairs and RM, ratio of the medians of the distribution pair. We demonstrate this relationship by systematic analysis of a quasi-steady state approximated model superimposed with an input gamma distribution constrained by the stimulus strength specific pMEK distribution measured on Jurkat-T cells stimulated with PMA. As a first, we show that introduction of cell-to-cell variability only in the upstream kinase achieved by superimposition of an appropriate input pMEK distribution on the dose-response curve can predict bimodal response pERK distribution in ST regime. Implementation of the proposed method on the input-response distribution pair obtained in stimulated Jurkat-T cells revealed that while low-dosage PMA stimulation preserves the H regime observed in resting cells, high-dosage causes H to ST regime transition.	[Parundekar, Akshay; Kalantre, Girija; Khadpekar, Akshada; Viswanathan, Ganesh A.] Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Viswanathan, GA (corresponding author), Indian Inst Technol, Dept Chem Engn, Mumbai, Maharashtra, India.	ganeshav@iitb.ac.in		Viswanathan, Ganesh A/0000-0001-6424-0765	Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India [SB/S3/CE/048/2014]; University Grants Commission, Government of India	Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India; University Grants Commission, Government of India(University Grants Commission, India)	This research was funded by the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India, SB/S3/CE/048/2014 to GAV; and University Grants Commission, Government of India to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Dhananjaneyulu V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035958; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Dobrzynski M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0383; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hasenauer J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-125; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Knijnenburg TA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.64; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Krutzik PO, 2011, FLUORESCENT CELL BAR, V6, P31, DOI DOI 10.1002/0471142956.CY0631S55; Levine J, 2007, BIOPHYS J, V92, P4473, DOI 10.1529/biophysj.106.088856; Lipshtat A, 2010, P NATL ACAD SCI USA, V107, P1247, DOI 10.1073/pnas.0908647107; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Manohar S, 2019, CYTOM PART A, V95A, P192, DOI 10.1002/cyto.a.23602; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Qian H, 2009, PHYS CHEM CHEM PHYS, V11, P4861, DOI 10.1039/b900335p; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; ROUSSEEUW PJ, 1993, J AM STAT ASSOC, V88, P1273, DOI 10.2307/2291267; Ruf F, 2006, J BIOL CHEM, V281, P30967, DOI 10.1074/jbc.M606486200; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Straube R, 2017, J THEOR BIOL, V431, P39, DOI 10.1016/j.jtbi.2017.08.006; van den Brink MRM, 1999, J BIOL CHEM, V274, P11178, DOI 10.1074/jbc.274.16.11178; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220243	10.1371/journal.pone.0220243	http://dx.doi.org/10.1371/journal.pone.0220243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369598	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900038
J	van Horn, N; Faizy, TD; Schoenfeld, MH; Kohlmann, P; Broocks, G; Haag, P; Fiehler, J; Habermann, CR; Karul, M				van Horn, Noel; Faizy, Tobias Djamsched; Schoenfeld, Michael Hinrich; Kohlmann, Patrick; Broocks, Gabriel; Haag, Pascal; Fiehler, Jens; Habermann, Christian Richard; Karul, Murat			Computed tomography findings in patients with primarily unknown causes of severe or recurrent epistaxis	PLOS ONE			English	Article							EMERGENCY-DEPARTMENTS; EMBOLIZATION; MANAGEMENT; DIAGNOSIS	Objective In addition to rhinoscopy, computed tomography of paranasal sinuses (CT) may be performed on patients with primary unknown cause of severe epistaxis (SE) or recurrent epistaxis (RE) to further assess the potential cause of bleeding. The aim of this study was to evaluate CT findings during the work-up of intractable epistaxis patients. Methods 6937 patients were treated in our emergency department with acute epistaxis between 2009-2018. 304/6937 patients underwent CT and rhinoscopy due to intractable SE or RE. 33 patients presented with head trauma prior to epistaxis and were excluded from the final analysis. In 271 cases the primary causes of SE (n = 252) or RE (n = 19) remained unknown. Two observers retrospectively evaluated CT scans for potential sources of epistaxis. Disagreement was settled by consensus. CT and rhinoscopy findings were compared. Results In 247/271 (91.1%) SE patients no related pathology was found on CT. A possible cause for epistaxis was found in all RE patients, but only in 5/252 (1.9%) patients with SE. Most tumours (10/11) and inflammatory conditions (9/10) were found in patients with RE. In three SE cases, a tumour was suspected on CT, from which two suspicions were refuted during rhinoscopy. CT revealed 10 cases of inflammatory conditions of the sinus and anatomical variant as potential cause of bleeding. Conclusion For patients with unknown causes of epistaxis, supplementary CT imaging may be a useful diagnostic add-on to rhinoscopy in the event of RE, tumour suspicion or inflammation of the paranasal sinuses. However, in most cases of first-time SE, CT does not necessarily add to the diagnosis. In these cases, the marginal benefit of CT needs to be weighed carefully against its risks.	[van Horn, Noel; Faizy, Tobias Djamsched; Haag, Pascal; Habermann, Christian Richard; Karul, Murat] Marien Hosp, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Faizy, Tobias Djamsched; Schoenfeld, Michael Hinrich; Broocks, Gabriel; Fiehler, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Kohlmann, Patrick] Marien Hosp, Dept Otolaryngol, Hamburg, Germany	St. Marien Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; St. Marien Hospital	Faizy, TD (corresponding author), Marien Hosp, Dept Diagnost & Intervent Radiol, Hamburg, Germany.; Faizy, TD (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	T.Faizy@uke.de	van Horn, Noel/AAW-5274-2020	van Horn, Noel/0000-0001-5764-1982; Schonfeld, Michael/0000-0003-2096-3448; Haag, Pascal/0000-0001-8764-0665				Andersen PJ, 2005, ACTA OTO-LARYNGOL, V125, P293, DOI 10.1080/00016480410023029; [Anonymous], 2018, CLINICAL PRACTICE GU; Beck R, 2018, DTSCH ARZTEBL INT, V115, P12, DOI 10.3238/arztebl.2018.0012; Chiu TW, 2007, OTOLARYNG HEAD NECK, V137, P390, DOI 10.1016/j.otohns.2006.10.035; DENHOLM SW, 1993, J LARYNGOL OTOL, V107, P195, DOI 10.1017/S0022215100122613; Eggesbo HB, 2012, CANCER IMAGING, V12, P136, DOI 10.1102/1470-7330.2012.0015; Folz BJ, 2008, HNO, V56, P1157, DOI 10.1007/s00106-008-1838-3; Fuchs FD, 2003, BLOOD PRESSURE, V12, P145, DOI 10.1080/08037050310001750; Gurney TA, 2004, AM J RHINOL, V18, P335, DOI 10.1177/194589240401800513; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kawaguchi M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6120116; Krajina A, 2014, CARDIOVASC INTER RAD, V37, P26, DOI 10.1007/s00270-013-0776-y; Likness MM, 2014, OTOLARYNG HEAD NECK, V150, P305, DOI 10.1177/0194599813513881; Myga-Porosilo J, 2011, POL J RADIOL, V76, P41; Nikupaavo U, 2015, AM J ROENTGENOL, V204, P117, DOI 10.2214/AJR.14.12763; Nouraei SAR, 2007, LARYNGOSCOPE, V117, P1452, DOI 10.1097/MLG.0b013e318065b86f; Pallin DJ, 2005, ANN EMERG MED, V46, P77, DOI 10.1016/j.annemergmed.2004.12.014; Pantanowitz L, 1999, J AM GERIATR SOC, V47, P631, DOI 10.1111/j.1532-5415.1999.tb02585.x; PETRUSON B, 1975, Rhinology (Utrecht), V13, P129; ROWE LD, 1981, LARYNGOSCOPE, V91, P745; Simmen D, 1998, LARYNGO RHINO OTOL, V77, P100, DOI 10.1055/s-2007-996941; Small M, 1982, Health Bull (Edinb), V40, P20; Soyka MB, 2011, RHINOLOGY, V49, P474, DOI 10.4193/Rhino10.313; Soyka MB, 2010, LARYNGOSCOPE, V120, P200, DOI 10.1002/lary.20695; Stewart F. A., 2012, Annals of the ICRP, V41, P37, DOI 10.1016/j.icrp.2012.02.001; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stokes SM, 2010, HEAD NECK PATHOL, V4, P210, DOI 10.1007/s12105-010-0181-7; Szymanska Anna, 2005, Otolaryngol Pol, V59, P85; Tay HL, 1998, ANN OTO RHINOL LARYN, V107, P671, DOI 10.1177/000348949810700808; Traboulsi Henri, 2015, Int J Otolaryngol, V2015, P263987, DOI 10.1155/2015/263987; Tseng EY, 1998, LARYNGOSCOPE, V108, P615, DOI 10.1097/00005537-199804000-00028; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Viehweg TL, 2006, J ORAL MAXIL SURG, V64, P511, DOI 10.1016/j.joms.2005.11.031; Vosler PS, 2016, OTOLARYNG HEAD NECK, V155, P879, DOI 10.1177/0194599816657045; Wani AA, 2009, INDIAN J OTOLARYNGOL, V61, P163, DOI 10.1007/s12070-009-0059-8; Weigel K, 2016, LARYNGO RHINO OTOL, V95, P837, DOI 10.1055/s-0042-111013; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Willems PWA, 2009, AM J NEURORADIOL, V30, P1637, DOI 10.3174/ajnr.A1607	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220380	10.1371/journal.pone.0220380	http://dx.doi.org/10.1371/journal.pone.0220380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369603	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900045
J	Ge, Y; Dansokho, SC; Liao, XP				Ge, Yi; Dansokho, Selma Chipenda; Liao, Xiang-Peng			Advanced neonatal medicine in China: Is newborn ward capacity associated with inpatient antibiotic usage?	PLOS ONE			English	Article							CARE; PRESCRIPTION; INFECTIONS; GUIDELINES; PATTERNS	Previous surveys of neonatal medicine in China have not collected comprehensive information on antibiotic use in newborns. The goal of the present study was to assess the trends in antibiotic use in inpatient newborns from advanced hospitals in mainland China and to evaluate the contributing factors. We extracted retrospective data on newborn clinical units from a database containing key clinical subspecialty area indicators from provincial or ministerial (Class A level III) hospitals over three consecutive years (2008-2010) and in 25 of 31 provincial districts of mainland China. Fifty-five newborn units were included in the study. The results showed that two thirds (65.7% +/- 23.1%) of inpatient new-borns were prescribed antibiotic products. Antibiotic use rates were significantly different by newborn ward bed capacity (p = 0.023; 60.6% for d capacity (ficant65.7% +/- 23-100 beds group, and 77.1% for (ficant65.7% +/- 23.1%) of inpatient newb significantly different by type of hospital, geographic area, admission to physician or nurse ratio, or physician or nurse academic degree. Factors contributing significantly to antibiotic use included ward bed capacity, physician to nurse ratio, average hospital stay, and pneumonia to preterm infant ratio. Our data suggested that the use of antibiotics among inpatient newborns in advanced hospitals in mainland China was prevalent and should be subject to rigorous monitoring, and highlighted the need to explore how newborn ward bed capacity potentially impacts antibiotic use.	[Ge, Yi; Liao, Xiang-Peng] Second Mil Med Univ, Gongli Hosp, Dept Pediat, Shanghai, Peoples R China; [Dansokho, Selma Chipenda] Laval Univ, Fac Med, Off Educ & Continuing Profess Dev, Quebec City, PQ, Canada	Naval Medical University; Laval University	Liao, XP (corresponding author), Second Mil Med Univ, Gongli Hosp, Dept Pediat, Shanghai, Peoples R China.	lxp4848@aliyun.com	Liao, Xiangpeng/GNP-2312-2022	/0000-0002-4588-8803	Canadian Institutes of Health Research - Quebec Training Network in Perinatal Research Program	Canadian Institutes of Health Research - Quebec Training Network in Perinatal Research Program(Canadian Institutes of Health Research (CIHR))	This study was supported by a scholarship from the Canadian Institutes of Health Research - Quebec Training Network in Perinatal Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; This study was supported by a scholarship from the Canadian Institutes of Health Research-Quebec Training Network in Perinatal Research Program. We are extremely thankful to the government agencies for the open access to the data, and to the physicians, nurses, information engineers, and other staffs to collect data from the participating hospitals.	Baggs J, 2016, JAMA INTERN MED, V176, P1639, DOI 10.1001/jamainternmed.2016.5651; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Bert F, 2017, EUR J PUBLIC HEALTH, V27, P506, DOI 10.1093/eurpub/ckw209; Bianco A, 2018, INFECT DRUG RESIST, V11, P2199, DOI 10.2147/IDR.S170349; Boyle J, 2014, IEEE J BIOMED HEALTH, V18, P15, DOI 10.1109/JBHI.2013.2262053; Cantey JB, 2016, LANCET INFECT DIS, V16, P1178, DOI 10.1016/S1473-3099(16)30205-5; Cox LM, 2015, NAT REV ENDOCRINOL, V11, P182, DOI 10.1038/nrendo.2014.210; Currie J, 2011, ADV APPL MATH, V47, P116, DOI 10.1016/j.aam.2010.05.001; Ding H, 2008, ACTA PAEDIATR, V97, P100, DOI 10.1111/j.1651-2227.2007.00580.x; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Driscoll A, 2018, EUR J CARDIOVASC NUR, V17, P6, DOI 10.1177/1474515117721561; Hauge C, 2017, ACTA PAEDIATR, V106, P1674, DOI 10.1111/apa.13935; Hecker MT, 2003, ARCH INTERN MED, V163, P972, DOI 10.1001/archinte.163.8.972; Lapin B, 2014, J ALLERGY CLIN IMMUN, V134, P728, DOI 10.1016/j.jaci.2014.05.006; Leroux S, 2015, ARCH DIS CHILD, V100, P394, DOI 10.1136/archdischild-2014-306873; Liang XY, 2014, FAM PRACT, V31, P311, DOI 10.1093/fampra/cmu001; Liao XP, 2018, J MATERN-FETAL NEO M, V31, P843, DOI 10.1080/14767058.2017.1299127; Liao XP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169970; Mendelson M, 2015, SAMJ S AFR MED J, V105, P325, DOI [10.7196/samj.9644, 10.7196/SAMJ.9644]; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; National action plan for combating antibiotic-resistant bacteria  2015, 2015, NAT ACT PLAN COMB AN; National Bureau of Statistics of China, 2014, CHIN POP EMPL STAT Y; National Health and Family Planning Commission of the People's Republic of China (NHFPC), 2010, PIL PROJ EV DEV NAT; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Organisation for Economic Co-operation Development Staff, 2005, HLTH AT A GLANC; Poulsen MN, 2017, OBESITY, V25, P438, DOI 10.1002/oby.21719; Schulman J, 2015, PEDIATRICS, V135, P826, DOI 10.1542/peds.2014-3409; Shah PS, 2015, J PERINATOL, V35, P522, DOI 10.1038/jp.2015.4; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Sun Q, 2008, HEALTH AFFAIR, V27, P1042, DOI 10.1377/hlthaff.27.4.1042; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; United Nations Development Programme, 2013, HUM DEV IND 2010; USA Centers for Disease Control and Prevention, 2017, ANT US US 2017 PROGR; Wang J, 2014, JAMA INTERN MED, V174, P1914, DOI 10.1001/jamainternmed.2014.5214; World Health Organization, 2004, PRACTICAL GUIDELINES; World Health Organization, 1993, SEL DRUG US IND EDM; World Health Organization, 2016, ANTIMICROBIAL RESIST; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556; Yin XX, 2013, J ANTIMICROB CHEMOTH, V68, P2445, DOI 10.1093/jac/dkt223; Zhang WS, 2008, EUR J CLIN PHARMACOL, V64, P821, DOI 10.1007/s00228-008-0489-3; 吴安华, 2002, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V12, P881	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0219630	10.1371/journal.pone.0219630	http://dx.doi.org/10.1371/journal.pone.0219630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408462	Green Submitted, Green Published, gold			2022-12-27	WOS:000485009500005
J	Toriz, CG; Melo, AI; Solano-Agama, C; Gomez-Dominguez, EG; Martinez-Munoz, MD; Castaneda-Obeso, J; Vera-Aguilar, E; Aguirre-Benitez, EL; Romero-Aguilar, L; Gonzalez-del Pliego, M; Jimenez-Estrada, I; Luna, M; Pardo, JP; Camacho, J; Mendoza-Garrido, ME				Toriz, Cesar G.; Melo, Angel, I; Solano-Agama, Carmen; Gomez-Dominguez, Edgar Giovanhi; de los Angeles Martinez-Munoz, Ma; Castaneda-Obeso, Jorge; Vera-Aguilar, Eunice; Liliana Aguirre-Benitez, Elsa; Romero-Aguilar, Lucero; Gonzalez-del Pliego, Margarita; Jimenez-Estrada, Ismael; Luna, Maricela; Pablo Pardo, Juan; Camacho, Javier; Eugenia Mendoza-Garrido, Maria			Physiological changes of growth hormone during lactation in pup rats artificially reared	PLOS ONE			English	Article							NEONATAL-RAT; DEVELOPMENTAL-CHANGES; SOMATOSTATIN ANALOGS; MATERNAL-DEPRIVATION; FACTOR-I; SECRETION; PITUITARY; GHRELIN; RELEASE; STIMULATION	During the lactation period, rat pups are fed by the dam, and the patterns of mother-pup interaction change during this period. Additionally, there are changes in feeding; first, mother's milk is the only food needed for sustenance, and later, it is combined with solid food and water. GH serum concentrations depend on both maternal-pup interaction and energy metabolism. In the artificial rearing (AR) procedure, pups are deprived of mother-pup interaction, and the feeding pattern is controlled. This rearing paradigm has been used in rats to analyze the effects of maternal deprivation on social behavior. In the present study, we analyzed the variation in GH, acylated ghrelin and IGF-1 serum concentrations throughout the lactation period in AR pups. At pnd7, the maternal rearing (MR) pups responded to a 4 h fast with a drop in GH serum concentration, which is a well-known response to maternal deprivation. GH serum levels in the AR pups did not change, suggesting an adaptation phenomenon. A dopamine inhibitory effect of GH secretion was observed in pnd7 cultured somatotropes, suggesting dopamine regulation of GH secretion at this age. Acylated ghrelin serum levels in the AR pups showed an inverted pattern compared to that in the MR pups, which was related to the artificial feeding pattern. IGF-1 serum levels were lower in the AR pups than in MR pups, which was associated with hepatic GH resistance and with low Igf1 mRNA expression at pnd7. Interestingly, at pnd14, both pup groups showed high hepatic Igf1 mRNA expression but low IGF-1 serum levels, and this was inverted at pnd21. However, serum glucose levels were lower in the AR pups at pnd14 but reached the same levels as the MR pups at pnd21. Moreover, hepatomegaly and higher hepatic GH-receptor levels were observed in the AR pups at pnd21, which was in agreement with an absence of a solid food meal. During AR, the pups lost the maternal interaction-stimulated GH secretion, which correlated with lower IGF-1 serum levels during the first week of postnatal development.	[Toriz, Cesar G.; Solano-Agama, Carmen; Gomez-Dominguez, Edgar Giovanhi; Castaneda-Obeso, Jorge; Jimenez-Estrada, Ismael; Eugenia Mendoza-Garrido, Maria] Inst Politecn Nacl, CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico; [Melo, Angel, I; de los Angeles Martinez-Munoz, Ma] Univ Autonoma Tlaxcala, IPN, CINVESTAV, Ctr Invest Reprod & Anim, Ixtacuixtla, Tlaxcala, Mexico; [Vera-Aguilar, Eunice; Camacho, Javier] IPN, CINVESTAV, Dept Farmacol, Mexico City, DF, Mexico; [Liliana Aguirre-Benitez, Elsa; Gonzalez-del Pliego, Margarita] Univ Nacl Autonoma Mexico, Fac Med, Dept Embriol, Mexico City, DF, Mexico; [Romero-Aguilar, Lucero; Pablo Pardo, Juan] Univ Nacl Autonoma Mexico, Dept Bioquim, Fac Med, Mexico City, DF, Mexico; [Luna, Maricela] UNAM, Neurobiol Celular & Mol, Inst Neurobiol, Juriquilla, Queretaro, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Mendoza-Garrido, ME (corresponding author), Inst Politecn Nacl, CINVESTAV, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico.	mmendoza@fisio.cinvestav.mx	, Javier/AAS-1379-2021; Melo, Angel I./AAZ-7094-2021	Melo, Angel I./0000-0003-4842-7217; Toriz Gonzalez, Cesar Gabriel/0000-0002-9691-8435	National Council of Sciences and Technology of Mexico (CONACyT) [181334, 45270]	National Council of Sciences and Technology of Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work and CG Toriz were supported by the National Council of Sciences and Technology of Mexico (CONACyT) with grant number: 181334 and fellowship number 45270, respectively.	Aguayo-Mazzucato C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000035; Aguirre-Benitez EL, 2017, DEV NEUROBIOL, V77, P1413, DOI 10.1002/dneu.22548; Al Ain S, 2017, SOC NEUROSCI-UK, V12, P32, DOI 10.1080/17470919.2016.1159605; Arellanes-Licea EC, 2018, ENDOCR CONNECT, V7, P258, DOI 10.1530/EC-17-0380; Bello-Pineda J, 1999, J ENDOCRINOL, V160, P333, DOI 10.1677/joe.0.1600333; Bergan-Roller HE, 2018, GEN COMP ENDOCR, V258, P119, DOI 10.1016/j.ygcen.2017.07.028; BLASS EM, 1980, SCIENCE, V210, P15, DOI 10.1126/science.6997992; Bonnefont X, 2005, P NATL ACAD SCI USA, V102, P16880, DOI 10.1073/pnas.0508202102; Chanoine JP, 2006, HORM RES, V66, P81, DOI 10.1159/000093585; Dvorak B, 2010, J PEDIATR-US, V156, pS31, DOI 10.1016/j.jpeds.2009.11.018; EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555; Fak F, 2007, J ENDOCRINOL, V192, P345, DOI [10.1677/joe.1.07077, 10.1677/JOE.1.07077]; Gavalda-Navarro A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13717; GROSVENOR CE, 1993, ENDOCR REV, V14, P710, DOI 10.1210/edrv-14-6-710; Gruszka A, 2012, MOL CELL ENDOCRINOL, V362, P104, DOI 10.1016/j.mce.2012.05.020; GULYAS M, 1993, HISTOCHEMISTRY, V100, P503, DOI 10.1007/BF00267832; HALL WG, 1975, SCIENCE, V190, P1313, DOI 10.1126/science.1198116; HENNING SJ, 1981, AM J PHYSIOL, V241, pG199, DOI 10.1152/ajpgi.1981.241.3.G199; INIGUEZ C, 1995, NEUROENDOCRINOLOGY, V62, P308, DOI 10.1159/000127018; Jouihan H, 2012, BIO-PROTOCOL, V2, P223, DOI [10.21769/BioProtoc.223, DOI 10.21769/BIOPROTOC.223, DOI 10.21769/BioProtoc.223]; KACSOH B, 1989, ENDOCRINOLOGY, V125, P1326, DOI 10.1210/endo-125-3-1326; KACSOH B, 1990, J ENDOCRINOL, V124, P233, DOI 10.1677/joe.0.1240233; KACSOH B, 1991, J NEUROENDOCRINOL, V3, P529, DOI 10.1111/j.1365-2826.1991.tb00314.x; KEEN CL, 1981, J NUTR, V111, P226, DOI 10.1093/jn/111.2.226; KHORRAM O, 1983, ENDOCRINOLOGY, V113, P720, DOI 10.1210/endo-113-2-720; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; KUHN CM, 1978, SCIENCE, V201, P1034, DOI 10.1126/science.684424; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Le Roith D, 2001, TRENDS ENDOCRIN MET, V12, P48; Levy F, 2003, DEV PSYCHOBIOL, V43, P177, DOI 10.1002/dev.10131; Lomanowska AM, 2016, HORM BEHAV, V77, P224, DOI 10.1016/j.yhbeh.2015.05.017; LOPEZ F, 1986, ACTA ENDOCRINOL-COP, V113, P317, DOI 10.1530/acta.0.1130317; Mani BK, 2017, TRENDS ENDOCRIN MET, V28, P843, DOI 10.1016/j.tem.2017.10.001; Melo AI, 2006, DEV PSYCHOBIOL, V48, P209, DOI 10.1002/dev.20130; MESSER M, 1969, J NUTR, V98, P404, DOI 10.1093/jn/98.4.404; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Murray PG, 2015, J ENDOCRINOL, V226, pT123, DOI 10.1530/JOE-15-0120; Newman-Tancredi A, 2002, J PHARMACOL EXP THER, V303, P815, DOI 10.1124/jpet.102.039883; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; Pacha J, 2000, PHYSIOL REV, V80, P1633, DOI 10.1152/physrev.2000.80.4.1633; Papageorgiou A, 2007, ENDOCRINOLOGY, V148, P4509, DOI 10.1210/en.2007-0034; Raineki C, 2010, BRAZ J MED BIOL RES, V43, P914, DOI 10.1590/S0100-879X2010001000001; RENIER G, 1991, NEUROENDOCRINOLOGY, V54, P521, DOI 10.1159/000125947; RIEUTORT M, 1981, J ENDOCRINOL, V89, P355, DOI 10.1677/joe.0.0890355; Sakata I, 2012, AM J PHYSIOL-ENDOC M, V302, pE1300, DOI 10.1152/ajpendo.00041.2012; SCHANBERG SM, 1984, P SOC EXP BIOL MED, V175, P135; Shumate ML, 2005, AM J PHYSIOL-GASTR L, V289, pG227, DOI 10.1152/ajpgi.00424.2004; Sjogren K, 2002, J BONE MINER RES, V17, P1977, DOI 10.1359/jbmr.2002.17.11.1977; SMART JL, 1983, BRIT J NUTR, V49, P497, DOI 10.1079/BJN19830058; Sperling MA, 2016, GROWTH HORM IGF RES, V28, P69, DOI 10.1016/j.ghir.2015.06.005; Steculorum SM, 2015, J CLIN INVEST, V125, P846, DOI 10.1172/JCI73688; Steculorum SM, 2011, PEPTIDES, V32, P2362, DOI 10.1016/j.peptides.2011.06.021; Taniguchi Y, 2002, ANAT EMBRYOL, V206, P1, DOI 10.1007/s00429-002-0271-8; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; WALKER P, 1977, ENDOCRINOLOGY, V101, P782, DOI 10.1210/endo-101-3-782; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Zatelli C, 2005, J MOL ENDOCRINOL, V35, P333, DOI 10.1677/jme.1.01876; Zempoalteca R, 2018, DEV NEUROBIOL, V78, P351, DOI 10.1002/dneu.22561; Zhang P., 2012, BIO-PROTOCOL, V2, pe186	60	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220853	10.1371/journal.pone.0220853	http://dx.doi.org/10.1371/journal.pone.0220853			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408482	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500022
J	Pstras, L; Debowska, M; Wojcik-Zaluska, A; Zaluska, W; Waniewski, J				Pstras, Leszek; Debowska, Malgorzata; Wojcik-Zaluska, Alicja; Zaluska, Wojciech; Waniewski, Jacek			Hemodialysis-induced changes in hematocrit, hemoglobin and total protein: Implications for relative blood volume monitoring	PLOS ONE			English	Article							PHOSPHATE KINETICS; PLASMA-VOLUME; SESSIONS	Background Relative blood volume (RBV) changes during hemodialysis (HD) are typically estimated based on online measurements of hematocrit, hemoglobin or total blood protein. The aim of this study was to assess changes in the above parameters during HD in order to compare the potential differences in the RBV changes estimated by individual methods. Methods 25 anuric maintenance HD patients were monitored during a 1-week conventional HD treatment. Blood samples were collected from the arterial dialysis blood line at the beginning and at the end of each HD session. The analysis of blood samples was performed using the hematology analyzer Advia 2120 and clinical chemistry analyzer Advia 1800 (Siemens Healthcare). Results During the analyzed 30 HD sessions with ultrafiltration in the range 0.7-4.0 L (2.5 +/- 0.8 L) hematocrit (HCT) increased by 9.1 +/- 7.0% (mean +/- SD), hemoglobin (HGB) increased by 10.6 +/- 6.3%, total plasma protein (TPP) increased by 15.6 +/- 9.5%, total blood protein (TBP) increased by 10.4 +/- 5.8%, red blood cell count (RBC) increased by 10.8 +/- 7.1%, while mean corpuscular red cell volume (MCV) decreased by 1.5 +/- 1.1% (all changes statistically significant, p < 0.001). HGB increased on average by 1.5% more than HCT (p < 0.001). The difference between HGB and TBP increase was insignificant (p = 0.16). Conclusions Tracking HGB or TBP can be treated as equivalent for the purpose of estimating RBV changes during HD. Due to the reduction of MCV, the HCT-based estimate of RBV changes may underestimate the actual blood volume changes.	[Pstras, Leszek; Debowska, Malgorzata; Waniewski, Jacek] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Wojcik-Zaluska, Alicja] Med Univ Lublin, Dept Phys Therapy & Rehabil, Lublin, Poland; [Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, Lublin, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Medical University of Lublin; Medical University of Lublin	Pstras, L (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	leszek.pstras@ibib.waw.pl	Debowska, Malgorzata/F-3035-2015	Debowska, Malgorzata/0000-0001-8741-7930; Zaluska, Wojciech/0000-0001-6043-3236; Pstras, Leszek/0000-0001-5705-6142; Jacek, Waniewski/0000-0002-2705-504X; Wojcik-Zaluska, Alicja/0000-0001-7971-0141	National Science Centre (Poland) [N N518 289840]	National Science Centre (Poland)	The clinical data presented in this article were originally collected within the study "Evaluation of disturbances of calcium-phosphate management in patients on dialysis" funded by the National Science Centre (Poland), grant no N N518 289840 to MD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTELS PC, 1990, J CLIN CHEM CLIN BIO, V28, P113; CHAPLIN H, 1953, J CLIN INVEST, V32, P1309, DOI 10.1172/JCI102859; Dasselaar JJ, 2005, NEPHROL DIAL TRANSPL, V20, P2043, DOI 10.1093/ndt/gfi056; Dasselaar Judith J, 2007, Hemodial Int, V11, P448, DOI 10.1111/j.1542-4758.2007.00216.x; Dasselaar JJ, 2007, CLIN J AM SOC NEPHRO, V2, P669, DOI 10.2215/CJN.00880207; Dasselaar JJ, 2012, BLOOD PURIFICAT, V33, P177, DOI 10.1159/000334142; Debowska M, 2015, ARTIF ORGANS, V39, P1005, DOI 10.1111/aor.12489; Debowska M, 2015, NEPHROL DIAL TRANSPL, V30, P129, DOI 10.1093/ndt/gfu266; FAIRBANKS VF, 1996, BLOOD CELL MOL DIS, V22, P169, DOI DOI 10.1006/BCMD.1996.0024; FLEMING SJ, 1988, CLIN NEPHROL, V29, P63; Gellert R., 1989, DEV NEPHROLOGY, V24; HSU CH, 1984, NEPHRON, V38, P202, DOI 10.1159/000183308; Johnson DW, 1996, KIDNEY INT, V49, P255, DOI 10.1038/ki.1996.36; Keane DF, 2018, ASAIO J, V64, P812, DOI 10.1097/MAT.0000000000000795; KIRSCHBAUM B, 1989, INT J ARTIF ORGANS, V12, P307; Krepel HP, 2000, NEPHROL DIAL TRANSPL, V15, P673, DOI 10.1093/ndt/15.5.673; Kron J, 2014, BLOOD PURIFICAT, V38, P180, DOI 10.1159/000368157; LEYPOLDT JK, 1995, J AM SOC NEPHROL, V6, P214; Linne J., 1999, CLIN LAB SCI BASICS; Longanbach S., 2007, HEMATOLOGY CLIN PRIN; MALIN MJ, 1989, AM J CLIN PATHOL, V92, P286, DOI 10.1093/ajcp/92.3.286; Mitra S, 2004, J AM SOC NEPHROL, V15, P463, DOI 10.1097/01.ASN.0000108970.48370.33; Pietribiasi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209553; Pietribiasi M, 2018, INT J ARTIF ORGANS, V41, P706, DOI 10.1177/0391398818803439; Pietribiasi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159748; Pietribiasi M, 2015, ASAIO J, V61, P350, DOI 10.1097/MAT.0000000000000206; Polaschegg H. D., 2004, REPLACEMENT RENAL FU; Poleszczuk J, 2016, BLOOD PURIFICAT, V42, P177, DOI 10.1159/000445934; RASMUSSEN KC, 1993, SCAND J CLIN LAB INV, V53, P211, DOI 10.3109/00365519309088411; Samandari H, 2018, ASAIO J, V64, P77, DOI 10.1097/MAT.0000000000000608; SCHALLENBERG U, 1987, LIFE SUPPORT SYST, V5, P293; Schneditz D, 1996, J AM SOC NEPHROL, V7, P1241; SCHNEDITZ D, 1992, KIDNEY INT, V42, P1425, DOI 10.1038/ki.1992.437; Schneditz D, 2018, ASAIO J, V64, P697, DOI 10.1097/MAT.0000000000000885; Schneditz D, 2016, HEMODIAL INT, V20, P120, DOI 10.1111/hdi.12338; Schneditz D, 2014, ASAIO J, V60, P436, DOI 10.1097/MAT.0000000000000086; Siemens Healthcare Diagnostics Inc, 2010, ADVIA 2120 2120I HEM; STOTT RAW, 1995, CLIN CHEM, V41, P306; SWARTZ RD, 1982, AM J NEPHROL, V2, P189, DOI 10.1159/000166644; Thijssen S, 2013, BLOOD PURIFICAT, V35, P63, DOI 10.1159/000345484; Waniewski J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153285; Yu AW, 1997, KIDNEY INT, V51, P1986, DOI 10.1038/ki.1997.270	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220764	10.1371/journal.pone.0220764	http://dx.doi.org/10.1371/journal.pone.0220764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404089	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800030
J	Tan, CJ; Zhang, JH; Chen, WL; Feng, FF; Yu, C; Lu, XD; Lin, RH; Li, ZF; Huang, YM; Zheng, LP; Huang, MY; Wu, GW				Tan, Chunjiang; Zhang, Jiahui; Chen, Wenlie; Feng, Fangfang; Yu, Chao; Lu, Xiaodong; Lin, Ruhui; Li, Zuanfang; Huang, Yunmei; Zheng, Liangpu; Huang, Meiya; Wu, Guangwen			Inflammatory cytokines via up-regulation of aquaporins deteriorated the pathogenesis of early osteoarthritis	PLOS ONE			English	Article							TOUGU XIAOTONG CAPSULE; ARTICULAR-CARTILAGE; RAT MODEL; CHONDROCYTE APOPTOSIS; KNEE OSTEOARTHRITIS; IN-VIVO; ALPHA; EXPRESSION; DEGRADATION; INHIBITION	Background Inflammatory cytokines enhanced the progress of the pathogenesis of osteoarthritis, however the mechanisms remain unclear. The objective is to determine aquaporins (AQPs) in the pathogenesis of osteoarthritis. Methods and findings Primary rat articular chondrocytes were treated with IL-1 beta to mimic the early stage of osteoarthritis in vitro. Early osteoarthritis animal model was established by intra-articular injection of 4% papain. Micro- or ultra-structure histopathologic changes, cell viability, apoptosis cells and cell membrane permeability, locations and expressions of AQP1 and AQP3 and matrix were detected in the cartilage or in the chondrocytes of knee. IL-1 beta could reduce the chondrocytes viability, increase the apoptosis cells, and also impair the cell membrane and organelles. IL-1 beta significantly induced the up-regulation of AQP1 and AQP3 in the chondrocytes. In the chondrocytes, AQPs were mainly clustered in both membrane and perinuclear region of cytoplasm, while higher AQPs were detected in the superficial and middle layers of the cartilage. With the up-regulation of AQPs, the cartilage matrix was considerably decreased in both the chondrocytes and in the osteoarthritis cartilage. In the early osteoarthritis rat model, serum and synovial fluid confirmed that higher IL-1 beta could increase the expressions of AQPs, and decrease the cartilage matrix in both the chondrocytes and the cartilage. Conclusions Inflammatory cytokine IL-1 beta via up-regulation of AQPs caused the abnormal metabolism of water transport and loss of the cartilage matrix in the chondrocytes, and ultimately exacerbated the pathogenesis of early osteoarthritis. Therefore, AQPs may be a candidate therapeutic target for prevention and treatment of osteoarthritis.	[Tan, Chunjiang; Zhang, Jiahui; Chen, Wenlie; Feng, Fangfang; Yu, Chao; Lu, Xiaodong; Lin, Ruhui; Li, Zuanfang; Huang, Yunmei; Zheng, Liangpu; Huang, Meiya; Wu, Guangwen] Fujian Univ Tradit Chinese Med, Fuzhou, Fujian, Peoples R China; [Tan, Chunjiang; Chen, Wenlie; Lin, Ruhui; Li, Zuanfang; Huang, Yunmei; Zheng, Liangpu; Huang, Meiya] Fujian Acad Integrat Med, Fuzhou, Fujian, Peoples R China; [Tan, Chunjiang; Chen, Wenlie; Li, Zuanfang; Zheng, Liangpu; Wu, Guangwen] Fujian Key Lab Integrat Med Geriatr, Fuzhou, Fujian, Peoples R China; [Zhang, Jiahui] First Hosp Fuzhou, Fuzhou, Fujian, Peoples R China; [Chen, Wenlie; Lin, Ruhui; Huang, Yunmei; Huang, Meiya; Wu, Guangwen] Natl Lab Tradit Chinese Med Pharmacol Cell Struct, Fuzhou, Fujian, Peoples R China	Fujian University of Traditional Chinese Medicine	Tan, CJ; Chen, WL (corresponding author), Fujian Univ Tradit Chinese Med, Fuzhou, Fujian, Peoples R China.; Tan, CJ; Chen, WL (corresponding author), Fujian Acad Integrat Med, Fuzhou, Fujian, Peoples R China.; Tan, CJ; Chen, WL (corresponding author), Fujian Key Lab Integrat Med Geriatr, Fuzhou, Fujian, Peoples R China.; Chen, WL (corresponding author), Natl Lab Tradit Chinese Med Pharmacol Cell Struct, Fuzhou, Fujian, Peoples R China.	tchunj@126.com; chen.wl@163.com			National Natural Science Foundation of China [81573801]; Natural Science Foundation of Fujian Province [2017J06018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This work was supported by the National Natural Science Foundation of China No. 81573801 and the Natural Science Foundation of Fujian Province No. 2017J06018 to WC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton Nicola J, 2007, J Inflamm (Lond), V4, P13, DOI 10.1186/1476-9255-4-13; BRADLEY JD, 1992, J RHEUMATOL, V19, P1950; Cai L, 2018, IMMUNOPHARM IMMUNOT, V40, P117, DOI 10.1080/08923973.2017.1417998; Chen QZ, 2012, FOLIA HISTOCHEM CYTO, V50, P137, DOI [10.2478/18709, 10.5603/FHC.2012.0020]; Chowdhury TT, 2001, BIOCHEM BIOPH RES CO, V285, P1168, DOI 10.1006/bbrc.2001.5311; Cohen NP, 1998, J ORTHOP SPORT PHYS, V28, P203, DOI 10.2519/jospt.1998.28.4.203; DIJKGRAAF LC, 1995, J ORAL MAXIL SURG, V53, P1182, DOI 10.1016/0278-2391(95)90632-0; Gao HF, 2016, INT J MOL MED, V38, P1752, DOI 10.3892/ijmm.2016.2785; Gao H, 2011, SURG INNOV, V18, P279, DOI 10.1177/1553350611399587; Geyer M, 2009, OSTEOARTHR CARTILAGE, V17, P328, DOI 10.1016/j.joca.2008.07.010; Hagiwara K, 2013, MED MOL MORPHOL, V46, P104, DOI 10.1007/s00795-013-0014-3; Honorati MC, 2004, OSTEOARTHR CARTILAGE, V12, P683, DOI 10.1016/j.joca.2004.05.009; Huang GL, 2018, EXP THER MED, V15, P3096, DOI 10.3892/etm.2018.5794; Kraus VB, 2015, OSTEOARTHR CARTILAGE, V23, P1233, DOI 10.1016/j.joca.2015.03.036; Laurent D, 2003, MAGNET RESON MED, V50, P541, DOI 10.1002/mrm.10566; Li HT, 2013, INT J MOL MED, V32, P1329, DOI 10.3892/ijmm.2013.1527; Li XH, 2013, INT J MOL MED, V31, P1349, DOI 10.3892/ijmm.2013.1341; Liao NS, 2015, EXP THER MED, V10, P1908, DOI 10.3892/etm.2015.2739; Liess C, 2002, OSTEOARTHR CARTILAGE, V10, P907, DOI 10.1053/joca.2002.0847; Meng JH, 2007, CHINESE MED J-PEKING, V120, P2191, DOI 10.1097/00029330-200712020-00006; Minguzzi M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3075293; Murat Nergis, 2007, Acta Orthop Traumatol Turc, V41, P233; Musumeci G, 2013, TISSUE CELL, V45, P145, DOI 10.1016/j.tice.2012.10.004; Permuy M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0458-x; Raman S, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00022; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; Shakibaei M, 2005, ANN ANAT, V187, P487, DOI 10.1016/j.aanat.2005.06.007; Shakibaei M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/509383; Taruc-Uy RL, 2013, PRIMARY CARE, V40, P821, DOI 10.1016/j.pop.2013.08.003; Trujillo E, 2004, HISTOL HISTOPATHOL, V19, P435, DOI 10.14670/HH-19.435; Verkman Alan S, 2009, Handb Exp Pharmacol, P359, DOI 10.1007/978-3-540-79885-9_18; Wang SN, 2015, INT IMMUNOPHARMACOL, V24, P408, DOI 10.1016/j.intimp.2014.12.029; Yang Y, 2016, INFLAMMATION, V39, P1, DOI [10.1007/s10753-015-0215-0, DOI 10.1007/S10753-015-0215-0]; Zhang XH, 2015, CHIN J NAT MEDICINES, V13, P283, DOI 10.1016/S1875-5364(15)30015-7; Zhao HH, 2014, J CELL MOL MED, V18, P283, DOI 10.1111/jcmm.12186; Zhou PH, 2008, J ORTHOP RES, V26, P1643, DOI 10.1002/jor.20683	36	10	11	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220846	10.1371/journal.pone.0220846	http://dx.doi.org/10.1371/journal.pone.0220846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404098	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800037
J	Badgujar, NV; Tarapara, BV; Shah, FD				Badgujar, Nutan V.; Tarapara, Bhoomi V.; Shah, Franky D.			Computational analysis of high-risk SNPs in human CHK2 gene responsible for hereditary breast cancer: A functional and structural impact	PLOS ONE			English	Article							PROTEIN STABILITY CHANGES; DNA-DAMAGE; CHEK2 GENE; DELETERIOUS NSSNPS; MISSENSE MUTATIONS; KINASE; SEQUENCE; VARIANTS; RECOGNITION; PREDICTION	Nowadays CHK2 mutation is studied frequently in hereditary breast and ovarian cancer patients in addition to BRCA1/BRCA2. CHK2 is a tumor suppressor gene that encodes a serine/threonine kinase, also involved in pathways such as DNA repair, cell cycle regulation and apoptosis in response to DNA damage. CHK2 is a well-studied moderate penetrance gene that correlates with third high risk susceptibility gene with an increased risk for breast cancer. Hence before planning large population study, it is better to scrutinize putative functional SNPs of CHK2 using different computational tools. In this study, we have used various computational approaches to identify nsSNPs which are deleterious to the structure and/or function of CHK2 protein that might be causing this disease. Computational analysis was performed by different in silico tools including SIFT, Align GVGD, SNAP-2, PROVEAN, Poly-Phen-2, PANTHER, PhD-SNP, MUpro, iPTREE-STAB, Consurf, InterPro, NCBI Conserved Domain Search tool, ModPred, SPARKS-X, RAMPAGE, Verify-3D, FT Site, COACH and PyMol. Out of 78 nsSNP of human CHK2 gene, seven nsSNPs were predicted functionally most significant SNPs. Among these seven nsSNP, p.Arg160Gly, p.Gly210Arg and p.Ser415Phe are highly conserved residues with conservation score of 9 and three nsSNP were predicted to be involved in post translational modification. The p.Arg160Gly and p.Gly210Arg may interfere in phosphopeptide binding site on FHA conserved domain. The p.Ser415Phe may interfere in formation of activation loop of protein-kinase domain and might interfere in interactions of CHK2 with ligand. The study concludes that mutation of serine to phenylalanine at position 415 is a major mutation in native CHK2 protein which might contribute to its malfunction, ultimately causing disease. This is the first comprehensive study, where CHK2 gene variants are analyzed using in silico tools hence it will be of great help while considering large scale studies and also in developing precision medicines related to these polymorphisms in the era of personalized medicine.	[Badgujar, Nutan V.; Tarapara, Bhoomi V.; Shah, Franky D.] Gujarat Canc Res Inst, Dept Canc Biol, Stem Cell Biol Lab, Ahmadabad, Gujarat, India	The Gujarat Cancer & Research Institute	Shah, FD (corresponding author), Gujarat Canc Res Inst, Dept Canc Biol, Stem Cell Biol Lab, Ahmadabad, Gujarat, India.	franky.shah@gcriindia.org		Tarapara, Bhoomi/0000-0001-9262-925X; Shah, Franky/0000-0002-7265-2839				Abdelraheem N.E., 2016, AM J BIOINFORMATICS, V6, P56; Abdelraheem NE., 2016, AM J BIOINFORM RES, V6, P32, DOI [10.5923/j.bioinformatics.20160602.02, DOI 10.5923/J.BIOINFORMATICS.20160602.02]; Alanazi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025876; Apostolou P, 2017, BREAST CANCER-TARGET, V9, P331, DOI 10.2147/BCTT.S111394; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baloch Abdul Hameed, 2016, Asian Pac J Cancer Prev, V17, P1089; Baloch AH, 2014, MOL BIOL REP, V41, P1103, DOI 10.1007/s11033-013-2956-x; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Baysal BE, 2004, GYNECOL ONCOL, V95, P62, DOI 10.1016/j.ygyno.2004.07.015; Bell DW, 2007, INT J CANCER, V121, P2661, DOI 10.1002/ijc.23026; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Bhagwat M., 2010, CURRENT PROTOCOLS BI, V32; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046688, 10.1371/journal.pone.0039927]; Delimitsou A, 2019, HUMAN MUTATION; Desai M, 2018, COMPUT BIOL CHEM, V74, P20, DOI 10.1016/j.compbiolchem.2018.02.022; Desai M, 2017, COMPUT BIOL CHEM, V70, P7, DOI 10.1016/j.compbiolchem.2017.07.001; Desai M, 2016, META GENE, V10, P1, DOI 10.1016/j.mgene.2016.09.004; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gassoum A, 2016, OPEN ACCESS LIB J, V3, P1; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Hines SL, 2019, MOL OMICS, V15, P59, DOI 10.1039/c8mo00137e; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Huang LT, 2007, BIOINFORMATICS, V23, P1292, DOI 10.1093/bioinformatics/btm100; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jalilvand Manizheh, 2017, Comp Clin Path, V26, P837, DOI 10.1007/s00580-017-2455-x; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Kilpivaara O, 2004, INT J CANCER, V111, P543, DOI 10.1002/ijc.20299; Lovell SC, 2003, PROTEIN-STRUCT FUNCT, DOI [10.1093/bioinformatics/btt447, DOI 10.1093/BIOINFORMATICS/BTT447]; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Nachman MW, 2001, TRENDS GENET, V17, P481, DOI 10.1016/S0168-9525(01)02409-X; Nevanlinna H, 2006, ONCOGENE, V25, P5912, DOI 10.1038/sj.onc.1209877; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ngan CH, 2012, BIOINFORMATICS, V28, P286, DOI 10.1093/bioinformatics/btr651; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494; Pritzlaff M, 2017, BREAST CANCER RES TR, V161, P575, DOI 10.1007/s10549-016-4085-4; Rahner N, 2008, DTSCH ARZTEBL INT, V105, P706, DOI 10.3238/arztebl.2008.0706; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Roeb W, 2012, HUM MOL GENET, V21, P2738, DOI 10.1093/hmg/dds101; Ruijs MWG, 2009, HERED CANCER CLIN PR, V7, DOI 10.1186/1897-4287-7-4; Schmidt MK, 2016, J CLIN ONCOL, V34, P2750, DOI 10.1200/JCO.2016.66.5844; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Shaag A, 2005, HUM MOL GENET, V14, P555, DOI 10.1093/hmg/ddi052; Sodha N, 2006, CANCER RES, V66, P8966, DOI 10.1158/0008-5472.CAN-06-1990; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; Tang HM, 2016, BIOINFORMATICS, V32, P2230, DOI 10.1093/bioinformatics/btw222; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; Toss A, 2015, BIOMED RES INT; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yachdav G, 2014, F1000RESEARCH, P3; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350	61	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220711	10.1371/journal.pone.0220711	http://dx.doi.org/10.1371/journal.pone.0220711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398194	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000015
J	Carleton, RE; Graham, JH; Lee, A; Taylor, ZP; Carleton, JF				Carleton, Renee E.; Graham, John H.; Lee, Adel; Taylor, Zachary P.; Carleton, Jon F.			Reproductive success of Eastern Bluebirds (Sialia sialis) varies with the timing and severity of drought	PLOS ONE			English	Article							CLUTCH SIZE; CLIMATE-CHANGE; GRASSLAND BIRDS; EGG VIABILITY; SNAIL KITE; NORTH; CONSERVATION; DENSITY; TEMPERATURE; CONSTRAINT	Drought affects avian communities in complex ways. We used our own and citizen science-generated reproductive data acquired through The Cornell Lab of Ornithology's NestWatch Program, combined with drought and vegetation indices obtained from governmental agencies, to determine drought effects on Eastern Bluebird (Sialia sialis L.) reproduction across their North American breeding range for the years 2006-2013. Our results demonstrate that some aspects of bluebird reproductive success vary with the timing and severity of drought. Clutch size was unaffected by any level of drought at the time of clutch initiation or during the 30 to 60 days prior to clutch initiation. Hatching and fledging rates decreased as drought severity increased. Drought conditions occurring at least 30 days prior to the date eggs should have hatched and 60 days prior to the date offspring should have fledged negatively affected reproduction. We also demonstrate the value of datasets generated by citizen scientists in combination with climate data for examining biotic responses at large temporal and spatial scales.	[Carleton, Renee E.; Graham, John H.] Berry Coll, Dept Biol, Mt Berry, GA 30149 USA; [Lee, Adel] Etosha Business & Res Consulting LLC, Rome, GA USA; [Taylor, Zachary P.] Berry Coll, Dept Environm Sci, Mt Berry, GA USA; [Carleton, Jon F.] MIServ Consulting, Taylorsville, GA USA		Carleton, RE (corresponding author), Berry Coll, Dept Biol, Mt Berry, GA 30149 USA.	rcarleton@berry.edu		Taylor, Zachary/0000-0003-0736-570X	Berry College Bluebird Fund 2017	Berry College Bluebird Fund 2017	The study was funded by Berry College Bluebird Fund 2017 granted to REC. AL received a stipend to perform the statistical analysis from Etosha Business and Research Consulting, LLC (https://opencorporates.com/companies/us_ga/15093793).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albright TP, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00057.1; Albright TP, 2010, GLOBAL CHANGE BIOL, V16, P2158, DOI 10.1111/j.1365-2486.2009.02120.x; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Beissinger SR, 2005, ECOLOGY, V86, P2164, DOI 10.1890/04-1624; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; BOYCE MS, 1987, ECOLOGY, V68, P142, DOI 10.2307/1938814; BRENNER FJ, 1966, AM MIDL NAT, V76, P201, DOI 10.2307/2423243; Carleton Renee E., 2011, Oriole, V76, P57; Conway CJ, 2000, BEHAV ECOL, V11, P178, DOI 10.1093/beheco/11.2.178; Cooper CB, 2006, IBIS, V148, P221, DOI 10.1111/j.1474-919x.2006.00500.x; Cooper CB, 2005, ECOLOGY, V86, P2018, DOI 10.1890/03-8028; Crick HQP, GUIDELINES USE WILD, V146, P48; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Dhondt AA, 2002, IBIS, V144, P646, DOI 10.1046/j.1474-919X.2002.00103.x; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; Fair J., 2010, ORNITHOLOGICAL COUNC; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; GEORGE TL, 1992, ECOL APPL, V2, P275, DOI 10.2307/1941861; Gowaty P. A., 2015, BIRDS N AM ONLINE, DOI 10.2173/bna.381; Heim RR, 2002, B AM METEOROL SOC, V83, P1149, DOI 10.1175/1520-0477-83.8.1149; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Karnieli A, 2010, J CLIMATE, V23, P618, DOI 10.1175/2009JCLI2900.1; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; KOENIG WD, 1982, AUK, V99, P526; Lack D., 1968, pvii; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Langham GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135350; Langin KM, 2009, P 7 CAL ISL S, P293; Lehikoinen A, 2016, GLOBAL CHANGE BIOL, V22, P1121, DOI 10.1111/gcb.13150; McKinley DC, 2017, BIOL CONSERV, V208, P15, DOI 10.1016/j.biocon.2016.05.015; Mooij WM, 2002, ECOL MODEL, V149, P25, DOI 10.1016/S0304-3800(01)00512-9; Niemuth ND, 2008, CONDOR, V110, P211, DOI 10.1525/cond.2008.8514; Olsen B, 2008, OECOLOGIA, V158, P421, DOI 10.1007/s00442-008-1148-1; Phillips T, 2009, P 4 INT PARTN FLIGHT, P633; PINKOWSKI BC, 1977, CONDOR, V79, P289, DOI 10.2307/1368006; RICKLEFS RE, 1980, AUK, V97, P38; Sarhadi A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau3487; Seager R, 2009, J CLIMATE, V22, P5021, DOI 10.1175/2009JCLI2683.1; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Slagsvold T, 2007, ANIM BEHAV, V73, P691, DOI 10.1016/j.anbehav.2006.05.021; SMITH KG, 1982, ECOLOGY, V63, P952, DOI 10.2307/1937235; Stahle DW, 2007, CLIMATIC CHANGE, V83, P133, DOI 10.1007/s10584-006-9171-x; Stoleson SH, 1999, J ANIM ECOL, V68, P951, DOI 10.1046/j.1365-2656.1999.00342.x; Sullivan BL, 2017, BIOL CONSERV, V208, P5, DOI 10.1016/j.biocon.2016.04.031; TAKEKAWA JE, 1989, CONSERV BIOL, V3, P302, DOI 10.1111/j.1523-1739.1989.tb00090.x; Thacker JI, 1997, J APPL ENTOMOL, V121, P137, DOI 10.1111/j.1439-0418.1997.tb01383.x; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	49	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0214266	10.1371/journal.pone.0214266	http://dx.doi.org/10.1371/journal.pone.0214266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398191	Green Submitted, gold, Green Published			2022-12-27	WOS:000485004000001
J	Cunningham, SA; Chandrasekar, EK; Cartwright, K; Yount, KM				Cunningham, Solveig A.; Chandrasekar, Eeshwar K.; Cartwright, Kate; Yount, Kathryn M.			Protecting children's health in a calorie-surplus context: Household structure and child growth in the United States	PLOS ONE			English	Article							BODY-MASS INDEX; FAMILY-STRUCTURE; PHYSICAL-ACTIVITY; US CHILDREN; RISK-FACTORS; WEIGHT-GAIN; OBESITY; OVERWEIGHT; ADOLESCENTS; FOOD	Studies from the social and health sciences have tended to view the household as the locus of access to and distribution of care, resources, monitoring and modeling for children's wellbeing. Obesity may present a special case for the study of investments in children, being a component of health for which more of certain inputs may not lead to better outcomes. We expanded on common measures of household structure in the child health literature by considering co-residence and relatedness of parents, grandparents, other relatives, and other children. Data were from a longitudinal sample of 6,700 children participating in the Early Childhood Longitudinal Study Kindergarten Class of 1998-99 (ECLS-K), the largest U.S. national dataset with measures of child anthropometrics and household structure at seven time-points over nine years. We used lagged survey-adjusted regressions to estimate associations between household structure and subsequent changes in children's weight between ages 5 and 14 years in terms of BMI gain and incident obesity. Adjusting for household structure more thoroughly, children living in households with two parents rather than one parent did not experience advantages in terms of less excess weight gain or lower incidence of obesity during elementary and middle school. Children living with a grandmother gained more weight than children not living with a grandmother. Living with siblings and with non-related adults was associated with less weight gain. These findings corroborate a scenario in which, for health problems associated with caloric surplus, classic household factors have more complex associations with child wellbeing.	[Cunningham, Solveig A.; Yount, Kathryn M.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Cunningham, Solveig A.; Yount, Kathryn M.] Emory Univ, Dept Sociol, Atlanta, GA 30322 USA; [Chandrasekar, Eeshwar K.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Chandrasekar, Eeshwar K.] Emory Univ, Sch Med, Atlanta, GA USA; [Cartwright, Kate] Univ New Mexico, Sch Publ Adm, Albuquerque, NM 87131 USA	Emory University; Emory University; Emory University; Emory University; University of New Mexico	Cunningham, SA (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.; Cunningham, SA (corresponding author), Emory Univ, Dept Sociol, Atlanta, GA 30322 USA.	sargese@emory.edu	Cunningham, Solveig A/K-6760-2012; Yount, Kathryn M/K-1239-2012; Cunningham, Solveig/W-2672-2019	Cunningham, Solveig A/0000-0002-2354-1526; 	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R03HD060602]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK115937]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115937] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant R03HD060602 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and grant R01DK115937 from the National Institute of Diabetes and Digestive and Kidney Diseases to SAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health.	Adam EK, 2002, DEV PSYCHOL, V38, P792, DOI 10.1037//0012-1649.38.5.792; Adkins S, 2004, OBES RES, V12, p38S, DOI 10.1038/oby.2004.267; Agras WS, 2004, J PEDIATR-US, V145, P20, DOI 10.1016/j.jpeds.2004.03.023; Anderson PM, 2003, J HEALTH ECON, V22, P477, DOI 10.1016/S0167-6296(03)00022-5; Argeseanu S., 2004, African Population Studies, V19, P13; Arkes J, 2012, OBESITY, V20, P1696, DOI 10.1038/oby.2012.84; Augustine JM, 2017, J FAM ISSUES, V38, P2277, DOI 10.1177/0192513X15621344; Augustine JM, 2013, J APPL RES CHILDREN, V4; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Bates CR, 2018, OBES REV, V19, P716, DOI 10.1111/obr.12662; Beise J., 2005, GRANDMOTHERHOOD EVOL, P215; Birch LL, 2001, PEDIATR CLIN N AM, V48, P893, DOI 10.1016/S0031-3955(05)70347-3; Bogaert N, 2003, EUR J CLIN NUTR, V57, P1242, DOI 10.1038/sj.ejcn.1601677; Brunner EJ, 2007, AM J EPIDEMIOL, V165, P828, DOI 10.1093/aje/kwk058; Bruss MB, 2003, J AM DIET ASSOC, V103, P1042, DOI 10.1016/S0002-8223(03)00472-3; Burdette AM, 2008, SOC SCI MED, V67, P38, DOI 10.1016/j.socscimed.2008.03.029; Byrne LK, 2011, INT J PEDIATR OBES, V6, P415, DOI 10.3109/17477166.2011.598938; Case A, 2001, J HEALTH ECON, V20, P301, DOI 10.1016/S0167-6296(00)00088-6; Case A, 1999, AM EC REV, V89; Chaparro MP, 2014, SOC SCI MED, V120, P199, DOI 10.1016/j.socscimed.2014.09.024; Chen AY, 2010, PREV CHRONIC DIS, V7; Chen AY, 2014, MATERN CHILD HLTH J, V18, P1772, DOI 10.1007/s10995-013-1422-7; Cheung PC, 2016, CHILD OBES, V12, P1, DOI 10.1089/chi.2015.0055; Cole T, 2005, EUROPEAN J CLIN NUTR, V59; Costa-Font J, 2013, SOC SCI MED, V93, P29, DOI 10.1016/j.socscimed.2013.05.035; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Cunningham SA, 2010, POP STUD-J DEMOG, V64, P229, DOI 10.1080/00324728.2010.510201; Daly M., 1998, TRUTH CINDERELLA DAR; Datar A, 2004, OBES RES, V12, P58, DOI 10.1038/oby.2004.9; Datar A, 2014, SOC SCI MED, V107, P196, DOI 10.1016/j.socscimed.2013.12.022; Dattilo AM, 2012, J OBES, V2012, DOI 10.1155/2012/123023; DAWSON DA, 1991, J MARRIAGE FAM, V53, P573, DOI 10.2307/352734; DeLeire T, 2002, DEMOGRAPHY, V39, P393, DOI 10.1353/dem.2002.0016; Downey DB, 2001, AM PSYCHOL, V56, P497, DOI 10.1037//0003-066X.56.6-7.497; Duflo E, 2003, WORLD BANK ECON REV, V17, P1, DOI 10.1093/wber/lhg013; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Entwisle DR, 1996, J MARRIAGE FAM, V58, P341, DOI 10.2307/353500; Fertig A, 2009, REV ECON HOUSEHOLD, V7, P227, DOI 10.1007/s11150-009-9052-y; Fiese BH, 2012, ADV CHILD DEV BEHAV, V42, P307; Formisano A, 2014, PUBLIC HEALTH NUTR, V17, P2307, DOI 10.1017/S1368980013002474; Frankish H, 2001, LANCET, V358, P564, DOI 10.1016/S0140-6736(01)05750-6; Freeman E, 2012, INT J OBESITY, V36, P12, DOI 10.1038/ijo.2011.198; Gabel S, 2004, FAMILY PROCESSES, V31, P303; Ganong L ColemanM, 2017, EFFECTS STEPFAMILY L; Gennetian L, 2005, J POPUL ECON, V18, P415, DOI 10.1007/s00148-004-0215-0; Gerards SMPL, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-267; Geronimus AT, 1997, POLIT SCI QUART, V112, P405, DOI 10.2307/2657564; Ginther DK, 2004, DEMOGRAPHY, V41, P671, DOI 10.1353/dem.2004.0031; Goodman E, 2003, OBES RES, V11, P1018, DOI 10.1038/oby.2003.140; Gruber KJ, 2009, PREV CHRONIC DIS, V6; Halpern-Meekin S, 2008, J MARRIAGE FAM, V70, P435, DOI 10.1111/j.1741-3737.2008.00492.x; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hofferth SL, 2005, J POLICY ANAL MANAG, V24, P703, DOI 10.1002/pam.20134; Hofferth SL, 2003, J MARRIAGE FAM, V65, P213, DOI 10.1111/j.1741-3737.2003.00213.x; Hunsberger M, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.28; Jackson SL, 2017, PREV MED, V100, P229, DOI 10.1016/j.ypmed.2017.04.026; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Johnson-Taylor WL, 2006, OBESITY, V14, P929, DOI 10.1038/oby.2006.109; Kamo Y, 2000, SOCIOL PERSPECT, V43, P211, DOI 10.2307/1389794; Kimbro RT, 2013, SOC SCI MED, V95, P97, DOI 10.1016/j.socscimed.2012.09.032; Kreider R, 2005, LIVING ARRANGEMENTS; Kreider R.M., 2011, LIVING ARRANGEMENTS; Krueger PM, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0038-0; Landry-Meyer L, 1999, FAM RELAT, V48, P381, DOI 10.2307/585245; Leonetti D., 2005, GRANDMOTHERHOOD EVOL, P194; Li J, 2010, J SCHOOL HEALTH, V80, P96, DOI 10.1111/j.1746-1561.2009.00471.x; Lindsay AC, 2006, FUTURE CHILD, V16, P169, DOI 10.1353/foc.2006.0006; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; McConley RL, 2011, OBESITY, V19, P345, DOI 10.1038/oby.2010.177; McLanahan S., 1994, GROWING SINGLE PAREN; Muller MJ, 2005, P NUTR SOC, V64, P249, DOI 10.1079/PNS2005424; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Parikka S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1548-1; Patrick H, 2005, J AM COLL NUTR, V24, P83, DOI 10.1080/07315724.2005.10719448; Phipps SA, 2006, OBES REV, V7, P5, DOI 10.1111/j.1467-789X.2006.00217.x; Price J, 2012, ECON HUM BIOL, V2012, P1026, DOI [10.1038/oby.2003.140, DOI 10.1038/OBY.2003.140]; Ritchie LD, 2006, J AM DIET ASSOC, V106, P925, DOI 10.1016/j.jada.2006.03.001; Salmon J, 2005, OBES RES, V13, P1939, DOI 10.1038/oby.2005.239; Sear R, 2000, P ROY SOC B-BIOL SCI, V267, P1641, DOI 10.1098/rspb.2000.1190; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Singh GK, 2010, ARCH PEDIAT ADOL MED, V164, P598, DOI 10.1001/archpediatrics.2010.84; Singh GK, 2010, ANN EPIDEMIOL, V20, P40, DOI 10.1016/j.annepidem.2009.09.008; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Timperio A, 2008, INT J PEDIATR OBES, V3, P160, DOI 10.1080/17477160801970385; Tourangeau K., 2009, 2009004 NCES; Tourangeau Karen, 2006, 2006032 NCES; U. S. Department of Education- National Center for Education Statistics, 2004, 2001029 NCES US DEP; Voland E, 2002, MAX PLANCK I DEMOGRA; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wu Fei-Ling, 2003, J Nurs Res, V11, P19; Yelick A, 2017, CHILD ADOLESC SOC WO, V34, P381, DOI 10.1007/s10560-016-0468-y; Zvoch K, 1999, EVOL HUM BEHAV, V20, P453, DOI 10.1016/S1090-5138(99)00024-0	94	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220802	10.1371/journal.pone.0220802	http://dx.doi.org/10.1371/journal.pone.0220802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393933	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500064
J	Katchunga, PB; Mirindi, P; Baleke, A; Ntaburhe, T; Twagirumukiza, M; M'buyamba-Kabangu, JR				Katchunga, Philippe Bianga; Mirindi, Patrick; Baleke, Arsene; Ntaburhe, Theodore; Twagirumukiza, Marc; M'buyamba-Kabangu, Jean-Rene			The trend in blood pressure and hypertension prevalence in the general population of South Kivu between 2012 and 2016: Results from two representative cross-sectional surveys-The Bukavu observational study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOCIOECONOMIC-STATUS; BURDEN	Objective Data on blood pressure trends are scarce or unavailable in Sub-Saharan Africa in general and especially in the Democratic Republic of the Congo. This work addresses this gap by analyzing the dynamics in the prevalence and control of hypertension in a cohort of Congolese adults in South Kivu. Methods Two phases of data collection were conducted including a baseline at the beginning in 2012 and a follow up in 2016. The subjects were >= 18 years old living in urban (n = 4413) or rural areas (n = 6453). Hypertension was defined as a blood pressure >= 140/90 mmHg and/or taking antihypertensive medications. The crude prevalence of hypertension was ageadjusted to the WHO population. Results Between 2012 and 2016, there was a significant increase in blood pressure (+2.5/+1.4 mmHg; p = 0.001), age standardized prevalence of hypertension [19.0% vs. 18.0%; OR = 1.05 (1.02-1.08); p<0.0001], and obesity (7.9% to 9.8%; p< 0.0001) as well as the proportion of subjects > 60 years old (8.8% to 11.3%; p<0.0001) and those with tachycardia (10.5% to 14.4%; p<0.0001). The number of subjects under treatment of hypertension were statistically non-significant [16.1% vs. 14.3%; p = 0.29), but the level of control of hypertension was significantly reduced by 32.4% in 2016 compared in 2012 (43.5% vs. 64.4%; p = 0.0008). Conclusion There was an increase in the prevalence of hypertension as well as cardiovascular-associated risk factors in the population. However, this trend did not increase for treated subjects with no improvements in the level of AHT control. Therefore, improved strategies for the prevention and management of non-communicable diseases are very important in Sub-Saharan Africa.	[Katchunga, Philippe Bianga; Mirindi, Patrick] Catholic Univ Bukavu, Fac Med, Observ NCDs VLIR UOS UCB, Bukavu, South Kivu Prov, DEM REP CONGO; [Katchunga, Philippe Bianga] Reference Prov Gen Hosp Bukavu, Dept Internal Med, Cardiol, Bukavu, DEM REP CONGO; [Baleke, Arsene; Ntaburhe, Theodore] Hop Gen Reference Katana, Inst Tech Med, Katana, DEM REP CONGO; [Twagirumukiza, Marc] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium; [M'buyamba-Kabangu, Jean-Rene] Univ Kinshasa, Kinshasa, DEM REP CONGO	Ghent University; Universite de Kinshasa	Katchunga, PB (corresponding author), Catholic Univ Bukavu, Fac Med, Observ NCDs VLIR UOS UCB, Bukavu, South Kivu Prov, DEM REP CONGO.; Katchunga, PB (corresponding author), Reference Prov Gen Hosp Bukavu, Dept Internal Med, Cardiol, Bukavu, DEM REP CONGO.	philkatch@yahoo.fr	Twagirumukiza, Marc/B-5898-2012; M'BUYAMBA-KABANGU, Jean René/AAD-7736-2022	Twagirumukiza, Marc/0000-0003-1378-6922; 	Catholic University of Bukavu -UCB (DRC); Flemish Universities (Belgium) under the Flemish Interuniversity Council (Vlaamse Interuniversitaire Raad-VLIR) - Interuniversity Development Cooperation (UOS)	Catholic University of Bukavu -UCB (DRC); Flemish Universities (Belgium) under the Flemish Interuniversity Council (Vlaamse Interuniversitaire Raad-VLIR) - Interuniversity Development Cooperation (UOS)	This work was supported by an institutional university cooperation program between Catholic University of Bukavu -UCB (DRC) and Flemish Universities (Belgium) under the Flemish Interuniversity Council (Vlaamse Interuniversitaire Raad-VLIR) - Interuniversity Development Cooperation (UOS) funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], CAUS DEATH 2008; Antignac M, 2018, HYPERTENSION, V71, P577, DOI 10.1161/HYPERTENSIONAHA.117.10512; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Bayauli MP, 2018, J EPIDEMIOLOGICAL RE, V4, P33; Bayauli MP, 2014, WORLD J CARDIOVASC D, V4, P390; BLAIR D, 1984, AM J EPIDEMIOL, V119, P526, DOI 10.1093/oxfordjournals.aje.a113770; Cha SH, 2012, J EPIDEMIOL, V22, P425, DOI 10.2188/jea.JE20110132; Dewhurst MJ, 2013, J HUM HYPERTENS, V27, P374, DOI 10.1038/jhh.2012.59; Dzudie A, 2017, CARDIOVASC J AFR, V28, P262, DOI 10.5830/CVJA-2017-040; Gama H, 2013, REV SAUDE PUBL, V47, P301, DOI 10.1590/S0034-910.2013047004328; Heiniger S, 2017, J HYPERTENS, V35, P1465, DOI 10.1097/HJH.0000000000001358; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Horton R, 2015, LANCET, V386, P2378, DOI 10.1016/S0140-6736(15)01178-2; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Julius S, 2002, J PEDIATR-US, V140, P643, DOI 10.1067/mpd.2002.125519; Kabakambira JD, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001057; Katchunga PB, 2015, REV EPIDEMIOL SANTE, V63, P339, DOI 10.1016/j.respe.2015.07.044; Katchunga PB, 2011, PRESSE MED, V40, pe315, DOI DOI 10.1016/J.LPM.2010.10.036; Katchunga PB, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.20.1258; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Leng B, 2015, J HYPERTENS, V33, P221, DOI 10.1097/HJH.0000000000000428; MANN GV, 1962, J CHRON DIS, V15, P341, DOI 10.1016/0021-9681(62)90082-6; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Omar B. A, 2001, AGE STANDARDIZATION; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Pires JE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-90; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, GLOB STRAT PREV CONT; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Xing L, 2019, J HYPERTENS, V37, P2013; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219377	10.1371/journal.pone.0219377	http://dx.doi.org/10.1371/journal.pone.0219377			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393877	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500010
J	Miller, NJ; Bergtold, JS; Featherstone, AM				Miller, Noah J.; Bergtold, Jason S.; Featherstone, Allen M.			Economic elasticities of input substitution using data envelopment analysis	PLOS ONE			English	Article							MARGINAL RATES; CONSTANT ELASTICITY; COST-FUNCTIONS; EFFICIENCY; FRONTIERS; SCALE; RETURNS; MODELS	The use of elasticities of substitution between inputs is a standard method for addressing the effect of a change in the mix of inputs used for production from a technical or cost stand-point. Most estimation methods use parametric production or cost functions or frontiers to estimate these elasticities. A potentially useful nonparametric alternative is data envelopment analysis (DEA). The purpose of this paper is to derive elasticities of input substitution for both technical and cost frontiers using DEA, extending the use of this approach in the field of economics and associated fields. The paper provides derivations for both Hicksian (production and cost frontier) and Morishima (cost frontier) elasticities of input substitution, as well as a parsimonious method for estimating them using DEA. The derivations are presented using an agricultural example form Kansas, USA.	[Miller, Noah J.; Bergtold, Jason S.; Featherstone, Allen M.] Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA	Kansas State University	Bergtold, JS (corresponding author), Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA.	bergtold@ksu.edu	Bergtold, Jason/AAA-1041-2022		U.S. Department of Agriculture, National Institute of Food and Agriculture, Hatch Project [1007061]	U.S. Department of Agriculture, National Institute of Food and Agriculture, Hatch Project	This work was supported by the U.S. Department of Agriculture, National Institute of Food and Agriculture (https://www.nifa.usda.gov/), Hatch Project 1007061 (JSB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	AHN T, 1988, SOCIO ECON PLAN SCI, V22, P253, DOI 10.1016/0038-0121(88)90007-9; Allen R. G. D., 1938, MATH ANAL EC; Azadi M, 2015, COMPUT OPER RES, V54, P274, DOI 10.1016/j.cor.2014.03.002; Badin L, 2019, EUR J OPER RES, V277, P784, DOI 10.1016/j.ejor.2019.02.054; BANKER RD, 1984, MANAGE SCI, V30, P1078, DOI 10.1287/mnsc.30.9.1078; BLACKORBY C, 1989, AM ECON REV, V79, P882; BLACKORBY C, 1981, REV ECON STUD, V48, P147, DOI 10.2307/2297127; Chambers RG, 2008, J PROD ANAL, V30, P169, DOI 10.1007/s11123-008-0104-8; Chambers RobertG., 1988, APPL PRODUCTION ANAL; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Cooper WW, 2000, J PROD ANAL, V13, P105, DOI 10.1023/A:1007896629828; Cooper WW., 2007, DATA ENVELOPMENT ANA, V2nd; Fare R., 1985, MEASUREMENT EFFICIEN; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; FERRIER GD, 1990, J ECONOMETRICS, V46, P229, DOI 10.1016/0304-4076(90)90057-Z; Gonzalez-Mejia A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195286; HERTEL TW, 1989, AM J AGR ECON, V71, P559, DOI 10.2307/1242012; Hicks JR, 1934, ECONOMICA-NEW SER, V1, P52, DOI 10.2307/2548574; Hicks J.R., 1932, THEORY WAGES; JOHNSTON J, 1958, REV ECON STAT, V40, P339, DOI 10.2307/1926337; Kapelko M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128217; Krivonozhko VE, 2004, J OPER RES SOC, V55, P1049, DOI 10.1057/palgrave.jors.2601759; Lusk JL, 2002, AUST J AGR RESOUR EC, V46, P45, DOI 10.1111/1467-8489.00166; McCaffrey N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115544; MCFADDEN D, 1963, REV ECON STUD, V30, P73, DOI 10.2307/2295804; Mirbolouki M, 2019, EXPERT SYST APPL, V125, P170, DOI 10.1016/j.eswa.2019.01.065; Mirzaei M, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/1531282; Morishima M., 1967, KEIZAI HYORON EC REV, V16, P144; Mundra K, 2010, WORKING PAPER; Ouellette P, 2016, EUR J OPER RES, V253, P880, DOI 10.1016/j.ejor.2016.02.036; Parman BJ, 2019, J APPL ECON, V22, P59, DOI 10.1080/15140326.2018.1526868; Parman BJ, 2017, AGR ECON-BLACKWELL, V48, P523, DOI 10.1111/agec.12353; Podinovski VV, 2019, EUR J OPER RES, V279, P258, DOI 10.1016/j.ejor.2019.05.024; Podinovski VV, 2016, OPER RES, V64, P236, DOI 10.1287/opre.2015.1457; Podinovski VV, 2010, OPER RES, V58, P1743, DOI 10.1287/opre.1090.0794; Ravelojaona P, 2019, EUR J OPER RES, V272, P780, DOI 10.1016/j.ejor.2018.07.020; Ray S.C., 2004, DATA ENVELOPMENT ANA; RAY SC, 1982, AM J AGR ECON, V64, P490, DOI 10.2307/1240641; Rosen D, 1998, J PROD ANAL, V9, P205, DOI 10.1023/A:1018382904489; Russell LA, 2013, AGRIC FINANCE REV, V73, P413, DOI [10.1108/AFR-09-2012-0047, 10.]; THANASSOULIS E, 1993, J OPER RES SOC, V44, P1129, DOI 10.2307/2583874; UZAWA H, 1962, REV ECON STUD, V29, P291, DOI 10.2307/2296305; WALTERS AA, 1963, ECONOMETRICA, V31, P1, DOI 10.2307/1910949	43	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220478	10.1371/journal.pone.0220478	http://dx.doi.org/10.1371/journal.pone.0220478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393895	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500035
J	Saito, T; Motoki, K; Nouchi, R; Kawashima, R; Sugiura, M				Saito, Toshiki; Motoki, Kosuke; Nouchi, Rui; Kawashima, Ryuta; Sugiura, Motoaki			Does incidental pride increase competency evaluation of others who appear careless? Discrete positive emotions and impression formation	PLOS ONE			English	Article							SELF-ESTEEM; SOCIAL PROJECTION; MOOD; SIMILARITY; AWE; EXPERIENCE; DIMENSIONS; JUDGMENTS; PEOPLE	Emotion plays important and diverse roles across various social relations. Although the social functions of emotion have attracted increased attention, the effects of positive emotions such as pride on impression formation remain poorly understood. Drawing on social projection theory, this study examined how incidental experiences of pride influenced the impressions of those who made a blunder, along with two other characteristics: the person's warmth and competence. Participants were designated randomly to receive inductions of pride, awe, or a neutral emotion. Subsequently, they were asked to indicate their own impression of a person who had made a blunder and to rate their overall sense of that individual's warmth and competence. A laboratory experiment recruiting university students (Study 1, N = 79) demonstrated that pride, a positive emotion elicited by a self-relevant achievement, led to higher competency evaluations of others. However, a pre-registered online experiment in middle-aged adults (Study 2, N = 108) failed to replicate the effects of pride on competency evaluations of others. Furthermore, another pre-registered online experiment in younger adults (Study 3, N = 290) did not show successful manipulation of incidental emotions. These results suggest that strictly controlled experimental settings that induce robust incidental emotions might be better for demonstrating a strong pride effect on the evaluation of others.	[Saito, Toshiki; Motoki, Kosuke; Nouchi, Rui; Kawashima, Ryuta; Sugiura, Motoaki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan; [Saito, Toshiki; Motoki, Kosuke] Japan Soc Promot Sci, Tokyo, Japan; [Motoki, Kosuke] Miyagi Univ, Dept Food Management, Sendai, Miyagi, Japan; [Nouchi, Rui] Tohoku Univ, Smart Aging Res Ctr, Sendai, Miyagi, Japan; [Sugiura, Motoaki] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi, Japan	Tohoku University; Japan Society for the Promotion of Science; Miyagi University; Tohoku University; Tohoku University	Saito, T (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi, Japan.; Saito, T (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	toshiki.saito@med.tohoku.ac.jp	Motoki, Kosuke/S-9469-2019; Nouchi, Rui/GQH-1608-2022	Motoki, Kosuke/0000-0001-7803-2713; Saito, Toshiki/0000-0002-2089-3358; Nouchi, Rui/0000-0002-2078-9518	JSPS KAKENHI [17H06046]; Research Grant of Division for Interdisciplinary Advanced Research and Education, Tohoku University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Grant of Division for Interdisciplinary Advanced Research and Education, Tohoku University	This study is supported by JSPS KAKENHI grant number 17H06046 [Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)] and Research Grant of Division for Interdisciplinary Advanced Research and Education, Tohoku University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by JSPS KAKENHI Grant Number 17H06046 [Grant-in-Aid for Scientific Research on Innovative Areas (Research in a Proposed Research Area)] and Research Grant of Division for Interdisciplinary Advanced Research and Education, Tohoku University. Funding sources of the trial had no involvement in the study design, collection, analysis, interpretation of data, or the writing of the manuscript.	Ames DR, 2004, J PERS SOC PSYCHOL, V87, P573, DOI 10.1037/0022-3514.87.5.573; Angie AD, 2011, COGNITION EMOTION, V25, P1393, DOI 10.1080/02699931.2010.550751; [Anonymous], R LANG ENV STAT COMP; Aronson E., 1966, PSYCHON SCI, V4, P227, DOI [DOI 10.3758/BF03342263, 10.3758/BF03342263, 10.3758/bf03342263]; Aronson E, 2015, SOCIAL PSYCHOL, DOI [10.1027/1864-9335/a000219, DOI 10.1027/1864-9335/A000219]; Beall AT, 2017, SOC PERSONAL PSYCHOL, V11, DOI 10.1111/spc3.12303; Bless H, 2006, AFFECT SOCIAL THINKI, P6584; Brown JD, 2001, PERS SOC PSYCHOL B, V27, P575, DOI 10.1177/0146167201275006; Fischer AH., 2003, EUR REV SOC PSYCHOL, V14, P171, DOI [10.1080/10463280340000054, DOI 10.1080/10463280340000054]; Fiske ST, 2007, TRENDS COGN SCI, V11, P77, DOI 10.1016/j.tics.2006.11.005; Forgas JP, 2015, J EXP SOC PSYCHOL, V58, P136, DOI 10.1016/j.jesp.2015.01.007; Forgas JP, 2011, EUR J SOC PSYCHOL, V41, P812, DOI 10.1002/ejsp.842; FORGAS JP, 1992, J PERS SOC PSYCHOL, V62, P863, DOI 10.1037/0022-3514.62.5.863; FORGAS JP, 1987, J PERS SOC PSYCHOL, V53, P53, DOI 10.1037/0022-3514.53.1.53; Funder DC, 2012, CURR DIR PSYCHOL SCI, V21, P177, DOI 10.1177/0963721412445309; Gross JJ, 1997, PSYCHOL AGING, V12, P590, DOI 10.1037/0882-7974.12.4.590; HELMREICH R, 1970, J PERS SOC PSYCHOL, V16, P259, DOI 10.1037/h0029848; Herrald MM, 2002, J PERS SOC PSYCHOL, V83, P434, DOI 10.1037//0022-3514.83.2.434; Jakobs E, 1996, J NONVERBAL BEHAV, V20, P123, DOI 10.1007/BF02253073; Judd CM, 2005, J PERS SOC PSYCHOL, V89, P899, DOI 10.1037/0022-3514.89.6.899; Katzir M, 2010, J EXP PSYCHOL LEARN, V36, P1314, DOI 10.1037/a0020120; Keltner D, 2003, COGNITION EMOTION, V17, P297, DOI 10.1080/02699930302297; Keltner D., 2010, HDB SOCIAL PSYCHOL; Kocinski K., 2008, ANTHROPOL REV, V71, P77, DOI [10.2478/V10044-008-0012-6, DOI 10.2478/V10044-008-0012-6]; Krueger J. I., 2008, EUROPEAN REV SOCIAL, V18, P1; Krueger JI, 2013, CURR DIR PSYCHOL SCI, V22, P289, DOI 10.1177/0963721413481352; METTEE DR, 1972, J PERS SOC PSYCHOL, V22, P246, DOI 10.1037/h0032603; Mimura C, 2007, J PSYCHOSOM RES, V62, P589, DOI 10.1016/j.jpsychores.2006.11.004; Mislin A, 2015, J BEHAV EXP ECON, V58, P11, DOI 10.1016/j.socec.2015.06.001; Motoki K, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00076; Oveis C, 2010, J PERS SOC PSYCHOL, V98, P618, DOI 10.1037/a0017628; Piff PK, 2015, J PERS SOC PSYCHOL, V108, P883, DOI 10.1037/pspi0000018; Robbins JM, 2005, PERS SOC PSYCHOL REV, V9, P32, DOI 10.1207/s15327957pspr0901_3; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Schwarz N., 1988, AFFECT COGNITION SOC, P44, DOI DOI 10.2307/3172815; Shiota MN, 2007, COGNITION EMOTION, V21, P944, DOI 10.1080/02699930600923668; Simmons JP, 2018, PERSPECT PSYCHOL SCI, V13, P255, DOI 10.1177/1745691617698146; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Srivastava S, 2010, J PERS SOC PSYCHOL, V98, P520, DOI 10.1037/a0017057; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; Tracy JL, 2004, PSYCHOL SCI, V15, P194, DOI 10.1111/j.0956-7976.2004.01503008.x; Uanhoro JO., EFFECT SIZE CALCULAT; Van Bavel JJ, 2016, P NATL ACAD SCI USA, V113, P6454, DOI 10.1073/pnas.1521897113; Williams LA, 2008, J PERS SOC PSYCHOL, V94, P1007, DOI 10.1037/0022-3514.94.6.1007; Williams LA, 2009, PSYCHOL SCI, V20, P284, DOI 10.1111/j.1467-9280.2009.02292.x; Wood D, 2010, J PERS SOC PSYCHOL, V99, P174, DOI 10.1037/a0019390	46	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220883	10.1371/journal.pone.0220883	http://dx.doi.org/10.1371/journal.pone.0220883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393917	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500077
J	Pang, K; Zhu, ZK; Zhu, SB; Han, LQ				Pang, Kun; Zhu, Zhongke; Zhu, Songbo; Han, Liqiang			A high dose of conjugated linoleic acid increases fatty liver and insulin resistance in lactating mice	PLOS ONE			English	Article							MILK-FAT; LIPID-METABOLISM; BODY-COMPOSITION; ADIPOSE-TISSUE; LITTER GROWTH; TRANS-10; RATS; ISOMERS; SUPPLEMENTATION; ENZYMES	This study aimed to evaluate the effects of a high dose of conjugated linoleic acid (CLA) on lactating mice. In one experiment, Kunming mice were separated into four groups (n = 6 per group); the control (CON) group received 3.0% linoleic acid (LA) oil, the L-CLA group received a mixture of 2.0% LA and 1.0% CLA, the M-CLA group received a mixture of 1.0% LA and a 2.0% CLA, and the H-CLA group received 3.0% CLA. Feeding proceeded from day 4 to day 10 of lactation. In a second experiment, a CON group received 3.0% LA, and an H-CLA group received 3.0% CLA. Plasma parameters were analyzed for all groups, and insulin tolerance tests (ITTs) were conducted. CLA treatment did not affect dam weight but significantly decreased the food intake of dams during lactation. Furthermore, CLA decreased the weight of pups on day 10 of lactation; this effect was attributed to lower milk fat of dams in the CLA group than in those of the other groups. Relative to mice in the CON group, the mice in the H-CLA group displayed increased liver weight and liver triglyceride (TG) content as well as higher TG content and gamma-glutamyl transferase (gamma-GT) activity in the plasma. Moreover, high-dose CLA resulted in insulin resistance, possibly affecting the red blood cell (RBC) and hemoglobin (HCB) levels in the plasma. In conclusion, lactating mice receiving a high dose of CLA exhibited fatty liver, insulin resistance, and impaired lactation performance.	[Pang, Kun; Zhu, Zhongke] Xinyang Agr & Forestry Univ, Coll Anim Sci & Vet Med, Xinyang, Peoples R China; [Zhu, Songbo] Zhengzhou Acad Agr & Forestry Sci, Zhengzhou, Henan, Peoples R China; [Han, Liqiang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China	Xinyang Agriculture & Forestry University; Henan Agricultural University	Han, LQ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China.	qlhan2001@126.com						Assumpcao RP, 2004, NUTRITION, V20, P806, DOI 10.1016/j.nut.2004.05.004; Belury MA, 2002, ANNU REV NUTR, V22, P505, DOI 10.1146/annurev.nutr.22.021302.121842; Bezan PN, 2018, EXP CLIN ENDOCR DIAB, V126, P379, DOI 10.1055/s-0043-118348; Bhattacharya A, 2006, J NUTR BIOCHEM, V17, P789, DOI 10.1016/j.jnutbio.2006.02.009; BURNOL AF, 1983, AM J PHYSIOL, V245, pE351, DOI 10.1152/ajpendo.1983.245.4.E351; Chapman C, 2000, J NUTR, V130, P146, DOI 10.1093/jn/130.2.146; CHIN SF, 1994, J NUTR, V124, P2344, DOI 10.1093/jn/124.12.2344; Clement L, 2002, J LIPID RES, V43, P1400, DOI 10.1194/jlr.M20008-JLR200; Cocciardi RA, 2002, MILCHWISSENSCHAFT, V57, P90; DelPrado M, 1997, J NUTR, V127, P458, DOI 10.1093/jn/127.3.458; FOLCH J, 1957, J BIOL CHEM, V226, P497; Harvatine KJ, 2014, J NUTR, V144, P1928, DOI 10.3945/jn.114.198911; Hayashi AA, 2007, J DAIRY RES, V74, P160, DOI 10.1017/S002202990600224X; HILLER A, 1948, J BIOL CHEM, V176, P1421; Jiang YZ, 2014, J GASTROEN HEPATOL, V29, P1508, DOI 10.1111/jgh.12580; Kadegowda AKG, 2010, J NUTR, V140, P919, DOI 10.3945/jn.109.110890; Lee KW, 2005, CRIT REV FOOD SCI, V45, P135, DOI 10.1080/10408690490911800; Lock AL, 2008, J DAIRY SCI, V91, P3291, DOI 10.3168/jds.2008-1071; Lock AL, 2006, J DAIRY SCI, V89, P1525, DOI 10.3168/jds.S0022-0302(06)72220-2; Loor JJ, 2003, BRIT J NUTR, V90, P1039, DOI 10.1079/BJN20031002; Masters N, 2002, LIPIDS, V37, P133, DOI 10.1007/s11745-002-0872-8; Perfield JW, 2007, J DAIRY SCI, V90, P2211, DOI 10.3168/jds.2006-745; Ringseis R, 2004, J NUTR, V134, P3327, DOI 10.1093/jn/134.12.3327; Riserus U, 2002, DIABETES CARE, V25, P1516, DOI 10.2337/diacare.25.9.1516; Sandri EC, 2018, ANIMAL, V12, P1405, DOI [10.1017/S1751731117002956, 10.1017/s1751731117002956]; Tsuboyama-Kasaoka N, 2000, DIABETES, V49, P1534, DOI 10.2337/diabetes.49.9.1534; Urrutia NL, 2018, BRIT J NUTR, V120, P259, DOI 10.1017/S0007114518001551; Scalerandi MV, 2014, NUTR HOSP, V29, P591, DOI [10.3305/NH.2014.29.3.7180, 10.3305/nh.2014.29.3.7180]; Vyas D, 2014, LIPIDS, V49, P641, DOI 10.1007/s11745-014-3906-7; Wang YW, 2004, INT J OBESITY, V28, P941, DOI 10.1038/sj.ijo.0802641; West DB, 1998, AM J PHYSIOL-REG I, V275, pR667; Yang L, 2002, BRIT J NUTR, V87, P253, DOI 10.1079/BJN2001516; Zabala A, 2006, LIPIDS, V41, P993, DOI 10.1007/s11745-006-5050-5	33	3	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0214903	10.1371/journal.pone.0214903	http://dx.doi.org/10.1371/journal.pone.0214903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390361	Green Submitted, Green Published, gold			2022-12-27	WOS:000484999400002
J	Corboz, J; Siddiq, W; Hemat, O; Chirwa, ED; Jewkes, R				Corboz, Julienne; Siddiq, Wahid; Hemat, Osman; Chirwa, Esnat D.; Jewkes, Rachel			What works to prevent violence against children in Afghanistan? Findings of an interrupted time series evaluation of a school-based peace education and community social norms change intervention in Afghanistan	PLOS ONE			English	Article								Background Against a backdrop of more than four decades of war, conflict and insecurity, Afghanistan is recognised as suffering from endemic violence and children are exposed to multiple forms of violence, including at the family and school levels. This paper presents the results of an evaluation of school-based peace education and a community-based intervention to change harmful social norms and practices related to gender and the use of violence in conflict resolution, implemented in Afghanistan with the aim of reducing violence against and between children. Methods The evaluation consisted of a cross-sectional, interrupted time series design with three data collection points over 12 months. Data was collected from students in 11 secondary schools (seven girls' and four boys' schools) in Jawzjan province of Afghanistan, with a total of 361 boys and 373 girls sampled at endline. All children were interviewed with a questionnaire developed for the study. Key outcomes included children's experience of peer violence (both perpetration and victimization) at school, corporal punishment both at home and at school, and observation of family violence. Other outcomes included children's gender equitable attitudes, attitudes towards child punishment, depression and school performance. Results Between baseline and endline evaluation points, there were significant reductions in various forms of violence at the school level, including both boys' and girls' past month experience of peer violence victimization, peer violence perpetration, and corporal punishment by teachers. There were also significant reductions in boys' and girls' experience of corporal punishment at home and observation of family violence, with a particularly strong effect observed among girls. Both boys and girls had significantly more equitable gender attitudes and significantly less violence-supportive attitudes in relation to children's punishment, and significantly fewer symptoms of depression. Girls' school attendance was also significantly higher at endline. Discussion To our knowledge this is the first time that a peace education program has been evaluated in Afghanistan, with or without a community intervention to change harmful social norms and practices related to gender and the use of violence for conflict resolution. The evaluation suggests that the intervention may have led to a reduction in various forms of violence, including children's peer violence, corporal punishment of children both at school and at home, and in children's reports of domestic violence against women at the household level.	[Siddiq, Wahid; Hemat, Osman] Help Afghan Children, Kabul, Afghanistan; [Chirwa, Esnat D.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Chirwa, Esnat D.; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa	University of Witwatersrand; South African Medical Research Council		juliennecorboz@gmail.com		Jewkes, Rachel/0000-0002-4330-6267; Chirwa, Esnat/0000-0003-0471-4978; Corboz, Julienne/0000-0002-5320-2234	UK Aid; UK Aid from the UK Department for International Development (DFID)	UK Aid(CGIAR); UK Aid from the UK Department for International Development (DFID)	This work was supported by UK Aid. This document is an output from the What Works to Prevent Violence: A Global Programme which is funded by UK Aid from the UK Department for International Development (DFID) for the benefit of developing countries. The funding was managed by the South African Medical Research Council. However, the views expressed and information contained in it are not necessarily those of or endorsed by DFID, which can accept no responsibility for such views or information or for any reliance placed on them.; Funder: UK Aid. This document is an output from the What Works to Prevent Violence: A Global Programme which is funded by UK Aid from the UK Department for International Development (DFID) for the benefit of developing countries. The funding was managed by the South African Medical Research Council. However, the views expressed and information contained in it are not necessarily those of or endorsed by DFID, which can accept no responsibility for such views or information or for any reliance placed on them.	[Anonymous], 2017, AFGH DEM HLTH SURV 2; [Anonymous], 2010, AFGH REP SUBM UN COM; [Anonymous], 2017, CORPORAL PUNISHMENT; Bar-Tal D, 2002, PEACE EDUCATION, P27; Bar-Tal D., 2009, HDB PEACE ED, P21; Caireta Sampere M, 2013, PEACE COEXISTENCE ED; Corboz J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192768; CSO & UNICEF, 2012, AFGH MULT IND CLUST; Harris BR, 2014, PERSPECT INSTR TECHN, P3; Harris I, 2008, PEACE EDUC SER, P245; Jager U, 2014, ONLINE BERGHOF HDB C; Kovacs M., 2011, CHILDRENS DEPRESSION; Love Smith D., 2008, LOVE FEAR DISCIPLINE; Lumley T, 2015, CLASS 6 PROFICIENCY; McFarlane J, 2017, GLOB HEALTH-SCI PRAC, V5, P115, DOI 10.9745/GHSP-D-16-00215; Moore J, 2011, ADV PEACE ED AFGHANI; Mynard H, 2000, AGGRESSIVE BEHAV, V26, P169, DOI 10.1002/(SICI)1098-2337(2000)26:2<169::AID-AB3>3.0.CO;2-A; Robiolle-Moul T, 2016, THESIS; Rosen Y, 2011, SOC PSYCHOL EDUC, V14, P135, DOI 10.1007/s11218-010-9134-y; Salomon G, 2007, J PEACE PSYCHOL, V10, P257; Samoon AA, 2011, LEARNING FEAR VIOLEN; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Summers Raines S, 2004, PEACE RES, V36, P103; United Nations Children's Fund, 2014, HIDD PLAIN SIGHT STA; Washington Group on Disability Statistics, 2017, AN GUID CREAT DIS ID; WHO, 2014, GLOB SCH BAS STUD HL; Zupancic M., 2017, KNOWLEDGE ATTITUDES	27	16	16	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220614	10.1371/journal.pone.0220614	http://dx.doi.org/10.1371/journal.pone.0220614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386683	gold, Green Published, Green Submitted			2022-12-27	WOS:000484997100028
J	Kostner, N; Jurgens, K; Labrenz, M; Herndl, GJ; Winter, C				Koestner, Nicole; Juergens, Klaus; Labrenz, Matthias; Herndl, Gerhard J.; Winter, Christian			Uneven host cell growth causes lysogenic virus induction in the Baltic Sea	PLOS ONE			English	Article							WATER COLUMN; PROPHAGE INDUCTION; ESCHERICHIA-COLI; MARINE-BACTERIA; MITOMYCIN-C; ANTIBIOTICS; MORTALITY; BACTERIOPLANKTON; SUSCEPTIBILITY; COMMUNITIES	In the Baltic Sea redoxcline, lysogenic viruses infecting prokaryotes have rarely been detected using the commonly used inducing agent mitomycin C. However, it is well known that not all viruses are induceable by mitomycin C and growing evidence suggests that changes in trophic conditions may trigger the induction of lysogenic viruses. We hypothesized that using antibiotics to simulate a strong change in trophic conditions for antibioticaresistant cells due to reduced competition for resources might lead to the induction of lysogenic viruses into the lytic cycle within these cells. This hypothesis was tested by incubating prokaryotes obtained throughout the Baltic Sea redoxcline in seawater with substantially reduced numbers of viruses. We used a mixture of the protein synthesis-inhibiting antibiotics streptomycin and erythromycin to induce the desired changes in trophic conditions for resistant cells and at the same time ensuring that no progeny viruses were formed in sensitive cells. No inducible lysogenic viruses could be detected in incubations amended with mitomycin C. Yet, the presence of streptomycin and erythromycin increased virus-induced mortality of prokaryotes by 56-930% compared to controls, resulting in the induction of lysogenic viruses equivalent to 2-14% of in situ prokaryotic abundance. The results indicate the existence of a previously unrecognized induction mechanism for lysogenic viruses in the Baltic Sea redoxcline, as the mode of action distinctly differs between the used antibiotics (no virus production within affected cells) and mitomycin C (lysogenic viruses are produced within affected cells). Obtaining accurate experimental data on levels of lysogeny in prokaryotic host cells remains challenging, as relying on mitomycin C alone may severely underestimate lysogeny.	[Koestner, Nicole; Herndl, Gerhard J.; Winter, Christian] Univ Vienna, Ctr Funct Ecol, Dept Limnol & Biooceanog, Vienna, Austria; [Juergens, Klaus; Labrenz, Matthias] Leibniz Inst Baltic Sea Res IOW, Dept Biol Oceanog, Rostock, Germany; [Herndl, Gerhard J.] Univ Utrecht, Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, NIOZ, Ab Den Burg, Netherlands	University of Vienna; Leibniz Institut fur Ostseeforschung Warnemunde; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Winter, C (corresponding author), Univ Vienna, Ctr Funct Ecol, Dept Limnol & Biooceanog, Vienna, Austria.	christian.winter@univie.ac.at	Herndl, Gerhard J./S-3011-2019	Herndl, Gerhard J./0000-0002-2223-2852; Jurgens, Klaus/0000-0002-7999-9368; Winter, Christian/0000-0001-6327-0209	Austrian Science Fund (FWF) [P28781-B21, P24413-B21]; European Research Council Advanced Grant (MEDEA) [268595]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council Advanced Grant (MEDEA)	This study was financially supported by the Austrian Science Fund (FWF) project P24413-B21 to CW. Additional financial support came from a European Research Council Advanced Grant (MEDEA, grant number 268595) and the Austrian Science Fund (FWF) project P28781-B21, both to GJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R, 2012, MAR ECOL PROG SER, V467, P1, DOI 10.3354/meps10001; Berg C, 2015, ISME J, V9, P1319, DOI 10.1038/ismej.2014.218; Bettarel Y, 2011, MICROB ECOL, V62, P143, DOI 10.1007/s00248-011-9835-6; Binder B, 1999, AQUAT MICROB ECOL, V18, P207, DOI 10.3354/ame018207; BIZANEK R, 1992, BIOCHEMISTRY-US, V31, P3084, DOI 10.1021/bi00127a008; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; BUSSE HJ, 1992, J GEN MICROBIOL, V138, P551, DOI 10.1099/00221287-138-3-551; Chen F, 2006, APPL ENVIRON MICROB, V72, P4995, DOI 10.1128/AEM.00056-06; Cissoko M, 2008, FRESHWATER BIOL, V53, P1154, DOI 10.1111/j.1365-2427.2007.01930.x; De Paepe M, 2006, PLOS BIOL, V4, P1248, DOI 10.1371/journal.pbio.0040193; Dridi B, 2011, J ANTIMICROB CHEMOTH, V66, P2038, DOI 10.1093/jac/dkr251; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; Elmgren R., 2001, TheScientificWorldJOURNAL, V1, P371, DOI 10.1100/tsw.2001.291; Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049; Frank AH, 2016, AQUAT MICROB ECOL, V77, P99, DOI 10.3354/ame01792; Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09; Glaubitz S, 2009, ENVIRON MICROBIOL, V11, P326, DOI 10.1111/j.1462-2920.2008.01770.x; Grenni P, 2018, MICROCHEM J, V136, P25, DOI 10.1016/j.microc.2017.02.006; HELDAL M, 1991, MAR ECOL PROG SER, V72, P205, DOI 10.3354/meps072205; Hwang CY, 2002, AQUAT MICROB ECOL, V27, P211, DOI 10.3354/ame027211; Jiang SC, 1996, MAR ECOL PROG SER, V142, P27, DOI 10.3354/meps142027; Jost G, 2010, FEMS MICROBIOL ECOL, V71, P226, DOI 10.1111/j.1574-6941.2009.00798.x; Jurgens K, 2018, MICROBIAL ECOLOGY OC, P231; Khelaifia S, 2012, CLIN MICROBIOL INFEC, V18, P841, DOI 10.1111/j.1469-0691.2012.03913.x; Knowles B, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.64; Kostner N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178467; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Korneeva VA, 2015, MICROBIOLOGY+, V84, P268, DOI 10.1134/S002626171502006X; Labrenz M, 2007, AQUAT MICROB ECOL, V46, P177, DOI 10.3354/ame046177; Labrenz M, 2010, ISME J, V4, P1496, DOI 10.1038/ismej.2010.78; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Meyer KM, 2008, ANNU REV EARTH PL SC, V36, P251, DOI 10.1146/annurev.earth.36.031207.124256; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; Moskot M, 2012, INT MICROBIOL, V15, P131, DOI 10.2436/20.1501.01.166; Mudryk ZJ, 2015, BALTIC COASTAL ZONE, V19; Parvathi A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110588; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rogge A, 2017, ENVIRON MICROBIOL, V19, P2495, DOI 10.1111/1462-2920.13783; Rozanov DV, 1998, J BACTERIOL, V180, P6306; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shkilnyj P, 2007, J BACTERIOL, V189, P3115, DOI 10.1128/JB.01857-06; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Weber F, 2014, AQUAT MICROB ECOL, V73, P1, DOI 10.3354/ame01702; Weinbauer MG, 1999, AQUAT MICROB ECOL, V18, P217, DOI 10.3354/ame018217; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Weng MW, 2010, NUCLEIC ACIDS RES, V38, P6976, DOI 10.1093/nar/gkq576; Wilhelm SW, 2002, MICROBIAL ECOL, V43, P168, DOI 10.1007/s00248-001-1021-9; Williamson SJ, 2006, MICROB ECOL, V52, P217, DOI 10.1007/s00248-006-9113-1; Williamson SJ, 2004, AQUAT MICROB ECOL, V36, P9, DOI 10.3354/ame036009; Winter C, 2018, ECOLOGY, V99, P700, DOI 10.1002/ecy.2135	54	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220716	10.1371/journal.pone.0220716	http://dx.doi.org/10.1371/journal.pone.0220716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386696	Green Submitted, Green Published, gold			2022-12-27	WOS:000484997100033
J	Worbes, M; Schongart, J				Worbes, Martin; Schongart, Jochen			Measures for sustainable forest management in the tropics - A tree-ring based case study on tree growth and forest dynamics in a Central Amazonian lowland moist forest	PLOS ONE			English	Article							MAHOGANY SWIETENIA-MACROPHYLLA; WOOD DENSITY; AGE; PATTERNS; INCREMENT; RAINFALL; CEDRELA; BIOMASS; STAND; RADIOCARBON	The conservation of tropical forests is recognized as one of the most important challenges for forestry, ecology and politics. Besides strict protection, the sustainable management of natural forests should be enhanced as a key part of the foundation for the maintenance of tropical rain forest ecosystems. Due to methodological reasons it has been complicated to attain reliable growth data to plan sustainable felling cycles and rotation periods. Tree ring analyses enable the estimation of growth rates over the entire life span of trees and their age as well as giving hints from forest dynamics in previous centuries. For tree ring analysis, stem disk samples were taken from three important commercial tree species (Cariniana micrantha, Caryocar villosum and Manilkara huberi) in the upland (terra firme) forests of the Precious Woods Amazon logging company near Itacoatiara, Brazil. Based on radiocarbon estimates of individual growth zones, the annual nature of tree rings was proven for the three species. Tree rings were measured and the results used together with height estimates to model diameter, height and volume growth. The age of the eldest tree, a C. micrantha, was 585 yrs with 165 cm in diameter. The species' diameter increments range from 0.20 +/- 0.12 cm yr(-1) to 0.29 +/- 0.08 cm yr(-1). At first sight, this is considerably lower than increments reported from other Amazonian or African timber species. Considering the respective wood density there is no significant difference in growth performance of dominant timber species across continents. The interpretation of lifetime tree ring curves indicate differences in shadow tolerance among species, the persistence of individuals in the understory for up to 150 years and natural stand dynamics without major disturbances. Management criteria should be adapted for the measured growth rates as they differed considerably from the Brazilian standards fixed by laws (felling cycle of 25-35 years and a common minimum logging diameter of 50 cm). Felling cycles should be increased to 32-51 years and minimum logging diameters to 63-123 cm depending on the species.	[Worbes, Martin] Georg August Univ, Dept Crop Sci, Grisebachstr, Gottingen, Germany; [Schongart, Jochen] INPA, Manaus, Amazonas, Brazil	University of Gottingen; Institute Nacional de Pesquisas da Amazonia	Worbes, M (corresponding author), Georg August Univ, Dept Crop Sci, Grisebachstr, Gottingen, Germany.	mworbes@gwdg.de			Stiftung zur Forderung der nachhaltigen Forstwirtschaft in den Tropen, Zurich, Switzerland; Brazilian Council for Scientific and Technological Development [309199/2014-0]	Stiftung zur Forderung der nachhaltigen Forstwirtschaft in den Tropen, Zurich, Switzerland; Brazilian Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MWwas supported by Stiftung zur Forderung der nachhaltigen Forstwirtschaft in den Tropen, Zurich, Switzerland. JS was supported by Grant number: 309199/2014-0, Brazilian Council for Scientific and Technological Development.	Asner GP, 2005, SCIENCE, V310, P480, DOI 10.1126/science.1118051; Aubreville A., 1938, ANN ACAD SCI COLONIA, V9, P1, DOI DOI 10.2307/1787233; Baker PJ, 2005, ECOL MONOGR, V75, P317, DOI 10.1890/04-0488; Berlage H.P., 1931, TECTONA, V24, P939; BOOT RGA, 1995, ECOL APPL, V5, P896, DOI 10.2307/2269340; Brienen RJW, 2006, FOREST ECOL MANAG, V226, P256, DOI 10.1016/j.foreco.2006.01.038; Brienen RJW, 2006, J ECOL, V94, P481, DOI 10.1111/j.1365-2745.2005.01080.x; Brienen RJW, 2005, OECOLOGIA, V146, P1, DOI 10.1007/s00442-005-0160-y; Brienen RJW, 2016, TREE PHYSIOL-NETH, V6, P439, DOI 10.1007/978-3-319-27422-5_20; CANNELL MGR, 1984, FOREST ECOL MANAG, V8, P299, DOI 10.1016/0378-1127(84)90062-8; Castro TD, 2014, CIENC FLOREST, V24, P161, DOI 10.5902/1980509813333; Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Clement C.R., 1993, SELECTED SPECIES STR; Coster C., 1928, ANN JARD BOT BUITENZ, V37, P49; da Cunha TA, 2016, FOREST ECOL MANAG, V365, P174, DOI 10.1016/j.foreco.2015.12.031; da Fonseca SF, 2009, TREES-STRUCT FUNCT, V23, P127, DOI 10.1007/s00468-008-0261-4; da Silva RP, 2002, FOREST ECOL MANAG, V166, P295, DOI 10.1016/S0378-1127(01)00678-8; De Ridder M, 2013, FOREST ECOL MANAG, V304, P417, DOI 10.1016/j.foreco.2013.05.007; DEGRAAF NR, 1990, ALTERNATIVES TO DEFORESTATION : STEPS TOWARD SUSTAINABLE USE TO THE AMAZON RAIN FOREST, P116; Dunisch O, 2003, TREES-STRUCT FUNCT, V17, P244, DOI 10.1007/s00468-002-0230-2; Edwards DP, 2014, TRENDS ECOL EVOL, V29, P511, DOI 10.1016/j.tree.2014.07.003; Fearnside P., 2017, OXFORD RES ENCY ENV, DOI [10.1093/acrefore/9780199389414.013.102, DOI 10.1093/ACREFORE/9780199389414.013.102]; Fearnside PM, 1997, FOREST ECOL MANAG, V90, P59, DOI 10.1016/S0378-1127(96)03840-6; Free CM, 2017, FOREST ECOL MANAG, V386, P81, DOI 10.1016/j.foreco.2016.09.031; Free CM, 2014, FOREST ECOL MANAG, V330, P46, DOI 10.1016/j.foreco.2014.05.057; FSC, 2015, FSCSTD01001V52 EN; Groenendijk P, 2014, FOREST ECOL MANAG, V323, P65, DOI 10.1016/j.foreco.2014.03.037; Grogan J, 2014, J APPL ECOL, V51, P664, DOI 10.1111/1365-2664.12210; Henry M, 2010, FOREST ECOL MANAG, V260, P1375, DOI 10.1016/j.foreco.2010.07.040; Hua Q, 2013, RADIOCARBON, V55, P2059, DOI 10.2458/azu_js_rc.v55i2.16177; Kurokawa H, 2003, J TROP ECOL, V19, P1, DOI 10.1017/S0266467403003018; Lamprecht H., 1989, SILVICULTURE TROPICS; Laurance WF, 2004, FOREST ECOL MANAG, V190, P131, DOI 10.1016/j.foreco.2003.09.011; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorenzi, 2002, RVORES BRASILEIRAS M; Loureiro A, 1968, CATALOGO MADEIRAS AM; Loureiro AA, 1968, CATALOGO MADEIRAS AM, P411; Malhi Y, 2010, CURR OPIN ENV SUST, V2, P237, DOI 10.1016/j.cosust.2010.08.002; Nebel G, 2001, FOREST ECOL MANAG, V150, P115, DOI 10.1016/S0378-1127(00)00685-X; Newbery DM, 2013, ECOL MONOGR, V83, P339, DOI 10.1890/12-1699.1; Nowacki GJ, 1997, ECOL MONOGR, V67, P225, DOI 10.1890/0012-9615(1997)067[0225:RGACFR]2.0.CO;2; NYDAL R, 1970, J GEOPHYS RES, V75, P2271, DOI 10.1029/JC075i012p02271; Oldeman R.A.A., 1983, TROPICAL RAIN FOREST, P139; Pires JM, 1984, AMAZON LIMNOLOGY LAN, P581, DOI DOI 10.1007/978-94-009-6542-3; PRANCE GT, 1990, 4 NEOTROPICAL RAINFO, P112; Precious Woods, ANN REP 2017; Procopio LC, 2010, ACTA BOT BRAS, V24, P883, DOI 10.1590/S0102-33062010000400002; Putz FE, 2008, FOREST ECOL MANAG, V256, P1427, DOI 10.1016/j.foreco.2008.03.036; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; Rosa SA, 2017, TREES-STRUCT FUNCT, V31, P729, DOI 10.1007/s00468-016-1503-5; Rozendaal DMA, 2010, FOREST ECOL MANAG, V259, P2292, DOI 10.1016/j.foreco.2010.02.030; Santini NS, 2012, TREES-STRUCT FUNCT, V26, P1555, DOI 10.1007/s00468-012-0729-0; Schongart J, 2011, BIOGEOSCIENCES, V8, P3407, DOI 10.5194/bg-8-3407-2011; Schongart J, 2008, FOREST ECOL MANAG, V256, P46, DOI 10.1016/j.foreco.2008.03.037; Schongart J, 2007, ANN FOREST SCI, V64, P657, DOI 10.1051/forest:2007044; Schongart J, 2006, GLOBAL CHANGE BIOL, V12, P1139, DOI 10.1111/j.1365-2486.2006.01154.x; Schongart J, 2015, BIOTROPICA, V47, P550, DOI 10.1111/btp.12243; Schongart J., 2010, AMAZONIAN FLOODPLAIN, P437, DOI DOI 10.1007/978-90-481-8725-6_21; Schongart J, 2017, ECOL STUD-ANAL SYNTH, V231, P35, DOI 10.1007/978-3-319-61669-8_3; SFB/IMAZON, 2010, AT MAD AM BRAS PROD; Souza D. V., 2014, FLORESTA, V44, P485, DOI [10.5380/rf.v44i3.29423, DOI 10.5380/RF.V44I3.29423]; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; van Gardingen PR, 2006, FOREST ECOL MANAG, V231, P184, DOI 10.1016/j.foreco.2006.05.047; van Rheenen HMPJB, 2004, FOREST ECOL MANAG, V200, P39, DOI 10.1016/j.foreco.2004.06.024; VETTER RE, 1989, IAWA BULL, V10, P133, DOI 10.1163/22941932-90000481; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Vlam M, 2014, OECOLOGIA, V174, P1449, DOI 10.1007/s00442-013-2846-x; Wagner FH, 2016, BIOGEOSCIENCES, V13, P2537, DOI 10.5194/bg-13-2537-2016; Whitmore T.C, 1990, INTRO TROPICAL RAIN; Worbes M, 1999, J ECOL, V87, P391, DOI 10.1046/j.1365-2745.1999.00361.x; WORBES M, 1989, IAWA BULL, V10, P109, DOI 10.1163/22941932-90000479; Worbes M, 2003, FOREST ECOL MANAG, V173, P105, DOI 10.1016/S0378-1127(01)00814-3; Worbes M, 1999, IAWA J, V20, P255, DOI 10.1163/22941932-90000689; WORBES M, 1989, ECOLOGY, V70, P503, DOI 10.2307/1937554; Worbes Martin, 2002, Dendrochronologia, V20, P217, DOI 10.1078/1125-7865-00018; Zanne A.E., 2009, GLOBAL WOOD DENSITY, DOI [DOI 10.5061/DRYAD.234, 10.5061/dryad.234]	77	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219770	10.1371/journal.pone.0219770	http://dx.doi.org/10.1371/journal.pone.0219770			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386676	gold, Green Published, Green Submitted			2022-12-27	WOS:000484997100010
J	Huang, WM; Sung, SH; Yu, WC; Cheng, HM; Huang, CJ; Guo, CY; Lu, DY; Lee, CW; Chen, CH				Huang, Wei-Ming; Sung, Shih-Hsien; Yu, Wen-Chung; Cheng, Hao-Min; Huang, Chi-Jung; Guo, Chao-Yu; Lu, Dai-Yin; Lee, Ching-Wei; Chen, Chen-Huan			Perturbations of pulsatile hemodynamics and clinical outcomes in patients with acute heart failure and reduced, mid-range or preserved ejection fraction	PLOS ONE			English	Article							ARTERIAL STIFFNESS; VENTRICULAR STRUCTURE; WAVE REFLECTIONS; CHINESE PATIENTS; MORTALITY; SURVIVAL; HOSPITALIZATION; DETERMINANTS; DYSFUNCTION; MORBIDITY	Background Heart failure with mid-range ejection fraction (HFmrEF) has been proposed as a new phenotype of heart failure. We therefore investigated the pulsatile hemodynamic characteristics and outcomes in patients with HFmrEF, in comparison with those with reduced (HFrEF) or preserved (HFpEF) ejection fraction. Methods The study was composed of two cohorts of patients hospitalized due to acute heart failure. Pulsatile hemodynamic measures, including carotid-femoral pulse wave velocity (cf-PWV), carotid pulse pressure (cPP), amplitude of the backward pressure wave (Pb) and carotid augmentation index (cAIx), were recorded on admission and before discharge in Cohort A (n = 230, mean age 69.9 +/- 15.4 years), and long-term follow-up was performed in Cohort B (n = 2677, mean age 76.3 +/- 33.4 years). Results In Cohort A, patients with HFmrEF had persistently greater cf-PWV, cPP, Pb, and cAI than those with HFrEF, both on admission and before discharge. In contrast, patients with HFmrEF and HFpEF had similar pulsatile hemodynamic characteristics. In cohort B, patients with HFmrEF and HFrEF had similar three-year mortality rates and both were significantly higher than that in patients with HFpEF (both P values < 0.05). Conclusions Patients with HFmrEF were characterized by a worse left ventricular systolic function than patients with HFpEF and excessive wave reflections than patients with HFrEF. Future studies are required to confirm that the unfavorable ventriculo-arterial coupling in HFmrEF might play a role in the pathogenesis of high long-term mortality in these patients.	[Huang, Wei-Ming; Sung, Shih-Hsien; Yu, Wen-Chung; Lu, Dai-Yin; Lee, Ching-Wei; Chen, Chen-Huan] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Huang, Wei-Ming; Sung, Shih-Hsien; Yu, Wen-Chung; Cheng, Hao-Min; Huang, Chi-Jung; Lu, Dai-Yin; Lee, Ching-Wei; Chen, Chen-Huan] Natl Yang Ming Univ, Dept Med, Taipei, Taiwan; [Huang, Wei-Ming; Sung, Shih-Hsien; Guo, Chao-Yu; Chen, Chen-Huan] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Cheng, Hao-Min; Huang, Chi-Jung] Taipei Vet Gen Hosp, Dept Med Educ, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Sung, SH (corresponding author), Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan.; Sung, SH (corresponding author), Natl Yang Ming Univ, Dept Med, Taipei, Taiwan.; Sung, SH (corresponding author), Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan.	mr.sungsh@gmail.com	Chen, Chen-Huan/AAE-4036-2022	Sung, Shih-Hsien/0000-0001-9441-1836; Guo, Chao-Yu/0000-0002-9066-9933	Ministry of Health and Welfare, Taiwan [MOHW-104-TDU-B-211-113003, MOHW-105-TDU-B-211-133017, MOHW106-TDU-B-211-113001, MOHW107-TDU-B-211-123001]; Taipei Veterans General Hospital [V100C-145, V101C-092, V102C-119, V103B-017, V104C-172]	Ministry of Health and Welfare, Taiwan; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work received support from: Ministry of Health and Welfare, Taiwan with grant - MOHW-104-TDU-B-211-113003, MOHW-105-TDU-B-211-133017, MOHW106-TDU-B-211-113001, MOHW107-TDU-B-211-123001 (Dr. Shih-Hsien Sung); Taipei Veterans General Hospital - (V100C-145, V101C-092, V102C-119, V103B-017, and V104C-172) (Dr. Shih-Hsien Sung). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Cheng HM, 2008, EUR J HEART FAIL, V10, P1192, DOI 10.1016/j.ejheart.2008.09.003; Cheng YL, 2016, AM J CARDIOL, V117, P399, DOI 10.1016/j.amjcard.2015.11.011; Chow B, 2015, HEART FAIL REV, V20, P291, DOI 10.1007/s10741-015-9471-1; Cotter G, 2003, EUR J HEART FAIL, V5, P443, DOI 10.1016/S1388-9842(03)00100-4; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; Gladden JD, 2014, PFLUG ARCH EUR J PHY, V466, P1037, DOI 10.1007/s00424-014-1480-8; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; Halabi CM, 2015, AM J PHYSIOL-HEART C, V309, pH1008, DOI 10.1152/ajpheart.00288.2015; He KL, 2009, AM J CARDIOL, V103, P845, DOI 10.1016/j.amjcard.2008.11.050; Huang WM, 2016, CIRC J, V80, P404, DOI 10.1253/circj.CJ-15-0964; Lam CSP, 2014, EUR J HEART FAIL, V16, P1049, DOI 10.1002/ejhf.159; Lekavich CL, 2015, HEART FAIL REV, V20, P643, DOI 10.1007/s10741-015-9506-7; Lu DY, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002668; Lund LH, 2016, J CARD FAIL, V22, P769, DOI 10.1016/j.cardfail.2016.07.439; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Marti CN, 2012, J AM COLL CARDIOL, V60, P1455, DOI 10.1016/j.jacc.2011.11.082; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Milo-Cotter O, 2007, EUR J HEART FAIL, V9, P178, DOI 10.1016/j.ejheart.2006.06.004; Mottram PM, 2005, HEART, V91, P1551, DOI 10.1136/hrt.2004.046805; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Parragh S, 2015, INT J CARDIOL, V190, P308, DOI 10.1016/j.ijcard.2015.04.183; Penicka M, 2010, J AM COLL CARDIOL, V55, P1700, DOI 10.1016/j.jacc.2009.11.076; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Redfield MM, 2016, NEW ENGL J MED, V375, P1868, DOI 10.1056/NEJMcp1511175; Redfield MM, 2013, JAMA-J AM MED ASSOC, V309, P1268, DOI 10.1001/jama.2013.2024; SCHILLER NB, 1979, CIRCULATION, V60, P547, DOI 10.1161/01.CIR.60.3.547; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Sung SH, 2014, PULSE, V2, P18, DOI 10.1159/000367645; Sung SH, 2013, HYPERTENSION, V61, P1346, DOI 10.1161/HYPERTENSIONAHA.111.00569; Sung SH, 2012, EUR J HEART FAIL, V14, P1348, DOI 10.1093/eurjhf/hfs124; Sung SH, 2011, AM J HYPERTENS, V24, P775, DOI 10.1038/ajh.2011.26; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tsao CW, 2015, J AM HEART ASSOC, V4, P11; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220183	10.1371/journal.pone.0220183	http://dx.doi.org/10.1371/journal.pone.0220183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381586	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600012
J	Chen, T; Zhang, YJ; Wang, ZJ; Wang, DS; Li, H; Liu, W				Chen, Tao; Zhang, Yongjuan; Wang, Zhengjun; Wang, Dongsheng; Li, Hui; Liu, Wei			SinoPedia-A Linked Data Services platform for decentralized knowledge base	PLOS ONE			English	Article								Knowledge bases are largely developed and utilized in academic and industrial fields, such as DBPedia, VIAF, LoC, Getty, and which are published in the Linked Data format. However, if you want to view different resources on these knowledge bases, you have to switch between different web pages from these resources. Therefore, we proposed a decentralized data hub named SinoPedia, which consists of several linked data services and can re-publish these RDF data in one platform. Firstly, these different Linked Data services include: Linked Data Transformation Service (LDTS), Linked Data Query Service (LDQS), Linked Data Publishing Service (LDPS) and Linked Data Knowledge Service (LDKS). The resource URI is the basis and core of the linked data, thus we will focus on the resource forwarding mechanism in LDPS service which can rewrite resource URI using a global and standard format among knowledge bases. Some knowledge bases were configured in SinoPedia platform in this paper. In addition to the above services, Linked Data Reasoning Service (LDRS) and Linked Data Intelligence Service (LDIS) will be added to the platform in the future. In short, all of these Linked Data Services will form the core framework in order to providing a good linked data application ecosystem.	[Chen, Tao; Li, Hui; Liu, Wei] Inst Sci & Tech Informat Shanghai, Shanghai Lib, Shanghai, Peoples R China; [Chen, Tao; Li, Hui] Nanjing Univ, Sch Informat Management, Nanjing, Jiangsu, Peoples R China; [Zhang, Yongjuan] Shanghai Univ, Dept Lib Informat & Archives, Shanghai, Peoples R China; [Zhang, Yongjuan] Chinese Acad Sci, Shanghai Informat Ctr Life Sci, Shanghai, Peoples R China; [Wang, Zhengjun] Lund Univ, Dept Chem Phys, Lund, Sweden; [Wang, Dongsheng] Univ Copenhagen, Comp Sci, Copenhagen, Denmark	Nanjing University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; Lund University; University of Copenhagen	Chen, T; Liu, W (corresponding author), Inst Sci & Tech Informat Shanghai, Shanghai Lib, Shanghai, Peoples R China.; Chen, T (corresponding author), Nanjing Univ, Sch Informat Management, Nanjing, Jiangsu, Peoples R China.	tchen@libnet.sh.cn; wliu@libnet.sh.cn		tao, chen/0000-0002-6609-4914	China Postdoctoral Science Foundation - National Social Science Fund of China [2018M642058]; China Postdoctoral Science Foundation [19BTQ024]; National Social Science Fund of China [2018M642058]	China Postdoctoral Science Foundation - National Social Science Fund of China(China Postdoctoral Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Social Science Fund of China	T.C. received the award, which number is 2018M642058, and the full name is China Postdoctoral Science Foundation, the URL is http://jj.chinapostdoctor.org.cn.Also funded by the National Social Science Fund of China (19BTQ024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research is granted financial support from China Postdoctoral Science Foundation (2018M642058) and National Social Science Fund of China (19BTQ024).	Andreas K., 2017, LINK DISC WEB DAT; Belleau F, 2008, J BIOMED INFORM, V41, P706, DOI 10.1016/j.jbi.2008.03.004; Berrueta D., BEST PRACTICE RECIPE; Bizer C, 2009, INT J SEMANT WEB INF, V5, P1, DOI 10.4018/jswis.2009081901; Callahan Alison, 2013, J Biomed Semantics, V4 Suppl 1, pS1, DOI 10.1186/2041-1480-4-S1-S1; Camarda D.V., 2012, P 8 INT C SEM SYST, P197, DOI [10.1145/2362499.2362532, DOI 10.1145/2362499.2362532]; Chang QL, 2013, CHIN SEM WEB S WEB S, P11; Chen T., 2018, J LIB SCI CHINA, V44, P4; Frederick G., BUILDING MAINTAINING; Livingston KM, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0559-3; Ngomo A.C.N., 2011, P 22 INT JOINT C ART, P2312, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-385; Ruben V, 2014, 7 WORKSH LINK DAT WE; Souripriya D, R2RML RDB RDF MAPPIN; Tom H, 2011, SYNTHESIS LECT SEMAN; Verborgh R, 2014, LECT NOTES COMPUT SC, V8796, P180, DOI 10.1007/978-3-319-11964-9_12	15	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0219992	10.1371/journal.pone.0219992	http://dx.doi.org/10.1371/journal.pone.0219992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374080	Green Published, gold, Green Submitted			2022-12-27	WOS:000484991500004
J	Li, ZY; Konisky, DM; Zirogiannis, N				Li, Zhengyan; Konisky, David M.; Zirogiannis, Nikolaos			Racial, ethnic, and income disparities in air pollution: A study of excess emissions in Texas	PLOS ONE			English	Article							ENVIRONMENTAL JUSTICE; HAZARDOUS-WASTE; OZONE FORMATION; HUMAN HEALTH; EVENTS; HOUSTON; RISK; ENFORCEMENT; INEQUITIES; INEQUALITY	Objective Excess emissions are pollutant releases that occur during periods of startups, shutdowns or malfunctions and are considered violations of the U.S. Clean Air Act. They are an important, but understudied and under-regulated, category of pollution releases given their frequency and magnitude. In this paper, we examine the demographic correlates of excess emissions, using data from industrial sources in Texas. Methods We conduct two complementary sets of analyses: one at the census tract level and one at the facility level. At the census tract level, we use a multinomial logit model to examine the relationships between racial, ethnic, and income characteristics and the incidence of excess emissions. At the facility level, we first estimate a logit model to examine whether these characteristics are associated with facilities that emit excess emissions, and then, conditional on the presence of excess emissions, we use ordinary least square regression to estimate their correlation with the magnitude of releases. Results Across our analyses, we find that the percentage of Black population and median household income are positively associated with excess emissions; percentage of college graduate, population density, median housing value, and percentage of owner-occupied housing unit are negatively associated with excess emissions. We, however, have not found a clear and significant relationship between the percentage of Hispanic population and excess emissions.	[Li, Zhengyan; Konisky, David M.; Zirogiannis, Nikolaos] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Li, ZY (corresponding author), Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA.	zl31@indiana.edu	Li, Zhengyan/GSD-3935-2022; Zirogiannis, Nikolaos/GWC-7057-2022	Zirogiannis, Nikolaos/0000-0003-4903-8897; Konisky, David/0000-0002-1146-3938; Li, Zhengyan/0000-0003-2006-2922				Adar SD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001430; Arora S, 1999, SOUTHERN ECON J, V65, P691, DOI 10.2307/1061271; Ash M, 2004, SOC SCI QUART, V85, P441, DOI 10.1111/j.0038-4941.2004.08502011.x; Banzhaf S, 2019, J ECON PERSPECT, V33, P185, DOI 10.1257/jep.33.1.185; Been V, 1997, ECOL LAW QUART, V24, P1; Been V., 1995, J LAND USE ENV LAW, V11, P36; Bento A, 2015, REV ECON STAT, V97, P610, DOI 10.1162/REST_a_00493; Boer JT, 1997, SOC SCI QUART, V78, P793; Brulle RJ, 2006, ANNU REV PUBL HEALTH, V27, P103, DOI 10.1146/annurev.publhealth.27.021405.102124; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Choi YJ, 2006, ATMOS ENVIRON, V40, P5181, DOI 10.1016/j.atmosenv.2006.04.025; Chow JC, 2006, J AIR WASTE MANAGE, V56, P1368, DOI 10.1080/10473289.2006.10464545; Clark LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094431; Cole Luke, 2001, GROUND ENV RACISM RI; Cushing L, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002604; Daniels G, 1999, SOC SCI QUART, V80, P244; Environmental Integrity Project, 2004, GAM SYST OFF THE BOO; Environmental Protection Agency U.S, 2019, EPAR04OAR20190303; Gray WB, 2004, J ENVIRON ECON MANAG, V47, P510, DOI 10.1016/j.jeem.2003.01.001; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Hird JA, 1998, SOC SCI QUART, V79, P693; Hollingsworth AJ, 2019, HLTH CONSEQUENCES WE, DOI [10.2139/ssrn.3382541, DOI 10.2139/SSRN.3382541]; Jones MR, 2014, AM J PUBLIC HEALTH, V104, P2130, DOI 10.2105/AJPH.2014.302135; Kampa M, 2008, ENVIRON POLLUT, V151, P362, DOI 10.1016/j.envpol.2007.06.012; Konisky DM, 2018, POLICY STUD J, V46, P7, DOI 10.1111/psj.12203; Konisky DM, 2013, J POLIT, V75, P506, DOI 10.1017/S0022381613000170; Konisky DM, 2009, POLICY STUD J, V37, P475, DOI 10.1111/j.1541-0072.2009.00324.x; Konisky DM, 2009, J POLICY ANAL MANAG, V28, P102, DOI 10.1002/pam.20404; Konisky DM, 2015, AM COMP ENVIRON POLI, P1, DOI 10.7551/mitpress/9780262028837.001.0001; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Kulkarni P, 2007, ENV SCI TECHNOLOGY, V41; Mccoy BJ, 2010, ATMOS ENVIRON, V44, P4230, DOI 10.1016/j.atmosenv.2010.07.008; Mohai P, 2007, SOC PROBL, V54, P343, DOI 10.1525/sp.2007.54.3.343; Mohai P, 2006, DEMOGRAPHY, V43, P383, DOI 10.1353/dem.2006.0017; Mohai P, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125011; Mohai Paul, 2009, Am J Public Health, V99 Suppl 3, pS649, DOI 10.2105/AJPH.2007.131383; Mohai P, 2009, ANNU REV ENV RESOUR, V34, P405, DOI 10.1146/annurev.environ.082508-094348; Morello-Frosch R, 2001, URBAN AFF REV, V36, P551, DOI 10.1177/10780870122184993; Muller NZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192461; Murphy CF, 2005, ATMOS ENVIRON, V39, P3785, DOI 10.1016/j.atmosenv.2005.02.051; Nam J, 2006, ATMOS ENVIRON, V40, P5329, DOI 10.1016/j.atmosenv.2006.05.002; Ozymy J, 2011, REV POLICY RES, V28, P365, DOI 10.1111/j.1541-1338.2011.00502.x; Pastor M, 2001, J URBAN AFF, V23, P1, DOI 10.1111/0735-2166.00072; PERLIN SA, 1995, ENVIRON SCI TECHNOL, V29, P69, DOI 10.1021/es00001a008; Ringquist EJ, 2005, J POLICY ANAL MANAG, V24, P223, DOI 10.1002/pam.20088; Ringquist EJ, 1997, SOC SCI QUART, V78, P811; Schwarz K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122051; Shadbegian R.J., 2012, POLITICAL EC ENV JUS, P225, DOI [10.11126/stanford/9780804780612.001.0001, DOI 10.11126/STANFORD/9780804780612.001.0001]; Taylor DE, 2000, AM BEHAV SCI, V43, P508, DOI 10.1177/0002764200043004003; Texas Commission on Environmental Quality, 2016, TEX ADM COD GEN AIR; U.S. Environmental Protection Agency, DESCR TRI DAT TERMS; U.S. Environmental Protection Agency, 2018, SUMM NON AR POP EXP; U.S. Environmental Protection Agency, 2015, STAT IMPL PLANS RESP; U.S. Environmental Protection Agency, 2019, EPAR06OAR20180770; Viscusi WK, 1999, AM ECON REV, V89, P1010, DOI 10.1257/aer.89.4.1010; Vizuete W, 2008, ATMOS ENVIRON, V42, P7641, DOI 10.1016/j.atmosenv.2008.05.063; Wolverton Ann, 2012, POLITICAL EC ENV JUS, P119; Zirogiannis N, 2018, ENVIRON SCI TECHNOL, V52, P2482, DOI 10.1021/acs.est.7b04887	58	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220696	10.1371/journal.pone.0220696	http://dx.doi.org/10.1371/journal.pone.0220696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374099	Green Submitted, gold, Green Published			2022-12-27	WOS:000484991500026
J	Meurisse, GM; Bastien, GJ; Schepens, B				Meurisse, Guillaume M.; Bastien, Guillaume J.; Schepens, Benedicte			The step-to-step transition mode: A potential indicator of first-fall risk in elderly adults?	PLOS ONE			English	Article							POSTURAL STABILITY; BALANCE DISORDERS; TINETTI TEST; LEVEL GAIT; FALL-RISK; WALKING; PEOPLE; CONSEQUENCES; MECHANICS; FORCES		[Meurisse, Guillaume M.; Bastien, Guillaume J.; Schepens, Benedicte] Catholic Univ Louvain, Inst Neurosci IoNS, Lab Physiol & Biomech Locomot, Louvain La Neuve, Belgium	Universite Catholique Louvain	Schepens, B (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, Lab Physiol & Biomech Locomot, Louvain La Neuve, Belgium.	benedicte.schepens@uclouvain.be		Schepens, Benedicte/0000-0002-8352-1244	Universite catholique de Louvain	Universite catholique de Louvain	This work was supported by the Universite catholique de Louvain (BE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk PG, 2009, J EXP BIOL, V212, P2668, DOI 10.1242/jeb.027581; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Boyer KA, 2017, EXP GERONTOL, V95, P63, DOI 10.1016/j.exger.2017.05.005; Breniere Y, 1998, EXP BRAIN RES, V121, P255, DOI 10.1007/s002210050458; Browne MG, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.171673; CAVAGNA GA, 1975, J APPL PHYSIOL, V39, P174, DOI 10.1152/jappl.1975.39.1.174; Chastan N, 2010, NEUROSCI LETT, V469, P400, DOI 10.1016/j.neulet.2009.12.038; Chastan N, 2009, BRAIN, V132, P172, DOI 10.1093/brain/awn294; Chastan N, 2008, MOVEMENT DISORD, V23, P366, DOI 10.1002/mds.21840; Chastan N, 2009, MOVEMENT DISORD, V24, P188, DOI 10.1002/mds.22269; Chong RKY, 2009, NEUROSCI LETT, V458, P23, DOI 10.1016/j.neulet.2009.04.022; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Demain A, 2014, J NEUROL, V261, P196, DOI 10.1007/s00415-013-7174-x; Edginton Bigelow K., 2010, THE JOURNALS OF GERO, V66, P228; Franz JR, 2016, EXERC SPORT SCI REV, V44, P129, DOI 10.1249/JES.0000000000000086; Franz JR, 2013, J BIOMECH, V46, P535, DOI 10.1016/j.jbiomech.2012.09.032; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Gerdhem P, 2005, J CLIN EPIDEMIOL, V58, P226, DOI 10.1016/j.jclinepi.2004.06.013; Honeine JL, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.229; Honeine JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052943; Konig N, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0353; Koepke S, 2006, Z GERONTOL GERIATR, V39, P288, DOI 10.1007/s00391-006-0398-y; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Meurisse GM, 2019, J BIOMECH, V83, P253, DOI 10.1016/j.jbiomech.2018.12.001; Meurisse GM, 2016, GAIT POSTURE, V43, P245, DOI 10.1016/j.gaitpost.2015.10.005; Miodonska Z, 2018, BIOMED SIGNAL PROCES, V44, P38, DOI 10.1016/j.bspc.2018.03.012; NUTT JG, 1993, NEUROLOGY, V43, P268, DOI 10.1212/WNL.43.2.268; Panella L, 2002, FUNCT NEUROL, V17, P25; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Schloemer SA, 2017, ANN BIOMED ENG, V45, P695, DOI 10.1007/s10439-016-1713-4; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; Welter ML, 2007, GAIT POSTURE, V26, P393, DOI 10.1016/j.gaitpost.2006.10.005; Yardley L, 2002, GERONTOLOGIST, V42, P17, DOI 10.1093/geront/42.1.17	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220791	10.1371/journal.pone.0220791	http://dx.doi.org/10.1371/journal.pone.0220791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374108	Green Published, gold, Green Submitted			2022-12-27	WOS:000484991500034
J	Cheng, C; Liu, XB; Bi, SJ; Lu, QH; Zhang, J				Cheng, Chao; Liu, Xiao-Bo; Bi, Shao-Jie; Lu, Qing-Hua; Zhang, Juan			Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; DIABETES-MELLITUS; PREDICTORS; EVENTS; RISK; ASSOCIATION; MECHANISMS; IMPACT; DEATH; GFR	Background/Aim No-reflow is a serious and frequent event during primary percutaneous coronary intervention (PPCI) for acute ST segment elevation myocardial infarction (STEMI). The aim of this study was to identify possible predictors for no-reflow. Patients and methods We investigated 218 patients with acute anterior STEMI who underwent PPCI from December 2016 to December 2018. No-reflow was defined as a coronary TIMI flow grade of <= 2. TIMI flow grade 3 was defined as normal reflow. Results In our study, the no-reflow phenomenon was observed in 39 patients (18%) during angiography. The patients of no-reflow group were found to be more older, diabetics, longer pain-toballoon time, lower blood pressure, higher platelet counts and higher levels of D-Dimer and Cystatin C (Cys-C). In multivariate logistic regression analysis, only diabetes (OR = 0.371, 95% CI: 0.157-0.872, P = 0.023), longer pain-to-balloon time (OR = 1.147, 95% CI: 1.015-1.297, P = 0.028) and higher Cys-C level (OR = 10.07, 95% CI: 2.340-43.377, P = 0.002) were predictors for no-reflow. Conclusion Cys-C might be a useful predictor for the no-reflow phenomenon after PPCI in STEMI patients. It might help to screen STEMI patients with high risk of no-reflow on admission.	[Cheng, Chao; Bi, Shao-Jie; Lu, Qing-Hua; Zhang, Juan] Shandong Univ, Dept Cardiol, Hosp 2, Jinan, Shandong, Peoples R China; [Liu, Xiao-Bo] Shandong Blood Ctr, Jinan, Shandong, Peoples R China	Shandong University	Zhang, J (corresponding author), Shandong Univ, Dept Cardiol, Hosp 2, Jinan, Shandong, Peoples R China.	awwa69040@sina.com	zhang, juan/AAO-8519-2020	zhang, juan/0000-0001-6241-7176	National Natural Science Foundation of China (Youth Foundation) [81600284]	National Natural Science Foundation of China (Youth Foundation)	This work was supported by the National Natural Science Foundation of China (Youth Foundation), Grant Number: 81600284, Recipient: Juan Zhang, URL: http://www.nsfc.gov.cn/.	Abdi Seifollah, 2015, Res Cardiovasc Med, V4, pe25414, DOI 10.5812/cardiovascmed.4(2)2015.25414; Alidoosti Mohammad, 2018, J Tehran Heart Cent, V13, P108; Aronson D, 1996, J AM COLL CARDIOL, V27, P528, DOI 10.1016/0735-1097(95)00496-3; Arpegard J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001467; Bonderman D, 2002, BLOOD, V99, P2794, DOI 10.1182/blood.V99.8.2794; Brosh D, 2007, AM J CARDIOL, V99, P442, DOI 10.1016/j.amjcard.2006.08.054; Choo EH, 2014, CORONARY ARTERY DIS, V25, P392, DOI 10.1097/MCA.0000000000000108; Correa S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009077; Eeckhout E, 2001, EUR HEART J, V22, P729, DOI 10.1053/euhj.2000.2172; Gao RH, 2018, MED SCI MONITOR, V24, P3549, DOI 10.12659/MSM.908980; Gibson CM, 2004, CIRCULATION, V109, P3096, DOI 10.1161/01.CIR.0000134278.50359.CB; Harrison RW, 2013, AM J CARDIOL, V111, P178, DOI 10.1016/j.amjcard.2012.09.015; Jinnouchi H, 2014, HEART VESSELS, V29, P429, DOI 10.1007/s00380-013-0379-1; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Keller T, 2009, EUR HEART J, V30, P314, DOI 10.1093/eurheartj/ehn598; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Kubisz P, 2010, ACTA DIABETOL, V47, P119, DOI 10.1007/s00592-009-0127-2; Kurtul A, 2015, ANGIOLOGY, V66, P644, DOI 10.1177/0003319714546738; Li DB, 2010, CLIN CARDIOL, V33, pE7, DOI 10.1002/clc.20634; Macdonald J, 2006, AM J KIDNEY DIS, V48, P712, DOI 10.1053/j.ajkd.2006.07.001; Mazhar J, 2016, IJC HEART VASC, V10, P8, DOI 10.1016/j.ijcha.2015.11.002; Mirbolouk F, 2018, J CARDIOVASC THORAC, V10, P46, DOI 10.15171/jcvtr.2018.08; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; Ni L, 2007, STROKE, V38, P3287, DOI 10.1161/STROKEAHA.107.489625; Rezkalla Shereif H, 2005, Curr Treat Options Cardiovasc Med, V7, P75, DOI 10.1007/s11936-005-0008-0; Schwartz BG, 2012, J MOL CELL CARDIOL, V52, P873, DOI 10.1016/j.yjmcc.2011.06.009; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak Michael G, 2005, Am J Med, V118, P1416; Silva D, 2012, AM J CARDIOL, V109, P1431, DOI 10.1016/j.amjcard.2012.01.356; Singh D, 2007, NEPHROL DIAL TRANSPL, V22, P1087, DOI 10.1093/ndt/gfl744; Tang L, 2016, HEART VESSELS, V31, P1456, DOI 10.1007/s00380-015-0764-z; Wagdy S, 2016, CLIN MED INSIGHTS-CA, V10, P19, DOI 10.4137/CMC.S35555; Woitas RP, 2013, ATHEROSCLEROSIS, V229, P541, DOI 10.1016/j.atherosclerosis.2013.04.027; Wong DTL, 2013, INT J CARDIOL, V167, P1798, DOI 10.1016/j.ijcard.2012.12.049; Yetkin E, 2015, ANGIOGENESIS, V18, P201, DOI 10.1007/s10456-015-9460-y; Zhang JJ, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0483-8	37	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220654	10.1371/journal.pone.0220654	http://dx.doi.org/10.1371/journal.pone.0220654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369621	gold, Green Published, Green Submitted			2022-12-27	WOS:000484987900076
J	Ganz, M; Vogel, C; Czada, C; Jorke, V; Gwosch, EC; Kleiner, R; Pierzynska-Mach, A; Zanacchi, FC; Diaspro, A; Kappes, F; Burkle, A; Ferrando-May, E				Ganz, Magdalena; Vogel, Christopher; Czada, Christina; Joerke, Vera; Gwosch, Eva Christina; Kleiner, Rebecca; Pierzynska-Mach, Agnieszka; Zanacchi, Francesca Cella; Diaspro, Alberto; Kappes, Ferdinand; Buerkle, Alexander; Ferrando-May, Elisa			The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress	PLOS ONE			English	Article							DNA-DAMAGE; TERMINAL DOMAIN; PROTEIN DEK; POLY(ADP-RIBOSE); CHROMATIN; FORKS; PROTOONCOGENE; BINDING; OVEREXPRESSION; PROLIFERATION	DNA replication stress is a major source of genomic instability and is closely linked to tumor formation and progression. Poly(ADP-ribose) polymerases1/2 (PARP1/2) enzymes are activated in response to replication stress resulting in poly(ADP-ribose) (PAR) synthesis. PARy-lation plays an important role in the remodelling and repair of impaired replication forks, providing a rationale for targeting highly replicative cancer cells with PARP1/2 inhibitors. The human oncoprotein DEK is a unique, non-histone chromatin architectural protein whose deregulated expression is associated with the development of a wide variety of human cancers. Recently, we showed that DEK is a high-affinity target of PARylation and that it promotes the progression of impaired replication forks. Here, we investigated a potential functional link between PAR and DEK in the context of replication stress. Under conditions of mild replication stress induced either by topoisomerase1 inhibition with camptothecin or nucleotide depletion by hydroxyurea, we found that the effect of acute PARP1/2 inhibition on replication fork progression is dependent on DEK expression. Reducing DEK protein levels also overcomes the restart impairment of stalled forks provoked by blocking PARylation. Non-covalent DEK-PAR interaction via the central PAR-binding domain of DEK is crucial for counteracting PARP1/2 inhibition as shown for the formation of RPA positive foci in hydroxyurea treated cells. Finally, we show by iPOND and super resolved microscopy that DEK is not directly associated with the replisome since it binds to DNA at the stage of chromatin formation. Our report sheds new light on the still enigmatic molecular functions of DEK and suggests that DEK expression levels may influence the sensitivity of cancer cells to PARP1/2 inhibitors.	[Ganz, Magdalena; Vogel, Christopher; Czada, Christina; Joerke, Vera; Gwosch, Eva Christina; Kleiner, Rebecca; Ferrando-May, Elisa] Univ Konstanz, Bioimaging Ctr, Dept Biol, Constance, Germany; [Pierzynska-Mach, Agnieszka; Zanacchi, Francesca Cella; Diaspro, Alberto] Ist Italiano Tecnol, Nanoscopy & NIC IIT, Genoa, Italy; [Pierzynska-Mach, Agnieszka] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Zanacchi, Francesca Cella] Natl Res Council CNR, Biophys Inst IBF, Genoa, Italy; [Diaspro, Alberto] Univ Genoa, Dept Phys, DIFILAB, Genoa, Italy; [Kappes, Ferdinand] Xian Jiaotong Liverpool Univ, Dushu Lake Higher Educ Town, Suzhou, Peoples R China; [Buerkle, Alexander] Univ Konstanz, Dept Biol, Mol Toxicol Grp, Constance, Germany	University of Konstanz; Istituto Italiano di Tecnologia - IIT; IRCCS European Institute of Oncology (IEO); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Genoa; Xi'an Jiaotong-Liverpool University; University of Konstanz	Ferrando-May, E (corresponding author), Univ Konstanz, Bioimaging Ctr, Dept Biol, Constance, Germany.	elisa.may@uni-konstanz.de	Ferdinand, Kappes/H-4445-2014; Zanacchi, Francesca Cella/ABI-1651-2020; Diaspro, Alberto/E-7833-2010	Ferdinand, Kappes/0000-0002-0369-0065; Pierzynska-Mach, Agnieszka/0000-0002-4094-6189; Diaspro, Alberto/0000-0002-4916-5928	German Research Foundation (DFG), Research Training Group 1331 [RTG1331]; German Research Foundation (DFG), Collaborative Research Center 969 [CRC969]; Excellence Initiative of the German Federal Government through funds of the Konstanz Research School Chemical Biology; Excellence Initiative of the German State Government through funds of the Konstanz Research School Chemical Biology	German Research Foundation (DFG), Research Training Group 1331(German Research Foundation (DFG)); German Research Foundation (DFG), Collaborative Research Center 969(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government through funds of the Konstanz Research School Chemical Biology; Excellence Initiative of the German State Government through funds of the Konstanz Research School Chemical Biology	This work was supported by funds of the German Research Foundation (DFG), Research Training Group 1331 (RTG1331, to EFM), and of the Collaborative Research Center 969 (CRC969, project B04, to EFM and AB), and by the Excellence Initiative of the German Federal and State Governments through funds of the Konstanz Research School Chemical Biology (to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiadis V, 2000, GENE DEV, V14, P1308; Bai P, 2015, MOL CELL, V58, P947, DOI 10.1016/j.molcel.2015.01.034; Ball G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15915; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; Bonfiglio JJ, 2017, NUCLEIC ACIDS RES, V45, P6259, DOI 10.1093/nar/gkx446; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Cleary J, 2005, J BIOL CHEM, V280, P31760, DOI 10.1074/jbc.M500884200; Dantzer F, 2013, FEBS J, V280, P3508, DOI 10.1111/febs.12368; Datta A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-234; DEMURCIA G, 1983, EMBO J, V2, P543, DOI 10.1002/j.1460-2075.1983.tb01460.x; Deutzmann A, 2015, ONCOGENE, V34, P4270, DOI 10.1038/onc.2014.346; Devany M, 2008, PROTEIN SCI, V17, P205, DOI 10.1110/ps.073244108; Dungrawala H, 2015, MOL CELL, V59, P998, DOI 10.1016/j.molcel.2015.07.030; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; Fahrer J, 2010, BIOCHEMISTRY-US, V49, P7119, DOI 10.1021/bi1004365; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fischbach A, 2018, NUCLEIC ACIDS RES, V46, P804, DOI 10.1093/nar/gkx1205; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Gill SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140988; Grasemann C, 2005, ONCOGENE, V24, P6441, DOI 10.1038/sj.onc.1208792; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Hacker KE, 2018, NEOPLASIA, V20, P1209, DOI 10.1016/j.neo.2018.10.005; Han SY, 2009, PATHOL INT, V59, P443, DOI 10.1111/j.1440-1827.2009.02392.x; Hanzlikova H, 2018, MOL CELL, V71, P319, DOI 10.1016/j.molcel.2018.06.004; Illuzzi G, 2014, NUCLEIC ACIDS RES, V42, P7776, DOI 10.1093/nar/gku505; Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07; Kappes F, 2004, MOL CELL BIOL, V24, P6011, DOI 10.1128/MCB.24.13.6011-6020.2004; Kappes F, 2004, MOL CELL BIOL, V24, P6000, DOI 10.1128/MCB.24.13.6000-6010.2004; Kappes F, 2011, GENE DEV, V25, P673, DOI 10.1101/gad.2036411; Kappes F, 2011, HUM PATHOL, V42, P932, DOI 10.1016/j.humpath.2010.10.022; Kavanaugh GM, 2011, NUCLEIC ACIDS RES, V39, P7465, DOI 10.1093/nar/gkr454; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Kurnit KC, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0572-7; Lin LJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-366; Lopez-Contreras AJ, 2013, CELL REP, V3, P1105, DOI 10.1016/j.celrep.2013.03.009; Lossaint G, 2013, MOL CELL, V51, P678, DOI 10.1016/j.molcel.2013.07.023; Marechal A, 2015, CELL RES, V25, P9, DOI 10.1038/cr.2014.147; Martello R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12917; Maya-Mendoza A, 2018, NATURE, V559, P279, DOI 10.1038/s41586-018-0261-5; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; MIWA M, 1971, J BIOL CHEM, V246, P6362; Mor-Vaknin N, 2011, ARTHRITIS RHEUM-US, V63, P556, DOI 10.1002/art.30138; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nozaki T, 2017, MOL CELL, V67, P282, DOI 10.1016/j.molcel.2017.06.018; Palazzo L, 2018, BIOCHEM SOC T, V46, P1681, DOI 10.1042/BST20180418; Ribeyre C, 2016, CELL REP, V15, P300, DOI 10.1016/j.celrep.2016.03.027; Riveiro-Falkenbach E, 2017, PIGM CELL MELANOMA R, V30, P194, DOI 10.1111/pcmr.12563; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saha AK, 2013, P NATL ACAD SCI USA, V110, P6847, DOI 10.1073/pnas.1220751110; Salvati E, 2010, ONCOGENE, V29, P6280, DOI 10.1038/onc.2010.344; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Smith EA, 2018, PROTEINS, V86, P88, DOI 10.1002/prot.25411; Smith EA, 2017, SCI REP-UK, V7, DOI 10.1038/srep44662; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Velic D, 2015, BIOMOLECULES, V5, P3204, DOI 10.3390/biom5043204; Vinnedge LMP, 2011, ONCOGENE, V30, P2741, DOI 10.1038/onc.2011.2; Vinnedge LMP, 2013, CELL CYCLE, V12, P51, DOI 10.4161/cc.23121; Waldmann T, 2004, GENE, V343, P1, DOI 10.1016/j.gene.2004.08.029; Waldmann T, 2003, NUCLEIC ACIDS RES, V31, P7003, DOI 10.1093/nar/gkg864; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Ying SM, 2016, CANCER RES, V76, P1078, DOI 10.1158/0008-5472.CAN-15-0608; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou QC, 2018, ONCOL LETT, V15, P8573, DOI 10.3892/ol.2018.8436	73	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0213130	10.1371/journal.pone.0213130	http://dx.doi.org/10.1371/journal.pone.0213130			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408463	Green Submitted, gold, Green Published			2022-12-27	WOS:000485009500001
J	Schroer, AB; Mohamed, JS; Willard, MD; Setola, V; Oestreich, E; Siderovski, DP				Schroer, Adam B.; Mohamed, Junaith S.; Willard, Melinda D.; Setola, Vincent; Oestreich, Emily; Siderovski, David P.			A role for Regulator of G protein Signaling-12 (RGS12) in the balance between myoblast proliferation and differentiation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SKELETAL-MUSCLE; SATELLITE CELL; RHABDOMYOSARCOMA CELL; SCAFFOLD PROTEINS; GENE-EXPRESSION; H-RAS; KINASE; BINDING; PAX7	Regulators of G Protein Signaling (RGS proteins) inhibit G protein-coupled receptor (GPCR) signaling by accelerating the GTP hydrolysis rate of activated Ga subunits. Some RGS proteins exert additional signal modulatory functions, and RGS12 is one such protein, with five additional, functional domains: a PDZ domain, a phosphotyrosine-binding domain, two Ras-binding domains, and a Ga. GDP-binding GoLoco motif. RGS12 expression is temporospatially regulated in developing mouse embryos, with notable expression in somites and developing skeletal muscle. We therefore examined whether RGS12 is involved in the skeletal muscle myogenic program. In the adult mouse, RGS12 is expressed in the tibialis anterior (TA) muscle, and its expression is increased early after cardiotoxin-induced injury, suggesting a role in muscle regeneration. Consistent with a potential role in coordinating myogenic signals, RGS12 is also expressed in primary myoblasts; as these cells undergo differentiation and fusion into myotubes, RGS12 protein abundance is reduced. Myoblasts isolated from mice lacking Rgs12 expression have an impaired ability to differentiate into myotubes ex vivo, suggesting that RGS12 may play a role as a modulator/switch for differentiation. We also assessed the muscle regenerative capacity of mice conditionally deficient in skeletal muscle Rgs12 expression (via Pax7-driven Cre recombinase expression), following cardiotoxin-induced damage to the TA muscle. Eight days post-damage, mice lacking RGS12 in skeletal muscle had attenuated repair of muscle fibers. However, when mice lacking skeletal muscle expression of Rgs12 were cross-bred with mdx mice (a model of human Duchenne muscular dystrophy), no increase in muscle degeneration was observed over time. These data support the hypothesis that RGS12 plays a role in coordinating signals during the myogenic program in select circumstances, but loss of the protein may be compensated for within model syndromes of prolonged bouts of muscle damage and repair.	[Schroer, Adam B.; Siderovski, David P.] West Virginia Univ, Dept Physiol & Pharmacol, WVU Sch Med, Morgantown, WV 26506 USA; [Mohamed, Junaith S.] West Virginia Univ, Div Exercise Physiol, Morgantown, WV 26506 USA; [Willard, Melinda D.; Oestreich, Emily] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Setola, Vincent] West Virginia Univ, Dept Neurosci, Morgantown, WV 26506 USA; [Mohamed, Junaith S.] Univ Tennessee, Dept Clin Lab Sci, Hlth Sci Ctr, Memphis, TN USA; [Willard, Melinda D.] Eli Lilly & Co, Lilly Res Labs, Oncol Early Phase, Indianapolis, IN 46285 USA; [Oestreich, Emily] Pacific Northwest Univ Hlth Sci, Coll Osteopath Med, Dept Biomed Sci, Yakima, WA 98901 USA	West Virginia University; West Virginia University; University of North Carolina; University of North Carolina Chapel Hill; West Virginia University; University of Tennessee System; University of Tennessee Health Science Center; Eli Lilly	Siderovski, DP (corresponding author), West Virginia Univ, Dept Physiol & Pharmacol, WVU Sch Med, Morgantown, WV 26506 USA.; Oestreich, E (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.; Oestreich, E (corresponding author), Pacific Northwest Univ Hlth Sci, Coll Osteopath Med, Dept Biomed Sci, Yakima, WA 98901 USA.	eoestreich@pnwu.edu; dpsiderovski@hsc.wvu.edu	Mohamed, Junaith/AAC-4050-2020; Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Setola, Vincent/0000-0002-9791-2270	Pharmaceutical Research and Manufacturers of America Foundation predoctoral fellowship; National Institute of Arthritis and Musculoskeletal and Skin Diseases postdoctoral fellowship [F32 AR057644]; NIDA [R01 DA048153]; WVU E.J. Van Liere Endowed Medicine Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	Pharmaceutical Research and Manufacturers of America Foundation predoctoral fellowship; National Institute of Arthritis and Musculoskeletal and Skin Diseases postdoctoral fellowship; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); WVU E.J. Van Liere Endowed Medicine Professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided from a Pharmaceutical Research and Manufacturers of America Foundation predoctoral fellowship (to M.D.W.), a National Institute of Arthritis and Musculoskeletal and Skin Diseases postdoctoral fellowship (F32 AR057644 to E.A.O.), and and in part from NIDA (R01 DA048153), and from the WVU E.J. Van Liere Endowed Medicine Professorship (to D.P.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bennett AM, 1997, SCIENCE, V278, P1288, DOI 10.1126/science.278.5341.1288; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Bray D, 1997, P NATL ACAD SCI USA, V94, P13493, DOI 10.1073/pnas.94.25.13493; Brinegar AE, 2017, ELIFE, V6, DOI 10.7554/eLife.27192; Brooks MJ, 2018, J APPL PHYSIOL, V124, P1616, DOI 10.1152/japplphysiol.00451.2017; CHARDIN P, 1985, INT J CANCER, V35, P647, DOI 10.1002/ijc.2910350513; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chatterjee TK, 2002, MOL CELL BIOL, V22, P4334, DOI 10.1128/MCB.22.12.4334-4345.2002; CHOI KY, 1994, CELL, V78, P499; Corvera S, 2001, TRAFFIC, V2, P859, DOI 10.1034/j.1600-0854.2001.21201.x; Dagher R, 1999, Oncologist, V4, P34; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; DALBIS A, 1989, DEV BIOL, V135, P320, DOI 10.1016/0012-1606(89)90182-6; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Diggins NL, 2017, BIOCHEM SOC T, V45, P771, DOI 10.1042/BST20160191; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gerber KJ, 2016, MOL PHARMACOL, V89, P273, DOI 10.1124/mol.115.102210; Girardi F, 2018, PROG MOL BIOL TRANSL, V153, P157, DOI 10.1016/bs.pmbts.2017.11.026; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gross JD, 2018, J PSYCHOPHARMACOL, V32, P191, DOI 10.1177/0269881117742100; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Haramizu S, 2017, J NUTR BIOCHEM, V50, P103, DOI 10.1016/j.jnutbio.2017.08.008; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; Huang JA, 2014, AM J PHYSIOL-GASTR L, V306, pG802, DOI 10.1152/ajpgi.00440.2013; Hutsell SQ, 2010, METHODS MOL BIOL, V627, P75, DOI 10.1007/978-1-60761-670-2_4; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kaplow ME, 2008, GENETICS, V178, P2003, DOI 10.1534/genetics.107.086397; Karasarides M, 2006, CELL BIOL INT, V30, P308, DOI 10.1016/j.cellbi.2005.12.003; Keller C, 2004, GENE DEV, V18, P2608, DOI 10.1101/gad.1243904; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; KONG YF, 1995, MOL CELL BIOL, V15, P5205; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; Le Grand F, 2007, CURR OPIN CELL BIOL, V19, P628, DOI 10.1016/j.ceb.2007.09.012; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Li WQ, 2007, FASEB J, V21, P3606, DOI 10.1096/fj.07-8159com; Li Z, 2018, J BONE MINER RES; Lin DC, 2006, MOL CELL BIOL, V26, P8928, DOI 10.1128/MCB.00228-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu AP, 2014, HUM MOL GENET, V23, P4786, DOI 10.1093/hmg/ddu194; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Martin-McCaffrey L, 2005, DEV DYNAM, V234, P438, DOI 10.1002/dvdy.20555; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; PAYNE PA, 1987, P NATL ACAD SCI USA, V84, P8956, DOI 10.1073/pnas.84.24.8956; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Sambi BS, 2006, CELL SIGNAL, V18, P971, DOI 10.1016/j.cellsig.2005.08.003; SARTORE S, 1982, NATURE, V298, P294, DOI 10.1038/298294a0; Schaaf G, 2010, CANCER RES, V70, P762, DOI 10.1158/0008-5472.CAN-09-2532; Scholz ME, 2009, AM J PHYSIOL-CELL PH, V297, pC1012, DOI 10.1152/ajpcell.00567.2008; Schroer AB, 2018, CHEM SENSES, V43, P367, DOI 10.1093/chemse/bjy024; SCHULTZ E, 1978, J EXP ZOOL, V206, P451, DOI 10.1002/jez.1402060314; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Sethakorn N, 2010, CELL SIGNAL, V22, P1274, DOI 10.1016/j.cellsig.2010.03.016; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Snow BE, 1998, J BIOL CHEM, V273, P17749, DOI 10.1074/jbc.273.28.17749; SPIZZ G, 1986, J BIOL CHEM, V261, P9483; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Suzuki J, 2000, ONCOGENE, V19, P1138, DOI 10.1038/sj.onc.1203402; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; VAIDYA TB, 1989, MOL CELL BIOL, V9, P3576, DOI 10.1128/MCB.9.8.3576; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wang Y, 2013, CELL TISSUE RES, V351, P183, DOI 10.1007/s00441-012-1515-4; Wang Y, 2011, J CELL SCI, V124, P3835, DOI 10.1242/jcs.086686; Wang YQ, 2017, CANCER RES, V77, P4247, DOI 10.1158/0008-5472.CAN-17-0669; Weston CR, 2002, SCIENCE, V296, P2345, DOI 10.1126/science.1073344; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Willard MD, 2007, EMBO J, V26, P2029, DOI 10.1038/sj.emboj.7601659; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Yoo J, 1999, CANCER, V86, P58, DOI 10.1002/(SICI)1097-0142(19990701)86:1<58::AID-CNCR10>3.3.CO;2-J; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Ziman MR, 1997, INT J BIOCHEM CELL B, V29, P1029, DOI 10.1016/S1357-2725(97)00023-X	86	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0216167	10.1371/journal.pone.0216167	http://dx.doi.org/10.1371/journal.pone.0216167			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408461	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500002
J	Chen, WQ; Zhao, L; Li, H; Dong, YL; Xu, H; Guan, Y; Rong, SH; Gao, XL; Chen, RJ; Li, LH; Xu, ZJ				Chen, Wenqian; Zhao, Lu; Li, Hui; Dong, Yilun; Xu, Hong; Guan, Ying; Rong, Songhao; Gao, Xiaoling; Chen, Rongjun; Li, Lihua; Xu, Zhengjun			The isolation of the antagonistic strain Bacillus australimaris CQ07 and the exploration of the pathogenic inhibition mechanism of Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST; ANTIFUNGAL ACTIVITY; BIOLOGICAL-CONTROL; BIOCONTROL AGENT; IN-VITRO	Biological control as a promising method to combat plant disease has gained public attention in recent years. In the present study, we isolated 12 strains resistant to Magnaporthe oryzae from western Sichuan subalpine soil. Among them, CQ07 exhibited remarkable activity against M. oryzae. The result of 16S rRNA sequence analysis revealed that CQ07 is approximately 99% similar to Bacillus australimaris. The sterilized culture filtrate of CQ07 inhibited the growth of M. oryzae, which motivated us to deduce the influence of CQ07 on the pathogenicity of M. oryzae. As shown by experimentation, sterilized culture filtrate (10 mu l/ml) of CQ07 can delay and even suppress the germination of conidia and prevent the formation of appressorium in vitro and in vivo. In addition, by simulative field tests, the spraying of conidia suspension diluted with sterilized culture filtrate of CQ07 reduced infection of rice blast. To better control rice blasts, understanding the infection mechanism of M. oryzae and inhibiting the mechanism of the antagonistic strain is of great importance.	[Chen, Wenqian; Zhao, Lu; Li, Hui; Dong, Yilun; Xu, Hong; Guan, Ying; Rong, Songhao; Gao, Xiaoling; Chen, Rongjun; Li, Lihua; Xu, Zhengjun] Sichuan Agr Univ, Crop Ecophysiol & Cultivat Key Lab Sichuan Prov, Rice Res Inst, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Li, LH; Xu, ZJ (corresponding author), Sichuan Agr Univ, Crop Ecophysiol & Cultivat Key Lab Sichuan Prov, Rice Res Inst, Chengdu, Sichuan, Peoples R China.	lilihua1976@tom.com; mywildrice@aliyun.com	Gao, xiao ling/GQI-2790-2022; Guan, Ying/AAN-5109-2020	Guan, Ying/0000-0002-1207-2656	International Cooperation Project of Sichuan Provincial Science And Technology Department.u Grant [2017HH0031]	International Cooperation Project of Sichuan Provincial Science And Technology Department.u Grant	This work was supported by the International Cooperation Project of Sichuan Provincial Science And Technology Department.u Grant number 2017HH0031. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo H, 2017, FOOD MICROBIOL, V63, P101, DOI 10.1016/j.fm.2016.11.004; Chaves JQ, 2011, INT J FOOD MICROBIOL, V147, P12, DOI 10.1016/j.ijfoodmicro.2011.02.029; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Gao MY, 2008, BIOL CONTROL, V44, P380, DOI 10.1016/j.biocontrol.2007.11.011; Geraldine M, 2010, MOL MICROBIOL, V46, P305; Han T, 2016, BIOCONTROL, V61, P195, DOI 10.1007/s10526-015-9705-0; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hyakumachi M, 2014, J GEN PLANT PATHOL, V80, P287, DOI 10.1007/s10327-014-0524-4; Karthikeyan V, 2008, CROP PROT, V27, P263, DOI 10.1016/j.cropro.2007.05.013; Kato Hajime, 2000, Journal of General Plant Pathology, V66, P30, DOI 10.1007/PL00012919; Li QL, 2011, BIOL CONTROL, V58, P139, DOI 10.1016/j.biocontrol.2011.04.013; Mu C, 2007, ACTA PHYTOPHYLACICA, P123; Ohtaka N, 2008, J GEN PLANT PATHOL, V74, P101, DOI 10.1007/s10327-007-0063-3; Park CH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005529; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Sellem I, 2017, J BASIC MICROB, V57, P393, DOI 10.1002/jobm.201600604; Sevgi E, 2010, TURK J BIOL, V34, P423, DOI 10.3906/biy-0901-23; Sha YX, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2858-1; Shan HY, 2013, CROP PROT, V44, P29, DOI 10.1016/j.cropro.2012.10.012; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Vidhyasekaran P, 2010, PLANT PATHOL, V46, P291; Wang JM, 2013, MOL PLANT PATHOL, V14, P470, DOI 10.1111/mpp.12020; Xiao X, 2011, PHYS CHEM EARTH, V36, P424, DOI 10.1016/j.pce.2010.03.028; Xiong ZQ, 2013, BIOTECHNOL LETT, V35, P1475, DOI 10.1007/s10529-013-1229-z; Yilmaz M, 2006, MICROBIOL RES, V161, P127, DOI 10.1016/j.micres.2005.07.001; Yoshida K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2690-6; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zhang HL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5518; Zhang YL, 2013, J AGR FOOD CHEM, V61, P1521, DOI 10.1021/jf305210u; Zhao ZZ, 2010, BIORESOURCE TECHNOL, V101, P292, DOI 10.1016/j.biortech.2009.07.071	30	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220410	10.1371/journal.pone.0220410	http://dx.doi.org/10.1371/journal.pone.0220410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404061	Green Submitted, Green Published, gold			2022-12-27	WOS:000485006800013
J	Jeon, JM; Kwon, OK; Na, AY; Sung, EJ; Cho, IJ; Kim, M; Yea, SS; Chun, SY; Lee, JH; Ha, YS; Kwon, TG; Lee, S				Jeon, Ju Mi; Kwon, Oh Kwang; Na, Ann-Yae; Sung, Eun Ji; Cho, Il Je; Kim, Mirae; Yea, Sung Su; Chun, So Young; Lee, Jun Hyung; Ha, Yun-Sok; Kwon, Tae Gyun; Lee, Sangkyu			Secretome profiling of PC3/nKR cells, a novel highly migrating prostate cancer subline derived from PC3 cells	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; MATRIX METALLOPROTEINASES; EXPRESSION; IDENTIFICATION; CARCINOMAS; NETWORKS; INVASION	Prostate cancer (PCa) is the most common cancer among men worldwide. Most PCa cases are not fatal; however, the outlook is poor when PCa spreads to another organ. Bone is the target organ in about 80% of patients who experience metastasis from a primary PCa tumor. In the present study, we characterized the secretome of PC3/nKR cells, which are a new subline of PC3 cells that were originally isolated from nude mice that were implanted with PC3 cells without anti-natural killer (NK) cell treatment. Wound healing and Transwell assays revealed that PC3/nKR cells had increased migratory and invasive activities in addition to a higher resistance to NK cells-induced cytotoxicity as compared to PC3 cells. We quantitatively profiled the secreted proteins of PC3/nKR and PC3 cells by liquid chromatography-tandem mass spectrometry analysis coupled with 2-plex tandem mass tag labeling. In total, 598 secretory proteins were identified, and 561 proteins were quantified, among which 45 proteins were secreted more and 40 proteins were secreted less by PC3/nKR cells than by PC3 cells. For validation, the adapter molecule crk, serpin B3, and cystatin-M were analyzed by western blotting. PC3/nKR cells showed the selective secretion of NKG2D ligand 2, HLA-A, and IL-6, which may contribute to their NK cell-mediated cytotoxicity resistance, and had a high secretion of crk protein, which may contribute to their high migration and invasion properties. Based on our secretome analysis, we propose that PC3/nKR cells represent a new cell system for studying the metastasis and progression of PCa.	[Jeon, Ju Mi; Kwon, Oh Kwang; Na, Ann-Yae; Sung, Eun Ji; Lee, Sangkyu] Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, BK21 Plus KNU Multiom Based Creat Drug Res Team, Daegu, South Korea; [Cho, Il Je] Daegu Haany Univ, Coll Korean Med, Gyongsan, Gyeongsangbuk D, South Korea; [Kim, Mirae; Yea, Sung Su] Inje Univ, Coll Med, Dept Biochem, Busan, South Korea; [Chun, So Young] Kyungpook Natl Univ Hosp, Joint Inst Regenerat Med, Daegu, South Korea; [Lee, Jun Hyung; Ha, Yun-Sok; Kwon, Tae Gyun] Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea; [Lee, Jun Hyung; Ha, Yun-Sok; Kwon, Tae Gyun] Kyungpook Natl Univ Hosp, Dept Urol, Daegu, South Korea	Kyungpook National University; Daegu Haany University; Inje University; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital	Lee, S (corresponding author), Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, BK21 Plus KNU Multiom Based Creat Drug Res Team, Daegu, South Korea.; Kwon, TG (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea.; Kwon, TG (corresponding author), Kyungpook Natl Univ Hosp, Dept Urol, Daegu, South Korea.	tgkwon@knu.ac.kr; sangkyu@knu.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [2014M3A9D3034164, 2015R1A2A2A01004286, 2016R1C1B1011180, 2019R1A2C1004046, 2019R1F1A1062343]; Korea Basic Science Institute (KBSI) National Research Facilities & Equipment Center (NFEC) [2019R1A6C1010001]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Korea Basic Science Institute (KBSI) National Research Facilities & Equipment Center (NFEC)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (grant number 2014M3A9D3034164 for TG, 2015R1A2A2A01004286 for SK, 2016R1C1B1011180 for YS, 2019R1A2C1004046 for SY, and 2019R1F1A1062343 for SS).; This work was carried out using the mass spectrometers belonging to the Mass Analysis Support Center supported by the Korea Basic Science Institute (KBSI) National Research Facilities & Equipment Center (NFEC) (2019R1A6C1010001).	Bell Emily S, 2012, Genes Cancer, V3, P341, DOI 10.1177/1947601912459951; Carretero R, 2014, ACTAS UROL ESP, V38, P192, DOI 10.1016/j.acuro.2013.06.006; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chou RH, 2012, ONCOL REP, V27, P238, DOI 10.3892/or.2011.1497; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dai YQ, 2011, CELL BIOCHEM FUNCT, V29, P625, DOI 10.1002/cbf.1797; Devoogdt N, 2009, CANCER SCI, V100, P434, DOI 10.1111/j.1349-7006.2009.01076.x; Dhupkar Pooja, 2016, Biochem Biophys Rep, V8, P382, DOI 10.1016/j.bbrep.2016.10.009; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Farooqi AA, 2012, ARCH IMMUNOL THER EX, V60, P191, DOI 10.1007/s00005-012-0169-y; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; FISCHER A, 1946, NATURE, V157, P442, DOI 10.1038/157442c0; Gandaglia G, 2015, EUR UROL, V68, P325, DOI 10.1016/j.eururo.2014.07.020; Garrido F, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5010007; Hodson R, 2015, NATURE, V528, pS137, DOI 10.1038/528S137a; Jin FY, 1998, INFECT IMMUN, V66, P2447, DOI 10.1128/IAI.66.6.2447-2452.1998; KAIGHN ME, 1979, INVEST UROL, V17, P16; Karagiannis GS, 2010, MOL ONCOL, V4, P496, DOI 10.1016/j.molonc.2010.09.001; KIM U, 1986, J SURG ONCOL, V33, P151, DOI 10.1002/jso.2930330303; Kwon OK, 2018, CANCER GENOM PROTEOM, V15, P279, DOI 10.21873/cgp.20086; Lee YC, 2015, MOL CELL PROTEOMICS, V14, P471, DOI 10.1074/mcp.M114.039909; Lima AR, 2016, TRANSL ONCOL, V9, P357, DOI 10.1016/j.tranon.2016.05.004; Lin QF, 2013, BBA-PROTEINS PROTEOM, V1834, P2360, DOI 10.1016/j.bbapap.2013.01.030; Liu G, 2013, J CLIN INVEST, V123, P4410, DOI 10.1172/JCI69369; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Malmberg KJ, 2017, SEMIN IMMUNOL, V31, P20, DOI 10.1016/j.smim.2017.08.002; Manca P, 2017, CRIT REV ONCOL HEMAT, V112, P59, DOI 10.1016/j.critrevonc.2017.02.013; Molfetta R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081677; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; OHNUKI Y, 1980, CANCER RES, V40, P524; Paltridge JL, 2013, BBA-PROTEINS PROTEOM, V1834, P2233, DOI 10.1016/j.bbapap.2013.03.014; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Roden MM, 1999, J IMMUNOL METHODS, V226, P29, DOI 10.1016/S0022-1759(99)00039-3; ROEB E, 1994, FEBS LETT, V349, P45, DOI 10.1016/0014-5793(94)00636-9; Savage N, 2015, NATURE, V528, pS128, DOI 10.1038/528S128a; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sung E, 2017, ELECTROPHORESIS, V38, P2638, DOI 10.1002/elps.201700052; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; Tsuda Masumi, 2012, Genes Cancer, V3, P334, DOI 10.1177/1947601912458687; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wei HF, 2012, GYNECOL ONCOL, V125, P727, DOI 10.1016/j.ygyno.2012.03.018; Xu LJ, 2018, MOL ONCOL, V12, P269, DOI 10.1002/1878-0261.12135; Yea SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099486; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40	50	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220807	10.1371/journal.pone.0220807	http://dx.doi.org/10.1371/journal.pone.0220807			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404090	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800034
J	Kaneda, K				Kaneda, Koichi			The features of muscle activity during chair standing and sitting motion in submerged condition	PLOS ONE			English	Article							SIT-TO-STAND; GROUND REACTION FORCES; WATER EXERCISE; JOINT MOMENTS; WALKING; SPEED; TORQUES; ABILITY; TRUNK	This study aimed to measure muscle activity and motion kinematics during chair-based exercises under submerged and non-submerged conditions. Twelve healthy men performed chair-based standing and sitting movements. Surface electrodes were attached at the tibialis anterior, gastrocnemius, rectus femoris, biceps femoris, rectus abdominis, and erector spinae. The ankle, knee, and hip joint angles and forward inclination angle of the trunk segment in the sagittal plane were calculated. The mean muscle activities during both movements in the submerged condition for the entire motion were lower than those in the non-submerged condition except in the tibialis anterior and biceps femoris during the sitting movement (in the standing exercise, rectus femoris: 14.1% and 5.2%; and erector spinae: 18.3% and 13.6% in non-submerged and submerged conditions, respectively; and in the sitting exercise, rectus femoris: 12.1% and 4.5% and erector spinae: 12.9% and 9.9% in the non-submerged and submerged conditions, respectively). However, the integrated muscle activity in submerged conditions was similar or higher to that in non-submerged conditions during both movements, except for the rectus femoris. This was mainly due to the increased duration of motion (44.3% and 39.9% longer for standing and sitting exercises in submerged conditions, respectively, compared with non-submerged conditions). The hip joint flexion at the beginning and end of movement and forward inclination angles of the trunk segment at the beginning of the movement in the submerged condition were larger than those in the non-submerged condition during both movements (hip: 126.1 degrees and 111.5 degrees at the beginning, 182.3 degrees and 178.4 degrees at the end and trunk: 2.7 degrees and 17.4 degrees at the beginning in non-submerged and submerged conditions for the standing exercise, respectively; hip: 182.4 degrees and 178.0 degrees at the beginning, 125.9 degrees and 111.1 degrees at the end and trunk: 2.2 degrees and 16.9 degrees at the end in non-submerged and submerged conditions for the sitting exercise, respectively). Reduced or similar muscle activity but similar or higher muscular effort was observed in the submerged condition for all the muscles except the rectus femoris, with the upper body inclined forward. These findings could have beneficial implications for the prescription of exercise and rehabilitation regimens.	[Kaneda, Koichi] Chiba Inst Technol, Fac Adv Engn, Narashino, Chiba, Japan	Chiba Institute of Technology	Kaneda, K (corresponding author), Chiba Inst Technol, Fac Adv Engn, Narashino, Chiba, Japan.	koichi.kaneda@p.chibakoudai.jp			JSPS KAKENHI [15K16521]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number 15K16521 to KK.D	ALEXANDER NB, 1991, J GERONTOL, V46, pM91, DOI 10.1093/geronj/46.3.M91; Barela AMF, 2006, J ELECTROMYOGR KINES, V16, P250, DOI 10.1016/j.jelekin.2005.06.013; Burnett DR, 2011, J ELECTROMYOGR KINES, V21, P610, DOI 10.1016/j.jelekin.2011.03.006; CLEMENT G, 1984, EXP BRAIN RES, V57, P61; Cuesta-Vargas AI, 2013, J ELECTROMYOGR KINES, V23, P1446, DOI 10.1016/j.jelekin.2013.06.001; Dehail P, 2007, CLIN BIOMECH, V22, P1096, DOI 10.1016/j.clinbiomech.2007.07.015; Devereux K, 2005, AUST J PHYSIOTHER, V51, P102, DOI 10.1016/S0004-9514(05)70038-6; Fantozzi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138105; Forwood M R, 2000, Aust Fam Physician, V29, P761; Goulart FR, 1999, CLIN NEUROPHYSIOL, V110, P1634, DOI 10.1016/S1388-2457(99)00109-1; Gross MM, 1998, GAIT POSTURE, V8, P175, DOI 10.1016/S0966-6362(98)00033-2; Janssen WGM, 2005, MED BIOL ENG COMPUT, V43, P265, DOI 10.1007/BF02345965; Kaneda K., 2018, MULTIDISCIPLINARY DI, V2, P298, DOI [10.3390/proceedings2060298, DOI 10.3390/PROCEEDINGS2060298]; Kaneda K, 2009, J ELECTROMYOGR KINES, V19, P1064, DOI 10.1016/j.jelekin.2008.11.001; Kaneda K, 2008, J ELECTROMYOGR KINES, V18, P965, DOI 10.1016/j.jelekin.2007.04.004; Killgore GL, 2012, PHYSICIAN SPORTSMED, V40, P116, DOI 10.3810/psm.2012.02.1958; MILLINGTON PJ, 1992, ARCH PHYS MED REHAB, V73, P609; Miyoshi T, 2005, CLIN BIOMECH, V20, P194, DOI 10.1016/j.clinbiomech.2004.10.006; Miyoshi T, 2004, DISABIL REHABIL, V26, P724, DOI 10.1080/09638280410001704313; MOENING D, 1993, ISOKINET EXERC SCI, V3, P207; NAKAZAWA K, 1994, MED SPORT SCI, V39, P28; NAKAZAWA K, 1994, INT CONGR SER, V1070, P255; PAI YC, 1991, ARCH PHYS MED REHAB, V72, P881, DOI 10.1016/0003-9993(91)90004-3; Perotto AO., 2011, ANATOMICAL GUIDE ELE; Roldan-Jimenez C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141675; Sato D, 2007, QUAL LIFE RES, V16, P1577, DOI 10.1007/s11136-007-9269-2; Sato D, 2009, ARCH GERONTOL GERIAT, V49, P123, DOI 10.1016/j.archger.2008.05.011; Orselli MIV, 2011, J BIOMECH, V44, P1170, DOI 10.1016/j.jbiomech.2011.01.017; Walaszek MC, 2017, J ELECTROMYOGR KINES, V34, P102, DOI 10.1016/j.jelekin.2017.04.005; Yamada Takayoshi, 2004, Journal of Physiological Anthropology and Applied Human Science, V23, P197, DOI 10.2114/jpa.23.197	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220602	10.1371/journal.pone.0220602	http://dx.doi.org/10.1371/journal.pone.0220602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393889	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500044
J	Pandey, PL; Seale, H; Razee, H				Pandey, Pushpa Lata; Seale, Holly; Razee, Husna			Exploring the factors impacting on access and acceptance of sexual and reproductive health services provided by adolescent-friendly health services in Nepal	PLOS ONE			English	Article							CARE; BEHAVIOR; PERCEPTIONS; WORKERS; NEEDS	Adolescent-friendly health programs have been in place in Nepal since 2008, yet uptake of the services for sexual and reproductive health remains suboptimal. For uptake of these services to improve, a rich understanding is needed of the factors impacting their acceptance and utilization from the perspectives of adolescents, health care staff, and key community informants. This study applied a qualitative research design involving six focus groups with 52 adolescents and in-depth interviews with 16 adolescents, 13 key informants, and 9 health care providers from six adolescent-friendly health facilities in Nepal. Thematic analysis was conducted for data analysis. The key themes identified as barriers include access issues due to travel, institutional health care barriers, perceived lack of privacy and confidentiality, and the unprofessional attitudes of staff towards the sexual health needs of adolescents. These themes are underpinned by gendered ideology and a moral framework around the sexual behavior of adolescents. Interview responses suggested that health care providers take a policing role in prescribing adolescents' conformity to this moral framework in their delivery of reproductive health care and services. While physical access to health services may be problematic for some adolescents, this is not the priority issue. Attention needs to be given to increasing the capacity of health care providers to deliver services without imposing their own and socially sanctioned moral frameworks around adolescent sexual behavior. Such capacity building should include training that is experiential and emphasizes the importance of confidentiality and non-judgmental attitudes.	[Pandey, Pushpa Lata; Seale, Holly; Razee, Husna] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of New South Wales Sydney	Pandey, PL (corresponding author), Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.	pushpa.pandey@student.unsw.edu.au	Seale, Holly/D-4200-2011	Seale, Holly/0000-0002-1877-5395; Razee, Husna/0000-0002-6845-8136	Australia Awards Scholarship; Ministry of Health, Nepal	Australia Awards Scholarship; Ministry of Health, Nepal	PLP is the recipient of an Australia Awards Scholarship to PhD, without which this study would not have been possible. The authors acknowledge the Ministry of Health, Nepal, for providing advice and support in conducting this study. We also gratefully acknowledge the contribution of the research participants who opening and enthusiastically shared their views on adolescent-friendly health services in Nepal. We also acknowledge Khumananda Subedi from SISo Nepal and Bhola Shankar Ghimire for their support during the data collection.	Abraham L, 2001, S ASIA, V24, P133, DOI 10.1080/00856400108723441; Acharya D R, 2009, Kathmandu Univ Med J (KUMJ), V7, P445; Adhikari R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-7; Adhikari R, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1472-698X-9-17, 10.1186/1471-2458-9-241]; [Anonymous], 2016, ADOLESCENT DEMOGRAPH; [Anonymous], 2010, TIMES INDIA WORLD; [Anonymous], 2012, THE KATHMANDU POST; Bam K., 2015, AM J PUBLIC HLTH RES, V3, P36; Barter C., 2000, INT J SOC RES METHOD, V3, P307, DOI [10.1080/13645570050178594, DOI 10.1080/13645570050178594]; Baumeister RF, 2002, REV GEN PSYCHOL, V6, P166, DOI 10.1037//1089-2680.6.2.166; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Braun V., 2022, THEMATIC ANAL PRACTI; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Cappiello J, 2011, JOGNN-J OBST GYN NEO, V40, P808, DOI 10.1111/j.1552-6909.2011.01307.x; Chandra-Mouli V, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-015-0111-y; Charmaz Bryant, 2007, SAGE HDB GROUNDED TH; Charmaz K, 2008, HDB CONSTRUCTIONIST, V1, P397, DOI DOI 10.1016/J.DESTUD.2004.08.003; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Cypress BS, 2017, DIMENS CRIT CARE NUR, V36, P253, DOI 10.1097/DCC.0000000000000253; Dagnew T, 2015, ETHIOP J HEALTH SCI, V25, P17, DOI 10.4314/ejhs.v25i1.4; Daley AM, 2017, J PEDIATR NURS, V36, P70, DOI 10.1016/j.pedn.2017.04.009; de Castro F, 2018, SEX REPROD HEALTHC, V16, P118, DOI 10.1016/j.srhc.2018.03.003; de Castro F, 2018, J ADOLESCENT HEALTH, V62, P265, DOI 10.1016/j.jadohealth.2017.08.001; Dickson-Tetteh K, 2001, REPROD HEALTH MATTER, V9, P160, DOI 10.1016/S0968-8080(01)90020-5; DoHS, 2017, ANN REPORT; DoHS, 2015, ANN REPORT; Feleke SA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-294; FINE B, 1977, ECON SOC, V6, P166, DOI 10.1080/03085147700000003; Foucault M., 1985, USE PLEASURE, V2, P25; Fusch PI, 2015, QUAL REP, V20, P1408; Galbin A, 2014, SOC RES REP, V26, P82; Ghimire Kumal A, 2013, J NEPAL HLTH RES COU; Goicolea I, 2017, GLOB PUBLIC HEALTH, V12, P1004, DOI 10.1080/17441692.2015.1123752; Goicolea Isabel, 2012, Glob Health Action, V5, DOI 10.3402/gha.v5i0.18748; Gopichandran V, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004115; Guba E.G., 1985, NATURALISTIC INQUIRY, DOI DOI 10.1016/0147-1767(85)90062-8; Guttmacher Institute, 2018, DEV REG GREAT INV NE; Hallstrom M, 2017, INT J ADOLESC YOUTH, V22, P107, DOI 10.1080/02673843.2015.1137777; Hoopes AJ, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0251-8; Hughes R, 2002, J ADV NURS, V37, P382, DOI 10.1046/j.1365-2648.2002.02100.x; Kennedy E, 2015, ASSESSING SUPPLY SID; Kennedy EC, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-455; Kidd R, 2003, UNDERSTANDING CHALLE; Mathur S, 2001, REPROD HEALTH MATTER, V9, P91, DOI 10.1016/S0968-8080(01)90012-6; Mchome Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120822; McIntyre, 2002, ADOLESCENT FRIENDLY; Ministry of Health Nepal, 2011, NAT AD SEX REPR HLTH; Mmari KN, 2003, J ADOLESCENT HEALTH, V33, P259, DOI 10.1016/S1054-139X(03)00062-4; Mngadi PT, 2008, INT NURS REV, V55, P148, DOI 10.1111/j.1466-7657.2007.00625.x; MOH Nepal New Era ICF, 2017, NEP DEM HLTH SURV 20; Mohseni M, 2007, SOC SCI MED, V64, P1373, DOI 10.1016/j.socscimed.2006.11.023; Morris JL, 2015, INT J GYNECOL OBSTET, V131, pS40, DOI 10.1016/j.ijgo.2015.02.006; Mpeli MR, 2015, EDUC CITIZSH SOC JUS, V10, P278, DOI 10.1177/1746197915607281; Muller A, 2016, SOC SCI MED, V148, P71, DOI 10.1016/j.socscimed.2015.11.048; Muller A, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0462-2; Nepal Law Commission, 2006, AM SOM NEP ACTS MAIN; Niaz U, 2013, KEY ISSUES MENT HEAL, V178, P38, DOI 10.1159/000343696; Niranjan S, 2012, INDAN J COMMUNITY HE, V24, P73; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Pokharel S, 2006, REPROD HEALTH MATTER, V14, P156, DOI 10.1016/S0968-8080(06)28255-7; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Pradhan A, 2003, ADOLESCENT YOUTH REP; Prayas Gautam, 2018, Journal of Medicine, V19, P79, DOI 10.3329/jom.v19i2.37224; Puri M, 2006, J ADOLESCENT HEALTH, V38, P237, DOI 10.1016/j.jadohealth.2004.10.001; Puri MC, 2004, CULT HEALTH SEX, V6, P145, DOI 10.1080/13691050310001619653; Regmi PR, 2011, J ADOLESCENT RES, V26, P675, DOI 10.1177/0743558410384735; Regmi PR, 2010, J HEALTH POPUL NUTR, V28, P619, DOI 10.3329/jhpn.v28i6.6611; Ross DA, 2006, WHO TECHN REP SER; Russell S, 2005, SOC SCI MED, V61, P1396, DOI 10.1016/j.socscimed.2004.11.077; Sanci LA, 2004, MED J AUSTRALIA, V180, P336, DOI 10.5694/j.1326-5377.2004.tb05969.x; Santelli John S, 2003, J Adolesc Health, V33, P396; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Stablein T, 2011, SOCIOL STUD CHILD YO, V14, P203, DOI 10.1108/S1537-4661(2011)0000014014; Suri H, 2011, QUAL RES J, V11, P63, DOI 10.3316/QRJ1102063; Terry G., 2017, SAGE HDB QUALITATIVE; Tilahun M, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-19; Turner KL, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0480-0; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; United Nations Population Fund, 2015, GIRLH NOT MOTH PREV; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; Warenius LU, 2006, REPROD HEALTH MATTER, V14, P119, DOI 10.1016/S0968-8080(06)27242-2; who, AD HLTH RISKS SOL; WHO, 2012, MAK HLTH SERV AD FRI; World Health Organization, 2016, CAUS DEATH AD MAT NE; World Health Organization, 2010, WHORHR1111; Yuval-Davis Nira., 1989, GENDER NATION; Zuch M, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-3	87	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220855	10.1371/journal.pone.0220855	http://dx.doi.org/10.1371/journal.pone.0220855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393927	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500072
J	Mack, EA; Xiao, YP; Allred, DR				Mack, Erin A.; Xiao, Yu-Ping; Allred, David R.			Knockout of Babesia bovis rad51 ortholog and its complementation by expression from the BbACc3 artificial chromosome platform	PLOS ONE			English	Article							BABESIA-BOVIS OCCURS; SINGLE-STRAND BREAKS; VES MULTIGENE FAMILY; ANTIGENIC VARIATION; HOMOLOGOUS RECOMBINATION; PLASMODIUM-FALCIPARUM; STRUCTURE PREDICTION; GENE-EXPRESSION; DNA-DAMAGE; PSI-BLAST	Babesia bovis establishes persistent infections of long duration in cattle, despite the development of effective anti-disease immunity. One mechanism used by the parasite to achieve persistence is rapid antigenic variation of the VESA1 cytoadhesion ligand through segmental gene conversion (SGC), a phenomenon thought to be a form of homologous recombination (HR). To begin investigation of the enzymatic basis for SGC we initially identified and knocked out the Bbrad51 gene encoding the B. bovis Rad51 ortholog. BbRad51 was found to be non-essential for in vitro growth of asexual-stage parasites. However, its loss resulted in hypersensitivity to methylmethane sulfonate (MMS) and an apparent defect in HR. This defect rendered attempts to complement the knockout phenotype by reinsertion of the Bbrad51 gene into the genome unsuccessful. To circumvent this difficulty, we constructed an artificial chromosome, BbACc3, into which the complete Bbrad51 locus was inserted, for expression of BbRad51 under regulation by autologous elements. Maintenance of BbACc3 makes use of centromeric sequences from chromosome 3 and telomeric ends from chromosome 1 of the B. bovis C9.1 line. A selection cassette employing human dihydrofolate reductase enables recovery of transformants by selection with pyrimethamine. We demonstrate that the BbACc3 platform is stably maintained once established, assembles nucleosomes to form native chromatin, and expands in telomere length over time. Significantly, the MMS-sensitivity phenotype observed in the absence of Bbrad51 was successfully complemented at essentially normal levels. We provide cautionary evidence, however, that in HR-competent parasites BbACc3 can recombine with native chromosomes, potentially resulting in crossover. We propose that, under certain circumstances this platform can provide a useful alternative for the genetic manipulation of this group of parasites, particularly when regulated gene expression under the control of autologous elements may be important.	[Mack, Erin A.; Xiao, Yu-Ping; Allred, David R.] Univ Florida, Coll Vet Med, Dept Infect Dis & Immunol, Gainesville, FL 32611 USA; [Allred, David R.] Univ Florida, Genet Inst, Gainesville, FL 32611 USA; [Allred, David R.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Mack, Erin A.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Idaho; University of Idaho	Allred, DR (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Immunol, Gainesville, FL 32611 USA.; Allred, DR (corresponding author), Univ Florida, Genet Inst, Gainesville, FL 32611 USA.; Allred, DR (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	allredd@ufl.edu	Allred, David/M-1299-2019	Allred, David/0000-0001-9347-5918	National Institutes of Health [R01 AI0055864, T32 AI0007110]; U. F. College of Veterinary Medicine Faculty Competitive Research Awards; USDA Animal Health project [FLA-VME-005011]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. F. College of Veterinary Medicine Faculty Competitive Research Awards; USDA Animal Health project	This work was supported by funds from National Institutes of Health grants R01 AI0055864 (DRA; https://www.niaid.nih.gov/) and T32 AI0007110 (University of Florida; https://www.niaid.nih.gov/), USDA Animal Health project FLA-VME-005011 (DRA; https://nifa.usda.gov/), and U. F. College of Veterinary Medicine Faculty Competitive Research Awards (DRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khedery B, 2006, MOL MICROBIOL, V59, P402, DOI 10.1111/j.1365-2958.2005.04993.x; Allred DR, 2006, VET PARASITOL, V138, P50, DOI 10.1016/j.vetpar.2006.01.039; Allred DR, 2004, MOL BIOCHEM PARASIT, V134, P27, DOI 10.1016/j.molbiopara.2003.09.012; ALLRED DR, 1993, MOL BIOCHEM PARASIT, V60, P121, DOI 10.1016/0166-6851(93)90035-V; Allred DR, 2000, MOL CELL, V5, P153, DOI 10.1016/S1097-2765(00)80411-6; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMBROSIO RE, 1986, ONDERSTEPOORT J VET, V53, P179; Asada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125993; Asada M, 2012, MOL BIOCHEM PARASIT, V181, P162, DOI 10.1016/j.molbiopara.2011.11.001; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; BOYCE RP, 1968, VIROLOGY, V35, P601, DOI 10.1016/0042-6822(68)90289-4; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Cable RG, 2003, CURR OPIN HEMATOL, V10, P405, DOI 10.1097/00062752-200311000-00002; Chen J, 2010, NUCLEIC ACIDS RES, V38, P4889, DOI 10.1093/nar/gkq209; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; de Koning-Ward TF, 2000, MOL BIOCHEM PARASIT, V106, P199, DOI 10.1016/S0166-6851(99)00189-9; de Vries E, 2006, VET PARASITOL, V138, P61, DOI 10.1016/j.vetpar.2006.01.040; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Ensminger M, 2014, J CELL BIOL, V206, P29, DOI 10.1083/jcb.201312078; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gonzalez-Prieto R, 2013, EMBO J, V32, P1307, DOI 10.1038/emboj.2013.73; Hakimi H, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1439-z; Huang YL, 2013, INT J PARASITOL, V43, P163, DOI 10.1016/j.ijpara.2012.10.018; Iwanaga S, 2012, GENOME RES, V22, P985, DOI 10.1101/gr.124164.111; Iwanaga S, 2010, CELL HOST MICROBE, V7, P245, DOI 10.1016/j.chom.2010.02.010; Jackson AP, 2014, NUCLEIC ACIDS RES, V42, P7113, DOI 10.1093/nar/gku322; KAMPER SM, 1992, MOL BIOCHEM PARASIT, V53, P33, DOI 10.1016/0166-6851(92)90004-4; Keroack CD, 2019, INT J PARASITOL, V49, P153, DOI 10.1016/j.ijpara.2018.09.005; Kim DE, 2014, PROTEINS, V82, P208, DOI 10.1002/prot.24374; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852; Krause PJ, 1998, NEW ENGL J MED, V339, P160, DOI 10.1056/NEJM199807163390304; Lau AOT, 2007, EXP PARASITOL, V117, P93, DOI 10.1016/j.exppara.2007.03.004; Leiby DA, 2005, TRANSFUSION, V45, P1804, DOI 10.1111/j.1537-2995.2005.00609.x; LEVY MG, 1980, SCIENCE, V207, P1218, DOI 10.1126/science.7355284; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Lundin C, 2005, NUCLEIC ACIDS RES, V33, P3799, DOI 10.1093/nar/gki681; Mack E, 2014, THESIS; Mack EA, 2019, BIORXIV, DOI [10.1101/606590, DOI 10.1101/606590]; Mamoun CB, 2018, ELS, DOI [10.1002/9780470015902.a0001945.pub2, DOI 10.1002/9780470015902.A0001945.PUB2]; Maniatis T, 1982, MOLECULAR CLONING A; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MARTIN WJ, 1971, NATURE-NEW BIOL, V233, P260, DOI 10.1038/newbio233260a0; McCulloch R, 1999, GENE DEV, V13, P2875, DOI 10.1101/gad.13.21.2875; O'Connor RM, 2000, J IMMUNOL, V164, P2037, DOI 10.4049/jimmunol.164.4.2037; OConnor RM, 1997, MOL BIOCHEM PARASIT, V89, P259, DOI 10.1016/S0166-6851(97)00125-4; Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010; Pascucci B, 2005, NUCLEIC ACIDS RES, V33, P280, DOI 10.1093/nar/gki168; Patnaik PK, 1996, NUCLEIC ACIDS RES, V24, P668, DOI 10.1093/nar/24.4.668; Pelle KG, 2015, CELL MICROBIOL, V17, P1618, DOI 10.1111/cmi.12460; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PONTKINGDON G, 1994, BIOTECHNIQUES, V16, P1010; Proudfoot C, 2005, NUCLEIC ACIDS RES, V33, P6906, DOI 10.1093/nar/gki996; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Rossi MJ, 2011, P NATL ACAD SCI USA, V108, P6432, DOI 10.1073/pnas.1016072108; ROTH C, 1989, P NATL ACAD SCI USA, V86, P9375, DOI 10.1073/pnas.86.23.9375; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Stark JM, 2002, J BIOL CHEM, V277, P20185, DOI 10.1074/jbc.M112132200; Suarez CE, 2006, INT J PARASITOL, V36, P965, DOI 10.1016/j.ijpara.2006.02.022; Suarez CE, 2015, MOL BIOCHEM PARASIT, V202, P23, DOI 10.1016/j.molbiopara.2015.09.003; Suarez CE, 2012, MOL BIOCHEM PARASIT, V185, P52, DOI 10.1016/j.molbiopara.2012.05.003; Suarez CE, 2009, INT J PARASITOL, V39, P289, DOI 10.1016/j.ijpara.2008.08.006; Suarez CE, 2004, INT J PARASITOL, V34, P1177, DOI 10.1016/j.ijpara.2004.07.001; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; TRIPP CA, 1989, EXP PARASITOL, V69, P211, DOI 10.1016/0014-4894(89)90068-4; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; Wang X, 2010, THESIS; Wang XY, 2012, EUKARYOT CELL, V11, P260, DOI 10.1128/EC.05318-11; Zintl A, 2014, IRISH VET J, V67, DOI 10.1186/2046-0481-67-19	77	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0215882	10.1371/journal.pone.0215882	http://dx.doi.org/10.1371/journal.pone.0215882			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386669	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100002
J	Simsa, R; Vila, XM; Salzer, E; Teuschl, A; Jenndahl, L; Bergh, N; Fogelstrand, P				Simsa, Robin; Vila, Xavier Monforte; Salzer, Elias; Teuschl, Andreas; Jenndahl, Lachmi; Bergh, Niklas; Fogelstrand, Per			Effect of fluid dynamics on decellularization efficacy and mechanical properties of blood vessels	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; VASCULAR GRAFT; ARTERIAL-WALL; TISSUE; SCAFFOLD; ENDOTHELIALIZATION; FIBRONECTIN; STIFFNESS; IMPACT; CELLS	Decellularization of blood vessels is a promising approach to generate native biomaterials for replacement of diseased vessels. The decellularization process affects the mechanical properties of the vascular graft and thus can have a negative impact for in vivo functionality. The aim of this study was to determine how detergents under different fluid dynamics affects decellularization efficacy and mechanical properties of the vascular graft. We applied a protocol utilizing 1% TritonX, 1% Tributyl phosphate (TnBP) and DNase on porcine vena cava. The detergents were applied to the vessels under different conditions; static, agitation and perfusion with 3 different perfusion rates (25, 100 and 400 mL/min). The decellularized grafts were analyzed with histological, immunohistochemical and mechanical tests. We found that decellularization efficacy was equal in all groups, however the luminal ultrastructure of the static group showed remnant cell debris and the 400 mL/min perfusion group showed local damage and tearing of the luminal surface. The mechanical stiffness and maximum tensile strength were not influenced by the detergent application method. In conclusion, our results indicate that agitation or low-velocity perfusion with detergents are preferable methods for blood vessel decellularization.	[Simsa, Robin; Jenndahl, Lachmi] VERIGRAFT AB, Gothenburg, Sweden; [Simsa, Robin; Bergh, Niklas; Fogelstrand, Per] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Vila, Xavier Monforte; Salzer, Elias; Teuschl, Andreas] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Vila, Xavier Monforte; Salzer, Elias; Teuschl, Andreas] Univ Appl Sci Technikum Wien, Dept Life Sci Engn, Vienna, Austria	University of Gothenburg	Simsa, R (corresponding author), VERIGRAFT AB, Gothenburg, Sweden.; Simsa, R (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden.	robin.simsa@verigraft.com		Teuschl-Woller, Andreas/0000-0002-3817-1572; Simsa, Robin/0000-0003-2889-1442	European Union [722779]	European Union(European Commission)	This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 722779 and was conducted within the "Training 4 Cell Regenerative Medicine" (T4CRM) network.	Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Bharadwaj M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14348; Bourgine PE, 2013, BIOMATERIALS, V34, P6099, DOI 10.1016/j.biomaterials.2013.04.058; Breuls Roel G M, 2008, Open Orthop J, V2, P103, DOI 10.2174/1874325000802010103; Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003; BUDD JS, 1990, J VASC SURG, V12, P126, DOI 10.1067/mva.1990.21400; Consolo F, 2016, J TISSUE ENG REGEN M, V10, pE101, DOI 10.1002/term.1767; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016; Dixit P, 2001, J BIOMED MATER RES, V56, P545, DOI 10.1002/1097-4636(20010915)56:4<545::AID-JBM1126>3.0.CO;2-V; Dong CJ, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8020042; FARQUHARSON C, 1989, HISTOCHEM J, V21, P172, DOI 10.1007/BF01007492; Garreta E, 2017, MATER TODAY, V20, P166, DOI 10.1016/j.mattod.2016.12.005; Green EM, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2013.0058; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-9; Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0; Kuna VK, 2018, JOVE-J VIS EXP, DOI 10.3791/57803; Kuna VK, 2015, J VASC SURG-VENOUS L, V3, P421, DOI 10.1016/j.jvsv.2014.12.002; Leonel LCPC, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20176382, 10.1590/1414-431x20176382]; Madhavan K, 2013, J BIOMED MATER RES B, V101B, P506, DOI 10.1002/jbm.b.32851; Mallis P, 2018, BIOMED MAT ENG, P1, DOI [10.3233/BME-171708, DOI 10.3233/BME-171708]; Mattson JM, 2017, BIOMECH MODEL MECHAN, V16, P213, DOI 10.1007/s10237-016-0811-4; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Nerem RM, 2000, YONSEI MED J, V41, P735, DOI 10.3349/ymj.2000.41.6.735; Pashneh-Tala S, 2016, TISSUE ENG PART B-RE, V22, P68, DOI 10.1089/ten.teb.2015.0100; Pellegata AF, 2014, CELLS TISSUES ORGANS, V200, P363, DOI 10.1159/000439082; Pellegata AF, 2012, INT J ARTIF ORGANS, V35, P191, DOI 10.5301/ijao.5000079; Rambol MH, 2018, EBIOMEDICINE, V32, P215, DOI 10.1016/j.ebiom.2018.05.012; Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77; Sack KD, 2016, J CELL PHYSIOL, V231, P2026, DOI 10.1002/jcp.25312; Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033; Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002; Schneider KH, 2016, ACTA BIOMATER, V29, P125, DOI 10.1016/j.actbio.2015.09.038; Simsa R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209269; Thottappillil N, 2015, VASC HEALTH RISK MAN, V11, P79, DOI 10.2147/VHRM.S50536; Wang YJ, 2018, J MECH BEHAV BIOMED, V77, P634, DOI 10.1016/j.jmbbm.2017.10.023; Williams C, 2009, ACTA BIOMATER, V5, P993, DOI 10.1016/j.actbio.2008.11.028; Wingate K, 2014, TISSUE ENG PT A, V20, P2503, DOI [10.1089/ten.tea.2013.0249, 10.1089/ten.TEA.2013.0249]; Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088	39	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220743	10.1371/journal.pone.0220743	http://dx.doi.org/10.1371/journal.pone.0220743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381614	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600035
J	Lee, JS				Lee, Jong-Sun			Perceived social support functions as a resilience in buffering the impact of trauma exposure on PTSD symptoms via intrusive rumination and entrapment in firefighters	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; LIFE EVENTS; DEPRESSION; DEFEAT; METAANALYSIS; VETERANS; SUICIDE; ANXIETY; RISK; US	Resilience has been highlighted as a pivotal factor in overcoming the detrimental impact of trauma. The present study tests a resilience model of trauma using risk (rumination, emotion regulation, and entrapment) and protective (perceived social support) factors in a sample of firefighters who are at heightened risk for post-traumatic stress disorder, using a cross-sectional design. Specifically, the present study focuses on perceived social support as a resilience factor against PTSD symptoms, in response to trauma exposure. The sample included 545 firefighters from six large cities in Korea, who completed the following self-report questionnaires: Life Event Checklist, Event-related Rumination Inventory, Emotion Regulation Questionnaire, Entrapment scale, Impact of Event Scale-Revised, and Duke-UNC Functional Social Support Questionnaire. Exposure to traumatic events indirectly affected PTSD symptoms via intrusive rumination, emotional regulation, and perceptions of entrapment. Additionally, the mediating effects of intrusive rumination and perceptions of entrapment were moderated by perceived social support. That is, firefighters with high levels of perceived social support reported lower severity of rumination and PTSD symptoms. These findings suggest that perceptions of social support may operate as a resilience factor in buffering the effects of trauma on PTSD symptoms. Perceived social support interacts with intrusive rumination and perceptions of entrapment, thereby resisting the development of PTSD symptoms.	[Lee, Jong-Sun] Kangwon Natl Univ, Dept Psychol, Chunchon, South Korea	Kangwon National University	Lee, JS (corresponding author), Kangwon Natl Univ, Dept Psychol, Chunchon, South Korea.	jongsunlee@kangwon.ac.kr			Kangwon National University [520160007]; Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2018S1A3A2074932]; Seoul National Hospital, Ministry of Health & Welfare, Republic of Korea	Kangwon National University; Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Seoul National Hospital, Ministry of Health & Welfare, Republic of Korea	This study was supported by 2016 Research Grant from Kangwon National University (520160007), the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2018S1A3A2074932) & Seoul National Hospital, Ministry of Health & Welfare, Republic of Korea.	Abela JRZ, 2004, J SOC CLIN PSYCHOL, V23, P653, DOI 10.1521/jscp.23.5.653.50752; Bae H, 2008, PSYCHIAT INVEST, V5, P163, DOI 10.4306/pi.2008.5.3.163; Blackburn L, 2016, J AGGRESS MALTREAT T, V25, P197, DOI 10.1080/10926771.2015.1107174; Brancu M, 2014, PSYCHIAT RES, V217, P86, DOI 10.1016/j.psychres.2014.02.025; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Broadhead W, 1988, MED CARE; Cann A, 2011, ANXIETY STRESS COPIN, V24, P137, DOI 10.1080/10615806.2010.529901; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Corneil W, 1999, J Occup Health Psychol, V4, P131, DOI 10.1037/1076-8998.4.2.131; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Fergus S, 2005, ANNU REV PUBL HEALTH, V26, P399, DOI 10.1146/annurev.publhealth.26.021304.144357; Flynn M, 2010, COGNITIVE THER RES, V34, P456, DOI 10.1007/s10608-010-9300-8; Gilbert P, 2004, J AFFECT DISORDERS, V79, P149, DOI 10.1016/S0165-0327(02)00405-6; Gilbertson MW, 2010, J CLIN PSYCHIAT; Glantz M.D., 2002, RESILIENCE DEV POSIT, P109, DOI DOI 10.1007/0-306-47167-1_6; Hayes A.F, 2013, PROCESS SPSS MACRO C; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hyun-Nie Ahn，, 2013, [Cognitive Behavior Therapy in Korea, 인지행동치료], V13, P149; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kim Ye-Seul, 2017, Korean Journal of Clinical Psychology, V36, P325, DOI 10.15842/kjcp.2017.36.3.004; Lakey B, 2011, PSYCHOL REV, V118, P482, DOI 10.1037/a0023477; Lee J, 2012, KOREAN J PSYCHOL GEN, P239; Lee JS, 2014, J AFFECT DISORDERS, V162, P128, DOI 10.1016/j.jad.2014.02.031; Littlewood DL, 2016, J CLIN SLEEP MED, V12, P393, DOI 10.5664/jcsm.5592; Michael T, 2007, DEPRESS ANXIETY, V24, P307, DOI 10.1002/da.20228; Panagioti M, 2014, COMPR PSYCHIAT, V55, P104, DOI 10.1016/j.comppsych.2013.06.004; Panagioti M, 2012, DEPRESS ANXIETY, V29, P187, DOI 10.1002/da.21917; Prati G, 2010, J COMMUNITY PSYCHOL, V38, P403, DOI 10.1002/jcop.20371; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; PRIEL B, 1995, PERS INDIV DIFFER, V19, P235, DOI 10.1016/0191-8869(95)91936-T; Puterman E, 2010, J SOC CLIN PSYCHOL, V29, P797, DOI 10.1521/jscp.2010.29.7.797; SARASON BR, 1991, J PERS SOC PSYCHOL, V60, P273, DOI 10.1037/0022-3514.60.2.273; Schumm JA, 2006, J TRAUMA STRESS, V19, P825, DOI 10.1002/jts.20159; Siddaway AP, 2015, J AFFECT DISORDERS, V184, P149, DOI 10.1016/j.jad.2015.05.046; Southwick SM, 2016, WORLD PSYCHIATRY, V15, P77, DOI 10.1002/wps.20282; Stanley I. H., 2018, PSYCHOL SERV; Taylor PJ, 2011, PSYCHOL BULL, V137, P391, DOI 10.1037/a0022935; Wagner D, 1998, AM J PSYCHIAT, V155, P1727, DOI 10.1176/ajp.155.12.1727; Wastell CA, 2002, J NERV MENT DIS, V190, P839, DOI 10.1097/00005053-200212000-00006; Weathers F. W., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Weiss DS., 2007, CROSS CULTURAL ASSES, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; Zhao CY, 2013, QUAL LIFE RES, V22, P733, DOI 10.1007/s11136-012-0197-4	42	39	41	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220454	10.1371/journal.pone.0220454	http://dx.doi.org/10.1371/journal.pone.0220454			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374563	Green Submitted, Green Published, gold			2022-12-27	WOS:000484991500013
J	Oduor, FO; Boedecker, J; Kennedy, G; Termote, C				Oduor, Francis Odhiambo; Boedecker, Julia; Kennedy, Gina; Termote, Celine			Exploring agrobiodiversity for nutrition: Household on-farm agrobiodiversity is associated with improved quality of diet of young children in Vihiga, Kenya	PLOS ONE			English	Article							DIVERSITY; BIODIVERSITY; INDICATOR	Due to their limited access to the external productive inputs and the dependency on rain-fed agricultural production, small scale farmers in sub-Saharan Africa have continued to face undernutrition despite the significant advancements in agriculture. They however often live in areas endowed with high agrobiodiversity which could contribute, if explored, to improved diets and nutrition. Few studies have linked the contribution of agrobiodiversity to the micronutrient adequacy of the diets of young children among smallholder farmers. The study explored this relationship and contributes to the growing body of literature linking agrobiodiversity to nutrition of young children. Two cross-sectional surveys were conducted as part of baseline assessment for an intervention study, one in the lean and a second in the plenty season in Vihiga county, Kenya. Household level interviews were administered to 634 households with children 12-23 months. Agrobiodiversity was defined as the number of crop species cultivated or harvested from the wild and the number of livestock maintained by the household across two agricultural seasons. Dietary data were collected using two-non-consecutive quantitative 24-hour recalls and analyzed using Lucille software. Diet quality was assessed using dietary diversity score based on seven food groups and mean probability of micronutrient adequacy computed for eleven micronutrients. A total of 80 species were maintained or harvested from the wild by the households. Mean household species richness was 9.9 +/- 4.3. One in every four children did not meet the minimum dietary diversity score. The average mean probability of micronutrient adequacy was 68.11 +/- 16.08 in plenty season compared to 56.37 +/- 19.5% in the lean season. Iron, zinc and calcium were most limiting micronutrients in the diet, with less than 30% average probability of adequacy in both seasons. Household agrobiodiversity was positively associated with both dietary diversity score (r = 0.09, p = 0.029) and micronutrient adequacy (r = 0.15, p<0.000) in the pooled sample. One unit increase in species diversity was associated with 12.7% improvement in micronutrient adequacy. Despite the rich agrobiodiversity in the study area the diets were low in diversity and there is an unrealized opportunity to improve micronutrient intake through greater promotion and consumption of locally available agrobiodiversity.	[Oduor, Francis Odhiambo; Boedecker, Julia; Termote, Celine] Biovers Int, Hlth Diets Sustainable Food Syst Initiat, Nairobi, Kenya; [Kennedy, Gina] Biovers Int, Hlth Diets Sustainable Food Syst Initiat, Rome, Italy	Alliance; Bioversity International; Alliance; Bioversity International	Oduor, FO (corresponding author), Biovers Int, Hlth Diets Sustainable Food Syst Initiat, Nairobi, Kenya.	francodhis@gmail.com		Oduor, Francis/0000-0001-8082-6387; Termote, Celine/0000-0003-3217-0226	HumidTropics CGIAR Research Program; Agriculture for Nutrition and Health (A4NH) CGIAR Research Program; Biovision Foundation Switzerland	HumidTropics CGIAR Research Program(CGIAR); Agriculture for Nutrition and Health (A4NH) CGIAR Research Program(CGIAR); Biovision Foundation Switzerland	The research was supported by funding from the HumidTropics CGIAR Research Program, the Agriculture for Nutrition and Health (A4NH) CGIAR Research Program, and the Biovision Foundation Switzerland. The funds were awarded to Bioversity International. The funders did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2015, AFSUN FOOD SECURITY; [Anonymous], LUC SOFTW PROC YOUR; Bahadur KCK, 2016, REG ENVIRON CHANGE, V16, P1239, DOI 10.1007/s10113-015-0851-9; Bridson D, 1998, HERBARIUM HDB; Daelmans B, 2013, MATERN CHILD NUTR, V9, P116, DOI 10.1111/mcn.12083; Daniels MC, 2009, EUR J CLIN NUTR, V63, P199, DOI 10.1038/sj.ejcn.1602927; Dioula B. M., ENHANCING ROLE SMALL; Ekesa B. N., 2008, African Journal of Food, Agriculture, Nutrition and Development, V8, P390; Ferguson E, 2015, MATERN CHILD NUTR, V11, P6, DOI 10.1111/mcn.12243; Food and Agriculture Organization; Platform for Agrobiodiversity Research, 2011, BIODIVERSITY FOR FOO; Frei M, 2004, BIODIVERS CONSERV, V13, P1591, DOI 10.1023/B:BIOC.0000021330.81998.bb; Gewa CA, 2014, PUBLIC HEALTH NUTR, V17, P2667, DOI 10.1017/S1368980014000469; Gibson RS, 2008, INTERACTIVE 24 HOUR; Hillocks R. J, 2011, AFR J FOOD AGR NUTR, V11; Hirvonen K, 2017, AGR ECON-BLACKWELL, V48, P469, DOI 10.1111/agec.12348; Institute of Medicine (US) Subcommittee on Interpretation and Uses of Dietary Reference Intakes; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2000, DRI DIET REF INT APP; Jones AD, 2018, J NUTR, V148, P1625, DOI 10.1093/jn/nxy166; Jones AD, 2014, FOOD POLICY, V46, P1, DOI 10.1016/j.foodpol.2014.02.001; Kahane R, 2013, AGRON SUSTAIN DEV, V33, P671, DOI 10.1007/s13593-013-0147-8; Keding G. B., 2013, LINKING NUTR AGROBIO; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Kenya National Bureau of Statistics, 2013, COUNT STAT; Kenya National Bureau of Statistics, EXPL KEN IN PULL AP; Kenya National Bureau of Statistics (KNBS); Division of Nutrition Ministry of Public Health and Sanitation (MOPHS); Kenya Medical Research Institute (KEMRI), 2011, KEN NAT MICR SURV 20; [Kenya National Bureau of Statistics; Ministry of Health/ Kenya; National AIDS Control Council/ Kenya Kenya Medical Research Institute; National Council for Population and Development/ Kenya; ICF International], 2015, KEN DEM HLHT SURV 20; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kindt R, 2006, BIODIVERS CONSERV, V15, P3235, DOI 10.1007/s10531-005-0311-9; Lukmanji Z., 2008, TANZANIA FOOD COMPOS; Magnani R., 1999, SAMPLING GUIDE; Mburu SW., 2016, AGR FOOD SECUR, V5, P1, DOI [10.1186/s40066-016-0068-2, DOI 10.1186/S40066-016-0068-2]; Mirmiran P, 2006, J AM COLL NUTR, V25, P354, DOI 10.1080/07315724.2006.10719546; Mosites EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136686; Ng'endo M, 2018, FOOD NUTR BULL, V39, P86, DOI 10.1177/0379572117723135; Ng'endo M, 2015, AGROECOL SUST FOOD, V39, P1071, DOI 10.1080/21683565.2015.1073206; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Rathnayake Kumari Malkanthi, 2012, BMC Res Notes, V5, P469, DOI 10.1186/1756-0500-5-469; Sehmi J.K., 1993, NATL FOOD COMPOSITIO; Stadlmayr B, 2012, INT NETW FOOD DAT SY; Thompson B., 2014, IMPROVING DIETS NUTR; U.S. Department of Agriculture Agriculture Research Service, 2014, USDA NAT NUTR DAT ST; USDA, 2007, NUTR DAT LAB 2007 US; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walingo M. K., 2013, Pakistan Journal of Nutrition, V12, P854; Waswa L.B, 2016, NUTR BASELINE SURVEY; WHO/UNICEF, 2010, INDICATORS FOR ASSES	47	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0219680	10.1371/journal.pone.0219680	http://dx.doi.org/10.1371/journal.pone.0219680			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374090	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500002
J	Burger, P; Kanhai, S; Pleijter, A; Verberne, S				Burger, Peter; Kanhai, Soeradj; Pleijter, Alexander; Verberne, Suzan			The reach of commercially motivated junk news on Facebook	PLOS ONE			English	Article							FAKE NEWS; MEDIA	Commercially motivated junk news-i.e. money-driven, highly shareable clickbait with low journalistic production standards-constitutes a vast and largely unexplored news media ecosystem. Using publicly available Facebook data, we compared the reach of junk news on Facebook pages in the Netherlands to the reach of Dutch mainstream news on Facebook. During the period 2013-2017 the total number of user interactions with junk news significantly exceeded that with mainstream news. Over 5 Million of the 10 Million Dutch Facebook users have interacted with a junk news post at least once. Junk news Facebook pages also had a significantly stronger increase in the number of user interactions over time than mainstream news. Since the beginning of 2016 the average number of user interactions per junk news post has consistently exceeded the average number of user interactions per mainstream news post.	[Burger, Peter; Pleijter, Alexander] Leiden Univ, Ctr Linguist LUCL, Dept Journalism & New Media, Leiden, Netherlands; [Kanhai, Soeradj; Verberne, Suzan] Leiden Univ, LIACS, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Verberne, S (corresponding author), Leiden Univ, LIACS, Leiden, Netherlands.	s.verberne@liacs.leidenuniv.nl	Pleijter, Alexander/HIK-0677-2022	Verberne, Suzan/0000-0002-9609-9505; Burger, Peter/0000-0003-3366-9977				Allcott H., 2018, ARXIV180905901; Allcott Hunt, 2017, J ECON PERSPECT, V31, P211, DOI DOI 10.1257/JEP.31.2.211; Burger P., NIEUWSCHECKERS; Burger P., 2017, HOAX ASIELZOEKERS MI; Coltelli M., 2018, REUTERS I STUDY JOUR; Drozdiak N., 2018, GOOGLE FACEBOOK TWIT; Funke D, 2018, WE ASKED 19 FACT CHE; Guess A, 2018, SELECTIVE EXPOSURE M, DOI [10.1016/j.aap.2010.08.010, DOI 10.1016/J.AAP.2010.08.010]; Hazenberg HGG, 2018, MICROTARGETING ICT M; House of Commons Digital Culture Media and Sport Committee, 2018, DIS FAK NEWS INT REP; Howard P. N., 2017, JUNK NEWS BOTS FRENC; Howard PN, 2018, J INF TECHNOL POLITI, V15, P81, DOI 10.1080/19331681.2018.1448735; Humprecht E., 2018, INFORM COMMUNICATION, P1; King G., 2018, NEW MODEL IND ACAD P; Kist R, 2017, GEEN GROTE ROL NEPNI; MATHESONPOLLOCK H, 2018, MEASURING REACH FAKE, P1, DOI DOI 10.1007/978-3-319-76974-5_1; Nelson JL, 2018, SMALL DISLOYAL FAKE; Neudert L-M., 2018, POLARIZATION PARTISA; Newman N., 2018, REUTERS I DIGITAL NE; Nielsen RK, 2017, REUTERS I STUDY JOUR, DOI [10.2174/1874205X01105010068, DOI 10.2174/1874205X01105010068]; Powers S., 2017, DIGIT COMMONS, V377; Rieder B., 2013, P 5 ANN ACM WEB SCI, V2013, P346, DOI [10.1145/2464464.2464475, DOI 10.1145/2464464.2464475]; Roozenbeek J, 2019, J RISK RES, V22, P570, DOI 10.1080/13669877.2018.1443491; Senecat A., 2017, MONDE; Silverman C, 2018, MACEDONIAS PROTRUMP; Silverman C., 2016, BUZZFEED NEWS, DOI [10.1016/S0006-3207(03)00230-1, DOI 10.1016/S0006-3207(03)00230-1]; Tandoc EC, 2018, DIGIT JOURNAL, V6, P137, DOI 10.1080/21670811.2017.1360143; Tucker J. A., 2018, SOCIAL MEDIA POLITIC, P22, DOI [DOI 10.2139/SSRN.3144139, 10.2139/ssrn.3144139]; van Keulen I., 2018, DIGITALISERING NIEUW; Vargo CJ, 2018, NEW MEDIA SOC, V20, P2028, DOI 10.1177/1461444817712086; Venturini T, 2019, DATA POLITICS WORLDS; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wardle C., 2017, COUNCIL EUROPE POLIC; Wieringa M, 2017, WIE IS WAAKHOND SOCI	34	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220446	10.1371/journal.pone.0220446	http://dx.doi.org/10.1371/journal.pone.0220446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369596	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900049
J	Choi, WR; Yang, JH; Jeong, SY; Lee, JK				Choi, Won Rak; Yang, Jae-Hyuk; Jeong, Soo-Young; Lee, Jin Kyu			MRI comparison of injury mechanism and anatomical factors between sexes in non-contact anterior cruciate ligament injuries	PLOS ONE			English	Article							VIDEO ANALYSIS; TIBIAL SLOPE; NEUROMUSCULAR CONTROL; KNEE ABDUCTION; RISK; ACL; ASSOCIATION; BASKETBALL; KINEMATICS; TRUNK	Non-contact anterior cruciate ligament (ACL) rupture is mostly caused by a pivot shift mechanism including valgus collapse and internal tibial rotation. In female athletes, the incidence of ACL rupture has been reported to be significantly higher than in their male counterparts. However, to date, there have been limited reports and controversy regarding sex differences underlying injury mechanisms of ACL and severity of injury. In this study, we hypothesized that 1) in patients with non-contact ACL rupture, the incidence and severity of pivot shift injury, which are determined by injury pattern on MRI, would be significantly higher in females, and 2) anatomical factors associated with pivot shift injury would be significantly associated with female sex. A total of 148 primary ACL ruptures (145 patients) caused by non-contact injury mechanisms were included in this study. Among them, 41 knees (41 patients) were female and 107 knees (104 patients) were male. The status of the osseous lesions, lateral and medial tibial slope, depth of the medial tibial plateau, collateral ligaments, and menisci were assessed by MRI and compared between sexes. The severity of osseous lesions at the lateral tibial plateau, lateral femoral condyle, medial tibial plateau, and medial femoral condyle were comparable between sexes. There were no significant differences between sexes in the location of tibial contusions (p = 0.21), femoral contusions (p = 0.23), or meniscus tears (p = 0.189). Lateral tibial slope was found to be significantly larger in females (8.95 degrees vs. 6.82 degrees; p<0.0001; odds ratio = 1.464), and medial tibial depth was significantly shallower in females (1.80mm vs. 2.41mm; p<0.0001; odds ratio = 0.145). In conclusion, females showed greater lateral tibial slope and shallower medial tibial depth compared to males, however it did not affect the sex differences in injury pattern.	[Choi, Won Rak; Jeong, Soo-Young; Lee, Jin Kyu] Hanyang Univ, Dept Orthopaed Surg, Seoul Hosp, Seoul, South Korea; [Yang, Jae-Hyuk] Hanyang Univ, Dept Orthopaed Surg, Guri Hosp, Guri, Gyeonggi Do, South Korea	Hanyang University; Hanyang University	Lee, JK (corresponding author), Hanyang Univ, Dept Orthopaed Surg, Seoul Hosp, Seoul, South Korea.	jklee77@hanyang.ac.kr		Lee, Jin Kyu/0000-0001-8547-4616; Jeong, Soo-Young/0000-0002-4513-0461; Choi, Won Rak/0000-0002-0854-7567; Yang, Jae-Hyuk/0000-0001-8853-1997	Hanyang University [HY2018]	Hanyang University	The study was supported by the research fund of Hanyang University (grant number HY2018).	Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Barber-Westin SD, 1999, AM J SPORT MED, V27, P402, DOI 10.1177/03635465990270040201; Beynnon BD, 2014, AM J SPORT MED, V42, P1806, DOI 10.1177/0363546514540862; Boden BP, 2009, AM J SPORT MED, V37, P252, DOI 10.1177/0363546508328107; Brandon ML, 2006, ARTHROSCOPY, V22, P894, DOI 10.1016/j.arthro.2006.04.098; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008; Chappell JD, 2002, AM J SPORT MED, V30, P261, DOI 10.1177/03635465020300021901; De Smet AA, 2012, AM J ROENTGENOL, V199, P481, DOI 10.2214/AJR.12.8663; DeMorat G, 2004, AM J SPORT MED, V32, P477, DOI 10.1177/0363546503258928; Fayad LM, 2003, SKELETAL RADIOL, V32, P639, DOI 10.1007/s00256-003-0694-1; Ford KR, 2010, MED SCI SPORT EXER, V42, P1923, DOI 10.1249/MSS.0b013e3181dc99b1; Griffin LY, 2006, AM J SPORT MED, V34, P1512, DOI 10.1177/0363546506286866; Hashemi J, 2010, AM J SPORT MED, V38, P54, DOI 10.1177/0363546509349055; Hewett TE, 2009, BRIT J SPORT MED, V43, P417, DOI 10.1136/bjsm.2009.059162; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hohmann E, 2011, KNEE SURG SPORT TR A, V19, pS109, DOI 10.1007/s00167-011-1547-4; Hudek R, 2009, CLIN ORTHOP RELAT R, V467, P2066, DOI 10.1007/s11999-009-0711-3; Ireland ML, 2002, ORTHOP CLIN N AM, V33, P637, DOI 10.1016/S0030-5898(02)00028-7; Kim SY, 2015, AM J SPORT MED, V43, P2515, DOI 10.1177/0363546515594446; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Lipps DB, 2012, AM J SPORT MED, V40, P2731, DOI 10.1177/0363546512461749; NOYES FR, 1989, CLIN ORTHOP RELAT R, P238; Oh YK, 2012, AM J SPORT MED, V40, P574, DOI 10.1177/0363546511432544; Owusu-Akyaw KA, 2018, AM J SPORT MED, V46, P1559, DOI 10.1177/0363546518764681; Prodromos CC, 2007, ARTHROSCOPY, V23, P1174, DOI 10.1016/j.arthro.2007.06.018; Quatman CE, 2009, BRIT J SPORT MED, V43, P328, DOI 10.1136/bjsm.2009.059139; Quatman CE, 2010, SPORTS MED, V40, P729, DOI 10.2165/11534950-000000000-00000; Schneider A, 2018, KNEE SURG SPORT TR A, V26, P1375, DOI 10.1007/s00167-017-4756-7; SCHWEITZER ME, 1995, RADIOLOGY, V194, P825, DOI 10.1148/radiology.194.3.7862987; Shimokochi Y, 2008, J ATHL TRAINING, V43, P396, DOI 10.4085/1062-6050-43.4.396; Stijak L, 2008, KNEE SURG SPORT TR A, V16, P112, DOI 10.1007/s00167-007-0438-1; Wittstein J, 2014, AM J SPORT MED, V42, P1401, DOI 10.1177/0363546514527415; Zazulak BT, 2007, AM J SPORT MED, V35, P1123, DOI 10.1177/0363546507301585	35	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219586	10.1371/journal.pone.0219586	http://dx.doi.org/10.1371/journal.pone.0219586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369583	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900014
J	Mirinaviciute, G; Barlinn, R; Dudman, SG; Flem, E				Mirinaviciute, Grazina; Barlinn, Regine; Dudman, Susanne Gjeruldsen; Flem, Elmira			Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study	PLOS ONE			English	Article							PARVOVIRUS B19 INFECTION; SEROPREVALENCE; POPULATION; ANTIBODIES; MANAGEMENT; CHICKENPOX	Introduction Infection with varicella zoster virus (VZV) in pregnancy may lead to serious outcomes both for the mother and the newborn. Targeted screening and vaccination of non-immune women during reproductive age could prevent varicella infection in pregnancy. Currently, no universal varicella screening of pregnant women is implemented in Norway, but serological testing in pregnancy is recommended in particular situations. We examined seroprevalence of VZV in a national pregnancy cohort in order to help assess a need for VZV screening of women during reproductive age. Methods We determined the susceptibility to VZV and the reliability of self-reported history of VZV infection in the Norwegian obstetric population by using a random sample of 1,184 pregnant women from the Norwegian Mother and Child Cohort study (MoBa). The MoBa study included approximately 95,200 pregnant women in Norway between 1998 and 2009. Blood samples taken at gestational week 17-18 were analysed using a commercial enzyme immunoassay for specific IgG antibodies to Varicella-Zoster virus. Second sample taken at birth was tested if the first sample result was negative or equivocal. Results Of the 1,184 pregnant women, 98.6% (n = 1,167) were seropositive, 0.83% (n = 10) remained seronegative, and four women (0.34%) seroconverted during their pregnancy. No significant associations were found between serological status and women's age at birth, gestational age, women's country of birth and year of child's birth. One woman reported prior history of varicella, whereas 143 (12.1%) women reported a household exposure to childhood diseases with fever and rash, of which 25 reported exposure to varicella, of which all were seropositive. Conclusions The findings support antenatal screening recommendations in Norway advising testing for VZV in pregnant women with unknown immunity to VZV. Further studies are however needed to better identify target groups for screening and vaccination.	[Mirinaviciute, Grazina; Flem, Elmira] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol & Modeling, Infect Control & Environm Hlth, Oslo, Norway; [Barlinn, Regine; Dudman, Susanne Gjeruldsen] Oslo Univ Hosp, Dept Microbiol, Oslo, Norway; [Dudman, Susanne Gjeruldsen] Univ Oslo, Inst Clin Med, Oslo, Norway	Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo	Mirinaviciute, G (corresponding author), Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol & Modeling, Infect Control & Environm Hlth, Oslo, Norway.	grazina.mirinaviciute@gmail.com	Dudman, Susanne/A-8411-2013; Flem, Elmira/AFS-7695-2022; Flem, Elmira/GOG-9451-2022; Dudman, Susanne/ABC-5434-2020	Dudman, Susanne/0000-0001-5047-4982; Flem, Elmira/0000-0002-5099-1960; Flem, Elmira/0000-0002-5099-1960; Dudman, Susanne/0000-0001-5047-4982; Mirinaviciute, Grazina/0000-0002-2512-3328	Norwegian Institute of Public Health; Norwegian Ministry of Health and Care Services; Ministry of Education and Research	Norwegian Institute of Public Health; Norwegian Ministry of Health and Care Services; Ministry of Education and Research	The project was fully funded by the Norwegian Institute of Public Health. It is a national study and no international partners are involved in this study. Material and data for this study was obtained from the Norwegian Mother and Child Cohort Study, which is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We are grateful to all the participating families in Norway who take part in this on-going cohort study.	Alanen A, 2005, BJOG-INT J OBSTET GY, V112, P50, DOI 10.1111/j.1471-0528.2004.00320.x; [Anonymous], IS2712 HLTH TNDO; [Anonymous], VAR ZOST CHICK PREGN; [Anonymous], NORSK MOR BARN UND M; [Anonymous], SCREEN VAR PREGN EXT; [Anonymous], PEDIAT INFECT DIS J; [Anonymous], NAT GUID PREGN CAR P; [Anonymous], 2019, CLASS IMM CAT; [Anonymous], J OSLO CITY HOSP; [Anonymous], VAR VACC EUR UN; [Anonymous], SAMPL SIZ CALC; [Anonymous], EPIDEMIOLOGY INFECT; Barlinn R, 2018, APMIS, V126, P899, DOI 10.1111/apm.12899; Barlinn R, 2017, J CLIN VIROL, V94, P57, DOI 10.1016/j.jcv.2017.07.010; Biskupska M, 2017, GINEKOL POL, V88, P13, DOI 10.5603/GP.a2017.0003; Bjerke SEY, 2011, SCAND J PUBLIC HEALT, V39, P464, DOI 10.1177/1403494811399653; de Moira AP, 2006, VACCINE, V24, P1298, DOI 10.1016/j.vaccine.2005.09.028; HARRIS RE, 1965, OBSTET GYNECOL, V25, P734; Khandaker G, 2011, ARCH DIS CHILD, V96, P453, DOI 10.1136/adc.2010.206037; Knowles S J, 2004, Commun Dis Public Health, V7, P344; LAFORET EG, 1947, NEW ENGL J MED, V236, P534, DOI 10.1056/NEJM194704102361504; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x; Leuridan E, 2011, VACCINE, V29, P2222, DOI 10.1016/j.vaccine.2010.06.004; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; Mandelbrot L, 2012, PRENATAL DIAG, V32, P511, DOI 10.1002/pd.3843; Marin M, 2007, CTR DIS CONTROL, V56, P1; McKendrick MW, 2007, J INFECTION, V55, P64, DOI 10.1016/j.jinf.2007.02.003; Mustonen K, 2001, J Perinatol, V21, P141, DOI 10.1038/sj.jp.7200508; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Paltiel L., 2014, Norsk Epidemiologi, V24, P29; Passi A, 2017, VACCINE, V35, P570, DOI 10.1016/j.vaccine.2016.12.014; Pembrey L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081881; PREBLUD SR, 1985, PEDIATR INFECT DIS J, V4, P503, DOI 10.1097/00006454-198509000-00013; Puhakka L, 2016, INFECT DIS-NOR, V48, P406, DOI 10.3109/23744235.2015.1123290; Rimseliene G, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1581-4; Saadatian-Elahi M, 2007, EUR J EPIDEMIOL, V22, P405, DOI 10.1007/s10654-007-9136-z; Sauerbrei A, 2001, J Perinatol, V21, P545, DOI 10.1038/sj.jp.7210599; SAVAGE MO, 1973, LANCET, V1, P352; Shrim A, 2012, J OBSTET GYNAECOL CA, V34, P287, DOI 10.1016/S1701-2163(16)35190-8; Statistics Norway, 2021, POP STAT; Vilibic-Cavlek T, 2012, ARCH GYNECOL OBSTET, V286, P901, DOI 10.1007/s00404-012-2398-z	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221084	10.1371/journal.pone.0221084	http://dx.doi.org/10.1371/journal.pone.0221084			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408478	Green Published, Green Submitted, gold			2022-12-27	WOS:000485009500036
J	Sui, J; Luan, S; Yang, GL; Xia, ZL; Luo, K; Tang, QY; Lu, X; Meng, XH; Kong, J				Sui, Juan; Luan, Sheng; Yang, Guoliang; Xia, Zhenglong; Luo, Kun; Tang, Qiongying; Lu, Xia; Meng, Xianhong; Kong, Jie			Genetic parameters and selection response for the harvest body weight of the giant freshwater prawn (Macrobrachium rosenbergii) in a breeding program in China	PLOS ONE			English	Article							OPTIMUM CONTRIBUTION SELECTION; LINEAR UNBIASED PREDICTION; MORPHOTYPIC DIFFERENTIATION; SIBSHIP INFERENCE; GROWTH TRAITS; DE-MAN; PARENTAGE; HERITABILITY; POPULATIONS; FISH	A multi-trait selective breeding program of Macrobrachium rosenbergii was initiated in China in 2015. In this program, the M. rosenbergii resources were widely collected from four countries, the origin of the founders was verified with 16 microsatellites and the pedigree was reconstructed, and the optimum contribution selection was used to make the mating design. In this study, we evaluated the genetic parameters and selection response for the harvest body weight (HBW) of M. rosenbergii after being communally reared for 95-109 days. The data were collected from two generations that comprised 25,212 progenies from 150 sires and 198 dams. The residual maximum-likelihood methodology was employed to evaluate the variance components, by fitting an animal model. The accuracy of estimated breeding values increased by 0.38% after pedigree reconstruction using microsatellite markers. The estimated heritability (h(2)) for HBW was moderate (0.212 +/- 0.049) and the common environmental coefficient (c(2)) was low (0.063 +/- 0.017) when all the data were used for the analysis. Within generations, h(2) was moderate to high (0.198 +/- 0.080 to 0.338 +/- 0.049). c(2) could only be estimated in G(1), which was 0.055 +/- 0.030. The average HBW of males was significantly larger than that of females (P < 0.01). h(2) estimated for female HBWs were higher than that for males within generations, while h(2) estimated for female HBWs were lower than that for males across generations. But they were not significantly different (P > 0.05). The genetic correlations between sexes were moderate to high within each generation (0.529 to 0.763). Two methods were used to estimate the realized response. One method was calculated from the differences between the least squares means of the selected population HBW and that of control population HBW, which was 14.01%. The other method was calculated from the differences between the EBVs of the selected population HBW and that of control population HBW, which was 11.52%. The predicted responses derived from two sets of genetic parameters acquired from within- and across-generation datasets were 11.68% and 10.67%, respectively. The present study provides valuable information for breeding programs of M. rosenbergii.	[Sui, Juan; Luan, Sheng; Luo, Kun; Lu, Xia; Meng, Xianhong; Kong, Jie] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Shandong, Peoples R China; [Sui, Juan; Luan, Sheng; Luo, Kun; Lu, Xia; Meng, Xianhong; Kong, Jie] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Shandong, Peoples R China; [Yang, Guoliang; Tang, Qiongying] Huzhou Univ, Huzhou, Peoples R China; [Xia, Zhenglong] Jiangsu Shufeng Prawn Breeding Co LTD, Gaoyou, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology; Huzhou University	Kong, J (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Qingdao, Shandong, Peoples R China.; Kong, J (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Shandong, Peoples R China.	kongjie@ysfri.ac.cn			China Agriculture Research System [CARS-48]; Projects of International Exchange and Cooperation in Agriculture, Ministry of Agriculture and Rural Affairs of China-Science; Technology and Innovation Cooperation in Aquaculture with Tropical Countries; Taishan scholar program for seed industry; Special funds for major science and technology of breeding new agriculture (aquatic) varieties in Zhejiang province [2016C02055-2-1]	China Agriculture Research System; Projects of International Exchange and Cooperation in Agriculture, Ministry of Agriculture and Rural Affairs of China-Science; Technology and Innovation Cooperation in Aquaculture with Tropical Countries; Taishan scholar program for seed industry; Special funds for major science and technology of breeding new agriculture (aquatic) varieties in Zhejiang province	This study was supported by China Agriculture Research System (CARS-48); Projects of International Exchange and Cooperation in Agriculture, Ministry of Agriculture and Rural Affairs of China-Science; Technology and Innovation Cooperation in Aquaculture with Tropical Countries; The Taishan scholar program for seed industry; Special funds for major science and technology of breeding new agriculture (aquatic) varieties in Zhejiang province (2016C02055-2-1). The funder provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial company: Jiangsu Shufeng Prawn Breeding Co. LTD did not provided financial support but did play a role in this study. The specific roles of all the authors are articulated in the ` author contributions' section.	Avendano S, 2004, GENET RES, V83, P55, DOI 10.1017/S0016672303006566; Avendano S, 2003, J ANIM SCI, V81, P2964; Bijma P, 1999, GENETICS, V151, P1197; Charoentawee K, 2006, MOL ECOL NOTES, V6, P823, DOI 10.1111/j.1471-8286.2006.01358.x; Dai XL, BIOTECHNOLOGY B, V32, P192; Hung D, 2013, AQUACULTURE, V412, P70, DOI 10.1016/j.aquaculture.2013.07.015; Hung D, 2013, AQUACULTURE, V404, P122, DOI 10.1016/j.aquaculture.2013.04.027; Gheyas AA, 2009, AQUACULTURE, V294, P187, DOI 10.1016/j.aquaculture.2009.06.013; Gilmour A. R., 2015, ASREML USER GUIDE RE; Gitterle T, 2005, AQUACULTURE, V243, P83, DOI 10.1016/j.aquaculture.2004.10.015; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Gjedrem T, 2012, AQUACULTURE, V344, P12, DOI 10.1016/j.aquaculture.2012.03.003; Gopal C, 2010, AQUACULTURE, V300, P237, DOI 10.1016/j.aquaculture.2010.01.007; Grundy B, 1998, GENET RES, V72, P159, DOI 10.1017/S0016672398003474; HANSFORD SW, 1994, AQUACULTURE, V125, P147, DOI 10.1016/0044-8486(94)90291-7; Howard DM, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0392-z; HULATA G, 1990, Journal of the World Aquaculture Society, V21, P295, DOI 10.1111/j.1749-7345.1990.tb00542.x; Dinh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090142; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karplus I, 2005, AQUAC RES, V36, P238, DOI 10.1111/j.1365-2109.2005.01239.x; Kause A, 2005, AQUACULTURE, V247, P177, DOI 10.1016/j.aquaculture.2005.02.023; Kearney JF, 2004, J DAIRY SCI, V87, P3503, DOI 10.3168/jds.S0022-0302(04)73485-2; Kinghorn BP., 2000, ANIMAL BREEDING USE, P291; Kitcharoen N, 2012, AQUAC RES, V43, P19, DOI 10.1111/j.1365-2109.2011.02796.x; KURIS AM, 1987, J CRUSTACEAN BIOL, V7, P219, DOI 10.2307/1548603; Luan S, 2012, AQUACULTURE, V362, P88, DOI 10.1016/j.aquaculture.2012.05.011; Meuwissen THE, 1997, J ANIM SCI, V75, P934; Mohanty P, 2013, CONSERV GENET RESOUR, V5, P133, DOI 10.1007/s12686-012-9751-1; New M.B., 2010, FRESHWATER PRAWNS BI, Vfirst; Nguyen NH, 2007, AQUACULTURE, V272, pS38, DOI 10.1016/j.aquaculture.2007.08.013; Nguyen TTT, 2011, J ANIM BREED GENET, V128, P482, DOI 10.1111/j.1439-0388.2011.00948.x; Nielsen HM, 2011, J ANIM SCI, V89, P630, DOI 10.2527/jas.2009-2731; Pillai BR, 2017, AQUAC RES, V48, P5741, DOI 10.1111/are.13397; Pillai BR, 2015, AQUAC RES, V46, P2644, DOI 10.1111/are.12419; Ponzoni RW, 2005, AQUACULTURE, V247, P203, DOI 10.1016/j.aquaculture.2005.02.020; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SAGI A, 1988, J CRUSTACEAN BIOL, V8, P43, DOI 10.2307/1548428; Sambrook J., 2001, MOL CLONING LAB MANU; Skaarud A, 2011, AQUACULTURE, V311, P110, DOI 10.1016/j.aquaculture.2010.11.023; Sonesson AK, 2005, GENET SEL EVOL, V37, P587, DOI 10.1051/gse:2005020; Sonesson AK, 2005, AQUACULTURE, V243, P61, DOI 10.1016/j.aquaculture.2004.09.024; Sorensen AC, 2005, GENET SEL EVOL, V37, P57, DOI 10.1051/gse:2004036; Sorensen MK, 2008, LIVEST SCI, V118, P212, DOI 10.1016/j.livsci.2008.01.027; Sui J, 2016, AQUACULTURE, V452, P134, DOI 10.1016/j.aquaculture.2015.08.011; Thanh NM, 2010, AQUACULTURE, V299, P30, DOI 10.1016/j.aquaculture.2009.12.011; Vandeputte M, 2004, AQUACULTURE, V235, P223, DOI 10.1016/j.aquaculture.2003.12.019; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Woolliams JA, 2015, J ANIM BREED GENET, V132, P89, DOI 10.1111/jbg.12148; Woolliams JA, 1999, GENETICS, V153, P1009; Zhong DD, 2015, AGR SCI GUANGDONG, V5, P140	52	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0218379	10.1371/journal.pone.0218379	http://dx.doi.org/10.1371/journal.pone.0218379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404067	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800005
J	Saha, UR; Chattapadhayay, A; Richardus, JH				Saha, Unnati Rani; Chattapadhayay, Aparajita; Richardus, Jan Hendrik			Trends, prevalence and determinants of childhood chronic undernutrition in regional divisions of Bangladesh: Evidence from demographic health surveys, 2011 and 2014	PLOS ONE			English	Article							FERTILITY DECLINE; CHILDREN; MALNUTRITION; NUTRITION; WOMEN; URBAN	Background Undernutrition, an important indicator for monitoring progress of development goals, is a matter of concern in many developing countries, including Bangladesh. Despite regional differences in chronic undernutrition in Bangladesh, regional determinants among children under the age of five were not extensively explored. Data and methods Using combined repeated cross-sectional nationwide Bangladesh Demographic and Health Surveys (BDHS 2011 and 2014) and employing bivariate and logistic regression analyses, we estimated prevalence, changes and variations in regional determinants of stunting among children aged 6-59 months over two time periods 2011 and 2014. Results Our benchmark results suggested that the children from Rajshahi, Khulna, Rangpur, Chittagong and Dhaka tend to be significantly less stunted by 51% (p = 0.000; CI = [0.38, 0.63]), 44% (p = 0.000; CI = [0.44, 0.71]), 26% (p = 0.012; CI = [0.58, 0.93]), 23% (p = 0.012; CI = [0.62, 0.95]) and 22% (p = 0.033; [0.63, 0.97]) respectively, against Sylhet in 2011. With the exception of Dhaka, no region showed significant differences in the odds of stunting over two time periods 2011 and 2014, i. e. only Dhaka revealed significant difference by 30% reductions in the odds of stunting in 2014. Also, rural children were less likely to be stunted (by 19%) of the urban counterparts. Regional covariates of stunting differ. However, children's age, household wealth, mother's height, and parental education were important determinants of stunting in Bangladesh. Conclusion Dhaka made an impressive improvement in child nutrition, thus contributed largely to the reduction of stunting levels in Bangladesh for 2014 over 2011. Sylhet and Barisal require strong push to improve nutritional status of children. Further decline is possible through region-specific multipronged interventions that can address area-specific covariates to break the cycle of undernutrition like strengthening economic and educational status, emphasizing the role of father to augment their knowledge in varying aspects like family planning, reduction of fertility and by improving mother's health.	[Saha, Unnati Rani; Richardus, Jan Hendrik] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Chattapadhayay, Aparajita] IIPS, Mumbai, Maharashtra, India	Erasmus University Rotterdam; Erasmus MC; International Institute for Population Sciences	Saha, UR (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands.	u.saha@erasmusmc.nl	Richardus, Jan Hendrik/AAE-1278-2021	Richardus, Jan Hendrik/0000-0003-0564-6313; Saha, Unnati Rani/0000-0002-4019-9697				Ahmed T, 2012, J HEALTH POPUL NUTR, V30, P1; Amin S, 2002, POPUL RES POLICY REV, V21, P275, DOI 10.1023/A:1020030616075; Basu AM, 2000, POPUL DEV REV, V26, P761, DOI 10.1111/j.1728-4457.2000.00761.x; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Chattopadhyay A., 2005, DEMOGRAPHY INDIA, V34, P299; Chattopadhyay A, 2007, J BIOSOC SCI, V39, P267, DOI 10.1017/S002193200600126X; Das S., 2009, Asia-Pacific Population Journal, V24, P51; FANTA, SCAL NUTR INT BANGL; Government of India Ministry of Health and Family Welfare, 2017, NATL FAMILY HLTH SUR; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Hanchett S., 2016, CLTS KNOWLEDGE HUB L; Hasan MM, 2018, INDIAN J PUBLIC HLTH, V62, P82, DOI 10.4103/ijph.IJPH_153_17; Hasan MT, 2015, PUBLIC HEALTH NUTR, V18, P1728, DOI 10.1017/S1368980014003279; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; Hong Rathavuth, 2006, Int J Equity Health, V5, P15, DOI 10.1186/1475-9276-5-15; Kent JL, 2014, J PLAN LIT, V29, P239, DOI 10.1177/0885412214520712; Ministry of Planning, 2007, STAT POCK BOOK BANGL; National Encyclopedia of Bangladesh, BANGL SOIL; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Nisbett N, 2017, GLOB FOOD SECUR-AGR, V13, P21, DOI 10.1016/j.gfs.2017.01.005; Quddus MA, 2004, J AGR ECON, V2, P57; Rahman AM, 2018, J HLTH RES, V5; Rahman A, 2009, ASIA-PAC J PUBLIC HE, V21, P294, DOI 10.1177/1010539509335399; Rahman MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157814; Rajia S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211875; Saha KK, 2009, PUBLIC HEALTH NUTR, V12, P1556, DOI 10.1017/S1368980009004765; Shetty P, 2003, WHO TECHN REP SER, V916; Siddhanta A., 2017, ROLE WOMENS EMPOWERM, V3, P38; Smith LC, 2005, WORLD DEV, V33, P1285, DOI 10.1016/j.worlddev.2005.03.002; Srinivasan CS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-581; Tanwi TS, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0725-2; UN, 2015, 2030 AG SUST DEV; Unicef and World Health Organization, 2015, PROGR SAN DRINK WAT; United Nations, 2001, SECR GEN REP GEN ASS; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; World Health Organization, 2016, CHILDR RED MORT; Zahangir MS, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.2	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220062	10.1371/journal.pone.0220062	http://dx.doi.org/10.1371/journal.pone.0220062			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398208	gold, Green Published, Green Submitted			2022-12-27	WOS:000485004000009
J	Tang, YK; Wu, YS; Liu, K; Li, JL; Li, HX; Wang, Q; Yu, JH; Xu, P				Tang, Yongkai; Wu, Yunsheng; Liu, Kai; Li, Jianlin; Li, Hongxia; Wang, Qin; Yu, Juhua; Xu, Pao			Investigating the distribution of the Yangtze finless porpoise in the Yangtze River using environmental DNA	PLOS ONE			English	Article							BIODIVERSITY; EDNA	Determining the distribution of the Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis, YFP) in the Yangtze River has to date relied on traditional visual and counting methods, but such field surveys are time-consuming and expensive. Analyses using environmental DNA (eDNA) to investigate the presence and range of endangered aquatic species have proven to be more economical and effective detection methods, and are a non-invasive approach to sampling. A challenge of relying on eDNA for YFP monitoring is that the Yangtze River is characterized by high turbidity and a strong current. Here, we used an eDNA-based approach to estimate the presence of YFP at 18 sites in the Yangtze River in August 2017 and at an additional 11 sites in January 2018. At each sampling site, we filtered six 1 L water samples with 5 pm pore size filter paper and quantified the amount of YFP eDNA in each water sample using quantitative real-time polymerase chain reaction (qPCR). In addition, YFP eDNA was successfully detected in locations where we visually observed YFP, as well as in locations where YFP were not observed directly. We found that our eDNA-based method had higher detection rates than traditional field survey methods. Although YFP was visually observed in the Yangtze River in winter, water samples collected during the summer contained significantly higher YFP eDNA than winter water samples. Our results demonstrate the potential effectiveness of eDNA detection methods in determining the distribution of YFP in the Yangtze River.	[Tang, Yongkai; Liu, Kai; Li, Jianlin; Li, Hongxia; Yu, Juhua; Xu, Pao] Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China; [Tang, Yongkai; Wu, Yunsheng; Liu, Kai; Wang, Qin; Yu, Juhua; Xu, Pao] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China	Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Yu, JH; Xu, P (corresponding author), Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China.; Yu, JH; Xu, P (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Jiangsu, Peoples R China.	yujh@ffrc.cn; xup@ffrc.cn		tang, yongkai/0000-0002-5643-2844	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of fishery Science [2017HY-XKQ0201]; Project on rehabilitation of fishery resources in the Xiangjiaba reservoir and protection of rare and endemic species of the Yangtze River (F02 Yangtze finless porpoises migration and domestication in Xijiang reserve); Jiangsu Province Yangtze finless porpoises Breeding project [2016-36]	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of fishery Science; Project on rehabilitation of fishery resources in the Xiangjiaba reservoir and protection of rare and endemic species of the Yangtze River (F02 Yangtze finless porpoises migration and domestication in Xijiang reserve); Jiangsu Province Yangtze finless porpoises Breeding project	Funding for this study was provided by the Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of fishery Science (2017HY-XKQ0201), Project on rehabilitation of fishery resources in the Xiangjiaba reservoir and protection of rare and endemic species of the Yangtze River (F02 Yangtze finless porpoises migration and domestication in Xijiang reserve), Jiangsu Province Yangtze finless porpoises Breeding project (2016-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Dai L.L., 2011, J HYDROECOL, V32, P30, DOI [10.15928/j.1674-3075.2011.05.001, DOI 10.15928/J.1674-3075.2011.05.001]; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Ding W., 2019, CHINESE SCI BULL, V54, P3473; Doi H, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170568; Dong LJ, 2015, MAR MAMMAL SCI, V31, P612, DOI 10.1111/mms.12181; Geerts AN, 2018, ECOL INDIC, V84, P564, DOI 10.1016/j.ecolind.2017.08.068; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; LI MZ, 2017, SCI FISH FARM, V8, P19621, DOI DOI 10.3389/FPHAR.2017.00142; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Minamoto T, 2016, LIMNOLOGY, V17, P23, DOI 10.1007/s10201-015-0457-4; Parajuli N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048590; Shaw JLA, 2016, BIOL CONSERV, V197, P131, DOI 10.1016/j.biocon.2016.03.010; Stewart K, 2017, CONSERV BIOL, V183, P410; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Williams KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179282; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Yamanaka H, 2016, ECOL INDIC, V62, P147, DOI 10.1016/j.ecolind.2015.11.022	24	3	4	9	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221120	10.1371/journal.pone.0221120	http://dx.doi.org/10.1371/journal.pone.0221120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398225	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000046
J	Kim, KJ; Kim, KH; Kim, WH; Sohn, DW				Kim, Kyung-Jin; Kim, Kyung-Hwan; Kim, Woong-Han; Sohn, Dae-Won			Postoperative persistent diastolic dyssynchronous expansion in patients with Ebstein's anomaly	PLOS ONE			English	Article							TRICUSPID-VALVE; TASK-FORCE; ECHOCARDIOGRAPHY; COMMITTEE; FEATURES; FETUS	In Ebstein's anomaly, maximal expansion in the atrialized right ventricle (RV) occurs during early diastole, whereas that of the functional RV occurs in late diastole, resulting in diastolic dyssynchronous expansion (DSE). We quantitatively assessed DSE and identified preoperative factors correlated with persistent DSE after surgery. Seventeen patients diagnosed with Ebstein's anomaly in whom transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR) images available were retrospectively analyzed for quantitative DSE assessment and 10 patients who underwent surgery and postoperative TTE available were additionally analyzed for postoperative DSE. Severity of DSE was assessed by the time difference of maximal expansion between the atrialized and functional RV divided by the cardiac cycle length x 100 ("DSE index"). Relations between DSE and, clinical, electrophysiologic parameters and the severity of tricuspid valve (TV) tethering (the RV length / tethering height during diastole: "Tethering index") were assessed. In total patients, median DSE index and tethering index were 30.3 and 2.1 respectively, and the DSE index was correlated with tethering index (r(s) = 0.664, P = 0.004). In 10 patients who underwent surgery, this association remained after surgery and at 2-year follow up. Tethering index >= 2.5 separated patients with and without persistent DSE. In conclusion, DSE exists in Ebstein's anomaly. DSE index is related to the tethering index and DSE persists postoperatively if tethering index >= 2.5. As the persistent DSE might possibly impede the optimal recovery of RV function after surgery, severity of TV tethering should take into account in considering surgery.	[Kim, Kyung-Jin] Ewha Womans Univ, Med Ctr, Sch Med, Dept Internal Med,Div Cardiol, Seoul, South Korea; [Kim, Kyung-Hwan; Kim, Woong-Han] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Sohn, Dae-Won] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Cardiovasc Ctr,Dept Internal Med, Seoul, South Korea	Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Sohn, DW (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Cardiovasc Ctr,Dept Internal Med, Seoul, South Korea.	dwsohn@snu.ac.kr		Sohn, Dae-Won/0000-0002-1092-3285; Kim, Kyung-Hwan Kim/0000-0002-2718-8758				Attie F, 2000, MEDICINE, V79, P27, DOI 10.1097/00005792-200001000-00003; Badiu CC, 2010, EUR J CARDIO-THORAC, V37, P186, DOI 10.1016/j.ejcts.2009.06.052; BENSON LN, 1987, CIRCULATION, V75, P353, DOI 10.1161/01.CIR.75.2.353; CARPENTIER A, 1988, J THORAC CARDIOV SUR, V96, P92; CELERMAJER DS, 1992, J AM COLL CARDIOL, V19, P1041, DOI 10.1016/0735-1097(92)90291-T; CELERMAJER DS, 1994, J AM COLL CARDIOL, V23, P170, DOI 10.1016/0735-1097(94)90516-9; Cheitlin MD, 1997, CIRCULATION, V95, P1686; Daliento L, 1997, AM J CARDIOL, V80, P1051, DOI 10.1016/S0002-9149(97)00602-4; Dearani JA, 2015, EXPERT REV CARDIOVAS, V13, P1101, DOI 10.1586/14779072.2015.1087849; Ebstein W., 1866, UEBER SEHR SELTENEN; Fabian C E, 1966, Invest Radiol, V1, P63, DOI 10.1097/00004424-196601000-00030; Fratz S, 2013, INT J CARDIOL, V167, P258, DOI 10.1016/j.ijcard.2011.12.081; Frescura C, 2000, THORAC CARDIOV SURG, V48, P203, DOI 10.1055/s-2000-6893; Hosch O, 2014, CIRC-CARDIOVASC IMAG, V7, P601, DOI 10.1161/CIRCIMAGING.113.001467; Jost CHA, 2007, CIRCULATION, V115, P277, DOI 10.1161/CIRCULATIONAHA.106.619338; Park JB, 2016, RADIOLOGY, V280, P723, DOI 10.1148/radiol.2016151556; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; ROBERSON DA, 1989, J AM COLL CARDIOL, V14, P1300, DOI 10.1016/0735-1097(89)90432-4; SHIINA A, 1983, CIRCULATION, V68, P534, DOI 10.1161/01.CIR.68.3.534; Silva José Pedro da, 2004, Arq. Bras. Cardiol., V82, P212, DOI 10.1590/S0066-782X2004000300002; Tobler D, 2013, INT J CARDIOL, V165, P146, DOI 10.1016/j.ijcard.2011.08.004; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; WATSON H, 1974, BRIT HEART J, V36, P417; Yalonetsky S, 2011, AM J CARDIOL, V107, P767, DOI 10.1016/j.amjcard.2010.10.058; YIM BJB, 1958, CIRCULATION, V17, P543, DOI 10.1161/01.CIR.17.4.543	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220890	10.1371/journal.pone.0220890	http://dx.doi.org/10.1371/journal.pone.0220890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393951	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500079
J	Pons, E; Garcia-Calvo, T; Resta, R; Blanco, H; del Campo, RL; Garcia, JD; Pulido, JJ				Pons, Eduard; Garcia-Calvo, Tomas; Resta, Ricardo; Blanco, Hugo; Lopez del Campo, Roberto; Diaz Garcia, Jesus; Jose Pulido, Juan			A comparison of a GPS device and a multi-camera video technology during official soccer matches: Agreement between systems	PLOS ONE			English	Article							TRACKING-SYSTEMS; PERFORMANCE; POSITION; DISTANCE; LOAD	The aim of this study was to compare the agreement of the movement demands data during a soccer match (total distance, distance per minute, average speed, maximum speed and distance covered in different speed sectors) between an optical tracking system (Media-coach System) and a GPS device (Wimu Pro). Participants were twenty-six male professional soccer players (age: 21.65 +/- 2.03 years; height: 180.00 +/- 7.47 cm; weight: 73.81 +/- 5.65 kg) from FC Barcelona B, of whom were recorded a total of 759 measurements during 38 official matches in the Spanish second division. The Mediacoach System and the Wimu Pro were compared using the standardized mean bias, standard error of estimate, intraclass correlation coefficients (ICC), coefficient of variation (%), and the regression equation to estimate data for each variable. In terms of agreement between systems, the magnitude of the ICC was almost perfect (>0.90-1.00) for all variables analyzed. The coefficient of the variations between devices was close to zero (<5%) for total distance, distance per minute, average speed, maximum speed, and walking and jogging, and between 9% and 15% for running, intense running, and sprinting at low and at high intensities. It can be observed that, compared to Wimu Pro the Mediacoach System slightly overestimated all the variables analyzed except for average speed, maximum speed, and walking variables. In conclusion, both systems can be used, and the information they provide in the analyzed variables can be interchanged, with the benefits implied for practitioners and researchers.	[Pons, Eduard] FC Barcelona, Sports Performance Area, Barcelona, Spain; [Garcia-Calvo, Tomas; Diaz Garcia, Jesus; Jose Pulido, Juan] Univ Extremadura, Fac Sport Sci, Dept Didact Musical Plast & Body Express, Caceres, Spain; [Resta, Ricardo; Blanco, Hugo; Lopez del Campo, Roberto] Sports Res Area LaLiga, Madrid, Spain; [Jose Pulido, Juan] Univ Lisbon, Fac Human Kinet, Lisbon, Portugal	Universidad de Extremadura; Universidade de Lisboa	Garcia-Calvo, T (corresponding author), Univ Extremadura, Fac Sport Sci, Dept Didact Musical Plast & Body Express, Caceres, Spain.	tgarciac@unex.es	PONS, EDUARD/AAH-2147-2020; García-Calvo, Tomás/K-8501-2014; García-Calvo, Tomas/AAN-6825-2021; Pulido, Juan/AAX-2599-2020; Pulido, Juan José/L-1596-2014	García-Calvo, Tomás/0000-0002-2550-418X; García-Calvo, Tomas/0000-0002-2550-418X; Pulido, Juan José/0000-0003-2416-4141	European Social Foundation; Government of Extremadura [PO17012]	European Social Foundation; Government of Extremadura	This research was funded by the European Social Foundation and the Government of Extremadura - "PO17012" to TGC. Author EP is employed by FC Barcelona. FC Barcelona provided support in the form of salary for author EP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. RR, HB and RLdC are employed by LaLiga. LaLiga provided support in the form of salaries for authors RR, HB and RLdC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2015, FIFA IFAB DEV GLOBAL; Barrett S, 2017, INT J SPORT PHYSIOL, V12, P1285, DOI 10.1123/ijspp.2016-0516; Bartlett R, 2012, INT J PERF ANAL SPOR, V12, P398, DOI 10.1080/24748668.2012.11868607; Castillo AB, 2018, EUR J SPORT SCI, V18, P450, DOI 10.1080/17461391.2018.1427796; Castillo AB, 2017, INT J PERF ANAL SPOR, V17, P600, DOI 10.1080/24748668.2017.1374633; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bradley Paul, 2007, INT J PERF ANAL SPOR, V7, P117, DOI DOI 10.1080/24748668.2007.11868415; Buchheit M, 2017, INT J SPORT PHYSIOL, V12, P35, DOI 10.1123/ijspp.2016-0499; Buchheit M, 2014, J SPORT SCI, V32, P1271, DOI 10.1080/02640414.2014.884721; Carling C, 2013, SPORTS MED, V43, P655, DOI 10.1007/s40279-013-0055-8; Castagna C, 2017, INT J SPORT PHYSIOL, V12, P490, DOI 10.1123/ijspp.2016-0160; Castellano J, 2015, INT J PERF ANAL SPOR, V15, P135, DOI 10.1080/24748668.2015.11868782; Castellano J, 2014, SPORTS MED, V44, P701, DOI 10.1007/s40279-014-0144-3; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cust EE, 2019, J SPORT SCI, V37, P568, DOI 10.1080/02640414.2018.1521769; Edgecomb SJ, 2006, J SCI MED SPORT, V9, P25, DOI 10.1016/j.jsams.2006.01.003; Folgado H., 2018, J SPORT SCI, V14, P1; Folgado H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097145; Harley JA, 2011, J STRENGTH COND RES, V25, P2334, DOI 10.1519/JSC.0b013e3181f0a88f; Hennessy L, 2018, STRENGTH COND J, V40, P83, DOI 10.1519/SSC.0000000000000386; Hopkins WG., 2015, SPORTSCIENCE, V19, P36; Imai T, 2019, LECT NOTES DATA ENG, P22; Linke D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199519; Malone JJ, 2017, INT J SPORT PHYSIOL, V12, P18, DOI 10.1123/ijspp.2016-0236; McLaren SJ, 2018, SPORTS MED, V48, P641, DOI 10.1007/s40279-017-0830-z; Memmert D, 2017, SPORTS MED, V47, P1, DOI 10.1007/s40279-016-0562-5; Vieira LHP, 2019, J STRENGTH COND RES, V33, P2202, DOI 10.1519/JSC.0000000000002577; Polglaze T, 2016, SPORTS MED, V46, P657, DOI 10.1007/s40279-015-0449-x; Rago V, 2019, SPORTS, V7, DOI 10.3390/sports7030068; Randers MB, 2010, J SPORT SCI, V28, P171, DOI 10.1080/02640410903428525; Rawstorn JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093693; Ryan M, 2018, J STRENGTH COND RES, V32, P812, DOI 10.1519/JSC.0000000000001818; Sampaio J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132894; Sanders GJ, 2017, J STRENGTH COND RES, V31, P2728, DOI 10.1519/JSC.0000000000002105; Sarmento H, 2018, SPORTS MED, V48, P799, DOI 10.1007/s40279-017-0836-6; Sweeting A, 2017, FRONT PHYSIOL, P8; Wellman AD, 2016, J STRENGTH COND RES, V30, P11, DOI 10.1519/JSC.0000000000001206	39	52	52	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220729	10.1371/journal.pone.0220729	http://dx.doi.org/10.1371/journal.pone.0220729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393932	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500056
J	Richter, J; Tryfonos, C; Christodoulou, C				Richter, Jan; Tryfonos, Christina; Christodoulou, Christina			Molecular epidemiology of enteroviruses in Cyprus 2008-2017	PLOS ONE			English	Article							NON-POLIO ENTEROVIRUSES; MOUTH-DISEASE; ECHOVIRUS 30; COXSACKIEVIRUS A6; VIRAL MENINGITIS; HAND; FOOT; OUTBREAK; INFECTIONS; SURVEILLANCE	Enteroviruses (EVs) are associated with a broad spectrum of disease manifestations, including aseptic meningitis, encephalitis, hand, foot and mouth disease, acute flaccid paralysis and acute flaccid myelitis with outbreaks being reported frequently world-wide. The aim of this study was the molecular characterization of all enteroviruses detected in Cyprus in the ten-year period from January 2008 and December 2017 as well as a description of the circulation patterns associated with the most frequently encountered genotypes. For this purpose, serum, cerebrospinal fluid, nasal swab, skin swab and/or stool samples from 2666 patients with a suspected EV infection were analysed between January 2008 and December 2017. Enteroviruses were detected in 295 (11.1%) patients, which were then investigated further for epidemiological analysis by VP1 genotyping. Overall, 24 different enterovirus types belonging to three different species were identified. The predominant species was EV-B (209/295, 71%), followed by species EV-A (77/295, 26.1%). Only one virus belonged to species EV-D, whereas EV-C enteroviruses were not identified at all. The most frequent genotypes identified were echovirus 30 (26.1%), echovirus 6 (14.2%) and coxsackievirus A6 (10.9%). While Echovirus 30 and echovirus 6 frequency was significantly higher in patients older than 3 years of age, the opposite was observed for CV-A16 and EV-A71, which dominated in young children less than 3 years. Importantly, for the current study period a significant increase of previously only sporadically observed EV-A types, such as EV-A71 and CV-A16 was noted. A phylogenetic analysis of EV-A71 showed that the majority of the EV-A71 strains from Cyprus belonged to sub-genogroup C1 and C2, with the exception of one C4 strain that was observed in 2011. The data presented provide a comprehensive picture of enteroviruses circulating in Cyprus over the last decade and will be helpful to clinicians and researchers involved in the treatment, prevention and control of enteroviral infections by helping interpret trends in enteroviral diseases by associating them with circulating serotypes, for studying the association of enteroviruses with clinical manifestations and develop strategies for designing future EV vaccines.	[Richter, Jan; Tryfonos, Christina; Christodoulou, Christina] Cyprus Inst Neurol & Genet, Dept Mol Virol, Nicosia, Cyprus		Richter, J (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Virol, Nicosia, Cyprus.	richter@cing.ac.cy						Abedi GR, 2015, MMWR-MORBID MORTAL W, V64, P940, DOI 10.15585/mmwr.mm6434a3; Akhmadishina LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097404; Bailly JL, 2011, INFECT GENET EVOL, V11, P276, DOI 10.1016/j.meegid.2010.06.019; Bailly JL, 2009, INFECT GENET EVOL, V9, P699, DOI 10.1016/j.meegid.2008.04.009; Benschop KS, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.39.30351; Bian LL, 2015, EXPERT REV ANTI-INFE, V13, P1061, DOI 10.1586/14787210.2015.1058156; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Broberg EK, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.44.1800537; Cabrerizo M, 2014, CLIN MICROBIOL INFEC, V20, pO150, DOI 10.1111/1469-0691.12361; Cabrerizo M, 2014, J MED VIROL, V86, P857, DOI 10.1002/jmv.23741; Christian Kira A, 2013, Emerg Health Threats J, V6, P20632, DOI 10.3402/ehtj.v6i0.20632; Cordey S, 2017, J CLIN VIROL, V89, P22, DOI 10.1016/j.jcv.2017.01.008; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Fischer TK, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.38.20911; Gonzalez-Sanz R, 2016, EUROSURVEILLANCE, V24, DOI [10.2807/1560-7917.ES.2019.24.7, DOI 10.2807/1560-7917.ES.2019.24.7]; Guerra JA, 2017, J MED VIROL, V89, P1550, DOI 10.1002/jmv.24765; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Henquell C, 2013, J VIROL, V87, P12249, DOI 10.1128/JVI.02075-13; Holm-Hansen CC, 2016, LANCET INFECT DIS, V16, pE64, DOI 10.1016/S1473-3099(15)00543-5; Holmes CW, 2016, J CLIN VIROL, V81, P90, DOI 10.1016/j.jcv.2016.06.007; Jubelt B, 2014, HAND CLINIC, V123, P379, DOI 10.1016/B978-0-444-53488-0.00018-3; Khetsuriani N., 2006, ENTEROVIRUS SURVEILL; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitch ECM, 2009, J VIROL, V83, P2109, DOI 10.1128/JVI.02109-08; Li H, 2017, ADV BIO SCI RES, V4, P113; Lu YQ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/210490; Mantadakis E, 2013, PEDIATR INFECT DIS J, V32, P914, DOI 10.1097/INF.0b013e31828f875c; Milia MG, 2013, J CLIN VIROL, V58, P579, DOI 10.1016/j.jcv.2013.08.023; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Oermann CM, 2015, ANN AM THORAC SOC, V12, P775, DOI 10.1513/AnnalsATS.201412-592FR; Osterback R, 2015, J CLIN VIROL, V69, P7, DOI 10.1016/j.jcv.2015.05.012; Papa A, 2009, EUR J CLIN MICROBIOL, V28, P683, DOI 10.1007/s10096-008-0685-1; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Poelman R, 2015, J CLIN VIROL, V71, P1, DOI 10.1016/j.jcv.2015.07.296; Pons-Salort M, 2015, CURR OPIN INFECT DIS, V28, P479, DOI 10.1097/QCO.0000000000000187; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Richter J, 2011, J APPL MICROBIOL, V111, P491, DOI 10.1111/j.1365-2672.2011.05061.x; Richter J, 2006, J MED MICROBIOL, V55, P1035, DOI 10.1099/jmm.0.46447-0; Rudolph H, 2017, EUR J CLIN MICROBIOL, V36, P1651, DOI 10.1007/s10096-017-2979-7; Savolainen C, 2001, ARCH VIROL, V146, P521, DOI 10.1007/s007050170160; Savolainen-Kopra C, 2011, VIRUS GENES, V42, P28, DOI 10.1007/s11262-010-0536-x; Schuffenecker I, 2014, EMERG INFECT DIS, V20, P1343, DOI 10.3201/eid2008.131858; Schuffenecker I, 2011, J CLIN VIROL, V50, P50, DOI 10.1016/j.jcv.2010.09.019; Smura T, 2013, INFECT GENET EVOL, V16, P234, DOI 10.1016/j.meegid.2013.02.011; Tan XJ, 2015, ARCH VIROL, V160, P1097, DOI 10.1007/s00705-015-2340-3; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Tao ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089766; Tao ZX, 2012, APPL ENVIRON MICROB, V78, P6946, DOI 10.1128/AEM.01861-12; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; Trallero G, 2010, J CLIN VIROL, V47, P170, DOI 10.1016/j.jcv.2009.11.013; Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yarmolskaya MS, 2015, INFECT GENET EVOL, V30, P244, DOI 10.1016/j.meegid.2014.12.033; Zell R, 2017, J GEN VIROL, V98, P2421, DOI 10.1099/jgv.0.000911; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhuang ZC, 2015, VIRUSES-BASEL, V7, P6400, DOI 10.3390/v7122947	59	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220938	10.1371/journal.pone.0220938	http://dx.doi.org/10.1371/journal.pone.0220938			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393960	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500084
J	Stolerman, LM; Maia, PD; Kutz, JN				Stolerman, Lucas M.; Maia, Pedro D.; Kutz, J. Nathan			Forecasting dengue fever in Brazil: An assessment of climate conditions	PLOS ONE			English	Article							RIO-DE-JANEIRO; AEDES-AEGYPTI; TEMPERATURE; VECTOR; TRANSMISSION; VIRUS; CULICIDAE; EPIDEMICS; DIPTERA; MODEL	Local climate conditions play a major role in the biology of the Aedes aegypti mosquito, the main vector responsible for transmitting dengue, zika, chikungunya and yellow fever in urban centers. For this reason, a detailed assessment of periods in which changes in climate conditions affect the number of human cases may improve the timing of vector-control efforts. In this work, we develop new machine-learning algorithms to analyze climate time series and their connection to the occurrence of dengue epidemic years for seven Brazilian state capitals. Our method explores the impact of two key variables-frequency of precipitation and average temperature-during a wide range of time windows in the annual cycle. Our results indicate that each Brazilian state capital considered has its own climate signatures that correlate with the overall number of human dengue-cases. However, for most of the studied cities, the winter preceding an epidemic year shows a strong predictive power. Understanding such climate contributions to the vector's biology could lead to more accurate prediction models and early warning systems.	[Stolerman, Lucas M.] Fiocruz MS, Programa Comp Cient PROCC, Rio De Janeiro, RJ, Brazil; [Stolerman, Lucas M.] IMPA, Rio De Janeiro, RJ, Brazil; [Maia, Pedro D.; Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	Fundacao Oswaldo Cruz; Instituto Nacional de Matematica Pura e Aplicada (IMPA); University of Washington; University of Washington Seattle	Stolerman, LM (corresponding author), Fiocruz MS, Programa Comp Cient PROCC, Rio De Janeiro, RJ, Brazil.; Stolerman, LM (corresponding author), IMPA, Rio De Janeiro, RJ, Brazil.	lstolerman@eng.ucsd.edu	Batista, Ewerthon/AAY-5409-2020	D. Maia, Pedro/0000-0002-3335-4257; Stolerman, Lucas/0000-0001-6313-0126				Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Adde A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004681; Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421; Bakar A.A., 2011, EL ENG INF ICEEI 201, P1; Banu S, 2015, SCI REPORT, P5; Baquero OS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195065; Barmak DH, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011901; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bishop C.M., 2006, MACH LEARN, V128; Brazilian Ministry of Health, PROM NAT MOB EFF AED; Brazilian National Institute of Meteorology (INMET), TEMP PREC TIM SER; Buczak AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002771; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Choi Y, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2923-2; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; Dibo MR, 2008, MEM I OSWALDO CRUZ, V103, P554, DOI 10.1590/S0074-02762008000600008; Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Gambhir S., 2019, PRESCREENING SYSTEMS, P69; Guo P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005973; Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505; Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442; Pena-Garcia VH, 2017, ANN GLOB HEALTH, V83, P509, DOI 10.1016/j.aogh.2017.10.011; Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382; Kesorn K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125049; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lana RM, 2014, ACTA TROP, V129, P25, DOI 10.1016/j.actatropica.2013.07.025; Lana RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190673; Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560; Liao CM, 2015, STOCH ENV RES RISK A, V29, P947, DOI 10.1007/s00477-014-0948-6; Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549; Lowe R, 2011, COMPUT GEOSCI-UK, V37, P371, DOI 10.1016/j.cageo.2010.01.008; Luiz T.M.F., 2003, DENGUE B, V27, P25; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Pessanha JEMP, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/760951; Ministry of Health, 2008, EP REP DENG FEV; Mondini A, 2008, SCI TOTAL ENVIRON, V393, P241, DOI 10.1016/j.scitotenv.2008.01.010; Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568; Ong J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006587; Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002581; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064; Rahman D, 2016, IEEE ENER CONV; Silva FD, 2016, CIENC SAUDE COLETIVA, V21, P641, DOI 10.1590/1413-81232015212.09592015; Stolerman LM, 2015, SIAM J APPL MATH, V75, P2581, DOI 10.1137/140996148; Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085; Tsuda Y, 2001, ENVIRON ENTOMOL, V30, P855, DOI 10.1603/0046-225X-30.5.855; Valdez L. D., 2017, ARXIV171107164; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112; Xu L, 2017, P NATL ACAD SCI USA, V114, P113, DOI 10.1073/pnas.1618558114	54	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220106	10.1371/journal.pone.0220106	http://dx.doi.org/10.1371/journal.pone.0220106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393908	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500021
J	Chaparro-Moreno, LJ; Justice, LM; Logan, JAR; Purtell, KM; Lin, TJ				Chaparro-Moreno, Leydi Johana; Justice, Laura M.; Logan, Jessica A. R.; Purtell, Kelly M.; Lin, Tzu-Jung			The preschool classroom linguistic environment: Children's first-person experiences	PLOS ONE			English	Article							TEACHERS LANGUAGE; CONVERSATIONS; EDUCATION; INPUT; TALK; ACQUISITION; QUALITY; GROWTH; LINKS	The linguistic environment of the classroom is influential to young children's language development. To date, however, literature on the linguistic environment of child-care centers has largely examined teacher practices or children's aggregate environment, overlooking the child's first-person experiences and differentiated experiences within the classroom. In this study we used a new method in the educational setting that captures the learner's perspective: head-mounted cameras. Thirteen children in one preschool classroom wore a headmounted camera to capture their first-person experiences in one morning session, including interactions with others and the features of the child-directed speech (CDS) addressed to them. Results revealed that, from children's personal view, the linguistic environment of the classroom is more dynamic from what previous studies have reported. Children interacted for longer with their teachers than their peers and heard more CDS from them, but for some children peers served as an additional source of language. Further, our analysis highlighted within-classroom variability in language experiences in terms of the properties of the CDS addressed to target children and how they were exposed to this input over time. Results are discussed with respect to peer influence on children's learning, heterogeneity in learning opportunities in classrooms, and the variability of the linguistic environment over time.	[Chaparro-Moreno, Leydi Johana; Justice, Laura M.; Lin, Tzu-Jung] Ohio State Univ, Dept Educ Studies, Educ Psychol Program, Columbus, OH 43210 USA; [Chaparro-Moreno, Leydi Johana; Justice, Laura M.; Logan, Jessica A. R.; Purtell, Kelly M.; Lin, Tzu-Jung] Ohio State Univ, Crane Ctr Early Childhood Res & Policy, Columbus, OH 43210 USA; [Logan, Jessica A. R.] Ohio State Univ, Dept Educ Studies, Quantitat Res Evaluat & Measurement Program, Columbus, OH 43210 USA; [Purtell, Kelly M.] Ohio State Univ, Dept Human Sci, Human Dev & Family Sci Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chaparro-Moreno, LJ (corresponding author), Ohio State Univ, Dept Educ Studies, Educ Psychol Program, Columbus, OH 43210 USA.; Chaparro-Moreno, LJ (corresponding author), Ohio State Univ, Crane Ctr Early Childhood Res & Policy, Columbus, OH 43210 USA.	chaparromoreno.1@osu.edu	Logan, Jessica/I-6698-2019	Logan, Jessica/0000-0003-3113-4346; Chaparro-Moreno, Leydi Johana/0000-0003-1852-1878; Lin, Tzu-Jung/0000-0002-4525-1001				Akhtar N, 2005, DEVELOPMENTAL SCI, V8, P199, DOI 10.1111/j.1467-7687.2005.00406.x; Akhtar N, 2001, CHILD DEV, V72, P416, DOI 10.1111/1467-8624.00287; Bakeman R., 2011, SEQUENTIAL ANAL OBSE; Behrens H, 2009, LINGUISTICS, V47, P383, DOI 10.1515/LING.2009.014; Cabell SQ, 2015, EARLY CHILD RES Q, V30, P80, DOI 10.1016/j.ecresq.2014.09.004; Cabell SQ, 2011, AM J SPEECH-LANG PAT, V20, P315, DOI 10.1044/1058-0360(2011/10-0104); Dickinson DK, 2014, EARLY CHILD RES Q, V29, P231, DOI 10.1016/j.ecresq.2014.02.006; Dickinson DK, 2011, SCIENCE, V333, P964, DOI 10.1126/science.1204526; Dominey PF, 2004, J NEUROLINGUIST, V17, P121, DOI 10.1016/S0911-6044(03)00056-3; Fernyhough C, 1997, INT J BEHAV DEV, V20, P651, DOI 10.1080/016502597385108; Fuligni AS, 2012, EARLY CHILD RES Q, V27, P198, DOI 10.1016/j.ecresq.2011.10.001; Grifenhagen JF, 2017, EARLY CHILD DEV CARE, V187, P509, DOI 10.1080/03004430.2016.1246444; Huang YT, 2017, COGNITION, V159, P61, DOI 10.1016/j.cognition.2016.11.004; Hurtado N, 2008, DEVELOPMENTAL SCI, V11, pF31, DOI 10.1111/j.1467-7687.2008.00768.x; Huttenlocher J, 2002, COGNITIVE PSYCHOL, V45, P337, DOI 10.1016/S0010-0285(02)00500-5; Jeon HJ, 2010, EARLY EDUC DEV, V21, P912, DOI 10.1080/10409280903292500; Chaparro-Moreno LJ, 2017, EARLY CHILD RES Q, V40, P52, DOI 10.1016/j.ecresq.2017.03.001; Justice LM, 2018, EARLY CHILD RES Q, V42, P79, DOI 10.1016/j.ecresq.2017.09.003; Justice LM, 2014, PSYCHOL SCI, V25, P1722, DOI 10.1177/0956797614538978; Justice LM, 2013, EARLY CHILD RES Q, V28, P496, DOI 10.1016/j.ecresq.2013.02.005; Justice LM, 2011, CHILD DEV, V82, P1768, DOI 10.1111/j.1467-8624.2011.01665.x; Miller J., 2008, SYSTEMATIC ANAL LANG; National Center for Education Statistics, 2017, PRESCH KIND ENR; Ohio Department of Education, 2014, CHAPTER 3301 37 OF T; Pan BA, 2005, CHILD DEV, V76, P763, DOI 10.1111/j.1467-8624.2005.00876.x; Pelatti CY, 2014, EARLY CHILD RES Q, V29, P445, DOI 10.1016/j.ecresq.2014.05.004; Perry LK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199893; Shneidman LA, 2012, DEVELOPMENTAL SCI, V15, P659, DOI 10.1111/j.1467-7687.2012.01168.x; Strasser K, 2018, EARLY EDUC DEV, V29, P357, DOI 10.1080/10409289.2018.1429765; Tamis-LeMonda CS, 2014, CURR DIR PSYCHOL SCI, V23, P121, DOI 10.1177/0963721414522813; Test JE, 2013, J EARLY CHILD RES, V11, P165, DOI 10.1177/1476718X12466217; Tomasello M, 2000, COGNITION, V74, P209, DOI 10.1016/S0010-0277(99)00069-4; Weisleder A, 2013, PSYCHOL SCI, V24, P2143, DOI 10.1177/0956797613488145; West KL, 2017, COGNITIVE DEV, V43, P190, DOI 10.1016/j.cogdev.2017.05.004; Yoshida H, 2008, INFANCY, V13, P229, DOI 10.1080/15250000802004437; Yu C, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12735; Yu C, 2012, COGNITION, V125, P244, DOI 10.1016/j.cognition.2012.06.016; Yurovsky D, 2013, DEVELOPMENTAL SCI, V16, P959, DOI 10.1111/desc.12036; Zauche LH, 2016, EARLY CHILD RES Q, V36, P318, DOI 10.1016/j.ecresq.2016.01.015; Zimmerman FJ, 2009, PEDIATRICS, V124, P342, DOI 10.1542/peds.2008-2267	40	14	14	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220227	10.1371/journal.pone.0220227	http://dx.doi.org/10.1371/journal.pone.0220227			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390357	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400013
J	Kim, JH; Kim, JH; Lee, SH; Park, J; Lee, SK				Kim, Jun-Ho; Kim, Jung-Hyun; Lee, So-Hee; Park, Jinhyoung; Lee, Seung-Kyun			Fabrication of a spherical inclusion phantom for validation of magnetic resonance-based magnetic susceptibility imaging	PLOS ONE			English	Article							MAPPING QSM; CONTRAST; IRON; MAP	Fabrication of a spherical multi-compartment MRI phantom is demonstrated that can be used to validate magnetic resonance (MR)-based susceptibility imaging reconstruction. The phantom consists of a 10 cm diameter gelatin sphere that encloses multiple smaller gelatin spheres doped with different concentrations of paramagnetic contrast agents. Compared to previous multi-compartment phantoms with cylindrical geometry, the phantom provides the following benefits: (1) no compartmental barrier materials are used that can introduce signal voids and spurious phase; (2) compartmental geometry is reproducible; (3) spherical susceptibility boundaries possess a ground-truth analytical phase solution for easy experimental validation; (4) spherical geometry of the overall phantom eliminates background phase due to air-phantom boundary in any scan orientation. The susceptibility of individual compartments can be controlled independently by doping. During fabrication, formalin cross-linking and water-proof surface coating effectively blocked water diffusion between the compartments to preserve the phantom's integrity. The spherical shapes were realized by molding the inner gel compartments in acrylic spherical shells, 3 cm in diameter, and constructing the whole phantom inside a larger acrylic shell. From gradient echo images obtained at 3T, we verified that the phantom produced phase images in agreement with the theoretical prediction. Factors that limit the agreement include: air bubbles trapped at the gel interfaces, imperfect magnet shimming, and the susceptibility of external materials such as the phantom support hardware. The phantom images were used to validate publicly available codes for quantitative susceptibility mapping. We believe that the proposed phantom can provide a useful testbed for validation of MR phase imaging and MR-based magnetic susceptibility reconstruction.	[Kim, Jun-Ho; Kim, Jung-Hyun; Lee, So-Hee; Park, Jinhyoung; Lee, Seung-Kyun] Sungkyunkwan Univ, Dept Biomed Engn, Suwon, South Korea; [Kim, Jun-Ho; Kim, Jung-Hyun; Lee, So-Hee; Lee, Seung-Kyun] IBS Ctr Neurosci Imaging Res, Suwon, South Korea	Sungkyunkwan University (SKKU); Institute for Basic Science - Korea (IBS)	Park, J; Lee, SK (corresponding author), Sungkyunkwan Univ, Dept Biomed Engn, Suwon, South Korea.; Lee, SK (corresponding author), IBS Ctr Neurosci Imaging Res, Suwon, South Korea.	jin.park@skku.edu; lee.seungkyun@gmail.com	lee, seungkyun/A-3464-2008	lee, seungkyun/0000-0001-7625-3141	Institute for Basic Science of the government of South Korea [IBS-R015-D1]	Institute for Basic Science of the government of South Korea	Jun-Ho Kim, Jung-Hyun Kim, S-H Lee, SK Lee were funded by the Institute for Basic Science (https://ibs.re.kr) of the government of South Korea, under grant IBS-R015-D1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewer K, 2015, AACR SNMMI JOINT C S; Brewer KD, 2018, MOL IMAGING BIOL, V20, P65, DOI 10.1007/s11307-017-1093-7; Brown RW, 2014, MAGNETIC RESONANCE I, DOI 10.1002/9781118633953.ch18; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Deh K, 2019, MAGN RESON MED, V81, P1229, DOI 10.1002/mrm.27410; Hwang Seon-ha, 2018, Investigative Magnetic Resonance Imaging, V22, P141, DOI 10.13104/imri.2018.22.3.141; Langkammer C, 2018, MAGN RESON MED, V79, P1661, DOI 10.1002/mrm.26830; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Li W, 2015, NEUROIMAGE, V108, P111, DOI 10.1016/j.neuroimage.2014.12.043; Liu J, 2012, NEUROIMAGE, V59, P2560, DOI 10.1016/j.neuroimage.2011.08.082; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Madsen EL, 2005, PHYS MED BIOL, V50, P5597, DOI 10.1088/0031-9155/50/23/013; Nayek C, 2017, MAGNETOCHEMISTRY, V3, DOI 10.3390/magnetochemistry3020019; Park J, 2017, MAGN RESON MED, V77, P848, DOI 10.1002/mrm.26570; Schafer A, 2009, NEUROIMAGE, V48, P126, DOI 10.1016/j.neuroimage.2009.05.093; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; SHEN T, 1993, MAGN RESON MED, V29, P599, DOI 10.1002/mrm.1910290504; Wang Y, 2015, MAGN RESON MED, V73, P82, DOI 10.1002/mrm.25358; Wapler MC, 2014, J MAGN RESON, V242, P233, DOI 10.1016/j.jmr.2014.02.005; Wei HJ, 2015, NMR BIOMED, V28, P1294, DOI 10.1002/nbm.3383; Wu B, 2012, MAGN RESON MED, V67, P137, DOI 10.1002/mrm.23000; Zhou D, 2017, MAGN RESON MED, V78, P1080, DOI 10.1002/mrm.26475	22	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220639	10.1371/journal.pone.0220639	http://dx.doi.org/10.1371/journal.pone.0220639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381587	Green Submitted, Green Published, gold			2022-12-27	WOS:000484993600026
J	Pongjantarasatian, S; Kadegasem, P; Sasanakul, W; Sangiamsuntorn, K; Borwornpinyo, S; Sirachainan, N; Chuansumrit, A; Tanratana, P; Hongeng, S				Pongjantarasatian, Sarai; Kadegasem, Praguywan; Sasanakul, Werasak; Sangiamsuntorn, Khanit; Borwornpinyo, Suparerk; Sirachainan, Nongnuch; Chuansumrit, Ampaiwan; Tanratana, Pansakorn; Hongeng, Suradej			Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line	PLOS ONE			English	Article							ESTABLISHMENT; HEMOPHILIA; DEFICIENCY; EXPRESSION; VARIANTS; PROTEINS; MOUSE	Human mesenchymal stem cells (hMSCs) have the potential to differentiate into hepatocyte-like cells, indicating that these cells may be the new target cell of interest to produce biopharmaceuticals. Our group recently established a hMSC-derived immortalized hepatocyte-like cell line (imHC) that demonstrates several liver-specific phenotypes. However, the ability of imHC to produce coagulation factors has not been characterized. Here, we examined the potential for imHC as a source of coagulation protein production by investigating the ability of imHC to produce human factor VII (FVII) using a lentiviral transduction system. Our results showed that imHC secreted a low amount of FVII (similar to 22 ng/mL) into culture supernatant. Moreover, FVII from the transduced imHC (0.11 +/- 0.005 IU/mL) demonstrated a similar coagulant activity compared with FVII from transduced HEK293T cells (0.12 +/- 0.004 IU/mL) as determined by chromogenic assay. We demonstrate for the first time, to the best of our knowledge, that imHC produced FVII, albeit at a low level, indicating the unique characteristic of hepatocytes. Our study suggests the possibility of using imHC for the production of coagulation proteins.	[Pongjantarasatian, Sarai] Mahidol Univ, Fac Sci, Mol Med Program, Bangkok, Thailand; [Kadegasem, Praguywan; Sasanakul, Werasak; Sirachainan, Nongnuch; Chuansumrit, Ampaiwan; Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Hematol Oncol,Dept Pediat, Bangkok, Thailand; [Sangiamsuntorn, Khanit] Mahidol Univ, Fac Pharm, Dept Biochem, Bangkok, Thailand; [Borwornpinyo, Suparerk] Mahidol Univ, Fac Sci, Dept Biotechnol, Bangkok, Thailand; [Borwornpinyo, Suparerk] Mahidol Univ, Fac Sci, Excellent Ctr Drug Discovery, Bangkok, Thailand; [Tanratana, Pansakorn] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Tanratana, P (corresponding author), Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok, Thailand.	pansakorn.tan@mahidol.ac.th		Hongeng, Suradej/0000-0002-7376-9393; Tanratana, Pansakorn/0000-0002-9434-2719; Borwornpinyo, Suparerk/0000-0001-6211-3615; Sa-ngiamsuntorn, Khanit/0000-0001-7010-345X	Mahidol University; Children Cancer Fund	Mahidol University; Children Cancer Fund	Suradej Hongeng received funding from Mahidol University and Children Cancer Fund under the patronage of HRH Princess Soamsawali.	Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; Branchini A, 2012, HAEMATOL-HEMATOL J, V97, P705, DOI 10.3324/haematol.2011.049403; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; Clayton RF, 2005, LIVER INT, V25, P389, DOI 10.1111/j.1478-3231.2005.01017.x; de Freitas MCC, 2017, PROTEIN EXPRES PURIF, V137, P26, DOI 10.1016/j.pep.2017.06.012; Deurholt T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-89; Dongiovanni P, 2008, AM J PATHOL, V172, P738, DOI 10.2353/ajpath.2008.070097; Fliedl L, 2015, NEW BIOTECHNOL, V32, P673, DOI 10.1016/j.nbt.2014.11.005; FORTE TM, 1989, J LIPID RES, V30, P817; Freguia CF, 2004, HAEMATOLOGICA, V89, P1504; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; Hariparsad N, 2008, DRUG METAB DISPOS, V36, P1046, DOI 10.1124/dmd.108.020677; Hedner U, 2006, J BIOTECHNOL, V124, P747, DOI 10.1016/j.jbiotec.2006.03.042; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lentz SR, 2014, J THROMB HAEMOST, V12, P1244, DOI 10.1111/jth.12634; Mao J, 2013, J GENET SYNDR GEN S1, DOI [10.4172/2157-7412.S1-014, DOI 10.4172/2157-7412.S1-014]; Marcos-Contreras OA, 2016, BLOOD, V127, P565, DOI 10.1182/blood-2015-09-671420; Meier M, 2007, J ENDOCRINOL, V193, P45, DOI 10.1677/joe.1.07087; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; Napolitano M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6040038; PEDERSEN AH, 1989, BIOCHEMISTRY-US, V28, P9331, DOI 10.1021/bi00450a013; Perry  DJ, 2002, BRIT J HAEMATOL, V118, P689, DOI 10.1046/j.1365-2141.2002.03545.x; Pewkliang Y, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2198-4; RAO LVM, 1988, P NATL ACAD SCI USA, V85, P6687, DOI 10.1073/pnas.85.18.6687; Reid Y, 2009, IN VITRO CELL DEV-AN, V45, P535, DOI 10.1007/s11626-009-9219-0; Sa-ngiamsuntorn K, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-89; Sakoda T, 2007, PREP BIOCHEM BIOTECH, V37, P1, DOI 10.1080/10826060601039345; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Toso R, 2002, BIOCHEM J, V363, P411, DOI 10.1042/0264-6021:3630411; Tsuruga Y, 2008, CELL TRANSPLANT, V17, P1083, DOI 10.3727/096368908786991542; Unger C, 2009, HUM REPROD, V24, P2567, DOI 10.1093/humrep/dep232; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; WILDGOOSE P, 1992, BLOOD, V80, P25; Wongkajornsilp A, 2012, METHODS MOL BIOL, V826, P73, DOI 10.1007/978-1-61779-468-1_7; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Yamamoto Y, 2008, FEBS J, V275, P1260, DOI 10.1111/j.1742-4658.2008.06287.x; Zemel R, 2009, LIVER INT, V29, P1326, DOI 10.1111/j.1478-3231.2009.02054.x	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220825	10.1371/journal.pone.0220825	http://dx.doi.org/10.1371/journal.pone.0220825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381603	Green Published, gold, Green Submitted			2022-12-27	WOS:000484993600037
J	Bruns, DR; Tatman, PD; Kalkur, RS; Brown, RD; Stenmark, KR; Buttrick, PM; Walker, LA				Bruns, Danielle R.; Tatman, Philip D.; Kalkur, Roshni S.; Brown, R. Dale; Stenmark, Kurt R.; Buttrick, Peter M.; Walker, Lori A.			The right ventricular fibroblast secretome drives cardiomyocyte dedifferentiation	PLOS ONE			English	Article							PERIOSTIN EXPRESSION; MYOCARDIAL FIBROSIS; EJECTION FRACTION; CALF MODEL; HEART; EXOSOMES; SURVIVAL; SERUM; PROLIFERATION; CYTOKINES	Rationale In virtually all models of heart failure, prognosis is determined by right ventricular (RV) function; thus, understanding the cellular mechanisms contributing to RV dysfunction is critical. Whole organ remodeling is associated with cell-specific changes, including cardiomyocyte dedifferentiation and activation of cardiac fibroblasts (Cfib) which in turn is linked to disorganization of cytoskeletal proteins and loss of sarcomeric structures. However, how these cellular changes contribute to RV function remains unknown. We've previously shown significant organ-level RV dysfunction in a large animal model of pulmonary hypertension (PH) which was not mirrored by reduced function of isolated cardiomyocytes. We hypothesized that factors produced by the endogenous Cfib contribute to global RV dysfunction by generating a heterogeneous cellular environment populated by dedifferentiated cells. Objective To determine the effect of Cfib conditioned media (CM) from the PH calf (PH-CM) on adult rat ventricular myocytes (ARVM) in culture. Methods and results Brief exposure (<2 days) to PH-CM results in rapid, marked dedifferentiation of ARVM to a neonatal-like phenotype exhibiting spontaneous contractile behavior. Dedifferentiated cells maintain viability for over 30 days with continued expression of cardiomyocyte proteins including TnI and alpha-actinin yet exhibit myofibroblast characteristics including expression of a-smooth muscle actin. Using a bioinformatics approach to identify factor(s) that contribute to dedifferentiation, we found activation of the PH Cfib results in a unique transcriptome correlating with factors both in the secretome and with activated pathways in the dedifferentiated myocyte. Further, we identified upregulation of periostin in the Cfib and CM, and demonstrate that periostin is sufficient to drive cardiomyocyte dedifferentiation. Conclusions These data suggest that paracrine factor(s) released by Cfib from the PH calf signal a phenotypic transformation in a population of cardiomyocytes that likely contributes to RV dysfunction. Therapies targeting this process, such as inhibition of periostin, have the potential to prevent RV dysfunction.	[Bruns, Danielle R.; Tatman, Philip D.; Kalkur, Roshni S.; Buttrick, Peter M.; Walker, Lori A.] Univ Colorado Denver, Dept Med Cardiol, Aurora, CO 80204 USA; [Tatman, Philip D.] Med Scientist Training Program, Aurora, CO USA; [Brown, R. Dale; Stenmark, Kurt R.] Univ Colorado Denver, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Walker, LA (corresponding author), Univ Colorado Denver, Dept Med Cardiol, Aurora, CO 80204 USA.	lori.walker@ucdenver.edu	stenmark, kurt/AAH-3124-2022; stenmark, kurt/AFI-6776-2022; Walker, Lori/J-7098-2013	Walker, Lori/0000-0003-2556-8076	American Heart Association [17POST32720003]; National Institutes of Health [HL014985]; Temple Hoyne Buell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Temple Hoyne Buell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by American Heart Association 17POST32720003 (DRB), National Institutes of Health HL014985 (KRS) and the Temple Hoyne Buell Foundation (PMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Batlle M, 2009, TRANSPL P, V41, P2231, DOI 10.1016/j.transproceed.2009.06.009; Beohar N, 2010, J AM COLL CARDIOL, V56, P1287, DOI 10.1016/j.jacc.2010.05.039; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; Dispersyn GD, 2002, EUR HEART J, V23, P849, DOI 10.1053/euhj.2001.2963; Gillan L, 2002, CANCER RES, V62, P5358; Gonzalez A, 2011, J AM COLL CARDIOL, V58, P1833, DOI 10.1016/j.jacc.2011.06.058; Guan J, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0084-3; HEGEWISCH S, 1990, LANCET, V335, P294, DOI 10.1016/0140-6736(90)90115-L; Hein S, 2000, CARDIOVASC RES, V45, P273, DOI 10.1016/S0008-6363(99)00268-0; Hunter KS, 2010, J APPL PHYSIOL, V108, P968, DOI 10.1152/japplphysiol.01173.2009; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lemler MS, 2000, AM J PHYSIOL-HEART C, V279, pH1365; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034; Lorts A, 2009, CIRC RES, V104, pE1, DOI 10.1161/CIRCRESAHA.108.188649; Malik ZA, 2013, AM J PHYSIOL-HEART C, V304, pH954, DOI 10.1152/ajpheart.00835.2012; Neuss M, 1996, CELL TISSUE RES, V286, P145, DOI 10.1007/s004410050683; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Port JD, 2011, PHYSIOL GENOMICS, V43, P1087, DOI 10.1152/physiolgenomics.00074.2011; Roche PL, 2015, COMPR PHYSIOL, V5, P721, DOI 10.1002/cphy.c140044; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Rucker-Martin C, 2002, CARDIOVASC RES, V55, P38, DOI 10.1016/S0008-6363(02)00338-3; Sakata Y, 2008, BASIC RES CARDIOL, V103, P60, DOI 10.1007/s00395-007-0689-5; Schwanekamp JA, 2016, ARTERIOSCL THROM VAS, V36, P60, DOI 10.1161/ATVBAHA.115.306397; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; SOLTIS RD, 1979, IMMUNOLOGY, V36, P37; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; STENMARK K R, 1988, Chest, V93, p127S, DOI 10.1378/chest.93.3.127S; Stumpf C, 2003, CLIN SCI, V105, P45, DOI 10.1042/CS20020359; Szibor M, 2014, CELL MOL LIFE SCI, V71, P1907, DOI 10.1007/s00018-013-1535-6; Taniyama Y, 2016, HYPERTENSION, V67, P356, DOI 10.1161/HYPERTENSIONAHA.115.06265; VOLZ A, 1991, J MOL CELL CARDIOL, V23, P161, DOI 10.1016/0022-2828(91)90103-S; Walker LA, 2011, AM J PHYSIOL-HEART C, V301, pH832, DOI 10.1152/ajpheart.00249.2011; Weber KT, 2016, AM J MED SCI, V352, P428, DOI 10.1016/j.amjms.2016.05.026; Wolska BM, 1996, AM J PHYSIOL-HEART C, V271, pH1250, DOI 10.1152/ajpheart.1996.271.3.H1250; Wu H, 2016, MOL MED REP, V14, P776, DOI 10.3892/mmr.2016.5308; Xu JY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00494; York M, 2011, CURR OPIN RHEUMATOL, V23, P536, DOI 10.1097/BOR.0b013e32834ba6a7; Zhao S, 2014, J CARDIOL, V63, P373, DOI 10.1016/j.jjcc.2013.09.013; Zhong JY, 2014, LAB INVEST, V94, P633, DOI 10.1038/labinvest.2014.51; ZUCKERMAN BD, 1991, J APPL PHYSIOL, V70, P859, DOI 10.1152/jappl.1991.70.2.859; ZUCKERMAN BD, 1992, J APPL PHYSIOL, V72, P2118, DOI 10.1152/jappl.1992.72.6.2118	45	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220573	10.1371/journal.pone.0220573	http://dx.doi.org/10.1371/journal.pone.0220573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374110	gold, Green Published, Green Submitted			2022-12-27	WOS:000484991500021
J	Smith, KA; Setlhare, S; DeCaen, A; Donoghue, A; Mensinger, JL; Zhang, BQ; Snow, B; Zambo, D; Ndlovu, K; Littman-Quinn, R; Bhanji, F; Meaney, PA				Smith, Katherine A.; Setlhare, Segolame; DeCaen, Allan; Donoghue, Aaron; Mensinger, Janell L.; Zhang, Bingqing; Snow, Brennan; Zambo, Dikai; Ndlovu, Kagiso; Littman-Quinn, Ryan; Bhanji, Farhan; Meaney, Peter A.			Feasibility and preliminary validity evidence for remote video-based assessment of clinicians in a global health setting	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; PEDIATRIC CARE; MORTALITY; IMPLEMENTATION; COUNTRIES; EDUCATION; QUALITY; DISEASE; DELPHI; BURDEN	Background Serious childhood illnesses (SCI), defined as severe pneumonia, severe dehydration, sepsis, and severe malaria, remain major contributors to amenable child mortality worldwide. Inadequate recognition and treatment of SCI are factors that impact child mortality in Botswana. Skills assessments of providers caring for SCI have not been validated in low and middle-income countries. Objective To establish preliminary inter-rater reliability, validity evidence, and feasibility for an assessment of providers who care for SCI using simulated patients and remote video capture in community clinic settings in Botswana. Methods This was a pilot study. Four scenarios were developed via a modified Delphi technique and implemented at primary care clinics in Kweneng, Botswana. Sessions were video captured and independently reviewed. Response process and internal structure analysis utilized intra-class correlation (ICC) and Fleiss' Kappa. A structured log was utilized for feasibility of remote video capture. Results Eleven subjects participated. Scenarios of Lower Airway Obstruction (ICC = 0.925, 95% CI 0.695-0.998) and Hypovolemic Shock from Severe Dehydration (ICC = 0.892, 95% CI 0.596-0.997) produced excellent ICC among raters while Lower Respiratory Tract Infection (LRTI, ICC = 0, 95% CI -0.034-0.97) and LRTI + Distributive Shock from Sepsis (0.365, 95% CI -0.025-0.967) were poor. Oxygen therapy (0.707), arranging transport (0.706), and fluid administration (0.701) demonstrated substantial task reliability. Conclusions Initial development of an assessment tool demonstrates many, but not all, criteria for validity evidence. Some scenarios and tasks demonstrate excellent reliability among raters, but others may be limited by manikin design and study implementation. Remote simulation assessment of some skills by clinic-based providers in global health settings is reliable and feasible.	[Smith, Katherine A.; Zhang, Bingqing] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Setlhare, Segolame] Amer Heart Assoc, Kweneng, Botswana; [DeCaen, Allan] Univ Alberta, Edmonton, AB, Canada; [Donoghue, Aaron] Univ Penn, Perlman Sch Med, Philadelphia, PA 19104 USA; [Mensinger, Janell L.] Drexel Univ, Philadelphia, PA 19104 USA; [Snow, Brennan] B Line Med Charitable Fund, Washington, DC USA; [Zambo, Dikai; Littman-Quinn, Ryan] Botswana UPenne Partnership, Gaborone, Botswana; [Ndlovu, Kagiso] Univ Botswana, Gaborone, Botswana; [Bhanji, Farhan] McGill Dept Pediat, Montreal, PQ, Canada; [Meaney, Peter A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Alberta; University of Pennsylvania; Drexel University; University of Botswana; Stanford University	Smith, KA (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	smithka1@email.chop.edu	Mensinger, Janell/AAR-3375-2021	Smith, Katherine/0000-0003-3559-9538; Meaney, Peter/0000-0001-9898-6928; Mensinger, Janell/0000-0001-7675-8879	American Heart Association; B-Line Foundation	American Heart Association(American Heart Association); B-Line Foundation	Funding was provided through philanthropic grants to the Saving Children's Lives organization from the American Heart Association and B-Line Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Educational Research Association American Psychological Association Na- tional Council on Measurement in Education, 2014, STAND ED PSYCH TEST; [Anonymous], 1998, HEALTH TECHNOL ASSES, DOI DOI 10.1186/s12888-014-0241-8; Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Boyle WA, 2018, CRIT CARE MED, V46, pE516, DOI 10.1097/CCM.0000000000003073; Butterwick Dale J, 2006, J Allied Health, V35, P147; Cf. NAT'L CRIME VICTIM L. INST, 2017, VIT STAT 2015, P1; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cohen SR., 2011, CLIN SIMUL NURS, V7, pe11, DOI DOI 10.1016/J.ECNS.2009.11.012; Cook D. A., 2006, AM J MED, V119, DOI [10.1016/j.amjmed.2005.10.036, DOI 10.1016/J.AMJMED.2005.10.036]; Donoghue A, 2010, RESUSCITATION, V81, P331, DOI 10.1016/j.resuscitation.2009.11.011; Downing SM, 2003, MED EDUC, V37, P830, DOI 10.1046/j.1365-2923.2003.01594.x; Egenberg S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1478-2; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Finn JC, 2015, RESUSCITATION, V95, pE203, DOI 10.1016/j.resuscitation.2015.07.046; Graefe A, 2011, INT J FORECASTING, V27, P183, DOI 10.1016/j.ijforecast.2010.05.004; GUSTAFSON DH, 1973, ORGAN BEHAV HUM PERF, V9, P280, DOI 10.1016/0030-5073(73)90052-4; Gustafson DH, 1977, HUMAN JUDGMENT DECIS, P145; Kapadia FN, 1999, CHEST, V115, P1483, DOI 10.1378/chest.115.5.1483; Lockyer J, 2006, PEDIATRICS, V118, pE1739, DOI 10.1542/peds.2006-0537; LYNN MR, 1986, NURS RES, V35, P382; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Meaney PA, 2010, RESUSCITATION, V81, P1462, DOI 10.1016/j.resuscitation.2010.06.024; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Patlakwe T, 2013, PEDIAT ACAD SOC M; Setlhare S, 2016, GLOB HLTH S PHIL PA; Shilkofski N, 2015, PEDIATRICS, V136, pE1569, DOI 10.1542/peds.2015-2677; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Statistics Botswana, 2015, KWEN E SUBD POP HOUS, P1; Statistics Botswana, 2018, BOTSW DEM SURV REP 2, P1; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Wright SW, 2015, RESUSCITATION, V88, P57, DOI 10.1016/j.resuscitation.2014.12.007	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220565	10.1371/journal.pone.0220565	http://dx.doi.org/10.1371/journal.pone.0220565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374102	Green Submitted, Green Published, gold			2022-12-27	WOS:000484991500020
J	Dineen-Griffin, S; Garcia-Cardenas, V; Williams, K; Benrimoj, SI				Dineen-Griffin, Sarah; Garcia-Cardenas, Victoria; Williams, Kylie; Benrimoj, Shalom I.			Helping patients help themselves: A systematic review of self-management support strategies in primary health care practice	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; OBSTRUCTIVE PULMONARY-DISEASE; IRRITABLE-BOWEL-SYNDROME; NURSE CASE-MANAGEMENT; CHRONIC ILLNESS CARE; PSYCHOMETRIC PROPERTIES; COST-EFFECTIVENESS; BLOOD-GLUCOSE; PHARMACIST INTERVENTION	Background Primary health professionals are well positioned to support the delivery of patient self-management in an evidence-based, structured capacity. A need exists to better understand the active components required for effective self-management support, how these might be delivered within primary care, and the training and system changes that would subsequently be needed. Objectives (1) To examine self-management support interventions in primary care on health outcomes for a wide range of diseases compared to usual standard of care; and (2) To identify the effective strategies that facilitate positive clinical and humanistic outcomes in this setting. Method A systematic review of randomized controlled trials evaluating self-management support interventions was conducted following the Cochrane handbook & PRISMA guidelines. Published literature was systematically searched from inception to June 2019 in PubMed, Scopus and Web of Science. Eligible studies assessed the effectiveness of individualized interventions with follow-up, delivered face-to-face to adult patients with any condition in primary care, compared with usual standard of care. Matrices were developed that mapped the evidence and components for each intervention. The methodological quality of included studies were appraised. Results 6,510 records were retrieved. 58 studies were included in the final qualitative synthesis. Findings reveal a structured patient-provider exchange is required in primary care (including a one-on-one patient-provider consultation, ongoing follow up and provision of self-help materials). Interventions should be tailored to patient needs and may include combinations of strategies to improve a patient's disease or treatment knowledge; independent monitoring of symptoms, encouraging self-treatment through a personalized action plan in response worsening symptoms or exacerbations, psychological coping and stress management strategies, and enhancing responsibility in medication adherence and lifestyle choices. Followup may include tailored feedback, monitoring of progress with respect to patient set healthcare goals, or honing problem-solving and decision-making skills. Theoretical models provided a strong base for effective SMS interventions. Positive outcomes for effective SMS included improvements in clinical indicators, health-related quality of life, self-efficacy (confidence to self-manage), disease knowledge or control. An SMS model has been developed which sets the foundation for the design and evaluation of practical strategies for the construct of self-management support interventions in primary healthcare practice. Conclusions These findings provide primary care professionals with evidence-based strategies and structure to deliver SMS in practice. For this collaborative partnership approach to be more widely applied, future research should build on these findings for optimal SMS service design and upskilling healthcare providers to effectively support patients in this collaborative process.	[Dineen-Griffin, Sarah; Garcia-Cardenas, Victoria; Williams, Kylie] Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia; [Benrimoj, Shalom I.] Univ Sydney, Sydney, NSW, Australia; [Dineen-Griffin, Sarah] Univ Technol Sydney, Grad Sch Hlth, Ultimo, NSW, Australia	University of Technology Sydney; University of Sydney; University of Technology Sydney	Dineen-Griffin, S (corresponding author), Univ Technol Sydney, Grad Sch Hlth, Sydney, NSW, Australia.; Dineen-Griffin, S (corresponding author), Univ Technol Sydney, Grad Sch Hlth, Ultimo, NSW, Australia.	sarah.dineen-griffin@uts.edu.au	Garcia-Cardenas, Victoria/B-7456-2013	Garcia-Cardenas, Victoria/0000-0003-3770-4557; Benrimoj, Shalom (charlie)/0000-0001-9768-7838; Dineen-Griffin, Sarah/0000-0001-7080-0108				Adachi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-467; Andrae DA, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-208; Australian Better Health Initiative Senior Officials Working Group, 2006, AUSTR BETT HLTH IN N; Australian Institute of Health and Welfare, 2016, PRIM HLTH CAR AUSTR; Bair MJ, 2009, PAIN MED, V10, P1280, DOI 10.1111/j.1526-4637.2009.00707.x; Banasiak SJ, 2005, PSYCHOL MED, V35, P1283, DOI 10.1017/S0033291705004769; Barbanel D, 2003, THORAX, V58, P851, DOI 10.1136/thorax.58.10.851; Barley EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098704; Bartels SJ, 2014, PSYCHIAT SERV, V65, P330, DOI 10.1176/appi.ps.201300023; Bayliss EA, 2008, FAM PRACT, V25, P287, DOI 10.1093/fampra/cmn040; Bell J, 2016, ADV THER, V33, P1691, DOI 10.1007/s12325-016-0395-5; Bischoff EWMA, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7642; Blinkhorn Andy, 2010, Evid Based Dent, V11, P41, DOI 10.1038/sj.ebd.6400716; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Broderick JE, 2014, PAIN, V155, P1743, DOI 10.1016/j.pain.2014.05.024; Browning C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009319; Browning CJ, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00181; Bush T, 2001, AM PSYCH SOC TOR; Cameron J, 2009, HEART LUNG, V38, P410, DOI 10.1016/j.hrtlng.2008.11.004; Chalder T, 1997, BRIT J HEALTH PSYCH, V2, P189, DOI 10.1111/j.2044-8287.1997.tb00535.x; Cherkin DC, 1996, SPINE, V21, P345, DOI 10.1097/00007632-199602010-00019; Chilcot J, 2013, BEHAV RES THER, V51, P690, DOI 10.1016/j.brat.2013.07.007; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Clark M, 2004, BRIT J HEALTH PSYCH, V9, P365, DOI 10.1348/1359107041557066; Clark M, 2001, PATIENT EDUC COUNS, V42, P247, DOI 10.1016/S0738-3991(00)00128-2; Clarkson JE, 2009, J DENT RES, V88, P933, DOI 10.1177/0022034509345627; Cochrane Effective Practice and Organisation of Care Review Group (EPOC), 2013, DAT COLL FOR; Cochrane Effective Practice and Organisation of Care Review Group (EPOC), 2002, DAT COLL CHECKL; Cochrane EHective Practice and Organisation of Care (EPOC), 2017, SUGG RISK BIAS CRIT; Contant E, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-0943-6; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Crespo-Gonzalez C, 2017, RES SOC ADMIN PHARM, V13, P896, DOI 10.1016/j.sapharm.2017.05.020; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; DeBar LL, 2011, PSYCHIAT SERV, V62, P367, DOI 10.1176/ps.62.4.pss6204_0367; Deedat S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003453; Doucette WR, 2009, ANN PHARMACOTHER, V43, P882, DOI 10.1345/aph.1L605; Dritsaki M, 2016, CHRON RESP DIS, V13, P48, DOI 10.1177/1479972315619578; Du SZ, 2011, PATIENT EDUC COUNS, V85, pE299, DOI 10.1016/j.pec.2011.02.021; Duke SAS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005268.pub2; Durks D, 2017, HEALTH EDUC BEHAV, V44, P524, DOI 10.1177/1090198117709885; Dziedzic KS, 2018, OSTEOARTHR CARTILAGE, V26, P43, DOI 10.1016/j.joca.2017.09.010; Dziedzic KS, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0095-y; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Effing T, 2007, COCHRANE DB SYST REV, V4; Efraimsson EO, 2008, SCAND J CARING SCI, V22, P178, DOI 10.1111/j.1471-6712.2007.00510.x; Eikelenboom N, 2016, BRIT J GEN PRACT, V66, pE354, DOI 10.3399/bjgp16X684985; Eikelenboom N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-336; Ekman I, 2011, EUR J CARDIOVASC NUR, V10, P248, DOI 10.1016/j.ejcnurse.2011.06.008; Evans C, 2002, BRIT J PSYCHIAT, V180, P51, DOI 10.1192/bjp.180.1.51; Farmer AJ, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13150; Farmer A, 2007, BMJ-BRIT MED J, V335, P132, DOI 10.1136/bmj.39247.447431.BE; Ferrone M, 2019, NPJ PRIM CARE RESP M, V29, DOI 10.1038/s41533-019-0119-9; Fortin Martin, 2016, CMAJ Open, V4, pE588, DOI 10.9778/cmajo.20160031; Freund KS, 2012, HEALTH EDUC RES, V27, P927, DOI 10.1093/her/cys048; Friedberg F, 2013, PSYCHOSOM MED, V75, P650, DOI 10.1097/PSY.0b013e31829dbed4; Gabbay RA, 2006, DIABETES RES CLIN PR, V71, P28, DOI 10.1016/j.diabres.2005.05.002; Gabbay RA, 2013, J DIABETES, V5, P349, DOI 10.1111/1753-0407.12030; Gibson PG, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD001117], 10.1002/14651858.CD001117]; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gillespie P, 2016, FAMILY PRACTICE; Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04; Glasgow Russell E, 2003, Jt Comm J Qual Saf, V29, P563; Goudswaard AN, 2004, DIABETIC MED, V21, P491, DOI 10.1111/j.1464-5491.2004.01153.x; Grammatopoulou E, 2008, QUAL LIFE RES, V17, P323, DOI 10.1007/s11136-007-9297-y; Grilo CM, 2013, BEHAV RES THER, V51, P855, DOI 10.1016/j.brat.2013.10.002; Haslbeck J, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1251-z; Heitkemper MM, 2004, CLIN GASTROENTEROL H, V2, P585, DOI 10.1016/S1542-3565(04)00242-3; Heneghan C, 2010, COCHRANE DB SYST REV, V4; Herrero R, 2014, COMPR PSYCHIAT, V55, P1738, DOI 10.1016/j.comppsych.2014.05.015; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Hill K, 2010, PATIENT EDUC COUNS, V81, P14, DOI 10.1016/j.pec.2009.09.035; Hoffmann W, 2008, ANN PHARMACOTHER, V42, P1804, DOI 10.1345/aph.1K635; Hsu CC, 2014, DIABETES RES CLIN PR, V106, pS328, DOI 10.1016/S0168-8227(14)70738-7; Huang MC, 2010, DIABETES CARE, V33, P233, DOI 10.2337/dc09-1092; Ismail M, 2013, SINGAP MED J, V54, P391, DOI 10.11622/smedj.2013140; Jaipakdee J, 2015, NURS HEALTH SCI, V17, P362, DOI 10.1111/nhs.12198; Jonkma NH, 2016, J CLIN EPIDEMIOL, V80, P34, DOI 10.1016/j.jclinepi.2016.08.001; Jonkman N, 2016, SELF MANAGEMENT INTE; Jordan JE, 2008, MED J AUSTRALIA, V189, pS9; Jovicic Aleksandra, 2006, BMC Cardiovasc Disord, V6, P43, DOI 10.1186/1471-2261-6-43; Kennedy A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2882; Kennedy A, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-7; Lee EH, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0142-z; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Liddy C, 2014, CAN FAM PHYSICIAN, V60, P1123; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Malanda UL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005060.pub3; Malet-Larrea A, 2016, EXPERT REV PHARM OUT, V16, P747, DOI 10.1080/14737167.2016.1259071; McGeoch GRB, 2006, RESPIROLOGY, V11, P611, DOI 10.1111/j.1440-1843.2006.00892.x; McLean William, 2003, Can Respir J, V10, P195; McWilliam CL, 2009, CHRONIC ILLN, V5, P277, DOI 10.1177/1742395309349315; Mehuys E, 2008, EUR RESPIR J, V31, P790, DOI 10.1183/09031936.00112007; Mehuys E, 2011, J CLIN PHARM THER, V36, P602, DOI 10.1111/j.1365-2710.2010.01218.x; Meland E, 1999, SCAND J PUBLIC HEALT, V27, P11, DOI 10.1177/14034948990270011001; Meland E, 1997, SCAND J PRIM HEALTH, V15, P57, DOI 10.3109/02813439709043432; Meng HD, 2014, BMC FAM PRACT, V15, DOI 10.1186/s12875-014-0184-7; Messina R, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0901-3; Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033; Mitchell KE, 2014, EUR RESPIR J, V44, P1538, DOI 10.1183/09031936.00047814; Mohler R, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0709-y; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Montgomery HE, 2017, ANN ONCOL, V28, P1751, DOI 10.1093/annonc/mdx136; Morgan M, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-46; Moss-Morris R, 2010, PSYCHOL MED, V40, P85, DOI 10.1017/S0033291709990195; Murphy AW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4220; Murphy AW, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-11; Norris SL, 2000, PREV MED, V30, P513, DOI 10.1006/pmed.2000.0673; O'Connel S, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3387-0; Olry de Labry Lima A, 2016, EFFECTIVENESS INTERV; Partapsingh VA, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-13; Porcheret M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-25; Ren XS, 1999, ARTHRIT CARE RES, V12, P163, DOI 10.1002/1529-0131(199906)12:3<163::AID-ART3>3.0.CO;2-Z; Richards A, 2003, BRIT J GEN PRACT, V53, P764; Roberto Karen A, 2005, Health Care Women Int, V26, P672, DOI 10.1080/07399330500177147; Rosemann T, 2007, ARTHRIT RHEUM-ARTHR, V57, P1390, DOI 10.1002/art.23080; Simon J, 2008, BRIT MED J, V336, P1177, DOI 10.1136/bmj.39526.674873.BE; Smit A, 2005, PRIMARY CARE COMMUN, V10, P39, DOI 10.1185/135525705X40382; Soon SS, 2010, APPL HEALTH ECON HEA, V8, P239, DOI 10.2165/11313920-000000000-00000; Stant AD, 2009, J MENT HEALTH POLICY, V12, P195; Striegel-Moore RH, 2010, J CONSULT CLIN PSYCH, V78, P312, DOI 10.1037/a0018915; Sturt JA, 2008, DIABETIC MED, V25, P722, DOI 10.1111/j.1464-5491.2008.02451.x; Syddall HE, 2009, J NUTR HEALTH AGING, V13, P57, DOI 10.1007/s12603-009-0010-4; Thorarinsdottir K, 2014, NURS ETHICS, V21, P129, DOI 10.1177/0969733013490593; Tiessen AH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-148; Tiessen AH, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-90; Toobert DJ, 2000, DIABETES CARE, V23, P943, DOI 10.2337/diacare.23.7.943; Topolski Tari D, 2006, Prev Chronic Dis, V3, pA118; van der Bijl J, 1999, J ADV NURS, V30, P352, DOI 10.1046/j.1365-2648.1999.01077.x; van Dijk-de Vries A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007014; Viswanathan M., 2017, J CLIN EPIDEMIOL, V97, DOI [10.1016/j.jclinepi.2017.12.004, DOI 10.1016/J.JCLINEPI.2017.12.004]; Von Korff M, 2005, PAIN, V113, P323, DOI 10.1016/j.pain.2004.11.007; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Waite P, 2012, J BEHAV THER EXP PSY, V43, P1049, DOI 10.1016/j.jbtep.2012.04.006; Walker Christine, 2003, Aust Health Rev, V26, P34; Wang Yu-lin, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P416, DOI 10.3881/j.issn.1000-503X.2013.04.011; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; Watkins ER, 2012, PSYCHOL MED, V42, P1359, DOI 10.1017/S0033291711002480; Watson PB, 1997, EUR RESPIR J, V10, P1267, DOI 10.1183/09031936.97.10061267; White R, 2006, Chron Respir Dis, V3, P123, DOI 10.1191/1479972306cd117oa; WIGAL JK, 1991, CHEST, V99, P1193, DOI 10.1378/chest.99.5.1193; Williams C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052735; Wood-Baker R, 2006, RESPIROLOGY, V11, P619, DOI 10.1111/j.1440-1843.2006.00902.x; Yardley L, 2004, ANN INTERN MED, V141, P598, DOI 10.7326/0003-4819-141-8-200410190-00007; Zimmermann T, 2016, INT J NURS STUD, V63, P101, DOI 10.1016/j.ijnurstu.2016.08.007	152	99	103	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220116	10.1371/journal.pone.0220116	http://dx.doi.org/10.1371/journal.pone.0220116			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369582	Green Published, gold			2022-12-27	WOS:000484987900025
J	Hsu, YC; Yang, HY; Huang, WT; Chen, SCC; Lee, HS				Hsu, Yung-Chu; Yang, Hsin-Yi; Huang, Wan-Ting; Chen, Solomon Chih-Cheng; Lee, Herng-Sheng			Use of antidepressants and risks of restless legs syndrome in patients with irritable bowel syndrome: A population-based cohort study	PLOS ONE			English	Article							DOPAMINE NEURONS; ASSOCIATION; PREVALENCE; EPIDEMIOLOGY; SEROTONIN; MOVEMENTS; ADULTS	Previous research has suggested an association between antidepressants use and clinical restless legs syndrome (RLS) in patients, but there has never been a single study investigating the risk of RLS in irritable bowel syndrome (IBS) patients treated with antidepressants. Hence, we aimed to explore the association between IBS and RLS and to examine the risk of RLS in IBS patients treated with antidepressants. With the use of the National Health Insurance Research Database of Taiwan, 27,437 adults aged. 20 years with newly diagnosed IBS (ICD-9-CM Code 564.1) and gender-and age-matched 54,874 controls without IBS were enrolled between 2000 and 2012. All patients were followed-up until RLS diagnosis, withdrawal from the National Health Insurance program, or end of 2013. We used the Cox proportional hazards model to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) of RLS. RLS was more prevalent in IBS patients than in the non-IBS group (7.57 versus 3.36 per 10,000 person-years), with an increased risk of RLS (adjusted HR [aHR], 1.91; 95% CI, 1.52-2.40). Multivariate Cox proportional hazards analysis identified older age (age, 51-65 years; aHR, 1.67; 95% CI, 1.09-2.56; and age > 65; aHR, 1.59; 95% CI, 1.02-2.48), hypothyroidism (aHR, 4.24; 95% CI, 1.92-9.37), CAD (aHR, 1.70; 95% CI, 1.17-2.48), and depression (aHR, 3.15; 95% CI, 2.14-4.64) as independent RLS risk factors in IBS patients. In addition, the male SSRIs users were associated with significantly higher risk of RLS (aHR, 3.05 95% CI, 1.34-6.92). Our study showed that the IBS group has higher risk of RLS. Moreover, SSRIs use may increase the risk of RLS in male IBS patients.	[Hsu, Yung-Chu] Chia Yi Christian Hosp, Dept Internal Med, Div Neurol, Ditmanson Med Fdn, Chiayi, Taiwan; [Yang, Hsin-Yi; Huang, Wan-Ting] Chia Yi Christian Hosp, Clin Med Res Ctr, Ditmanson Med Fdn, Chiayi, Taiwan; [Chen, Solomon Chih-Cheng] Taipei Med Univ, Coll Med, Sch Med, Dept Pediat, Taipei, Taiwan; [Chen, Solomon Chih-Cheng] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Pediat, Kaohsiung, Taiwan; [Lee, Herng-Sheng] Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan	Taipei Medical University; Kaohsiung Medical University; Kaohsiung Veterans General Hospital	Yang, HY (corresponding author), Chia Yi Christian Hosp, Clin Med Res Ctr, Ditmanson Med Fdn, Chiayi, Taiwan.; Lee, HS (corresponding author), Kaohsiung Vet Gen Hosp, Dept Pathol & Lab Med, Kaohsiung, Taiwan.	cych13018@gmail.com; herngsheng131419@gmail.com		Yang, Hsin-Yi/0000-0002-8571-5202				Acar BA, 2018, SINGAP MED J, V59, P539, DOI 10.11622/smedj.2018010; Acay A, 2016, WIEN KLIN WOCHENSCHR, V128, pS604, DOI 10.1007/s00508-016-1065-y; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allen RP, 2005, ARCH INTERN MED, V165, P1286, DOI 10.1001/archinte.165.11.1286; Basu PP, 2011, WORLD J GASTROENTERO, V17, P4404, DOI 10.3748/wjg.v17.i39.4404; Baughman KR, 2009, MOVEMENT DISORD, V24, P1054, DOI 10.1002/mds.22517; Borji R, 2012, J NEUROGASTROENTEROL, V18, P426, DOI 10.5056/jnm.2012.18.4.426; Brown LK, 2005, SLEEP MED, V6, P443, DOI 10.1016/j.sleep.2005.03.005; Chen BR, 2018, J GASTROENTEROL, V53, P807, DOI 10.1007/s00535-018-1476-9; Chen Longtu, 2017, Anesth Pain Med, V7, pe42747, DOI 10.5812/aapm.42747; Clouse RE, 2003, GUT, V52, P598, DOI 10.1136/gut.52.4.598; Connor JR, 2011, BRAIN, V134, P959, DOI 10.1093/brain/awr012; Cozma-Petrut A, 2017, WORLD J GASTROENTERO, V23, P3771, DOI 10.3748/wjg.v23.i21.3771; Cui X, 2013, NEUROSCIENCE, V236, P77, DOI 10.1016/j.neuroscience.2013.01.035; Dhawan V, 2006, POSTGRAD MED J, V82, P626, DOI 10.1136/pgmj.2006.045690; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Ford AC, 2009, GUT, V58, P367, DOI 10.1136/gut.2008.163162; Ford AC, 2017, NEW ENGL J MED, V376, P2566, DOI 10.1056/NEJMra1607547; Guo SY, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00171; Hsiao CW, 2014, EUR J INTERN MED, V25, P82, DOI 10.1016/j.ejim.2013.11.005; Khan FH, 2017, J NEUROL, V264, P1634, DOI 10.1007/s00415-017-8431-1; Khayyat Yasir, 2015, Oman Med J, V30, P115, DOI 10.5001/omj.2015.25; Kolla BP, 2018, SLEEP MED REV, V38, P131, DOI 10.1016/j.smrv.2017.06.002; Lai SW, 2014, EUR J EPIDEMIOL, V29, P57, DOI [10.1007/s10654-014-9878-3, 10.1007/s10654-014-9903-6]; Lee HB, 2008, J NEUROPSYCH CLIN N, V20, P101, DOI 10.1176/jnp.2008.20.1.101; Leutgeb U, 2002, EUR J MED RES, V7, P368; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; McKenzie YA, 2016, J HUM NUTR DIET, V29, P549, DOI 10.1111/jhn.12385; Nellesen D, 2013, POSTGRAD MED, V125, DOI 10.3810/pgm.2013.03.2640; Norgaard M, 2011, BRIT J CANCER, V104, P1202, DOI 10.1038/bjc.2011.65; Ohayon MM, 2012, SLEEP MED REV, V16, P283, DOI 10.1016/j.smrv.2011.05.002; Patatanian E, 2018, ANN PHARMACOTHER, V52, P662, DOI 10.1177/1060028018760296; Pimentel M, 2004, ANN RHEUM DIS, V63, P450, DOI 10.1136/ard.2003.011502; Rothdach AJ, 2000, NEUROLOGY, V54, P1064, DOI 10.1212/WNL.54.5.1064; Rottach KG, 2008, J PSYCHIATR RES, V43, P70, DOI 10.1016/j.jpsychires.2008.02.006; Schlesinger I, 2009, MOVEMENT DISORD, V24, P1587, DOI 10.1002/mds.22486; Sramek JJ, 2016, DIALOGUES CLIN NEURO, V18, P447; Szentkiralyi A, 2011, SLEEP MED, V12, P815, DOI 10.1016/j.sleep.2011.06.016; Tan EK, 2004, PARKINSONISM RELAT D, V10, P149, DOI 10.1016/j.parkreldis.2003.11.003; Tasdemir M, 2010, SLEEP MED, V11, P82, DOI 10.1016/j.sleep.2008.10.008; Trenkwalder C, 2016, NEUROLOGY, V86, P1336, DOI 10.1212/WNL.0000000000002542; Trotti LM, 2012, BRAIN BEHAV IMMUN, V26, P1239, DOI 10.1016/j.bbi.2012.06.003; Varim C, 2016, SINGAP MED J, V57, P514, DOI 10.11622/smedj.2016154; Weinstock LB, 2008, DIGEST DIS SCI, V53, P1252, DOI 10.1007/s10620-007-0021-0; Weinstock LB, 2012, SLEEP MED REV, V16, P341, DOI 10.1016/j.smrv.2011.09.003; Weinstock LB, 2011, SLEEP MED, V12, P610, DOI 10.1016/j.sleep.2011.03.007; Weinstock LB, 2010, SLEEP MED, V11, P427, DOI 10.1016/j.sleep.2009.06.005; Winkelmann J, 2017, SLEEP MED, V31, P18, DOI 10.1016/j.sleep.2016.10.012; Xie C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127815; Yang FC, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002646; Yang FC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002109; Yun CH, 2012, J SLEEP RES, V21, P569, DOI 10.1111/j.1365-2869.2012.01011.x; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9; Zhou FM, 2005, NEURON, V46, P65, DOI 10.1016/j.neuron.2005.02.010	55	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220641	10.1371/journal.pone.0220641	http://dx.doi.org/10.1371/journal.pone.0220641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369638	gold, Green Submitted, Green Published			2022-12-27	WOS:000484987900074
J	Lee, JG; Kim, SA; Eun, CS; Han, DS; Kim, YS; Choi, BY; Song, KS; Kim, HJ; Park, CH				Lee, Jae Gon; Kim, Shin Ah; Eun, Chang Soo; Han, Dong Soo; Kim, Young Sung; Choi, Bo Youl; Song, Kyu Sang; Kim, Hyun Ja; Park, Chan Hyuk			Impact of age on stage-specific mortality in patients with gastric cancer: A long-term prospective cohort study	PLOS ONE			English	Article							CLINICOPATHOLOGICAL CHARACTERISTICS; PROGNOSIS; SURVIVAL; YOUNG; OUTCOMES; MUCOSA; SCORE	Controversies exist regarding the impact of age on gastric cancer-related mortality according to cancer stage. In our prospective cohort study, we evaluated the impact of age on stage-specific mortality in patients with gastric cancer. Between 2002 and 2006, patients with newly diagnosed gastric cancer were recruited from two university-affiliated hospitals in Korea. Follow-up data were updated regularly based on medical records and telephone surveys. Patients were classified into four subgroups according to age: < 50, 50-59, 60-69, and 70-79 years. A total of 448 patients were followed up for 81.6 months (interquartile range, 25.0-139.3 months). The number of patients with stage I, II, III, and IV disease was 247, 74, 88, and 39, respectively. Overall, age was an independent risk factor for gastric cancer-specific mortality (hazard ratio [HR], [95% confidence interval (CI)]: 1.53 [0.91-2.57], 1.88 [1.21-2.91], and 2.64 [1.69-4.14] in the 50-59, 60-69, and 70-79 years groups, respectively, with the < 50 years group as reference). In patients with stage I and II gastric cancer, the 70-79 years group was associated with a significantly higher rate of cancer-specific mortality than the < 50 years group (stage I: HR [95% CI], 9.55 [2.11-43.12]; stage II: HR [95% CI], 7.17 [2.32-22.18]). However, age was not an independently associated factor for cancer-specific mortality in patients with stage III and IV gastric cancer. Although age was an independent risk factor for gastric cancer-related mortality in patients with gastric cancer, its impact may differ depending on the stage of cancer.	[Lee, Jae Gon; Eun, Chang Soo; Han, Dong Soo; Park, Chan Hyuk] Hanyang Univ, Coll Med, Dept Internal Med, Guri Hosp, Guri, Peoples R China; [Kim, Shin Ah; Kim, Hyun Ja] Gangneung Wonju Natl Univ, Dept Food & Nutr, Kangnung, South Korea; [Kim, Young Sung] KRIBB, Genome Editing Res Ctr, Daejeon, South Korea; [Kim, Young Sung] UST, Korea & Dept Funct Genom, Daejeon, South Korea; [Choi, Bo Youl] Hanyang Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Coll Med, Dept Pathol, Daejeon, South Korea	Hanyang University; Kangnung Wonju National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Hanyang University; Chungnam National University	Park, CH (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Guri Hosp, Guri, Peoples R China.; Kim, HJ (corresponding author), Gangneung Wonju Natl Univ, Dept Food & Nutr, Kangnung, South Korea.	wisekim@gwnu.ac.kr; yesable7@gmail.com	Han, Dong Soo/P-1753-2015; Park, Chan Hyuk/I-1794-2016; Lee, Jae Gon/AAE-7558-2022; Han, Dong Soo/AHD-6285-2022	Park, Chan Hyuk/0000-0003-3824-3481; Han, Dong Soo/0000-0001-7103-3318	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A3B03032996]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number: 2017R1D1A3B03032996, grant receiver: HJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2016, J SURG RES, V202, P428, DOI 10.1016/j.jss.2016.02.043; American Joint Committee on Cancer, DESK REF; Ariake K, 2014, J SURG ONCOL, V109, P586, DOI 10.1002/jso.23542; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujiwara Y, 2017, WORLD J GASTRO ONCOL, V9, P257, DOI 10.4251/wjgo.v9.i6.257; Hamilton SR, 2000, WHO CLASSIFICATION T; Isobe T, 2013, ONCOL REP, V30, P43, DOI 10.3892/or.2013.2467; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Kim KH, 2014, WORLD J GASTROENTERO, V20, P3369, DOI 10.3748/wjg.v20.i12.3369; Kubota T, 2014, ANN SURG ONCOL, V21, P891, DOI 10.1245/s10434-013-3384-9; Lai JF, 2008, ANN SURG ONCOL, V15, P1464, DOI 10.1245/s10434-008-9809-1; Levi Edi, 2014, World J Gastrointest Pathophysiol, V5, P366, DOI 10.4291/wjgp.v5.i3.366; Llanos O, 2006, WORLD J SURG, V30, P17, DOI 10.1007/s00268-005-7935-5; Nakamura R, 2011, INT J CLIN ONCOL, V16, P328, DOI 10.1007/s10147-011-0185-7; Nashimoto A, 2013, INT J CLIN ONCOL, V18, P969, DOI 10.1007/s10147-012-0498-1; Nelen SD, 2018, BRIT J SURG, V105, P1163, DOI 10.1002/bjs.10836; Orsenigo E, 2007, GASTRIC CANCER, V10, P39, DOI 10.1007/s10120-006-0409-0; Schlesinger-Raab A, 2017, VISC MED, V33, P245, DOI 10.1159/000477104; Schwarz RE, 2007, ANN SURG ONCOL, V14, P317, DOI 10.1245/s10434-006-9218-2; Sierzega M, 2010, BRIT J SURG, V97, P1035, DOI 10.1002/bjs.7038; Song P, 2016, ONCOTARGET, V7, P48614, DOI 10.18632/oncotarget.9548; Sonnenberg A, 2015, CLIN GASTROENTEROL H, V13, P2276, DOI 10.1016/j.cgh.2015.02.020; Tarnawski AS, 2014, J GASTROEN HEPATOL, V29, P112, DOI 10.1111/jgh.12734; Tavares A, 2013, PATHOL ONCOL RES, V19, P111, DOI 10.1007/s12253-012-9530-z; Wagner AD, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub4	26	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220660	10.1371/journal.pone.0220660	http://dx.doi.org/10.1371/journal.pone.0220660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369631	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900077
J	Parashar, P; Chen, CH; Akbar, C; Fu, ZM; Rawat, TS; Pratik, S; Butola, R; Chen, SH; Lin, AS				Parashar, Parag; Chen, Chun Han; Akbar, Chandni; Fu, Sze Ming; Rawat, Tejender S.; Pratik, Sparsh; Butola, Rajat; Chen, Shih Han; Lin, Albert S.			Analytics-statistics mixed training and its fitness to semisupervised manufacturing	PLOS ONE			English	Article							YIELD MANAGEMENT; MACHINE; PREDICTION; CLASSIFICATION; OPTIMIZATION; REGRESSION	While there have been many studies using machine learning (ML) algorithms to predict process outcomes and device performance in semiconductor manufacturing, the extensively developed technology computer-aided design (TCAD) physical models should play a more significant role in conjunction with ML. While TCAD models have been effective in predicting the trends of experiments, a machine learning statistical model is more capable of predicting the anomalous effects that can be dependent on the chambers, machines, fabrication environment, and specific layouts. In this paper, we use an analytics-statistics mixed training (ASMT) approach using TCAD. Under this method, the TCAD models are incorporated into the machine learning training procedure. The mixed dataset with the experimental and TCAD results improved the prediction in terms of accuracy. With the application of ASMT to the BOSCH process, we show that the mean square error (MSE) can be effectively decreased when the analytics-statistics mixed training (ASMT) scheme is used instead of the classic neural network (NN) used in the baseline study. In this method, statistical induction and analytical deduction can be combined to increase the prediction accuracy of future intelligent semiconductor manufacturing.	[Parashar, Parag; Akbar, Chandni; Rawat, Tejender S.; Pratik, Sparsh; Butola, Rajat] Natl Chiao Tung Univ, Coll Elect Engn & Comp Sci, Hsinchu, Taiwan; [Chen, Chun Han; Fu, Sze Ming; Chen, Shih Han; Lin, Albert S.] Natl Chiao Tung Univ, Inst Elect Engn, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, AS (corresponding author), Natl Chiao Tung Univ, Inst Elect Engn, Hsinchu, Taiwan.	hdtd5746@gmail.com	Akbar, Chandni/AFQ-1024-2022	Pratik, Sparsh/0000-0002-2927-7121	Ministry of Science and Technology (MOST) [106-2628-E-009 -010 -MY3]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China)	Funding support for this work is provided by The Ministry of Science and Technology (MOST) under grant no. 106-2628-E-009 -010 -MY3.	Abrokwah KO, 2007, IEEE T SEMICONDUCT M, V20, P77, DOI 10.1109/TSM.2007.896638; Buitinck L., 2013, ECML PKDD WORKSH LAN, DOI DOI 10.48550/ARXIV.1309.0238; Choi A, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P2861; COBURN JW, 1989, APPL PHYS LETT, V55, P2730, DOI 10.1063/1.101937; Duo Ding, 2011, 2011 16th Asia and South Pacific Design Automation Conference, ASP-DAC 2011, P775, DOI 10.1109/ASPDAC.2011.5722294; Erman J, 2007, PERFORM EVALUATION, V64, P1194, DOI 10.1016/j.peva.2007.06.014; Fan XH, 2009, 2009 INTERNATIONAL JOINT CONFERENCE ON BIOINFORMATICS, SYSTEMS BIOLOGY AND INTELLIGENT COMPUTING, PROCEEDINGS, P529, DOI 10.1109/IJCBS.2009.27; Gaur Aditya, 2016, 2016 IEEE Sensors Applications Symposium (SAS), P1, DOI 10.1109/SAS.2016.7479866; Gosalvez MA, 2015, 2015 TRANSDUCERS - 2015 18TH INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS), P1255, DOI 10.1109/TRANSDUCERS.2015.7181158; Huang CY, 2018, IEEE ACCESS, V6, P78402, DOI 10.1109/ACCESS.2018.2885024; IRANI KB, 1993, IEEE EXPERT, V8, P41, DOI 10.1109/64.193054; Kampichler C, 2010, ECOL INFORM, V5, P441, DOI 10.1016/j.ecoinf.2010.06.003; Kang BS, 1998, EXPERT SYST APPL, V15, P123, DOI 10.1016/S0957-4174(98)00017-7; Kaur N., 2018, MAJLESI J ELECT ENG, V12, P61; Kaur N, 2019, ARAB J SCI ENG, V44, P3101, DOI 10.1007/s13369-018-3428-3; Kim B, 2006, MICROELECTRON ENG, V83, P513, DOI 10.1016/j.mee.2005.12.001; Kim B, 2003, IEEE T PLASMA SCI, V31, P1330, DOI 10.1109/TPS.2003.820681; Kim B, 2004, J APPL PHYS, V96, P3612, DOI 10.1063/1.1789276; Kim B, 2009, MICROELECTRON ENG, V86, P63, DOI 10.1016/j.mee.2008.09.015; Kingma D, 2015, 2015 ICLR; Laermer F., 1996, METHOD ANISOTROPICAL; Lai SL, 2006, J VAC SCI TECHNOL A, V24, P1283, DOI 10.1116/1.2172944; Larranaga P, 2006, BRIEF BIOINFORM, V7, P86, DOI 10.1093/bib/bbk007; Lee SK, 2014, NEUROCOMPUTING, V131, P427, DOI 10.1016/j.neucom.2013.10.001; Lin WY, 2012, IEEE T SYST MAN CY C, V42, P421, DOI 10.1109/TSMCC.2011.2170420; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Menz W, 2005, MIKROSYSTEMTECHNIK I; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Moore A. W., 2005, Performance Evaluation Review, V33, P50, DOI 10.1145/1071690.1064220; Nanni L, 2010, ARTIF INTELL MED, V49, P117, DOI 10.1016/j.artmed.2010.02.006; Nguyen TTT, 2008, IEEE COMMUN SURV TUT, V10, P56, DOI 10.1109/SURV.2008.080406; Overstall AM, 2019, COMPUT STAT DATA AN, V132, P126, DOI 10.1016/j.csda.2018.10.013; Owens T, 2011, CVPR 2011; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qi T, 2004, LEARNING BASED KERNE, P461; Rahman MM, 2007, IEEE T INF TECHNOL B, V11, P58, DOI 10.1109/TITB.2006.884364; Shin CK, 2000, INT J PROD RES, V38, P4261, DOI 10.1080/00207540050205073; Sommer C, 2013, J CELL SCI; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; Wernick MN, 2010, IEEE SIGNAL PROC MAG, V27, P25, DOI 10.1109/MSP.2010.936730; Wuu J-Y, 2011, EFFICIENT APPROACH E, P8; Yu J, 2012, SEMICONDUCTOR MANUFA; Yu L, 2010, NEUROCOMPUTING, V73, P716, DOI 10.1016/j.neucom.2008.11.035; Yuan T, 2008, EUR J OPER RES, V190, P228, DOI 10.1016/j.ejor.2007.06.007	47	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220607	10.1371/journal.pone.0220607	http://dx.doi.org/10.1371/journal.pone.0220607			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408473	Green Published, Green Submitted, gold			2022-12-27	WOS:000485009500015
J	Choi, JG; Huh, E; Kim, N; Kim, DH; Oh, MS				Choi, Jin Gyu; Huh, Eugene; Kim, Namkwon; Kim, Dong-Hyun; Oh, Myung Sook			High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PARKINSONS-DISEASE; NONMOTOR SYMPTOMS; BRAIN AXIS; SYMPATHETIC INNERVATION; PROBIOTIC MIXTURE; MODEL; DYSFUNCTION; DISORDERS; DIAGNOSIS	Recently, there has been a rapid increase in studies on the relationship between brain diseases and gut microbiota, and clinical evidence on gut microbial changes in Parkinson's disease (PD) has accumulated. 6-Hydroxydopamine (6-OHDA) is a widely used neurotoxin that leads to PD pathogenesis, but whether 6-OHDA affects gut microbial environment has not been investigated. Here we performed the 16S rRNA gene sequencing to analyze the gut microbial community of mice. We found that there were no significant changes in species richness and its diversity in the 6-OHDA-lesioned mice. The relative abundance of Lactobacillus gasseri and L. reuteri probiotic species in feces of 6-OHDA-lesioned mice was significantly decreased compared with those of sham-operated mice, while the commensal bacterium Bacteroides acidifaciens in 6-OHDA-treated mice was remarkably higher than sham-operated mice. These results provide a baseline for understanding the microbial communities of 6-OHDA-induced PD model to investigate the role of gut microbiota in the pathogenesis of PD.	[Choi, Jin Gyu; Huh, Eugene; Oh, Myung Sook] Kyung Hee Univ, Coll Pharm, Dept Oriental Pharmaceut Sci, Seoul, South Korea; [Choi, Jin Gyu; Huh, Eugene; Oh, Myung Sook] Kyung Hee Univ, Kyung Hee East West Pharmaceut Res Inst, Seoul, South Korea; [Huh, Eugene] Kyung Hee Univ, Grad Sch, Dept Med Sci Meridian, Seoul, South Korea; [Kim, Namkwon; Kim, Dong-Hyun; Oh, Myung Sook] Kyung Hee Univ, Grad Sch, Dept Life & Nanopharmaceut Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University	Oh, MS (corresponding author), Kyung Hee Univ, Coll Pharm, Dept Oriental Pharmaceut Sci, Seoul, South Korea.; Oh, MS (corresponding author), Kyung Hee Univ, Kyung Hee East West Pharmaceut Res Inst, Seoul, South Korea.; Oh, MS (corresponding author), Kyung Hee Univ, Grad Sch, Dept Life & Nanopharmaceut Sci, Seoul, South Korea.	msohok@khu.ac.kr	Oh, Myung Sook/AAH-9948-2020	Oh, Myung Sook/0000-0001-8189-4066	National Research Foundation of Korea (NRF) - Korea government (MEST) [NRF2015R1A2A2A01004341]; Medical Research Center Program through the NRF - Ministry of Science and ICT [NRF2017R1A5A2014768]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); Medical Research Center Program through the NRF - Ministry of Science and ICT	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (NRF2015R1A2A2A01004341), to MSO; Medical Research Center Program through the NRF funded by the Ministry of Science and ICT (NRF2017R1A5A2014768), to MSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; .	Alrafas HR, 2019, J LEUKOCYTE BIOL, V106, P467, DOI 10.1002/JLB.3A1218-476RR; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Antonini A, 2012, J NEUROL, V259, P2621, DOI 10.1007/s00415-012-6557-8; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 2004, J PEDIATR GASTR NUTR, V38, P414, DOI 10.1097/00005176-200404000-00009; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonfili L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02587-2; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Bundzikova-Osacka J, 2015, STRESS, V18, P221, DOI 10.3109/10253890.2015.1013531; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Delang C.O., 2013, ECOLOGICAL SUCCESSIO, VVolume 978, P39; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Dinan TG, 2012, PSYCHONEUROENDOCRINO, V37, P1369, DOI 10.1016/j.psyneuen.2012.03.007; Donaldson GP, 2018, SCIENCE, V360, P795, DOI 10.1126/science.aaq0926; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Galley JD, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-189; Georgescu D, 2016, CLIN INTERV AGING, V11, P1601, DOI 10.2147/CIA.S106284; Gerhardt S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060708; Gonzalez-Ariki S, 2000, DEV COMP IMMUNOL, V24, P61, DOI 10.1016/S0145-305X(99)00056-7; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hopfner F, 2017, BRAIN RES, V1667, P41, DOI 10.1016/j.brainres.2017.04.019; Houlden A, 2016, BRAIN BEHAV IMMUN, V57, P10, DOI 10.1016/j.bbi.2016.04.003; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kato LM, 2014, IMMUNOL CELL BIOL, V92, P49, DOI 10.1038/icb.2013.54; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Kwon HK, 2013, CLIN IMMUNOL, V146, P217, DOI 10.1016/j.clim.2013.01.001; Lavasani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009009; Lo BC, 2019, J IMMUNOL, V202, P956, DOI 10.4049/jimmunol.1801308; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Mukherjee A, 2016, WORLD J GASTROENTERO, V22, P5742, DOI 10.3748/wjg.v22.i25.5742; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Ojetti V, 2014, J GASTROINTEST LIVER, V23, P387, DOI 10.15403/jgld.2014.1121.234.elr; Olanow CW, 2014, MOVEMENT DISORD, V29, P963, DOI 10.1002/mds.25966; Park AJ, 2013, NEUROGASTROENT MOTIL, V25, P733, DOI 10.1111/nmo.12153; Paxinos G, 2012, PAXINOS FRANKLINS MO; Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002; Petrov VA, 2017, B EXP BIOL MED+, V162, P734, DOI 10.1007/s10517-017-3700-7; Pistollato F, 2016, NUTR REV, V74, P624, DOI 10.1093/nutrit/nuw023; Ribiere C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31027; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shultz Jeanette M, 2016, J Alzheimers Dis Parkinsonism, V6, DOI 10.4172/2161-0460.1000279; Simola N, 2007, NEUROTOX RES, V11, P151, DOI 10.1007/BF03033565; Soderholm JD, 2002, AM J PHYSIOL-GASTR L, V283, pG1257, DOI 10.1152/ajpgi.00314.2002; Thiele SL, 2012, JOVE-J VIS EXP, DOI 10.3791/3234; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; Varghese AK, 2006, GASTROENTEROLOGY, V130, P1743, DOI 10.1053/j.gastro.2006.02.007; Wang SQ, 2019, NEUROSCI LETT, V696, P93, DOI 10.1016/j.neulet.2018.12.021; WILLIAMS JM, 1981, BRAIN RES BULL, V6, P83, DOI 10.1016/S0361-9230(81)80072-X; Yanagibashi T, 2013, IMMUNOBIOLOGY, V218, P645, DOI 10.1016/j.imbio.2012.07.033; YODLOWSKI ML, 1984, J NEUROSCI, V4, P1535; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Zheng LF, 2014, ACTA PHYSIOL, V211, P434, DOI 10.1111/apha.12229; Zhu XQ, 2017, ONCOTARGET, V8, P53829, DOI 10.18632/oncotarget.17754	65	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0217194	10.1371/journal.pone.0217194	http://dx.doi.org/10.1371/journal.pone.0217194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404072	gold, Green Published, Green Submitted			2022-12-27	WOS:000485006800003
J	Kanai, Y; Ishiki, H; Maeda, I; Iwase, S				Kanai, Yoshiaki; Ishiki, Hiroto; Maeda, Isseki; Iwase, Satoru			A survey of practice in management of malignancy-related ascites in Japan	PLOS ONE			English	Article							REINFUSION THERAPY CART; CANCER-PATIENTS; DEXAMETHASONE; HYDRATION	Although ascites is a distressing complication observed commonly in the course of advanced cancer, there is no effective treatment established for malignancy-related ascites. We conducted a nationwide survey of cancer physicians in Japan who treat malignancy related ascites in order to determine what kind of therapeutic approach is thought to be significant and what kind of diuretic prescriptions are thought to be standard for malignancy related ascites. From 2017 to 2018, we sent a one-page memo to oncologists in Japan asking them to participate in a questionnaire-style survey that they could complete online. The significance of each of the nine representative interventions was measured on a 5-stage Likert scale. At the same time, participants were asked about what type and dosage of diuretics they thought to be standard as a treatment for malignancy-related ascites. Ultimately, 187 oncologists responded to our invitation. The interventions that were particularly significant were reducing hydration volume, paracentesis, and symptom management with analgesics. The respondents indicated that the importance of diuretics was significantly lower than that of these three interventions. Furthermore, 86.2% of the respondents in Japan regarded the use of loop diuretics aldosterone antagonists as the standard of diuretic therapy for malignancy-related ascites, and the most common regimen was 20 mg of oral furosemide 25 mg of spironolactone daily at the start, and 30-40 mg 50 mg daily at the time of initial escalation. Although our study revealed that the attitude of oncologists in Japan toward therapeutic options for malignancy-related ascites was nearly consistent with that of previous reports from other countries, it was newly found that they seemed to commonly be concerned with preventing overhydration of terminally ill cancer patients and that analgesics were also thought to be a significant form of intervention.	[Kanai, Yoshiaki] TMG Asaka Med Ctr, Palliat Care Ctr, Saitama, Japan; [Kanai, Yoshiaki] Univ Tokyo Hosp, Div Palliat Med, Tokyo, Japan; [Ishiki, Hiroto] Natl Canc Ctr, Dept Palliat Med, Tokyo, Japan; [Maeda, Isseki] Gratia Hosp, Gratia Hospice, Osaka, Japan; [Iwase, Satoru] Saitama Med Univ, Dept Palliat Med, Saitama, Japan	University of Tokyo; National Cancer Center - Japan; Saitama Medical University	Kanai, Y (corresponding author), TMG Asaka Med Ctr, Palliat Care Ctr, Saitama, Japan.; Kanai, Y (corresponding author), Univ Tokyo Hosp, Div Palliat Med, Tokyo, Japan.	kanai-hongou@umin.ac.jp	Hiroto, Ishiki/AHC-0321-2022	Maeda, Isseki/0000-0002-0018-3359	Japanese society of palliative medicine	Japanese society of palliative medicine	This work was supported by the Japanese society of palliative medicine (https://www.jspm.ne.jp/) to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker G, 2006, EUR J CANCER, V42, P589, DOI 10.1016/j.ejca.2005.11.018; Bruera E, 2004, J PAIN SYMPTOM MANAG, V28, P381, DOI 10.1016/j.jpainsymman.2004.01.009; Bruera E, 2013, J CLIN ONCOL, V31, P111, DOI 10.1200/JCO.2012.44.6518; GOUGH IR, 1993, CANCER, V71, P2377, DOI 10.1002/1097-0142(19930401)71:7<2377::AID-CNCR2820710732>3.0.CO;2-H; Hardy JR, 2001, PALLIATIVE MED, V15, P3, DOI 10.1191/026921601673324846; Jehn CF, 2015, SUPPORT CARE CANCER, V23, P2073, DOI 10.1007/s00520-014-2557-9; Lee CW, 1998, J PAIN SYMPTOM MANAG, V16, P96, DOI 10.1016/S0885-3924(98)00037-2; Morita T, 2005, ANN ONCOL, V16, P640, DOI 10.1093/annonc/mdi121; Newman G, 2006, CLIN ONCOL-UK, V18, P154, DOI 10.1016/j.clon.2005.11.016; POCKROS PJ, 1992, GASTROENTEROLOGY, V103, P1302, DOI 10.1016/0016-5085(92)91520-E; Riedel AN, 2018, WORLD J GASTROENTERO, V24, P1650, DOI 10.3748/wjg.v24.i15.1650; RUNYON BA, 1988, HEPATOLOGY, V8, P1104, DOI 10.1002/hep.1840080521; Runyon Bruce A., AM ASS STUDY LIVER D, P66; Teunissen SCCM, 2007, J PAIN SYMPTOM MANAG, V34, P94, DOI 10.1016/j.jpainsymman.2006.10.015; Togami S, 2014, EUR J GYNAECOL ONCOL, V35, P301; Yamaguchi H, 2015, EJSO-EUR J SURG ONC, V41, P875, DOI 10.1016/j.ejso.2015.04.013	16	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220869	10.1371/journal.pone.0220869	http://dx.doi.org/10.1371/journal.pone.0220869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398238	gold, Green Published, Green Submitted			2022-12-27	WOS:000485004000024
J	Kulkarni, G				Kulkarni, Gourihar			Ice nucleation ability of loess from the northwestern United States	PLOS ONE			English	Article							MINERAL DUST PARTICLES; SURFACE SITE DENSITY; ADSORPTION; AEROSOL; NUCLEI; WATER	The heterogeneous nucleation of ice processes involving loess particles that influences the formation of mixed-phase clouds are poorly understood. Here, the ice nucleating ability of wind-blown dust or loess accumulated from the past glaciated area was investigated at three temperatures:-26,-30, and -34 degrees C and at below and above saturation with respect to liquid water conditions. Total six loess samples from different regions across Columbia Basin province, WA, USA were collected, dry dispersed, size-selected at mobility diameter 200 nm, and investigated for their ice nucleation efficiency. To understand the effect of atmospheric processing during long-range transport on their ice nucleating ability, similar experiments were also performed on acid-treated loess samples. Additionally, the ice nucleating properties of Arizona Test Dust (ATD) were investigated as a surrogate for natural mineral dust particles to test the experimental approach. Results show that treated particles have lower ice nucleation efficiency compared to untreated particles at all temperature and saturation with respect to liquid water conditions. Comparison based on ice-active site density (N-s) metric indicate that loess particles at saturation with respect to liquid water conditions are marginally more efficient than the mineral and soil dust values reported in the literature, but they have lower efficiencies than the predicted N-s efficiency of K-feldspar particles at supercooled temperatures greater than -38 degrees C.	[Kulkarni, Gourihar] Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Kulkarni, G (corresponding author), Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA.	Gourihar.Kulkarni@pnnl.gov			US DOE	US DOE(United States Department of Energy (DOE))	This work was supported by the US DOE to GK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JD, 2013, NATURE, V498, P355, DOI 10.1038/nature12278; Baron PAaW, 2001, MEASUREMENT PRINCIPL; Chernoff DI, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014254; China S, 2017, J GEOPHYS RES-ATMOS, V122, P3065, DOI 10.1002/2016JD025817; Connolly PJ, 2009, ATMOS CHEM PHYS, V9, P2805, DOI 10.5194/acp-9-2805-2009; Crouvi O, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001083; DeMott PJ, 2018, ATMOS MEAS TECH, V11, P6231, DOI 10.5194/amt-11-6231-2018; Friedman B, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015999; Gaylord DR, 2003, QUATERNARY GEOLOGY U, P438; Hiranuma N, 2015, ATMOS CHEM PHYS, V15, P2489, DOI 10.5194/acp-15-2489-2015; Hiranuma N, 2019, ATMOS CHEM PHYS, V19, P4823, DOI 10.5194/acp-19-4823-2019; Knopf DA, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006894; Kulkarni G, 2012, ATMOS CHEM PHYS, V12, P7295, DOI 10.5194/acp-12-7295-2012; Kulkarni G, 2018, ATMOSPHERE-BASEL, V9, DOI 10.3390/atmos9020055; Kulkarni G, 2014, J GEOPHYS RES-ATMOS, V119, P9993, DOI 10.1002/2014JD021567; Marcolli C, 2014, ATMOS CHEM PHYS, V14, P2071, DOI 10.5194/acp-14-2071-2014; Mason RH, 2016, ATMOS CHEM PHYS, V16, P1637, DOI 10.5194/acp-16-1637-2016; Muhs DR, 2013, AEOLIAN RES, V9, P3, DOI 10.1016/j.aeolia.2012.08.001; Muhs DR., 2014, GLOBAL CHANGES, V22, P84, DOI [10.22498/pages.22.2, DOI 10.22498/PAGES.22.2]; Muhs DR, 2013, LOESS ITS GEOMORPHIC; Murphy DM, 2005, Q J ROY METEOR SOC, V131, P1539, DOI 10.1256/qj.04.94; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Niedermeier D, 2011, ATMOS CHEM PHYS, V11, P11131, DOI 10.5194/acp-11-11131-2011; Niedermeier D, 2015, J GEOPHYS RES-ATMOS, V120, P5036, DOI 10.1002/2014JD022814; Niemand M, 2012, J ATMOS SCI, V69, P3077, DOI 10.1175/JAS-D-11-0249.1; Panda AK, 2010, COLLOID SURFACE A, V363, P98, DOI 10.1016/j.colsurfa.2010.04.022; Paramonov M, 2018, ATMOS CHEM PHYS, V18, P16515, DOI 10.5194/acp-18-16515-2018; Pye K, 1995, QUATERNARY SCI REV, V14, P653, DOI 10.1016/0277-3791(95)00047-X; Reitz P, 2011, ATMOS CHEM PHYS, V11, P7839, DOI 10.5194/acp-11-7839-2011; Sihvonen SK, 2014, J PHYS CHEM A, V118, P8787, DOI 10.1021/jp504846g; Steinke I, 2015, ATMOS CHEM PHYS, V15, P3703, DOI 10.5194/acp-15-3703-2015; Sullivan RC, 2010, ATMOS CHEM PHYS, V10, P11471, DOI 10.5194/acp-10-11471-2010; Sullivan RC, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045540; Suski KJ, 2018, ATMOS CHEM PHYS, V18, P13755, DOI 10.5194/acp-18-13755-2018; Sweeney MR, 2004, GEOLOGY, V32, P705, DOI 10.1130/G20584.1; Tang MJ, 2016, CHEM REV, V116, P4205, DOI 10.1021/acs.chemrev.5b00529; Tobo Y, 2014, ATMOS CHEM PHYS, V14, P8521, DOI 10.5194/acp-14-8521-2014; Tobo Y, 2019, NAT GEOSCI, V12, P253, DOI 10.1038/s41561-019-0314-x; Tobo Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053007; Vali G, 2015, ATMOS CHEM PHYS, V15, P10263, DOI 10.5194/acp-15-10263-2015; Veghte DP, 2014, AEROSOL SCI TECH, V48, P715, DOI 10.1080/02786826.2014.920484; Volzone C, 2011, J ENVIRON MANAGE, V92, P2590, DOI 10.1016/j.jenvman.2011.05.031; Wex H, 2014, ATMOS CHEM PHYS, V14, P5529, DOI 10.5194/acp-14-5529-2014; Woodward X, 2015, AEROSOL SCI TECH, V49, P229, DOI 10.1080/02786826.2015.1017550	45	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220991	10.1371/journal.pone.0220991	http://dx.doi.org/10.1371/journal.pone.0220991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398218	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000038
J	Barone, M; Turroni, S; Rampelli, S; Soverini, M; D'Amico, F; Biagi, E; Brigidi, P; Troiani, E; Candela, M				Barone, Monica; Turroni, Silvia; Rampelli, Simone; Soverini, Matteo; D'Amico, Federica; Biagi, Elena; Brigidi, Patrizia; Troiani, Emidio; Candela, Marco			Gut microbiome response to a modern Paleolithic diet in a Western lifestyle context	PLOS ONE			English	Article							INFLAMMATION; IMPACT	The modern Paleolithic diet (MPD), featured by the consumption of vegetables, fruit, nuts, seeds, eggs, fish and lean meat, while excluding grains, dairy products, salt and refined sugar, has gained substantial public attention in recent years because of its potential multiple health benefits. However, to date little is known about the actual impact of this dietary pattern on the gut microbiome (GM) and its implications for human health. In the current scenario where Western diets, low in fiber while rich in industrialized and processed foods, are considered one of the leading causes of maladaptive GM changes along human evolution, likely contributing to the increasing incidence of chronic non-communicable diseases, we hypothesize that the MPD could modulate the Western GM towards a more "ancestral" configuration. In an attempt to shed light on this, here we profiled the GM structure of urban Italian subjects adhering to the MPD, and compared data with other urban Italians following a Mediterranean Diet (MD), as well as worldwide traditional hunter-gatherer populations from previous publications. Notwithstanding a strong geography effect on the GM structure, our results show an unexpectedly high degree of biodiversity in MPD subjects, which well approximates that of traditional populations. The GM of MPD individuals also shows some peculiarities, including a high relative abundance of bile-tolerant and fat-loving microorganisms. The consumption of plant-based foods-albeit with the exclusion of grains and pulses-along with the minimization of the intake of processed foods, both hallmarks of the MPD, could therefore contribute to partially rewild the GM but caution should be taken in adhering to this dietary pattern in the long term.	[Barone, Monica; Turroni, Silvia; Rampelli, Simone; Soverini, Matteo; D'Amico, Federica; Biagi, Elena; Brigidi, Patrizia; Candela, Marco] Univ Bologna, Dept Pharm & Biotechnol, Unit Microbial Ecol Hlth, Bologna, Italy; [Troiani, Emidio] Social Secur Inst, Primary Care Unit, Cailungo, San Marino; [Troiani, Emidio] Social Secur Inst, Terr Hlth, Cailungo, San Marino	University of Bologna	Turroni, S (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Unit Microbial Ecol Hlth, Bologna, Italy.	silvia.turroni@unibo.it	Rampelli, Simone/K-5675-2016; Barone, Monica/AAA-3514-2019; Turroni, Silvia/J-7195-2016; D'Amico, Federica/AAA-7556-2019; TROIANI, EMIDIO/AHC-2826-2022	Rampelli, Simone/0000-0002-5655-6695; Turroni, Silvia/0000-0003-2345-9482; D'Amico, Federica/0000-0002-2136-9558; TROIANI, EMIDIO/0000-0002-5173-8174; Soverini, Matteo/0000-0002-3026-9460; Barone, Monica/0000-0001-5229-570X				Ayeni FA, 2018, CELL REP, V23, P3056, DOI 10.1016/j.celrep.2018.05.018; Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016; Blaser MJ, 2017, NAT REV IMMUNOL, V17, P461, DOI 10.1038/nri.2017.77; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Cani PD, 2018, NAT REV GASTRO HEPAT, V15, P671, DOI 10.1038/s41575-018-0025-6; Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Dall'Asta C, 2012, MOL NUTR FOOD RES, V56, P632, DOI 10.1002/mnfr.201100515; Danchin A, 2018, ENVIRON MICROBIOL, V20, P1966, DOI 10.1111/1462-2920.14255; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Davenport ER, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0454-7; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Genoni A, 2016, NUTRIENTS, V8; Genoni A, 2019, BRIT J NUTR, V121, P322, DOI 10.1017/S000711451800329X; Girard C, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00297-16; Gorvitovskaia A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0160-7; Groves HT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00182; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x; Johnson KVA, 2016, GUT MICROBES, V7, P455, DOI 10.1080/19490976.2016.1241933; Jonsson T, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-35; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lindeberg S, 2007, DIABETOLOGIA, V50, P1795, DOI 10.1007/s00125-007-0716-y; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Martin G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01153; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mellberg C, 2014, EUR J CLIN NUTR, V68, P350, DOI 10.1038/ejcn.2013.290; Moeller AH, 2014, P NATL ACAD SCI USA, V111, P16431, DOI 10.1073/pnas.1419136111; Mosca A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00455; Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505; Otten J, 2018, DIABETOLOGIA, V61, P1548, DOI 10.1007/s00125-018-4618-y; Otten J, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2828; Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Whalen KA, 2016, J NUTR, V146, P1217, DOI 10.3945/jn.115.224048; Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zuo T, 2018, NAT REV GASTRO HEPAT, V15, P440, DOI 10.1038/s41575-018-0003-z	48	34	37	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220619	10.1371/journal.pone.0220619	http://dx.doi.org/10.1371/journal.pone.0220619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393934	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500048
J	Rider, AT; Henning, GB; Stockman, A				Rider, Andrew T.; Henning, G. Bruce; Stockman, Andrew			Light adaptation controls visual sensitivity by adjusting the speed and gain of the response to light	PLOS ONE			English	Article							TIME-DEPENDENT STIMULI; MODULATION SENSITIVITY; DYNAMIC PROPERTIES; TEMPORAL IMPULSE; GANGLION-CELLS; PRIMATE CONES; FLICKER; ISOCHROME; MODEL; LUMINANCE	The range of c. 10(12) ambient light levels to which we can be exposed massively exceeds the <10(3) response range of neurons in the visual system, but we can see well in dim starlight and bright sunlight. This remarkable ability is achieved largely by a speeding up of the visual response as light levels increase, causing characteristic changes in our sensitivity to different rates of flicker. Here, we account for over 65 years of flicker-sensitivity measurements with an elegantly-simple, physiologically-relevant model built from first-order low-pass filters and subtractive inhibition. There are only two intensity-dependent model parameters: one adjusts the speed of the visual response by shortening the time constants of some of the filters in the direct cascade as well as those in the inhibitory stages; the other parameter adjusts the overall gain at higher light levels. After reviewing the physiological literature, we associate the variable gain and three of the variable-speed filters with biochemical processes in cone photoreceptors, and a further variable-speed filter with processes in ganglion cells. The variable-speed but fixed-strength subtractive inhibition is most likely associated with lateral connections in the retina. Additional fixed-speed filters may be more central. The model can explain the important characteristics of human flicker-sensitivity including the approximate dependences of low-frequency sensitivity on contrast (Weber's law) and of high-frequency sensitivity on amplitude ("high-frequency linearity"), the exponential loss of high-frequency sensitivity with increasing frequency, and the logarithmic increase in temporal acuity with light level (Ferry-Porter law). In the time-domain, the model can account for several characteristics of flash sensitivity including changes in contrast sensitivity with light level (de Vries-Rose and Weber's laws) and changes in temporal summation (Bloch's law). The new model provides fundamental insights into the workings of the visual system and gives a simple account of many visual phenomena.	[Rider, Andrew T.; Henning, G. Bruce; Stockman, Andrew] UCL, UCL Inst Ophthalmol, London, England	University of London; University College London	Stockman, A (corresponding author), UCL, UCL Inst Ophthalmol, London, England.	a.stockman@ucl.ac.uk		Rider, Andy/0000-0001-8251-1100; Stockman, Andrew/0000-0001-9807-6289	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M01858X/1, BB/R019487/1]; BBSRC [BB/M01858X/1, BB/R019487/1]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) grants BB/M01858X/1 and BB/R019487/1 to AS.; This work was supported by BBSRC grants BB/M01858X/1 and BB/R019487/1. We thank Rhea Eskew for comments and an anonymous reviewer who encouraged us to make substantial improvements to the original manuscript.	BARLOW HB, 1976, J PHYSIOL-LONDON, V259, P737, DOI 10.1113/jphysiol.1976.sp011492; Barten PGJ., 1999, CONTRAST SENSITIVITY, DOI 10.1117/3.353254; Baudin J, 2019, ELIFE, V8, DOI 10.7554/eLife.39166; BAYLOR DA, 1974, J PHYSIOL-LONDON, V242, P729, DOI 10.1113/jphysiol.1974.sp010732; Bills MA, 1920, LAG VISUAL SENSATION, Vvi; Bloch M. A. -M., 1885, CR HEBD ACAD SCI, V37, P493; BOYNTON RM, 1970, SCIENCE, V170, P1423, DOI 10.1126/science.170.3965.1423; Cao LH, 2014, P NATL ACAD SCI USA, V111, P2752, DOI 10.1073/pnas.1400268111; CHEN B, 1987, J PHYSIOL-LONDON, V394, P41, DOI 10.1113/jphysiol.1987.sp016859; DELAN.H, 1961, J OPT SOC AM, V51, P415, DOI 10.1364/JOSA.51.000415; DELANGE H, 1952, PHYSICA, V18, P935, DOI 10.1016/S0031-8914(52)80230-7; deLange H., 1957, ATTENUATION CHARACTE; DELANGEDZN H, 1958, J OPT SOC AM, V48, P777, DOI 10.1364/JOSA.48.000777; DONNER K, 1995, VISION RES, V35, P2255, DOI 10.1016/0042-6989(94)00319-H; Dunn FA, 2007, NATURE, V449, P603, DOI 10.1038/nature06150; Enoch JM, 1972, HDB SENSORY PHYSL, VVII, P537; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P579, DOI 10.1113/jphysiol.1975.sp010948; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; Eskew Jr R.T., 1999, COLOR VISION GENES P, P345, DOI DOI 10.1016/B978-012370880-9.00302-9; FUORTES MGF, 1964, J PHYSIOL-LONDON, V172, P239, DOI 10.1113/jphysiol.1964.sp007415; GEISLER WS, 1978, VISION RES, V18, P279, DOI 10.1016/0042-6989(78)90162-1; GRAHAM N, 1992, VISION RES, V32, P1373, DOI 10.1016/0042-6989(92)90230-G; GRAHAM N, 1992, VISION RES, V32, P779, DOI 10.1016/0042-6989(92)90193-M; HARTMANN EE, 1992, VISION RES, V32, P1163, DOI 10.1016/0042-6989(92)90018-E; Hecht S, 1936, J GEN PHYSIOL, V19, P965, DOI 10.1085/jgp.19.6.965; Hood DC, 1998, ANNU REV PSYCHOL, V49, P503, DOI 10.1146/annurev.psych.49.1.503; Howlett MHC, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001210; Ives HE, 1922, J OPT SOC AM REV SCI, V6, P343, DOI 10.1364/JOSA.6.000343; Kamar S, 2019, J VISION, V19, DOI 10.1167/19.5.14; Kaufman L, 1986, HDB PERCEPTION HUMAN, Vfirst, P1; KELLY DH, 1961, J OPT SOC AM, V51, P422, DOI 10.1364/JOSA.51.000422; KELLY DH, 1969, J OPT SOC AM, V59, P1665, DOI 10.1364/JOSA.59.001665; KELLY DH, 1962, J OPT SOC AM, V52, P89, DOI 10.1364/JOSA.52.000089; Kelly DH, 1972, HDB SENSORY PHYSL, VVII, P273; KULIKOWSKI JJ, 1971, VISION RES, V11, P83, DOI 10.1016/0042-6989(71)90206-9; LAUGHLIN SB, 1989, J EXP BIOL, V146, P39; LEE BB, 1990, J OPT SOC AM A, V7, P2223, DOI 10.1364/JOSAA.7.002223; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI 10.1090/qam/10666; MACLEOD DIA, 1978, ANNU REV PSYCHOL, V29, P613, DOI 10.1146/annurev.ps.29.020178.003145; MACLEOD DIA, 1993, NATURE, V361, P256, DOI 10.1038/361256a0; Manahilov V, 1998, VISION RES, V38, P447, DOI 10.1016/S0042-6989(97)00149-1; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MATIN L, 1968, J OPT SOC AM, V58, P404, DOI 10.1364/JOSA.58.000404; Packer OS, 2005, J VISION, V5, P1038, DOI 10.1167/5.11.9; Parinaud H., 1881, CR HEBD ACAD SCI, V93, P286; Petrova D, 2013, J VISION, V13, DOI 10.1167/13.7.15; Petrova D, 2013, J VISION, V13, DOI 10.1167/13.4.2; Porter TC, 1902, P R SOC LONDON, V70, P313, DOI 10.1098/rspl.1902.0032; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P714, DOI 10.1007/BF01564983; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P596, DOI 10.1007/BF01565761; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P569, DOI 10.1007/BF01565573; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P735, DOI 10.1007/BF01566229; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P553, DOI 10.1007/BF01571319; Pulfrich C., 1922, NATURWISSENSCHAFTEN, V10, P51; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; ROGERS BJ, 1972, VISION RES, V12, P909, DOI 10.1016/0042-6989(72)90014-4; ROUFS JAJ, 1981, VISION RES, V21, P1203, DOI 10.1016/0042-6989(81)90225-X; ROUFS JAJ, 1972, VISION RES, V12, P261, DOI 10.1016/0042-6989(72)90117-4; ROUFS JAJ, 1972, VISION RES, V12, P279, DOI 10.1016/0042-6989(72)90118-6; Rovamo J, 1999, VISION RES, V39, P533, DOI 10.1016/S0042-6989(98)00120-5; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Schultze M., 1866, ARCH MICROSK ANAT, V2, P175, DOI DOI 10.1007/BF02962033; SEIPLE W, 1992, VISION RES, V32, P2043, DOI 10.1016/0042-6989(92)90065-Q; Shapley R.M., 1984, PROG RETIN RES, V3, P263, DOI [DOI 10.1016/0278-4327(84)90011-7, 10.1016/0278-4327(84)90011-7]; Shapley R, 2009, VISION RES, V49, P907, DOI 10.1016/j.visres.2008.09.026; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Sinha R, 2017, CELL, V168, P413, DOI 10.1016/j.cell.2017.01.005; Smith VC, 2001, J NEUROPHYSIOL, V85, P545, DOI 10.1152/jn.2001.85.2.545; SPERLING G, 1968, J OPT SOC AM, V58, P1133, DOI 10.1364/JOSA.58.001133; Stiles W. S, 1978, MECH COLOUR VISION; Stockman A, 1998, VISION RES, V38, P3703, DOI 10.1016/S0042-6989(98)00049-2; Stockman A., 2010, OSA HDB OPTICS, V3rd Edn, p11.11; Stockman A, 2006, J VISION, V6, P1194, DOI 10.1167/6.11.5; Stockman A, 2017, J VISION, V17, DOI 10.1167/17.9.2; Stockman A, 2014, J VISION, V14, DOI 10.1167/14.3.1; Stockman A, 2010, J VISION, V10, DOI 10.1167/10.2.12; SWANSON WH, 1987, J OPT SOC AM A, V4, P1992, DOI 10.1364/JOSAA.4.001992; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; TRANCHINA D, 1984, NATURE, V310, P314, DOI 10.1038/310314a0; TYLER CW, 1985, J OPT SOC AM A, V2, P393, DOI 10.1364/JOSAA.2.000393; VALETON JM, 1983, VISION RES, V23, P1539, DOI 10.1016/0042-6989(83)90167-0; van Hateren H, 2005, J VISION, V5, P331, DOI 10.1167/5.4.5; van Hateren JH, 2007, J VISION, V7, DOI 10.1167/7.4.1; Veringa F., 1961, ENIGE NATUURKUNDIGE; vonKries J., 1894, BERICHT NATURFORSCHU, V9, P61; VonKries J., 1892, AM J SCI, V44, P192; VONWIEGAND TE, 1995, VISION RES, V35, P3037, DOI 10.1016/0042-6989(95)00047-4; Watson A.B., 2015, SID S SID S, V46, P30; Watson A. B., 1986, HDB PERCEPTION HUMAN, P6, DOI DOI 10.1016/0003-6870(87)90144-X	91	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220358	10.1371/journal.pone.0220358	http://dx.doi.org/10.1371/journal.pone.0220358			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390358	Green Submitted, Green Published, gold			2022-12-27	WOS:000484999400016
J	Grosse, C; Soltermann, A; Rechsteiner, M; Grosse, A				Grosse, Claudia; Soltermann, Alex; Rechsteiner, Markus; Grosse, Alexandra			Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome	PLOS ONE			English	Article							EML4-ALK FUSION GENE; KRAS MUTATIONS; CLINICAL CHARACTERISTICS; BRAIN METASTASIS; YOUNG-PATIENTS; CANCER; EGFR; FEATURES; SURVIVAL; PREVALENCE	Purpose Lung cancer in never smokers is recognized as a distinct molecular, clinicopathologic and epidemiologic entity. The aim of the study was to investigate the molecular profile in Swiss never smokers with lung adenocarcinoma and to correlate the mutation status with clinicopathologic and demographic patient characteristics and outcome. Methods One hundred thirty-eight never smokers diagnosed with lung adenocarcinoma at the University Hospital Zurich between 2011-2018 were included in the study. Data from the electronic medical records were reviewed to characterize clinicopathologic and demographic features, molecular profile, treatment and outcome. Results The majority of patients were female (58.7%) with a median age at diagnosis of 64.5 years (range, 27.1-94.2 years). The most common mutations were EGFR (58.7%) followed by ALK (12.3%), TP53 (5.8%), MET (5.8%), KRAS (4.3%), ERBB2 (4.3%), PIK3CA (2.9%), BRAF (2.2%), ROS1 (1.4%), RET (1.4%), CTNNB1 (0.7%), PARP1 (0.7%), TET1 (0.7%) and PIK3CG (0.7%). Median overall survival (mOS) was 51.0 months (mo). Early clinical stage (p = 0.002) and treatment with targeted therapy (HR 2.53, 95% CI 1.35-4.74, p = 0.004) were independently associated with longer mOS. Patients with oncogenic driver mutations had significantly longer mOS (52.2 mo) compared to patients without mutations (16.9 mo) (HR 3.38, 95% CI 1.52-7.55, p = 0.003). Besides, patients with EGFR mutated (57.8 mo) or ALK rearranged (59.9 mo) tumors had significantly longer mOS compared to the EGFR wildtype (35.0 mo), ALK wildtype (46.5 mo) and pan-negative (16.9 mo) cohorts (HR 2.35, 95% CI 1.37-4.04, p = 0.002; HR 7.80, 95% CI 3.28-18.55, p < 0.001; HR 3.96, 95% CI 1.21-12.95, p = 0.023 and HR 34.78, 95% CI 3.48-34.65, p = 0.003). Conclusion Never smokers with lung adenocarcinoma display distinct clinicopathologic and molecular features and are characterized by a high incidence of targetable mutations. Never smokers with targetable mutations have significantly longer survival compared to patients without mutations.	[Grosse, Claudia; Soltermann, Alex; Grosse, Alexandra] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Clin Pathol, Zurich, Switzerland; [Rechsteiner, Markus] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Diagnost Mol Pathol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Grosse, C (corresponding author), Univ Hosp Zurich, Inst Pathol & Mol Pathol, Clin Pathol, Zurich, Switzerland.	claudiagrosse@gmx.at	Soltermann, Alex/GRR-3265-2022; Soltermann, Alex/AAE-3012-2020	Soltermann, Alex/0000-0001-9509-6938				Bauml J, 2013, LUNG CANCER, V81, P347, DOI 10.1016/j.lungcan.2013.05.011; Brierley JD, 2017, TNM CLASSIFICATION M; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Costa DB, 2015, J CLIN ONCOL, V33, P1881, DOI 10.1200/JCO.2014.59.0539; Couraud S, 2015, EUR RESPIR J, V45, P1403, DOI 10.1183/09031936.00097214; Couraud S, 2012, EUR J CANCER, V48, P1299, DOI 10.1016/j.ejca.2012.03.007; Eichler AF, 2010, NEURO-ONCOLOGY, V12, P1193, DOI 10.1093/neuonc/noq076; Fekrazad MH, 2007, J CLIN ONCOL, V25, P5024, DOI 10.1200/JCO.2007.13.3751; Fidler MM, 2017, LANCET ONCOL, V18, P1579, DOI 10.1016/S1470-2045(17)30677-0; Gao B, 2010, J THORAC ONCOL, V5, P1130, DOI 10.1097/JTO.0b013e3181e05016; Gounant V, 2007, LUNG CANCER, V58, P425, DOI 10.1016/j.lungcan.2007.07.010; Grosse A, 2019, DIAGN PATHOL, V14, DOI 10.1186/s13000-019-0789-1; Hsu CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-241; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kim HR, 2012, CANCER-AM CANCER SOC, V118, P729, DOI 10.1002/cncr.26311; Korpanty Grzegorz J, 2018, Oncotarget, V9, P22559, DOI 10.18632/oncotarget.25176; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lee CK, 2015, J CLIN ONCOL, V33, DOI [10.1200/JCO.2014.60.4769, DOI 10.1200/JCO.2014.60.4769]; Lee HL, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-181; Lee YJ, 2011, LUNG CANCER, V72, P9, DOI 10.1016/j.lungcan.2010.12.013; Lee YJ, 2010, J CLIN ONCOL, V28, P487, DOI 10.1200/JCO.2009.24.5480; Luo WX, 2018, INT J CANCER, V143, P1696, DOI 10.1002/ijc.31542; Midha A, 2015, AM J CANCER RES, V5, P2892; Mounawar M, 2007, CANCER RES, V67, P5667, DOI 10.1158/0008-5472.CAN-06-4229; Nagashima O, 2013, J THORAC DIS, V5, P27, DOI 10.3978/j.issn.2072-1439.2012.12.02; Ng TL, 2019, CANCER-AM CANCER SOC, V125, P1038, DOI 10.1002/cncr.31871; Paik JH, 2012, LUNG CANCER, V76, P403, DOI 10.1016/j.lungcan.2011.11.008; Paik PK, 2011, J CLIN ONCOL, V29, P2046, DOI 10.1200/JCO.2010.33.1280; Lamelas IP, 2014, ARCH BRONCONEUMOL, V50, P62, DOI 10.1016/j.arbres.2013.09.015; Ramlau R, 2015, J THORAC ONCOL, V10, P1370, DOI 10.1097/JTO.0000000000000621; Sacher AG, 2016, JAMA ONCOL, V2, P313, DOI 10.1001/jamaoncol.2015.4482; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; She CH, 2019, THORAC CANCER, V10, P137, DOI 10.1111/1759-7714.12913; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Sun YH, 2010, J CLIN ONCOL, V28, P4616, DOI 10.1200/JCO.2010.29.6038; Tanaka K, 2017, CANCER-AM CANCER SOC, V123, P1731, DOI 10.1002/cncr.30539; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Toh CK, 2006, J CLIN ONCOL, V24, P2245, DOI 10.1200/JCO.2005.04.8033; Travis WD., 2014, WHO CLASSIFICATION T, V4 ed; Vallee A, 2013, INT J ONCOL, V43, P1045, DOI 10.3892/ijo.2013.2056; VandenBussche CJ, 2014, HUM PATHOL, V45, P2379, DOI 10.1016/j.humpath.2014.08.005; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Xia N, 2013, EXP LUNG RES, V39, P328, DOI 10.3109/01902148.2013.819535; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Ye T, 2014, J THORAC DIS, V6, P1396, DOI 10.3978/j.issn.2072-1439.2014.08.50; Zhang J, 2010, CANCER-AM CANCER SOC, V116, P3656, DOI 10.1002/cncr.25100; Zhao FZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117333	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220691	10.1371/journal.pone.0220691	http://dx.doi.org/10.1371/journal.pone.0220691			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386689	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000484997100031
J	Kiya, GT; Zewudie, FM				Kiya, Girum Tesfaye; Zewudie, Fitsum Mesfin			Comparison of three-fold converted hematocrit and micro-hematocrit in pregnant women	PLOS ONE			English	Article								Background Anemia is one of the common complications of pregnancy. Hemoglobin concentration, Hematocrit, and Red cell count are laboratory tests used to diagnose anemia. In are source poor setting, there is a practice of using three-fold converted Hematocrit. This study is designed to assess the association and acceptability of three-fold converted Hematocrit as compared to the standard Micro-hematocrit method, in pregnant women. Method The cross-sectional study conducted from May 18 to June 12, 2018 involved 200 pregnant women who visited the Laboratory for a Hematocrit test. Three milliliter of venous blood was collected with EDTA tube to determine Hematocrit by the Micro-hematocrit method and Hemoglobin concentration measured by a HemoCue Hemoglobin B analyzer. A scatter plot, correlation coefficient, Bland and Altman plot, and Area under curve were employed to assess the agreement and acceptability of the calculated Hematocrit as compared to the standard Micro-hematocrit. Result The correlation coefficient, Intraclass correlation coefficient and concordance correlation coefficient were 0.91, 0.94, and 0.89, respectively. The Bland and Altman plot showed a mean difference of 0.94 with the limit of agreement ranges from 0.6 to 1.3. The area under the receiver operating characteristics with cut-off point of Hematocrit < 33% was 0.86. The sensitivity and specificity of the calculated method was 95.5% and 71.4%, respectively. Conclusion Generally there is excellent association between the two methods. The two methods were identical within inherent imprecision of both methods. Hence, the Hematocrit value, threefold calculated from the Hemoglobin was found to be acceptable to diagnose anemia in pregnant women.	[Kiya, Girum Tesfaye] Jimma Univ, Sch Med Lab Sci, Inst Hlth, Jimma, Ethiopia; [Zewudie, Fitsum Mesfin] Jimma Univ, Jimma Med Ctr, Clin Chem Lab Unit, Jimma, Ethiopia	Jimma University; Jimma University	Kiya, GT (corresponding author), Jimma Univ, Sch Med Lab Sci, Inst Hlth, Jimma, Ethiopia.	girumtesfaye12@gmail.com	Tesfaye, Girum/AAB-3547-2022	Tesfaye, Girum/0000-0001-7858-3793				Abbott point of care, 2016, HEM DET I STAT SYST; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Amarasiri AM, 2014, KDU INT RES C, P24; Bain BJ, 2006, BATES 1 PRACTICAL HE, P31; Behal M, 2018, INT J REPRODCONTRACE, V7, P552; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BLAND M, 1995, INTRO MED STAT; Carneiro IA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-67; Chris H, 2005, HEMOGLOBIN ITS MEASU; CLSI, 2000, H7A3 CLSI; ENGLAND JM, 1972, BRIT J HAEMATOL, V23, P247, DOI 10.1111/j.1365-2141.1972.tb03477.x; FDA, 2018, PROC DET PACK CELL V; Gowers W. R., 1879, T CLIN SOC LOND, V12, P64; Henny H, 1990, BILLETT CLIN METHODS; Kenneth B, 2008, ANEMIAS OTHER RED CE; Nkrumah B, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-5; Quinto L, 2006, TROP MED INT HEALTH, V11, P1295, DOI 10.1111/j.1365-3156.2006.01679.x; Rodriguez-Morales AJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-166; Wintrobe MM, 1929, J LAB CLIN MED, V15, P287; World Health Organization, 2015, GLOB PREV AN 2011; Zhou XY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-228	21	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220740	10.1371/journal.pone.0220740	http://dx.doi.org/10.1371/journal.pone.0220740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369624	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900083
J	Walteros, DM; Soares, J; Styczynski, AR; Abrams, JY; Galindo-Buitrago, JI; Acosta-Reyes, J; Bravo-Ribero, E; Arteta, ZE; Solano-Sanchez, A; Prieto, FE; Gonzalez-Duarte, M; Navarro-Lechuga, E; Salinas, JL; Belay, ED; Schonberger, LB; Damon, IK; Ospina, ML; Sejvar, JJ				Walteros, Diana M.; Soares, Jesus; Styczynski, Ashley R.; Abrams, Joseph Y.; Galindo-Buitrago, Jose, I; Acosta-Reyes, Jorge; Bravo-Ribero, Elsa; Arteta, Zuleima E.; Solano-Sanchez, Alma; Prieto, Franklyn E.; Gonzalez-Duarte, Maritza; Navarro-Lechuga, Edgar; Salinas, Jorge L.; Belay, Ermias D.; Schonberger, Lawrence B.; Damon, Inger K.; Ospina, Martha L.; Sejvar, James J.			Long-term outcomes of Guillain-Barre syndrome possibly associated with Zika virus infection	PLOS ONE			English	Article							QUALITY-OF-LIFE; MORTALITY; VALIDATION; DISABILITY; DEPRESSION; EXPERIENCE; PROGNOSIS; DIAGNOSIS; COLOMBIA; ADULTS	Background This prospective cohort investigation analyzed the long-term functional and neurologic outcomes of patients with Zika virus-associated Guillain-Barre syndrome (GBS) in Barranquilla, Colombia. Methods Thirty-four Zika virus-associated GBS cases were assessed a median of 17 months following acute GBS illness. We assessed demographics, results of Overall Disability Sum Scores (ODSS), Hughes Disability Score (HDS), Zung Depression Scale (ZDS), and Health Related Quality of Life (HRQL) questionnaires; and compared outcomes indices with a normative sample of neighborhood-selected control subjects in Barranquilla without GBS. Results Median age at time of acute neurologic onset was 49 years (range, 10-80); 17 (50%) were male. No deaths occurred. At long-term follow-up, 25 (73%) patients had a HDS 0-1, indicating complete / near complete recovery. Among the group, HDS (mean 1.4, range 0-4), ODSS (mean 1.9, range 0-9) and ZDS score (mean 34.4, range 20-56) indicated mild / moderate ongoing disability. Adjusting for age and sex, Zika virus-associated GBS cases were similar to a population comparison group (n = 368) in Barranquilla without GBS in terms of prevalence of physical or mental health complaints, though GBS patients were more likely to have an ODSS of >= 1 (OR 8.8, 95% CI 3.2-24.5) and to suffer from moderate / moderate-severe depression (OR 3.89, 95% CI 1.23-11.17) than the comparison group. Conclusions Long-term outcomes of Zika virus-associated GBS are consistent with those associated with other antecedent antigenic stimuli in terms of mortality and ongoing long-term morbidity, as published in the literature. Persons with Zika virus-associated GBS more frequently reported disability and depression after approximately one year compared with those without GBS.	[Walteros, Diana M.; Prieto, Franklyn E.; Gonzalez-Duarte, Maritza; Ospina, Martha L.] Inst Nacl Salud, Bogota, Colombia; [Soares, Jesus; Abrams, Joseph Y.; Belay, Ermias D.; Schonberger, Lawrence B.; Damon, Inger K.; Sejvar, James J.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Styczynski, Ashley R.] Stanford Univ, Dept Infect Dis, Palo Alto, CA 94304 USA; [Galindo-Buitrago, Jose, I] TEPHINET Inst Global Hlth, Decatur, GA USA; [Acosta-Reyes, Jorge; Navarro-Lechuga, Edgar] Univ Norte, Barranquilla, Colombia; [Bravo-Ribero, Elsa; Arteta, Zuleima E.; Solano-Sanchez, Alma] Secretaria Salud Barranquilla, Barranquilla, Colombia; [Salinas, Jorge L.] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA	Instituto Nacional de Salud (Colombia); Centers for Disease Control & Prevention - USA; Stanford University; Universidad del Norte; University of Iowa	Sejvar, JJ (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	zea3@cdc.gov	Galindo-Buitrado, Dr. José I/R-1399-2018; Salinas, Jorge/ABC-7735-2021; Lechuga, Edgar Navarro/ABB-2780-2021; Acosta-Reyes, Jorge/D-1906-2011; Soares, Jesus/D-2992-2016	Galindo-Buitrado, Dr. José I/0000-0002-3790-6725; Salinas, Jorge/0000-0002-9193-820X; Acosta-Reyes, Jorge/0000-0003-4303-3243; Navarro-Lechuga, Edgar/0000-0002-3181-2891; Styczynski, Ashley/0000-0002-4682-8087; Abrams, Joseph/0000-0002-2278-2467; PRIETO ALVARADO, FRANKLYN EDWIN/0000-0002-2079-7251; Soares, Jesus/0000-0002-8640-8618; Bravo, Elsa/0000-0003-2985-3843; Belay, Ermias/0000-0002-9837-0960				Alshekhlee A, 2008, NEUROLOGY, V70, P1608, DOI 10.1212/01.wnl.0000310983.38724.d4; Bernsen RAJAM, 2005, ACTA NEUROL SCAND, V112, P51, DOI 10.1111/j.1600-0404.2005.00429.x; Bersano A, 2006, J NEUROL, V253, P214, DOI 10.1007/s00415-005-0958-x; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Chang AY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0151-9; Cheng BC, 2003, J CLIN APHERESIS, V18, P175, DOI 10.1002/jca.10066; Cheng Q, 2000, EUR J NEUROL, V7, P685, DOI 10.1046/j.1468-1331.2000.00128.x; Cornblath DR, 2006, HDB CLIN NEUROPHYSIO, V7, P695; Darweesh SKL, 2014, J PERIPHER NERV SYST, V19, P24, DOI 10.1111/jns5.12051; Dimachkie MM, 2013, CURR TREAT OPTION NE, V15, P338, DOI 10.1007/s11940-013-0231-z; Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058; Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1; Dominguez-Moreno R, 2014, REV NEUROLOGIA, V58, P4, DOI 10.33588/rn.5801.2013370; Farbu E, 2016, CLIN NEUROL NEUROSUR, V141, P33, DOI 10.1016/j.clineuro.2015.12.008; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Fletcher DD, 2000, NEUROLOGY, V54, P2311, DOI 10.1212/WNL.54.12.2311; Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285; Gupta A, 2010, DISABIL REHABIL, V32, P1897, DOI 10.3109/09638281003734474; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8; Merkies ISJ, 2006, J NEUROL NEUROSUR PS, V77, P970, DOI 10.1136/jnnp.2005.076174; Merkies ISJ, 2016, EUR NEUROL, V75, P199, DOI 10.1159/000445347; Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511; Rees JH, 1998, J NEUROL NEUROSUR PS, V64, P74, DOI 10.1136/jnnp.64.1.74; Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Soysal A, 2011, ACTA NEUROL SCAND, V123, P181, DOI 10.1111/j.1600-0404.2010.01366.x; Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869; US Centers for Disease Control and Prevention, 2000, MEASURING HEALTHY DA; van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; Walling AD, 2013, AM FAM PHYSICIAN, V87, P191; Wang Y, 2017, ONCOTARGET, V8, P79991, DOI 10.18632/oncotarget.20620; Wei JCC, 2018, INT J RHEUM DIS, V21, P1443, DOI 10.1111/1756-185X.12973; Wong AHY, 2014, J NEUROL SCI, V344, P60, DOI 10.1016/j.jns.2014.06.021; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	40	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220049	10.1371/journal.pone.0220049	http://dx.doi.org/10.1371/journal.pone.0220049			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369576	Green Submitted, gold, Green Published			2022-12-27	WOS:000484987900021
J	Huang, CC; Huang, CC; Lin, SY; Chang, CYY; Lin, WC; Chung, CH; Lin, FH; Tsao, CH; Lo, CM; Chien, WC				Huang, Chun-Chung; Huang, Chien-Chu; Lin, Shao-Yi; Chang, Cherry Yin-Yi; Lin, Wu-Chou; Chung, Chi-Hsiang; Lin, Fu-Huang; Tsao, Chang-Huei; Lo, Chun-Min; Chien, Wu-Chien			Association of pelvic inflammatory disease (PID) with ectopic pregnancy and preterm labor in Taiwan: A nationwide population-based retrospective cohort study	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; BACTERIAL VAGINOSIS; SEXUAL-BEHAVIOR; SEQUELAE; INFECTION; DIAGNOSIS; EPIDEMIOLOGY; ENDOMETRITIS; SALPINGITIS; PREVALENCE	Background Pelvic inflammatory disease (PID) is an infectious disease that causes tubal occlusion and other pelvic and abdominal adhesions. The incidence of pelvic inflammatory disease (PID) has increased due to the sexually active status of the young population. This leads to a more serious problem and a larger effect than previously observed. However, there have been few studies on this topic in Asian populations. Aim We aimed to evaluate the risk of preterm labor and/or ectopic pregnancy in Taiwanese women following PID. Design Using the Taiwan National Health Insurance Database, we designed a retrospective cohort study that included 12-to 55-year-old pregnant women between 2000 and 2010. We selected a 1: 3 age-matched control group of non-PID women. The endpoint was any episode of preterm labor or ectopic pregnancy; otherwise, the patients were tracked until 31 December 2010. Methods The risk factors for preterm labor or ectopic pregnancy were explored. For cases included from the index date until the end of 2010, we analyzed the risk of incident preterm labor or ectopic pregnancy. With the use of a multivariate Cox proportional hazard regression analysis, we calculated the hazard ratio (HR) with a 95% CI and compared it with that of the control group. Results This study examined 30,450 patients with PID and 91,350 controls. During the follow-up period, patients in the PID group were more likely to develop preterm labor or ectopic pregnancy than patients in the control group. The cumulative incidence rates for developing preterm labor were 1.84% (561/30,450 individuals) in patients with PID and 1.63% (1492/91,350 individuals) in patients without PID. On the other hand, the cumulative incidence rate for developing ectopic pregnancy in patients with PID was 0.05% (14/30,450 individuals) but was only 0.04% (33/91,350 individuals) in patients without PID. Compared with those without PID, the patients with PID had a 1.864 times (P< 0.001) higher risk of developing preterm labor and a 2.121 times (P = 0.003) higher risk of developing ectopic pregnancy. Conclusion Our study provided evidence of an increased risk of preterm labor or ectopic pregnancy in PID patients.	[Huang, Chun-Chung; Lo, Chun-Min] Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan; [Huang, Chien-Chu; Chang, Cherry Yin-Yi; Lin, Wu-Chou] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Huang, Chien-Chu] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Lin, Shao-Yi] Natl Formosa Univ, Dept Mech & Comp Aided Engn, Huwei Township, Yunlin, Taiwan; [Chang, Cherry Yin-Yi; Lin, Wu-Chou] China Med Univ, Dept Med, Taichung, Taiwan; [Chung, Chi-Hsiang; Lin, Fu-Huang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Tsao, Chang-Huei; Chien, Wu-Chien] Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Tsao, Chang-Huei] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Formosa University; China Medical University Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Lo, CM (corresponding author), Natl Yang Ming Univ, Dept Biomed Engn, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chien, WC (corresponding author), Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	cmlo@ym.edu.tw; chienwu@ndmctsgh.edu.tw	Chung, Chi-Hsiang/AAY-3386-2021	Huang, Chun Chung/0000-0002-3285-0523; Lo, Chun-Min/0000-0003-4382-4512; Huang, Chien Chu/0000-0003-1782-5722	Tri-Service General Hospital Research Foundation [TSGH-C107-004, TSGH-C108-003]	Tri-Service General Hospital Research Foundation	This study was funded by Tri-Service General Hospital Research Foundation (TSGH-C107-004 and TSGH-C108-003). The funder has no role in the design, concept, data collection and interpretation, analysis, drafting or other process in this paper.	Adinkra P, 2000, HOSP MED, V61, P475, DOI 10.12968/hosp.2000.61.7.1377; Andrews WW, 2005, AM J OBSTET GYNECOL, V193, P739, DOI 10.1016/j.ajog.2005.02.128; Banikarim C, 2005, PELVIC INFLAMMATORY, P175; Bjartling C, 2000, ACTA OBSTET GYN SCAN, V79, P123, DOI 10.1034/j.1600-0412.2000.079002123.x; Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426; Bugg Charles Walter, 2016, Emerg Med Pract, V18, P1; Cheng TM, 2009, 6 COUNTRIES 6 REFORM, P171, DOI [10.1142/9789814261593_000710, 1142/9789814261593_0007, DOI 10.1142/9789814261593_0007]; CUMMING DC, 1988, INT J FERTIL, V33, P324; DUBUISSON J B, 1987, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V16, P27; ESCHENBACH DA, 1980, OBSTET GYNECOL, V55, pS142, DOI 10.1097/00006250-198003001-00037; Espinoza J, 2006, AM J OBSTET GYNECOL, V194, P630, DOI 10.1016/j.ajog.2005.11.050; Goller JL, 2018, SEX TRANSM INFECT, V94, P534, DOI 10.1136/sextrans-2017-053423; Haggerty CL, 2003, AM J OBSTET GYNECOL, V188, P141, DOI 10.1067/mob.2003.87; HILLIS SD, 1993, AM J OBSTET GYNECOL, V168, P1503, DOI 10.1016/S0002-9378(11)90790-X; Houck CD, 2014, PEDIATRICS, V133, pE276, DOI 10.1542/peds.2013-1157; ISMAIL MA, 1992, AM J PERINAT, V9, P368, DOI 10.1055/s-2007-999266; Jennings LK, 2018, PELVIC INFLAMMATORY; JOESOEF MR, 1991, AM J OBSTET GYNECOL, V165, P46, DOI 10.1016/0002-9378(91)90221-C; Jurstrand M, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2007.024752; KIMBALL MW, 1970, NEW ENGL J MED, V282, P1082, DOI 10.1056/NEJM197005072821908; Knudtson EJ, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.004; Kotchick BA, 2001, CLIN PSYCHOL REV, V21, P493, DOI 10.1016/S0272-7358(99)00070-7; Koumans EH, 2001, SEX TRANSM DIS, V28, P292, DOI 10.1097/00007435-200105000-00011; Lenz JD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02710; Li C, 2015, PHARMACOEPIDEM DR S, V24, P548, DOI 10.1002/pds.3775; Locksmith G, 2001, SEMIN PERINATOL, V25, P295, DOI 10.1053/sper.2001.27163; Ma JS, 2016, J REPROD MED, V61, P139; Mindjah YAA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207699; Mitchell C, 2013, INFECT DIS CLIN N AM, V27, P793, DOI 10.1016/j.idc.2013.08.004; Morris M, 2001, BRIT J OBSTET GYNAEC, V108, P439; Ngui R, 2014, J CLIN MICROBIOL, V52, P3468, DOI 10.1128/JCM.01191-14; Peter NG, 2004, CLEV CLIN J MED, V71, P233, DOI 10.3949/ccjm.71.3.233; Pitegoff J G, 1986, Semin Adolesc Med, V2, P215; Reddy UM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.064; Rein DB, 2000, OBSTET GYNECOL, V95, P397, DOI 10.1016/S0029-7844(99)00551-7; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; Romero R, 2004, FERTIL STERIL, V82, P799, DOI 10.1016/j.fertnstert.2004.05.076; ROSEN Y, 1974, OBSTET GYNECOL, V43, P413; Rutgers JKL, 2014, INT J GYNECOL PATHOL, V33, P385, DOI 10.1097/PGP.0000000000000143; SAFRIN S, 1992, AM J OBSTET GYNECOL, V166, P1300, DOI 10.1016/S0002-9378(11)90626-7; Savel'eva G M, 1995, Akush Ginekol (Mosk), P36; Shaaban OM, 2013, BMC WOMENS HEALTH, V13, DOI 10.1186/1472-6874-13-23; Thinkhamrop J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002250.pub2; Tita A, 2007, AM J OBSTET GYNECOL, V197, pS37, DOI 10.1016/j.ajog.2007.10.096; TOTH M, 1988, OBSTET GYNECOL, V71, P723; Toth M, 1993, Infect Dis Obstet Gynecol, V1, P12, DOI 10.1155/S1064744993000043; Twenge JM, 2015, ARCH SEX BEHAV, V44, P2273, DOI 10.1007/s10508-015-0540-2; WANG SP, 1980, AM J OBSTET GYNECOL, V138, P1034, DOI 10.1016/0002-9378(80)91103-5; WESTROM L, 1995, VENEREOLOGY, V8, P219; WESTROM L, 1980, AM J OBSTET GYNECOL, V138, P880, DOI 10.1016/0002-9378(80)91077-7; WESTROM L, 1975, AM J OBSTET GYNECOL, V121, P707, DOI 10.1016/0002-9378(75)90477-9; Wiesenfeld HC, 2012, OBSTET GYNECOL, V120, P37, DOI 10.1097/AOG.0b013e31825a6bc9; Wiesenfeld HC, 2005, SEX TRANSM DIS, V32, P400, DOI 10.1097/01.olq.0000154508.26532.6a; Workowski KA., 2015, REPROD ENDOCRINOL, V24, P51	54	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0219351	10.1371/journal.pone.0219351	http://dx.doi.org/10.1371/journal.pone.0219351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408465	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500003
J	Velazquez-Lizarraga, AE; Juarez-Morales, JL; Racotta, IS; Villarreal-Colmenares, H; Valdes-Lopez, O; Luna-Gonzalez, A; Rodriguez-Jaramillo, C; Estrada, N; Ascencio, F				Velazquez-Lizarraga, Adrian E.; Luis Juarez-Morales, Jose; Racotta, Ilie S.; Villarreal-Colmenares, Humberto; Valdes-Lopez, Oswaldo; Luna-Gonzalez, Antonio; Rodriguez-Jaramillo, Carmen; Estrada, Norma; Ascencio, Felipe			Transcriptomic analysis of Pacific white shrimp (Litopenaeus vannamei, Boone 1931) in response to acute hepatopancreatic necrosis disease caused by Vibrio parahaemolyticus	PLOS ONE			English	Article							REAL-TIME PCR; RNA-SEQ DATA; MOLECULAR-CLONING; CAUSATIVE AGENT; EXPRESSED TRANSCRIPTS; HYPERCAPNIC HYPOXIA; MINIMUM INFORMATION; PENAEUS-MONODON; CHINESE SHRIMP; AHPND	Acute hepatopancreatic necrosis disease (AHPND), caused by marine bacteria Vibrio Parahaemolyticus, is a huge problem in shrimp farms. The V. parahaemolyticus infecting material is contained in a plasmid which encodes for the lethal toxins PirAB(Vp), whose primary target tissue is the hepatopancreas, causing sloughing of epithelial cells, necrosis, and massive hemocyte infiltration. To get a better understanding of the hepatopancreas response during AHPND, juvenile shrimp Litopenaeus vannamei were infected by immersion with V. parahaemolyticus. We performed transcriptomic mRNA sequencing of infected shrimp hepatopancreas, at 24 hours post-infection, to identify novel differentially expressed genes a total of 174,098 transcripts were examined of which 915 transcripts were found differentially expressed after comparative transcriptomic analysis: 442 up-regulated and 473 down-regulated transcripts. Gene Ontology term enrichment analysis for up-regulated transcripts includes metabolic process, regulation of programmed cell death, carbohydrate metabolic process, and biological adhesion, whereas for down-regulated transcripts include, microtubule-based process, cell activation, and chitin metabolic process. The analysis of protein-protein network between up and down-regulated genes indicates that the first gene interactions are connected to oxidation-processes and sarcomere organization. Additionally, protein-protein networks analysis identified 20-top highly connected hub nodes. Based on their immunological or metabolic function, ten candidate transcripts were selected to measure their mRNA relative expression levels in AHPND infected shrimp hepatopancreas by RT-qPCR. Our results indicate a close connection between the immune and metabolism systems during AHPND infection. Our RNA-Seq and RT-qPCR data provide the possible immunological and physiological scenario as well as the molecular pathways that take place in the shrimp hepatopancreas in response to an infectious disease.	[Velazquez-Lizarraga, Adrian E.; Ascencio, Felipe] Ctr Invest Biol Noroeste SC CIBNOR, Lab Patogenesis Microbiana, La Paz, Baja California, Mexico; [Luis Juarez-Morales, Jose; Estrada, Norma] Ctr Invest Biol Noroeste SC CIBNOR, Programa Catedras CONACyT, La Paz, Baja California, Mexico; [Racotta, Ilie S.] Ctr Invest Biol Noroeste SC CIBNOR, Lab Metab Energet, La Paz, Baja California, Mexico; [Villarreal-Colmenares, Humberto] Ctr Invest Biol Noroeste SC CIBNOR, Parque Innovac Tecnol, La Paz, Baja California, Mexico; [Valdes-Lopez, Oswaldo] Univ Autonoma Mexico, Dept Bioquim, Fac Estudios Super, Tlalnepantla De Baz, Estado De Mexic, Mexico; [Luna-Gonzalez, Antonio] Inst Politecn Nacl, Ctr Interdisciplinario Invest Desarrollo Integral, Unidad Sinaloa IPN CIIDIR Sinaloa, Dept Acuacultura, Guasave, Sinaloa, Mexico; [Rodriguez-Jaramillo, Carmen] Ctr Invest Biol Noroeste SC CIBNOR, Lab Histol, La Paz, Baja California, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Universidad Nacional Autonoma de Mexico; Instituto Politecnico Nacional - Mexico; CIBNOR - Centro de Investigaciones Biologicas del Noroeste	Ascencio, F (corresponding author), Ctr Invest Biol Noroeste SC CIBNOR, Lab Patogenesis Microbiana, La Paz, Baja California, Mexico.; Estrada, N (corresponding author), Ctr Invest Biol Noroeste SC CIBNOR, Programa Catedras CONACyT, La Paz, Baja California, Mexico.	nestrada@cibnor.mx; ascencio@cibnor.mx	Valdés-López, Oswaldo/K-8695-2019	Valdés-López, Oswaldo/0000-0002-4760-048X; Rodriguez-Jaramillo, Maria del Carmen/0000-0003-3926-9560; JUAREZ-MORALES, JOSE-LUIS/0000-0001-6356-3415; Ascencio, Felipe/0000-0003-3515-8708; Velazquez-Lizarraga, Adrian Esteban/0000-0001-7049-7209	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [247567]; CIBNOR (PAC); CONACyT [466639]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) Problemas Nacionales [247567]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CIBNOR (PAC); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (CONACyT) Problemas Nacionales(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grants of Consejo Nacional de Ciencia y Tecnologia (CONACyT) No. 247567 to NE and from CIBNOR (PAC) To FA. AEVL have a scholarship from CONACyT No. 466639. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants of Consejo Nacional de Ciencia y Tecnologia (CONACyT) Problemas Nacionales 247567 to NE and from CIBNOR (PAC) To FA. AEVL have a scholarship from CONACyT No. 466639. Mayra de Fatima Vargas Mendieta and Jesus Antonio Aguilar Villavicencio for technical support in organism maintenance. Eulalia Meza Chavez of Histology Laboratory in CIBNOR. Dr. Ricardo Vazquez-Juarez of bioinformatics laboratory. Rosa Maria Morelos-Castro for technical support for gene expression analysis.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], INT J INFORM TECHNOL; [Anonymous], 2014, NEW IMPROVED PCR MET; Aranda PS, 2012, ELECTROPHORESIS, V33, P366, DOI 10.1002/elps.201100335; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell TA, 1988, HDB NORMAL PENAEID S; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boonchuen P, 2018, DEV COMP IMMUNOL, V84, P371, DOI 10.1016/j.dci.2018.03.010; Brinkmann U, 1996, BIOCHEMISTRY-US, V35, P6891, DOI 10.1021/bi952829+; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaikeeratisak V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047384; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Cesar JRD, 2006, AQUACULTURE, V261, P688, DOI 10.1016/j.aquaculture.2006.08.003; De Schryver P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003919; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; Duan YF, 2013, MOL BIOL REP, V40, P6569, DOI 10.1007/s11033-013-2702-4; ELLERTON HD, 1983, PROG BIOPHYS MOL BIO, V41, P143, DOI 10.1016/0079-6107(83)90028-7; Evans DL, 2000, FISH SHELLFISH IMMUN, V10, P419, DOI 10.1006/fsim.1999.0250; Fagutao FF, 2009, FEBS J, V276, P5298, DOI 10.1111/j.1742-4658.2009.07225.x; FAO, 2018, M SUSTAINABLE DEV GO; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FINNEY D J, 1971, P333; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Galindo-Torres P, 2018, MAR GENOM, V37, P161, DOI 10.1016/j.margen.2017.11.004; Ge QQ, 2017, FISH SHELLFISH IMMUN, V67, P620, DOI 10.1016/j.fsi.2017.06.047; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han JE, 2015, DIS AQUAT ORGAN, V113, P33, DOI 10.3354/dao02830; Hardy KM, 2013, AM J PHYSIOL-REG I, V305, pR1356, DOI 10.1152/ajpregu.00519.2012; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hu KJ, 2007, COMP BIOCHEM PHYS B, V146, P69, DOI 10.1016/j.cbpb.2006.09.010; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026; Ji PF, 2011, DIS AQUAT ORGAN, V96, P9, DOI 10.3354/dao02373; Joshi J, 2014, AQUACULTURE, V428, P297, DOI 10.1016/j.aquaculture.2014.03.030; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khimmakthong U, 2017, MICROB PATHOGENESIS, V113, P107, DOI 10.1016/j.micpath.2017.10.028; Koiwai K, 2016, J FISH DIS, V39, P603, DOI 10.1111/jfd.12387; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuwabara K, 1996, J BIOL CHEM, V271, P5025; Lai HC, 2015, FISH SHELLFISH IMMUN, V47, P1006, DOI 10.1016/j.fsi.2015.11.008; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAYCOCK MV, 1991, FEBS LETT, V292, P115, DOI 10.1016/0014-5793(91)80847-V; Leano E.M., 2012, GLOB AQUACULT, P38; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liao C, 2011, CHINESE J INORG CHEM, V27, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Lopez-Leon P, 2016, LAT AM J AQUAT RES, V44, P470, DOI 10.3856/vol44-issue3-fulltext-5; Maralit BA, 2018, FISH SHELLFISH IMMUN, V81, P284, DOI 10.1016/j.fsi.2018.06.054; Meng QG, 2014, FISH SHELLFISH IMMUN, V40, P182, DOI 10.1016/j.fsi.2014.06.029; Mikulski CM, 2000, J SHELLFISH RES, V19, P301; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nunan L, 2014, DIS AQUAT ORGAN, V111, P81, DOI 10.3354/dao02776; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pongsomboon S, 2008, FISH SHELLFISH IMMUN, V25, P485, DOI 10.1016/j.fsi.2008.07.010; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Rao M. Sreenivasa, 2008, Biotechnology, V7, P153; Rao R, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0052-6; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Reyes-Ramos CA, 2018, COMP BIOCHEM PHYS B, V226, P1, DOI 10.1016/j.cbpb.2018.08.001; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rosas C, 2001, J EXP MAR BIOL ECOL, V259, P1, DOI 10.1016/S0022-0981(01)00222-2; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Roszer T, 2014, CELL TISSUE RES, V358, P685, DOI 10.1007/s00441-014-1985-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi XZ, 2008, FISH SHELLFISH IMMUN, V25, P589, DOI 10.1016/j.fsi.2008.07.011; Soonthornchai W, 2016, DEV COMP IMMUNOL, V65, P53, DOI 10.1016/j.dci.2016.06.013; Soto-Rodriguez SA, 2015, APPL ENVIRON MICROB, V81, P1689, DOI 10.1128/AEM.03610-14; Su G, 2010, BIOINFORMATICS, V26, P3135, DOI 10.1093/bioinformatics/btq596; Sun YD, 2006, MOL IMMUNOL, V43, P1202, DOI 10.1016/j.molimm.2005.07.014; Tassanakajon A, 2013, FISH SHELLFISH IMMUN, V34, P954, DOI 10.1016/j.fsi.2012.09.021; Tyagi A, 2009, INT J FOOD MICROBIOL, V129, P124, DOI 10.1016/j.ijfoodmicro.2008.11.006; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wen R, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092635; Xiao JZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42177; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Zheng ZH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4728-4; Zheng ZH, 2018, FISH SHELLFISH IMMUN, V74, P10, DOI 10.1016/j.fsi.2017.12.032; ZIMMERMANN J, 1988, FEBS LETT, V233, P432, DOI 10.1016/0014-5793(88)80477-0; Zorriehzahra M.J., 2015, ADV ANIMAL VET SCI, V3, P64, DOI [DOI 10.14737/J0URNAL.AAVS/2015/3.2S.64.72, DOI 10.14737/JOURNAL.AAVS/2015/3.2S.64.72]	91	20	20	7	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220993	10.1371/journal.pone.0220993	http://dx.doi.org/10.1371/journal.pone.0220993			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408485	Green Submitted, gold, Green Published			2022-12-27	WOS:000485009500032
J	Wolsink, I; Den Hartog, DD; Belschak, FD; Oosterwijk, S				Wolsink, Inge; Den Hartog, Deanne D.; Belschak, Frank D.; Oosterwijk, Suzanne			Do you feel like being proactive today? Trait-proactivity moderates affective causes and consequences of proactive behavior	PLOS ONE			English	Article							POSITIVE AFFECT; CREATIVITY; MOOD; EMOTIONS; WORK; ANTECEDENTS; INFORMATION; PERSONALITY; PERCEPTION; MOTIVATION	Proactive people take initiative when others do not and persist in improving their environment or themselves. Although scholars assume that how we feel influences how proactive we are, there is no experimental research yet to support this. This experiment therefore tests whether positive and negative affect influence proactive behavior and additionally investigates whether engaging in proactivity also has affective consequences. While current theory proposes that positive affect enhances proactive behavior by stimulating broad-flexible thinking, we argue that negative affect should make people proactive through stimulating systematic-persistent thinking. Furthermore, we propose that proactive behavior increases subsequent positive affect rather than positive affect increasing proactive behavior. Last, we hypothesize that affective causes and consequences of proactive behavior are different for people who are rarely proactive (trait-passive-reactive individuals) and people who are often proactive (trait-proactive individuals). We pre-tested 180 participants on trait-proactivity. In the lab, we manipulated affect (negative/positive/neutral), measured proactive behavior in a team interaction task, and repeatedly measured participants' affective experiences and physiological activation. Results showed that the link between affect and proactive behavior differed depending on participants' trait-proactivity. First, positive affect made trait-proactive individuals less proactive, whereas negative affect made passive-reactive individuals more proactive. Second, passive-reactive individuals reported decreased negative affect after engaging in proactivity, whereas proactive individuals reported increased positive affect. These results suggest that proactive behavior can serve an affect regulation purpose, which is different for trait proactive individuals (up regulating positive affect) than for trait passivereactive individuals (down regulating negative affect). These results are limited to core affect (feeling pleasant or unpleasant) and do not apply to specific emotions (feeling proud or anxious), and they are limited to short term and successful proactive behavior and do not apply to more long term, or unsuccessful proactive behavior.	[Wolsink, Inge; Den Hartog, Deanne D.; Belschak, Frank D.] Univ Amsterdam, Fac Econ & Business, Dept Leadership & Management, Amsterdam, Netherlands; [Wolsink, Inge; Oosterwijk, Suzanne] Univ Amsterdam, Fac Social & Behav Sci, Dept Social Psychol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Wolsink, I (corresponding author), Univ Amsterdam, Fac Econ & Business, Dept Leadership & Management, Amsterdam, Netherlands.; Wolsink, I (corresponding author), Univ Amsterdam, Fac Social & Behav Sci, Dept Social Psychol, Amsterdam, Netherlands.	ingewolsink@gmail.com						Akinola M, 2008, PERS SOC PSYCHOL B, V34, P1677, DOI 10.1177/0146167208323933; Amabile TM, 2005, ADMIN SCI QUART, V50, P367, DOI 10.2189/asqu.2005.50.3.367; Avery DR, 2002, J APPL PSYCHOL, V87, P81, DOI 10.1037//0021-9010.87.1.81; Baumeister RF, 2007, PERS SOC PSYCHOL REV, V11, P167, DOI 10.1177/1088868307301033; Baumgartner T, 2006, INT J PSYCHOPHYSIOL, V60, P34, DOI 10.1016/j.ijpsycho.2005.04.007; Bindl UK, 2012, J APPL PSYCHOL, V97, P134, DOI 10.1037/a0024368; CACIOPPO JT, 1990, AM PSYCHOL, V45, P16, DOI 10.1037/0003-066X.45.1.16; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; Crant JM, 2000, J MANAGE, V26, P435, DOI 10.1177/014920630002600303; De Dreu CKW, 2008, J PERS SOC PSYCHOL, V94, P739, DOI 10.1037/0022-3514.94.5.739; Den Hartog DN, 2007, J OCCUP ORGAN PSYCH, V80, P601, DOI 10.1348/096317906X171442; Fay D, 2001, HUM PERFORM, V14, P97, DOI 10.1207/S15327043HUP1401_06; Fay D, 2016, DRAWBACKS PROACTIVIT; Fay Doris, 2002, J Occup Health Psychol, V7, P221, DOI 10.1037/1076-8998.7.3.221; Foo MD, 2009, J APPL PSYCHOL, V94, P1086, DOI 10.1037/a0015599; Forgas JP, 2013, CURR DIR PSYCHOL SCI, V22, P225, DOI 10.1177/0963721412474458; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Frese M, 2001, RES ORGAN BEHAV, V23, P133, DOI 10.1016/S0191-3085(01)23005-6; Frese M, 1996, ACAD MANAGE J, V39, P37, DOI 10.2307/256630; Frese M, 1997, J OCCUP ORGAN PSYCH, V70, P139, DOI 10.1111/j.2044-8325.1997.tb00639.x; Fritz C, 2009, J MANAGE, V35, P94, DOI 10.1177/0149206307308911; Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406; Gasper K, 2004, COGNITION EMOTION, V18, P405, DOI 10.1080/02699930341000068; Grant AM, 2008, RES ORGAN BEHAV, V28, P3, DOI 10.1016/j.riob.2008.04.002; Grant AM, 2013, ACAD MANAGE J, V56, P1703, DOI 10.5465/amj.2011.0035; Gross J.J., 1998, REV GEN PSYCHOL, V2, P271, DOI [10.1037/1089-2680.2.3.271, DOI 10.1037/1089-2680.2.3.271]; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Ironson G, 2005, INT J BEHAV MED, V12, P86, DOI 10.1207/s15327558ijbm1202_6; Isen AM, 2000, PSYCHOL INQ, V11, P184; Isen AM, 2001, J CONSUM PSYCHOL, V11, P75, DOI 10.1207/S15327663JCP1102_01; Keller MC, 2015, NAT NEUROSCI, V18, P928, DOI 10.1038/nn.4047; Keri S, 2009, PSYCHOL SCI, V20, P1070, DOI 10.1111/j.1467-9280.2009.02398.x; Kim TY, 2010, CREATIVITY RES J, V22, P37, DOI 10.1080/10400410903579536; Lang P.J., 1997, INT AFFECTIVE PICTUR, V1, P3, DOI DOI 10.1027/0269-8803/A000147; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lassiter GD, 1996, PERS SOC PSYCHOL B, V22, P794, DOI 10.1177/0146167296228003; Major DA, 2006, J APPL PSYCHOL, V91, P927, DOI 10.1037/0021-9010.91.4.927; Marchewka A, 2014, BEHAV RES METHODS, V46, P596, DOI 10.3758/s13428-013-0379-1; Norris CJ, 2007, PSYCHOPHYSIOLOGY, V44, P823, DOI 10.1111/j.1469-8986.2007.00551.x; Oosterwijk S, 2010, SOC PSYCHOL PERS SCI, V1, P65, DOI 10.1177/1948550609355328; Parker SK, 2006, J APPL PSYCHOL, V91, P636, DOI 10.1037/0021-9010.91.3.636; Parker SK, 2010, J MANAGE, V36, P827, DOI 10.1177/0149206310363732; Payne AFH, 2016, PSYCHOPHYSIOLOGY, V53, P1084, DOI 10.1111/psyp.12643; Power RA, 2015, NAT NEUROSCI, V18, P953, DOI 10.1038/nn.4040; Rank J, 2004, APPL PSYCHOL-INT REV, V53, P518, DOI 10.1111/j.1464-0597.2004.00185.x; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Rutherford HJV, 2011, EMOT REV, V3, P333, DOI 10.1177/1754073911402392; Schwarz N, 2003, PSYCHOL INQ, V14, P296, DOI 10.1207/S15327965PLI1403&4_20; Sonnentag S, 2015, J ORGAN BEHAV, V36, P806, DOI 10.1002/job.2005; Thomas MSC, 2009, J SPEECH LANG HEAR R, V52, P336, DOI 10.1044/1092-4388(2009/07-0144); Tims M, 2013, J OCCUP HEALTH PSYCH, V18, P230, DOI 10.1037/a0032141; Tornau K, 2013, APPL PSYCHOL-INT REV, V62, P44, DOI 10.1111/j.1464-0597.2012.00514.x; van Beek W, 2014, TIME PERSPECTIVE THE; VanVoorhis CRW, 2007, TUTOR QUANT METHODS, V3, P43, DOI 10.20982/tqmp.03.2.p043; Verhaeghen P, 2005, EMOTION, V5, P226, DOI 10.1037/1528-3542.5.2.226; Wolsink I, 2017, ATTENTION AFFECTIVE; Wolsink I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212608	59	2	3	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220172	10.1371/journal.pone.0220172	http://dx.doi.org/10.1371/journal.pone.0220172			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408471	Green Published, Green Submitted, gold			2022-12-27	WOS:000485009500009
J	Malinska, H; Huttl, M; Oliyarnyk, O; Markova, I; Poruba, M; Racova, Z; Kazdova, L; Vecera, R				Malinska, Hana; Huttl, Martina; Oliyarnyk, Olena; Markova, Irena; Poruba, Martin; Racova, Zuzana; Kazdova, Ludmila; Vecera, Rostislav			Beneficial effects of troxerutin on metabolic disorders in non-obese model of metabolic syndrome	PLOS ONE			English	Article							OXIDATIVE STRESS; INSULIN-RESISTANCE; HEPATIC EXPRESSION; HIGH-FAT; PROTECTS; MUSCLE; CYTOCHROME-P450; CELLS; HEART; RAT	Background Troxerutin (TRX) has a beneficial effect on blood viscosity and platelet aggregation, and is currently used for the treatment of chronic varicosity. Recently, TRX can improve lipid abnormalities, glucose intolerance and oxidative stress in high-fat diet-induced metabolic disorders. In this study, we tested the effect of TRX on metabolic syndrome-associated disorders using a non-obese model of metabolic syndrome-the Hereditary Hypertriglyceridaemic rats (HHTg). Methods Adult male HHTg rats were fed standard diet without or with TRX (150 mg/kg bwt/day for 4 weeks). Results Compared to untreated rats, TRX supplementation in HHTg rats decreased serum glucose (p<0.05) and insulin (p<0.05). Although blood lipids were not affected, TRX decreased hepatic cholesterol concentrations (p<0.01) and reduced gene expression of HMGCR, SREBP2 and SCD1 (p<0.01), involved in cholesterol synthesis and lipid homeostasis. TRX-treated rats exhibited decreased lipoperoxidation and increased activity of antioxidant enzymes SOD and GPx (p<0.05) in the liver. In addition, TRX supplementation increased insulin sensitivity in muscles and epididymal adipose tissue (p<0.05). Elevated serum adiponectin (p<0.05) and decreased muscle triglyceride (p<0.05) helped improve insulin sensitivity. Among the beneficial effects of TRX were changes to cytochrome P450 family enzymes. Hepatic gene expression of CYP4A1, CYP4A3 and CYP5A1 (p<0.01) decreased, while there was a marked elevation in gene expression of CYP1A1 (p<0.01). Conclusion Our results indicate that TRX improves hepatic lipid metabolism and insulin sensitivity in peripheral tissues. As well as ameliorating oxidative stress, TRX can reduce ectopic lipid deposition, affect genes involved in lipid metabolism, and influence the activity of CYP family enzymes.	[Malinska, Hana; Huttl, Martina; Oliyarnyk, Olena; Markova, Irena] Inst Clin & Expt Med, Ctr Expt Med, Prague, Czech Republic; [Poruba, Martin; Racova, Zuzana; Kazdova, Ludmila; Vecera, Rostislav] Palacky Univ, Fac Med & Dent, Dept Pharmacol, Olomouc, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Palacky University Olomouc	Malinska, H (corresponding author), Inst Clin & Expt Med, Ctr Expt Med, Prague, Czech Republic.	hana.malinska@ikem.cz	Stefanadis, Christodoulos/ABH-2232-2020; Oliyarnyk, Olena/Q-6380-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; Oliyarnyk, Olena/0000-0002-4912-6187; Markova, Irena/0000-0002-4331-7636; Racova, Zuzana/0000-0001-9478-9513; Poruba, Martin/0000-0003-1252-4971	Czech Science Foundation [17-08888S]	Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by grant of Czech Science Foundation, project number 17-08888S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz Z, 2015, J CLIN PHARM THER, V40, P177, DOI 10.1111/jcpt.12247; Belcaro G, 2017, INT J ANGIOL, V26, P170, DOI 10.1055/s-0036-1597756; Chatuphonprasert W, 2010, BIOL PHARM BULL, V33, P1698, DOI 10.1248/bpb.33.1698; Chiva-Blanch G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5812401; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Das A, 2014, CHEMBIOCHEM, V15, P892, DOI 10.1002/cbic.201300646; Divisova J, 2002, ANN NY ACAD SCI, V967, P440; Endo T, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0090-1; Geetha R, 2017, CHEM-BIOL INTERACT, V278, P74, DOI 10.1016/j.cbi.2017.09.012; Geetha R, 2014, MOL CELL BIOCHEM, V387, P123, DOI 10.1007/s11010-013-1877-2; Gomes WF, 2017, FOOD CHEM, V218, P261, DOI 10.1016/j.foodchem.2016.08.132; Karakurt S, 2016, ACTA PHARMACEUT, V66, P491, DOI 10.1515/acph-2016-0046; Karnieli E, 2008, AM J PHYSIOL-ENDOC M, V295, pE38, DOI 10.1152/ajpendo.90306.2008; Lu J, 2011, BRAIN, V134, P783, DOI 10.1093/brain/awq376; Malinska H, 2018, PHYSIOL RES, V67, P181, DOI 10.33549/physiolres.933606; Malinska H, 2015, NUTRITION, V31, P1045, DOI 10.1016/j.nut.2015.03.011; Mar-Heyming R, 2008, ARTERIOSCL THROM VAS, V28, P1193, DOI 10.1161/ATVBAHA.107.160150; Murillo AG, 2017, CURR PHARM DESIGN, V23, P2444, DOI 10.2174/1381612823666170329144307; Oh SJ, 2012, CHEM-BIOL INTERACT, V195, P173, DOI 10.1016/j.cbi.2011.12.010; Panat NA, 2016, FOOD CHEM, V194, P32, DOI 10.1016/j.foodchem.2015.07.078; Park SY, 2016, FOOD CHEM TOXICOL, V96, P244, DOI 10.1016/j.fct.2016.08.010; Qi NN, 2002, J BIOL CHEM, V277, P48501, DOI 10.1074/jbc.M206655200; Rajagopalan G, 2017, CLIN EXP PHARMACOL P, V44, P103, DOI 10.1111/1440-1681.12671; Sampath S, 2014, MOL CELL BIOCHEM, V395, P11, DOI 10.1007/s11010-014-2107-2; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; Uno T, 2018, BIOPHARM DRUG DISPOS, V39, P371, DOI 10.1002/bdd.2153; Vinayagam R, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0057-7; Voulgari C, 2011, J AM COLL CARDIOL, V58, P1343, DOI 10.1016/j.jacc.2011.04.047; VRANA A, 1990, TRANSPLANT P, V22, P2579; Yang HJ, 2016, NUTRITION, V32, P129, DOI 10.1016/j.nut.2015.07.012; Zhang ZF, 2009, J AGR FOOD CHEM, V57, P7731, DOI 10.1021/jf9012357; Zhang ZF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010031; Zicha J, 2006, PHYSIOL RES, V55, pS49, DOI 10.33549/physiolres.930000.55.S1.49	33	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220377	10.1371/journal.pone.0220377	http://dx.doi.org/10.1371/journal.pone.0220377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404079	Green Submitted, Green Published, gold			2022-12-27	WOS:000485006800012
J	Ohira, T; Kojima, H; Kuroda, Y; Aoki, S; Inaoka, D; Osaki, M; Wanibuchi, H; Okada, F; Oshimura, M; Kugoh, H				Ohira, Takahito; Kojima, Hirotada; Kuroda, Yuko; Aoki, Sayaka; Inaoka, Daigo; Osaki, Mitsuhiko; Wanibuchi, Hideki; Okada, Futoshi; Oshimura, Mitsuo; Kugoh, Hiroyuki			PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription	PLOS ONE			English	Article							TELOMERASE REVERSE-TRANSCRIPTASE; HOMEOBOX GENE-EXPRESSION; MUTANT TERT PROMOTER; CANCER; GROWTH; CELLS; ACTIVATION; REPRESSION; COMPONENTS; MUTATIONS	Telomerase is a ribonucleoprotein ribonucleic enzyme that is essential for cellular immortalization via elongation of telomere repeat sequences at the end of chromosomes. Human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase holoenzyme, is a key regulator of telomerase activity. Telomerase activity, which has been detected in the majority of cancer cells, is accompanied by hTERT expression, suggesting that this enzyme activity contributes to an unlimited replication potential of cancer cells via regulation of telomere length. Thus, hTERT is an attractive target for cancer-specific treatments. We previously reported that pared-like homeodomain 1 (PITX1) is a negative regulator of hTERT through direct binding to the hTERT promoter. However, the mechanism by which the function of PITX1 contributes to transcriptional silencing of the hTERT gene remains to be clarified. Here, we show that PITX1 and zinc finger CCHC-type containing 10 (ZCCHC10) proteins cooperate to facilitate the transcriptional regulation of the hTERT gene by functional studies via FLAG pull-down assay. Co-expression of PITX1 and ZCCHC10 resulted in inhibition of hTERT transcription, in melanoma cell lines, whereas mutate-deletion of homeodomain in PITX1 that interact with ZCCHC10 did not induce similar phenotypes. In addition, ZCCHC10 expression levels showed marked decrease in the majority of melanoma cell lines and tissues. Taken together, these results suggest that ZCCHC10-PITX1 complex is the functional unit that suppresses hTERT transcription, and may play a crucial role as a novel tumor suppressor complex.	[Ohira, Takahito; Kuroda, Yuko; Aoki, Sayaka; Inaoka, Daigo; Kugoh, Hiroyuki] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Ohira, Takahito; Osaki, Mitsuhiko; Okada, Futoshi; Oshimura, Mitsuo; Kugoh, Hiroyuki] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Kojima, Hirotada] Osaka City Univ, Grad Sch Med, Dept Immunol, Abeno Ku, Osaka, Japan; [Osaki, Mitsuhiko; Okada, Futoshi] Tottori Univ, Fac Med, Sch Life Sci, Div Pathol Biochem, Yonago, Tottori, Japan; [Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, Osaka, Japan	Tottori University; Tottori University; Osaka Metropolitan University; Tottori University; Osaka Metropolitan University	Kugoh, H (corresponding author), Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan.; Kugoh, H (corresponding author), Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan.	kugoh@tottori-u.ac.jp		Okada, Futoshi/0000-0003-4733-1037	Japan Society for the Promotion of Science (JSPS) [15H06414, 18K16030, 15K08304]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Young Scientists (Start-up) Grant Number 15H06414, Early-Career Scientists Grant Number 18K16030, and Grant-in-Aid for Scientific Research (C) Grant Number 15K08304. This research was partly performed at the Tottori Bio Frontier managed by Tottori prefecture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partly performed at the Tottori Bio Frontier managed by Tottori prefecture. We would like to thank Dr. Teruhiko Suzuki for assisting with our FLAG-Pull down examination.	Akincilar SC, 2016, CANCER DISCOV, V6, P1276, DOI 10.1158/2159-8290.CD-16-0177; Akincilar SC, 2015, FEBS LETT, V589, P974, DOI 10.1016/j.febslet.2015.02.035; Allan LA, 1999, ONCOGENE, V18, P5403, DOI 10.1038/sj.onc.1202931; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Arndt GM, 2016, NAT REV CANCER, V16, P508, DOI 10.1038/nrc.2016.55; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen YN, 2008, WORLD J GASTROENTERO, V14, P292, DOI 10.3748/wjg.14.292; Chen Y, 2007, LUNG CANCER, V55, P287, DOI 10.1016/j.lungcan.2006.11.001; Chiba K, 2017, SCIENCE, V357, P1416, DOI 10.1126/science.aao0535; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; Ebert BL, 2010, BEST PRACT RES CL HA, V23, P457, DOI 10.1016/j.beha.2010.09.006; Eisenmann KM, 2009, ONCOGENE, V28, P3429, DOI 10.1038/onc.2009.207; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Ghosh A, 2012, NAT CELL BIOL, V14, P1270, DOI 10.1038/ncb2621; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Island ML, 2002, MOL CELL BIOL, V22, P7120, DOI 10.1128/MCB.22.20.7120-7133.2002; Izutsu T, 2006, ACTA OBSTET GYN SCAN, V85, P3, DOI 10.1080/00016340500317096; Ji ZY, 2012, J INVEST DERMATOL, V132, P356, DOI 10.1038/jid.2011.313; Khattar E, 2016, J CLIN INVEST, V126, P4045, DOI 10.1172/JCI86042; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Kugoh H, 2003, GENE CHROMOSOME CANC, V36, P37, DOI 10.1002/gcc.10135; Kugoh H, 2016, CANCERS, V8, DOI 10.3390/cancers8010004; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Lee KM, 2004, CYTOTECHNOLOGY, V45, P33, DOI 10.1007/s10616-004-5123-3; Li M, 2015, MOL MED REP, V11, P4645, DOI 10.3892/mmr.2015.3287; Li YH, 2016, P NATL ACAD SCI USA, V113, P14402, DOI 10.1073/pnas.1611106113; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Liu X, 2014, ENVIRON MOL MUTAGEN, V55, P223, DOI 10.1002/em.21827; Lord RVN, 2005, SURGERY, V138, P924, DOI 10.1016/j.surg.2005.05.007; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Nakabayashi M, 2014, ONCOL LETT, V7, P750, DOI 10.3892/ol.2013.1775; Ohira T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08201; Osaki M, 2013, EUR J DERMATOL, V23, P344, DOI 10.1684/ejd.2013.2021; Qi DL, 2011, MOL CELL BIOL, V31, P1624, DOI 10.1128/MCB.00470-10; Qi DL, 2010, BIOCHEM BIOPH RES CO, V398, P695, DOI 10.1016/j.bbrc.2010.07.003; Ramlee MK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080050; Schubert SW, 2004, J BIOL CHEM, V279, P50358, DOI 10.1074/jbc.M404587200; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Wei GF, 2015, ONCOTARGET, V6, P17065, DOI 10.18632/oncotarget.4185; Wright WE, 1996, DEV GENET, V18, P173; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560; Yamaguchi T, 2010, APOPTOSIS, V15, P927, DOI 10.1007/s10495-010-0488-6; Yan TD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02601-1; Yin SJ, 2018, INT J BIOL MACROMOL, V106, P1052, DOI 10.1016/j.ijbiomac.2017.08.109	53	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0217605	10.1371/journal.pone.0217605	http://dx.doi.org/10.1371/journal.pone.0217605			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404068	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800004
J	Park, MR; Wong, MS; Arauzo-Bravo, MJ; Lee, H; Nam, D; Park, SY; Seo, HD; Lee, SM; Zeilhofer, HF; Zaehres, H; Scholer, HR; Kim, JB				Park, Myung Rae; Wong, Man Sze; Arauzo-Bravo, Marcos J.; Lee, Hyunah; Nam, Donggyu; Park, Soo Yong; Seo, Hong Dae; Lee, Sang Min; Zeilhofer, Hans Florian; Zaehres, Holm; Schoeler, Hans R.; Kim, Jeong Beom			Oct4 and Hnf4 alpha-induced hepatic stem cells ameliorate chronic liver injury in liver fibrosis model	PLOS ONE			English	Article							HEPATOCYTE-LIKE CELLS; PROGENITOR CELLS; HUMAN FIBROBLASTS; FUNCTIONAL HEPATOCYTES; DIRECT CONVERSION; DIFFERENTIATION; TRANSPLANTATION; PROLIFERATION; GENERATION; FAILURE	Direct conversion from fibroblasts to generate hepatocyte like-cells (iHeps) bypassing the pluripotent state has been described in previous reports as an attractive method acquiring hepatocytes for cell-based therapy. The limited proliferation of iHeps, however, has hampered it uses in cell-based therapy. Since hepatic stem cells (HepSCs) possess self-renewal and bipotency with the capacity to differentiate into both hepatocytes and cholangiocytes, they have therapeutic potential for treating liver disease. Here, we investigated the therapeutic effects of induced HepSCs (iHepSCs) on a carbon tetrachloride (CCl4)-induced liver fibrosis model. We demonstrate that Oct4 and Hnf4a are sufficient to convert fibroblasts into expandable iHepSCs. Hepatocyte-like cells derived from iHepSCs (iHepSC-HEPs) exhibit the typical morphology of hepatocytes and hepatic functions, including glycogen storage, low-density lipoprotein (LDL) uptake, Indocyanine green (ICG) detoxification, drug metabolism, urea production, and albumin secretion. iHepSCs-derived cholangiocyte-like cells (iHepSC-CLCs) expressed cholangiocyte-specific markers and formed cysts and tubule-like structures with apical-basal polarity and secretory function in three-dimensional culture condition. Furthermore, iHepSCs showed anti-inflammatory and anti-fibrotic effects in CCl4-induced liver fibrosis. This study demonstrates that Oct4 and Hnf4 alpha-induced HepSCs show typical hepatic and biliary functionality in vitro. It also presents the therapeutic effect of iHepSCs in liver fibrosis. Therefore, directly converting iHepSCs from somatic cells may facilitate the development of patient-specific cell-based therapy for chronic liver damage.	[Park, Myung Rae; Wong, Man Sze; Lee, Hyunah; Nam, Donggyu; Park, Soo Yong; Seo, Hong Dae; Lee, Sang Min; Kim, Jeong Beom] UNIST, Sch Life Sci, HSSCRC, Ulsan, South Korea; [Arauzo-Bravo, Marcos J.] Biodonostia Hlth Res Inst, Grp Computat Biol & Bioinformat, San Sebastian, Spain; [Arauzo-Bravo, Marcos J.] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Zeilhofer, Hans Florian] Univ Hosp Basel, Dept Craniomaxillofacial Surg, Basel, Switzerland; [Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany	Ulsan National Institute of Science & Technology (UNIST); Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science; University of Basel; Max Planck Society	Kim, JB (corresponding author), UNIST, Sch Life Sci, HSSCRC, Ulsan, South Korea.	jbkim@unist.ac.kr		Seo, Hongdae/0000-0002-4907-8445; Nam, Donggyu/0000-0003-4571-5547; Kim, Jeong Beom/0000-0001-6230-8826; Scholer, Hans/0000-0003-2643-5136; Wong, Man Sze/0000-0002-1323-7299	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT [2016M3A9B4919719, 2017M3A9C6033875]; Tech Incubator Program for Startup (TIPS) - Ministry of SMEs and Startups [S2566811]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT; Tech Incubator Program for Startup (TIPS) - Ministry of SMEs and Startups	JBK received funding for this work by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (Grant No. 2016M3A9B4919719 and Grant No. 2017M3A9C6033875) and Tech Incubator Program for Startup (TIPS) funded by the Ministry of SMEs and Startups (S2566811). The funders (www.nrf.re.kr) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy I, 2013, STEM CELLS, V31, P2632, DOI 10.1002/stem.1522; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhave VS, 2011, HEPATOLOGY, V54, P1360, DOI 10.1002/hep.24507; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chang HM, 2012, INT J MOL SCI, V13, P3598, DOI 10.3390/ijms13033598; Chen C, 2018, BIOTECHNOL BIOENG, V115, P2807, DOI 10.1002/bit.26784; Chiba T, 2010, HEPATOLOGY, V52, P1111, DOI 10.1002/hep.23793; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Huang PY, 2014, CELL STEM CELL, V14, P370, DOI 10.1016/j.stem.2014.01.003; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kim JB, 2015, EMBO J, V34, P2971, DOI 10.15252/embj.201592652; Kim JB, 2009, NAT PROTOC, V4, P1464, DOI 10.1038/nprot.2009.173; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li FM, 2010, GASTROENTEROLOGY, V139, P2158, DOI 10.1053/j.gastro.2010.08.042; Li JX, 2000, GENE DEV, V14, P464; Li WL, 2006, STEM CELLS, V24, P322, DOI 10.1634/stemcells.2005-0108; Lim KT, 2016, CELL REP, V15, P814, DOI 10.1016/j.celrep.2016.03.071; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632; Mitchell R, 2014, STEM CELLS, V32, P2178, DOI 10.1002/stem.1721; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nussler A, 2006, J HEPATOL, V45, P144, DOI 10.1016/j.jhep.2006.04.002; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Pournasr B, 2015, EUR J CELL BIOL, V94, P603, DOI 10.1016/j.ejcb.2015.10.003; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Shen L, 2012, JOVE-J VIS EXP, DOI 10.3791/3917; Song GQ, 2016, CELL STEM CELL, V18, P797, DOI 10.1016/j.stem.2016.01.010; Soto-Gutierrez A, 2006, NAT BIOTECHNOL, V24, P1412, DOI 10.1038/nbt1257; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Tabibian JH, 2013, COMPR PHYSIOL, V3, P541, DOI 10.1002/cphy.c120019; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Walesky C, 2015, GENE EXPRESSION, V16, P101, DOI 10.3727/105221615X14181438356292; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Zhang RR, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-017-0747-3; Zhao R, 2014, P NATL ACAD SCI USA, V111, P15768, DOI 10.1073/pnas.1417518111; Zhu SY, 2014, NATURE, V508, P93, DOI 10.1038/nature13020	50	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221085	10.1371/journal.pone.0221085	http://dx.doi.org/10.1371/journal.pone.0221085			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404112	Green Submitted, Green Published, gold			2022-12-27	WOS:000485006800054
J	Dobia, A; Ryan, K; Abutaleb, M; Edwards, A				Dobia, Ali; Ryan, Kath; Abutaleb, Mohammed; Edwards, Alexander			Perceptions of physicians in Saudi Arabia on the use of international clinical guidelines for managing primary insomnia	PLOS ONE			English	Article							SLEEP MEDICINE; GPS ATTITUDES; IMPLEMENTATION; GUIDANCE	Introduction While there are no national clinical guidelines for managing primary insomnia in Saudi Arabia, there are also no published studies of physicians' perceptions of and attitudes towards using international guidelines. The objective of this study was to explore the knowledge, perceptions, and attitudes of physicians practising in Saudi Arabia about using international guidelines for managing insomnia. Methods A qualitative study using in-depth, face-to-face, and semi-structured interviews with 15 physicians held in July 2017 at a tertiary care hospital in Jazan, the distal south-western province in Saudi Arabia. Interviews were audio-recorded, transcribed verbatim, coded using the qualitative software NVivo11 and analysed thematically. Data saturation was assumed as no new understandings of the broad thematic issues were produced by the last three interviews. Results Themes identified were: Knowledge, Resistance, Barriers and Facilitators. Participants acknowledged their lack of awareness of available guidelines and their lack of training and education about Cognitive Behavioural Therapy for Insomnia (CBT-I). They highlighted a lack of education for patients about insomnia and its treatment. Beliefs about dependence on hypnotics and the inappropriateness of international guidelines for Saudi Arabia inclined many to resist using them. Inability to document diagnosis and consultations due to limited time and lack of suitable electronic systems, lack of suitably trained practitioners for referral for CBT-I, and lack of accountability for practice were identified as key barriers to following international guidelines. Development of national guidelines was the most important facilitator suggested by participants. Conclusions The health authorities in the government of the Kingdom of Saudi Arabia (KSA) should improve general public awareness about sleep disorders and provide focused training for specialists and technologists. Above all, KSA needs its own nationwide guidelines for treating sleep-disorders based on evidence-based clinical trials, consistent with its history, culture, socioeconomic conditions and traditions.	[Dobia, Ali; Ryan, Kath; Edwards, Alexander] Univ Reading, Reading Sch Pharm, Reading, Berks, England; [Dobia, Ali] Gen Directorate Med Serv, Riyadh, Saudi Arabia; [Abutaleb, Mohammed] Minist Hlth, Jazan Hlth Affairs, Jazan, Saudi Arabia	University of Reading; Ministry of Health - Saudi Arabia	Dobia, A (corresponding author), Univ Reading, Reading Sch Pharm, Reading, Berks, England.; Dobia, A (corresponding author), Gen Directorate Med Serv, Riyadh, Saudi Arabia.	a.m.a.dobia@pgr.reading.ac.uk	Edwards, Alexander/F-7440-2010; Edwards, Alexander Daniel/AAX-8524-2021; Abutaleb, Mohammed/I-2595-2013	Edwards, Alexander/0000-0003-2369-989X; Edwards, Alexander Daniel/0000-0003-2369-989X; Abutaleb, Mohammed/0000-0002-5300-5900; Dobia, Ali/0000-0001-5579-5056	Saudi Arabian Cultural Bureau in London	Saudi Arabian Cultural Bureau in London	The first author AD is supported by a full time scholarship provided by the Saudi Arabian Cultural Bureau in London. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AE, 2017, ETHNIC HEALTH, V22, P285, DOI 10.1080/13557858.2016.1244624; Alahmari T, 2019, MOJ ADDICTION MED TH, V6; Albejaidi F., 2010, J ALTERN PERSPECT SO, V2, P794; Almeneessier AS, 2017, J CLIN SLEEP MED, V13, P641, DOI 10.5664/jcsm.6566; Alnaim L, 2017, INDIAN J PHARM SCI, V79, P923, DOI 10.4172/pharmaceutical-sciences.1000309; Altokhais TI, 2017, J EVAL CLIN PRACT, V23, P156, DOI 10.1111/jep.12658; Amer YS, 2019, J EVAL CLIN PRACT, V25, P543, DOI 10.1111/jep.12923; Bahammam AS, 2014, ANN THORAC MED, V9, P45, DOI 10.4103/1817-1737.124444; BaHammam AS, 2000, SAUDI MED J, V21, P1164; Baynouna Al Ketbi Latifa Mohammad, 2018, Asia Pac Fam Med, V17, P5, DOI 10.1186/s12930-018-0041-2; Birrenbach Tanja, 2016, Adv Med Educ Pract, V7, P673, DOI 10.2147/AMEP.S115149; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell N, 2003, AM J HYPERTENS, V16, P698, DOI 10.1016/S0895-7061(03)00055-4; Carlsen B, 2007, BRIT J GEN PRACT, V57, P971, DOI 10.3399/096016407782604820; Cook JM, 2007, J GEN INTERN MED, V22, P303, DOI 10.1007/s11606-006-0021-3; Dobia A, 2019, PHARMACY, V7, DOI 10.3390/pharmacy7010015; Farquhar CM, 2002, MED J AUSTRALIA, V177, P502, DOI 10.5694/j.1326-5377.2002.tb04920.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Grol R, 2001, MED CARE, V39, pII46; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Gundersen L, 2000, ANN INTERN MED, V133, P317, DOI 10.7326/0003-4819-133-4-200008150-00102; Hasanain R, 2014, HLTH INFORM INT J, V3, DOI [10.5121/HIIJ.2014.3201, DOI 10.5121/HIIJ.2014.3201]; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; Heselmans A, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-64; Layard R, 2006, BRIT MED J, V332, P1030, DOI 10.1136/bmj.332.7548.1030; Lugtenberg M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-54; Morriss R, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0464-7; Pagliari H, 1999, J CLIN NURSES, V13, P731, DOI [10.1111/J.1365-2702.2004.00941.X, DOI 10.1111/J.1365-2702.2004.00941.X]; Robbie F, 2001, BR J CLIN GOV, V6, P166, DOI [DOI 10.1108/EUM0000000005680, 10.1108/EUM0000000005680]; Rycroft-Malone J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-80; Sheldon TA, 2004, BRIT MED J, V329, P999, DOI 10.1136/bmj.329.7473.999; Siriwardena AN, 2006, BRIT J GEN PRACT, V56, P964; Sola I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086065; Storm-Versloot MN, 2012, J EVAL CLIN PRACT, V18, P841, DOI 10.1111/j.1365-2753.2011.01687.x; Taba P, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-455; van Dulmen SA, 2014, PHYS THER, V94, P1396, DOI 10.2522/ptj.20130286; Wahabi HA, 2011, J EVAL CLIN PRACT, V17, P763, DOI 10.1111/j.1365-2753.2011.01694.x; World Health Organization, 2014, MENT HLTH ATL COUNTR	39	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220960	10.1371/journal.pone.0220960	http://dx.doi.org/10.1371/journal.pone.0220960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398230	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000485004000031
J	Abu Musa, M; Kabir, M; Hossain, MI; Ahmed, E; Siddique, A; Rashid, H; Mahfuz, M; Mondal, D; Ahmed, T; Petri, WA; Haque, R				Abu Musa, Md.; Kabir, Mamun; Hossain, Md. Iqbal; Ahmed, Emtiaz; Siddique, Abdullah; Rashid, Humaira; Mahfuz, Mustafa; Mondal, Dinesh; Ahmed, Tahmeed; Petri, William A.; Haque, Rashidul			Measurement of intestinal permeability using lactulose and mannitol with conventional five hours and shortened two hours urine collection by two different methods: HPAE-PAD and LC-MSMS	PLOS ONE			English	Article							BARRIER FUNCTION; CHILDREN; GROWTH; ENTEROPATHY; SEX	Urinary excretion of two orally-administered non-metabolizable sugars, lactulose and mannitol, is a valuable marker for evaluating intestinal permeability. Usually this test involves a time consuming procedure of about 5 hour's urine collection, which makes the test incompatible to some extent. As the results are expressed as the ratio of lactulose and mannitol recovered in urine within certain time, it may be possible to get similar result despite the reduced urine collection time of 2 hours. Moreover, different laboratories do the test by different methods, which make the results incomparable between laboratories. Here, we are also trying to find the correlation between results from most commonly used methods: HPAE-PAD and LC-MSMS. The lactulose: mannitol (LM) test was performed in a cohort of Bangladeshi infants considered at-risk for environmental enteropathy. 208 urine specimens from 104 (52 male and 52 female) infants were collected at 2 and 5 hours after LM solution administration and were tested for lactulose and mannitol by two different methods, one HPAE-PAD platform and another LC-MSMS platform. Median age of the children was 15.0 months (range 6.9 to 25.8 months) and their mean weight-for-age z-score was -0.92. A higher percentage of lactulose and mannitol recovery was found in 5 hours urine collection than in the corresponding 2 hours by both HPAE-PAD and LC-MSMS method, but when results were expressed as lactulose to mannitol ratio (LMR) there was no significant difference between 2 and 5 hours urine collection in both HPAE-PAD (P = 0.138) and LC-MSMS (P = 0.099) method. LMR based on 2 hours urine collection correlated well with LMR based on traditional 5 hours urine collection (Spearman's correlation coefficient 0.578 and 0.604 respectively for HPAE-PAD and LC-MSMS). In future, LM test to assess intestinal permeability in children can be simplified by shortening the urine collection time from 5 hours to 2 hours.	[Abu Musa, Md.; Kabir, Mamun; Ahmed, Emtiaz; Siddique, Abdullah; Mondal, Dinesh; Haque, Rashidul] Int Ctr Diarrhoeal Dis Res, Infect Dis Div, Emerging Infect & Parasitol Lab, Dhaka, Bangladesh; [Hossain, Md. Iqbal; Rashid, Humaira; Mahfuz, Mustafa; Ahmed, Tahmeed] Int Ctr Diarrhoeal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Petri, William A.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Abu Musa, Md.] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Parasitol, Nagasaki, Japan	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); University of Virginia; Nagasaki University	Haque, R (corresponding author), Int Ctr Diarrhoeal Dis Res, Infect Dis Div, Emerging Infect & Parasitol Lab, Dhaka, Bangladesh.	rhaque@icddrb.org	Mahfuz, Mustafa/H-5923-2017; Petri, William/AAL-3642-2020	Mahfuz, Mustafa/0000-0002-4090-785X; Petri, William/0000-0002-7268-1218; Haque, Rashidul/0000-0001-5100-136X	Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043596] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research study was funded by grants from the Bill and Melinda Gates Foundation awarded to T.A. (Dr. Tahmeed Ahmed). The sponsors had no role in study design, interpretation or manuscript preparation.	Akram S, 1998, DIGEST DIS SCI, V43, P1946, DOI 10.1023/A:1018826307489; ANDRE F, 1988, GUT, V29, P511, DOI 10.1136/gut.29.4.511; Bao YD, 1996, J CHROMATOGR B, V685, P105, DOI 10.1016/0378-4347(96)00159-4; Barboza MS, 1999, BRAZ J MED BIOL RES, V32, P1499, DOI 10.1590/S0100-879X1999001200008; Camilleri M, 2010, NEUROGASTROENT MOTIL, V22, pE15, DOI 10.1111/j.1365-2982.2009.01361.x; Drago F, 1999, LIFE SCI, V64, P2341, DOI 10.1016/S0024-3205(99)00187-3; DUPONT C, 1989, J PEDIATR GASTR NUTR, V8, P459, DOI 10.1097/00005176-198905000-00007; FURR MO, 1992, EQUINE VET J, V24, P37, DOI 10.1111/j.2042-3306.1992.tb02776.x; Goto R, 2009, BRIT J NUTR, V101, P1509, DOI 10.1017/S0007114508083554; Hossain MI, 2010, J PEDIATR GASTR NUTR, V51, P638, DOI 10.1097/MPG.0b013e3181eb3128; JALONEN T, 1991, J ALLERGY CLIN IMMUN, V88, P737, DOI 10.1016/0091-6749(91)90180-V; Johnston SD, 2000, ANN CLIN BIOCHEM, V37, P512, DOI 10.1258/0004563001899500; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; Lee GO, 2014, J PEDIATR GASTR NUTR, V59, P544, DOI 10.1097/MPG.0000000000000459; Lima AAM, 1997, AM J GASTROENTEROL, V92, P1861; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; Machowska A., 2008, Inflammopharmacology, V16, P40, DOI 10.1007/s10787-007-1600-6; Marshall JK, 2004, ALIMENT PHARM THER, V20, P1317, DOI 10.1111/j.1365-2036.2004.02284.x; McOmber ME, 2010, J PEDIATR GASTR NUTR, V50, P269, DOI 10.1097/MPG.0b013e3181aa3aa9; SALTZMAN JR, 1995, J AM GERIATR SOC, V43, P160, DOI 10.1111/j.1532-5415.1995.tb06382.x; Sun M, 1999, Zhonghua Wai Ke Za Zhi, V37, P298; Thurnham DI, 2000, J INFECT DIS, V182, pS23, DOI 10.1086/315912; Vojdani A, 2013, ALTERN THER HEALTH M, V19, P12	23	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220397	10.1371/journal.pone.0220397	http://dx.doi.org/10.1371/journal.pone.0220397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393913	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500031
J	Haider, M; Dambuza, IM; Asamaphan, P; Stappers, M; Reid, D; Yamasaki, S; Brown, GD; Gow, NAR; Erwig, LP				Haider, Mohammed; Dambuza, Ivy M.; Asamaphan, Patawee; Stappers, Mark; Reid, Delyth; Yamasaki, Sho; Brown, Gordon D.; Gow, Neil A. R.; Erwig, Lars P.			The pattern recognition receptors dectin-2, mincle, and FcR gamma impact the dynamics of phagocytosis of Candida, Saccharomyces, Malassezia, and Mucor species	PLOS ONE			English	Article							C-TYPE LECTIN; HOST-DEFENSE; PATHOGEN INTERACTIONS; ACTIVATING RECEPTOR; ALBICANS; MATURATION; PHAGOSOMES; RESPONSES; INSIGHTS; FAMILY	Phagocytosis is a receptor-mediated process critical to innate immune clearance of pathogens. It proceeds in a regulated sequence of stages: (a) migration of phagocytes towards pathogens, (b) recognition of PAMPs and binding through PRRs, (c) engulfment and internalisation into phagosomes, (d) phagosome maturation, and (e) killing of pathogen or host cells. However, little is known about the role that individual receptors play in these discrete stages in the recognition of fungal cells. In a previous study, we found that dectin-2 deficiency impacted some but not all stages of macrophage-mediated phagocytosis of Candida glabrata. Because the C-type lectin receptor dectin-2 critically requires coupling to the FcR gamma chain for signalling, we hypothesised that this coupling may be important for regulating phagocytosis of fungal cargo. We therefore examined how deficiency in FcR gamma itself or two receptors to which it couples (dectin-2 and mincle) impacts phagocytosis of six fungal organisms representing three different fungal taxa. Our data show that deficiency in these proteins impairs murine bone marrow-derived macrophage migration, engulfment, and phagosome maturation, but not macrophage survival. Therefore, FcR gamma engagement with selective C-type lectin receptors (CLRs) critically affects the spatio-temporal dynamics of fungal phagocytosis.	[Haider, Mohammed; Dambuza, Ivy M.; Asamaphan, Patawee; Stappers, Mark; Reid, Delyth; Brown, Gordon D.; Gow, Neil A. R.; Erwig, Lars P.] Univ Aberdeen, Ctr Med Mycol, Inst Med Sci, Med Res Council,Aberdeen Fungal Grp, Aberdeen, Scotland; [Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Fukuoka, Fukuoka, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Dept Mol Immunol, Chiba, Japan; [Haider, Mohammed] Kuwait Univ, Fac Sci, Dept Biol Sci, Microbiol Programme, Kuwait, Kuwait; [Asamaphan, Patawee] Univ Glasgow, Ctr Virus Res, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Stappers, Mark; Gow, Neil A. R.] Univ Exeter, Sch Biosci, Geoffrey Pope Bldg, Exeter, Devon, England; [Reid, Delyth] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Erwig, Lars P.] Galvani Bioelect, Gunnels Wood Rd, Stevenage, Herts, England	University of Aberdeen; Kyushu University; Chiba University; Kuwait University; University of Glasgow; University of Exeter; Osaka University	Gow, NAR; Erwig, LP (corresponding author), Univ Aberdeen, Ctr Med Mycol, Inst Med Sci, Med Res Council,Aberdeen Fungal Grp, Aberdeen, Scotland.; Gow, NAR (corresponding author), Univ Exeter, Sch Biosci, Geoffrey Pope Bldg, Exeter, Devon, England.; Erwig, LP (corresponding author), Galvani Bioelect, Gunnels Wood Rd, Stevenage, Herts, England.	n.gow@exeter.ac.uk; lars.x.erwig@galvani.bio	GOW, Neil/AAS-5323-2021; Haider, Mohammed/AAZ-7803-2020	GOW, Neil/0000-0002-2776-5850; Haider, Mohammed/0000-0002-4660-338X; Stappers, Mark/0000-0003-4154-7160	MRC Centre for Medical Mycology [MR/N006364/1]; Wellcome Trust [080088, 086827, 075470, 099215, 097377, 101873/Z/13/Z, 200208/A/15/Z]; MRC [MR/N006364/1, MR/N006364/2] Funding Source: UKRI	MRC Centre for Medical Mycology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MRC Centre for Medical Mycology (MR/N006364/1). NARG thanks The Wellcome Trust (080088, 086827, 075470, 099215, 097377, 101873/Z/13/Z, and 200208/A/15/Z) for support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Microscopy and Histology core facility at the University of Aberdeen. In particular, we extend our thanks to Mr Kevin MacKenzie and Ms Lucinda Wight for their helpful support and advice on imaging. We are also grateful to Prof. Sho Yamasaki (Kyushu University, Japan) for the generous gift of bone marrow cells from FcR gamma<SUP>-/-</SUP> mice. This work was supported by the MRC Centre for Medical Mycology (MR/N006364/1). NARG thanks The Wellcome Trust (080088, 086827, 075470, 099215, 097377, 101873/Z/13/Z, and 200208/A/15/Z) for support.	Alvarez M, 2006, CURR BIOL, V16, P2161, DOI 10.1016/j.cub.2006.09.061; Bain J, 2015, SEMIN IMMUNOPATHOL, V37, P131, DOI 10.1007/s00281-014-0463-3; Bain JM, 2014, MBIO, V5, DOI 10.1128/mBio.01874-14; Bain JM, 2012, FUNGAL GENET BIOL, V49, P677, DOI 10.1016/j.fgb.2012.01.008; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Danhof HA, 2015, INFECT IMMUN, V83, P4416, DOI 10.1128/IAI.00984-15; Drummond RA, 2011, EUR J IMMUNOL, V41, P276, DOI 10.1002/eji.201041252; Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369; Ifrim DC, 2016, J INTERF CYTOK RES, V36, P267, DOI 10.1089/jir.2015.0040; Ifrim DC, 2014, INFECT IMMUN, V82, P1064, DOI 10.1128/IAI.01189-13; Kano R, 1999, MICROBIOL IMMUNOL, V43, P813, DOI 10.1111/j.1348-0421.1999.tb02475.x; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Kimura Y, 2016, P NATL ACAD SCI USA, V113, P14097, DOI 10.1073/pnas.1617903113; Lee SC, 2015, MOL MICROBIOL, V97, P844, DOI 10.1111/mmi.13071; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Levin R, 2016, IMMUNOL REV, V273, P156, DOI 10.1111/imr.12439; Lewis LE, 2013, JOVE-J VIS EXP, DOI 10.3791/50196; Lewis LE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002578; Li CH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002086; Lim J, 2018, J IMMUNOL, V200, P3539, DOI 10.4049/jimmunol.1700790; Ma HS, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-15; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; McPhillips KA, 2009, METHODS MOL BIOL, V559, P247, DOI 10.1007/978-1-60327-017-5_17; Moretti J, 2014, CURR OPIN IMMUNOL, V26, P100, DOI 10.1016/j.coi.2013.11.003; MORTIMER RK, 1986, GENETICS, V113, P35; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Okai B, 2015, INFECT IMMUN, V83, P1523, DOI 10.1128/IAI.02917-14; Patterson MJ, 2013, ANTIOXID REDOX SIGN, V19, P2244, DOI 10.1089/ars.2013.5199; Rudkin FM, 2013, MBIO, V4, DOI 10.1128/mBio.00810-13; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Satoh K, 2009, MICROBIOL IMMUNOL, V53, P41, DOI 10.1111/j.1348-0421.2008.00083.x; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; Slesiona S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031223; Strasser JE, 1999, J IMMUNOL, V162, P6148; Sugita T, 2002, J CLIN MICROBIOL, V40, P1363, DOI 10.1128/JCM.40.4.1363-1367.2002; Uwamahoro N, 2014, MBIO, V5, DOI 10.1128/mBio.00003-14; Vijayan D, 2012, IMMUNOL CELL BIOL, V90, P889, DOI 10.1038/icb.2012.24; Vylkova S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003995; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhuang LH, 2012, J IMMUNOL METHODS, V385, P1, DOI 10.1016/j.jim.2012.06.008	47	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220867	10.1371/journal.pone.0220867	http://dx.doi.org/10.1371/journal.pone.0220867			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393930	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500074
J	Liao, RR; Lv, YH; Zhu, LH; Lin, YX				Liao, Rongrong; Lv, Yuhua; Zhu, Lihui; Lin, Yuexia			Altered expression of miRNAs and mRNAs reveals the potential regulatory role of miRNAs in the developmental process of early weaned goats	PLOS ONE			English	Article							MUSCLE-CELL PROLIFERATION; SKELETAL-MUSCLE; MAINTENANCE; MICRORNAS; GROWTH	MicroRNAs (miRNAs) play pivotal roles in growth, development, and stress responses. However, the regulatory function of miRNAs in early weaned goats remains unclear. Deep sequencing comparison of mRNA and miRNA expression profiles showed that 18 miRNAs and 373 genes were differentially expressed in pre- and post-weaning Chongming white goats. Bioinformatics analysis indicated that these differentially expressed genes are involved in cellular processes, developmental processes, and growth in terms of biological process analysis. KEGG analysis showed that downregulated genes were enriched in salivary secretion, bile secretion, vascular smooth muscle contraction, and calcium signaling pathways. Additionally, a miRNA-mRNA co-expression network of the 18 dysregulated miRNAs and their 107 target mRNAs was constructed using a combination of Pearson's correlation analysis and prediction by miRanda software. Among the downregulated miRNAs, two (chi-miR-206 and chi-miR-133a/b) were muscle development-related and the others were cell proliferation associated. Further RT-qPCR analysis confirmed that downregulated miRNAs (chi-miR-99b-3p, chi-miR-224, and chi-miR-10b-5p) were highly expressed in muscle tissues (heart, spleen, or kidney) of the rapid growth period (7-month old) in Chongming white goats. The results of the present study suggested that weaning induced cell proliferation repression in post-weaning goats, providing new insight into the mechanism of muscle development of goats, although additional details remain to be elucidated in the future.	[Liao, Rongrong; Lv, Yuhua; Zhu, Lihui; Lin, Yuexia] Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Zhu, LH; Lin, YX (corresponding author), Shanghai Acad Agr Sci, Inst Anim Husb & Vet Sci, Shanghai, Peoples R China.	zhulihui@saas.sh.cn; linyuexia@saas.sh.cn		Zhu, Lihui/0000-0002-2931-6207	Youth Talent Development Plan of Shanghai Municipal Agricultural System [20170116]; Shanghai Agriculture Applied Technology Development Program [Z20170303]; Young Scientist Plan of Shanghai Academy of Agricultural Sciences [ZP173]	Youth Talent Development Plan of Shanghai Municipal Agricultural System; Shanghai Agriculture Applied Technology Development Program; Young Scientist Plan of Shanghai Academy of Agricultural Sciences	This work was financially supported by the Youth Talent Development Plan of Shanghai Municipal Agricultural System (Grant No. 20170116) to RL, Shanghai Agriculture Applied Technology Development Program (Grant No. Z20170303) to Y. Lin, and the Young Scientist Plan of Shanghai Academy of Agricultural Sciences (Grant No. ZP173) to RL.	Bai L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173912; Boettger T, 2014, SKELET MUSCLE, V4, DOI 10.1186/s13395-014-0023-5; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Do DN, 2018, GENOMICS; Do DN, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090134; Esumi M, 2015, HEPATOLOGY, V61, P437, DOI 10.1002/hep.27426; Gheinani AH, 2015, J BIOL CHEM, V290, P7067, DOI 10.1074/jbc.M114.618694; Greenwood PL, 2007, ANIMAL, V1, P1283, DOI 10.1017/S175173110700050X; Hao Y, 2016, ANIM GENET, V47, P365, DOI 10.1111/age.12419; He K, 2015, INT J ONCOL, V47, P1528, DOI 10.3892/ijo.2015.3135; He M, 2017, CELL PHYSIOL BIOCHEM, V42, P2078, DOI 10.1159/000479903; Kelly D, 2000, LIVEST PROD SCI, V66, P161, DOI 10.1016/S0301-6226(00)00223-2; Ling YH, 2015, J ANIM PLANT SCI, V25, P146; Liu C, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010994; Ma GD, 2015, INT J BIOL SCI, V11, P345, DOI 10.7150/ijbs.10921; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Miao XY, 2015, GENE, V562, P188, DOI 10.1016/j.gene.2015.02.070; Mu YH, 2016, EMBO REP, V17, P94, DOI 10.15252/embr.201540964; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ren FH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135544; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tao X, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-017-0199-9; Tao X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162776; Tao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079343; Teke B, 2012, SMALL RUMINANT RES, V103, P176, DOI 10.1016/j.smallrumres.2011.08.012; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Wang C, 2019, J CELL PHYSIOL, V234, P9467, DOI 10.1002/jcp.27632; Wang L, 2017, EUR REV MED PHARMACO, V21, P3223; Wang Z, 2018, SCI REP, V8; Wei CH, 2018, CELL PHYSIOL BIOCHEM, V49, P447, DOI 10.1159/000492979; Xu JC, 2018, GENE, V679, P266, DOI 10.1016/j.gene.2018.09.010; Yates C, 2017, FRONT BIOSCI-LANDMRK, V22, P212, DOI 10.2741/4482; Yu X, 2015, CURR VASC PHARMACOL, V13, P679, DOI 10.2174/1570161113666150123112751; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Yue YX, 2018, CARDIOVASC PATHOL, V37, P15, DOI 10.1016/j.carpath.2018.08.003; Zhang WR, 2017, IN VITRO CELL DEV-AN, V53, P265, DOI 10.1007/s11626-016-0109-y; Zhen L, 2017, J THERM BIOL, V66, P114, DOI 10.1016/j.jtherbio.2017.03.005; Zhou JZ, 2017, INT J MED SCI, V14, P937, DOI 10.7150/ijms.19565; Zhu LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25885; Zuo JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124873	45	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220907	10.1371/journal.pone.0220907	http://dx.doi.org/10.1371/journal.pone.0220907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393969	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500081
J	Luniewska, M; Wodniecka, Z; Miller, CA; Smolik, F; Butcher, M; Chondrogianni, V; Hreich, EK; Messarra, C; Razak, RA; Treffers-Daller, J; Yap, NT; Abboud, L; Talebi, A; Gureghian, M; Tuller, L; Haman, E				Luniewska, Magdalena; Wodniecka, Zofia; Miller, Carol A.; Smolik, Filip; Butcher, Morna; Chondrogianni, Vasiliki; Hreich, Edith Kouba; Messarra, Camille; Razak, Rogayah A.; Treffers-Daller, Jeanine; Yap, Ngee Thai; Abboud, Layal; Talebi, Ali; Gureghian, Maribel; Tuller, Laurice; Haman, Ewa			Age of acquisition of 299 words in seven languages: American English, Czech, Gaelic, Lebanese Arabic, Malay, Persian and Western Armenian	PLOS ONE			English	Article							OF-ACQUISITION; NAME AGREEMENT; IMAGE AGREEMENT; OBJECTIVE AGE; NAMING TIMES; PSYCHOLINGUISTIC NORMS; VANDERWART PICTURES; VISUAL COMPLEXITY; CONCEPTUAL FAMILIARITY; CUMULATIVE FREQUENCY	We present a new set of subjective Age of Acquisition (AoA) ratings for 299 words (158 nouns, 141 verbs) in seven languages from various language families and cultural settings: American English, Czech, Scottish Gaelic, Lebanese Arabic, Malaysian Malay, Persian, and Western Armenian. The ratings were collected from a total of 173 participants and were highly reliable in each language. We applied the same method of data collection as used in a previous study on 25 languages which allowed us to create a database of fully comparable AoA ratings of 299 words in 32 languages. We found that in the seven languages not included in the previous study, the words are estimated to be acquired at roughly the same age as in the previously reported languages, i.e. mostly between the ages of 1 and 7 years. We also found that the order of word acquisition is moderately to highly correlated across all 32 languages, which extends our previous conclusion that early words are acquired in similar order across a wide range of languages and cultures.	[Luniewska, Magdalena; Haman, Ewa] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Wodniecka, Zofia] Jagiellonian Univ, Inst Psychol, Krakow, Poland; [Wodniecka, Zofia; Miller, Carol A.] Penn State Univ, Dept Commun Sci & Disorders, University Pk, PA 16802 USA; [Smolik, Filip] Czech Acad Sci, Inst Psychol, Prague, Czech Republic; [Butcher, Morna; Chondrogianni, Vasiliki] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland; [Hreich, Edith Kouba; Abboud, Layal; Gureghian, Maribel] St Joseph Univ Beirut, Fac Med, Beirut, Lebanon; [Messarra, Camille] St Joseph Univ Beirut, High Inst Speech & Language Therapy, Beirut, Lebanon; [Razak, Rogayah A.] Univ Kebangsaan Malaysia, Fac Hlth Sci, Kuala Lumpur, Malaysia; [Treffers-Daller, Jeanine] Univ Reading, Dept English Language & Appl Linguist, Reading, Berks, England; [Yap, Ngee Thai] Univ Putra Malaysia, Fac Modern Languages & Commun, Serdang, Malaysia; [Talebi, Ali] Allameh Tabatabai Univ, Dept Linguist & Teaching Persian Speakers Other L, Tehran, Iran; [Tuller, Laurice] Univ Tours, UMR 1253, iBrain, Tours, France	University of Warsaw; Jagiellonian University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Czech Academy of Sciences; Institute of Psychology of the Czech Academy of Sciences; University of Edinburgh; Universiti Kebangsaan Malaysia; University of Reading; Universiti Putra Malaysia; Allameh Tabataba'i University; Universite de Tours	Luniewska, M (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	magdalena.luniewska@psych.uw.edu.pl	Treffers-Daller, Jeanine/ABD-7048-2021; Chondrogianni, Vicky/AAL-6763-2021; Haman, Ewa/P-6347-2019; Hreich, Edith Kouba/ABH-3228-2020; Smolík, Filip/B-6342-2013; Łuniewska, Magdalena/GZK-3110-2022; Yap, Ngee Thai/AAO-4488-2020; A Razak, Rogayah/AGI-4578-2022; Yap, Ngee Thai/AAV-1975-2020; Luniewska-Etenkowska, Magdalena/N-4471-2017; Tuller, Laurice/T-2124-2018	Treffers-Daller, Jeanine/0000-0002-6575-6736; Haman, Ewa/0000-0003-1615-711X; Hreich, Edith Kouba/0000-0002-6086-2046; Smolík, Filip/0000-0003-4160-6124; A Razak, Rogayah/0000-0002-2968-7745; Yap, Ngee Thai/0000-0001-8672-7128; Luniewska-Etenkowska, Magdalena/0000-0001-5504-9766; Chondrogianni, Vasiliki/0000-0002-8580-5662; Tuller, Laurice/0000-0002-7491-0379	Polish Ministry of Science and Higher Education [809/N-COST/2010/0]; Institute of Psychology, Jagiellonian University; Visegrad Fund [21420015]; Faculty of Psychology, University of Warsaw [DSM 11710/2017]; Kosciuszko Foundation fellowship; Mobility Plus Fellowship from Ministry of Science and Higher Education; CeLM Pump Priming Fund, University of Reading, UK; Bord na Gaidhlig grant; networking program COST Action [IS0804]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Institute of Psychology, Jagiellonian University; Visegrad Fund; Faculty of Psychology, University of Warsaw; Kosciuszko Foundation fellowship; Mobility Plus Fellowship from Ministry of Science and Higher Education; CeLM Pump Priming Fund, University of Reading, UK; Bord na Gaidhlig grant; networking program COST Action	This study was designed as a part of a multilingual parallel construction procedure of LITMUS Cross-linguistic Lexical Tasks (www.psychologia.pl/clts) within the networking program COST Action IS0804 "Language Impairment in a Multilingual Society: Linguistic Patterns and the Road to Assessment"(www.bi-sli.org; 2010-2013). The research (website design and maintenance) was supported by the Polish Ministry of Science and Higher Education (Grant No. 809/N-COST/2010/0, awarded to the Faculty of Psychology, University of Warsaw, in cooperation with Institute of Psychology, Jagiellonian University; Principal Investigators: Ewa Haman & Zofia Wodniecka). The research was supported by Visegrad Fund (Standard Grant 21420015: "Bilingual assessment of child lexical knowledge: new method for Polish, Czech, Slovak and Hungarian" awarded to the Faculty of Psychology, University of Warsaw; PI Ewa Haman), internal grant of Faculty of Psychology, University of Warsaw (DSM 11710/2017; PI Magdalena Luniewska), Kosciuszko Foundation fellowship awarded to Ewa Haman (2015) and Mobility Plus Fellowship from Ministry of Science and Higher Education awarded to Zofia Wodniecka (2015), CeLM Pump Priming Fund, University of Reading, UK awarded to Jeanine Treffers-Daller (2014): "Developing Crosslinguistic Lexical Tasks for Bilingual Malay Children in Malaysia", and Bord na Gaidhlig grant awarded to Vicky Chondrogianni (2017, award number: 1718/44): "Supporting children with Developmental Language Disorder in Gaelic-medium primary education".; This study was designed as a part of a multilingual parallel construction procedure of LITMUS Cross-linguistic Lexical Tasks (www.psychologia.pl/clts) within the networking program COST Action IS0804 "Language Impairment in a Multilingual Society: Linguistic Patterns and the Road to Assessment" (www.bi-sli.org; 2010-2013).	Akinina Y, 2015, BEHAV RES METHODS, V47, P691, DOI 10.3758/s13428-014-0492-9; Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Alario FX, 2004, BEHAV RES METH INS C, V36, P140, DOI 10.3758/BF03195559; Alvarez B, 2007, BEHAV RES METHODS, V39, P377, DOI 10.3758/BF03193006; Alonso MA, 2015, BEHAV RES METHODS, V47, P268, DOI 10.3758/s13428-014-0454-2; [Anonymous], 2018, OXFORD HDB PERSIAN L, DOI [10.1093/oxfordhb/9780198736745.001.0001, DOI 10.1093/OXFORDHB/9780198736745.001.0001]; Armon-Lotem S., 2017, CLIN LINGUIST PHONET, P1, DOI [10.1080/02699206.2017.1308553, DOI 10.1080/02699206.2017, 10.1080/02699206.2017]; Arnon I, 2017, J MEM LANG, V92, P265, DOI 10.1016/j.jml.2016.07.004; Auer ET, 2008, J SPEECH LANG HEAR R, V51, P750, DOI 10.1044/1092-4388(2008/053); Baisa V., 2014, LEXICOGRAPHY, V1, P7, DOI [10.1007/s40607-014-0009-9, DOI 10.1007/S40607-014-0009-9]; Bakhtiar M, 2013, BEHAV RES METHODS, V45, P834, DOI 10.3758/s13428-012-0298-6; Barbarotto R, 2005, BEHAV RES METHODS, V37, P644, DOI 10.3758/BF03192735; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barry C, 1997, Q J EXP PSYCHOL-A, V50, P560, DOI 10.1080/783663595; Barry C, 2001, J MEM LANG, V44, P350, DOI 10.1006/jmla.2000.2743; Biemiller A, 2014, SCI STUD READ, V18, P130, DOI 10.1080/10888438.2013.821992; Birchenough JMH, 2017, BEHAV RES METHODS, V49, P484, DOI 10.3758/s13428-016-0718-0; Bird H, 2001, BEHAV RES METH INS C, V33, P73, DOI 10.3758/BF03195349; Blomberg F, 2015, NORD J LINGUIST, V38, P351, DOI 10.1017/S0332586515000220; Bonin P, 2001, Q J EXP PSYCHOL-A, V54, P469, DOI 10.1080/02724980042000219; Bonin P, 2004, BEHAV RES METH INS C, V36, P127, DOI 10.3758/BF03195558; Bonin P, 2004, J MEM LANG, V50, P456, DOI 10.1016/j.jml.2004.02.001; Bonin P, 2003, BEHAV RES METH INS C, V35, P158, DOI 10.3758/BF03195507; Bonin P, 2009, Q J EXP PSYCHOL, V62, P1132, DOI 10.1080/17470210802618850; Braginsky, 2016, P 38 ANN C COGN SCI; Brysbaert M, 2006, VIS COGN, V13, P992, DOI 10.1080/13506280544000165; Brysbaert M, 2017, BEHAV RES METHODS, V49, P1520, DOI 10.3758/s13428-016-0811-4; Brysbaert M, 2017, Q J EXP PSYCHOL, V70, P1129, DOI 10.1080/17470218.2016.1172097; Brysbaert M, 2016, J EXP PSYCHOL HUMAN, V42, P441, DOI 10.1037/xhp0000159; Brysbaert M, 2014, ACTA PSYCHOL, V150, P80, DOI 10.1016/j.actpsy.2014.04.010; Brysbaert M, 2011, Q J EXP PSYCHOL, V64, P545, DOI 10.1080/17470218.2010.503374; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Cameirao ML, 2010, BEHAV RES METHODS, V42, P474, DOI 10.3758/BRM.42.2.474; Cannard C, 2008, BEHAV RES METHODS, V40, P1055, DOI 10.3758/BRM.40.4.1055; CARROLL JB, 1973, J VERB LEARN VERB BE, V12, P563, DOI 10.1016/S0022-5371(73)80036-2; CARROLL JB, 1973, Q J EXP PSYCHOL, V25, P85, DOI 10.1080/14640747308400325; Catling JC, 2008, ACTA PSYCHOL, V129, P130, DOI 10.1016/j.actpsy.2008.05.005; Chalard M, 2003, EUR J COGN PSYCHOL, V15, P209, DOI 10.1080/09541440244000076; Chavent M., 2011, ARXIV11120295STAT; Clackson J., 1995, LINGUISTIC RELATIONS; Clark E. V., 2003, 1 LANGUAGE ACQUISITI; Colombo L, 2002, BRAIN LANG, V81, P398, DOI 10.1006/brln.2001.2533; Cortese MJ, 2008, BEHAV RES METHODS, V40, P791, DOI 10.3758/BRM.40.3.791; Cortese MJ, 2007, Q J EXP PSYCHOL, V60, P1072, DOI 10.1080/17470210701315467; Cortese MJ, 2015, Q J EXP PSYCHOL, V68, P1489, DOI 10.1080/17470218.2014.945096; Cortese MJ, 2010, MEMORY, V18, P595, DOI 10.1080/09658211.2010.493892; Cuetos F, 1999, BEHAV RES METH INS C, V31, P650, DOI 10.3758/BF03200741; Cuetos F, 2012, PSICOLOGICA, V33, P59; Davies SK, 2016, BEHAV RES METHODS, V48, P349, DOI 10.3758/s13428-015-0579-y; Della Rosa PA, 2010, BEHAV RES METHODS, V42, P1042, DOI 10.3758/BRM.42.4.1042; Dimitropoulou M, 2009, BEHAV RES METHODS, V41, P584, DOI 10.3758/BRM.41.2.584; Dirix N, 2017, PSYCHON B REV, V24, P1915, DOI 10.3758/s13423-017-1233-8; Eberhard D., 2022, ETHNOLOGUE LANGUAGES, V25th ed.; Ferrand L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00306; Ferrand L, 2008, BEHAV RES METHODS, V40, P1049, DOI 10.3758/BRM.40.4.1049; Gerhand S, 1999, COGNITION, V73, pB27, DOI 10.1016/S0010-0277(99)00052-9; Gerhand S, 1999, MEM COGNITION, V27, P592, DOI 10.3758/BF03211553; Ghyselinck M, 2000, PSYCHOL BELG, V40, P77; GILHOOLY KJ, 1980, BRIT J PSYCHOL, V71, P105, DOI 10.1111/j.2044-8295.1980.tb02736.x; GILHOOLY KJ, 1977, BEHAV RES METH INSTR, V9, P12, DOI 10.3758/BF03202210; GILHOOLY KJ, 1980, BEHAV RES METH INSTR, V12, P395, DOI 10.3758/BF03201693; Goz I, 2017, BEHAV RES METHODS, V49, P1736, DOI 10.3758/s13428-016-0817-y; Grigoriev A, 2013, BEHAV RES METHODS, V45, P1208, DOI 10.3758/s13428-013-0319-0; Haman E, 2017, CLIN LINGUIST PHONET, V31, P818, DOI 10.1080/02699206.2017.1308553; Haman E, 2015, COMMUN D ACROSS LANG, V13, P196; Hansen P, 2019, INT J BILINGUAL, V23, P437, DOI 10.1177/1367006917733067; Hansen P, 2017, CLIN LINGUIST PHONET, V31, P910, DOI 10.1080/02699206.2017.1307455; Hinojosa JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155866; Imbir KK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01081; Iyer GK, 2001, CTR RES LANGUAGE NEW, V13; Moreno-Martinez FJ, 2014, BEHAV RES METHODS, V46, P1088, DOI 10.3758/s13428-013-0435-x; Johnston RA, 2006, VIS COGN, V13, P789, DOI 10.1080/13506280544000066; Johnston RA, 2010, BEHAV RES METHODS, V42, P461, DOI 10.3758/BRM.42.2.461; Juhasz BJ, 2006, VIS COGN, V13, P846, DOI 10.1080/13506280544000075; Juhasz BJ, 2019, J EXP PSYCHOL LEARN, V45, P82, DOI 10.1037/xlm0000564; Juhasz BJ, 2005, PSYCHOL BULL, V131, P684, DOI 10.1037/0033-2909.131.5.684; Keuleers E, 2012, BEHAV RES METHODS, V44, P287, DOI 10.3758/s13428-011-0118-4; Khanna MM, 2011, BEHAV RES METHODS, V43, P89, DOI 10.3758/s13428-010-0027-y; Khwaileh T, 2018, MENT LEX, V13, P354, DOI 10.1075/ml.18016.khw; Kuperman V, 2012, BEHAV RES METHODS, V44, P978, DOI 10.3758/s13428-012-0210-4; Lahl O, 2009, BEHAV RES METHODS, V41, P13, DOI 10.3758/BRM.41.1.13; Leclerc J., 2015, LIBAN AMENAGEMENT LI; Lind M, 2015, CLIN LINGUIST PHONET, V29, P276, DOI 10.3109/02699206.2014.999952; Lindgren J, 2019, LINGUISTIC APPROACHE, DOI [10.1075/lab.17022.sho, DOI 10.1075/LAB.17022.SHO]; Liu YY, 2007, BEHAV RES METHODS, V39, P192, DOI 10.3758/BF03193147; Lotto L, 2010, BEHAV RES METHODS, V42, P126, DOI 10.3758/BRM.42.1.126; Luniewska M, 2016, BEHAV RES METHODS, V48, P1154, DOI 10.3758/s13428-015-0636-6; Manoiloff L, 2010, BEHAV RES METHODS, V42, P452, DOI 10.3758/BRM.42.2.452; Marful A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155110; Marques JF, 2007, BEHAV RES METHODS, V39, P439, DOI 10.3758/BF03193013; Momenian M., 2015, LANGUAGE RELATED RES, V5, P229; Montefinese M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00278; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; Morrison CM, 1997, Q J EXP PSYCHOL-A, V50, P528, DOI 10.1080/027249897392017; Morrison CM, 2002, EUR J COGN PSYCHOL, V14, P435, DOI 10.1080/09541440143000159; Navarrete E, 2015, MEM COGNITION, V43, P1085, DOI 10.3758/s13421-015-0525-3; Nishimoto T, 2005, BEHAV RES METHODS, V37, P398, DOI 10.3758/BF03192709; Nishimoto T, 2012, BEHAV RES METHODS, V44, P934, DOI 10.3758/s13428-011-0176-7; Perez MA, 2005, EUR J COGN PSYCHOL, V17, P179, DOI 10.1080/09541440340000547; Pind J, 2000, SCAND J PSYCHOL, V41, P41, DOI 10.1111/1467-9450.00169; Raling R, 2017, Q J EXP PSYCHOL, V70, P2094, DOI 10.1080/17470218.2016.1223704; Raman I, 2014, BEHAV RES METHODS, V46, P588, DOI 10.3758/s13428-013-0376-4; Salmon JP, 2010, BEHAV RES METHODS, V42, P82, DOI 10.3758/BRM.42.1.82; Schock J, 2012, BEHAV RES METHODS, V44, P374, DOI 10.3758/s13428-011-0162-0; Schroder A, 2012, BEHAV RES METHODS, V44, P380, DOI 10.3758/s13428-011-0164-y; Shao ZS, 2014, BEHAV RES METHODS, V46, P274, DOI 10.3758/s13428-013-0358-6; Sirois M, 2006, BEHAV RES METHODS, V38, P300, DOI 10.3758/BF03192781; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; Stadthagen-Gonzalez H, 2006, BEHAV RES METHODS, V38, P598, DOI 10.3758/BF03193891; STRATTON RP, 1975, BEHAV RES METH INSTR, V7, P1, DOI 10.3758/BF03201278; Tsaparina D, 2011, BEHAV RES METHODS, V43, P1085, DOI 10.3758/s13428-011-0121-9; Volkovyskaya E., 2017, WRITING SYST RES, V9, P148, DOI [10.1080/17586801.2017.1405136, DOI 10.1080/17586801.2017.1405136]; Wikse Barrow C, 2019, J CHILD LANG, V46, P199, DOI 10.1017/S0305000918000363; WINTERS JJ, 1978, B PSYCHONOMIC SOC, V12, P361; Zevin JD, 2004, MEM COGNITION, V32, P31, DOI 10.3758/BF03195818; Zevin JD, 2002, J MEM LANG, V47, P1, DOI 10.1006/jmla.2001.2834	116	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220611	10.1371/journal.pone.0220611	http://dx.doi.org/10.1371/journal.pone.0220611			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393919	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000485002500046
J	Zaren, P; Alson, S; Henic, E; Bungum, M; Giwercman, A				Zaren, Peter; Alson, Sara; Henic, Emir; Bungum, Mona; Giwercman, Aleksander			Interaction between serum levels of Anti-Mullerian Hormone and the degree of sperm DNA fragmentation measured by sperm chromatin structure assay can be a predictor for the outcome of standard in vitro fertilization	PLOS ONE			English	Article							ANTIMULLERIAN HORMONE; ASSISTED CONCEPTION; METAANALYSIS; PREGNANCY; UTILITY; DAMAGE; IVF; AMH	Serum levels of Anti-Mullerian Hormone (AMH) have been shown to be biomarker for prediction of the quantitative aspects of ovarian reserve. On the male side, sperm chromatin structure assay (SCSA) DNA fragmentation index (DFI) has been demonstrated to be an important predictor of outcomes in standard IVF procedures but to less degree in intracytoplasmic sperm injection procedures (ICSI). The purpose of this study was to investigate whether the combination of female AMH serum levels and sperm DFI adds to prediction of the outcome of assisted reproduction. A total of 352 couples was included (ICSI-148: IVF-204) A venous blood sample was drawn for AMH analysis before IVF/ICSI treatment. DFI was measured in the ejaculate used for assisted reproduction. Regression models for the following odds ratio calculations were constructed: for obtaining at least one Good Quality Embryo; for live birth in all procedures; for pregnancy in procedures where embryo transfer was performed; for miscarriage. For DFI increase by 10 percentage points (not increased DFI as reference) odds ratio for Good Quality Embryo was statistically significantly lower when AMH was at lower quartile (AMH < 12 pmol/L; OR = 0.29, 95% CI: 0.14-0.59,) but not when AMH was at upper quartile (AMH >= 36 pmol/L; OR = 0.95, 95% CI: 0.43-2.13,). The marginal effect of an increase in DFI by 10 percentage points was statistically significant only when AMH < 25.2 pmol/L. Similar results were obtained as considers live birth following standard IVF. No interactions were seen for standard IVF in relation to the risk of miscarriage and for any of the outcomes when ICSI was used as method of treatment. We conclude that the impact of high DFI on the outcome of standard IVF is most pronounced if the female partner has relatively low AMH levels. This finding may help in defining the role of sperm DNA integrity testing in management of infertile couples. It may also explain some of the heterogeneity in results of studies focusing on predictive value of DFI measurements in assisted reproduction.	[Zaren, Peter; Giwercman, Aleksander] Lund Univ, Dept Translat Med, Malmo, Sweden; [Alson, Sara] Skane Univ Hosp, Dept Obstet & Gynaecol, Malmo, Sweden; [Henic, Emir; Bungum, Mona; Giwercman, Aleksander] Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Giwercman, A (corresponding author), Lund Univ, Dept Translat Med, Malmo, Sweden.; Giwercman, A (corresponding author), Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden.	aleksander.giwercman@med.lu.se		Giwercman, Giwercman/0000-0001-5816-0785	Merck-Serono; ReproUnion (Interreg V EU Regional Fund)	Merck-Serono(Merck & Company); ReproUnion (Interreg V EU Regional Fund)	The study was supported by an unrestricted research grant from Merck-Serono and grants from ReproUnion (Interreg V EU Regional Fund) to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; Bungum M, 2006, HUM REPROD, V21, P518, DOI 10.1093/humrep/dei350; Bungum M, 2004, HUM REPROD, V19, P1401, DOI 10.1093/humrep/deh280; Centers for Disease Control and Prevention, 2017, 2015 ASS REPR TECHN; Chi HJ, 2017, CLIN EXP REPROD MED, V44, P132, DOI 10.5653/cerm.2017.44.3.132; Comhaire F., 1987, INT J ANDROL S, V7, P1; De Geyter C, 2018, HUM REPROD, V33, P1586, DOI 10.1093/humrep/dey242; de Marcillac FD, 2017, J GYNECOL OBSTET HUM, V46, P629, DOI 10.1016/j.jogoh.2017.08.001; Evenson Donald, 2000, Methods in Cell Science, V22, P169, DOI 10.1023/A:1009844109023; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Harrell F.E., 2017, HMISC HARRELL MISCEL; Harrell FE., 2017, BIOS, V330, P14; Henkel Ralf, 2005, Reprod Med Biol, V4, P7, DOI 10.1111/j.1447-0578.2005.00087.x; Iliodromiti S, 2015, HUM REPROD UPDATE, V21, P698, DOI 10.1093/humupd/dmu062; Iliodromiti S, 2014, HUM REPROD UPDATE, V20, P560, DOI 10.1093/humupd/dmu003; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; La Marca A, 2009, HUM REPROD, V24, P2264, DOI 10.1093/humrep/dep210; Lee TH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-100; Nelson SM, 2015, FERTIL STERIL, V104, P325, DOI 10.1016/j.fertnstert.2015.04.032; Oleszczuk K, 2016, ANDROLOGY-US, V4, P290, DOI 10.1111/andr.12153; Pfeifer S, 2013, FERTIL STERIL, V99, P673, DOI 10.1016/j.fertnstert.2012.12.049; Simon L, 2017, ASIAN J ANDROL, V19, P80, DOI 10.4103/1008-682X.182822; Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8; Tal R, 2015, FERTIL STERIL, V103, P119, DOI 10.1016/j.fertnstert.2014.09.041; van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065; van Rooij IAJ, 2006, REPROD BIOMED ONLINE, V12, P182, DOI 10.1016/S1472-6483(10)60859-0; Verhaak CM, 2005, HUM REPROD, V20, P2253, DOI 10.1093/humrep/dei015; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220909	10.1371/journal.pone.0220909	http://dx.doi.org/10.1371/journal.pone.0220909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393936	gold, Green Submitted, Green Published			2022-12-27	WOS:000485002500082
J	Kartschmit, N; Mikolajczyk, R; Schubert, T; Lacruz, ME				Kartschmit, Nadja; Mikolajczyk, Rafael; Schubert, Torsten; Lacruz, Maria Elena			Measuring Cognitive Reserve (CR) - A systematic review of measurement properties of CR questionnaires for the adult population	PLOS ONE			English	Review							TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; SCALE; IMPAIRMENT; DEPRESSION; DECLINE; IMPACT; MODEL	Aim The aim of this systematic review was to summarize and critically appraise the quality of published literature on measurement properties of questionnaires assessing Cognitive Reserve (CR) in adults (> 18 years). Methods We systematically searched for published studies on MEDLINE, PsycINFO, and Web of Science through August 2018. We evaluated the methodological quality of the included studies and the results on measurement properties based on a consensus-based standard checklist. Results The search strategy identified 991 publications, of which 37 were selected evaluating the measurement properties of six different questionnaires. Construct validity of the Cognitive Reserve Index questionnaire was most extensively evaluated, while evaluation of the remaining measurement properties of this questionnaire was scarce. Measurement properties of the Cognitive Reserve Questionnaire and the Cognitive Reserve Scale were assessed more completely. While the Lifetime of Experience Questionnaire seems to be the most thorough instrument, a finale recommendation for one specific questionnaire cannot be drawn, since about half of the measurement properties for each questionnaire were poorly or not assessed at all. Conclusions There is a need of high quality methodological studies assessing measurement properties of CR questionnaires, especially regarding content validity, structural validity, and responsiveness.	[Kartschmit, Nadja; Mikolajczyk, Rafael; Lacruz, Maria Elena] Martin Luther Univ Halle Wittenberg, Med Fac, IMEBI, Halle, Germany; [Schubert, Torsten] Martin Luther Univ Halle Wittenberg, Dept Psychol, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Mikolajczyk, R (corresponding author), Martin Luther Univ Halle Wittenberg, Med Fac, IMEBI, Halle, Germany.	rafael.mikolajczyk@medizin.uni-halle.de	Mikolajczyk, Rafael/ABB-5259-2021	Schubert, Torsten/0000-0002-6514-6145; Lacruz, Maria/0000-0003-2036-3039; Mikolajczyk, Rafael/0000-0003-1271-7204				Adam S, 2013, CLIN INTERV AGING, V8, P377, DOI 10.2147/CIA.S39921; Altieri M, 2018, NEUROL SCI, V39, P1383, DOI 10.1007/s10072-018-3432-0; Amodio P, 2017, METAB BRAIN DIS, V32, P1287, DOI 10.1007/s11011-017-0032-2; Apolinario D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060084; Arcara G, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00429; Bartres-Faz D, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0381-z; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Benedet MJA M. A, 1998, TAVEC TEST DE APREND; Bilbao-Bilbao A, 2004, REV NEUROLOGIA, V38, P431; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Cancino M, 2018, REV MED CHILE, V146, P315, DOI 10.4067/s0034-98872018000300315; Chapko D, 2018, AGING MENT HEALTH, V22, P915, DOI 10.1080/13607863.2017.1348471; Ciccarelli N, 2018, AGING CLIN EXP RES, V30, P877, DOI 10.1007/s40520-017-0838-0; Conroy RM, 2010, PSYCHOL HEALTH MED, V15, P463, DOI 10.1080/13548506.2010.487103; Silva AM, 2015, MULT SCLER J, V21, P1312, DOI 10.1177/1352458515581874; Fenu G, 2018, J NEUROL SCI, V386, P19, DOI 10.1016/j.jns.2018.01.011; Ferreira D, 2016, BEHAV BRAIN RES, V311, P375, DOI 10.1016/j.bbr.2016.05.061; Giogkaraki E, 2013, J CLIN EXP NEUROPSYC, V35, P1024, DOI 10.1080/13803395.2013.847906; Hambleton RK, 1998, SOC INDIC RES, V45, P153, DOI 10.1023/A:1006941729637; Harris P, 2015, NEUROPSYCH DIS TREAT, V11, P2599, DOI 10.2147/NDT.S84292; Hindle JV, 2017, INT J GERIATR PSYCH, V32, pE157, DOI 10.1002/gps.4677; Hindle JV, 2014, PARKINSONISM RELAT D, V20, P1, DOI 10.1016/j.parkreldis.2013.08.010; Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748; Lavrencic LM, 2016, AGING NEUROPSYCHOL C, V23, P61, DOI 10.1080/13825585.2015.1048773; Leon I, 2016, AN PSICOL-SPAIN, V32, P218, DOI 10.6018/analesps.32.1.182331; Leon I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102632; Leon I, 2011, REV NEUROLOGIA, V52, P653, DOI 10.33588/rn.5211.2010704; Leon-Estrada I, 2017, REV NEUROLOGIA, V64, P7, DOI 10.33588/rn.6401.2016295; Lopez R., 2014, REV LOGOPEDIA FONIAT, V34, P51, DOI [10.1016/j.rlfa.2013.11.004, DOI 10.1016/J.RLFA.2013.11.004]; Lopez-Higes R, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00023; Lopez-Higes R, 2013, REV NEUROLOGIA, V57, P97, DOI 10.33588/rn.5703.2013120; Maiovis P, 2018, NEURODEGENER DIS, V18, P69, DOI 10.1159/000486621; Maiovis P, 2016, NEUROL SCI, V37, P633, DOI 10.1007/s10072-015-2457-x; McGinnis D, 2012, EXP AGING RES, V38, P370, DOI 10.1080/0361073X.2012.699365; Milanini B, 2016, J NEUROVIROL, V22, P575, DOI 10.1007/s13365-016-0426-7; Minogue C, 2018, INT PSYCHOGERIATR, V30, P519, DOI 10.1017/S104161021700179X; Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1186/s13643-015-0087-2]; Mokkink LB, 2018, QUAL LIFE RES, V27, P1171, DOI 10.1007/s11136-017-1765-4; Mondini S, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00084; Nucci M, 2012, AGING CLIN EXP RES, V24, P218, DOI 10.3275/7800; Nunnari D, 2016, J CLIN EXP NEUROPSYC, V38, P1158, DOI 10.1080/13803395.2016.1200538; Nunnari D, 2014, NEUROL SCI, V35, P1513, DOI 10.1007/s10072-014-1897-z; Opdebeeck C, 2015, AGING MENT HEALTH, V19, P705, DOI 10.1080/13607863.2014.962005; Pedrero-Perez EJ, 2014, REV NEUROLOGIA, V59, P481, DOI 10.33588/rn.5911.2014435; Pettigrew C, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0917-z; Puccioni O, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00327; Rainey L, 2014, QUAL LIFE RES, V23, P2793, DOI 10.1007/s11136-014-0743-3; Rami L, 2011, REV NEUROLOGIA, V52, P195, DOI 10.33588/rn.5204.2010478; Reed BR, 2010, BRAIN, V133, P2196, DOI 10.1093/brain/awq154; Roldan-Tapia MD, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00340; Sobral M, 2015, ARQ NEURO-PSIQUIAT, V73, P480, DOI 10.1590/0004-282X20150044; Sobral Margarida, 2014, Trends Psychiatry Psychother., V36, P160, DOI 10.1590/2237-6089-2014-0012; Stern Y, 2003, J CLIN EXP NEUROPSYC, V25, P589, DOI 10.1076/jcen.25.5.589.14571; Stern Y, 2020, ALZHEIMERS DEMENT, V16, P1305, DOI 10.1016/j.jalz.2018.07.219; Stern Y, 2018, NEUROIMAGE, V178, P36, DOI 10.1016/j.neuroimage.2018.05.033; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2014, NEUROLOGY, V82, P1776, DOI 10.1212/WNL.0000000000000433; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Sumowski JF, 2013, MULT SCLER J, V19, P1122, DOI 10.1177/1352458513498834; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Valenzuela MJ, 2006, PSYCHOL MED, V36, P1065, DOI 10.1017/S0033291706007744; van Dierendonck D, 2008, SOC INDIC RES, V87, P473, DOI 10.1007/s11205-007-9174-7; van Loenhoud AC, 2017, HUM BRAIN MAPP, V38, P4703, DOI 10.1002/hbm.23695; Vasquez-Amezquita M, 2016, REV CHIL NEUROPSICOL, V11, P5, DOI 10.5839/rcnp.2016.11.01.02; Volpi L, 2017, J NEUROL SCI, V377, P12, DOI 10.1016/j.jns.2017.03.034; Wikee G, 2018, REV MED CHILE, V146, P570, DOI 10.4067/s0034-98872018000500570	67	34	36	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0219851	10.1371/journal.pone.0219851	http://dx.doi.org/10.1371/journal.pone.0219851			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390344	Green Published, gold, Green Submitted			2022-12-27	WOS:000484999400008
J	Pamphlett, R; Jew, SK; Cherepanoff, S				Pamphlett, Roger; Jew, Stephen Kum; Cherepanoff, Svetlana			Mercury in the retina and optic nerve following prenatal exposure to mercury vapor	PLOS ONE			English	Article							FIBER LAYER; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; SYSTEMIC EXPOSURE; OXIDATIVE DAMAGE; BRAIN; ACCUMULATION; MOUSE; FETAL; ABNORMALITIES	Damage to the retina and optic nerve is found in some neurodegenerative disorders, but it is unclear whether the optic pathway and central nervous system (CNS) are affected by the same injurious agent, or whether optic pathway damage is due to retrograde degeneration following the CNS damage. Finding an environmental agent that could be responsible for the optic pathway damage would support the hypothesis that this environmental toxicant also triggers the CNS lesions. Toxic metals have been implicated in neurodegenerative disorders, and mercury has been found in the retina and optic nerve of experimentally-exposed animals. Therefore, to see if mercury exposure in the prenatal period could be one link between optic pathway damage and human CNS disorders of later life, we examined the retina and optic nerve of neonatal mice that had been exposed prenatally to mercury vapor, using a technique, autometallography, that detects the presence of mercury within cells. Pregnant mice were exposed to a non-toxic dose of mercury vapor for four hours a day for five days in late gestation, when the mouse placenta most closely resembles the human placenta. The neonatal offspring were sacrificed one day after birth and gapless serial sections of formalin-fixed paraffin-embedded blocks containing the eyes were stained with silver nitrate autometallography to detect inorganic mercury. Mercury was seen in the nuclear membranes of retinal ganglion cells and endothelial cells. A smaller amount of mercury was present in the retinal inner plexiform and inner nuclear layers. Mercury was conspicuous in the peripapillary retinal pigment epithelium. In the optic nerve, mercury was seen in the nuclear membranes and processes of glia and in endothelial cells. Optic pathway and CNS endothelial cells contained mercury. In conclusion, mercury is taken up preferentially by fetal retinal ganglion cells, optic nerve glial cells, the retinal pigment epithelium, and endothelial cells. Mercury induces free radical formation, autoimmunity, and genetic and epigenetic changes, so these findings raise the possibility that mercury plays a part in the pathogenesis of degenerative CNS disorders that also affect the retina and optic nerve.	[Pamphlett, Roger; Jew, Stephen Kum] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Cherepanoff, Svetlana] St Vincents Hosp, Sydpath, Sydney, NSW, Australia; [Cherepanoff, Svetlana] Univ Sydney, Northern Clin Sch, Sydney, NSW, Australia; [Cherepanoff, Svetlana] Univ New South Wales, St Vincents Clin Sch, Sydney, NSW, Australia	University of Sydney; University of Sydney; St Vincents Hospital Sydney; University of Sydney; University of New South Wales Sydney	Pamphlett, R (corresponding author), Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au		Pamphlett, Roger/0000-0003-3326-7273	Aimee Stacy Memorial bequest; Ignacy Burnett bequest	Aimee Stacy Memorial bequest; Ignacy Burnett bequest	RP is supported by the Aimee Stacy Memorial and Ignacy Burnett bequests.	Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; BERLIN M, 1963, ARCH ENVIRON HEALTH, V6, P610, DOI 10.1080/00039896.1963.10663449; BERLIN M, 1963, ARCH ENVIRON HEALTH, V6, P589, DOI 10.1080/00039896.1963.10663447; Bilak S, 2019, HUM EXP TOXICOL, V38, P814, DOI 10.1177/0960327119842637; Bjorklund G, 2017, ENVIRON RES, V159, P545, DOI 10.1016/j.envres.2017.08.051; Blanchette M, 2015, MECH DEVELOP, V138, P8, DOI 10.1016/j.mod.2015.07.007; Bridges CC, 2007, TOXICOL APPL PHARM, V221, P251, DOI 10.1016/j.taap.2007.03.004; Bridges CC, 2017, ARCH TOXICOL, V91, P63, DOI 10.1007/s00204-016-1803-y; Burton Erik V, 2011, Pathophysiology, V18, P81, DOI 10.1016/j.pathophys.2010.04.009; Cardenas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00384-5; Cariccio VL, 2019, BIOL TRACE ELEM RES, V187, P341, DOI 10.1007/s12011-018-1380-4; CHANG LW, 1972, EXP NEUROL, V35, P122, DOI 10.1016/0014-4886(72)90064-7; Chang P, 2016, INVEST OPHTH VIS SCI, V57, P2277, DOI 10.1167/iovs.15-18629; Chow BW, 2017, NEURON, V93, P1325, DOI 10.1016/j.neuron.2017.02.043; CLARKSON TW, 1972, BIOL NEONATE, V21, P239; Clarkson TW, 1997, CRIT REV CL LAB SCI, V34, P369, DOI 10.3109/10408369708998098; Cohen SY, 2016, RETINA-J RET VIT DIS, V36, P458, DOI 10.1097/IAE.0000000000000741; Crespo-Lopez ME, 2009, PHARMACOL RES, V60, P212, DOI 10.1016/j.phrs.2009.02.011; DANSCHER G, 1994, NEUROPATH APPL NEURO, V20, P454, DOI 10.1111/j.1365-2990.1994.tb00996.x; Ekinci M, 2014, MED SCI MONITOR, V20, P1284, DOI 10.12659/MSM.890756; El-Sherbeeny AM, 2006, CUTAN OCUL TOXICOL, V25, P173, DOI 10.1080/15569520600860215; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Fahrenkrog B, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120232; Fawzi AA, 2014, AMYOTROPH LAT SCL FR, V15, P569, DOI 10.3109/21678421.2014.951941; Fyfe I, 2018, NAT REV NEUROL, V14, P449, DOI 10.1038/s41582-018-0044-5; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Garbuzova-Davis S, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00021; Gray MT, 2015, J CEREBR BLOOD F MET, V35, P747, DOI 10.1038/jcbfm.2015.32; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Holson JF, 2005, CRIT REV TOXICOL, V35, P739, DOI 10.1080/10408440591007412; Huber G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013403; Hubers A, 2016, J NEURAL TRANSM, V123, P281, DOI 10.1007/s00702-015-1483-4; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; KHAYAT A, 1984, ACTA PHARMACOL TOX, V55, P145; Khayat A, 1983, J APPL TOXICOL, V3, P66, DOI 10.1002/jat.2550030203; Ko F, 2018, JAMA NEUROL, V75, P1198, DOI 10.1001/jamaneurol.2018.1578; Korbas M, 2008, P NATL ACAD SCI USA, V105, P12108, DOI 10.1073/pnas.0803147105; Korbas M, 2013, ACS CHEM BIOL, V8, P2256, DOI 10.1021/cb4004805; Kullmann JAP, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122874; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; LUND BO, 1991, BIOCHEM PHARMACOL, V42, pS181, DOI 10.1016/0006-2952(91)90408-W; Manjunath V, 2011, OPHTHALMOLOGY, V118, P531, DOI 10.1016/j.ophtha.2010.07.013; MOLLERMADSEN B, 1992, ARCH TOXICOL, V66, P79, DOI 10.1007/BF02342499; Monteiro MLR, 2012, INVEST OPHTH VIS SCI, V53, P3959, DOI 10.1167/iovs.11-9324; Mukherjee N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185242; Mutlu U, 2018, JAMA NEUROL, V75, P1256, DOI 10.1001/jamaneurol.2018.1563; Pamphlett R, 2001, NEUROTOXICOL TERATOL, V23, P191, DOI 10.1016/S0892-0362(00)00122-7; Pamphlett R, 1998, J NEUROL SCI, V159, P121, DOI 10.1016/S0022-510X(98)00161-0; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203627; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Porter LF, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0608-2; Rodriguez-Farre E, 2016, REGUL TOXICOL PHARM, V79, P108, DOI 10.1016/j.yrtph.2015.12.015; Rothman AL, 2015, AM J OPHTHALMOL, V160, P1296, DOI 10.1016/j.ajo.2015.09.015; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Sakamoto M, 2018, ENVIRON RES, V167, P15, DOI 10.1016/j.envres.2018.06.038; Smith RS, 2002, RES METH MUT M SER, P45; Solan TD, 2014, J PERINAT MED, V42, P725, DOI 10.1515/jpm-2013-0349; Tartaglione AM, 2016, CURR TOP BEHAV NEURO, V29, P231, DOI 10.1007/7854_2015_416; Toimela TA, 2001, TOXICOL IN VITRO, V15, P7, DOI 10.1016/S0887-2333(00)00057-6; ULSHAFER RJ, 1990, ARCH OPHTHALMOL-CHIC, V108, P113, DOI 10.1001/archopht.1990.01070030119041; Vas J, 2008, ANN NY ACAD SCI, V1143, P240, DOI 10.1196/annals.1443.022; Volland S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125631; Wang GY, 2013, J ADOLESCENT HEALTH, V52, pS14, DOI 10.1016/j.jadohealth.2012.04.019; Warfvinge K, 1996, TOXICOLOGY, V107, P189, DOI 10.1016/0300-483X(95)03257-G; WARFVINGE K, 1995, INT J EXP PATHOL, V76, P29; Wiggers GA, 2008, AM J PHYSIOL-HEART C, V295, pH1033, DOI 10.1152/ajpheart.00430.2008; Yoshida M, 2002, TOHOKU J EXP MED, V196, P79, DOI 10.1620/tjem.196.79; Yoshida M, 1997, TOXICOLOGY, V119, P193, DOI 10.1016/S0300-483X(96)03611-6	73	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220859	10.1371/journal.pone.0220859	http://dx.doi.org/10.1371/journal.pone.0220859			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390377	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400033
J	Yoshino, H; Yin, GW; Kawaguchi, R; Popov, KI; Temple, B; Sasaki, M; Kofuji, S; Wolfe, K; Kofuji, K; Okumura, K; Randhawa, J; Malhotra, A; Majd, N; Ikeda, Y; Shimada, H; Kahoud, ER; Haviv, S; Iwase, S; Asara, JM; Campbell, SL; Sasaki, AT				Yoshino, Hirofumi; Yin, Guowei; Kawaguchi, Risa; Popov, Konstantin, I; Temple, Brenda; Sasaki, Mika; Kofuji, Satoshi; Wolfe, Kara; Kofuji, Kaori; Okumura, Koichi; Randhawa, Jaskirat; Malhotra, Akshiv; Majd, Nazanin; Ikeda, Yoshiki; Shimada, Hiroko; Kahoud, Emily Rose; Haviv, Sasson; Iwase, Shigeki; Asara, John M.; Campbell, Sharon L.; Sasaki, Atsuo T.			Identification of lysine methylation in the core GTPase domain by GoMADScan	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; K-RAS; COSTELLO-SYNDROME; KRAS MUTATIONS; HISTONE ACETYLATION; H-RAS; CANCER; ONCOGENES; PROTEINS; ISOFORMS	RAS is the founding member of a superfamily of GTPases and regulates signaling pathways involved in cellular growth control. While recent studies have shown that the activation state of RAS can be controlled by lysine ubiquitylation and acetylation, the existence of lysine methylation of the RAS superfamily GTPases remains unexplored. In contrast to acetylation, methylation does not alter the side chain charge and it has been challenging to deduce its impact on protein structure by conventional amino acid substitutions. Herein, we investigate lysine methylation on RAS and RAS-related GTPases. We developed GoMADScan (Go language-based Modification Associated Database Scanner), a new user-friendly application that scans and extracts posttranslationally modified peptides from databases. The GoMADScan search on PhosphoSitePlus databases identified methylation of conserved lysine residues in the core GTPase domain of RAS superfamily GTPases, including residues corresponding to RAS Lys-5, Lys-16, and Lys-117. To follow up on these observations, we immunoprecipitated endogenous RAS from HEK293T cells, conducted mass spectrometric analysis and found that RAS residues, Lys-5 and Lys-147, undergo dimethylation and monomethylation, respectively. Since mutations of Lys-5 have been found in cancers and RASopathies, we set up molecular dynamics (MD) simulations to assess the putative impact of Lys-5 dimethylation on RAS structure. Results from our MD analyses predict that dimethylation of Lys-5 does not significantly alter RAS conformation, suggesting that Lys-5 methylation may alter existing protein interactions or create a docking site to foster new interactions. Taken together, our findings uncover the existence of lysine methylation as a novel posttranslational modification associated with RAS and the RAS superfamily GTPases, and putative impact of Lys-5 dimethylation on RAS structure.	[Yoshino, Hirofumi; Kawaguchi, Risa; Sasaki, Mika; Kofuji, Satoshi; Wolfe, Kara; Kofuji, Kaori; Okumura, Koichi; Randhawa, Jaskirat; Malhotra, Akshiv; Ikeda, Yoshiki; Shimada, Hiroko; Sasaki, Atsuo T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Hematol & Oncol, Cincinnati, OH 45267 USA; [Yin, Guowei; Popov, Konstantin, I; Campbell, Sharon L.] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA; [Yin, Guowei; Popov, Konstantin, I; Campbell, Sharon L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27515 USA; [Kawaguchi, Risa] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan; [Temple, Brenda] Univ N Carolina, RL Juliano Struct Bioinformat Core Facil, Chapel Hill, NC 27515 USA; [Majd, Nazanin] Univ Cincinnati, Dept Neurol, Coll Med, Cincinnati, OH USA; [Kahoud, Emily Rose; Iwase, Shigeki; Asara, John M.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Kahoud, Emily Rose; Iwase, Shigeki; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Haviv, Sasson] Univ Michigan, Dept Human Genet, 5815 Med Sci 2, Ann Arbor, MI 48109 USA; [Sasaki, Atsuo T.] Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH 45267 USA; [Sasaki, Atsuo T.] UC Gardner Neurosci Inst, Brain Tumor Ctr, Dept Neurosurg, Cincinnati, OH 45229 USA; [Sasaki, Atsuo T.] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	University System of Ohio; University of Cincinnati; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Tokyo; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Cincinnati; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; University of Michigan System; University of Michigan; University System of Ohio; University of Cincinnati; Keio University	Sasaki, AT (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Hematol & Oncol, Cincinnati, OH 45267 USA.; Campbell, SL (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA.; Campbell, SL (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27515 USA.; Sasaki, AT (corresponding author), Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH 45267 USA.; Sasaki, AT (corresponding author), UC Gardner Neurosci Inst, Brain Tumor Ctr, Dept Neurosurg, Cincinnati, OH 45229 USA.; Sasaki, AT (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	campbesl@med.unc.edu; atsuo.sasaki@uc.edu	Iwase, Shigeki/J-8294-2019	Iwase, Shigeki/0000-0003-2280-7422; campbell, sharon/0000-0003-0311-409X; Sasaki, Atsuo/0000-0003-2963-4501; Yin, Guowei/0000-0003-2669-7160; Kawaguchi, Risa Karakida/0000-0003-1764-5721	Kanae Foundation; Uehara Memorial Foundation; University of Cincinnati startup fund; Marlene Harris-Ride Cincinnati Breast Cancer Grant [R21NS100077, 1R01NS089815]; NIH [5P01CA120964]; UC Brain Tumor Center MTP fund;  [14J00402];  [R01 GM106227];  [P01CA203567]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA016086, P01CA203657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089815, R21NS100077] Funding Source: NIH RePORTER	Kanae Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); University of Cincinnati startup fund; Marlene Harris-Ride Cincinnati Breast Cancer Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Brain Tumor Center MTP fund; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	S. K. was supported, in part, by the Kanae Foundation. H. Y. was supported by the Uehara Memorial Foundation. R. K. by Grant-in Aid for JSPS Fellows [Grant Number 14J00402]. The work is supported in part by R01 GM106227 and P01CA203567 (S.L.C.), the Kanae foundation, the University of Cincinnati startup fund, UC Brain Tumor Center MTP fund, Marlene Harris-Ride Cincinnati Breast Cancer Grant, R21NS100077 and 1R01NS089815 (A.T.S.). J.M.A. is supported in part by NIH grant 5P01CA120964.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahearn I, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031484; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Alam H, 2015, CELL MOL LIFE SCI, V72, P4577, DOI 10.1007/s00018-015-2023-y; AMARO AM, 1984, J BACTERIOL, V158, P84, DOI 10.1128/JB.158.1.84-93.1984; AMBLER RP, 1959, NATURE, V184, P56, DOI 10.1038/184056b0; AMES GFL, 1979, J BIOL CHEM, V254, P9947; Baker R, 2013, J BIOL CHEM, V288, P36856, DOI 10.1074/jbc.C113.525691; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Bernardes GJL, 2008, J AM CHEM SOC, V130, P5052, DOI 10.1021/ja800800p; Bertola DR, 2012, CLIN GENET, V81, P595, DOI 10.1111/j.1399-0004.2011.01764.x; Bertola DR, 2007, J HUM GENET, V52, P521, DOI 10.1007/s10038-007-0146-1; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bigenzahn JW, 2018, SCIENCE, V362, P1171, DOI 10.1126/science.aap8210; Borrie SC, 2017, ANNU REV GENOM HUM G, V18, P115, DOI 10.1146/annurev-genom-091416-035332; BOS JL, 1989, CANCER RES, V49, P4682; Case, 2016, AMBER 2016 REFERENCE, P1, DOI DOI 10.13140/RG.2.2.27958.70729; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cruz-Migoni A, 2019, P NATL ACAD SCI USA, V116, P2545, DOI 10.1073/pnas.1811360116; DELANGE RJ, 1970, J BIOL CHEM, V245, P3325; Denayer E, 2008, HUM MUTAT, V29, P232, DOI 10.1002/humu.20616; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; HALLBERG B, 1994, J BIOL CHEM, V269, P3913; HARDY MF, 1970, BIOCHEM J, V120, P653, DOI 10.1042/bj1200653; Hennig A, 2015, BIOL CHEM, V396, P831, DOI 10.1515/hsz-2014-0257; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hobbs GA, 2016, J CELL SCI, V129, P1287, DOI 10.1242/jcs.182873; Homma Y, 2019, J CELL BIOL, V218, P2035, DOI 10.1083/jcb.201810134; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Hunter JC, 2014, P NATL ACAD SCI USA, V111, P8895, DOI 10.1073/pnas.1404639111; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jinesh GG, 2018, ONCOGENE, V37, P839, DOI 10.1038/onc.2017.377; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim SE, 2009, J CELL SCI, V122, P842, DOI 10.1242/jcs.040493; Knyphausen P, 2016, BIOL CHEM, V397, P1071, DOI 10.1515/hsz-2016-0118; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lee SH, 2003, ONCOGENE, V22, P6942, DOI 10.1038/sj.onc.1206749; LHOEST J, 1984, EUR J BIOCHEM, V141, P585, DOI 10.1111/j.1432-1033.1984.tb08233.x; LITALIEN JJ, 1981, J BIOL CHEM, V256, P8092; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Lo FS, 2009, EUR J PEDIATR, V168, P919, DOI 10.1007/s00431-008-0858-z; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Malumbres M, 2003, NAT REV CANC; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nava C, 2007, J MED GENET, V44, P763, DOI 10.1136/jmg.2007.050450; Niihori T, 2011, J HUM GENET, V56, P707, DOI 10.1038/jhg.2011.85; Nussinov R, 2018, CANCER RES, V78, P593, DOI 10.1158/0008-5472.CAN-17-2727; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Papamokos GV, 2012, BIOPHYS J, V102, P1926, DOI 10.1016/j.bpj.2012.03.030; Papke B, 2017, SCIENCE, V355, P1158, DOI 10.1126/science.aam7622; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ratner N, 2015, NAT REV CANCER, V15, P290, DOI 10.1038/nrc3911; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Sasaki AT, 2009, METHODS MOL BIOL, V571, P333, DOI 10.1007/978-1-60761-198-1_23; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Song HY, 2016, ONCOTARGET, V7, P80336, DOI 10.18632/oncotarget.12015; Steklov M, 2018, SCIENCE, V362, P1177, DOI 10.1126/science.aap7607; Stenmark H, 2001, GENOME BIOL, V2; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sumita K, 2014, J BIOL CHEM, V289, P3950, DOI 10.1074/jbc.M113.531178; Taylor SJ, 2001, METHOD ENZYMOL, V333, P333; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Welsch ME, 2017, CELL, V168, P878, DOI 10.1016/j.cell.2017.02.006; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Zenker M, 2007, J MED GENET, V44, P131, DOI 10.1136/jmg.2006.046300	94	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0219436	10.1371/journal.pone.0219436	http://dx.doi.org/10.1371/journal.pone.0219436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390367	Green Published, gold, Green Submitted			2022-12-27	WOS:000484999400006
J	Darwich, L; Vidal, A; Seminati, C; Albamonte, A; Casado, A; Lopez, F; Molina-Lopez, RA; Migura-Garcia, L				Darwich, Laila; Vidal, Anna; Seminati, Chiara; Albamonte, Andreu; Casado, Alba; Lopez, Ferran; Molina-Lopez, Rafael A.; Migura-Garcia, Lourdes			High prevalence and diversity of extended-spectrum beta-lactamase and emergence of OXA-48 producing Enterobacterales in wildlife in Catalonia	PLOS ONE			English	Article							RESISTANT ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; CTX-M; SALMONELLA; ANIMALS; STRAINS; SPAIN; BIRDS; FOOD; INFECTIONS	Most of the studies focused on antimicrobial resistance (AMR) performed in wildlife describe Escherichia coli as the principal indicator of the selective pressure. In the present study, several species of Enterobacterales with a large panel of cephalosporin resistant (CR) genes have been isolated from wildlife in Catalonia. A total of 307 wild animals were examined to determine the prevalence of CR enterobacteria, AMR phenotypes and the presence of common carbapenem and CR genes. The overall prevalence of CR-phenotype was 13% (40/307): 17.3% in wild mammals (18/104) and 11.5% in wild birds (22/191) (p< 0.01). Hedgehogs showed the highest prevalence (13.5% of 104) of the mammal specimens, and raptors the highest in bird specimen (7.3% of 191). Although CR E. coli was the most frequently isolated (45%), other CR- Enterobacterales like Klebsiella pneumoniae (20%), Citrobacter freundii (15%), Enterobacter cloacae (5%), Proteus mirabilis (5%), Providencia spp (5%) and Serratia marcescens (2.5%) were also isolated. A high diversity of CR genes was identified among the isolates, with 50% yielding blaCMY-2, 23% blaSHV-12, 20% blaCMY-1 and 18% blaCTX-M-15. Additionally, resistance to carbapenems associated to OXA-48 gene was found. Most of the CR isolates, principally K. pneumoniae and C. freundii, were multiresistant with co-resistance to fluoroquinolones, tetracycline, sulphonamides and aminoglycosides. This study reports high prevalence of Enterobacterales harbouring a variety of CR genes and OXA-48 mediated-carbapenem resistance, all of them frequently associated to nosocomial human infections, for the first time in wild mammals and wild birds. Implementation of control measures to reduce the impact of anthropogenic pressure in the environment is urgently needed.	[Darwich, Laila; Vidal, Anna; Seminati, Chiara; Albamonte, Andreu; Casado, Alba; Lopez, Ferran] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Cerdanyola Del Valles, Spain; [Darwich, Laila; Migura-Garcia, Lourdes] IRTA UAB, CReSA, IRTA, Campus Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain; [Molina-Lopez, Rafael A.] Catalan Wildlife Serv, Ctr Fauna Salvatge Torreferrussa, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; IRTA	Darwich, L (corresponding author), Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Cerdanyola Del Valles, Spain.; Darwich, L (corresponding author), IRTA UAB, CReSA, IRTA, Campus Univ Autonoma Barcelona, Cerdanyola Del Valles, Spain.	laila.darwich@uab.cat	Darwich, Laila/F-5330-2016; Migura-Garcia, Lourdes/E-3560-2016; Casado, Alba/AGY-6067-2022	Darwich, Laila/0000-0001-9027-9452; Migura-Garcia, Lourdes/0000-0003-2935-928X; Casado, Alba/0000-0002-1172-3728; Molina Lopez, Rafael/0000-0002-9043-2346	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA); European Social Fund; PIF grant from the Universitat Autonoma de Barcelona	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Social Fund(European Social Fund (ESF)); PIF grant from the Universitat Autonoma de Barcelona	The contract of LMG was supported by the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) and the European Social Fund. AV was supported by a PIF grant from the Universitat Autonoma de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala L, 2016, MICROB ECOL, V72, P861, DOI 10.1007/s00248-015-0718-0; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Alonso CA, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix097; Alonso CA, 2017, J ANTIMICROB CHEMOTH, V72, P1589, DOI 10.1093/jac/dkx024; Annavajhala MK, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00044; Aracil-Garcia B, 2017, ENFERM INFEC MICR CL, V35, P478, DOI [10.1016/j.eimce.2017.08.007, 10.1016/j.eimc.2016.06.007]; Arlet G, 1997, FEMS MICROBIOL LETT, V152, P163, DOI 10.1111/j.1574-6968.1997.tb10423.x; Atterby C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190380; Ben Sallem R, 2013, VECTOR-BORNE ZOONOT, V13, P98, DOI 10.1089/vbz.2012.1047; Ben Yahia H, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1163-2; Bonnedahl J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141315; Bonnedahl J, 2014, EMERG INFECT DIS, V20, P897, DOI 10.3201/eid2005.130325; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Canton R, 2019, REV ESP QUIM, V32, P145; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Criatovao F, 2017, FEMS MICROBIOL LETT, V364, P49; Davin-Regli A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00392; Dessi A, 2009, J CHEMOTHERAPY, V21, P493, DOI 10.1179/joc.2009.21.5.493; Diaz MA, 2010, J CLIN MICROBIOL, V48, P2840, DOI 10.1128/JCM.02147-09; Dierikx C, 2013, J ANTIMICROB CHEMOTH, V68, P60, DOI 10.1093/jac/dks349; Dolejska M, 2009, J APPL MICROBIOL, V106, P1941, DOI 10.1111/j.1365-2672.2009.04155.x; Dorado-Garcia A, 2018, J ANTIMICROB CHEMOTH, V73, P339, DOI 10.1093/jac/dkx397; Fernandez J, 2015, INT J ANTIMICROB AG, V46, P469, DOI 10.1016/j.ijantimicag.2015.07.003; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P2954, DOI 10.1093/jac/dkt260; Garcia-Menino I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02659; Grundmann H, 2017, LANCET INFECT DIS, V17, P153, DOI 10.1016/S1473-3099(16)30257-2; Guenther S, 2017, J ANTIMICROB CHEMOTH, V72, P1289, DOI 10.1093/jac/dkw585; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Hasan B, 2016, MICROB DRUG RESIST, V22, P682, DOI 10.1089/mdr.2015.0323; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Huijbers PMC, 2015, ENVIRON SCI TECHNOL, V49, P11993, DOI 10.1021/acs.est.5b02566; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jouini A, 2007, J ANTIMICROB CHEMOTH, V60, P1137, DOI 10.1093/jac/dkm316; Kim J, 1998, J CLIN MICROBIOL, V36, P1446, DOI 10.1128/JCM.36.5.1446-1449.1998; Liakopoulos A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01374; Literak I, 2010, APPL ENVIRON MICROB, V76, P8126, DOI 10.1128/AEM.01446-10; Merino I, 2016, J ANTIMICROB CHEMOTH, V71, P2125, DOI 10.1093/jac/dkw133; Miro E, 2002, ANTIMICROB AGENTS CH, V46, P3991, DOI 10.1128/AAC.46.12.3991-3994.2002; Mohsin M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02476; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Oteo J, 2018, MICROB DRUG RESIST, V24, P932, DOI 10.1089/mdr.2018.0004; Parker D, 2016, LETT APPL MICROBIOL, V63, P11, DOI 10.1111/lam.12589; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Ranjan KP, 2013, UROL ANNALS, V5, P313; Rashid Mahmudur, 2015, Infection Ecology & Epidemiology, V5, P26712, DOI 10.3402/iee.v5.26712; Raza S, 2017, ECOHEALTH, V14, P182, DOI 10.1007/s10393-016-1204-y; Rebelo AR, 2018, EUROSURVEILLANCE, V23, P29, DOI 10.2807/1560-7917.ES.2018.23.6.17-00672; Simoes RR, 2010, EMERG INFECT DIS, V16, P110, DOI 10.3201/eid1601.090896; Skov RL, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.9.30155; Smet A, 2010, FEMS MICROBIOL REV, V34, P295, DOI 10.1111/j.1574-6976.2009.00198.x; Stedt J, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0166-3; Tzouvelekis LS, 2012, CLIN MICROBIOL REV, V25, P682, DOI 10.1128/CMR.05035-11; Veldman K, 2013, APPL ENVIRON MICROB, V79, P7556, DOI 10.1128/AEM.01880-13; Vergara A, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02071-16; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009	57	34	34	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0210686	10.1371/journal.pone.0210686	http://dx.doi.org/10.1371/journal.pone.0210686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381578	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600001
J	Odgerel, Z; Sonti, S; Hernandez, N; Park, J; Ottman, R; Louis, ED; Clark, LN				Odgerel, Zagaa; Sonti, Shilpa; Hernandez, Nora; Park, Jemin; Ottman, Ruth; Louis, Elan D.; Clark, Lorraine N.			Whole genome sequencing and rare variant analysis in essential tremor families	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; CANDIDATE GENES; AXON GUIDANCE; IDENTIFICATION; MUTATION; LINKAGE; AGE; CONTRIBUTES; ASSOCIATION; FRAMEWORK	Essential tremor (ET) is one of the most common movement disorders. The etiology of ET remains largely unexplained. Whole genome sequencing (WGS) is likely to be of value in understanding a large proportion of ET with Mendelian and complex disease inheritance patterns. In ET families with Mendelian inheritance patterns, WGS may lead to gene identification where WES analysis failed to identify the causative single nucleotide variant (SNV) or indel due to incomplete coverage of the entire coding region of the genome, in addition to accurate detection of larger structural variants (SVs) and copy number variants (CNVs). Alternatively, in ET families with complex disease inheritance patterns with gene x gene and gene x environment interactions enrichment of functional rare coding and non-coding variants may explain the heritability of ET. We performed WGS in eight ET families (n = 40 individuals) enrolled in the Family Study of Essential Tremor. The analysis included filtering WGS data based on allele frequency in population databases, rare SNV and indel classification and association testing using the Mixed-Model Kernel Based Adaptive Cluster (MM-KBAC) test. A separate analysis of rare SV and CNVs segregating within ET families was also performed. Prioritization of candidate genes identified within families was performed using phenolyzer. WGS analysis identified candidate genes for ET in 5/8 (62.5%) of the families analyzed. WES analysis in a subset of these families in our previously published study failed to identify candidate genes. In one family, we identified a deleterious and damaging variant (c.1367G>A, p.(Arg456Gln)) in the candidate gene, CAC-NA1G, which encodes the pore forming subunit of T-type Ca(2+) channels, Ca(V)3.1, and is expressed in various motor pathways and has been previously implicated in neuronal autorhythmicity and ET. Other candidate genes identified include SLIT3 which encodes an axon guidance molecule and in three families, phenolyzer prioritized genes that are associated with hereditary neuropathies (family A, KARS, family B, KIF5A and family F, NTRK1). Functional studies of CACNA1G and SLIT3 suggest a role for these genes in ET disease pathogenesis.	[Odgerel, Zagaa; Sonti, Shilpa; Clark, Lorraine N.] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Hernandez, Nora; Park, Jemin; Louis, Elan D.] Yale Univ, Yale Sch Med, Dept Neurol, New Haven, CT USA; [Ottman, Ruth] Columbia Univ, GH Sergievsky Ctr, New York, NY USA; [Ottman, Ruth] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY USA; [Ottman, Ruth] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Ottman, Ruth] New York State Psychiat Inst & Hosp, Div Epidemiol, New York, NY 10032 USA; [Louis, Elan D.] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Clark, Lorraine N.] Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA	Columbia University; Yale University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Yale University; Columbia University	Clark, LN (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10027 USA.; Clark, LN (corresponding author), Columbia Univ, Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10027 USA.	lc654@cumc.columbia.edu	Sonti, Shilpa/AAI-4841-2021	Sonti, Shilpa/0000-0001-8804-3010; Ottman, Ruth/0000-0001-7074-242X	National Institutes of Health [NIH R01 NS073872]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, NIH R01 NS073872 (LNC and EDL). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alakbarzade V, 2019, NEUROL-GENET, V5, DOI 10.1212/NXG.0000000000000307; BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Belkadi A, 2015, P NATL ACAD SCI USA, V112, P5473, DOI 10.1073/pnas.1418631112; Bergareche A, 2015, HUM MOL GENET, V24, P7111, DOI 10.1093/hmg/ddv410; Bhatia KP, 2018, MOVEMENT DISORD, V33, P75, DOI 10.1002/mds.27121; Calhoun JD, 2016, EPILEPSIA, V57, pE103, DOI 10.1111/epi.13390; Carr L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172736; Choe M, 2016, MOVEMENT DISORD, V31, P393, DOI 10.1002/mds.26490; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Coutelier M, 2015, AM J HUM GENET, V97, P726, DOI 10.1016/j.ajhg.2015.09.007; Crimella C, 2012, CLIN GENET, V82, P157, DOI 10.1111/j.1399-0004.2011.01717.x; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Filip P, 2016, CEREBELLUM, V15, P774, DOI 10.1007/s12311-015-0740-2; Findley LJ, 2000, NEUROLOGY, V54, pS8; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; Gonzalez-Alegre P, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8FB51G3; Gulcher JR, 1997, NAT GENET, V17, P84, DOI 10.1038/ng0997-84; Handforth A, 2012, TREMOR OTHER HYPERK, V2; Hicks JE, 2016, MOVEMENT DISORD, V31, P1059, DOI 10.1002/mds.26582; Higgins JJ, 1997, MOVEMENT DISORD, V12, P859, DOI 10.1002/mds.870120605; Hor H, 2015, HUM MOL GENET, V24, P5677, DOI 10.1093/hmg/ddv281; Hu H, 2014, NAT BIOTECHNOL, V32, P663, DOI 10.1038/nbt.2895; Kim CH, 2015, BRAIN RES, V1622, P204, DOI 10.1016/j.brainres.2015.06.015; Kimura M., 1983, NEUTRAL THEORY MOL E; Kimura M, 2017, J HUM GENET, V62, P857, DOI 10.1038/jhg.2017.51; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; LEBOURG E, 1992, GERONTOLOGY, V38, P59; Leng XR, 2017, J HUM GENET, V62, P641, DOI 10.1038/jhg.2017.21; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin L, 2009, TRENDS NEUROSCI, V32, P142, DOI 10.1016/j.tins.2008.11.006; Linford NJ, 2013, JOVE-J VIS EXP, DOI 10.3791/50068; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu XM, 2016, EUR J HUM GENET, V24, P1009, DOI 10.1038/ejhg.2015.228; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lorenz D, 2004, NEUROLOGY, V62, P208, DOI 10.1212/01.WNL.0000103236.26934.41; Louis ED, 1997, NEUROEPIDEMIOLOGY, V16, P124, DOI 10.1159/000109681; Louis ED, 2007, NEUROEPIDEMIOLOGY, V29, P208, DOI 10.1159/000111584; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Meienberg J, 2016, HUM GENET, V135, P359, DOI 10.1007/s00439-015-1631-9; Meienberg J, 2015, NUCLEIC ACIDS RES, V43, pE76, DOI 10.1093/nar/gkv216; Merner ND, 2012, AM J HUM GENET, V91, P313, DOI 10.1016/j.ajhg.2012.07.002; Monteil A, 2015, J BIOL CHEM, V290, P16168, DOI 10.1074/jbc.M114.634261; Morino H, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0180-4; Park YG, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0093-2; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Peterson LG, 2014, ANN M AM SOC HUM GEN; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Saifee TA, 2013, J NEUROL NEUROSUR PS, V84, P1282, DOI 10.1136/jnnp-2012-303013; Sanchez Elena, 2015, ASN Neuro, V7, DOI 10.1177/1759091415598290; Sarnthein J, 2007, J NEUROSCI, V27, P124, DOI 10.1523/JNEUROSCI.2411-06.2007; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shatunov A, 2006, BRAIN, V129, P2318, DOI 10.1093/brain/awl120; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129; SINTON CM, 1989, PFLUG ARCH EUR J PHY, V414, P31, DOI 10.1007/BF00585623; Tanner CM, 2001, NEUROLOGY, V57, P1389, DOI 10.1212/WNL.57.8.1389; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trost B, 2018, AM J HUM GENET, V102, P142, DOI 10.1016/j.ajhg.2017.12.007; Ueda A, 2006, J NEUROSCI, V26, P6238, DOI 10.1523/JNEUROSCI.0862-06.2006; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Yang H, 2015, NAT METHODS, V12, P841, DOI [10.1038/NMETH.3484, 10.1038/nmeth.3484]	72	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220512	10.1371/journal.pone.0220512	http://dx.doi.org/10.1371/journal.pone.0220512			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404076	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800015
J	Cornejo, A; Tonin, AM; Checa, B; Tunon, AR; Perez, D; Coronado, E; Gonzalez, S; Rios, T; Macchi, P; Correa-Araneda, F; Boyero, L				Cornejo, Aydee; Tonin, Alan M.; Checa, Brenda; Tunon, Ana Raquel; Perez, Diana; Coronado, Enilda; Gonzalez, Stefani; Rios, Tomas; Macchi, Pablo; Correa-Araneda, Francisco; Boyero, Luz			Effects of multiple stressors associated with agriculture on stream macroinvertebrate communities in a tropical catchment	PLOS ONE			English	Article							INVERTEBRATE COMMUNITIES; WATER-QUALITY; NUTRIENT ENRICHMENT; SAMPLING METHODS; RAIN-FOREST; PESTICIDES; RIVER; DEFORESTATION; ECOSYSTEMS; POLLUTION	Tropical forests are declining at unprecedented rates in favour of agriculture, and streams can be severely impacted due to effects of multiple stressors that have rarely been considered together in tropical studies. We studied the effects of multiple stressors associated with agricultural practices (pesticide toxicity, nutrient enrichment and habitat alteration-quantified as TUmax, soluble reactive phosphorus concentration and sedimentation, respectively) on macroinvertebrate communities in a tropical catchment in Panama (13 stream sites sampled in 20 occasions from 2015 to 2017, with 260 samples in total). We examined how macroinvertebrate abundance, taxonomic richness, community composition and biotic indices (SPEAR and BMWP/PAN, which were specifically designed to detect pesticide toxicity and nutrient enrichment, respectively) varied depending on the studied stressors, considering their single and combined effects. Our analyses revealed significant effects of the studied stressors on macroinvertebrate communities, with two particular results that merit further attention: (1) the fact that pesticide toxicity affected BMWP/PAN, but not SPEAR, possibly because the former had been adapted for local fauna; and (2) that most stressors showed antagonistic interactions (i.e., lower combined effects than expected from their individual effects). These results highlight the need for toxicity bioassays with tropical species that allow adaptations of biotic indices, and of observational and manipulative studies exploring the combined effects of multiple stressors on tropical macroinvertebrate communities and ecosystems, in order to predict and manage future anthropogenic impacts on tropical streams.	[Cornejo, Aydee] Gorgas Mem Inst Hlth Studies COZEM ICGES, Zool Collect Dr Eustorgio Mendez, Freshwater Macroinvertebrate Lab, Panama City, Panama; [Cornejo, Aydee] Univ Panama, Doctoral Program Nat Sci Emphasis Entomol, Panama City, Panama; [Tonin, Alan M.] Univ Brasilia, IB, Dept Ecol, Brasilia, DF, Brazil; [Checa, Brenda; Coronado, Enilda; Gonzalez, Stefani] Agr Dev Minist MIDA, Plant Hlth Lab, Panama City, Panama; [Tunon, Ana Raquel] Minist Environm, Environm Qual Lab, Panama City, Panama; [Perez, Diana] Aquat Resources Author Panama ARAP, Pacific Mariculture Stn, Panama City, Panama; [Rios, Tomas] Autonomous Univ Chiriqui, Museum Freshwater Fish & Invertebrates, David, Panama; [Macchi, Pablo] Natl Univ Rio Negro, CONICET, Res Inst Paleobiol & Geol, Rio Negro, Argentina; [Macchi, Pablo] Natl Univ Comahue, CONICET, Ctr Res Environm Toxicol & Agrobiotechnol Comahue, Buenos Aires, DF, Argentina; [Correa-Araneda, Francisco] Univ Autonoma Chile, Fac Arquitectura & Construcc, IEH, Unidad Cambio Climat & Medio Ambiente, Temuco, Chile; [Boyero, Luz] Univ Basque Country, UPV EHU, Fac Sci & Technol, Dept Plant Biol & Ecol, Leioa, Spain; [Boyero, Luz] Ikerbasque, Bilbao, Spain	Universidad de Panama; Universidade de Brasilia; Universidad Autonoma de Chiriqui; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Autonoma de Chile; University of Basque Country	Cornejo, A (corresponding author), Gorgas Mem Inst Hlth Studies COZEM ICGES, Zool Collect Dr Eustorgio Mendez, Freshwater Macroinvertebrate Lab, Panama City, Panama.; Cornejo, A (corresponding author), Univ Panama, Doctoral Program Nat Sci Emphasis Entomol, Panama City, Panama.	acornejo@gorgas.gob.pa	Macchi, Pablo/AAN-2694-2020; Cornejo, Aydeé/ACU-1078-2022; Tonin, Alan M./J-4575-2014	Macchi, Pablo/0000-0002-1930-0041; Cornejo, Aydeé/0000-0001-6789-5847; Tonin, Alan M./0000-0002-8463-8823; Rios, Tomas/0000-0003-0590-6488; Correa, Francisco Javier/0000-0001-6670-6661	ARCAL project [RLA7019]; International Atomic Energy Agency (IAEA); National Secretariat of Science, Technology and Innovation (SENACYT); National Research System of Panama (SNI)	ARCAL project; International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); National Secretariat of Science, Technology and Innovation (SENACYT); National Research System of Panama (SNI)	This study was part of AC's PhD thesis and TR's MSc thesis, both supported by the ARCAL RLA7019 project led by the MIDA and funded by the International Atomic Energy Agency (IAEA). AC and TR were supported by fellowships of the National Secretariat of Science, Technology and Innovation (SENACYT), and AC was supported as member of the National Research System of Panama (SNI).	ANAM, 2006, INF MON CAL AG CUENC; ANAM CATIE, 2014, PLAN MAN CUENC RIO C; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], NLME LINEAR NONLINEA; ARMITAGE PD, 1983, WATER RES, V17, P333, DOI 10.1016/0043-1354(83)90188-4; Barbour M.T., 1999, RAPID BIOASSESSMENT, V339; Beketov MA, 2009, ENVIRON POLLUT, V157, P1841, DOI 10.1016/j.envpol.2009.01.021; Berenzen N, 2005, ECOTOX ENVIRON SAFE, V60, P37, DOI 10.1016/j.ecoenv.2003.10.010; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Boulton AJ, 2008, AQUAT ECOL-SAN DIEGO, P257, DOI 10.1016/B978-012088449-0.50011-X; Castillo LE, 1997, ENVIRON TOXICOL CHEM, V16, P41, DOI [10.1002/etc.5620160104, 10.1897/1551-5028(1997)016&lt;0041:EAPITA&gt;2.3.CO;2]; Castillo LE, 2006, SCI TOTAL ENVIRON, V367, P418, DOI 10.1016/j.scitotenv.2006.02.052; Connolly NM, 2013, HYDROBIOLOGIA, V718, P85, DOI 10.1007/s10750-013-1605-7; Connolly NM, 2007, HYDROBIOLOGIA, V592, P423, DOI 10.1007/s10750-007-0774-7; Connolly NM, 2004, J N AM BENTHOL SOC, V23, P251, DOI 10.1899/0887-3593(2004)023&lt;0251:EOLDOO&gt;2.0.CO;2; Cornejo A, 2017, DIAGNOSTICO CONDICIO; Cote IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2592; De Romedi A, 2011, REV SALUD PUBLICA-CO, V15, P27; Deknock A, 2019, SCI TOTAL ENVIRON, V646, P996, DOI 10.1016/j.scitotenv.2018.07.185; ETESA, 2008, RES TECN AN REG CREC; Gessner MO, 2002, ECOL APPL, V12, P498, DOI 10.1890/1051-0761(2002)012[0498:ACFULB]2.0.CO;2; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Graeber D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16328; Gutierrez-Fonseca PE, 2010, FORMULACION GUIA MET; Hanson P, 2010, REV BIOL TROP, V58, P3; Hawkes HA, 1998, WATER RES, V32, P964, DOI 10.1016/S0043-1354(97)00275-3; Heartsill-Scalley T, 2003, ECOL APPL, V13, P225, DOI 10.1890/1051-0761(2003)013[0225:RVASCI]2.0.CO;2; Hunt L, 2017, SCI TOTAL ENVIRON, V580, P699, DOI 10.1016/j.scitotenv.2016.12.016; Iwata T, 2003, ECOL APPL, V13, P461, DOI 10.1890/1051-0761(2003)013[0461:IOPRDO]2.0.CO;2; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Legendre P., 2012, NUMERICAL ECOLOGY; Liess M, 2005, ENVIRON TOXICOL CHEM, V24, P954, DOI 10.1897/03-652.1; Liess M, 2008, SCI TOTAL ENVIRON, V406, P484, DOI 10.1016/j.scitotenv.2008.05.054; Lorion CM, 2009, FRESHWATER BIOL, V54, P165, DOI 10.1111/j.1365-2427.2008.02092.x; Matthaei CD, 2010, J APPL ECOL, V47, P639, DOI 10.1111/j.1365-2664.2010.01809.x; Menjivar Rosa R.A., 2010, FORMULACION GUIA MET; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Pacheco-Chaves B., 2010, FORMULACION GUIA MET; Pearson RG, 2000, FRESHWATER BIOL, V43, P31, DOI 10.1046/j.1365-2427.2000.00504.x; PETERSON DR, 1994, CHEMOSPHERE, V29, P2493, DOI 10.1016/0045-6535(94)90052-3; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; Rasmussen JJ, 2016, SCI TOTAL ENVIRON, V542, P12, DOI 10.1016/j.scitotenv.2015.10.062; Reemtsma T, 2013, J CHROMATOGR A, V1271, P95, DOI 10.1016/j.chroma.2012.11.023; Rice E.W., 2012, STANDARD METHODS EXA; Ruiz-Picos RA, 2017, INT J ENVIRON SCI TE, V14, P1835, DOI 10.1007/s13762-017-1299-x; Schafer RB, 2013, ENVIRON SCI TECHNOL, V47, P7996, DOI 10.1021/es4014954; Schafer RB, 2012, ENVIRON SCI TECHNOL, V46, P5134, DOI 10.1021/es2039882; Schafer RB, 2011, ENVIRON SCI TECHNOL, V45, P1665, DOI 10.1021/es103227q; Schafer RB, 2007, SCI TOTAL ENVIRON, V382, P272, DOI 10.1016/j.scitotenv.2007.04.040; Stein H, 2008, ECOL ENG, V34, P267, DOI 10.1016/j.ecoleng.2007.06.010; Suga CM, 2013, HYDROBIOLOGIA, V703, P203, DOI 10.1007/s10750-012-1360-1; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Townsend CR, 2008, J APPL ECOL, V45, P1810, DOI 10.1111/j.1365-2664.2008.01548.x; Van den Berg SJP, 2019, ENVIRON SCI TECHNOL, V53, P6025, DOI 10.1021/acs.est.9b00893; Vega MJ, 2012, HUMANITATES, V1, P94; von Schiller D, 2017, SCI TOTAL ENVIRON, V596, P465, DOI 10.1016/j.scitotenv.2017.04.081; Woodward G, 2012, SCIENCE, V336, P1438, DOI 10.1126/science.1219534; Yule CM, 2010, MAR FRESHWATER RES, V61, P204, DOI 10.1071/MF09065; ZAMORAMUNOZ C, 1995, WATER RES, V29, P285, DOI 10.1016/0043-1354(94)E0125-P; Zuur Alain F., 2009, P1	62	21	21	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220528	10.1371/journal.pone.0220528	http://dx.doi.org/10.1371/journal.pone.0220528			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393898	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500036
J	Carlos, MD; Cavaletti, ACL; Caldas, CP				Carlos, Marcelo de Jesus; Lima Cavaletti, Ana Carolina; Caldas, Celia Pereira			Hospitalization of the aged due to stroke: An ecological perspective	PLOS ONE			English	Article							HEALTH-CARE; GLOBAL BURDEN; RISK-FACTORS; BRAZIL; POPULATION; PREVALENCE; DETERMINANTS; DISEASES	Contextual variables have been associated with the incidence of stroke, but their association with hospitalization of older persons remains unclear. This study evaluated the association between social context variables and hospitalization of 60 years old and older patients due to stroke in Rio de Janeiro, Brazil. An ecological cross-sectional study was conducted, with secondary data from the Brazilian Hospital Information System from 2006 to 2014. Hospitalization rates were calculated and categorized by tertiles. For subsequent analyzes, the polar extremes method was used to select the groups with extremes values. After that, Student t or Mann-Whitney tests were used to compare the contextual variables and the hospitalization rates clusters. Then, a Binary Logistic Regression analysis was used to assess the association between hospitalization rates clusters and the contextual variables. The total number of hospitalizations was 82 796; the hospitalization rate varied in extremes groups from the lowest (3.49) to the highest (11.95) (p< 0.001). The highest rates group was positively associated with the proportion of elderly (p< 0.001), the illiteracy rate of the aged (p = 0.01), primary care coverage (p< 0.001) and ambulatory care for hypertension and diabetes, while the income ratio showed negative association with the highest rates of hospitalization (p = 0.01). In the multivariate analysis, only the proportion of elderly (OR = 1.55; 95% CI 1.07-2.25), primary care coverage (OR = 1.05; 95% CI 1.01-1.11) and income ratio (OR = 0.82; 95% CI 0.67-0.99) maintained the association. In conclusion, contextual variables in the three dimensions studied were associated with the rate of hospitalization of aged due to stroke in the municipalities in Rio de Janeiro State. Transitional care and other improvements in both the health care and social services are demanded.	[Carlos, Marcelo de Jesus; Lima Cavaletti, Ana Carolina; Caldas, Celia Pereira] Univ Estado Rio De Janeiro, Med Sci Coll, Postgrad Program Med Sci, Rio De Janeiro, RJ, Brazil; [Caldas, Celia Pereira] Univ Estado Rio De Janeiro, Nursing Sch, Dept Aging, Rio De Janeiro, RJ, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Carlos, MD (corresponding author), Univ Estado Rio De Janeiro, Med Sci Coll, Postgrad Program Med Sci, Rio De Janeiro, RJ, Brazil.	marcelojcarlos@gmail.com	Caldas, Celia/K-5370-2019	Caldas, Celia/0000-0001-6903-1778; Carlos, Marcelo/0000-0002-8810-3092				Adami F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152739; Afonso MPD, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015322; Bittencourt Sonia Azevedo, 2006, Cad. Saúde Pública, V22, P19, DOI 10.1590/S0102-311X2006000100003; Bousquat A, 2017, CIENC SAUDE COLETIVA, V22, P1141, DOI 10.1590/1413-81232017224.28632016; Cabral NL, 2011, NEUROEPIDEMIOLOGY, V36, P258, DOI 10.1159/000328865; Cavalini LT, 2008, INT J EPIDEMIOL, V37, P775, DOI 10.1093/ije/dyn088; Copstein L, 2013, ARQ NEURO-PSIQUIAT, V71, P294, DOI 10.1590/0004-282X20130024; da Rocha PR, 2015, REV ESC ENFERM USP, V49, P127, DOI 10.1590/S0080-623420150000100017; Silva AMD, 2017, REV SAUDE PUBL, V51, DOI [10.1590/s1518-8787.2017051000243, 10.1590/S1518-8787.2017051000243]; Campos GWD, 2016, CIENC SAUDE COLETIVA, V21, P2655, DOI 10.1590/1413-81232015219.18922016; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Lentsck MH, 2015, REV LAT-AM ENFERM, V23, P611, DOI 10.1590/0104-1169.0078.2595; Lima Cavaletti Ana Carolina, 2018, Value Health Reg Issues, V17, P8, DOI 10.1016/j.vhri.2017.12.002; Lopes Johnnatas Mikael, 2016, Rev. bras. epidemiol., V19, P122, DOI 10.1590/1980-5497201600010011; Lotufo PA, 2015, SAO PAULO MED J, V133, P457, DOI 10.1590/1516-3180.2015.13360510; Macinko James, 2018, Saúde debate, V42, P18, DOI 10.1590/0103-11042018s102; Marmot M, 2016, ANN EPIDEMIOL, V26, P238, DOI 10.1016/j.annepidem.2016.02.003; Marmot M, 2011, B WORLD HEALTH ORGAN, V89, P702, DOI 10.2471/BLT.11.094862; Marques AP, 2014, REV SAUDE PUBL, V48, P817, DOI 10.1590/S0034-8910.2014048005133; Melo Eduardo Alves, 2018, Saúde debate, V42, P38, DOI 10.1590/0103-11042018s103; Moffat K, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0344-4; de Andrade LOM, 2015, LANCET, V385, P1343, DOI 10.1016/S0140-6736(14)61494-X; Morosini Márcia Valéria Guimarães Cardoso, 2018, Saúde debate, V42, P11, DOI 10.1590/0103-1104201811601; Moura EC, 2009, REV PANAM SALUD PUBL, V26, P17, DOI 10.1590/S1020-49892009000700003; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Pereira ABCND, 2009, CAD SAUDE PUBLICA, V25, P1929, DOI 10.1590/S0102-311X2009000900007; Norrving B, 2013, NEUROLOGY, V80, pS5, DOI 10.1212/WNL.0b013e3182762397; Nunes BP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2505-8; O'Cathain A, 2014, BMJ QUAL SAF, V23, P47, DOI 10.1136/bmjqs-2013-002003; Pedigo A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-644; Perez LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166304; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Pinto LF, 2018, CIENC SAUDE COLETIVA, V23, P1903, DOI 10.1590/1413-81232018236.05592018; Ribeiro IJS, 2018, J STROKE CEREBROVASC, V27, P1616, DOI 10.1016/j.jstrokecerebrovasdis.2018.01.013; Rocha Suelen Alves, 2016, Physis, V26, P87, DOI 10.1590/S0103-73312016000100007; Rodriguez F, 2013, J COMMUN HEALTH, V38, P451, DOI 10.1007/s10900-012-9640-2; Rolim Cristina Lúcia Rocha Cubas, 2012, Rev. bras. epidemiol., V15, P179, DOI 10.1590/S1415-790X2012000100016; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Stubbs B, 2017, PSYCHOL MED, V47, P2107, DOI 10.1017/S0033291717000551; Travassos Claudia, 2004, Cad. Saúde Pública, V20, pS190; World Health Organization, 2008, GUIA GLOB CID AM DO	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220833	10.1371/journal.pone.0220833	http://dx.doi.org/10.1371/journal.pone.0220833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390380	Green Submitted, gold, Green Published			2022-12-27	WOS:000484999400031
J	Cho, SJ; Jung, SC; Suh, CH; Lee, JB; Kim, D				Cho, Se Jin; Jung, Seung Chai; Suh, Chong Hyun; Lee, Jung Bin; Kim, Donghyun			High-resolution magnetic resonance imaging of intracranial vessel walls: Comparison of 3D T1-weighted turbo spin echo with or without DANTE or iMSDE	PLOS ONE			English	Article							EXPERT CONSENSUS RECOMMENDATIONS; DIGITAL-SUBTRACTION-ANGIOGRAPHY; DRIVEN-EQUILIBRIUM IMSDE; BLACK-BLOOD MRI; ARTERIAL-WALL	Background The black-blood (BB) technique was developed to suppress the signal from blood and cerebrospinal fluid (CSF) to provide improved depiction of vessel walls. Purpose The aim was to compare three-dimensional turbo spin echo T1-weighted imaging (3D TSE T1WI) with or without two BB techniques (delay alternating with nutation for tailored excitation [DANTE], and improved motion-sensitized driven equilibrium [iMSDE]) for high-resolution magnetic resonance imaging (HR-MRI) of the vessel walls of intracranial arteries. Study type Prospective. Population Fourteen healthy volunteers who underwent 3D T1WI for examination of intracranial vessel walls. Field strength/Sequence 3 Tesla, 3D TSE T1WI (SPACE and BrainVIEW) and BB (DANTE and iMSDE). Assessment SPACE with or without DANTE, and BrainVIEW with or without iMSDE, were acquired in each subject. Two neuroradiologists independently assessed image quality, vessel wall delineation, BB effect, CSF, and acceptability using visual scoring systems, and measured signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) in vessel walls, lumen, and CSF, while blinded to the presence and type of BB technique used. Statistical tests Repeated measures ANOVA or Friedman tests were performed for the comparisons, followed by Bonferroni correction. Results The 3T T1WI sequences without BB are significantly superior in vessel wall delineation (P = 0.001). Black CSF scores were lower in SPACE with DANTE than SPACE without DANTE, and in BrainVIEW without iMSDE than SPACE without DANTE (P < 0.001). However, there were no significant differences in BB effect, image quality, and acceptability between the four 3D T1WI sequences (p >.05). The SNRVessel wall, CNRWall-Lumen, and CNRWall-CSF were higher (all p <.001) on SPACE with and without DANTE than on BrainVIEW with and without iMSDE. SNRLumen were higher (all p <.001) on BrainVIEW with and without iMSDE than on SPACE with and without DANTE. SNRCSF was higher (all p <.001) on BrainVIEW with iMSDE than on SPACE with DANTE. Data conclusion Both 3D TSE T1WI sequences were acceptable for intracranial vessel wall evaluation, with or without BB techniques. Therefore, BB techniques may not necessarily be required with 3D TSE T1WI with a long ETL and TR (below 1160 ms).	[Jung, Seung Chai] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; Univ Ulsan, Res Inst Radiol, Coll Med, Asan Med Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan	Jung, SC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.	dynamics79@gmail.com		Lee, Jungbin/0000-0002-6240-8277	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [HI12C1847]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HI12C1847) to SCJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HI12C1847).	Alexander AL, 1998, MAGNET RESON MED, V40, P298, DOI 10.1002/mrm.1910400216; Choi YJ, 2015, J STROKE, V17, P238, DOI 10.5853/jos.2015.17.3.238; Dieleman N, 2014, CIRCULATION, V130, P192, DOI 10.1161/CIRCULATIONAHA.113.006919; Fan ZY, 2017, MAGN RESON MED, V77, P1142, DOI 10.1002/mrm.26201; Kang HJ, 2016, RADIOLOGY, V279, P128, DOI 10.1148/radiol.2015150217; Lee JN, 2016, AM J NEURORADIOL, V37, P2245, DOI 10.3174/ajnr.A4950; Li LQ, 2014, RADIOLOGY, V273, P560, DOI 10.1148/radiol.14131717; Lindenholz A, 2018, RADIOLOGY, V286, P12, DOI 10.1148/radiol.2017162096; Mandell DM, 2017, AM J NEURORADIOL, V38, P218, DOI 10.3174/ajnr.A4893; Mossa-Basha M, 2017, STROKE, V48, P3026, DOI 10.1161/STROKEAHA.117.018227; Mossa-Basha M, 2016, NEUROIMAG CLIN N AM, V26, P129, DOI 10.1016/j.nic.2015.09.010; Obara M, 2014, J MAGN RESON IMAGING, V40, P824, DOI 10.1002/jmri.24430; Park JE, 2017, EUR RADIOL, V27, P4737, DOI 10.1007/s00330-017-4860-6; Qiao Y, 2011, J MAGN RESON IMAGING, V34, P22, DOI 10.1002/jmri.22592; Saba L, 2018, AM J NEURORADIOL, V39, pE9, DOI 10.3174/ajnr.A5488; Wang JN, 2016, MAGN RESON MED, V75, P831, DOI 10.1002/mrm.25667; Wang JN, 2010, J MAGN RESON IMAGING, V31, P1256, DOI 10.1002/jmri.22149; Xie YB, 2016, MAGN RESON MED, V75, P2286, DOI 10.1002/mrm.25785; Yoneyama M, 2014, MAGN RESON MED SCI, V13, P61, DOI 10.2463/mrms.2013-0047; Zhang L, 2017, MAGN RESON IMAGING, V44, P65, DOI 10.1016/j.mri.2017.08.004; Zhang L, 2015, MAGN RESON IMAGING, V33, P1026, DOI 10.1016/j.mri.2015.06.006	21	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220603	10.1371/journal.pone.0220603	http://dx.doi.org/10.1371/journal.pone.0220603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386679	Green Published, gold			2022-12-27	WOS:000484997100026
J	Poonsiri, J; Dekker, R; Dijkstra, PU; Nutchamlong, Y; Dismanopnarong, C; Puttipaisan, C; Suakonburi, S; Pimchan, P; Hijmans, JM; Geertzen, JHB				Poonsiri, Jutamanee; Dekker, Rienk; Dijkstra, Pieter U.; Nutchamlong, Yasmin; Dismanopnarong, Chanapak; Puttipaisan, Chiraphan; Suakonburi, Samai; Pimchan, Pensupa; Hijmans, Juha M.; Geertzen, Jan H. B.			Cycling of people with a lower limb amputation in Thailand	PLOS ONE			English	Article							SPORTS PARTICIPATION; BARRIERS; FACILITATORS; EXERCISE; AMPUTEES; MOBILITY; YOUNG	Aim To investigate cycling participation and barriers, and facilitators in adults with a lower limb amputation in Thailand. Method Questionnaires were given to 424 adults with uni/bilateral lower limb amputation from mid-foot to hip disarticulation level at five public hospitals in Bangkok and prosthetic mobile units in Thailand. Participant characteristics were summarized using descriptive statistics. Variables associated with cycling (p<0.1) were entered in a logistic regression model. Results Participants who cycled (46.7%, N = 197), mostly used their walking prostheses (91.9%, n = 188). Of cyclists, 92.4% had cycled before the amputation. Cyclists started cycling after the amputation by themselves (86.7%) mostly in order to increase/maintain health (67.0%). Most cyclists cycled on quiet roads. The most frequent destination was shops/market (64.1%). More facilitators were reported than barriers. Most reported barriers were related to health problems and negative attitudes toward cycling. Most reported facilitators were related to perceived health benefits and positive attitude toward cycling. The likelihood of cycling after the amputation increased in people who cycled before the amputation, were amputated lower than the knee, used a prosthetic foot with axis/axes, were amputated due to trauma, had income higher than 415 euro/month, and who reported a higher numbers of facilitators. Conclusion After a lower limb amputation, nearly half of people cycled. People with a below knee amputation due to trauma with prior cycling experience and higher income tended to cycle after the amputation. People who perceived more facilitators were more likely to cycle. Although cyclists could use a walking prosthesis to cycle, a prosthetic foot with a greater range of motion than the SACH increased the cycling likelihood.	[Poonsiri, Jutamanee; Dekker, Rienk; Dijkstra, Pieter U.; Hijmans, Juha M.; Geertzen, Jan H. B.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands; [Poonsiri, Jutamanee; Nutchamlong, Yasmin] Mahidol Univ, Fac Med Siriraj Hosp, Sirindhorn Sch Prosthet & Orthot, Bangkok, Thailand; [Dijkstra, Pieter U.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [Dismanopnarong, Chanapak] Vet Gen Hosp, Orthopaed Dept, Prosthet & Orthot Unit, Bangkok, Thailand; [Puttipaisan, Chiraphan] King Chulalongkorn Mem Hosp, Rehabil Med Dept, Prosthet & Orthot Unit, Bangkok, Thailand; [Suakonburi, Samai] Lerdsin Hosp, Rehabil Dept, Bangkok, Thailand; [Pimchan, Pensupa] Phramongkutklao Hosp, Orthopaed Dept, Prosthet & Orthot Unit, Bangkok, Thailand	University of Groningen; Mahidol University; University of Groningen; Chulalongkorn University; Phramongkutklao Hospital	Poonsiri, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Groningen, Netherlands.; Poonsiri, J (corresponding author), Mahidol Univ, Fac Med Siriraj Hosp, Sirindhorn Sch Prosthet & Orthot, Bangkok, Thailand.	j.poonsiri@umcg.nl	Poonsiri, Jutamanee/AGZ-8636-2022; Hijmans, Juha/X-5814-2019	Hijmans, Juha/0000-0003-3968-9602; Poonsiri, Jutamanee/0000-0002-4957-0990				Bragaru M, 2013, PROSTHET ORTHOT INT, V37, P454, DOI 10.1177/0309364613476533; Bragaru M, 2011, SPORTS MED, V41, P721, DOI 10.2165/11590420-000000000-00000; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Burger H, 1997, PROSTHET ORTHOT INT, V21, P35; Burger H, 1997, DISABIL REHABIL, V19, P272, DOI 10.3109/09638289709166538; Cavanagh PR, 1986, SCI CYCLING, P91; Childers WL, 2011, J APPL BIOMECH, V27, P314, DOI 10.1123/jab.27.4.314; Engbers LH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-89; Fishman E, 2012, TRANSPORT RES F-TRAF, V15, P686, DOI 10.1016/j.trf.2012.08.002; Gailey RSJ, 1992, TOP GERIATR REHABIL, V8, P39, DOI [10.1097/00013614-199209000-00007, DOI 10.1097/00013614-199209000-00007]; GOH JCH, 1984, PROSTHET ORTHOT INT, V8, P147; Heinisch O., 1963, PREIS S BIOM J, V1965, P203, DOI [10.1002/bimj.19650070312, DOI 10.1002/BIMJ.19650070312]; Jaarsma EA, 2014, SCAND J MED SCI SPOR, V24, P871, DOI 10.1111/sms.12218; Jarach K., 2017, BANGKOK JUST GOT A S; Kang M, 2007, REHABIL PSYCHOL, V52, P170, DOI 10.1037/0090-5550.52.2.170; Kars C, 2009, PROSTHET ORTHOT INT, V33, P356, DOI 10.3109/03093640902984579; KEGEL B, 1980, ARCH PHYS MED REHAB, V61, P258; Kienteka Marilson, 2012, Rev. bras. cineantropom. desempenho hum., V14, P624, DOI 10.5007/1980-0037.2012v14n6p624; Koutny D, 2013, INT J MED HEAL BIOME, V7, P812; Littman AJ, 2014, J REHABIL RES DEV, V51, P895, DOI 10.1682/JRRD.2013.06.0152; Macaluso A, 2002, MUSCLE NERVE, V25, P858, DOI 10.1002/mus.10113; Mead D, 2005, J PROSTHETICS ORTHOT, V17, P35, DOI [10.1097/00008526-200501000-00009, DOI 10.1097/00008526-200501000-00009]; NARANG IC, 1984, PROSTHET ORTHOT INT, V8, P43; National Statistical Office, 2012, 2012 DIS SURV; Poonsiri J, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2313-2; Reiser RF, 2004, TECH PAPERS ISA, V449, P36; Rimmer JH, 2008, J REHABIL RES DEV, V45, P315, DOI 10.1682/JRRD.2007.02.0042; Scheepers LG, 2015, PROSTHET ORTHOT INT, V39, P161, DOI 10.1177/0309364613515494; Snyder RD, 1995, J REHABIL RES DEV, V32, P309; The Government Public Relations Department, 2015, MOR 600 000 PEOPL HA; The Government Public Relations Department, 2018, UN AI RAK BIC RID EV; TIMMER C A W, 1991, Journal of Orthopaedic and Sports Physical Therapy, V14, P106; Udomkitti P., 2014, VERIDIAN J SILPAKORN, V7, P561; Vasudevan V, 2015, DISABIL HEALTH J, V8, P547, DOI 10.1016/j.dhjo.2015.04.007; WARD KH, 1995, SPORTS MED, V20, P207, DOI 10.2165/00007256-199520040-00001; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220649	10.1371/journal.pone.0220649	http://dx.doi.org/10.1371/journal.pone.0220649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374098	gold, Green Published, Green Submitted			2022-12-27	WOS:000484991500023
J	Tedder, RS; Dicks, S; Ijaz, S; de Souza, NCS; de Paula, AV; Levy, F; Medialdea-Carrera, R; Levi, JE; Pannuti, CS; de Sequeira, PC; Brown, DWG; Lumb, IU				Tedder, Richard S.; Dicks, Steve; Ijaz, Samreen; Santiago de Souza, Nathalia Caroline; de Paula, Anderson Vincente; Levy, Flavia; Medialdea-Carrera, Raquel; Levi, Jose Eduardo; Pannuti, Claudio S.; de Sequeira, Patricia Carvalho; Brown, David W. G.; Lumb, Ines Ushiro			Modulated Zika virus NS1 conjugate offers advantages for accurate detection of Zika virus specific antibody in double antigen binding and Ig capture enzyme immunoassays	PLOS ONE			English	Article							TRANSMISSION; INFECTION; DISEASE; ASSAY	The accurate diagnosis and seroprevalence investigations of Zika virus (ZKV) infections remain complex due to cross reactivity with other flaviviruses. Two assay formats, both using labelled Zika virus NS1 antigen as a revealing agent (a double antigen binding assay, DABA, and an immunoglobulin Ig capture assay, G capture) were initially developed and compared with the indirect EuroimmunZ assay for the detection of anti-Zika antibody. Of 147 pre-Zika period serum samples, 39 (27%) were reactive in the EuroimmunZ or the DABA assays, 28 sera concordantly so. Such false reactivity was influenced by the serotype of Dengue virus (DV) to which individuals had been exposed to. Thus, of sera from patients undergoing secondary Dengue virus infection of known serotype, 91%, 45% and 28% of Dengue virus serotype 2, 3 and 4 respectively were reactive in one or more of the three assays. A novel method of quenching false sero-reactivity was therefore developed for the DABA and G capture assays. Initial addition of a single homologous Dengue virus serotype 3 NS1Ag quench significantly ablated false reactivities in the pre-Zika period sera. An equipotent quadrivalent quench comprising homologous Dengue virus serotypes 1 to 4 NS1Ag was shown to be optimum yet retained sensitivity for the detection of specific anti-Zika antibody. Comparing DABA and G capture assays using quenched and unquenched conjugates in comparison with EuroimmunZ early in the course of PCR-confirmed infection indicated that a significant component of the apparent early anti-ZIKA antibody response is likely to be due to a Zika virus-driven anamnestic anti-Dengue virus response. The increased specificity provided by homologous antigen quenching is likely to provide a significant improvement in sero-diagnostics and to be of clinical value.	[Tedder, Richard S.; Dicks, Steve; Ijaz, Samreen; Brown, David W. G.; Lumb, Ines Ushiro] Publ Hlth England, Blood Borne Virus Unit, Virus Reference Dept, London, England; [Tedder, Richard S.; Dicks, Steve; Lumb, Ines Ushiro] NHS Blood & Transplant, Microbiol Serv, London, England; [Tedder, Richard S.] UCL, London, England; [Santiago de Souza, Nathalia Caroline; de Paula, Anderson Vincente; Levi, Jose Eduardo; Pannuti, Claudio S.] Univ Sao Paulo, Inst Med Trop, Virol Lab LIM HCFMUSP, Sao Paulo, Brazil; [Levy, Flavia; de Sequeira, Patricia Carvalho; Brown, David W. G.] Fiocruz MS, Flavivirus Reference Lab, IOC, Rio De Janeiro, Brazil; [Medialdea-Carrera, Raquel] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England; [Tedder, Richard S.] Imperial Coll London, Fac Med, Dept Infect Dis, London, England	Public Health England; University of London; University College London; Universidade de Sao Paulo; Fundacao Oswaldo Cruz; University of Liverpool; Imperial College London	Ijaz, S (corresponding author), Publ Hlth England, Blood Borne Virus Unit, Virus Reference Dept, London, England.	samreen.ijaz@phe.gov.uk		Tedder, Richard/0000-0002-9672-5721; Medialdea-Carrera, Raquel/0000-0002-0371-5138; De Paula, Anderson Vicente/0000-0002-7919-3516; Ijaz, Samreen/0000-0001-6658-3542	Medical Research Council Zika Rapid Response award [MC_PC_15093]; Public Health England Pipeline fund [PLF 1819-115/RA]; European Union's horizon 2020 research and innovation programme [734857]; Zikaction; Zikaplan [734584]	Medical Research Council Zika Rapid Response award; Public Health England Pipeline fund; European Union's horizon 2020 research and innovation programme; Zikaction; Zikaplan	This work was supported by Medical Research Council Zika Rapid Response award (MC_PC_15093) to RST, SI, DWGB, IUL, https://mrc.ukri.org/; Public Health England Pipeline fund (PLF 1819-115/RA) to RST, SI, https://www.gov.uk/government/organisations/public-health-england. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank colleagues in Diasorin for the kind gift of the conjugate diluent. DB is partially funded by European Union's horizon 2020 research and innovation programme (grant agreement no. 734857), Zikaction and Zikaplan consortia (grant agreement 734584). RMC is affiliated to the NIHR HPRU in Emerging and Zoonotic Infections at University of Liverpool in partnership with PHE, in collaboration with LSHTM.	Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114; Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681; Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2; BROWN DWG, 1994, BRIT MED J, V308, P1015, DOI 10.1136/bmj.308.6935.1015; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Glynn JR, 2017, LANCET INFECT DIS, V17, P645, DOI 10.1016/S1473-3099(17)30111-1; HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Mead PS, 2016, NEW ENGL J MED, V378, P1377; MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983; Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262; Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006; Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Tedder RS, 2018, TRANSFUSION, V58, P1289, DOI 10.1111/trf.14580	19	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0215708	10.1371/journal.pone.0215708	http://dx.doi.org/10.1371/journal.pone.0215708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374094	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500001
J	Valente, KP; Almeida, BL; Lazzarini, TR; de Souza, VF; Ribeiro, TDC; de Moraes, RAG; Pereira, TSS; Guandalini, VR				Valente, Katarina Papera; Almeida, Betullya Lucas; Lazzarini, Thailiny Ricati; de Souza, Vanusa Felicio; Chaves Ribeiro, Thamirys de Souza; Guedes de Moraes, Rafael Araujo; Silva Pereira, Taisa Sabrina; Guandalini, Valdete Regina			Association of Adductor Pollicis Muscle Thickness and Handgrip Strength with nutritional status in cancer patients	PLOS ONE			English	Article							MALNUTRITION; PREDICTOR; MASS; DYNAMOMETRY; MOBILITY; DECLINE; LENGTH; STAY	Background and aim Malnutrition is common in patients with cancer, and its early diagnosis can reduce or prevent further complications and improve the clinical and nutritional prognosis. Adductor Pollicis Muscle Thickness (APMT) and Handgrip Strength have been explored in this population to identify a reduction in strength and muscle mass prior to the use of conventional methods. We aimed to correlate APMT and Handgrip Strength with conventional anthropometric variables in cancer patients and verify their association with nutritional status as determined by the Patient-Generated Subjective Global Assessment (PG-SGA). Methods A cross-sectional study was conducted with 80 patients diagnosed with cancer who were candidates for surgery. Nutritional status was obtained from the PG-SGA. Conventional anthropometric measurements were taken, as well as APMT and Handgrip Strength. Pearson's correlation analysis and multivariate linear regression were applied to detect the influence of variables on APMT and HGS. A significance level of 5.0% was considered. Results A high prevalence of malnutrition and the need for dietotherapic intervention was found, identified by the PG-SGA. Correlations between APMT and Handgrip Strength with anthropometric variables and with the PG-SGA score were observed. After regression adjustments, the variables that interacted with APMT were TSF and AC, and the PG-SGA score, corrected Muscle Arm Area (CAMA), and age interacted with Handgrip Strength. Conclusion Correlations between anthropometric measurements and the PG-SGA score with APMT and Handgrip Strength were observed, even after adjusting for age and sex. These associations demonstrate that APMT and Handgrip Strength can be used with criterion in patients with cancer as complementary methods to evaluate nutritional risk and the need for nutritional intervention.	[Valente, Katarina Papera; Almeida, Betullya Lucas; Lazzarini, Thailiny Ricati; de Souza, Vanusa Felicio; Chaves Ribeiro, Thamirys de Souza; Guandalini, Valdete Regina] Univ Fed Espirito Santo, Dept Integrated Educ, Vitoria, ES, Brazil; [Guedes de Moraes, Rafael Araujo] Univ Cassiano Antonio Moraes Hosp, Vitoria, ES, Brazil; [Silva Pereira, Taisa Sabrina] Univ Americas Puebla, Ex Hacienda Sta Catarina Martir S-N, Cholula, Mexico	Universidade Federal do Espirito Santo; Universidad Americas Puebla (UDLAP)	Guandalini, VR (corresponding author), Univ Fed Espirito Santo, Dept Integrated Educ, Vitoria, ES, Brazil.; Pereira, TSS (corresponding author), Univ Americas Puebla, Ex Hacienda Sta Catarina Martir S-N, Cholula, Mexico.	taisa.silva@udlap.mx; valdete.guandalini@ufes.br	Guandalini, Valdete Regina/E-5165-2017; Pereira, Taísa Sabrina Silva/AAB-3715-2021	Guandalini, Valdete Regina/0000-0003-2266-6113; Pereira, Taísa Sabrina Silva/0000-0002-5922-7424	University Hospital Cassiano Antonio Moraes; Health Sciences Center/Federal University of Espirito Santo	University Hospital Cassiano Antonio Moraes; Health Sciences Center/Federal University of Espirito Santo	The authors would like to acknowledge the University Hospital Cassiano Antonio Moraes and the Health Sciences Center/Federal University of Espirito Santo for all support and assistance throughout the research. The authors also thank our study participants for their permission.	Alkan SB, 2018, SUPPORT CARE CANCER, V26, P2441, DOI 10.1007/s00520-018-4082-8; Allard JP, 2016, CLIN NUTR, V35, P144, DOI 10.1016/j.clnu.2015.01.009; Arends J, 2017, CLIN NUTR, V36, P11, DOI 10.1016/j.clnu.2016.07.015; Arvandi M, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0381-4; Barata AT, 2017, NUTR CANCER, V69, P154, DOI 10.1080/01635581.2017.1250923; Bragagnolo Rosalia, 2009, Rev. Col. Bras. Cir., V36, P371; Cruz A, 2019, ANIMAL, V13, P1358, DOI [10.1017/S1751731118003282, 10.1017/s1751731118003282]; Datema FR, 2011, ORAL ONCOL, V47, P910, DOI 10.1016/j.oraloncology.2011.06.510; Fess EE, CLIN ASSESSMENT RECO, P41; Fukuda Y, 2015, ANN SURG ONCOL, V22, pS778, DOI 10.1245/s10434-015-4820-9; Ghorabi S, 2016, NUTR CLIN PRACT, V31, P523, DOI 10.1177/0884533615621547; Gonzalez MC, 2010, CLIN NUTR, V29, P268, DOI 10.1016/j.clnu.2009.08.012; Gonzalez MC, 2015, CLIN NUTR, V34, P1025, DOI 10.1016/j.clnu.2014.11.006; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Guerra RS, 2015, JPEN-PARENTER ENTER, V39, P322, DOI 10.1177/0148607113514113; Jager-Wittenaar H, 2017, CURR OPIN CLIN NUTR, V20, P322, DOI 10.1097/MCO.0000000000000389; Karst Fernanda Pickrodt, 2015, Rev. bras. ter. intensiva, V27, P369, DOI 10.5935/0103-507X.20150062; Lameu Edson Braga, 2004, Rev. Hosp. Clin., V59, P57, DOI 10.1590/S0041-87812004000200002; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lipina C, 2017, J CACHEXIA SARCOPENI, V8, P190, DOI 10.1002/jcsm.12144; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Luna-Heredia E, 2005, CLIN NUTR, V24, P250, DOI 10.1016/j.clnu.2004.10.007; Martin L, 2020, JPEN-PARENTER ENTER, V44, P227, DOI 10.1002/jpen.1597; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Olguin T, 2017, CLIN NUTR ESPEN, V17, P28, DOI 10.1016/j.clnesp.2016.12.001; Opanga Yvonne, 2017, BMC Nutr, V3, P63, DOI 10.1186/s40795-017-0181-z; Ottery FD, 1996, NUTRITION, V12, pS15, DOI 10.1016/0899-9007(95)00067-4; Ozorio GA, 2017, NUTR CANCER, V69, P772, DOI 10.1080/01635581.2017.1321130; Pereira TG, 2018, CLIN NUTR ESPEN, V24, P165, DOI 10.1016/j.clnesp.2017.10.013; Pinho NB, 2018, CLIN NUTR, P1, DOI [10.1016/j.clnu.2018.05.010, DOI 10.1016/J.CLNU.2018.05.010]; Planas M, 2016, SUPPORT CARE CANCER, V24, P429, DOI 10.1007/s00520-015-2813-7; Poziomyck AK, 2018, ABCD-ARQ BRAS CIR DI, V31, DOI 10.1590/0102-672020180001e1340; Prado CMM, 2014, JPEN-PARENTER ENTER, V38, P940, DOI 10.1177/0148607114550189; Sampaio RMM, 2012, REV BRAS PROMOC SAUD, V25, P111; Sealy MJ, 2016, J CLIN EPIDEMIOL, V76, P125, DOI 10.1016/j.jclinepi.2016.02.020; Sharma Dibyendu, 2015, Asian Pac J Cancer Prev, V16, P8173; Shu-Fen CL, 2015, ASIA PAC J CLIN NUTR, V24, P605, DOI 10.6133/apjcn.2015.24.4.22; de Melo CYSV, 2014, ABCD-ARQ BRAS CIR DI, V27, P13, DOI 10.1590/s0102-67202014000100004; Souza NC, 2020, CLIN NUTR, V39, P484, DOI 10.1016/j.clnu.2019.02.026; Torres BT, 2018, NUTR HOSP, V35, P384, DOI 10.20960/nh.1315; Valente KP, 2016, EINSTEIN-SAO PAULO, V14, P18, DOI 10.1590/S1679-45082016AO3596; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; World Health Organization, 1995, WHO PHYS STAT US INT; World Health Organization, 2002, ACT AG POL FRAM; Zhang XS, 2017, BIOMED ENVIRON SCI, V30, P802, DOI 10.3967/bes2017.108; Zhou JD, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0054-8	47	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220334	10.1371/journal.pone.0220334	http://dx.doi.org/10.1371/journal.pone.0220334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374093	Green Submitted, Green Published, gold			2022-12-27	WOS:000484991500010
J	Grass, J; Krieger, F; Paulus, P; Greiff, S; Strobel, A; Strobel, A				Grass, Julia; Krieger, Florian; Paulus, Philipp; Greiff, Samuel; Strobel, Anja; Strobel, Alexander			Thinking in action: Need for Cognition predicts Self-Control together with Action Orientation	PLOS ONE			English	Article							EGO DEPLETION; STATE ORIENTATION; CONTROL CAPACITY; RESOURCE MODEL; POWER ANALYSIS; SAMPLE-SIZE; GRATIFICATION; PERFORMANCE; DELAY; INTELLIGENCE	Need for Cognition describes relatively stable interindividual differences in cognitive motivation. Previous research has shown relations of Need for Cognition to Self-Control-a capacity that can be broadly defined as resistance to temptation-yet, the processes underlying this relation remain unclear. One explanation for the prediction of Self-Control by Need for Cognition can be an increased motivation to invest cognitive effort with higher levels of Need for Cognition. Another possible link could be that individual differences in the implementation of Self-Control intentions may play a moderating or mediating role for the predictive value of Need for Cognition. Such individual differences in the self-motivated initiation and maintenance of intentions are described by dispositional Action Orientation. Therefore, in the present study, Action Orientation was examined with regard to its possible role in explaining the relation of Need for Cognition to Self-Control. In a sample of 1209 young adults, Self-Control was assessed with two different self-report instruments and moderation and mediation models of the relationship between Need for Cognition, Action Orientation, and Self-Control were tested. While there was no evidence for a moderating role of Action Orientation in explaining the relation of Need for Cognition and Self-Control, Action Orientation was found to partly mediate this relation with a remaining direct effect of Need for Cognition on Self-Control. These results add to the conceptual understanding of Need for Cognition and demonstrate the relevance of trait variables to predict Self-Control.	[Grass, Julia; Strobel, Anja] Tech Univ Chemnitz, Dept Psychol, Chemnitz, Germany; [Krieger, Florian; Greiff, Samuel] Univ Luxembourg, Cognit Sci & Assessment, Esch Sur Alzette, Luxembourg; [Paulus, Philipp; Strobel, Alexander] Tech Univ Dresden, Fac Psychol, Dresden, Germany	Technische Universitat Chemnitz; University of Luxembourg; Technische Universitat Dresden	Grass, J (corresponding author), Tech Univ Chemnitz, Dept Psychol, Chemnitz, Germany.	Julia.grass@psychologie.tu-chemnitz.de	Grass, Julia/AGF-0685-2022	Grass, Julia/0000-0002-6585-4782; Krieger, Florian/0000-0001-9981-8432; Greiff, Samuel/0000-0003-2900-3734	Deutsche Forschungsgemeinschaft [SFB 940/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by a grant of the Deutsche Forschungsgemeinschaft (SFB 940/2, subproject B6, received by Alexander Strobel; www.dfg.de).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allom V, 2016, PERS INDIV DIFFER, V90, P137, DOI 10.1016/j.paid.2015.10.051; Baumeister RF, 2002, SELF IDENTITY, V1, P129, DOI 10.1080/152988602317319302; Baumeister RF, 2014, NEUROPSYCHOLOGIA, V65, P313, DOI 10.1016/j.neuropsychologia.2014.08.012; Bertrams A., 2012, PSYCHOL ED, V49, P46; Bertrams A, 2012, J INDIVID DIFFER, V33, P69, DOI 10.1027/1614-0001/a000081; Bertrams A, 2009, DIAGNOSTICA, V55, P2, DOI 10.1026/0012-1924.55.1.2; Bertrams A, 2009, LEARN INDIVID DIFFER, V19, P135, DOI 10.1016/j.lindif.2008.06.005; BLESS H, 1994, Z SOZIALPSYCHOL, V25, P147; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; CACIOPPO JT, 1982, J PERS SOC PSYCHOL, V42, P116, DOI 10.1037/0022-3514.42.1.116; Cacioppo JT, 1996, PSYCHOL BULL, V119, P197, DOI 10.1037/0033-2909.119.2.197; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Coutinho S., 2004, COLL STUD J, V38, P203; Dang JH, 2015, SCAND J PSYCHOL, V56, P223, DOI 10.1111/sjop.12184; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; Diefendorff JM, 2000, J APPL PSYCHOL, V85, P250, DOI 10.1037/0021-9010.85.2.250; Duckworth AL, 2015, EDUC RESEARCHER, V44, P237, DOI 10.3102/0013189X15584327; Duckworth AL, 2015, CHILD DEV PERSPECT, V9, P32, DOI 10.1111/cdep.12107; Duckworth AL, 2011, J RES PERS, V45, P259, DOI 10.1016/j.jrp.2011.02.004; Evans DE, 2007, J RES PERS, V41, P868, DOI 10.1016/j.jrp.2006.11.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fischer R, 2015, J PERS, V83, P575, DOI 10.1111/jopy.12140; Fleischhauer M, 2014, J RES PERS, V48, P45, DOI 10.1016/j.jrp.2013.09.007; Fleischhauer M, 2010, PERS SOC PSYCHOL B, V36, P82, DOI 10.1177/0146167209351886; Fujita K, 2011, PERS SOC PSYCHOL REV, V15, P352, DOI 10.1177/1088868311411165; Grass J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00790; Gropel P, 2014, PERS SOC PSYCHOL B, V40, P476, DOI 10.1177/0146167213516636; Hill BD, 2016, PERS INDIV DIFFER, V98, P225, DOI 10.1016/j.paid.2016.04.043; Hill BD, 2013, J RES PERS, V47, P22, DOI 10.1016/j.jrp.2012.11.001; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Inzlicht M, 2015, SOC PERSONAL PSYCHOL, V9, P511, DOI 10.1111/spc3.12200; Inzlicht M, 2014, TRENDS COGN SCI, V18, P127, DOI 10.1016/j.tics.2013.12.009; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Jerusalem M., 1999, SKALEN ERFASSUNG LEH; Jostmann NB, 2007, J EXP PSYCHOL GEN, V136, P593, DOI 10.1037/0096-3445.136.4.593; Kirwan G, 2014, CYBERPSYCHOLOGY AND NEW MEDIA: A THEMATIC READER, P3; Kline R. B., 2005, PRINCIPLES PRACTICE; Kool W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072626; Kool W, 2014, J EXP PSYCHOL GEN, V143, P131, DOI 10.1037/a0031048; Kotabe HP, 2015, PERSPECT PSYCHOL SCI, V10, P618, DOI 10.1177/1745691615593382; Kuhl J., 1994, VOLITION PERSONALITY, P47; Kuhl J., 2000, HDB SELF REGULATION, P111, DOI [DOI 10.1016/B978-012109890-2/50034-2, 10.1016/B978-012109890-2/50034-2]; Kuhl J., 2008, MOTIVATION ACTION, P296, DOI [10.1017/CBO9780511499821, DOI 10.1017/CBO9780511499821]; Kurzban R, 2013, BEHAV BRAIN SCI, V36, P661, DOI 10.1017/S0140525X12003196; LimeSurvey GmbH, 2015, LIMESURVEY OP SOURV; Little TD, 2006, STRUCT EQU MODELING, V13, P59, DOI 10.1207/s15328007sem1301_3; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Mischel W, 2011, SOC COGN AFFECT NEUR, V6, P252, DOI 10.1093/scan/nsq081; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Mussel P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29245; Mussel P, 2013, J PERS SOC PSYCHOL, V104, P885, DOI 10.1037/a0031918; Nishiguchi Y, 2016, PSYCHIAT RES, V241, P8, DOI 10.1016/j.psychres.2016.04.092; Rammstedt B, 2005, DIAGNOSTICA, V51, P195, DOI 10.1026/0012-1924.51.4.195; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; SATORRA A, 1985, PSYCHOMETRIKA, V50, P83, DOI 10.1007/BF02294150; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Strobel A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01861; Strobel A, 2015, J RES PERS, V55, P10, DOI 10.1016/j.jrp.2014.11.002; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; von Stumm S, 2013, PSYCHOL BULL, V139, P841, DOI 10.1037/a0030746; Watts TW, 2018, PSYCHOL SCI, V29, P1159, DOI 10.1177/0956797618761661; Westbrook A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068210; Wiltink J, 2006, GMS PSYCHOSOCIAL MED, V3; Wolff M, 2016, J EXP PSYCHOL GEN, V145, P1635, DOI 10.1037/xge0000229	69	8	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220282	10.1371/journal.pone.0220282	http://dx.doi.org/10.1371/journal.pone.0220282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369611	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900040
J	Khachatryan, N; Pistilli, M; Maguire, MG; Salowe, RJ; Fertig, RM; Moore, T; Gudiseva, HV; Chavali, VRM; Collins, DW; Daniel, E; Murphy, W; Henderer, JD; Lehman, A; Cui, Q; Addis, V; Sankar, PS; Miller-Ellis, EG; O'Brien, JM				Khachatryan, Naira; Pistilli, Maxwell; Maguire, Maureen G.; Salowe, Rebecca J.; Fertig, Raymond M.; Moore, Tanisha; Gudiseva, Harini, V; Chavali, Venkata R. M.; Collins, David W.; Daniel, Ebenezer; Murphy, Windell; Henderer, Jeffrey D.; Lehman, Amanda; Cui, Qi; Addis, Victoria; Sankar, Prithvi S.; Miller-Ellis, Eydie G.; O'Brien, Joan M.			Primary Open-Angle African American Glaucoma Genetics (POAAGG) Study: gender and risk of POAG in African Americans	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; REFRACTIVE ERROR; BLOOD-PRESSURE; PREVALENCE; EYE; ASSOCIATIONS; PREDICTORS; MENOPAUSE; INDEX	The purpose of this study was to investigate the association between gender and primary open-angle glaucoma (POAG) among African Americans and to assess demographic, systemic, and behavioral factors that may contribute to differences between genders. The Primary Open-Angle African American Glaucoma Genetics (POAAGG) study had a case-control design and included African Americans 35 years and older, recruited from the greater Philadelphia, Pennsylvania. Diagnosis of POAG was based on evidence of both glaucomatous optic nerve damage and characteristic visual field loss. Demographic and behavioral information, history of systemic diseases and anthropometric measurements were obtained at study enrollment. Gender differences in risk of POAG were examined using multivariate logistic regression. A total of 2,290 POAG cases and 2,538 controls were included in the study. The percentage of men among cases was higher than among controls (38.6% vs 30.3%, P<0.001). The subjects' mean age at enrollment was significantly higher for cases compared to controls (70.2 +/- 11.3 vs. 61.6 +/- 11.8 years, P<0.003). Cases had lower rates of diabetes (40% vs. 46%, P<0.001), higher rates of systemic hypertension (80% vs. 72%, P<0.001), and lower body mass index (BMI) (29.7 +/- 6.7 vs. 31.9 +/- 7.4, P<0.001) than controls. In the final multivariable model, male gender was significantly associated with POAG risk (OR, 1.64; 95% CI, 1.44-1.87; P<0.001), after adjusting for age, systemic hypertension, diabetes, and BMI. Within the POAAGG study, men were at higher risk of having POAG than women. Pending genetic results from this study will be used to better understand the underlying genetic variations that may account for these differences.	[Khachatryan, Naira; Pistilli, Maxwell; Maguire, Maureen G.; Salowe, Rebecca J.; Fertig, Raymond M.; Moore, Tanisha; Gudiseva, Harini, V; Chavali, Venkata R. M.; Collins, David W.; Daniel, Ebenezer; Lehman, Amanda; Cui, Qi; Addis, Victoria; Sankar, Prithvi S.; Miller-Ellis, Eydie G.; O'Brien, Joan M.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Henderer, Jeffrey D.] Temple Univ, Dept Ophthalmol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	O'Brien, JM (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.	joan.obrien@uphs.upenn.edu	Cui, Qi/AAU-7327-2020; Cui, Qi/AAQ-7761-2021	Cui, Qi/0000-0002-5338-0401	National Eye Institute, Bethesda, Maryland [1RO1EY023557-01]; Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Vision Research Core Grant [P30 EY001583]; F.M. Kirby Foundation; Research to Prevent Blindness; UPenn Hospital Board of Women Visitors; Paul and Evanina Bell Mackall Foundation Trust; National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM; National Eye Institute, National Institutes of Health, Department of Health and Human Services [HHSN260220700001C, HHSN263201200001C]; NATIONAL EYE INSTITUTE [R01EY023557, P30EY001583, K12EY015398] Funding Source: NIH RePORTER	National Eye Institute, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Vision Research Core Grant; F.M. Kirby Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); UPenn Hospital Board of Women Visitors; Paul and Evanina Bell Mackall Foundation Trust; National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM; National Eye Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, Bethesda, Maryland (grant 1RO1EY023557-01) and the Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA. Funds also come from the Vision Research Core Grant (P30 EY001583), F.M. Kirby Foundation, Research to Prevent Blindness, The UPenn Hospital Board of Women Visitors, The Paul and Evanina Bell Mackall Foundation Trust, and the National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM and contract Nos. HHSN260220700001C and HHSN263201200001C. The sponsor or funding organization had no role in the design or conduct of this research.	BULPITT CJ, 1975, BRIT J OPHTHALMOL, V59, P717, DOI 10.1136/bjo.59.12.717; Chan MPY, 2016, OPHTHALMOLOGY, V123, P771, DOI 10.1016/j.ophtha.2015.11.031; Charlson ES, 2015, OPHTHALMOLOGY, V122, P711, DOI 10.1016/j.ophtha.2014.11.015; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Doshi V, 2008, OPHTHALMOLOGY, V115, P639, DOI 10.1016/j.ophtha.2007.05.032; Foster PJ, 2010, BRIT J OPHTHALMOL, V94, P827, DOI 10.1136/bjo.2009.163899; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Gupta P, 2016, INVEST OPHTH VIS SCI, V57, P2905, DOI 10.1167/iovs.15-18469; Henderson KD, 2008, AM J EPIDEMIOL, V167, P1287, DOI 10.1093/aje/kwn046; Hulsman CAA, 2001, AM J EPIDEMIOL, V154, P138, DOI 10.1093/aje/154.2.138; Hulsman CAA, 2007, ARCH OPHTHALMOL-CHIC, V125, P805, DOI 10.1001/archopht.125.6.805; KAHN HA, 1977, AM J EPIDEMIOL, V106, P33, DOI 10.1093/oxfordjournals.aje.a112429; Kaimbo DKW, 2001, J CLIN EPIDEMIOL, V54, P166, DOI 10.1016/S0895-4356(00)00291-2; Kaimbo Wa Kaimbo D, 1997, Bull Soc Belge Ophtalmol, V267, P29; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813, DOI 10.1093/oxfordjournals.aje.a117078; Khawaja AP, 2013, INVEST OPHTH VIS SCI, V54, P5028, DOI 10.1167/iovs.13-11971; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; McKnight KK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.014; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Mitchell P, 2004, J GLAUCOMA, V13, P319, DOI 10.1097/00061198-200408000-00010; Omoti AE, 2009, MIDDLE EAST AFR J OP, V16, P146, DOI 10.4103/0974-9233.56229; Parikh R, 2017, ETHN HLTH, P1; Pasquale LR, 2007, J GLAUCOMA, V16, P598, DOI 10.1097/IJG.0b013e318064c82d; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Schmidl D, 2015, CURR EYE RES, V40, P201, DOI 10.3109/02713683.2014.906625; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Vajaranant TS, 2012, MENOPAUSE, V19, P942, DOI 10.1097/gme.0b013e3182443137; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068, DOI 10.1001/archopht.1994.01090200074026; Viana LC, 2011, ARCH GYNECOL OBSTET, V283, P569, DOI 10.1007/s00404-010-1403-7; Weih LM, 2001, OPHTHALMOLOGY, V108, P1966, DOI 10.1016/S0161-6420(01)00799-0; ZANG EA, 1994, NUTR CANCER, V21, P247, DOI 10.1080/01635589409514323; Zetterberg M, 2016, MATURITAS, V83, P19, DOI 10.1016/j.maturitas.2015.10.005	38	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218804	10.1371/journal.pone.0218804	http://dx.doi.org/10.1371/journal.pone.0218804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369581	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900011
J	Veyron, JH; Friocourt, P; Jeanjean, O; Luquel, L; Bonifas, N; Denis, F; Belmin, J				Veyron, Jacques-Henri; Friocourt, Patrick; Jeanjean, Olivier; Luquel, Laurence; Bonifas, Nicolas; Denis, Fabrice; Belmin, Joel			Home care aides' observations and machine learning algorithms for the prediction of visits to emergency departments by older community-dwelling individuals receiving home care assistance: A proof of concept study	PLOS ONE			English	Article							TRENDS; MODEL; RISK	Background Older individuals receiving home assistance are at high risk for emergency visits and unplanned hospitalization. Anticipating their health difficulties could prevent these events. This study investigated the effectiveness of an at-home monitoring method using social workers' observations to predict risk for 7- and 14-day emergency department (ED) visits. Methods This was a prospective cohort study of persons. 75 years, living at home and receiving assistance from home care aides (HCA) at 6 French facilities. After each home visit, HCAs reported on participants' functional status using a smartphone application that recorded 27 functional items about each participant (e.g., ability to stand, move, eat, mood, loneliness). We recorded ED visits. Finally, we used machine learning techniques (i.e., leveraging random forest predictors) to develop a 7-and 14-day predictive algorithm for the risk of ED visit. Results The study included 301 participants, and the HCA made 9,987 observations. Over the mean 10-month follow-up, 97 participants (32%) had at least one ED visit. Modeling techniques identified 9 contributory factors from the longitudinal records of the HCA and developed a predictive algorithm for the risk of ED visit. The predictive performance (i.e., the area under the ROC curve) was 0.70 at 7 days and 0.67 at 14 days. Interpretation For frail elders receiving in-home care, information on functional status collected by HCA helps predict the risk of ED visits 7 to 14 days in advance. A survey system for real-time identification of risks could be developed using this exploratory work.	[Veyron, Jacques-Henri] ANAP, Paris, France; [Friocourt, Patrick] Hop Simone Veil, Serv Med Interne Geriatr, Blois, France; [Jeanjean, Olivier] Grp Hosp Nord Essonne, Soins Palliatifs, Pole Geriatrie, SSR, Longjumeau, France; [Luquel, Laurence] Hop Prive Geriatr Magnolias, Ballainvilliers, France; [Bonifas, Nicolas] Ecole Polytech, Palaiseau, France; [Denis, Fabrice] Inst Interreg Cancerol Jean Bernard, Le Mans, France; [Belmin, Joel] Hop Charles Foix, AP HP, Ivry, France; [Belmin, Joel] Sorbonne Univ, Paris, France	Institut Polytechnique de Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Veyron, JH (corresponding author), ANAP, Paris, France.	Jacques-Henri.veyron@anap.fr	Belmin, Joel/V-9995-2019; Belmin, Joël/Q-3914-2017	Belmin, Joel/0000-0003-1630-9582; Belmin, Joël/0000-0003-1630-9582				Adams JG, 2013, JAMA-J AM MED ASSOC, V309, P1173, DOI 10.1001/jama.2013.2476; Basch E, 2017, JAMA-J AM MED ASSOC, V318, P197, DOI 10.1001/jama.2017.7156; Belmin J, 2007, AGE AGEING, V36, P298, DOI 10.1093/ageing/afm026; Crane SJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-338; de Gelder J, 2018, J AM GERIATR SOC, V66, P735, DOI 10.1111/jgs.15301; Denis F, 2019, JAMA-J AM MED ASSOC, V321, P306, DOI 10.1001/jama.2018.18085; Duong HV, 2018, PREHOSP EMERG CARE, V22, P7, DOI 10.1080/10903127.2017.1347223; Gasperini B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189925; Hao SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112944; Hartig MT, 1997, J GERONTOL A-BIOL, V52, pM142, DOI 10.1093/gerona/52A.3.M142; Horng S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174708; Hu ZK, 2015, INTERACT J MED RES, V4, P39, DOI 10.2196/ijmr.4022; Hwang U, 2007, J AM GERIATR SOC, V55, P1873, DOI 10.1111/j.1532-5415.2007.01400.x; Jin B, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0074-5; Jones A, 2018, CAN MED ASSOC J, V190, pE525, DOI 10.1503/cmaj.170892; Kahn JH, 2016, EMERG MED CLIN N AM, V34, P435, DOI 10.1016/j.emc.2016.04.014; Nair NP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165757; Pishgoo B, 2011, J RES MED SCI, V16, P262; Shelton P, 2000, AM J MANAG CARE, V6, P925; Takahashi PY, 2016, AM J MANAG CARE, V22, P475; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; Thome B, 2003, J CLIN NURS, V12, P860, DOI 10.1046/j.1365-2702.2003.00803.x; Uscher-Pines L, 2013, AM J MANAG CARE, V19, P47; Wolinsky FD, 2008, J GERONTOL A-BIOL, V63, P204, DOI 10.1093/gerona/63.2.204; Wong A, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1018	25	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220002	10.1371/journal.pone.0220002	http://dx.doi.org/10.1371/journal.pone.0220002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408458	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500006
J	Chu, G; Suthers, B; Moores, L; Paech, GM; Hensley, MJ; McDonald, VM; Choi, P				Chu, Ginger; Suthers, Belinda; Moores, Luke; Paech, Gemma M.; Hensley, Michael J.; McDonald, Vanessa M.; Choi, Peter			Risk factors of sleep-disordered breathing in haemodialysis patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; DAYTIME SLEEPINESS; APNEA; PREVALENCE	Background Sleep-disordered breathing (SDB) is common in patients with kidney disease; but often underdiagnosed as it is infrequently assessed in clinical practice. The objective of this study was to assess the risk factors of SDB in haemodialysis patients, and to identify useful assessment tools to detect SDB in this population. Methods We used nocturnal oximetry, Epworth Sleepiness Scale (ESS) and STOPBANG questionnaire to screen for SDB in haemodialysis patients. Presence of SDB was defined by Oxygen desaturation index (ODI >= 5/h), and further confirmed by apnoea-hypopnea index (AHI) from an in-laboratory polysomnography. Blood samples were collected prior to commencing a haemodialysis treatment. Results SDB was detected in 70% of participants (N = 107, mean age 67 years). STOPBANG revealed that 89% of participants were at risk of SDB; however, only 17% reported daytime sleepiness on the ESS. Of the participants who underwent polysomnography (n = 36), obstructive sleep apnoea was identified in 86%, and median AHI was 34.5/h. Oximetry and AHI results were positively correlated (r = 0.62, P = 0.0001), as were oximetry and STOPBANG (r = 0.48; P<0.0001), but not ESS (r = 0.19; P = 0.08). Multivariate analysis showed that neck circumference (OR: 1.20; 95% CI: 1.07-1.34; P = 0.02) and haemoglobin (OR: 0.93; 95% CI: 0.88-0.97; P = 0.003) were independently associated with the presence of SDB. Conclusion Dialysis patients with a large neck circumference and anaemia are at risk of SDB; using nocturnal oximetry is practical and reliable to screen for SDB and should be considered in routine management of dialysis patients, particularly for those who demonstrate risk factors.	[Chu, Ginger; Choi, Peter] Hunter New England Local Hlth Dist, Dept Nephrol, John Hunter Hosp, Med & Intervent Serv, New Lambton, NSW, Australia; [Chu, Ginger; McDonald, Vanessa M.] Univ Newcastle, Sch Nursing & Midwifery, Callaghan, NSW, Australia; [Chu, Ginger] Hunter New England Local Hlth Dist, Res Innovat & Partnerships, New Lambton, NSW, Australia; [Chu, Ginger; Suthers, Belinda; Hensley, Michael J.; McDonald, Vanessa M.] Univ Newcastle, Prior Res Ctr Hlth Lungs, Callaghan, NSW, Australia; [Suthers, Belinda; Paech, Gemma M.; Hensley, Michael J.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Suthers, Belinda; Moores, Luke; Paech, Gemma M.; Hensley, Michael J.; McDonald, Vanessa M.] Hunter New England Local Hlth Dist, Dept Resp & Sleep Med, Med & Intervent Serv, John Hunter Hosp, New Lambton, NSW, Australia	John Hunter Hospital; University of Newcastle; University of Newcastle; University of Newcastle; John Hunter Hospital	Chu, G (corresponding author), Hunter New England Local Hlth Dist, Dept Nephrol, John Hunter Hosp, Med & Intervent Serv, New Lambton, NSW, Australia.; Chu, G (corresponding author), Univ Newcastle, Sch Nursing & Midwifery, Callaghan, NSW, Australia.; Chu, G (corresponding author), Hunter New England Local Hlth Dist, Res Innovat & Partnerships, New Lambton, NSW, Australia.; Chu, G (corresponding author), Univ Newcastle, Prior Res Ctr Hlth Lungs, Callaghan, NSW, Australia.	ginger.chu@health.nsw.gov.au	MCDONALD, VANESSA/AAQ-1845-2020; Suthers, Belinda/ABC-2892-2021	MCDONALD, VANESSA/0000-0001-9890-3408; Suthers, Belinda/0000-0002-4606-972X; Paech, Gemma/0000-0002-1969-5215; Chu, Ginger/0000-0001-7096-0144	Hunter New England Local Health District; Baxter Healthcare Graham Burnley Memorial Scholarship	Hunter New England Local Health District; Baxter Healthcare Graham Burnley Memorial Scholarship	This study was supported by grant support received from Hunter New England Local Health District and the Baxter Healthcare Graham Burnley Memorial Scholarship. Ginger Chu is the author who received these awards. We declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuyassin B, 2015, J CLIN SLEEP MED, V11, P915, DOI 10.5664/jcsm.4946; Ahmad S, 2013, N AM J MED SCI, V5, P641, DOI [10.4103/1947-2714.122306, 10.4103/1947-2714.117328]; Al-Jahdali H, 2012, SAUDI J KIDNEY DIS T, V23, P251; [Anonymous], 2017, 39TH REPORT CHAPTER; Beecroft JM, 2007, EUR RESPIR J, V30, P965, DOI 10.1183/09031936.00161906; Berry RB, 2017, J CLIN SLEEP MED, V13, P665, DOI 10.5664/jcsm.6576; Bhat S, 2016, SLEEP BREATH, V20, P1347, DOI 10.1007/s11325-016-1370-8; Chan GCW, 2016, NEPHROL DIAL TRANSPL, V31, P772, DOI 10.1093/ndt/gfv306; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; Douglas JA, 2017, SLEEP MED, V36, pS2, DOI 10.1016/j.sleep.2017.03.019; Ezzat H, 2015, RENAL FAILURE, V37, P1013, DOI 10.3109/0886022X.2015.1044401; Hang LW, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0017-z; Huang HC, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0544-3; Jhamb M, 2009, CLIN J AM SOC NEPHRO, V4, P1779, DOI 10.2215/CJN.00190109; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Lyons OD, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01789-2016; Murtagh FEM, 2007, J PALLIAT MED, V10, P1266, DOI 10.1089/jpm.2007.0017; Nicholl DDM, 2013, J CLIN SLEEP MED, V9, P31, DOI 10.5664/jcsm.2334; Ogna VF, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/103686; Roumelioti ME, 2011, CLIN J AM SOC NEPHRO, V6, P986, DOI 10.2215/CJN.05720710; Senaratna CV, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3703-8; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Shrivastava D, 2014, J COMMUNITY HOSP INT, V4, DOI 10.3402/jchimp.v4.24983; Tada T, 2007, NEPHROL DIAL TRANSPL, V22, P1190, DOI 10.1093/ndt/gfl748; Tang SCW, 2010, KIDNEY INT, V77, P1031, DOI 10.1038/ki.2010.76; Unruh ML, 2006, CLIN J AM SOC NEPHRO, V1, P802, DOI 10.2215/CJN.00710206; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Wali SO, 2015, ANN THORAC MED, V10, P263, DOI 10.4103/1817-1737.164300	29	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220932	10.1371/journal.pone.0220932	http://dx.doi.org/10.1371/journal.pone.0220932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404113	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800043
J	Wande, DP; Sangeda, RZ; Tibalinda, P; Mutta, IK; Mkumbwa, S; Bitegeko, A; Kaale, E				Wande, Dickson Pius; Sangeda, Raphael Zozimus; Tibalinda, Prosper; Mutta, Innocent Kairuki; Mkumbwa, Sonia; Bitegeko, Adonis; Kaale, Eliangiringa			Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021	PLOS ONE			English	Article								Background To assess the extent to which foreign pharmaceutical imports vary from year to year and identifying leading generic and branded formulations, key countries and key importers of pharmaceuticals in private sector supply chain. Methodology A systematic analysis of data for pharmaceutical imports from the Ministry of Health. Data from 2013 to 2016 fiscal years and relevant documents were accessed from the Tanzania Food and Drugs Authority (TFDA). Data cleaning was carried out to remove duplicate entries and to exclude pharmaceutical imports for individual uses, promotion purpose, donations, raw material, medical devices, government institutions and veterinary products. Results A total of 397 different suppliers imported pharmaceutical in Tanzania mainland from 2013 to 2016 fiscal years. In the 2013-2014 fiscal year, the private sector suppliers imported pharmaceutical worth 216 U.S million dollars. India ranked as the first country for exporting highest value of pharmaceutical into the country. It displays a 54% cumulative market share of total imports from 2013-2016, followed by Egypt (11.7%), Switzerland and the USA hold 4.1% of cumulative market share. By 2020-2021 fiscal years, we forecast for imported pharmaceuticals to reach a total value of 906 U.S million dollars for the private sector supply chain. All analysis in this study and the forecasted figures are limited to private sector pharmaceutical supply chain only and does not include data for government pharmaceutical supply chain. Conclusions Our result shows that the vast majority of pharmaceutical imports in the private sector supply chain are dominated by imports from India. India is competing with other countries such as Egypt, Switzerland, USA and South Africa among the top importing countries. There was almost an equal distribution of pharmaceutical for both communicable and non-communicable diseases. Data presented shows a growing trend for the market segment for medicines required for the management of non-communicable diseases. Generally, the private sector pharmaceutical market is keeping on rising at a rapid pace. By the year 2021, the growth is forecasted to increase by 28% compared to the current market value. The projected growth rate could be good news for foreign pharmaceutical companies seeking new sources of growth in international pharmaceutical trading. It is also good news to the poor patients if the availability of drugs previously unavailable in the country is significantly increased.	[Wande, Dickson Pius] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Pharmaceut & Pharm Practice, Dar Es Salaam, Tanzania; [Sangeda, Raphael Zozimus] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Pharmaceut Microbiol, Dar Es Salaam, Tanzania; [Tibalinda, Prosper; Kaale, Eliangiringa] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Pharmaceut R&D Lab, Dar Es Salaam, Tanzania; [Mutta, Innocent Kairuki] Hubert Kairuki Mem Univ, Dar Es Salaam, Tanzania; [Mkumbwa, Sonia; Bitegeko, Adonis] Minist Hlth, Tanzania Food & Drugs Author, Dar Es Salaam, Tanzania; [Kaale, Eliangiringa] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Med Chem, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Kaale, E (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Pharmaceut R&D Lab, Dar Es Salaam, Tanzania.; Kaale, E (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dept Med Chem, Dar Es Salaam, Tanzania.	elia.kaale@gmail.com	Kaale, Eliangiringa/AAC-8561-2019; Sangeda, Raphael Zozimus/V-6624-2018	Kaale, Eliangiringa/0000-0001-6008-3539; Sangeda, Raphael Zozimus/0000-0002-6574-5308; Wande, Dickson Pius/0000-0002-1788-3650				Alba S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-163; BOT, 2018, IND FOR EXCH MARK RA; Business Monitor International Ltd, 2016, TANZ PHARM HLTH REP, VQ3; CDC, GLOB HLTH TANZ; EAC, 2014, 2 E AFRIC COMM EAC R; Embrey M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164332; Ewen M, 2017, J Pharm Policy Pract, V10, P7, DOI 10.1186/s40545-016-0095-1; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Kaale E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165785; Kagashe LF G A, 2004, TANZANIA MED J, V19; Kengne AP, 2017, INT J EPIDEMIOL, V46, P1421, DOI 10.1093/ije/dyx078; Lee B., 2018, ANAL GOVT TANZANIAS; Losse K., 2007, VIABILITY LOCAL PHAR; Marty Francisco, 2002, Expert Opin Pharmacother, V3, P91; Mhamba RM, 2010, PHARM IND ACCESS ESS; MoHSW, 2006, NATL MED POLICY NMP; Mushi MF, 2017, TANZAN J HLTH RES, V19, P1; Mziray S, 2017, PHARM REGUL AFF, V6, P1, DOI 10.4172/2167-7689.1000191; NANRA RS, 1980, MED J AUSTRALIA, V1, P486, DOI 10.5694/j.1326-5377.1980.tb135047.x; Ogbera AO, 2014, WORLD J DIABETES, V5, P905, DOI 10.4239/wjd.v5.i6.905; Opiyo N, 2016, COCHRANE DATABASE SY; Ozioko Calistus, 2017, SOLID DOSAGE FORMS T; Rehman HA-U, 2011, PHARM DEV WORLD INDI; Sabot OJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006857; Samarasekera U, 2008, LANCET, V371, P1403, DOI 10.1016/S0140-6736(08)60611-X; Sikika, 2018, HLTH SECT BUDG AN FI; Simba Daudi, 2012, Tanzan J Health Res, V14, P89; Spyros G, 1998, FORECASTING METHODS; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122638; STEWART JH, 1976, AUST NZ J MED, V6, P498, DOI 10.1111/j.1445-5994.1976.tb03045.x; Tibandebage P., 2016, MAKING MED AFRICA PO, P45; UNAIDS, 2016, HIV AIDS TANZ; UNDP, 2016, LOC PROD PHARM CAN P; WHO, 2006, NAT GUID DIAGN TREAT, P105; WHO, 1990, AN THER CHEM CLASS S; WHO, 2015, UNIT REP TANZ WHO ST; Wilson R, 2012, SHAKESPEARE, V8, P1, DOI 10.1080/17450918.2012.660280; World Health Organization, 2010, GLOBAL STATUS REPORT, P176; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	39	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220701	10.1371/journal.pone.0220701	http://dx.doi.org/10.1371/journal.pone.0220701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404109	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800025
J	Yatsuoka, W; Ueno, T; Miyano, K; Uezono, Y; Enomoto, A; Kaneko, M; Ota, S; Soga, T; Sugimoto, M; Ushijima, T				Yatsuoka, Wakako; Ueno, Takao; Miyano, Kanako; Uezono, Yasuhito; Enomoto, Ayame; Kaneko, Miku; Ota, Sana; Soga, Tomoyoshi; Sugimoto, Masahiro; Ushijima, Toshikazu			Metabolomic profiling reveals salivary hypotaurine as a potential early detection marker for medication-related osteonecrosis of the jaw	PLOS ONE			English	Article							BISPHOSPHONATE-RELATED OSTEONECROSIS; SURGEONS POSITION PAPER; AMERICAN ASSOCIATION; RISK-FACTORS; MANAGEMENT; PROPOSAL; TAURINE	Medication-related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse event of bone-modifying agents used to prevent bone complications in cancer patients with bone metastasis. Currently, early treatment is the only way to prevent further progression, as the pathogenesis of MRONJ has not yet been elucidated, and a standard treatment has not been established. The aim of this study was to identify a marker for early detection marker of MRONJ by exploring substances in saliva specific to MRONJ at an early stage. We collected salivary samples from 17 patients with MRONJ and conducted metabolomic analyses using capillary electrophoresis mass spectrometry for non-targeted analysis of hydrophilic metabolites. In the screening cohort, we compared the saliva of patients with stage >= 1 advanced MRONJ (n = 9) with that of controls without MRONJ before chemotherapy (n = 9). The top 5 most elevated salivary metabolites were histamine, 3-(4-hydroxyphenyl)propionate, malonate, carnosine, and hypotaurine. In the validation cohort, we analyzed additional patients with stage >= 1 advanced MRONJ (n = 8) and controls without MRONJ after chemotherapy (n = 9), confirming a significant 2.28-fold elevation in the salivary concentration of hypotaurine. These results revealed elevated salivary hypotaurine concentration as a potential marker for the early detection of MRONJ.	[Yatsuoka, Wakako; Ueno, Takao] Natl Canc Ctr Hosp, Dent Div, Chuo Ku, Tsukiji, Japan; [Yatsuoka, Wakako; Ushijima, Toshikazu] Juntendo Univ, Grad Sch Med, Course Adv Clin Res Canc, Bunkyo Ku, Tokyo, Japan; [Miyano, Kanako; Uezono, Yasuhito] Natl Canc Ctr, Div Canc Pathophysiol, Res Inst, Chuo Ku, Tsukiji, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Div Support Care Res, Exploratory Oncol Res & Clin Trial Ctr, Chuo Ku, Tsukiji, Japan; [Uezono, Yasuhito] Natl Canc Ctr Hosp, Innovat Ctr Support Palliat & Psychosocial Care, Chuo Ku, Tsukiji, Japan; [Enomoto, Ayame; Kaneko, Miku; Ota, Sana; Soga, Tomoyoshi; Sugimoto, Masahiro] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Sugimoto, Masahiro] Tokyo Med Univ, Res & Dev Ctr Minimally Invas Therapies Hlth Prom, Shinjuku Ku, Tokyo, Japan; [Ushijima, Toshikazu] Natl Canc Ctr, Div Epigen, Res Inst, Chuo Ku, Tsukiji, Japan	National Cancer Center - Japan; Juntendo University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Keio University; Tokyo Medical University; National Cancer Center - Japan	Yatsuoka, W (corresponding author), Natl Canc Ctr Hosp, Dent Div, Chuo Ku, Tsukiji, Japan.; Yatsuoka, W (corresponding author), Juntendo Univ, Grad Sch Med, Course Adv Clin Res Canc, Bunkyo Ku, Tokyo, Japan.	wyatsuok@ncc.go.jp	Ushijima, Toshikazu/AAP-5742-2021	Ushijima, Toshikazu/0000-0003-3405-7817; Miyano, Kanako/0000-0003-1673-6074; Sugimoto, Masahiro/0000-0003-3316-2543	JSPS KAKENHI, Japanese Society for Palliative Medicine [JP17K11867]; Yamagata Prefectural Government	JSPS KAKENHI, Japanese Society for Palliative Medicine; Yamagata Prefectural Government	This work was supported by the JSPS KAKENHI Grant Number JP17K11867, Grant for Research Advancement on Palliative Medicine, Japanese Society for Palliative Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the research funds from Yamagata Prefectural Government and Tsuruoka City, Japan, JSPS KAKENHI Grant Number JP17K11867, Grant for Research Advancement on Palliative Medicine, Japanese Society for Palliative Medicine.	Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; ARUOMA OI, 1988, BIOCHEM J, V256, P251, DOI 10.1042/bj2560251; Bedogni A, 2012, ORAL DIS, V18, P621, DOI 10.1111/j.1601-0825.2012.01903.x; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Falus A, 2003, ACTA BIOL HUNG, V54, P27, DOI 10.1556/ABiol.54.2003.1.3; Fedele S, 2010, AM J MED, V123, P1060, DOI 10.1016/j.amjmed.2010.04.033; Ficarra G, 2005, J CLIN PERIODONTOL, V32, P1123, DOI 10.1111/j.1600-051X.2005.00842.x; Fleisher KE, 2010, ORAL SURG ORAL MED O, V110, P509, DOI 10.1016/j.tripleo.2010.04.023; Fliefel R, 2015, INT J ORAL MAX SURG, V44, P568, DOI 10.1016/j.ijom.2015.01.026; Fu X, 2016, FEBS LETT, V590, P22, DOI 10.1002/1873-3468.12049; GREEN TR, 1991, BIOCHIM BIOPHYS ACTA, V1073, P91, DOI 10.1016/0304-4165(91)90187-L; Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/jbmr.080205, 10.1359/JBMR.080205]; Hosseini E, 2011, NUTR REV, V69, P245, DOI 10.1111/j.1753-4887.2011.00388.x; Ishikawa S, 2017, AMINO ACIDS, V49, P761, DOI 10.1007/s00726-017-2378-5; Ishikawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31520; Kageyama G, 2015, CLIN EXP IMMUNOL, V182, P149, DOI 10.1111/cei.12683; Kawanishi N, 2019, CLIN CHIM ACTA, V489, P41, DOI 10.1016/j.cca.2018.11.030; Kitajima S, 2018, INTERNAL MED, V57, P3341, DOI 10.2169/internalmedicine.0643-17; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Li Y, 2004, CLIN CANCER RES, V10, P8442, DOI 10.1158/1078-0432.CCR-04-1167; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Nishimura T, 2015, PLACENTA, V36, P693, DOI 10.1016/j.placenta.2015.02.014; O'Ryan FS, 2009, J ORAL MAXIL SURG, V67, P1363, DOI 10.1016/j.joms.2009.03.005; Ohshima M, 2017, ONCOL REP, V37, P2727, DOI 10.3892/or.2017.5561; Otto S, 2015, J BONE MINER RES, V30, P1113, DOI 10.1002/jbmr.2525; Ozeki Miho, 2016, Mass Spectrom (Tokyo), V5, pA0047, DOI 10.5702/massspectrometry.A0047; Ra SG, 2014, APPL PHYSIOL NUTR ME, V39, P1120, DOI 10.1139/apnm-2013-0546; Ruggiero SL, 2014, J ORAL MAXIL SURG, V72, P1938, DOI 10.1016/j.joms.2014.04.031; Ruggiero SL, 2009, J ORAL MAXIL SURG, V67, P2, DOI 10.1016/j.joms.2009.01.009; Ruggiero SL, 2004, J ORAL MAXIL SURG, V62, P527, DOI 10.1016/j.joms.2004.02.004; Schiodt M, 2014, OR SURG OR MED OR PA, V117, P204, DOI 10.1016/j.oooo.2013.10.010; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sugimoto M, 2013, METABOLOMICS, V9, P454, DOI 10.1007/s11306-012-0464-y; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tomita A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30482-x; Yamamoto Y, 2018, J NUCL MED, V59	37	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220712	10.1371/journal.pone.0220712	http://dx.doi.org/10.1371/journal.pone.0220712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404085	Green Submitted, gold, Green Published			2022-12-27	WOS:000485006800026
J	Essayagh, T; Essayagh, M; El Rhaffouli, A; Khouchoua, M; Kazadi, GB; Khattabi, A; Essayagh, S				Essayagh, Touria; Essayagh, Meriem; El Rhaffouli, Abderrahmane; Khouchoua, Mohammed; Kazadi, Germain Bukassa; Khattabi, Asmae; Essayagh, Sanah			Prevalence of uncontrolled blood pressure in Meknes, Morocco, and its associated risk factors in 2017	PLOS ONE			English	Article							HYPERTENSIVE PATIENTS; MANAGEMENT; ALGERIA; BURDEN; ADULTS	Background Uncontrolled high blood pressure (UBP) can lead to various cardiovascular complications causing an estimated nine million deaths per year worldwide. In Meknes, epidemiologic data on UBP are scarce, depriving programs from evidence-based information that would allow a better management of hypertension. Hence, we aimed to assess UBP prevalence in hypertensive patients treated in Meknes and identify UBP-associated risk factors. Methods Between November and December 2017, we conducted a cross-sectional study enrolling 922 hypertensive patients managed at Meknes's primary health care facilities using the multistage sampling method. We interviewed patients face to face to collect their socio-demographic-characteristics, lifestyle behaviours, clinical parameters and the triad care system patient -physician. Another questionnaire was self-administered by physicians to characterize therapeutic inertia. A multivariate logistic regression analysis highlighted the risk factors associated with UBP. Results UBP prevalence was 73% with a mean age of 61 +/- 11 years (mean +/- standard deviation) and a male/female ratio of 1/3. Risk factors associated with UBP were: therapeutic inertia (adjusted odds ratio to other variables (AOR) = 18.2, 95% CI [8.35-39.84]), drug non-adherence (AOR = 1.8, 95% CI [1.07-3.04]), obesity/overweight (AOR = 1.6, 95% CI [1.0-32.58]), unemployment (AOR = 1.9, 95% CI [1.09-3.01]), low income (AOR = 2.6, 95% CI [1.01-6.86]), family history of hypertension (AOR = 1.5, 95% CI [1.07-2.08]) and male sex (AOR = 1.6, 95% CI [1.04-2.58]). Conclusion UBP prevalence is high in Meknes. Prevention should firstly focus on raised awareness of hypertensive patients' self-care management. Secondly, health professionals should better comply to the guidelines of anti-hypertensive treatments. Lastly, health professionals should frequently be reminded to reach therapeutic goals to overcome therapeutic inertia.	[Essayagh, Touria] Univ Hassan 1er, Lab Sci & Technol Sante, Inst Super Sci Sante, Settat, Morocco; [Essayagh, Touria; Khattabi, Asmae] Ecole Natl Sante Publ, Rabat, Morocco; [Essayagh, Meriem] Univ Mohammed 5, Fac Med & Pharm, Rabat, Morocco; [El Rhaffouli, Abderrahmane; Khouchoua, Mohammed] Delegat Sante, Meknes, Morocco; [Kazadi, Germain Bukassa] First Nations & Inuit Hlth, Dept Indigenous Serv Canada, Hlth Surveillance & Assessment Unit, Govt Canada, Regina, SK, Canada; [Essayagh, Sanah] Univ Hassan 1er, Lab Agroalimentaire & Sante, Fac Sci & Tech, Settat, Morocco	Hassan First University of Settat; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Moulay Ismail University of Meknes; Hassan First University of Settat	Essayagh, T (corresponding author), Univ Hassan 1er, Lab Sci & Technol Sante, Inst Super Sci Sante, Settat, Morocco.; Essayagh, T (corresponding author), Ecole Natl Sante Publ, Rabat, Morocco.	essayagh.toula@gmail.com	khattabi, asmae/X-8687-2019	khattabi, asmae/0000-0001-5194-996X				[Anonymous], 2000, INSERM COLLECTIVE EX; Asgedom SW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166432; Bachir Cherif A, 2017, Ann Cardiol Angeiol (Paris), V66, P123, DOI 10.1016/j.ancard.2017.04.009; Bencherif S., 2010, ADAPTATION TRAITEMEN, V5; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Cheong A T, 2015, Malays Fam Physician, V10, P19; Cortez-Dias N, 2013, J HYPERTENS, V31, P1991, DOI 10.1097/HJH.0b013e32836342f7; de Campos CL, 2017, EINSTEIN-SAO PAULO, V15, P45, DOI [10.1590/S1679-45082017AO3862, 10.1590/s1679-45082017ao3862]; Dong GH, 2008, INDIAN J MED RES, V128, P122; Doulougou B., 2014, HYPERTENSION ARTE RI; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; Geronooz I, 2000, Rev Med Liege, V55, P921; Girerd X, 2016, Ann Cardiol Angeiol (Paris), V65, P219, DOI 10.1016/j.ancard.2016.04.019; Giroux E, 2011, REV HIST SCI, V64, P297, DOI 10.3917/rhs.642.0297; Goverwa Tafadzwa Priscilla, 2014, BMC Res Notes, V7, P703, DOI 10.1186/1756-0500-7-703; Gudina EK, 2013, INTEGR BLOOD PRESS C, V6, P111, DOI 10.2147/IBPC.S47298; Hamida F, 2013, ANN CARDIOL ANGEIOL, V62, P172, DOI 10.1016/j.ancard.2013.04.008; Ikama M S, 2015, Ann Cardiol Angeiol (Paris), V64, P76, DOI 10.1016/j.ancard.2015.01.007; Jarab A., 2017, PALESTINIAN MED PHAR; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Le directeur et comite de redaction, 2012, CADR PANC PREV CONTR; Maginga J, 2016, J CLIN HYPERTENS, V18, P207, DOI 10.1111/jch.12646; Mainous AG, 2004, ANN FAM MED, V2, P563, DOI 10.1370/afm.119; Majernick TG, 2004, AM J HYPERTENS, V17, P915, DOI 10.1016/j.amjhyper.2004.05.016; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Menanga A, 2016, CARDIOVASC DIAGN THE, V6, P439, DOI 10.21037/cdt.2016.04.03; Mertens IL, 2000, OBES RES, V8, P270, DOI 10.1038/oby.2000.32; Mesli M F, 2015, Ann Cardiol Angeiol (Paris), V64, P32, DOI 10.1016/j.ancard.2014.04.009; Nejjari C, 2013, J HYPERTENS, V31, P49, DOI 10.1097/HJH.0b013e32835a6611; Omar SM, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0769-5; Organisation Mondiale de la Sante, 2017, MAL CARD; Perrine A. L., 2018, Bulletin Epidemiologique Hebdomadaire, P170; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Plouin P. F. CG, 1986, STRATEGIE EXPLORATIO; Sabbahi A, 2018, HYPERTENSION, V71, P229, DOI 10.1161/HYPERTENSIONAHA.117.10116; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; [Service des maladies cardiovasculaires Ministere de la Sante Maroc], 2017, PROGR PREV CONTR HYP; Steichen O, 2014, REV MED INTERNE, V35, P235, DOI 10.1016/j.revmed.2013.06.013; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Tazi MA, 2003, J HYPERTENS, V21, P897, DOI 10.1097/00004872-200305000-00013; Williams EA, 2013, DIABETES METAB SYND, V7, P123, DOI 10.1016/j.dsx.2013.06.015; Yameogo NV, 2013, ANN CARDIOL ANGEIOL, V62, P38, DOI 10.1016/j.ancard.2012.05.001; Zhang M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-301	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220710	10.1371/journal.pone.0220710	http://dx.doi.org/10.1371/journal.pone.0220710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398197	Green Published, gold, Green Submitted			2022-12-27	WOS:000485004000014
J	Kang, MS; Kim, HS				Kang, Michael Seungcheol; Kim, Han-Soo			Characteristics and trends of traumatic injuries in children visiting emergency departments in South Korea: A retrospective serial cross-sectional study using both nationwide-sample and single-institutional data	PLOS ONE			English	Article							TRAMPOLINE-RELATED INJURIES; PHYSICAL-ACTIVITY; UNINTENTIONAL INJURIES; FRACTURES	We investigated the incidences and characteristics of pediatric traumatic injuries requiring emergency department visits, through a complementary approach using both nationwide sample and single-institutional data. Data for children (aged <15 years) identified with traumatic injuries during a 10-year period from the Korean National Health Insurance Sharing Service (n = 35,064 among 10,114,909 randomly sampled cases from the claim records of the National Health Insurance) and the authors' institute (n = 39,228) were retrospectively reviewed. The incidences and characteristics of the injuries were investigated using both datasets; additionally, detailed information regarding the injury environments was investigated using the single-institutional data. The findings were similar across both datasets. The incidence of injuries increased during the study period; the head was most commonly injured, whereas the trunk or proximal extremities were rarely injured; low-energy head injuries accounted for >50% of the cases in children aged <5 years, although the incidences of lower extremity injuries and fractures increased in older children. Single-institutional data demonstrated that the proportion of indoor playground and trampoline-related injuries increased rapidly during the study period, and outdoor injuries and seasonal variation (with peak incidences in May and June) were more prominent in older children. Based on similarities between both datasets, the detailed results regarding pediatric traumatic injuries obtained from the single institutional data could be generalized nationally with adequate external validity. To prevent traumatic injuries, it may be more effective to wear protective equipment covering the head and distal extremities rather than the trunk or proximal extremities; simple clothing, such as caps, could prevent many injuries in preschoolers. Among older children, safety guidelines for outdoor sports/leisure activities are needed. The increase in pediatric traumatic injuries may be partially explained by the increased availability of indoor playgrounds and installation of trampolines. Stricter adherence to the preventive guidelines is needed.	[Kang, Michael Seungcheol] Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, Seoul, South Korea; [Kim, Han-Soo] Seoul Natl Univ Hosp, Dept Orthopaed Surg, Seoul, South Korea	University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University Hospital	Kang, MS (corresponding author), Asan Med Ctr Childrens Hosp, Dept Orthopaed Surg, Seoul, South Korea.	kang@amc.seoul.kr		Kang, Michael Seungcheol/0000-0002-0172-2721	Asan Medical Center Children's Hospital, Seoul, Korea [2017-0384]	Asan Medical Center Children's Hospital, Seoul, Korea	This study was supported by a grant (2017-0384) from Asan Medical Center Children's Hospital, Seoul, Korea.	Alonge O, 2016, PEDIATR CLIN N AM, V63, P167, DOI 10.1016/j.pcl.2015.08.009; Ashby K, 2015, AUST NZ J PUBL HEAL, V39, P491, DOI 10.1111/1753-6405.12404; Booth VM, 2015, J SCI MED SPORT, V18, P418, DOI 10.1016/j.jsams.2014.06.002; Briskin S, 2012, PEDIATRICS, V130, P774, DOI 10.1542/peds.2012-2082; Cheung MY, 2016, HONG KONG MED J, V22, P81, DOI 10.12809/hkmj144411; Choi ES, 2018, INJURY, V49, P443, DOI 10.1016/j.injury.2017.12.017; Dronina Yuliya, 2016, J Lifestyle Med, V6, P16, DOI 10.15280/jlm.2016.6.1.16; Eiosdottir SP, 2008, EUR J PUBLIC HEALTH, V18, P289, DOI 10.1093/eurpub/ckn004; Felfe C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151729; Gong HS, 2009, J BONE JOINT SURG AM, V91A, P2376, DOI 10.2106/JBJS.H.01871; Hashikawa AN, 2015, J CHILD HEALTH CARE, V19, P93, DOI 10.1177/1367493513501020; Houshian S, 2001, J Orthop Sci, V6, P312, DOI 10.1007/s007760100024; Jack A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3403; Johnston BD, 2013, ACAD PEDIATR, V13, P499, DOI 10.1016/j.acap.2013.04.016; JONGSCHAAP H C N, 1990, Health Bulletin (Edinburgh), V48, P58; Kang HY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-230; Kang S, 2015, J ORTHOP TRAUMA, V29, pE253, DOI 10.1097/BOT.0000000000000322; Khoshbin A, 2014, INJURY, V45, P701, DOI 10.1016/j.injury.2013.10.004; Konigshausen M, 2014, SPORTVERLETZ SPORTSC, V28, P69, DOI 10.1055/s-0034-1366544; Landry BW, 2012, PM&R, V4, P826, DOI 10.1016/j.pmrj.2012.09.585; McDonald NC, 2011, AM J PREV MED, V41, P146, DOI 10.1016/j.amepre.2011.04.006; Palmu SA, 2014, ACTA ORTHOP, V85, P513, DOI 10.3109/17453674.2014.916489; Park SG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055378, 10.1371/journal.pone.0057138]; Pearson M, 2012, INJURY PREV, V18, P113, DOI 10.1136/injuryprev-2011-040043; Salmon J, 2005, AUST NZ J PUBL HEAL, V29, P337, DOI 10.1111/j.1467-842X.2005.tb00204.x; Shin J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004880; Shin SY, 2013, HEALTHC INFORM RES, V19, P102, DOI 10.4258/hir.2013.19.2.102; Shin Y, 2015, STUD HEALTH TECHNOL, V216, P924, DOI 10.3233/978-1-61499-564-7-924; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Su AW, 2015, FOOT ANKLE CLIN, V20, P705, DOI 10.1016/j.fcl.2015.07.004; Welch R, 2017, CLIN PEDIATR, V56, P707, DOI 10.1177/0009922816672451; 2007, MMWR MORB MORTAL WKL, V56, P52	32	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220798	10.1371/journal.pone.0220798	http://dx.doi.org/10.1371/journal.pone.0220798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398222	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000022
J	Kleinberg, B; Arntz, A; Verschuere, B				Kleinberg, Bennett; Arntz, Arnoud; Verschuere, Bruno			Being accurate about accuracy in verbal deception detection	PLOS ONE			English	Article							CROSS-VALIDATION; CREDIBILITY; VALIDITY; CRITERIA; ADULTS; LIES; CBCA	Purpose Verbal credibility assessments examine language differences to tell truthful from deceptive statements (e.g., of allegations of child sexual abuse). The dominant approach in psycholegal deception research to date (used in 81% of recent studies that report on accuracy) to estimate the accuracy of a method is to find the optimal statistical separation between lies and truths in a single dataset. However, this method lacks safeguards against accuracy overestimation. Method & Results A simulation study and empirical data show that this procedure produces overoptimistic accuracy rates that, especially for small sample size studies typical of this field, yield misleading conclusions up to the point that a non-diagnostic tool can be shown to be a valid one. Cross-validation is an easy remedy to this problem. Conclusions We caution psycholegal researchers to be more accurate about accuracy and propose guidelines for calculating and reporting accuracy rates.	[Kleinberg, Bennett] UCL, Dept Secur & Crime Sci, London, England; [Kleinberg, Bennett; Arntz, Arnoud; Verschuere, Bruno] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of London; University College London; University of Amsterdam	Kleinberg, B (corresponding author), UCL, Dept Secur & Crime Sci, London, England.; Kleinberg, B (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	bennett.kleinberg@ucl.ac.uk		Kleinberg, Bennett/0000-0003-1658-9086; VERSCHUERE, BRUNO/0000-0002-6161-4415	Dutch Ministry of Security and Justice	Dutch Ministry of Security and Justice	This work was supported by a grant from the Dutch Ministry of Security and Justice to BK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado BG, 2016, INT J CLIN HLTH PSYC, V16, P201, DOI 10.1016/j.ijchp.2016.01.002; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2013, THESIS COLUMBIA U NE; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Bogaard G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00243; Bogaard G, 2014, J INVEST PSYCHOL OFF, V11, P151, DOI 10.1002/jip.1409; Bogaard G, 2014, PSYCHOL CRIME LAW, V20, P430, DOI 10.1080/1068316X.2013.793338; Brown Emma, 2018, WASHINGTON POST; Bull R, 2015, WILEY SER PSYCH CR, P3; DePaulo BM, 2003, PSYCHOL BULL, V129, P74, DOI 10.1037//0033-2909.129.1.74; Griesel D., 2013, APPL ISSUES INVESTIG, P293, DOI [10.1007/978-1-4614-5547-9_12, DOI 10.1007/978-1-4614-5547-9_12]; Hauch V, 2017, PSYCHOL ASSESSMENT, V29, P819, DOI 10.1037/pas0000426; Kelly E, 2018, USATODAY; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kleinberg B, 2018, APPL COGNITIVE PSYCH, V32, P592, DOI 10.1002/acp.3439; Kleinberg B, 2018, APPL COGNITIVE PSYCH, V32, P354, DOI 10.1002/acp.3407; KOHNKEN G, 1995, J APPL PSYCHOL, V80, P671, DOI 10.1037/0021-9010.80.6.671; Levine TR, 2018, LEGAL CRIMINOL PSYCH, V23, P7, DOI 10.1111/lcrp.12115; Luke TJ, 2018, OSF PREPR; Moshontz H, 2018, ADV METHODS PRACT PS, DOI [10.31234/OSF.IO/785QU, DOI 10.31234/OSF.IO/785QU]; Nahari G, 2019, LEGAL CRIMINOL PSYCH, V24, P1, DOI 10.1111/lcrp.12148; Oberlader VA, 2016, LAW HUMAN BEHAV, V40, P440, DOI 10.1037/lhb0000193; Ormerod TC, 2015, J EXP PSYCHOL GEN, V144, P76, DOI 10.1037/xge0000030; Savi AO, 2018, COMPUT EDUC, V119, P84, DOI 10.1016/j.compedu.2017.12.008; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Simons DJ, 2014, PERSPECT PSYCHOL SCI, V9, P76, DOI 10.1177/1745691613514755; Vanderhallen M, 2016, POLICE PRACT RES, V17, P279, DOI 10.1080/15614263.2015.1008479; Venables WN., 2002, MODERN APPL STAT S; Verschuere B, 2018, ADV METH PRACT PSYCH, V1, P299, DOI 10.1177/2515245918781032; Vrij A, 2017, LEGAL CRIMINOL PSYCH, V22, P1, DOI 10.1111/lcrp.12088; Vrij Aldert, 2010, Psychol Sci Public Interest, V11, P89, DOI 10.1177/1529100610390861; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willen RM, 2012, PSYCHOL CRIME LAW, V18, P745, DOI 10.1080/1068316X.2010.548815; Yarkoni T, 2017, PERSPECT PSYCHOL SCI, V12, P1100, DOI 10.1177/1745691617693393	38	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220228	10.1371/journal.pone.0220228	http://dx.doi.org/10.1371/journal.pone.0220228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393894	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500025
J	Macedo, DM; Smithers, LG; Roberts, RM; Haag, DG; Paradies, Y; Jamieson, LM				Macedo, Davi M.; Smithers, Lisa G.; Roberts, Rachel M.; Haag, Dandara G.; Paradies, Yin; Jamieson, Lisa M.			Does ethnic-racial identity modify the effects of racism on the social and emotional wellbeing of Aboriginal Australian children?	PLOS ONE			English	Article							DIFFICULTIES QUESTIONNAIRE; SELF-ESTEEM; P-VALUES; PERCEIVED DISCRIMINATION; HEALTH; CONFIDENCE; STRENGTHS; TIME; PERSPECTIVES; FOOTPRINTS	Objectives This study investigates the protective role of ethnic-racial identity (ERI) affirmation on the longitudinal association between racism and Aboriginal Australian children's social and emotional well-being (SEWB). Methods 408 children from the K-Cohort of the Longitudinal Study of Indigenous Children were included in the analysis. Data were collected through questionnaire-guided interviews at 7-10 and 9-12 years of age. Children's racism experience, SEWB (Strengths and Difficulties Questionnaire), and confounding were reported by caregivers. ERI was reported by children and dichotomized into high versus low. Generalized linear models with log-Poisson links and robust errors were used to estimate adjusted Risk Ratios (RRa) for the effect of racism on SEWB domains. Effect-measure modification analysis was used to verify differences on effect sizes per strata of ERI affirmation. The presence of modification was indicated by the Relative Excess Risk due to Interaction (RERI). Results Slightly above half (51.4%) of the children presented high ERI affirmation. Children exposed to racism and with low ERI affirmation were at increased risk of hyperactive behavior (RRa 2.53, 95% CI 1.17, 5.48), conduct problems (RRa 2.35, 95% CI 1.07, 5.15), and total difficulties (RRa 1.73, 95% CI 0.84, 3.55). Positive RERIs indicated the joint effects of racism and low ERI affirmation surpassed the sum of their separate effects in these domains. Children with high ERI affirmation were at increased risk of peer problems (RRa 1.66, 95% CI 0.78, 3.52). Conclusions These findings suggest that ERI may mitigate the risk of poor SEWB due to racism. Fostering affirmative ERI can be an important strategy in promoting resilience in Aboriginal Australian children.	[Macedo, Davi M.; Haag, Dandara G.; Jamieson, Lisa M.] Univ Adelaide, Adelaide Dent Sch, Indigenous Oral Hlth Unit, Adelaide, SA, Australia; [Smithers, Lisa G.; Haag, Dandara G.] Univ Adelaide, Sch Publ Hlth, BetterStart Child Hlth & Dev Res Grp, Adelaide, SA, Australia; [Roberts, Rachel M.] Univ Adelaide, Sch Psychol, Adelaide, SA, Australia; [Paradies, Yin] Deakin Univ, Alfred Deakin Inst Citizenship & Globalisat, Melbourne, Vic, Australia	University of Adelaide; University of Adelaide; University of Adelaide; Deakin University	Macedo, DM (corresponding author), Univ Adelaide, Adelaide Dent Sch, Indigenous Oral Hlth Unit, Adelaide, SA, Australia.	davi.manzinimacedo@adelaide.edu.au	Roberts, Rachel Margaret/AAE-5712-2020; Smithers, Lisa/D-1605-2009	Roberts, Rachel Margaret/0000-0002-9547-9995; Smithers, Lisa/0000-0002-6585-7836; Haag, Dandara/0000-0001-6722-6635; Macedo, Davi/0000-0001-9342-0888				Ashmore RD, 2004, PSYCHOL BULL, V130, P80, DOI 10.1037/0033-2909.130.1.80; Assari S, 2018, BEHAV SCI-BASEL, V8, DOI 10.3390/bs8050044; Australia Institute of Health and Welfare, 2015, REPORT NO IHW 147; Ben J, 2019, THE ROUTLEDGE INTERN; Berman G, 2010, ETHNIC RACIAL STUD, V33, P214, DOI 10.1080/01419870802302272; Bhaskaran K, 2014, INT J EPIDEMIOL, V43, P1336, DOI 10.1093/ije/dyu080; Biddle N, 2009, REPORT NO 50 2009; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Brondolo E, 2009, J BEHAV MED, V32, P1, DOI 10.1007/s10865-008-9190-3; Chae DH, 2017, J BLACK PSYCHOL, V43, P789, DOI 10.1177/0095798417690055; Cokley K, 2007, J COUNS PSYCHOL, V54, P224, DOI 10.1037/0022-0167.54.3.224; Corenblum B, 2012, CAN J BEHAV SCI, V44, P124, DOI 10.1037/a0027154; Corenblum B, 2014, J YOUTH ADOLESCENCE, V43, P387, DOI 10.1007/s10964-013-0081-8; Corenblum B, 2014, J YOUTH ADOLESCENCE, V43, P356, DOI 10.1007/s10964-013-0007-5; Cummings P, 2010, ARCH PEDIAT ADOL MED, V164, P193, DOI 10.1001/archpediatrics.2009.266; Department of Social Services, 2017, FOOTPRINTS IN TIME T; Elias A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3868-1; Farland LV, 2016, HUM REPROD, V31, P2406, DOI 10.1093/humrep/dew192; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Greenland S, 2001, ANNU REV PUBL HEALTH, V22, P189, DOI 10.1146/annurev.publhealth.22.1.189; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Helms JE, 2007, J COUNS PSYCHOL, V54, P235, DOI 10.1037/0022-0167.54.3.235; Jaramillo J, 2016, J RES ADOLESCENCE, V26, P769, DOI 10.1111/jora.12228; Jones MD, 2007, J RES ADOLESCENCE, V17, P683, DOI 10.1111/j.1532-7795.2007.00541.x; Kenney MK, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/7424239; Kickett-Tucker CS, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0234-3; Kickett-Tucker CS, 2009, HEALTH SOCIOL REV, V18, P119, DOI 10.5172/hesr.18.1.119; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Lucas T, 2017, PSYCHOSOM MED, V79, P293, DOI 10.1097/PSY.0000000000000406; Marcelo AK, 2019, CULT DIVERS ETHN MIN, V25, P253, DOI 10.1037/cdp0000220; Meltzer H, 2000, THE MENTAL HEALTH OF; Morey RD, 2016, PSYCHON B REV, V23, P103, DOI 10.3758/s13423-015-0947-8; Nohr EA, 2013, INT J EPIDEMIOL, V42, P1016, DOI 10.1093/ije/dyt102; Paradies Y, 2006, CRIT PUBLIC HEALTH, V16, P143, DOI [10.1080/09581590600828881, DOI 10.1080/09581590600828881]; Paradies Y, 2009, FULL REPORT; Phinney J. S., 1989, J EARLY ADOLESC, V9, P34, DOI [10.1177/0272431689091004, DOI 10.1177/0272431689091004]; Phinney JS, 2007, J COUNS PSYCHOL, V54, P271, DOI 10.1037/0022-0167.54.3.271; Priest N, 2017, ETHNIC HEALTH, V22, P631, DOI 10.1080/13557858.2016.1246418; Priest N, 2013, SOC SCI MED, V95, P115, DOI 10.1016/j.socscimed.2012.11.031; Priest N, 2012, HEALTH SOCIOL REV, V21, P180, DOI 10.5172/hesr.2012.21.2.180; Priest N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-568; Priest NC, 2011, MED J AUSTRALIA, V194, P546; Racism Paradies Y. and Health Indigenous, 2018, OXFORD RESEARCH ENCY, DOI DOI 10.1093/ACREFORE/9780190632366.001.0001; Ranganathan Priya, 2015, Perspect Clin Res, V6, P222, DOI 10.4103/2229-3485.167092; Rothman KJ, 2016, EUR J EPIDEMIOL, V31, P443, DOI 10.1007/s10654-016-0158-2; Salmon M, 2019, J DEV ORIG HLTH DIS, V10, P17, DOI 10.1017/S204017441800017X; Schwartz SJ, 2014, CHILD DEV, V85, P58, DOI 10.1111/cdev.12201; Seaton EK, 2009, CULT DIVERS ETHN MIN, V15, P137, DOI 10.1037/a0015506; Shepherd CCJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-756; Smokowski PR, 2014, J YOUTH ADOLESCENCE, V43, P343, DOI 10.1007/s10964-013-9992-7; Snowshoe A, 2017, J PRIM PREV, V38, P67, DOI 10.1007/s10935-016-0454-3; Tajfel H., 1986, DIFFERENTIATION SOCI, V5, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Temple JB, 2019, AUSTRALAS J AGEING, V38, P39, DOI 10.1111/ajag.12604; Thurber KA, 2015, INT J EPIDEMIOL, V44, P789, DOI 10.1093/ije/dyu122; Traub F, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2569; Turner JC, 1982, SOCIAL IDENTITY AND, P12; Umana-Taylor A.J., 2004, IDENTITY, V4, P9, DOI DOI 10.1207/S1532706XID0401_2; Umana-Taylor AJ, 2016, CURR DIR PSYCHOL SCI, V25, P111, DOI 10.1177/0963721415627858; Umana-Taylor AJ, 2014, CHILD DEV, V85, P21, DOI 10.1111/cdev.12196; Usborne E, 2010, PERS SOC PSYCHOL B, V36, P883, DOI 10.1177/0146167210372215; VanderWeele TJ, 2012, AM J EPIDEMIOL, V176, P608, DOI 10.1093/aje/kws213; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P863, DOI 10.1097/EDE.0b013e3181ba333c; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; Williamson A, 2014, AUST PSYCHOL, V49, P163, DOI 10.1111/ap.12045; Williamson A, 2010, AUST NZ J PSYCHIAT, V44, P894, DOI 10.3109/00048674.2010.489505; Yip T, 2018, CURR DIR PSYCHOL SCI, V27, P170, DOI 10.1177/0963721417739348; Young C, 2017, AUST NZ J PUBL HEAL, V41, P405, DOI 10.1111/1753-6405.12681; Zubrick SR, 2004, REPORT NO 01; Zubrick SR, 2006, REPORT NO 1351 0 55	72	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220744	10.1371/journal.pone.0220744	http://dx.doi.org/10.1371/journal.pone.0220744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390371	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400027
J	Mehmood, A; Yao, J; Fan, DY; Bongole, K; Liu, JR; Zhang, X				Mehmood, Asif; Yao, Jun; Fan, Dongyan; Bongole, Kelvin; Liu, Junrong; Zhang, Xu			Potential for heat production by retrofitting abandoned gas wells into geothermal wells	PLOS ONE			English	Article							NUMERICAL-SIMULATION; RENEWABLE ENERGY; POWER-GENERATION; OIL; TECHNOLOGY; EXTRACTION; SYSTEMS; FLOW; RESERVOIRS; PAKISTAN	Using abandoned gas wells as geothermal resources for energy production is an effective way to extract geothermal energy from geological formations. These abandoned wells have the potential to significantly contribute in the rising global demand for energy without requiring the land disruption resulting from deep drilling or digging, processes necessary for energy extraction from geological formations via more traditional methods. In this paper, a method to extract geothermal energy from abandoned gas wells is proposed. The method offers an efficient, economical, and environmentally-conscious way to generate electricity. A mathematical model of a thermal and hydraulic coupling process is constructed, and a 3D numerical model is generated to study the process of geothermal energy extraction by retrofitting an abandoned gas reservoir into a geothermal reservoir. Using the model, heat extraction and fluid flow are analyzed over a period of 50 years. The heat production, electricity generation, and thermal recovery over the lifetime of the reservoir indicate that a commercially viable geothermal dual well system can produce geothermal energy effectively. Dual-well systems contain at least one injection well and one production well. They are composed of a two-way flow system in which the fluid flows into the reservoir via an injection well and returns from the production well having absorbed thermal energy from the surrounding rocks. Sensitivity analysis of the main parameters controlling the average outlet temperature of the fluid from the sedimentary geothermal system reveals that abandoned gas wells are a suitable source of geothermal energy. This energy can be harvested via a method whose use of reservoir fluids differs from that of the traditional method of closed-loop circulation via a borehole heat exchanger. Here, it is demonstrated that abandoned oil and gas fields can be repurposed to be geothermal energy sources that provide low-cost electricity and are economically sustainable.	[Mehmood, Asif; Yao, Jun; Fan, Dongyan; Bongole, Kelvin; Liu, Junrong; Zhang, Xu] China Univ Petr East China, Sch Petr Engn, Qingdao, Shandong, Peoples R China	China University of Petroleum	Yao, J (corresponding author), China Univ Petr East China, Sch Petr Engn, Qingdao, Shandong, Peoples R China.	rcogfr_upc@126.com	Yao, Jun/HCI-2731-2022; Bongole, Kelvin/AAH-4939-2021	Bongole, Kelvin/0000-0001-5399-553X	National Natural Science Foundation of China [51674278]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by "The National Natural Science Foundation of China" under Grant 51674278. The National Natural Science Foundation of China (http://www.nsfc.gov.cn) provided support in the form of funding for author Junrong Liu, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2002, GEOTHERMICS, V31, P613, DOI 10.1016/S0375-6505(02)00009-3; [Anonymous], 1983, HYDRAULICS; Augustine C., 2006, P 31 WORKSH GEOTH RE, P5; Barbier E, 2002, RENEW SUST ENERG REV, V6, P3, DOI 10.1016/S1364-0321(02)00002-3; Baria R, 1999, GEOTHERMICS, V28, P533, DOI 10.1016/S0375-6505(99)00045-0; Beerepoot M., 2011, TECHNOLOGY ROADMAP G; Brown D, 1995, P WORLD GEOTHERMAL C, P2607; Bu XB, 2012, RENEW ENERG, V41, P80, DOI 10.1016/j.renene.2011.10.009; Bujok P., 2012, INT J GEOPHYS, V29, P97, DOI DOI 10.1155/2013/916541; Caulk RA, 2017, RENEW ENERG, V112, P388, DOI 10.1016/j.renene.2017.05.042; [陈继良 Chen Jiliang], 2013, [计算物理, Chinese Journal of Computational Physics], V30, P871; Davis AP, 2009, ENERGY, V34, P866, DOI 10.1016/j.energy.2009.03.017; ELSWORTH D, 1990, J VOLCANOL GEOTH RES, V44, P283, DOI 10.1016/0377-0273(90)90022-8; Evans K., 2010, ENHANCED ENG GEOTHER; Fridleifsson IB, 2001, RENEW SUST ENERG REV, V5, P299, DOI 10.1016/S1364-0321(01)00002-8; Gondal IA, 2017, RENEW SUST ENERG REV, V71, P687, DOI 10.1016/j.rser.2016.12.097; Guo T, 2011, INT J ENERG RES, V35, P530, DOI 10.1002/er.1710; Hussain SD, 1995, P FIN RES COORD M AP; Johnson L., 2009, P 34 WORKSH GEOTH RE; Kadri IB., 1995, PETROLEUM GEOLOGY PA; Kazmi A, 1977, 18 ANN SCI C MULT PA, P26; Kohl T, 2002, GEOTHERMICS, V31, P687, DOI 10.1016/S0375-6505(02)00031-7; Kujawa T, 2004, ICHMT DIGITAL LIB ON; Liang B, 2016, J NAT GAS SCI ENG, V28, P711, DOI 10.1016/j.jngse.2015.12.011; Macenic M, 2018, INTERPRETATION-J SUB, V6, pSB1, DOI 10.1190/INT-2017-0079.1; Mehmood A., 2017, J PETROLEUM ENV BIOT, V7, P332, DOI [10.4172/2157-7463.1000332, DOI 10.4172/2157-7463.1000332]; Mehmood A, 2017, OPEN J YANGTZE OIL G, V2, P191, DOI DOI 10.4236/ojogas.2017.24015; Mehmood A., 2019, ADV PETROLEUM ENG PE, P181, DOI [10.1007/978-3-030-01578-7_42, DOI 10.1007/978-3-030-01578-7_42]; Mikael H(o)(o)k, 2010, [石油勘探与开发, Petroleum Exploration and Development], V37, P237; Nian YL, 2018, ENERGY, V142, P592, DOI 10.1016/j.energy.2017.10.062; Pruess K, 2006, GEOTHERMICS, V35, P351, DOI 10.1016/j.geothermics.2006.08.002; Quadri V., 1986, PAKISTAN AM ASS PETR, V70, P730; Sanyal SK, 2005, WORLD GEOTH C ANT AP; Schulz R, 2005, P WORLD GEOTH C; Sliwa T., 2014, RES J ENVIRON SCI, V8, P231, DOI DOI 10.3923/rjes.2014.231.242; Stackhouse P, 2006, P SOL 06 DENV CO AM; Sun ZX, 2017, ENERGY, V120, P20, DOI 10.1016/j.energy.2016.10.046; Sun ZX, 2018, ENERGIES, V11, DOI 10.3390/en11020280; Templeton JD, 2014, ENERGY, V70, P366, DOI 10.1016/j.energy.2014.04.006; Tester J.W, 1994, SCI GLOBAL SECUR, V5, P99; Toth AN, 2018, 43 WORDSH GEOTH RES; Wang K, 2018, GEOTHERMICS, V76, P141, DOI 10.1016/j.geothermics.2018.07.005; Wang K, 2018, J PETROL SCI ENG, V168, P465, DOI 10.1016/j.petrol.2018.05.012; Xu CS, 2015, APPL ENERG, V140, P135, DOI 10.1016/j.apenergy.2014.11.050; Yao J, 2018, GEOTHERMICS, V74, P19, DOI 10.1016/j.geothermics.2017.12.005; Younas U, 2016, RENEW SUST ENERG REV, V63, P398, DOI 10.1016/j.rser.2016.04.038; Zaigham N.A., 2000, Thar rift and its significance for hydrocarbons; Zaigham NA., 2005, P WORLD GEOTH C ANT; Zaigham NA, 2010, RENEW SUST ENERG REV, V14, P1124, DOI 10.1016/j.rser.2009.10.002; Zhang L, 2008, GAS NOW DELIV EXPECT, V1, P495, DOI [10.2118/115055-ms, DOI 10.2118/115055-MS, 10.2118/115055-MS]; Zhang QF, 2017, ADV WATER RESOUR, V107, P180, DOI 10.1016/j.advwatres.2017.06.020; Zhang QF, 2017, J COMPUT APPL MATH, V323, P95, DOI 10.1016/j.cam.2017.04.005; Zhang YJ, 2014, ENERGY, V78, P788, DOI 10.1016/j.energy.2014.10.073; Zhu GP, 2016, J NAT GAS SCI ENG, V28, P305, DOI 10.1016/j.jngse.2015.11.051	54	12	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220128	10.1371/journal.pone.0220128	http://dx.doi.org/10.1371/journal.pone.0220128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386664	gold, Green Published, Green Submitted			2022-12-27	WOS:000484997100016
J	D'Angelo, A; Sobhani, N; Roviello, G; Bagby, S; Bonazza, D; Bottin, C; Giudici, F; Zanconati, F; De Manzini, N; Guglielmi, A; Generali, D				D'Angelo, Alberto; Sobhani, Navid; Roviello, Giandomenico; Bagby, Stefan; Bonazza, Deborah; Bottin, Cristina; Giudici, Fabiola; Zanconati, Fabrizio; De Manzini, Nicolo; Guglielmi, Alessandra; Generali, Daniele			Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma	PLOS ONE			English	Article							FAVORABLE CLINICOPATHOLOGICAL VARIABLES; ISOLATED LIMB PERFUSION; NECROSIS-FACTOR; GASTRIC ADENOCARCINOMA; FOXP3 EXPRESSION; TNF-ALPHA; IMMUNOTHERAPY; CELLS; SURVIVAL; MICROENVIRONMENT	Background We investigated the correlation between pancreatic ductal adenocarcinoma patient prognosis and the presence of tumour infiltrating lymphocytes and expression of 521 immune system genes. Methods Intratumoural CD3+, CD8+, and CD20+ lymphocytes were examined by immunohistochemistry in 12 PDAC patients with different outcomes who underwent pancreaticoduodenectomy. The results were correlated with gene expression profile using the digital multiplexed NanoString nCounter analysis system (NanoString Technologies, Seattle, WA, USA). Results Twenty immune system genes were significantly differentially expressed in patients with a good prognosis relative to patients with a worse prognosis: TLR2 and TLR7 (Toll-like receptor superfamily); CD4, CD37, FOXP3, PTPRC (B cell and T cell signalling); IRF5, IRF8, STAT1, TFE3 (transcription factors); ANP32B, CCND3 (cell cycle); BTK (B cell development); TNF, TNFRF1A (TNF superfamily); HCK (leukocyte function); C1QA (complement system); BAX, PNMA1 (apoptosis); IKBKE (NF kappa B pathway). Differential expression was more than twice log 2 for TLR7, TNF, C1QA, FOXP3, and CD37. Discussion Tumour infiltrating lymphocytes were present at higher levels in samples from patients with better prognosis. Our findings indicate that tumour infiltrating lymphocyte levels and expression level of the immune system genes listed above influence pancreatic ductal adenocarcinoma prognosis. This information could be used to improve selection of best responders to immune inhibitors.	[D'Angelo, Alberto; Bagby, Stefan] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [D'Angelo, Alberto; Sobhani, Navid; Roviello, Giandomenico; Guglielmi, Alessandra; Generali, Daniele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Sobhani, Navid; Generali, Daniele] ASST Cremona, Breast Canc Unit, Cremona, Italy; [Bonazza, Deborah; Bottin, Cristina; Giudici, Fabiola; Zanconati, Fabrizio; De Manzini, Nicolo; Generali, Daniele] Univ Trieste, Osped Cattinara, Dept Med Sci, Trieste, Italy	University of Bath; University of Trieste; University of Trieste	D'Angelo, A (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.; D'Angelo, A (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	A.DAngelo@bath.ac.uk	GIUDICI, FABIOLA/AAJ-4919-2020; Giudici, Fabiola/R-8426-2016; D'Angelo, Alberto/AAC-7434-2021; Roviello, Giandomenico/AAA-5310-2019; Sobhani, Navid/AAB-8484-2020; Sobhani, Navid/AAL-3475-2020	GIUDICI, FABIOLA/0000-0002-4160-3479; Giudici, Fabiola/0000-0002-4160-3479; D'Angelo, Alberto/0000-0001-8417-9172; Sobhani, Navid/0000-0003-1381-0283; GENERALI, DANIELE/0000-0003-2480-3855; Roviello, Giandomenico/0000-0001-5504-8237; BONAZZA, DEBORAH/0000-0002-5605-6711				Alexander HR, 2009, ANN SURG ONCOL, V16, P1852, DOI 10.1245/s10434-009-0482-9; Anz D, 2010, J IMMUNOL, V184, P939, DOI 10.4049/jimmunol.0901245; Azzato EM, 2010, BRIT J CANCER, V102, P1294, DOI 10.1038/sj.bjc.6605625; Beckwith KA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00091; Bourquin C, 2009, J IMMUNOL, V183, P6078, DOI 10.4049/jimmunol.0901594; Bray F, 2018, CA CANC J CLIN; Bulla R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10346; Caragine TA, 2002, CANCER RES, V62, P1110; Cauwels A, 2007, ARCH BIOCHEM BIOPHYS, V462, P132, DOI 10.1016/j.abb.2007.01.021; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Chen DT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133562; De Divitiis C, 2014, WORLD J GASTROENTERO, V20, P15049, DOI 10.3748/wjg.v20.i41.15049; Deroose JP, 2011, BRIT J SURG, V98, P1573, DOI 10.1002/bjs.7621; Douglass S, 2012, CANCER METAST REV, V31, P843, DOI 10.1007/s10555-012-9395-3; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Gartlan KH, 2013, EUR J IMMUNOL, V43, P1208, DOI 10.1002/eji.201242730; GLENN J, 1988, J CLIN ONCOL, V6, P462, DOI 10.1200/JCO.1988.6.3.462; Gruenhagen Dirk J., 2009, V179, P257; Guo SC, 2017, WORLD J CLIN ONCOL, V8, P230, DOI 10.5306/wjco.v8.i3.230; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Hotz C, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1232219; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Junt T, 2015, NAT REV IMMUNOL, V15, P529, DOI 10.1038/nri3875; Karakhanova S, 2015, BRIT J CANCER, V112, P1027, DOI 10.1038/bjc.2015.72; Koti M, 2015, BRIT J CANCER, V112, P1215, DOI 10.1038/bjc.2015.81; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Li XJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0790-8; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Martin JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095843; Morrison AH, 2018, TRENDS CANCER, V4, P418, DOI 10.1016/j.trecan.2018.04.001; Nejati R, 2017, PANCREAS, V46, P1180, DOI 10.1097/MPA.0000000000000914; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Peris K, 2005, DERMATOL SURG, V31, P318; Protti MP, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00210; Rudensky AY, 2011, IMMUNOL REV, V241, P260, DOI 10.1111/j.1600-065X.2011.01018.x; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Schaper F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01185; Schober M, 2014, CANCERS, V6, P2137, DOI 10.3390/cancers6042137; Sergeant G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-527; Sideras K, 2014, CANCER TREAT REV, V40, P513, DOI 10.1016/j.ctrv.2013.11.005; Slotwinski R, 2018, CENT EUR J IMMUNOL, V43, P314, DOI 10.5114/ceji.2018.80051; Spinetti T, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1230578; Steinman RM, 2016, INNATE IMMUN IMMUNOL, V64, P392, DOI [10.1007/3-540-32636-7_2, DOI 10.1007/3-540-32636-7_2]; Stromnes IM, 2017, CANCER IMMUNOL RES, V5, P978, DOI 10.1158/2326-6066.CIR-16-0322; Suh JH, 2015, INT J CLIN EXP PATHO, V8, P14608; Tao H, 2012, LUNG CANCER, V75, P95, DOI 10.1016/j.lungcan.2011.06.002; Tao LY, 2018, CANCER BIOL THER, V19, P296, DOI 10.1080/15384047.2017.1416932; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; Tesfaye AA, 2019, AM J PATHOL, V189, P58, DOI 10.1016/j.ajpath.2018.10.005; Tewari N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-436; Torphy RJ, 2018, ANN GASTROENT SURG, V2, P274, DOI 10.1002/ags3.12176; Van den Broeck A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073968; van Deventer SJ, 2017, BIOCHEM SOC T, V45, P741, DOI 10.1042/BST20160284; Vonderheide RH, 2013, CURR OPIN IMMUNOL, V25, P200, DOI 10.1016/j.coi.2013.01.006; Wang DQ, 2010, MOL CANCER THER, V9, P1788, DOI 10.1158/1535-7163.MCT-09-1198; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Waters JP, 2013, J PATHOL, V230, P241, DOI 10.1002/path.4188; Waters JP, 2013, J PATHOL, V230, P132, DOI 10.1002/path.4187; West NR, 2013, BRIT J CANCER, V108, P155, DOI 10.1038/bjc.2012.524; Winslow S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0530-2; Won KY, 2017, HUM PATHOL, V68, P112, DOI 10.1016/j.humpath.2017.08.023; Zhang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031507; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	69	15	15	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0219566	10.1371/journal.pone.0219566	http://dx.doi.org/10.1371/journal.pone.0219566			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381571	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600005
J	Komal, S; Simon, L; Garu, G; Mateu, A; Villaverde, MD; de la Sierra, A; Almagro, P				Komal, Shakeel; Simon, Lluis; Garu, Gemma; Mateu, Aina; de la Asuncion Villaverde, Maria; de la Sierra, Alex; Almagro, Pere			Utility of FEV1/FEV6 index in patients with multimorbidity hospitalized for decompensation of chronic diseases	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SPIROMETRY TECHNIQUE; COGNITIVE FUNCTION; PERFORMANCE; QUALITY; VALIDATION; COPD; CARE	Spirometry remains essential for the diagnosis of airway obstruction. Nevertheless, its performance in elderly hospitalized patients with multimorbidity can be difficult. The aim of this study is to assess the utility of the COPD-6 portable device in this population. We included all patients hospitalized for exacerbation of chronic diseases in a medical ward specialized in the care of multimorbidity patients, between September 2017 and May 2018. A questionnaire including sociodemographic, cognitive and functional impairment, among other variables, was completed the last day of admission. Subsequently, patients attempted to perform three valid respiratory manoeuvres with the COPD-6 device and then conventional spirometry. A total of 184 patients were included (mean age of 79.61 years, 55% men). Forty-seven (25.54%) patients were able to perform complete spirometric manoeuvres and 99 (53.8%) could perform a valid FEV1/FEV6 determination. The inability to perform a valid spirometry was related with the patient's age, functional physical disability, cognitive impairment or the presence of delirium or dysphagia during admission. Only 9% of patients with a Mini Mental Cognitive Examination (MMEC) lower than 24 points could perform a valid spirometry. Of the patients with an MMEC < 24 points and unable to perform spirometry, 34% were able to complete the FEV1/FEV6 manoeuvres. No differences were found in the Charlson index, multimorbidity scale, number of domiciliary drugs, or length of stay between those patients able and those not able to perform respiratory manoeuvres. The agreement between the values for FEV1 measured with COPD-6 and those observed in the spirometry was good (r:0.71; p<0.0001). Inability to perform a valid spirometry during hospitalization in elderly patients with multimorbidity is frequent and related with functional and cognitive impairment. FEV1/FEV6 determination using the COPD-6 portable device allows an important percentage of the patients with limitations to complete spirometric measurement.	[Komal, Shakeel; Simon, Lluis; Garu, Gemma; Mateu, Aina; de la Asuncion Villaverde, Maria; Almagro, Pere] Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Serv, Multimorbid Unit, Terrassa, Spain; [Komal, Shakeel; Simon, Lluis; Garu, Gemma; Mateu, Aina; de la Asuncion Villaverde, Maria; de la Sierra, Alex; Almagro, Pere] Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Dept, Terrassa, Spain	Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona	Almagro, P (corresponding author), Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Serv, Multimorbid Unit, Terrassa, Spain.; Almagro, P (corresponding author), Univ Barcelona, Univ Hosp Mutua Terrassa, Internal Med Dept, Terrassa, Spain.	19908pam@comb.cat		Almagro, Pere/0000-0002-8476-4942; Malik Khanam, Komal/0000-0001-9761-8445	Astra-Zeneca Spain grant [PAM-000-2017-01]; Astra-Zeneca Spain	Astra-Zeneca Spain grant; Astra-Zeneca Spain(AstraZeneca)	This study was supported in part by Astra-Zeneca Spain grant PAM-000-2017-01 to PA. The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript.r This study was supported in part by Astra-Zeneca Spain. The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript. The authors thank Tom Yohannan for medical writing services.	Allen SC, 2006, AGE AGEING, V35, P304, DOI 10.1093/ageing/afj090; Allen S, 2008, CLIN RESPIR J, V2, P208, DOI 10.1111/j.1752-699X.2008.00063.x; Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; Almagro P, 2017, LANCET RESP MED, V5, P367, DOI 10.1016/S2213-2600(17)30133-9; [Anonymous], 2018, PLAN ATENCION INTEGR; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bellia V, 2008, THORAX, V63, P60, DOI 10.1136/thx.2007.080572; Bellia V, 2000, AM J RESP CRIT CARE, V161, P1094, DOI 10.1164/ajrccm.161.4.9810093; CARVALHAESNETO N, 1995, AM J RESP CRIT CARE, V152, P1611, DOI 10.1164/ajrccm.152.5.7582303; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clerencia-Sierra M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132909; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; de Queiroz RS, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e374; Diez-Manglano J, 2015, INTERN EMERG MED, V10, P915, DOI 10.1007/s11739-015-1252-2; Eikhof KD, 2017, EUR CLIN RESPIR J, V4, DOI 10.1080/20018525.2017.1292376; Fernandez-Villar A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194983; Goncalves JMF, 2017, MED CLIN-BARCELONA, V149, P483, DOI 10.1016/j.medcli.2017.05.034; Fogg C, 2018, INT J GERIATR PSYCH, V33, P1177, DOI 10.1002/gps.4919; Garcia-Rio F, 2013, ARCH BRONCONEUMOL, V49, P388, DOI 10.1016/j.arbres.2013.04.001; Haynes JM, 2014, RESP CARE, V59, P16, DOI 10.4187/respcare.02331; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jing JY, 2009, CHEST, V135, P991, DOI 10.1378/chest.08-0723; Johnston MC, 2019, EUR J PUBLIC HEALTH, V29, P182, DOI 10.1093/eurpub/cky098; Kjeldgaard P, 2017, INT J CHRONIC OBSTR, V12, P2323, DOI 10.2147/COPD.S136244; Krumholz HM, 2013, NEW ENGL J MED, V368, P100, DOI 10.1056/NEJMp1212324; Llordes M, 2017, COPD, V14, P43, DOI 10.1080/15412555.2016.1239703; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; Lorenzo Hernandez Maria Vanesa, 2017, Rev Esp Geriatr Gerontol, V52, P193, DOI 10.1016/j.regg.2016.08.006; Lopez-Campos JL, 2016, RESPIROLOGY, V21, P14, DOI 10.1111/resp.12660; MAHONEY F I, 1965, Md State Med J, V14, P61; Matsuo H, 2017, GERIATR GERONTOL INT, V17, P1610, DOI 10.1111/ggi.12941; Melbye Hasse, 2006, Prim Care Respir J, V15, P294, DOI 10.1016/j.pcrj.2006.07.002; Perez-Padilla R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067960; Pezzoli L, 2003, AGE AGEING, V32, P43, DOI 10.1093/ageing/32.1.43; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Represas-Represas C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145571; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; SHERMAN CB, 1993, AM REV RESPIR DIS, V148, P123, DOI 10.1164/ajrccm/148.1.123; Singh B, 2013, MAYO CLIN PROC, V88, P1222, DOI 10.1016/j.mayocp.2013.08.012; Sorino C, 2011, CLIN PHYSIOL FUNCT I, V31, P101, DOI 10.1111/j.1475-097X.2010.00984.x; Turkeshi E, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.48; Vandevoorde J, 2006, EUR RESPIR J, V27, P378, DOI 10.1183/09031936.06.00036005; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Yarnall AJ, 2017, AGE AGEING, V46, P882, DOI 10.1093/ageing/afx150	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220491	10.1371/journal.pone.0220491	http://dx.doi.org/10.1371/journal.pone.0220491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374087	gold, Green Published, Green Submitted			2022-12-27	WOS:000484991500015
J	Klein-Joebstl, D; Quijada, NM; Dzieciol, M; Feldbacher, B; Wagner, M; Drillich, M; Schmitz-Esser, S; Mann, E				Klein-Joebstl, Daniela; Quijada, Narciso M.; Dzieciol, Monika; Feldbacher, Benjamin; Wagner, Martin; Drillich, Marc; Schmitz-Esser, Stephan; Mann, Evelyne			Microbiota of newborn calves and their mothers reveals possible transfer routes for newborn calves' gastrointestinal microbiota	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOTA; BACTERIA; CHEESE; BIODIVERSITY; COMMUNITIES; DIVERSITY; SEQUENCES; COLOSTRUM; MILK	The intestinal microbiota of newborns plays an important role in the development of immunity and metabolism. In livestock animals, knowledge of the intestinal microbiota is essential not only to prevent diseases but also to optimize weight gain and performance. The aim of our study was to examine faecal samples repeatedly within the first two days of life using 16S rRNA gene High Throughput Sequencing. Additionally, samples from the mouths of the calves and the vaginas, colostrum, and faeces of the dams were included to evaluate possible sources of the calf faecal microbiota. The calf faecal microbiota was highly variable during the first 48 hours post natum (p.n.). Significant changes were found in species diversity and richness, in copy numbers evaluated by qPCR and in predominant bacteria over time. The most pronounced changes occurred between 6 and 24 hours p.n. All calf faecal samples were dominated by Operational Taxonomic Units (OTUs) belonging to the family Enterobacteriaceae. Cow faecal samples showed significantly higher species richness, diversity, number of observed OTUs, and copy numbers compared to all other samples. OTUs belonging to the family Ruminococcaceae were most abundant in cow faecal and vaginal samples. Colostrum was dominated by Enhydrobacter affiliated OTUs. To identify possible inoculation routes for the calf microbiota, we analysed OTU sharing between samples. The calf microbiota during the first two days of life was clearly distinct from the dam's faecal microbiota. Furthermore, colostrum microbiota clearly differed from calf and cow faecal microbiota and thus most likely does not play an important role as inoculation source for calf microbiota during the first two days of life. In contrast, the cow vaginal and the calf faecal microbiota were more similar, suggesting that some of the calf faecal microbiota may derive from inoculation from the birth canal during birth.	[Klein-Joebstl, Daniela; Feldbacher, Benjamin; Drillich, Marc] Univ Vet Med Vienna, Univ Clin Ruminants, Dept Farm Anim & Vet Publ Hlth, Clin Unit Herd Hlth Management, Vienna, Austria; [Quijada, Narciso M.] Inst Tecnol Agr Castilla & Leon, Lab Mol Biol & Microbiol, Valladolid, Spain; [Dzieciol, Monika; Feldbacher, Benjamin; Wagner, Martin; Mann, Evelyne] Univ Vet Med Vienna, Inst Milk Hyg Milk Technol & Food Sci, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Schmitz-Esser, Stephan] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Iowa State University	Klein-Joebstl, D (corresponding author), Univ Vet Med Vienna, Univ Clin Ruminants, Dept Farm Anim & Vet Publ Hlth, Clin Unit Herd Hlth Management, Vienna, Austria.	Daniela.Klein@vetmeduni.ac.at	Dzieciol, Monika/ABC-7284-2020; Schmitz-Esser, Stephan/AAA-7287-2019; Selberherr, Evelyne/I-3795-2014; Selberherr, Evelyne/AAM-9702-2021; Quijada, Narciso Martin/HII-5674-2022	Dzieciol, Monika/0000-0002-0972-6241; Schmitz-Esser, Stephan/0000-0002-1907-0709; Selberherr, Evelyne/0000-0002-2253-5247; Klein-Jobstl, Daniela/0000-0001-5806-7601; Quijada, Narciso M./0000-0002-1956-7205; Drillich, Marc/0000-0002-2824-8185	University of Veterinary Medicine Vienna; Spanish National Institute for Agriculture and Food Research and Technology (INIA) - European Social Fund [FPI2014-020]; COST action [STSM-FA1202]	University of Veterinary Medicine Vienna; Spanish National Institute for Agriculture and Food Research and Technology (INIA) - European Social Fund; COST action(European Cooperation in Science and Technology (COST))	The authors received funding from: 1. start-up project (Profillinie 2) by the University of Veterinary Medicine Vienna; (no award number available); Recipient Daniela Klein-Jobstl; 2. Ph.D. studentship from the Spanish National Institute for Agriculture and Food Research and Technology (INIA) cofinanced by the European Social Fund; number: FPI2014-020; Recipient Narciso M. Quijada; and 3. COST action; STSM-FA1202; Recipient Narciso M. Quijada.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Aldrete-Tapia A, 2014, FOOD MICROBIOL, V44, P136, DOI 10.1016/j.fm.2014.05.022; Alegria A, 2012, APPL ENVIRON MICROB, V78, P1890, DOI 10.1128/AEM.06081-11; Alipour MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28733-y; Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Collado MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23129; Chase CCL, 2018, VET CLIN N AM-FOOD A, V34, P1, DOI 10.1016/j.cvfa.2017.10.006; Chen PW, 2018, J FOOD DRUG ANAL, V26, P1235, DOI 10.1016/j.jfda.2018.03.004; Clemmons BA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01047; Dill-McFarland KA, 2017, SCI REP-UK, V7, DOI 10.1038/srep40864; Dogra S, 2015, GUT MICROBES, V6, P321, DOI 10.1080/19490976.2015.1078051; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Drago L, 2017, ISME J, V11, P875, DOI 10.1038/ismej.2016.183; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edrington TS, 2012, J DAIRY SCI, V95, P4519, DOI 10.3168/jds.2011-5119; Gritz EC, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00017; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jeon SJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0328-9; Karstrup CC, 2017, THERIOGENOLOGY, V99, P41, DOI 10.1016/j.theriogenology.2017.05.013; Kawamura Y, 2012, MICROBIOL IMMUNOL, V56, P21, DOI 10.1111/j.1348-0421.2011.00401.x; Kim M, 2014, J ANIM SCI, V92, P683, DOI 10.2527/jas.2013-6841; Klein-Jobstl D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00622; Korpela K, 2018, CURR OPIN MICROBIOL, V44, P70, DOI 10.1016/j.mib.2018.06.003; Korpela K, 2018, GENOME RES, V28, P561, DOI 10.1101/gr.233940.117; Laguardia-Nascimento M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143294; Lim ES, 2016, TRENDS MICROBIOL, V24, P801, DOI 10.1016/j.tim.2016.06.001; Lima SF, 2017, J DAIRY SCI, V100, P3031, DOI 10.3168/jds.2016-11604; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Malmuthuge N, 2017, J DAIRY SCI, V100, P5996, DOI 10.3168/jds.2016-12239; Malmuthuge N, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00036; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Martinez KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197439; Mayer M, 2012, VET MICROBIOL, V161, P179, DOI 10.1016/j.vetmic.2012.07.023; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meale SJ, 2017, J DAIRY SCI, V100, P5984, DOI 10.3168/jds.2016-12474; Metzler-Zebeli BU, 2013, ANAEROBE, V20, P65, DOI 10.1016/j.anaerobe.2013.02.005; Mueller NT, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120364; Obermajer T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10244-x; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Ozutsumi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1793, DOI 10.1271/bbb.69.1793; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Prunner I, 2014, THERIOGENOLOGY, V82, P857, DOI 10.1016/j.theriogenology.2014.06.015; Riquelme C, 2015, INT J FOOD MICROBIOL, V192, P86, DOI 10.1016/j.ijfoodmicro.2014.09.031; Sakwinska O, 2017, BENEF MICROBES, V8, P763, DOI 10.3920/BM2017.0064; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shanks OC, 2011, APPL ENVIRON MICROB, V77, P2992, DOI 10.1128/AEM.02988-10; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Toscano M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02100; Uyeno Y, 2010, LETT APPL MICROBIOL, V51, P570, DOI 10.1111/j.1472-765X.2010.02937.x; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yeoman CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21440-8	57	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220554	10.1371/journal.pone.0220554	http://dx.doi.org/10.1371/journal.pone.0220554			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369600	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900064
J	von May, R; Catenazzi, A; Santa-Cruz, R; Gutierrez, AS; Moritz, C; Rabosky, DL				von May, Rudolf; Catenazzi, Alessandro; Santa-Cruz, Roy; Gutierrez, Andrea S.; Moritz, Craig; Rabosky, Daniel L.			Thermal physiological traits in tropical lowland amphibians: Vulnerability to climate warming and cooling	PLOS ONE			English	Article							MANU NATIONAL-PARK; PHYLOGENETIC SIGNAL; DIURNAL ACTIVITY; EASTERN SLOPES; HEAT TOLERANCE; EVOLUTION; FROGS; LATITUDE; TEMPERATURE; DIVERGENCE	Climate change is affecting biodiversity and ecosystem function worldwide, and the lowland tropics are of special concern because organisms living in this region experience temperatures that are close to their upper thermal limits. However, it remains unclear how and whether tropical lowland species will be able to cope with the predicted pace of climate warming. Additionally, there is growing interest in examining how quickly thermal physiological traits have evolved across taxa, and whether thermal physiological traits are evolutionarily conserved or labile. We measured critical thermal maximum (CTmax) and minimum (CTmin) in 56 species of lowland Amazonian frogs to determine the extent of phylogenetic conservatism in tolerance to heat and cold, and to predict species' vulnerability to climate change. The species we studied live in sympatry and represent similar to 65% of the known alpha diversity at our study site. Given that critical thermal limits may have evolved differently in response to different temperature constraints, we tested whether CTmax and CTmin exhibit different rates of evolutionary change. Measuring both critical thermal traits allowed us to estimate species' thermal breadth and infer their potential to respond to abrupt changes in temperature (warming and cooling). Additionally, we assessed the contribution of life history traits and found that both critical thermal traits were correlated with species' body size and microhabitat use. Specifically, small direct-developing frogs in the Strabomantidae family appear to be at highest risk of thermal stress while tree frogs (Hylidae) and narrow mouthed frogs (Microhylidae) tolerate higher temperatures. While CTmax and CTmin had considerable variation within and among families, both critical thermal traits exhibited similar rates of evolutionary change. Our results suggest that 4% of lowland rainforest frogs assessed will experience temperatures exceeding their CTmax, 25% might be moderately affected and 70% are unlikely to experience pronounced heat stress under a hypothetical 3 degrees C temperature increase.	[von May, Rudolf; Rabosky, Daniel L.] Univ Michigan, Museum Zool, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [von May, Rudolf; Moritz, Craig] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Catenazzi, Alessandro] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Santa-Cruz, Roy] Univ Nacl San Agustin MUSA, Area Herpetol, Museo Hist Nat, Arequipa, Peru; [Gutierrez, Andrea S.] Univ Nacl Agr La Molina, Fac Ciencias Biol, Lima, Peru; [Moritz, Craig] Australian Natl Univ, Ctr Biodivers Anal & Res Sch Biol, Canberra, ACT, Australia	University of Michigan System; University of Michigan; University of California System; University of California Berkeley; State University System of Florida; Florida International University; Universidad Nacional de San Agustin de Arequipa; University Nacional Agraria La Molina; Australian National University	von May, R (corresponding author), Univ Michigan, Museum Zool, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.; von May, R (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	rvonmay@gmail.com	Catenazzi, Alessandro/C-8615-2009	Catenazzi, Alessandro/0000-0002-3650-4783; von May, Rudolf/0000-0003-3981-2615; Santa-Cruz, Roy/0000-0002-0448-0270	National Science Foundation [DBI-1103087]; American Philosophical Society; National Geographic Society [9191-12]; Amazon Conservation Association; Swiss National Science Foundation [116305]; Rufford Small Grants Foundation; Chicago Board of Trade Endangered Species Fund; Amphibian Specialist Group; Disney Worldwide Conservation Fund	National Science Foundation(National Science Foundation (NSF)); American Philosophical Society; National Geographic Society(National Geographic Society); Amazon Conservation Association; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Rufford Small Grants Foundation; Chicago Board of Trade Endangered Species Fund; Amphibian Specialist Group; Disney Worldwide Conservation Fund	Research was supported with grants from the National Science Foundation (Postdoctoral Research Fellowship DBI-1103087), the American Philosophical Society, and the National Geographic Society (Grant #9191-12) to RvM; the Amazon Conservation Association to RvM and A. Catenazzi; and the Swiss National Science Foundation (#116305), the Rufford Small Grants Foundation, the Chicago Board of Trade Endangered Species Fund, the Amphibian Specialist Group and the Disney Worldwide Conservation Fund to A. Catenazzi. D. L. Rabosky thanks the David and Lucile Packard Foundation. A. Catenazzi thanks the Amazon Center for Environmental Education and Research for support during field courses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2013, SYST BIOL, V62, P181, DOI 10.1093/sysbio/sys083; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Ashton KG, 2004, J EVOLUTION BIOL, V17, P1157, DOI 10.1111/j.1420-9101.2004.00764.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bovo RP, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10040118; Brusch GA, 2016, OECOLOGIA, V180, P325, DOI 10.1007/s00442-015-3467-3; Burnham KP., 2004, MODEL SELECTION MULT, V2, DOI 10.1007/b97636; Bush MB, 2004, J QUATERNARY SCI, V19, P677, DOI 10.1002/jqs.883; Catenazzi A, 2001, MANU OTRAS EXPERIENC, P53; Catenazzi A, 2016, PEERJ, V4, DOI 10.7717/peerj.2072; Catenazzi A, 2014, CONSERV BIOL, V28, P509, DOI 10.1111/cobi.12194; Catenazzi A, 2013, BIOTA NEOTROP, V13, P269, DOI 10.1590/S1676-06032013000400024; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; CHRISTIAN KA, 1988, BIOTROPICA, V20, P236, DOI 10.2307/2388239; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Corl A, 2010, EVOLUTION, V64, P79, DOI 10.1111/j.1558-5646.2009.00791.x; Doan TM, 2004, J HERPETOL, V38, P422, DOI 10.1670/155-03N; Franken O, 2018, OECOLOGIA, V186, P311, DOI 10.1007/s00442-017-4032-z; Gunderson AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0401; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey P. H., 1991, COMP METHOD EVOLUTIO; HEATWOLE H, 1968, COMP BIOCHEM PHYSIOL, V27, P807, DOI 10.1016/0010-406X(68)90620-8; Heinicke MP, 2018, MOL PHYLOGENET EVOL, V118, P145, DOI 10.1016/j.ympev.2017.09.021; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; IPCC, 2014, CONTRIBUTION WORKING; Katzenberger M, 2018, J THERM BIOL, V76, P171, DOI 10.1016/j.jtherbio.2018.07.005; Londono GA, 2015, FUNCT ECOL, V29, P338, DOI 10.1111/1365-2435.12348; Marengo J, 1997, MON WEATHER REV, V125, P2759, DOI 10.1175/1520-0493(1997)125<2759:CSITAE>2.0.CO;2; Marengo J, 1984, REV FORESTAL PERU, V12, P55; Marengo JA, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00228; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Munoz MM, 2016, EVOLUTION, V70, P2537, DOI 10.1111/evo.13064; Munoz MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2433; Navas CA, 2007, COMP BIOCHEM PHYS A, V147, P647, DOI 10.1016/j.cbpa.2006.04.035; Nowakowski AJ, 2018, ECOL LETT, V21, P345, DOI 10.1111/ele.12901; Nowakowski AJ, 2017, CONSERV BIOL, V31, P96, DOI 10.1111/cobi.12769; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Rambaut A., 2007, TRACER V1 4; Renton K, 2002, J FIELD ORNITHOL, V73, P15, DOI 10.1648/0273-8570-73.1.15; Revell LJ, 2008, AM NAT, V172, P140, DOI 10.1086/588078; REVELL LJ, 2010, METHODS ECOLOGY EVOL, V3, P217; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rowley Jodi J. L., 2007, Herpetological Review, V38, P308; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Tracy CR, 2013, AUSTRAL ECOL, V38, P476, DOI 10.1111/j.1442-9993.2012.02416.x; von May R, 2018, TROP CONSERV SCI, V11, DOI 10.1177/1940082918797057; von May R, 2018, PEERJ, V6, DOI 10.7717/peerj.4313; von May R, 2017, ECOL EVOL, V7, P3257, DOI 10.1002/ece3.2929; von May R, 2010, J TROP ECOL, V26, P509, DOI 10.1017/S0266467410000301; von May R, 2009, HERPETOL CONSERV BIO, V4, P14; von May R, 2009, AUSTRAL ECOL, V34, P613, DOI 10.1111/j.1442-9993.2009.01965.x; Warren RJ, 2013, GLOBAL CHANGE BIOL, V19, P2082, DOI 10.1111/gcb.12169; Williams Stephen E, 2008, PLoS Biol, V6, P2621, DOI 10.1371/journal.pbio.0060325	65	18	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219759	10.1371/journal.pone.0219759	http://dx.doi.org/10.1371/journal.pone.0219759			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369565	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900017
J	Palaniappan, M; Nguyen, L; Grimm, SL; Xi, YX; Xia, Z; Li, W; Coartam, C				Palaniappan, Murugesan; Loc Nguyen; Grimm, Sandra L.; Xi, Yuanxin; Xia, Zheng; Li, Wei; Coartam, Cristian			The genomic landscape of estrogen receptor alpha binding sites in mouse mammary gland	PLOS ONE			English	Article							BREAST-CANCER; ER-ALPHA; MOLECULAR PORTRAITS; SIGNALING PATHWAYS; WIDE ANALYSIS; TARGET GENE; CHIP-SEQ; MORPHOGENESIS; EXPRESSION; GATA3	Estrogen receptor alpha (ER alpha) is the major driving transcription factor in the mammary gland development as well as breast cancer initiation and progression. However, the genomic landscape of ER alpha binding sites in the normal mouse mammary gland has not been completely elucidated. Here, we mapped genome-wide ER alpha binding events by chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) in the mouse mammary gland in response to estradiol. We identified 6237 high confidence ER alpha binding sites in two biological replicates and showed that many of these were located at distal enhancer regions. Furthermore, we discovered 3686 unique genes in the mouse genome that recruit ER in response to estradiol. Interrogation of ER-DNA binding sites in ER-positive luminal epithelial cells showed that the ERE, PAX2, SF1, and AP1 motifs were highly enriched at distal enhancer regions. In addition, comprehensive transcriptome analysis by RNA-seq revealed that 493 genes are differentially regulated by acute treatment with estradiol in the mouse mammary gland in vivo. Through integration of RNA-seq and ER alpha ChIP-seq data, we uncovered a novel ER alpha targetome in mouse mammary epithelial cells. Taken together, our study has identified the genomic landscape of ER alpha binding events in mouse mammary epithelial cells. Furthermore, our study also highlights the cis-regulatory elements and cofactors that are involved in estrogen signaling and may contribute to ductal elongation in the normal mouse mammary gland.	[Palaniappan, Murugesan; Loc Nguyen; Grimm, Sandra L.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Xi, Yuanxin; Xia, Zheng; Li, Wei] Baylor Coll Med, Div Biostat, Duncan L Canc Ctr, Houston, TX 77030 USA; [Coartam, Cristian] Baylor Coll Med, Duncan L Canc Ctr, Houston, TX 77030 USA; [Coartam, Cristian] Baylor Coll Med, Adv Technol Core, Houston, TX 77030 USA; [Palaniappan, Murugesan] Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA; [Palaniappan, Murugesan] Baylor Coll Med, Ctr Drug Discovery, One Baylor Plaza, Houston, TX 77030 USA; [Xi, Yuanxin] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Xia, Zheng] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University	Palaniappan, M (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Palaniappan, M (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA.; Palaniappan, M (corresponding author), Baylor Coll Med, Ctr Drug Discovery, One Baylor Plaza, Houston, TX 77030 USA.	palaniap@bcm.edu	Xia, Zheng/AAC-5360-2022	Xia, Zheng/0000-0003-3364-8324; PALANIAPPAN, MURUGESAN/0000-0003-4916-6565	CPRIT grant [RP110471-P3]	CPRIT grant	This work was supported by funding from CPRIT grant RP110471-P3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JM, 2010, BREAST CANCER RES TR, V119, P491, DOI 10.1007/s10549-008-0269-x; Asch-Kendrick R, 2016, HUM PATHOL, V48, P37, DOI 10.1016/j.humpath.2015.09.035; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Caizzi L, 2014, P NATL ACAD SCI USA, V111, P4892, DOI 10.1073/pnas.1315445111; Cakir A, 2017, PATHOL RES PRACT, V213, P227, DOI 10.1016/j.prp.2016.12.010; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2017, NAT REV CANCER, V17, P54, DOI 10.1038/nrc.2016.116; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chanock SJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1637; Chung D, 2015, MOL CELL ENDOCRINOL, V400, P48, DOI 10.1016/j.mce.2014.11.002; Ciarloni L, 2007, P NATL ACAD SCI USA, V104, P5455, DOI 10.1073/pnas.0611647104; Conneely O M, 2007, Ernst Schering Found Symp Proc, P45; Dall GV, 2018, J ENDOCRINOL, V237, P323, DOI 10.1530/JOE-17-0582; Dennis G, 2003, GENOME BIOL, V4; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Dupont S, 2000, DEVELOPMENT, V127, P4277; Durchdewald M, 2008, CANCER RES, V68, P6877, DOI 10.1158/0008-5472.CAN-08-0299; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; Franco HL, 2015, MOL CELL, V58, P21, DOI 10.1016/j.molcel.2015.02.001; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Garcia-Closas M, 2007, CANCER EPIDEM BIOMAR, V16, P2269, DOI 10.1158/1055-9965.EPI-07-0449; Ghosh MG, 2000, CANCER RES, V60, P6367; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grober OMV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-36; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korach KS, 1996, RECENT PROG HORM RES, V51, P159; Korach KS, 1996, RECENT PROG HORM RES, V51, P86; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Lain AR, 2013, MOL ENDOCRINOL, V27, P1743, DOI 10.1210/me.2013-1144; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Marinov GK, 2014, G3-GENES GENOM GENET, V4, P209, DOI 10.1534/g3.113.008680; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Mueller SO, 2002, ENDOCRINOLOGY, V143, P2357, DOI 10.1210/en.143.6.2357; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; Mulac-Jericevic B, 2003, P NATL ACAD SCI USA, V100, P9744, DOI 10.1073/pnas.1732707100; Murakami S, 2017, GENE DEV, V31, P1535, DOI 10.1101/gad.302182.117; Nautiyal J, 2013, DEVELOPMENT, V140, P1079, DOI 10.1242/dev.085720; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Palaniappan M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194913; Panigrahi AK, 2018, MOL CELL, V70, P679, DOI 10.1016/j.molcel.2018.04.014; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rae JM, 2005, BREAST CANCER RES TR, V92, P141, DOI 10.1007/s10549-005-1483-4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Shan L, 2014, ONCOGENE, V33, P3205, DOI 10.1038/onc.2013.270; Siersbaek R, 2018, GENE DEV, V32, P1141, DOI 10.1101/gad.316646.118; Sisto M, 2017, ARCH IMMUNOL THER EX, V65, P477, DOI 10.1007/s00005-017-0478-2; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Stingl John, 2011, Hormones & Cancer, V2, P85, DOI 10.1007/s12672-010-0055-1; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yi P, 2017, MOL CELL, V67, P733, DOI 10.1016/j.molcel.2017.07.026; Zhao GQ, 1998, DEVELOPMENT, V125, P1103	80	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220311	10.1371/journal.pone.0220311	http://dx.doi.org/10.1371/journal.pone.0220311			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408468	Green Published, gold, Green Submitted			2022-12-27	WOS:000485009500011
J	Xie, SZ; Cai, BH; Rasidi, E; Yen, CC; Hsu, CD; Chow, WT; De Busscher, V; Hsu, L				Xie, Shangzhe; Cai, Bohong; Rasidi, Ellen; Yen, Ching-Chivan; Hsu, Chia-da; Chow, Wai Tung; De Busscher, Virginie; Hsu, Li Chieh			The use of a 3D-printed prosthesis in a Great Hornbill (Buceros bicornis) with squamous cell carcinoma of the casque	PLOS ONE			English	Article							SURGICAL GUIDES; 3D; SURGERY	The advent of new technologies in medical imaging and 3D printing in recent years has made customization of surgical tools and implants more accessible, revolutionizing many surgical fields. In many human diseases, these implants have led to superior surgical outcomes and greatly improved patients' quality of life. Thus, it is of great interest to apply these technologies to the treatment of animal diseases. In this study, we report the use of computed tomography (CT) and 3D printing for the treatment of a Great Hornbill at Jurong Bird Park that was diagnosed with squamous cell carcinoma of the casque. A 3D printed prosthesis that perfectly fitted the subject was implanted to replace its resected casque. The subject exhibited natural eating behaviour with no post-operative complications. Using this case as an example, the positive outcomes suggest a great potential in applying these technologies to the treatment of other wildlife diseases.	[Xie, Shangzhe; Rasidi, Ellen; Hsu, Chia-da] Wildlife Reserves Singapore, Singapore, Singapore; [Cai, Bohong; Yen, Ching-Chivan; Chow, Wai Tung] Natl Univ Singapore, Keio NUS CUTE Ctr, Smart Syst Inst, Singapore, Singapore; [Yen, Ching-Chivan] Natl Univ Singapore, Sch Design & Environm, Div Ind Design, Singapore, Singapore; [De Busscher, Virginie] Vet Emergency & Specialty Hosp, Singapore, Singapore; [Hsu, Li Chieh] Anim Clin, Singapore, Singapore	National University of Singapore; National University of Singapore	Xie, SZ (corresponding author), Wildlife Reserves Singapore, Singapore, Singapore.	shangzhe.xie@wrs.com.sg	Xie, Shangzhe/AAQ-4480-2021; Rasidi, Ellen/CAJ-0581-2022; Yen, Ching Chiuan/C-5029-2017	Xie, Shangzhe/0000-0001-7880-5261; Cai, Bohong/0000-0001-8441-2747; Yen, Ching Chiuan/0000-0003-4325-1689	National Research Foundation, Prime Minister's Office, Singapore under its International Research Centres in Singapore Funding Initiative	National Research Foundation, Prime Minister's Office, Singapore under its International Research Centres in Singapore Funding Initiative	The 3D printing related design and research is supported by the National Research Foundation, Prime Minister's Office, Singapore under its International Research Centres in Singapore Funding Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The 3D printing related design and research is supported by the National Research Foundation, Prime Minister's Office, Singapore under its International Research Centres in Singapore Funding Initiative. We would also like to thank all the members of the Wildlife Reserves Singapore/Jurong Bird Park Avian Department and veterinary team who were involved in the care of the patient.	Bauer A, 2011, BRIT J DERMATOL, V165, P612, DOI 10.1111/j.1365-2133.2011.10425.x; Chen X, 2017, J NEUROSCI METH, V286, P38, DOI 10.1016/j.jneumeth.2017.05.013; Dahake SW, 2017, RAPID PROTOTYPING J, V23, P602, DOI 10.1108/RPJ-09-2015-0129; Gamble K. C, 2012, FOWLERS ZOO WILD ANI, DOI [10.1016/b978-1-4377-1986-4.00037-8, DOI 10.1016/B978-1-4377-1986-4.00037-8]; Gamble KC, 2007, J AVIAN MED SURG, V21, P38, DOI 10.1647/1082-6742(2007)21[38:IAOTHC]2.0.CO;2; Jung SY, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/4/045015; Lin HH, 2018, J FORMOS MED ASSOC, V117, P547, DOI 10.1016/j.jfma.2018.01.008; Louvrier A, 2017, J STOMATOL ORAL MAXI, V118, P206, DOI 10.1016/j.jormas.2017.07.002; Manucy TK, 1998, J AVIAN MED SURG, V12, P158; MILLER RE, 1985, J ZOO WILDLIFE MED, V16, P131, DOI 10.2307/20094768; OBENDORF DL, 1983, AUST VET J, V60, P62, DOI 10.1111/j.1751-0813.1983.tb05867.x; Popescu D, 2018, RAPID PROTOTYPING J, V24, P901, DOI 10.1108/RPJ-05-2017-0099; Shilo D, 2018, RAMBAM MAIMONIDES ME, V9, DOI 10.5041/RMMJ.10343; Sun W, 2002, COMPUT METH PROG BIO, V67, P85, DOI 10.1016/S0169-2607(01)00116-X; Wang FP, 2017, ONCOL LETT, V14, P4581, DOI 10.3892/ol.2017.6749; Zehnder AM, 2018, JAVMA-J AM VET MED A, V252, P309, DOI 10.2460/javma.252.3.309	16	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220922	10.1371/journal.pone.0220922	http://dx.doi.org/10.1371/journal.pone.0220922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408483	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500025
J	Chen, YY; Buceta, J				Chen, Yanyan; Buceta, Javier			A non-linear analysis of Turing pattern formation	PLOS ONE			English	Article							REACTION-DIFFUSION MODEL	Reaction-diffusion schemes are widely used to model and interpret phenomena in various fields. In that context, phenomena driven by Turing instabilities are particularly relevant to describe patterning in a number of biological processes. While the conditions that determine the appearance of Turing patterns and their wavelength can be easily obtained by a linear stability analysis, the estimation of pattern amplitudes requires cumbersome calculations due to non-linear terms. Here we introduce an expansion method that makes possible to obtain analytical, approximated, solutions of the pattern amplitudes. We check and illustrate the reliability of this methodology with results obtained from numerical simulations.	[Chen, Yanyan; Buceta, Javier] Lehigh Univ, Dept Bioengn, Iacocca Hall, Bethlehem, PA 18015 USA; [Buceta, Javier] Lehigh Univ, Dept Chem & Biomol Engn, Iacocca Hall, Bethlehem, PA 18015 USA	Lehigh University; Lehigh University	Buceta, J (corresponding author), Lehigh Univ, Dept Bioengn, Iacocca Hall, Bethlehem, PA 18015 USA.; Buceta, J (corresponding author), Lehigh Univ, Dept Chem & Biomol Engn, Iacocca Hall, Bethlehem, PA 18015 USA.	jbuceta@lehigh.edu	Buceta, Javier/ABB-1696-2021	Buceta, Javier/0000-0003-1791-0011	National Institutes of Health [1R15GM123422-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM123422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JB was supported by National Institutes of Health 1R15GM123422-01A1 (https://www.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S, 2015, INT J BIOMATH, V8, DOI 10.1142/S1793524515500060; Ball P, 1999, THE SELF MADE TAPEST, V198; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Brechmann P, 2018, MATH BIOSCI, V306, P152, DOI 10.1016/j.mbs.2018.09.012; Buceta J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.069902; Buceta J, 2003, PHYSICA A, V325, P230, DOI 10.1016/S0378-4371(03)00202-4; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Diego X, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021071; Dolnik M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.026101; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Engelhardt R., 1994, THESIS; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Glock P, 2019, ACS SYNTH BIOL, V8, P148, DOI 10.1021/acssynbio.8b00415; Hentschel HGE, 2004, P ROY SOC B-BIOL SCI, V271, P1713, DOI 10.1098/rspb.2004.2772; Jia YF, 2018, INT J BIOMATH, V11, DOI 10.1142/S1793524518500250; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Loose M, 2011, ANNU REV BIOPHYS, V40, P315, DOI 10.1146/annurev-biophys-042910-155332; Maini PK, 2012, INTERFACE FOCUS, V2, P487, DOI 10.1098/rsfs.2011.0113; Malchow H., 2007, SPATIOTEMPORAL PATTE, DOI DOI 10.1201/9781482286137; MEINHARDT H, 1984, Journal of Embryology and Experimental Morphology, V83, P289; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; Murray JD., 2001, INTERDISCIPLINARY AP, V18; NEWELL AC, 1969, J FLUID MECH, V38, P279, DOI 10.1017/S0022112069000176; Raspopovic J, 2014, SCIENCE, V345, P566, DOI 10.1126/science.1252960; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Schiesser W., 2012, NUMERICAL METHOD LIN; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wang W. Z., 2011, J ANHUI AGR U SOCIAL, V20, P7, DOI DOI 10.1088/1674-1056/20/7/074702; WolframResearch Inc., 2019, MATH VERS 12 0	31	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220994	10.1371/journal.pone.0220994	http://dx.doi.org/10.1371/journal.pone.0220994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398237	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000039
J	Hurtado, MO; Wolbert, J; Fisher, J; Flutter, B; Stafford, S; Barton, J; Jain, N; Barone, G; Majani, Y; Anderson, J				Hurtado, Marina Olle; Wolbert, Jolien; Fisher, Jonathan; Flutter, Barry; Stafford, Sian; Barton, Jack; Jain, Neha; Barone, Giuseppe; Majani, Yvonne; Anderson, John			Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function	PLOS ONE			English	Article							ADOPTIVE CELL TRANSFER; MHC CLASS-I; T-CELLS; METASTATIC MELANOMA; NKT CELLS; EXPRESSION; THERAPY; TARGET; COMBINATION; GENERATION	Adoptive transfer of ex vivo expanded tumor infiltrating lymphocytes (TILs) has led to clinical benefit in some patients with melanoma but has not demonstrated convincing efficacy in other solid cancers. Whilst the presence of TILs in many types of cancer is often associated with better clinical prognosis, their function has not been systematically evaluated across cancer types. Responses to immunological checkpoint inhibitors in a wide range of cancers, including those for which adoptive transfer of expanded TILs has not shown clinical benefit, has clearly delineated a number of tumor type associated with tumor-reactive lymphocytes capable of effecting tumor remissions. Neuroblastoma is an aggressive childhood solid cancer in which immunotherapy with GD2-directed antibodies confers a proven survival advantage through incompletely understood mechanisms. We therefore evaluated the feasibility of ex vivo expansion of TILs from freshly resected neuroblastoma tumors and the potential therapeutic utility of TIL expansions. TILs were successfully expanded from both tumor biopsies or resections. Significant numbers of NKT and gamma delta T cells were identified alongside the mixed population of cytotoxic (CD8(+)) and helper (CD4(+)) T cells of both effector and central memory phenotypes. Isolated TILs were broadly non-reactive against autologous tumor and neuroblastoma cell lines, so enhancement of neuroblastoma killing was attained by transducing TILs with a second-generation chimeric antigen receptor (CAR) targeting GD2. CAR-TILs demonstrated antigen-specific cytotoxicity against tumor cell lines. This study is the first to show reproducible expansion of TILs from pediatric neuroblastoma, the high proportion of innate-like lymphocytes, and the feasibility to use CAR-TILs therapeutically.	[Hurtado, Marina Olle; Wolbert, Jolien; Fisher, Jonathan; Flutter, Barry; Stafford, Sian; Barton, Jack; Majani, Yvonne; Anderson, John] UCL Great Ormond St Inst Child Hlth, Dev Biol & Canc Programme, Canc Sect, London, England; [Jain, Neha; Barone, Giuseppe; Anderson, John] Great Ormond St Hosp Sick Children, Dept Oncol, London, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Anderson, J (corresponding author), UCL Great Ormond St Inst Child Hlth, Dev Biol & Canc Programme, Canc Sect, London, England.; Anderson, J (corresponding author), Great Ormond St Hosp Sick Children, Dept Oncol, London, England.	j.anderson@ucl.ac.uk		Jain, Neha/0000-0002-8499-3366; Wolbert, Jolien/0000-0003-2684-5098; Fisher, Jonathan/0000-0003-3302-2241; Anderson, William/0000-0001-7509-3203; Flutter, Barry/0000-0002-8084-6369	Olivia Hodson Cancer Fund via GOSHCC; GOSHCC infrastructure award; Action Medical Research [GN2400]; NIHR GOSH Biomedical Research Centre; GOSHCC leadership grant; Wellcome Trust; Research in Childhood Cancer (RICC); Great Ormond Street Hospital Charity [W1134, VS0118, W1029, W1076]	Olivia Hodson Cancer Fund via GOSHCC; GOSHCC infrastructure award; Action Medical Research; NIHR GOSH Biomedical Research Centre; GOSHCC leadership grant; Wellcome Trust(Wellcome TrustEuropean Commission); Research in Childhood Cancer (RICC); Great Ormond Street Hospital Charity	This work was funded by awards from Olivia Hodson Cancer Fund via GOSHCC (MH and JW), GOSHCC infrastructure award (JB, BF), Action Medical Research (GN2400 to BF), NIHR GOSH Biomedical Research Centre (JA), GOSHCC leadership grant (JA), Wellcome Trust fellowship (JF), Research in Childhood Cancer (RICC) (JA), Great Ormond Street Hospital Charity (JA leadership award and grants W1134, VS0118, W1029 and W1076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Anderson J, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26548; Baldan V, 2015, BRIT J CANCER, V112, P1510, DOI 10.1038/bjc.2015.96; Barrett DM, 2014, ANNU REV MED, V65, P333, DOI 10.1146/annurev-med-060512-150254; Bollard CM, 2002, BLOOD, V99, P3179, DOI 10.1182/blood.V99.9.3179; Bouet-Toussaint F, 2000, EUR CYTOKINE NETW, V11, P217; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Cabrera T, 2003, CANCER IMMUNOL IMMUN, V52, P1, DOI 10.1007/s00262-002-0332-0; Carlson LM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23618; Eaton D, 2002, GENE THER, V9, P527, DOI 10.1038/sj.gt.3301685; Fisher J, 2015, ONCOIMMUNOLOGY, V4, P1; Fisher J, 2017, MOL THER, V25, P1234, DOI 10.1016/j.ymthe.2017.03.002; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Hall M, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0164-7; Harao M, 2017, CANCER IMMUNOL RES, V5, P439, DOI 10.1158/2326-6066.CIR-16-0364; HELLSTROM IE, 1968, P NATL ACAD SCI USA, V60, P1231, DOI 10.1073/pnas.60.4.1231; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Jiang SS, 2015, ONCOTARGET, V6, P41339, DOI 10.18632/oncotarget.5463; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Kodumudi KN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153053; Kroesen M, 2014, INT J CANCER, V134, P1335, DOI 10.1002/ijc.28463; Kunkele A, 2017, CLIN CANCER RES, V23, P466, DOI 10.1158/1078-0432.CCR-16-0354; Ladenstein R, 2017, LANCET ONCOL, V18, P500, DOI 10.1016/S1470-2045(17)30070-0; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; London WB, 2017, CANCER-AM CANCER SOC, V123, P4914, DOI 10.1002/cncr.30934; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Mina M., 2015, ONCOIMMUNOLOGY, V4, P1; Mullinax JE, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00044; Newick K, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.6; Philip B, 2014, BLOOD, V124, P1277, DOI 10.1182/blood-2014-01-545020; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Radvanyi LG, 2012, CLIN CANCER RES, V18, P6758, DOI 10.1158/1078-0432.CCR-12-1177; Raffaghello L, 2005, ONCOGENE, V24, P4634, DOI 10.1038/sj.onc.1208594; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schilbach KE, 2000, J IMMUNOTHER, V23, P536, DOI 10.1097/00002371-200009000-00004; Song L, 2007, J CLIN INVEST, V117, P2702, DOI 10.1172/JCI30751; Suzuki M, 2015, EXPERT OPIN THER TAR, V19, P349, DOI 10.1517/14728222.2014.986459; Thomas S, 2016, PLOS ONE, V11; Turcotte S, 2013, J IMMUNOL, V191, P2217, DOI 10.4049/jimmunol.1300538; Turtle CJ, 2016, J CLIN INVEST, V1, P1; Wesolowski R, 2014, J CARCINOG MUTAGEN, V5, DOI [10.4172/2157-2518.1000199, DOI 10.4172/2157-2518.1000199]; Wolfl M, 2005, CANCER IMMUNOL IMMUN, V54, P400, DOI 10.1007/s00262-004-0603-z; Wu R, 2012, CANCER J, V18, P160, DOI 10.1097/PPO.0b013e31824d4465; Yang SC, 2013, CANCER IMMUNOL IMMUN, V62, P727, DOI 10.1007/s00262-012-1378-2; Yannelli JR, 1996, INT J CANCER, V65, P413, DOI 10.1002/(SICI)1097-0215(19960208)65:4<413::AID-IJC3>3.0.CO;2-#; Yu SN, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0444-9	55	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0216373	10.1371/journal.pone.0216373	http://dx.doi.org/10.1371/journal.pone.0216373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398192	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000002
J	Jiang, J; Tang, MZ; Chen, JF; Yang, YW				Jiang, Jie; Tang, Meizhen; Chen, Junfeng; Yang, Yuewei			Identification and degradation characteristics of Bacillus cereus strain WD-2 isolated from prochloraz-manganese-contaminated soils	PLOS ONE			English	Article							BACTERIAL CONSORTIUM; BIODEGRADATION; PESTICIDES; CHLORPYRIFOS; MANGO; WATER	The bacterial strain WD-2, which was capable of efficiently degrading prochloraz-manganese, was isolated from soil contaminated with prochloraz-manganese, selected through enrichment culturing and identified as Bacillus cereus. Test results indicated that the optimal temperature and pH for bacterial growth were 35-40 degrees C and 7.0-8.0, respectively. The highest degradation rate was above 88-90% when the pH was 7.0 similar to 8.0 and reached a maximum value (90.7%) at approximately 8.0. In addition, the bacterium showed the greatest growth ability with an OD600 of 0.805 and the highest degradation rate (68.2%) when glucose was chosen as the carbon source, while the difference in nitrogen source had no obvious influence on bacterial growth. The degradation rate exceeded 80% when the NaCI concentration was 0 similar to 2% and the rate reached 89.2% at 1%. When the concentration was higher than 7%, the growth of WD-2 and the degradation of prochloraz-manganese were found to be inhibited, and the degradation rate was merely 8.5%. The results indicated that strain WD-2 was able to effectively degrade prochloraz-manganese and might contribute to the bioremediation of contaminated soils.	[Jiang, Jie; Tang, Meizhen; Chen, Junfeng; Yang, Yuewei] Qufu Normal Univ, Key Lab Nasihu Lake Wetland Ecosystem & Environm, Qufu, Shandong, Peoples R China	Qufu Normal University	Tang, MZ (corresponding author), Qufu Normal Univ, Key Lab Nasihu Lake Wetland Ecosystem & Environm, Qufu, Shandong, Peoples R China.	tmzh0816@163.com		Jiang, Jie/0000-0002-1095-3839	National Natural Science Fund of China [31700433, 31672314]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Fund of China (no. 31700433 and no. 31672314). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, ANN MICROBIOL, V62, P233, DOI 10.1007/s13213-011-0251-4; Asemoloye MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183373; Aziz A, 2018, ENVIRON TECHNOL, V39, P527, DOI 10.1080/09593330.2017.1305455; Belal ESB, 2018, ENVIRON ENG SCI, V35, P1194, DOI 10.1089/ees.2018.0111; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; COOKE BK, 1979, PESTIC SCI, V10, P467, DOI 10.1002/ps.2780100605; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gea FJ, 2010, CROP PROT, V29, P1021, DOI 10.1016/j.cropro.2010.06.006; Itoh K., 2015, JAPANESE J PESTIC SC, V39, P115, DOI [10.1584/jpestics.w14-05, DOI 10.1584/JPESTICS.W14-05]; Journal B., 2009, BRAZ J MICROBIOL, P893; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kurt S, 2003, CROP PROT, V22, P51, DOI 10.1016/S0261-2194(02)00097-2; Liu MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084769; Mehrparvar M, 2013, J AGR SCI TECH-IRAN, V15, P389; Pino N, 2011, INT BIODETER BIODEGR, V65, P827, DOI 10.1016/j.ibiod.2011.06.001; Prusky D, 2006, POSTHARVEST BIOL TEC, V42, P134, DOI 10.1016/j.postharvbio.2006.06.001; Prusky D, 1999, POSTHARVEST BIOL TEC, V15, P165, DOI 10.1016/S0925-5214(98)00082-9; RAINER B, 2006, FUNGICIDAL MIXTURES; Rutters H, 1999, J AGR FOOD CHEM, V47, P1242, DOI 10.1021/jf980429y; Singh DP, 2011, ENVIRON SCI POLLUT R, V18, P1351, DOI 10.1007/s11356-011-0472-x; Taha MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144071; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang MQ, 2012, MICROBIOL RES, V167, P299, DOI 10.1016/j.micres.2011.10.004; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yadav IC, 2015, SCI TOTAL ENVIRON, V511, P123, DOI 10.1016/j.scitotenv.2014.12.041; Zhang H, 2016, INT BIODETER BIODEGR, V106, P53, DOI 10.1016/j.ibiod.2015.10.005; Zhao RB, 2010, AGR SCI CHINA, V9, P695, DOI 10.1016/S1671-2927(09)60145-0	27	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220975	10.1371/journal.pone.0220975	http://dx.doi.org/10.1371/journal.pone.0220975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398235	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000034
J	Brinks, MV; Redd, T; Lambert, WE; Zaback, T; Randall, J; Field, T; Wilson, D				Brinks, Mitchell V.; Redd, Travis; Lambert, William E.; Zaback, Tosha; Randall, Joan; Field, Teresa; Wilson, David			Using registry data to characterize the incidence and causes of blindness in Oregon	PLOS ONE			English	Article							VISUAL IMPAIRMENT; TIME TRENDS	In the United States, there is no reliable data to describe the prevalence of eye diseases leading to visual impairment and little active surveillance to address this knowledge gap. Data that is readily available from many state blind registries may provide helpful information on trends and causes of blindness. We analyzed new registrations with the Oregon Commission for the Blind (OCB) and Oregon State Department of Administrative Services (DAS) from 1961 to 2016 for causes of and trends in blindness. Persons with blindness self-refer into the OCB registry and the Oregon State Department of Administrative Services (DAS) includes those receiving social security disability financial support and other state services. Data for 9,273 blind persons registered were analyzed. The most frequent causes of blindness were age related macular degeneration (AMD) 3,308 (38%), followed by diabetic retinopathy (DR) 729 (8%), congenital conditions 697 (8%), optic nerve atrophy 611 (7%), glaucoma 549 (6%), retinitis pigmentosa 546 (6%), retinopathy of prematurity192 (2%), cataract 180 (2%), and trauma 174 (2%). The mean age of onset of blindness was younger for Blacks (31 years) and Hispanics (33 years) than for Whites (44 years). Analysis of state-based registries can provide useful and locally relevant vision and eye health data where little information is otherwise available.	[Brinks, Mitchell V.; Redd, Travis; Zaback, Tosha; Randall, Joan; Wilson, David] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Lambert, William E.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [Field, Teresa] Oregon Commiss Blind, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University	Brinks, MV (corresponding author), Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA.	brinks@ohsu.edu		Zaback, Tosha/0000-0003-2028-9684	Research to Prevent Blindness (New York, NY)	Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB))	This study was supported by unrestricted departmental funding from Research to Prevent Blindness (New York, NY). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen N, 2016, CLIN EPIDEMIOL, V8, P613, DOI 10.2147/CLEP.S99507; [Anonymous], 2017, LEADING INDICATORS C; Belkin M, 2013, AM J OPHTHALMOL, V155, P404, DOI 10.1016/j.ajo.2012.09.017; Bressler NM, 2011, ARCH OPHTHALMOL-CHIC, V129, P709, DOI 10.1001/archophthalmol.2011.140; Bureau UC, 2016, OR QUICK FACTS OR QU; CDC, 2017, LONG TERM TRENDS DIA; Cruickshanks KJ, 2017, JAMA OPHTHALMOL, V135, P1417, DOI 10.1001/jamaophthalmol.2017.5001; EDERER F, 1986, AM J PUBLIC HEALTH, V76, P160, DOI 10.2105/AJPH.76.2.160; Foran S, 2003, OPHTHALMIC EPIDEMIOL, V10, P215, DOI 10.1076/opep.10.4.215.15906; Hyman L, 2001, OPHTHALMOLOGY, V108, P1751, DOI 10.1016/S0161-6420(01)00590-5; Moorhead HB, 1973, STAT BLINDNESS MODEL; Skaat A, 2012, AM J OPHTHALMOL, V153, P214, DOI 10.1016/j.ajo.2011.08.035; U. S. Bureau of the Census, 1963, CHAR POP 39, VI; U. S. Census Bureau, 2012, CPH139 US CENS BUR; Varma R, 2010, AM J OPHTHALMOL, V149, P713, DOI 10.1016/j.ajo.2009.12.011; Warne D, 2014, AM J PUBLIC HEALTH, V104, pS263, DOI 10.2105/AJPH.2013.301682; Welp A., 2016, MAKING EYE HLTH POPU; William Kandel JC, 2012, USDA EC RES SERVICE; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Zhang X, 2012, AM J OPHTHALMOL S, V154, pe1, DOI DOI 10.1016/J.AJ0.2011.08.045	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220983	10.1371/journal.pone.0220983	http://dx.doi.org/10.1371/journal.pone.0220983			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393957	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500090
J	Ganesan, C; Thomas, IC; Song, S; Sun, AJ; Sohlberg, EM; Tamura, MK; Chertow, GM; Liao, JC; Conti, S; Elliott, CS; Leppert, JT; Pao, AC				Ganesan, Calyani; Thomas, I-Chun; Song, Shen; Sun, Andrew J.; Sohlberg, Ericka M.; Tamura, Manjula Kurella; Chertow, Glenn M.; Liao, Joseph C.; Conti, Simon; Elliott, Christopher S.; Leppert, John T.; Pao, Alan C.			Prevalence of twenty-four hour urine testing in Veterans with urinary stone disease	PLOS ONE			English	Article							QUALITY	Objective The American Urological Association guidelines recommend 24-hour urine testing in patients with urinary stone disease to decrease the risk of stone recurrence; however, national practice patterns for 24-hour urine testing are not well characterized. Our objective is to determine the prevalence of 24-hour urine testing in patients with urinary stone disease in the Veterans Health Administration and examine patient-specific and facility-level factors associated with 24-hour urine testing. Identifying variations in clinical practice can inform future quality improvement efforts in the management of urinary stone disease in integrated healthcare systems. Materials and methods We accessed national Veterans Health Administration data through the Corporate Data Warehouse (CDW), hosted by the Veterans Affairs Informatics and Computing Infrastructure (VINCI), to identify patients with urinary stone disease. We defined stone formers as Veterans with one inpatient ICD-9 code for kidney or ureteral stones, two or more outpatient ICD-9 codes for kidney or ureteral stones, or one or more CPT codes for kidney or ureteral stone procedures from 2007 through 2013. We defined a 24-hour urine test as a 24-hour collection for calcium, oxalate, citrate or sulfate. We used multivariable regression to assess demographic, geographic, and selected clinical factors associated with 24-hour urine testing. Results We identified 130,489 Veterans with urinary stone disease; 19,288 (14.8%) underwent 24-hour urine testing. Patients who completed 24-hour urine testing were younger, had fewer comorbidities, and were more likely to be White. Utilization of 24-hour urine testing varied widely by geography and facility, the latter ranging from 1 to 40%. Conclusions Fewer than one in six patients with urinary stone disease complete 24-hour urine testing in the Veterans Health Administration. In addition, utilization of 24-hour urine testing varies widely by facility identifying a target area for improvement in the care of patients with urinary stone disease. Future efforts to increase utilization of 24-hour urine testing and improve clinician awareness of targeted approaches to stone prevention may be warranted to reduce the morbidity and cost of urinary stone disease.	[Ganesan, Calyani; Song, Shen; Tamura, Manjula Kurella; Chertow, Glenn M.; Leppert, John T.; Pao, Alan C.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Thomas, I-Chun; Liao, Joseph C.; Conti, Simon; Leppert, John T.] Vet Affairs Palo Alto Hlth Care Syst, Dept Urol, Palo Alto, CA USA; [Thomas, I-Chun; Tamura, Manjula Kurella] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res & Educ Clin Ctr, Palo Alto, CA USA; [Sun, Andrew J.; Sohlberg, Ericka M.; Liao, Joseph C.; Conti, Simon; Elliott, Christopher S.; Leppert, John T.; Pao, Alan C.] Stanford Univ, Dept Urol, Sch Med, Stanford, CA USA; [Chertow, Glenn M.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA USA; [Elliott, Christopher S.] Santa Clara Valley Med Ctr, Div Urol, San Jose, CA 95128 USA; [Pao, Alan C.] Vet Affairs Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Santa Clara Valley Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Ganesan, C (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	calyani@stanford.edu	; Kurella Tamura, Manjula/C-8284-2014	Chertow, Glenn/0000-0002-7599-0534; Ganesan, Calyani/0000-0002-4050-9587; Liao, Joseph/0000-0003-2448-5463; Kurella Tamura, Manjula/0000-0001-5227-2479	ASN Ben J. Lipps Research Fellowship Award; NIH T32 Ruth L. Kirschstein Institutional National Research Service Award [DK 7357-34]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007357, F32DK118801] Funding Source: NIH RePORTER	ASN Ben J. Lipps Research Fellowship Award; NIH T32 Ruth L. Kirschstein Institutional National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work received funding through the ASN Ben J. Lipps Research Fellowship Award and the NIH T32 Ruth L. Kirschstein Institutional National Research Service Award DK 7357-34 to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha Z, 2000, ARCH INTERN MED, V160, P3252, DOI 10.1001/archinte.160.21.3252; Alruwaily AF, 2015, UROLOGY, V86, P454, DOI 10.1016/j.urology.2015.05.022; Dauw CA, 2015, J UROLOGY, V193, P885, DOI 10.1016/j.juro.2014.09.111; Ghiraldi EM, 2017, J ENDOUROL, V31, pS64, DOI 10.1089/end.2016.0594; Hsi RS, 2017, J UROLOGY, V197, P1084, DOI 10.1016/j.juro.2016.10.052; Milose JC, 2014, J UROLOGY, V191, P376, DOI 10.1016/j.juro.2013.08.080; Pearle MS, 2014, J UROLOGY, V192, P316, DOI 10.1016/j.juro.2014.05.006; Semins MJ, 2010, J UROLOGY, V184, P190, DOI 10.1016/j.juro.2010.03.011	8	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220768	10.1371/journal.pone.0220768	http://dx.doi.org/10.1371/journal.pone.0220768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393935	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500060
J	Gibbs, A; Said, N; Corboz, J; Jewkes, R				Gibbs, Andrew; Said, Nader; Corboz, Julienne; Jewkes, Rachel			Factors associated with 'honour killing' in Afghanistan and the occupied Palestinian Territories: Two cross-sectional studies	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; CHILDHOOD TRAUMA; WOMEN; MEN; MULTICOUNTRY; ATTITUDES	'Honour killing', the murder of women to preserve family reputation, is well recognised but infrequently systematically researched. This paper has three hypotheses. First, in families where women report an 'honour killing' there is more violence against women and girls, second these women are more likely to report more patriarchal gender attitudes than others, and third these families are exposed to higher levels of poverty. We asked (n = 1461) women enrolled in a trial in Afghanistan, and (n = 535) in a population-based sample in the occupied Palestinian Territories (oPT) if there had ever been an 'honour killing' in their family. In Afghanistan, 2.3% (n = 33), and the oPT 7.7% (n = 41), reported this. We built separate multivariable logistic regression models for each country, and for married and unmarried women in each country. Among Afghan married women, 'honour killing' was associated with borrowing because of hunger (adjusted odds ratio [aOR] 8.71, 95% CI 2.27-33.40), easier access to money in emergency (aOR11.39, 95% CI 3.05-42.50), and violence within the family; intimate partner violence (IPV) (aOR3.73, 95% CI 1.12-12.36), and IPV and mother-in-law violence (aOR10.52, 2.60-42.56). For unmarried women in Afghanistan, 'honour killing' was associated with easier access money in an emergency (aOR4.06, 95% CI 0.85-19.37), household violence (hit by parent or sibling, or parent and sibling [aOR5.47, 95% CI 0.82-36.70; aOR7.37, 95% CI 1.24-43.86, respectively]); more childhood traumas (aOR1.24, 1.11-1.38), and more patriarchal personal gender attitudes (aOR1.24, 1.00-1.54). In the oPT experiencing IPV (aOR3.07, 1.02-9.23) and borrowing and experiencing IPV (aOR5.89, 1.84-18.79) were risks for married women. For unmarried women borrowing because of hunger was associated with higher risk (aOR2.33, 95% CI 1.18-4.85). Despite limitations-specifically the potential women were reporting the same 'honour killing'-our analysis suggests 'honour killings' are associated with violence, patriarchy, and poverty. Research is needed for the prevention of 'honour killing', which must address the root causes.	[Gibbs, Andrew; Jewkes, Rachel] South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa; [Gibbs, Andrew] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Ctr Rural Hlth, Durban, South Africa; [Said, Nader] Arab World Res & Dev AWRAD, Ramallah, Palestine; [Jewkes, Rachel] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	South African Medical Research Council; University of Kwazulu Natal; University of Witwatersrand	Gibbs, A (corresponding author), South African Med Res Council, Gender & Hlth Res Unit, Pretoria, South Africa.; Gibbs, A (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Ctr Rural Hlth, Durban, South Africa.	Andrew.gibbs@mrc.ac.za		Gibbs, Andrew/0000-0003-2812-5377; Jewkes, Rachel/0000-0002-4330-6267	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council	What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) - UK Government's Department for International Development (DFID); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The two studies are funded through the What Works To Prevent Violence? A Global Programme on Violence Against Women and Girls (VAWG) funded by the UK Government's Department for International Development (DFID). However, the views expressed do not necessarily reflect the department's official policies and the funders had no role in study design; collection, management, analysis, and interpretation of data; writing of the report; and the decision to submit the paper for publication. Funding was managed by the South African Medical Research Council.	Abrahams N, 2009, VIOLENCE VICTIMS, V24, P546, DOI 10.1891/0886-6708.24.4.546; Afghanistan Independent Human Rights Commission, 2013, NAT INQ RAP HON KILL; Al Ashqar A., 2014, MURDER WOMEN PALESTI; Aplin R, 2017, WOMENS STUDIES INT F; Awwad A.M., 2001, SOCIAL THOUGHT RES, V24, P39; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Clark CJ, 2010, SOC SCI MED, V70, P144, DOI 10.1016/j.socscimed.2009.09.024; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Eisner M, 2013, AGGRESSIVE BEHAV, V39, P405, DOI 10.1002/ab.21485; Fulu E, 2017, LANCET GLOB HEALTH, V5, pE512, DOI 10.1016/s2214-109x(17)30103-1; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gibbs A, 2018, BMC PUBLIC HLTH; Gibbs A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5507-5; Jewkes R, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002381; Khan R, 2018, J AGGRESS CONFL PEAC, V10, P237, DOI 10.1108/JACPR-10-2018-360; Mathews S, 2011, BRIT J CRIMINOL, V51, P960, DOI 10.1093/bjc/azr051; Mayeda DT, 2016, SOCIOL COMPASS, V10, P353, DOI 10.1111/soc4.12367; Namy S, 2017, SOC SCI MED, V184, P40, DOI 10.1016/j.socscimed.2017.04.042; Nasrullah M, 2009, EUR J PUBLIC HEALTH, V19, P193, DOI 10.1093/eurpub/ckp021; Naved R, 2018, SOC SCI MED, V196, P150, DOI 10.1016/j.socscimed.2017.11.040; Paben S, 1999, P SECTION SURVEY RES; Payton J, 2014, J INTERPERS VIOLENCE, V29, P2863, DOI 10.1177/0886260514527171; Payton JL, 2017, J INTERPERS VIOLENCE, V32, P1332, DOI 10.1177/0886260515588918; Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778; Ruggi Suzanne, 1998, MERIP, V206, P12, DOI DOI 10.2307/3012473; Said N., 2018, CAUGHT ROCK HARD PLA; Said-Foqahaa N, 2011, HAWWA, V9, P234, DOI 10.1163/156920811X578539; Sev'er A, 2001, VIOLENCE AGAINST WOM, V7, P964, DOI 10.1177/10778010122182866; Shalhoub-Kervorkian N, 2013, VIOLENCE AGAINST WOM, V19, P295, DOI 10.1177/1077801213485548; Special Rapporteur on Violence Against Women, 2017, REP SPEC RAPP VIOL W; United Nations Assistance Mission in Afghanistan Office of the United Nations High Commissioner for Human Rights, 2018, INJ IMP MED CRIM OFF; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; WHO, 2012, UND ADDR VIOL WOM FE	33	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219125	10.1371/journal.pone.0219125	http://dx.doi.org/10.1371/journal.pone.0219125			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393873	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500005
J	Ingrosso, A; Abbott, LF				Ingrosso, Alessandro; Abbott, L. F.			Training dynamically balanced excitatory-inhibitory networks	PLOS ONE			English	Article							STATE; MECHANISM; PATTERNS; CHAOS; MODEL	The construction of biologically plausible models of neural circuits is crucial for understanding the computational properties of the nervous system. Constructing functional networks composed of separate excitatory and inhibitory neurons obeying Dale's law presents a number of challenges. We show how a target-based approach, when combined with a fast online constrained optimization technique, is capable of building functional models of rate and spiking recurrent neural networks in which excitation and inhibition are balanced. Balanced networks can be trained to produce complicated temporal patterns and to solve input-output tasks while retaining biologically desirable features such as Dale's law and response variability.	[Ingrosso, Alessandro; Abbott, L. F.] Columbia Univ, Brain Behav Inst, Zuckerman Mind, New York, NY 10027 USA	Columbia University	Ingrosso, A (corresponding author), Columbia Univ, Brain Behav Inst, Zuckerman Mind, New York, NY 10027 USA.	ai2367@columbia.edu		Ingrosso, Alessandro/0000-0001-5430-7559	NSF NeuroNex Award [DBI-1707398]; Gatsby Charitable Foundation [GAT3419]; Simons Collaboration for the Global Brain [542939SPI]; Swartz Foundation	NSF NeuroNex Award; Gatsby Charitable Foundation; Simons Collaboration for the Global Brain; Swartz Foundation	Funding is provided by NSF NeuroNex Award (LFA, DBI-1707398, https://nsf.gov/), the Gatsby Charitable Foundation (LFA, GAT3419, http://www.gatsby.org.uk/), the Simons Collaboration for the Global Brain (LFA, 542939SPI, https://www.simonsfoundation.org/collaborations/global-brain/) and the Swartz Foundation (LFA, AI, http://www.theswartzfoundation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2016, NAT NEUROSCI, V19, P350, DOI 10.1038/nn.4241; Alemi A, 2017, ARXIV170508026; [Anonymous], 2003, NEURAL ENG COMPUTATI; Boerlin M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001080; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; del Molino LCG, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042824; Deneve S, 2017, NEURON, V94, P969, DOI 10.1016/j.neuron.2017.05.016; DePasquale B., 2016, ARXIV160107620; DePasquale B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191527; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Harish O, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004266; Hennequin G, 2017, ANNU REV NEUROSCI, V40, P557, DOI 10.1146/annurev-neuro-072116-031005; Hennequin G, 2014, NEURON, V82, P1394, DOI 10.1016/j.neuron.2014.04.045; Huh D., 2018, ADV NEURAL INFORM PR, V31, P1440; Jaeger H., 2002, 159 GMD GERM NAT RES; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Kadmon J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041030; Kim CM, 2018, ELIFE, V7, DOI 10.7554/eLife.37124; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Laje R, 2013, NAT NEUROSCI, V16, P925, DOI 10.1038/nn.3405; Lee D., 2014, ABS14127525 CORR; Lee JH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00508; Mastrogiuseppe F, 2018, NEURON, V99, P609, DOI 10.1016/j.neuron.2018.07.003; Mastrogiuseppe F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005498; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Nicola W, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01827-3; Pehlevan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089992; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Rubin R, 2017, P NATL ACAD SCI USA, V114, pE9366, DOI 10.1073/pnas.1705841114; Song H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005411; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tetzlaff T, 2012, PLOS COMPUTATIONAL B, V8, P1, DOI [10.1371/journal.pcbi, DOI 10.1371/JOURNAL.PCBI]; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vincent-Lamarre P, 2016, J COMPUT NEUROSCI, V41, P305, DOI 10.1007/s10827-016-0619-3; Wright SJ, 2015, MATH PROGRAM, V151, P3, DOI 10.1007/s10107-015-0892-3; Zenke F, 2018, NEURAL COMPUT, V30, P1514, DOI 10.1162/neco_a_01086	38	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220547	10.1371/journal.pone.0220547	http://dx.doi.org/10.1371/journal.pone.0220547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393909	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500037
J	Kou, HW; Yeh, CH; Tsai, HI; Hsu, CC; Hsieh, YC; Chen, WT; Cheng, HT; Yu, MC; Lee, CW				Kou, Hao-Wei; Yeh, Chih-Hua; Tsai, Hsin-I; Hsu, Chih-Chieh; Hsieh, Yi-Chung; Chen, Wei-Ting; Cheng, Hao-Tsai; Yu, Ming-Chin; Lee, Chao-Wei			Sarcopenia is an effective predictor of difficult-to-wean and mortality among critically ill surgical patients	PLOS ONE			English	Article							MECHANICAL VENTILATION; DEFINITION; SURVIVAL; IMPACT	Background Critically-ill surgical patients are at higher risk for sarcopenia, which is associated with worse survival. Sarcopenia may impair the respiratory musculature, which can subsequently influence the outcome of ventilator weaning. Although there are a variety of weaning parameters predictive of weaning outcomes, none have tried to incorporate "muscle strength" or "sarcopenia". The aim of the current study was to explore the association between sarcopenia and difficult-to-wean (DtW) in critically-ill surgical patients. The influence of sarcopenia on ICU mortality was also analyzed. Methods Ninety-six patients undergoing mechanical ventilation in the surgical intensive care unit (ICU) were enrolled. Demographic data and weaning parameters were recorded from the prospectively collected database, and the total psoas muscle area (TPA) was determined at the level of the 3 rd lumbar vertebra by computed tomography. Sarcopenia was defined by previously established cut-off points and its influence on clinical outcomes was examined. Receiver operating characteristic (ROC) curve analysis was conducted to investigate the predictive capability of TPA and weaning parameters for predicting weaning outcomes. Results The median age of the studied patients was 73 years. Thirty patients (31.3%) were sarcopenic and 30 (31.3%) were defined as DtW. Eighteen patients (18.8%) had ICU mortality. Multivariate logistic regression analyses revealed that sarcopenia was an independent risk factor for DtW and ICU mortality. The area under the ROC curve (AUC) of TPA for predicting successful weaning was 0.727 and 0.720 in female and male patients, respectively. After combining TPA and conventional weaning parameters, the AUC for DtW increased from 0.836 to 0.911 and from 0.835 to 0.922 in female and male patients, respectively. Conclusion Sarcopenia is an independent risk factor for DtW and ICU mortality. TPA has predictive value when assessing weaning outcomes and can be used as an effective adjunct predictor along with conventional weaning parameters.	[Kou, Hao-Wei; Hsu, Chih-Chieh; Yu, Ming-Chin; Lee, Chao-Wei] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Surg, Div Gen Surg, Taoyuan, Taiwan; [Yeh, Chih-Hua] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Yeh, Chih-Hua; Tsai, Hsin-I; Cheng, Hao-Tsai; Yu, Ming-Chin; Lee, Chao-Wei] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Tsai, Hsin-I] Chang Gung Mem Hosp, Dept Anesthesiol, Linkou Med Ctr, Taoyuan, Taiwan; [Tsai, Hsin-I; Cheng, Hao-Tsai; Yu, Ming-Chin; Lee, Chao-Wei] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Hsieh, Yi-Chung; Chen, Wei-Ting; Cheng, Hao-Tsai] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Hepatogastroenterol, Taoyuan, Taiwan; [Yu, Ming-Chin] Xiamen Chang Gung Hosp, Dept Surg, Xiamen, Fujian, Peoples R China	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Lee, CW (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Surg, Div Gen Surg, Taoyuan, Taiwan.; Lee, CW (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Lee, CW (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	alanchaoweilee@hotmail.com	Yeh, Chih-Hua/N-5165-2018	Yeh, Chih-Hua/0000-0001-6988-8739; Lee, Chao-Wei/0000-0002-6853-4557	Chang Gung Memorial Hospital [CMRPG3I0301, CMRPG3F0122]; Ministry of Science and Technology, Taiwan, R.O.C. [MOST 107-2314-B-182A-119-/NMRPG3H0291]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by Chang Gung Memorial Hospital (www.cgmh.org.tw) (Grant number: CMRPG3I0301 (CW Lee) and CMRPG3F0122 (MC Yu)) and Ministry of Science and Technology, Taiwan, R.O.C. (www.most.gov.tw)(Grant number: MOST 107-2314-B-182A-119-/NMRPG3H0291 (CW Lee)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptistella AR, 2018, J CRIT CARE, V48, P56, DOI 10.1016/j.jcrc.2018.08.023; Beduneau G, 2017, AM J RESP CRIT CARE, V195, P772, DOI 10.1164/rccm.201602-0320OC; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Burton LA, 2010, CLIN INTERV AGING, V5, P217; CAPDEVILA XJ, 1995, CHEST, V108, P482, DOI 10.1378/chest.108.2.482; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; Croce MA, 2003, J TRAUMA, V54, P724, DOI 10.1097/01.TA.0000054643.54218.C5; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Damuth E, 2015, LANCET RESP MED, V3, P544, DOI 10.1016/S2213-2600(15)00150-2; Elliott JE, 2016, RESP PHYSIOL NEUROBI, V226, P137, DOI 10.1016/j.resp.2015.10.001; Friedman J, 2015, NUTR CLIN PRACT, V30, P175, DOI 10.1177/0884533615569888; Fuggle N, 2017, BEST PRACT RES CL RH, V31, P218, DOI 10.1016/j.berh.2017.11.007; Funk GC, 2010, EUR RESPIR J, V35, P88, DOI 10.1183/09031936.00056909; Heard RSM, 2017, SURG-J R COLL SURG E, V15, P366, DOI 10.1016/j.surge.2017.06.001; Heunks LM, 2010, CRIT CARE, V14, DOI 10.1186/cc9296; Izawa KP, 2016, AGING CLIN EXP RES, V28, P1143, DOI 10.1007/s40520-016-0534-5; Jeong BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122810; Joglekar S, 2015, J SURG ONCOL, V112, P503, DOI 10.1002/jso.24025; Jones KI, 2015, COLORECTAL DIS, V17, pO20, DOI 10.1111/codi.12805; Jones K, 2017, WORLD J SURG, V41, P2266, DOI 10.1007/s00268-017-3999-2; Kim J, 2009, ARCH GERONTOL GERIAT, V48, P361, DOI 10.1016/j.archger.2008.03.006; Kizilarslanoglu MC, 2016, J ANESTH, V30, P884, DOI 10.1007/s00540-016-2211-4; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P805, DOI 10.1097/TA.0000000000000989; Magalhaes PAF, 2018, RESP MED, V134, P54, DOI 10.1016/j.rmed.2017.11.023; Mccusker A, 2018, AM J SURG; Mirkin KA, 2017, J GASTROINTEST ONCOL, V8, P589, DOI 10.21037/jgo.2017.03.02; Moisey LL, 2013, CRIT CARE, V17, DOI 10.1186/cc12901; Nemer SN, 2009, CRIT CARE, V13, DOI 10.1186/cc8051; Pu L, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.04.001; Rangel EL, 2017, J TRAUMA ACUTE CARE, V83, P1179, DOI 10.1097/TA.0000000000001657; Shibahashi K, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0205-9; Simonsen C, 2018, ANN SURG, V268, P58, DOI 10.1097/SLA.0000000000002679; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Toptas M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5263208; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/cc13189; YANG KL, 1991, NEW ENGL J MED, V324, P1445, DOI 10.1056/NEJM199105233242101	36	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220699	10.1371/journal.pone.0220699	http://dx.doi.org/10.1371/journal.pone.0220699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393937	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500052
J	Meierhofer, MB; Johnson, JS; Leivers, SJ; Pierce, BL; Evans, JE; Morrison, ML				Meierhofer, Melissa B.; Johnson, Joseph S.; Leivers, Samantha J.; Pierce, Brian L.; Evans, Jonah E.; Morrison, Michael L.			Winter habitats of bats in Texas	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; EASTERN PIPISTRELLE; ENERGY AVAILABILITY; RELATIVE-HUMIDITY; HIBERNATING BATS; METABOLIC-RATE; HOT BATS; SELECTION; TORPOR; TEMPERATURE	Few studies have described winter microclimate selection by bats in the southern United States. This is of particular importance as the cold-adapted fungus, Pseudogymnoascus destructans, which causes the fatal bat disease white-nose syndrome (WNS), continues to spread into southern United States. To better understand the suitability of winter bat habitats for the growth of P. destructans in this region, we collected roost temperature and vapor pressure deficit from 97 hibernacula in six ecoregions in Texas during winter 2016-17 and 2017-18. We also measured skin temperature of Rafinesque's big-eared bats (Corynorhinus townsendii), Townsend's big-eared bats (C. townsendii), big-brown bats (Eptesicus fuscus), southeastern myotis (Myotis austroriparius), cave myotis (M. velifer), tri-colored bats (Perimyotis subflavus), and Mexican free-tailed bats (Tadarida brasiliensis) during hibernation to study their use of torpor in these habitats. We found that temperatures within hibernacula were strongly correlated with external air temperatures and were often within the optimal range of temperatures for P. destructans growth. Hibernacula and skin temperatures differed among species, with Rafinesque's big-eared bats, southeastern myotis, and Mexican free-tailed bats occupying warmer microclimates and having higher torpid skin temperatures. For species that were broadly distributed throughout Texas, hibernacula and skin temperatures differed within species by ecoregion; Tri-colored bats and cave myotis in colder, northern regions occupied colder microclimates within hibernacula and exhibited colder skin temperatures, than individuals of the same species in warmer, southern regions. These data illustrate the variability in microclimates used as hibernacula by bats in Texas and suggest similar variation in susceptibility to WNS in the state. Thus, monitoring microclimates at winter roosts may help predict where WNS may develop, and where management efforts would be most effective.	[Meierhofer, Melissa B.; Morrison, Michael L.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Meierhofer, Melissa B.; Leivers, Samantha J.; Pierce, Brian L.] Texas A&M Univ, Nat Resources Inst, College Stn, TX 77843 USA; [Johnson, Joseph S.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Evans, Jonah E.] Texas Parks & Wildlife Dept, Wildlife Div Program, Boerne, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio University	Meierhofer, MB (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.; Meierhofer, MB (corresponding author), Texas A&M Univ, Nat Resources Inst, College Stn, TX 77843 USA.	melissa.meierhofer@ag.tamu.edu	Meierhofer, Melissa/AAS-3473-2021	Meierhofer, Melissa/0000-0003-2384-1999; Leivers, Samantha/0000-0003-3635-3863	U.S. Fish and Wildlife Service's State Wildlife Grant Program (CFDA) [15.611]; U.S. Fish and Wildlife Service (CFDA) [15.657]; Fightwns 'Micro Grants for Microbats'; Texas Ecolab research grants; National Speleological Society WNS Rapid Response Grant	U.S. Fish and Wildlife Service's State Wildlife Grant Program (CFDA); U.S. Fish and Wildlife Service (CFDA); Fightwns 'Micro Grants for Microbats'; Texas Ecolab research grants; National Speleological Society WNS Rapid Response Grant	This work was funded by the U.S. Fish and Wildlife Service's State Wildlife Grant Program (CFDA#15.611) as administered by Texas Parks and Wildlife Department, https://tpwd.texas.gov/and the U.S. Fish and Wildlife Service (CFDA#15.657), https://www.fws.gov/(MLM, BLP). Additional funding support was provided by the Fightwns ` Micro Grants for Microbats', https://www.fightwns.org/, Texas Ecolab research grants, https://texasecolab.org/, and National Speleological Society WNS Rapid Response Grant, https://caves.org/WNS/Rapid_ Response. shtml (BLP, MBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman LK, 2012, BATS TEXAS; Anderson DB, 1936, ECOLOGY, V17, P277, DOI 10.2307/1931468; Avila-Flores R, 2004, J MAMMAL, V85, P675, DOI 10.1644/BOS-127; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bondarenco A, 2014, NATURWISSENSCHAFTEN, V101, P679, DOI 10.1007/s00114-014-1202-2; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Boyles JG, 2010, ECOL MODEL, V221, P1644, DOI 10.1016/j.ecolmodel.2010.03.018; Briggler JT, 2003, AM MIDL NAT, V149, P406, DOI 10.1674/0003-0031(2003)149[0406:SUASOC]2.0.CO;2; Buck CL, 2000, AM J PHYSIOL-REG I, V279, pR255, DOI 10.1152/ajpregu.2000.279.1.R255; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Czenze ZJ, 2017, CAN J ZOOL, V95, P909, DOI 10.1139/cjz-2016-0318; Dausmann KH, 2004, NATURE, V429, P825, DOI 10.1038/429825a; DAVIS RB, 1962, ECOL MONOGR, V32, P311, DOI 10.2307/1942378; Dunbar MB, 2010, J COMP PHYSIOL B, V180, P885, DOI 10.1007/s00360-010-0457-y; FRENCH AR, 1982, J APPL PHYSIOL, V52, P216, DOI 10.1152/jappl.1982.52.1.216; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2013, CURR BIOL, V23, pR188, DOI 10.1016/j.cub.2013.01.062; Geiser F, 2011, INTEGR COMP BIOL, V51, P337, DOI 10.1093/icb/icr042; Griffith G., 2007, ECOREGIONS TEXAS; Herreid II C. F., 1963, Journal of Mammalogy, V44, P560, DOI 10.2307/1377140; Humphrey SR, RARE AND ENDANGERED, V1, P335; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Humphries MM, 2002, NATURE, V418, P313, DOI 10.1038/nature00828; Johnson J.S., 2016, CONSERV ECOL, P181; Johnson JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049754; Johnson JI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106014; Jonasson KA, 2012, J EXP BIOL, V90, P891; Kasper Stephen, 2018, Texas Journal of Science, V70, P57, DOI 10.32011/txjsci_70_1_Article4; Kobbe S, 2009, NATURWISSENSCHAFTEN, V96, P1221, DOI 10.1007/s00114-009-0580-3; Kurta A, 2014, NORTHEAST NAT, V21, P587, DOI 10.1656/045.021.0407; Kurta A, 2014, ACTA CHIROPTEROL, V16, P249, DOI 10.3161/150811014X683444; Langwig KE, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0456; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lilley TM, 2018, FUNCT ECOL, V32, P2483, DOI 10.1111/1365-2435.13183; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; MCNAB BK, 1974, ECOLOGY, V55, P943, DOI 10.2307/1940347; Meierhofer MB, 2019, J MAMMAL, V100, P1274, DOI 10.1093/jmammal/gyz099; Moore MS, 2018, J COMP PHYSIOL B, V188, P163, DOI 10.1007/s00360-017-1109-2; Park KJ, 2000, FUNCT ECOL, V14, P580, DOI 10.1046/j.1365-2435.2000.00460.x; Perry RW, 2013, ENVIRON REV, V21, P28, DOI 10.1139/er-2012-0042; R Development Core Team, 2009, R LANG ENV STAT COMP; RAESLY RL, 1987, AM MIDL NAT, V118, P15, DOI 10.2307/2425624; Reeder DeeAnn M., 2013, P413; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; RICE DALE W., 1957, JOUR MAMMAL, V38, P15, DOI 10.2307/1376471; Sandel JK, 2001, J MAMMAL, V82, P173, DOI 10.1644/1545-1542(2001)082<0173:UASOWH>2.0.CO;2; SCHMIDLY D.J., 2016, MAMMALS TEXAS; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Stawski C, 2010, J EXP BIOL, V213, P393, DOI 10.1242/jeb.038224; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Texas Parks and Wildlife Department, 2017, FUNG CAUS WHIT NOS S; Texas Parks and Wildlife Department, 2019, FUNG CAUS WHIT NOS S; Texas Parks and Wildlife Department, 2018, FUNGUS CAUSING WHITE; Tinkle D. W., 1965, Journal of Mammalogy, V46, P612, DOI 10.2307/1377932; Turner Gregory G., 2009, Bat Research News, V50, P47; Tuttle MD, 1977, NAT CAV MAN S P ALB, P108; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Vincent Elizabeth A., 2007, Proceedings of the Indiana Academy of Science, V116, P58; Walker CW, 1996, TEX J SCI, V48, P166; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076	63	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220839	10.1371/journal.pone.0220839	http://dx.doi.org/10.1371/journal.pone.0220839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393965	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500068
J	Nachar, W; Merlet, N; Maafi, F; Shi, YF; Mihalache-Avram, T; Mecteau, M; Ferron, M; Rheaume, E; Tardif, JC				Nachar, Walid; Merlet, Nolwenn; Maafi, Foued; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Ferron, Marine; Rheaume, Eric; Tardif, Jean-Claude			Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits	PLOS ONE			English	Article							HEART-FAILURE; MODEL; UPDATE	Background Left ventricular diastolic dysfunction (LVDD) is present in more than 50% of patients suffering from heart failure. LVDD animal models are limited and its underlying mechanisms remain largely unknown. Aortic valve stenosis (AVS) may cause LVDD, and we recently reported LVDD in an AVS rabbit model. Here we aimed to develop a rabbit model of LVDD without AVS. Methods Rabbits were fed with a 0.5% cholesterol-enriched diet (n = 9) or normal diet (n = 8) until they developed LVDD defined by a value of the echocardiographic parameter E/Em ratio higher than the mean at baseline +2SD. Rabbits were then fed a 0.2% cholesterol-enriched diet for 4 weeks (average total diet duration: 20 weeks). Detailed cardiac structure and function measurements were assessed by echocardiography at baseline, weeks 8, 12 and 14 to 20, when applicable. Histological analyses and RT-qPCR were performed on LV samples. Results The hypercholesterolemic diet induced LVDD without systolic dysfunction or AVS, as shown by multiple echocardiographic parameters, including early filling mitral peak velocity and deceleration rate, Em/Am ratio and E/Em ratio (all p<0.05), and by increased cardiac mRNA expression of brain natriuretic peptide (Bnp). Cardiac expression of mRNA for Nox2, Vcam1, Mmp12, Mmp12/Timp1, Il1b and Col1/Col3 ratios was also higher in these rabbits (p<0.05). In contrast, cardiac Sod2 mRNA expression was reduced in hypercholesterolemic rabbits compared to controls. Conclusion Rabbits fed with a cholesterol-enriched diet develop LVDD with preserved systolic function and evidence of cardiac inflammation and oxidative stress. This rabbit model may be used in future studies to test treatment strategies against LVDD.	[Nachar, Walid; Merlet, Nolwenn; Maafi, Foued; Shi, Yanfen; Mihalache-Avram, Teodora; Mecteau, Melanie; Ferron, Marine; Rheaume, Eric; Tardif, Jean-Claude] Montreal Heart Inst, Montreal, PQ, Canada; [Nachar, Walid; Maafi, Foued; Rheaume, Eric; Tardif, Jean-Claude] Univ Montreal, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Tardif, JC (corresponding author), Montreal Heart Inst, Montreal, PQ, Canada.; Tardif, JC (corresponding author), Univ Montreal, Montreal, PQ, Canada.	jean-claude.tardif@icm-mhi.org	Rheaume, Eric/ABA-4918-2021	Merlet, Nolwenn/0000-0002-0092-2326; Tardif, Jean-Claude/0000-0002-8200-8983				Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Busseuil D, 2008, BRIT J PHARMACOL, V154, P765, DOI 10.1038/bjp.2008.122; Dubi S, 2010, CARDIOVASC PATHOL, V19, P147, DOI 10.1016/j.carpath.2008.12.008; Franssen C, 2016, JACC-HEART FAIL, V4, P312, DOI 10.1016/j.jchf.2015.10.007; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Horgan S, 2014, J Card Fail, V20, P984, DOI 10.1016/j.cardfail.2014.09.001; Huang Y, 2004, CIRCULATION, V109, P97, DOI 10.1161/01.CIR.0000109213.10461.F6; Kai H, 2005, HYPERTENS RES, V28, P483, DOI 10.1291/hypres.28.483; Khatibzadeh S, 2013, INT J CARDIOL, V168, P1186, DOI 10.1016/j.ijcard.2012.11.065; Merlet N, 2016, INT J CARDIOL, V215, P364, DOI 10.1016/j.ijcard.2016.04.029; Moller S, 2016, HEART FAIL REV, V21, P599, DOI 10.1007/s10741-016-9552-9; Murase T, 2012, HYPERTENS RES, V35, P186, DOI 10.1038/hr.2011.157; Nachar W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089331; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Periasamy Muthu, 2008, Heart Fail Clin, V4, P13, DOI 10.1016/j.hfc.2007.10.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pober JS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016345; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Silberman GA, 2010, CIRCULATION, V121, P519, DOI 10.1161/CIRCULATIONAHA.109.883777; Sorop O, 2018, CARDIOVASC RES, V114, P954, DOI 10.1093/cvr/cvy038; Takatsu M, 2013, HYPERTENSION, V62, P957, DOI 10.1161/HYPERTENSIONAHA.113.02093; Van Linthout Sophie, 2017, Curr Heart Fail Rep, V14, P251, DOI 10.1007/s11897-017-0337-9; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220707	10.1371/journal.pone.0220707	http://dx.doi.org/10.1371/journal.pone.0220707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393963	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500054
J	Rashidi, A; Ebadi, M; Shields-Cutler, RR; Kruziki, K; Manias, DA; Barnes, AMT; DeFor, TE; Ferrieri, P; Young, JAH; Knights, D; Blazar, BR; Weisdorf, DJ; Dunny, GM				Rashidi, Armin; Ebadi, Maryam; Shields-Cutler, Robin R.; Kruziki, Kathryn; Manias, Dawn A.; Barnes, Aaron M. T.; DeFor, Todd E.; Ferrieri, Patricia; Young, Jo-Anne H.; Knights, Dan; Blazar, Bruce R.; Weisdorf, Daniel J.; Dunny, Gary M.			Early E. casseliflavus gut colonization and outcomes of allogeneic hematopoietic cell transplantation	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; INTESTINAL MICROBIOTA; ENTEROCOCCI; SUSCEPTIBILITY; RESISTANT; INDOLE; INFECTIONS; BACTEREMIA; DOMINATION; GALLINARUM	Gut dysbiosis has been associated with worse allogeneic hematopoietic cell transplantation (allo-HCT) outcomes. We reported an association between intrinsically vancomycin-resistant enterococci (iVRE: E. gallinarum and E. casseliflavus) gut colonization and lower posttransplant mortality. In this study, using an expanded cohort, we evaluated whether our previously observed association is species-specific. We included allo-HCT recipients with >= 1 positive rectal swab or stool culture for iVRE between days-14 and +14 of transplant. To investigate whether iVRE modulate the gut microbiota, we performed agar diffusion assays. To investigate whether iVRE differ in their ability to activate the aryl hydrocarbon receptor, we analyzed iVRE genomes for enzymes in the shikimate and tryptophan pathways. Sixty six (23 E. casseliflavus and 43 E. gallinarum) of the 908 allograft recipients (2011-2017) met our inclusion criteria. Overall survival was significantly higher in patients with E. casseliflavus (91% vs. 62% at 3 years, P = 0.04). In multivariable analysis, E. casseliflavus gut colonization was significantly associated with reduced all-cause mortality (hazard ratio 0.20, 95% confidence interval 0.04-0.91, P = 0.04). While agar assays were largely unremarkable, genome mining predicted that E. casseliflavus encodes a larger number of enzymes in the tryptophan metabolism pathway. In conclusion, E. casseliflavus gut colonization is associated with reduced post-HCT morality. Further research is needed to understand the mechanisms for this association.	[Rashidi, Armin; Weisdorf, Daniel J.] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA; [Ebadi, Maryam] Univ Minnesota, Dept Pediat, Div Pediat Hematol Oncol, Minneapolis, MN 55455 USA; [Shields-Cutler, Robin R.; Knights, Dan] Univ Minnesota, Coll Biol Sci, Biotechnol Inst, Minneapolis, MN USA; [Shields-Cutler, Robin R.] Macalester Coll, Dept Biol, St Paul, MN 55105 USA; [Kruziki, Kathryn; Manias, Dawn A.; Barnes, Aaron M. T.; Dunny, Gary M.] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN USA; [Barnes, Aaron M. T.; Ferrieri, Patricia] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [DeFor, Todd E.] Univ Minnesota, Masonic Canc Ctr, Biostat Core, Minneapolis, MN USA; [Young, Jo-Anne H.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Macalester College; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Rashidi, A (corresponding author), Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.	arashidi@umn.edu	Young, Jo-Anne/G-2617-2013; Barnes, Aaron/B-7009-2012	Young, Jo-Anne/0000-0003-4182-341X; Barnes, Aaron/0000-0002-7014-7556; Rashidi, Armin/0000-0002-9384-272X	National Institutes of Health [P30 CA77598]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]; NATIONAL CANCER INSTITUTE [P01CA111412, P30CA077598] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Institutes of Health [grant number P30 CA77598] utilizing the Biostatistics and Bioinformatics Core shared resource of the Masonic Cancer Center, University of Minnesota and the National Center for Advancing Translational Sciences of the National Institutes of Health [grant number UL1TR000114]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no conflicts of interest to declare.	ALEXEEV EE, REGULATION, DOI DOI 10.1016/J.AJPATH.2018.01.01; Andermann TM, 2018, BIOL BLOOD MARROW TR, V24, P1322, DOI 10.1016/j.bbmt.2018.02.009; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; DUNNY GM, 1975, J BACTERIOL, V124, P784, DOI 10.1128/JB.124.2.784-790.1975; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; GORDON S, 1992, J CLIN MICROBIOL, V30, P2373, DOI 10.1128/JCM.30.9.2373-2378.1992; JASPERSON LK, 2008, BLOOD, V111, P3, DOI DOI 10.1038/S41385-018-0019-2; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Koch LK, 2009, BLOOD, V114, P5062, DOI 10.1182/blood-2009-06-227587; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Lamas B, 2018, MUCOSAL IMMUNOL, V11, P1024, DOI 10.1038/s41385-018-0019-2; LECLERCQ R, 1992, ANTIMICROB AGENTS CH, V36, P2005, DOI 10.1128/AAC.36.9.2005; Li G, 2013, MICROBIOL-SGM, V159, P402, DOI 10.1099/mic.0.064139-0; Mathewson ND, 2016, NAT IMMUNOL, V17, P505, DOI 10.1038/ni.3400; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; PATTERSON JE, 1995, MEDICINE, V74, P191, DOI 10.1097/00005792-199507000-00003; Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Rashidi A, 2018, BIOL BLOOD MARROW TR, V24, P1260, DOI 10.1016/j.bbmt.2018.01.025; RECEPTOR AMJ, AM J PATHOL, DOI DOI 10.1016/J.AJPATH.2018.01; RECEPTOR AMJ, AM J PATHOL, DOI DOI 10.1016/J.AJPATH.2018.01; RECEPTOR AMJ, AM J PATHOL, DOI DOI 10.1016/J.AJPATH.2018.01; RECEPTOR AMJ, 2018, AM J PATHOL, V188, P1183, DOI DOI 10.1016/J.AJPATH.2018.01; Reid KC, 2001, CLIN INFECT DIS, V32, P1540, DOI 10.1086/320542; RUOFF KL, 1990, J CLIN MICROBIOL, V28, P435, DOI 10.1128/JCM.28.3.435-437.1990; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Swimm A, 2018, BLOOD, V132, P2506, DOI 10.1182/blood-2018-03-838193; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Toye B, 1997, J CLIN MICROBIOL, V35, P3166, DOI 10.1128/JCM.35.12.3166-3170.1997; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; VINCENT S, 1991, J CLIN MICROBIOL, V29, P2335, DOI 10.1128/JCM.29.10.2335-2337.1991; Whitfield-Cargile CM, 2016, GUT MICROBES, V7, P246, DOI 10.1080/19490976.2016.1156827; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	39	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220850	10.1371/journal.pone.0220850	http://dx.doi.org/10.1371/journal.pone.0220850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393924	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500071
J	Swan, T; Halberstadt, J				Swan, Thomas; Halberstadt, Jamin			The Mickey Mouse problem: Distinguishing religious and fictional counterintuitive agents	PLOS ONE			English	Article							COGNITIVE SCIENCE; SELF-ESTEEM; GOD; TRANSMISSION; INCREASES; BELIEF; FOUNDATIONS; COMMITMENT; BEHAVIOR; MOTIVES	The Mickey Mouse problem refers to the difficulty in predicting which supernatural agents are capable of eliciting belief and religious devotion. We approached the problem directly by asking participants to invent a "religious" or a "fictional" agent with five supernatural abilities. Compared to fictional agents, religious agents were ascribed a higher proportion of abilities that violated folk psychology or that were ambiguous-violating nonspecific or multiple domains of folk knowledge-and fewer abilities that violated folk physics and biology. Similarly, participants rated folk psychology violations provided by the experimenter as more characteristic of religious agents than were violations of folk physics or folk biology, while fictional agents showed no clear pattern. Religious agents were also judged as more potentially beneficial, and more ambivalent (i.e., similar ratings of benefit and harm), than fictional agents, regardless of whether the agents were invented or well-known to participants. Together, the results support a motivational account of religious belief formation that is facilitated by these biases.	[Swan, Thomas; Halberstadt, Jamin] Univ Otago, Dept Psychol, Dunedin, New Zealand	University of Otago	Swan, T (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	tomswan@gmail.com		Swan, Thomas/0000-0002-2343-2776	John Templeton Foundation [52257, 60624]; New Zealand Royal Society's Marsden Fund [UOO1312]	John Templeton Foundation; New Zealand Royal Society's Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This research was supported by grants from the John Templeton Foundation (JH: 52257 and 60624; https://templeton.org) and The New Zealand Royal Society's Marsden Fund (JH: UOO1312; https://royalsociety.org.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1989, HUMAN REVOLUTION, P455; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Atran S, 2004, BEHAV BRAIN SCI, V27, P713, DOI 10.1017/S0140525X04000172; Atran Scott, 2002, GODS WE TRUST EVOLUT; Banerjee K, 2013, COGNITIVE SCI, V37, P1251, DOI 10.1111/cogs.12037; Barrett J.L., 2004, WHY WOULD ANYONE BEL; Barrett J. L., 2001, J COGNIT CULTURE, V1, P69, DOI [10.1163/156853701300063589, DOI 10.1163/156853701300063589]; Barrett JL, 2001, CHILD DEV, V72, P50, DOI 10.1111/1467-8624.00265; Barrett JL, 2009, J COGN CULT, V9, P271, DOI 10.1163/156770909X12489459066345; Barrett JL, 2008, J COGN CULT, V8, P149, DOI 10.1163/156770908X289251; Barrett JL, 2008, METH THEORY STUD REL, V20, P308, DOI 10.1163/157006808X371806; Bering Jesse, 2011, BELIEF INSTINCT PSYC; Bering JM, 2006, BEHAV BRAIN SCI, V29, P453, DOI 10.1017/S0140525X06009101; Boyer P, 2003, TRENDS COGN SCI, V7, P119, DOI 10.1016/S1364-6613(03)00031-7; Boyer P, 2001, COGNITIVE SCI, V25, P535, DOI 10.1016/S0364-0213(01)00045-3; Boyer Pascal, 2001, RELIG EXPLAINED EVOL; Brown JD, 2012, PERS SOC PSYCHOL B, V38, P209, DOI 10.1177/0146167211432763; Carey S., 2009, ORIGIN CONCEPTS; Cofnas N, 2018, PHILOS PSYCHOL, V31, P609, DOI 10.1080/09515089.2017.1409888; DUNNING D, 1989, J PERS SOC PSYCHOL, V57, P1082, DOI 10.1037/0022-3514.57.6.1082; Durkheim E., 1995, ELEMENTARY FORMS REL; Eilam D, 2011, NEUROSCI BIOBEHAV R, V35, P999, DOI 10.1016/j.neubiorev.2010.08.002; ELLISON CG, 1989, SOC FORCES, V68, P100, DOI 10.2307/2579222; Fessler DMT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095167; Fondevila S, 2012, SOC NEUROSCI-UK, V7, P445, DOI 10.1080/17470919.2011.641228; Gebauer JE, 2012, PSYCHOL SCI, V23, P158, DOI 10.1177/0956797611427045; Gervais WM, 2011, RELIGION, V41, P389, DOI 10.1080/0048721X.2011.604510; Gervais WM, 2010, J COGN CULT, V10, P383, DOI 10.1163/156853710X531249; Gill A, 2004, RATION SOC, V16, P399, DOI 10.1177/1043463104046694; Harmon-Vukic M, 2016, RELIG BRAIN BEHAV, V6, P256, DOI 10.1080/2153599X.2015.1015044; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Inzlicht M, 2011, RELIG BRAIN BEHAV, V1, P192, DOI 10.1080/2153599X.2011.647849; Jong J, 2012, J EXP SOC PSYCHOL, V48, P983, DOI 10.1016/j.jesp.2012.03.005; Kay AC, 2008, J PERS SOC PSYCHOL, V95, P18, DOI 10.1037/0022-3514.95.1.18; Kirkpatrick LA, 2015, EVOL PSYCHOL-SER, P69, DOI 10.1007/978-3-319-12697-5_6; Knight N, 2004, COGNITIVE SCI, V28, P117, DOI 10.1016/j.cogsci.2003.09.002; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Landau MJ, 2009, PSYCHOL SCI, V20, P1421, DOI 10.1111/j.1467-9280.2009.02462.x; Lanman JA, 2012, J CONTEMP RELIG, V27, P49, DOI 10.1080/13537903.2012.642726; Lawson ET, 2012, WIRES COGN SCI, V3, P525, DOI 10.1002/wcs.1189; Legare CH, 2014, COGNITIVE SCI, V38, P152, DOI 10.1111/cogs.12077; Lienard P, 2006, AM ANTHROPOL, V108, P814, DOI 10.1525/aa.2006.108.4.814; MAASS A, 1989, J PERS SOC PSYCHOL, V57, P981, DOI 10.1037/0022-3514.57.6.981; McCauley RN, 2010, PHILOS COMPASS, V5, P779, DOI 10.1111/j.1747-9991.2010.00326.x; McGregor I, 2010, J PERS SOC PSYCHOL, V99, P148, DOI 10.1037/a0019702; Nichols Shaun, 2004, J COGN CULT, V4, P347, DOI DOI 10.1163/1568537041725079; Norenzayan A, 2006, PERS SOC PSYCHOL B, V32, P174, DOI 10.1177/0146167205280251; Norenzayan A, 2013, BIG GODS RELIG TRANS; Purzycki BG, 2018, EVOL HUM BEHAV, V39, P490, DOI 10.1016/j.evolhumbehav.2018.04.004; Purzycki BG, 2015, RELIG BRAIN BEHAV, V5, DOI [10.1080/2153599X.2014.910255, 10.1080/2153599X.2015.1024915]; Pyysaiinen I, 2003, RELIGION, V33, P341, DOI 10.1016/j.religion.2003.09.001; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Shariff AF, 2010, EVOLUTION, CULTURE, AND THE HUMAN MIND, P119; Smith JJ., 1997, J LINGUIST ANTHROPOL, V7, P208, DOI [10.1525/jlin.1997.7.2.208, DOI 10.1525/JLIN.1997.7.2.208]; Sorensen J, 2005, NUMEN-INT REV HIST R, V52, P465, DOI 10.1163/156852705775219974; Sperber D, 2004, TRENDS COGN SCI, V8, P40, DOI 10.1016/j.tics.2003.11.002; Sterelny K, 2018, RELIG BRAIN BEHAV, V8, P406, DOI 10.1080/2153599X.2017.1323779; Suls J, 2002, J PERS SOC PSYCHOL, V82, P252, DOI 10.1037//0022-3514.82.2.252; Swan T, 2019, FITNESS RELEVA UNPUB; Swan T., 2012, THESIS, DOI [10.13140/RG.2.2.10454.09283, DOI 10.13140/RG.2.2.10454.09283]; Swan T, 2018, MICKEY MOUSE PROBLEM; Thibodeau PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016782; Toburen T, 2010, J SOC CLIN PSYCHOL, V29, P127, DOI 10.1521/jscp.2010.29.2.127; Tweney RD, 2006, J COGN CULT, V6, P483, DOI 10.1163/156853706778554904; Upal MA, 2007, COGNITIVE SCI, V31, P415, DOI 10.1080/15326900701326568; WELLMAN HM, 1992, ANNU REV PSYCHOL, V43, P337, DOI 10.1146/annurev.ps.43.020192.002005; Willard AK, 2016, HUM NATURE-INT BIOS, V27, P221, DOI 10.1007/s12110-016-9259-6	68	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220886	10.1371/journal.pone.0220886	http://dx.doi.org/10.1371/journal.pone.0220886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393944	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500078
J	Winter, B; Perez-Sobrino, P; Brown, L				Winter, Bodo; Perez-Sobrino, Paula; Brown, Lucien			The sound of soft alcohol: Crossmodal associations between interjections and liquor	PLOS ONE			English	Article							VOWEL HARMONY; SENSORY CORRESPONDENCES; PERCEPTUAL DIMENSIONS; MECHANICAL TURK; BRAND-NAME; SYMBOLISM; ICONICITY; TASTE; SYNAESTHESIA; ROUGHNESS	An increasing number of studies reveal crossmodal correspondences between speech sounds and perceptual features such as shape and size. In this study, we show that an interjection Koreans produce when downing a shot of liquor reliably triggers crossmodal associations in American English, German, Spanish, and Chinese listeners who do not speak Korean. Based on how this sound is used in advertising campaigns for the Korean liquor soju, we derive predictions for different crossmodal associations. Our experiments show that the same speech sound is reliably associated with various perceptual, affective, and social meanings. This demonstrates what we call the 'pluripotentiality' of iconicity, that is, the same speech sound is able to trigger a web of interrelated mental associations across different dimensions. We argue that the specific semantic associations evoked by iconic stimuli depend on the task, with iconic meanings having a 'latent' quality that becomes 'actual' in specific semantic contexts. We outline implications for theories of iconicity and advertising.	[Winter, Bodo] Univ Birmingham, Dept English Language & Linguist, Birmingham, W Midlands, England; [Perez-Sobrino, Paula] Univ Politecn Madrid, Appl Linguist Dept, Madrid, Spain; [Brown, Lucien] Monash Univ, Korean Studies Program, Melbourne, Vic, Australia; [Winter, Bodo] Univ Birmingham, Dept English Language, Edgbaston, England	University of Birmingham; Universidad Politecnica de Madrid; Monash University; University of Birmingham	Winter, B (corresponding author), Univ Birmingham, Dept English Language & Linguist, Birmingham, W Midlands, England.; Winter, B (corresponding author), Univ Birmingham, Dept English Language, Edgbaston, England.	bodo@bodowinter.com	Winter, Bodo/K-6975-2018	Winter, Bodo/0000-0001-6036-6774	Laboratory Program for Korean Studies through the Ministry of Education; Laboratory Program for Korean Studies through Republic of Korea; Korean Studies Promotion Service of the Academy of Korean Studies [AKS-2016-LAB225003]; FEDER/Spanish Ministry of Science, Innovation and Universities, State Research Agency [FFI2017-82730-P]	Laboratory Program for Korean Studies through the Ministry of Education(Ministry of Education (MOE), Republic of Korea); Laboratory Program for Korean Studies through Republic of Korea; Korean Studies Promotion Service of the Academy of Korean Studies; FEDER/Spanish Ministry of Science, Innovation and Universities, State Research Agency(Spanish Government)	Lucien Brown received funding from the Laboratory Program for Korean Studies through the Ministry of Education and the Republic of Korea and Korean Studies Promotion Service of the Academy of Korean Studies (AKS-2016-LAB225003). Paula P. Sobrino has been supported by Financed by FEDER/Spanish Ministry of Science, Innovation and Universities, State Research Agency, project no. FFI2017-82730-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlner F., 2010, SIGN SYST STUD, V38, P298, DOI [10.12697/SSS.2010.38.1-4.11, DOI 10.12697/SSS.2010.38.1-4.11]; Aryani A, 2016, PSYCHOL AESTHET CREA, V10, P191, DOI 10.1037/aca0000033; Aryani A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00654; Auracher J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187196; Bankieris K, 2015, COGNITION, V136, P186, DOI 10.1016/j.cognition.2014.11.013; Bankieris K, 2014, NEUROCASE, V20, P640, DOI 10.1080/13554794.2013.826693; Blasi DE, 2016, P NATL ACAD SCI USA, V113, P10818, DOI 10.1073/pnas.1605782113; Bohannon J, 2011, SCIENCE, V334, P307, DOI 10.1126/science.334.6054.307; BROWN R W, 1955, J Abnorm Psychol, V50, P388, DOI 10.1037/h0046820; Cho Young-mee Yu, 2006, KOREAN LANGUAGE CULT, P64; Crisinel AS, 2012, CHEMOSENS PERCEPT, V5, P266, DOI 10.1007/s12078-012-9133-9; D'Onofrio A, 2014, LANG SPEECH, V57, P367, DOI 10.1177/0023830913507694; Dingemanse M, 2016, LANGUAGE, V92, pE117, DOI 10.1353/lan.2016.0034; Dingemanse M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078273; EKMAN G, 1965, J EXP PSYCHOL, V70, P18, DOI 10.1037/h0021985; Elder RS, 2010, J CONSUM RES, V36, P748, DOI 10.1086/605327; Essick GK, 1999, NEUROREPORT, V10, P2083, DOI 10.1097/00001756-199907130-00017; Essick GK, 2010, NEUROSCI BIOBEHAV R, V34, P192, DOI 10.1016/j.neubiorev.2009.02.003; Fitch WTS, 1994, THESIS; Fonagy Ivan, 1963, METAPHERN PHONETIK; French P. L., 1977, WORD, V28, P305, DOI [DOI 10.1080/00437956.1977.11435647, 10.1080/00437956.1977.11435647]; Gallace A, 2011, COGN NEUROSCI-UK, V2, P34, DOI 10.1080/17588928.2010.516820; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Guest S, 2011, ATTEN PERCEPT PSYCHO, V73, P531, DOI 10.3758/s13414-010-0037-y; Harkness N, 2013, ANTHROPOL THEOR, V13, P12, DOI 10.1177/1463499613483394; Harkness N, 2012, J SOCIOLING, V16, P358, DOI 10.1111/j.1467-9841.2012.00536.x; Harkness N, 2011, J LINGUIST ANTHROPOL, V21, P99, DOI 10.1111/j.1548-1395.2011.01084.x; HOLLINS M, 1993, PERCEPT PSYCHOPHYS, V54, P697, DOI 10.3758/BF03211795; Hultun B., 2015, SENSORY MARKETING TH, DOI 10.4324/9781315690681; KIM KO, 1977, J LINGUIST, V13, P67, DOI 10.1017/S0022226700005211; KLANK LJK, 1971, J VERB LEARN VERB BE, V10, P140, DOI 10.1016/S0022-5371(71)80005-1; Klink R. R., 2000, MARKET LETT, V11, P5, DOI DOI 10.1023/A:1008184423824; Klink RR, 2012, MARKET LETT, V23, P109, DOI 10.1007/s11002-011-9140-7; Klink RR, 2003, MARKET LETT, V14, P143, DOI 10.1023/A:1027476132607; Kohler W., 1929, GESTALT PSYCHOL; Krishna A, 2012, J CONSUM PSYCHOL, V22, P332, DOI 10.1016/j.jcps.2011.08.003; Kwon N., 2018, LAB PHONOLOGY, V9, P1, DOI [10.5334/labphon.53, DOI 10.5334/LABPH0N.53]; Kwon Nahyun, 2015, THESIS; Larsen D, 2012, PHONOLOGY, V29, P433, DOI 10.1017/S095267571200022X; Lindstrom M., 2010, BRAND SENSE SENSORY; Lowrey TM, 2007, J CONSUM RES, V34, P406, DOI 10.1086/518530; Major DR, 1895, THOUGHTS DECLINE MAJ, V7, P57, DOI [10.2307/1412037, DOI 10.2307/1412037]; McQuarrie EF, 2005, J ADVERTISING, V34, P7, DOI 10.1080/00913367.2005.10639188; Nielsen A, 2011, CAN J EXP PSYCHOL, V65, P115, DOI 10.1037/a0022268; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Patel Aniruddh D, 2003, P 15 INT C PHON SCI, P925; Peer E, 2014, BEHAV RES METHODS, V46, P1023, DOI 10.3758/s13428-013-0434-y; Perez Sobrino Paula, 2017, MULTIMODAL METAPHOR; Perez-Sobrino P, 2019, APPL LINGUIST, V40, P957, DOI 10.1093/applin/amy039; Perlman M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01433; Perry LK, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12572; Perry LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137147; Picard D, 2003, ACTA PSYCHOL, V114, P165, DOI 10.1016/j.actpsy.2003.08.001; Rakova M, 2003, EXTENT OF THE LITERAL: METAPHOR, POLYSEMY AND THEORIES OF CONCEPTS, P1, DOI 10.1057/9780230512801; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Ripin R, 1937, J APPL PSYCHOL, V21, P198, DOI 10.1037/h0058436; ROSENSTEIN D, 1988, CHILD DEV, V59, P1555, DOI 10.1111/j.1467-8624.1988.tb03683.x; Rouse SV, 2015, COMPUT HUM BEHAV, V43, P304, DOI 10.1016/j.chb.2014.11.004; Rummer R, 2014, EMOTION, V14, P246, DOI 10.1037/a0035752; Sakamoto M, 2016, CHEM SENSES, V41, P197, DOI 10.1093/chemse/bjv078; Sapir E, 1929, J EXP PSYCHOL, V12, P225, DOI 10.1037/h0070931; Shrum LJ, 2012, INT J RES MARK, V29, P275, DOI 10.1016/j.ijresmar.2012.03.002; Sidhu DM, 2018, PSYCHON B REV, V25, P1619, DOI 10.3758/s13423-017-1361-1; Silverstein M, 2003, LANG COMMUN, V23, P193, DOI 10.1016/S0271-5309(03)00013-2; Simner J, 2010, PERCEPTION, V39, P553, DOI 10.1068/p6591; Sohn HoMin., 1999, KOREAN LANGUAGE; Spence C, 2011, FOOD QUAL PREFER, V22, P290, DOI 10.1016/j.foodqual.2010.11.005; Sprouse J, 2011, BEHAV RES METHODS, V43, P155, DOI 10.3758/s13428-010-0039-7; Stadtlander LM, 2000, BEHAV RES METH INS C, V32, P579, DOI 10.3758/BF03200831; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; Tiest WMB, 2006, ACTA PSYCHOL, V121, P1, DOI 10.1016/j.actpsy.2005.04.005; Topolinski S, 2014, J PERS SOC PSYCHOL, V106, P885, DOI 10.1037/a0036477; Tzeng CY, 2017, COGNITIVE SCI, V41, P2191, DOI 10.1111/cogs.12474; Ullrich S, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01200; Walker L, 2012, PERCEPTION, V41, P1186, DOI 10.1068/p7149; Walker P, 2016, J EXP PSYCHOL LEARN, V42, P1339, DOI 10.1037/xlm0000253; Wiggins S, 2013, BRIT J SOC PSYCHOL, V52, P489, DOI 10.1111/j.2044-8309.2012.02106.x; Winter B., 2016, THESIS; Winter B, 2017, INTERACT STUD, V18, P430, DOI 10.1075/is.18.3.07win; Yeomans MR, 2008, FOOD QUAL PREFER, V19, P565, DOI 10.1016/j.foodqual.2008.02.009; Yorkston E, 2004, J CONSUM RES, V31, P43, DOI 10.1086/383422; YOSHIDA M, 1968, JPN PSYCHOL RES, V10, P123, DOI 10.4992/psycholres1954.10.123	82	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220449	10.1371/journal.pone.0220449	http://dx.doi.org/10.1371/journal.pone.0220449			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393912	gold, Green Published			2022-12-27	WOS:000485002500032
J	Li, C; Zhang, Z; Peng, Y; Gao, HX; Wang, YX; Zhao, J; Pan, CL				Li, Chao; Zhang, Zheng; Peng, Yu; Gao, Hanxiang; Wang, Yongxiang; Zhao, Jing; Pan, Chenliang			Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; ARTERY-DISEASE; ESC GUIDELINES; ST; REFLECTS; FAILURE; NGAL; ATHEROSCLEROSIS; EXPRESSION	Objective This study aimed to compare the levels of plasma neutrophil gelatinase-associated lipocalin (NGAL), matrix metalloproteinase (MMP)-9, high-sensitivity C-reactive protein (hs-CRP), and interleukin (IL)-1 beta across different clinical presentations of coronary artery disease and to evaluate the relationship between those biomarkers and the severity of coronary artery lesions in patients without kidney disease. Methods We examined 365 eligible patients who underwent coronary angiography. A total of 124 ST-segment elevation myocardial infarction (STEMI) patients, 117 stable angina pectoris (SAP) patients and 124 patients without atherosclerotic plaques were enrolled in the study. Plasma NGAL, MMP-9, hs-CRP, and IL-1 beta were measured in all patients using the enzyme-linked immunosorbent assay (ELISA) method. According to the SYNTAX score, the STEMI patients and SAP patients were divided into another set of 2 groups: a high score group (>= 33, n = 29) and a low score group (< 33, n = 212). The relationship between those biomarkers and the severity of coronary stenosis was examined by Spearman correlation analysis; the ability for NGAL to discriminate severe coronary stenosis was examined by receiver operating characteristic (ROC) curve; the influencing factors for the SYNTAX score were determined by logistic regression analysis. Results Plasma NGAL, MMP-9, and hs-CRP levels in STEMI patients were higher than in the SAP patients and control subjects (P< 0.05, respectively), and plasma NGAL and hs-CRP levels were significantly higher in the SAP patients than in control subjects (P< 0.05, respectively), while plasma IL-1 beta was similar among the 3 groups (P> 0.05, respectively). The SYNTAX score was positively related to NGAL (r = 0.363, P< 0.001), MMP-9 (r = 0.377, P< 0.001), and hs-CRP (r = 0.163, P< 0.011); the SYNTAX score was not related to IL-1 beta (r = -0.043, P = 0.510). Plasma NGAL was positively related to MMP-9 (r = 0.601, P< 0.001) and IL-1 beta (r = 0.159, P = 0.014). The area under the ROC curve for NGAL discriminating severe coronary stenosis was 0.838 (95% CI: 0.752-0.923, P< 0.001), which was greater than that for MMP-9 [0.818, (95% CI: 0.724-0.912, P< 0.001)], IL-1 beta [0.485, (95% CI: 0.369-0.601, P = 0.791)], and hs-CRP [0.607, (95% CI: 0.492-0.722, P = 0.061)]. Multivariate regression analysis showed that plasma NGAL levels were independently related to high SYNTAX scores [OR = 1.109, (95% CI: 1.104-1.114), P< 0.001]. Conclusion Plasma NGAL, MMP-9, and hs-CRP levels in STEMI patients were higher than those in the SAP patients and control subjects. NGAL had a better ability to discriminate severe coronary stenosis than MMP-9, IL-1 beta, and hs-CRP. NGAL may be a novel biomarker to aid in risk stratification in coronary heart disease patients.	[Li, Chao] Lanzhou Univ, Clin Coll 1, Lanzhou, Gansu, Peoples R China; [Li, Chao; Zhang, Zheng; Peng, Yu; Gao, Hanxiang; Wang, Yongxiang; Zhao, Jing; Pan, Chenliang] Lanzhou Univ, Hosp 1, Dept Cardiol, Lanzhou, Gansu, Peoples R China; [Li, Chao] Gansu Key Lab Cardiovasc Dis, Lanzhou, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Zhang, Z (corresponding author), Lanzhou Univ, Hosp 1, Dept Cardiol, Lanzhou, Gansu, Peoples R China.	Zhangccu@163.com						Ahmadi A, 2015, CIRC RES, V117, P99, DOI 10.1161/CIRCRESAHA.117.305637; Boekhorst BCT, 2011, CARDIOVASC RES, V89, P680, DOI 10.1093/cvr/cvq340; Bolignano D, 2008, KIDNEY BLOOD PRESS R, V31, P255, DOI 10.1159/000143726; Bundhun PK, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007140; [全国eGFR课题协作组 Chinese eGFR Investigation Collaboration], 2006, [中华肾脏病杂志, Chinese Journal of Nephrology], V22, P589; Chong JJH, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011028; Cruz DN, 2012, CLIN CHEM LAB MED, V50, P1533, DOI 10.1515/cclm-2012-0307; Ding LM, 2010, CIRC J, V74, P523, DOI 10.1253/circj.CJ-09-0485; Dong L, 2015, AM J CARDIOL, V115, P860, DOI 10.1016/j.amjcard.2015.01.008; Hemdahl AL, 2006, ARTERIOSCL THROM VAS, V26, P136, DOI 10.1161/01.ATV.0000193567.88685.f4; Hong MK, 2004, CIRCULATION, V110, P928, DOI 10.1161/01.CIR.0000139858.69915.2E; Kafkas N, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/189797; Kai HK, 1998, J AM COLL CARDIOL, V32, P368, DOI 10.1016/S0735-1097(98)00250-2; Katagiri M, 2016, HEART VESSELS, V31, P1595, DOI 10.1007/s00380-015-0776-8; Kirbis S, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0054-9; Kunutsor SK, 2018, CLIN CHIM ACTA, V486, P66, DOI 10.1016/j.cca.2018.07.034; Lahiri A, 2018, INDIAN HEART J, V70, P220, DOI 10.1016/j.ihj.2017.06.005; Lim YM, 2017, CORONARY ARTERY DIS, V28, P690, DOI 10.1097/MCA.0000000000000542; Lindberg S, 2016, CARDIORENAL MED, V6, P180, DOI 10.1159/000443846; Lindberg S, 2012, J AM COLL CARDIOL, V60, P339, DOI 10.1016/j.jacc.2012.04.017; Loftus IM, 2000, STROKE, V31, P40, DOI 10.1161/01.STR.31.1.40; Ma QQ, 2016, EUR REV MED PHARMACO, V20, P4294; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mortara A, 2013, J CARDIOVASC MED, V14, P629, DOI 10.2459/JCM.0b013e3283629ca6; Nymo SH, 2018, INT J CARDIOL, V262, P79, DOI 10.1016/j.ijcard.2018.03.028; Sahinarslan A, 2011, CORONARY ARTERY DIS, V22, P333, DOI 10.1097/MCA.0b013e3283472a71; Sano T, 2003, CIRCULATION, V108, P282, DOI 10.1161/01.CIR.0000079173.84669.4F; Sivalingam Z, 2018, SCAND J CLIN LAB INV, V78, P470, DOI 10.1080/00365513.2018.1499956; Soylu K, 2015, ANATOL J CARDIOL, V15, P450, DOI 10.5152/akd.2014.5513; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Takahashi M, 2011, TRENDS CARDIOVAS MED, V21, P37, DOI 10.1016/j.tcm.2012.02.002; Woitas RP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171574; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088; Zografos T, 2009, AM J CARDIOL, V104, P917, DOI 10.1016/j.amjcard.2009.05.023	35	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220841	10.1371/journal.pone.0220841	http://dx.doi.org/10.1371/journal.pone.0220841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31387110	gold, Green Published, Green Submitted			2022-12-27	WOS:000484997100038
J	Carregaro, AB; Ferrari, BG; da Silva, ANE; Xavier, NV; Duarte, JMB				Carregaro, Adriano B.; Ferrari, Barbara G.; da Silva, Andre N. E.; Xavier, Nathalia, V; Duarte, Jose M. B.			Azaperone and xylazine: A pharmacological combination to facilitate captive deer management for red brocket deer (Mazama americana)	PLOS ONE			English	Article							WHITE-TAILED DEER; TILETAMINE-ZOLAZEPAM; CERVUS-ELAPHUS; BLOOD-GAS; ACID-BASE; MEDETOMIDINE; IMMOBILIZATION; KETAMINE; ANESTHESIA; BUTORPHANOL	The care and management of deer in captivity is challenging, especially in the case of red brocket deer (Mazama americana), whose routine management using physical restraint is difficult. Our study evaluated the effects of azaperone and xylazine combination for immobilizing red brocket deer and allow for the standard capture and handling protocols (e.g., biological material, horn cutting, and trimming) to be conducted safely. Six adult, captive, red brocket deer received an intramuscular injection of either 1 mg/kg azaperone and 0.5 mg/kg xylazine (AX0.5) or 1 mg/kg azaperone and 1 mg/kg xylazine (AX1.0). Sedation latency, sternal recumbency, safe handling, and quality of the sedation were evaluated to provide an overview of how the immobilizing drugs affected managing the species in captivity. Additionally, heart rate, respiratory rate, mean arterial pressure, rectal temperature, pH, PaO2, PaCO2, SaO(2), HCO3-, BE, Na+, K+ and serum lactate were also measured. The latency period of the animals in the AX0.5 group was greater than that of the animals in the AX1.0 group (7 +/- 6.6 min vs. 5 +/- 2.0 min), as was the time for them to assume sternal recumbency (12 +/- 9.7 min vs. 6 +/- 3.1 min). However, the time after the initial dose at which the animals could safely be handled (14 +/- 4.5 min vs. 12 +/- 5.2 min), and the time until the end of the safe handling period (75 +/- 12.3 min vs. 85 +/- 6.8 min) were similar for both groups. Animals in both groups showed physiological stability during all evaluations, but hypoxemia was observed in one animal in each group. We conclude that both drug combinations are safe and effective at sedating red brocket deer in captivity and suggest that the procedure be performed with oxygen supplementation to reduce the potential for hypoxia.	[Carregaro, Adriano B.; Ferrari, Barbara G.; da Silva, Andre N. E.; Xavier, Nathalia, V] Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil; [Duarte, Jose M. B.] Sao Paulo State Univ UNESP, Fac Agr & Vet Sci, Deer Res & Conservat Ctr NUPECCE, Dept Anim Sci, Jaboticabal, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista	Carregaro, AB (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil.	carregaro@usp.br	Duarte, José Maurício Barbanti/AAG-5149-2019; Carregaro, Adriano Bonfim/C-2832-2012	Duarte, José Maurício Barbanti/0000-0002-7805-0265; Carregaro, Adriano Bonfim/0000-0002-0580-0467				Abril VV, 2010, CYTOGENET GENOME RES, V128, P177, DOI 10.1159/000298819; Auer U, 2010, J WILDLIFE DIS, V46, P1196, DOI 10.7589/0090-3558-46.4.1196; Barbanti Duarte Jose Mauricio, 2010, P218; Catao-Dias Jose Luiz, 2010, P324; Caulkett NA, 2000, CAN J VET RES, V64, P64; Caulkett NA, 1997, CAN VET J, V38, P389; Cursino MS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-40; Duarte JMB, 2006, TRATADO ANIMAIS SELV, P641; Duarte JMB, 2016, IUCN RED LIST THREAT, V8235, P1; Duarte JMB, 2009, ENDANGERED FAUNA STA, P645; Fahlman A, 2014, J ZOO WILDLIFE MED, V45, P272, DOI 10.1638/2013-0097R.1; Flôres Fabíola Niederauer, 2009, Cienc. Rural, V39, P1101, DOI 10.1590/S0103-84782009000400022; KREEGER TJ, 1986, J WILDLIFE DIS, V22, P407, DOI 10.7589/0090-3558-22.3.407; Lemke KA, 2004, CAN VET J, V45, P475; Mich PM, 2008, J ZOO WILDLIFE MED, V39, P480, DOI 10.1638/2007-0150.1; Miller BF, 2004, J WILDLIFE DIS, V40, P533, DOI 10.7589/0090-3558-40.3.533; Monteith KL, 2012, J WILDLIFE MANAGE, V76, P1412, DOI 10.1002/jwmg.383; Muller LI, 2012, J WILDLIFE DIS, V48, P477, DOI 10.7589/0090-3558-48.2.477; Navas-Suarez PE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198670; PINHO MP, 2010, NEOTROPICAL CERVIDOL, P228; Posner LP, 2005, J ZOO WILDLIFE MED, V36, P642, DOI 10.1638/04-072.1; Salviano MB, 2017, BIOL REPROD, V96, P1279, DOI 10.1093/biolre/iox041; Sente C, 2014, J WILDLIFE DIS, V50, P359, DOI 10.7589/2012-10-267; Siegal-Willott J, 2009, J WILDLIFE DIS, V45, P468, DOI 10.7589/0090-3558-45.2.468; Smith KM, 2006, J ZOO WILDLIFE MED, V37, P513, DOI 10.1638/06-027.1; Stewart JL, 2018, J FISH WILDL MANAG, V9, P631, DOI 10.3996/032018-JFWM-025; Suzuki M, 2001, J WILDLIFE DIS, V37, P366, DOI 10.7589/0090-3558-37.2.366; VANWOERKENS LJ, 1990, BRIT J ANAESTH, V65, P393, DOI 10.1093/bja/65.3.393; Varela DM, 2015, NEOTROPICAL CERVIDOL, P151; Wilson PR, 1996, NEW ZEAL VET J, V44, P81, DOI 10.1080/00480169.1996.35941; Wolfe LL, 2014, J WILDLIFE DIS, V50, P676, DOI 10.7589/2014-02-026	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220288	10.1371/journal.pone.0220288	http://dx.doi.org/10.1371/journal.pone.0220288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374096	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500008
J	Alessandrini, V; Anselem, O; Girault, A; Mandelbrot, L; Luton, D; Launay, O; Goffinet, F				Alessandrini, Vivien; Anselem, Olivia; Girault, Aude; Mandelbrot, Laurent; Luton, Dominique; Launay, Odile; Goffinet, Francois			Does the availability of influenza vaccine at prenatal care visits and of immediate vaccination improve vaccination coverage of pregnant women?	PLOS ONE			English	Article							MATERNAL IMMUNIZATION; VIRUS-INFECTION; UNITED-STATES; PHASE 4; A H1N1; MOTHERS; PREDICTORS; ACCEPTABILITY; DETERMINANTS; DISPARITIES	Introduction Although vaccination against influenza is recommended for pregnant women in France because it exposes them to a risk of death and severe respiratory complications, their vaccination coverage in 2016 was estimated at 7%. This study's principal objective was to assess the association between the availability of influenza vaccination at prenatal care visits and vaccination coverage. Material and methods This multicenter survey took place in 3 Paris-area public hospital (AP-HP) maternity wards (A, B, and C). Only maternity ward A offered the vaccine and vaccination without charge at prenatal visits. Data were collected from parturients during 10 days in January 2017 by a self-administered anonymous questionnaire. Results Data from 248 women showed overall vaccination coverage of 19.4% (48/248): 35.4% (46/130) in maternity unit A, 2.7% (2/75) in B, and 0% (0/43) in C (P<0.01). After adjustment for socio-demographic characteristics, women at maternity ward A were significantly more likely to be vaccinated than those at B and C (aOR 25.52, 95% CI [5.76-113.10]). Other factors significantly associated with higher vaccination coverage were the mother's French birth (aOR 2.37 CI [1.03-5.46]) and previous influenza vaccination (aOR 3.13, 95% CI [1.25-7.86]). Vaccinated women generally considered they had received adequate information (aOR 4.15 CI [2.10-8.22]), principally from the professional providing their prenatal care. Nonvaccination was attributed to the absence of an offer of vaccination (81.5%), fear of fetal side effects (59.5%), and inadequate information (51.4%). Conclusion Our results show that availability of influenza vaccination, free of charge, at prenatal consultations at the maternity ward increases vaccination coverage significantly.	[Alessandrini, Vivien; Anselem, Olivia; Girault, Aude; Goffinet, Francois] Univ Paris 05, Grp Hosp Cochin Broca Hotel Dieu, AP HP, Maternite Port Royal, Paris, France; [Alessandrini, Vivien; Anselem, Olivia; Girault, Aude; Mandelbrot, Laurent; Luton, Dominique; Launay, Odile; Goffinet, Francois] PRES Sorbonne Paris Cite, DHU Risques & Grossesse, Paris, France; [Mandelbrot, Laurent] Univ Diderot Paris 7, Maternite Louis Mourier, Hop Univ Paris Nord Val de Seine, AP HP, Colombes, France; [Luton, Dominique] Univ Diderot Paris 7, Maternite Bichat Claude Bernard, Hop Univ Paris Nord Val de Seine, AP HP, Paris, France; [Launay, Odile] Univ Paris 05, Sorbonne Paris Cite, Ctr Invest Clin Cochin Pasteur, Grp Hosp Cochin Broca Hotel Dieu,AP HP,Inserm,CIC, Paris, France; [Goffinet, Francois] UPMC, Unite INSERM U953, Rech Epidemiol Sante Perinatale & Sante Femmes &, Paris, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Alessandrini, V (corresponding author), Univ Paris 05, Grp Hosp Cochin Broca Hotel Dieu, AP HP, Maternite Port Royal, Paris, France.; Alessandrini, V (corresponding author), PRES Sorbonne Paris Cite, DHU Risques & Grossesse, Paris, France.	alessandrini.viven@hotmail.fr	Mandelbrot, Laurent/AAD-3554-2019	Mandelbrot, Laurent/0000-0002-5883-7597				Anselem O, 2013, PRESSE MED, V42, P1453, DOI 10.1016/j.lpm.2013.01.064; Bianco A, 2019, VACCINE, V37, P984, DOI 10.1016/j.vaccine.2018.12.062; Blanchard-Rohner G, 2012, J MATERN-FETAL NEO M, V25, P1800, DOI 10.3109/14767058.2012.663835; Bonmarin I, 2011, BEH, V37-38, P398; Bonville CA, 2015, HUM VACC IMMUNOTHER, V11, P713, DOI 10.1080/21645515.2015.1011999; Bratton KN, 2015, CLIN INFECT DIS, V60, pE11, DOI 10.1093/cid/ciu915; Cohen R, 2019, MED MALADIES INFECT, V49, P34, DOI 10.1016/j.medmal.2018.10.004; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; D'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809; Danchin MH, 2018, VACCINE, V36, P6473, DOI 10.1016/j.vaccine.2017.08.003; Ding H, 2017, MMWR-MORBID MORTAL W, V66, P1016, DOI 10.15585/mmwr.mm6638a2; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; Equipes de surveillance de la grippe, 2017, B EPIDEMIOL HEBD, P466; Freund R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020900; Fridman D, 2011, AM J OBSTET GYNECOL, V204, pS124, DOI 10.1016/j.ajog.2011.04.011; Gilkey MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159087; Goldfarb I, 2011, AM J OBSTET GYNECOL, V204, pS112, DOI 10.1016/j.ajog.2011.01.007; Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Henninger ML, 2015, J WOMENS HEALTH, V24, P394, DOI 10.1089/jwh.2014.5105; Henrikson NB, 2017, PUBLIC HEALTH REP, V132, P451, DOI 10.1177/0033354917711175; Jamieson DJ, 2011, AM J OBSTET GYNECOL, V204, pS1, DOI 10.1016/j.ajog.2011.04.010; Krishnaswamy S, 2018, VACCINE, V36, P1796, DOI 10.1016/j.vaccine.2017.12.080; Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042; Link MW, 2006, AM J EPIDEMIOL, V163, P571, DOI 10.1093/aje/kwj086; Linn ST, 2010, J AM GERIATR SOC, V58, P1333, DOI 10.1111/j.1532-5415.2010.02904.x; Loubet P, 2015, J DES ANTIINFECTIEUX, V17, P173; Loubet P, 2014, EXPERT OPIN DRUG SAF, V13, P1709, DOI 10.1517/14740338.2014.977252; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480; Ministere des Solidarite &PRIME; s et de la Sante, ENQ NAT PER 2010; Ministere des Solidarites et de la Sante, ENQ NAT PER 2016; Mohammed H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214538; Mohammed H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197867; Moro PL, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.047; Myers KL, 2016, VACCINE, V34, P3942, DOI 10.1016/j.vaccine.2016.06.042; Napolitano F, 2018, HUM VACC IMMUNOTHER, V14, P1558, DOI 10.1080/21645515.2018.1463943; Napolitano F, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2138-2; Nordin JD, 2013, OBSTET GYNECOL, V121, P519, DOI 10.1097/AOG.0b013e3182831b83; Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Regan AK, 2016, WOMEN BIRTH, V29, P423, DOI 10.1016/j.wombi.2016.01.009; Sakaguchi S, 2011, J OBSTET GYNAECOL CA, V33, P460, DOI 10.1016/S1701-2163(16)34879-4; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Steinhoff MC, 2017, LANCET INFECT DIS, V17, P981, DOI 10.1016/S1473-3099(17)30252-9; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Tapia MD, 2016, LANCET INFECT DIS, V16, P1026, DOI 10.1016/S1473-3099(16)30054-8; Tarrant M, 2013, MATERN CHILD HLTH J, V17, P23, DOI 10.1007/s10995-011-0943-1; van Lier A, 2012, VACCINE, V30, P2892, DOI 10.1016/j.vaccine.2012.02.030; Ward JK, 2018, VACCINE, V36, P1801, DOI 10.1016/j.vaccine.2018.02.095; Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121; Yudin MH, 2010, J OBSTET GYNAECOL CA, V32, P745, DOI 10.1016/S1701-2163(16)34614-X; Yuen CYS, 2014, VACCINE, V32, P4602, DOI 10.1016/j.vaccine.2014.06.067; Yuen CYS, 2013, VACCINE, V31, P5281, DOI 10.1016/j.vaccine.2013.08.063; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	57	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220705	10.1371/journal.pone.0220705	http://dx.doi.org/10.1371/journal.pone.0220705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369626	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900080
J	Bergt, S; Grub, A; Mueller, M; Bajorat, R; Barilar, I; Vollmar, B; Roesner, JP; Wagner, NM				Bergt, Stefan; Grub, Andrea; Mueller, Melanie; Bajorat, Rika; Barilar, Ivan; Vollmar, Brigitte; Roesner, Jan Patrick; Wagner, Nana-Maria			Toll-like receptor 4 deficiency or inhibition does not modulate survival and neurofunctional outcome in a murine model of cardiac arrest and resuscitation	PLOS ONE			English	Article							CARDIOPULMONARY-RESUSCITATION; NEUROLOGICAL REHABILITATION; BRAIN-INJURY; MICE; MANAGEMENT; CARE	Background Patients experiencing cardiac arrest (CA) and cardiopulmonary resuscitation (CPR) often die or suffer from severe neurological impairment. Post resuscitation syndrome is characterized by a systemic inflammatory response. Toll-like receptor 4 (TLR4) is a major mediator of inflammation and TLR4 has been implicated in the pathogenesis of post-resuscitation encephalopathy. The aim of this study was to evaluate whether TLR4 deficiency or inhibition can modulate survival and neurofunctional outcome after CA/CPR. Methods Following intubation and central venous cannulation, CA was induced in wild type (C57Bl/6J, n = 38), TLR4 deficient (TLR4(-/-), n = 37) and TLR4 antibody treated mice (5mg/kg MTS510, n = 15) by high potassium. After 10min, CPR was performed using a modified sewing machine until return of spontaneous circulation (ROSC). Cytokines and cerebral TNFalpha levels were measured 8h after CA/CPR. Survival, early neurological recovery, locomotion, spatial learning and memory were assessed over a period of 28 days. Results Following CA/CPR, all mice exhibited ROSC and 31.5% of wild type mice survived until day 28. Compared to wild type mice, neither TLR4(-/-) nor MTS510 treated wild type mice had statistically significant altered survival following CA/ CPR (51.3 and 26.7%, P = 0.104 and P = 0.423 vs. WT, respectively). Antibody-treated but not TLR4(-/-) mice had higher IL-1 beta and IL-6 levels and TLR4(-/-) mice had higher IL-10 and cerebral TNFalpha levels. No differences existed between mice of all groups in early neurological recovery, locomotion, spatial learning ability or remembrance. Conclusion Therapeutic strategies targeting TLR4 may not be suitable for the reduction of mortality or neurofunctional impairment after CA/CPR.	[Bergt, Stefan; Grub, Andrea; Bajorat, Rika; Roesner, Jan Patrick] Rostock Univ, Clin Anesthesiol & Crit Care Med, Med Ctr, Rostock, Germany; [Mueller, Melanie; Wagner, Nana-Maria] Univ Hosp Muenster, Clin Anesthesiol Intens Care Med & Pain Therapy, Munster, Germany; [Barilar, Ivan] Res Ctr Borstel, Prior Area Infect, Mol & Expt Mycobacteriol, Borstel, Germany; [Vollmar, Brigitte] Rostock Univ, Inst Expt Surg, Med Ctr, Rostock, Germany	University of Rostock; University of Munster; Forschungszentrum Borstel; University of Rostock	Wagner, NM (corresponding author), Univ Hosp Muenster, Clin Anesthesiol Intens Care Med & Pain Therapy, Munster, Germany.	nmwagner@uni-muenster.de	Wagner, Nana-Maria/AAB-3953-2021	Wagner, Nana-Maria/0000-0002-4610-6666	departmental funds of the Clinic for Anesthesiology and Critical Care Medicine, Rostock, Germany	departmental funds of the Clinic for Anesthesiology and Critical Care Medicine, Rostock, Germany	The study was funded by departmental funds of the Clinic for Anesthesiology and Critical Care Medicine, Rostock, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella BS, 2004, CIRCULATION, V109, P2786, DOI 10.1161/01.CIR.0000131940.19833.85; Andresen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148428; Asmussen A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1340-3; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Bergt S, 2017, JACC BASIC TRANSLATI, V105; Bergt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074944; DECKER MW, 1989, BRAIN RES, V477, P29, DOI 10.1016/0006-8993(89)91391-7; Dvoriantchikova G, 2010, MOL VIS, V16, P1907; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Gesuete R, 2014, J NEUROPATH EXP NEUR, V73, P378, DOI 10.1097/NEN.0000000000000068; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Hutchens MP, 2008, RESUSCITATION, V76, P89, DOI 10.1016/j.resuscitation.2007.06.031; Jiang H, 2017, CANCER IMMUNOL IMMUN, V66, P1037, DOI 10.1007/s00262-017-2003-1; Krupinski J, 2007, BIOMARK INSIGHTS, V2, P361; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Liu FD, 2013, ACTA PHARMACOL SIN, V34, P1121, DOI 10.1038/aps.2013.89; Maramattom BV, 2005, NEUROLOGIST, V11, P234, DOI 10.1097/01.nrl.0000159985.07242.22; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; Neigh GN, 2004, EUR J NEUROSCI, V20, P1865, DOI 10.1111/j.1460-9568.2004.03649.x; Neigh GN, 2004, J CEREBR BLOOD F MET, V24, P372, DOI 10.1097/00004647-200404000-00002; Nicholson A, 2009, J AM ASSOC LAB ANIM, V48, P740; NIEMANN JT, 1984, ANN EMERG MED, V13, P849, DOI 10.1016/S0196-0644(84)80458-8; Oda Y, 2012, RESUSCITATION, V83, P1006, DOI 10.1016/j.resuscitation.2012.01.030; Orr JS, 2012, DIABETES; Packard AEB, 2012, J CEREBR BLOOD F MET, V32, P2193, DOI 10.1038/jcbfm.2012.140; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pradillo JM, 2009, J NEUROCHEM, V109, P287, DOI 10.1111/j.1471-4159.2009.05972.x; Pusswald G, 2000, RESUSCITATION, V47, P241, DOI 10.1016/S0300-9572(00)00240-9; Puttgen HA, 2009, CURR OPIN CRIT CARE, V15, P118, DOI 10.1097/MCC.0b013e328326077c; Shi X, 2017, NEUROSCIENCE, V360, P128, DOI 10.1016/j.neuroscience.2017.07.052; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Thaete LG, 2013, REPRODUCTION; Wang Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/124614; Xu L, 2015, CHINESE MED J-PEKING, V128, P2646, DOI 10.4103/0366-6999.166024; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220404	10.1371/journal.pone.0220404	http://dx.doi.org/10.1371/journal.pone.0220404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369614	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900046
J	Chao, WC; Lin, CH; Chen, YM; Jiang, RS; Chen, HH				Chao, Wen-Cheng; Lin, Ching-Heng; Chen, Yi-Ming; Jiang, Rong-San; Chen, Hsin-Hua			Association between tonsillitis and newly diagnosed ankylosing spondylitis: A nationwide, population-based, case-control study	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PERIODONTITIS; APPENDECTOMY; MICROBIOME; INFECTION; HLA-B27; RISK	Objectives To investigate the association between tonsillitis and the risk of newly diagnosed ankylosing spondylitis (AS). Methods We used 2003-2012 data from Taiwan's National Health Insurance Research Database to conduct this nationwide, population-based, case-control study. We identified AS patients newly diagnosed between 2005 to 2012 as the study group and selected age, sex and index-year matched (1: 6) non-AS individuals as controls. The association between tonsillitis and risk of newly diagnosed AS was determined by calculating odds ratios (ORs) with 95% confidence intervals (CIs) using conditional logistic regression analysis. Results We identified 37,002 newly diagnosed AS cases and 222,012 matched non-AS controls. Patients with AS were more likely to have tonsillitis (aOR 1.46, 95% CI 1.43-1.50), appendicitis (aOR 1.29, 95% CI 1.13-1.48) and periodontitis (aOR 1.35, 95% CI 1.31-1.38) than non-AS control subjects. The association between tonsillitis and AS was consistent using varying definitions for tonsillitis, and we further found that a high frequency of visits for tonsillitis, a high medical cost for tonsillitis and a long interval between diagnosis were associated with newly diagnosed AS in a dose-response manner. Furthermore, the association between tonsillitis and AS appeared to be stronger in females (aOR 1.59, 95% CI 1.53-1.65) than those in males (aOR 1.39, 95% CI 1.35-1.44). Conclusions The present study revealed an association between AS risk and prior tonsillitis and indicates the need for vigilance of AS-associated symptoms in patients who had been diagnosed with tonsillitis, particularly in females.	[Chao, Wen-Cheng; Lin, Ching-Heng; Chen, Yi-Ming; Jiang, Rong-San; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Chao, Wen-Cheng] Hung Kuang Univ, Coll Med & Nursing, Dept Nursing, Taichung, Taiwan; [Chao, Wen-Cheng] Natl Changhua Univ Educ, Dept Business Adm, Changhua, Taiwan; [Lin, Ching-Heng] Natl Taipei Univ Nursing & Hlth Sci, Dept Healthcare Management, Taipei, Taiwan; [Lin, Ching-Heng] Fu Jen Catholic Univ, Coll Med, Dept Publ Hlth, New Taipei, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Jiang, Rong-San] Taichung Vet Gen Hosp, Dept Otolaryngol, Taichung, Taiwan; [Jiang, Rong-San] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Chen, Hsin-Hua] Tunghai Univ, Dept Ind Engn & Enterprise Informat, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; Hungkuang University; National Changhua University of Education; National Taipei University of Nursing & Health Science (NTUNHS); Fu Jen Catholic University; Taichung Veterans General Hospital; National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tunghai University	Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.; Chen, HH (corresponding author), Tunghai Univ, Dept Ind Engn & Enterprise Informat, Taichung, Taiwan.	shc5555@hotmail.com	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Chao, Wen-Cheng/0000-0001-9631-8934	Taichung Veterans General Hospital, Taiwan [TCVGH-1057329D]	Taichung Veterans General Hospital, Taiwan	This study was supported in part by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-1057329D). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson RE, 2003, GASTROENTEROLOGY, V124, P40, DOI 10.1053/gast.2003.50021; Andersson RE, 2001, NEW ENGL J MED, V344, P808, DOI 10.1056/NEJM200103153441104; [Anonymous], 2015, THE NATIONAL HEALTH; Blair AB, 2015, AM J OTOLARYNG, V36, P517, DOI 10.1016/j.amjoto.2015.03.002; Burke Kristin E, 2017, Curr Gastroenterol Rep, V19, P21, DOI 10.1007/s11894-017-0562-0; Campisi L, 2016, NAT IMMUNOL, V17, P1084, DOI 10.1038/ni.3512; Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chen HH, 2011, CLINICS, V66, P251, DOI 10.1590/S1807-59322011000200012; Ciccia F, 2012, ARTHRITIS RHEUM-US, V64, P1869, DOI 10.1002/art.34355; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Dean LE, 2014, RHEUMATOLOGY, V53, P650, DOI 10.1093/rheumatology/ket387; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kawano M, 2003, ARTHRITIS RHEUM-US, V48, P2483, DOI 10.1002/art.11212; Keller JJ, 2013, ARTHRITIS RHEUM-US, V65, P167, DOI 10.1002/art.37746; Kobayashi S, 2011, ADV OTO-RHINO-LARYNG, V72, P79, DOI 10.1159/000324612; Kordeluk S, 2011, OTOLARYNG HEAD NECK, V145, P940, DOI 10.1177/0194599811415802; Lau AS, 2014, ANN ROY COLL SURG, V96, P307, DOI 10.1308/003588414X13946184900363; Lin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105684; Lindstrom U, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1141-8; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Millington AJ, 2014, ANN ROY COLL SURG, V96, P586, DOI 10.1308/003588414X13946184901966; Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5; Palomares O, 2012, J ALLERGY CLIN IMMUN, V129, P510, DOI 10.1016/j.jaci.2011.09.031; Picchianti-Diamanti A, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02696; Reveille JD, 2013, AM J MED SCI, V345, P431, DOI 10.1097/MAJ.0b013e318294457f; Rizzetto L, 2018, J AUTOIMMUN, V92, P12, DOI 10.1016/j.jaut.2018.05.008; Rosenbaum JT, 2011, ARTHRITIS RHEUM-US, V63, P3195, DOI 10.1002/art.30558; Salo M, 2017, INT J COLORECTAL DIS, V32, P19, DOI 10.1007/s00384-016-2639-x; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Tzeng YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126816; Yang LH, 2016, INT J MOL SCI, V17, DOI [10.3390/ijms17030403, 10.3390/ijms17122126]	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220721	10.1371/journal.pone.0220721	http://dx.doi.org/10.1371/journal.pone.0220721			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369625	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900081
J	Ruiz, HH; Becker, S; Bai, Y; Cortes-Burgos, LA; Eckersdorff, MM; Macdonald, LE; Croll, SD				Ruiz, Henry H.; Becker, Stephanie; Bai, Yu; Cortes-Burgos, Luz A.; Eckersdorff, Melissa M.; Macdonald, Lynn E.; Croll, Susan D.			Pharmacological inhibition of NPY receptors illustrates dissociable features of experimental colitis in the mouse DSS model: Implications for preclinical evaluation of efficacy in an inflammatory bowel disease model	PLOS ONE			English	Article							NEUROPEPTIDE-Y; ULCERATIVE-COLITIS; MURINE COLITIS; NERVOUS-SYSTEM; ANIMAL-MODELS; CELLS; MICE	Administration of dextran sodium sulfate (DSS) to rodents at varying concentrations and exposure times is commonly used to model human inflammatory bowel disease (IBD). Currently, the criteria used to assess IBD-like pathology seldom include surrogate measures of visceral pain. Thus, we sought to standardize the model and then identify surrogate measures to assess effects on visceral pain. We used various 4% DSS protocols and evaluated effects on weight loss, colon pathology, biochemistry, RNA signature, and open field behavior. We then tested the therapeutic potential of NPY Y1 and/or Y2 receptor inhibition for the treatment of IBD pathology using this expanded panel of outcome measures. DSS caused weight loss and colon shrinkage, increased colon NPY and inflammatory cytokine expression, altered behaviors in the open field and induced a distinct gene metasignature that significantly overlapped with that of human IBD patients. Inhibition of Y1 and/or Y2 receptors failed to improve gross colon pathology. Y1 antagonism significantly attenuated colon inflammatory cytokine expression without altering pain-associated behaviors while Y2 antagonism significantly inhibited pain-associated behaviors in spite of a limited effect on inflammatory markers. A protocol using 7 days of 4% DSS most closely modeled human IBD pathology. In this model, rearing behavior potentially represents a tool for evaluating visceral pain/discomfort that may be pharmacologically dissociable from other features of pathology. The finding that two different NPY receptor antagonists exhibited different efficacy profiles highlights the benefit of including a variety of outcome measures in IBD efficacy studies to most fully evaluate the therapeutic potential of experimental treatments.	[Ruiz, Henry H.; Becker, Stephanie; Bai, Yu; Cortes-Burgos, Luz A.; Eckersdorff, Melissa M.; Macdonald, Lynn E.; Croll, Susan D.] Regeneron Pharmaceut, Neurosci, Tarrytown, NY 10591 USA; [Ruiz, Henry H.; Croll, Susan D.] CUNY, Grad Ctr, Grad Program Neuropsychol, New York, NY 10017 USA; [Croll, Susan D.] CUNY, Queens Coll, Psychol, Flushing, NY 11367 USA	Regeneron; City University of New York (CUNY) System; City University of New York (CUNY) System; Queens College NY (CUNY)	Croll, SD (corresponding author), Regeneron Pharmaceut, Neurosci, Tarrytown, NY 10591 USA.; Croll, SD (corresponding author), CUNY, Grad Ctr, Grad Program Neuropsychol, New York, NY 10017 USA.; Croll, SD (corresponding author), CUNY, Queens Coll, Psychol, Flushing, NY 11367 USA.	Susan.croll@regeneron.com	Ruiz, Henry H./AAA-1872-2020	Ruiz, Henry H./0000-0002-0213-6759; Becker, Stephanie/0000-0003-0565-5930; Croll, Susan/0000-0002-3949-1877	Regeneron Pharmaceuticals	Regeneron Pharmaceuticals(Regeneron)	All work presented here was funded by Regeneron Pharmaceuticals.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; AlSharari SD, 2013, J PHARMACOL EXP THER, V344, P207, DOI 10.1124/jpet.112.198796; Ananthakrishnan AN, 2010, J CLIN GASTROENTEROL, V44, P272, DOI 10.1097/MCG.0b013e3181b2682a; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bedoui S, 2008, J NEUROIMMUNOL, V195, P88, DOI 10.1016/j.jneuroim.2008.01.012; Bielefeldt K, 2009, INFLAMM BOWEL DIS, V15, P778, DOI 10.1002/ibd.20848; Boisse L, 2009, CLIN EXP PHARMACOL P, V36, P1026, DOI 10.1111/j.1440-1681.2009.05242.x; Browning KN, 2014, COMPR PHYSIOL, V4, P1339, DOI 10.1002/cphy.c130055; Chandrasekharan B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003304; Chidlow JH, 2006, AM J PATHOL, V169, P2014, DOI 10.2353/ajpath.2006.051021; Cross RK, 2005, AM J GASTROENTEROL, V100, P2225, DOI 10.1111/j.1572-0241.2005.00256.x; Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; Di Giovangiulio M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00590; El-Salhy M, 2016, NEUROPEPTIDES, V55, P137, DOI 10.1016/j.npep.2015.09.005; Furlan R, 2006, AM J PHYSIOL-REG I, V290, pR224, DOI 10.1152/ajpregu.00442.2005; Gohil Kunj, 2014, P T, V39, P576; Goyal N, 2014, INFLAMMOPHARMACOLOGY, V22, P219, DOI 10.1007/s10787-014-0207-y; Hassani H, 2005, AM J PHYSIOL-GASTR L, V288, pG550, DOI 10.1152/ajpgi.00182.2004; HOYLE CHV, 1989, J ANAT, V166, P7; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Michel MC, 1998, PHARMACOL REV, V50, P143; Mitic K, 2011, PEPTIDES, V32, P1626, DOI 10.1016/j.peptides.2011.06.007; MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184; Nair DG, 2014, J CELL MOL MED, V18, P444, DOI 10.1111/jcmm.12193; Nave H, 2004, J NEUROIMMUNOL, V155, P1, DOI 10.1016/j.jneuroim.2004.05.009; Obermeier F, 1999, CLIN EXP IMMUNOL, V116, P238; Pang XH, 2010, INT J COLORECTAL DIS, V25, P1047, DOI 10.1007/s00384-010-0964-z; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Randhawa PK, 2014, KOREAN J PHYSIOL PHA, V18, P279, DOI 10.4196/kjpp.2014.18.4.279; Sartor RB, 1997, ALIMENT PHARM THERAP, V11, P89; Sharma P, 2009, DIGEST DIS SCI, V54, P853, DOI 10.1007/s10620-008-0424-6; Shirazi T, 2000, POSTGRAD MED J, V76, P473, DOI 10.1136/pmj.76.898.473; Specian RD, FUNCTIONAL BIOL INTE; Taylor CT, 2007, AUTON NEUROSCI-BASIC, V133, P104, DOI 10.1016/j.autneu.2006.11.005; Ten Hove T, 2002, DIGEST DIS SCI, V47, P2056, DOI 10.1023/A:1019629013945; Valatas V, 2013, AM J PHYSIOL-GASTR L, V305, pG763, DOI 10.1152/ajpgi.00004.2013; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971	40	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220156	10.1371/journal.pone.0220156	http://dx.doi.org/10.1371/journal.pone.0220156			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369588	gold, Green Submitted, Green Published			2022-12-27	WOS:000484987900030
J	Buchman, AS; Yu, L; Petyuk, VA; Gaiteri, C; Tasaki, S; Blizinsky, KD; Schneider, JA; De Jager, PL; Bennett, DA				Buchman, Aron S.; Yu, Lei; Petyuk, Vladislav A.; Gaiteri, Chris; Tasaki, Shinya; Blizinsky, Katherine D.; Schneider, Julie A.; De Jager, Philip L.; Bennett, David A.			Cognition may link cortical IGFBP5 levels with motor function in older adults	PLOS ONE			English	Article							BRAIN PATHOLOGY; ALZHEIMER-DISEASE; RUSH MEMORY; ASSOCIATION; NEUROPATHOLOGY; SUPPLEMENTARY; DEMENTIA; DECLINE; FRAILTY	Alzheimer's disease and related disorders (ADRD) may manifest cognitive and non-cognitive phenotypes including motor impairment, suggesting a shared underlying biology. We tested the hypothesis that five cortical proteins identified from a gene network that drives AD and cognitive phenotypes are also related to motor function in the same individuals. We examined 1208 brains of older adults with motor and cognitive assessments prior to death. Cortical proteins were quantified with SRM proteomics and we collected indices of AD and other related pathologies. A higher level of IGFBP5 was associated with poorer motor function proximate to death but AK4, HSPB2, ITPK1 and PLXNB1 were unrelated to motor function. The association of IGFBP5 with motor function was unrelated to the presence of indices of brain pathologies. In contrast, the addition of a term for cognition attenuated the association of IGFBP5 with motor function by about 90% and they were no longer related. These data lend support for the idea that unidentified cortical proteins like IGFBP5, which may not manifest a known pathologic footprint, may contribute to motor and cognitive function in older adults.	[Buchman, Aron S.; Yu, Lei; Gaiteri, Chris; Tasaki, Shinya; Blizinsky, Katherine D.; Schneider, Julie A.; Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Buchman, Aron S.; Yu, Lei; Gaiteri, Chris; Tasaki, Shinya; Schneider, Julie A.; Bennett, David A.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Petyuk, Vladislav A.] Pacific Northwest Natl Lab, Washington, DC USA; [Blizinsky, Katherine D.] NHGRI, NIH, Bethesda, MD 20892 USA; [Schneider, Julie A.] Rush Univ, Dept Pathol Neuropathol, Med Ctr, Chicago, IL 60612 USA; [De Jager, Philip L.] Columbia Univ, Ctr Translat & Computat Neu Roimmunol, Dept Neurol, Med Ctr, New York, NY USA; [De Jager, Philip L.] Broad Inst, Cell Circuits Program, Cambridge, MA USA	Rush University; Rush University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Rush University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Buchman, AS (corresponding author), Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA.; Buchman, AS (corresponding author), Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA.	Aron_S_Buchman@rush.edu	Yu, Lei/AAT-3685-2020	Gaiteri, Chris/0000-0001-7838-8664	NIH [R01AG17917, P30AG10161, RF1AG15819, U01AG46152, R01AG42210, R01AG57911, R56AG59732, R01AG5632, IDPH, R01AG056352, P41GM103493];  [R01AG017917];  [P30AG010161];  [R01AG057911];  [R56AG059732];  [RF1AG015819]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010161, U01AG046152, R01AG042210, R01AG015819, R01AG056352, R01AG017917, R56AG059732, R01AG057911] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The following grants provided support for the this study: NIH (R01AG17917 (DAB), P30AG10161 (DAB), RF1AG15819 (DAB), U01AG46152 (DAB), R01AG42210 (DAB), R01AG57911 (DAB), R56AG59732 (ASB), R01AG5632 (ASB), IDPH (DAB), P41GM103493 (DAB). These grants provided salary support to the following investigators: Buchman: R01AG017917, P30AG010161, R56AG059732, R01AG056352; Gaiteri: R01AG057911, R56AG059732, RF1AG015819; Yu: RF1AG015819; Tasaki: RF1AG015819; Schneider: R01AG017917, P30AG010161, RF1AG015819, R01AG057911, R01AG056352; Bennett: R01AG017917, P30AG010161, RF1AG015819. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MW, 2015, ALZHEIMERS DEMENT, V11, P70, DOI 10.1016/j.jalz.2014.04.514; Andreev VP, 2012, J PROTEOME RES, V11, P3053, DOI 10.1021/pr3001546; Arvanitakis Z, 2016, LANCET NEUROL, V15, P934, DOI 10.1016/S1474-4422(16)30029-1; Benarroch EE, 2013, NEUROLOGY, V80, P1148, DOI 10.1212/WNL.0b013e3182886a76; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Buchman AS, 2019, NEUROLOGY, V92, pE1821, DOI 10.1212/WNL.0000000000007315; Buchman AS, 2018, NEUROLOGY, V90, pE1911, DOI 10.1212/WNL.0000000000005552; Buchman AS, 2017, STROKE, V48, P2792, DOI 10.1161/STROKEAHA.117.017643; Buchman AS, 2016, J GERONTOL A-BIOL, V71, P549, DOI 10.1093/gerona/glv153; Buchman AS, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00197; Buchman AS, 2014, J GERONTOL A-BIOL, V69, P1536, DOI 10.1093/gerona/glu117; Buchman AS, 2013, NEUROLOGY, V80, P2055, DOI 10.1212/WNL.0b013e318294b462; Buchman AS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-42; Buchman AS, 2013, NEUROLOGY, V80, P712, DOI 10.1212/WNL.0b013e3182825116; Buchman AS, 2012, ANN NEUROL, V71, P258, DOI 10.1002/ana.22588; Canli T, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0086-2; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Jacobs JV, 2009, NEUROSCIENCE, V164, P877, DOI 10.1016/j.neuroscience.2009.08.002; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mostafavi S, 2018, NAT NEUROSCI, V21, P811, DOI 10.1038/s41593-018-0154-9; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Petyuk VA, 2010, METHODS, V50, P77, DOI 10.1016/j.ymeth.2009.07.009; Richard A, 2017, NEUROSCIENCE, V358, P181, DOI 10.1016/j.neuroscience.2017.06.047; Rosso AL, 2013, J GERONTOL A-BIOL, V68, P1379, DOI 10.1093/gerona/glt089; Rothwell JC, 2012, CLIN NEUROL NEUROSUR, V114, P432, DOI 10.1016/j.clineuro.2011.12.053; Schneider JA, 2005, STROKE, V36, P954, DOI 10.1161/01.STR.0000160747.27470.2a; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Wilson RS, 2015, PSYCHOL AGING, V30, P74, DOI 10.1037/pag0000013; Wilson RS, 2013, NEUROLOGY, V81, P314, DOI 10.1212/WNL.0b013e31829c5e8a; Wilson RS, 2012, PSYCHOL AGING, V27, P998, DOI 10.1037/a0028182; Yu L, 2018, ANN NEUROL, V84, P78, DOI 10.1002/ana.25266; Yu L, 2015, NEUROBIOL AGING, V36, P2946, DOI 10.1016/j.neurobiolaging.2015.08.008; Yu L, 2015, NEUROLOGY, V84, P927, DOI 10.1212/WNL.0000000000001313	38	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220968	10.1371/journal.pone.0220968	http://dx.doi.org/10.1371/journal.pone.0220968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404102	gold, Green Published, Green Submitted			2022-12-27	WOS:000485006800046
J	Dornelles, A				Dornelles, Adriana			Impact of multiple food environments on body mass index	PLOS ONE			English	Article							NEIGHBORHOOD ENVIRONMENT; DIETARY-INTAKE; WEIGHT STATUS; RISK-FACTORS; OBESITY; RESTAURANTS; SCHOOL; PROXIMITY; ASSOCIATIONS; CONSUMPTION	Background Although the relationship between residential food environments and health outcomes have been extensively studied, the relationship between body mass index (BMI) and multiple food environments have not been fully explored. We examined the relationship between characteristics of three distinct food environments and BMI among elementary school employees in the metropolitan area of New Orleans, LA. We assessed the food environments around the residential and worksite neighborhoods and the commuting corridors. Research methodology/principal findings This study combined data from three different sources: individual and worksite data (ACTION), food retailer database (Dunn and Bradstreet), and the U.S. Census TIGER/Line Files. Spatial and hierarchical analyses were performed to explore the impact of predictors at the individual and environmental levels on BMI. When the three food environments were combined, the number of supermarkets and the number of grocery stores at residential food environment had a significant association with BMI (beta = 0.56 and beta = 0.24, p < 0.01), whereas the number of full-service restaurants showed an inverse relationship with BMI (beta = -0.15, p < 0.001). For the commute corridor food environment, it was found that each additional fast-food restaurant in a vicinity of one kilometer traveled contributed to a higher BMI (beta = 0.80, p < 0.05), while adjusting for other factors. No statistical associations were found between BMI and worksite food environment. Conclusions The current study was the first to examine the relationship between BMI and food environments around residential neighborhoods, work neighborhoods, and the commuting corridor. Significant results were found between BMI and the availability of food stores around residential neighborhoods and the commuting corridor, adjusted for individual-level factors. This study expands the analysis beyond residential neighborhoods, illustrating the importance of multiple environmental factors in relation to BMI.	[Dornelles, Adriana] Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Dornelles, A (corresponding author), Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA.	adriana.dornelles@asu.edu		dornelles, adriana/0000-0003-4674-3654				Abdel-Aty M., 1994, TRANSP RES REC, V1453, P46; Adam A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3985-x; An RP, 2012, AM J PREV MED, V42, P129, DOI 10.1016/j.amepre.2011.10.012; Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341; Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244; Block JP, 2004, AM J PREV MED, V27, P211, DOI 10.1016/j.amepre.2004.06.007; Bodor JN, 2010, J URBAN HEALTH, V87, P771, DOI 10.1007/s11524-010-9460-6; Burdette HL, 2004, PREV MED, V38, P57, DOI 10.1016/j.ypmed.2003.09.029; Cobb LK, 2015, OBESITY, V23, P1331, DOI 10.1002/oby.21118; Courtemanche C, 2011, J URBAN ECON, V69, P165, DOI 10.1016/j.jue.2010.09.005; Currie J, 2010, AM EC J EC POLICY AM, V2, P23; Davis B, 2009, AM J PUBLIC HEALTH, V99, P505, DOI 10.2105/AJPH.2008.137638; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Drewnowski Adam, 2012, Am J Public Health, V102, pe74, DOI 10.2105/AJPH.2012.300660; Dubowitz T, 2012, OBESITY, V20, P862, DOI 10.1038/oby.2011.141; Duffell J., 1988, TRAFFIC ENG CONTROL, V29, P398; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; EKELUND RB, 1991, KYKLOS, V44, P613; Ellaway A, 1997, INT J OBESITY, V21, P304, DOI 10.1038/sj.ijo.0800405; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820; Gibson DM, 2011, AM J PUBLIC HEALTH, V101, P71, DOI 10.2105/AJPH.2009.187567; Hales Craig M, 2017, NCHS Data Brief, P1; Hartline-Grafton HL, 2009, J AM DIET ASSOC, V109, P1548, DOI 10.1016/j.jada.2009.06.366; Hunt MK, 2000, HEALTH EDUC BEHAV, V27, P223, DOI 10.1177/109019810002700208; Jekanowski MD, 2001, J AGR RESOUR ECON, V26, P58; Joshu CE, 2008, J EPIDEMIOL COMMUN H, V62, P202, DOI 10.1136/jech.2006.058321; Kestens Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041418; Kwate NOA, 2010, PREV MED, V51, P153, DOI 10.1016/j.ypmed.2010.04.020; Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025; Laska MN, 2010, PUBLIC HEALTH NUTR, V13, P1757, DOI 10.1017/S1368980010001564; Lear SA, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-117; Lemon SC, 2010, J OCCUP ENVIRON MED, V52, pS1, DOI 10.1097/JOM.0b013e3181c8527e; Leung CW, 2011, AM J PREV MED, V41, P43, DOI 10.1016/j.amepre.2011.03.013; Li HN, 2005, TRANSPORT RES REC, P162; Lopez RP, 2007, OBESITY, V15, P2111, DOI 10.1038/oby.2007.251; McCrory MA, 1999, OBES RES, V7, P564, DOI 10.1002/j.1550-8528.1999.tb00715.x; Mehta NK, 2008, AM J PREV MED, V34, P127, DOI 10.1016/j.amepre.2007.09.031; Mills S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182842; Moore LV, 2008, J URBAN HEALTH, V85, P206, DOI 10.1007/s11524-008-9259-x; Moore LV, 2006, AM J PUBLIC HEALTH, V96, P325, DOI 10.2105/AJPH.2004.058040; Morland K, 2006, AM J PREV MED, V30, P333, DOI 10.1016/j.amepre.2005.11.003; Morland KB, 2009, HEALTH PLACE, V15, P491, DOI 10.1016/j.healthplace.2008.09.004; Ogden CL, 2018, MMWR-MORBID MORTAL W, V67, P186, DOI 10.15585/mmwr.mm6706a3; Papinski D, 2009, TRANSPORT RES F-TRAF, V12, P347, DOI 10.1016/j.trf.2009.04.001; Perchoux C, 2016, HEALTH PLACE, V40, P116, DOI 10.1016/j.healthplace.2016.05.004; Powell LM, 2007, AM J PREV MED, V33, pS301, DOI 10.1016/j.amepre.2007.07.007; Powell LM, 2009, ECON HUM BIOL, V7, P64, DOI 10.1016/j.ehb.2009.01.004; Reitzel LR, 2014, AM J PUBLIC HEALTH, V104, P110, DOI 10.2105/AJPH.2012.301140; Richardson AS, 2015, HEALTH PLACE, V36, P74, DOI 10.1016/j.healthplace.2015.09.003; Rose D, 2009, AM J PREV MED, V37, P214, DOI 10.1016/j.amepre.2009.04.024; Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x; Rydell SA, 2008, J AM DIET ASSOC, V108, P2066, DOI 10.1016/j.jada.2008.09.008; Simon PA, 2008, PREV MED, V47, P284, DOI 10.1016/j.ypmed.2008.02.021; Sorensen G, 1999, AM J PUBLIC HEALTH, V89, P54, DOI 10.2105/AJPH.89.1.54; Spence JC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-192; Sturm R, 2005, PUBLIC HEALTH, V119, P1059, DOI 10.1016/j.puhe.2005.05.007; Sundquist J, 1999, INT J EPIDEMIOL, V28, P841, DOI 10.1093/ije/28.5.841; Tamers SL, 2011, PREV MED, V53, P53, DOI 10.1016/j.ypmed.2011.04.012; US Census Bureau, N AM IND CLASS SYST; Wang MC, 2007, J EPIDEMIOL COMMUN H, V61, P491, DOI 10.1136/jech.2006.051680; Webber LS, 2007, OBESITY, V15, p48S, DOI 10.1038/oby.2007.387; Zenk SN, 2005, AM J PUBLIC HEALTH, V95, P660, DOI 10.2105/AJPH.2004.042150; Zick CD, 2009, SOC SCI MED, V69, P1493, DOI 10.1016/j.socscimed.2009.08.032	64	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0219365	10.1371/journal.pone.0219365	http://dx.doi.org/10.1371/journal.pone.0219365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390365	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400005
J	Lee, SJ; Lee, HS; Hwang, YH; Kim, JJ; Kang, KY; Kim, SJ; Kim, HK; Kim, JD; Jeong, D; Paik, MJ; Yee, ST				Lee, Sung-Ju; Lee, Hyeon-Seong; Hwang, Yun-Ho; Kim, Jong-Jin; Kang, Kyung-Yun; Kim, Seong Jin; Kim, Hong Kee; Kim, Jung Dong; Jeong, Do Hyeon; Paik, Man-Jeong; Yee, Sung-Tae			Enhanced anti-tumor immunotherapy by dissolving microneedle patch loaded ovalbumin	PLOS ONE			English	Article							T-CELL RESPONSES; HELPER-CELLS; ANTIGEN; VACCINATION; DELIVERY; SKIN; NANOPARTICLES; VACCINES; PROTEIN; IMMUNIZATION	The skin is a very suitable organ for the induction of immune responses to vaccine antigens. Antigen delivery systems to the skin by needle and syringe directly deposit the antigen into the epidermal-dermal compartment, one of the most immunocompetent sites due to the presence of professional antigen-presenting cells aimed at the induction of antigen-specific T cells. In this study, we analyzed the amount of ovalbumin as an antigen delivered to the skin by a micro-needle. When ovalbumin protein as an antigen was delivered to the skin of mice using a dissolving microneedle, it induced an immune response through the enhanced proliferation and cytokines production by the splenocytes and lymph nodes. Also, it effectively increased the ovalbumin-specific CD8(+) T cell and CD4(+) T cell population and induced an ovalbumin-specific CTL response against the graft of ovalbumin-expressing EG7 tumor cells in the immunized mice. Also, we identified the inhibition of tumor growth and prevention of tumor formation in the context of the therapeutic and prophylactic vaccine, respectively through EG-7 tumor mouse model. Finally, these data show the potential of patches as attractive antigen delivery vehicles.	[Lee, Sung-Ju; Hwang, Yun-Ho; Yee, Sung-Tae] Sunchon Natl Univ, Dept Pharm, Sunchon, South Korea; [Lee, Hyeon-Seong; Paik, Man-Jeong] Sunchon Natl Univ, Coll Pharm, Sunchon, South Korea; [Lee, Hyeon-Seong; Paik, Man-Jeong] Sunchon Natl Univ, Res Inst Life & Pharmaceut Sci, Sunchon, South Korea; [Kim, Jong-Jin] Inst for Basic Sci Korea, Ctr Self Assembly & Complex, Pohang, South Korea; [Kang, Kyung-Yun] Suncheon Res Ctr Nat Med, Sunchon, South Korea; [Kim, Seong Jin; Kim, Hong Kee; Kim, Jung Dong; Jeong, Do Hyeon] Yonsei Univ, Coll Med, Res Ctr, RAPHAS Co Ltd, 512 ABMRC, Seoul, South Korea	Sunchon National University; Sunchon National University; Sunchon National University; Institute for Basic Science - Korea (IBS); Yonsei University; Yonsei University Health System	Yee, ST (corresponding author), Sunchon Natl Univ, Dept Pharm, Sunchon, South Korea.	sungtae@sunchon.ac.kr			Sunchon National University Research Fund	Sunchon National University Research Fund	This study was supported by the Sunchon National University Research Fund in 2017. Raphas Co., Ltd. provided support in the form of salaries for authors [SJK, HKK, JDK, DHJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali OA, 2016, CANCER IMMUNOL RES, V4, P95, DOI 10.1158/2326-6066.CIR-14-0126; Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089; Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Becker PD, 2015, VACCINE, V33, P4691, DOI 10.1016/j.vaccine.2015.04.046; Boss JD., 1981, CUTANEOUS IMMUNOLOGY; Carey JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022442; Chen JZ, 2011, CELL IMMUNOL, V269, P5, DOI 10.1016/j.cellimm.2011.03.003; Fallarino F, 2000, J IMMUNOL, V165, P5495, DOI 10.4049/jimmunol.165.10.5495; Fichtelius KE, 2006, INT ARCH ALLER A IMM, V37, P607; Gerritsen WR, 2012, ANN ONCOL, V23, P22, DOI 10.1093/annonc/mds259; Glenn GM, 2000, NAT MED, V6, P1403, DOI 10.1038/82225; Gonzalez G, 2011, CURR CANCER DRUG TAR, V11, P103, DOI 10.2174/156800911793743583; Grotefend S, 2012, J PHARMACEUT BIOMED, V71, P127, DOI 10.1016/j.jpba.2012.08.024; Hamdy S, 2007, J BIOMED MATER RES A, V81A, P652, DOI 10.1002/jbm.a.31019; Han M, 2009, SENSOR ACTUAT B-CHEM, V137, P274, DOI 10.1016/j.snb.2008.11.017; Ibana JA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-66; Kang YX, 2013, PROTEIN CELL, V4, P86, DOI 10.1007/s13238-012-2111-9; Kim JJ, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2471627; Kim JJ, 2014, INT IMMUNOPHARMACOL, V21, P309, DOI 10.1016/j.intimp.2014.05.010; Kim JD, 2013, J CONTROL RELEASE, V170, P430, DOI 10.1016/j.jconrel.2013.05.026; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Knutson KL, 2005, CANCER IMMUNOL IMMUN, V54, P721, DOI 10.1007/s00262-004-0653-2; Ko BK, 2015, MOL ONCOL, V9, P398, DOI 10.1016/j.molonc.2014.09.007; Lee SJ, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1045-9; Matriano JA, 2002, PHARMACEUT RES, V19, P63, DOI 10.1023/A:1013607400040; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Ng HI, 2012, J CONTROL RELEASE, V162, P477, DOI 10.1016/j.jconrel.2012.07.024; Pearson FE, 2015, VACCINE, V33, P3248, DOI 10.1016/j.vaccine.2015.03.039; Rahimian S, 2015, BIOMATERIALS, V37, P469, DOI 10.1016/j.biomaterials.2014.10.043; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Silva JM, 2013, J CONTROL RELEASE, V168, P179, DOI 10.1016/j.jconrel.2013.03.010; Teunissen MBM, 2012, CURR TOP MICROBIOL, V351, P25, DOI 10.1007/82_2011_169; van der Maaden K, 2014, EUR J PHARM BIOPHARM, V88, P310, DOI 10.1016/j.ejpb.2014.05.003; Wang C, 2016, NANO LETT, V16, P2334, DOI 10.1021/acs.nanolett.5b05030; Wen ZS, 2011, MAR DRUGS, V9, P1038, DOI 10.3390/md9061038; Widera G, 2006, VACCINE, V24, P1653, DOI 10.1016/j.vaccine.2005.09.049; YU RC, 1994, BRIT J DERMATOL, V131, P843, DOI 10.1111/j.1365-2133.1994.tb08587.x; Zaiss DMW, 2010, VACCINE, V28, P7716, DOI 10.1016/j.vaccine.2010.08.101	39	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220382	10.1371/journal.pone.0220382	http://dx.doi.org/10.1371/journal.pone.0220382			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386690	Green Published, gold, Green Submitted			2022-12-27	WOS:000484997100020
J	Pinna, S; Lanzi, F; Cordella, A; Diana, A				Pinna, Stefania; Lanzi, Francesco; Cordella, Alessia; Diana, Alessia			Relationship between the stage of osteoarthritis before and six months after tibial tuberosity advancement procedure in dogs	PLOS ONE			English	Article							CRANIAL CRUCIATE LIGAMENT; PLATEAU LEVELING OSTEOTOMY; CANINE STIFLE JOINT; CONTACT MECHANICS; DEFICIENT STIFLES; IN-VIVO; PROGRESSION; RUPTURE; COMPLICATIONS; INSUFFICIENCY	The present retrospective study evaluated the progression of osteoarthritis in stifle joints based on the radiographic grade of osteoarthritis (OA) scored in dogs with cranial cruciate ligament rupture. The aim of the study was to search for a correlation between the stage of radiographic osteoarthritis prior to surgery and the osteoarthritis progression occurring after the tibial tuberosity advancement (TTA) procedure. It was hypothesized that the procedure carried out in dogs in the early stages of OA could reduce the OA changes. A total of 190 X-ray images obtained from the medical records of 38 dogs were evaluated. The radiographic signs of osteoarthritis of 38 stifle joints were scored from 0 to 3 in 10 specific anatomic locations. The radiographs were divided into 4 groups based on the global scores: A) no-OA, B) mild-OA, C) moderate-OA, D) severe-OA; they were assessed prior to surgery, and 1, 2, 3 and 6 months post-operatively (T0, T1, T2, T3 and T6). There were no differences in osteoarthritis progression in Groups A and C at any time. Osteoarthritis changes from T0 to T6 were statistically significant in Group B. The OA changes in the anatomic locations were investigated. The most common anatomic sites for OA changes were the patella apex, the proximal and distal trochlear ridges, and the caudal aspect of the tibial plateau assessed before surgery. After surgery, the score increased in the first three locations in 10, 9 and 11 joints, respectively; instead, the progression of osteoarthritis in the caudal aspect of the tibial plateau occurred in 23 out of 38 stifle joints. The results indicated that the TTA procedure could be effective in slowing down the OA progression when carried out in the absence of or in the early stages of disease. Therefore, an early intervention may be suggested in clinical practice to obtain minimal or no progression 6 months postoperatively.	[Pinna, Stefania; Lanzi, Francesco; Cordella, Alessia; Diana, Alessia] Univ Bologna, Sch Agr & Vet Med, Dept Vet Med Sci, Alma Mater Studiorum, Bologna, Italy	University of Bologna	Pinna, S (corresponding author), Univ Bologna, Sch Agr & Vet Med, Dept Vet Med Sci, Alma Mater Studiorum, Bologna, Italy.	stefania.pinna@unibo.it	Cordella, Alessia/AGY-6618-2022	Pinna, Stefania/0000-0002-0005-9753				Allan G, 2006, MANUAL CANINE FELINE, P71; Altman DG, 1991, PRACTICAL STAT MED R, P397; Apelt D, 2007, VET SURG, V36, P170, DOI 10.1111/j.1532-950X.2007.00250.x; BENNETT D, 1988, J SMALL ANIM PRACT, V29, P275, DOI 10.1111/j.1748-5827.1988.tb02286.x; Boudrieau RJ, 2009, VET SURG, V38, P1, DOI 10.1111/j.1532-950X.2008.00439.x; Carey K, 2005, VET COMP ORTHOPAED, V18, P235; Coulson A., 2008, ATLAS INTERPRETATIVE; COX JS, 1975, CLIN ORTHOP RELAT R, P178; Danielson B, 2016, J AM ANIM HOSP ASSOC, V52, P109, DOI 10.5326/JAAHA-MS-6194; de Bruin T, 2007, VET REC, V161, P745, DOI 10.1136/vr.161.22.745; Ferreira MP, 2016, VET COMP ORTHOPAED, V29, P209, DOI 10.3415/VCOT-15-01-0009; Franklin SP, 2017, JAVMA-J AM VET MED A, V251, P71, DOI 10.2460/javma.251.1.71; Gordon WJ, 2003, VET SURG, V32, P451, DOI 10.1053/jvet.2003.50051; Guerrero TG, 2011, VET SURG, V40, P839, DOI 10.1111/j.1532-950X.2011.00866.x; Hoelzler MG, 2004, VET SURG, V33, P146, DOI 10.1111/j.1532-950X.2004.04022.x; Hoffmann DE, 2006, VET COMP ORTHOPAED, V19, P219; Hurley CR, 2007, JAVMA-J AM VET MED A, V230, P1674, DOI 10.2460/javma.230.11.1674; Innes JF, 1998, J SMALL ANIM PRACT, V39, P325, DOI 10.1111/j.1748-5827.1998.tb03723.x; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Kim SE, 2008, VET SURG, V37, P111, DOI 10.1111/j.1532-950X.2007.00361.x; Kim SE, 2009, VET SURG, V38, P33, DOI 10.1111/j.1532-950X.2008.00471.x; Kowaleski MP, 2012, VET SURG SMALL ANIMA, V1, P906; Krotscheck U, 2016, VET SURG, V45, P261, DOI 10.1111/vsu.12445; Lafaver S, 2007, VET SURG, V36, P573, DOI 10.1111/j.1532-950X.2007.00307.x; Leach ES, 2018, VET SURG, V47, P566, DOI 10.1111/vsu.12790; Lineberger JA, 2005, VET COMP ORTHOPAED, V18, P13; LUKOSCHEK M, 1988, J ORTHOP RES, V6, P475, DOI 10.1002/jor.1100060403; MacDonald TL, 2013, CAN VET J, V54, P249; Mahn MM, 2005, VET SURG, V34, P318, DOI 10.1111/j.1532-950X.2005.00049.x; MARSHALL JL, 1969, CLIN ORTHOP RELAT R, P37; Montavon P.M, 2004, P 12 ESVOT C, P254; Morgan JP, 2010, VET SURG, V39, P425, DOI 10.1111/j.1532-950X.2010.00669.x; Musahl V, 2010, AM J SPORT MED, V38, P1591, DOI 10.1177/0363546510364402; NAKAMURA N, 1985, J BONE JOINT SURG BR, V67, P255, DOI 10.1302/0301-620X.67B2.3980537; Pelletier JP, 1998, ARTHRITIS RHEUM-US, V41, P1275, DOI 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T; Pozzi A, 2006, VET SURG, V35, P486, DOI 10.1111/j.1532-950X.2006.00180.x; Pozzi A, 2010, VET SURG, V39, P489, DOI 10.1111/j.1532-950X.2010.00662.x; Rayward RM, 2004, J SMALL ANIM PRACT, V45, P92, DOI 10.1111/j.1748-5827.2004.tb00209.x; SCAVELLI TD, 1990, J AM VET MED ASSOC, V196, P1135; Skinner OT, 2013, VET J, V196, P86, DOI 10.1016/j.tvjl.2012.08.003; SLOCUM B, 1993, VET CLIN N AM-SMALL, V23, P777, DOI 10.1016/S0195-5616(93)50082-7; Steffey MA, 2010, MECH DIS SMALL ANIMA, P731; TARVIN GB, 1981, VET SURG, V10, P94, DOI 10.1111/j.1532-950X.1981.tb00637.x; Thieman KM, 2009, VET SURG, V38, P803, DOI 10.1111/j.1532-950X.2009.00571.x; Valen S, 2017, J SMALL ANIM PRACT, V58, P109, DOI 10.1111/jsap.12619; VASSEUR PB, 1992, J AM ANIM HOSP ASSOC, V28, P129; VASSEUR PB, 1984, VET SURG, V13, P243, DOI 10.1111/j.1532-950X.1984.tb00801.x; von Pfeil DJF, 2018, JAVMA-J AM VET MED A, V253, P586, DOI 10.2460/javma.253.5.586; Warzee CC, 2001, VET SURG, V30, P278, DOI 10.1053/jvet.2001.21400; Wessely M, 2017, VET COMP ORTHOPAED, V30, P377, DOI [10.3415/VCOT-16-09-0134, 10.3415/vcot-16-09-0134]; WIDMER WR, 1994, VET RADIOL ULTRASOUN, V35, P371, DOI 10.1111/j.1740-8261.1994.tb02057.x; Wiseman-Orr ML, 2004, AM J VET RES, V65, P1077, DOI 10.2460/ajvr.2004.65.1077	52	4	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219849	10.1371/journal.pone.0219849	http://dx.doi.org/10.1371/journal.pone.0219849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386673	gold, Green Published			2022-12-27	WOS:000484997100011
J	Munisi, DZ; Nyundo, AA; Mpondo, BC				Munisi, David Zadock; Nyundo, Azan A.; Mpondo, Bonaventura C.			Knowledge, attitude and practice towards malaria among symptomatic patients attending Tumbi Referral Hospital: A cross-sectional study	PLOS ONE			English	Article							COMMUNITY KNOWLEDGE	Background Despite significant improvement in prevention and control over the past decades malaria remains a significant public health concern in Tanzania with 93% of the population being at risk. To prevent malaria infection and promote malaria free zones, understanding the community's knowledge, attitudes, and practices toward malaria control are essential. This study therefore aimed at determining the levels of understanding, and attitudes, as well as socio-cultural aspects of malaria prevention and treatment-seeking behaviours among suspected malaria patients. Methods This study was a hospital based cross-sectional study, in which patients attending Tumbi Referral Hospital with symptoms and signs that warrant inclusion of suspicion of malaria, were recruited. We used a pre-tested semi-structured questionnaire to collect participants' demographic characteristics, as well as information on their knowledge, attitudes, and practices towards malaria infection. Data were analysed using Stata Version 12.1. Results We enrolled a total of 295 respondents of which 179 (60.68%) were females. Participants' ages ranged from 1-91 years, with a mean of 31.4 years. Seventy-nine (26.8%) patients reported having malaria in the previous 28 days, with 57 (72.2%) being laboratory confirmed. Only 52 (65.8%) individuals reported taking prescribed medications for malaria. A total of 277 (93.90%) were aware of malaria, and 264 (95.31%) knew that it is transmitted by mosquito. Nearly all participants (263, 94.95%), identified sleeping under bed nets to be protective against malaria. About half of the respondents either agreed 63 (22.74%) or strongly agreed 62 (22.38%) that malaria can be transmitted like the common cold. Self-reported mosquito net use was 88.09% (244). Conclusion Despite the endemicity of malaria in our study site, patients had adequate knowledge, encouraging attitudes, and good practices related to malaria prevention and control.	[Munisi, David Zadock] Univ Dodoma, Coll Hlth Sci, Sch Med & Dent, Dept Parasitol & Entomol, Dodoma, Tanzania; [Nyundo, Azan A.] Univ Dodoma, Coll Hlth Sci, Sch Med & Dent, Dept Psychiat, Dodoma, Tanzania; [Mpondo, Bonaventura C.] Univ Dodoma, Coll Hlth Sci, Sch Med & Dent, Dept Internal Med, Dodoma, Tanzania		Munisi, DZ (corresponding author), Univ Dodoma, Coll Hlth Sci, Sch Med & Dent, Dept Parasitol & Entomol, Dodoma, Tanzania.	massugii@gmail.com	Munisi, David Zadock/S-5765-2017	Munisi, David Zadock/0000-0001-8437-7988	University of Dodoma; University of Dodoma 10th Anniversary Research Grant	University of Dodoma; University of Dodoma 10th Anniversary Research Grant	We are grateful to the University of Dodoma for providing the grant to conduct this study through the University of Dodoma 10th Anniversary Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Tumbi Regional Referral Hospital for allowing us to conduct this study at the hospital. We are grateful to the University of Dodoma for providing the grant to conduct this study through the University of Dodoma 10th Anniversary Research Grant.	Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; Adedotun AA, 2010, J VECTOR DIS, V47, P155; Adongo PB, 2005, TROP MED INT HEALTH, V10, P366, DOI 10.1111/j.1365-3156.2005.01361.x; Ahmed SM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-357; Amusan VO., 2017, SCI J PUB HLTH, V5, P240, DOI [10.11648/j.sjph.20170503.22, DOI 10.11648/J.SJPH.20170503.22]; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-113; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1016/S0033-3549(04)50218-2; Hlongwana KW, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-29; Kebede DL, 2017, J TROP DIS, V5, P2; KISH L, 1965, AM SOCIOL REV, V30, P564, DOI 10.2307/2091346; Makoge V., 2016, INT J TROPICAL DIS H, V15, P1, DOI [DOI 10.9734/IJTDH/2016/24808, 10.9734/ijtdh/2016/24808]; Mazigo Humphrey D, 2010, Malar Res Treat, V2010, P794261, DOI 10.4061/2010/794261; Moon AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089814; Mubi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-293; Musuva RM, 2014, AM J TROP MED HYG, V90, P646, DOI 10.4269/ajtmh.13-0488; Nkulikwa ZA, 2018, HLTH CARE CURRENT RE, V6, P229, DOI [10.4172/2375-4273.1000229, DOI 10.4172/2375-4273.1000229]; President's Malaria Initiative, 2017, TANZ MAL OP PLAN FY; RUEBUSH TK, 1995, B WORLD HEALTH ORGAN, V73, P229; RUEBUSH TK, 1994, AM J TROP MED HYG, V50, P85, DOI 10.4269/ajtmh.1994.50.85; Sansom C, 2009, LANCET INFECT DIS, V9, P596, DOI 10.1016/S1473-3099(09)70247-6; Singh N, 1998, CURR SCI INDIA, V75, P1386; Taremwa IM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4824-4; Tyagi Padmawati, 2005, Journal of Vector Borne Diseases, V42, P30; Tynan A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-204; Wanzira H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1360-0; WHO, 2018, WHO RECOGNIZES NATL; World Health Organization, 2017, DEPRESSION; World Health Organization, 2015, GUID TREATM MAL, Vthird; Ye Y, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-32	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220501	10.1371/journal.pone.0220501	http://dx.doi.org/10.1371/journal.pone.0220501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381600	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600020
J	Castagne, B; Viprey, M; Martin, J; Schott, AM; Cucherat, M; Soubrier, M				Castagne, Benjamin; Viprey, Marie; Martin, Julie; Schott, Anne-Marie; Cucherat, Michel; Soubrier, Martin			Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis	PLOS ONE			English	Review							RHEUMATOID-ARTHRITIS PATIENTS; NECROSIS-FACTOR INHIBITORS; CORONARY-ARTERY-DISEASE; CERTOLIZUMAB PEGOL; DOUBLE-BLIND; MENDELIAN RANDOMIZATION; INADEQUATE RESPONSE; CIRCULATING LEVELS; RISK; INTERLEUKIN-6	Objectives Our objective was to compare the cardiovascular safety of tocilizumab and other biological disease-modifying antirheumatic drugs (bDMARD) in rheumatoid arthritis using a network meta-analysis (NMA). Methods A systematic literature search through May 2018 identified randomized controlled trials (RCT) or observational studies (cohort only) reporting cardiovascular outcomes of tocilizumab (TCZ) and/or abatacept (ABA) and/or rituximab (RTX) and/or tumor necrosis factor inhibitors (TNFi) in rheumatoid arthritis patients. The composite primary outcome was the rate of major adverse cardiovascular outcomes (MACE, myocardial infarction (MI), peripheral artery disease (PAD) and cardiac heart failure (CHF)). Results 19 studies were included in the NMA, including 11 RCTs and 8 cohort studies. We found less events with RTX (5.41 [1.70; 17.26]. We found no difference between TCZ and other treatments. Concerning MI, we found no difference between TCZ and csDMARD (4.23 [0.22; 80.64]), no difference between TCZ and TNFi (2.00 [0.18; 21.84]). There was no difference between TCZ and csDMARD (1.51[0.02; 103.50] and between TCZ and TNFi (1.00 [0.06; 15.85]) for stroke event. With cohorts and RCT NMA, we found no difference between TCZ and other treatments for MACE (0.66 [0.42; 1.03] with ABA, 1.04 [0.60; 1.81] with RTX, 0.78[0.53; 1.16] and 0.91 [0.54; 1.51] with csDMARD), but the risk of myocardial infarction was lower with TCZ compared to ABA (0.67 [0.47; 0.97]). We lacked data to compare TCZ and other bDMARD for stoke and MI. Not enough data was available to perform a NMA for CHF and PAD. Conclusions Despite an increase in cholesterol levels, TCZ has safe cardiovascular outcomes compared to other bDMARD.	[Castagne, Benjamin; Soubrier, Martin] Gabriel Montpied Univ Hosp, Rheumatol Dept, Clermont Ferrand, France; [Castagne, Benjamin; Viprey, Marie; Martin, Julie; Schott, Anne-Marie] Claude Bernard Univ Lyon 1, Univ Lyon, HESPER, EA 7425, Lyon, France; [Viprey, Marie; Martin, Julie; Schott, Anne-Marie] Hosp Civils Lyon, Publ Hlth Ctr, Lyon, France; [Cucherat, Michel] Univ Lyon, CNRS, UMR 5558, Lab Biometry & Evolutionary Biol, Villeurbanne, France; [Cucherat, Michel] Hosp Civils Lyon, Dept Pharmacol & Toxicol, Lyon, France	CHU Clermont Ferrand; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; CHU Lyon	Castagne, B (corresponding author), Gabriel Montpied Univ Hosp, Rheumatol Dept, Clermont Ferrand, France.; Castagne, B (corresponding author), Claude Bernard Univ Lyon 1, Univ Lyon, HESPER, EA 7425, Lyon, France.	bcastagne@chu-clermontferrand.fr	Viprey, Marie/AAH-2856-2020; Schott, Anne-Marie/V-7580-2018	Viprey, Marie/0000-0002-3281-1970; Schott, Anne-Marie/0000-0003-3337-4474	French society of rheumatology	French society of rheumatology	BC received financial support from the French society of rheumatology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca R, 2017, ANN RHEUM DIS, V76, P17, DOI 10.1136/annrheumdis-2016-209775; Al-Aly Z, 2011, TRANSL RES, V157, P10, DOI 10.1016/j.trsl.2010.09.005; Anderson DR, 2013, CYTOKINE, V62, P395, DOI 10.1016/j.cyto.2013.03.020; Arts EEA, 2015, ANN RHEUM DIS, V74, P998, DOI 10.1136/annrheumdis-2013-204531; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Bacchiega BC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005038; Bellosta S, 2018, EXPERT OPIN DRUG SAF, V17, P25, DOI 10.1080/14740338.2018.1394455; Burmester GR, 2017, ANN RHEUM DIS, V76, P1279, DOI 10.1136/annrheumdis-2016-210561; Cardenas M, 2016, RHEUMATOL INT, V36, P231, DOI 10.1007/s00296-015-3374-2; Charles-Schoeman C, 2016, SEMIN ARTHRITIS RHEU, V46, P71, DOI 10.1016/j.semarthrit.2016.03.004; Chen SL, 2014, J INTERV CARDIOL, V27, P142, DOI 10.1111/joic.12103; Choy EH, 2017, ARTHRIT CARE RES, V69, P1484, DOI 10.1002/acr.23303; Curtis JR, 2015, SEMIN ARTHRITIS RHEU, V44, P381, DOI 10.1016/j.semarthrit.2014.07.006; Dias S, 2013, MED DECIS MAKING, V33, P597, DOI 10.1177/0272989X13487604; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Emery P, 2017, ANN RHEUM DIS, V76, P96, DOI 10.1136/annrheumdis-2015-209057; Emery P, 2010, ANN RHEUM DIS, V69, P1629, DOI 10.1136/ard.2009.119933; Gabay C, 2016, ANN RHEUM DIS, V75, P1806, DOI 10.1136/annrheumdis-2015-207872; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Geborek P, 2002, ANN RHEUM DIS, V61, P793, DOI 10.1136/ard.61.9.793; Giles JT, 2018, ACR M; Gottenberg J-E, 2016, ARTHRITIS RHEUMATOL, V68; Guillemin F, 2005, ANN RHEUM DIS, V64, P1427, DOI 10.1136/ard.2004.029199; Harrold LR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0776-1; Hartaigh BO, 2013, INT J CARDIOL, V168, P2609, DOI 10.1016/j.ijcard.2013.03.043; Iannone F, 2018, CLIN RHEUMATOL, V37, P315, DOI 10.1007/s10067-017-3846-8; Jansen H, 2014, EUR HEART J, V35, P1917, DOI 10.1093/eurheartj/ehu208; Jin Y, 2017, ANN RHEUM DIS, V76, P544, DOI 10.1136/annrheumdis-2017-eular.2727; Jobanputra P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001395; John A, ACR M; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kavanaugh A, 2013, ANN RHEUM DIS, V72, P674, DOI 10.1136/annrheumdis-2013-204345; Kay J, 2008, ARTHRITIS RHEUM-US, V58, P964, DOI 10.1002/art.23383; Keystone EC, 2016, J RHEUMATOL, V43, P298, DOI 10.3899/jrheum.150712; Kim HY, 2012, INT J RHEUM DIS, V15, P188, DOI 10.1111/j.1756-185X.2011.01680.x; Kim SC, 2018, SEMIN ARTHRITIS RHEU, V48, P399, DOI 10.1016/j.semarthrit.2018.03.012; Kim SC, 2017, ARTHRITIS RHEUMATOL, V69, P1154, DOI 10.1002/art.40084; Kobayashi H, 2014, J RHEUMATOL, V41, P1916, DOI 10.3899/jrheum.131540; Kobayashi Y, 2016, INT J RHEUM DIS, V19, P1169, DOI 10.1111/1756-185X.12632; Mahrholdt H, 2007, HEART, V93, P122, DOI 10.1136/hrt.2005.071290; Manders SHM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0630-5; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Morieri ML, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1396398; Niu WQ, 2012, INT J CARDIOL, V157, P243, DOI 10.1016/j.ijcard.2011.12.098; Ogdie A, 2015, ANN RHEUM DIS, V74, P326, DOI 10.1136/annrheumdis-2014-205675; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rucker G, 2012, RES SYNTH METHODS, V3, P312, DOI 10.1002/jrsm.1058; Sakai R, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0583-8; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Senn S, 2007, STAT MED, V26, P1417, DOI 10.1002/sim.2639; Smolen JS, 2015, ANN RHEUM DIS, V74, P843, DOI 10.1136/annrheumdis-2013-204632; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Smolen JS, 2016, LANCET, V388, P2763, DOI 10.1016/S0140-6736(16)31651-8; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Velasquez IM, 2015, ATHEROSCLEROSIS, V240, P477, DOI 10.1016/j.atherosclerosis.2015.04.014; Virone A., ACR MEETING ABSTRACT; Weisman MH, 2007, RHEUMATOLOGY, V46, P1122, DOI 10.1093/rheumatology/kem033; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734; Winchester R, 2016, ARTHRITIS RHEUMATOL, V68, P92, DOI 10.1002/art.39419; Yamamoto K, 2014, MOD RHEUMATOL, V24, P715, DOI 10.3109/14397595.2013.864224; Zhang J, 2016, ANN RHEUM DIS, V75, P1813, DOI 10.1136/annrheumdis-2015-207870; Zoller B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-41	63	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220178	10.1371/journal.pone.0220178	http://dx.doi.org/10.1371/journal.pone.0220178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369575	Green Submitted, gold, Green Published			2022-12-27	WOS:000484987900034
J	Chen, XM; Chen, YH; Liu, CG; Li, XJ; Liu, HY; Yin, XC; Bai, XF; Ge, M; Chen, HY; Liu, M; Du, YZ; Fan, GC; Zhang, Y				Chen, Xueming; Chen, Yuhuan; Liu, Chungguo; Li, Xiaojun; Liu, Hongyu; Yin, Xiuchen; Bai, Xiaofei; Ge, Ming; Chen, Hongyan; Liu, Ming; Du, Yuanzhao; Fan, Gencheng; Zhang, Yun			Improved one-tube RT-PCR method for simultaneous detection and genotyping of duck hepatitis A virus subtypes 1 and 3	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; MOLECULAR ANALYSIS; TYPE-1 VIRUS; ASSAY; ANTIBODIES; SEROTYPE; GOOSE; VP1	Background The cocirculation of duck hepatitis A virus subtypes 1 (DHAV-1) and 3 (DHAV-3) in ducklings has resulted in significant economic losses. Ducklings with DHAV-1 or DHAV-3 infection show similar clinical signs and gross lesions; hence, it is important to identify the viral subtypes in infected ducklings as early as possible for better clinical management. Methods and results Based on multiple 5' noncoding region (5'-NCR) sequences of DHAV-1 and DHAV-3 strain alignments, universal and type-specific primers were designed and synthesized. With three primers in one-tube reverse transcription-PCR (RT-PCR), reference DHAV-1 and DHAV-3 isolates ranging over 60 years and across many different countries were successfully amplified, indicating that the primer sequences were completely conserved. The sequence results and the sizes of amplicons from reference DHAV-1 and DHAV-3 isolates are completely correlated with their subtypes. Moreover, with this one-tube RT-PCR system, amplicon sizes from liver samples of reference DHAV-1- or DHAV-3-infected birds fit closely with their subtypes, which was determined by virus isolation and neutralization testing. No other duck-origin RNA viruses were detected. The sensitivity of viral RNA detection was 10 pg. With this system, 20% subtype 1, 45% subtype 3, and 9% coinfection of two subtypes were detected in 55 clinical samples. Conclusions and significance This novel approach could be used for rapidly typing DHAV-1 or DHAV-3 infection in routine clinical surveillance or epidemiological screening.	[Chen, Xueming; Chen, Yuhuan; Liu, Chungguo; Li, Xiaojun; Liu, Hongyu; Yin, Xiuchen; Bai, Xiaofei; Chen, Hongyan; Liu, Ming; Zhang, Yun] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China; [Chen, Yuhuan; Ge, Ming] Northeast Agr Univ, Coll Vet Med, Harbin, Heilongjiang, Peoples R China; [Du, Yuanzhao; Fan, Gencheng] YeBio Qingdao, State Key Lab Genetically Engn Vet Vaccine, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Agricultural University - China	Chen, HY; Liu, M; Zhang, Y (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Heilongjiang, Peoples R China.	hychen02@126.com; liuming04@126.com; yunzhang03@yahoo.com			National Natural Science Foundation of China [31670153]; National Key Technologies R&D Program from the State Key Lab of Genetically Engineered Veterinary Vaccine [2016YFD0500100, CAAS-XTCX2016011-04-9, AGVSKL-ZD-201804]; National Key Technologies RD Program [2016YFD0500100, CAAS-XTCX2016011-04-9]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program from the State Key Lab of Genetically Engineered Veterinary Vaccine; National Key Technologies RD Program(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (31670153), National Key Technologies R&D Program (2016YFD0500100), CAAS-XTCX2016011-04-9, and AGVSKL-ZD-201804 from the State Key Lab of Genetically Engineered Veterinary Vaccine. Yun Zhang supervised and provided the funding the National Natural Science Foundation of China (31670153), National Key Technologies R&D Program (2016YFD0500100), and CAAS-XTCX2016011-04-9 and Ming Liu supervised and provided the funding AGVSKL-ZD-201804 for the study. We declared that commercial company eBio of Qingdao did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. It only provided financial support in the form of research materials. The specific roles of DYZ and CGF are articulated in the 'author contributions' section.	Chen LL, 2013, J VIROL METHODS, V192, P12, DOI 10.1016/j.jviromet.2013.04.012; Doan HT, 2006, J INFECT DEV COUNTR, V10, P988; Fu Y, 2008, VET MICROBIOL, V131, P247, DOI 10.1016/j.vetmic.2008.03.011; Hu Q, 2016, J VIROL METHODS, V236, P207, DOI 10.1016/j.jviromet.2016.07.011; Huang QX, 2012, J CLIN MICROBIOL, V50, P3318, DOI 10.1128/JCM.01080-12; HWANG J, 1969, AM J VET RES, V30, P861; Kim MC, 2007, ARCH VIROL, V152, P2059, DOI 10.1007/s00705-007-1023-0; Kim MC, 2008, AVIAN PATHOL, V37, P171, DOI 10.1080/03079450801918670; Kim MC, 2007, AVIAN DIS, V51, P540, DOI 10.1637/0005-2086(2007)51[540:DOORTC]2.0.CO;2; Kim MC, 2006, J GEN VIROL, V87, P3307, DOI 10.1099/vir.0.81804-0; Li CF, 2014, J VIROL METHODS, V196, P193, DOI 10.1016/j.jviromet.2013.11.009; Li XJ, 2017, VIRUS RES, V227, P240, DOI 10.1016/j.virusres.2016.10.018; Liu CG, 2013, VET MICROBIOL, V167, P296, DOI 10.1016/j.vetmic.2013.09.004; Liu M, 2012, J VIROL, V86, P3398, DOI 10.1128/JVI.07086-11; Liu M, 2011, VET MICROBIOL, V152, P280, DOI 10.1016/j.vetmic.2011.05.015; Liu M, 2010, J VIROL METHODS, V169, P66, DOI 10.1016/j.jviromet.2010.06.018; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saha K, 2013, J VIROL METHODS, V193, P521, DOI 10.1016/j.jviromet.2013.07.029; Shen YL, 2015, J VIROL METHODS, V225, P30, DOI 10.1016/j.jviromet.2015.08.016; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tseng CH, 2007, VIRUS RES, V126, P19, DOI 10.1016/j.virusres.2007.01.012; Tseng CH, 2007, VIRUS RES, V123, P190, DOI 10.1016/j.virusres.2006.09.007; Wang LY, 2008, VIRUS GENES, V37, P52, DOI 10.1007/s11262-008-0233-1; Wen XJ, 2014, POULTRY SCI, V93, P2184, DOI 10.3382/ps.2014-04024; Woolcock PR, 2003, DIS POULTRY; Wu XJ, 2017, INT J AEROSPACE ENG, V2017, P1, DOI 10.1155/2017/8107190; Wu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118041; Yang M, 2008, J VIROL METHODS, V153, P55, DOI 10.1016/j.jviromet.2008.06.012; Zhang TT, 2014, J VIROL METHODS, V208, P166, DOI 10.1016/j.jviromet.2014.07.035; Zhang Y, 2006, ARCH VIROL, V151, P1525, DOI 10.1007/s00705-006-0731-1	30	4	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219750	10.1371/journal.pone.0219750	http://dx.doi.org/10.1371/journal.pone.0219750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369566	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900016
J	Ho, WKY; Ahmed, MD; Khoo, S; Tan, CH; Dehkordi, MR; Gallardo, M; Lee, K; Yamaguchi, Y; Tao, YP; Shu, CN				Ho, Walter King Yan; Ahmed, Md Dilsad; Khoo, Selina; Tan, Chee Hian; Dehkordi, Mitra Rouhi; Gallardo, Mila; Lee, Kicheon; Yamaguchi, Yasuo; Tao, Yuping; Shu, Chunong			Towards developing and validating Quality Physical Education in schools-The Asian physical education professionals' voice	PLOS ONE			English	Article							SOCIAL DESIRABILITY BIAS; ATTITUDES; VALIDITY	Physical education professionals aim to develop quality programmes for physical education. This study aimed to develop and validate a scale using professionals' perceptions of Quality Physical Education QPE in Asia using twenty-four items regarding QPE quality issues. The items covered status and roles, development of educational elements and supportive features in physical education. A sample of N = 799 sport and physical education professionals from eleven Asian cities participated in this questionnaire survey. Twenty-four items relating to QPE were examined via exploratory factor analysis (EFA) using maximum likelihood extraction and direct oblimin rotation methods. Nevertheless, only 20 items were extracted following the EFA examination. Items 1, 9, 14 and 18 were excluded because of low factor loadings. The remaining items were clustered into four subscales: Development and Supportive Elements for Quality Physical Education in Schools (DSFQPE; alpha = .918), Core Values of Quality Physical Education (CVPE; alpha = .908), Curriculum Arrangement of Physical Activities (CAPA; alpha = .884) and Provision and Norms in Physical Education (PNPE; alpha = .865). The Cronbach's alpha coefficient (alpha = .875) indicated excellent internal consistency for the overall measure. Furthermore, the 4 retained factors from the EFA were assessed via robust confirmatory factor analysis (CFA). The 4-factor model demonstrated a good fit with the data (CMIN/DF = 3.450, CFI = .928, TLI = .916, PCFI = .801, RMSEA = .078). The study identified a 4-factor structure with internal consistency and acceptable interfactor correlations. The structure seemed to be applicable, including the twenty items identified as useful and necessary tools for the framework of analysis in the investigation of diverse settings for the study of quality physical education.	[Ho, Walter King Yan] Univ Macau, Fac Educ, Taipa, Macao, Peoples R China; [Ahmed, Md Dilsad] Univ Alberta, Fac Educ, Dept Elementary Educ, Edmonton, AB, Canada; [Khoo, Selina] Univ Malaya, Sports Ctr, Kuala Lumpur, Malaysia; [Tan, Chee Hian] Univ Teknol MARA, Fac Sports Sci & Recreat, Shah Alam, Malaysia; [Dehkordi, Mitra Rouhi] Farhangian Univ, Fac Phys Educ, Tehran, Iran; [Gallardo, Mila] Mindanao State Univ, Coll Sports Phys Educ & Recreat, Mawari, Philippines; [Lee, Kicheon] Korea Univ, Dept Leisure & Sports Studies, Seoul, South Korea; [Yamaguchi, Yasuo] Kobe Univ, Dept Phys Educ, Kobe, Hyogo, Japan; [Tao, Yuping] Chengdu Sport Univ, Chengdu, Sichuan, Peoples R China; [Shu, Chunong] Hunan Normal Univ, Changsha, Hunan, Peoples R China	University of Macau; University of Alberta; Universiti Malaya; Universiti Teknologi MARA; Korea University; Kobe University; Chengdu Sport University; Hunan Normal University	Ahmed, MD (corresponding author), Univ Alberta, Fac Educ, Dept Elementary Educ, Edmonton, AB, Canada.	walterdilsad@gmail.com	Khoo, Selina/B-3962-2009; López de D'Amico, Rosa/AGT-7658-2022; Hian, Tan Chee/AAO-6334-2020; Ho, Walter/X-1563-2019	Khoo, Selina/0000-0002-3090-9309; López de D'Amico, Rosa/0000-0002-8091-7200; Ahmed, Md Dilsad/0000-0003-1837-5276; Chee Hian, Tan/0000-0002-3112-7229	University of Macau through the MYRG fund	University of Macau through the MYRG fund	The Study was funded by the University of Macau through the MYRG fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D. M., 2016, J PHYS ED SPORTS, V124, P776, DOI DOI 10.7752/JPES.2016.03124; Ahmed MD, 2017, COGENT PSYCHOL, V4, DOI 10.1080/23311908.2017.1331602; [Anonymous], 2003, SCALE DEV THEORY APP; [Anonymous], 2004, MOV FUT NAT STAND PH; Araki Kaori, 2013, J Prev Med Public Health, V46 Suppl 1, pS43, DOI 10.3961/jpmph.2013.46.S.S43; Arar KH, 2009, SPORT EDUC SOC, V14, P183, DOI 10.1080/13573320902809088; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Brown GTL, 2004, PSYCHOL REP, V94, P1015; Browne MW., 1993, SOCIOL METHOD RES, V154, P136; CDC, 2001, LEARN LEARN WAY FORW; Chen JJ, 2016, ASIA PAC J EDUC, V36, P570, DOI 10.1080/02188791.2015.1005052; COMREY AL, 1978, J CONSULT CLIN PSYCH, V46, P648, DOI 10.1037/0022-006X.46.4.648; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DeVon HA, 2007, J NURS SCHOLARSHIP, V39, P155, DOI 10.1111/j.1547-5069.2007.00161.x; Eccles J. S, 2002, COMMUNITY PROGRAMS P; Field A., 2000, DISCOVERING STAT USI; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Gable R.K., 1993, INSTRUMENT DEV AFFEC, V2nd; Guan J, 2005, ASIA PACIFIC J TEACH, V33, P147, DOI DOI 10.1080/13598660500121928; Haladyna T., 1999, DEV VALIDATING MULTI; Hardman K., 2000, European Physical Education Review, V6, P203, DOI 10.1177/1356336X000063001; Hardman K, 2000, WORLD WID SURV STAT; Hardman K., 2009, INT J PHYS ED, V46, P106; Ho Walter, 2018, Rev. Bras. Ciênc. Esporte, V40, P361, DOI 10.1016/j.rbce.2018.05.006; Ho WKY, 2017, COGENT EDUC, V4, DOI 10.1080/2331186X.2017.1408945; Ho WKY, 2019, S AFR J SPORTS MED, V1, P31; Holzweg M, 2013, INT J PHYS ED, V3, P29; Jin C, 2011, SHS WEB C, V24, P1; Keating XD, 2004, J TEACH PHYS EDUC, V23, P143, DOI 10.1123/jtpe.23.2.143; Kumar P, 2017, ACS ENERGY LETT, V2, P81, DOI 10.1021/acsenergylett.6b00554; LAM T. C. M., 1982, J EDUC MEAS, V19, P312, DOI DOI 10.1111/J.1745-3984.1982.TB00137.X; Larson RW, 2000, AM PSYCHOL, V55, P170, DOI 10.1037/0003-066X.55.1.170; LYNN MR, 1986, NURS RES, V35, P382; Marsh HW, 2004, PSYCHOL METHODS, V9, P275, DOI 10.1037/1082-989X.9.3.275; McNeill M, 2009, EUR PHYS EDUC REV, V15, P201, DOI 10.1177/1356336X09345224; Mottet TP, 2006, COMMUN EDUC, V3, P295; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Ofir C, 1987, MULTIVARIATE BEHAV R, V2, p[1, 8]; Ota N, 2000, INT STUDIES SOCIOLOG, V10, P43; POORTINGA YH, 1989, INT J PSYCHOL, V24, P737, DOI 10.1080/00207598908247842; Quality Physical Education (QPE), 2015, GUID POL MAK; Sanchez GFL, 2017, SPORTS TK EURO AM J, V6, P1; Sarwar M, 2010, ASIAN SOCIAL SCI, V6, P11; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; Song LH, 2013, EUR PHYS EDUC REV, V19, P110, DOI 10.1177/1356336X12465512; Starc G, 2012, BMC PUBLIC HEALTH, V61, P1; Straub D., 2004, COMMUN ASSOC INF SYS, V3, P380, DOI [10.17705/1CAIS.01324, DOI 10.17705/1CAIS.01324]; Subramaniam PR, 2007, TEACH TEACH EDUC, V23, P602, DOI 10.1016/j.tate.2007.02.003; Trochim William M. K, 2001, RES METHODS KNOWLEDG, V2nd; Whitehead M., 2001, European Journal of Physical Education, V6, P127; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yan W, 2009, J BEIJING SPORT U, V4, P32	53	5	5	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218158	10.1371/journal.pone.0218158	http://dx.doi.org/10.1371/journal.pone.0218158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369586	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900007
J	Teychenne, M; Lamb, KE; Main, L; Miller, C; Hahne, A; Ford, J; Rosenbaum, S; Belavy, D				Teychenne, Megan; Lamb, Karen E.; Main, Luana; Miller, Clint; Hahne, Andrew; Ford, Jon; Rosenbaum, Simon; Belavy, Daniel			General strength and conditioning versus motor control with manual therapy for improving depressive symptoms in chronic low back pain: A randomised feasibility trial	PLOS ONE			English	Article							TREATMENT PROTOCOL; PHYSICAL-ACTIVITY; EXERCISE; OLDER; CLASSIFICATION; DISORDERS; QUALITY; ADULTS; WOMEN	Objectives Exercise can be used as a treatment for depressive symptoms in the general population. However, little is known as to whether exercise has mental health benefits for adults experiencing chronic low back pain (CLBP). The aim of this study was to examine the feasibility of two intervention protocols commonly used in clinical practice for treating chronic low back pain, but with differing exercise dose, on depressive symptoms. Methods Forty men and women (mean age = 35) experiencing chronic persistent (>3 months), nonspecific low back pain were recruited into a randomised clinical trial during 2015-2016. Participants were randomised to receive motor control (low-dose exercise) and manual therapy (n = 20), or general strength and conditioning training (moderate-dose exercise) (n = 20). Depressive symptoms were assessed fortnightly throughout a 6-month follow-up period using the Centre for Epidemiologic Studies Depression Scale (CES-D 10). Linear mixed models were used to examine within-group and between-group changes in depressive symptoms. Results Mean CES-D 10 score at baseline was 9.17 (SD = 4.32). There was evidence of a small decrease in average depressive symptoms over time (beta -0.19 per fortnight, 95% CI = -0.34, -0.02). However, there was no evidence that change over time was dependent on treatment group Conclusions Reduction in depressive symptoms amongst adults with CLBP occurred with both treatment methods (motor control [low-dose exercise] and manual therapy; or general strength and conditioning [moderate-dose exercise]). Further interventions including a true control group are needed to draw conclusions as to the effectiveness of each of these treatment methods on depressive symptoms amongst adults with CLBP.	[Teychenne, Megan; Lamb, Karen E.; Main, Luana; Belavy, Daniel] Deakin Univ, IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Lamb, Karen E.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Lamb, Karen E.] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Miller, Clint] Deakin Univ, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Hahne, Andrew; Ford, Jon] La Trobe Univ, Melbourne, Vic, Australia; [Rosenbaum, Simon] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Rosenbaum, Simon] Black Dog Inst, Sydney, NSW, Australia	Deakin University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Deakin University; La Trobe University; University of New South Wales Sydney; Black Dog Institute	Teychenne, M (corresponding author), Deakin Univ, IPAN, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.	mteych@deakin.edu.au	Hahne, Andrew/AAK-5728-2021; Belavy, Daniel/P-4947-2016; Main, L.C./L-2359-2015	Belavy, Daniel/0000-0002-9307-832X; Main, L.C./0000-0002-9576-9466; Rosenbaum, Simon/0000-0002-8984-4941; Ford, Jon/0000-0001-5524-190X; Miller, Clint/0000-0001-7743-6986	Deakin University School of Exercise and Nutrition Sciences	Deakin University School of Exercise and Nutrition Sciences	This study was supported by internal institutional funding (Deakin University School of Exercise and Nutrition Sciences. ID number: Belavy 2014-2017) to DB. The funder played no role in the study design, data collection, analysis, decision to publish or prepare the manuscript.	Ahn, 2015, SAMPLE SIZE CALCULAT; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Ashworth NL, 2005, HOME VERSUS CTR BASE, V1; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Coulter ID, 2018, SPINE J, V18, P866, DOI 10.1016/j.spinee.2018.01.013; Dhar AK, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00033; Dishman RK, 1997, MED SCI SPORT EXER, V29, P63, DOI 10.1097/00005768-199701000-00010; Focht BC, 2004, J BEHAV MED, V27, P101, DOI 10.1023/B:JOBM.0000019847.80315.4d; Ford JJ, 2012, PHYS THER REV, V17, P55, DOI 10.1179/1743288X11Y.0000000037; Ford JJ, 2011, PHYS THER REV, V16, P168, DOI 10.1179/1743288X11Y.0000000005; Gordon BR, 2018, JAMA PSYCHIAT, V75, P566, DOI 10.1001/jamapsychiatry.2018.0572; Gorman J M, 1996, Depress Anxiety, V4, P160, DOI 10.1002/(SICI)1520-6394(1996)4:4<160::AID-DA2>3.0.CO;2-J; Gowans SE, 2004, ARTHRIT RHEUM-ARTHR, V51, P890, DOI 10.1002/art.20828; Hallgren M, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00036; Hoffman Martin D, 2007, Curr Pain Headache Rep, V11, P93; Laske C, 2010, INT J NEUROPSYCHOPH, V13, P595, DOI 10.1017/S1461145709991234; Maitland GD., 1987, CLIN PHYS THER, V13, P135; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Pinheiro MB, 2015, ARTHRIT CARE RES, V67, P1591, DOI 10.1002/acr.22619; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Richardson C A, 1995, Man Ther, V1, P2, DOI 10.1054/math.1995.0243; Schuch FB, 2018, AM J PSYCHIAT, V175, P631, DOI 10.1176/appi.ajp.2018.17111194; Schuch FB, 2016, J PSYCHIATR RES, V77, P42, DOI 10.1016/j.jpsychires.2016.02.023; Sculco A D, 2001, Spine J, V1, P95, DOI 10.1016/S1529-9430(01)00026-2; Simson KJ, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1913-8; Sivertsen H, 2015, DEMENT GERIATR COGN, V40, P311, DOI 10.1159/000437299; SULLIVAN MJL, 1992, PAIN, V50, P5, DOI 10.1016/0304-3959(92)90107-M; Teychenne M, 2017, PREV MED, V102, P72, DOI 10.1016/j.ypmed.2017.07.005; Espi-Lopez GV, 2016, INT J OSTEOPATH MED, V22, P11, DOI 10.1016/j.ijosm.2016.05.003; Wang PS, 2004, AM J PSYCHIAT, V161, P1885, DOI 10.1176/appi.ajp.161.10.1885; WHO, 2017, DEPR OTH COMM MENT D; World Confederation for Physical Therapy, 2018, PROM INT EXC UN CLIN; Zhang YQ, 2017, J CLIN EPIDEMIOL, V88, P67, DOI 10.1016/j.jclinepi.2017.05.016	34	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220442	10.1371/journal.pone.0220442	http://dx.doi.org/10.1371/journal.pone.0220442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369613	Green Published, gold			2022-12-27	WOS:000484987900047
J	Mandelbrot, L; Ceccaldi, PF; Duro, D; Le, M; Pencole, L; Peytavin, G				Mandelbrot, Laurent; Ceccaldi, Pierre-Francois; Duro, Dominique; Le, Minh; Pencole, Lucile; Peytavin, Gilles			Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PHARMACOKINETICS; PREGNANCY; ANTIPYRINE; EXPOSURE; WOMEN	Objective To determine the transplacental pharmacokinetics of the HIV integrase inhibitor dolutegravir. Study design Maternal-to-fetal transfer across the term human placenta was investigated with the ex-vivo dually perfused cotyledon model, in 5 closed-circuit, recirculating experiments. Dolutegravir was added to a maternal perfusate containing antipyrine, a marker to validate the cotyledon's viability, and 2 g/liter of human albumin. Results After 3h of recirculating perfusion, the mean (+/- SD) DTG concentrations in the maternal and in the fetal compartments were respectively 2450 +/- 286 ng/mL and 715 +/- 369 ng/mL, with a fetal-to-maternal ratio of 34% +/- 18% and a clearance index (in comparison with antipyrine transfer) of 79% +/- 23%. The mean cotyledon accumulation index was 153% +/- 25%. Conclusion Fetal transplacental exposure to dolutegravir was considerable as well as accumulation in placental tissue. Whether this may lead to risks for the exposed fetus requires more investigation.	[Mandelbrot, Laurent; Duro, Dominique; Pencole, Lucile] Hop Univ Paris Nord Val Seine, Serv Gynecol Obstet, Hop Louis Mourier, AP HP, Colombes, France; [Mandelbrot, Laurent; Ceccaldi, Pierre-Francois; Pencole, Lucile] Univ Paris Diderot, Univ Sorbonne Paris Cite, Paris, France; [Mandelbrot, Laurent; Ceccaldi, Pierre-Francois] Dept Hosp Univ Risques & Grossesse, Paris, France; [Mandelbrot, Laurent; Le, Minh; Pencole, Lucile; Peytavin, Gilles] INSERM, IAME, UMR 1137, Paris, France; [Ceccaldi, Pierre-Francois] Hop Univ Paris Nord Val Seine, Hop Beaujon, AP HP, Serv Gynecol Obstet, Clichy, France; [Duro, Dominique] Agence Natl Rech Sida & Hepatites Virales Inserm, Paris, France; [Le, Minh; Peytavin, Gilles] Hop Univ Paris Nord Val Seine, Hop Bichat Claude Bernard, AP HP, Pharmacotoxicol Dept, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Mandelbrot, L (corresponding author), Hop Univ Paris Nord Val Seine, Serv Gynecol Obstet, Hop Louis Mourier, AP HP, Colombes, France.; Mandelbrot, L (corresponding author), Univ Paris Diderot, Univ Sorbonne Paris Cite, Paris, France.; Mandelbrot, L (corresponding author), Dept Hosp Univ Risques & Grossesse, Paris, France.; Mandelbrot, L (corresponding author), INSERM, IAME, UMR 1137, Paris, France.	laurent.mandelbrot@lmr.aphp.fr	Ceccaldi, Pierre-Francois/B-7966-2008; Mandelbrot, Laurent/AAD-3554-2019	Ceccaldi, Pierre-Francois/0000-0003-4716-9199; Mandelbrot, Laurent/0000-0002-5883-7597	Agence Nationale de Recherches sur le Sida et Hepatites Virales (Inserm-ANRS)	Agence Nationale de Recherches sur le Sida et Hepatites Virales (Inserm-ANRS)	The salary of Dominique Duro was funded by the Agence Nationale de Recherches sur le Sida et Hepatites Virales (Inserm-ANRS). The Agence Nationale de Recherches sur le Sida et Hepatites Virales (Inserm-ANRS) also also provided funding to purchase equipment and for publication costs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bapat P, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.065; Berveiller P, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.007; Berveiller P, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.07.023; Ceccaldi PF, 2009, OBSTET GYNECOL INT, V2009, DOI 10.1155/2009/726593; Ceccaldi PF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.802; CHALLIER JC, 1983, REPROD NUTR DEV, V23, P41, DOI 10.1051/rnd:19830104; Cottrell ML, 2013, CLIN PHARMACOKINET, V52, P981, DOI 10.1007/s40262-013-0093-2; De Sousa Mendes M, 2016, CLINICAL PHARMACOKIN; Fauchet F, 2015, ANTIMICROB AGENTS CH, V59, P5727, DOI 10.1128/AAC.00863-15; Faure-Bardon V, 2018, AIDS, V32, P321, DOI 10.1097/QAD.0000000000001681; Gavard L, 2006, AM J OBSTET GYNECOL, V195, P296, DOI 10.1016/j.ajog.2006.01.017; Gavard L, 2009, EUR J OBSTET GYN R B, V147, P157, DOI 10.1016/j.ejogrb.2009.08.007; Jung BH, 2007, BIOMED CHROMATOGR, V21, P1095, DOI 10.1002/bmc.865; Lewis JM, 2016, AIDS, V30, P1313, DOI 10.1097/QAD.0000000000001055; Mandelbrot L, 2015, CROI 2015; Mandelbrot L, 2015, CLIN INFECT DIS, V61, P1715, DOI 10.1093/cid/civ578; Mandelbrot L, 2015, ANTIMICROB AGENTS CH, V59, P2901, DOI 10.1128/AAC.00075-15; Mandelbrot L, 2014, ANTIMICROB AGENTS CH, V58, P5617, DOI 10.1128/AAC.03184-14; Mofenson LM, 2018, LANCET GLOB HEALTH, V6, pE716, DOI 10.1016/S2214-109X(18)30272-9; Mofenson LM, 2016, J INFECT DIS, V213, P1051, DOI 10.1093/infdis/jiv390; Mulligan N BB, 2016, DOLUTEGRAVIR PHARMAC; Pain JB, 2015, ANTIMICROB AGENTS CH, V59, P3660, DOI 10.1128/AAC.00173-15; Rimawi BH, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02213-16, 10.1128/aac.02213-16]; Schalkwijk S, 2016, J ANTIMICROB CHEMOTH, V71, P480, DOI 10.1093/jac/dkv358; SCHNEIDE.H, 1972, AM J OBSTET GYNECOL, V114, P822, DOI 10.1016/0002-9378(72)90909-X; Schomaker M, 2018, LANCET GLOB HEALTH, V6, pE958, DOI 10.1016/S2214-109X(18)30326-7; Sibiude J, 2015, EXPERT OPIN DRUG SAF, V14, P643, DOI 10.1517/14740338.2015.1019462; Slogrove AL, 2017, CURR OPIN HIV AIDS, V12, P359, DOI 10.1097/COH.0000000000000386; Smith JA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.013; Vinot C, 2013, ANTIMICROB AGENTS CH, V57, P1415, DOI 10.1128/AAC.01821-12; Vinot C, 2016, ANTIMICROB AGENTS CH, V60, P3112, DOI 10.1128/AAC.00007-16; Zash R, 2018, LANCET GLOB HEALTH, V6, pE804, DOI 10.1016/S2214-109X(18)30218-3; Zhang JP, 2015, BRIT J CLIN PHARMACO, V80, P502, DOI 10.1111/bcp.12639; 2018, LANCET, V391, P2296	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220323	10.1371/journal.pone.0220323	http://dx.doi.org/10.1371/journal.pone.0220323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408460	Green Published, Green Submitted, gold			2022-12-27	WOS:000485009500013
J	Tlale, LB; Morake, B; Lesetedi, O; Maribe, L; Masweu, M; Faye, C; Asiki, G				Tlale, Lebapotswe B.; Morake, Barnabas; Lesetedi, Onalethata; Maribe, Lucy; Masweu, Mabole; Faye, Cheikh; Asiki, Gershim			Data quality self-assessment of child health and sexual reproductive health indicators in Botswana, 2016-2017	PLOS ONE			English	Article							CARE	There is no published data on quality of administrative data for various health indicators in Botswana, yet such data are used for policy making and future planning. This article reports on quality of data on child health and sexual and reproductive health (SRH) indicators in Botswana. The main objective of the study was to assess the quality of administrative data from Expanded Immunization Program (EPI) and condom use, Depo-Provera uptake and domiciliary care attendance in Botswana. This was a retrospective study entailing a review of data retrieved from district health records and District Health Information System (DHIS). A total of 30 clinics and health posts were randomly selected from two cities, a town and three rural villages which makes up 6 districts commonly denoted urban, semi-urban and rural respectively. Through a stratified random sampling health facilities were selected. EPI data (Penta 3-third dose of pentavalent vaccine and Measles vaccine) and SRH data (condom use, Depo-Provera uptake and Domiciliary care) were assessed for completeness, discrepancies and verification factor using WHO Routine data quality (RDQA) assessment tool. A verification score of less than 90%% was considered as underreporting while more than 110% is over reporting. However, the score which is within +-10% is acceptable, reliable and a good indicator of data quality and reporting system. About 56% (9/16) SRH indicators had a verification factor score outside the accepted range and 87% (13/15) discrepancy value outside the accepted range. For immunization, 10% (1/10) had a verification factor score outside the accepted range and 33% (3/9) had a discrepancy value outside the accepted range. The level of completeness was high for both Penta3 and Measles coverage and it was lowest for condom. Our findings highlight a poorer data quality for SRH indicators compared to child health indicators. A comprehensive program review drawing lessons from the child health indicators is required to improve the quality of administrative data in Botswana.	[Tlale, Lebapotswe B.; Morake, Barnabas; Masweu, Mabole] Minist Hlth & Wellness, Gaborone, Botswana; [Lesetedi, Onalethata] Univ Botswana, Gaborone, Botswana; [Maribe, Lucy] WHO, Botswana Off, Gaborone, Botswana; [Faye, Cheikh; Asiki, Gershim] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Asiki, Gershim] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden	University of Botswana; World Health Organization; African Population & Health Research Centre; Karolinska Institutet	Tlale, LB (corresponding author), Minist Hlth & Wellness, Gaborone, Botswana.	cypro330@yahoo.com	Faye, Mbacké/AAI-1674-2019	Faye, Mbacké/0000-0002-4028-0575; Morake, Barnabas/0000-0002-3915-3552; Tlale, Lebapotswe/0000-0001-5689-2755	African Population Health Research Council (APHRC)	African Population Health Research Council (APHRC)	Data collection was Funded by African Population Health Research Council (APHRC). The funding was to facilitate data collection at facility level. The individuals who received the per diem to conduct data collection include Lebapotswe Tlale, Barnabus Morake, Lucy maribe, Onalethata Lesetedi and Mabole Masweu.	Ahanhanzo YG, 2015, HEALTH POLICY PLANN, V30, P837, DOI 10.1093/heapol/czu067; [Anonymous], 2015, BOTSW MILL DEV GOALS; [Anonymous], 2005, GLOB IMM VIS STRAT 2; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Boeldosser-Boesch A, 2017, LANCET, V389, p[10010, 696]; Burton A, 2009, B WORLD HEALTH ORGAN, V87, P535, DOI 10.2471/BLT.08.053819; Darmstadt GL, 2006, J HEALTH POPUL NUTR, V24, P380; Hotchkiss DR, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-188; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Jacqueline E, 2013, LANCE, V381, P1756; Kihuba E, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24859; Lim S, 2008, LANCET, V362, P9655; Lin B., 2000, J INT INF MANAG, V9, P33; Ministry of health Botswana, 2016, BOTSW MEASL RUB DEW; Ministry of health Botswana, BOTSW MULT IMM PLAN; Munya A, 2016, J HLTH INFORM DEV CO, V10; Murray C, 2003, LANCET, V362, P9389; Potts M, 1986, J Obstet Gynaecol East Cent Africa, V5, P29; Statistics Botswana, 2016, BOTSW MAT MORT RAT; Statistics Botswana, 2013, POP HOUS CENS 2011 D; United States Agency for International Development, 2015, US MAN ROUT DAT QUAL; Vandelaer J, 2007, B WHO, V86; Wang R. Y., 1996, Journal of Management Information Systems, V12, P5; *WHO, 2003, GLOB POL ER IN STRAT; *WHO, 2001, MEASL MORT RED REG E; WINIKOFF B, 1987, STUD FAMILY PLANN, V18, P128, DOI 10.2307/1966808; World Health Organization, 2013, COUNS MAT NEWB HLTH; World Health Organization, 2005, WHOIVB0518; World Health Organization, 2000, MAT NEON TET EL 2005; You D, 2015, LANCET, V386, P2256	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220313	10.1371/journal.pone.0220313	http://dx.doi.org/10.1371/journal.pone.0220313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408470	Green Submitted, Green Published, gold			2022-12-27	WOS:000485009500012
J	Das, G; Patra, JK; Debnath, T; Ansari, A; Shin, HS				Das, Gitishree; Patra, Jayanta Kumar; Debnath, Trishna; Ansari, Abuzar; Shin, Han-Seung			Investigation of antioxidant, antibacterial, antidiabetic, and cytotoxicity potential of silver nanoparticles synthesized using the outer peel extract of Ananas comosus (L.)	PLOS ONE			English	Article							GREEN SYNTHESIS; LEAF EXTRACT; GOLD NANOPARTICLES; ESSENTIAL OIL; SEED EXTRACT; PINEAPPLE; WASTE; BIOSYNTHESIS; OXIDE	Currently, green nanotechnology-based approaches using waste materials from food have been accepted as an environmentally friendly and cost-effective approach with various biomedical applications. In the current study, AgNPs were synthesized using the outer peel extract of the fruit Ananas comosus (AC), which is a food waste material. Characterization was done using UV-visible spectroscopy, X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectroscopy, scanning electronic microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDX) analyses. The formation of AgNPs has confirmed through UV-visible spectroscopy (at 485 nm) by the change of color owing to surface Plasmon resonance. Based on the XRD pattern, the crystalline property of AgNPs was established. The functional group existing in AC outer peel extract accountable for the reduction of Ag+ ion and the stabilization of AC-AgNPs was investigated through FT-IR. The morphological structures and elemental composition was determined by SEM and EDX analysis. With the growing application of AgNPs in biomedical perspectives, the biosynthesized AC-AgNPs were evaluated for their antioxidative, antidiabetic, and cytotoxic potential against HepG(2) cells along with their antibacterial potential. The results showed that AC-AgNPs are extremely effective with high antidiabetic potential at a very low concentration as well as it exhibited higher cytotoxic activity against the HepG(2) cancer cells in a dose-dependent manner. It also exhibited potential antioxidant activity and moderate antibacterial activity against the four tested foodborne pathogenic bacteria. Overall, the results highlight the effectiveness and potential applications of AC-AgNPs in biomedical fields such as in the treatment of acute illnesses as well as in drug formulation for treating various diseases such as cancer and diabetes. Further, it has applications in wound dressing or in treating bacterial related diseases.	[Das, Gitishree; Patra, Jayanta Kumar] Dongguk Univ Seoul, Res Inst Biotechnol & Med Converged Sci, Seoul, Gyeonggi Do, South Korea; [Debnath, Trishna; Shin, Han-Seung] Dongguk Univ Seoul, Dept Food Sci & Biotechnol, Seoul, Gyeonggi Do, South Korea; [Ansari, Abuzar] Ewha Womans Univ, Ewha Med Res Inst, Dept Obstet & Gynecol, Med Sch, Seoul, South Korea	Dongguk University; Dongguk University; Ewha Womans University	Shin, HS (corresponding author), Dongguk Univ Seoul, Dept Food Sci & Biotechnol, Seoul, Gyeonggi Do, South Korea.	spartan@dongguk.edu	PATRA, JAYANTA KUMAR/AEM-6689-2022; ANSARI, ABUZAR/AAZ-2578-2020	Das, Gitishree/0000-0002-5676-0768; PATRA, JAYANTA KUMAR/0000-0003-4118-4355	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through High Value-added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [118056-2]; Korea Environmental Industry & Technology Institute [A117-00197-0703-0]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through High Value-added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA); Korea Environmental Industry & Technology Institute	This work was supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries (IPET) through High Value-added Food Technology Development Program funded by Ministry of Agriculture, Food and Rural Affairs (MAFRA) (118056-2) and funded by Korea Environmental Industry & Technology Institute (A117-00197-0703-0) to H-SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedapo AA, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-54; Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007; Anand MAV, 2019, MICROB PATHOGENESIS, V135, DOI 10.1016/j.micpath.2019.103609; Annu, 2018, J APPL BIOMED, V16, P221, DOI 10.1016/j.jab.2018.02.002; [Anonymous], 2014, J PHARMACOGNOSY PHYT; Ashraf JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20414; Balan K, 2016, RSC ADV, V6, P40162, DOI 10.1039/c5ra24391b; Baruwa Olayinka Isiaka, 2013, Journal of Horticultural Research, V21, P59, DOI 10.2478/johr-2013-0022; Basavegowda N, 2017, CATAL LETT, V147, P2630, DOI 10.1007/s10562-017-2168-4; Butala MA, 2018, STARCH-STARKE, V70, DOI 10.1002/star.201700182; Cao YW, 2001, J AM CHEM SOC, V123, P7961, DOI 10.1021/ja011342n; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Cheng R, 2010, ADV MOLEC TOXICOL, V4, P157, DOI 10.1016/S1872-0854(10)04005-1; Choi SM, 2011, SYNTHETIC MET, V161, P2405, DOI 10.1016/j.synthmet.2011.09.008; Coates J., 2000, INTERPRETATION OF IN; Diao WR, 2013, J AGR FOOD CHEM, V61, P6044, DOI 10.1021/jf4007856; Faedmaleki F, 2014, IRAN J PHARM RES, V13, P235; Femi-Adepoju A, 2019, GREEN SYNTHESIS SILV; Gangula A, 2011, LANGMUIR, V27, P15268, DOI 10.1021/la2034559; Govindappa M, 2018, RESULTS PHYS, V9, P400, DOI 10.1016/j.rinp.2018.02.049; He D, 2013, ENVIRON SCI TECHNOL, V47, P9148, DOI 10.1021/es400391a; He YQ, 2018, NEW J CHEM, V42, P2882, DOI 10.1039/c7nj04224h; He YQ, 2017, RSC ADV, V7, P39842, DOI 10.1039/c7ra05286c; IALENTI A, 1993, BRIT J PHARMACOL, V110, P701, DOI 10.1111/j.1476-5381.1993.tb13868.x; Iravani S, 2014, RES PHARM SCI, V9, P385; Jagtap UB, 2013, IND CROP PROD, V46, P132, DOI 10.1016/j.indcrop.2013.01.019; Jain PK, 2008, ACCOUNTS CHEM RES, V41, P1578, DOI 10.1021/ar7002804; Kalaiyarasu T., 2016, ASIAN J PHARM CLIN R, V9, P1; Kalpana M. B., 2014, Der Pharmacia Lettre, V6, P22; Kargutkar S, 2016, PHARM BIOL, V54, P2616, DOI 10.3109/13880209.2016.1173066; Kumar B, 2017, SAUDI J BIOL SCI, V24, P45, DOI 10.1016/j.sjbs.2015.09.006; Li T, 2014, INT J FOOD PROP, V17, P1805, DOI 10.1080/10942912.2012.732168; Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003; Mousavi Bita, 2018, Artif Cells Nanomed Biotechnol, V46, P499, DOI 10.1080/21691401.2018.1430697; Naganathan K, 2017, IOP C SERIES MAT SCI; de Barros CHN, 2018, NANOTECHNOL SCI APPL, V11, P1, DOI 10.2147/NSA.S156115; Naz S, 2017, IET NANOBIOTECHNOL, V11, P1040, DOI 10.1049/iet-nbt.2017.0082; Nguyen NHA, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2575-5; Omran BA, 2018, ENERG SOURCE PART A, V40, P227, DOI 10.1080/15567036.2017.1410597; Oves M, 2018, MAT SCI ENG C-MATER, V89, P429, DOI 10.1016/j.msec.2018.03.035; P Patil Shriniwas, 2017, Biochem Biophys Rep, V10, P76, DOI 10.1016/j.bbrep.2017.03.002; Parveen M, 2016, APPL NANOSCI, V6, P267, DOI 10.1007/s13204-015-0433-7; Patil S, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-016-0589-1; Patra J. K., 2017, MICROBIOL, V8, P167, DOI [10.3389/fmicb.2017.00167, DOI 10.3389/FMICB.2017.00167]; Patra JK, 2018, J PHOTOCH PHOTOBIO B, V188, P116, DOI 10.1016/j.jphotobiol.2018.08.004; Patra JK, 2016, IET NANOBIOTECHNOL, V10, P326, DOI 10.1049/iet-nbt.2015.0102; Patra JK, 2015, INT J NANOMED, V10, P7253, DOI 10.2147/IJN.S95483; Patra JK, 2015, J FOOD BIOCHEM, V39, P80, DOI 10.1111/jfbc.12110; Pirtarighat S, 2019, J NANOSTRUCTURE CHEM, V9, P1, DOI 10.1007/s40097-018-0291-4; Poadang S, 2017, SYNTHESIS CHARACTERI; Poadang Sarinya, 2017, Chiang Mai University Journal of Natural Sciences, V16, P123, DOI 10.12982/cmujns.2017.0010; Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017; Prasannaraj Govindaraj, 2017, Advances in Natural Sciences: Nanoscience & Nanotechnology, V8, DOI 10.1088/2043-6254/aa6d2c; Punbusayakul N., 2018, P INN FUNCT FOODS AS; Putri D A, 2018, MAL J FUND APPL SCI, V14, P307; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Rajeshkumar S., 2014, BIOINORGANIC CHEM AP, V2014; Rajkumar T, 2019, J PHOTOCH PHOTOBIO B, V193, P1, DOI 10.1016/j.jphotobiol.2019.01.008; Ramesh PS, 2015, SPECTROCHIM ACTA A, V142, P339, DOI 10.1016/j.saa.2015.01.062; Rashad M M, 2015, INT J TOXICOL PHARM, V7, P287; Reenaa M., 2017, INT J CURRENT MICROB, V6, P2358, DOI DOI 10.20546/IJCMAS.2017.607.337; Rehan M, 2018, ACS SUSTAIN CHEM ENG, V6, P5911, DOI 10.1021/acssuschemeng.7b04302; Riya MP, 2014, J SCI FOOD AGR, V94, P943, DOI 10.1002/jsfa.6340; Romelle FD., 2016, EURO J FOOD SCI TECH, V4, P12, DOI DOI 10.2527/JAS2012-5761.; Sah BNP, 2016, J FOOD SCI TECH MYS, V53, P1698, DOI 10.1007/s13197-015-2100-0; Santiso R, 2012, MUTAT RES-FUND MOL M, V734, P41, DOI 10.1016/j.mrfmmm.2012.03.006; Saraswaty V, 2017, IOP C SERIES EARTH E; Shafiya Rafiq, 2018, Journal of the Saudi Society of Agricultural Sciences, V17, P351; Sharma D., 2015, ARABIAN J CHEM; Shen WN, 2011, CHEM ENG J, V175, P592, DOI 10.1016/j.cej.2011.09.121; Sivaranjani K., 2013, INT RES J PHARM, V4, P225; Soto KM, 2019, LWT-FOOD SCI TECHNOL, V103, P293, DOI 10.1016/j.lwt.2019.01.023; Sre PRR, 2015, SPECTROCHIM ACTA A, V135, P1137, DOI 10.1016/j.saa.2014.08.019; Tashi T., 2016, J CHEM PHARM RES, V8, P526; Vanaja M, 2013, APPL NANOSCI, V3, P217, DOI 10.1007/s13204-012-0121-9; Wypij M, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-017-2406-3; Zhou Y, 2001, CHEM COMMUN, P613, DOI 10.1039/b100636n; Zhou Y, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-19	78	80	81	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220950	10.1371/journal.pone.0220950	http://dx.doi.org/10.1371/journal.pone.0220950			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404086	Green Submitted, Green Published, gold			2022-12-27	WOS:000485006800045
J	Megias-Robles, A; Gutierrez-Cobo, MJ; Gomez-Leal, R; Cabello, R; Gross, JJ; Fernandez-Berrocal, P				Megias-Robles, Alberto; Jose Gutierrez-Cobo, Maria; Gomez-Leal, Raquel; Cabello, Rosario; Gross, James J.; Fernandez-Berrocal, Pablo			Emotionally intelligent people reappraise rather than suppress their emotions	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; CONSEQUENCES; ABILITIES; BEHAVIOR	It has long been thought that emotional intelligence (EI) involves skillful emotion regulation, but surprisingly little is known about the precise links between EI and emotion regulation. To address this gap in the literature, we examined the relation between EI-operationalised as an ability-and the use of two common emotion regulation strategies-cognitive reappraisal and expressive suppression. Seven hundred and twelve participants from a community sample in Spain were assessed on ability EI (using the MSCEIT) and emotion regulation (using the ERQ). Findings revealed that EI ability was positively associated with cognitive reappraisal and negatively associated with expressive suppression. These relationships were moderated by gender and age. The strength of the association between EI and cognitive reappraisal increased with age for men, while this strength decreased with age for women. Conversely, the strength of the association between EI and suppression decreased with age for men, but increased with age for women. These findings confirm the expectation that EI is associated with greater use of generally adaptive forms of emotion regulation (reappraisal), and lesser use of generally maladaptive forms of emotion regulation (suppression), although effect sizes were quite modest. Observed differences in the strength of associations between EI and emotion regulation may be the result of gender differences in the development of emotional skills along with cultural changes in emotional education and social norms.	[Megias-Robles, Alberto; Gomez-Leal, Raquel; Fernandez-Berrocal, Pablo] Univ Malaga, Fac Psychol, Dept Basic Psychol, Malaga, Spain; [Jose Gutierrez-Cobo, Maria; Cabello, Rosario] Univ Granada, Fac Psychol, Dept Dev & Educ Psychol, Granada, Spain; [Gross, James J.] Stanford Univ, Dept Psychol, Stanford, CA USA	Universidad de Malaga; University of Granada; Stanford University	Megias-Robles, A (corresponding author), Univ Malaga, Fac Psychol, Dept Basic Psychol, Malaga, Spain.	amegias@uma.es	Cabello, Rosario/F-9927-2018; Gross, James/AAM-4104-2020; Berrocal, Pablo Fernández/C-4440-2018; Megías-Robles, Alberto/AAA-7458-2020	Cabello, Rosario/0000-0001-6908-7181; Berrocal, Pablo Fernández/0000-0002-0844-2976; Megías-Robles, Alberto/0000-0002-4563-7465; Gomez-Leal, Raquel/0000-0003-1847-6966	Spanish Ministry of Economy, Industry and Competitiveness [PSI2017-84170-R]; University of Malaga	Spanish Ministry of Economy, Industry and Competitiveness; University of Malaga	This work was supported by The Spanish Ministry of Economy, Industry and Competitiveness (PSI2017-84170-R to P.F-B.) and by a postdoctoral fellowship from the University of Malaga to A.M-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almran J. I., 2008, INDIVIDUAL DIFFERENC, V6, P104; Andrei F, 2016, MEAS EVAL COUNS DEV, V49, P34, DOI 10.1177/0748175615596786; Brackett MA, 2006, J PERS SOC PSYCHOL, V91, P780, DOI 10.1037/0022-3514.91.4.780; Butler EA, 2003, EMOTION, V3, P48, DOI 10.1037/1528-3542.3.1.48; Cabello R, 2016, DEV PSYCHOL, V52, P1486, DOI 10.1037/dev0000191; Cabello R, 2013, EUR J PSYCHOL ASSESS, V29, P234, DOI 10.1027/1015-5759/a000150; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Hayes A. F., 2018, INTRO MEDIATION MODE; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; Kafetsios K., 2007, International Journal of Work Organisation and Emotion, V2, P79, DOI 10.1504/IJWOE.2007.013616; Kafetsios K, 2004, PERS INDIV DIFFER, V37, P129, DOI 10.1016/j.paid.2003.08.006; Mayer J, 2002, EMOTIONAL INTELLIGEN; Mayer J.D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; Mayer JD, 1999, INTELLIGENCE, V27, P267, DOI 10.1016/S0160-2896(99)00016-1; Mesquita B., 2014, HDB EMOTION REGULATI, P284; Moore SA, 2008, BEHAV RES THER, V46, P993, DOI 10.1016/j.brat.2008.05.001; Nozaki Y, 2018, PERS INDIV DIFFER, V130, P150, DOI 10.1016/j.paid.2018.04.013; Pena-Sarrionandia A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00160; Sanchez-Garcia M, 2016, PSYCHOL ASSESSMENT, V28, P1404, DOI 10.1037/pas0000269; Schutte NS, 2009, CURR PSYCHOL, V28, P21, DOI 10.1007/s12144-009-9044-3; Shiota MN, 2009, PSYCHOL AGING, V24, P890, DOI 10.1037/a0017896; Smieja M., 2011, STUD PSYCHOL, V49, P55, DOI DOI 10.2478/V10167-010-0040-X; Smieja M, 2007, STUD PSYCHOL, V1, P19; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Urry HL, 2010, CURR DIR PSYCHOL SCI, V19, P352, DOI 10.1177/0963721410388395; Williams WC, 2018, J PERS SOC PSYCHOL, V115, P224, DOI 10.1037/pspi0000132	28	21	21	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220688	10.1371/journal.pone.0220688	http://dx.doi.org/10.1371/journal.pone.0220688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404096	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800024
J	Wallwitz, J; Aigner, P; Gadermaier, E; Bauer, E; Casanova, E; Bauer, A; Stoiber, D				Wallwitz, Jacqueline; Aigner, Petra; Gadermaier, Elisabeth; Bauer, Eva; Casanova, Emilio; Bauer, Anton; Stoiber, Dagmar			Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritis	PLOS ONE			English	Article							KIDNEY INJURY; EXPRESSION; ANGIOGENESIS; ETV6/RUNX1; DISEASE	Endostatin, the C-terminal fragment of type XVIII collagen, was shown to be one of the most potent endothelial cell-specific inhibitors of angiogenesis. As altered circulating endostatin concentration is associated with impaired kidney function, new tools for measuring endostatin in rodents may be helpful to further investigate and understand its role within kidney disease progression. A novel and commercially available ELISA for the quantification of mouse and rat endostatin was developed and validated according to international quality guidelines including the parameters specificity, robustness, accuracy, dilution linearity, precision, limit of detection (LOD) and lower limit of quantification (LLOQ). Endostatin and blood urea nitrogen (BUN) concentration were measured in mice with a glomerulonephritis phenotype. The validation revealed that within the range of 0.5-32 nmol/L the immunoassay is robust and highly specific for the measurement of rodent endostatin with high sensitivity (LOD 0.24 nmol/L, LLOQ 0.5 nmol/L) and good reproducibility (intra-and inter-assay CV <10%). Also accuracy and dilution linearity were within the range of acceptance. BCL2 transgenic and ETV6/RUNX1; BCL2 double transgenic mice develop a glomerulonephritis phenotype over time, which was displayed by staining of kidney sections. Even before full manifestation of disease serum endostatin concentration rises significantly, whereas BUN levels just slightly increase. This newly developed and commercially available ELISA provides a reliable and accurate tool for the quantification of mouse and rat endostatin and may give new perspectives in the investigation of the role of endostatin as an important and early biomarker for reduced kidney function. Measurement of endostatin concentration is recommended to be used as a superior biomarker for chronic kidney disease compared to BUN.	[Wallwitz, Jacqueline; Gadermaier, Elisabeth; Bauer, Anton] Antibody Lab GmbH, Vienna, Austria; [Aigner, Petra; Bauer, Eva; Casanova, Emilio; Stoiber, Dagmar] Ludwig Boltzmann Inst Canc Res, Vienna, Austria; [Casanova, Emilio] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Physiol, Vienna, Austria; [Stoiber, Dagmar] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Stoiber, Dagmar] Karl Landsteiner Univ Hlth Sci, Dept Pharmacol Physiol & Microbiol, Div Pharmacol, Krems, Austria	Ludwig Boltzmann Institute; Medical University of Vienna; Medical University of Vienna	Wallwitz, J (corresponding author), Antibody Lab GmbH, Vienna, Austria.	j.wallwitz@theantibodylab.com	Casanova, Emilio/Y-6553-2019	Casanova, Emilio/0000-0001-7992-5361; Wallwitz, Jacqueline/0000-0002-7335-362X	European Community's Seventh Framework Program (FP7/2007-2013) [305436]; St. Anna Kinderkrebsforschung, Children's Cancer Research Institute, Vienna, Austria	European Community's Seventh Framework Program (FP7/2007-2013); St. Anna Kinderkrebsforschung, Children's Cancer Research Institute, Vienna, Austria	This work was funded from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement number 305436 (STELLAR, www.stellarproject.eu) partly financing the position of JW. Financial support for this project was also provided by the St. Anna Kinderkrebsforschung, Children's Cancer Research Institute, Vienna, Austria (http://science.ccri.at), financing the position of EB and PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Antibody Lab GmbH provided support in the form of salaries for authors (JW, EG, AB) and research material, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179; Bauer E, 2016, ONCOTARGET, V7, P12191, DOI 10.18632/oncotarget.7687; Bellini MH, 2007, NEPHROLOGY, V12, P459, DOI 10.1111/j.1440-1797.2007.00850.x; Carlsson AC, 2016, DIABETES METAB, V42, P351, DOI 10.1016/j.diabet.2016.03.006; Chen J, 2012, AM J NEPHROL, V35, P335, DOI 10.1159/000336109; Devarajan P, 2014, NEPHRON CLIN PRACT, V127, P176, DOI 10.1159/000363206; Egle A, 2004, BLOOD, V103, P2276, DOI 10.1182/blood-2003-07-2469; Fu Y, 2010, BIOCHEMISTRY-US, V49, P6420, DOI 10.1021/bi100489x; Hamano Y, 2010, J AM SOC NEPHROL, V21, P1445, DOI 10.1681/ASN.2009050492; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Kantner HP, 2013, NEOPLASIA, V15, P1292, DOI 10.1593/neo.131310; Kantola T, 2014, BRIT J CANCER, V111, P1605, DOI 10.1038/bjc.2014.456; Kato Y, 2017, J ATHEROSCLER THROMB; Lin CHS, 2016, KIDNEY INT, V89, P1281, DOI 10.1016/j.kint.2016.01.030; Lin CHS, 2014, AM J PHYSIOL-HEART C, V306, pH1692, DOI 10.1152/ajpheart.00064.2014; Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155; Maciel TT, 2008, J NEPHROL, V21, P753; Martensson J, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0108-x; Mohajeri A, 2017, ADV PHARM BULL, V7, P21, DOI 10.15171/apb.2017.004; Ogilvy S, 1999, P NATL ACAD SCI USA, V96, P14943, DOI 10.1073/pnas.96.26.14943; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Pena MJ, 2015, NEPHROL DIAL TRANSPL, V30, P86, DOI 10.1093/ndt/gfv252; Ruge T, 2014, AM J NEPHROL, V40, P417, DOI 10.1159/000369076; Salza R, 2015, J ALZHEIMERS DIS, V44, P1253, DOI 10.3233/JAD-142544; Walia A, 2015, BBA-GEN SUBJECTS, V1850, P2422, DOI 10.1016/j.bbagen.2015.09.007; Wang ZH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/623939	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220935	10.1371/journal.pone.0220935	http://dx.doi.org/10.1371/journal.pone.0220935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404120	Green Submitted, Green Published, gold			2022-12-27	WOS:000485006800044
J	Weise, LD; ten Tusscher, KHWJ				Weise, Louis D.; ten Tusscher, Kirsten H. W. J.			Discrete mechanical growth model for plant tissue	PLOS ONE			English	Article							BIOLOGICAL-MATERIALS; AUXIN; STRESS; ORIENTATION; ELONGATION; EPIDERMIS; NETWORK; CELLS; SHAPE	We present a discrete mechanical model to study plant development. The method is built up of mass points, springs and hinges mimicking the plant cell wall's microstructure. To model plastic growth the resting lengths of springs are adjusted; when springs exceed a threshold length, new mass points, springs and hinges, are added. We formulate a stiffness tensor for the springs and hinges as a function of the fourth rank tensor of elasticity and the geometry of the mesh. This allows us to approximate the material law as a generalized orthotropic Hooke's law, and control material properties during growth. The material properties of the model are illustrated in numerical simulations for finite strain and plastic growth. To solve the equations of motion of mass points we assume elastostatics and use Verlet integration. The method is demonstrated in simulations when anisotropic growth causes emergent residual strain fields in cell walls and a bending of tissue. The method can be used in multilevel models to study plant development, for example by coupling it to models for cytoskeletal, hormonal and gene regulatory processes.	[Weise, Louis D.; ten Tusscher, Kirsten H. W. J.] Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands	Utrecht University	Weise, LD (corresponding author), Univ Utrecht, Theoret Biol & Bioinformat, Utrecht, Netherlands.	Louis.Daniel.Weise@gmail.com			Netherlands Organization for Scientific Research NWO-VIDI [864.14.003]	Netherlands Organization for Scientific Research NWO-VIDI(Netherlands Organization for Scientific Research (NWO))	This research is funded by the Netherlands Organization for Scientific Research (www.nwo.nl) NWO-VIDI to Kirsten H.W.J. ten Tusscher (Grant No. 864.14.003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2014, ANNU REV CELL DEV BI, V30, P59, DOI 10.1146/annurev-cellbio-101512-122410; Armezzani A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162255; Barbez E, 2017, P NATL ACAD SCI USA, V114, pE4884, DOI 10.1073/pnas.1613499114; Baskin TI, 2013, J EXP BOT, V64, P4697, DOI 10.1093/jxb/ert176; Bidhendi AJ, 2018, PLANT PHYSIOL, V176, P41, DOI 10.1104/pp.17.01684; Biot MA, 1939, PHILOS MAG, V27, P468; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bonilla MR, 2015, SOFT MATTER, V11, P1281, DOI 10.1039/c4sm02440k; Boudon F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003950; Bozorg B, 2016, PHYS BIOL, V13, DOI 10.1088/1478-3975/13/6/065002; Bozorg B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003410; Braden B., 1986, COLL MATH J, V17, P326, DOI [10.2307/2686282, DOI 10.1080/07468342.1986.11972974]; Chanliaud E, 2002, PLANTA, V215, P989, DOI 10.1007/s00425-002-0783-8; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Eringen AC, 1980, MECH CONTINUA; Feynman RP, 1969, FEYNMAN LECT PHYS MA; Fozard JA, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2016.0043; Fozard JA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00233; Geitmann A, 2013, CELL BIOL, P1; Gibson LJ, 2012, J R SOC INTERFACE, V9, P2749, DOI 10.1098/rsif.2012.0341; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Grieneisen VA, 2007, NATURE, V449, P1008, DOI 10.1038/nature06215; Grieneisen VA, 2009, CURR OPIN PLANT BIOL, V12, P606, DOI 10.1016/j.pbi.2009.07.008; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hamant O, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0403-5; Hamant O, 2010, NEW PHYTOL, V185, P369, DOI 10.1111/j.1469-8137.2009.03100.x; Hejnowicz Z, 2000, J PLANT GROWTH REGUL, V19, P31, DOI 10.1007/s003440000005; Hogeweg P, 2009, LECT NOTES COMPUT SC, V5391, P29; Jensen OE, 2015, PHYSIOLOGY, V30, P159, DOI 10.1152/physiol.00030.2014; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; Kumpf RP, 2013, P NATL ACAD SCI USA, V110, P5235, DOI 10.1073/pnas.1210835110; Kutschera U, 2007, J PLANT PHYSIOL, V164, P1395, DOI 10.1016/j.jplph.2007.08.002; Landau L. D., 1975, COURSE THEORETICAL P, V7; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Louveaux M, 2016, P NATL ACAD SCI USA, V113, pE4294, DOI 10.1073/pnas.1600677113; Mahonen AP, 2014, NATURE, V515, P125, DOI 10.1038/nature13663; Merks RMH, 2011, PLANT PHYSIOL, V155, P656, DOI 10.1104/pp.110.167619; Meyers MA, 2009, MECHANICAL BEHAVIOR OF MATERIALS, 2ND EDITION, P1; Mullen JL, 1998, PLANTA, V206, P598, DOI 10.1007/s004250050437; Niklas KJ, 1997, AM J BOT, V84, P735, DOI 10.2307/2445809; Oliveri H, 2019, J MATH BIOL, V78, P625, DOI 10.1007/s00285-018-1286-y; Radotic K, 2012, BIOPHYS J, V103, P386, DOI 10.1016/j.bpj.2012.06.046; Rebocho AB, 2017, CURR BIOL, V27, P2610, DOI 10.1016/j.cub.2017.07.064; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; Sampathkumar A, 2014, CURR BIOL, V24, pR475, DOI 10.1016/j.cub.2014.03.014; Saxe F, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-25; Seth B, 1964, 2 ORDER EFFECTS ELAS, P162; Shabala SN, 2002, PLANT PHYSIOL, V129, P290, DOI 10.1104/pp.020005; Thimann KV, 1935, J BIOL CHEM, V109, P279; Valero C, 2016, J MECH BEHAV BIOMED, V62, P222, DOI 10.1016/j.jmbbm.2016.05.006; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Weise LD, 2015, MS A MOD SIMUL, V14, P29, DOI 10.1007/978-3-319-05230-4_2; Weise LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059317; Weise LD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021934; Yavari A, 2010, J NONLINEAR SCI, V20, P781, DOI 10.1007/s00332-010-9073-y	59	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221059	10.1371/journal.pone.0221059	http://dx.doi.org/10.1371/journal.pone.0221059			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404094	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800050
J	Alene, KA; Clements, ACA				Alene, Kefyalew Addis; Clements, Archie C. A.			Spatial clustering of notified tuberculosis in Ethiopia: A nationwide study	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RISK-FACTORS; URBAN; PREVALENCE; INFECTION; BURDEN	Background Tuberculosis (TB) remains a major health problem worldwide and in Ethiopia. This study aimed to investigate the spatial distributions of notified TB over the whole territory of Ethiopia and to quantify the role of health care access, environmental, socio-demographic, and behavioural factors associated with the clustering of TB. Methods A spatial analysis was conducted using national TB data reported between June 2016 and June 2017 in Ethiopia. Spatial clustering of TB was explored using Moran's I statistic and the local indicator of spatial autocorrelation (LISA). A multivariate Poisson regression model was developed with a conditional autoregressive (CAR) prior structure and with posterior parameters estimated using Bayesian Markov chain Monte Carlo (MCMC) simulation with Gibbs sampling to investigate the drivers of the clustering. Result A total of 120,149 TB cases were reported from 745 districts in Ethiopia during the study period; 41,343 (34%) were bacteriologically confirmed new pulmonary TB and 33,997 (28%) were clinically diagnosed, new, smear-negative pulmonary TB patients. The nationwide annual incidence rate of notified TB was 112 per 100,000 population. The highest incidence was observed in three city administrative regions, namely Dire Dewa (348 cases per 100,000 population), Addis Ababa (262 per 100,000 population) and Harari (206 per 100,000 population), and the lowest incidence was observed in Somali region (51 per 100,000 population). High-high spatial clustering of notified TB was detected at Humera, Gog, and Surima district, and low-low clustering was detected in some districts located in the Somali region. Poor health care access (IRR = 0.78; 95%Cl: 0.66, 0.90) and good knowledge about TB (IRR = 0.84; 95%CI: 0.73, 0.96) were negatively associated with the incidence of notified TB. Conclusion Substantial spatial clustering of notified TB was detected at region, zone and district level in Ethiopia. Health care access and knowledge about TB was associated with incidence of TB. This study may provide policy makers target hotspot areas, where national control programs could be implemented more efficiently for the prevention and control of TB, and to address potential under-reporting in poor access areas.	[Alene, Kefyalew Addis; Clements, Archie C. A.] Curtin Univ, Fac Hlth Sci, Perth, WA, Australia; [Alene, Kefyalew Addis; Clements, Archie C. A.] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia; [Alene, Kefyalew Addis] Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	Curtin University; Telethon Kids Institute; Wesfarmers Limited; University of Gondar	Alene, KA (corresponding author), Curtin Univ, Fac Hlth Sci, Perth, WA, Australia.; Alene, KA (corresponding author), Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia.; Alene, KA (corresponding author), Univ Gondar, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	kefyalew.alene@telethonkids.org.au	Alene, Dr Kefyalew Addis/V-8240-2018; Clements, Archie/ABD-1615-2020	Alene, Dr Kefyalew Addis/0000-0002-1904-4682; 				Abebe Y, 2003, AIDS, V17, P1835, DOI 10.1097/00002030-200308150-00013; Alene KA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4099-8; Alene KA, 2019, TRANSBOUND EMERG DIS, V66, P1611, DOI 10.1111/tbed.13188; Alene KA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022948; Alene KA, 2017, GEOSPATIAL HEALTH, V12, P342, DOI 10.4081/gh.2017.575; Alene KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171800; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Couceiro L, 2011, INT J TUBERC LUNG D, V15, P1445, DOI 10.5588/ijtld.10.0302; CSA I, 2012, ETHIOPIA DEMOGRAPHIC; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Getnet F, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0551-y; Golub JE, 2005, INT J TUBERC LUNG D, V9, P992; Hussen Awol, 2012, BMC Res Notes, V5, P320, DOI 10.1186/1756-0500-5-320; Kyu HH, 2018, LANCET INFECT DIS, V18, P1329, DOI 10.1016/S1473-3099(18)30625-X; Lakew Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008669; Marais B, 2018, LANCET CHILD ADOLESC, V2, P7, DOI 10.1016/S2352-4642(17)30150-5; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; MNYIKA KS, 1994, AIDS, V8, P1477, DOI 10.1097/00002030-199410000-00016; MOH, 2015, ANN TUB B; NPC, 2016, FED DEM REP ETH GROW; Reves R, 2016, ETHIOPIA MOVES TUBER; Shank J., 2015, HIGH COUNTRY NEWS; Shen XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039256; United Nations, 2017, WORLD POPULATION PRO; World Health Organization, 2018, GLOBAL TUBERCULOSIS; World Health Organization, 2015, GEAR END TB INTR END; World Health Organization, 2008, COMMUNITY INVOLVEMEN, P1	28	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221027	10.1371/journal.pone.0221027	http://dx.doi.org/10.1371/journal.pone.0221027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398220	gold, Green Published, Green Submitted			2022-12-27	WOS:000485004000044
J	Ameyaw, EK; Budu, E; Sambah, F; Baatiema, L; Appiah, F; Seidu, AA; Ahinkorah, BO				Ameyaw, Edward Kwabena; Budu, Eugene; Sambah, Francis; Baatiema, Linus; Appiah, Francis; Seidu, Abdul-Aziz; Ahinkorah, Bright Opoku			Prevalence and determinants of unintended pregnancy in sub-Saharan Africa: A multi-country analysis of demographic and health surveys	PLOS ONE			English	Article							UNPLANNED PREGNANCY; CONTRACEPTIVE USE; TRENDS; CHILDBEARING; ABORTION; LUANDA	Introduction Approximately 14 million unintended pregnancies are recorded annually in sub-Saharan Africa (SSA). We sought to investigate the prevalence and determinants of unintended pregnancies among women in sub-Saharan Africa. Materials and methods The study pooled data from current Demographic and Health Surveys (DHS) conducted from January 1, 2010 to December 31, 2016 from 29 countries in SSA. Logistic regression analysis was used to examine the factors that influence unintended pregnancies in SSA. Results were presented using odds ratios (OR). Results We found overall unintended pregnancy prevalence rate of 29%, ranging from 10.8% in Nigeria to 54.5% in Namibia. As compared to women aged 15-19 years, women of all other age categories had higher odds of unintended pregnancies. Married women were 6 times more probable to report unintended pregnancy as compared to women who had never married (OR = 6.29, CI = 5.65-7.01). The phenomenon had higher odds among rural residents as compared to urban residents (OR = 1.08, CI = 1.01-1.16). Women with primary (OR = 0.74, CI = 0.69-0.80) and secondary (OR = 0.71, CI = 0.65-0.77) levels of education had less chances of unintended pregnancies, compared to those with no education. Again, women in all other wealth categories had less probability of unintended pregnancy, as compared to women with poorest wealth status. Conclusion Our study contributes substantially towards the discourse of maternal wellbeing by unveiling the prevalence and determinants of unintended pregnancy across the SSA region. There is the need for SSA countries with high prevalence of unintended pregnancies to consider past and present successful interventions of other countries within the region such as health education, counselling, skills-building, comprehensive sex education and access to contraception. Much of these efforts rest with the governments of SSA countries.	[Ameyaw, Edward Kwabena; Ahinkorah, Bright Opoku] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia; [Budu, Eugene; Baatiema, Linus; Appiah, Francis; Seidu, Abdul-Aziz] Univ Cape Coast, Dept Populat & Hlth, Coll Humanities & Legal Studies, Cape Coast, Ghana; [Appiah, Francis] Univ Cape Coast, Dept Hlth Phys Educ & Recreat, Cape Coast, Ghana	University of Technology Sydney; University of Cape Coast; University of Cape Coast	Seidu, AA (corresponding author), Univ Cape Coast, Dept Populat & Hlth, Coll Humanities & Legal Studies, Cape Coast, Ghana.	abdul-aziz.seidu@stu.ucc.edu.gh	Ameyaw, Edward/AAF-2526-2020; Seidu, Abdul-Aziz/S-2521-2019	Ameyaw, Edward/0000-0002-6617-237X; Seidu, Abdul-Aziz/0000-0001-9734-9054				Abayu H., 2015, J PREG CHILD HLTH, V2, P1, DOI DOI 10.4172/2376-127X.1000137; Abraha TH, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0632-2; Adeniyi OV, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2942-z; Ajayi AI, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2328-7; Aliaga A., 2006, OPTIMAL SAMPLE SIZES; Ameyaw Edward Kwabena, 2018, Matern Health Neonatol Perinatol, V4, P17, DOI 10.1186/s40748-018-0085-1; Amin SF, 2009, EUR J SCI RES, V26, P108; [Anonymous], 2001, NAT POL REPR HLTH; Baschieri A, 2017, MATERN CHILD HLTH J, V21, P467, DOI 10.1007/s10995-016-2124-8; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Calvert C, 2013, J FAM PLAN REPROD H, V39, P1, DOI 10.1136/jfprhc-2012-100389; Centers for Disease Control and Prevention, 2015, UN PREGN PREV; Central Statistical Agency [Ethiopia] ORC Macro, 2006, ORC MACR; Chanda MM, 2017, CONTRACEPTION, V96, P196, DOI 10.1016/j.contraception.2017.07.003; Chol C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023128; Christofides NJ, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23719; Claridge AM, 2013, WOMEN HEALTH, V53, P777, DOI 10.1080/03630242.2013.831018; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Darteh EKM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209985; Decker Martha, 2011, Afr J Reprod Health, V15, P68; Eugene KY, 2018, SCIENCE, V6, P6, DOI DOI 10.11648/J.SJPH.20180601.12; Federal Government of Nigeria, 2014, NIG FAM PLANN BLUEPR; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Fishbein M., 1979, NEBRASKA S MOTIVATIO, V27, P65; Getu MK, 2016, OBSTET GYNECOLOGY IN; Habte D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082987; Haffejee F, 2018, S AFR FAM PRACT, V60, P79, DOI 10.1080/20786190.2017.1396790; Hubacher D, 2008, CONTRACEPTION, V78, P73, DOI 10.1016/j.contraception.2008.03.002; Hulton L, 2000, FRAMEWORK EVALUATION; Ikamari L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-69; Jayaweera RT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191412; Kebede E, 2019, P NATL ACAD SCI; Lamina M A, 2015, Ghana Med J, V49, P187, DOI 10.4314/gmj.v49i3.10; Little P, 2001, FAM PRACT, V18, P449, DOI 10.1093/fampra/18.4.449; Maxwell L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118234; McGowan PJ, 2003, J MOD AFR STUD, V41, P339, DOI 10.1017/S0022278X0300435X; Mejia-Guevara I, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002757; Messer LC, 2005, MATERN CHILD HLTH J, V9, P403, DOI 10.1007/s10995-005-0021-7; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; Ministry of Health and Social Services, 2010, NAT HLTH POL FRAM 20; Mkandawire P, 2019, MIDWIFERY, V68, P30, DOI 10.1016/j.midw.2018.08.017; Morris N, 2018, OPEN ACCESS J CONTR, V9, P45, DOI 10.2147/OAJC.S164736; Muanda MF, 2017, CULT HEALTH SEX, V19, P1011, DOI 10.1080/13691058.2017.1286690; Mueni E., 2016, CHANGING NARRATIVE F; Nieto-Andrade B, 2017, GLOB HEALTH-SCI PRAC, V5, P75, DOI 10.9745/GHSP-D-16-00304; Noor FR, 2012, INT Q COMMUNITY HEAL, V32, P101, DOI 10.2190/IQ.32.2.b; Nyarko SH, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/2920491; Polis CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173639; Powell J, 2016, STUD COMP INT DEV, V51, P482, DOI 10.1007/s12116-015-9210-6; Rottenstreich M, 2018, ISR J HEALTH POLICY, V7, DOI 10.1186/s13584-018-0239-7; Rowe H, 2016, AUST NZ J PUBL HEAL, V40, P104, DOI 10.1111/1753-6405.12461; Roy TK, 2003, INT FAM PLAN PERSPEC, V29, P25, DOI 10.2307/3180998; Shah PS, 2011, MATERN CHILD HLTH J, V15, P205, DOI 10.1007/s10995-009-0546-2; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Sutton A, 2017, POP ASS AM C; Tsegaye AT, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0649-6; Wellings K, 2013, LANCET, V382, P1807, DOI 10.1016/S0140-6736(13)62071-1; Wong LP, 2014, BMC PUBLIC HEALTH, V14, P1; Yaya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209801; Zahr C. A., 2004, MATERNAL MORTALITY 2	61	62	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220970	10.1371/journal.pone.0220970	http://dx.doi.org/10.1371/journal.pone.0220970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398240	gold, Green Submitted, Green Published			2022-12-27	WOS:000485004000032
J	Corder, RM; Paula, GA; Pincelli, A; Ferreira, MU				Corder, Rodrigo M.; Paula, Gilberto A.; Pincelli, Anaclara; Ferreira, Marcelo U.			Statistical modeling of surveillance data to identify correlates of urban malaria risk: A population-based study in the Amazon Basin	PLOS ONE			English	Article							CENTRAL-AFRICA; TRANSMISSION; URBANIZATION; EPIDEMIOLOGY; BRAZZAVILLE; PREVALENCE; DIVERSITY; CHILDREN; EXAMPLE; REGION	Despite the recent malaria burden reduction in the Americas, focal transmission persists across the Amazon Basin. Timely analysis of surveillance data is crucial to characterize high-risk individuals and households for better targeting of regional elimination efforts. Here we analyzed 5,480 records of laboratory-confirmed clinical malaria episodes combined with demographic and socioeconomic information to identify risk factors for elevated malaria incidence in Mancio Lima, the main urban transmission hotspot of Brazil. Overdispersed malaria count data clustered into households were fitted with random-effects zero-inflated negative binomial regression models. Random-effect predictors were used to characterize the spatial heterogeneity in malaria risk at the household level. Adult males were identified as the population stratum at greatest risk, likely due to increased occupational exposure away of the town. However, poor housing and residence in the less urbanized periphery of the town were also found to be key predictors of malaria risk, consistent with a substantial local transmission. Two thirds of the 8,878 urban residents remained uninfected after 23,975 person-years of follow-up. Importantly, we estimated that nearly 14% of them, mostly children and older adults living in the central urban hub, were free of malaria risk, being either unexposed, naturally unsusceptible, or immune to infection. We conclude that statistical modeling of routinely collected, but often neglected, malaria surveillance data can be explored to characterize drivers of transmission heterogeneity at the community level and provide evidence for the rational deployment of control interventions.	[Corder, Rodrigo M.; Pincelli, Anaclara; Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil; [Paula, Gilberto A.] Univ Sao Paulo, Inst Math & Stat, Dept Stat, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Corder, RM; Ferreira, MU (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.	rodrigo.corder@usp.br; muferrei@usp.br	Corder, Rodrigo M./K-6132-2017; Paula, Gilberto/D-2924-2012; Ferreira, Marcelo U/G-8289-2011	Corder, Rodrigo M./0000-0002-8929-2200; Paula, Gilberto/0000-0002-9906-9942; Ferreira, Marcelo U/0000-0002-5293-9090; Pincelli Cintra, Anaclara/0000-0002-2071-1139	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil [2016/18740-9]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States of America [U19 AI089681]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP [2018/18557-5]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089681] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, United States of America; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br/en/), Brazil (grant 2016/18740-9), and by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, (https://www.niaid.nih.gov/), United States of America (grant U19 AI089681). RMC receives a doctoral fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://cnpq.br/), which also provides senior research scholarships to GAP and MUF. FAPESP (2018/18557-5) provides a doctoral fellowship to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-173; Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109; Bejon P, 2014, ELIFE, V3, DOI 10.7554/eLife.02130; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Cairns ME, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-355; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; dos Reis IC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0947-1; dos Reis IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137521; Ferreira MU, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1335-1; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Saraiva MDG, 2009, REV SOC BRAS MED TRO, V42, P515, DOI 10.1590/S0037-86822009000500008; GOMEZ KM, 2017, PLOS NEGLECT TROP D, V11, pNIL_1337, DOI DOI 10.1371/journal.pntd.0005780; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hiwat H, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-177; Kang Su Yun, 2018, Gates Open Res, V2, P32, DOI 10.12688/gatesopenres.12838.2; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Killeen GF, 2019, LANCET PLANET HEALTH, V3, pE132, DOI 10.1016/S2542-5196(19)30035-X; Lana RM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2045-z; Maheu-Giroux M, 2010, ACTA TROP, V115, P112, DOI 10.1016/j.actatropica.2010.02.011; Martins LMO, 2018, J VECTOR ECOL, V43, P235, DOI 10.1111/jvec.12307; Mathanga DP, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1623-9; Ministry of Health of Brazil, 2015, MAL EP STAT BRAZ 201; Ministry of Health of Brazil, 2010, PRACT GUID MAL THER; Ministry of Health of Brazil, 2017, LIST MUN BEL RISK MA; Ministry of Health of Brazil, MAL CAS MON BRAZ 201; Mwangi TW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002196; Ndungu FM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0422-4; Osorio L, 2007, TROP MED INT HEALTH, V12, P331, DOI 10.1111/j.1365-3156.2006.01791.x; Padilla JC, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0956-0; Pan JX, 2014, STAT COMPUT, V24, P725, DOI 10.1007/s11222-013-9398-0; Qi QY, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-403; Reis IC, 2018, NEOTROP ENTOMOL, V47, P412, DOI 10.1007/s13744-018-0595-6; Rek JC, 2018, LANCET PLANET HEALTH, V2, pE83, DOI 10.1016/S2542-5196(18)30010-X; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Rosas-Aguirre A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0670-y; Stasinopoulos MD., 2020, FLEXIBLE REGRESSION, V1st ed, P571, DOI [DOI 10.1201/B21973, 10.1201/b21973]; Tada MS, 2007, MEM I OSWALDO CRUZ, V102, P263, DOI 10.1590/S0074-02762007005000012; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P10, DOI 10.1016/0035-9203(87)90472-X; TRAPE JF, 1987, T ROY SOC TROP MED H, V81, P26, DOI 10.1016/0035-9203(87)90474-3; Tusting LS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002234; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; Wilson ML, 2015, AM J TROP MED HYG, V93, P110, DOI 10.4269/ajtmh.14-0834; World Health Organization, 2018, WORLD MAL REP 2018; Yau KKW, 2003, BIOMETRICAL J, V45, P437, DOI 10.1002/bimj.200390024	48	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220980	10.1371/journal.pone.0220980	http://dx.doi.org/10.1371/journal.pone.0220980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398228	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000035
J	Chiku, C; Zolfo, M; Senkoro, M; Mabhala, M; Tweya, H; Musasa, P; Shukusho, FD; Mazarura, E; Mushavi, A; Mangwanya, D				Chiku, Charles; Zolfo, Maria; Senkoro, Mbazi; Mabhala, Mzwandile; Tweya, Hannock; Musasa, Patience; Shukusho, Fungai D.; Mazarura, Exervia; Mushavi, Angela; Mangwanya, Douglas			Common causes of EID sample rejection in Zimbabwe and how to mitigate them	PLOS ONE			English	Article							HIV	Early infant diagnosis (EID) of HIV provides an opportunity for early HIV detection and access to appropriate Antiretroviral treatment (ART). Dried Blood Spot (DBS) samples are used for EID of exposed infants, born to HIV-positive mothers. However, DBS rejection rates in Zimbabwe have been exceeding the target of less than 2% per month set by the National Microbiology Reference Laboratory (NMRL), in Harare. The aim of this study was to determine the DBS sample rejection rate, the reasons for rejection and the possible associations between rejection and level of health facility where the samples were collected. This is an analytical cross-sectional study using routine DBS sample data from the NMRL in Harare, Zimbabwe, between January and December 2017. A total of 34 950 DBS samples were received at the NMRL. Of these, 1291(4%) were rejected. Reasons for rejection were insufficient specimen volume (72%), missing request form (11%), missing sample (6%), cross-contamination (6%), mismatch of information (4%) and clotted sample (1%). Samples collected from clinics/rural health facilities were five times more likely to be rejected compared to those from a central hospital. Rejection rates were above the set target of <2%. The reasons for rejection were 'pre-analytical' errors including labelling errors, missing or inconsistent data, and insufficient blood collected. Samples collected at primary healthcare facilities had higher rejection rates.	[Chiku, Charles; Musasa, Patience; Shukusho, Fungai D.; Mazarura, Exervia] Natl Microbiol Reference Lab, Harare, Zimbabwe; [Zolfo, Maria] Inst Trop Med, Antwerp, Belgium; [Senkoro, Mbazi] Natl Inst Med Res, Muhimbili, Tanzania; [Mabhala, Mzwandile] Univ Chester, Chester, Cheshire, England; [Tweya, Hannock] Lighthouse Trust, Lilongwe, Malawi; [Mushavi, Angela] Prevent Mother Child Transmiss HIV, Harare, Zimbabwe; [Mangwanya, Douglas] Directorate Lab Serv, Harare, Zimbabwe	Institute of Tropical Medicine (ITM); University of Chester	Chiku, C (corresponding author), Natl Microbiol Reference Lab, Harare, Zimbabwe.	charleschiku@gmail.com	; zolfo, maria/B-9787-2015	Chiku, Charles/0000-0003-3455-598X; zolfo, maria/0000-0001-9756-9380	United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch	United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch	The programme was funded by: the United Kingdom's Department for International Development (DFID); La Fondation Veuve Emile Metz-Tesch supported open access publications costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Programme for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The training model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres (MSF). The specific SORT IT programme which resulted in this publication was implemented by: Medecins Sans Frontieres, Brussels Operational Centre, Luxembourg and the Centre for Operational Research, The Union, Paris, France. Mentorship and coordination/facilitation of the SORT IT workshops were provided through the Centre for Operational Research, The Union, Paris, France; the Operational Research Unit (LuxOR); AMPATH, Eldoret, Kenya; The Institute of Tropical Medicine, Antwerp, Belgium; The Centre for International Health, University of Bergen, Norway; University of Washington, USA; The Luxembourg Institute of Health, Luxembourg; The Institute of Medicine, University of Chester, UK; The National Institute for Medical Research, Muhimbili Medical Research Centre, Dar es Salaam, Tanzania.	Agarwal R, 2012, INDIAN J CLIN BIOCHE, V27, P61, DOI 10.1007/s12291-011-0182-7; [Anonymous], 2018, GLOB TUB REP; Gill MM, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/2572594; Govender K, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.349; Inalegwu Auchi, 2016, World J Virol, V5, P73, DOI 10.5501/wjv.v5.i2.73; Lippi G, 2011, CLIN CHEM LAB MED, V49, P1113, DOI 10.1515/CCLM.2011.600; Mazanderani AH, 2017, PLOS ONE, V585, P2010; Mugauri H, 2018, AIDS RES TREAT, V2018, DOI 10.1155/2018/4234256; Nkengasong JN, 2010, AM J CLIN PATHOL, V134, P368, DOI 10.1309/AJCPMPSINQ9BRMU6; Smit PW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086461; Thomson KA, 2011, T ROY SOC TROP MED H, V105, P320, DOI 10.1016/j.trstmh.2011.02.011; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Warstrom, 2014, MENTIMETER; World Health Organization, 2017, INT NEGL TROP DIS GL, V4, P1	14	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0210136	10.1371/journal.pone.0210136	http://dx.doi.org/10.1371/journal.pone.0210136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393883	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500002
J	Iverson, AR; Fujisaki, I; Lamont, MM; Hart, KM				Iverson, Autumn R.; Fujisaki, Ikuko; Lamont, Margaret M.; Hart, Kristen M.			Loggerhead sea turtle (Caretta caretta) diving changes with productivity, behavioral mode, and sea surface temperature	PLOS ONE			English	Article							TUNA THUNNUS-THYNNUS; LEPIDOCHELYS-OLIVACEA; SUBMERGENCE PATTERNS; MEDITERRANEAN SEA; FORAGING BEHAVIOR; BUOYANCY CONTROL; CHELONIA-MYDAS; DIVE BEHAVIOR; MOVEMENTS; ECOLOGY	The relationship between dive behavior and oceanographic conditions is not well understood for marine predators, especially sea turtles. We tagged loggerhead turtles (Caretta caretta) with satellite-linked depth loggers in the Gulf of Mexico, where there is a minimal amount of dive data for this species. We tested for associations between four measurements of dive behavior (total daily dive frequency, frequency of dives to the bottom, frequency of long dives and time-at-depth) and both oceanographic conditions (sea surface temperature [SST], net primary productivity [NPP]) and behavioral mode (inter-nesting, migration, or foraging). From 2011-2013 we obtained 26 tracks from 25 adult female loggerheads tagged after nesting in the Gulf of Mexico. All turtles remained in the Gulf of Mexico and spent about 10% of their time at the surface (10% during inter-nesting, 14% during migration, 9% during foraging). Mean total dive frequency was 41.9 times per day. Most dives were <= 25 m and between 30-40 min. During inter-nesting and foraging, turtles dived to the bottom 95% of days. SST was an important explanatory variable for all dive patterns; higher SST was associated with more dives per day, more long dives and more dives to the seafloor. Increases in NPP were associated with more long dives and more dives to the bottom, while lower NPP resulted in an increased frequency of overall diving. Longer dives occurred more frequently during migration and a higher proportion of dives reached the seafloor during foraging when SST and NPP were higher. Our study stresses the importance of the interplay between SST and foraging resources for influencing dive behavior.	[Iverson, Autumn R.] US Geol Survey, Cherokee Nat Technol, Contracted Wetland & Aquat Res Ctr, Davie, FL 33314 USA; [Fujisaki, Ikuko] Univ Florida, Ft Lauderdale Res & Educ Ctr, Davie, FL USA; [Lamont, Margaret M.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA; [Hart, Kristen M.] US Geol Survey, Wetland & Aquat Res Ctr, Davie, FL USA	United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Iverson, AR (corresponding author), US Geol Survey, Cherokee Nat Technol, Contracted Wetland & Aquat Res Ctr, Davie, FL 33314 USA.	ariverson@contractor.usgs.gov		Iverson, Autumn/0000-0002-8353-6745	Natural Resource Damage Assessment (NRDA); U.S. Geological Survey Priority Ecosystem Science Program (PES)	Natural Resource Damage Assessment (NRDA); U.S. Geological Survey Priority Ecosystem Science Program (PES)	This work was supported by the Natural Resource Damage Assessment (NRDA) to KMH; and the U.S. Geological Survey Priority Ecosystem Science Program (PES) to KMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, NMFSSEFSC57992 NOAA; Bauer RK, 2017, DEEP-SEA RES PT II, V141, P248, DOI 10.1016/j.dsr2.2017.04.006; Bjorndal K.A., 1997, BIOL SEA TURTLES, V1, P199; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Blumenthal J.M., 2006, ENDANGER SPECIES RES, V2, P51, DOI [DOI 10.3354/ESR00044, 10.3354/esr002051]; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Casale P, 2008, MAR ECOL PROG SER, V372, P265, DOI 10.3354/meps07702; Chambault P, 2016, PROG OCEANOGR, V142, P58, DOI 10.1016/j.pocean.2016.01.006; Coyne MS, 2005, MAR ECOL PROG SER, V301, P1, DOI 10.3354/meps301001; Dalleau M, 2014, MAR BIOL, V161, P1835, DOI 10.1007/s00227-014-2465-z; DODGE KL, 2014, ATLANTIC OCEAN, V9, DOI DOI 10.1371/JOURNAL.PONE.0091726; Enstipp MR, 2016, FUNCT ECOL, V30, P1810, DOI 10.1111/1365-2435.12667; FELGER RS, 1976, SCIENCE, V191, P283, DOI 10.1126/science.191.4224.283; Foley AM, 2014, MAR BIOL, V161, P1251, DOI 10.1007/s00227-014-2415-9; Foley AM, 2013, ENDANGER SPECIES RES, V21, P129, DOI 10.3354/esr00512; Fuentes MMPB, 2015, J EXP MAR BIOL ECOL, V471, P77, DOI 10.1016/j.jembe.2015.05.003; Godley BJ, 2003, J EXP MAR BIOL ECOL, V287, P119, DOI 10.1016/S0022-0981(02)00547-6; Hardy RF, 2014, CAN J FISH AQUAT SCI, V71, P1924, DOI 10.1139/cjfas-2014-0128; Hart KM, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00336; Hart KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103453; Hart KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066921; Hatase H, 2007, J ZOOL, V273, P46, DOI 10.1111/j.1469-7998.2007.00298.x; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hays GC, 2004, ECOLOGY, V85, P1137, DOI 10.1890/03-0251; Hochscheid S, 2004, PHYSIOL BIOCHEM ZOOL, V77, P209, DOI 10.1086/381472; Hochscheid S, 2010, J EXP BIOL, V213, P1328, DOI 10.1242/jeb.037184; Hochscheid S, 2007, MAR ECOL PROG SER, V340, P287, DOI 10.3354/meps340287; Hochscheid S, 2014, J EXP MAR BIOL ECOL, V450, P118, DOI 10.1016/j.jembe.2013.10.016; Houghton JDR, 2000, J MAR BIOL ASSOC UK, V80, P761, DOI 10.1017/S002531540000271X; Houghton JDR, 2002, MAR ECOL PROG SER, V227, P63, DOI 10.3354/meps227063; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Lamont MM, 2018, ECOLOGY, V99, P2621, DOI 10.1002/ecy.2439; Lamont MM, 2015, HERPETOL CONSERV BIO, V10, P26; Lutcavage M.E., 1997, BIOL SEA TURTLES, VI; Manickchand-Heileman S, 1998, ESTUAR COAST SHELF S, V46, P885, DOI 10.1006/ecss.1997.0324; McIntyre T, 2011, MAR ECOL PROG SER, V441, P257, DOI 10.3354/meps09383; MENDONCA MT, 1983, COPEIA, P1013, DOI 10.2307/1445104; Minamikawa S, 2000, J EXP BIOL, V203, P2967; Minamikawa S, 1997, J ETHOL, V15, P109, DOI 10.1007/BF02769396; Narazaki T, 2015, MAR BIOL, V162, P1251, DOI 10.1007/s00227-015-2666-0; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; NMFS & USFWS, 2008, REC PLAN NORTHW ATL; Okuyama J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0040; Patel SH, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00254; Patel SH, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00358.1; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; R Core Team, 2018, R LANG ENV STAT COMP; RENAUD ML, 1994, B MAR SCI, V55, P1; Richards Paul M., 2011, Endangered Species Research, V15, P151, DOI 10.3354/esr00379; Roxy MK, 2016, GEOPHYS RES LETT, V43, P826, DOI 10.1002/2015GL066979; Southwood AL, 2006, CAN J ZOOL, V84, P125, DOI 10.1139/Z05-185; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Thomson JA, 2013, BIOL CONSERV, V165, P154, DOI 10.1016/j.biocon.2013.06.005; Tucker Anton D., 2009, Marine Turtle Newsletter, P16; Turtle Expert Working Group, 2009, ASS LOGG TURTL POP W; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Wilson M, 2017, J EXP BIOL, V220, P3432, DOI 10.1242/jeb.162644	59	6	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220372	10.1371/journal.pone.0220372	http://dx.doi.org/10.1371/journal.pone.0220372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390354	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400018
J	Rocha, LS; Silva, DM; Silva, MP; Vidigal, PMP; Silva, JCF; Guerra, ST; Ribeiro, MG; Mendes, TAD; Ribon, AD				Rocha, Lis S.; Silva, Danielle M.; Silva, Monica P.; Vidigal, Pedro Marcus P.; Silva, Jose Cleydson F.; Guerra, Simony T.; Ribeiro, Marcio G.; Mendes, Tiago Antonio de O.; Ribon, Andrea de B.			Comparative genomics of Staphylococcus aureus associated with subclinical and clinical bovine mastitis	PLOS ONE			English	Article							INTRAMAMMARY INFECTIONS; VIRULENCE FACTORS; SIGNAL PEPTIDES; RISK-FACTORS; DAIRY FARMS; PREDICTION; SEQUENCE; IDENTIFICATION; ANNOTATION; ALIGNMENT	Many efforts have been made to understand the pathogenesis of bovine mastitis to reduce losses and promote animal welfare. Staphylococcus aureus may cause bovine clinical mastitis, but it is mainly associated with subclinical infection, which is usually persistent and can easily reoccur. Here, we conducted a comparative genomic analysis between strains of S. aureus causing subclinical infection (Sau170, 302, 1269, 1364), previously sequenced by our group, and two well-characterized strains causing clinical mastitis (N305 and RF122) to find differences that could be linked to mastitis outcome. A total of 146 virulence-associated genes were compared and no appreciable differences were found between the bacteria. However, several nonsynonymous single nucleotide polymorphisms (SNPs) were identified in genes present in the subclinical strains when compared to RF122 and N305, especially in genes encoding host immune evasion and surface proteins. The secreted and surface proteins predicted by in silico tools were compared through multidimensional scaling analysis (MDS), revealing a high degree of similarity among the strains. The comparison of orthologous genes by OrthoMCL identified a membrane transporter and a lipoprotein as exclusive of bacteria belonging to the subclinical and clinical groups, respectively. No hit was found in RF122 and N305 for the membrane transporter using BLAST algorithm. For the lipoprotein, sequences of Sau170, 302, 1269, and 1364 with identities between 68-73% were found in the MDS dataset. A conserved region found only in the lipoprotein genes of RF122 and N305 was used for primer design. Although the polymerase chain reaction (PCR) on field isolates of S. aureus did not validate the findings for the transporter, the lipoprotein was able to separate the clinical from the subclinical isolates. These results show that sequence variation among bovine S. aureus, and not only the presence/absence of virulence factors, is an important aspect to consider when comparing isolates causing different mastitis outcomes.	[Rocha, Lis S.; Silva, Danielle M.; Silva, Monica P.; Mendes, Tiago Antonio de O.; Ribon, Andrea de B.] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Vidigal, Pedro Marcus P.] Univ Fed Vicosa, Nucleo Anal Biomol, Vicosa, MG, Brazil; [Silva, Jose Cleydson F.] Univ Fed Vicosa, Inst Nacl Ciencia & Tecnol Interacoes Planta Prag, Vicosa, MG, Brazil; [Guerra, Simony T.; Ribeiro, Marcio G.] UNESP Botucatu, Fac Med Vet & Zootecnia, Dept Higiene Vet & Saude Publ, Botucatu, SP, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Estadual Paulista	Ribon, AD (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil.	abribon@ufv.br	Silva, Cleydson/AAR-8163-2020; Ribon, Andrea O. B./C-8318-2017; Vidigal, Pedro Marcus/G-3100-2011; Garcia Ribeiro, Márcio/GLV-6457-2022; Mendes, Tiago/AAG-1709-2021	Ribon, Andrea O. B./0000-0001-8485-3075; Vidigal, Pedro Marcus/0000-0002-5116-9856; Garcia Ribeiro, Márcio/0000-0003-2682-9389; Mendes, Tiago/0000-0002-5569-4893; Silva, Jose Cleydson F/0000-0001-5435-702X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ 00-582-16]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research received funding from the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (https://fapemig.br/pt/) (APQ 00-582-16) awarded to A.O.B.R, and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (https://www.capes.gov.br/) Scholarship awarded to LSR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00074-17; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amare A., 2016, FOOD SCI QUAL MANAG, V52, P56; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Capra E, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0931-8; Collery MM, 2009, J MED MICROBIOL, V58, P13, DOI 10.1099/jmm.0.005215-0; Constable P.D., 2016, DIS MAMMARY GLAND VE, P1994; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabres-Klein MH, 2014, EUR J CLIN MICROBIOL, V33, P2095, DOI 10.1007/s10096-014-2181-0; Haveri M, 2007, J APPL MICROBIOL, V103, P993, DOI 10.1111/j.1365-2672.2007.03356.x; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Hisatsune J, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomea.00852-17, 10.1128/genomeA.00852-17]; Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langley RJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006549; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Loffler B, 2014, INT J MED MICROBIOL, V304, P170, DOI 10.1016/j.ijmm.2013.11.011; Maddamsetti R, 2015, MOL BIOL EVOL, V32, P2897, DOI 10.1093/molbev/msv161; Marklevitz J, 2016, BIOINFORMATION, V12, P254, DOI 10.6026/97320630012254; McCarthy AJ, 2013, INFECT GENET EVOL, V19, P7, DOI 10.1016/j.meegid.2013.06.012; Mdegela RH, 2009, J S AFR VET ASSOC, V80, P163; Nguyen MT, 2016, MICROBIOL MOL BIOL R, V80, P891, DOI 10.1128/MMBR.00028-16; Nguyen MT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004984; Muller P, 2010, INFECT IMMUN, V78, P4243, DOI 10.1128/IAI.00538-10; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Nibret Moges, 2012, Global Veterinaria, V9, P441; Ono HK, 2008, INFECT IMMUN, V76, P4999, DOI 10.1128/IAI.00045-08; Ortega E, 2010, TOXINS, V2, P2117, DOI 10.3390/toxins2082117; Ote I, 2011, VET MICROBIOL, V153, P285, DOI 10.1016/j.vetmic.2011.05.042; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parkhill J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-230; Pele J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-133; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Peton V, 2014, VET RES, V45, DOI 10.1186/s13567-014-0106-7; Piccinini R, 2012, J DAIRY RES, V79, P249, DOI 10.1017/S002202991200009X; Pinzon-Sanchez C, 2011, J DAIRY SCI, V94, P3397, DOI 10.3168/jds.2010-3925; Rabello RF, 2007, J MED MICROBIOL, V56, P1505, DOI 10.1099/jmm.0.47357-0; Rainard P, 2018, TRANSBOUND EMERG DIS, V65, P149, DOI 10.1111/tbed.12698; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Sasaki T, 2010, J CLIN MICROBIOL, V48, P765, DOI 10.1128/JCM.01232-09; Schmidt T, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00511; Schukken YH, 2011, VET IMMUNOL IMMUNOP, V144, P270, DOI 10.1016/j.vetimm.2011.08.022; Siddiquee N. U., 2013, Bangladesh Journal of Veterinary Medicine, V11, P37; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva DM, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01594-15; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith EM, 2005, J CLIN MICROBIOL, V43, P4737, DOI 10.1128/JCM.43.9.4737-4743.2005; Sogawa K, 2017, BIOCONTROL SCI, V22, P163, DOI 10.4265/bio.22.163; Stach CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154762; Stutz K, 2011, J CLIN MICROBIOL, V49, P638, DOI 10.1128/JCM.01148-10; SUTRA L, 1994, J MED MICROBIOL, V40, P79, DOI 10.1099/00222615-40-2-79; Swofford David L., 1996, P407; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Veh KA, 2015, J DAIRY SCI, V98, P155, DOI 10.3168/jds.2014-8044; Vrieling M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37759; Whelehan CJ, 2011, VET IMMUNOL IMMUNOP, V140, P181, DOI 10.1016/j.vetimm.2010.11.013; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zecconi A, 2006, MICROB PATHOGENESIS, V40, P177, DOI 10.1016/j.micpath.2006.01.001	62	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220804	10.1371/journal.pone.0220804	http://dx.doi.org/10.1371/journal.pone.0220804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390381	Green Submitted, Green Published, gold			2022-12-27	WOS:000484999400029
J	Skugor, A; Kjos, NP; Sundaram, AYM; Mydland, LT; Anestad, R; Tauson, AH; Overland, M				Skugor, Adrijana; Kjos, Nils Petter; Sundaram, Arvind Y. M.; Mydland, Liv Torunn; Anestad, Ragnhild; Tauson, Anne-Helene; Overland, Margareth			Effects of long-term feeding of rapeseed meal on skeletal muscle transcriptome, production efficiency and meat quality traits in Norwegian Landrace growing-finishing pigs	PLOS ONE			English	Article							SYMPOSIUM EXTRACELLULAR-MATRIX; PYRUVATE-DEHYDROGENASE KINASE; GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; DIVERGENT SELECTION; GROWTH-PERFORMANCE; ENERGY-METABOLISM; IN-VIVO; PROTEIN; FIBER	This study was performed to investigate the effects of dietary inclusion of 20% rapeseed meal (RSM) as an alternative to soybean meal (SBM) in a three-month feeding experiment with growing finishing pigs. Dietary alteration affected growth performance, several carcass traits and transcriptional responses in the skeletal muscle, but did not affect measured meat quality traits. In general, pigs fed the RSM test diet exhibited reduced growth performance compared to pigs on SBM control diet. Significant transcriptional changes in the skeletal muscle of growing pigs fed RSM diet were likely the consequence of an increased amount of fiber and higher polyunsaturated fatty acids, and presence of bioactive phytochemicals, such as glucosinolates. RNAseq pipeline using Tophat2-Cuffdiff identified 57 upregulated and 63 downregulated genes in RSM compared to SBM pigs. Significantly enriched among downregulated pathways was p53-mediated signalling involved in cellular proliferation, while activation of negative growth regulators (IER5, KLF10, BTG2, KLF11, RETREG1, PRUNE2) in RSM fed pigs provided further evidence for reduced proliferation and increased cellular death, in accordance with the observed reduction in performance traits. Upregulation of well-known metabolic controllers (PDK4, UCP3, ESRRG and ESRRB), involved in energy homeostasis (glucose and lipid metabolism, and mitochondrial function), suggested less available energy and nutrients in RSM pigs. Furthermore, several genes supported more pronounced proteolysis (ABTB1, OTUD1, PADI2, SPP1) and reduced protein synthesis (THBS1, HSF4, AP1S2) in RSM muscle tissue. In parallel, higher levels of NR4A3, PDK4 and FGF21, and a drop in adropin, ELOVL6 and CIDEC/FSP27 indicated increased lipolysis and fatty acid oxidation, reflective of lower dressing percentage. Finally, pigs exposed to RSM showed greater expression level of genes responsive to oxidative stress, indicated by upregulation of GPX1, GPX2, and TXNIP.	[Skugor, Adrijana; Kjos, Nils Petter; Mydland, Liv Torunn; Anestad, Ragnhild; Tauson, Anne-Helene; Overland, Margareth] Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, As, Norway; [Sundaram, Arvind Y. M.] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Tauson, Anne-Helene] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark	Norwegian University of Life Sciences; University of Oslo; University of Copenhagen	Skugor, A (corresponding author), Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, As, Norway.	adrijana.skugor@nmbu.no	Mydland, Liv Torunn/AAO-2783-2020	Sundaram, Arvind/0000-0002-3007-7784	FeedMileage-Efficient use of Feed Resources for a Sustainable Norwegian Food Production (Research Council of Norway, Oslo, Norway) [233685/E50]; Foods of Norway, Centre for Research-based Innovation (Research Council of Norway) [237841/030]; SusPig ERA-Net (Research Council of Norway, Oslo, Norway) [272334/E50]; Research Council of Norway; Southeastern Regional Health Authorities	FeedMileage-Efficient use of Feed Resources for a Sustainable Norwegian Food Production (Research Council of Norway, Oslo, Norway); Foods of Norway, Centre for Research-based Innovation (Research Council of Norway); SusPig ERA-Net (Research Council of Norway, Oslo, Norway)(Research Council of Norway); Research Council of Norway(Research Council of Norway); Southeastern Regional Health Authorities	Funding for this research was provided by the FeedMileage-Efficient use of Feed Resources for a Sustainable Norwegian Food Production (Research Council of Norway, Oslo, Norway; grant no. 233685/E50), Foods of Norway, Centre for Research-based Innovation (Research Council of Norway; grant no. 237841/030), and SusPig ERA-Net (Research Council of Norway, Oslo, Norway; grant no. 272334/E50) projects.; The sequencing service was provided by the Norwegian Sequencing Centre (www.sequencing.uio.no), a national technology platform hosted by the Oslo University Hospital and the University of Oslo and supported by the "Functional Genomics" and "Infrastructure" programs of the Research Council of Norway and the Southeastern Regional Health Authorities.	Agyekum AK, 2017, ENGINEERING-PRC, V3, P716, DOI 10.1016/J.ENG.2017.03.010; Alhawiti NM, 2017, CURR DRUG TARGETS, V18, P1095, DOI 10.2174/1389450118666170130145514; Ali ZA, 2014, J CLIN INVEST, V124, P5159, DOI 10.1172/JCI77484; Ampatzidou E, 2006, MOL CELL BIOL, V26, P9387, DOI 10.1128/MCB.01335-06; Anderson S, 2007, J AOAC INT, V90, P1073; Anderssohn AM, 2011, INVEST OPHTH VIS SCI, V52, P7548, DOI 10.1167/iovs.11-7723; [Anonymous], [No title captured]; [Anonymous], 2016, ASIAN J ANIM VET ADV, DOI DOI 10.3923/AJAVA.2016.89.97; Association of Official Analytical Chemists AOAC, 1990, OFFICIAL METHODS ANA, P1102; Ayuso M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167858; Ayuso M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145162; Balasubramanian MN, 2013, AM J PHYSIOL-ENDOC M, V304, pE789, DOI 10.1152/ajpendo.00015.2013; Baudet C, 2008, J NEUROSCI, V28, P963, DOI 10.1523/JNEUROSCI.4489-07.2008; Behlke-Steinert S, 2009, CELL CYCLE, V8, P2211, DOI 10.4161/cc.8.14.8979; Brigelius-Flohe R, 2006, BIOL CHEM, V387, P1329, DOI 10.1515/BC.2006.166; Bushnell B., BBTOOLS SOFTWARE PAC; Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; Chibalin AV, 2000, P NATL ACAD SCI USA, V97, P38, DOI 10.1073/pnas.97.1.38; Choi DW, 2008, J BIOL CHEM, V283, P4682, DOI 10.1074/jbc.M708873200; Christensen LB, 2003, MEAT SCI, V63, P469, DOI 10.1016/S0309-1740(02)00106-7; Coletta DK, 2008, AM J PHYSIOL-ENDOC M, V294, pE910, DOI 10.1152/ajpendo.00607.2007; Conte C, 2009, NUCLEIC ACIDS RES, V37, P5267, DOI 10.1093/nar/gkp550; Corominas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053687; Costford SR, 2007, APPL PHYSIOL NUTR ME, V32, P884, DOI 10.1139/H07-063; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; de Nanclares MP, 2017, LIVEST SCI, V203, P1, DOI 10.1016/j.livsci.2017.06.008; Deckx S, 2016, FASEB J, V30, P2651, DOI 10.1096/fj.201500096R; Dekkers JC, 2010, 9 WORLD C GEN APPL L; Ding KK, 2009, RADIAT ENVIRON BIOPH, V48, P205, DOI 10.1007/s00411-009-0213-4; Do DN, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00307; Du M, 2012, J ANIM SCI, V90, P922, DOI 10.2527/jas.2011-4937; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; EFSA, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.590; Eriksson IS, 2005, INT J LIFE CYCLE ASS, V10, P143, DOI 10.1065/lca2004.06.160; Fan WW, 2018, CELL REP, V22, P2521, DOI 10.1016/j.celrep.2018.02.047; Fan WW, 2013, J MOL ENDOCRINOL, V51, pT87, DOI 10.1530/JME-13-0258; Faure J, 2013, MEAT SCI, V93, P37, DOI 10.1016/j.meatsci.2012.07.006; Feng Z, 2007, GENE, V403, P170, DOI 10.1016/j.gene.2007.08.009; Cardoso TF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3986-x; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gameiro PA, 2018, CELL REP, V24, P1415, DOI 10.1016/j.celrep.2018.07.021; Gao S, 2015, MOL METAB, V4, P310, DOI 10.1016/j.molmet.2015.01.005; Greenberg CC, 2006, AM J PHYSIOL-ENDOC M, V291, pE1, DOI 10.1152/ajpendo.00652.2005; Grumati P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217364; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; Hai T, 1999, GENE EXPRESSION, V7, P321; HALLIWELL B, 1995, CRIT REV FOOD SCI, V35, P7, DOI 10.1080/10408399509527682; Hamidi T, 2012, CLIN CANCER RES, V18, P5234, DOI 10.1158/1078-0432.CCR-12-0026; Hamill RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-453; Hand LE, 2013, ENDOCRINOLOGY, V154, P2081, DOI 10.1210/en.2012-2051; Inanc B, 2013, MOL BIOL CELL, V24, P2645, DOI 10.1091/mbc.E13-03-0149; International Organization for Standardization, 1998, 98311998 ISO; Jan AT, 2016, INT J BIOCHEM CELL B, V80, P66, DOI 10.1016/j.biocel.2016.09.023; Ji KQ, 2015, FREE RADICAL BIO MED, V84, P161, DOI 10.1016/j.freeradbiomed.2015.03.020; Jing L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11953; Jorgensen H, 1996, BRIT J NUTR, V75, P365, DOI 10.1079/BJN19960140; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaur N, 2014, J FOOD SCI TECH MYS, V51, P2289, DOI 10.1007/s13197-012-0677-0; Kawasaki E, 2011, J PHYSIOL SCI, V61, P1, DOI 10.1007/s12576-010-0114-y; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knight RD, 2011, DEVELOPMENT, V138, P2015, DOI 10.1242/dev.061002; KNUDSEN KEB, 1991, BRIT J NUTR, V65, P217, DOI 10.1079/BJN19910082; Knudsen KEB, 2014, POULTRY SCI, V93, P2380, DOI 10.3382/ps.2014-03902; Kojima M, 2018, PLOS ONE, V13; Kolstad K, 1996, LIVEST PROD SCI, V47, P23, DOI 10.1016/S0301-6226(96)01007-X; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Landero JL, 2011, ANIM FEED SCI TECH, V170, P136, DOI 10.1016/j.anifeedsci.2011.08.003; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsson VJ, 2018, J CELL SCI, V131, DOI 10.1242/jcs.211664; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; Liaw L, 1998, J CLIN INVEST, V101, P1468; Lindberg JE, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-15; Liu JS, 2009, J AGR FOOD CHEM, V57, P3808, DOI 10.1021/jf8033144; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; MAWSON R, 1994, NAHRUNG, V38, P167, DOI 10.1002/food.19940380209; McCullough MJ, 2011, NEUROSCIENCE, V174, P234, DOI 10.1016/j.neuroscience.2010.11.016; Medina VA, 2010, BRIT J PHARMACOL, V161, P755, DOI 10.1111/j.1476-5381.2010.00961.x; Mejicanos G., 2016, Journal of Animal Science and Technology, V58, P7, DOI 10.1186/s40781-016-0085-5; Messerschmidt U, 2014, ANIM FEED SCI TECH, V187, P68, DOI 10.1016/j.anifeedsci.2013.10.009; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Micheli L, 2011, J BIOL CHEM, V286, P5691, DOI 10.1074/jbc.M110.162842; Miyake M, 2011, J CELL PHYSIOL, V226, P1128, DOI 10.1002/jcp.22434; Montagne L, 2014, J ANIM SCI, V92, P1512, DOI 10.2527/jas.2013-6623; Moyle LA, 2016, ELIFE, V5, DOI 10.7554/eLife.11405; Napierala JS, 2017, DIS MODEL MECH, V10, P1353, DOI 10.1242/dmm.030536; Narasimhan A, 2018, J CACHEXIA SARCOPENI, V9, P60, DOI 10.1002/jcsm.12235; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Noblet J, 2001, ANIM FEED SCI TECH, V90, P35, DOI 10.1016/S0377-8401(01)00195-X; Noblet J, 2013, ANIMAL, V7, P1259, DOI 10.1017/S1751731113000463; Nyachoti CM, 2000, LIVEST PROD SCI, V65, P229, DOI 10.1016/S0301-6226(00)00157-3; O'Farrell M, 2010, J NEAR INFRARED SPEC, V18, P135, DOI 10.1255/jnirs.876; Oczkowicz M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5265-x; Oczkowicz M, 2016, ANN ANIM SCI, V16, P1073, DOI 10.1515/aoas-2016-0033; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ogluszka M, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0552-8; Orzechowski A, 2002, REPROD NUTR DEV, V42, P461, DOI [10.1051/rnd:2002034, 10.1051/rnd:2002037]; Overland M, 2000, J ANIM SCI, V78, P1875; Pagel CN, 2014, J CELL COMMUN SIGNAL, V8, P95, DOI 10.1007/s12079-013-0217-3; Patience JF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0031-2; Pearen MA, 2013, MOL ENDOCRINOL, V27, P1897, DOI 10.1210/me.2013-1205; Perez de Nanclares M, 2018, ANIMAL INT J ANIMAL, P1; POTKINS ZV, 1991, BRIT J NUTR, V65, P391, DOI 10.1079/BJN19910100; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Qin S, 2017, ENGINEERING-PRC, V3, P738, DOI 10.1016/J.ENG.2017.03.011; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Ren HX, 2008, J CELL BIOL, V182, P979, DOI 10.1083/jcb.200712110; Ribeiro A, 1999, HEPATOLOGY, V30, P1490, DOI 10.1002/hep.510300620; Robertson NG, 2000, GENOMICS, V66, P242, DOI 10.1006/geno.2000.6224; Santini E, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan0665; SAS, 1990, US GUID; SAUVAGEAU M, 2013, CUMMERBUND ANAL EXPL, V2, DOI DOI 10.7554/ELIFE.01749; Sauvant D., 2004, Tables of composition and nutritional value of feed materials: pigs, poultry, cattle, sheep, goats, rabbits, horses and fish; Schedle K., 2016, Die Bodenkultur: Journal of Land Management, Food and Environment, V67, P45, DOI 10.1515/boku-2016-0005; Scheffler TL, 2016, J ANIM SCI, V94, P3601, DOI 10.2527/jas.2015-0055; SCHOENE F, 1990, Endocrinologia Experimentalis, V24, P415; Seno MMG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-345; Sfyri P, 2015, NEUROMUSCULAR DISORD, V25, pS185, DOI 10.1016/j.nmd.2015.06.009; Shukunami C, 2016, JPN DENT SCI REV, V52, P84, DOI 10.1016/j.jdsr.2016.04.003; Sidyakin AA, 2018, J MOL NEUROSCI, V65, P28, DOI 10.1007/s12031-018-1064-8; Silva Figueiredo P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101158; Singh R, 2014, J BIOL CHEM, V289, P19383, DOI 10.1074/jbc.M114.575159; Sirri R, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0297-2; Skugor Stanko, 2016, Parasit Vectors, V9, P639; Spittau B, 2012, CELL TISSUE RES, V347, P65, DOI 10.1007/s00441-011-1186-6; Stinckens A, 2008, ANIM GENET, V39, P586, DOI 10.1111/j.1365-2052.2008.01774.x; TAO X, 2017, PLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0184120; Tatsumi Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.568; Thorsteinsdottir S, 2011, DEV BIOL, V354, P191, DOI 10.1016/j.ydbio.2011.03.015; Tizioto PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep39493; Tosetti F, 2009, INT J CANCER, V125, P1997, DOI 10.1002/ijc.24677; Tripathi MK, 2007, ANIM FEED SCI TECH, V132, P1, DOI 10.1016/j.anifeedsci.2006.03.003; Triphathi M. K., 2017, J ADV DAIRY RES, V5, P180, DOI DOI 10.4172/2329-888X.1000180; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Turner DC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40787-0; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valgimigli L, 2009, ENVIRON MOL MUTAGEN, V50, P222, DOI 10.1002/em.20468; Velleman SG, 2012, J ANIM SCI, V90, P936, DOI 10.2527/jas.2011-4497; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Vig AP, 2009, LWT-FOOD SCI TECHNOL, V42, P1561, DOI 10.1016/j.lwt.2009.05.023; Vincent A, 2015, J ANIM SCI, V93, P2745, DOI 10.2527/jas.2015-8928; Vitali M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204869; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wan XB, 2016, SCI REP-UK, V6, DOI 10.1038/srep36589; Weightman R, 2014, HGCA RESEARCH REVIEW, V80, P58; Weiss N, 2015, GEN PHYSIOL BIOPHYS, V34, P101, DOI 10.4149/gpb_2015011; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Yang LX, 2004, NEUROSCIENCE, V128, P497, DOI 10.1016/j.neuroscience.2004.06.067; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhou C, 2015, FASEB J, V29, P4083, DOI 10.1096/fj.14-267500	161	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220441	10.1371/journal.pone.0220441	http://dx.doi.org/10.1371/journal.pone.0220441			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390356	gold, Green Published, Green Submitted			2022-12-27	WOS:000484999400019
J	Martinez, RH; Lansner, A; Herman, P				Martinez, Ramon H.; Lansner, Anders; Herman, Pawel			Probabilistic associative learning suffices for learning the temporal structure of multiple sequences	PLOS ONE			English	Article							VISUAL-CORTEX; SPARSE CODE; TIME; NETWORK; MEMORY; MODEL; DISAMBIGUATION; NEURONS; REPLAY; REPRESENTATION	From memorizing a musical tune to navigating a well known route, many of our underlying behaviors have a strong temporal component. While the mechanisms behind the sequential nature of the underlying brain activity are likely multifarious and multi-scale, in this work we attempt to characterize to what degree some of this properties can be explained as a consequence of simple associative learning. To this end, we employ a parsimonious firing-rate attractor network equipped with the Hebbian-like Bayesian Confidence Propagating Neural Network (BCPNN) learning rule relying on synaptic traces with asymmetric temporal characteristics. The proposed network model is able to encode and reproduce temporal aspects of the input, and offers internal control of the recall dynamics by gain modulation. We provide an analytical characterisation of the relationship between the structure of the weight matrix, the dynamical network parameters and the temporal aspects of sequence recall. We also present a computational study of the performance of the system under the effects of noise for an extensive region of the parameter space. Finally, we show how the inclusion of modularity in our network structure facilitates the learning and recall of multiple overlapping sequences even in a noisy regime.	[Martinez, Ramon H.; Lansner, Anders; Herman, Pawel] KTH Royal Inst Technol, Computat Brain Sci Lab, Stockholm, Sweden; [Lansner, Anders] Stockholm Univ, Math Dept, Stockholm, Sweden	Royal Institute of Technology; Stockholm University	Martinez, RH (corresponding author), KTH Royal Inst Technol, Computat Brain Sci Lab, Stockholm, Sweden.	rhmm@kth.se	; Lansner, Anders/E-4824-2016	Martinez Mayorquin, Ramon Heberto/0000-0002-5937-7537; Lansner, Anders/0000-0002-2358-7815; Herman, Pawel/0000-0001-6553-823X	Swedish Science Council (Vetenskapsradet) [VR2018-05360]; Swedish e-Science Research Center (SeRC); EuroSPIN Erasmus Mundus doctoral programme	Swedish Science Council (Vetenskapsradet)(Swedish Research Council); Swedish e-Science Research Center (SeRC); EuroSPIN Erasmus Mundus doctoral programme	This work was supported by grants from the Swedish Science Council (Vetenskapsradet, VR2018-05360), Swedish e-Science Research Center (SeRC) and the EuroSPIN Erasmus Mundus doctoral programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Agster KL, 2002, J NEUROSCI, V22, P5760; AMARI SI, 1972, IEEE T COMPUT, VC 21, P1197, DOI 10.1109/T-C.1972.223477; Amit Daniel J., 1992, MODELING BRAIN FUNCT; Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; Bakhurin KI, 2017, J NEUROSCI, V37, P854, DOI 10.1523/JNEUROSCI.1789-16.2016; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; Bhalla US, 2017, DENDRITES DEEP LEARN; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Byrnes S, 2011, NEURAL COMPUT, V23, P2567, DOI 10.1162/NECO_a_00184; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; CARR CE, 1990, J NEUROSCI, V10, P3227; Chrysanthidis N, 2018, BIORXIV; COOLEN ACC, 1988, EUROPHYS LETT, V7, P281, DOI 10.1209/0295-5075/7/3/016; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Dhawale AK, 2017, ELIFE, V6, DOI 10.7554/eLife.27702; Dominey PF, 2000, LANG COGNITIVE PROC, V15, P87, DOI 10.1080/016909600386129; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Fiebig F, 2017, J NEUROSCI, V37, P83, DOI 10.1523/JNEUROSCI.1989-16.2016; Fiete IR, 2010, NEURON, V65, P563, DOI 10.1016/j.neuron.2010.02.003; Foldiak Peter, 2003, HDB BRAIN THEORY NEU; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; FUKUSHIMA K, 1973, KYBERNETIK, V12, P58, DOI 10.1007/BF00272461; Golombek DA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0465; Gouvea TS, 2015, ELIFE, V4, DOI 10.7554/eLife.11386; GUYON I, 1988, PHYS REV A, V38, P6365, DOI 10.1103/PhysRevA.38.6365; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hawkins J, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00023; HERZ AV, 1989, BIOL CYBERN, V60, P457, DOI 10.1007/BF00204701; Holthoff K, 2010, J PHYSIOL-LONDON, V588, P1085, DOI 10.1113/jphysiol.2009.184960; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Jin DZZ, 2009, P NATL ACAD SCI USA, V106, P19156, DOI 10.1073/pnas.0909881106; Johnson HA, 2010, NAT NEUROSCI, V13, P917, DOI 10.1038/nn.2579; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; KLEINFELD D, 1986, P NATL ACAD SCI USA, V83, P9469, DOI 10.1073/pnas.83.24.9469; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kuhn R, 1991, MODELS NEURAL NETWOR, P213; Lansner A., 1989, International Journal of Neural Systems, V1, P77, DOI 10.1142/S0129065789000499; Lansner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073776; Lansner A, 2009, TRENDS NEUROSCI, V32, P178, DOI 10.1016/j.tins.2008.12.002; Lapish CC, 2008, P NATL ACAD SCI USA, V105, P11963, DOI 10.1073/pnas.0804045105; Lawrence M, 2006, NEUROCOMPUTING, V69, P634, DOI 10.1016/j.neucom.2005.12.003; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lipton PA, 2007, J NEUROSCI, V27, P5787, DOI 10.1523/JNEUROSCI.1063-07.2007; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Lundqvist M, 2006, NETWORK-COMP NEURAL, V17, P253, DOI 10.1080/09548980600774619; MacDonald CJ, 2013, J NEUROSCI, V33, P14607, DOI 10.1523/JNEUROSCI.1537-13.2013; Meli C, 2013, NETWORK-COMP NEURAL, V24, P129, DOI 10.3109/0954898X.2013.859323; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Miller KD, 2012, NEURAL COMPUT, V24, P25, DOI 10.1162/NECO_a_00221; Minai AA, 1994, P 1994 WORLD C NEUR, V4, P176; Mostafa H, 2014, NEURAL COMPUT, V26, P1973, DOI 10.1162/NECO_a_00619; Murray JM, 2017, ELIFE, V6, DOI 10.7554/eLife.26084; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakajima T, 2009, J NEUROPHYSIOL, V101, P1883, DOI 10.1152/jn.90636.2008; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pasupathy R, 2010, OPER RES, V58, P889, DOI 10.1287/opre.1090.0773; Paton JJ, 2018, NEURON, V98, P687, DOI 10.1016/j.neuron.2018.03.045; Pereira U, 2018, BIORXIV; Rajan K, 2016, NEURON, V90, P128, DOI 10.1016/j.neuron.2016.02.009; Rueda-Orozcol PE, 2015, NAT NEUROSCI, V18, P453, DOI 10.1038/nn.3924; Samura T, 2008, NEUROCOMPUTING, V71, P3176, DOI 10.1016/j.neucom.2008.04.026; Sandberg A, 2002, NETWORK-COMP NEURAL, V13, P179, DOI 10.1088/0954-898X/13/2/302; Seidemann E, 1996, J NEUROSCI, V16, P752; Sohal VS, 1998, HIPPOCAMPUS, V8, P171, DOI 10.1002/(SICI)1098-1063(1998)8:2<171::AID-HIPO9>3.0.CO;2-O; SOMPOLINSKY H, 1986, PHYS REV LETT, V57, P2861, DOI 10.1103/PhysRevLett.57.2861; Spreizer S, 2018, BIORXIV; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Tully PJ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004954; Tully Philip J, 2014, Front Synaptic Neurosci, V6, P8, DOI 10.3389/fnsyn.2014.00008; van Hemmen JL, 1991, MODELS NEURAL NETWOR; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Veliz-Cuba A, 2015, J COMPUT NEUROSCI, V39, P235, DOI 10.1007/s10827-015-0574-4; Verduzco-Flores SO, 2012, J COMPUT NEUROSCI, V32, P403, DOI 10.1007/s10827-011-0360-x; Wang Q, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005632; WILLWACHER G, 1982, BIOL CYBERN, V43, P115, DOI 10.1007/BF00336974; WILSON HR, 1972, BIOPHYS J, V12, P1, DOI 10.1016/S0006-3495(72)86068-5; Xu XM, 2016, J PHYSIOL-LONDON, V594, P1891, DOI 10.1113/JP271891	89	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220161	10.1371/journal.pone.0220161	http://dx.doi.org/10.1371/journal.pone.0220161			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369571	gold, Green Submitted, Green Published			2022-12-27	WOS:000484987900031
J	Yang, YQ; Easa, S; Zheng, XY; Hu, AX; Liu, FS; Chen, MF				Yang, Yanqun; Easa, Said M.; Zheng, Xinyi; Hu, Aixiu; Liu, Fashui; Chen, Meifeng			Evaluation effects of two types of freeway deceleration markings in China	PLOS ONE			English	Article							SPEED REDUCTION MARKINGS; DESIGN	This paper presents an evaluation of the effectiveness of two types of deceleration markings on freeways in China: fishbone-shaped (FS) markings and edge-rate (ER) markings. An actual 4-lane, 6-km long freeway in Province Hebei was created in a driving simulator and used for the experiments. Three scenarios of deceleration markings were adopted: one without markings, one with FS markings, and the third with ER markings. For each scenario, three traffic flow levels were adopted (low, medium, and heavy). The appropriate dimensions of deceleration markings were first established using relevant design guidelines and then used to develop the simulation scenarios using Multigen Creator software. Sixty drivers carried out the simulation experiments with eye tracker equipment. The adequacy of deceleration markings was analyzed with respect to speed, perceived distance, pupil diameter, and geometric parameters. The results showed that both types of deceleration markings made a certain effect on vehicle speed, drivers'visual behavior, and mental characteristics. However, the effect of the FS markings was more pronounced than that of the ER marking. Specifically, the FS markings showed a speed reduction of 12.3 km/h to 15.2 km/h and a perceived distance of 70 m to 90 m, compared with 6.7 km/h to 9.9 km/h and 40 m to 60 m, respectively, for the ER markings. Application comments of the results are provided in the conclusion.	[Yang, Yanqun; Hu, Aixiu; Chen, Meifeng] Fuzhou Univ, Coll Civil Engn, Fuzhou, Fujian, Peoples R China; [Easa, Said M.] Ryerson Univ Toronto, Dept Civil Engn, Toronto, ON, Canada; [Zheng, Xinyi] Fuzhou Univ, Fac Humanities & Social Sci, Fuzhou, Fujian, Peoples R China; [Liu, Fashui] Highway Bur Fuzhou, Fuzhou, Fujian, Peoples R China	Fuzhou University; Toronto Metropolitan University; Fuzhou University	Zheng, XY (corresponding author), Fuzhou Univ, Fac Humanities & Social Sci, Fuzhou, Fujian, Peoples R China.	zhengxinyi@fzu.edu.cn	yang, yanqun/Q-2894-2019	yang, yanqun/0000-0003-1474-4409; Zheng, Xinyi/0000-0002-1292-7597	office of Shijiazhuang-Anyang Freeway Re-construction in Heibei province in China	office of Shijiazhuang-Anyang Freeway Re-construction in Heibei province in China	The office of Shijiazhuang-Anyang Freeway Re-construction in Heibei province in China has provided the financial and technical support of the research.	[Anonymous], 2016, WHIT PAP DEV CHIN TR; [Anonymous], 2009, GB576832009; [Anonymous], 2017, CHINA STAT B DEV TRA; [Anonymous], 2014, JTGB012014, P120; Charlton SG, 2007, ACCIDENT ANAL PREV, V39, P873, DOI 10.1016/j.aap.2006.12.007; Chaurand N, 2015, TRANSPORT RES F-TRAF, V35, P37, DOI 10.1016/j.trf.2015.09.001; Ding H, 2015, ACCIDENT ANAL PREV, V75, P119, DOI 10.1016/j.aap.2014.11.018; Ding NK, 2019, SAFETY SCI, V119, P50, DOI 10.1016/j.ssci.2018.08.021; Drakopoulos A., 2003, EVALUATION CONVERGIN; Gates TJ, 2008, TRANSP RES RECORD, P95, DOI 10.3141/2056-12; Gilmore DK, 2013, TRANSPORT RES REC, P47, DOI 10.3141/2348-06; Godley S. T., 2000, TRANSPORTATION HUMAN, V2, P297, DOI [10.1207/STHF2-4_1., DOI 10.1207/STHF2-4_1]; Griffin L.I.andR.N., 1995, REV 2 INNOVATIVE PAV; Huestegge Lynn, 2016, J Vis, V16, P11, DOI 10.1167/16.2.11; Hunter M, 2010, TRANSPORT RES REC, P50, DOI 10.3141/2149-06; Ma C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198931; Mackenzie AK, 2015, VIS COGN, V23, P736, DOI 10.1080/13506285.2015.1079583; Molan AM, 2014, J TRANSP ENG, V140, DOI 10.1061/(ASCE)TE.1943-5436.0000686; Retting RA, 2000, TRANSPORT RES REC, P116; Vest A, 2005, INT S HIGHW GEOM DES; Voigt A.P, 2008, EVALUATION CHEVRON M; Wan HL, 2018, TRANSPORT-VILNIUS, V33, P647, DOI 10.3846/transport.2018.1574; Xia ZG, 2017, ADV INTELL SYST, V484, P689, DOI 10.1007/978-3-319-41682-3_58; Yan J, 2013, MODERN TRAFFIC TECHN, V10, P55, DOI [10.3969/j.issn.1672-9889.2013.01.016, DOI 10.3969/J.ISSN.1672-9889.2013.01.016]; Yan X., 2011, THESIS, DOI 10.7666/d.Y1948202; Yang Y, 2018, J ADV TRANSPORT, DOI [10.1007/s11116-016-9747-x, DOI 10.1007/S11116-016-9747-X]; [张丽霞 Zhang Lixia], 2014, [中国安全科学学报, China Safety Science Journal（CSSJ）], V24, P79; Zhao XH, 2018, ACCIDENT ANAL PREV, V115, P41, DOI 10.1016/j.aap.2018.02.027; Zhao X, 2018, ASIA PAC CONF POSTGR, P47; Zhou JP, 2013, J HIGHW TRANSP RES D, V4, P294; Zimasa T, 2017, TRANSPORT RES F-TRAF, V46, P14, DOI 10.1016/j.trf.2016.12.005	31	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220811	10.1371/journal.pone.0220811	http://dx.doi.org/10.1371/journal.pone.0220811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408464	Green Published, gold, Green Submitted			2022-12-27	WOS:000485009500019
J	Azevedo, A; Bailey, L; Bandeira, V; Dehnhard, M; Fonseca, C; de Sousa, L; Jewgenow, K				Azevedo, Alexandre; Bailey, Liam; Bandeira, Victor; Dehnhard, Martin; Fonseca, Carlos; de Sousa, Liliana; Jewgenow, Katarina			Age, sex and storage time influence hair cortisol levels in a wild mammal population	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; FECAL GLUCOCORTICOID METABOLITES; MONGOOSE HERPESTES-ICHNEUMON; LONG-TERM CORTISOL; EGYPTIAN MONGOOSE; ENVIRONMENTAL-STRESS; STEROID-HORMONES; EXTERNAL FACTORS; RESPONSES; ECOLOGY	The measurement of hair cortisol is increasingly used to understand the effect of natural and anthropogenic stressors on wild animals, but it is potentially confounded by individual, seasonal and sex-dependant variations in baseline cortisol secretion. This study validated an enzyme-linked immunoassay for hair cortisol measurement and characterized its baseline variation in a wild population of Egyptian mongoose. The analysis encompassed individuals of both sexes and all ages, across a range of geographic, environmental and seasonal conditions that the species experiences in Portugal allowing us to account for spatial, temporal and biological factors that contribute to hair cortisol variation. Our results showed that age, sex and storage time had an effect on hair cortisol, but season did not. Hair cortisol was higher in early stage juveniles compared to other age cohorts, in males when compared to females, and decreased with longer storage time. By identifying the factors that influence baseline hair cortisol in this wild population, we establish the basis for its application as an indicator of the effect of natural and anthropogenic stressors.	[Azevedo, Alexandre; Bailey, Liam; Dehnhard, Martin; Jewgenow, Katarina] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, Berlin, Germany; [Azevedo, Alexandre; de Sousa, Liliana] Inst Ciencias Biomed Abel Salazar, Porto, Portugal; [Bandeira, Victor; Fonseca, Carlos] Univ Aveiro, Dept Biol, Aveiro, Portugal; [Bandeira, Victor; Fonseca, Carlos] Univ Aveiro, CESAM, Aveiro, Portugal	Leibniz Institut fur Zoo und Wildtierforschung; Universidade do Porto; Universidade de Aveiro; Universidade de Aveiro	Azevedo, A (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Biol, Berlin, Germany.; Azevedo, A (corresponding author), Inst Ciencias Biomed Abel Salazar, Porto, Portugal.	ax.c.azevedo@gmail.com	Bandeira, Victor/AAE-7487-2020; Azevedo, Alexandre/GRR-7158-2022; Fonseca, Carlos MMS/D-9744-2011; AZEVEDO, ALEXANDRE/HII-5648-2022; de Sousa, Liliana/K-9756-2014	Fonseca, Carlos MMS/0000-0001-6559-7133; Azevedo, Alexandre/0000-0001-5449-1157; Bailey, Liam D./0000-0002-8226-9454; Bandeira, Victor/0000-0002-2181-3372; de Sousa, Liliana/0000-0001-6656-4595	Leibniz Institute for Zoo and Wildlife Research (IZW), Berlin, Germany; FCT; European funds through the COMPETE; European funds through FEDER by project "Genetic assessment of a successful invasion: Population genetics of the Egyptian mongoose (Herpestes ichneumon) in Portugal" [PTDC/BIA-BEC/104401/2008]; CESAM, through FCT/MCTES [UID/AMB/50017/2019]; FEDER, within the PT2020 Partnership Agreement; FEDER, within the Compete 2020; CESAM [UID/AMB/50017/2019]	Leibniz Institute for Zoo and Wildlife Research (IZW), Berlin, Germany; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European funds through the COMPETE; European funds through FEDER by project "Genetic assessment of a successful invasion: Population genetics of the Egyptian mongoose (Herpestes ichneumon) in Portugal"; CESAM, through FCT/MCTES; FEDER, within the PT2020 Partnership Agreement; FEDER, within the Compete 2020; CESAM	This research was supported by the Leibniz Institute for Zoo and Wildlife Research (IZW), Berlin, Germany. VB and CF were supported by National Funds through FCT and European funds through the COMPETE and FEDER by co-funding through the project "Genetic assessment of a successful invasion: Population genetics of the Egyptian mongoose (Herpestes ichneumon) in Portugal"[PTDC/BIA-BEC/104401/2008]; and by CESAM [UID/AMB/50017/2019], through FCT/MCTES and national funds, and co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi PA, 2008, GEN COMP ENDOCR, V155, P398, DOI 10.1016/j.ygcen.2007.07.002; Ashley NT, 2011, GEN COMP ENDOCR, V172, P382, DOI 10.1016/j.ygcen.2011.03.029; Ashley Noah T., 2011, P45; Aurich J, 2015, DOMEST ANIM ENDOCRIN, V52, P11, DOI 10.1016/j.domaniend.2015.01.003; Bandeira V, 2019, CURR ZOOL, V65, P11, DOI 10.1093/cz/zoy031; Bandeira V, 2016, ZOOL ANZ, V264, P1, DOI 10.1016/j.jcz.2016.06.001; Barros T, 2016, BIOL J LINN SOC, DOI [10.1111/bij.12867, DOI 10.1111/BIJ.12867]; Barros T, 2016, MAMM BIOL, V81, P176, DOI 10.1016/j.mambio.2015.09.003; Barros T, 2016, BIOL J LINN SOC, V118, P686, DOI 10.1111/bij.12743; BATES D, 2015, J STAT SOFTW, DOI 10.18637/jss.v067.i01; Bechshoft TO, 2012, ENVIRON INT, V45, P15, DOI 10.1016/j.envint.2012.04.005; Beltran RS, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0318; BENYAACOV R, 1983, Z SAUGETIERKD, V48, P34; Brunton PJ, 2008, J NEUROENDOCRINOL, V20, P764, DOI 10.1111/j.1365-2826.2008.01735.x; Brunton PJ, 2016, J STEROID BIOCHEM, V160, P160, DOI 10.1016/j.jsbmb.2015.08.003; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Davenport MD, 2008, BIOL PSYCHIAT, V63, P990, DOI 10.1016/j.biopsych.2007.10.025; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Dehnhard M, 2010, GEN COMP ENDOCR, V167, P287, DOI 10.1016/j.ygcen.2010.03.023; Gonzalez-de-la-Vara MD, 2011, CAN J VET RES, V75, P216; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2011.619239, 10.3109/10253890.2012.654479]; Evans MR, 2006, J EVOLUTION BIOL, V19, P343, DOI 10.1111/j.1420-9101.2005.01034.x; Fanson KV, 2015, HORM BEHAV, V76, P41, DOI 10.1016/j.yhbeh.2015.05.012; Ferreira APS, 2005, VET IMMUNOL IMMUNOP, V106, P239, DOI 10.1016/j.vetimm.2005.02.024; Finkenwirth C, 2010, THERIOGENOLOGY, V73, P530, DOI 10.1016/j.theriogenology.2009.10.008; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Fourie NH, 2011, GEN COMP ENDOCR, V174, P150, DOI 10.1016/j.ygcen.2011.08.013; Gaubert P, 2011, J BIOGEOGR, V38, P341, DOI 10.1111/j.1365-2699.2010.02406.x; Gesquiere LR, 2005, AM J PRIMATOL, V67, P83, DOI 10.1002/ajp.20171; HALEKOH U, 2014, J STAT SOFTW; Ito N, 2004, J INVEST DERMATOL, V122, pA111; JONES RB, 1994, PHYSIOL BEHAV, V56, P379, DOI 10.1016/0031-9384(94)90210-0; Keckeis K, 2012, J COMP PHYSIOL B, V182, P985, DOI 10.1007/s00360-012-0674-7; LEFCOURT AM, 1993, J DAIRY SCI, V76, P2607, DOI 10.3168/jds.S0022-0302(93)77595-5; Levine JE, 2002, ENDOCRINOLOGY, V143, P4502, DOI 10.1210/en.2002-221041; LING JK, 1970, Q REV BIOL, V45, P16, DOI 10.1086/406361; Ludwig C, 2013, GEN COMP ENDOCR, V180, P15, DOI 10.1016/j.ygcen.2012.10.005; Macbeth BJ, 2010, CAN J ZOOL, V88, P935, DOI 10.1139/Z10-057; Manenschijn L, 2012, J CLIN ENDOCR METAB, V97, pE1836, DOI 10.1210/jc.2012-1852; Manenschijn L, 2011, STEROIDS, V76, P1032, DOI 10.1016/j.steroids.2011.04.005; Mastromonaco G. F., 2014, CONSERV PHYSL, V2; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Palme R, 2019, PHYSIOL BEHAV, V199, P229, DOI 10.1016/j.physbeh.2018.11.021; PALOMARES F, 1993, J APPL ECOL, V30, P752, DOI 10.2307/2404253; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; PALOMARES F, 1992, Z SAUGETIERKD, V57, P251; PALOMARES F, 1993, ANIM BEHAV, V45, P917, DOI 10.1006/anbe.1993.1111; Palomares F., 1991, VOCALIZATIONS EMITTE; Palomares F., 1993, INDIVIDUAL VARIATION; Perani CV, 2017, STRESS, P1; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Rhodes ME, 1999, BRAIN RES REV, V30, P135, DOI 10.1016/S0165-0173(99)00011-9; Romeo RD, 2010, FRONT NEUROENDOCRIN, V31, P232, DOI 10.1016/j.yfrne.2010.02.004; Romero LM, 2008, AM J PHYSIOL-REG I, V294, pR614, DOI 10.1152/ajpregu.00752.2007; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Russell E, 2012, PSYCHONEUROENDOCRINO, V37, P589, DOI 10.1016/j.psyneuen.2011.09.009; Salaberger T, 2016, GEN COMP ENDOCR, V233, P73, DOI 10.1016/j.ygcen.2016.05.005; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sharpley CF, 2009, PHYSIOL RES, V58, P757, DOI 10.33549/physiolres.931544; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Stoffel MA, 2017, METHODS ECOL EVOL, V8, P1639, DOI 10.1111/2041-210X.12797; Terwissen CV, 2013, GEN COMP ENDOCR, V194, P162, DOI 10.1016/j.ygcen.2013.09.010; Thayer ZM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23169-w; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Turner AI, 2002, J ENDOCRINOL, V173, P113, DOI 10.1677/joe.0.1730113; van Lier E, 2003, ANIM REPROD SCI, V79, P81, DOI 10.1016/S0378-4320(03)00083-6; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Webb E, 2010, J ARCHAEOL SCI, V37, P807, DOI 10.1016/j.jas.2009.11.010; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wingfield JC, 2013, ANIM BEHAV, V85, P1127, DOI 10.1016/j.anbehav.2013.02.018; Wingfield JC, 2013, FUNCT ECOL, V27, P37, DOI 10.1111/1365-2435.12039	74	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221124	10.1371/journal.pone.0221124	http://dx.doi.org/10.1371/journal.pone.0221124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398221	Green Published, gold, Green Submitted			2022-12-27	WOS:000485004000047
J	Mitra, M; Agarwal, P; Kundu, A; Banerjee, V; Roy, S				Mitra, Mehali; Agarwal, Puja; Kundu, Anurima; Banerjee, Victor; Roy, Sujit			Investigation of the effect of UV-B light on Arabidopsis MYB4 (AtMYB4) transcription factor stability and detection of a putative MYB4-binding motif in the promoter proximal region of AtMYB4	PLOS ONE			English	Article							PROTEIN; ACID; SUNSCREENS; CRYSTALLIN; RESPONSES; FAMILY	Here, we have investigated the possible effect of UV-B light on the folding/unfolding properties and stability of Arabidopsis thaliana MYB4 (AtMYB4) transcription factor in vitro by using biophysical approaches. Urea-induced equilibrium unfolding analyses have shown relatively higher stability of the wild-type recombinant AtMYB4 protein than the N-terminal deletion forms after UV-B exposure. However, as compared to wild-type form, AtMYB4.2 protein, lacking both the two N-terminal MYB domains, showed appreciable alteration in the secondary structure following UV-B exposure. UV-B irradiated AtMYB4.2 also displayed higher propensity of aggregation in light scattering experiments, indicating importance of the N-terminal modules in regulating the stability of AtMYB4 under UV-B stress. DNA binding assays have indicated specific binding activity of AtMYB4 to a putative MYB4 binding motif located about 212 bp upstream relative to transcription start site of AtMYB4 gene promoter, while relatively weak DNA binding activity was detected for another putative MYB4 motif located at -908 bp in AtMYB4 promoter. Gel shift and fluorescence anisotropy studies have shown increased binding affinity of UV-B exposed AtMYB4 to the promoter proximal MYB4 motif. ChIP assay has revealed binding of AtMYB4 to the promoter proximal (-212 position) MYB4 motif (ACCAAAC) in vivo. Docking experiments further revealed mechanistic detail of AtMYB4 interaction with the putative binding motifs. Overall, our results have indicated that the N-terminal 62-116 amino acid residues constituting the second MYB domain plays an important role in maintaining the stability of the C-terminal region and the overall stability of the protein, while a promoter proximal MYB-motif in AtMYB4 promoter may involve in the regulation of its own expression under UV-B light.	[Mitra, Mehali; Agarwal, Puja; Kundu, Anurima; Roy, Sujit] Univ Burdwan, UGC Ctr Adv Studies, Dept Bot, Burdwan, W Bengal, India; [Banerjee, Victor] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	University of Burdwan; University of California System; University of California San Francisco	Roy, S (corresponding author), Univ Burdwan, UGC Ctr Adv Studies, Dept Bot, Burdwan, W Bengal, India.	sujitroy2006@gmail.com	Banerjee, Victor/N-8427-2014	Banerjee, Victor/0000-0002-3906-3362	Council of Scientific and Industrial Research, Govt. of India [38(1417)/16/EMR-II]; UGC, Govt. of India [F. 30-141/2015(BSR)]; DST, Govt. of India [DST/INSPIRE Fellowship/2017/IF17001]; CSIR, GOI	Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); UGC, Govt. of India(University Grants Commission, India); DST, Govt. of India(Department of Science & Technology (India)); CSIR, GOI(Council of Scientific & Industrial Research (CSIR) - India)	This research has been financially supported by the research grants from Council of Scientific and Industrial Research, Govt. of India, (Ref. No. 38(1417)/16/EMR-II, dated: 17/05/2016 to SR) and a Start-Up research grant to SR from UGC, Govt. of India (No. F. 30-141/2015(BSR). MM is the recipient of Inspire Fellowship from DST, Govt. of India (DST/INSPIRE Fellowship/2017/IF17001). PA is the recipient of junior research fellowship from the above mentioned CSIR, GOI funded project.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ambawat S, 2013, PHYSIOL MOL BIOL PLA, V19, P307, DOI 10.1007/s12298-013-0179-1; Banerjee V, 2014, LANGMUIR, V30, P4775, DOI 10.1021/la5007007; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Banerjee V, 2012, COLLOID SURFACE B, V92, P142, DOI 10.1016/j.colsurfb.2011.11.036; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biswas A, 2004, J BIOL CHEM, V279, P42648, DOI 10.1074/jbc.M404444200; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chakraborty A, 2018, INT J BIOL MACROMOL, V119, P604, DOI 10.1016/j.ijbiomac.2018.07.151; Choudhury SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044361; Das KP, 1996, J BIOL CHEM, V271, P10449, DOI 10.1074/jbc.271.18.10449; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Fornale S, 2014, PLANT CELL PHYSIOL, V55, P507, DOI 10.1093/pcp/pct187; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Hollosy F, 2002, MICRON, V33, P179, DOI 10.1016/S0968-4328(01)00011-7; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Kim J, 2010, PLANT PHYSIOL, V154, P611, DOI 10.1104/pp.110.162271; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lippold F, 2009, PLANT PHYSIOL, V149, P1761, DOI 10.1104/pp.108.134874; Nguyen NH, 2018, BIOCHEM BIOPH RES CO, V507, P437, DOI 10.1016/j.bbrc.2018.11.057; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pradhan L, 2015, ACTA CRYSTALLOGR D, V71, P667, DOI 10.1107/S1399004715000139; Ray S, 2014, PROTEIN J, V33, P143, DOI 10.1007/s10930-014-9546-1; Roy S, 2015, PLOS ONE, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Segarra G, 2009, PLANT BIOLOGY, V11, P90, DOI 10.1111/j.1438-8677.2008.00162.x; Sergeev YV, 2005, INVEST OPHTH VIS SCI, V46, P3263, DOI 10.1167/iovs.05-0112; Sharma KK, 1998, J BIOL CHEM, V273, P8965, DOI 10.1074/jbc.273.15.8965; Sreerama N, 1999, PROTEIN SCI, V8, P370; Stetefeld Jorg, 2016, Biophys Rev, V8, P409, DOI 10.1007/s12551-016-0218-6; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Talukdar AS, 1999, IEEE T MED IMAGING, V18, P604, DOI 10.1109/42.790460; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weigel D, 2002, ARABIDOPSIS A LABORA; Wen W-S, 2010, MOL VIS, V16, P2777; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Xie JZ, 2010, J BIOL CHEM, V285, P4153, DOI 10.1074/jbc.M109.078881; Zhao JF, 2007, PLANT CELL, V19, P3805, DOI 10.1105/tpc.106.048900; Zhou ML, 2015, PLANT J, V84, P395, DOI 10.1111/tpj.13008	46	7	7	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220123	10.1371/journal.pone.0220123	http://dx.doi.org/10.1371/journal.pone.0220123			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393961	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500023
J	Nakamura, T; Sekimoto, S; Oyama, G; Shimo, Y; Hattori, N; Kajimoto, H				Nakamura, Takuto; Sekimoto, Satoko; Oyama, Genko; Shimo, Yasushi; Hattori, Nobutaka; Kajimoto, Hiroyuki			Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia	PLOS ONE			English	Article							MICROSOFT KINECT; VALIDITY; RELIABILITY	The objective of this study is to test the feasibility of a semi-automated scoring system for the Toronto Western Spasmodic Torticollis Scale (TWSTRS) severity scale in patients with cervical dystonia. The TWSTRS requires training and experience. We previously developed a system to measure neck angle by analyzing three-dimensional position, obtained using Kinect, a marker-less three-dimensional depth sensor. The system can track patients' faces and bodies, automatically analyze neck angles, and semi-automatically calculate the TWSTRS severity scale score. We compared the TWSTRS severity scale scores calculated by the system with the video-based scores calculated by a neurologist trained in movement disorders. A correlation coefficient analysis was then conducted. Absolute accuracy was measured using intra-class correlation (ICC) (3,1), with 95% limits of agreement. To analyze the subscales, Cohen's kappa coefficient (kappa) was calculated. A p-value of <.05 was considered statistically significant. Thirty patients were enrolled. Their average age was 52.3 +/- 16.0 years, and the male to female ratio was 3:2. The average disease duration was 11.3 +/- 12.7 years. Total score measurements by the system were significantly correlated with those rated by the movement disorder-trained neurologist (r = .596, p <.05). There was a significant correlation (r =.655, p<.05) with regard to the automated part of the scale. An adequate ICC (3,1) of .562 was obtained for total severity score (p <.001, 95% confidence interval [CI]:.259-.765), while the equivalent score was.617 for the total automated part (p <.001, 95% CI.336-.798). Our three-dimensional motion capture system, which can measure head angles and semi-automatically calculate the TWSTRS severity scale score utilizing a single-depth camera, demonstrated adequate validity and reliability. This low-cost and portable system could be applied by general practitioners treating cervical dystonia to obtain objective measurements.	[Nakamura, Takuto; Shimo, Yasushi; Kajimoto, Hiroyuki] Univ Electrocommun, Dept Informat, Tokyo, Japan; [Nakamura, Takuto] Japan Soc Promot Sci, Tokyo, Japan; [Sekimoto, Satoko; Oyama, Genko; Hattori, Nobutaka] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan	University of Electro-Communications - Japan; Japan Society for the Promotion of Science; Juntendo University	Hattori, N (corresponding author), Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan.	nhattori@juntendo.ac.jp	Hattori, Nobutaka/ACR-0069-2022		Novartis Pharma	Novartis Pharma	This study was supported by a grant from Novartis Pharma (Novartis Research Grants; 2015, 2016). The funders had no role in study design, data collection or analysis, decision to publish, or manuscript preparation.	Allahyari T, 2017, INT J OCCUP SAF ERGO, V23, P524, DOI 10.1080/10803548.2016.1219148; Boyce MJ, 2012, PARKINSONISM RELAT D, V18, P635, DOI 10.1016/j.parkreldis.2012.02.007; Clark RA, 2012, GAIT POSTURE, V36, P372, DOI 10.1016/j.gaitpost.2012.03.033; Comella CL, 1997, MOVEMENT DISORD, V12, P570, DOI 10.1002/mds.870120414; CONSKY E, 1990, Neurology, V40, P445; Darby J, 2016, GAIT POSTURE, V48, P83, DOI 10.1016/j.gaitpost.2016.04.030; Espay AJ, 2018, PARKINSONISM RELAT D, V52, P94, DOI 10.1016/j.parkreldis.2018.03.002; Fukuda H, 2006, MOVEMENT DISORD, V21, P1503, DOI 10.1002/mds.20986; Gregori B, 2008, CLIN NEUROPHYSIOL, V119, P273, DOI 10.1016/j.clinph.2007.10.007; Jankovic J, 2004, MOVEMENT DISORD, V19, pS109, DOI 10.1002/mds.20024; Lee SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129398; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Nakamura T, 2014, IEEE S 3D US INT 3DU; Timmi A, 2018, MED ENG PHYS, V59, P63, DOI 10.1016/j.medengphy.2018.04.020; Wang Q, 2015, INT C HEALTHC INF; Xu X, 2015, APPL ERGON, V49, P47, DOI 10.1016/j.apergo.2015.01.005	17	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219758	10.1371/journal.pone.0219758	http://dx.doi.org/10.1371/journal.pone.0219758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393884	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500017
J	Dal Bom, JP; Mazzucchetti, L; Malta, MB; Ladeia-Andrade, S; de Castro, MC; Cardoso, MA; Lourenco, BH; Manitto, AM; Abanto, J; Gimeno, SGA; Damasceno, AA; da Silva, BP; de Souza, RM				Dal Bom, Juliana Paghi; Mazzucchetti, Lalucha; Malta, Maira Barreto; Ladeia-Andrade, Simone; de Castro, Marcia Caldas; Cardoso, Marly Augusto; Lourenco, Barbara Hatzlhoffer; Manitto, Alicia Matijasevich; Abanto, Jenny; Agostinho Gimeno, Suely Godoy; Damasceno, Ana Alice; da Silva, Bruno Pereira; de Souza, Rodrigo Medeiros		MINA-Brazil Study Working Grp	Early determinants of linear growth and weight attained in the first year of life in a malaria endemic region	PLOS ONE			English	Article							BODY-MASS INDEX; CASH TRANSFER PROGRAM; CHILD UNDERNUTRITION; HEALTH; OVERWEIGHT; INCOME; AGE	We investigated linear growth and weight attained among 772 children at 10-15 months of age in the first population-based birth cohort in the Brazilian Amazon. Sociodemographic, maternal and birth characteristics were collected in interviews soon after birth at baseline. Anthropometric evaluation was conducted at 10-15 months. Multiple linear regression models were fitted for length-for-age (LAZ) and body mass index (BMI)-for-age Z scores (BAZ), considering a hierarchical conceptual framework with determinants at distal, intermediate and proximal levels, with adjustment for the child's sex and age. Mean LAZ and BAZ were 0.31 (SD: 1.13) and 0.35 (SD: 1.06), respectively. Overall, 2.2% of children were stunted and 6.6% overweight. Among socioeconomic factors, household wealth index was positively associated with LAZ (p for trend = 0.01), while children whose families received assistance from the Bolsa Familia conditional cash transfer program were 0.16 Z score thinner (95% CI: -0.31, -0.00). Maternal height and BMI were positively associated with both LAZ and BAZ at 10-15 months of age (p for trend <0.001). Child's size at birth was positively related with LAZ (p< 0.001 for both birth weight and length). BAZ was 0.34 (95% CI: 0.24, 0.44) higher, but 0.11 lower (95% CI: -0.21, -0.02), for each increase in 1 Z score of birth weight and length, respectively. Children with at least one reported malaria episode within the first year of life were 0.58 (95% CI: -1.05, -0.11) Z score shorter. Socioeconomic and intergenerational factors were consistently associated with LAZ and BAZ at 10-15 months of age. The occurrence of malaria was detrimental to linear growth. In a malaria endemic region, reduction of inequalities and disease burden over the first 1,000 days of life is essential for taking advantage of a critical window of opportunity that can redirect child growth trajectories toward better health and nutrition conditions in the long term.	[Dal Bom, Juliana Paghi] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, SP, Brazil; [Mazzucchetti, Lalucha; Malta, Maira Barreto; Cardoso, Marly Augusto; Lourenco, Barbara Hatzlhoffer] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil; [Ladeia-Andrade, Simone] Fiocruz MS, Oswaldo Cruz Inst, Rio De Janeiro, RJ, Brazil; [de Castro, Marcia Caldas] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Malta, Maira Barreto; Cardoso, Marly Augusto; Lourenco, Barbara Hatzlhoffer; Manitto, Alicia Matijasevich; Abanto, Jenny; Agostinho Gimeno, Suely Godoy] Univ Sao Paulo, Sao Paulo, Brazil; [Damasceno, Ana Alice; da Silva, Bruno Pereira; de Souza, Rodrigo Medeiros] Univ Fed Acre, Cruzeiro Do Sul, Brazil; [de Castro, Marcia Caldas] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Fundacao Oswaldo Cruz; Harvard University; Harvard T.H. Chan School of Public Health; Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health	Lourenco, BH (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil.; Lourenco, BH (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.	barbaralourenco@usp.br	Castro, Marcia/S-2681-2019; LADEIA-ANDRADE, SIMONE/AGD-9884-2022; Lourenco, Barbara/H-8291-2012; Cardoso, Marly Augusto/B-8010-2013; Medeiros de Souza, Rodrigo/F-4749-2014	Castro, Marcia/0000-0003-4606-2795; LADEIA-ANDRADE, SIMONE/0000-0003-0912-5937; Lourenco, Barbara/0000-0002-2006-674X; Cardoso, Marly Augusto/0000-0003-0973-3908; Medeiros de Souza, Rodrigo/0000-0002-7775-6901	Brazilian National Council of Technological and Scientific Development, CNPq [407255/2013-3]; Sao Paulo Research Foundation, FAPESP [2016/00270-6]; Maria Cecilia Souto Vidigal Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]	Brazilian National Council of Technological and Scientific Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Maria Cecilia Souto Vidigal Foundation; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present study was funded by the Brazilian National Council of Technological and Scientific Development, CNPq (http://cnpq.br/grant 407255/2013-3; M.A.C., M.C.C.), the Sao Paulo Research Foundation, FAPESP (http://fapesp.br/-grant 2016/00270-6; M.A.C.) and the Maria Cecilia Souto Vidigal Foundation (http://www.fmcsv.org.br/-M.C.C.).This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES - http://www.capes.gov.br/) Finance Code 001, with a masters scholarship to J. P.D.B. The views expressed in the present article are those of the authors and not necessarily those of any funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Addo OY, 2013, J PEDIATR-US, V163, P549, DOI 10.1016/j.jpeds.2013.02.002; Alderman H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195904; Alexandre MAA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003743; Bann D, 2014, INT J OBESITY, V38, P69, DOI 10.1038/ijo.2013.115; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brasil, 2008, PESQ NAC DEM SAUD CR; Brasil Ministerio da Saude, 2011, OR COL AN DAD ANTR S; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Onis M, 2015, J PEDIAT-BRAZIL, V91, P105, DOI 10.1016/j.jped.2014.10.002; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gea-Horta T, 2017, NUTR HOSP, V34, P308, DOI 10.20960/nh.327; Goncalves H, 2019, INT J EPIDEMIOL, V48, pi80, DOI 10.1093/ije/dyy233; Hug L., 2020, LEVELS TRENDS CHILD; IBGE, 2013, ATL CENS DEM 2010; Jackson BD, 2017, J NUTR, V147, p2163S, DOI 10.3945/jn.116.242289; Labrecque JA, 2018, SOC SCI MED, V211, P9, DOI 10.1016/j.socscimed.2018.05.040; Lee G, 2012, INT J EPIDEMIOL, V41, P531, DOI 10.1093/ije/dyr190; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lourenco BH, 2015, MATERN CHILD NUTR, V11, P240, DOI 10.1111/mcn.12005; Lourenco BH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-265; Menezes AMB, 2012, J EPIDEMIOL COMMUN H, V66, P149, DOI 10.1136/jech.2010.124842; Ministerio da Saude, SIT EP MAL; Mook-Kanamori DO, 2011, EUR J ENDOCRINOL, V165, P623, DOI 10.1530/EJE-11-0067; Natama HM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1187-3; Paes-Sousa R, 2011, B WORLD HEALTH ORGAN, V89, P496, DOI 10.2471/BLT.10.084202; Pincelli A, 2018, AM J TROP MED HYG, V99, P73, DOI 10.4269/ajtmh.18-0135; Reynaldi A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2657-6; Victora CG, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1431; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Villar J, 2018, AM J OBSTET GYNECOL, V218, pS841, DOI 10.1016/j.ajog.2017.11.564; WHO, 1995, EXP COMM PHYS STAT P; Woolfenden S, 2013, J PAEDIATR CHILD H, V49, pE365, DOI 10.1111/jpc.12171; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR	37	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220513	10.1371/journal.pone.0220513	http://dx.doi.org/10.1371/journal.pone.0220513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386682	gold, Green Published, Green Submitted			2022-12-27	WOS:000484997100022
J	Hau, SJ; Mou, KT; Bayles, DO; Brockmeier, SL				Hau, Samantha J.; Mou, Kathy T.; Bayles, Darrell O.; Brockmeier, Susan L.			Transcriptomic differences noted in Glaesserella parasuis between growth in broth and on agar	PLOS ONE			English	Article							HAEMOPHILUS-PARASUIS; EXPRESSION; OMPA	Glaesserella parasuis is the cause of Glasser's disease in pigs and is a significant contributor to post-weaning mortality in the swine industry. Prevention of G. parasuis disease relies primarily on bacterin vaccines, which have shown good homologous protection and variable heterologous protection. Bacterin production involves large scale growth of the bacteria and proteins produced during the proliferation phase of production become important antigens that stimulate the immune response. In order to evaluate genes activated during G. parasuis growth on different media substrates, the transcriptome of broth and agar grown G. parasuis strain 29755 were sequenced and compared. The transcription of most purported virulence genes were comparable between broth and agar grown G. parasuis; however, four virulence-associated genes, including ompA and vapD, had elevated expression under agar growth, while six virulence-associate genes had elevated expression during broth growth, including several protease genes. Additionally, there were metabolic shifts toward increased protein and lipid production and increased cellular division in broth grown G. parasuis. The results contribute to the understanding of how growth substrate alters gene transcription and protein expression, which may impact vaccine efficacy if immunogens important to the protective immune response are not produced under specific in vitro conditions. While the results of this work are unable to fully elucidate which growth medium presents a transcriptome more representative of in vivo samples or best suited for bacterin production, it forms a foundation that can be used for future comparisons and provides a better understanding of the metabolic differences in broth and agar grown bacteria.	[Hau, Samantha J.; Mou, Kathy T.; Brockmeier, Susan L.] ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA; [Hau, Samantha J.; Mou, Kathy T.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Bayles, Darrell O.] ARS, Infect Bacterial Dis Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Department of Agriculture (USDA)	Brockmeier, SL (corresponding author), ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	susan.brockmeier@usda.gov						Ahn J, 2012, J MICROBIOL BIOTECHN, V22, P1307, DOI 10.4014/jmb.1201.01003; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aragon V, 2012, DIS SWINE, P760; Bello-Orti B, 2015, VET RES, V46, DOI 10.1186/s13567-015-0225-9; Blair JMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063912; Blanco I, 2004, VET MICROBIOL, V103, P21, DOI 10.1016/j.vetmic.2004.06.011; Brockmeier SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103787; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Daines DA, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-30; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence Paulraj, 2015, J Genomics, V3, P59, DOI 10.7150/jgen.10924; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maskell D.J, 2014, BMC GENOMICS, V15, P1179, DOI 10.1186/1471-2164-15-1179; Metcalf DS, 2007, CAN J VET RES, V71, P181; MINIATS OP, 1991, CAN J VET RES, V55, P37; MINIATS OP, 1991, CAN J VET RES, V55, P33; Newman SD, 2011, PREV CHRONIC DIS, V8; Nicholson TL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205700; SMART NL, 1989, CAN J VET RES, V53, P390; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Xu ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019631	23	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220365	10.1371/journal.pone.0220365	http://dx.doi.org/10.1371/journal.pone.0220365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386681	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100019
J	Siagian, RC; Ayuningtyas, D				Siagian, Ria Christine; Ayuningtyas, Dumilah			Gap analysis for drug development policymaking: An attempt to close the gap between policy and its implementation	PLOS ONE			English	Article							STRATEGIES	Introduction Most drug development policies in developing countries are enacted without achieving the desired results. This study aims to determine the prioritization of drug development in Indonesia through the evidence-based policymaking process in order to close the distance between stated policy goals and the realization of planned goals. Methods A quantitative approach in the form of cross-sectional research using a structured survey was adopted and validated using a set of techniques involved in the calculation of a structural equation model. An independent samples t-test was used to test the significance of the differences between two views: pharmaceutical industries and the government of Indonesia. Findings The study reveals that pharmaceutical industries and governments were highly consistent in their perceived challenges in facing the drug development. It also reveals drivers and weaknesses of drug development, including market opportunities, push-pull-regulatory pull factors and regulation, as priorities for improvement. Conclusions Gap analysis based on a structural model was borne out to address gap challenges between policy and its implementation, with the use of evidence-based policymaking.	[Siagian, Ria Christine; Ayuningtyas, Dumilah] Univ Indonesia, Sch Publ Hlth, Depok, Indonesia	University of Indonesia	Ayuningtyas, D (corresponding author), Univ Indonesia, Sch Publ Hlth, Depok, Indonesia.	dumilah@gmail.com	Siagian, Christine/GMX-4263-2022	siagian, christine/0000-0002-9037-6831; Ayuningtyas, Dumilah/0000-0002-7621-326X	Universitas Indonesia [PENG-1/UN2.R3.1/PPM]	Universitas Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	The work was supported by Universitas Indonesia (PENG-1/UN2.R3.1/PPM. 00/2019) to DA and by Badan POM to RCS scholarship. There was no additional external funding received for this study. The funder has no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Ahmadiani S, 2016, DARU, V24, DOI 10.1186/s40199-016-0151-z; Ahonkhai V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166515; Banerjee K, 2015, J GENERIC MED, V12, P50; Beran Tanya N, 2010, BMC Res Notes, V3, P267, DOI 10.1186/1756-0500-3-267; Bigdeli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059158; Britton K., 2018, EXPANDING MARKETS IM; Buse K., 2012, MAKING HLTH POLICY; Business Monitor International, 2019, Q22019 BUS MON INT; Chau PYK, 1997, DECISION SCI, V28, P309, DOI 10.1111/j.1540-5915.1997.tb01313.x; Cowlrick I, 2009, DRUG INF J, V43, P617, DOI 10.1177/009286150904300510; Da Costa O, 2008, TECHNOL ANAL STRATEG, V20, P369, DOI 10.1080/09537320802000146; Ferrara E., 2013, ILSP LAW J, V14, P13; Gammie T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140002; Hair J.F., 2010, MULTIVARIATE DATA AN; Head BW, 2016, PUBLIC ADMIN REV, V76, P472, DOI 10.1111/puar.12475; Hennink M, 2005, J HEALTH COMMUN, V10, P163, DOI 10.1080/10810730590915128; Kamoru Ahmed I, 2016, PROBLEMS CHALLENGES, V6, P2225; Kaplan Warren Allan, 2011, South Med Rev, V4, P51, DOI 10.5655/smr.v4i2.1002; Liverani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077404; Lockhart MM, 2010, NEW ZEAL MED J, V123, P52; Lockhart MM, 2013, INT J ENV RES PUB HE, V10, P4339, DOI 10.3390/ijerph10094339; Lockhart MM, 2012, EVALUATION DRUG DEV; MARTILLA JA, 1977, J MARKETING, V41, P77, DOI 10.2307/1250495; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; Mueller-Langer F, 2013, HEALTH ECON POLICY L, V8, P185, DOI 10.1017/S1744133112000321; Ni JY, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0244-6; Oh H, 2001, TOURISM MANAGE, V22, P617, DOI 10.1016/S0261-5177(01)00036-X; Renwick MJ, 2016, J ANTIBIOT, V69, P73, DOI 10.1038/ja.2015.98; Ringle CM, 2016, IND MANAGE DATA SYST, V116, P1865, DOI 10.1108/IMDS-10-2015-0449; Saguin K, 2018, J ASIAN PUBLIC POLIC, V11, P188, DOI 10.1080/17516234.2018.1462559; Siagian RC, 2018, INT J HEALTH GOV, V23, P288, DOI 10.1108/IJHG-03-2018-0011; Uzochukwu B, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0209-1; Wasir R, 2018, VALUE HEALTH, V21, pS1, DOI 10.1016/j.jval.2018.09.004; Weiss B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184846; WHO, 1996, COMP AN NAT DRUG POL; WHO, 2011, LOC PROD PHARM REL T; WHO, 2017, INDIAN POLICIES PROM; WHO, 2011, LOC PROD ACC MED PRO; World Health Organization, 2017, CHIN POL PROM LOC PR	39	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220605	10.1371/journal.pone.0220605	http://dx.doi.org/10.1371/journal.pone.0220605			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5CU	31386680	Green Submitted, Green Published, gold			2022-12-27	WOS:000484997100027
J	Hill, LJ; Parades, WC; Willemes, MJ; Pereira, MG; Salomon, PS; Mariath, R; Moura, RL; Atella, GC; Farina, M; Amado, GM; Salgado, LT				Hill, Lilian J.; Parades, Wladimir C.; Willemes, Maria Julia; Pereira, Miria G.; Salomon, Paulo S.; Mariath, Rodrigo; Moura, Rodrigo L.; Atella, Georgia C.; Farina, Marcos; Amado-Filho, Gilberto M.; Salgado, Leonardo T.			Acidification-induced cellular changes in Symbiodinium isolated from Mussismilia braziliensis	PLOS ONE			English	Article							OCEAN ACIDIFICATION; FATTY-ACID; THERMAL TOLERANCE; CLIMATE-CHANGE; REEF CORALS; DINOFLAGELLATE; ZOOXANTHELLAE; DIVERSITY; ATLANTIC; PHOTOSYNTHESIS	Dinoflagellates from the Symbiodiniaceae family and corals have an ecologically important endosymbiotic relationship. Scleractinian corals cannot survive for long periods without their symbionts. These algae, also known as zooxanthellae, on the other hand, thrives outside the coral cells. The free-living populations of zooxanthellae are essential for the resilience of the coral to environmental stressors such as temperature anomalies and ocean acidification. Yet, little is known about how ocean acidification may affect the free-living zooxanthellae. In this study we aimed to test morphological, physiological and biochemical responses of zooxanthellae from the Symbiodinium genus isolated from the coral Mussismilia braziliensis, endemic to the Brazilian coast, to acidification led by increased atmospheric CO2. We tested whether photosynthetic yield, cell ultrastructure, cell density and lipid profile would change after up to 16 days of exposure to pH 7.5 in an atmospheric pCO(2) of 1633 mu atm. Photosynthetic yield and cell density were negatively affected and chloroplasts showed vesiculated thylakoids, indicating morphological damage. Moreover, Symbiodinium fatty acid profile drastically changed in acidified condition, showing lower polyunsaturated fatty acids and higher saturated fatty acids contents, when compared to the control, non-acidified condition. These results show that seawater acidification as an only stressor causes significant changes in the physiology, biochemistry and ultrastructure of free-living Symbiodinium.	[Hill, Lilian J.; Parades, Wladimir C.; Willemes, Maria Julia; Mariath, Rodrigo; Amado-Filho, Gilberto M.; Salgado, Leonardo T.] Inst Pesquisas Jardim Bot Rio de Janeiro, Diretoria Pesquisas, Rio De Janeiro, Brazil; [Pereira, Miria G.] Univ Fed Rio de Janeiro UFRJ, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Salomon, Paulo S.; Moura, Rodrigo L.] Univ Fed Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, Brazil; [Atella, Georgia C.] Univ Fed Rio de Janeiro UFRJ, Inst Bioquim Med, Rio De Janeiro, Brazil; [Farina, Marcos] Univ Fed Rio de Janeiro UFRJ, Inst Ciencias Biomed, Rio De Janeiro, Brazil	Jardim Botanico do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Salgado, LT (corresponding author), Inst Pesquisas Jardim Bot Rio de Janeiro, Diretoria Pesquisas, Rio De Janeiro, Brazil.	lsalgado.jbrj@gmail.com	Atella, Georgia/AAK-7897-2020; Pereira, Miria G/AAJ-9998-2021; Farina, Marcos/I-3744-2014; de Moura, Rodrigo Leao/AAL-5781-2020; Salomon, Paulo Sergio/D-3310-2011	de Moura, Rodrigo Leao/0000-0002-5597-6196; Salomon, Paulo Sergio/0000-0002-0037-6011	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Agencia Nacional do Petrleo, Gas Natural e Biocombustiveis/BRASOIL	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Agencia Nacional do Petrleo, Gas Natural e Biocombustiveis/BRASOIL	This study was financed by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Agencia Nacional do Petrleo, Gas Natural e Biocombustiveis/BRASOIL. GCA, GMAF, LTS, MF, PSS and RLM. received CNPq research productivity fellowships. GMAF, MF and LTS received FAPERJ research productivity fellowships.	Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Baghdasarian G, 2017, BIOL BULL-US, V232, P123, DOI 10.1086/692718; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; BANASZAK AT, 1993, J PHYCOL, V29, P517, DOI 10.1111/j.1529-8817.1993.tb00153.x; Barott KL, 2015, P NATL ACAD SCI USA, V112, P607, DOI 10.1073/pnas.1413483112; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bidle KD, 2016, CURR BIOL, V26, pR594, DOI 10.1016/j.cub.2016.05.056; BLANK RJ, 1985, ENDOCYT CELL RES, V2, P113; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Carlos AA, 1999, J PHYCOL, V35, P1054, DOI 10.1046/j.1529-8817.1999.3551054.x; Castro Clovis B., 1999, Revista Brasileira de Oceanografia, V47, P87; Cheng JL, 2009, HISTOCHEM CELL BIOL, V132, P281, DOI 10.1007/s00418-009-0615-z; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Colombo-Pallotta MF, 2010, CORAL REEFS, V29, P899, DOI 10.1007/s00338-010-0638-x; Fabina NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044970; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Francini RB, 2008, MAR POLLUT BULL, V56, P1008, DOI 10.1016/j.marpolbul.2008.02.013; Francini RB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054260; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; FRENZ J, 1989, BIOTECHNOL BIOENG, V34, P755, DOI 10.1002/bit.260340605; Fujise L, 2018, J EUKARYOT MICROBIOL, V65, P505, DOI 10.1111/jeu.12497; Garcia GD, 2013, MICROB ECOL, V65, P1076, DOI 10.1007/s00248-012-0161-4; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Gotelli N.J., 1995, PRIMER ECOLOGY; Guiheneuf F, 2009, J EXP MAR BIOL ECOL, V369, P136, DOI 10.1016/j.jembe.2008.11.009; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hansen G, 2009, J PHYCOL, V45, P251, DOI 10.1111/j.1529-8817.2008.00621.x; Harrison PL, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P59, DOI 10.1007/978-94-007-0114-4_6; Harwood JL, 1996, BBA-LIPID LIPID MET, V1301, P7, DOI 10.1016/0005-2760(95)00242-1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; HORVATH G, 1987, BIOCHIM BIOPHYS ACTA, V891, P68, DOI 10.1016/0005-2728(87)90084-3; Jokiel PL, 2011, J EXP MAR BIOL ECOL, V409, P1, DOI 10.1016/j.jembe.2011.10.008; KLEPPEL GS, 1989, LIMNOL OCEANOGR, V34, P1331, DOI 10.4319/lo.1989.34.7.1331; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KORN ED, 1967, J CELL BIOL, V34, P627, DOI 10.1083/jcb.34.2.627; Kwok ACM, 2005, PLANT CELL PHYSIOL, V46, P1973, DOI 10.1093/pcp/pci213; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; Leao ZMAN, 2005, MAR POLLUT BULL, V51, P599, DOI 10.1016/j.marpolbul.2005.04.024; Leggat W, 1999, PLANT PHYSIOL, V121, P1247, DOI 10.1104/pp.121.4.1247; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; Mansour MP, 1999, J PHYCOL, V35, P710, DOI 10.1046/j.1529-8817.1999.3540710.x; McGinley MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050439; McGinty ES, 2012, MICROB ECOL, V64, P1000, DOI 10.1007/s00248-012-0085-z; Mock T, 2002, PHYTOCHEMISTRY, V61, P53, DOI 10.1016/S0031-9422(02)00215-7; Moura RL, 2013, CONT SHELF RES, V70, P109, DOI 10.1016/j.csr.2013.04.036; Muscatine L., 1990, P75; Nanjo Y, 2010, BBA-BIOENERGETICS, V1797, P1483, DOI 10.1016/j.bbabio.2010.03.014; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Papina M, 2003, COMP BIOCHEM PHYS B, V135, P533, DOI 10.1016/S1096-4959(03)00118-0; Paradas WC, 2016, PLANT CELL PHYSIOL, V57, P1008, DOI 10.1093/pcp/pcw039; Pierrot D., 2006, TECH REP; Pochon X, 2001, MAR BIOL, V139, P1069; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; POSTBEITTENMILLER D, 1992, PLANT PHYSIOL, V100, P923, DOI 10.1104/pp.100.2.923; Putnam HM, 2012, P ROY SOC B-BIOL SCI, V279, P4352, DOI 10.1098/rspb.2012.1454; Richier S, 2010, SYMBIOSIS STRESS, P651; Rocker MM, 2019, CORAL REEFS, V38, P215, DOI 10.1007/s00338-019-01768-x; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHREIBER U, 1995, PLANT CELL PHYSIOL, V36, P873, DOI 10.1093/oxfordjournals.pcp.a078833; Silva-Lima AW, 2015, MICROB ECOL, V70, P301, DOI 10.1007/s00248-015-0573-z; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Takahashi S, 2009, P NATL ACAD SCI USA, V106, P3237, DOI 10.1073/pnas.0808363106; Tortell PD, 2000, LIMNOL OCEANOGR, V45, P744, DOI 10.4319/lo.2000.45.3.0744; Volkman JK, 1998, ORG GEOCHEM, V29, P1163, DOI 10.1016/S0146-6380(98)00062-X; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072486; Webster NS, 2013, GLOBAL CHANGE BIOL, V19, P303, DOI 10.1111/gcb.12008; WHITNEY SM, 1995, P ROY SOC B-BIOL SCI, V259, P271, DOI 10.1098/rspb.1995.0040; Zuppini A, 2009, J EXP BOT, V60, P4189, DOI 10.1093/jxb/erp264; [No title captured]	78	5	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220130	10.1371/journal.pone.0220130	http://dx.doi.org/10.1371/journal.pone.0220130			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381568	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600010
J	van Witteloostuijn, M; Boersma, P; Wijnen, F; Rispens, J				van Witteloostuijn, Merel; Boersma, Paul; Wijnen, Frank; Rispens, Judith			Statistical learning abilities of children with dyslexia across three experimental paradigms	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; PROCEDURAL MEMORY; VISUAL-ATTENTION; READING-ABILITY; WORKING-MEMORY; LANGUAGE; DEFICIT; ACQUISITION; IMPAIRMENT; SEQUENCES	Statistical learning (SL) difficulties have been suggested to contribute to the linguistic and non-linguistic problems observed in children with dyslexia. Indeed, studies have demonstrated that children with dyslexia experience problems with SL, but the extent of the problems is unclear. We aimed to examine the performance of children with and without dyslexia across three distinct paradigms using both on-and offline measures, thereby tapping into different aspects of SL. 100 children with and without dyslexia (aged 8-11, 50 per group) completed three SL tasks: serial reaction time (SRT), visual statistical learning (VSL), and auditory nonadjacent dependency learning (A-NADL). Learning was measured through online reaction times during exposure in all tasks, and through offline questions in the VSL and A-NADL tasks. We find significant learning effects in all three tasks, from which we conclude that, collapsing over groups, children are sensitive to the statistical structures presented in the SRT, VSL and A-NADL tasks. No significant interactions of learning effect with group were found in any of the tasks, so we cannot conclude whether or not children with dyslexia perform differently on the SL tasks than their TD peers. These results are discussed in light of the proposed SL deficit in dyslexia.	[van Witteloostuijn, Merel; Boersma, Paul; Rispens, Judith] Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands; [Wijnen, Frank] Univ Utrecht, Utrecht Inst Linguist OTS, Utrecht, Netherlands	University of Amsterdam; Utrecht University	van Witteloostuijn, M (corresponding author), Univ Amsterdam, Amsterdam Ctr Language & Commun, Amsterdam, Netherlands.	M.T.G.vanWitteloostuijn@uva.nl		van Witteloostuijn, Merel/0000-0003-3159-8247; Wijnen, Frank/0000-0002-7196-6000	Netherlands Organization for Scientific Research (NWO) [276-89-005]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This paper is part of a project entitled 'Examining the contribution of procedural memory to grammar and literacy'. It was funded by the Netherlands Organization for Scientific Research (NWO): personal Vidi grant awarded to JR (Judith Rispens; grant number 276-89-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The data reported here is part of a project funded by the Netherlands Organization for Scientific Research (NWO) entitled 'Examining the contribution of procedural memory to grammar and literacy' (personal Vidi grant awarded to Judith Rispens, 276-89-005). We would like to thank all children, their parents, the primary schools (Anne Frankschool, De Binnenmeer, De Wheermolen and Het Startnest) and the dyslexia organisations (IWAL institute Amsterdam, RID institute Amersfoort) for participating in the present study. We are also grateful to Darlene Keydeniers, Iris Broedelet and Sascha Couvee (testing assistance) and Dirk Jan Vet (technical assistance). Finally, we would like to express our gratitude to Imme Lammertink for the collaboration on designing the experiments conducted in this study.	Alloway T. P., 2012, ALLOWAY WORKING MEMO; Arciuli J, 2018, CURRENT DIRECTIONS P, P1; Arciuli J, 2018, LANG SPEECH HEAR SER, V49, P634, DOI 10.1044/2018_LSHSS-STLT1-17-0135; Arciuli J, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0058; Arciuli J, 2012, COGNITIVE SCI, V36, P286, DOI 10.1111/j.1551-6709.2011.01200.x; Arciuli J, 2011, DEVELOPMENTAL SCI, V14, P464, DOI 10.1111/j.1467-7687.2009.00937.x; Baguley T, 2012, SERIOUS STATS GUIDE; Baker CI, 2004, PSYCHOL SCI, V15, P460, DOI 10.1111/j.0956-7976.2004.00702.x; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; Braams T, 2015, SCHOOLVAARDIGHEIDSTO; Brus B, 1972, MINUUT TEST VORM A B; Buchholz J, 2005, BRAIN COGNITION, V57, P30, DOI 10.1016/j.bandc.2004.08.017; Bussy G., 2011, REV NEUROPSYCHOL, V3, P141, DOI [10.3917/rne.033.0141, DOI 10.3917/RNE.033.0141]; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cowan N, 2017, DYSLEXIA, V23, P209, DOI 10.1002/dys.1557; Deroost N, 2010, J CLIN EXP NEUROPSYC, V32, P561, DOI 10.1080/13803390903313556; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Frost R, 2015, TRENDS COGN SCI, V19, P117, DOI 10.1016/j.tics.2014.12.010; Frost R, 2013, PSYCHOL SCI, V24, P1243, DOI 10.1177/0956797612472207; Gabay Y, 2015, J SPEECH LANG HEAR R, V58, P934, DOI 10.1044/2015_JSLHR-L-14-0324; Gabay Y, 2012, NEUROPSYCHOLOGIA, V50, P2435, DOI 10.1016/j.neuropsychologia.2012.06.014; Gathercole SE, 2006, J EXP CHILD PSYCHOL, V93, P265, DOI 10.1016/j.jecp.2005.08.003; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Grama IC, 2016, J PSYCHOLINGUIST RES, V45, P1427, DOI 10.1007/s10936-016-9412-8; He XJ, 2017, AM J SPEECH-LANG PAT, V26, P1080, DOI 10.1044/2017_AJSLP-15-0190; Hedenius M, 2013, RES DEV DISABIL, V34, P3924, DOI 10.1016/j.ridd.2013.08.014; Henderson LM, 2017, RES DEV DISABIL, V60, P198, DOI 10.1016/j.ridd.2016.11.002; Iao LS, 2017, J SPEECH LANG HEAR R, V60, P694, DOI 10.1044/2016_JSLHR-L-15-0232; Inacio F, 2018, ANN DYSLEXIA, V68, P1, DOI 10.1007/s11881-018-0158-x; Janacsek K, 2015, CORTEX, V64, P411, DOI 10.1016/j.cortex.2014.07.020; Jimenez-Fernandez G, 2011, ANN DYSLEXIA, V61, P85, DOI 10.1007/s11881-010-0048-3; Kelly Steve W, 2002, Dyslexia, V8, P43, DOI 10.1002/dys.208; Kerkhoff A, 2017, DEVELOPMENTAL PERSPE, P315; Kerkhoff A, 2013, J CHILD LANG, V40, P11, DOI 10.1017/S0305000912000098; Kidd E, 2018, TRENDS COGN SCI, V22, P154, DOI 10.1016/j.tics.2017.11.006; Kidd E, 2012, DEV PSYCHOL, V48, P171, DOI 10.1037/a0025405; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Kort W., 2008, CLIN EVALUATION LANG; Laasonen M, 2014, ANN DYSLEXIA, V64, P1, DOI 10.1007/s11881-013-0083-y; Lammertink I, 2018, APPLIED PSYCHOLINGUI, P1; Lopez-Barroso D, 2016, COGNITION, V152, P61, DOI 10.1016/j.cognition.2016.03.016; Lum J, 2010, AUST J PSYCHOL, V62, P139, DOI 10.1080/00049530903150547; Lum JAG, 2013, RES DEV DISABIL, V34, P3460, DOI 10.1016/j.ridd.2013.07.017; Lum JAG, 2012, CORTEX, V48, P1138, DOI 10.1016/j.cortex.2011.06.001; Melby-Lervag M, 2012, PSYCHOL BULL, V138, P322, DOI 10.1037/a0026744; Menghini D, 2010, NEUROPSYCHOLOGIA, V48, P863, DOI 10.1016/j.neuropsychologia.2009.11.003; Misyak JB, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00031; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; Nigro L., 2015, ANN DYSLEXIA, P1, DOI [DOI 10.1007/S11881-015-0096-9, 10.1007/s11881-015-0096-9]; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Pavlidou EV, 2014, RES DEV DISABIL, V35, P1457, DOI 10.1016/j.ridd.2014.03.040; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Plante E, 2018, LANG SPEECH HEAR SER, V49, P710, DOI 10.1044/2018_LSHSS-STLT1-17-0131; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramus F, 2003, BRAIN, V126, P841, DOI 10.1093/brain/awg076; Ramus F, 2003, J CHILD PSYCHOL PSYC, V44, P712, DOI 10.1111/1469-7610.00157; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Raven J, 2003, HANDBOOK OF NONVERBAL ASSESSMENT, P223; Raviv L, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12593; Rispens J, 2007, INT J LANG COMM DIS, V42, P293, DOI 10.1080/13682820600988777; Roodenrys S, 2008, DYSLEXIA, V14, P1, DOI 10.1002/dys.340; Russeler J, 2006, J CLIN EXP NEUROPSYC, V28, P808, DOI 10.1080/13803390591001007; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Schittekatte M., 2007, TEACH TEST EVERYDAY; Schmalz X, 2018, SCI STUD READ, P1, DOI [10.1080/10888438.2018, DOI 10.1080/10888438.2018]; Schmalz X, 2017, ANN DYSLEXIA, V67, P147, DOI 10.1007/s11881-016-0136-0; Schneider W., 2002, E PRIME USERS GUIDE; Siegelman N, 2018, COGNITIVE SCI, V42, P692, DOI 10.1111/cogs.12556; Siegelman N, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0059; Siegelman N, 2015, J MEM LANG, V81, P105, DOI 10.1016/j.jml.2015.02.001; Sigurdardottir HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00554-5; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Singh S, 2020, ARCH PHYSIOL BIOCHEM, V126, P348, DOI 10.1080/13813455.2018.1538249; Snowling M., 2000, DYSLEXIA; Snowling M J, 2001, Dyslexia, V7, P37; Staels E, 2017, NEUROPSYCHOLOGY, V31, P371, DOI 10.1037/neu0000348; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Van den Bos K. P., 2007, CONTINU BENOEMEN WOO; van Witteloostuijn M, 2017, RES DEV DISABIL, V70, P126, DOI 10.1016/j.ridd.2017.09.006; vandenBos KP, 1994, VORM A B TEST LEESVA; vanWitteloostuijn M, FRONTIERS IN PSYCHOL; Vicari S, 2003, NEUROPSYCHOLOGIA, V41, P108, DOI 10.1016/S0028-3932(02)00082-9; Vicari S, 2005, J NEUROL, V76, P1359, DOI [10.1177/0956797611417632, DOI 10.1177/0956797611417632]; Waber DP, 2003, J EXP CHILD PSYCHOL, V84, P338, DOI 10.1016/S0022-0965(03)00030-4; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Waltzman DE, 2000, APPL PSYCHOLINGUIST, V21, P263, DOI 10.1017/S014271640000206X; West G, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12552	94	18	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220041	10.1371/journal.pone.0220041	http://dx.doi.org/10.1371/journal.pone.0220041			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381565	Green Published, gold, Green Submitted			2022-12-27	WOS:000484993600009
J	Kalka, E; Pastuszak, A; Busko, K				Kalka, Ewa; Pastuszak, Anna; Busko, Krzysztof			Secular trends in body height, body weight, BMI and fat percentage in Polish university students in a period of 50 years	PLOS ONE			English	Article							MASS INDEX; CHILDREN; ADOLESCENTS; STATURE; OBESITY	Objectives The aim of the study was to determine changes in the magnitude and direction of secular trends in body height, body weight, body mass index (BMI) and fat percentage in university students from a university of technology and a university of physical education in a period of 50 years. Methods The data were derived from the examinations of male students from the Warsaw University of Technology, conducted four times, in 1959, 1971, 1994, 2011, and male students from the Jozef Pilsudski University of Physical Education in Warsaw, who were examined in 1963, 1972, 1996, and 2012. Body height, body weight and thickness of 2 skinfolds (triceps skinfold and abdomen skinfold) were measured. Body mass index (BMI) and fat percentage (FAT%) were also calculated. Results Current university students are taller and heavier than their peers from the previous decades, with BMI remaining within the reference range. A substantial increase in fat percentage was found in both groups. Over the period of fifty years, mean fat percentage in students from the university of technology increased by 6.3% (F1,3 = 116.56, p < 0.001, eta(2) = 0.3736), whereas this increase in the students from the university of physical education rose by 3.5% (F1,3 = 72.94, p < 0.001, eta(2) = 0.3181). Conclusion Changes in secular trends in the students from both universities are likely to be linked to the dynamic economic and systematic transformation in Poland observed in the period of the last 50 years. The period of economic transformations in the last decade was more conducive to physical development of university students than the previous period of economic crises.	[Kalka, Ewa] Inst Mother & Child Hlth, Clin Children & Youth, Warsaw, Poland; [Pastuszak, Anna] Natl Res Inst, Team Projects, Inst Sport, Warsaw, Poland; [Busko, Krzysztof] Kazimierz Wielki Univ, Dept Anat & Biomech, Bydgoszcz, Poland	Institute of Sport - National Research Institute; Kazimierz Wielki University	Busko, K (corresponding author), Kazimierz Wielki Univ, Dept Anat & Biomech, Bydgoszcz, Poland.	krzysztof.busko@ukw.edu.pl	Buśko, Krzysztof/ABE-7456-2020	Buśko, Krzysztof/0000-0002-6456-3502	Ministry of Science and Higher Education (Grants of Jozef Pilsudski University of Physical Education in Warsaw) [DS-145, DM-22]	Ministry of Science and Higher Education (Grants of Jozef Pilsudski University of Physical Education in Warsaw)	The study was supported by the Ministry of Science and Higher Education (Grants of Jozef Pilsudski University of Physical Education in Warsaw No.: DS-145 and DM-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabric M, 2010, MED BIOLL SCI, V24, P19; Cole TJ, 2003, ECON HUM BIOL, V1, P161, DOI 10.1016/S1570-677X(02)00033-3; Du TT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-327; Falkner F., 1986, HUMAN GROWTH, V3, P283; Hulanicka B., 1990, MONOGRAPHS I ANTHR, V7; Ji CY, 2013, BIOMED ENVIRON SCI, V26, P520, DOI 10.3967/0895-3988.2013.07.002; Johnson W, 2013, ANN HUM BIOL, V40, P107, DOI 10.3109/03014460.2012.720710; KEYS A, 1953, PHYSIOL REV, V33, P245, DOI 10.1152/physrev.1953.33.3.245; Kolodziej H M, 2015, AM J HUM BIOL, P1, DOI [10.1002/ajhb.22646, DOI 10.1002/AJHB.22646]; Krajenska A, 2008, PHYS ACTIVITY PEOPLE, V12, P201; Larnkjaer A, 2006, ACTA PAEDIATR, V95, P754, DOI 10.1080/08035250500527323; Laska-Mierzejewska T, 2007, ANN HUM BIOL, V34, P362, DOI 10.1080/03014460701317798; Lewandowska J, 2006, HUM MOVEMENT, V7, P65; Martin R., 1957, LEHRBUCH ANTHR, V3rd; Nagel G, 2009, EUR J CLIN NUTR, V63, P1440, DOI 10.1038/ejcn.2009.86; Oberg S, 2014, ECON HUM BIOL, V15, P140, DOI 10.1016/j.ehb.2014.08.003; Padez C, 2003, ANN HUM BIOL, V30, P262, DOI 10.1080/0301446031000064530; Papaidimitriou A, 2008, OBES REV, V9, P100, DOI 10.1111/j.1467-789X.2007.00420.x; Petranovic MZ, 2014, ECON HUM BIOL, V13, P155, DOI 10.1016/j.ehb.2013.09.002; Pheasant S, 2003, ANTHROPOMETRY ERGONO; Piechaczek H., 1976, STUD PHYS ANTHR, V2, P33; Piechaczek H, 1996, PHYS ED SPORT, V40, P3; Podstawski R. S., 2012, Zeszyty Naukowe Uniwersytetu Przyrodniczego we Wroclawiu - Biologia i Hodowla Zwierzat, V64, P9; Poti JM, 2014, AM J CLIN NUTR, V99, P162, DOI 10.3945/ajcn.113.071928; Rebacz-Maron E, 2013, INT MARIT HEALTH, V64, P12; Schonbeck Y, 2013, PEDIATR RES, V73, P371, DOI 10.1038/pr.2012.189; Stachon A, 2013, HUM MOV, V14, P205; Sun SMS, 2012, AM J HUM BIOL, V24, P506, DOI 10.1002/ajhb.22256; WHO, 2015, HLTH TOP OB OV	29	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220514	10.1371/journal.pone.0220514	http://dx.doi.org/10.1371/journal.pone.0220514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369619	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900060
J	Pennucci, R; Gucciardi, I; de Curtis, I				Pennucci, Roberta; Gucciardi, Irene; de Curtis, Ivan			Rac1 and Rac3 GTPases differently influence the morphological maturation of dendritic spines in hippocampal neurons	PLOS ONE			English	Article							RHO-GTPASES; MOLECULAR-MECHANISMS; ACTIN; SYNAPTOGENESIS; PLASTICITY; EXPRESSION; FILOPODIA; ADHESION; PROTEINS; INSIGHTS	The Rac1 and Rac3 GTPases are co-expressed in the developing nervous system, where they are involved in different aspects of neuronal development, including the formation of synapses. The deletion of both Rac genes determines a stronger reduction of dendritic spines in vitro compared to the knockout of either gene, indicating that Rac1 and Rac3 play a synergistic role in the formation of these structures. Here, we have addressed the role of each GTPase in the formation of dendritic spines by overexpressing either Rac1 or Rac3 in wildtype neurons, or by re-expressing either GTPase in double knockout hippocampal cultures. We show that the Rac3 protein is expressed with Rac1 in developing hippocampal neurons. Overexpression of either GTPase in WT neurons increases the density of dendritic spines, suggesting the involvement of both GTPases in their formation. We also found that the re-expression of either Rac1 or Rac3 in double knockout neurons is sufficient to restore spinogenesis. Rac1 is significantly more efficient than Rac3 in restoring the formation of spines. On the other hand the quantitative analysis in neurons overexpressing or reexpressing either GTPase shows that Rac3 induces a more pronounced increase in the size of the spines compared to Rac1. These enlarged spines form morphological synapses identified by the juxtaposition of postsynaptic and presynaptic markers. Thus, while Rac1 appears more efficient in inducing the formation of mature spines, Rac3 is more efficient in promoting their enlargement. Our study highlights specific roles of Rac1 and Rac3, which may be functionally relevant also to synaptic plasticity.	[Pennucci, Roberta; Gucciardi, Irene; de Curtis, Ivan] San Raffaele Vita Salute Univ, Milan, Italy; [Pennucci, Roberta; Gucciardi, Irene; de Curtis, Ivan] Ist Sci San Raffaele, Cell Adhes Unit, Div Neurosci, Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	de Curtis, I (corresponding author), San Raffaele Vita Salute Univ, Milan, Italy.	decurtis.ivan@hsr.it		DE CURTIS, Ivanmatteo/0000-0002-7651-1515	Telethon Foundation, Italy [GGP12126]; AIRC, Italy [20203]	Telethon Foundation, Italy(Fondazione Telethon); AIRC, Italy(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Telethon Foundation, Italy (grant GGP12126 to IdC) and AIRC, Italy (20203 to IdC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bolis A, 2003, EUR J NEUROSCI, V18, P2417, DOI 10.1046/j.1460-9568.2003.02938.x; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Corbetta S, 2008, BEHAV BRAIN RES, V186, P246, DOI 10.1016/j.bbr.2007.08.019; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Costain G, 2019, GENET MED, V21, P1021, DOI 10.1038/s41436-018-0323-y; De Curtis I, 2008, DEV NEUROSCI-BASEL, V30, P47, DOI 10.1159/000109851; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Fiala JC, 1998, J NEUROSCI, V18, P8900; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gualdoni S, 2007, BIOL CELL, V99, P455, DOI 10.1042/BC20060119; Haataja L, 1997, J BIOL CHEM, V272, P20384, DOI 10.1074/jbc.272.33.20384; Hajdo-Milasinovic A, 2007, J CELL SCI, V120, P555, DOI 10.1242/jcs.03364; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Malosio ML, 1997, J NEUROSCI, V17, P6717; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; MOLL J, 1991, ONCOGENE, V6, P863; Nakahata Y, 2018, FRONT SYNAPTIC NEURO, V10, DOI 10.3389/fnsyn.2018.00029; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; Newey SE, 2005, J NEUROBIOL, V64, P58, DOI 10.1002/neu.20153; Pennucci R, 2016, CEREB CORTEX, V26, P873, DOI 10.1093/cercor/bhv274; Pennucci R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024819; Pyronneau A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan0852; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Rico B, 2004, NAT NEUROSCI, V7, P1059, DOI 10.1038/nn1317; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Vaghi V, 2014, CEREB CORTEX, V24, P1247, DOI 10.1093/cercor/bhs402; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zamboni V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25354-3; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	39	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220496	10.1371/journal.pone.0220496	http://dx.doi.org/10.1371/journal.pone.0220496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369617	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900058
J	Jun, T; Min, IS				Jun, Tackseung; Min, In-sik			Air pollution, respiratory illness and behavioral adaptation: Evidence from South Korea	PLOS ONE			English	Article							LONG-TERM EXPOSURE; LUNG-FUNCTION GROWTH; AVOIDANCE-BEHAVIOR; TRACT DEPOSITION; CLIMATE-CHANGE; HEALTH; MORTALITY; CHILDREN; ASTHMA; FINE	Air pollution is closely associated with the development of respiratory illness. Behavioral adaptations of people to air pollution may influence its impact, yet this has not been investigated in the literature. Our hypothesis is that people experience and learn the underlying air quality to decide their adaptation, and they have a stronger incentive to behaviorally adapt to the air quality as it deteriorates. We tested our hypothesis on a sample of approximately 25,700 individuals from South Korea from 2002 to 2013 that contained information on daily doctor's visits due to respiratory disease. We matched individuals to the mean of the past seven-day concentration of the particulate matter of size between 2.5 and 10 micrometers (PM10) in their county of residence. We examined whether people living in counties with greater air pollution suffer less from respiratory disease when the concentration increases. For the analysis, we separated counties into quintiles based on their mean seven-day PM10, and regressed the binary indicator of a daily doctor's visit with a resulting diagnosis of respiratory disease on the seven-day PM10 concentration of the county of residence interacted with the quintile dummies. The key findings are that a 1-standard-deviation increase in the seven-day PM10 concentration in the two lowest quintiles is associated with an increase of 0.054 percentage points in the likelihood of a doctor's visit with a resulting diagnosis of respiratory disease, which is about 40% larger than the effect in higher quintiles, and the size of 1-standard-deviation gradually increases from 0.037 percentage points in the third quintile to 0.040 percentage points in the fifth quintile. The smaller increase in the likelihood of respiratory disease in more polluted locations can be explained by the behavioral adaptation to the environment, but the effectiveness of the adaptation seems limited among the highly polluted locations.	[Jun, Tackseung; Min, In-sik] Kyung Hee Univ, Dept Econ, Seoul, South Korea; [Jun, Tackseung] Columbia Univ, Dept Econ, Barnard Coll, New York, NY 10027 USA	Kyung Hee University; Columbia University	Jun, T (corresponding author), Kyung Hee Univ, Dept Econ, Seoul, South Korea.; Jun, T (corresponding author), Columbia Univ, Dept Econ, Barnard Coll, New York, NY 10027 USA.	tj32k@khu.ac.kr	Min, Insik/AAH-9100-2020; Jun, Tackseung/ABH-6646-2020	Jun, Tackseung/0000-0002-7701-3411				Aguilera I, 2013, ENVIRON HEALTH PERSP, V121, P387, DOI 10.1289/ehp.1205281; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; Barreca A, 2016, J POLIT ECON, V124, P105, DOI 10.1086/684582; Berhane K, 2000, AM J RESP CRIT CARE, V162, P1723, DOI 10.1164/ajrccm.162.5.2001116; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Brown JS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-12; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Chen H, 2018, LANCET PLANET HEALTH, V2, pE19, DOI 10.1016/S2542-5196(17)30185-7; Chen Hong, 2008, Reviews on Environmental Health, V23, P243; Chien LC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040829; Ciccone G, 1998, OCCUP ENVIRON MED, V55, P771, DOI 10.1136/oem.55.11.771; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022470; Esposito S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-130; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; Gauderman WJ, 2002, AM J RESP CRIT CARE, V166, P76, DOI 10.1164/rccm.2111021; Gauderman WJ, 2014, NEW ENGL J MED, V351, P1051, DOI [10.1016/S0140-6736(07)60037-3, DOI 10.1016/S0140-6736(07)60037-3]; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Halonen JI, 2008, THORAX, V63, P635, DOI 10.1136/thx.2007.091371; Heutel G, 2018, NBER WORKING PAPER, P23271; Hou P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23792; Janke K, 2014, J HEALTH ECON, V38, P23, DOI 10.1016/j.jhealeco.2014.07.002; Johansson C, 2007, ENVIRON MONIT ASSESS, V127, P477, DOI 10.1007/s10661-006-9296-4; Keitt SK, 2004, ENVIRON HEALTH PERSP, V112, P604, DOI 10.1289/ehp.6714; Kelly FJ, 2015, ANN NY ACAD SCI, V1340, P84, DOI 10.1111/nyas.12720; Kim KH, 2015, ENVIRON INT, V74, P136, DOI 10.1016/j.envint.2014.10.005; Lin HL, 2018, J EXPO SCI ENV EPID, V28, P392, DOI 10.1038/s41370-018-0034-0; Londahl J, 2007, INHAL TOXICOL, V19, P109, DOI 10.1080/08958370601051677; Londahl J, 2006, J AEROSOL SCI, V37, P1152, DOI 10.1016/j.jaerosci.2005.11.004; MacIntyre EA, 2014, ENVIRON HEALTH PERSP, V122, P107, DOI 10.1289/ehp.1306755; Magnus P, 1998, INT J EPIDEMIOL, V27, P995, DOI 10.1093/ije/27.6.995; Mearns BM, 2002, NAT REV CARDIOL, V9, P672; Mo Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19939-1; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morgenstern V, 2007, OCCUP ENVIRON MED, V64, P8, DOI 10.1136/oem.2006.028241; Neidell M, 2009, J HUM RESOUR, V44, P450, DOI 10.1353/jhr.2009.0018; Oftedal B, 2009, ENVIRON HEALTH PERSP, V117, P839, DOI 10.1289/ehp.11491; Ostro B, 2001, EPIDEMIOLOGY, V12, P200, DOI 10.1097/00001648-200103000-00012; Ostro B, 2009, ENVIRON HEALTH PERSP, V117, P475, DOI 10.1289/ehp.11848; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Ranzi A, 2014, OCCUP ENVIRON MED, V71, P430, DOI 10.1136/oemed-2013-101867; Rojas-Martinez R, 2007, AM J RESP CRIT CARE, V176, P377, DOI 10.1164/rccm.200510-1678OC; Semenza JC, 2008, ENVIRON RES, V107, P401, DOI 10.1016/j.envres.2008.03.005; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Simoni M, 2015, J THORAC DIS, V7, P34, DOI 10.3978/j.issn.2072-1439.2014.12.10; Stockfelt L, 2017, ENVIRON RES, V158, P61, DOI 10.1016/j.envres.2017.05.036; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; World Bank/IHME, 2016, COST AIR POLL STRENG; Zanobetti A, 2003, ENVIRON HEALTH PERSP, V111, P1188, DOI 10.1289/ehp.5712; Zivin JG, 2009, J ENVIRON ECON MANAG, V58, P119, DOI 10.1016/j.jeem.2009.03.001; Zora JE, 2013, SCI TOTAL ENVIRON, V448, P56, DOI 10.1016/j.scitotenv.2012.11.067	54	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221098	10.1371/journal.pone.0221098	http://dx.doi.org/10.1371/journal.pone.0221098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408479	Green Published, gold, Green Submitted			2022-12-27	WOS:000485009500039
J	Tumendemberel, O; Zedrosser, A; Proctor, MF; Reynolds, HV; Adams, JR; Sullivan, JM; Jacobs, SJ; Khorloojav, T; Tserenbataa, T; Batmunkh, M; Swenson, JE; Waits, LP				Tumendemberel, Odbayar; Zedrosser, Andreas; Proctor, Michael F.; Reynolds, Harry, V; Adams, Jennifer R.; Sullivan, Jack M.; Jacobs, Sarah J.; Khorloojav, Tumennasan; Tserenbataa, Tuya; Batmunkh, Mijiddorj; Swenson, Jon E.; Waits, Lisette P.			Phylogeography, genetic diversity, and connectivity of brown bear populations in Central Asia	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; MULTIPLE SEQUENCE ALIGNMENT; URSUS-ARCTOS POPULATIONS; NATAL DISPERSAL; MICROSATELLITE ANALYSIS; GRIZZLY BEARS; POLYMORPHISM; SOFTWARE; EURASIA; REVEAL	Knowledge of genetic diversity and population structure is critical for conservation and management planning at the population level within a species' range. Many brown bear populations in Central Asia are small and geographically isolated, yet their phylogeographic relationships, genetic diversity, and contemporary connectivity are poorly understood. To address this knowledge gap, we collected brown bear samples from the Gobi Desert (n = 2360), Altai, Sayan, Khentii, and Ikh Khyangan mountains of Mongolia (n = 79), and Deosai National Park in the Himalayan Mountain Range of Pakistan (n = 5) and generated 927 base pairs of mitochondrial DNA (mtDNA) sequence data and genotypes at 13 nuclear DNA microsatellite loci. We documented high levels of mtDNA and nDNA diversity in the brown bear populations of northern Mongolia (Altai, Sayan, Buteeliin nuruu and Khentii), but substantially lower diversity in brown bear populations in the Gobi Desert and Himalayas of Pakistan. We detected 3 brown bear mtDNA phylogeographic groups among bears of the region, with clade 3a1 in Sayan, Khentii, and Buteeliin nuruu mountains, clade 3b in Altai, Sayan, Buteeliin nuruu, Khentii, and Ikh Khyangan, and clade 6 in Gobi and Pakistan. Our results also clarified the phylogenetic relationships and divergence times with other brown bear mtDNA clades around the world. The nDNA genetic structure analyses revealed distinctiveness of Gobi bears and different population subdivisions compared to mtDNA results. For example, genetic distance for nDNA microsatellite loci between the bears in Gobi and Altai (F-ST = 0.147) was less than that of the Gobi and Pakistan (F-ST = 0.308) suggesting more recent male-mediated nuclear gene flow between Gobi and Altai than between Gobi and the Pakistan bears. Our results provide valuable information for conservation and management of bears in this understudied region of Central Asia and highlight the need for special protection and additional research on Gobi brown bears.	[Tumendemberel, Odbayar; Zedrosser, Andreas] Univ South Eastern Norway, Dept Nat Sci & Environm Hlth, Bo i Telemark, Norway; [Proctor, Michael F.] Birchdale Ecol, Kaslo, BC, Canada; [Reynolds, Harry, V] Gobi Bear Fund Inc, Fairbanks, AK USA; [Adams, Jennifer R.; Waits, Lisette P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Sullivan, Jack M.; Jacobs, Sarah J.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Khorloojav, Tumennasan] Mongolian Acad Sci, Inst Gen & Expt Biol, Genet Lab, Ulan Bator, Mongolia; [Tserenbataa, Tuya] Sunshine Village Complex, Ulan Bator, Mongolia; [Batmunkh, Mijiddorj] Mongolian Chinese Joint Mol Biol Lab, Ulan Bator, Mongolia; [Swenson, Jon E.] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway	Idaho; University of Idaho; Idaho; University of Idaho; Mongolian Academy of Sciences; Norwegian University of Life Sciences	Tumendemberel, O (corresponding author), Univ South Eastern Norway, Dept Nat Sci & Environm Hlth, Bo i Telemark, Norway.	odbayar.tumendemberel@usn.no	Swenson, Jon/AAE-2890-2019; Jacobs, Sarah/S-9703-2017	Jacobs, Sarah/0000-0002-3125-6266; Tumendemberel, Odbayar/0000-0002-2105-3836; Proctor, Michael/0000-0002-9461-2774	Mongolian Ministry of Environment and Tourism; University of South-Eastern Norway, Gobi Bear Project; International Association for Bear Research and Management; Mongolian Ministry of Education, Culture and Science	Mongolian Ministry of Environment and Tourism; University of South-Eastern Norway, Gobi Bear Project; International Association for Bear Research and Management; Mongolian Ministry of Education, Culture and Science	The project was supported by the Mongolian Ministry of Environment and Tourism (formerly the Mongolian Ministry of Nature and Green Development), University of South-Eastern Norway, Gobi Bear Project, and International Association for Bear Research and Management. O. Tumendemberel was granted a graduate student scholarship-loan from Mongolian Ministry of Education, Culture and Science in 2016-2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JR, 2007, CONSERV GENET, V8, P123, DOI 10.1007/s10592-006-9154-5; Allendorf FW., 2009, CONSERV GENET; Anijalg P, 2018, J BIOGEOGR, V45, P394, DOI 10.1111/jbi.13126; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Badamjav L, 2007, STATUS BEARS MONGOLI; Bannikov AG., 1954, MAMMALS MONGOLIAN PE; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Bellemain E, 2007, BIOL CONSERV, V134, P537, DOI 10.1016/j.biocon.2006.09.004; Boitani L, 2012, TECH ECOL CONSERVAT, P1, DOI 10.1093/acprof:oso/9780199558520.001.0001; Bold A, 1967, J I BIOL ACAD SCI MO, V2, P5; Bon C, 2008, P NATL ACAD SCI USA, V105, P17447, DOI 10.1073/pnas.0806143105; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Breen M, 2001, GENOME RES, V11, P1784, DOI 10.1101/gr.189401; Calvignac S, 2009, DIVERS DISTRIB, V15, P742, DOI 10.1111/j.1472-4642.2009.00586.x; Chestin IE, 1992, ANN ZOOLOGICI FENNIC; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frenzel B, 1992, ATLAS PALEOCLIMATES; Galbreath GJ, 2007, URSUS, V18, P129, DOI 10.2192/1537-6176(2007)18[129:GROCAP]2.0.CO;2; GOLDSTEIN DB, 1995, GENETICS, V139, P463; GRACHEV YA, 1982, ZOOL ZH, V61, P1242; Guskov VY, 2018, BIOL BULL+, V45, P368, DOI 10.1134/S1062359018040064; Gustafson EP, 1978, VERTEBRATE FAUNAS PL; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heptner VG, 1998, MAMMALS SOVIET UNION; Hirata D, 2013, MOL BIOL EVOL, V30, P1644, DOI 10.1093/molbev/mst077; Hou WR, 2007, INT J BIOL SCI, V3, P85; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Kopatz A, 2017, ECOL EVOL, V7, P10721, DOI 10.1002/ece3.3577; Kopatz A, 2012, CONSERV GENET, V13, P681, DOI 10.1007/s10592-012-0317-2; Korsten M, 2009, MOL ECOL, V18, P1963, DOI 10.1111/j.1365-294X.2009.04163.x; Kumar V, 2017, SCI REP-UK, V7, DOI 10.1038/srep46487; Lan TY, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1804; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Masuda R, 1998, HEREDITAS, V128, P277, DOI 10.1111/j.1601-5223.1998.00277.x; Matsuhashi T, 2001, ZOOL SCI, V18, P1137, DOI 10.2108/zsj.18.1137; McLellan BN, 2001, CAN J ZOOL, V79, P838, DOI 10.1139/cjz-79-5-838; Meredith EP, 2009, CONSERV GENET, V10, P693, DOI 10.1007/s10592-008-9617-y; Michel S., 2017, IUCN RED LIST THREAT, V2017; Miller CR, 2006, MOL ECOL, V15, P4477, DOI 10.1111/j.1365-294X.2006.03097.x; Miller CR, 2002, GENETICS, V160, P357; Moritz C, 1998, MOL ECOL, V7, P419, DOI 10.1046/j.1365-294x.1998.00317.x; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Ognev SJG, 1931, MAMMALS E EUROPE NO, V2; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; PAETKAU D, 1994, MOL ECOL, V3, P489, DOI 10.1111/j.1365-294X.1994.tb00127.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peyton B., 1999, BEARS STATUS SURVEY; POTTER S, 1974, GENETICS, V77, pS52; Pritchard JK, 2000, GENETICS, V155, P945; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; RANDI E, 1994, HEREDITY, V73, P480, DOI 10.1038/hdy.1994.146; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; SAITOU N, 1987, JPN J GENET, V62, P547; Salomashkina VV, 2014, BIOL BULL+, V41, P38, DOI 10.1134/S1062359014010087; Schaller G, 1993, OBSERVATIONS GOBI BR, P110; Shiirevdamba T., 2013, MONGOLIAN RED BOOK U; Sokolov V, 1992, INT S ERF BIOL RESS; Sokolov VE, 1978, GEOGRAFIYA DINAMIKA, V10, P112; Sommer RS, 2005, MAMMAL REV, V35, P156, DOI 10.1111/j.1365-2907.2005.00063.x; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1046/j.1365-294X.1997.00251.x; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; Tumendemberel O, 2015, URSUS, V26, P129, DOI 10.2192/URSUS-D-15-00001.1; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Waits LP, 1998, CONSERV BIOL, V12, P408, DOI 10.1046/j.1523-1739.1998.96351.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wakkinen WL, 2004, URSUS, V15, P65, DOI 10.2192/1537-6176(2004)015<0065:DAPTOG>2.0.CO;2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zedrosser A, 2007, ANIM BEHAV, V74, P369, DOI 10.1016/j.anbehav.2006.09.015; Zhirnov L, 1985, BOLISHOI GOBIISKII Z; Zwickl D, 2006, THESIS U TEXAS AUSTI	91	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220746	10.1371/journal.pone.0220746	http://dx.doi.org/10.1371/journal.pone.0220746			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408475	Green Published, gold, Green Submitted			2022-12-27	WOS:000485009500017
J	Kobayashi, K; Kegasa, T; Hwang, SW; Sugiyama, JJ				Kobayashi, Kayoko; Kegasa, Takahiro; Hwang, Sung-Wook; Sugiyama, Junji			Anatomical features of Fagaceae wood statistically extracted by computer vision approaches: Some relationships with evolution	PLOS ONE			English	Article							IDENTIFICATION; CLASSIFICATION; QUERCUS; IMAGES; OAKS	The anatomical structure of wood is complex and contains considerable information about its specific species, physical properties, growth environment, and other factors. While conventional wood anatomy has been established by systematizing the xylem anatomical features, which enables wood identification generally up to genus level, it is difficult to describe all the information comprehensively. This study apply two computer vision approaches to optical micrographs: the scale-invariant feature transform algorithm and connected-component labelling. They extract the shape and pore size information, respectively, statistically from the whole micrographs. Both approaches enable the efficient detection of specific features of 18 species from the family Fagaceae. Although the methods ignore the positional information, which is important for the conventional wood anatomy, the simple information on the shape or size of the elements is enough to describe the species-specificity of wood. In addition, according to the dendrograms calculated from the numerical distances of the features, the closeness of some taxonomic groups is inconsistent with the types of porosity, which is one of the typical classification systems for wood anatomy, but consistent with the evolution based on molecular phylogeny; for example, ring-porous group Cerris and radial-porous group Ilex are nested in the same cluster. We analyse which part of the wood structure gave the taxon-specific information, indicating that the latewood zone of group Cerris is similar to the whole zone of group Ilex. Computer vision approaches provide statistical information that uncovers new aspects of wood anatomy that have been overlooked by conventional visual inspection.	[Kobayashi, Kayoko; Kegasa, Takahiro; Hwang, Sung-Wook; Sugiyama, Junji] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Sugiyama, Junji] Nanjing Forestry Univ, Coll Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Kobayashi, Kayoko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan	Kyoto University; Nanjing Forestry University; University of Tokyo	Kobayashi, K; Sugiyama, JJ (corresponding author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan.; Sugiyama, JJ (corresponding author), Nanjing Forestry Univ, Coll Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China.; Kobayashi, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan.	aka.kobayashi@mail.ecc.u-tokyo.ac.jp; sugiyama.junji.6m@kyoto-u.ac.jp	Sugiyama, Junji/ABD-5589-2020	Sugiyama, Junji/0000-0002-5388-4925; Hwang, Sung-Wook/0000-0001-8265-8700; Kobayashi, Kayoko/0000-0003-0459-7900	RISH Cooperative Research (database); Japan Society for the Promotion of Science [25252033, 18H05485]	RISH Cooperative Research (database); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by RISH Cooperative Research (database) to KK and JS. This work was also partially supported by Grants-in-Aid for Scientific Research (Grant Numbers 25252033, 18H05485) from the Japan Society for the Promotion of Science to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas P, 2004, IAWA J, V25, P1, DOI 10.1163/22941932-90000349; Brunel G, 2014, ANN BOT-LONDON, V114, P829, DOI 10.1093/aob/mcu119; Camus A, 1936, MONOGRAPHIE GENRE QU, VVII; Camus A., 1936, ENCY EC SYLVICULTURE, VVIII, DOI DOI 10.1038/srep12395; Deng M, 2018, MOL PHYLOGENET EVOL, V119, P170, DOI 10.1016/j.ympev.2017.11.003; Denk T, 2010, TAXON, V59, P351, DOI 10.1002/tax.592002; Hafemann LG, 2014, INT C PATT RECOG, P1103, DOI 10.1109/ICPR.2014.199; Hwang SW, 2018, J WOOD SCI, V64, P69, DOI 10.1007/s10086-017-1680-x; IAWA Committee, 1989, IAWA B, V10, P219, DOI DOI 10.1163/22941932-90000496; Jones E., SCIPY OPEN SOURCE SC; Khalid M, 2008, INT J SIMUL SYST SCI, V9, P9; Kobayashi K, 2017, J WOOD SCI, V63, P322, DOI 10.1007/s10086-017-1625-4; Martins J, 2013, MACH VISION APPL, V24, P567, DOI 10.1007/s00138-012-0417-5; Martins JG, 2015, MACH VISION APPL, V26, P279, DOI 10.1007/s00138-015-0659-0; Noshiro S, 2011, IAWA J, V32, P383, DOI 10.1163/22941932-90000066; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; R Development Core Team, 2009, R LANG ENV STAT COMP; Shen Pan, 2011, Advances in Data Mining Applications and Theoretical Aspects. Proceedings 11th Industrial Conference, ICDM 2011, P147, DOI 10.1007/978-3-642-23184-1_12; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; von Arx G, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00781; von Arx G, 2014, DENDROCHRONOLOGIA, V32, P290, DOI 10.1016/j.dendro.2013.12.001; Wang B-H, 2010, WOOD RECOGNITION BAS, DOI [10.1109/ICCASM.2010.5619388, DOI 10.1109/ICCASM.2010.5619388]; Wang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076101; Wang HJ, 2013, NEUROCOMPUTING, V116, P192, DOI 10.1016/j.neucom.2012.02.045; Yadav AR, 2015, APPL SOFT COMPUT, V32, P101, DOI 10.1016/j.asoc.2015.03.039; Yadav AR, 2013, NAT CONF COMPUT VIS; Yadav AR, 2014, 2014 INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING AND INTEGRATED NETWORKS (SPIN), P9, DOI 10.1109/SPIN.2014.6776912; Yan MX, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00569; Yusof R, 2013, MACH VISION APPL, V24, P1589, DOI 10.1007/s00138-013-0526-9; Yusof R, 2010, 2010 12TH INTERNATIONAL CONFERENCE ON COMPUTER MODELLING AND SIMULATION (UKSIM), P289, DOI 10.1109/UKSIM.2010.61	31	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220762	10.1371/journal.pone.0220762	http://dx.doi.org/10.1371/journal.pone.0220762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404108	Green Submitted, Green Published, gold			2022-12-27	WOS:000485006800029
J	Stangou, M; Marinaki, S; Papachristou, E; Kolovou, K; Sambani, E; Zerbala, S; Papadea, P; Balafa, O; Rapsomanikis, KP; Andrikos, A; Manolakaki, P; Papadopoulou, D; Mitsopoulos, E; Liakou, H; Andronikidi, PE; Choulitoudi, V; Moustakas, G; Galitsiou, D; Dafnis, E; Stylianou, K; Stefanidis, I; Golfinopoulos, S; Panagoutsos, S; Tsilivigkou, M; Papadogianakis, A; Tzanakis, I; Sioulis, A; Vlachakos, D; Grapsa, E; Spaia, S; Kaperonis, N; Paliouras, C; Dioudis, C; Papoulidou, F; Apostolou, T; Iatrou, C; Boletis, I; Goumenos, D; Papagianni, A				Stangou, Maria; Marinaki, Smaragdi; Papachristou, Evangelos; Kolovou, Kyriaki; Sambani, Erasmia; Zerbala, Synodi; Papadea, Panagiota; Balafa, Olga; Rapsomanikis, Karolos-Pavlos; Andrikos, Aimilios; Manolakaki, Panagiota; Papadopoulou, Dorothea; Mitsopoulos, Efstathios; Liakou, Helen; Andronikidi, Paraskevi-Evi; Choulitoudi, Vasiliki; Moustakas, George; Galitsiou, Dimitra; Dafnis, Eugene; Stylianou, Kostas; Stefanidis, Ioannis; Golfinopoulos, Spyridon; Panagoutsos, Stylianos; Tsilivigkou, Maria; Papadogianakis, Apostolos; Tzanakis, Ioannis; Sioulis, Athanasios; Vlachakos, Dimitrios; Grapsa, Eirini; Spaia, Sophia; Kaperonis, Nikolaos; Paliouras, Christos; Dioudis, Christos; Papoulidou, Fani; Apostolou, Theofanis; Iatrou, Christos; Boletis, Ioannis; Goumenos, Dimitrios; Papagianni, Aikaperini			Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy	PLOS ONE			English	Article							TACROLIMUS; CORTICOSTEROIDS; CYCLOSPORINE; THERAPY; TARGET	Introduction Management of the Primary Membranous Nephropathy (PMN) usually involves administration of immunosuppressives. Cyclophosphamide (Cyclo) and Calcineurin Inhibitors (CNIs) are both widely used but only limited data exist to compare their efficacy in long term follow-up. Aim The aim of the present study was to estimate and compare long term effects of Cyclo and CNIs in patients with PMN. Patients-methods Clinical data, histologic findings and long term outcome were retrospectively studied. The response to treatment and rate of relapse was compared between patients treated with CNIs or Cyclo based immunosuppressive regimens. Results Twenty three centers participated in the study, with 752 PMN patients (Mean age 53.4(14-87) yrs, M/F 467/285), followed for 10.1 +/- 5.7 years. All patients were initially treated with Renin Angiotensin Aldosterone System inhibitors (RAASi) for at least 6 months. Based on their response and tolerance to initial treatment, patients were divided into 3 groups, group I with spontaneous remission, who had no further treatment, group II, continued on RAASi only, and group III on RAASi+immunosuppression. Immunosuppressive regimes were mainly based on CNIs or Cyclo. Frequent relapses and failure to treatment were more common between patients who had started on CNIs (n = 381) compared to those initially treated with Cyclo (n = 110), relapse rate: 25.2% vs. 6.4%, p<0.0001, and no response rate: 22.5% vs. 13.6%, p = 0.04, respectively. Conclusions Long term follow up showed that administration of Cyclo in PMN is followed by better preservation of renal function, increased response rate and less frequent relapses, compared to CNIs.	[Stangou, Maria; Sambani, Erasmia; Liakou, Helen; Papagianni, Aikaperini] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Dept Nephrol, Thessaloniki, Greece; [Marinaki, Smaragdi; Kolovou, Kyriaki; Boletis, Ioannis] Natl & Kapodistrian Univ, Laiko Gen Hosp, Dept Nephrol, Athens, Greece; [Papachristou, Evangelos; Goumenos, Dimitrios] Univ Hosp Patras, Dept Nephrol, Patras, Greece; [Zerbala, Synodi; Papadea, Panagiota; Iatrou, Christos] Gen Hosp Nikaia, Dept Nephrol, Piraeus, Greece; [Balafa, Olga; Rapsomanikis, Karolos-Pavlos] Univ Hosp Ioannina, Dept Nephrol, Ioannina, Greece; [Andrikos, Aimilios; Manolakaki, Panagiota] Hatzikosta Gen Hosp Ioannina, Dept Nephrol, Ioannina, Greece; [Papadopoulou, Dorothea; Mitsopoulos, Efstathios] Papageorgiou Gen Hosp Thessaloniki, Dept Nephrol, Thessaloniki, Greece; [Andronikidi, Paraskevi-Evi; Choulitoudi, Vasiliki; Apostolou, Theofanis] Evangelismos Gen Hosp, Dept Nephrol, Athens, Greece; [Moustakas, George; Galitsiou, Dimitra] Gennimatas Gen Hosp Athens, Dept Nephrol, Athens, Greece; [Dafnis, Eugene; Stylianou, Kostas] Univ Hosp Heraklion, Dept Nephrol, Iraklion, Greece; [Stefanidis, Ioannis; Golfinopoulos, Spyridon] Univ Hosp Larissa, Dept Nephrol, Larisa, Greece; [Panagoutsos, Stylianos] Univ Hosp Alexandroupolis, Dept Nephrol, Alexandroupolis, Greece; [Tsilivigkou, Maria] Tzaneion Gen Hosp Piraeus, Dept Nephrol, Athens, Greece; [Papadogianakis, Apostolos] Venizelio Gen Hosp Heraklion, Dept Nephrol, Iraklion, Greece; [Tzanakis, Ioannis] Gen Hosp Chania, Dept Nephrol, Khania, Greece; [Sioulis, Athanasios] AHEPA Univ Gen Hosp, Dept Med 1, Sect Nephrol, Thessaloniki, Greece; [Vlachakos, Dimitrios] Natl & Kapodistrian Univ, Attikon Univ Hosp, Dept Nephrol, Athens, Greece; [Grapsa, Eirini] Univ Athens, Aretaieio Hosp, Dept Nephrol, Athens, Greece; [Spaia, Sophia] Gen Hosp Thessaloniki Agios Pavlos, Dept Nephrol, Thessaloniki, Greece; [Kaperonis, Nikolaos] Hellenic Red Cross Hosp Korgialeneio Benakeio, Dept Nephrol, Athens, Greece; [Paliouras, Christos] Gen Hosp Rhodes, Dept Nephrol, Rhodes, Greece; [Dioudis, Christos] Gen Hosp Drama, Renal Unit, Drama, Greece; [Papoulidou, Fani] Gen Hosp Kavala, Dept Nephrol, Kavala, Greece	Aristotle University of Thessaloniki; Laiko General Hospital; National & Kapodistrian University of Athens; University of Patras; University Hospital Ioannina; Papageorgiou Hospital; Evangelismos Hospital; University Hospital of Heraklion; General University Hospital of Larissa; Aristotle University of Thessaloniki; Ahepa University Hospital; National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens	Stangou, M (corresponding author), Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Dept Nephrol, Thessaloniki, Greece.	mstangou@auth.gr	Smaragdi, Marinaki/AAM-6731-2020; Olga, Balafa/N-9543-2019; Eirini, Grapsa/AAG-3121-2020; Panagoutsos, Stylianos/AAO-9052-2021	Olga, Balafa/0000-0002-1467-1492; Panagoutsos, Stylianos/0000-0003-3857-3819; Stefanidis, Ioannis/0000-0002-5515-8089; Stangou, Maria/0000-0003-2496-9863; Papagianni, Aikaterini/0000-0003-0437-5208				Alexopoulos E, 2006, NEPHROL DIAL TRANSPL, V21, P3127, DOI 10.1093/ndt/gfl360; [Anonymous], 2012, Kidney Int Suppl (2011), V2, P186; Bae E, 2018, ARCH GERONTOL GERIAT, V76, P175, DOI 10.1016/j.archger.2018.03.002; Bech AP, 2014, CLIN J AM SOC NEPHRO, V9, P1386, DOI 10.2215/CJN.10471013; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bomback AS, 2018, AM J NEPHROL, V47, P30, DOI 10.1159/000481635; Cai JY, 2018, NEPHROL DIAL TRANSPL, V33, P1968, DOI 10.1093/ndt/gfy001; Cattran DC, 2017, KIDNEY INT, V91, P566, DOI 10.1016/j.kint.2016.09.048; Cattran DC, 2001, KIDNEY INT, V59, P1484, DOI 10.1046/j.1523-1755.2001.0590041484.x; Cattran DC, 1997, KIDNEY INT, V51, P901, DOI 10.1038/ki.1997.127; Chen M, 2010, AM J MED SCI, V339, P233, DOI 10.1097/MAJ.0b013e3181ca3a7d; Couser WG, 2017, CLIN J AM SOC NEPHRO, V12, P983, DOI 10.2215/CJN.11761116; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Gupta S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0615-5; He LY, 2013, J NEPHROL, V26, P564, DOI 10.5301/jn.5000199; Hofstra JM, 2010, NEPHROL DIAL TRANSPL, V25, P129, DOI 10.1093/ndt/gfp390; Horvatic I, 2012, PATHOL RES PRACT, V208, P662, DOI 10.1016/j.prp.2012.08.004; Hoxha E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110681; Lai WL, 2015, J FORMOS MED ASSOC, V114, P102, DOI 10.1016/j.jfma.2014.11.002; Li PKT, 2013, AM J MED, V126, P162, DOI 10.1016/j.amjmed.2012.06.028; Li WH, 2018, CLIN CHIM ACTA, V482, P178, DOI 10.1016/j.cca.2018.04.009; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; PEI Y, 1992, KIDNEY INT, V42, P960, DOI 10.1038/ki.1992.374; Peng L, 2016, J FORMOS MED ASSOC, V115, P11, DOI 10.1016/j.jfma.2015.07.021; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; Ponticelli C, 1998, J AM SOC NEPHROL, V9, P444; Ponticelli C, 2018, AUTOIMMUN REV, V17, P1022, DOI 10.1016/j.autrev.2018.04.007; Ramachandran R, 2017, KIDNEY INT REP, V2, P610, DOI 10.1016/j.ekir.2017.02.004; Ramachandran R, 2016, NEPHROLOGY, V21, P139, DOI 10.1111/nep.12569; Xu J, 2013, CONTRIB NEPHROL, V181, P152, DOI 10.1159/000348475; Yue C, 2018, J RHEUMATOL, V45, P655, DOI 10.3899/jrheum.170561	31	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0217116	10.1371/journal.pone.0217116	http://dx.doi.org/10.1371/journal.pone.0217116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404062	Green Submitted, Green Published, gold			2022-12-27	WOS:000485006800002
J	Kulawiak, DA; Lober, J; Bar, M; Engel, H				Kulawiak, Dirk Alexander; Loeber, Jakob; Baer, Markus; Engel, Harald			Active poroelastic two-phase model for the motion of physarum microplasmodia	PLOS ONE			English	Article							PROTOPLASMIC DROPLETS; CELL MOTION; PATTERNS; OSCILLATIONS; LOCOMOTION; MECHANICS; CONTRACTION; PLASMODIUM; MIGRATION; MOVEMENT	The onset of self-organized motion is studied in a poroelastic two-phase model with free boundaries for Physarum microplasmodia (MP). In the model, an active gel phase is assumed to be interpenetrated by a passive fluid phase on small length scales. A feedback loop between calcium kinetics, mechanical deformations, and induced fluid flow gives rise to pattern formation and the establishment of an axis of polarity. Altogether, we find that the calcium kinetics that breaks the conservation of the total calcium concentration in the model and a nonlinear friction between MP and substrate are both necessary ingredients to obtain an oscillatory movement with net motion of the MP. By numerical simulations in one spatial dimension, we find two different types of oscillations with net motion as well as modes with time-periodic or irregular switching of the axis of polarity. The more frequent type of net motion is characterized by mechano-chemical waves traveling from the front towards the rear. The second type is characterized by mechano-chemical waves that appear alternating from the front and the back. While both types exhibit oscillatory forward and backward movement with net motion in each cycle, the trajectory and gel flow pattern of the second type are also similar to recent experimental measurements of peristaltic MP motion. We found moving MPs in extended regions of experimentally accessible parameters, such as length, period and substrate friction strength. Simulations of the model show that the net speed increases with the length, provided that MPs are longer than a critical length of approximate to 120 mu m. Both predictions are in line with recent experimental observations.	[Kulawiak, Dirk Alexander; Loeber, Jakob; Engel, Harald] TU Berlin, Inst Theoret Phys, Berlin, Germany; [Loeber, Jakob] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Baer, Markus] Phys Tech Bundesanstalt, Berlin, Germany	Technical University of Berlin; Max Planck Society; Physikalisch-Technische Bundesanstalt (PTB)	Engel, H (corresponding author), TU Berlin, Inst Theoret Phys, Berlin, Germany.	harald.engel@tu-berlin.de	Engel, Harald/ABD-2272-2020	Kulawiak, Dirk Alexander/0000-0002-9848-3818	German Science Foundation (DFG) [GRK 1558, SFB 910]	German Science Foundation (DFG)(German Research Foundation (DFG))	DAK was funded by the German Science Foundation (DFG) within the GRK 1558 and the collaborative research center SFB 910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim K, 2017, P NATL ACAD SCI USA, V114, P5136, DOI 10.1073/pnas.1618114114; Alonso S, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8a1d; Alonso S, 2016, PHYSICA D, V318, P58, DOI 10.1016/j.physd.2015.09.017; Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; Bauerle FK, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8a21; Banks HT, 2011, ADV APPL MATH MECH, V3, P1, DOI 10.4208/aamm.10-m1030; Barnhart EL, 2010, BIOPHYS J, V98, P933, DOI 10.1016/j.bpj.2009.10.058; Baumgarten W, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026003; Beekman M, 2015, J MOL BIOL, V427, P3734, DOI 10.1016/j.jmb.2015.07.007; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Boisseau RP, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0446; Coussy O., 2004, POROMECHANICS; DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0; DeSimone A, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12085-x; Dirnberger M, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa6e7b; Epstein Irving R, 2017, Chemistry, V23, P11181, DOI 10.1002/chem.201700725; Fessel A, 2015, NANO COMMUN NETW, V6, P87, DOI 10.1016/j.nancom.2015.04.001; Fessel A, 2018, J PHYS D APPL PHYS, V51, DOI 10.1088/1361-6463/aa9d2c; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Gross P, 2017, ANNU REV BIOPHYS, V46, P337, DOI 10.1146/annurev-biophys-070816-033602; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Joanny JF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/422; Joanny JF, 2009, HFSP J, V3, P94, DOI 10.2976/1.3054712; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; Julien JD, 2018, P NATL ACAD SCI USA, V115, P10612, DOI 10.1073/pnas.1805981115; Kopf MH, 2013, PHYSICA D, V259, P48, DOI 10.1016/j.physd.2013.05.009; Kopf MH, 2013, SOFT MATTER, V9, P3727, DOI 10.1039/c3sm26955h; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Kulawiak DA, 2019, J PHYS D APPL PHYS, V52, DOI 10.1088/1361-6463/aae41d; Kumar KV, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.208101; Kuroda S, 2015, J EXP BIOL, V218, P3729, DOI 10.1242/jeb.124354; Kuroda S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0205; Lai JH, 2010, J EXP BIOL, V213, P3920, DOI 10.1242/jeb.046706; Larripa K, 2006, PHYSICA A, V372, P113, DOI 10.1016/j.physa.2006.05.008; Lewis OL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1359; Lober J, 2014, SOFT MATTER, V10, P1365, DOI 10.1039/c3sm51597d; Lu XJ, 2013, CHEM COMMUN, V49, P7690, DOI 10.1039/c3cc44480e; Matsumoto K, 2008, BIOPHYS J, V94, P2492, DOI 10.1529/biophysj.107.113050; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Mondesert-Deveraux S, 2018, MOL CELLULAR BIOMECH, V15, P22; Nickaeen M, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005862; Nishikawa M, 2017, ELIFE, V6, DOI [10.7554/eLife.19595.001, 10.7554/eLife.19595, 10.7554/eLife.30537]; Oettmeier C, 2016, CLOSE LOOK AMOEBOID; Oettmeier C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215622; Oettmeier C, 2018, J PHYS D APPL PHYS, V51, DOI 10.1088/1361-6463/aab147; Oettmeier C, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8699; Radszuweit M, 2010, EUR PHYS J-SPEC TOP, V191, P159, DOI 10.1140/epjst/e2010-01348-2; Radszuweit M., 2013, ACTIVE POROELASTIC M; Radszuweit M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099220; Radszuweit M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.138102; Ren L, 2017, P NATL ACAD SCI USA, V114, P8704, DOI 10.1073/pnas.1704094114; Ren L, 2016, ANGEW CHEM INT EDIT, V55, P14299, DOI 10.1002/anie.201608367; Rieu JP, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0099; Rodiek B, 2015, EUR PHYS J-SPEC TOP, V224, P1199, DOI 10.1140/epjst/e2015-02455-2; Rodiek B, 2015, EUR BIOPHYS J BIOPHY, V44, P349, DOI 10.1007/s00249-015-1028-7; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Taber LA, 2011, J MECH MATER STRUCT, V6, P569, DOI 10.2140/jomms.2011.6.569; Takagi S, 2008, PHYSICA D, V237, P420, DOI 10.1016/j.physd.2007.09.012; Tanaka Y, 2012, J R SOC INTERFACE, V9, P222, DOI 10.1098/rsif.2011.0339; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; Weber CA, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.248003; Werthmann B, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa8e2b; YOSHIMOTO Y, 1984, CELL STRUCT FUNCT, V9, P135, DOI 10.1247/csf.9.135; YOSHIMOTO Y, 1981, CELL MOTIL CYTOSKEL, V1, P433, DOI 10.1002/cm.970010404; Zhang S, 2017, J PHYS D	65	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0217447	10.1371/journal.pone.0217447	http://dx.doi.org/10.1371/journal.pone.0217447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398215	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000005
J	Alkawareek, MY; Bahlool, A; Abulateefeh, SR; Alkilany, AM				Alkawareek, Mahmoud Y.; Bahlool, Ahmad; Abulateefeh, Samer R.; Alkilany, Alaaldin M.			Synergistic antibacterial activity of silver nanoparticles and hydrogen peroxide	PLOS ONE			English	Article							MECHANISMS; GENERATION; OXIDATION	The increasing challenge of antibiotic resistance requires not only the discovery of new antibiotics, but also the development of new alternative approaches. Herein, the synergistic antibacterial activity of silver nanoparticles and hydrogen peroxide combination is reported. Unlike the bacteriostatic or slightly bactericidal activity achieved by using each agent alone, using these two agents in combination, even at relatively low concentrations, resulted in complete eradication of both the Gram negative Escherichia coli and the Gram positive Staphylococcus aureus in short treatment times indicating a clear synergistic effect between them. Modifying the surface chemistry of silver nanoparticles and the accompanied change in their surface charge enabled a further enhancement of such synergistic effect implying the importance of this aspect. Mechanistically, a Fenton-like reaction between silver nanoparticles and hydrogen peroxide is discussed and hypothesized to be the basis of the observed synergy. Achieving such a significant antibacterial activity at low concentrations reduces the potential toxicity of these agents and hence enables their utilization as an alternative antibacterial approach in wider range of applications.	[Alkawareek, Mahmoud Y.; Bahlool, Ahmad; Abulateefeh, Samer R.; Alkilany, Alaaldin M.] Univ Jordan, Sch Pharm, Amman, Jordan	University of Jordan	Alkawareek, MY (corresponding author), Univ Jordan, Sch Pharm, Amman, Jordan.	m.alkawareek@ju.edu.jo	Abulateefeh, Samer/H-3874-2015; Alkawareek, Mahmoud/H-5871-2012	Abulateefeh, Samer/0000-0001-7980-7429; Bahlool, Ahmad/0000-0002-9992-7476; Alkawareek, Mahmoud/0000-0002-4852-0617	Deanship of Scientific Research, The University of Jordan [2100]	Deanship of Scientific Research, The University of Jordan	This work was supported by the Deanship of Scientific Research, The University of Jordan [grant number: 2100], URL: research.ju.edu.jo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Deanship of Scientific Research, The University of Jordan [grant number: 2100]. The authors also acknowledge the technical assistance of Miss Bayan Tbakhi and Miss Aya Barqawi.	Bastus NG, 2014, CHEM MATER, V26, P2836, DOI 10.1021/cm500316k; Bleyer L, 1925, BIOCHEM Z, V161, P91; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1; Dai XM, 2016, ACS APPL MATER INTER, V8, P25798, DOI 10.1021/acsami.6b09267; Feng ZV, 2015, CHEM SCI, V6, P5186, DOI 10.1039/c5sc00792e; Fu PP, 2014, J FOOD DRUG ANAL, V22, P64, DOI 10.1016/j.jfda.2014.01.005; Gorman SP, 2011, HUGO RUSSELLS PHARM, P312; He D, 2012, LANGMUIR, V28, P10266, DOI 10.1021/la300929g; He WW, 2012, BIOMATERIALS, V33, P7547, DOI 10.1016/j.biomaterials.2012.06.076; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Iuga C, 2011, J PHYS CHEM B, V115, P12234, DOI 10.1021/jp206347u; Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Laura G.C., 2014, AM J ENV ENG, V4, P56, DOI DOI 10.5923/J.AJEE.20140403.03; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Linley E, 2012, J ANTIMICROB CHEMOTH, V67, P1589, DOI 10.1093/jac/dks129; Martin NL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131345; Naylor NR, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0336-y; Paramelle D, 2014, ANALYST, V139, P4855, DOI 10.1039/c4an00978a; Raza MA, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6040074; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Song KC, 2009, KOREAN J CHEM ENG, V26, P153, DOI 10.1007/s11814-009-0024-y; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Watt Barbara E, 2004, Toxicol Rev, V23, P51, DOI 10.2165/00139709-200423010-00006	25	20	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220575	10.1371/journal.pone.0220575	http://dx.doi.org/10.1371/journal.pone.0220575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393906	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500043
J	Burnell, SEA; Spencer-Harty, S; Howarth, S; Bodger, O; Kynaston, H; Morgan, C; Doak, SH				Burnell, Stephanie E. A.; Spencer-Harty, Samantha; Howarth, Suzie; Bodger, Owen; Kynaston, Howard; Morgan, Claire; Doak, Shareen H.			Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer	PLOS ONE			English	Article							6-TRANSMEMBRANE EPITHELIAL ANTIGEN; MOLECULAR-CLONING; TRANSPORT; STAMP2; GROWTH; MEN	Prostate cancer is the second most common cancer diagnosed in men worldwide; however, few patients are affected by clinically significant disease within their lifetime. Unfortunately, the means to discriminate between patients with indolent disease and those who progress to aggressive prostate cancer is currently unavailable, resulting in over-treatment of patients. We therefore aimed to determine biomarkers of prostate cancer that can be used in the clinic to aid the diagnosis and prognosis. Immunohistochemistry analysis was carried out on prostate cancer specimens with a range of Gleason scores. Samples were stained and analysed for intensity of the Seven Transmembrane Epithelial Antigen of the Prostate (STEAP)-1, -2, -3, -4 and the Divalent Metal Transporter 1 (DMT1) proteins to determine suitable biomarkers for classification of patients likely to develop aggressive prostate cancer. Additionally, these proteins were also analysed to determine whether any would be able to predict future relapse using Kaplan Meier analysis. Data generated demonstrated that the protein expression levels of STEAP2 correlated significantly with Gleason score; furthermore, STEAP4 was a significant predictor of relapse. This data indicates that STEAP2 could be potential prognostic candidate for use in combination with the current prostate cancer detection methods and the presence of STEAP4 could be an indicator of possible relapse.	[Burnell, Stephanie E. A.; Bodger, Owen; Morgan, Claire; Doak, Shareen H.] Swansea Univ, Med Sch, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales; [Spencer-Harty, Samantha] Abertawe Bro Morgannwg Univ Hlth Board, Singleton Hosp, Cellular Pathol, Sketty Lane, Swansea, W Glam, Wales; [Howarth, Suzie] Abertawe Bro Morgannwg Univ Hlth Board, Morriston Hosp, Histopathol, Swansea, W Glam, Wales; [Kynaston, Howard] Cardiff Univ, Cardiff Sch Med, Heath Pk, Cardiff, S Glam, Wales	Swansea University; Singleton Hospital; Morriston Hospital; Cardiff University	Doak, SH (corresponding author), Swansea Univ, Med Sch, Inst Life Sci, Singleton Pk, Swansea, W Glam, Wales.	S.H.Doak@swansea.ac.uk		Burnell, Stephanie/0000-0003-3920-6180; Morgan, Claire/0000-0002-3969-0710; Bodger, Owen/0000-0002-4022-9964	Tenovus Cancer Care [PHD2013/L01]	Tenovus Cancer Care	This work was funded from Tenovus Cancer Care (https://tenovuscancercare.org.uk/) as a PhD Studentship (PHD2013/L01) to SHD and HK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABAIAN RJ, 1992, J UROLOGY, V147, P837, DOI 10.1016/S0022-5347(17)37400-1; Brookes MJ, 2006, GUT, V55, P1449, DOI 10.1136/gut.2006.094060; Challita-Eid PM, 2007, CANCER RES, V67, P5798, DOI 10.1158/0008-5472.CAN-06-3849; Cheng R, 2011, MOL MED REP, V4, P519, DOI 10.3892/mmr.2011.443; DeAntoni E P, 1997, Oncology (Williston Park), V11, P475; DeAntoni EP, 1997, ONCOLOGY WILLISTON P, V11, P89; DeAntoni EP, 1997, ONCOLOGY WILLISTON P, V11, P85; Fedchenko N, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0221-9; Gomes IM, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.08.028; Graham RM, 2007, WORLD J GASTROENTERO, V13, P4725, DOI 10.3748/wjg.v13.i35.4725; Grunewald TGP, 2012, BIOL CELL, V104, P641, DOI 10.1111/boc.201200027; Gupta A, 2014, INDIAN J MED RES, V140, P507; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Ihlaseh-Catalano SM, 2013, HISTOPATHOLOGY, V63, P678, DOI 10.1111/his.12226; Konstantopoulos N, 2011, PHYSIOL GENOMICS, V43, P110, DOI 10.1152/physiolgenomics.00115.2010; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Lloyd T, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0405-5; Lojanapiwat B, 2014, PROSTATE INT, V2, P133, DOI 10.12954/PI.14054; Moreaux J, 2012, BIOCHEM BIOPH RES CO, V429, P148, DOI 10.1016/j.bbrc.2012.10.123; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Pepe P, 2015, WSPOLCZESNA ONKOL, V19, P471, DOI 10.5114/wo.2015.56654; Pollock PA, 2015, CURR ONCOL, V22, P10, DOI 10.3747/co.22.2102; Porkka KP, 2002, LAB INVEST, V82, P1573, DOI 10.1097/01.LAB.0000038554.26102.C6; Rizzardi AE, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0511-5; Wang L, 2010, CANCER RES, V70, P5818, DOI 10.1158/0008-5472.CAN-09-4697; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Yamamoto T, 2013, EXP CELL RES, V319, P2617, DOI 10.1016/j.yexcr.2013.07.025; Zhang F, 2012, HAEMATOL-HEMATOL J, V97, P1826, DOI 10.3324/haematol.2012.063974	32	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220456	10.1371/journal.pone.0220456	http://dx.doi.org/10.1371/journal.pone.0220456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393902	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000485002500033
J	Kanayama, T; Tomita, H; Binh, NH; Hatano, Y; Aoki, H; Okada, H; Hirata, A; Fujihara, Y; Kunisada, T; Hara, A				Kanayama, Tomohiro; Tomita, Hiroyuki; Nguyen Huy Binh; Hatano, Yuichiro; Aoki, Hitomi; Okada, Hideshi; Hirata, Akihiro; Fujihara, Yoshitaka; Kunisada, Takahiro; Hara, Akira			Characterization of a BAC transgenic mouse expressing Krt19-driven iCre recombinase in its digestive organs	PLOS ONE			English	Article							LACZ EXPRESSION; GENERATION; EFFICIENT; MICE; CYTOKERATINS; CELLS; LINES; RNA	Cytokeratin 19 (KRT19) protein is highly expressed in the epithelium of the gastrointestinal (GI) tract, hepatobiliary tissues, and pancreas of humans and mice. In the present study, we used an improved Cre (iCre) gene to enhance the efficiency of Cre expression in mammalian cells. We established a new transgenic Krt19-iCre bacterial artificial chromosome (BAC) mouse model using the BAC recombineering strategy. Site-specific iCre expression pattern was examined in embryos, adults, and elderly Krt19-iCre mice crossed with Tomato or LacZ reporter mice. Both iCre and reporter protein expressions in adult Krt19-iCre; Tomato(flox/+) (Krt19-iCre Tomato reporter) mice were observed mainly in the epithelial cells of the GI tract, hepatobiliary tissues, and pancreas. However, the expression in the intrahepatic and small pancreatic duct were lower than those in the common bile and large pancreatic duct. In the Krt19-iCre; LacZ reporter embryos, beta-galactosidase for the LacZ reporter was expressed in the glandular epithelial cells of the GI tract in 9.5-day embryos, 12-day embryos, and newborn mice. The reporter protein expression in Krt19-iCre-Tomato reporter mice was consistent with the KRT19 expression in human GI tissues. In conclusion, Krt19-iCre BAC transgenic mice can be used to investigate developmental and pathological conditions using the iCre-loxP system.	[Kanayama, Tomohiro; Tomita, Hiroyuki; Nguyen Huy Binh; Hatano, Yuichiro; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan; [Nguyen Huy Binh] Hanoi Med Univ, Physiol Dept, Hanoi, Vietnam; [Aoki, Hitomi; Kunisada, Takahiro] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev, Gifu, Japan; [Okada, Hideshi] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan; [Hirata, Akihiro] Gifu Univ, Life Sci Res Ctr, Div Anim Expt, Gifu, Japan; [Fujihara, Yoshitaka] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan	Gifu University; Hanoi Medical University; Gifu University; Gifu University; Gifu University; Osaka University	Tomita, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan.	h_tomita@gifu-u.ac.jp	Hatano, Yuichiro/K-7454-2013; Tomita, Hiroyuki/L-5571-2019; Fujihara, Yoshitaka/G-2043-2011	Hatano, Yuichiro/0000-0002-5121-6325; Tomita, Hiroyuki/0000-0002-3291-0274; Fujihara, Yoshitaka/0000-0001-8332-3507; Okada, Hideshi/0000-0002-7775-4308	KAKENHI [24590911, 15K11289]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research is supported by KAKENHI (Grant Number: 24590911 and 15K11289) (H.T. and A.H.).	Asfaha S, 2015, CELL STEM CELL, V16, P627, DOI 10.1016/j.stem.2015.04.013; Barak V, 2004, CLIN BIOCHEM, V37, P529, DOI 10.1016/j.clinbiochem.2004.05.009; Brembeck FH, 2001, GASTROENTEROLOGY, V120, P1720, DOI 10.1053/gast.2001.24846; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Cacioppo JA, 2016, GENESIS, V54, P38, DOI 10.1002/dvg.22911; Cacioppo JA, 2015, GENESIS, V53, P245, DOI 10.1002/dvg.22845; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Gebhard S, 2007, HISTOCHEM CELL BIOL, V127, P183, DOI 10.1007/s00418-006-0236-8; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Jain R, 2010, APPL IMMUNOHISTO M M, V18, P9, DOI 10.1097/PAI.0b013e3181ad36ea; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Means AL, 2005, GENESIS, V42, P23, DOI 10.1002/gene.20119; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Park CJ, 2017, GENESIS, V55, DOI 10.1002/dvg.23084; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stempel AJ, 2014, MOL VIS, V20, P1366; Tamai Y, 2000, J CELL BIOL, V151, P563, DOI 10.1083/jcb.151.3.563; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Ting JT, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00111; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Zhao GF, 2017, ONCOTARGET, V8, P18303, DOI 10.18632/oncotarget.15435	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220818	10.1371/journal.pone.0220818	http://dx.doi.org/10.1371/journal.pone.0220818			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393940	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500065
J	Yamase, K; Tanigawa, Y; Yamamoto, Y; Tanaka, H; Komiya, T				Yamase, Kenya; Tanigawa, Yoko; Yamamoto, Yasufumi; Tanaka, Hiromitsu; Komiya, Tohru			Mouse TMCO5 is localized to the manchette microtubules involved in vesicle transfer in the elongating spermatids	PLOS ONE			English	Article							INTESTINAL GOBLET CELLS; TAIL-ANCHORED PROTEINS; INTRAMANCHETTE TRANSPORT; MEMBRANE-FUSION; MESSENGER-RNA; PANETH CELLS; GENE; GOLGI; COMPLEX; CLONING	As a result of a high-throughput in situ hybridization screening for adult mouse testes, we found that the mRNA for Tmco5 is expressed in round and elongating spermatids. Tmco5 belongs to the Tmco (Transmembrane and coiled-coil domains) gene family and has a coiled-coil domain in the N-terminal and a transmembrane domain in the C-terminal region. A monoclonal antibody raised against recombinant TMCO5 revealed that the protein is expressed exclusively in the elongating spermatids of step 9 to 12 and is localized to the manchette, a transiently emerging construction, which predominantly consists of cytoskeleton microtubules and actin filaments. This structure serves in the transport of Golgi-derived non-acrosomal vesicles. Moreover, induced expression of TMCO5 in CHO cells resulted in the co-localization of TMCO5 with beta-tubulin besides the reorganization of the Golgi apparatus. Judging from the results and considering the domain structure of TMCO5, we assume that Tmco5 may have a role in vesicle transport along the manchette.	[Yamase, Kenya; Tanigawa, Yoko; Yamamoto, Yasufumi; Komiya, Tohru] Osaka City Univ, Grad Sch Sci, Dept Biol Funct, Sumiyoshi Ku, Osaka, Japan; [Tanaka, Hiromitsu] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	Osaka Metropolitan University; Nagasaki International University	Komiya, T (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Biol Funct, Sumiyoshi Ku, Osaka, Japan.	tkom@sci.osaka-cu.ac.jp						Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Amaral A, 2013, MOL CELL PROTEOMICS, V12, P330, DOI 10.1074/mcp.M112.020552; Aruffo A., 2002, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb1612s60, DOI 10.1002/0471142727.MB1612S60]; Bao JQ, 2016, REPRODUCTION, V151, pR55, DOI 10.1530/REP-15-0562; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Chen XX, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0166-4; Cole NB, 1996, SCIENCE, V273, P797, DOI 10.1126/science.273.5276.797; Costa BF, 2018, TRAFFIC, V19, P182, DOI 10.1111/tra.12550; Dacheux JL, 2005, THERIOGENOLOGY, V63, P319, DOI 10.1016/j.theriogenology.2004.09.015; Daste F, 2015, J CELL SCI, V128, P4263, DOI 10.1242/jcs.178574; Fukuda N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003858; Gervasi MG, 2018, J CELL SCI, V131, DOI 10.1242/jcs.215897; GONG S, 1990, VIROLOGY, V178, P81, DOI 10.1016/0042-6822(90)90381-Z; Haseeb A, 2018, REPROD FERT DEVELOP, V30, P1514, DOI 10.1071/RD18010; Hayasaka S, 2008, ASIAN J ANDROL, V10, P561, DOI 10.1111/j.1745-7262.2008.00392.x; Hinsch KD, 1999, ANDROLOGIA, V31, P320; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; James PS, 2004, J CELL SCI, V117, P6485, DOI 10.1242/jcs.01578; Kalbfleisch T, 2007, TRAFFIC, V8, P1687, DOI 10.1111/j.1600-0854.2007.00661.x; Kaneko T, 2019, MOL REPROD DEV, V86, P330, DOI 10.1002/mrd.23108; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kiessling V, 2015, METHOD CELL BIOL, V128, P339, DOI 10.1016/bs.mcb.2015.02.005; Kleene KC, 2016, MOL REPROD DEV, V83, P190, DOI 10.1002/mrd.22616; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Komiya T, 1999, BIOCHEM BIOPH RES CO, V255, P347, DOI 10.1006/bbrc.1999.0168; Komiya T, 1999, BBA-GENE STRUCT EXPR, V1444, P434, DOI 10.1016/S0167-4781(99)00010-X; Komiya T, 1998, BIOCHEM BIOPH RES CO, V251, P759, DOI 10.1006/bbrc.1998.9513; Komiya T, 1997, ANAL BIOCHEM, V254, P23, DOI 10.1006/abio.1997.2399; Kotaja N, 2014, FERTIL STERIL, V101, P1552, DOI 10.1016/j.fertnstert.2014.04.025; Kwon JT, 2017, PLOS ONE, V12; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laiho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061558; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Nomikos M, 2015, ASIAN J ANDROL, V17, P444, DOI 10.4103/1008-682X.142145; O'Donnell L., 2014, SPERMATOGENESIS, V4, pe979623, DOI [10.4161/21565562.2014.979623, DOI 10.4161/21565562.2014.979623]; Russell LD, 1990, HISTOLOGICAL HISTOPA, Vxiv; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Suarez Susan S, 2007, Soc Reprod Fertil Suppl, V65, P331; Swann K, 2004, REPRODUCTION, V127, P431, DOI 10.1530/rep.1.00169; Tanaka H, 2005, CELL MOL LIFE SCI, V62, P344, DOI 10.1007/s00018-004-4394-y; Tanigawa Y, 2007, GENE EXPR PATTERNS, V7, P709, DOI 10.1016/j.modgep.2007.02.003; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wei YL, 2018, GENE, V660, P28, DOI 10.1016/j.gene.2018.03.059; Wu ATH, 2007, DEV BIOL, V312, P471, DOI 10.1016/j.ydbio.2007.08.051; Zhu XD, 2013, HISTOCHEM CELL BIOL, V140, P361, DOI 10.1007/s00418-013-1119-4	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220917	10.1371/journal.pone.0220917	http://dx.doi.org/10.1371/journal.pone.0220917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393949	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500083
J	Gonciarz, W; Krupa, A; Hinc, K; Obuchowski, M; Moran, AP; Gajewski, A; Chmiela, M				Gonciarz, Weronika; Krupa, Agnieszka; Hinc, Krzysztof; Obuchowski, Michel; Moran, Anthony P.; Gajewski, Adrian; Chmiela, Magdalena			The effect of Helicobacter pylori infection and different H. pylori components on the proliferation and apoptosis of gastric epithelial cells and fibroblasts	PLOS ONE			English	Article							NEUTROPHIL-ACTIVATING PROTEIN; IMMUNE-RESPONSE; GUINEA-PIGS; CYTOKINE EXPRESSION; DENDRITIC CELLS; T-CELLS; LIPOPOLYSACCHARIDE; CAGA; PERSISTENCE; INTERLEUKIN-8	Background Helicobacter pylori colonizes the human gastric mucosa, causing chronic inflammation, peptic ulcers and gastric cancer. A cascade of harmful processes results from the interaction of these bacteria with the gastric epithelium. Aim To investigate these processes in terms of upregulation of oxidative stress and cell apoptosis and downregulation of the pro-regenerative activity of cells. Methods We employed an in vivo guinea pig model at 7 or 28 days postinoculation with H. pylori, corresponding to an acute or chronic stage of infection, respectively, and an in vitro model of guinea pig primary gastric epithelial cells and fibroblasts treated with bacterial components: glycine acid extract (GE), urease subunit A (UreA), cytotoxin-associated gene A protein (CagA) and lipopolysaccharide (LPS). Cells were evaluated for metabolic activity (MTT reduction), myeloperoxidase (MPO) and metalloproteinase (MMP-9) secretion, lipid peroxidation (4-hydroxynonenal (4HNE)), migration (wound healing), proliferation (Ki-67 antigen) and cell apoptosis (TUNEL assay; Bcl-xL, Bax, Bcl-2 expression; caspase 3 cleavage). Results Significant infiltration of the gastric mucosa by inflammatory cells in vivo in response to H. pylori was accompanied by oxidative stress and cell apoptosis, which were more intense 7 than 28 days after inoculation. The increase in cell proliferation was more intense in chronic than acute infection. H. pylori components GE, CagA, UreA, and LPS upregulated oxidative stress and apoptosis. Only H. pylori LPS inhibited cell migration and proliferation, which was accompanied by the upregulation of MMP-9. Conclusions H. pylori infection induces cell apoptosis in conjunction with increased oxidative stress. Elevated apoptosis protects against deleterious inflammation and neoplasia; however, it reduces cell integrity. Upregulation of cell migration and proliferation in response to injury in the milieu of GE, CagA or UreA facilitates tissue regeneration but increases the risk of neoplasia. By comparison, downregulation of cell regeneration by H. pylori LPS may promote chronic inflammation.	[Gonciarz, Weronika; Krupa, Agnieszka; Gajewski, Adrian; Chmiela, Magdalena] Univ Lodz, Fac Biol & Environm Protect, Inst Microbiol Biotechnol & Immunol, Dept Immunol & Infect Biol, Lodz, Poland; [Hinc, Krzysztof; Obuchowski, Michel] Med Univ Gdansk, Intercoll Fac Biotechnol UG MUG, Lab Mol Bacteriol, Gdansk, Poland; [Moran, Anthony P.] Natl Univ Ireland Galway, Sch Nat Sci, Dept Microbiol, Galway, Ireland	University of Lodz; Fahrenheit Universities; Medical University Gdansk; Ollscoil na Gaillimhe-University of Galway	Chmiela, M (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Inst Microbiol Biotechnol & Immunol, Dept Immunol & Infect Biol, Lodz, Poland.	magdalena.chmiela@biol.uni.lodz.pl	Hinc, Krzysztof/B-9543-2014; Gajewski, Adrian/AAN-9957-2021; Obuchowski, Michal/F-5836-2011	Hinc, Krzysztof/0000-0002-6067-7852; Gajewski, Adrian/0000-0001-7445-9752; Obuchowski, Michal/0000-0001-5410-2350; Gonciarz, Weronika/0000-0002-5231-5341; Krupa, Agnieszka/0000-0003-1303-4608; Chmiela, Magdalena/0000-0002-5447-2922				Allen LAH, 2007, CELL MICROBIOL, V9, P817, DOI 10.1111/j.1462-5822.2007.00906.x; Amedei A, 2006, J CLIN INVEST, V116, P1092, DOI 10.1172/JCI27177; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Backhed F, 2003, INFECT IMMUN, V71, P3357, DOI 10.1128/IAI.71.6.3357-3360.2003; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Beswick EJ, 2006, INFECT IMMUN, V74, P1148, DOI 10.1128/IAI.74.2.1148-1155.2006; Bimczok D, 2013, J IMMUNOL, V190, P6626, DOI 10.4049/jimmunol.1203330; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Caron TJ, 2015, WORLD J GASTROENTERO, V21, P11411, DOI 10.3748/wjg.v21.i40.11411; Cheng HH, 2012, WORLD J GASTROENTERO, V18, P34, DOI 10.3748/wjg.v18.i1.34; Chmiela M, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0480-y; Chmiela M, 2017, WORLD J GASTROENTERO, V23, P1521, DOI 10.3748/wjg.v23.i9.1521; Chmiela M, 2014, WORLD J GASTROENTERO, V20, P9882, DOI 10.3748/wjg.v20.i29.9882; Cho SJ, 2003, TOXICON, V42, P601, DOI 10.1016/j.toxicon.2003.08.003; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Czkwianianc Elzbieta, 1997, Central-European Journal of Immunology, V22, P240; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Du SY, 2016, J MICROBIOL IMMUNOL, V49, P636, DOI 10.1016/j.jmii.2014.05.011; Ernst PB, 2006, GASTROENTEROLOGY, V130, P188, DOI 10.1053/j.gastro.2005.06.032; EVANS GS, 1992, J CELL SCI, V101, P219; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Florence JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171427; Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921; Gonciarz W, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0515-z; Grebowska A, 2008, POL J MICROBIOL, V57, P185; Hatakeyama M, 2017, P JPN ACAD B-PHYS, V93, P196, DOI 10.2183/pjab.93.013; Hinc K, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-2; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Honig A, 2000, ANTICANCER RES, V20, P1641; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Kaebisch R, 2014, J IMMUNOL, V192, P316, DOI 10.4049/jimmunol.1302476; Kelly PJ, 2008, STROKE, V39, P100, DOI 10.1161/STROKEAHA.107.488189; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kranzer K, 2004, INFECT IMMUN, V72, P4416, DOI 10.1128/IAI.72.8.4416-4423.2004; Kronsteiner B, 2013, INFECT IMMUN, V81, P3803, DOI 10.1128/IAI.00660-13; Lai WC, 2003, J IMMUNOL, V170, P6244, DOI 10.4049/jimmunol.170.12.6244; Lamb A, 2013, J CELL BIOCHEM, V114, P491, DOI 10.1002/jcb.24389; Lee A, 1999, MOL MED TODAY, V5, P500, DOI 10.1016/S1357-4310(99)01591-9; Li HL, 2012, MOL MED REP, V6, P774, DOI 10.3892/mmr.2012.1010; Lina TT, 2014, WORLD J GASTROENTERO, V20, P12753, DOI 10.3748/wjg.v20.i36.12753; LOGAN SM, 1983, INFECT IMMUN, V42, P675, DOI 10.1128/IAI.42.2.675-682.1983; Lu HS, 2009, J BIOL CHEM, V284, P23024, DOI 10.1074/jbc.M109.001008; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Miszczyk E, 2011, POST HIG MED DOSW, V68, P603, DOI DOI 10.5604/17322693.1102583; Miszczyk E, 2014, ACTA BIOCHIM POL, V61, P295; Miszczyk E, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/206463; Mnich E, 2016, WORLD J GASTROENTERO, V22, P7536, DOI 10.3748/wjg.v22.i33.7536; Mnich E, 2015, ACTA BIOCHIM POL, V62, P641, DOI 10.18388/abp.2015_1045; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Nedrud JG, 1999, FEMS IMMUNOL MED MIC, V24, P243, DOI 10.1111/j.1574-695X.1999.tb01290.x; Nishioka H, 2003, EUR J IMMUNOL, V33, P840, DOI 10.1002/eji.200323726; Paziak-Domanska B, 2000, CELL IMMUNOL, V202, P136, DOI 10.1006/cimm.2000.1654; Perfetto B, 2004, RES MICROBIOL, V155, P259, DOI 10.1016/j.resmic.2004.01.007; Pierzchalski P, 2009, J PHYSIOL PHARMACOL, V60, P119; Ramarao N, 2001, INFECT IMMUN, V69, P2604, DOI 10.1128/IAI.69.4.2604-2611.2001; Rechcinski T, 1997, MICROBIOL IMMUNOL, V41, P387, DOI 10.1111/j.1348-0421.1997.tb01869.x; Rijpkema SG, 2001, FEMS IMMUNOL MED MIC, V30, P151, DOI 10.1016/S0928-8244(00)00248-0; Rudnicka K, 2015, INNATE IMMUN-LONDON, V21, P127, DOI 10.1177/1753425913518225; Rudnicka K, 2013, APMIS, V121, P806, DOI 10.1111/apm.12120; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Schwartz JT, 2006, J LEUKOCYTE BIOL, V79, P1214, DOI 10.1189/jlb.0106030; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Sjunnesson H, 2003, APMIS, V111, P634, DOI 10.1034/j.1600-0463.2003.1110606.x; Slomiany BL, 1999, BIOCHEM BIOPH RES CO, V261, P15, DOI 10.1006/bbrc.1999.1003; Smith RS, 1997, AM J PATHOL, V151, P317; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Stromberg E, 2003, FEMS IMMUNOL MED MIC, V36, P159, DOI 10.1016/S0928-8244(03)00026-9; Sturegard E, 1998, J MED MICROBIOL, V47, P1123, DOI 10.1099/00222615-47-12-1123; Subhash VV, 2015, MICROBIOL-SGM, V161, P1150, DOI 10.1099/mic.0.000066; Sun YQ, 2004, HELICOBACTER, V9, P217, DOI 10.1111/j.1083-4389.2004.00227.x; Tan MP, 2008, INFECT IMMUN, V76, P1289, DOI 10.1128/IAI.00779-07; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Tanahashi T, 2000, INFECT IMMUN, V68, P664, DOI 10.1128/IAI.68.2.664-671.2000; TERANO A, 1982, GASTROENTEROLOGY, V83, P1280; Walencka M, 2015, ACTA BIOCHIM POL, V62, P697, DOI 10.18388/abp.2015_1110; Wang JF, 2011, J CELL PHYSIOL, V226, P1265, DOI 10.1002/jcp.22454; WARREN JR, 1983, LANCET, V1, P1273; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Wroblewski LE, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-29; XIANG Z, 1993, EUR J CLIN MICROBIOL, V12, P739, DOI 10.1007/BF02098460; Yang JCh, 2011, GASTRITIS GASTRIC CA, DOI [10.5772/24767, DOI 10.5772/24767]	88	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220636	10.1371/journal.pone.0220636	http://dx.doi.org/10.1371/journal.pone.0220636			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390383	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400024
J	Lindsey, RC; Cheng, SH; Mohan, S				Lindsey, Richard C.; Cheng, Shaohong; Mohan, Subburaman			Vitamin C effects on 5-hydroxymethylcytosine and gene expression in osteoblasts and chondrocytes: Potential involvement of PHD2	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ASCORBIC-ACID; PROTEASOMAL DEGRADATION; ALKALINE-PHOSPHATASE; OSTERIX EXPRESSION; PROLYL HYDROXYLASE; IN-VITRO; DIFFERENTIATION; COLLAGEN; ACTIVATION	Vitamin C (ascorbic acid, AA) is a well-known regulator of bone and cartilage metabolism. However, the mechanisms of AA's action in these tissues are only partly understood. In this study, we confirmed that AA contributes to bone and cartilage metabolism by showing decreased articular cartilage and trabecular bone in AA-deficient spontaneous fracture (sfx) mutant mice. In vitro, we found that AA exerts differential effects on chondrocyte and osteoblast differentiation. Since AA is known to increase levels of 5-hydroxymethylcytosine (5-hmC) and induce DNA demethylation via the ten-eleven translocases (TETs), and since prolyl hydroxylase domain-containing protein 2 (PHD2), a known mediator of AA's effects in these tissues, is part of the same enzyme family as the TETs, we next investigated whether increases in 5-hmC might mediate some of these effects. All TETs and PHDs are expressed in chondrocytes and osteoblasts, and PHD2 is localized in both the cytoplasm and nucleus of the cell, lending plausibility to the hypothesis of altered 5-hmC content in these cells. We found that AA treatment increased levels of 5-hmC in both cell types globally, notably including promoter regions of osteoblast differentiation genes. Furthermore, inhibition of PHD2 decreased 5-hmC levels in chondrocyte differentiation gene promoters, and knockdown of Phd2 in chondrocytes reduced global 5-hmC levels, suggesting for the first time that PHD2 may itself directly mediate increases in 5-hmC in chondrocyte and osteoblast genes. Further investigation of this mechanism could lead to novel therapeutic approaches to treat debilitating diseases such as osteoarthritis and osteoporosis.	[Lindsey, Richard C.; Cheng, Shaohong; Mohan, Subburaman] VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA; [Lindsey, Richard C.; Mohan, Subburaman] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92354 USA; [Lindsey, Richard C.; Mohan, Subburaman] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA; [Mohan, Subburaman] Loma Linda Univ, Sch Med, Dept Orthoped, Loma Linda, CA 92354 USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University	Mohan, S (corresponding author), VA Loma Linda Healthcare Syst, Musculoskeletal Dis Ctr, Loma Linda, CA 92357 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92354 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Biochem, Loma Linda, CA 92354 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Dept Med, Loma Linda, CA 92354 USA.; Mohan, S (corresponding author), Loma Linda Univ, Sch Med, Dept Orthoped, Loma Linda, CA 92354 USA.	subburaman.mohan@va.gov		Lindsey, Richard/0000-0001-9911-4136	US Department of Veterans Affairs BLR&D merit review grant [101-BX-001396]; NIH [2 R25 GM060507]; US Department of Veterans Affairs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001396] Funding Source: NIH RePORTER	US Department of Veterans Affairs BLR&D merit review grant(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by funding from the US Department of Veterans Affairs BLR&D merit review grant (101-BX-001396) to SM and NIH grant 2 R25 GM060507 to the Loma Linda University Center for Health Disparities and Molecular Medicine. Salary support for SM is provided by a Senior Research Career Scientist Award from the US Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funding from the US Department of Veterans Affairs BLR&D merit review grant (101-BX-001396) to SM and NIH grant 2 R25 GM060507 to the Loma Linda University Center for Health Disparities and Molecular Medicine. Salary support for SM is provided by a Senior Research Career Scientist Award from the US Department of Veterans Affairs.	Aghajanian P, 2015, J BONE MINER RES, V30, P1945, DOI 10.1002/jbmr.2709; [Anonymous], 2019, R LANG ENV STAT COMP; Beamer WG, 2000, BONE, V27, P619, DOI 10.1016/S8756-3282(00)00369-0; Berchner-Pfannschmidt U, 2008, J BIOL CHEM, V283, P31745, DOI 10.1074/jbc.M804390200; Berra E, 2001, EMBO REP, V2, P615, DOI 10.1093/embo-reports/kve130; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Buo AM, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.21; Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323; Cheng SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep45408; Cheng SH, 2014, J BONE MINER RES, V29, P2276, DOI 10.1002/jbmr.2258; Cheng SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032887; DANIEL JC, 1984, J CELL BIOL, V99, P1960, DOI 10.1083/jcb.99.6.1960; Depping R, 2015, J MOL MED, V93, P599, DOI 10.1007/s00109-015-1276-0; Digaleh H, 2013, CELL MOL LIFE SCI, V70, P4681, DOI 10.1007/s00018-013-1409-y; Ezura Y, 2009, ARTHRITIS RHEUM, V60, P1416, DOI 10.1002/art.24472; Fan LH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/239356; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; FRANCESCHI RT, 1990, J BONE MINER RES, V5, P1157; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gabbay KH, 2010, J BIOL CHEM, V285, P19510, DOI 10.1074/jbc.M110.110247; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Hadzir SN, 2014, CYTOTHERAPY, V16, P674, DOI 10.1016/j.jcyt.2013.07.013; Hall SL, 1998, CALCIFIED TISSUE INT, V63, P183, DOI 10.1007/s002239900512; HARADA S, 1991, J BONE MINER RES, V6, P903; Ilich JZ, 2003, EUR J CLIN NUTR, V57, P554, DOI 10.1038/sj.ejcn.1601577; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Jiao Y, 2005, MAMM GENOME, V16, P20, DOI 10.1007/s00335-004-2414-0; KAWAI T, 1992, J BIOL CHEM, V267, P21973; Kim J, 2010, PHYSIOL GENOMICS, V40, P100, DOI 10.1152/physiolgenomics.00105.2009; LEBOY PS, 1989, J BIOL CHEM, V264, P17281; Leveille SG, 1997, J EPIDEMIOL COMMUN H, V51, P479, DOI 10.1136/jech.51.5.479; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Malmir H, 2018, BRIT J NUTR, V119, P847, DOI [10.1017/s0007114518000430, 10.1017/S0007114518000430]; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Minor EA, 2013, J BIOL CHEM, V288, P13669, DOI 10.1074/jbc.C113.464800; MIZUSHIMA Y, 1984, EXPERIENTIA, V40, P359, DOI 10.1007/BF01952551; Mohan S, 2005, J BONE MINER RES, V20, P1597, DOI 10.1359/JBMR.050406; New SA, 1997, AM J CLIN NUTR, V65, P1831, DOI 10.1093/ajcn/65.6.1831; New SA, 2000, AM J CLIN NUTR, V71, P142; Osipyants AI, 2018, BIOCHIMIE, V147, P46, DOI 10.1016/j.biochi.2017.12.011; Otsuka E, 1999, AM J PHYSIOL-CELL PH, V277, pC132, DOI 10.1152/ajpcell.1999.277.1.C132; Prynne CJ, 2006, AM J CLIN NUTR, V83, P1420, DOI 10.1093/ajcn/83.6.1420; Sanghi D, 2015, J AM COLL NUTR, V34, P15, DOI 10.1080/07315724.2013.875439; Simon JA, 2001, AM J EPIDEMIOL, V154, P427, DOI 10.1093/aje/154.5.427; Sugiura M, 2011, OSTEOPOROSIS INT, V22, P143, DOI 10.1007/s00198-010-1239-9; Takamizawa S, 2004, CELL BIOL INT, V28, P255, DOI 10.1016/j.cellbi.2004.01.010; Taylor SEB, 2016, J BONE MINER RES, V31, P524, DOI 10.1002/jbmr.2711; Taylor SEB, 2014, ARTHRITIS RHEUMATOL, V66, P90, DOI 10.1002/art.38200; Temu TM, 2010, AM J PHYSIOL-ENDOC M, V299, pE325, DOI 10.1152/ajpendo.00145.2010; Walmsley AR, 1999, J BIOL CHEM, V274, P14884, DOI 10.1074/jbc.274.21.14884; Wolf RL, 2005, AM J CLIN NUTR, V82, P581, DOI 10.1093/ajcn/82.3.581; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xing WR, 2007, J BIOL CHEM, V282, P22052, DOI 10.1074/jbc.M702614200; Xing WR, 2011, PHYSIOL GENOMICS, V43, P749, DOI 10.1152/physiolgenomics.00229.2010; Xing WR, 1998, MOL ENDOCRINOL, V12, P1310, DOI 10.1210/me.12.9.1310; Young JI, 2015, ANNU REV NUTR, V35, P545, DOI 10.1146/annurev-nutr-071714-034228	57	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220653	10.1371/journal.pone.0220653	http://dx.doi.org/10.1371/journal.pone.0220653			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390373	Green Published, gold, Green Submitted			2022-12-27	WOS:000484999400026
J	Holm, J; Eiermann, B; Kimland, E; Mannheimer, B				Holm, Johan; Eiermann, Birgit; Kimland, Elin; Mannheimer, Buster			Prevalence of potential drug-drug interactions in Swedish pediatric outpatients	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; PRESCRIPTIONS; POLYPHARMACY; CARE	Purpose To describe the occurrence of potential drug-drug interactions (DDIs) in prescribed drugs, dispensed to pediatric outpatients in Sweden. Methods A cross sectional study was conducted based on data from a national register of prescribed drugs, dispensed at pharmacies, to children 0-17 years old. The study period was January 1 to April 30, 2010. Drug dispensing data was linked to the DDI database SFINX. Prevalence and frequencies of potential interactions were investigated, and drugs commonly involved in interactions were identified. The study focused on clinically relevant potential interactions, class D (should be avoided), and class C (can be handled, e.g. by dose adjustment). Results In the Swedish pediatric population, 0 to 17 years of age, 12% (n = 231 078) of children had at least two dispensed drugs. In this group of patients, 0.14% had potential D-interactions and 1,3% had potential C-interactions. The number of D- and C-interactions that may lead to reduced effects were 181 (52%), and 1224 (32%) respectively. The ten most frequent drugs were involved in 78% and 65% of all potential D-, and C-interactions respectively. Furthermore, 80%, and 58% of the D-, and C-interactions respectively occurred in patients aged 12 to 17. Conclusions We identified a limited number of drugs that were represented in the majority of potential interactions. Interactions that can lead to a reduced treatment effect constituted approximately half of D-interactions, and a third of C-interactions. The frequency of potential interactions was higher in older children. The results may contribute to increased prescriber awareness of important potential drug interactions among pediatric outpatients.	[Holm, Johan; Eiermann, Birgit] Karolinska Univ Hosp Huddinge, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden; [Eiermann, Birgit] Inera AB, Swedish Assoc Local Author & Reg, Stockholm, Sweden; [Kimland, Elin] Swedish Med Prod Agcy, Uppsala, Sweden; [Mannheimer, Buster] Karolinska Inst, Dept Clin Sci & Educ Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Medical Products Agency; Karolinska Institutet	Holm, J (corresponding author), Karolinska Univ Hosp Huddinge, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden.	johan.holm@ki.se		Holm, Johan/0000-0001-6398-7672	Karolinska Institutet; Swedish Foundation for Clinical Pharmacology and Pharmacotherapy; Swedish Society for Medical Research; Stockholm County Council	Karolinska Institutet(Karolinska Institutet); Swedish Foundation for Clinical Pharmacology and Pharmacotherapy; Swedish Society for Medical Research; Stockholm County Council(Stockholm County Council)	No specific funding has been received for this study. General research grants have been received from Karolinska Institutet (www.ki.se), the Swedish Foundation for Clinical Pharmacology and Pharmacotherapy, Stockholm County Council (www.sll.se), and the Swedish Society for Medical Research (www.ssmf.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balk TE, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26410; Bazzano ATF, 2009, ACAD PEDIATR, V9, P81, DOI 10.1016/j.acap.2008.11.010; Bottiger Y, 2009, EUR J CLIN PHARMACOL, V65, P627, DOI 10.1007/s00228-008-0612-5; Dai DW, 2016, PEDIATR CRIT CARE ME, V17, pE218, DOI 10.1097/PCC.0000000000000684; Espinosa MAFD, 2014, INT J CLIN PHARM-NET, V36, P1160, DOI 10.1007/s11096-014-0011-1; Feinstein J, 2015, PEDIATRICS, V135, pE99, DOI 10.1542/peds.2014-2015; Feudtner C, 2012, ARCH PEDIAT ADOL MED, V166, P9, DOI 10.1001/archpediatrics.2011.161; Holm J, 2014, EUR J CLIN PHARMACOL, V70, P1375, DOI 10.1007/s00228-014-1745-3; Ismail M, 2017, J CRIT CARE, V40, P243, DOI 10.1016/j.jcrc.2017.04.028; Kimland E, 2012, ACTA PAEDIATR, V101, P772, DOI 10.1111/j.1651-2227.2012.02656.x; Langerova P, 2013, EUR J PEDIATR, V172, P631, DOI 10.1007/s00431-013-1933-7; Lebowitz Mollie Blazar, 2016, Hosp Pediatr, V6, P282, DOI 10.1542/hpeds.2015-0249; Lisby S M, 1987, Hosp Pharm, V22, P356; Mannheimer B, 2010, J INTERN MED, V268, P540, DOI 10.1111/j.1365-2796.2010.02303.x; Mannheimer B, 2010, BRIT J CLIN PHARMACO, V69, P411, DOI 10.1111/j.1365-2125.2009.03598.x; Morales-Rios O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190882; Novak PH, 2005, BRIT J CLIN PHARMACO, V59, P712, DOI 10.1111/j.1365-2125.2004.02237.x; Ogawa R, 2011, DRUGS, V71, P1839, DOI 10.2165/11593990-000000000-00000; Olsson J, 2011, ACTA PAEDIATR, V100, P1272, DOI 10.1111/j.1651-2227.2011.02287.x; Oshikoya KA, 2016, EXPERT REV CLIN PHAR, V9, P1505, DOI 10.1080/17512433.2016.1232619; R Core Team, 2018, MOA SIGNED MANILA BA; Rashed AN, 2012, EUR J CLIN PHARMACOL, V68, P801, DOI 10.1007/s00228-011-1183-4; Shah SS, 2007, ARCH PEDIAT ADOL MED, V161, P282, DOI 10.1001/archpedi.161.3.282; Sjoqvist F., 1997, European Journal of Clinical Pharmacology, V52, pA126; Statistics Sweden, 2018, STAT DAT; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; WHO collaborating centre for drug statistics methodology, 2018, ATC STRUCT PRINC; Yeh ML, 2014, COMPUT METH PROG BIO, V113, P15, DOI 10.1016/j.cmpb.2013.07.016	28	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220685	10.1371/journal.pone.0220685	http://dx.doi.org/10.1371/journal.pone.0220685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381591	Green Submitted, Green Published, gold			2022-12-27	WOS:000484993600029
J	Naganuma, M; Hirai, F; Kobayashi, K; Watanabe, K; Takeuchi, K; Aoyama, N; Nozawa, H; Motoye, S; Ohmori, T; Harada, A; Nagai, Y; Abe, T; Yamada, Y; Inagaki, K; Shimizu, N; Kanai, T; Watanabe, M; Tanaka, S; Arai, T; Kishi, M; Watanabe, C; Sakata, Y; Ashida, T; Maemoto, A; Sai, S; Kitano, A; Sameshima, Y; Yokoyama, K; Kobayashi, T; Suekane, T; Matsuda, K; Obata, H; Fujiya, M; Shirai, T; Tominaga, K; Takedatsu, H; Suzuki, R				Naganuma, Makoto; Hirai, Fumihito; Kobayashi, Kiyonori; Watanabe, Kenji; Takeuchi, Ken; Aoyama, Nobuo; Nozawa, Hiroshi; Motoye, Satoshi; Ohmori, Toshihide; Harada, Akio; Nagai, Yushi; Abe, Takayuki; Yamada, Yoji; Inagaki, Katsutoshi; Shimizu, Naoki; Kanai, Takanori; Watanabe, Mamoru; Tanaka, Shinji; Arai, Takehiro; Kishi, Masahiro; Watanabe, Chiyuki; Sakata, Yasuhisa; Ashida, Toshifumi; Maemoto, Atsuo; Sai, Souken; Kitano, Atsuo; Sameshima, Yukinori; Yokoyama, Kaoru; Kobayashi, Taku; Suekane, Takehisa; Matsuda, Koichiro; Obata, Hirozumi; Fujiya, Mikihiro; Shirai, Takayuki; Tominaga, Keiichi; Takedatsu, Hidetoshi; Suzuki, Ryouichi		ESCORT Study Grp	Middle-term prognosis in patients with ulcerative colitis who achieved clinical and endoscopic remission by budesonide rectal foam	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PROCTITIS; MULTICENTER; MESALAMINE; SEVERITY; OUTCOMES; INDEX	Background Budesonide foam is effective in inducing clinical remission in ulcerative colitis (UC) patients with active proctosigmoiditis. The aim of this study was to evaluate the duration of remission and predictors of relapse in UC patients who achieved clinical remission and mucosal healing by 6-week treatment with topical budesonide. Methods This is a retrospective, observational, multicenter study with a 2-year follow-up period. UC patients who were treated with budesonide foam in phase 2 or phase 3 clinical trials and achieved both clinical remission and mucosal healing were enrolled. Results Among 84 patients who met the eligibility criteria, 60 participated in the study. Eighteen of the 60 patients (30.0%; 95% confidence interval [CI]: 18.9-43.2) experienced no relapse (i.e., maintenance of remission) during the 2-year follow-up period. The median relapse-free survival time was 0.82 years (95% CI: 0.51-1.52). Of 37 patients with a Mayo endoscopic subscore of 0 after inducing remission with budesonide foam, 25 (67.6%) relapsed within 2 years. Patients with a disease duration of <1 year experienced a worse clinical outcome than patients with a disease duration of >5 years, and the hazard ratio was 2.38 (95% CI: 1.04-5.45). Conclusion This is the first study to evaluate the short- to middle-term prognosis in UC patients who achieved mucosal healing with topical preparations. After inducing remission by budesonide foam, treatment for maintaining remissions and strict follow-up may be needed for patients with shorter disease duration.	[Naganuma, Makoto; Kanai, Takanori] Keio Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan; [Hirai, Fumihito; Takedatsu, Hidetoshi] Fukuoka Univ, Dept Gastroenterol & Med, Fac Med, Fukuoka, Fukuoka, Japan; [Kobayashi, Kiyonori] Kitasato Univ, Sch Med, Dept Res & Dev, Ctr New Med Frontiers, Sagamihara, Kanagawa, Japan; [Watanabe, Kenji] Hyogo Coll Med, Dept Intestinal Inflammat Res, Nishinomiya, Hyogo, Japan; [Takeuchi, Ken] Tsujinaka Hosp Kashiwanoha, IBD Ctr, Div Gastroenterol & Hepatol, Chiba, Japan; [Aoyama, Nobuo] Gastrointestinal Endoscopy & Inflammatory Bowel D, Aoyama Med Clin, Tokyo, Hyogo, Japan; [Nozawa, Hiroshi] Matsushima Clin, Yokohama, Kanagawa, Japan; [Motoye, Satoshi] Sapporo Kosei Gen Hosp, IBD Ctr, Sapporo, Hokkaido, Japan; [Ohmori, Toshihide] Ageo, Ohmori Toshihide Gastrointestinal Clin, Ageo, Japan; [Harada, Akio] Yokoyama Mem Hosp, Nagoya, Aichi, Japan; [Nagai, Yushi] Keio Univ, Sch Med, Clin & Translat Res Ctr, Data Management Off, Tokyo, Japan; [Abe, Takayuki] Yokohama City Univ, Sch Data Sci, Yokohama, Kanagawa, Japan; [Abe, Takayuki] Keio Univ, Sch Med, Tokyo, Japan; [Yamada, Yoji] EA Pharma Co Ltd, Clin Dev Dept, Tokyo, Japan; [Inagaki, Katsutoshi] EA Pharma Co Ltd, Med Dept, Med Sci Grp, Tokyo, Japan; [Shimizu, Naoki] Kissei Pharmaceut Co Ltd, Med Res Dept, Tokyo, Japan; [Watanabe, Mamoru] Tokyo Med & Dent Univ, TMDU Adv Res Inst, Tokyo, Japan; [Tanaka, Shinji] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Arai, Takehiro] Toukatsu Tsujinaka Hosp, Abiko, Chiba, Japan; [Kishi, Masahiro] Fukuoka Univ, Dept Gastroenterol, Chikushi Hosp, Chikushino, Japan; [Watanabe, Chiyuki] Hiroshima Prefectural Hosp, Dept Endoscopy, Hiroshima, Japan; [Sakata, Yasuhisa] Saga Med Sch, Dept Internal Med, Saga, Japan; [Ashida, Toshifumi] Sapporo Tokushukai Hosp, IBD Ctr, Sapporo, Hokkaido, Japan; [Maemoto, Atsuo] Sapporo Higashi Tokushukai Hosp, IBD Ctr, Sapporo, Hokkaido, Japan; [Sai, Souken] Sai Gastroenterol Proctol Clin, Dept Gastroenterol & Proctol, Osaka, Japan; [Kitano, Atsuo] Wakakusa First Hosp, Dept Gastroenterol, Osaka, Japan; [Sameshima, Yukinori] Sameshima Hosp, Dept Internal Med, Kagoshima, Japan; [Yokoyama, Kaoru] Kitasato Univ, Dept Gastroenterol, Sch Med, Sagamihara, Kanagawa, Japan; [Kobayashi, Taku] Kitasato Univ, Kitasato Inst Hosp, Dept Res, Ctr Adv IBD Res & Treatment, Tokyo, Japan; [Suekane, Takehisa] Osaka City Gen Hosp, Dept Gastroenterol, Osaka, Japan; [Matsuda, Koichiro] Toyama Prefectural Cent Hosp, Dept Internal Med Gastroenterol, Toyama, Japan; [Obata, Hirozumi] Obata Med Clin, Kyoto, Japan; [Fujiya, Mikihiro] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan; [Shirai, Takayuki] Tokai Univ, Hachioji Hosp, Dept Gastroenterol, Hachioji, Tokyo, Japan; [Tominaga, Keiichi] Dokkyo Med Univ, Dept Gastroenterol, Shimotsuga, Tochigi, Japan; [Suzuki, Ryouichi] Kannai Suzuki Clin, Yokohama, Kanagawa, Japan	Keio University; Fukuoka University; Kitasato University; Hyogo College of Medicine; Sapporo Kosei General Hospital; Keio University; Yokohama City University; Keio University; Eisai Co Ltd; Eisai Co Ltd; Kissei Pharmaceutical Co Ltd; Tokyo Medical & Dental University (TMDU); Hiroshima University; Fukuoka University; Saga University; Kitasato University; Kitasato University; Osaka City General Hospital; Asahikawa Medical College; Tokai University; Dokkyo Medical University	Naganuma, M (corresponding author), Keio Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo, Japan.	nagamakoto@keio.jp	Watanabe, Mamoru/AHE-0489-2022; Tominaga, Keiichi/AAN-2986-2020; Takedatsu, Hidetoshi/AAD-1037-2020; Kobayashi, Taku/AAO-6437-2020	Takedatsu, Hidetoshi/0000-0002-0318-0129; Kobayashi, Taku/0000-0002-2073-4234; Naganuma, Makoto/0000-0002-4244-3243; Watanabe, Kenji/0000-0002-3781-4724	EA Pharma Co.; Kissei Pharmaceutical Co., Ltd.; EA Pharma Co., Ltd.	EA Pharma Co.; Kissei Pharmaceutical Co., Ltd.(Kissei Pharmaceutical Co Ltd); EA Pharma Co., Ltd.	This work was funded by EA Pharma Co. and Kissei Pharmaceutical Co., Ltd. The commercial affiliates provided support in the form of salaries for authors [YY, KI and NS]. The specific roles of these authors are articulated in the Author Contributions section. The funders had no additional role in the study design, data collection and analysis, or decision to publish.; Collaborators of the Study: Shinji Tanaka (Department of Endoscopy, Hiroshima University Hospital, Hiroshima, Japan), Takehiro Arai (Toukatsu Tsujinaka Hospital, Abiko, Japan), Masahiro Kishi (Department of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan.), Chiyuki Watanabe (Department of Endoscopy, Hiroshima Prefectural Hospital, Hiroshima, Japan), Yasuhisa Sakata (Departments of Internal Medicine, Saga Medical School, Saga, Japan), Toshifumi Ashida (IBD Center, Sapporo Tokushukai Hospital, Sapporo, Japan), Atsuo Maemoto (IBD Center, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan), Souken Sai (Department of Gastroenterology and Proctology, Sai Gastroenterology/Proctology Clinic, Osaka, Japan), Atsuo Kitano (Department of Gastroenterology, Wakakusa First Hospital, Osaka, Japan), Yukinori Sameshima (Department of Internal Medicine, Sameshima Hospital, Kagoshima, Japan), Kaoru Yokoyama (Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan), Taku Kobayashi (Center for Advanced IBD Research and Treatment, Department of Research, Kitasato University Kitasato Institute Hospital, Tokyo, Japan), Takehisa Suekane (Department of Gastroenterology, Osaka City General Hospital, Osaka, Japan), Koichiro Matsuda (Department of Internal Medicine [Gastroenterology], Toyama Prefectural Central Hospital, Toyama, Japan), Hirozumi Obata (Obata Medical Clinic, Kyoto, Japan), Mikihiro Fujiya (Division of Gastroenterology and Hematology/Oncology Department of Medicine, Asahikawa Medical University, Asahikawa, Japan), Takayuki Shirai (Department of Gastroenterology, Tokai University Hachioji Hospital, Hachioji, Japan), Keiichi Tominaga (Department of Gastroenterology, Dokkyo Medical University, Tochigi, Japan), Hidetoshi Takedatsu (Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Fukuoka, Japan), Ryouichi Suzuki (Kannai Suzuki Clinic, Yokohama, Japan). This study was supported by EA Pharma Co., Ltd. and Kissei Pharmaceutical Co., Ltd. We thank all participating patients and their families, the study investigators, study nurses, study monitors, data manager, and all other members of the study team. The authors received medical writing assistance from Dr. Tetsuji Asao (SunFlare Co., Ltd., Tokyo, Japan) for preparation of the initial and final drafts of the manuscript, which was funded by EA Pharma Co., Ltd. and Kissei Pharmaceutical Co., Ltd.	Arai M, 2016, J CROHNS COLITIS, V10, P1303, DOI 10.1093/ecco-jcc/jjw104; Ardizzone S, 2011, CLIN GASTROENTEROL H, V9, P483, DOI 10.1016/j.cgh.2010.12.028; Brattsand R, 1990, CAN J GASTROENTEROL, V4, P407; Christensen Britt, 2016, Curr Gastroenterol Rep, V18, P5, DOI 10.1007/s11894-015-0477-6; Colombel JF, 2011, GASTROENTEROLOGY, V141, P1194, DOI 10.1053/j.gastro.2011.06.054; Darr Umar, 2017, Curr Treat Options Gastroenterol, V15, P116, DOI 10.1007/s11938-017-0130-6; Faubion WA, 2001, GASTROENTEROLOGY, V121, P255, DOI 10.1053/gast.2001.26279; Feagan BG, 2013, GASTROENTEROLOGY, V145, P149, DOI 10.1053/j.gastro.2013.03.025; Feagan BG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000544.pub3; Froslie KF, 2007, GASTROENTEROLOGY, V133, P412, DOI 10.1053/j.gastro.2007.05.051; Greenberg G, 2002, CLIN PERSPECT GASTRO, V5, P9; Gross V, 2006, ALIMENT PHARM THERAP, V23, P303, DOI 10.1111/j.1365-2036.2006.02743.x; JONSSON G, 1995, DRUG METAB DISPOS, V23, P137; Matsuoka K, 2018, J GASTROENTEROL, V53, P305, DOI 10.1007/s00535-018-1439-1; Ministry of Education Culture Sports Science and Technology, 2017, ETH GUID MED HLTH RE; Nagahori M, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0604-y; Naganuma M, 2018, J GASTROENTEROL, V53, P494, DOI 10.1007/s00535-017-1376-4; Naganuma M, 2016, J CROHNS COLITIS, V10, P828, DOI 10.1093/ecco-jcc/jjv208; Nakarai A, 2014, WORLD J GASTROENTERO, V20, P18367, DOI 10.3748/wjg.v20.i48.18367; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Rubin DT, 2015, DIGEST DIS SCI, V60, P3408, DOI 10.1007/s10620-015-3868-5; RYRFELDT A, 1982, EUR J RESPIR DIS, V63, P86; Sandborn WJ, 2015, GASTROENTEROLOGY, V148, P740, DOI 10.1053/j.gastro.2015.01.037; Suzuki Y, 2017, INFLAMM BOWEL DIS, V23, P822, DOI 10.1097/MIB.0000000000001065; Suzuki Y, 2015, J CLIN GASTROENTEROL, V49, P401, DOI 10.1097/MCG.0000000000000199; Walmsley RS, 1998, GUT, V43, P29, DOI 10.1136/gut.43.1.29; Yokoyama K, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/192794; Yoshino T, 2016, INTEST RES, V14, P37, DOI 10.5217/ir.2016.14.1.37	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220413	10.1371/journal.pone.0220413	http://dx.doi.org/10.1371/journal.pone.0220413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381615	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600017
J	Boswald, LF; Klein, C; Dobenecker, B; Kienzle, E				Boeswald, Linda Franziska; Klein, Carmen; Dobenecker, Britta; Kienzle, Ellen			Factorial calculation of calcium and phosphorus requirements of growing dogs	PLOS ONE			English	Article							VITAMIN-D; FECAL CALCIUM; METABOLISM; DIET; NUTRIENT; ENERGY; DIGESTIBILITY; DEFICIENCY; ABSORPTION; EXCRETION	Calcium and phosphorus requirements for growing dogs can be calculated by different methods. The current standard feeding recommendations are based on experimental data derived from young giant breed puppies. In order to determine the absolute requirement, an extrapolation via metabolisable energy requirement is recommended. Another approach is to calculate the requirement factorially, taking into account the endogenous losses and the amount of calcium and phosphorus retained due to tissue accretion during growth as well as the expected availability of these nutrients. The working hypothesis was that both methods are valid and lead to comparable results in young puppies of a high mature body weight (BW). Yet, deviations for other age and mature BW groups were expected. Thus, the aim of the present study was to compare the results of both methods using exemplary puppies of different age and mature BW groups. The hypotheses could be verified for calcium. The extrapolated requirements overestimate the factorial requirements by up to 59.7% for puppies <60kg mature BW and/or >6 months of age. In case of phosphorus requirement, the deviations between both methods are overall very high in all stages. Taking into account the potentially harmful effects of calcium and phosphorus excess, the feeding recommendations based on the extrapolation should be reconsidered.	[Boeswald, Linda Franziska; Klein, Carmen; Dobenecker, Britta; Kienzle, Ellen] Ludwig Maximilians Univ Munchen, Dept Vet Sci, Chair Anim Nutr & Dietet, Munich, Germany	University of Munich	Boswald, LF (corresponding author), Ludwig Maximilians Univ Munchen, Dept Vet Sci, Chair Anim Nutr & Dietet, Munich, Germany.	linda.boeswald@lmu.de	Böswald, Linda/AAN-2058-2020	Böswald, Linda/0000-0002-5363-335X; Dobenecker, Britta/0000-0003-0534-4219				Becker N, 2012, TIERAERZTL PRAX K H, V40, P135; Boswald LF, 2018, J ANIM PHYSIOL AN N, V102, P370, DOI 10.1111/jpn.12844; BURGER IH, 1991, J NUTR, V121, pS18, DOI 10.1093/jn/121.suppl_11.S18; CAMPBELL JR, 1965, BRIT J NUTR, V19, P339, DOI 10.1079/BJN19650032; Dobenecker B, 2006, J ANIM PHYSIOL AN N, V90, P394, DOI 10.1111/j.1439-0396.2006.00618.x; Dobenecker B, 1998, J ANIM PHYSIOL AN N, V80, P76, DOI 10.1111/j.1439-0396.1998.tb00506.x; Dobenecker B, 2004, J NUTR, V134, p2151S, DOI 10.1093/jn/134.8.2151S; Dobenecker B, 2010, J ANIM PHYSIOL AN N, V94, pe109, DOI 10.1111/j.1439-0396.2010.00989.x; Dobenecker B, 2002, J NUTR, V132, p1665S, DOI 10.1093/jn/132.6.1665S; Dobenecker B, 2011, BRIT J NUTR, V106, pS142, DOI 10.1017/S0007114511002959; Flachowsky G., 2004, Kraftfutter, V87, P260; GERSHOFF SN, 1958, J NUTR, V64, P303, DOI 10.1093/jn/64.2.303; GOEDEGEBUURE SA, 1986, VET PATHOL, V23, P594, DOI 10.1177/030098588602300508; Goodman SA, 1998, RECENT ADV CANINE FE, V3, P3; HAZEWINKEL HAW, 1989, J SMALL ANIM PRACT, V30, P625, DOI 10.1111/j.1748-5827.1989.tb01493.x; HAZEWINKEL HAW, 1991, J NUTR, V121, pS99, DOI 10.1093/jn/121.suppl_11.S99; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; Hedhammar A, 1978, NUTRITION OF THE DOG; JENKINS KJ, 1960, J NUTR, V70, P235, DOI 10.1093/jn/70.2.235; Kamphues J., 2014, SUPPLEMENTE TIERERNA, Vtwelfth; Kiefer-Hecker B, 2018, J ANIM PHYSIOL AN N, V102, P789, DOI 10.1111/jpn.12868; Kienzle E, 1998, J NUTR, V128, p2609S, DOI [10.1093/jn/128.12.2609S, 10.1093/jn/128.12.2598S, 10.1093/jn/128.12.2680S]; KIENZLE E, 1991, J NUTR, V121, pS122, DOI 10.1093/jn/121.suppl_11.S122; Kienzle E, 1989, J NUTR, V128, p2680S; Kirchge&beta;ner M., 2014, TIERERNAHRUNG, V14th; Klein C, 2019, J ANIM PHYSL A UNPUB; Kober N, 2017, P 21 C ESVCN CIR UK; Kolle P, 2006, TIERAERZTL PRAX K H, V34, P104; Laflamme DP, 2001, COMPENDIUM CONTINUIN, V23, P66; LAUTEN SD, 1998, RECENT ADV CANINE FE, V2, P63; LIU CH, 1953, J GERONTOL, V8, P264; Lupatsch I, 2009, BASICS, P417, DOI 10.1533/9781845696474.3.417; Mack JK, 2015, J ANIM PHYSIOL AN N, V99, P801, DOI 10.1111/jpn.12294; Meyer H, 1983, ERNAHRUNG HUNDES; Morgan AF, 1933, AM J PHYSIOL, V105, P621, DOI 10.1152/ajplegacy.1933.105.3.621; Morgan AF, 1930, J BIOL CHEM, V85, P687; NAP RC, 1993, J NUTR, V123, P1826, DOI 10.1093/jn/123.11.1826; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Schmitt S, 2018, J ANIM PHYSIOL AN N, V102, pE798, DOI 10.1111/jpn.12837; Schoenmakers I, 1999, VET QUART, V21, P147, DOI 10.1080/01652176.1999.9695010; Shohl AT, 1928, J BIOL CHEM, V76, P633; Slater MR., 1991, VET COMP ORTHOPAED T, V4, P100; Smith MC, 1940, J NUTR, V20, P19, DOI 10.1093/jn/20.1.19; Society of Nutrition Physiolog (GfE), 2006, EMPF EN NAHRST SCHW, P112; Society of Nutrition Physiology (GfE), 1989, EN NUTR REQ 5 DOGS; Zentek J, 1992, J VET MED; Zentek J., 2016, ERNAHRUNG HUNDES	47	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220305	10.1371/journal.pone.0220305	http://dx.doi.org/10.1371/journal.pone.0220305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374084	Green Published, gold, Green Submitted			2022-12-27	WOS:000484991500009
J	Jiang, WD; Yuan, PC				Jiang, Wei-dong; Yuan, Ping-cheng			Molecular network-based identification of competing endogenous RNAs in bladder cancer	PLOS ONE			English	Article							INVASIVE UROTHELIAL CARCINOMA; CIRCULAR RNAS; EAU GUIDELINES; METASTASIS; PROLIFERATION; PREDICTION; MIGRATION; PROMOTES; INSIGHTS; ABUNDANT	Background Circular RNAs (circRNAs) have been shown to interact with microRNAs (miRNA) as competitive endogenous RNAs (ceRNAs) to regulate target gene expression and participate in tumorigenesis. However, the role of circRNA-mediated ceRNAs in bladder cancer (BC) remains unknown. Accordingly, the aim of this study was to elucidate the regulatory mechanisms in BC based on construction of the ceRNA network. Methods The RNA expression profiles were obtained from public datasets in the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) database, and were used to establish a circRNA-miRNA-mRNA network. The interactions among proteins were analyzed using the STRING database and hubgenes were extracted using the cytoHubba application. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of differentially expressed mRNAs in BC and normal tissue samples were performed to determine the functions of the intersecting mRNAs. Results A total of 27 circRNAs, 76 miRNAs, and 4744 mRNAs were found to be differentially expressed between BC and normal tissues. The circRNA-miRNA-mRNA ceRNA network was established based on 21 circRNAs, 14 miRNAs, and 150 mRNAs differentially expressed in BC. We also established a protein-protein interaction network and identified 10 hubgenes, which were used to construct circRNA-miRNA-hubgene regulatory modules. The most enriched biological process GO term was strand displacement (P<0.05), and the homologous recombination and Fanconi anemia pathways were significantly enriched (P<0.05) for the differentially expressed genes in BC. Conclusions We screened several dysregulated circRNAs and established a circRNA-associated ceRNA network by bioinformatics analysis. The identified ceRNAs are likely critical in the pathogenesis of BC and may serve as future therapeutic biomarkers.	[Jiang, Wei-dong; Yuan, Ping-cheng] Hubei Polytech Univ, Huangshi Cent Hosp, Dept Urol, Affiliated Hosp,Edong Healthcare Grp, Huangshi, Hubei, Peoples R China; [Jiang, Wei-dong; Yuan, Ping-cheng] Hubei Polytech Univ, Huangshi Cent Hosp, Hubei Key Lab Kidney Dis Pathogenesis & Intervent, Affiliated Hosp,Edong Healthcare Grp, Huangshi, Hubei, Peoples R China	Hubei Polytechnic University; Hubei Polytechnic University	Yuan, PC (corresponding author), Hubei Polytech Univ, Huangshi Cent Hosp, Dept Urol, Affiliated Hosp,Edong Healthcare Grp, Huangshi, Hubei, Peoples R China.	dryuanpc@sina.com						Amin MB, 2015, MODERN PATHOL, V28, P612, DOI 10.1038/modpathol.2014.158; Babjuk M, 2017, EUR UROL, V71, pE173, DOI 10.1016/j.eururo.2016.11.029; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Bandettini WP, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-83; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Chen X, 2018, CLIN CANCER RES, V24, P6319, DOI 10.1158/1078-0432.CCR-18-1270; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006418; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Chen X, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005912; Clark PE, 2016, J NATL COMPR CANC NE, V14, P1213, DOI 10.6004/jnccn.2016.0131; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Du LT, 2017, ONCOTARGET, V8, P40832, DOI 10.18632/oncotarget.16586; Fromm B, 2015, ANNU REV GENET, V49, P213, DOI 10.1146/annurev-genet-120213-092023; Huang WP, 2018, GENE, V678, P337, DOI 10.1016/j.gene.2018.08.036; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Jiang YJ, 2019, AM J TRANSL RES, V11, P1644; Jin Y, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431x20187811, 10.1590/1414-431X20187811]; Kang M, 2017, ONCOTARGET, V8, P12891, DOI 10.18632/oncotarget.14179; Kristensen LS, 2018, ONCOGENE, V37, P555, DOI 10.1038/onc.2017.361; Li JQ, 2015, AM J CANCER RES, V5, P472; Li P, 2018, CELL PHYSIOL BIOCHEM, V46, P1606, DOI 10.1159/000489208; Li WT, 2018, NEOPLASIA, V20, P364, DOI 10.1016/j.neo.2018.01.008; Li Y, 2019, METHODS, V166, P4, DOI 10.1016/j.ymeth.2019.04.008; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14270; Liu J, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0630-y; Liu M, 2018, EUR REV MED PHARMACO, V22, P8248, DOI 10.26355/eurrev_201812_16519; Lv CF, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1726-x; Madubata CJ, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0032-5; Pla A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006185; Qiao BL, 2013, CANCER RES, V73, P1611, DOI 10.1158/0008-5472.CAN-12-1170; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Wei YP, 2016, TUMOR BIOL, V37, P12555, DOI 10.1007/s13277-016-5121-z; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu Z, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0039-0; Xu XW, 2017, ONCOTARGET, V8, P91674, DOI 10.18632/oncotarget.21748; Xu ZQ, 2018, J CELL BIOCHEM, V119, P3317, DOI 10.1002/jcb.26492; Yang C, 2019, CANCER SCI, V110, P99, DOI 10.1111/cas.13857; Yang CD, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0771-7; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu HH, 2018, NEW ADVANCES IN GEOTECHNICAL ENGINEERING, P455; Zhang G, 2018, J CELL BIOCHEM, DOI [10.1002/jcb.28224, DOI 10.1002/JCB.28224]; Zhang J, 2018, ELEVATED EXPRESSION, DOI [10.1002/jcb.28224, DOI 10.1002/JCB.28224]; Zhang X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1132-6; Zhong YX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0827-8; Zhou BS, 2018, CELL CYCLE, V17, P2644, DOI 10.1080/15384101.2018.1553354; Zhuang C, 2019, BMB REPORTS	50	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220118	10.1371/journal.pone.0220118	http://dx.doi.org/10.1371/journal.pone.0220118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369587	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900026
J	Yeware, A; Gample, S; Agrawal, S; Sarkar, D				Yeware, Amar; Gample, Suwarna; Agrawal, Sonia; Sarkar, Dhiman			Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis	PLOS ONE			English	Article							DORMANCY; MODEL; BIOSYNTHESIS; ADAPTATION; METHIONINE; HYPOXIA; CELLS; VIVO	Depletion of oxygen levels is a well-accepted model for induction of non-replicating, persistent states in mycobacteria. Increasing the stress levels in mycobacterium bacilli facilitates their entry into a non-cultivable, dormant state. In this study, it was shown that diphenyleneiodonium, an inhibitor of NADH oxidase, induced a viable, but non-culturable state in mycobacteria, having similar features to dormant bacilli, like loss of acid-fastness, upregulation of stress-regulated genes and decreased superoxide levels as compared to actively growing bacilli. Comprehensive, untargeted metabolic profiling also confirmed a decrease in biogenesis of amino acids, NAD, unsaturated fatty acids and nucleotides. Additionally, an increase in the level of lactate, fumarate, succinate and pentose phosphate pathways along with increased mycothiol and sulfate metabolites, similar to dormant bacilli, was observed in the granuloma. These non-cultivable bacilli were resuscitated by supplementation of fetal bovine serum, regaining their culturability in liquid as well as on agar medium. This study focused on the effect of diphenyleneiodonium treatment in causing mycobacteria to rapidly transition from an active state into a viable, but non-cultivable state, and comparing their characteristics with dormant phenotypes.	[Yeware, Amar; Gample, Suwarna; Agrawal, Sonia; Sarkar, Dhiman] Acad Sci & Innovat Res AcSIR, Ghaziabad, India; [Yeware, Amar; Gample, Suwarna; Agrawal, Sonia; Sarkar, Dhiman] Natl Chem Lab, Organ Chem Div, Combi Chem Bio Resource Ctr, Pune, Maharashtra, India	Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Sarkar, D (corresponding author), Acad Sci & Innovat Res AcSIR, Ghaziabad, India.; Sarkar, D (corresponding author), Natl Chem Lab, Organ Chem Div, Combi Chem Bio Resource Ctr, Pune, Maharashtra, India.	d.sarkar@ncl.res.in	Sarkar, Dhiman/AAK-7481-2020; Yeware, Amar/J-6346-2019	Sarkar, Dhiman/0000-0002-3912-1104; Yeware, Amar/0000-0003-1729-9865; Agrawal, Sonia/0000-0003-1528-7166	Council of Scientific and Industrial Research (CSIR) India [BSC0103, CSC0406]; DSTINSPIRE; UGC; CSIR	Council of Scientific and Industrial Research (CSIR) India(Council of Scientific & Industrial Research (CSIR) - India); DSTINSPIRE(Department of Science & Technology (India)); UGC(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Council of Scientific and Industrial Research (CSIR) India through grant aid projects BSC0103 and CSC0406 supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to the Center for Applications of Mass Spectrometry (CAMS) NCL Innovation Park, Pune, India for using UPLC system. AY, SG and SA are thankful to DSTINSPIRE, CSIR, and UGC for their research fellowships, respectively.	Akhtar S, 2011, ANAL BIOCHEM, V417, P286, DOI 10.1016/j.ab.2011.06.028; Ayrapetyan M, 2015, TRENDS MICROBIOL, V23, P7, DOI 10.1016/j.tim.2014.09.004; Belisle John T., 2008, V465, P1, DOI 10.1007/978-1-59745-207-6_1; Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649; Berney M, 2015, P NATL ACAD SCI USA, V112, P10008, DOI 10.1073/pnas.1513033112; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bloomfield G, 2003, J CELL SCI, V116, P3387, DOI 10.1242/jcs.00649; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Boshoff Helena I M, 2010, Drug Discov Today Dis Mech, V7, pe75, DOI 10.1016/j.ddmec.2010.09.008; Brennan RJ, 1997, MUTAGENESIS, V12, P215, DOI 10.1093/mutage/12.4.215; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dhillon J, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-51; Drapal M, 2016, MICROBIOL-SGM, V162, P1456, DOI 10.1099/mic.0.000325; Eoh H, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.84; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Kapoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053657; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Khan A, 2008, J MICROBIOL METH, V73, P62, DOI 10.1016/j.mimet.2008.01.015; Lakshminarayana SB, 2015, J ANTIMICROB CHEMOTH, V70, P857, DOI 10.1093/jac/dku457; Li L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00258; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; Patti GJ, 2014, METABOLOMICS, V10, P737, DOI 10.1007/s11306-013-0608-8; RAHMAN I, 1994, APPL ENVIRON MICROB, V60, P3573, DOI 10.1128/AEM.60.10.3573-3578.1994; Salina EG, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140106; Shi L, 2008, TUBERCULOSIS, V88, P1, DOI 10.1016/j.tube.2007.08.007; Shleeva M, 2004, MICROBIOL-SGM, V150, P1687, DOI 10.1099/mic.0.26893-0; Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581; Sikri K, 2013, CURR SCI, V105, P5; Sikri K, 2018, REDOX BIOL, V15, P452, DOI 10.1016/j.redox.2017.12.020; Singh U, 2011, J MICROBIOL METH, V84, P202, DOI 10.1016/j.mimet.2010.11.013; Singhal A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02264; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; Voskuil MI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00105; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; Yeware A, 2018, TUBERCULOSIS, V110, P15, DOI 10.1016/j.tube.2018.02.008; Yeware AM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00105	43	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220628	10.1371/journal.pone.0220628	http://dx.doi.org/10.1371/journal.pone.0220628			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369628	gold, Green Submitted, Green Published			2022-12-27	WOS:000484987900070
J	Zhang, KR; Hassan, M				Zhang, Kairan; Hassan, Mohamed			Crash severity analysis of nighttime and daytime highway work zone crashes	PLOS ONE			English	Article							INJURY SEVERITY; FATAL CRASHES; ACCIDENTS; VEHICLE; DRIVERS; MULTIPLE; IMPACTS; MODELS; LEVEL; AGE	Introduction Egypt's National Road Project is a large infrastructure project which presently aims to upgrade 2500 kilometers of road networks as well as construct 4000 kilometers of new roads to meet today's need. This leads to an increase in the number of work zones on highways and therefore a rise in hazardous traffic conditions. This is why highways agencies are shifting towards night construction in order to reduce the adverse traffic impacts on the public. Although many studies have investigated work zone crashes, only a few studies provide comparative analysis of the difference between nighttime and daytime work zone crashes. Methods Data from Egyptian long-term highway work zone projects between 2010 and 2016 are studied with respect to the difference in injury severity between nighttime and daytime crashes by using separate mixed logit models. Results The results indicate that significant differences exist between factors contributing to injury severity. Four variables are found significant only in the nighttime model and four other variables significant in the daytime model. The results show that older and male drivers, the number of lane closures, sidewise crashes, and rainy weather have opposite effects on injury severity in nighttime and daytime crashes. The findings presented in this paper could serve as an aid for transportation agencies in development of efficient measures to improve safety in work zones.	[Zhang, Kairan] Southwest Jiaotong Univ, Natl Engn Lab Integrated Transportat Big Data App, Chengdu, Sichuan, Peoples R China; [Hassan, Mohamed] Southwest Jiaotong Univ, Natl United Engn Lab Integrated & Intelligent Tra, Chengdu, Sichuan, Peoples R China	Southwest Jiaotong University; Southwest Jiaotong University	Hassan, M (corresponding author), Southwest Jiaotong Univ, Natl United Engn Lab Integrated & Intelligent Tra, Chengdu, Sichuan, Peoples R China.	abo_heseny@yahoo.com		Hassan, Mohamed/0000-0002-7805-7635				Abdel-Aty M, 2003, J SAFETY RES, V34, P597, DOI 10.1016/j.jsr.2003.05.009; Abdel-Aty MA, 2003, TRANSPORT RES REC, P140, DOI 10.3141/1840-16; Abdel-Aty MA, 1998, ACCIDENT ANAL PREV, V30, P851, DOI 10.1016/S0001-4575(98)00038-4; Akepati S., 2011, INTEGR TRANSP DEV BE, P472; Anarkooli AJ, 2016, J SAFETY RES, V56, P57, DOI 10.1016/j.jsr.2015.12.003; [Anonymous], 2015, DAILYNEWSEGYPT; Arditi D, 2004, J TRANSP ENG, V130, P725, DOI 10.1061/(ASCE)0733-947X(2004)130:6(725); Arditi D, 2007, J SAFETY RES, V38, P399, DOI 10.1016/j.jsr.2007.04.001; Bai Y, 2006, KTRANKU051 KANS DEP, P168; Borowsky A, 2010, ACCIDENT ANAL PREV, V42, P1240, DOI 10.1016/j.aap.2010.02.001; Bryden J. E., 2002, PROCEDURE ASSESSING; Cantin V, 2009, ACCIDENT ANAL PREV, V41, P763, DOI 10.1016/j.aap.2009.03.019; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Daniel J, 2000, TRANSPORT RES REC, P18, DOI 10.3141/1715-03; Dias I., 2016, COMPARISON FACTORS A; Dias I. M., 2015, WORK ZONE CRASH ANAL; Dissanayake S, 2009, MIDC TRANSP RES S; Dong CJ, 2015, INT J INJ CONTROL SA, V22, P116, DOI 10.1080/17457300.2013.844713; Elshamly Ahmed Fathalla, 2017, MATEC Web of Conferences, V124, DOI 10.1051/matecconf/201712404009; Garber N.J., 2002, 02R12 VTRC; Geedipally SR, 2011, TRANSPORT RES REC, P62, DOI 10.3141/2265-07; Gkritza K, 2010, ACCIDENT ANAL PREV, V42, P1392, DOI 10.1016/j.aap.2010.03.003; Gray RC, 2008, J SAFETY RES, V39, P483, DOI 10.1016/j.jsr.2008.07.003; Guo Y, 2019, TRANSP RES REC; Guo YY, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11072071; Guo YY, 2019, ACCIDENT ANAL PREV, V128, P164, DOI 10.1016/j.aap.2019.04.013; Guo YY, 2019, IEEE ACCESS, V7, P11809, DOI 10.1109/ACCESS.2019.2892135; Guo YY, 2018, TRANSPORT RES F-TRAF, V59, P212, DOI 10.1016/j.trf.2018.09.008; Gupta S, 2016, INJURY PREV, V22, pA53, DOI 10.1136/injuryprev-2016-042156.143; Harb R, 2008, J TRANSP ENG, V134, P203, DOI 10.1061/(ASCE)0733-947X(2008)134:5(203); Hosseinpour M, 2018, ACCIDENT ANAL PREV, V118, P277, DOI 10.1016/j.aap.2018.05.003; Hu W, 2011, J SAFETY RES, V42, P375, DOI 10.1016/j.jsr.2011.07.004; Johansson O, 2009, ACCIDENT ANAL PREV, V41, P809, DOI 10.1016/j.aap.2009.04.003; Katta V., 2013, DEV CRASH SEVERITY M; Kim JK, 2008, ACCIDENT ANAL PREV, V40, P1695, DOI 10.1016/j.aap.2008.06.005; Lee C, 2014, ACCIDENT ANAL PREV, V71, P286, DOI 10.1016/j.aap.2014.06.008; Li YF, 2009, J TRANSP ENG, V135, P694, DOI 10.1061/(ASCE)TE.1943-5436.0000055; Li ZB, 2012, ACCIDENT ANAL PREV, V45, P478, DOI 10.1016/j.aap.2011.08.016; Manner H, 2013, ACCIDENT ANAL PREV, V57, P40, DOI 10.1016/j.aap.2013.03.022; Meng Q, 2010, ACCIDENT ANAL PREV, V42, P1866, DOI 10.1016/j.aap.2010.05.007; Mosa AI, 2013, TRANSP LETT, V5, P201, DOI 10.1179/1942787513Y.0000000006; Osman M, 2018, ACCIDENT ANAL PREV, V111, P161, DOI 10.1016/j.aap.2017.11.026; Osman M, 2016, ACCIDENT ANAL PREV, V97, P261, DOI 10.1016/j.aap.2016.10.020; Ozturk F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-113; PIGMAN JG, 1990, TRANSPORT RES REC, V1270, P12; Rifaat SM, 2009, TRANSPORT RES REC, P61, DOI 10.3141/2102-08; Savolainen PT, 2011, ACCIDENT ANAL PREV, V43, P1666, DOI 10.1016/j.aap.2011.03.025; Schrock SD, 2004, FHWATX0504028; Sisiopiku V. P., 2015, 2015 ROAD SAF SIM IN, P40; Sullivan JM, 2002, ACCIDENT ANAL PREV, V34, P487, DOI 10.1016/S0001-4575(01)00046-X; Sze N. N., 2019, International Journal of Sustainable Transportation, V13, P148, DOI 10.1080/15568318.2018.1452083; Tang JJ, 2019, ACCIDENT ANAL PREV, V122, P226, DOI 10.1016/j.aap.2018.10.016; Ulfarsson GF, 2004, ACCIDENT ANAL PREV, V36, P135, DOI 10.1016/S0001-4575(02)00135-5; Van Ristell J, 2013, TRANSPORTATION, V40, P69, DOI 10.1007/s11116-012-9410-0; Wang Q., 2009, STUDY CRASH CHARACTE; Wei XX, 2017, J ADV TRANSPORT, DOI 10.1155/2017/5783696; Weng JX, 2016, P I CIVIL ENG-TRANSP, V169, P97, DOI 10.1680/jtran.14.00019; World Health Organisation, 2018, NONC DIS COUNTR PROF; Wu Biao, 2009, International Conference on transportation engineering 2009, Volumes 1-5. Proceedings of the Second International Conference, Southwest Jiatong University, Chengdu, China, 25-27 July, 2009, P2183; Wu Q, 2016, ACCIDENT ANAL PREV, V94, P28, DOI 10.1016/j.aap.2016.04.005; Wu Q, 2014, ACCIDENT ANAL PREV, V72, P105, DOI 10.1016/j.aap.2014.06.014; Yang X, 2013, APPL SOFT COMPUT, V13, P1, DOI 10.1016/j.asoc.2012.07.002; Ye X, 2013, ACCIDENT ANAL PREV, V57, P140, DOI 10.1016/j.aap.2013.03.025; Zhang KR, 2018, J ADV TRANSPORT, DOI 10.1155/2018/8570207; Zhang L, 2019, COMPLEXITY, DOI 10.1155/2019/1671340	65	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221128	10.1371/journal.pone.0221128	http://dx.doi.org/10.1371/journal.pone.0221128			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408489	Green Published, gold, Green Submitted			2022-12-27	WOS:000485009500044
J	Lai, CC; Weng, TC; Tseng, YF; Chiang, JR; Lee, MS; Hu, AYC				Lai, Chia-Chun; Weng, Tsai-Chuan; Tseng, Yu-Fen; Chiang, Jen-Ron; Lee, Min-Shi; Hu, Alan Yung-Chih			Evaluation of novel disposable bioreactors on pandemic influenza virus production	PLOS ONE			English	Article							CELL CULTURE; A VIRUS; FUTURE	Since 1997, the highly pathogenic influenza H5N1 virus has spread from Hong Kong. According to the WHO bulletin report, the H5N1 virus is a zoonotic disease threat that has infected more than 850 humans, causing over 450 deaths. In addition, an outbreak of another new and highly pathogenic influenza virus (H7N9) occurred in 2013 in China. These highly pathogenic influenza viruses could potentially cause a worldwide pandemic. it is crucial to develop a rapid production platform to meet this surge demand against any possible influenza pandemic. A potential solution for this problem is the use of cell-based bioreactors for rapid vaccine production. These novel bioreactors, used for cell-based vaccine production, possess various advantages. For example, they enable a short production time, allow for the handling highly pathogenic influenza in closed environments, and can be easily scaled up. In this study, two novel disposable cell-based bioreactors, BelloCell and TideCell, were used to produce H5N1 clade II and H7N9 candidate vaccine viruses (CVVs). Madin-Darby canine kidney (MDCK) cells were used for the production of these influenza CVVs. A novel bench-scale bioreactor named BelloCell bioreactor was used in the study. All culturing conditions were tested and scaled to 10 L industrial-scale bioreactor known as TideCell002. The performances of between BelloCell and TideCell were similar in cell growth, the average MDCK cell doubling time was slightly decreased to 25 hours. The systems yielded approximately 39.2 and 18.0 mu g/ml of HA protein with the 10-liter TideCell002 from the H5N1 clade II and H7N9 CVVs, respectively. The results of this study not only highlight the overall effectiveness of these bioreactors but also illustrate the potential of maintaining the same outcome when scaled up to industrial production, which has many implications for faster vaccine production. Although additional studies are required for process optimization, the results of this study are promising and show that oscillating bioreactors may be a suitable platform for pandemic influenza virus production.	[Lai, Chia-Chun; Weng, Tsai-Chuan; Tseng, Yu-Fen; Lee, Min-Shi; Hu, Alan Yung-Chih] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan; [Lai, Chia-Chun] Natl Tsing Hua Univ, Coll Life Sci Biol, Hsinchu, Taiwan; [Chiang, Jen-Ron] Ctr Dis Control, Vaccine Ctr, Taipei, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; Centers For Disease Control - Taiwan	Hu, AYC (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.	alanhu@nhri.edu.tw		Hu, Alan Yung-Chih/0000-0003-4501-8645	Ministry of Science and Technology (R.O.C.) [102-2622-B-400-001-CC2, 103-2622-B-400-001-CC2]	Ministry of Science and Technology (R.O.C.)	The authors would like to thank Mr. Anthony Chang for English editing, and the US CDC for supplying the egg-derived vaccine strains. The authors would also like to thank the funding support from the Ministry of Science and Technology (R.O.C. 102-2622-B-400-001-CC2; 103-2622-B-400-001-CC2). Mr. Chia-Chun Lai is currently pursuing his Ph.D. studies under the Graduate Program of Biotechnology in Medicine, National Tsing Hua University and the National Health Research Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Mr. Anthony Chang for English editing, and the US CDC for supplying the egg-derived vaccine strains. The authors would also like to thank the funding support from the Ministry of Science and Technology (R.O.C. 102-2622-B-400-001-CC2; 103-2622-B-400-001-CC2). Chia-Chun Lai carried out his PhD study under the auspices of the Graduate Program of Biotechnology in Medicine, National Tsing Hua University and National Health Research Institutes.	Bock A, 2011, BIOTECHNOL PROGR, V27, P241, DOI 10.1002/btpr.539; Chen A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-81; Chen YH, 2005, J BIOTECHNOL, V118, P135, DOI 10.1016/j.jbiotec.2005.02.018; Eisfeld AJ, 2014, NAT PROTOC, V9, P2663, DOI 10.1038/nprot.2014.180; Genzel Y, 2014, VACCINE, V32, P2770, DOI 10.1016/j.vaccine.2014.02.016; Genzel Y, 2013, APPL MICROBIOL BIOT, V97, P111, DOI 10.1007/s00253-012-4238-2; Genzel Y, 2010, APPL MICROBIOL BIOT, V88, P461, DOI 10.1007/s00253-010-2742-9; Hamamoto I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059892; Hu AZ, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-91; Hu YC, 2003, CYTOTECHNOLOGY, V42, P145, DOI 10.1023/B:CYTO.0000015841.98225.27; Huang D, 2015, MATH PROBL ENG, V2015, P11; Huang KS, 2007, HUM GENE THER, V18, P1161, DOI 10.1089/hum.2007.107; Kamen A, 2004, J GENE MED, V6, pS184, DOI 10.1002/jgm.503; Lee MS, 2012, TRENDS MICROBIOL, V20, P103, DOI 10.1016/j.tim.2011.12.002; Lu JT, 2005, BIOTECHNOL LETT, V27, P1059, DOI 10.1007/s10529-005-8450-3; Manini I, 2015, EXPERT REV VACCINES, V14, P789, DOI 10.1586/14760584.2015.1039520; Merten OW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0040; Milian E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504831; Perdue ML, 2011, EXPERT REV VACCINES, V10, P1183, DOI [10.1586/erv.11.82, 10.1586/ERV.11.82]; Rao G, 2009, BIOTECHNOL BIOENG, V102, P348, DOI 10.1002/bit.22192; Rourou S, 2009, APPL MICROBIOL BIOT, V85, P53, DOI 10.1007/s00253-009-2064-y; Shin D, 2015, VIRUS RES, V204, P40, DOI 10.1016/j.virusres.2015.04.005; Shukla AA, 2013, TRENDS BIOTECHNOL, V31, P147, DOI 10.1016/j.tibtech.2012.10.004; Souza MCO, 2009, VACCINE, V27, P6420, DOI 10.1016/j.vaccine.2009.06.023; Tapia F, 2014, VACCINE, V32, P1003, DOI 10.1016/j.vaccine.2013.11.044; To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24; Toriniwa H, 2007, BIOLOGICALS, V35, P221, DOI 10.1016/j.biologicals.2007.02.002; Tseng YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024057; Wang Yu-Chi, 2003, NOVEL DISPOSABLE BIO; WHO, 2017, CUM NUMB CONF HUM CA; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2017, ANT GEN CHAR ZOON IN; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07	33	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220803	10.1371/journal.pone.0220803	http://dx.doi.org/10.1371/journal.pone.0220803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404117	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800033
J	Obrisca, B; Stefan, G; Gherghiceanu, M; Mandache, E; Ismail, G; Stancu, S; Boitan, B; Ion, O; Mircescu, G				Obrisca, Bogdan; Stefan, Gabriel; Gherghiceanu, Mihaela; Mandache, Eugen; Ismail, Gener; Stancu, Simona; Boitan, Bianca; Ion, Oana; Mircescu, Gabriel			"Associated" or "Secondary" IgA nephropathy? An outcome analysis	PLOS ONE			English	Article							OXFORD CLASSIFICATION; NATURAL-HISTORY; GLOMERULONEPHRITIS; DISEASE	Background Whether differences in outcome between primary (pIgAN) and secondary IgA nephropathy (sIgAN) exist is uncertain. Methods We conducted a retrospective, observational study that included all histologically diagnosed IgAN patients between 2010-2017 (N = 306), 248 with pIgAN and 58 with sIgAN. To obtain samples with similar risk of progression, sIgAN patients were grouped as liver disease and autoimmune/viral disease and propensity score matched to corresponding pIgAN samples. Univariate (Kaplan Meier) and multivariate time-dependent (Cox modelling) analyses were performed to identify predictors of the composite end-point (doubling of serum creatinine, end-stage kidney disease or death). Results Of the whole cohort, 20% had sIgAN (6% alcoholic cirrhosis, 6% autoimmune disease and 8% viral infections). sIgAN patients were older, had more comorbidities, lower proteinuria and higher haematuria, but similar distribution in MESTC lesions and eGFR as those with pIgAN. They reached the end-point in similar proportions with those with pIgAN (43 vs. 30%; p = 0.09) but their mortality was higher (19 vs. 3%; p<0.0001). Both in unmatched (HR 0.80, 95%CI 0.42-1.52; p = 0.5) and matched samples (log-rank test: liver disease-IgAN vs. pIgAN, p = 0.1; autoimmune/viral-IgAN vs. pIgAN, p = 0.3), sIgAN was not predictive for end-point. In analyses restricted only to sIgAN, those with viral infections (HR, 10.98; 95% CI, 1.12-107.41; p = 0.03) and lower eGFR (HR, 0.94; 95%CI, 0.89-0.98; p = 0.007) had a worse prognosis. Immunosuppression did not influence outcome. Conclusions The differences in MESTC score and outcome between pIgAN and sIgAN seems to be minimal, suggesting that "associated" describes better than "secondary" the relationship among the two. Immunosuppression did not to influence outcome of sIgAN.	[Obrisca, Bogdan; Ismail, Gener; Ion, Oana] Fundeni Clin Inst, Nephrol Dept, Bucharest, Romania; [Obrisca, Bogdan; Stefan, Gabriel; Gherghiceanu, Mihaela; Ismail, Gener; Stancu, Simona; Mircescu, Gabriel] Carol Davila Univ Med & Pharm, Nephrol Dept, Bucharest, Romania; [Stefan, Gabriel; Mandache, Eugen; Stancu, Simona; Boitan, Bianca; Mircescu, Gabriel] Dr Carol Davila Teaching Hosp Nephrol, Bucharest, Romania; [Gherghiceanu, Mihaela] Victor Babes Natl Inst Pathol, Bucharest, Romania	Institutul Clinic Fundeni; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; Carol Davila Hospital of Nephrology, Bucharest; Victor Babes National Institute of Pathology	Ismail, G (corresponding author), Fundeni Clin Inst, Nephrol Dept, Bucharest, Romania.; Ismail, G (corresponding author), Carol Davila Univ Med & Pharm, Nephrol Dept, Bucharest, Romania.	gener732000@yahoo.com	Gherghiceanu, Mihaela/G-4621-2016; Stefan, Gabriel/ABC-8061-2020; Obrisca, Bogdan/B-8729-2019; Obrisca, Bogdan/L-9009-2019; Obrisca, Bogdan/GVT-4314-2022	Gherghiceanu, Mihaela/0000-0001-6117-4328; Stefan, Gabriel/0000-0002-7336-5874; Obrisca, Bogdan/0000-0003-4796-4950; Obrisca, Bogdan/0000-0003-4796-4950; Obrisca, Bogdan/0000-0003-4796-4950; Ismail, Gener/0000-0003-3306-189X				Ahuja TS, 1998, AM J NEPHROL, V18, P425, DOI 10.1159/000013388; Ambruzs JM, 2014, CLIN J AM SOC NEPHRO, V9, P265, DOI 10.2215/CJN.04660513; Barbour SJ, 2016, KIDNEY INT, V89, P167, DOI 10.1038/ki.2015.322; Berthoux FC, 2008, SEMIN NEPHROL, V28, P4, DOI 10.1016/j.semnephrol.2007.10.001; Bu R, 2015, AM J NEPHROL, V41, P98, DOI 10.1159/000377684; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coppo R., 2018, NEPHROL DIAL TRANSPL, P1, DOI [10.1093/ndt/gfx330, DOI 10.1093/NDT/GFX330]; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Filiopoulos V, 2010, RENAL FAILURE, V32, P523, DOI 10.3109/08860221003710554; Geddes CC, 2003, NEPHROL DIAL TRANSPL, V18, P1541, DOI 10.1093/ndt/gfg207; Jarrick S, 2019, J AM SOC NEPHROL; Kocak G, 2012, CLIN ENDOCRINOL, V76, P759, DOI 10.1111/j.1365-2265.2011.04302.x; LAI KN, 1989, ANN RHEUM DIS, V48, P435, DOI 10.1136/ard.48.5.435; LAI KN, 1989, AM J CLIN PATHOL, V92, P159, DOI 10.1093/ajcp/92.2.159; Lv JC, 2013, AM J KIDNEY DIS, V62, P891, DOI 10.1053/j.ajkd.2013.04.021; Magistroni R, 2015, KIDNEY INT, V88, P974, DOI 10.1038/ki.2015.252; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Nasr SH, 2011, NEPHRON CLIN PRACT, V119, pC18, DOI 10.1159/000324180; O'Shaughnessy MM, 2018, NEPHROL DIAL TRANSPL, V33, P661, DOI 10.1093/ndt/gfx189; Oh HJ, 2012, KIDNEY INT, V82, P1304, DOI 10.1038/ki.2012.302; Pouria S, 2008, SEMIN NEPHROL, V28, P27, DOI 10.1016/j.semnephrol.2007.10.004; Rollino C, 2016, J NEPHROL, V29, P463, DOI 10.1007/s40620-016-0265-x; Saha MK, 2018, KIDNEY INT, V94, P674, DOI 10.1016/j.kint.2018.02.030; Seville A, 2019, CULTURAL LEGACY OF THE ROYAL GAME OF THE GOOSE: 400 YEARS OF PRINTED BOARD GAMES, P1, DOI 10.5117/9789462984974; Shim Y.A., 2018, P 2018 CHI C HUM FAC, P1; Sun IO, 2013, RENAL FAILURE, V35, P446, DOI 10.3109/0886022X.2013.775659; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221014	10.1371/journal.pone.0221014	http://dx.doi.org/10.1371/journal.pone.0221014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398224	gold, Green Submitted, Green Published			2022-12-27	WOS:000485004000040
J	von Hermanni, H; Tutic, A				von Hermanni, Hagen; Tutic, Andreas			Does economic inequality moderate the effect of class on prosocial behavior? A large-scale test of a recent hypothesis by Cote et al	PLOS ONE			English	Article							SOCIAL-CLASS	Empirical research has provided mixed evidence regarding the question of whether higher social class promotes prosocial behavior. Recently, Cote et al. [1] hypothesized that these conflicting evidences might result from a hitherto neglected interaction between the individual's level of income and the degree of inequality in one's society. They argue that societies with a higher level of inequality foster a sense of entitlement in high-income individuals, which in turn leads them to be less generous. We put this reasoning to a large-scale test using observational data from the European Social Survey (ESS) and push the scope of our investigation towards a broader conception of social class, using next to income two additional measures of class. First, we examine whether high-class individuals in societies with high levels of inequality do in fact feel more entitled than their counterparts in more equal societies. While we find that an individual's class and the disposition towards entitlement are strongly correlated, our results show a negative interaction with inequality, i.e. the effect of class on the personal sense of entitlement is weaker in societies with high levels of inequality. Second, we test whether the effect of class on prosocial behavior is moderated by economic inequality with respect to two real-life acts of prosocial behavior, namely engaging in volunteer work and donating money to a humanitarian organization. Our results indicate a substantial positive effect of class on prosocial behavior throughout, as well as a moderate, yet positive, interaction effect of class and inequality.	[von Hermanni, Hagen; Tutic, Andreas] Univ Leipzig, Inst Soziol, Leipzig, Germany	Leipzig University	von Hermanni, H (corresponding author), Univ Leipzig, Inst Soziol, Leipzig, Germany.	Hagen.von_Hermanni@uni-leipzig.de			German Research Foundation (DFG) [324311331]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was funded by the German Research Foundation (DFG), project number 324311331, receiver of the funding: Andreas Tutic. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; [Anonymous], 2010, OECD REG INC DISTR D; [Anonymous], 2002, ESS ROUND 1 EUR SOC, DOI [10.21338/NSD-ESS1-2002, DOI 10.21338/NSD-ESS1-2002]; Bekkers R, 2011, QUAL QUANT, V45, P1369, DOI 10.1007/s11135-010-9341-9; Berry WD, 2012, J POLIT, V74, P653, DOI 10.1017/S0022381612000199; Callan MJ, 2017, SOC PSYCHOL PERS SCI, V8, P660, DOI 10.1177/1948550616673877; Campbell WK, 2000, J RES PERS, V34, P329, DOI 10.1006/jrpe.2000.2282; Cote S, 2015, P NATL ACAD SCI USA, V112, P15838, DOI 10.1073/pnas.1511536112; European Central Bank, 2018, EUR FOR EXCH REF RAT; Hofstede G., 2010, CULTURES ORG SOFTWAR, V3rd ed., DOI [10.2307/2393257, DOI 10.2307/2393257]; Hofstede G., 2001, CULTURES CONSEQUENCE, V2nd ed.; Hout M., 2004, GETTING MOST OUT GSS; Kemmelmeier M, 2006, J CROSS CULT PSYCHOL, V37, P327, DOI 10.1177/0022022106286927; Korndorfer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133193; Kraus MW, 2012, PSYCHOL REV, V119, P546, DOI 10.1037/a0028756; Liebe U, 2017, KOLNER Z SOZIOL SOZ, V69, P109, DOI 10.1007/s11577-016-0399-9; Liebe U, 2010, RATION SOC, V22, P353, DOI 10.1177/1043463110366232; Maas C.J., 2005, METHODOLOGY-EUR, V1, P86, DOI [DOI 10.1027/1614-2241.1.3.86, 10.1027/1614-2241.1.3.86]; Norwegian Centre for Research Data , 2012, ESS ROUND 6 EUR SOC, DOI [10.21338/NSD-ESS6-2012, DOI 10.21338/NSD-ESS6-2012]; OECD, 2022, PURCHASING POWER PAR; Piff PK, 2018, ADV EXP SOC PSYCHOL, V57, P53, DOI 10.1016/bs.aesp.2017.10.002; Piff PK, 2017, CURR OPIN PSYCHOL, V18, P6, DOI 10.1016/j.copsyc.2017.06.003; Piff PK, 2014, PERS SOC PSYCHOL B, V40, P34, DOI 10.1177/0146167213501699; Piff PK, 2010, J PERS SOC PSYCHOL, V99, P771, DOI 10.1037/a0020092; Schwartz SH, 2004, J RES PERS, V38, P230, DOI 10.1016/S0092-6566(03)00069-2; Schwartz SH, 2012, J PERS SOC PSYCHOL, V103, P663, DOI 10.1037/a0029393; Tamborski M, 2012, PERS INDIV DIFFER, V52, P942, DOI 10.1016/j.paid.2012.01.030; Treiman D. J., 1977, OCCUPATIONAL PRESTIG	28	12	12	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220723	10.1371/journal.pone.0220723	http://dx.doi.org/10.1371/journal.pone.0220723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398193	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000016
J	Yang, SY; Fu, SH; Chen, KL; Hsieh, PL; Lin, PH				Yang, Shang-Yu; Fu, Shih-Hau; Chen, Kai-Li; Hsieh, Pei-Lun; Lin, Pin-Hsuan			Relationships between depression, health-related behaviors, and internet addiction in female junior college students	PLOS ONE			English	Article							LIFE-STYLE BEHAVIORS; SELF-ACTUALIZATION; GENDER-DIFFERENCES; PSYCHOMETRIC PROPERTIES; ADOLESCENT FEMALES; PHYSICAL-ACTIVITY; SYMPTOMS; ASSOCIATION; ANXIETY; STRESS	Introduction Depressive emotions can lead to subsequent unhealthy behaviors such as Internet addiction, especially in female adolescents; therefore, studies that examine the relationships among depression, health-related behaviors, and Internet addiction in female adolescents are warranted. Purpose To examine (1) the relationship between depression and health-related behaviors and (2) the relationship between depression and Internet addiction. Method A cross-sectional study design was adopted using a structured questionnaire to measure depression, health-related behaviors, and Internet addiction in female adolescents. The data were collected from students of a junior college in southern Taiwan using convenience sampling to select the participants. The questionnaire was divided into four sections: demographics, the Center for Epidemiologic Studies Depression Scale (CES-D), the Health Promoting Lifestyle Profile (HPLP), and the Internet Addiction Test (IAT). Results The final sample comprised 503 female junior college students, with the participants mainly aged between 15 to 22 years (mean age = 17.30 years, SD = 1.34). Regarding the HPLP scores, the overall score, nutrition subscale score, and self-actualization subscale score were significantly and negatively associated with the CES-D depression score (p < 0.05-0.01). In other words, depression level was lower in students who exhibited more healthy behaviors, put more emphasis on dietary health, and had higher levels of self-admiration and confidence toward life. Regarding the IAT scores, the overall score and six domain scores were all positively associated (p < 0.01) to the CES-D depression score. In other words, the higher an individual's Internet addiction score was, the higher her depression level was. Conclusions The results confirmed the relationship between depression, health-related behaviors, and Internet addiction. The cultivation of health-related behaviors may help in lowering depressive symptoms. Teenagers with depression have higher risks of developing Internet addiction, and such addiction is likely to affect their daily functioning.	[Yang, Shang-Yu] Asia Univ, Dept Occupat Therapy, Coll Med & Hlth Sci, Taichung, Taiwan; [Yang, Shang-Yu] Asia Univ, Dept Healthcare Adm, Coll Med & Hlth Sci, Taichung, Taiwan; [Fu, Shih-Hau] Chung Hwa Univ Med Technol, Dept Acupressure Technol, Tainan, Taiwan; [Chen, Kai-Li] Tajen Univ, Dept Nursing, Coll Pharm & Hlth Care, Pingtung, Taiwan; [Hsieh, Pei-Lun] Natl Taichung Univ Sci & Technol, Dept Nursing, Coll Hlth, Taichung, Taiwan; [Lin, Pin-Hsuan] Shu Zen Jr Coll Med & Management, Dept Hlth & Beauty, Kaohsiung, Taiwan	Asia University Taiwan; Asia University Taiwan; Chung Hua University; National Taichung University of Science & Technology	Lin, PH (corresponding author), Shu Zen Jr Coll Med & Management, Dept Hlth & Beauty, Kaohsiung, Taiwan.	pinhsuan12@ms.szmc.edu.tw						Aki A, 2015, J MED INVESTIG, V62, P204, DOI 10.2152/jmi.62.204; Allison S, 2001, AUST NZ J PSYCHIAT, V35, P498, DOI 10.1046/j.1440-1614.2001.00927.x; Ando M, 2011, J ADOLESCENCE, V34, P929, DOI 10.1016/j.adolescence.2010.12.003; Ardic A, 2016, J TRANSCULT NURS, V27, P583, DOI 10.1177/1043659615587585; Bai S, 2018, J PEDIATR PSYCHOL, V43, P1004, DOI 10.1093/jpepsy/jsy048; BERNDT DJ, 1982, J CLIN PSYCHOL, V38, P142, DOI 10.1002/1097-4679(198201)38:1<142::AID-JCLP2270380123>3.0.CO;2-D; Ceyhan E., 2018, SLEEP HYPNOSIS, V21, P123, DOI [10.5350/Sleep.Hypn.2019.21.0181, DOI 10.5350/SLEEP.HYPN.2019.21.0181, DOI 10.5350/Sleep.Hypn.2019.21.0181]; Chang FC, 2015, COMPR PSYCHIAT, V57, P21, DOI 10.1016/j.comppsych.2014.11.013; Chen M.Y., 1997, CHANG GUNG NURS, V8, P14; Chen TY, 2015, NEUROPSYCH DIS TREAT, V11, P741, DOI 10.2147/NDT.S77179; Chien C P, 1985, Seishin Shinkeigaku Zasshi, V87, P335; Davidson WB, 2007, PSYCHOL REP, V100, P604, DOI 10.2466/PRO.100.2.604-612; Derdikman-Eiron R, 2011, SCAND J PSYCHOL, V52, P261, DOI 10.1111/j.1467-9450.2010.00859.x; Eaton WW, USE PSYCHOL TESTING, P363; Ferrer-Cascales R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081781; Finning K, 2018, J AFFECT DISORDERS; Gijzen MWM, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1710-2; Giletta M, 2017, DEV PSYCHOPATHOL, V29, P1161, DOI 10.1017/S0954579416001218; Gotlib IH, 1998, J ABNORM PSYCHOL, V107, P686, DOI 10.1037/0021-843X.107.4.686; Ha JH, 2007, PSYCHOPATHOLOGY, V40, P424, DOI 10.1159/000107426; Hankin BL, 2001, PSYCHOL BULL, V127, P773, DOI 10.1037//0033-2909.127.6.773; Helgeson VS, 2007, J ADOLESCENT HEALTH, V40, P36, DOI 10.1016/j.jadohealth.2006.07.007; Hoare E, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00581; Hoare E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4272-1; Isasi CR, 2013, EAT BEHAV, V14, P518, DOI 10.1016/j.eatbeh.2013.07.009; John Tung Foundation Mental Health Center, 2018, INV APPL CAMP MENT H; Kardefelt-Winther D, 2014, COMPUT HUM BEHAV, V31, P351, DOI 10.1016/j.chb.2013.10.059; Khalid S, 2016, BRIT J NUTR, V116, P2097, DOI 10.1017/S0007114516004359; Kim KH, 2005, CREATIVITY RES J, V17, P337, DOI 10.1207/s15326934crj1704_5; Kim MJ, 2017, KOREAN J FAM MED, V38, P256, DOI 10.4082/kjfm.2017.38.5.256; Krems JA, 2017, PERS SOC PSYCHOL B, V43, P1337, DOI 10.1177/0146167217713191; Lai CM, 2013, J PEDIATR PSYCHOL, V38, P794, DOI 10.1093/jpepsy/jst022; Laird Y, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0405-7; Laukkanen M, 2016, CHILD PSYCHIAT HUM D, V47, P918, DOI 10.1007/s10578-015-0622-3; Lawrence D., 2015, MENTAL HLTH CHILDREN; Lee Eunsook, 2007, Taehan Kanho Hakhoe Chi, V37, P576; Lee K, 2009, FORMOSA J MENTAL HLT, V22, P383; Li GM, 2019, ADDICT BEHAV, V90, P421, DOI 10.1016/j.addbeh.2018.12.009; Lin HC, 2008, PSYCHIAT CLIN NEUROS, V62, P412, DOI 10.1111/j.1440-1819.2008.01820.x; Lin P. H, 2018, SOC HLTH BEHAV, V1, P31, DOI [10.3389/fpsyg.2018.02316, DOI 10.3389/FPSYG.2018.02316]; Lin PH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00599; Mannan M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157240; McKenna KYA, 2000, PERS SOC PSYCHOL REV, V4, P57, DOI 10.1207/S15327957PSPR0401_6; McLeod, 2007, SIMPLY PSYCHOL, V1, P1; McMahon EM, 2017, EUR CHILD ADOLES PSY, V26, P111, DOI 10.1007/s00787-016-0875-9; Mills NT, 2013, J CHILD PSYCHOL PSYC, V54, P816, DOI 10.1111/jcpp.12080; Ministry of Health and Welfare, 2018, ANT DRUG US STAT; Monacis L, 2018, INT J MENT HEALTH AD, V16, P680, DOI 10.1007/s11469-017-9823-2; Monacis L, 2017, INT J MENT HEALTH AD, V15, P853, DOI 10.1007/s11469-017-9768-5; Morahan-Martin J, 2003, COMPUT HUM BEHAV, V19, P659, DOI 10.1016/S0747-5632(03)00040-2; Musavian AS, 2014, NURS MIDWIFERY STUD, V3, DOI 10.17795/nmsjournal14560; Nilsen W, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1100-4; O'Shea G, 2014, CLIN PSYCHOL PSYCHOT, V21, P548, DOI 10.1002/cpp.1849; Park S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1143; Piko Bettina, 2014, Psychiatr Hung, V29, P48; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raiyat A, 2012, J HLTH HYGIENE, V3, P46; Rodgers RF, 2010, J YOUTH ADOLESCENCE, V39, P393, DOI 10.1007/s10964-009-9431-y; Rogers PJ, 2008, BRIT J NUTR, V99, P421, DOI 10.1017/S0007114507801097; Silvers KM, 2006, ASIA PAC J CLIN NUTR, V15, P30; Su WL, 2019, COMPUT HUM BEHAV, V99, P86, DOI 10.1016/j.chb.2019.04.021; Tajik E, 2017, J SPORT MED PHYS FIT, V57, P1382, DOI 10.23736/S0022-4707.16.06658-5; Tajik E, 2016, OBES RES CLIN PRACT, V10, P114, DOI 10.1016/j.orcp.2015.06.001; Tsai CC, 2003, CYBERPSYCHOL BEHAV, V6, P649, DOI 10.1089/109493103322725432; Van Beveren ML, 2016, J CHILD FAM STUD, V25, P1954, DOI 10.1007/s10826-016-0368-y; Walker S. N., 1987, HLTH PROMOTING LIFES; Wang PY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214769; Webster-Gandy J, 2011, OXFORD HANDBOOK OF N; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; Whang LSM, 2003, CYBERPSYCHOL BEHAV, V6, P143, DOI 10.1089/109493103321640338; Widyanto L, 2004, CYBERPSYCHOL BEHAV, V7, P443, DOI 10.1089/cpb.2004.7.443; Wirback T, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1765-0; Wu AMS, 2016, COMPR PSYCHIAT, V70, P41, DOI 10.1016/j.comppsych.2016.06.011; Xin Miao, 2018, Addict Behav Rep, V7, P14, DOI 10.1016/j.abrep.2017.10.003; Yang S.-Y., 2019, SOC HLTH BEHAV, V2, P26, DOI 10.4103/SHB.SHB-44-18; Yang SY, 2018, J AM COLL HEALTH, V66, P693, DOI 10.1080/07448481.2018.1454930; Young KS., 1998, CYBERPSYCHOL BEHAV, V1, P25, DOI [10.1089/cpb.1998.1.25, DOI 10.1089/CPB.1998.1.25]	77	17	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220784	10.1371/journal.pone.0220784	http://dx.doi.org/10.1371/journal.pone.0220784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398212	gold, Green Published, Green Submitted			2022-12-27	WOS:000485004000019
J	Alelign, A; Petros, B; Ameni, G				Alelign, Amir; Petros, Beyene; Ameni, Gobena			Smear positive tuberculosis and genetic diversity of M. tuberculosis isolates in individuals visiting health facilities in South Gondar Zone, northwest Ethiopia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; PREVALENCE; LINEAGES; STRAINS; BURDEN; CATTLE	Background Tuberculosis (TB), a bacterial infectious disease, continues to be a public health concern in many developing countries. However, lack of data concerning the public health burden and potential risk factors for the disease hampers control programs in target areas. Therefore, the aims of present study were to determine the prevalence of TB and genetic diversity of M. tuberculosis isolates from individuals visiting health facilities in South Gondar Zone, north-west Ethiopia. Methods A cross-sectonal study was conducted between March 2015 and April 2017. Bacteriological examination, region of difference (RD) 9 based polymerase chain reaction (PCR) and spoligotyping were used. Results The overall prevalence of all smear positive TB was 6.3% (186/2953). Extra pulmonary TB (EPTB) was clinically characterized in about 62.4% (116/186) TB-positive cases. Some demographic characteristics, such as patients' origin (districts where patients were recruited) [patients' origin (chi-square (chi(2)) value; 62.8, p<0.001) were found to be significantly associated risk factors for the occurrence of TB in the study area. All the mycobacterial isolates were found to be M. tuberculosis. Among the 35 different spoligotype patterns identified, 22 patterns were shared types. The three dominantly identified families were T, CAS and Manu, each consisting of 46.9%, 24.0% and 10.4% of the isolates, respectively. Conclusion The present study revealed that TB continues to be a public health problem in South Gondar Zone which suggests a need of implementing effective disease control strategies.	[Alelign, Amir; Ameni, Gobena] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Alelign, Amir; Petros, Beyene] Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Alelign, Amir] Debrebrhan Univ, Coll Nat & Computat Sci, Dept Biol, Debrebrhan, Ethiopia	Addis Ababa University; Addis Ababa University	Alelign, A (corresponding author), Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.; Alelign, A (corresponding author), Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.; Alelign, A (corresponding author), Debrebrhan Univ, Coll Nat & Computat Sci, Dept Biol, Debrebrhan, Ethiopia.	aleamiro2009@gmail.com	Ameni, Gobena/AAR-4201-2020; Alelign, Amir/P-4524-2018	Ameni, Gobena/0000-0003-3987-0671; Alelign, Amir/0000-0003-2750-7904	Addis Ababa University [0162230106072100101]; National Institute of Health (NIH, USA), H3Africa Consortium Program [U01HG007472-01]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007472] Funding Source: NIH RePORTER	Addis Ababa University; National Institute of Health (NIH, USA), H3Africa Consortium Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was funded by Addis Ababa University (Grant Ref. No. 0162230106072100101) and the National Institute of Health (NIH, USA), H3Africa Consortium Program (Grant Ref. No. U01HG007472-01).	Addis Z, 2015, ASIAN PAC J TROP MED, V8, P127, DOI 10.1016/S1995-7645(14)60302-3; Ahmed Esmael, 2014, Journal of Microbial and Biochemical Technology, V6, P075; Alemayehu M, 2017, AM J INFECT DIS MICR, V5, P61; Ali H, 2012, ETHIOP J HEALTH SCI, V22, P70; Amare H, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-6; [Anonymous], 2000, INT UNION TUBERCULOS; Anwar Nuru, 2015, Ethiopian Veterinary Journal, V19, P27, DOI 10.4314/evj.v19i2.3; Belay M, BIOMEDICAL RES INT, DOI [10.1155/2014/, DOI 10.1155/2014/]; Berg S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005068; Centers for Disease Control and Prevention (CDC), 2002, PUBLIC MED, V28, P250; Central Statistical Agency, 2011, ETH DEM HLTH SURV; Central Statistics Agency Addis Ababa Ethiopia, 2007, SUMM STAT REP THE200; Converse P. J., 2000, RISK PREVENTIVE BE 1, V7, P147; Debebe T, 2014, J MICROBIOL IMMUNOL, V47, P333, DOI 10.1016/j.jmii.2013.03.012; Desikan P, 2016, INDIAN J MED RES, V143, P481, DOI 10.4103/0971-5916.184287; Diriba B, 2013, INT J TUBERC LUNG D, V17, P246, DOI 10.5588/ijtld.12.0195; Disassa H, 2015, BR MICROBIOL RES J, V10, P1, DOI DOI 10.9734/BMRJ/2015/20032; Eliso E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1411-4; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Garcia de Viedma D, 2005, J INFECT DIS, V192, P2059, DOI 10.1086/498245; Garedew L, 2013, INT J TUBERC LUNG D, V17, P1076, DOI 10.5588/ijtld.12.0854; Gebrecherkos T, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3761-y; Gele AA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-5; Getahun Asebe, 2016, African Journal of Microbiology Research, V10, P1086, DOI 10.5897/AJMR2015.7415; Gumi B, 2012, ECOHEALTH, V9, P139, DOI 10.1007/s10393-012-0754-x; Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012; Iliyasu Z, 2009, J EPIDEMIOL, V19, P81, DOI 10.2188/jea.JE20080026; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kapata Nathan, 2016, PLoS One, V11, pe0146392, DOI 10.1371/journal.pone.0146392; Korma W, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1177-4; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Maru M., 2015, TUBERC RES TREAT, V2015, DOI 10.1155/2015/215015; Mathema B, 2015, ANN AM THORAC SOC, V12, P12, DOI 10.1513/AnnalsATS.201404-150OC; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P13; Mihret A, 2012, AFR HEALTH SCI, V12, P339, DOI 10.4314/ahs.v12i3.15; Moges B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-352; Mozafari M, 2013, IRAN J MICROBIOL, V5, P366; Mumpe-Mwanja D, 2015, AFR HEALTH SCI, V15, P851, DOI 10.4314/ahs.v15i3.20; Ngowi BJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-341; Nuru Anwar, 2017, BMC Res Notes, V10, P31, DOI 10.1186/s13104-016-2349-z; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Pareek M, 2012, THORAX J; Parsons LM, 2002, J CLIN MICROBIOL, V40, P2339, DOI 10.1128/JCM.40.7.2339-2345.2002; Tesgaye F, 2014, PUBLIC HEALTH ACTION, V4, pS25, DOI 10.5588/pha.14.0052; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; TIBEBU M, 2014, J MYCOBACT DIS, V4, P139; Tulu Begna, 2014, BMC Res Notes, V7, P285, DOI 10.1186/1756-0500-7-285; WHO, 2017, GLOB TUB REP; Wondimeneh Yitayih, 2012, BMC Res Notes, V5, P331, DOI 10.1186/1756-0500-5-331; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; World Health Organization, 1998, LAB SERV TUB CONTR 3; World Health Organization, 2018, GLOB TUB REP 2018; Zenebe Yohannes, 2013, BMC Res Notes, V6, P21, DOI 10.1186/1756-0500-6-21	56	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0216437	10.1371/journal.pone.0216437	http://dx.doi.org/10.1371/journal.pone.0216437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393882	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500004
J	Dinstag, G; Amar, D; Ingelsson, E; Ashley, E; Shamir, R				Dinstag, Gal; Amar, David; Ingelsson, Erik; Ashley, Euan; Shamir, Ron			Personalized prediction of adverse heart and kidney events using baseline and longitudinal data from SPRINT and ACCORD	PLOS ONE			English	Article							REGULARIZATION PATHS; MODELS	Background The 2017 guidelines of the American College of Cardiology and the American Heart Association propose substantial changes to hypertension management. The guidelines lower the blood pressure threshold defining hypertension and promote more aggressive treatments. Thus, more individuals are now classified as hypertensive and as a result, medication usage may become more extensive. An inevitable byproduct of greater medication use is higher incidence of adverse effects. Here, we examined these issues by developing models that predict both cardiovascular events and other adverse events based on the treatment chosen and other patient's data. Methods and results We used data from the SPRINT trial to produce patient-specific predictions of the risks for adverse cardiovascular or kidney outcomes. Unlike prior models, we used both the baseline characteristics collected upon recruitment and the longitudinal data during the follow-up. Importantly, our cardiovascular predictor outperformed extant models on SPRINT participants, achieving AUC = 0.765, and was validated with good performance in an independent cohort of the ACCORD trial. Conclusions Our study illustrates the importance of including longitudinal data for assessing personalized risk and provides means for recommending personalized treatment decisions.	[Dinstag, Gal; Shamir, Ron] Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel; [Amar, David; Ingelsson, Erik; Ashley, Euan] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA USA; [Ingelsson, Erik] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA	Tel Aviv University; Stanford University; Stanford University	Shamir, R (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, Tel Aviv, Israel.	rshamir@tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870; Ingelsson, Erik/0000-0003-2256-6972	Israel Science Foundation (ISF) as part of the ISF-NSFC joint program [2193/15]; ISF [1339/18]; Blavatnik Family foundation; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Israel Science Foundation (ISF) as part of the ISF-NSFC joint program; ISF(Israel Science Foundation); Blavatnik Family foundation; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Study supported in part by the Israel Science Foundation (ISF) as part of the ISF-NSFC joint program (grant 2193/15), by ISF grant 1339/18, and by Len Blavatnik and the Blavatnik Family foundation (to RS) and a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University (to GD).	Basu S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002410; Burns NS, 2017, NEW ENGL J MED, V376, P2205, DOI 10.1056/NEJMp1705323; Chandrasekhar A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8674; COX DR, 1972, J R STAT SOC B, V34, P187; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Huang CX, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007509; Huesch MD, 2017, DRUGS R&D, V17, P623, DOI 10.1007/s40268-017-0213-9; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P115, DOI 10.1001/jama.2017.19672; Mezue K, 2018, AM J HYPERTENS, V31, P48, DOI 10.1093/ajh/hpx128; Patel KK, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.003624; Pearl J, 2009, CAUSALITY, DOI 10.1017/CBO9780511803161; Pool LR, 2018, JAMA CARDIOL, V3, P1096, DOI 10.1001/jamacardio.2018.2763; Simon N, 2011, J STAT SOFTW, V39, P1; SPRINT, 2016, NEW ENGL J MED, V36, P140, DOI [10.1097/HCR.0000000000000175, DOI 10.1097/HCR.0000000000000175]; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Whelton P.K., 2017, J AM COLL CARDIOL, V71, P85	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219728	10.1371/journal.pone.0219728	http://dx.doi.org/10.1371/journal.pone.0219728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393900	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500016
J	Kokkoris, V; Hamel, C; Hart, MM				Kokkoris, Vasilis; Hamel, Chantal; Hart, Miranda M.			Mycorrhizal response in crop versus wild plants	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZA; GENETIC-VARIABILITY; RHIZOPHAGUS-IRREGULARIS; GLOMUS-INTRARADICES; PHOTON IRRADIANCE; FIELD TRIALS; FUNGI; GROWTH; COLONIZATION; POPULATION	We proposed a theoretical framework predicting mutualistic outcomes for the arbuscular mycorrhizal (AM) symbiosis based on host provenance (crop versus wild). To test the framework, we grew two isolates of Rhizoglomus irregulare (commercial versus an isolate locally isolated), with five crop plants and five wild plants endemic to the region that co-occur with the locally sourced fungus. While inoculation with either isolate had no effect on plant biomass, it decreased leaf P content, particularly for wild plants. All plants associating with the commercial fungus had lower leaf P. Overall, our data shows that wild plants may be more sensitive to differences in mutualistic quality among fungal isolates.	[Kokkoris, Vasilis; Hart, Miranda M.] Univ British Columbia, Dept Biol, Okanagan Campus, Kelowna, BC, Canada; [Hamel, Chantal] Agr & Agri Food Canada, Quebec Res & Dev Ctr, Quebec City, PQ, Canada	University of British Columbia; Agriculture & Agri Food Canada	Kokkoris, V (corresponding author), Univ British Columbia, Dept Biol, Okanagan Campus, Kelowna, BC, Canada.	bill.kokkoris@ubc.ca	Hart, Miranda m/D-1562-2011; Kokkoris, Vasilis/V-5228-2019	Kokkoris, Vasilis/0000-0002-1667-0493				Al-Karaki G, 2004, MYCORRHIZA, V14, P263, DOI 10.1007/s00572-003-0265-2; Alejandro-Cordova A, RESPONSES ARBUSCULAR, DOI [10.1007/s11270-017-3247-2, DOI 10.1007/S11270-017-3247-2]; Antunes PM, 2011, NEW PHYTOL, V189, P507, DOI 10.1111/j.1469-8137.2010.03480.x; BALTRUSCHAT H, 1987, Z PFLANZENK PFLANZEN, V94, P419; BAON JB, 1993, PLANT SOIL, V157, P97, DOI 10.1007/BF02390231; Bates D, 2015, PARSIMONIOUS MIXED M, DOI DOI 10.1177/0146167220913363; Bethlenfalvay GJ, 1983, PLANT PHYSL; Borstler B, 2008, NEW PHYTOL, V180, P452, DOI 10.1111/j.1469-8137.2008.02574.x; Buysens C, 2016, APPL SOIL ECOL, V105, P137, DOI 10.1016/j.apsoil.2016.04.011; Calvet C, 2013, HORTSCIENCE; Campagnac E, 2014, MYCORRHIZA, V24, P121, DOI 10.1007/s00572-013-0517-8; Ceballos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070633; Cely MVT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00720; CHABOT S, 1992, MYCOLOGIA, V84, P315, DOI 10.2307/3760183; Christophersen HM, 2009, NEW PHYTOL, V184, P962, DOI 10.1111/j.1469-8137.2009.03009.x; Croll D, 2008, NEW PHYTOL, V180, P564, DOI 10.1111/j.1469-8137.2008.02602.x; DAFT MJ, 1978, NEW PHYTOL, V80, P365, DOI 10.1111/j.1469-8137.1978.tb01570.x; Delavaux CS, 2017, ECOLOGY, V98, P2111, DOI 10.1002/ecy.1892; Druille M, 2013, APPL SOIL ECOL, V72, P143, DOI 10.1016/j.apsoil.2013.06.011; Ehinger M, 2009, NEW PHYTOL, V184, P412, DOI 10.1111/j.1469-8137.2009.02983.x; Emam T, 2016, RESTOR ECOL, V24, P35, DOI 10.1111/rec.12287; Engelmoer DJP, 2014, MOL ECOL, V23, P1584, DOI 10.1111/mec.12451; Facelli E, 2010, NEW PHYTOL, V185, P1050, DOI 10.1111/j.1469-8137.2009.03162.x; FITTER AH, 1991, EXPERIENTIA, V47, P350, DOI 10.1007/BF01972076; Fortin JA, 2002, CAN J BOT, V80, P1, DOI 10.1139/b01-139; FRANSON RL, 1989, SOIL SCI SOC AM J, V53, P754, DOI 10.2136/sssaj1989.03615995005300030020x; Gianinazzi S, 2004, CAN J BOT, V82, P1264, DOI [10.1139/b04-072, 10.1139/B04-072]; Grace EJ, 2009, NEW PHYTOL, V181, P938, DOI 10.1111/j.1469-8137.2008.02720.x; Hamel C, 1996, AGR ECOSYST ENVIRON, V60, P197, DOI 10.1016/S0167-8809(96)01071-7; HAMEL C, 1991, SOIL BIOL BIOCHEM, V23, P661, DOI 10.1016/0038-0717(91)90080-4; Hart MM, 2018, FUNCT ECOL, V32, P126, DOI 10.1111/1365-2435.12976; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; HETRICK BAD, 1993, CAN J BOT, V71, P512, DOI 10.1139/b93-056; Hijri M, 2016, MYCORRHIZA, V26, P209, DOI 10.1007/s00572-015-0661-4; Jackson LE, 2002, SCI HORTIC-AMSTERDAM, V94, P205, DOI 10.1016/S0304-4238(01)00341-7; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Keymer A, 2017, ELIFE, V6, DOI [10.7554/eLife.29107, 10.7554/eLife.29107.001]; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Koch AM, 2017, NEW PHYTOL, V214, P1330, DOI 10.1111/nph.14465; Koch AM, 2006, ECOL LETT, V9, P103, DOI 10.1111/j.1461-0248.2005.00853.x; Koch AM, 2004, P NATL ACAD SCI USA, V101, P2369, DOI 10.1073/pnas.0306441101; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Lee EH, 2015, MYCOBIOLOGY, V43, P444, DOI 10.5941/MYCO.2015.43.4.444; Lekberg Y, 2005, NEW PHYTOL, V168, P189, DOI 10.1111/j.1469-8137.2005.01490.x; Li HY, 2008, NEW PHYTOL, V178, P852, DOI 10.1111/j.1469-8137.2008.02410.x; Luginbuehl LH, 2017, SCIENCE, V356, P1175, DOI 10.1126/science.aan0081; McGonigle TP, 1988, FUNCT ECOL, V2, P473, DOI 10.2307/2389390; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; MENGE JA, 1983, CAN J BOT, V61, P1015, DOI 10.1139/b83-109; Middleton EL, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00152.1; MILLER RM, 1995, OECOLOGIA, V103, P17, DOI 10.1007/BF00328420; Munkvold L, 2004, NEW PHYTOL, V164, P357, DOI 10.1111/j.1469-8137.2004.01169.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Oksanen J., 2011, MULTIVARIATE ANAL EC; Pellegrino E, 2015, SOIL BIOL BIOCHEM, V84, P210, DOI 10.1016/j.soilbio.2015.02.020; Perner H, 2007, MYCORRHIZA, V17, P469, DOI 10.1007/s00572-007-0116-7; Poulsen KH, 2005, NEW PHYTOL, V168, P445, DOI 10.1111/j.1469-8137.2005.01523.x; RAVNSKOV S, 1995, NEW PHYTOL, V129, P611, DOI 10.1111/j.1469-8137.1995.tb03029.x; Rodriguez A, 2015, ISME J, V9, P1053, DOI 10.1038/ismej.2014.207; Rowe HI, 2007, RESTOR ECOL, V15, P44, DOI 10.1111/j.1526-100X.2006.00188.x; Rua MA, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0698-9; Ryan MH, 2002, PLANT SOIL, V244, P263, DOI 10.1023/A:1020207631893; Shukla A, PHOSPHORUS THRESHOLD, DOI [10.1007/s00374-011-0576-y, DOI 10.1007/S00374-011-0576-Y]; Sieverding E, 2014, MYCOTAXON, V129, P373, DOI 10.5248/129.373; Smith FA, 2009, NEW PHYTOL, V182, P347, DOI 10.1111/j.1469-8137.2008.02753.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd; SON CL, 1988, NEW PHYTOL, V108, P305, DOI 10.1111/j.1469-8137.1988.tb04167.x; STAHL PD, 1991, MYCOL RES, V95, P300, DOI 10.1016/S0953-7562(09)81238-0; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Tarbell TJ, 2007, MYCORRHIZA, V18, P51, DOI 10.1007/s00572-007-0152-3; TESTER M, 1986, NEW PHYTOL, V103, P375, DOI 10.1111/j.1469-8137.1986.tb00623.x; Vosatka M, 2012, SYMBIOSIS, V58, P29, DOI 10.1007/s13199-012-0208-9; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; Wright DP, 2005, NEW PHYTOL, V167, P881, DOI 10.1111/j.1469-8137.2005.01472.x; Xing XK, 2012, P ROY SOC B-BIOL SCI, V279, P1122, DOI 10.1098/rspb.2011.1550; Zhu YG, 2001, PLANT SOIL, V237, P249, DOI 10.1023/A:1013343811110	79	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0221037	10.1371/journal.pone.0221037	http://dx.doi.org/10.1371/journal.pone.0221037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393956	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500092
J	Schmedt, N; Schiffner-Rohe, J; Sprenger, R; Walker, J; von Eiff, C; Hackl, D				Schmedt, Niklas; Schiffner-Rohe, Julia; Sprenger, Ralf; Walker, Jochen; von Eiff, Christof; Haeckl, Dennis			Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RHEUMATOID-ARTHRITIS; RESPIRATORY SOCIETY; POSITION PAPER; ADULTS; PREVENTION; COVERAGE; CHILDREN; BURDEN	Background The German Committee on Vaccination recommends pneumococcal vaccination for infants, seniors 60+ years and patients at risk with defined underlying diseases. Aim of this study was to assess the pneumococcal vaccination rate (pnc-VR) in patients with certain incident inherited or acquired immunodeficiency or immunosuppression and to understand who vaccinates these patients who are particularly at high risk to develop a pneumococcal infection. Methods We conducted a cohort study in patients aged 2 years or older, with a first episode of a "high-risk" condition between January 2013 and December 2014 based on a representative sample of German claims data. Pnc-VR was calculated as the proportion of patients receiving any pneumococcal vaccine within two years after first episode of "high-risk" condition. Further analyses cover pnc-VR stratified by high risk conditions and region, time to vaccination, and physician specialty administering the pneumococcal vaccination. Results The study population comprised 204,088 incident "high-risk" patients (56% female). The overall pnc-VR within two years was 4.4% (95%-confidence interval: 4.3%-4.5%). Within specific high-risk conditions, we found the highest vaccination rate of 11.5% (10.1%-13.0%) among patients starting immunosuppressants with underlying rheumatoid arthritis followed by 9.9% (7.8%-12.4%) in HIV patients. Stratification by region revealed a slightly higher vaccination rate in Eastern (6.5%: 6.0%-6.9%) compared to Western Germany (4.2%: 4.1-4.3%). Median time to vaccination within the first two years in vaccinated patients was 332.5 days (Q1 142 days, Q3 528 days). The majority of patients (92.6%) got vaccinated by a general practitioner. Conclusion Although these vulnerable patients need protection most, our study suggests that the overall pnc-VR after a first episode of a high-risk condition for pneumococcal disease is very low and vaccination is far too late. To prevent pneumococcal disease in patients at high risk, further efforts are needed to increase awareness and improve the timeliness of pneumococcal vaccination.	[Schmedt, Niklas; Walker, Jochen] InGef Inst Appl Hlth Res Berlin, Berlin, Germany; [Schiffner-Rohe, Julia] Pfizer Deutschland GmbH, Berlin, Germany; [Sprenger, Ralf; von Eiff, Christof] Pfizer Pharma GmbH, Berlin, Germany; [Haeckl, Dennis] WIG2 Sci Inst Hlth Econ & Hlth Syst Res, Leipzig, Germany	Pfizer; Pfizer	Schmedt, N (corresponding author), InGef Inst Appl Hlth Res Berlin, Berlin, Germany.	niklas.schmedt@ingef.de			Pfizer Deutschland GmbH	Pfizer Deutschland GmbH	This study was supported by an unrestricted research grant from Pfizer Deutschland GmbH. The funder provided support in the form of salaries for authors [JSR, RS, CvE], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andersohn F, 2016, PHARMACOEPIDEM DR S, V25, P106, DOI 10.1002/pds.3895; Braeter U., 2016, INFOBLATT PNEUMOKOKK; European Centre for Disease Prevention and Control (ECDC), 2018, VACC SCHED PNEUM DIS; Ewig S, 2016, PNEUMOLOGIE, V70, P151, DOI 10.1055/s-0042-101873; Ewig S, 2017, KRITIK STIKO EMPFEHL, V114; Fatkenheuer G, 2014, Z GERONTOL GERIATR, V47, P302, DOI 10.1007/s00391-014-0650-9; Falkenhorst G, 2017, PLADOYER STIKO EMPFE, V114; Falkenhorst G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169368; Hocker B, 2018, PEDIATR NEPHROL, V33, P341, DOI 10.1007/s00467-017-3776-3; Institute for Quality Assurance and Transparency in Healthcare (IQTiQ), QUAL REP 2017; Klett-Tammen CJ, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0502-3; Krasselt M, 2017, RHEUMATOL INT, V37, P229, DOI 10.1007/s00296-016-3608-y; Pelton SI, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1162-y; Pletz MW, 2015, PNEUMOLOGIE, V69, P633, DOI 10.1055/s-0034-1393413; Pletz M W, 2012, Pneumologie, V66, P470; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P845, DOI 10.1007/s00103-013-1693-6; Ramos AL, 2016, RHEUMATOL INT, V36, P1255, DOI 10.1007/s00296-016-3516-1; Robert Koch- Institut (RKI), 2017, EMPF STAND IMPFK STI; Robert Koch-Institut (RKI), 2016, WISS BEGR AKT EMPF I; Robert Koch- Institut (RKI), 2016, EMPF STAND IMPFK STI; Robert Koch-Institut (RKI), 2016, WISS BEGR AKT PNEUM; Schiffner-Rohe J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146338; Theidel U, 2013, DTSCH ARZTEBL INT, V110, P743, DOI 10.3238/arztebl.2013.0743; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502	24	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220848	10.1371/journal.pone.0220848	http://dx.doi.org/10.1371/journal.pone.0220848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393931	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500069
J	Pouladi, N; Abdolahi, S; Farajzadeh, D; Feizi, MAH				Pouladi, Nasser; Abdolahi, Sepehr; Farajzadeh, Davoud; Feizi, Mohammad Ali Hosseinpour			Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; TP53 GENE; RISK; ASSOCIATION; REGION; POLYMORPHISMS; REGULATOR; VARIANTS; PATHWAY; ROLES	Among the cancer susceptibility genes, TP53 is one of the crucial genes involved in cell cycle regulations and, therefore, it greatly affects breast cancer initiation and progression. In addition, WRAP53-a natural antisense transcript-regulates TP53 transcription and, as a protein, modulates the normal cell cycle, which results in breast cancer susceptibility. In this study, we aimed to analyze a haplotype comprising four SNPs, including rs1042522, rs17878362, rs2287499, and rs2287498, which are located at 5' regions of the TP53 and WRAP53 genes, in 118 patients and 110 healthy controls of the Iranian-Azeri population. In silico studies were conducted using the SIFT, Polyphen2, Fanthmm, RNAsnp, and SNP&GO online servers. Linkage disequilibrium (LD) and D' for each combination of the markers were calculated via the Haploview program. Our results showed that the GA(1)CC haplotype was the most frequent in the studied population. Additionally, no significant LD between any pairwise haplotypes was observed. The GA(1)CC and CA(2)GC haplotypes were significantly associated with breast cancer susceptibility. Moreover, the in silico analysis revealed the negative effects of rs2287499 and rs1042522 on WRAP53 and P53, respectively. In conclusion, the CA(1)GC haplotype was strongly identified as a breast cancer risk factor, and the GA(1)CC haplotype was assumed to be a protective factor against breast cancer risk. Hence, these markers may potentially be used as molecular prognostic and predictive biomarkers for breast cancer.	[Pouladi, Nasser; Abdolahi, Sepehr; Farajzadeh, Davoud] Azarbaijan Shahid Madani Univ, Fac Basic Sci, Dept Biol, Tabriz, Iran; [Pouladi, Nasser; Farajzadeh, Davoud] Azarbaijan Shahid Madani Univ, Dept Mol Biol & Canc Res, Tabriz, Iran; [Feizi, Mohammad Ali Hosseinpour] Tabriz Univ, Fac Nat Sci, Dept Anim Biol, Tabriz, Iran	Azarbaijan Shahid Madani University; Azarbaijan Shahid Madani University; University of Tabriz	Pouladi, N (corresponding author), Azarbaijan Shahid Madani Univ, Fac Basic Sci, Dept Biol, Tabriz, Iran.; Pouladi, N (corresponding author), Azarbaijan Shahid Madani Univ, Dept Mol Biol & Canc Res, Tabriz, Iran.	srna52@gmail.com	Abdolahi, Sepehr/Y-2643-2019; Abdolahi, Sepehr/ABE-3231-2020; Farajzadeh, Davoud/W-2236-2017; Farajzadeh, Davoud/AAQ-5732-2021; Pouladi, Nasser/AAP-4036-2021	Abdolahi, Sepehr/0000-0002-5565-6096; Abdolahi, Sepehr/0000-0002-5565-6096; Farajzadeh, Davoud/0000-0002-9267-4277; Pouladi, Nasser/0000-0001-8125-5352				Alonso S, 2010, HUM HERED, V69, P34, DOI 10.1159/000243152; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellazzo A, 2018, BREAST CANCER-TARGET, V10, P101, DOI 10.2147/BCTT.S145826; Bonab AS, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0168-4; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buyru N, 2007, CANCER DETECT PREV, V31, P207, DOI 10.1016/j.cdp.2007.04.004; Cao HY, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15037976; Dehghan R, 2015, PATHOL ONCOL RES, V21, P449, DOI 10.1007/s12253-014-9846-y; Dehghan Roghayeh, 2015, Asian Pac J Cancer Prev, V16, P3073; Devi KR, 2015, TUMOR BIOL, V36, P9995, DOI 10.1007/s13277-015-3795-2; Edvardsen H, 2018, BIORXIV; Enwerem II, 2014, BIOL OPEN, V3, P240, DOI 10.1242/bio.20147443; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Farnebo M, 2009, CELL CYCLE, V8, P2343, DOI 10.4161/cc.8.15.9223; Vitiello GAF, 2018, J CANCER RES CLIN, V144, P645, DOI 10.1007/s00432-018-2585-9; Hao WM, 2018, EUR J MED RES, V23, DOI 10.1186/s40001-018-0345-6; Henriksson S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00091; Joruiz SM, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026039; Kim G., 2014, ONCOGENE, V34, P671, DOI DOI 10.1038/0NC.2014.4; Leroy B, 2017, CANCER RES, V77, P1250, DOI 10.1158/0008-5472.CAN-16-2179; Lin HY, 2013, UROL ONCOL-SEMIN ORI, V31, P1231, DOI 10.1016/j.urolonc.2011.11.031; Medrek K, 2013, MOL BIOL REP, V40, P2145, DOI 10.1007/s11033-012-2273-9; Naccarati A, 2010, CARCINOGENESIS, V31, P666, DOI 10.1093/carcin/bgq032; Ni XQ, 2005, NEUROSCI LETT, V388, P173, DOI 10.1016/j.neulet.2005.06.050; Nikkhoo A, 2019, J CELL BIOCHEM, V120, P9300, DOI 10.1002/jcb.28205; Pouladi N, 2019, META GENE, V19, P117, DOI 10.1016/j.mgene.2018.11.009; Pouladi N, 2013, ASIAN PAC J CANCER P, V14, P3503, DOI 10.7314/APJCP.2013.14.6.3503; Rassoolzadeh H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.172; Stracquadanio G, 2016, NAT REV CANCER, V16, P251, DOI 10.1038/nrc.2016.15; Sung H, 2018, NPJ BREAST CANCER, V4, DOI 10.1038/s41523-018-0055-9; Surowy H, 2018, INT J CANCER, V142, P757, DOI 10.1002/ijc.31105; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Uehara I, 2018, CANCERS, V10, DOI 10.3390/cancers10070219; Vymetalkova V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134463; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Yuan JM, 2011, ASIAN PAC J CANCER P, V12, P3465; Zee RYL, 2004, HUM GENET, V114, P386, DOI 10.1007/s00439-003-1080-8; Zhang YJ, 2009, FEBS LETT, V583, P3725, DOI 10.1016/j.febslet.2009.10.002	38	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220727	10.1371/journal.pone.0220727	http://dx.doi.org/10.1371/journal.pone.0220727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31387111	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100034
J	Carbone, E; Meneghetti, C; Borella, E				Carbone, Elena; Meneghetti, Chiara; Borella, Erika			The influence of personality traits and facets on visuo-spatial task performance and self-assessed visuo-spatial inclinations in young and older adults	PLOS ONE			English	Article							SPATIAL ABILITIES; INDIVIDUAL-DIFFERENCES; COGNITIVE PERFORMANCE; MENTAL ROTATION; INTELLIGENCE; MEMORY; BIG-5; ASSOCIATIONS; METAANALYSIS; ENGAGEMENT	Aims Personality traits are suggested to influence adults' cognitive performance, but little is known about their association with visuo-spatial competence, in terms of those visuo-spatial abilities and inclinations crucial to remaining autonomous, especially with aging. This study newly investigated whether, and to what extent, major traits and narrower facets of personality influence young and older adults' performance in the so-called objective visuo-spatial abilities (mental rotation and visuo-spatial working memory [VSWM]), and self-assessed visuo-spatial inclinations (pleasure and anxiety in exploring places). Method Seventy young adults (18-35 years old) and 70 older adults (65-75 years old) completed the Big-Five questionnaire, objective rotation and VSWM tasks, and spatial self-assessments on pleasure and anxiety in exploring places. Results Hierarchical regression models confirmed that age negatively predicted the variance in objective visuo-spatial tasks, but not in self-assessed visuo-spatial inclinations, while only the latter were slightly influenced by gender (in favor of men). Further, both objective visuo-spatial abilities (albeit modestly) and self-assessed visuo-spatial inclinations were predicted by higher Conscientiousness. The latter were also predicted by higher Emotional Stability. Finally, a better objective visuo-spatial performance was explained (again modestly) by lower Dynamism and Politeness, and higher Emotion Control, while higher Perseverance, Emotion Control and Cooperativeness explained a moderate part of the variance in the positive self-assessed visuo-spatial inclinations. Conclusions Our findings indicate that, beyond age and gender, some personality traits and facets predict self-assessed visuo-spatial inclinations to a larger extent than objective visuo-spatial performance. These results are discussed within the spatial cognition and aging framework.	[Carbone, Elena; Meneghetti, Chiara; Borella, Erika] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Carbone, E (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	elena.carbone@phd.unipd.it	Meneghetti, Chiara/D-1691-2014; CARBONE, ELENA/ABB-6361-2020	Meneghetti, Chiara/0000-0002-4232-4244; CARBONE, ELENA/0000-0003-4141-3824; Meneghetti, Chiara/0000-0002-1838-7958; , ERIKA/0000-0001-8943-2958				Ackerman Phillip L, 2018, J Intell, V6, DOI 10.3390/jintelligence6010002; Ackerman PL, 1997, PSYCHOL BULL, V121, P219, DOI 10.1037/0033-2909.121.2.219; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baker TJ, 2006, PERS INDIV DIFFER, V41, P861, DOI 10.1016/j.paid.2006.02.017; Borella E, 2014, DEV PSYCHOL, V50, P384, DOI 10.1037/a0033818; BRYANT KJ, 1982, J PERS SOC PSYCHOL, V43, P1318, DOI 10.1037/0022-3514.43.6.1318; Caprara GV, 2006, POLIT PSYCHOL, V27, P1, DOI 10.1111/j.1467-9221.2006.00447.x; CAPRARA GV, 1993, PERS INDIV DIFFER, V15, P281, DOI 10.1016/0191-8869(93)90218-R; Caselli RJ, 2018, J AM GERIATR SOC, V66, P671, DOI 10.1111/jgs.15182; Chapman BP, 2017, AM J GERIAT PSYCHIAT, V25, P900, DOI 10.1016/j.jagp.2017.03.006; Colom R, 2005, INTELLIGENCE, V33, P623, DOI 10.1016/j.intell.2005.05.006; Condon DM, 2015, PERS INDIV DIFFER, V86, P38, DOI 10.1016/j.paid.2015.05.023; Corsi P., 1972, THESIS; Costa P.T., 1992, PERS INDIVID DIF, V13, P653, DOI [10.1016/0191-8869(92)90236-I, DOI 10.1016/0191-8869(92)90236-I]; Costa PT, 2019, ANNU REV PSYCHOL, V70, P423, DOI 10.1146/annurev-psych-010418-103244; Curtis RG, 2015, AGING NEUROPSYCHOL C, V22, P42, DOI 10.1080/13825585.2014.888392; De Beni R., 2008, PORTFOLIO VALUTAZION; De Beni R., 2014, VISUO SPATIAL ABILIT; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Graham EK, 2014, PERS INDIV DIFFER, V59, P89, DOI 10.1016/j.paid.2013.11.011; Graham EK, 2012, J GERONTOL B-PSYCHOL, V67, P545, DOI 10.1093/geronb/gbr149; Hegarty M, 2006, INTELLIGENCE, V34, P151, DOI 10.1016/j.intell.2005.09.005; Hegarty M., 2005, CAM BRIDGE HDB VISUO, P121, DOI DOI 10.1017/CBO9780511610448.005; Hess TM, 2014, PERSPECT PSYCHOL SCI, V9, P388, DOI 10.1177/1745691614527465; HOFSTEE WKB, 1992, J PERS SOC PSYCHOL, V63, P146, DOI 10.1037/0022-3514.63.1.146; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; HUMPHREYS MS, 1984, PSYCHOL REV, V91, P153, DOI 10.1037/0033-295X.91.2.153; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Kaltner S, 2016, ADV COGN PSYCHOL, V12, P67, DOI 10.5709/acp-0187-y; Klencklen G, 2012, AGEING RES REV, V11, P123, DOI 10.1016/j.arr.2011.10.001; Kretzschmar Andre, 2018, J Intell, V6, DOI 10.3390/jintelligence6030030; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Low LF, 2013, AM J GERIAT PSYCHIAT, V21, P713, DOI 10.1016/j.jagp.2012.08.004; Luchetti M, 2016, J GERONTOL B-PSYCHOL, V71, P591, DOI 10.1093/geronb/gbu184; Mammarella I. C., 2008, BVS CORSI BATTERIA V; Mammarella IC, 2013, LEARN INDIVID DIFFER, V25, P99, DOI 10.1016/j.lindif.2013.01.014; Martinez K, 2011, INTELLIGENCE, V39, P473, DOI 10.1016/j.intell.2011.09.001; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; McCrae RR, 2015, PERS SOC PSYCHOL REV, V19, P97, DOI 10.1177/1088868314541857; Meneghetti C, 2014, LEARN INDIVID DIFFER, V35, P113, DOI 10.1016/j.lindif.2014.07.006; Moe A, 2009, PERS INDIV DIFFER, V46, P187, DOI 10.1016/j.paid.2008.09.030; Mottus R, 2017, J PERS SOC PSYCHOL, V112, P474, DOI 10.1037/pspp0000100; Muffato V, 2019, PSYCHOL RES-PSYCH FO, V83, P1836, DOI 10.1007/s00426-018-1033-4; Muffato V, 2016, J ENVIRON PSYCHOL, V47, P230, DOI 10.1016/j.jenvp.2016.07.003; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Pazzaglia F, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00225; Reeve CL, 2006, INTELLIGENCE, V34, P387, DOI 10.1016/j.intell.2005.11.001; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Salimi Shirin, 2018, Alzheimers Dement (Amst), V10, P66, DOI 10.1016/j.dadm.2017.10.004; Schaie KW, 2004, AGING NEUROPSYCHOL C, V11, P304, DOI 10.1080/13825580490511134; Sharp ES, 2010, PSYCHOL AGING, V25, P60, DOI 10.1037/a0018748; Soubelet A, 2011, DEV PSYCHOL, V47, P303, DOI 10.1037/a0021816; Soubelet A, 2010, PERS INDIV DIFFER, V49, P896, DOI 10.1016/j.paid.2010.07.026; Techentin C, 2014, EXP AGING RES, V40, P395, DOI 10.1080/0361073X.2014.926773; Uttal DH, 2013, PSYCHOL BULL, V139, P352, DOI 10.1037/a0028446; VANDENBERG SG, 1978, PERCEPT MOTOR SKILL, V47, P599, DOI 10.2466/pms.1978.47.2.599; Voyer D, 2017, PSYCHON B REV, V24, P307, DOI 10.3758/s13423-016-1085-7; Wang L, 2014, LEARN INDIVID DIFFER, V36, P140, DOI 10.1016/j.lindif.2014.10.006; Waris O, 2018, PERS INDIV DIFFER, V130, P26, DOI 10.1016/j.paid.2018.03.027; Wyllie DS, 1996, PROF GEOGR, V48, P166, DOI 10.1111/j.0033-0124.1996.00166.x	63	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220525	10.1371/journal.pone.0220525	http://dx.doi.org/10.1371/journal.pone.0220525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381616	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600021
J	Gomez-Ayerbe, C; Martinez-Sanz, J; Muriel, A; Elias, PP; Moreno, A; Barea, R; Polo, L; Cano, A; Uranga, A; Santos, C; Casado, JL; Quereda, C; Robledillo, G; Diaz-de Santiago, A; Vivancos, MJ; Dronda, F; Navas, E; Moreno, S; Elias, MJP				Gomez-Ayerbe, Cristina; Martinez-Sanz, Javier; Muriel, Alfonso; Perez Elias, Pilar; Moreno, Ana; Barea, Rafael; Polo, Lidia; Cano, Agustina; Uranga, Almudena; Santos, Cristina; Luis Casado, Jose; Quereda, Carmen; Robledillo, Gema; Diaz-de Santiago, Alberto; Jesus Vivancos, Maria; Dronda, Fernando; Navas, Enrique; Moreno, Santiago; Perez Elias, Maria Jesus			Impact of a structured HIV testing program in a hospital emergency department and a primary care center	PLOS ONE			English	Article							INDICATOR CONDITION; RISK SCORE; INFECTION; VIRUS; PREVALENCE; TRANSMISSION; VALIDATION; DIAGNOSES; SUPPORT; ROUTINE	Introduction HIV testing guidelines are poorly implemented in most clinical settings. The best screening strategy and healthcare scenario are still unknown. The aim of our study is to evaluate the impact of a structured HIV testing intervention (DRIVE), compared to HIV testing as routinely performed in clinical practice, in two different clinical settings: a primary care center and an emergency department. Methods Prospective evaluation of an HIV testing strategy in two clinical settings from the same healthcare area. The DRIVE program included trained nurse practitioners to perform the screening, a questionnaire to assess the risk of exposure and HIV indicator conditions (RE&IC), and rapid HIV tests. The main variables between the DRIVE program and clinical practice were the absolute number of newly diagnosed HIV infections and testing coverage. Results The DRIVE program included 5,329 participants, of which 51.2% reported at least one positive answer in the questionnaire. The estimated HIV testing coverage was significantly higher in the DRIVE program than in the routine clinical practice (7.17% vs. 0.96%, p < 0.001), and was better in the primary care center than in the emergency department with the two strategies. Twenty-two HIV-positive people were identified, with a rate of 8.6% in the emergency department vs. 2.2% in the primary care center (p = 0.001). A higher rate of new HIV diagnoses was found in the DRIVE program compared to routine clinical practice (29.6 vs. 3.1 per 100,000 patients attended; p < 0.001). Conclusions An easy-to-implement, structured intervention increased the absolute number of new HIV diagnoses and HIV tests, compared to routine clinical practice.	[Gomez-Ayerbe, Cristina; Martinez-Sanz, Javier; Moreno, Ana; Luis Casado, Jose; Quereda, Carmen; Robledillo, Gema; Diaz-de Santiago, Alberto; Jesus Vivancos, Maria; Dronda, Fernando; Navas, Enrique; Moreno, Santiago; Perez Elias, Maria Jesus] IRYCIS, Dept Infect Dis, Hosp Univ Ramon & Cajal, Madrid, Spain; [Muriel, Alfonso] IRYCIS, Hosp Univ Ramon & Cajal, Biostat Unit, Madrid, Spain; [Muriel, Alfonso] Univ Alcala, Dept Enfermeria, CIBERESP, Madrid, Spain; [Perez Elias, Pilar; Cano, Agustina; Uranga, Almudena; Santos, Cristina] Ctr Salud Garcia Noblejas, Madrid, Spain; [Barea, Rafael] Ctr Salud Canal Panama, Madrid, Spain; [Polo, Lidia] Hosp Gen Univ Gregorio Maranon, Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Alcala; General University Gregorio Maranon Hospital	Moreno, S (corresponding author), IRYCIS, Dept Infect Dis, Hosp Univ Ramon & Cajal, Madrid, Spain.	smguillen@salud.madrid.org	Muriel, Alfonso AM/F-9948-2015; Elias, Maria Jesus Perez/AAD-8652-2020	Muriel, Alfonso AM/0000-0002-4805-4011; Martinez-Sanz, Javier/0000-0003-2020-3908; Casado, Jose Luis/0000-0002-7639-8591; Perez Elias/0000-0001-5700-5257	Instituto de Salud Carlos III (Plan Estatal de I+ D+ i 2013-2016) [PI1200995, PI16/00551]; Ministerio de Sanidad, Seguridad Social e Igualdad Project [EC11144]; European Development Regional Fund "A way to achieve Europe'' (ERDF); Plan Nacional R+ D+ I [RD16/0025/0001]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III (Plan Estatal de I+ D+ i 2013-2016); Ministerio de Sanidad, Seguridad Social e Igualdad Project; European Development Regional Fund "A way to achieve Europe'' (ERDF)(European Commission); Plan Nacional R+ D+ I; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER)	This study was supported by 3 competitive Grants: Instituto de Salud Carlos III (Plan Estatal de I+ D+ i 2013-2016) Grants PI1200995, PI16/00551, Ministerio de Sanidad, Seguridad Social e Igualdad Project code: EC11144, all cofinanced by the European Development Regional Fund "A way to achieve Europe'' (ERDF) and partially funded by the RD16/0025/0001 project as part of the Plan Nacional R+ D+ I, and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER).	Agusti C, 2016, SEX TRANSM INFECT, V92, P387, DOI 10.1136/sextrans-2015-052328; [Anonymous], 2014, AM FAMILY PHYS, V89, p666AD; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chin T, 2013, AIDS PATIENT CARE ST, V27, P392, DOI 10.1089/apc.2013.0099; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; d'Almeida KW, 2012, ARCH INTERN MED, V172, P12, DOI 10.1001/archinternmed.2011.535; de la Fuente L, 2009, J EPIDEMIOL COMMUN H, V63, P552, DOI 10.1136/jech.2008.076240; Ellis S, 2012, CLIN MED, V12, P430, DOI 10.7861/clinmedicine.12-5-430; Esteban-Vasallo MD, 2014, INT J INFECT DIS, V19, P39, DOI 10.1016/j.ijid.2013.10.006; European Centre for Disease Prevention and Control, 2018, PUBL HLTH GUID HIV H; Gerbert B, 1998, AM J PREV MED, V15, P103, DOI 10.1016/S0749-3797(98)00025-7; Gokengin D, 2014, INT J STD AIDS, V25, P695, DOI 10.1177/0956462414531244; Greenwald Jeffrey L, 2006, Curr Infect Dis Rep, V8, P125, DOI 10.1007/s11908-006-0008-6; Haukoos JS, 2014, SEX TRANSM DIS, V41, P403, DOI 10.1097/OLQ.0000000000000139; Haukoos JS, 2013, ANN EMERG MED, V61, P353, DOI 10.1016/j.annemergmed.2012.10.031; Haukoos JS, 2012, AM J EPIDEMIOL, V175, P838, DOI 10.1093/aje/kwr389; Haukoos JS, 2012, ARCH INTERN MED, V172, P20, DOI 10.1001/archinternmed.2011.538; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; HIV in Europe Initiative, 2015, HIV INDICATOR CONDIT; Hoskins K., 2018, MIAM DAD COUNT GETT; Joore IK, 2015, SEX TRANSM INFECT, V91, P467, DOI 10.1136/sextrans-2015-052073; Klein PW, 2014, SEX TRANSM DIS, V41, P395, DOI 10.1097/OLQ.0000000000000141; Krentz HB, 2004, HIV MED, V5, P93, DOI 10.1111/j.1468-1293.2004.00193.x; Lyons MS, 2016, CLIN INFECT DIS, V62, P1066, DOI 10.1093/cid/ciw073; Mahendran P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124394; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Martinez Colubi M, 2011, 13 EUR AIDS C EACS B, P12; Ministerio de Sanidad Servicios Sociales e Igualdad., GUIA REC DIAGN PREC; Moreno S, 2012, SEX TRANSM INFECT, V88, P522, DOI 10.1136/sextrans-2012-050481; Nunez O, 2018, AIDS, V32, P2573, DOI 10.1097/QAD.0000000000001989; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Elias MJP, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002612; Porter K, 2018, JAIDS-J ACQ IMM DEF, V79, P28, DOI [10.1097/QAI.0000000000001761, 10.1097/qai.0000000000001761]; Raben D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140845; Rodger Alison J, 2016, JAMA, V316, P171, DOI 10.1001/jama.2016.5148; SALTZMAN SP, 1987, PUBLIC HEALTH REP, V102, P692; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Sullivan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052845	39	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220375	10.1371/journal.pone.0220375	http://dx.doi.org/10.1371/journal.pone.0220375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369594	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900044
J	Kaya, T; Nagatoishi, S; Nagae, K; Nakamura, Y; Tsumoto, K				Kaya, Takatoshi; Nagatoishi, Satoru; Nagae, Kosuke; Nakamura, Yukito; Tsumoto, Kohei			Highly sensitive biomolecular interaction detection method using optical bound/free separation with grating-coupled surface plasmon field-enhanced fluorescence spectroscopy (GC-SPFS)	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; MONOCLONAL-ANTIBODIES; IMMUNOASSAY; EMISSION; RESONANCE; FILMS	Grating-coupled surface plasmon field-enhanced fluorescence spectroscopy (GC-SPFS) with optical bound/free (B/F) separation technique was developed by employing a highly directional fluorescence with polarization of surface plasmon-coupled emission (SPCE) to realize highly sensitive immunoassay regardless of the ligand affinity. A highly sensitive immunoassay system with GC-SPFS was constructed using a plastic sensor chip reproducibly fabricated in-house by nanoimprinting and applied to the quantitative detection of an anti-lysozyme single-domain antibody (sdAb), to compare conventional washing B/F separation with optical B/F separation. Differences in the affinity of the anti-lysozyme sdAb, induced by artificial mutation of only one amino acid residue in the variable domain were attributed to higher sensitivity than that of the conventional Biacore surface plasmon resonance (SPR) system. The detection limit (LOD; means of six replicates of the zero standard plus three standard deviations) of the GC-SPFS immunoassay with optical B/F separation, was estimated to be 1.2 ng/ml with the low-affinity ligand (mutant sdAb Y52A: K-D level was of the order of 10(-7) similar to 10(-6) M) and was clearly improved as compared to that (LOD: 9.4 ng/ml) obtained with the conventional washing B/F separation. These results indicate that GC-SPFS with the optical B/F separation technique offers opportunities to re-evaluate low-affinity biomaterials that are neither fully utilized nor widespread, and could facilitate the creation of novel and innovative methods in drug and diagnostic development.	[Kaya, Takatoshi; Nagae, Kosuke; Nakamura, Yukito] Kon Minolta Inc, Corp R&D Headquarters, Hino, Tokyo, Japan; [Nagatoishi, Satoru; Tsumoto, Kohei] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Nagatoishi, Satoru; Tsumoto, Kohei] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan	Konica Minolta Inc.; University of Tokyo; University of Tokyo	Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo, Japan.	takatoshi.kaya@konicaminolta.com; tsumoto@bioeng.t.u-tokyo.ac.jp	Satoru, NAGATOISHI/AAY-8198-2021	Satoru, NAGATOISHI/0000-0002-0794-3963	Konica Minolta, Inc.	Konica Minolta, Inc.	The authors received no specific funding for this work. T.K., K.N., Y.N. are employed by Konica Minolta, Inc.. Konica Minolta, Inc. provided support in the form of salaries for authors T.K., K.N., Y.N., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], 2014, GUID IND IMM ASS THE; Arakawa T., 2007, BIOPROCESS INT, V5, P36; Arima Yusuke, 2009, V503, P3, DOI 10.1007/978-1-60327-567-5_1; Bernhagen D, 2019, ACS COMB SCI, V21, P198, DOI 10.1021/acscombsci.8b00144; BRECHT A, 1993, BIOSENS BIOELECTRON, V8, P387, DOI 10.1016/0956-5663(93)80078-4; Cao SH, 2012, ANNU REV ANAL CHEM, V5, P317, DOI 10.1146/annurev-anchem-062011-143208; Chiu NF, 2007, OPT EXPRESS, V15, P11608, DOI 10.1364/OE.15.011608; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Cui XQ, 2010, ADV FUNCT MATER, V20, P546, DOI 10.1002/adfm.200901401; Foltz IN, 2013, CIRCULATION, V127, P2222, DOI 10.1161/CIRCULATIONAHA.113.002033; Gryczynski I, 2004, ANAL BIOCHEM, V324, P170, DOI 10.1016/j.ab.2003.09.036; Hagiwara K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020261; JOHNE B, 1993, J IMMUNOL METHODS, V160, P191, DOI 10.1016/0022-1759(93)90177-9; Kaya T, 2015, ANAL CHEM, V87, P1797, DOI 10.1021/ac503735e; Knoll W, 1998, ANNU REV PHYS CHEM, V49, P569, DOI 10.1146/annurev.physchem.49.1.569; Kreiter M, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075406; Kurihara Y, 2012, LANGMUIR, V28, P13609, DOI 10.1021/la302221y; Lakowicz JR, 2003, BIOCHEM BIOPH RES CO, V307, P435, DOI 10.1016/S0006-291X(03)01214-2; Lakowicz JR, 2005, ANAL BIOCHEM, V337, P171, DOI 10.1016/j.ab.2004.11.026; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; LUNDSTROM I, 1994, BIOSENS BIOELECTRON, V9, P725, DOI 10.1016/0956-5663(94)80071-5; Malicka J, 2003, ANAL CHEM, V75, P6629, DOI 10.1021/ac034881e; Matveeva E, 2004, J IMMUNOL METHODS, V286, P133, DOI 10.1016/j.jim.2003.12.009; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Narhi LO, 2009, CURR PHARM BIOTECHNO, V10, P373, DOI 10.2174/138920109788488905; Patel AR, 2012, ANAL CHEM, V84, P6833, DOI 10.1021/ac300976g; Reather H, 1988, SURFACE PLASMON SMOO; SANDSTROM T, 1985, APPL OPTICS, V24, P472, DOI 10.1364/AO.24.000472; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; Shankar G, 2007, NAT BIOTECHNOL, V25, P555, DOI 10.1038/nbt1303; Song S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3072586; Tawa K, 2015, ANAL CHEM, V87, P3871, DOI 10.1021/ac504642j; Tawa K, 2011, ANAL CHEM, V83, P5944, DOI 10.1021/ac200898e; Wedge S, 2004, OPT EXPRESS, V12, P3673, DOI 10.1364/OPEX.12.003673; Wei Q, 2014, ANGEW CHEM INT EDIT, V53, P8004, DOI 10.1002/anie.201400546; Yu F, 2004, ANAL CHEM, V76, P6765, DOI 10.1021/ac048937w; Yu F, 2003, ANAL CHEM, V75, P2610, DOI 10.1021/ac026161y	37	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220578	10.1371/journal.pone.0220578	http://dx.doi.org/10.1371/journal.pone.0220578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369601	gold, Green Submitted, Green Published			2022-12-27	WOS:000484987900065
J	Morris, A; Phillips, J; Gerstenberg, T; Cushman, F				Morris, Adam; Phillips, Jonathan; Gerstenberg, Tobias; Cushman, Fiery			Quantitative causal selection patterns in token causation	PLOS ONE			English	Article							MODEL-THEORY; COVARIATION; JUDGMENT	When many events contributed to an outcome, people consistently judge some more causal than others, based in part on the prior probabilities of those events. For instance, when a tree bursts into flames, people judge the lightning strike more of a cause than the presence of oxygen in the air-in part because oxygen is so common, and lightning strikes are so rare. These effects, which play a major role in several prominent theories of token causation, have largely been studied through qualitative manipulations of the prior probabilities. Yet, there is good reason to think that people's causal judgments are on a continuum-and relatively little is known about how these judgments vary quantitatively as the prior probabilities change. In this paper, we measure people's causal judgment across parametric manipulations of the prior probabilities of antecedent events. Our experiments replicate previous qualitative findings, and also reveal several novel patterns that are not well-described by existing theories.	[Morris, Adam; Phillips, Jonathan; Cushman, Fiery] Harvard Univ, Psychol Dept, Cambridge, MA 02138 USA; [Gerstenberg, Tobias] Stanford Univ, Dept Psychol, Stanford, CA USA	Harvard University; Stanford University	Morris, A (corresponding author), Harvard Univ, Psychol Dept, Cambridge, MA 02138 USA.	adam.mtc.morris@gmail.com	Phillips, Jonathan Scott/GYE-2506-2022	Phillips, Jonathan Scott/0000-0002-9536-1794; Cushman, Fiery/0000-0002-6929-9982; Morris, Adam/0000-0002-8810-8694	Office of Naval Research [N00014-141-0800]; Center for Brains, Minds & Machines (CBMM) - National Science Foundation's Science and Technology Center [CCF-1231216]	Office of Naval Research(Office of Naval Research); Center for Brains, Minds & Machines (CBMM) - National Science Foundation's Science and Technology Center	FC was supported by Grant N00014-141-0800 from the Office of Naval Research. TG was supported by the Center for Brains, Minds & Machines (CBMM), which is funded by the National Science Foundation's Science and Technology Center (Award CCF-1231216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHENG PW, 1991, COGNITION, V40, P83, DOI 10.1016/0010-0277(91)90047-8; Cheng PW, 1997, PSYCHOL REV, V104, P367, DOI 10.1037/0033-295X.104.2.367; Cheng PW, 2005, CONSTRAINTS NONCONST; Danks D., 2017, OXFORD HDB CAUSAL RE, P201; Dowe P., 2000, PHYS CAUSATION; EINHORN HJ, 1986, PSYCHOL BULL, V99, P3, DOI 10.1037/0033-2909.99.1.3; Gerstenberg T, 2014, P ANN M COGN SCI SOC, V36; Gerstenberg T., 2015, P 37 ANN C COGN SCI, P782; Gerstenberg T, 2012, P ANN M COGN SCI SOC, V34; Gerstenberg T, 2017, PSYCHOL SCI, V28, P1731, DOI 10.1177/0956797617713053; Griffiths TL, 2005, COGNITIVE PSYCHOL, V51, P334, DOI 10.1016/j.cogpsych.2005.05.004; Halpern JY, 2015, BRIT J PHILOS SCI, V66, P413, DOI 10.1093/bjps/axt050; Halpern JY, 2013, COGNITIVE SCI, V37, P986, DOI 10.1111/cogs.12059; Halpern JY, 2005, BRIT J PHILOS SCI, V56, P843, DOI 10.1093/bjps/axi147; Hart H., 1959, CAUSATION LAW; Hesslow G., 1988, CONT SCI NATURAL EXP, P11; HILTON DJ, 1986, PSYCHOL REV, V93, P75, DOI 10.1037/0033-295X.93.1.75; Holyoak KJ, 2010, J EXP PSYCHOL GEN, V139, P702, DOI 10.1037/a0020488; Icard TF, 2017, COGNITION, V161, P80, DOI 10.1016/j.cognition.2017.01.010; JENKINS HM, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093874; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 1982, JUDGMENT UNCERTAINTY, DOI [10.1017/CBO9780511809477, DOI 10.1017/CBO9780511809477, 10.1017/cbo9780511809477]; Kominsky JF, 2015, COGNITION, V137, P196, DOI 10.1016/j.cognition.2015.01.013; Lewis D., 1974, J PHILOS, V70, P556, DOI DOI 10.2307/2025310; Mackie JL., 1974, CEMENT UNIVERSE STUD; McGill AL, 2000, J PERS SOC PSYCHOL, V79, P677, DOI 10.1037/0022-3514.79.5.677; Perales JC, 2007, PSYCHON B REV, V14, P577, DOI 10.3758/BF03196807; Sloman S, 2009, COGNITIVE SCI, V33, P21, DOI 10.1111/j.1551-6709.2008.01002.x; Spellman BA, 1997, J EXP PSYCHOL GEN, V126, P323, DOI 10.1037/0096-3445.126.4.323; Stephan S., 2016, P 38 ANN C COGNITIVE, P2795; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Walsh CR, 2011, MIND LANG, V26, P21, DOI 10.1111/j.1468-0017.2010.01409.x; Wolff P, 2007, J EXP PSYCHOL GEN, V136, P82, DOI 10.1037/0096-3445.136.1.82; Wolff P, 2010, J EXP PSYCHOL GEN, V139, P191, DOI 10.1037/a0018129	36	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219704	10.1371/journal.pone.0219704	http://dx.doi.org/10.1371/journal.pone.0219704			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369584	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900015
J	Benski, AC; Viviano, M; Jinoro, J; Alec, M; Catarino, R; Herniainasolo, J; Vassilakos, P; Petignat, P				Benski, Anne-Caroline; Viviano, Manuela; Jinoro, Jeromine; Alec, Milena; Catarino, Rosa; Herniainasolo, Josea; Vassilakos, Pierre; Petignat, Patrick			HPV self-testing for primary cervical cancer screening in Madagascar: VIA/VILI triage compliance in HPV-positive women	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; VISUAL INSPECTION; ACETIC-ACID; RANDOMIZED-TRIAL; CYTOLOGY	Objective To assess triage compliance and the effect of the time from screening to triage on follow-up among HPV-positive women. Methods We recruited 1232 women in a screening campaign in Madagascar from February to October 2015. In the first period (February-May), HPV tests were performed remotely using the cobas test. In the second period (May-October), testing was performed on-site using the Xpert HPV assay. HPV-positive women were invited for triage with visual inspection with acetic acid (VIA) and Lugol's iodine (VILI). Systematic biopsy and endocervical brushing were performed on all HPV-positive women for quality control. Three groups were defined according to time from HPV testing to triage invitation for HPV-positive women-Group I: delayed (>3 months), Group II: prompt (24-48 hours), and Group III: immediate (< 24 hours). Results A total 1232 self-sampled HPV tests were performed in the study period (496 in Group I, 512 in Group II, and 224 in Group III). Participants' mean age was 43.2 +/- 9.3 years. Mean time from screening to VIA/VILI testing was 103.5 +/- 43.6 days. Overall HPV prevalence was 28.0%. HPV prevalence was 27.2% in Group I (cobas test), 29.2% in Group 2 (Xpert test), and 26,7% in Group III (Xpert test). The VIA/VILI compliance rate was 77.8% for Group I, 82.7% for Group II, and 95.0% for Group III. Of women undergoing VIA/VILI, 56.3% in Group I and 43.5% in Groups II/III had positive results. Prevalence of cervical intraepithelial neoplasia grade 2 or worse among HPV-positive women was 9.8% for Group I and 6.8% for Groups II/III. Non-adherence was higher among rural women, uneducated women, and women in Group I. Conclusion HPV-positive women with immediate VIA/VILI triage invitation had the best triage compliance. A single-day test and triage strategy is preferred for low-resource settings.	[Benski, Anne-Caroline; Viviano, Manuela; Catarino, Rosa; Petignat, Patrick] Geneva Univ Hosp, Gynecol Div, Geneva, Switzerland; [Benski, Anne-Caroline; Jinoro, Jeromine; Herniainasolo, Josea] St Damien Hlth Ctr, Ambanja, Madagascar; [Alec, Milena] Univ Geneva, Geneva, Switzerland; [Vassilakos, Pierre] Geneva Fdn Med Educ & Res, Geneva, Switzerland	University of Geneva; University of Geneva	Benski, AC (corresponding author), Geneva Univ Hosp, Gynecol Div, Geneva, Switzerland.; Benski, AC (corresponding author), St Damien Hlth Ctr, Ambanja, Madagascar.	caroline.benski@gmail.com		Petignat, Patrick/0000-0002-6835-533X; Catarino, Rosa/0000-0002-5317-7710	Action Madagascar Foundation, Fribourg, Switzerland; University Hospital of Geneva, Switzerland	Action Madagascar Foundation, Fribourg, Switzerland; University Hospital of Geneva, Switzerland	This study was supported by the Action Madagascar Foundation, Fribourg, Switzerland and the University Hospital of Geneva, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrossi S, 2015, LANCET GLOB HEALTH, V3, pE85, DOI 10.1016/S2214-109X(14)70354-7; Austad K, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00228; Bigoni J, 2015, INT J CANCER, V137, P127, DOI 10.1002/ijc.29353; Bruni L, 2019, HUM PAP REL DIS WORL; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Catarino R, 2015, WORLD J CLIN ONCOL, V6, P281, DOI 10.5306/wjco.v6.i6.281; Cremer M, 2017, J LOW GENIT TRACT DI, V21, P26, DOI 10.1097/LGT.0000000000000280; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Des Marais AC, 2018, OBSTET GYNECOL, V132, P1412, DOI [10.1097/aog.0000000000002964, 10.1097/AOG.0000000000002964]; Doh AS, 2005, INT J GYNECOL OBSTET, V89, P167, DOI 10.1016/j.ijgo.2004.12.040; Einstein MH, 2014, J CLIN MICROBIOL, V52, P2089, DOI 10.1128/JCM.00176-14; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gage JC, 2012, INT J CANCER, V131, P2903, DOI 10.1002/ijc.27563; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Kunckler M, 2017, CANCER MED-US, V6, P1752, DOI 10.1002/cam4.1089; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; Poli UR, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.2016.008078; Polman NJ, 2019, LANCET ONCOL, V20, P229, DOI 10.1016/S1470-2045(18)30763-0; Qiao L, 2015, J OBSTET GYNAECOL RE, V41, P1313, DOI 10.1111/jog.12732; Rebolj M, 2010, BRIT J CANCER, V103, P310, DOI 10.1038/sj.bjc.6605771; Safaeian M, 2007, OBSTET GYN CLIN N AM, V34, P739, DOI 10.1016/j.ogc.2007.09.004; Sankaranarayanan R, 2004, INT J CANCER, V109, P461, DOI 10.1002/ijc.11726; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Tebeu PM, 2015, INT J CANCER, V136, pE743, DOI 10.1002/ijc.29250; Untiet S, 2014, INT J CANCER, V135, P1911, DOI 10.1002/ijc.28834; Wesley RS, 2003, IARC TECHNICAL PUBLI, V41; WHO, 2014, COMPR CERV CANC CONT; WHO, 2013, WHO GUID SCREEN TREA; World Health Organization, 2019, HUM PAP HPV CERV CAN; World Health Organization Africa, CERVICAL CANCER COMM; World Health Organization and Pan-American Health Organization, 2013, MON NAT CERV CANC PR; Yeh PT, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001351	32	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220632	10.1371/journal.pone.0220632	http://dx.doi.org/10.1371/journal.pone.0220632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408474	gold, Green Submitted, Green Published			2022-12-27	WOS:000485009500016
J	Ihara, F; Tanaka, S; Fereig, RM; Nishimura, M; Nishikawa, Y				Ihara, Fumiaki; Tanaka, Sachi; Fereig, Ragab M.; Nishimura, Maki; Nishikawa, Yoshifumi			Involvement of Toll-like receptor 2 in the cerebral immune response and behavioral changes caused by latent Toxoplasma infection in mice	PLOS ONE			English	Article							GONDII INFECTION; IL-12 PRODUCTION; SCHIZOPHRENIA; ANXIETY; BRAIN; MYD88; NEUROGENESIS; MANIPULATION; DOPAMINE; NEURONS	Subacute and chronic infections with the intracellular protozoan parasite Toxoplasma gondii are associated with an increased risk of psychiatric diseases like schizophrenia. However, little is known about the mechanisms involved in T. gondii-induced neuronal disorders. Recently, we reported that Toll-like receptor 2 (TLR2) was required to initiate the innate immune response in cultured mouse brain cells. However, how TLR2 contributes to latent infection with T. gondii remains unclear. Therefore, we examined the role of TLR2 in brain pathology and behavior using wild-type (TLR2(+/+)) and TLR2-deficient (TLR2(-/-)) mice. The behavioral analyses showed that TLR2 deficiency increased the anxiety state of the uninfected and infected animals alike, and TLR2 deficiency showed no relationship with the infection. In the contextual and cued fear-conditioning tests, T. gondii infection decreased the mouse freezing reaction while TLR2 deficiency increased it, but there was no interaction between the two factors. Our histopathological analysis showed that the TLR2(+/+) and TLR2(-/-) mice had similar brain lesions at 30 days post infection (dpi) with T. gondii. Higher numbers of parasites were detected in the brains of the TLR2(-/-) mice than in those from the TLR2(+/+) mice at 30 dpi, but not at 7 and 14 dpi. No significant differences were observed in the proinflammatory gene expression levels in the TLR2(+/+) and TLR2(-/-) mice. Therefore, it appears that TLR2 signaling in the brain might contribute to the control of parasite growth, but not to brain pathology or the impaired fear memory response induced by infection with T. gondii.	[Ihara, Fumiaki; Tanaka, Sachi; Fereig, Ragab M.; Nishimura, Maki; Nishikawa, Yoshifumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan; [Fereig, Ragab M.] South Valley Univ, Fac Vet Med, Dept Anim Med, Qena City, Qena, Egypt; [Tanaka, Sachi] Shinshu Univ, Fac Agr, Nagano, Japan	Obihiro University of Agriculture & Veterinary Medicine; Egyptian Knowledge Bank (EKB); South Valley University Egypt; Shinshu University	Nishikawa, Y (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan.	nisikawa@obihiro.ac.jp	Fereig, Ragab/AAA-2500-2022	Fereig, Ragab Makhlouf/0000-0003-1845-1312; nishikawa, yoshifumi/0000-0001-5005-6377	Funding Program for Next Generation World-Leading Researchers (NEXT Program); Council for Science and Technology Policy [2011/LS003]; Japan Society for the Promotion of Science, Japan [JP15K15118, 17K19538, 24880006, 18K14577, 15J03171]; Agency for Medical Research and Development [17fk0108120h0001]	Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agency for Medical Research and Development	This research was supported by the Funding Program for Next Generation WorldLeading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (2011/LS003) (to Y.N.), Grant-in-Aid for Exploratory Research JP15K15118 (to Y.N.) and Challenging Research (Exploratory) 17K19538 (to Y.N.), a Grant-in-Aid for Research Activity Start-up (24880006) (to S. T.), a Grant-in-Aid for Young Scientists (18K14577) (to F.I.),and a research fellowship (15J03171) (to F. I.) from the Japan Society for the Promotion of Science, Japan. This work was also supported by a Research Program on Emerging and Re-emerging Infectious Diseases (17fk0108120h0001) (to Y.N.) from the Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNEA A, 1994, P NATL ACAD SCI USA, V91, P11217, DOI 10.1073/pnas.91.23.11217; Barragan A, 2003, TRENDS MICROBIOL, V11, P426, DOI 10.1016/S0966-842X(03)00205-1; Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Chen M, 2002, J PARASITOL, V88, P1017, DOI 10.1645/0022-3395(2002)088[1017:IOMIHD]2.0.CO;2; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Fereig RM, 2016, PARASITOL INT, V65, P741, DOI 10.1016/j.parint.2016.09.008; Feustel SM, 2012, VIRULENCE, V3, P182, DOI 10.4161/viru.19004; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Gonzalez LE, 2007, BEHAV BRAIN RES, V177, P70, DOI 10.1016/j.bbr.2006.11.012; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; HAY J, 1983, ANN TROP MED PARASIT, V77, P483, DOI 10.1080/00034983.1983.11811741; Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267; HUTCHISON WM, 1980, ANN TROP MED PARASIT, V74, P145, DOI 10.1080/00034983.1980.11687324; Ihara F, 2016, INFECT IMMUN, V84, P2861, DOI 10.1128/IAI.00217-16; Ihara F, 2016, SCI REP-UK, V6, DOI 10.1038/srep23052; Ingram WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075246; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029; Lamberton PHL, 2008, PARASITOLOGY, V135, P1143, DOI 10.1017/S0031182008004666; Lim JE, 2012, BEHAV BRAIN RES, V227, P36, DOI 10.1016/j.bbr.2011.10.027; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Nishimura M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07936; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Park SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08502; PIEKARSKI G, 1981, ZBL BAKT-INT J MED M, V250, P403, DOI 10.1016/S0174-3031(81)80133-3; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Takeda H, 1998, EUR J PHARMACOL, V350, P21, DOI 10.1016/S0014-2999(98)00223-4; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Torrey EF, 2003, EMERG INFECT DIS, V9, P1375, DOI 10.3201/eid0911.030143; Umeda K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187703; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; WEBSTER JP, 1994, PARASITOLOGY, V109, P583, DOI 10.1017/S0031182000076460; Worth AR, 2013, TRENDS PARASITOL, V29, P150, DOI 10.1016/j.pt.2013.01.004	43	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220560	10.1371/journal.pone.0220560	http://dx.doi.org/10.1371/journal.pone.0220560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404078	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800017
J	Bao, T; Su, L; Kinnaird, C; Kabeto, M; Shull, PB; Sienko, KH				Bao, Tian; Su, Lydia; Kinnaird, Catherine; Kabeto, Mohammed; Shull, Peter B.; Sienko, Kathleen H.			Vibrotactile display design: Quantifying the importance of age and various factors on reaction times	PLOS ONE			English	Article							TRUNK SWAY; FEEDBACK; CONDUCTION; TOUCH; STIMULATION; INFORMATION; PERFORMANCE; BIOFEEDBACK; ATTENTION; MODELS	Numerous factors affect reaction times to vibrotactile cues. Therefore, it is important to consider the relative magnitudes of these time delays when designing vibrotactile displays for real-time applications. The objectives of this study were to quantify reaction times to typical vibrotactile stimuli parameters through direct comparison within a single experimental setting, and to determine the relative importance of these factors on reaction times. Young (n = 10, 21.9 +/- 1.3 yrs) and older adults (n = 13, 69.4 +/- 5.0 yrs) performed simple reaction time tasks by responding to vibrotactile stimuli using a thumb trigger while frequency, location, auditory cues, number of tactors in the same location, and tactor type were varied. Participants also performed a secondary task in a subset of the trials. The factors investigated in this study affected reaction times by 20-300 ms (reaction time findings are noted in parentheses) depending on the specific stimuli condition. In general, auditory cues generated by the tactors (<20 ms), vibration frequency (<20 ms), number of tactors in the same location (<30 ms) and tactor type (<50 ms) had relatively small effects on reaction times, while stimulus location (20-120 ms) and secondary cognitive task (> 130 ms) had relatively large effects. Factors affected young and older adults' reaction times in a similar manner, but with different magnitudes. These findings can inform the development of vibrotactile displays by enabling designers to directly compare the relative effects of key factors on reaction times.	[Bao, Tian; Su, Lydia; Kinnaird, Catherine; Sienko, Kathleen H.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Kabeto, Mohammed] Univ Michigan, Internal Med, Ann Arbor, MI 48109 USA; [Shull, Peter B.] Shanghai Jiao Tong Univ, State Key Lab Mech Syst & Vibrat, Shanghai, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Shanghai Jiao Tong University	Sienko, KH (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	sienko@umich.edu	Bao, Tian/AGX-5250-2022	Bao, Tian/0000-0002-7310-3436; Su, Lydia/0000-0001-7278-149X	National Science Foundation [CAREER RAPD-0846471, GARDE 1159635]; National Institute on Deafness and Other Communication Disorders of the National Institutes of Health [R21DC012410]; University of Michigan-Shanghai Jiao Tong University Collaboration on Nanotechnology for Energy and Biomedical Applications [14X120010006]; University of Michigan Pepper Center [NIH RCDC/KL2 P30AG024824]; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Deafness and Other Communication Disorders of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); University of Michigan-Shanghai Jiao Tong University Collaboration on Nanotechnology for Energy and Biomedical Applications; University of Michigan Pepper Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Science Foundation under grant: GARDE 1159635 (https://www.nsf.gov/) received by KS; National Science Foundation under grant: CAREER RAPD-0846471 (https://www.nsf.gov/) received by KS; National Institute on Deafness and Other Communication Disorders of the National Institutes of Health under award number R21DC012410 (https://www.nidcd.nih.gov/) received by KS; University of Michigan-Shanghai Jiao Tong University Collaboration on Nanotechnology for Energy and Biomedical Applications (14X120010006) received by PS and KS; and University of Michigan Pepper Center (NIH RCDC/KL2 P30AG024824) (https://www.nih.gov/) received by KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseman F, 2007, J NEUROL, V254, P1555, DOI 10.1007/s00415-007-0587-7; Bao T, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-017-0339-6; Bark K., 2011, 2011 IEEE World Haptics Conference (WHC 2011), P355, DOI 10.1109/WHC.2011.5945512; Bloomfield A, 2008, PRESENCE-TELEOP VIRT, V17, P103, DOI 10.1162/pres.17.2.103; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Broadbent D. E., 1971, DECISION STRESS; Brown LA, 1999, J GERONTOL A-BIOL, V54, pM165, DOI 10.1093/gerona/54.4.M165; Choi S, 2013, P IEEE, V101, P2093, DOI 10.1109/JPROC.2012.2221071; Cholewiak RW, 2004, PERCEPT PSYCHOPHYS, V66, P970, DOI 10.3758/BF03194989; CRAIG JC, 1969, PERCEPT PSYCHOPHYS, V6, P97, DOI 10.3758/BF03210689; Davis JR, 2010, GAIT POSTURE, V31, P465, DOI 10.1016/j.gaitpost.2010.02.002; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; DORFMAN LJ, 1979, NEUROLOGY, V29, P38, DOI 10.1212/WNL.29.1.38; Forster B, 2002, EXP BRAIN RES, V143, P480, DOI 10.1007/s00221-002-1017-9; Goebel JA, 2009, OTOL NEUROTOL, V30, P210, DOI 10.1097/MAO.0b013e318194f84d; Haggerty S, 2012, GAIT POSTURE, V35, P523, DOI 10.1016/j.gaitpost.2011.10.359; Harrar V, 2005, EXP BRAIN RES, V166, P465, DOI 10.1007/s00221-005-2386-7; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Ho C, 2005, TRANSPORT RES F-TRAF, V8, P397, DOI 10.1016/j.trf.2005.05.002; Ho C, 2014, ACTA PSYCHOL, V151, P32, DOI 10.1016/j.actpsy.2014.05.014; Ho C, 2014, IEEE T HAPTICS, V7, P86, DOI 10.1109/TOH.2013.62; Kentala E, 2003, ANN OTO RHINOL LARYN, V112, P404, DOI 10.1177/000348940311200503; Klatzky RL, 2014, MULTISENS RES, V27, P359, DOI 10.1163/22134808-00002447; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kosinski R.J., 2008, LIT REV REACTION TIM; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; Lee BC, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-21; Lee BC, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-10; Lee J, 2015, INT SOC POST GAIT RE; Lin CC, 2015, J NEUROPHYSIOL, V113, P2127, DOI 10.1152/jn.00083.2014; MACEFIELD G, 1989, BRAIN, V112, P1519, DOI 10.1093/brain/112.6.1519; Meng FX, 2015, ERGONOMICS, V58, P411, DOI 10.1080/00140139.2014.976278; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; Mohebbi R, 2005, DRIVER REACTION TIME, V51, P102, DOI [10.1177/0018720809333517, DOI 10.1177/0018720809333517]; Mortimer BJP, 2007, J ACOUST SOC AM, V121, P2970, DOI 10.1121/1.2715669; Myles K, 2007, TACTILE MODALITY REV, P1, DOI DOI 10.1109/HAPTIC.2004.1287224; Nanhoe-Mahabier W, 2012, PARKINSONISM RELAT D, V18, P1017, DOI 10.1016/j.parkreldis.2012.05.018; Neal R., 1982, INT J SPORT BIOMECH, V1, P221; Ng AWY, 2012, LECT NOTES ENG COMP, P1449; O'Modhrain S, 2015, IEEE T HAPTICS, V8, P248, DOI 10.1109/TOH.2015.2466231; Okamura AM, 2001, IEEE-ASME T MECH, V6, P245, DOI 10.1109/3516.951362; Palani HP, 2017, ACM T ACCESS COMPUT, V9, DOI 10.1145/3035537; Pan YS, 2013, PROCEEDINGS 27TH EUROPEAN CONFERENCE ON MODELLING AND SIMULATION ECMS 2013, P177, DOI 10.7148/2013-0177; Park D. C., 2000, COGNITIVE AGING PRIM, V11, P3; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pashler H., 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; Peon AR, 2013, 2013 WORLD HAPTICS CONFERENCE (WHC), P657, DOI 10.1109/WHC.2013.6548486; Proctor R, 2005, PROC; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Salzer Y, 2011, HUM FACTORS, V53, P118, DOI 10.1177/0018720811403139; Shull PB, 2014, GAIT POSTURE, V40, P11, DOI 10.1016/j.gaitpost.2014.03.189; Shull PB, 2011, J BIOMECH, V44, P1605, DOI 10.1016/j.jbiomech.2011.03.016; Shull PB, 2017, IEEE T HAPTICS, V10, P466, DOI 10.1109/TOH.2017.2689023; Sienko KH, 2008, J VESTIBUL RES-EQUIL, V18, P273; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Stenfelt S, 2011, ADV OTO-RHINO-LARYNG, V71, P10, DOI 10.1159/000323574; STERNBERG S, 1969, AM SCI, V57, P421; Suied C, 2008, J EXP PSYCHOL-APPL, V14, P201, DOI 10.1037/1076-898X.14.3.201; Taware G. B., 2012, Al Ameen Journal of Medical Sciences, V5, P90; Tennison JL, 2016, LECT NOTES COMPUT SC, V9775, P384, DOI 10.1007/978-3-319-42324-1_38; THORNBURY JM, 1981, J GERONTOL, V36, P34, DOI 10.1093/geronj/36.1.34; Van Erp JBF, 2004, TRANSPORT RES F-TRAF, V7, P247, DOI 10.1016/j.trf.2004.09.003; van Veen HAHC, 2001, LECT NOTES COMPUT SC, V2058, P174; VERRILLO RT, 1963, J ACOUST SOC AM, V35, P1962, DOI 10.1121/1.1918868; VONBEKESY G, 1948, J ACOUST SOC AM, V20, P749; Wall C, 2010, J VESTIBUL RES-EQUIL, V20, P61, DOI 10.3233/VES-2010-0369; Weinstein S., 1968, 1 INT S SKI SENS; Welford A.T., 1980, REACTION TIMES; WILSKA A, 1954, ACTA PHYSIOL SCAND, V31, P285, DOI 10.1111/j.1748-1716.1954.tb01139.x; Yogev G, 2009, ROLE EXECUTIVE FUNCT, P23, DOI [10.1002/mds.21720, DOI 10.1002/MDS.21720]	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0219737	10.1371/journal.pone.0219737	http://dx.doi.org/10.1371/journal.pone.0219737			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398207	gold, Green Published, Green Submitted			2022-12-27	WOS:000485004000007
J	Evans, A; Dunstan, F; Fone, DL; Bandyopadhyay, A; Schofield, B; Demmler, JC; Rahman, MA; Lyons, RA; Paranjothy, S				Evans, Annette; Dunstan, Frank; Fone, David L.; Bandyopadhyay, Amrita; Schofield, Behnaz; Demmler, Joanne C.; Rahman, Muhammad A.; Lyons, Ronan A.; Paranjothy, Shantini			The role of health and social factors in education outcome: A record-linked electronic birth cohort analysis	PLOS ONE			English	Article							LATE PRETERM BIRTH; SCHOOL PERFORMANCE; GESTATIONAL-AGE; EARLY-TERM; ACADEMIC-PERFORMANCE; STUDENT PERFORMANCE; EARLY-CHILDHOOD; CHILDREN; WEIGHT; NEEDS	Background and objective Health status in childhood is correlated with educational outcomes. Emergency hospital admissions during childhood are common but it is not known how these unplanned breaks from schooling impact on education outcomes. We hypothesised that children who had emergency hospital admissions had an increased risk of lower educational attainment, in addition to the increased risks associated with other health, social and school factors. Methods This record-linked electronic birth cohort, included children born in Wales between 1 January 1998 and 31 August 2001. We fitted multilevel logistic regression models grouped by schools, to determine whether emergency hospital inpatient admission before age 7 years was associated with the educational outcome of not attaining the expected level in a teacher-based assessment at age 7 years (KS1). We adjusted for pregnancy, perinatal, socio-economic, neighbourhood, pupil mobility and school-level factors. Results The cohort comprised 64 934 children. Overall, 4680 (7.2%) did not attain the expected educational level. Emergency admission to hospital was associated with poor educational attainment (OR 1.12 95% Credible Interval (CI) 1.05, 1.20 for all causes during childhood, OR 1.19 95%Cl 1.07, 1.32 for injuries and external causes and OR 1.31 95%Cl 1.04, 1.22 for admissions during infancy), after adjusting for known determinants of education outcomes such as extreme prematurity, being small for gestational age and socio-economic indicators, such as eligibility for free school meals. Conclusion Emergency inpatient hospital admission during childhood, particularly during infancy or for injuries and external causes was associated with an increased risk of lower education attainment at age 7 years, in addition to the effects of pregnancy factors (gestational age, birth weight) and social deprivation. These findings support the need for injury prevention measures and additional support in school for affected children to help them to achieve their potential.	[Evans, Annette; Dunstan, Frank; Fone, David L.; Schofield, Behnaz; Paranjothy, Shantini] Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales; [Bandyopadhyay, Amrita; Demmler, Joanne C.; Rahman, Muhammad A.; Lyons, Ronan A.] Swansea Univ, Hlth Data Res UK, Swansea, W Glam, Wales; [Paranjothy, Shantini] Cardiff Univ, Div Populat Med, 3rd Floor Neuadd Meirionnydd, Cardiff, S Glam, Wales	Cardiff University; Swansea University; Cardiff University	Paranjothy, S (corresponding author), Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales.; Paranjothy, S (corresponding author), Cardiff Univ, Div Populat Med, 3rd Floor Neuadd Meirionnydd, Cardiff, S Glam, Wales.	ParanjothyS@cardiff.ac.uk	Rahman, Muhammad Azizur/GLR-8606-2022; Demmler, Joanne/N-1609-2015	Rahman, Muhammad Azizur/0000-0002-0805-7461; Demmler, Joanne/0000-0002-4675-6271; Paranjothy, Shantini/0000-0002-0528-3121	National Institute for Social Care and Health Research [TPR08-006]; Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research: Centre of Excellence; British Heart Foundation; Cancer Research UK; Economic and Social Research Council [RES-590-28-0005]; Medical Research Council; Welsh Government; Wellcome Trust under UK Clinical Research Collaboration [WT087640MA]; Arthritis Research UK; Chief Scientist Office (Scottish Government Health Directorates); Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research (Welsh Government); Wellcome Trust [MR/K006525/1]; MRC [MR/K023233/1, MR/K006525/1] Funding Source: UKRI	National Institute for Social Care and Health Research; Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research: Centre of Excellence(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Government; Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); Arthritis Research UK(Versus Arthritis); Chief Scientist Office (Scottish Government Health Directorates); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Government); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	FD, DF, RAL and SP received a Translational Health Research Platform Award from the National Institute for Social Care and Health Research (grant reference: TPR08-006) for the development of WECC. DF, RAL and JD were supported by The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer), a UKCRC Public Health Research: Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council (RES-590-28-0005), Medical Research Council, the Welsh Government and the Wellcome Trust (WT087640MA), under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. SP and RAL were co-applicants in the Centre for the Improvement of Population Health through E-records Research (CIPHER), one of four UK e-health Informatics Research Centres funded by a joint investment from: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Chief Scientist Office (Scottish Government Health Directorates), the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute for Health Research, the National Institute for Social Care and Health Research (Welsh Government) and the Wellcome Trust (Grant reference: MR/K006525/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylin P, 2010, HSMR MORTALITY INDIC; Azzam N, 2018, ARCH DIS CHILD, V103, P444, DOI 10.1136/archdischild-2017-313355; Barre N, 2011, J PEDIATR-US, V158, P766, DOI 10.1016/j.jpeds.2010.10.032; Bell MF, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2475; Browne WJ, 2012, MCMC ESTIMATION MLWI; Caughy MO, 1996, DEV PSYCHOL, V32, P515; Chan E, 2016, CHILD CARE HLTH DEV, V42, P297, DOI 10.1111/cch.12320; Chan E, 2014, ARCH DIS CHILD-FETAL, V99, pF451, DOI 10.1136/archdischild-2014-306124; Collaboration for accident prevention and injury control, 2012, BURD INJ WAL; Crawford C., 2011, DOES YOU ARE BORN MA; Crump C, 2013, ANN EPIDEMIOL, V23, P179, DOI 10.1016/j.annepidem.2013.01.001; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Forrest CB, 2011, PEDIATRICS, V128, P303, DOI 10.1542/peds.2010-3347; Gabbe BJ, 2014, J EPIDEMIOL COMMUN H, V68, P466, DOI 10.1136/jech-2013-203427; Gershenson S, 2015, EDUC EVAL POLICY AN, V37, p135S, DOI 10.3102/0162373715576075; Goldstein H, 2007, J ROY STAT SOC A STA, V170, P941, DOI 10.1111/j.1467-985X.2007.00491.x; Gottfried M. A., 2013, TEACH COLL REC, V115, P1; Gottfried MA, 2009, EDUC EVAL POLICY AN, V31, P392, DOI 10.3102/0162373709342467; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; King G, 2005, INT J DISABIL DEV ED, V52, P313, DOI DOI 10.1080/10349120500348680; Kirkegaard I, 2006, PEDIATRICS, V118, P1600, DOI 10.1542/peds.2005-2700; Kohler-Forsber O, 2018, PEDIAT INFECT DIS J, V37; Kotecha SJ, 2012, THORAX, V67, P54, DOI 10.1136/thoraxjnl-2011-200329; Kull MA, 2015, SOC SCI MED, V142, P145, DOI 10.1016/j.socscimed.2015.08.030; Leckie G, 2009, J ROY STAT SOC A STA, V172, P537, DOI 10.1111/j.1467-985X.2008.00577.x; Lyons, 2011, ARCH DIS CHILD-FETAL, V96, pFA18, DOI DOI 10.1136/ARCHDISCHILD.2011.300164.6; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; Mahon M, 2004, ARCH DIS CHILD, V89, P165, DOI 10.1136/adc.2002.019158; MCCORMICK MC, 1992, JAMA-J AM MED ASSOC, V267, P2204, DOI 10.1001/jama.267.16.2204; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Midouhas E, 2015, POPUL SPACE PLACE, V21, P157, DOI 10.1002/psp.1815; Nasuuna E, 2016, J PAEDIATR CHILD H, V52, P750, DOI 10.1111/jpc.13183; O'Connor M, 2015, CHILD CARE HLTH DEV, V41, P15, DOI 10.1111/cch.12164; Office for National Statistics, 2004, RURAL URBAN DEFINITI; Paranjothy S, 2018, LANCET PUBLIC HEALTH, V3, pE279, DOI 10.1016/S2468-2667(18)30069-0; Paranjothy S, 2013, PEDIATRICS, V132, pE1562, DOI 10.1542/peds.2013-1737; Peacock PJ, 2012, ARCH DIS CHILD, V97, P118, DOI 10.1136/adc.2011.300925; Poulsen G, 2013, PAEDIATR PERINAT EP, V27, P371, DOI 10.1111/ppe.12058; Quigley MA, 2012, ARCH DIS CHILD-FETAL, V97, pF167, DOI 10.1136/archdischild-2011-300888; Rasbash J, 2009, MLWIN VERSION 21; Rasbash J, 2010, J R STAT SOC A STAT, V173, P657, DOI 10.1111/j.1467-985X.2010.00642.x; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Saigal S, 2003, PEDIATRICS, V112, P943, DOI 10.1542/peds.112.4.943; Seaman S, 2013, STAT SCI, V28, P257, DOI 10.1214/13-STS415; Searle AK, 2017, ARCH DIS CHILD-FETAL, pF1; Sesko AM, 2005, J PEDIATR ORTHOPED, V25, P661, DOI 10.1097/01.bpo.0000164869.35179.0f; Silverstein MD, 2001, J PEDIATR-US, V139, P278, DOI 10.1067/mpd.2001.115573; Statistics for Wales, 2008, SDR1292008 WELSH ASS; Sturdy P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043977; Taras H, 2005, J SCHOOL HEALTH, V75, P296, DOI 10.1111/j.1746-1561.2005.00041.x; Taras H, 2005, J SCHOOL HEALTH, V75, P255, DOI 10.1111/j.1746-1561.2005.00034.x; Tweed EJ, 2016, ARCH DIS CHILD-FETAL, V101, pF121, DOI 10.1136/archdischild-2015-308483; Wang Y, 2014, BRAIN BEHAV IMMUN, V38, P1, DOI 10.1016/j.bbi.2013.12.015; Welsh Government, 2015, WELSH IND MULT DEPR; Welsh Government Statistics & Research, 2005, WELSH IND MULT DEPR; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; World Health Organization, 2019, INT CLASS DIS	59	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220771	10.1371/journal.pone.0220771	http://dx.doi.org/10.1371/journal.pone.0220771			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398202	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000485004000017
J	Kasper, KJ; Manoharan, I; Hallam, B; Coleman, CE; Koivu, SL; Weir, MA; Mccormick, JK; Silverman, MS				Kasper, Katherine J.; Manoharan, Iswarya; Hallam, Brian; Coleman, Charlotte E.; Koivu, Sharon L.; Weir, Matthew A.; Mccormick, John K.; Silverman, Michael S.			A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; USERS; TRENDS	Background Injection drug use-associated endocarditis (IDUaIE) incidence in Ontario has recently been associated with hydromorphone prescribing rates. Staphylococcus aureus causes the majority of cases of IDUaIE in Ontario and across North America. Hydromorphone controlled-release (Hydromorphone-CR) requires a complex technique for injection and therefore provides multiple opportunities for contamination. Hydromorphone-CR contains several excipients, which could enhance staphylococcal survival and increase risk of contaminating the injectate. Methods Used injection drug preparation equipment (cookers/filters) was collected from persons who inject drugs (PWID), rinsed with water, and plated on Mannitol salt agar. Bacterial isolates from bacteremic PWID were used to assess the survival of S. aureus and Streptococcus pyogenes on cookers/filters with Hydromorphone-CR, hydromorphone immediate-release (Hydromorphone-IR) or oxycodone controlled-release (Oxycodone-CR). The solutions spiked with S. aureus were heated and the remaining viable bacteria enumerated. Results S. aureus was detected in 12/87 (14%, 95% CI 8-23%) cookers/filters samples used for injection of Hydromorphone-CR. Hydromorphone-CR was the only opioid associated with greater survival of methicillin-sensitive S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) on cookers/filters when compared to sterile water vehicle control. There was a similar to 2 log reduction in the number of S. aureus that survived when cookers/filters were heated. Conclusion 14% of all cookers/filters used in the preparation of Hydromorphone-CR were contaminated with S. aureus. Hydromorphone-CR prolongs the survival of MRSA and MSSA in cookers/filters. Heating cookers/filters may be a harm-reduction strategy.	[Kasper, Katherine J.; Coleman, Charlotte E.; Mccormick, John K.; Silverman, Michael S.] Western Univ, Dept Microbiol & Immunol, London, ON, Canada; [Manoharan, Iswarya; Weir, Matthew A.; Silverman, Michael S.] Western Univ, Dept Med, London, ON, Canada; [Hallam, Brian] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Koivu, Sharon L.] Western Univ, Dept Family Med, London, ON, Canada; [Weir, Matthew A.; Mccormick, John K.; Silverman, Michael S.] Lawson Hlth Res Inst, London, ON, Canada; [Silverman, Michael S.] Western Univ, Div Infect Dis, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Silverman, MS (corresponding author), Western Univ, Dept Microbiol & Immunol, London, ON, Canada.; Silverman, MS (corresponding author), Western Univ, Dept Med, London, ON, Canada.; Silverman, MS (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.; Silverman, MS (corresponding author), Western Univ, Div Infect Dis, London, ON, Canada.	michael.silverman@sjhc.london.on.ca	Silverman, Michael/J-3776-2014; Weir, Matthew/G-3354-2011	Silverman, Michael/0000-0002-0389-7656; , Brian/0000-0003-1636-4215; McCormick, John/0000-0003-3742-7289	Ontario HIV Treatment Network; St Joseph's Hospital Foundation	Ontario HIV Treatment Network; St Joseph's Hospital Foundation	This study was supported in part by an unrestricted grant from the Ontario HIV Treatment Network (www.ohtn.on.ca/) and by the St Joseph's Hospital Foundation (https://www.sjhcfoundation.org/). Both grants were awarded to MSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ONTARIO NARCOTICS AT; Ball LJ, 2019, JAIDS-J ACQ IMM DEF, V81, pE127, DOI 10.1097/QAI.0000000000002063; Ball LJ, 2019, JAIDS-J ACQ IMM DEF, V81, pE99, DOI 10.1097/QAI.0000000000002062; Bassetti S, 2004, INFECTION, V32, P163, DOI 10.1007/s15010-004-3106-0; Campanella E., 2015, LONDON FREE PRESS; Dickson C, 2018, Can Commun Dis Rep, V44, P182, DOI 10.14745/ccdr.v44i78a06; Dublin S, 2018, ANN INTERN MED, V168, P444, DOI 10.7326/M18-0001; DURACK DT, 1973, BRIT J EXP PATHOL, V54, P142; Edelman EJ, 2019, JAMA INTERN MED, V179, P297, DOI 10.1001/jamainternmed.2018.6101; Gera Kanika, 2013, Curr Protoc Microbiol, V30, DOI 10.1002/9780471729259.mc09d02s30; Gibson GW, 2007, COMPARATIVE MED, V57, P563; Gordon RJ, 2005, NEW ENGL J MED, V353, P1945, DOI 10.1056/NEJMra042823; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Gwizdala RA, 2011, AM J PUBLIC HEALTH, V101, P1268, DOI 10.2105/AJPH.2010.300028; Hryniewicz MM, 2017, J MED MICROBIOL, V66, P1367, DOI 10.1099/jmm.0.000585; Jackson KA, 2018, MMWR-MORBID MORTAL W, V67, P625, DOI 10.15585/mmwr.mm6722a2; Jain V, 2008, J INFECTION, V57, P132, DOI 10.1016/j.jinf.2008.05.008; Missiakas Dominique M, 2013, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09c01s28; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Murphy EL, 2001, CLIN INFECT DIS, V33, P35, DOI 10.1086/320879; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Plein LM, 2018, BRIT J PHARMACOL, V175, P2717, DOI 10.1111/bph.13750; Pulvirenti JJ, 1996, CLIN INFECT DIS, V22, P40, DOI 10.1093/clinids/22.1.40; Purdue Pharma, PACK INS OXYCONTIN; Purdue Pharma, RESCR INF INCL PAT M; Purdue Pharma, 2015, PROD MON HYDROMORPH; Richmond R., 2017, THE LONDON FREE PRES; Rodger L, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.5220; Roy E, 2016, CAN J PSYCHIAT, V61, P136, DOI 10.1177/0706743716632503; RUDIN L, 1974, J BACTERIOL, V118, P155, DOI 10.1128/JB.118.1.155-164.1974; Schranz AJ, 2019, ANN INTERN MED, V170, P31, DOI 10.7326/M18-2124; Smith HS, 2009, PAIN MED, V10, pS30, DOI 10.1111/j.1526-4637.2009.00597.x; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1; Tookes H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129360; Toyoda N, 2017, JAMA-J AM MED ASSOC, V317, P1652, DOI 10.1001/jama.2017.4287; Weir MA, 2019, CAN MED ASSOC J, V191, pE93, DOI 10.1503/cmaj.180694; Wiese AD, 2018, ANN INTERN MED, V168, P396, DOI 10.7326/M17-1907; Wilson LE, 2002, J INFECT DIS, V185, P1761, DOI 10.1086/340827	38	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0219777	10.1371/journal.pone.0219777	http://dx.doi.org/10.1371/journal.pone.0219777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398210	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000008
J	Galavis, PE; Sanfilippo, NJ; Das, IJ				Galavis, Paulina E.; Sanfilippo, Nicholas J.; Das, Indra J.			Glamour, expression, and consequences of tattoos in radiation treatment	PLOS ONE			English	Article							ELECTRONS	It is estimated that approximately 24% of the US population has at least one tattoo. However, tattoo ink ingredients include heavy metals (high atomic number Z) that are not regulated, which can cause skin reactions. This study investigates the dosimetric effects in surface dose due to high-Z elements in tattoo ink under electron beam irradiation. Four commercially available tattoo ink colors, black, red, yellow, and blue were chosen. The elemental composition of the tattoo ink samples was analyzed using X-ray Fluorescence (XRF). An ultrathin-window parallel plate ion chamber was used to measure the surface dose perturbation (ratio of ionizations with and without tattoo ink) for 6 - 20 MeV electron beams. The elemental concentration in the tattoo ink samples showed high-Z elements, with Z ranging from 11 to 92. The dose perturbation ranged from 1.4% up to 6% for the yellow ink for the 6 MeV electron beam, with similar values across the rest of the electron energies, whereas the black, red, and blue inks presented up to 3% dose perturbation for the same range of energies. Based on this initial study, we conclude that commercially available tattoo inks contain large amounts of high-Z metals that may contribute to dose perturbation. Therefore treatment of superficial lesions with electron beams in a tattooed area should be monitored for signs of early skin reaction during radiation therapy treatments.	[Galavis, Paulina E.; Das, Indra J.] NYU Langone Hlth, Dept Radiat Oncol, NYU Permuletter Canc Ctr, New York, NY 10016 USA; [Sanfilippo, Nicholas J.] Weill Cornell Med, Dept Radiat Oncol, New York, NY USA	NYU Langone Medical Center; Cornell University	Galavis, PE (corresponding author), NYU Langone Hlth, Dept Radiat Oncol, NYU Permuletter Canc Ctr, New York, NY 10016 USA.	paulina.galavis@nyumc.org		Galavis, Paulina/0000-0002-2154-2488				ARCHARD GD, 1961, J APPL PHYS, V32, P1505, DOI 10.1063/1.1728385; Beute TC, 2008, DERMATOL SURG, V34, P508, DOI 10.1111/j.1524-4725.2007.34096.x; Brady BG, 2015, CONTACT DERMATITIS, V73, P91, DOI 10.1111/cod.12425; Buffa FM, 1992, MED PHYS, V19, P1423; DAS IJ, 1995, INT J RADIAT ONCOL, V33, P695, DOI 10.1016/0360-3016(95)00172-U; GAGNON WF, 1980, BRIT J RADIOL, V53, P466, DOI 10.1259/0007-1285-53-629-466; KHAN FM, 1981, MED PHYS, V8, P712, DOI 10.1118/1.594841; KLEVENHAGEN SC, 1991, PHYS MED BIOL, V36, P1013, DOI 10.1088/0031-9155/36/7/009; LAMBERT GD, 1982, PHYS MED BIOL, V27, P721, DOI 10.1088/0031-9155/27/5/007; Laumann AE, 2006, J AM ACAD DERMATOL, V55, P413, DOI 10.1016/j.jaad.2006.03.026; Laux P, 2016, LANCET, V387, P395, DOI 10.1016/S0140-6736(15)60215-X; LeBlanc PM, 2012, NEW ENGL J MED, V367, P985, DOI 10.1056/NEJMp1206063; McEwen M, 2014, MED PHYS, V41, DOI 10.1118/1.4866223; Pablo C, 2008, J APPL MED PHYS, V9; TABATA T, 1992, MED PHYS, V19, P1423, DOI 10.1118/1.596796; Yoong C, 2010, AUSTRALAS J DERMATOL, V51, P21, DOI 10.1111/j.1440-0960.2009.00608.x	16	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220030	10.1371/journal.pone.0220030	http://dx.doi.org/10.1371/journal.pone.0220030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390347	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400009
J	Potter, GE; Wong, J; Sugimoto, J; Diallo, A; Victor, JC; Neuzil, K; Halloran, ME				Potter, Gail E.; Wong, Jimmy; Sugimoto, Jonathan; Diallo, Aldiouma; Victor, John C.; Neuzil, Kathleen; Halloran, M. Elizabeth			Networks of face-to-face social contacts in Niakhar, Senegal	PLOS ONE			English	Article							PANDEMIC INFLUENZA; SUPER-SPREADERS; INFECTIOUS-DISEASE; TRANSMISSION; STRATEGIES; IGNORABILITY; HOUSEHOLD; PATTERNS; SARS	We present the first analysis of face-to-face contact network data from Niakhar, Senegal. Participants in a cluster-randomized influenza vaccine trial were interviewed about their contact patterns when they reported symptoms during their weekly household surveillance visit. We employ a negative binomial model to estimate effects of covariates on contact degree. We estimate the mean contact degree for asymptomatic Niakhar residents to be 16.5 (95% C.I. 14.3, 18.7) in the morning and 14.8 in the afternoon (95% C.I. 12.7, 16.9). We estimate that symptomatic people make 10% fewer contacts than asymptomatic people (95% C.I. 5%, 16%; p = 0.006), and those aged 0-5 make 33% fewer contacts than adults (95% C.I. 29%, 37%; p < 0.001). By explicitly modelling the partial rounding pattern observed in our data, we make inference for both the underlying (true) distribution of contacts as well as for the reported distribution. We created an estimator for homophily by compound (household) membership and estimate that 48% of contacts by symptomatic people are made to their own compound members in the morning (95% CI, 45%, 52%) and 60% in the afternoon/evening (95% CI, 56%, 64%). We did not find a significant effect of symptom status on compound homophily. We compare our findings to those from other countries and make design recommendations for future surveys.	[Potter, Gail E.] Emmes Co, Rockville, MD 20850 USA; [Potter, Gail E.; Wong, Jimmy] Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA; [Sugimoto, Jonathan; Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Diallo, Aldiouma] Inst Rech Dev, Niakhar, Senegal; [Victor, John C.] PATH, Seattle, WA USA; [Neuzil, Kathleen] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	California State University System; California Polytechnic State University San Luis Obispo; Fred Hutchinson Cancer Center; Institut de Recherche pour le Developpement (IRD); University System of Maryland; University of Maryland Baltimore; University of Washington; University of Washington Seattle	Potter, GE (corresponding author), Emmes Co, Rockville, MD 20850 USA.; Potter, GE (corresponding author), Calif Polytech State Univ San Luis Obispo, San Luis Obispo, CA 93407 USA.	gpotter@emmes.com		Potter, Gail/0000-0001-6667-6992	General Medical Sciences/National Institute of Health [U01-GM070749]; Thomas Francis Global Health Fellowship; National Institute of General Medical Sciences/National Institute of Health [U54 GM111274]; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention [1U01IP000174]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM111274] Funding Source: NIH RePORTER	General Medical Sciences/National Institute of Health; Thomas Francis Global Health Fellowship; National Institute of General Medical Sciences/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GEP was supported previously by General Medical Sciences/National Institute of Health U01-GM070749 (PI MEH, https://www.nigms.nih.gov/) and received a Thomas Francis Global Health Fellowship (https://globalhealth.washington.edu/connect/funding-for-fieldwork). JW received no specific funding for this work. JS was supported by National Institute of General Medical Sciences/National Institute of Health U54 GM111274 (PI MEH, https://www.nigms.nih.gov/) and received a Thomas Francis Jr. Global Health Fellowship (https://globalhealth.washington.edu/connect/funding-for-fieldwork), and was also supported previously by U01-GM070749 (PI MEH). JCV, KN and AD were supported by grant 1U01IP000174 (CoAg between CDC and PATH, PI JCV) funded by National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (www.cdc.gov, https://www.path.org/). MEH was supported by National Institute of General Medical Sciences/National Institute of Health U54 GM111274 (PI MEH, https://www.nigms.nih.gov/), and previously received U01-GM070749 (PI MEH). PATH was involved in conceptualization, funding acquisition, project administration, resources, supervision, and writing. The Emmes Company did not play a role in the design of the study. The Emmes Company was contracted to perform data cleaning and data analysis of the clinical trial data (but not the social contact network data) for this study before GEP joined the Emmes Company (in October 2015). After GEP joined the Emmes Company, the sole support from Emmes for this social network analysis manuscript was in the form of salary support for GEP. The specific roles of GEP are articulated in the 'author contributions' section. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Barclay VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087042; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Beraud G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133203; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Danon L, 2012, J R SOC INTERFACE, V9, P2826, DOI 10.1098/rsif.2012.0357; Delaunay V, 2013, INT J EPIDEMIOL, V42, P1002, DOI 10.1093/ije/dyt100; Diop-Ousmane M., 2019, CLIN INFECT DIS, DOI [10.1093/cid/ciz066, DOI 10.1093/CID/CIZ066]; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; Fu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045113; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Genois M, 2015, NETW SCI, V3, P326, DOI 10.1017/nws.2015.10; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Grijalva CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118457; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; HEITJAN DF, 1993, BIOMETRICS, V49, P1099, DOI 10.2307/2532251; HEITJAN DF, 1991, ANN STAT, V19, P2244, DOI 10.1214/aos/1176348396; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-187; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kiti MC, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0084-2; Kiti MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104786; Leecaster M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153690; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Melegaro A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170459; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Meyer S, 2017, BIOSTATISTICS, V18, P338, DOI 10.1093/biostatistics/kxw051; Miller JC, 2009, J R SOC INTERFACE, V6, P1121, DOI 10.1098/rsif.2008.0524; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pellis L, 2015, EPIDEMICS-NETH, V10, P58, DOI 10.1016/j.epidem.2014.07.003; Potter GE, 2012, ANN APPL STAT, V6, P1, DOI 10.1214/11-AOAS505; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Rolls DA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1237-9; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Schomaker M, 2018, STAT MED, V37, P2252, DOI 10.1002/sim.7654; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Smieszek T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-136; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Stein ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113711; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Van Kerckhove K, 2013, AM J EPIDEMIOL, V178, P1655, DOI 10.1093/aje/kwt196; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	64	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220443	10.1371/journal.pone.0220443	http://dx.doi.org/10.1371/journal.pone.0220443			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386686	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100021
J	Duy, SV; Munoz, G; Dinh, QT; Do, DT; Simon, DF; Sauve, S				Sung Vo Duy; Munoz, Gabriel; Quoc Tuc Dinh; Dat Tien Do; Simon, Dana F.; Sauve, Sebastien			Analysis of the neurotoxin beta-N-methylamino-L-alanine (BMAA) and isomers in surface water by FMOC derivatization liquid chromatography high resolution mass spectrometry	PLOS ONE			English	Article							DANSYL CHLORIDE DERIVATIZATION; PRECOLUMN DERIVATIZATION; CYANOBACTERIAL BLOOMS; FRESH-WATER; ACID; MICROCYSTINS; GLYPHOSATE; CYANOTOXINS; VALIDATION; QUANTIFICATION	The neurotoxin beta-N-methylamino-L-alanine (BMAA), suspected to trigger neurodegenerative diseases, can be produced during cyanobacterial bloom events and subsequently affect ecosystems and water sources. Some of its isomers including beta-amino-N-methylalanine (BAMA), N-(2-aminoethyl) glycine (AEG), and 2,4-diaminobutyric acid (DAB) may show different toxicities than BMAA. Here, we set out to provide a fast and sensitive method for the monitoring of AEG, BAMA, DAB and BMAA in surface waters. A procedure based on aqueous derivatization with 9-fluorenylmethyl chloroformate (FMOC-Cl) was investigated for this purpose. Under optimized conditions, a small aqueous sample aliquot (5 mL) was spiked with BMAA-d3 internal standard, subjected to FMOC-Cl derivatization, centrifuged, and analyzed. The high-throughput instrumental method (10 min per sample) involved on-line pre-concentration and desalting coupled to ultra-high-performance liquid chromatography high-resolution mass spectrometry (UHPLC-HRMS). Chromatographic gradient and mobile phases were adjusted to obtain suitable separation of the 4 isomers. The method limits of detection were in the range of 2-5 ng L-1. In-matrix validation parameters including linearity range, accuracy, precision, and matrix effects were assessed. The method was applied to surface water samples (n = 82) collected at a large spatial scale in lakes and rivers in Canada. DAB was found in > 70% of samples at variable concentrations (< 3-1,900 ng L-1), the highest concentrations corresponding to lake samples in cyanobacterial bloom periods. BMAA was only reported (110 ng L-1) at one HAB-impacted location. This is one of the first studies to report on the profiles of AEG, BAMA, DAB, and BMAA in background and impacted surface waters.	[Sung Vo Duy; Munoz, Gabriel; Quoc Tuc Dinh; Dat Tien Do; Simon, Dana F.; Sauve, Sebastien] Univ Montreal, Dept Chem, Montreal, PQ, Canada	Universite de Montreal	Sauve, S (corresponding author), Univ Montreal, Dept Chem, Montreal, PQ, Canada.	sebastien.sauve@umontreal.ca		Simon, Dana/0000-0003-3725-2482	Genome Canada; Genome Quebec; Natural Sciences and Engineering Research Council of Canada (NSERC-CRSNG) [STPGP 478774]; Quebec Research Fund (FRQ) [PR-183278]; Canada Foundation for Innovation (CFI) [30044]	Genome Canada(Genome Canada); Genome Quebec; Natural Sciences and Engineering Research Council of Canada (NSERC-CRSNG)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Research Fund (FRQ); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This study was conducted under the framework of the ATRAPP project (Algal Blooms, Treatment, Risk Assessment, Prediction and Prevention through Genomics), with financial support from Genome Canada and Genome Quebec to SS. We thank the Natural Sciences and Engineering Research Council of Canada (NSERC-CRSNG) for funding to SS (STPGP 478774), the Quebec Research Fund (FRQ) for funding to SS (PR-183278), and the Canada Foundation for Innovation (CFI) for their financial support to SS (30044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted under the framework of the ATRAPP project (Algal Blooms, Treatment, Risk Assessment, Prediction and Prevention through Genomics), with financial support from Genome Canada and Genome Quebec. We thank the Natural Sciences and Engineering Research Council of Canada (NSERC-CRSNG; STPGP 478774), the Quebec Research Fund (FRQ; PR-183278), and the Canada Foundation for Innovation (CFI; 30044) for their financial support. We thank N. Fortin and C. Greer (National Research Council Canada, Montreal, QC, Canada), M. Larsen and J. J. Venkiteswaran (Wilfrid Laurier University, Waterloo, ON, Canada), E. McAlister and H. Baulch (University of Saskatchewan, Saskatoon, SK, Canada), D. Taylor (Nova Scotia Environment, Halifax, NS, Canada), as well as Barry Husk (BlueLeaf Inc., Drummondville, QC, Canada) for their help in obtaining the field samples. We thank the NSERC Canadian Lake Pulse Network for sharing samples collected on 7 lakes. The authors gratefully acknowledge the crew from the Lampsilis research vessel, F. Guillemette and G. Cabana (Universite du Quebec a Trois-Rivieres, Trois-Rivieres, QC, Canada), and all those who participated in the sampling campaigns. We also acknowledge technical support from Thermo Fisher Scientific and Phytronix Technologies.	[Anonymous], 2017, SANTE118132017 SANCO; Anumol T, 2015, TALANTA, V132, P77, DOI 10.1016/j.talanta.2014.08.011; Banack SA, 2011, TOXICON, V57, P730, DOI 10.1016/j.toxicon.2011.02.005; Banack SA, 2003, NEUROLOGY, V61, P387, DOI 10.1212/01.WNL.0000078320.18564.9F; Banack SA, 2007, MAR DRUGS, V5, P180, DOI 10.3390/md20070014; Banack SA, 2018, NEUROTOX RES, V33, P184, DOI 10.1007/s12640-017-9744-7; Beach DG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18392-w; Beach DG, 2015, ANAL BIOANAL CHEM, V407, P8397, DOI 10.1007/s00216-015-9012-8; Beltran E, 2012, J CHROMATOGR A, V1266, P61, DOI 10.1016/j.chroma.2012.10.017; Birbeck JA, 2019, TOXINS, V11, DOI 10.3390/toxins11010013; Bishop SL, 2018, NEUROTOX RES, V33, P133, DOI 10.1007/s12640-017-9820-z; Blahova L, 2017, TOXICON, V133, P48, DOI 10.1016/j.toxicon.2017.04.011; Chatziefthimiou AD, 2016, TOXICON, V114, P75, DOI 10.1016/j.toxicon.2016.02.016; Cohen SA, 2012, ANALYST, V137, P1991, DOI 10.1039/c2an16250d; Davis DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213346; Druart C, 2011, ANAL BIOANAL CHEM, V399, P1725, DOI 10.1007/s00216-010-4468-z; Dufour V, 2017, CHIMIE ANALYTIQUE EN, P1; Faassen EJ, 2014, TOXINS, V6, P1109, DOI 10.3390/toxins6031109; Faassen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065260; Faassen EJ, 2009, AMYOTROPH LATERAL SC, V10, P79, DOI 10.3109/17482960903272967; Fan H, 2015, ENVIRON SCI POLLUT R, V22, P5943, DOI 10.1007/s11356-014-3766-y; Fayad PB, 2015, TOXICON, V108, P167, DOI 10.1016/j.toxicon.2015.10.010; Foss AJ, 2018, TOXICON, V152, P150, DOI 10.1016/j.toxicon.2018.07.028; Freuze I, 2007, J CHROMATOGR A, V1175, P197, DOI 10.1016/j.chroma.2007.10.092; Goeury K, 2019, J CHROMATOGR A, V1591, P87, DOI 10.1016/j.chroma.2019.01.016; Gonzalez O, 2014, J CHROMATOGR A, V1353, P10, DOI 10.1016/j.chroma.2014.03.077; Gurbuz F, 2016, SCI TOTAL ENVIRON, V562, P860, DOI 10.1016/j.scitotenv.2016.04.027; Hanke I, 2008, ANAL BIOANAL CHEM, V391, P2265, DOI 10.1007/s00216-008-2134-5; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA110, DOI 10.1289/ehp.120-a110; Jiang LY, 2013, ANAL BIOANAL CHEM, V405, P1283, DOI 10.1007/s00216-012-6550-1; Jiang LY, 2012, ANAL BIOANAL CHEM, V403, P1719, DOI 10.1007/s00216-012-5966-y; Kabore HA, 2018, SCI TOTAL ENVIRON, V616, P1089, DOI 10.1016/j.scitotenv.2017.10.210; Kerrin ES, 2017, ANAL BIOANAL CHEM, V409, P1481, DOI 10.1007/s00216-016-0091-y; KISBY GE, 1988, J NEUROSCI METH, V26, P45, DOI 10.1016/0165-0270(88)90128-8; Koh HJ, 2011, B KOREAN CHEM SOC, V32, P3799, DOI 10.5012/bkcs.2011.32.10.3799; Lance E, 2018, TOXINS, V10, DOI 10.3390/toxins10020083; Lee JI, 2006, J CHROMATOGR A, V1116, P57, DOI 10.1016/j.chroma.2006.03.053; Main BJ, 2018, HARMFUL ALGAE, V74, P10, DOI 10.1016/j.hal.2018.03.004; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Matuszewski BK, 2006, J CHROMATOGR B, V830, P293, DOI 10.1016/j.jchromb.2005.11.009; Meriluoto J., 2017, HDB CYANOBACTERIAL M; Metcalf JS, 2008, ENVIRON MICROBIOL, V10, P702, DOI 10.1111/j.1462-2920.2007.01492.x; Montiel-Leon JM, 2019, ENVIRON POLLUT, V250, P29, DOI 10.1016/j.envpol.2019.03.125; Montiel-Leon JM, 2018, ANAL BIOANAL CHEM, V410, P2765, DOI 10.1007/s00216-018-0957-2; MOTEKAITIS RJ, 1982, CAN J CHEM, V60, P1207, DOI 10.1139/v82-179; Munoz G, 2017, J CHROMATOGR A, V1516, P9, DOI 10.1016/j.chroma.2017.07.096; Munoz G, 2015, ANAL CHIM ACTA, V881, P98, DOI 10.1016/j.aca.2015.04.015; Nedelkoska TV, 2004, ANAL CHIM ACTA, V511, P145, DOI 10.1016/j.aca.2004.01.027; Nunn PB, 2017, PHYTOCHEMISTRY, V144, P253, DOI 10.1016/j.phytochem.2017.09.015; Ploux O, 2017, HDB CYANOBACTERIAL M; Poiger T, 2017, ENVIRON SCI POLLUT R, V24, P1588, DOI 10.1007/s11356-016-7835-2; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; RIDEOUT JM, 1983, J LIQ CHROMATOGR, V6, P383, DOI 10.1080/01483918308066898; Roy-Lachapelle A, 2015, ANAL BIOANAL CHEM, V407, P5487, DOI 10.1007/s00216-015-8722-2; Rutkowska M, 2019, TRAC-TREND ANAL CHEM, V112, P112, DOI 10.1016/j.trac.2019.01.001; Salomonsson ML, 2013, ANAL METHODS-UK, V5, P4865, DOI 10.1039/c3ay40657a; Scott LL, 2018, TOXINS, V10, DOI 10.3390/toxins10010022; Shoemaker JA, 2015, 544 EPA; Turner AD, 2018, J CHROMATOGR B, V1074, P111, DOI 10.1016/j.jchromb.2017.12.032; Violi JP, 2019, ECOTOX ENVIRON SAFE, V172, P72, DOI 10.1016/j.ecoenv.2019.01.046; Vyas KJ, 2009, AMYOTROPH LATERAL SC, V10, P50, DOI 10.3109/17482960903268742; Wang JG, 2010, J HAZARD MATER, V176, P333, DOI 10.1016/j.jhazmat.2009.11.032	62	8	8	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220698	10.1371/journal.pone.0220698	http://dx.doi.org/10.1371/journal.pone.0220698			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386693	Green Submitted, Green Published, gold			2022-12-27	WOS:000484997100032
J	Liu, YZ; Manners, J; Bittar, Y; Chou, SHY; Gopalakrishnan, V				Liu, Yuzhe; Manners, Jody; Bittar, Yazan; Chou, Sherry H-Y; Gopalakrishnan, Vanathi			Towards precision critical care management of blood pressure in hemorrhagic stroke patients using dynamic linear models	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTRACEREBRAL HEMORRHAGE; HYPERTENSION; GUIDELINES; LABETALOL; PROFESSIONALS; PHARMACOKINETICS; NICARDIPINE	Finding optimal blood pressure (BP) target and BP treatment after acute ischemic or hemorrhagic strokes is an area of controversy and a significant unmet need in the critical care of stroke victims. Numerous large prospective clinical trials have been done to address this question but have generated neutral or conflicting results. One major limitation that may have contributed to so many neutral or conflicting clinical trial results is the "one-size fit all" approach to BP targets, while the optimal BP target likely varies between individuals. We address this problem with the Acute Intervention Model of Blood Pressure (AIM-BP) framework: an individualized, human interpretable model of BP and its control in the acute care setting. The framework consists of two components: one, a model of BP homeostasis and the various effects that perturb it; and two, a parameter estimator that can learn clinically important model parameters on a patient by patient basis. By estimating the parameters of the AIM-BP model for a given patient, the effectiveness of antihypertensive medication can be quantified separately from the patient's spontaneous BP trends. We hypothesize that the AIM-BP is a sufficient framework for estimating parameters of a homeostasis perturbation model of a stroke patient's BP time course and the AIM-BP parameter estimator can do so as accurately and consistently as a state-of-the-art maximum likelihood estimation method. We demonstrate that this is the case in a proof of concept of the AIM-BP framework, using simulated clinical scenarios modeled on stroke patients from real world intensive care datasets.	[Liu, Yuzhe; Gopalakrishnan, Vanathi] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA; [Manners, Jody] Naval Med Ctr Portsmouth, Dept Neurol, Portsmouth, VA USA; [Bittar, Yazan] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Chou, Sherry H-Y] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Chou, Sherry H-Y] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Chou, Sherry H-Y] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Defense; United States Navy; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, YZ (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.	y.liu@pitt.edu		Liu, Brian/0000-0003-2102-4848; Gopalakrishnan, Vanathi/0000-0002-7813-4055	National Library of Medicine [NLM 2T15LM007059]; National Institute of Health [1K23-NS073806]; University of Pittsburgh Dean's Faculty Advancement ward; Edge Therapeutics; National Institute of General Medical Sciences [R01GM100387]; UPMC Academic Foundation Award; Merck; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100387] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007059] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Dean's Faculty Advancement ward; Edge Therapeutics(General Electric); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UPMC Academic Foundation Award; Merck(Merck & Company); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Author YL gratefully acknowledges the National Library of Medicine (https://www.nlm.nih.gov/) for training grant NLM 2T15LM007059. Author SHYC received research support from the National Institute of Health (https://www.ninds.nih.gov/, 1K23-NS073806), The University of Pittsburgh Dean's Faculty Advancement ward and UPMC Academic Foundation Award. SHYC also received support from Edge Therapeutics as site principal investigator for the NEWTON 2 study and from Merck for consultation. Author VG gratefully acknowledges a grant from the National Institute of General Medical Sciences, Award Number R01GM100387 (https://www.nigms.nih.gov/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; We would like to thank the National Library of Medicine for funding this work (NLM 2T15LM007059).	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Alqadri SL, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0426-7; Anderson CS, 2016, NEW ENGL J MED, V374, P2313, DOI 10.1056/NEJMoa1515510; Appleton JP, 2016, STROKE VASC NEUROL, V1, P72, DOI 10.1136/svn-2016-000020; Bath PMW, 2015, LANCET, V385, P617, DOI 10.1016/S0140-6736(14)61121-1; Bowry Ritvij, 2014, Neurol Clin Pract, V4, P419; BRITTON M, 1986, STROKE, V17, P861, DOI 10.1161/01.STR.17.5.861; Butcher K, 2016, STROKE, V47, P3065, DOI 10.1161/STROKEAHA.116.015060; CARLIN BP, 1992, J AM STAT ASSOC, V87, P493, DOI 10.2307/2290282; CARTER CK, 1994, BIOMETRIKA, V81, P541; Castillo J, 2004, STROKE, V35, P520, DOI 10.1161/01.STR.0000109769.22917.B0; CHAUVIN M, 1987, BRIT J ANAESTH, V59, P1250, DOI 10.1093/bja/59.10.1250; Curran MP, 2006, DRUGS, V66, P1755, DOI 10.2165/00003495-200666130-00010; de Castilho FM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180060; Fearnhead P, 2011, CH CRC HANDB MOD STA, P513; GRAHAM DJM, 1985, BRIT J CLIN PHARMACO, V20, pS23, DOI 10.1111/j.1365-2125.1985.tb05141.x; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; LALONDE RL, 1990, CLIN PHARMACOL THER, V48, P509, DOI 10.1038/clpt.1990.187; Lau EHY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038346; Lehman LWH, 2018, IEEE J BIOMED HEALTH, V22, P56, DOI 10.1109/JBHI.2016.2636808; Lehman LWH, 2015, IEEE J BIOMED HEALTH, V19, P1068, DOI 10.1109/JBHI.2014.2330827; Lehman LWH, 2013, IEEE ENG MED BIO, P7072, DOI 10.1109/EMBC.2013.6611187; Lehman LWH, 2013, CRIT CARE MED, V41, P34, DOI 10.1097/CCM.0b013e318265ea46; Li Q, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-13; Liu ZT, 2016, AAAI CONF ARTIF INTE, P1273; Liu ZT, 2015, AAAI CONF ARTIF INTE, P1798; MacDougall J, 2006, STAT BIOL HEALTH, P127; Mahdi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003384; Mancia G, 2012, HYPERTENSION, V60, P512, DOI 10.1161/HYPERTENSIONAHA.112.194340; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; McManus M, 2016, J CLIN NEUROL, V12, P137, DOI 10.3988/jcn.2016.12.2.137; Petris G, 2009, USE R, P1, DOI 10.1007/b135794_1; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Raphan T, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00096; Ribezzo S, 2014, SCI WORLD J, DOI 10.1155/2014/353628; RICHARDS DA, 1977, EUR J CLIN PHARMACOL, V11, P85, DOI 10.1007/BF00562897; SAOTOME T, 1993, J CLIN PHARMACOL, V33, P979, DOI 10.1002/j.1552-4604.1993.tb01933.x; Schoemaker RC, 1998, J PHARMACOKINET BIOP, V26, P581, DOI 10.1023/A:1023277201179; SERLIN MJ, 1979, BRIT J CLIN PHARMACO, V7, P165, DOI 10.1111/j.1365-2125.1979.tb00916.x; Stevens SL, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4098; Strbian D, 2016, STROKE, V47, P3063, DOI 10.1161/STROKEAHA.116.015594; WALLACE JD, 1981, JAMA-J AM MED ASSOC, V246, P2177, DOI 10.1001/jama.246.19.2177; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; WILSON DJ, 1983, AM J MED, V75, P95, DOI 10.1016/0002-9343(83)90141-9; Wu J, 2017, STAT METHODS MED RES; Yapps B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08137-0	48	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220283	10.1371/journal.pone.0220283	http://dx.doi.org/10.1371/journal.pone.0220283			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381589	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600014
J	Zappi, DC; Moro, MF; Walker, B; Meagher, T; Viana, PL; Mota, NFO; Watanabe, MTC; Lughadha, EN				Zappi, Daniela C.; Moro, Marcelo F.; Walker, Barnaby; Meagher, Thomas; Viana, Pedro L.; Mota, Nara F. O.; Watanabe, Mauricio T. C.; Lughadha, Eimear Nic			Plotting a future for Amazonian canga vegetation in a campo rupestre context	PLOS ONE			English	Article							TREE; COMMUNITY; IRONSTONE; DIVERSITY; FRAMEWORK; RECOVERY; ECOLOGY	In order to establish effective conservation strategy, drivers of local and regional patterns of biodiversity need to be understood. The composition of local biodiversity is dependent on a number of factors including evolution and redistribution of lineages through dispersal and environmental heterogeneity. Brazilian canga is characterised by a ferrugineous substrate, found both in the Iron Quadrangle of Minas Gerais and in the Carajas mountains in Amazonia. Canga is one of several specialised habitat types comprising Brazilian campo rupestre, a montane vegetation found within or adjacent to several major Brazilian bioregions, including the Atlantic Forest and Amazonia, with exceptionally high levels of diversity and endemism arising from both history of dispersal and environmental variation. In order to inform biodiversity conservation for canga, and more broadly for campo rupestre, we performed floristic and phylogenetic analyses investigating affinities between 28 sites on different substrates (canga and quartzite) and geographic locations (Carajas, Para[Amazonia]; Cadeia do Espinhaco, Minas Gerais; Chapada Diamantina, Bahia). Through analysis of 11204 occurrences of 4705 species of angiosperms, we found that Amazonian Carajas canga plant communities formed a cohesive group, distinct from species assemblages found in Eastern Brazil (Minas Gerais, Bahia), either on canga or quartzite. The phylogenetic megatree of species across all sites investigated shows associations between certain clades and Amazonian canga, with few shared species between the Amazonian Carajas and Eastern Brazil sites, while the floristic comparison shows high levels of heterogeneity between sites. The need for reserves for Amazonian Carajas canga has been recognized and addressed by the creation of a national park. However, current sampling does not provide sufficient reassurance that the canga areas now benefitting from full legal protection adequately represent the regional canga flora.	[Zappi, Daniela C.; Mota, Nara F. O.; Watanabe, Mauricio T. C.] Inst Tecnol Vale, Belem, Para, Brazil; [Zappi, Daniela C.; Viana, Pedro L.; Mota, Nara F. O.] Museu Paraense Emilio Goeldi, Coordenacao Bot, Belem, Para, Brazil; [Moro, Marcelo F.] Univ Fed Ceara, Inst Ciencias Mar Labomar, Fortaleza, Ceara, Brazil; [Walker, Barnaby; Lughadha, Eimear Nic] Royal Bot Gardens, Conservat Sci Dept, Richmond, Surrey, England; [Meagher, Thomas] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Museu Paraense Emilio Goeldi; Universidade Federal do Ceara; Royal Botanic Gardens, Kew; University of St Andrews	Zappi, DC (corresponding author), Inst Tecnol Vale, Belem, Para, Brazil.; Zappi, DC (corresponding author), Museu Paraense Emilio Goeldi, Coordenacao Bot, Belem, Para, Brazil.	daniela.zappi14@gmail.com	Viana, Pedro/S-3127-2019; Zappi, Daniela C./F-9007-2015; Moro, Marcelo F/J-9882-2012; Nic Lughadha, Eimear/N-4560-2014	Zappi, Daniela C./0000-0001-6755-2238; Moro, Marcelo F/0000-0003-4527-346X; WATANABE, MAURICIO/0000-0001-9690-5565; Walker, Barnaby/0000-0002-3884-671X; Nic Lughadha, Eimear/0000-0002-8806-4345	CNPq [455505/2014-4]; MPEG/ITVDS/FADESP [01205.000250/2014-10]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [BR-88887/130640/2016-00]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MPEG/ITVDS/FADESP; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq project (455505/2014-4) to all authors; The MPEG/ITVDS/FADESP Term of Agreement (01205.000250/2014-10); DCZ - CNPq productivity grant; NFOM - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR-88887/130640/2016-00).	Absaber AN, 1986, CARAJAS DESAFIO POLI, P88; AUSTIN D F, 1981, Acta Amazonica, V11, P291; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borregaard MK, 2014, METHODS ECOL EVOL, V5, P1225, DOI 10.1111/2041-210X.12283; Bustamante MMC, 2016, GLOBAL CHANGE BIOL, V22, P92, DOI 10.1111/gcb.13087; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carvalho GH, 2010, PLANTMINER WEB TOOL, DOI [10.1016/j.envsoft.2009.11.014, DOI 10.1016/J.ENVSOFT.2009.11.014]; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; Colwell RK, 2014, ECOGRAPHY, V37, P609, DOI 10.1111/ecog.00814; Porto MFD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00211015; Dexter KG, 2017, P NATL ACAD SCI USA, V114, P2645, DOI 10.1073/pnas.1613655114; Duarte LDS, 2012, ECOGRAPHY, V35, P952, DOI 10.1111/j.1600-0587.2011.07193.x; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Freitas L, 2016, PHYTOKEYS, P65, DOI 10.3897/phytokeys.58.5643; Gastauer M, 2017, ACTA BOT BRAS, V31, P191, DOI 10.1590/0102-33062016abb0306; Gibson N, 2012, J ARID ENVIRON, V77, P25, DOI 10.1016/j.jaridenv.2011.08.021; Giulietti AM, 1987, B BOT U SAO PAULO, V9, P1, DOI DOI 10.11606/ISSN.2316-9052.V9I0P1-151; Giulietti AM., 2018, GUIA ESPECIES INVASO; Gotelli Nicholas J., 2011, P39; Hopper SD, 2016, PLANT SOIL, V403, P167, DOI 10.1007/s11104-015-2764-2; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Jacobi CM, 2007, BIODIVERS CONSERV, V16, P2185, DOI 10.1007/s10531-007-9156-8; Jacobi CM, 2008, REV ARVORE, V32, P345, DOI 10.1590/S0100-67622008000200017; KING R M, 1980, Phytologia, V47, P113; KING R M, 1980, Phytologia, V47, P110; KIRKBRIDE J H JR, 1980, Acta Amazonica, V10, P97; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lohmann Lúcia G., 2018, Rodriguésia, V69, P1063, DOI 10.1590/2175-7860201869313; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Monteiro DA, 2018, FLORA CANGAS SERRA C, P69; Moro MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119166; Moro MF, 2012, ACTA BOT BRAS, V26, P991, DOI 10.1590/S0102-33062012000400029; Mota Nara Furtado de Oliveira, 2018, Rodriguésia, V69, P1435, DOI 10.1590/2175-7860201869336; Ometto JP, 2014, CLIMATIC CHANGE, V124, P545, DOI 10.1007/s10584-014-1058-7; Pereira AV, 2018, PRS-GLOB OPEN, V6, DOI 10.1097/GOX.0000000000001635; Peres CA, 2010, BIOL CONSERV, V143, P2314, DOI 10.1016/j.biocon.2010.01.021; Pifano Daniel Salgado, 2010, Biota Neotrop., V10, P55, DOI 10.1590/S1676-06032010000100005; Pimm SL, 2010, NAT CONSERVACAO, V8, P71, DOI 10.4322/natcon.00801011; Pirani JR, 2009, B BOT, V27; R Core Team, 2018, R LANG ENV STAT COMP; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Silva Manoela F. F. De, 1996, Acta Amazonica, V26, P17; Silveira FAO, 2016, PLANT SOIL, V403, P129, DOI 10.1007/s11104-015-2637-8; Stannard BL., 1995, FLORA PICO ALMAS; Takahasi Adriana, 2014, Hoehnea, V41, P515, DOI 10.1590/2236-8906-63/2013; Taylor P.G., 1989, KEW B, V14, P1; Messias MCTB, 2013, FOLIA GEOBOT, V48, P509, DOI 10.1007/s12224-013-9154-4; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Viana Pedro Lage, 2007, Rodriguésia, V58, P157, DOI 10.1590/2175-7860200758112; Viana Pedro Lage, 2016, Rodriguésia, V67, P1107, DOI 10.1590/2175-7860201667501; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Workman D., 2018, WORLDSTOPEXPORTS; Zappi D. C., 2017, PAISAGENS PLANTAS CA; Zappi Daniela C., 2003, Boletim de Botanica da Universidade de Sao Paulo, V21, P345; Zappi DC, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02141; Zappi Daniela C., 2015, Rodriguésia, V66, P1085, DOI 10.1590/2175-7860201566411	57	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0219753	10.1371/journal.pone.0219753	http://dx.doi.org/10.1371/journal.pone.0219753			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381566	gold, Green Published, Green Submitted			2022-12-27	WOS:000484993600006
J	Caversaccio, M; Wimmer, W; Anso, J; Mantokoudis, G; Gerber, N; Rathgeb, C; Schneider, D; Hermann, J; Wagner, F; Scheidegger, O; Huth, M; Anschuetz, L; Kompis, M; Williamson, T; Bell, B; Gavaghan, K; Weber, S				Caversaccio, Marco; Wimmer, Wilhelm; Anso, Juan; Mantokoudis, Georgios; Gerber, Nicolas; Rathgeb, Christoph; Schneider, Daniel; Hermann, Jan; Wagner, Franca; Scheidegger, Olivier; Huth, Markus; Anschuetz, Lukas; Kompis, Martin; Williamson, Tom; Bell, Brett; Gavaghan, Kate; Weber, Stefan			Robotic middle ear access for cochlear implantation: First in man	PLOS ONE			English	Article							INSERTION; TOOL	To demonstrate the feasibility of robotic middle ear access in a clinical setting, nine adult patients with severe-to-profound hearing loss indicated for cochlear implantation were included in this clinical trial. A keyhole access tunnel to the tympanic cavity and targeting the round window was planned based on preoperatively acquired computed tomography image data and robotically drilled to the level of the facial recess. Intraoperative imaging was performed to confirm sufficient distance of the drilling trajectory to relevant anatomy. Robotic drilling continued toward the round window. The cochlear access was manually created by the surgeon. Electrode arrays were inserted through the keyhole tunnel under microscopic supervision via a tympanomeatal flap. All patients were successfully implanted with a cochlear implant. In 9 of 9 patients the robotic drilling was planned and performed to the level of the facial recess. In 3 patients, the procedure was reverted to a conventional approach for safety reasons. No change in facial nerve function compared to baseline measurements was observed. Robotic keyhole access for cochlear implantation is feasible. Further improvements to workflow complexity, duration of surgery, and usability including safety assessments are required to enable wider adoption of the procedure.	[Caversaccio, Marco; Wimmer, Wilhelm; Mantokoudis, Georgios; Huth, Markus; Anschuetz, Lukas; Kompis, Martin] Univ Bern, Bern Univ Hosp, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, Bern, Switzerland; [Caversaccio, Marco; Wimmer, Wilhelm; Rathgeb, Christoph] Univ Bern, ARTORG Ctr Biomed Engn Res, Hearing Res Lab, Bern, Switzerland; [Anso, Juan; Gerber, Nicolas; Schneider, Daniel; Hermann, Jan; Williamson, Tom; Bell, Brett; Gavaghan, Kate; Weber, Stefan] Univ Bern, ARTORG Ctr Biomed Engn Res, Image Guided Therapy, Bern, Switzerland; [Wagner, Franca] Univ Bern, Bern Univ Hosp, Dept Diagnost & Intervent Neuroradiol, Inselspital, Bern, Switzerland; [Scheidegger, Olivier] Univ Bern, Bern Univ Hosp, Dept Neurol, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Wimmer, W (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Otorhinolaryngol Head & Neck Surg, Bern, Switzerland.; Wimmer, W (corresponding author), Univ Bern, ARTORG Ctr Biomed Engn Res, Hearing Res Lab, Bern, Switzerland.	wilhelm.wimmer@artorg.unibe.ch	Anschuetz, Lukas/X-3595-2019; Scheidegger, Olivier/AAF-8714-2020; Anso, Juan/X-4992-2019; Mantokoudis, Georgios/J-6318-2013; Gerber, Kate/GSD-6162-2022	Anschuetz, Lukas/0000-0001-6927-0664; Scheidegger, Olivier/0000-0003-3925-5142; Anso, Juan/0000-0001-9127-0396; Caversaccio, Marco/0000-0002-7090-8087; Mantokoudis, Georgios/0000-0003-2268-7811; Gerber, Kate/0000-0003-4086-4973; Wimmer, Wilhelm/0000-0001-5392-2074	Swiss National Science Foundation (project NCCR Co-Me); Swiss Commission for Technology and Innovation [MIRACI 17618.1]; European Commission (project HEAR-EU) [304857]; Swiss Nano-Tera initiative (project HearRestore); MED-EL GmbH (Innsbruck, Austria); CAScination AG (Bern, Switzerland); Xoran Technologies (Ann Arbor, USA); University of Bern; Inselspital University hospital Bern	Swiss National Science Foundation (project NCCR Co-Me)(Swiss National Science Foundation (SNSF)); Swiss Commission for Technology and Innovation; European Commission (project HEAR-EU); Swiss Nano-Tera initiative (project HearRestore); MED-EL GmbH (Innsbruck, Austria); CAScination AG (Bern, Switzerland); Xoran Technologies (Ann Arbor, USA); University of Bern; Inselspital University hospital Bern	Work leading to this clinical study was supported by the Swiss National Science Foundation (project NCCR Co-Me), the Swiss Commission for Technology and Innovation (project MIRACI 17618.1), the European Commission (project HEAR-EU, 304857), the Swiss Nano-Tera initiative (project HearRestore), MED-EL GmbH (Innsbruck, Austria), CAScination AG (Bern, Switzerland), and Xoran Technologies (Ann Arbor, USA). The study itself was solely funded by institutional support of the University of Bern and the Inselspital University hospital Bern. Support by commercial partners was provided in the form of research material and in-kind contributions. None of the commercial funders had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anschuetz L, 2018, OTOL NEUROTOL, V39, pE996, DOI 10.1097/MAO.0000000000002034; Anso J, 2018, ANN BIOMED ENG, V46, P1568, DOI 10.1007/s10439-018-2094-7; Anso J, 2016, OTOL NEUROTOL, V37, P89, DOI 10.1097/MAO.0000000000000914; Bell B, 2013, OTOL NEUROTOL, V34, P1284, DOI 10.1097/MAO.0b013e31829561b6; Brand Y, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13909; Caversaccio M, 2017, ACTA OTO-LARYNGOL, V137, P447, DOI 10.1080/00016489.2017.1278573; Crowson MG, 2017, AUDIOL NEURO-OTOL, V22, P236, DOI 10.1159/000481767; Feldmann A, 2016, ANN BIOMED ENG, V44, P1576, DOI 10.1007/s10439-015-1450-0; Gerber N, 2014, INT J COMPUT ASS RAD, V9, P11, DOI 10.1007/s11548-013-0908-5; Gerber N, 2013, IEEE T BIO-MED ENG, V60, P960, DOI 10.1109/TBME.2013.2241063; Hausler R, 2002, ACTA OTO-LARYNGOL, V122, P715, DOI 10.1080/00016480260349773; House WF., 1976, ANN OTO RHINOL LARYN, V85, pS1; Kiratzidis T, 2002, ORL-J OTO-RHIN-LARYN, V64, P413, DOI 10.1159/000067577; Labadie RF, 2014, LARYNGOSCOPE, V124, P1915, DOI 10.1002/lary.24520; Marchioni D, 2014, EUR ARCH OTO-RHINO-L, V271, P959, DOI 10.1007/s00405-013-2490-4; Migirov Lela, 2010, Cochlear Implants Int, V11 Suppl 1, P195, DOI 10.1179/146701010X12671177818786; Muller J, 2017, HNO, V65, P561, DOI 10.1007/s00106-017-0370-8; Rathgeb C, 2019, INT J COMPUT ASS RAD, V14, P83, DOI 10.1007/s11548-018-1834-3; Roland JT, 2018, LARYNGOSCOPE, V128, P1939, DOI 10.1002/lary.27073; Ross BG, 1996, OTOLARYNG HEAD NECK, V114, P380, DOI 10.1016/S0194-5998(96)70206-1; Skarzynski H, 2013, ACTA OTO-LARYNGOL, V133, P3, DOI 10.3109/00016489.2013.869059; Stenin I, 2017, INT J COMPUT ASS RAD, V12, P889, DOI 10.1007/s11548-017-1533-5; Weber S, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aal4916; Williamson T, 2017, OTOL NEUROTOL, V38, P759, DOI 10.1097/MAO.0000000000001357; Williamson TM, 2013, IEEE T BIO-MED ENG, V60, P969, DOI 10.1109/TBME.2012.2235439; Wimmer W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/596498; Wimmer W, 2014, AUDIOL NEURO-OTOL, V19, P22, DOI 10.1159/000356165; Yang GZ, SCI ROBOT, V2; Zeh R, 2015, HNO, V63, P557, DOI 10.1007/s00106-015-0037-2	29	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220543	10.1371/journal.pone.0220543	http://dx.doi.org/10.1371/journal.pone.0220543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374092	Green Submitted, Green Published, gold			2022-12-27	WOS:000484991500016
J	Raliou, M; Dembele, D; Duvel, A; Bolifraud, P; Aubert, J; Mary-Huard, T; Rocha, D; Piumi, F; Mockly, S; Heppelmann, M; Dieuzy-Labaye, I; Zieger, P; Smith, DGE; Schuberth, HJ; Sheldon, IM; Sandra, O				Raliou, Mariam; Dembele, Doulaye; Duevel, Anna; Bolifraud, Philippe; Aubert, Julie; Mary-Huard, Tristan; Rocha, Dominique; Piumi, Francois; Mockly, Sophie; Heppelmann, Maike; Dieuzy-Labaye, Isabelle; Zieger, Peter; Smith, David G. E.; Schuberth, Hans-Joachim; Sheldon, Iain Martin; Sandra, Olivier			Subclinical endometritis in dairy cattle is associated with distinct mRNA expression patterns in blood and endometrium	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PERIPHERAL-BLOOD; INFLAMMATORY CYTOKINES; BOVINE; COWS; ATHEROSCLEROSIS; LEUKOCYTES; APOPTOSIS; S100A8; CELLS	Cattle with subclinical endometritis (SCE) are sub-fertile and diagnosing subclinical uterine disease remains a challenge. The hypothesis for this study was that endometrial inflammation is reflected in mRNA expression patterns of peripheral blood leucocytes. Transcriptome profiles were evaluated in healthy cows and in cows with SCE using circulating white blood cells (WBC) and endometrial biopsy samples collected from the same animals at 45-55 days postpartum. Bioinformatic analyses of microarray-based transcriptional data identified gene profiles associated with distinct biological functions in circulating WBC and endometrium. In circulating WBC, SCE promotes a pro-inflammatory environment, whereas functions related to tissue remodeling are also affected in the endometrium. Nineteen differentially expressed genes associated with SCE were common to both circulating WBC and the endometrium. Among these genes, transcript abundance of immune factors C3, C2, LTF, PF4 and TRAPPC13 were up-regulated in SCE cows at 45-55 days postpartum. Moreover, mRNA expression of C3, CXCL8, LTF, TLR2 and TRAPPC13 was temporally regulated during the postpartum period in circulating WBC of healthy cows compared with SCE cows. This observation might indicate an advantageous modulation of the immune system in healthy animals. The transcript abundance of these genes represents a potential source of indicators for postpartum uterine health.	[Raliou, Mariam; Bolifraud, Philippe; Piumi, Francois; Mockly, Sophie; Sandra, Olivier] Univ Paris Saclay, ENVA, INRA, UMR BDR, Jouy En Josas, France; [Dembele, Doulaye] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104, Inserm 964, Illkirch Graffenstaden, France; [Duevel, Anna; Schuberth, Hans-Joachim] Univ Vet Med, Fdn Hannover, Immunol Unit, Hannover, Germany; [Aubert, Julie; Mary-Huard, Tristan] AgroParisTech, UMR MIA 518, Paris, France; [Rocha, Dominique] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France; [Heppelmann, Maike] Univ Vet Med Hannover, Clin Cattle, Endocrinol Lab, Hannover, Germany; [Dieuzy-Labaye, Isabelle] Zoetis, Zaventem, Belgium; [Zieger, Peter] Zoetis, Berlin, Germany; [Smith, David G. E.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Sheldon, Iain Martin] Swansea Univ, Swansea Univ Med Sch, Inst Life Sci, Swansea, W Glam, Wales; [Piumi, Francois] Ecole Natl Vet Alfort, UPE, INRA,UMR Virol, ENVA,ANSES, Maisons Alfort, France; [Mockly, Sophie] Univ Montpellier, Inst Genet Humaine, CNRS UMR9002, Montpellier, France; [Dieuzy-Labaye, Isabelle] OIE Org Mondiale Sante Anim, Paris, France	Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Veterinary Medicine Hannover, Foundation; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Veterinary Medicine Hannover, Foundation; Zoetis; Zoetis; University of Glasgow; Swansea University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Raliou, M; Sandra, O (corresponding author), Univ Paris Saclay, ENVA, INRA, UMR BDR, Jouy En Josas, France.	mariam.raliou@inra.fr; olivier.sandra@inra.fr	AUBERT, Julie/AAJ-8960-2021; Sheldon, I Martin/E-1567-2013; Schuberth, Hans-Joachim/AAE-4845-2020; Rocha, Dominique/R-5546-2019; Dembele, Doulaye/O-6513-2017	AUBERT, Julie/0000-0001-5203-5748; Sheldon, I Martin/0000-0001-7902-5558; Rocha, Dominique/0000-0003-4998-9641; PIUMI, Francois/0000-0001-6036-7662; Raliou, Mariam/0000-0002-3828-1421; Dembele, Doulaye/0000-0003-3879-6940	ERA-NET EMIDA (Coordination of European Research on Emerging and Major Infectious Diseases of Livestock); UK Biotechnology and Biological Sciences Research Council; BBSRC [BB/I017283/1, BB/K006592/1] Funding Source: UKRI	ERA-NET EMIDA (Coordination of European Research on Emerging and Major Infectious Diseases of Livestock); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was funded by the ERA-NET EMIDA (Coordination of European Research on Emerging and Major Infectious Diseases of Livestock), 2010. IMS was supported by the UK Biotechnology and Biological Sciences Research Council Grant BB/1017240/.	Al-Gubory KH, 2017, THERIOGENOLOGY, V99, P111, DOI 10.1016/j.theriogenology.2017.05.017; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Baber I, 2011, INFECT GENET EVOL, V11, P765, DOI 10.1016/j.meegid.2010.10.008; Baker JR, 2011, DEV DYNAM, V240, P2194, DOI 10.1002/dvdy.22709; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Benjamini Y, 1995, CONTROLLING FALSE DI, DOI [10.1176/ajp.156.6, DOI 10.1176/AJP.156.6]; Bolger MS, 2007, AM J PHYSIOL-LUNG C, V292, pL748, DOI 10.1152/ajplung.00127.2006; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bondurant RH, 1999, J ANIM SCI, V77, P101; Brodzki P, 2015, THERIOGENOLOGY, V84, P11, DOI 10.1016/j.theriogenology.2015.02.006; Calder PC, 2013, BRIT J NUTR, V109, pS1, DOI 10.1017/S0007114512005119; Chow WN, 2009, MOL REPROD DEV, V76, P647, DOI 10.1002/mrd.21013; Credille BC, 2015, RES VET SCI, V101, P6, DOI 10.1016/j.rvsc.2015.05.013; Davies D, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-53; Dembele D, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-14; Duvel A, 2014, THERIOGENOLOGY, V81, P906, DOI 10.1016/j.theriogenology.2014.01.007; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Foley C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1967-5; Gabler C, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-152; Galvao KN, 2012, THERIOGENOLOGY, V77, P356, DOI 10.1016/j.theriogenology.2011.08.008; Galvao KN, 2011, THERIOGENOLOGY, V76, P290, DOI 10.1016/j.theriogenology.2011.02.006; Ghasemi F, 2012, THERIOGENOLOGY, V78, P1538, DOI 10.1016/j.theriogenology.2012.06.022; Gilbert RO, 2005, THERIOGENOLOGY, V64, P1879, DOI 10.1016/j.theriogenology.2005.04.022; Herath S, 2006, ENDOCRINOLOGY, V147, P562, DOI 10.1210/en.2005-1113; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Ishii Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080297; Kannaki TR, 2011, ANIM REPROD SCI, V125, P1, DOI 10.1016/j.anireprosci.2011.03.008; KEHRLI ME, 1989, AM J VET RES, V50, P215; KEHRLI ME, 1989, AM J VET RES, V50, P207; Kim JJ, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00020; Kimura K, 1999, J DAIRY SCI, V82, P315, DOI 10.3168/jds.S0022-0302(99)75238-0; Kiracofe G H, 1980, J Anim Sci, V51 Suppl 2, P16; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lewis GS, 2003, J ANIM SCI, V81, P285; Lokki AI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00589; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; McGuire K, 2006, ANIM GENET, V37, P47, DOI 10.1111/j.1365-2052.2005.01364.x; Menzies M, 2006, VET IMMUNOL IMMUNOP, V109, P23, DOI 10.1016/j.vetimm.2005.06.014; Muller MP, 2017, J DAIRY SCI, V100, P1987, DOI 10.3168/jds.2016-11506; Naderi S, 2018, ANIM GENET, V49, P178, DOI 10.1111/age.12661; Passey RJ, 1999, J IMMUNOL, V163, P2209; Peter S, 2015, J PHYSIOL PHARMACOL, V66, P449; Pomeroy B, 2017, VET RES, V48, DOI 10.1186/s13567-017-0415-8; Ramirez-Peinado S, 2017, J CELL SCI, V130, P2251, DOI 10.1242/jcs.199521; Ramos RS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0036-x; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Salilew-Wondim D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2513-9; Sheldon IM, 2009, REPROD DOMEST ANIM, V44, P1, DOI 10.1111/j.1439-0531.2009.01465.x; Sheldon IM, 2008, VET J, V176, P115, DOI 10.1016/j.tvjl.2007.12.031; Sheldon IM, 2006, THERIOGENOLOGY, V65, P1516, DOI 10.1016/j.theriogenology.2005.08.021; Shuster DE, 1997, INFECT IMMUN, V65, P3286, DOI 10.1128/IAI.65.8.3286-3292.1997; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Swain DK, 2014, VET RES COMMUN, V38, P209, DOI 10.1007/s11259-014-9606-1; Ueno K, 2015, CIRC J, V79, P1349, DOI 10.1253/circj.CJ-14-1323; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagener K, 2017, THERIOGENOLOGY, V94, P21, DOI 10.1016/j.theriogenology.2017.02.005; Wierda RJ, 2010, J CELL MOL MED, V14, P1225, DOI 10.1111/j.1582-4934.2010.01022.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Ye L, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006323; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	65	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220244	10.1371/journal.pone.0220244	http://dx.doi.org/10.1371/journal.pone.0220244			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374089	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000484991500005
J	Stevenson, SA; Ciucci, MR; Kelm-Nelson, CA				Stevenson, Sharon A.; Ciucci, Michelle R.; Kelm-Nelson, Cynthia A.			Intervention changes acoustic peak frequency and mesolimbic neurochemistry in the Pink1-/- rat model of Parkinson disease	PLOS ONE			English	Article							50-KHZ ULTRASONIC VOCALIZATIONS; VENTRAL TEGMENTAL AREA; INTENSIVE VOICE TREATMENT; NUCLEUS-ACCUMBENS; GABA NEURONS; LARGE-SAMPLE; DOPAMINE; COMMUNICATION; SPEECH; REWARD	The neural mechanisms underlying behavioral therapy for vocal acoustic deficits in patients with Parkinson disease is unknown. A primary hypothesis is that voice therapy may modulate mesolimbic brainstem regions, including the ventral tegmental area (VTA). The VTA is implicated in ultrasonic call peak frequency, involved in rewarding behaviors, and impacted by Parkinsonism. We tested the hypothesis that chronic (daily) behavioral vocal exercise of male Pink1-/- rats would alter ultrasonic vocalization acoustics and mesolimbic neurochemistry (catecholamines, GABA, mu-opioid receptor) compared to three different controls: sham-exercised Pink1-/-, unexercised Pink1-/-, and unexercised wildtype (WT) rats. A subhypothesis is that sham-exercise rats may exhibit changes to VTA neurochemistry as a result of a type or rewarding intervention. Results demonstrate that average bandwidth (frequency range) of ultrasonic vocalizations did not differ between WT, Pink1-/- no exercise vs. sham and vocal-exercise rats. However, average peak frequency is significantly reduced in vocal-exercised Pink1-/- rats compared to Pink1-/- no exercise, and WT groups. Unexpectedly, there were no significant acoustic differences between the vocal- and sham-exercised groups. There were no differences in catecholamine protein concentrations or tyrosine hydroxylase mRNA expression in the VTA between any of the groups. However, there was significant upregulation of all GABA-related genes in both vocal- and sham-exercised Pink1-/- rats (Gad1, Gad2, Gls, Glul); this finding was confirmed with follow up quantitative Western blotting for GAD. Additionally, there were differential results for mu-opioid receptor quantification in the VTA: vocal-exercised Pink1-/- rats showed increased mRNA expression for mu-opioid receptors whereas Western blotting indicated decreased protein levels in all Pink1-/- rats compared to WT controls suggesting the possible onset of pathology in this model. These data demonstrate modulatory effects of a rewarding behavioral paradigm on ultrasonic vocalization peak frequency. The results suggest that neuromodulators such as GABA and opioid activity, as well as the rewarding aspects of therapy may play a key role in shaping vocal treatments.	[Stevenson, Sharon A.; Ciucci, Michelle R.; Kelm-Nelson, Cynthia A.] Univ Wisconsin, Dept Surg, Div Otolaryngol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kelm-Nelson, CA (corresponding author), Univ Wisconsin, Dept Surg, Div Otolaryngol, Madison, WI 53706 USA.	CAKelm@wisc.edu	Ciucci, Michelle/O-9144-2016	Ciucci, Michelle/0000-0002-9913-8784; Kelm-Nelson, Cynthia/0000-0001-6670-2177	National Institutes of Health-National Institute on Deafness and Other Communication Disorders [R01 DC014358]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC016135, F32DC014399, R01DC014358] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by: R21 DC016135, National Institutes of Health-National Institute on Deafness and Other Communication Disorders (https://www.nidcd.nih.gov/) to CKN; and by R01 DC014358, National Institutes of Health-National Institute on Deafness and Other Communication Disorders (https://www.nidcd.nih.gov/) to MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberico SL, 2015, BASAL GANGLIA, V5, P51, DOI 10.1016/j.baga.2015.06.001; Baptista MAS, 2013, DIS MODEL MECH, V6, P1316, DOI 10.1242/dmm.011940; Behrman A, 2006, AM J SPEECH-LANG PAT, V15, P215, DOI 10.1044/1058-0360(2006/020); Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bialy M, 2000, BEHAV NEUROSCI, V114, P983, DOI 10.1037//0735-7044.114.5.983; Blaszczyk JW, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00269; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bressan RA, 2005, ACTA PSYCHIAT SCAND, V111, P14, DOI 10.1111/j.1600-0447.2005.00540.x; Bromberg-Martin ES, 2009, NEURON, V63, P119, DOI 10.1016/j.neuron.2009.06.009; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Brudzynski SM, 2002, J COMP PSYCHOL, V116, P73, DOI 10.1037//0735-7036.116.1.73; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Brudzynski SM, 2013, CURR OPIN NEUROBIOL, V23, P310, DOI 10.1016/j.conb.2013.01.014; Brudzynski SM, 2009, ILAR J, V50, P43, DOI 10.1093/ilar.50.1.43; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; Burgdorf J, 2007, BEHAV BRAIN RES, V182, P274, DOI 10.1016/j.bbr.2007.03.010; Caminiti SP, 2017, NEUROIMAGE-CLIN, V14, P734, DOI 10.1016/j.nicl.2017.03.011; CHINAGLIA G, 1992, NEUROSCIENCE, V49, P317, DOI 10.1016/0306-4522(92)90099-N; Ciucci MR, 2007, BEHAV BRAIN RES, V182, P284, DOI 10.1016/j.bbr.2007.02.020; Ciucci MR, 2013, SEMIN SPEECH LANG, V34, P185, DOI 10.1055/s-0033-1358367; Ciucci Michelle R, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS172, DOI 10.1016/j.parkreldis.2008.04.027; Clucci MR, 2009, BEHAV NEUROSCI, V123, P328, DOI 10.1037/a0014593; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cullen KP, 2018, DYSPHAGIA, V33, P749, DOI 10.1007/s00455-018-9896-5; Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; De Letter M, 2006, ACTA NEUROL BELG, V106, P19; De Letter M, 2007, CLIN LINGUIST PHONET, V21, P783, DOI 10.1080/02699200701538181; Fleming SM, 2012, BEHAV BRAIN RES, V231, P317, DOI 10.1016/j.bbr.2012.02.034; Fox Cynthia M., 2006, Seminars in Speech and Language, V27, P283, DOI 10.1055/s-2006-955118; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; GAUTHIER L, 1987, AM J OCCUP THER, V41, P360, DOI 10.5014/ajot.41.6.360; Grant LM, 2015, J NEUROSCI RES, V93, P1713, DOI 10.1002/jnr.23625; Grant LM, 2015, BEHAV BRAIN RES, V291, P361, DOI 10.1016/j.bbr.2015.05.042; Grant LM, 2018, BEHAV NEUROSCI; Groppe SE, 2013, BIOL PSYCHIAT, V74, P172, DOI 10.1016/j.biopsych.2012.12.023; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; Ikemoto S, 2010, NEUROSCI BIOBEHAV R, V35, P129, DOI 10.1016/j.neubiorev.2010.02.001; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Johnson AM, 2011, JOVE-J VIS EXP, DOI 10.3791/2835; Kelm-Nelson CA, 2018, NEUROSCIENCE, V379, P126, DOI 10.1016/j.neuroscience.2018.02.027; Kelm-Nelson CA, 2016, DATA BRIEF, V8, P360, DOI 10.1016/j.dib.2016.05.056; Kelm-Nelson CA, 2016, NEUROSCI LETT, V621, P75, DOI 10.1016/j.neulet.2016.04.003; Kelm-Nelson CA, 2016, BEHAV BRAIN RES, V307, P54, DOI 10.1016/j.bbr.2016.03.006; Kelm-Nelson CA, 2015, J PARKINSON DIS, V5, P749, DOI 10.3233/JPD-150688; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Knutson B, 1998, J COMP PSYCHOL, V112, P65, DOI 10.1037/0735-7036.112.1.65; LOGEMANN JA, 1978, J SPEECH HEAR DISORD, V43, P47, DOI 10.1044/jshd.4301.47; Lopuch S, 2011, J COMP PSYCHOL, V125, P250, DOI 10.1037/a0021532; Marien MM, 1994, NORADRENERGIC MECH P; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; McGinnis MY, 2003, PHYSIOL BEHAV, V80, P81, DOI 10.1016/S0031-9384(03)00227-0; Miller N, 2006, AGE AGEING, V35, P235, DOI 10.1093/ageing/afj053; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Nikulina EM, 2005, NEUROPSYCHOPHARMACOL, V30, P1096, DOI 10.1038/sj.npp.1300658; Pinto S, 2004, LANCET NEUROL, V3, P547, DOI 10.1016/S1474-4422(04)00854-3; Plowman-Prine EK, 2009, NEUROREHABILITATION, V24, P131, DOI 10.3233/NRE-2009-0462; Pultorak JD, 2016, SOC NEUROSCI-UK, V11, P365, DOI 10.1080/17470919.2015.1086434; Ramig L, 2001, J NEUROL NEURSURG PS, V71, P793; Ramig LO, 2001, MOVEMENT DISORD, V16, P79, DOI 10.1002/1531-8257(200101)16:1<79::AID-MDS1013>3.0.CO;2-H; Ringel LE, 2013, BEHAV BRAIN RES, V252, P252, DOI 10.1016/j.bbr.2013.06.006; Russell JA, 2010, BRAIN RES, V1341, P3, DOI 10.1016/j.brainres.2010.03.029; SANDYK R, 1985, MED HYPOTHESES, V16, P361, DOI 10.1016/0306-9877(85)90055-6; Sapir S, 2007, J SPEECH LANG HEAR R, V50, P899, DOI 10.1044/1092-4388(2007/064); Sapir S, 2008, CURR OPIN OTOLARYNGO, V16, P205, DOI 10.1097/MOO.0b013e3282febd3a; Schapira AHV, 2017, NAT REV NEUROSCI, V18, P435, DOI 10.1038/nrn.2017.62; Snoeren EMS, 2014, J COMP PSYCHOL, V128, P40, DOI 10.1037/a0033204; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Thompson B, 2006, BEHAV BRAIN RES, V168, P64, DOI 10.1016/j.bbr.2005.10.012; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Villeneuve LM, 2016, MOL NEUROBIOL, V53, P171, DOI 10.1007/s12035-014-8927-y; Willadsen M, 2014, J COMP PSYCHOL, V128, P56, DOI 10.1037/a0034778; Wohr M, 2008, PHYSIOL BEHAV, V93, P766, DOI 10.1016/j.physbeh.2007.11.031; Wright JM, 2012, NEUROPSYCHOPHARMACOL, V37, P808, DOI 10.1038/npp.2011.258; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337	80	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220734	10.1371/journal.pone.0220734	http://dx.doi.org/10.1371/journal.pone.0220734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374106	Green Published, gold, Green Submitted			2022-12-27	WOS:000484991500029
J	Suarez-Sanchez, P; Garcia, B; Nzang, J; Ncogo, P; Riloha, M; Berzosa, P; Benito, A; Romay-Barja, M				Suarez-Sanchez, Pablo; Garcia, Belen; Nzang, Jesus; Ncogo, Policarpo; Riloha, Matilde; Berzosa, Pedro; Benito, Agustin; Romay-Barja, Maria			Failures in the case management of children with uncomplicated malaria in Bata district of Equatorial Guinea and associated factors	PLOS ONE			English	Article							RESISTANCE; ARTEMISININ; ARTEMETHER	Background In Equatorial Guinea, malaria continues to be one of the main causes of morbidity and mortality among children. The National Therapeutic Guide established artesunate-amodiaquine (ASAQ) as first-line treatment for uncomplicated malaria, but compliance with this treatment is low. The aim of this study was to assess, for the first time, the performance of public healthcare workers in the diagnosis and treatment of uncomplicated malaria, their compliance with first-line Malaria National Therapeutic Guide and the associated factors. Methods A cross-sectional survey was conducted at the nine public health facilities in the Bata District of Equatorial Guinea to assess the management of uncomplicated malaria in children < 15 years of age. Bivariate and multivariate statistical analyses were used to determine the recommended treatment compliance and related factors. Results A total of 227 children with uncomplicated malaria were recorded from 9 public health facilities. Most of the treatments prescribed (83.3%) did not follow the first-line treatment recommended for uncomplicated malaria. The diagnosis was established with parasite confirmation in 182 cases (80.2%). After adjustment for other variables, children under 2 months of age, the use of parasite confirmation to the diagnosis of malaria and being familiar with the national therapeutic guide were significantly associated with the prescription of the first-line recommended treatment. Cases attended at the hospital or in a health facility with ASAQ in the pharmacy at the time of the study were also more likely to be prescribed with the recommended treatment, but with non-significant association after adjustment for other variables. Conclusions This study identified the factors associated with the low compliance with the first-line treatment by the public healthcare facilities of Bata District of Equatorial Guinea. It seems necessary to improve case management of children with uncomplicated malaria; to reinforce the use of Malaria National Therapeutic Guide and to inform about the danger of using artemisinin monotherapy. Furthermore, it is crucial to provide recommended first-line treatment to the pharmacies of all public health facilities to ensure access to this treatment.	[Suarez-Sanchez, Pablo; Garcia, Belen; Berzosa, Pedro; Benito, Agustin; Romay-Barja, Maria] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Suarez-Sanchez, Pablo] Hosp Clin San Carlos, Serv Med Prevent, Madrid, Spain; [Nzang, Jesus; Ncogo, Policarpo] Ctr Referencia Control Endemias, Malabo, Equat Guinea; [Riloha, Matilde] Minist Salud & Bienestar Social, Malabo, Equat Guinea; [Berzosa, Pedro; Benito, Agustin; Romay-Barja, Maria] RICET, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Hospital Clinico San Carlos	Romay-Barja, M (corresponding author), Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain.; Romay-Barja, M (corresponding author), RICET, Madrid, Spain.	mromay@isciii.es		Suarez Sanchez, Pablo/0000-0001-7617-6799; Berzosa, Pedro/0000-0002-8768-717X; Garcia Fernandez, Belen/0000-0001-6317-6984; Romay-Barja, Maria/0000-0002-0177-6885; Benito, Agustin/0000-0001-8229-5540	Agencia Espanola de Cooperacion Internacional [AECID2017/CTR/0900237]; Tropical Diseases Research Network [RD16CIII/003/001RICET]	Agencia Espanola de Cooperacion Internacional; Tropical Diseases Research Network	This study was funded by the by the Agencia Espanola de Cooperacion Internacional AECID2017/CTR/0900237 (http://www.aecid.es/ES) and the Tropical Diseases Research Network RD16CIII/003/001RICET (https://www.ricet.es/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgader TM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-11; [Anonymous], 2001, ANT DRUG COMB THER; Asante KP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-409; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baird JK, 2005, NEW ENGL J MED, V352, P1565, DOI 10.1056/NEJMra043207; Banek K, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2370-x; Berzosa P, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1672-0; Bilal JA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0575-9; Chuma J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-243; Ezenduka CC, 2014, J PHARM POLICY PRACT, V7, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1186/2052-3211-7-1; Graz B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-136; Hensen B, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-218; HURWITZ ES, 1981, LANCET, V1, P1068; Instituto Nacional de Estadistica de Guinea Ecuatorial INEGE, 2018, GUIN EC CIFR 2018; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-327; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Ministerio de Sanidad y Bienestar Social y Ministerio de Economia Planificacion e Inversiones Publicas Guinea Ecuatorial, 2012, ENCUESTA DEMOGRAFICA; Minsiterio de Sanidad y Bienestar Social, 2014, GUIA TER NAC PAL GUI; Namuyinga RJ, 2017, MALARIA J, V16, P1; Nauli TS, 2014, EMERGENCE SPREAD ART, P1; Ncogo P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0986-7; Oswald D., 2014, REV SOC STUD, V1, P53, DOI DOI 10.21586/ROSS0000004; Reeler AV, 2000, B WORLD HEALTH ORGAN, V78, P135; Rehman AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-154; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Romay-Barja M, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2254-0; Romay-Barja M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135887; Salomao CA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0996-5; Wang LT, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2454-7; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 1996, PARASITOL TODAY, V12, P399, DOI 10.1016/0169-4758(96)10055-7; Williams HA, 1999, TROP MED INT HEALTH, V4, P641, DOI 10.1046/j.1365-3156.1999.00471.x; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; World Health Organization, 2018, WORLD MAL REP 2018; World Health Organization, 1999, GUIDELINES FOR FOLLO; World Health Organization, 2013, VIT MIN NUTR INF SYS, P1; World Health Organization, 2015, GUID TREATM MAL; Zurovac D, 2005, BRIT MED J, V331, P734, DOI 10.1136/bmj.331.7519.734; Zurovac D, 2004, INT J EPIDEMIOL, V33, P1080, DOI 10.1093/ije/dyh253	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220789	10.1371/journal.pone.0220789	http://dx.doi.org/10.1371/journal.pone.0220789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374107	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500033
J	Lung, JH; Hung, MS; Lin, YC; Lee, KF; Jiang, YY; Huang, SL; Fang, YH; Lu, MS; Lin, CK; Yang, TM; Lin, PY; Hsieh, MJ; Tsai, YH				Lung, Jrhau; Hung, Ming-Szu; Lin, Yu-Ching; Lee, Kam-Fai; Jiang, Yuan Yuan; Huang, Shao-Lan; Fang, Yu-Hung; Lu, Ming-Shian; Lin, Chin-Kuo; Yang, Tsung-Ming; Lin, Paul Yann; Hsieh, Meng-Jer; Tsai, Ying Huang			MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population	PLOS ONE			English	Article							OVEREXPRESSION; CARCINOMA; CMET; PROTOONCOGENE; EXPRESSION; RESISTANCE; INHIBITORS; SURVIVAL; TARGET; OCCURS	Somatic mutations of MET gene are emerging as important driver mutations for lung cancers. To identify the common clinicopathological features of MET exon 14 skipping mutations and amplification and clarify whether the two MET gene alterations cause protein overexpression were investigated using 196 lung cancer samples of Taiwan through real time-qPCR/sequencing, fluorescence in situ hybridization, and immunohistochemistry. The two MET gene alterations are both present in low frequency, similar to 1%, in the studied lung cancer population of Taiwan. MET exon 14 skipping mutations were identified from two early-stage patients, who were both relatively advanced in age, and did not carry other driver mutations. One was an adenocarcinoma and the other was a rare carcinosarcoma. Three gene amplifications cases were identified. Neither of the two MET gene alterations would lead to protein overexpression; hence, direct detection in nucleic acid level would be a preferred and straightforward solution for the identification of skipping mutations. The presence of MET exon 14 mutations in minor histological types of lung cancers urge to extend screening scope of this mutation in lung cancer and treatment response evaluation in clinical trials. These would be important next steps for the success of MET target therapy in clinical practice.	[Lung, Jrhau; Huang, Shao-Lan] Chang Gung Mem Hosp, Dept Med Res & Dev, Chiayi Branch, Chiayi, Taiwan; [Hung, Ming-Szu; Lin, Yu-Ching; Jiang, Yuan Yuan; Fang, Yu-Hung; Lin, Chin-Kuo; Yang, Tsung-Ming; Hsieh, Meng-Jer; Tsai, Ying Huang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Chiayi Branch, Chiayi, Taiwan; [Hung, Ming-Szu; Lin, Yu-Ching] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Hung, Ming-Szu; Lin, Yu-Ching] Chang Gung Univ Sci & Technol, Dept Resp Care, Chiayi Campus, Chiayi, Taiwan; [Lee, Kam-Fai] Chang Gung Mem Hosp, Dept Pathol, Chiayi Branch, Chiayi, Taiwan; [Lu, Ming-Shian] Chang Gung Mem Hosp, Dept Surg, Div Thorac & Cardiovasc Surg, Chiayi Branch, Chiayi, Taiwan; [Lin, Paul Yann] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Anat Pathol, Chiayi, Taiwan; [Hsieh, Meng-Jer] Chang Gung Univ, Coll Med, Dept Resp Care, Taoyuan, Taiwan; [Tsai, Ying Huang] Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Linkou Branch, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Chang Gung University; Chang Gung Memorial Hospital	Tsai, YH (corresponding author), Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Chiayi Branch, Chiayi, Taiwan.; Tsai, YH (corresponding author), Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Linkou Branch, Linkou, Taiwan.	chestmed@cgmh.org.tw	jiang, anyi/GPT-0379-2022	Lin, Chin-Kuo/0000-0002-5940-3715; Fang, Yu Hung/0000-0002-3971-6191; Hsieh, Meng-Jer/0000-0002-2077-0470	Chang Gung Memorial Hospital, Chiayi, Taiwan [CORPG6F0021-3, CMRPG6F0471-3]	Chang Gung Memorial Hospital, Chiayi, Taiwan(Chang Gung Memorial Hospital)	This work was supported by the Chang Gung Memorial Hospital, Chiayi, Taiwan (to YHT, Grant No: CORPG6F0021-3; to JL, Grant No: CMRPG6F0471-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad MM, 2016, J CLIN ONCOL, V34, P721, DOI 10.1200/JCO.2015.63.4600; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Brambilla E, 2015, WORLD CANC REPORT 20; Camidge DR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8001; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; DIRENZO MF, 1992, ONCOGENE, V7, P2549; Drilon A, 2017, J THORAC ONCOL, V12, P15, DOI 10.1016/j.jtho.2016.10.014; Frampton GM, 2015, CANCER DISCOV, V5, P850, DOI 10.1158/2159-8290.CD-15-0285; Fujita S, 1997, JPN J CLIN ONCOL, V27, P378, DOI 10.1093/jjco/27.6.378; Gow CH, 2017, LUNG CANCER, V103, P82, DOI 10.1016/j.lungcan.2016.12.001; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Huang TJ, 2001, ACTA ONCOL, V40, P638; Kahles A, 2018, CANCER CELL, V34, P211, DOI 10.1016/j.ccell.2018.07.001; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lai GG, 2019, J CLIN ONCOL, V37, P876, DOI 10.1200/JCO.18.00177; Lee GD, 2017, J THORAC ONCOL, V12, P1233, DOI 10.1016/j.jtho.2017.04.031; Lewandowska MA, 2013, INT J CLIN EXP PATHO, V6, P2675; Liu SY, 2016, J THORAC ONCOL, V11, P1503, DOI 10.1016/j.jtho.2016.05.016; Liu XW, 2016, J CLIN ONCOL, V34, P794, DOI 10.1200/JCO.2015.62.0674; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Ozasa H, 2014, CANCER SCI, V105, P1032, DOI 10.1111/cas.12447; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Preusser M, 2014, HISTOPATHOLOGY, V65, P684, DOI 10.1111/his.12475; Raghav KP, 2012, CLIN CANCER RES, V18, P2269, DOI 10.1158/1078-0432.CCR-11-2830; Reungwetwattana T, 2017, LUNG CANCER, V103, P27, DOI 10.1016/j.lungcan.2016.11.011; Reungwetwattana T, 2015, TRANSL LUNG CANCER R, V4, P820, DOI 10.3978/j.issn.2218-6751.2015.12.03; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Schrock AB, 2016, J THORAC ONCOL, V11, P1493, DOI 10.1016/j.jtho.2016.06.004; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sweeney P, 2002, J UROLOGY, V168, P51, DOI 10.1016/S0022-5347(05)64830-6; Tong JH, 2016, CLIN CANCER RES, V22, P3048, DOI 10.1158/1078-0432.CCR-15-2061; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Van der Steen N, 2016, J THORAC ONCOL, V11, P1423, DOI 10.1016/j.jtho.2016.05.005; Zheng DF, 2016, ONCOTARGET, V7, P41691, DOI 10.18632/oncotarget.9541	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220670	10.1371/journal.pone.0220670	http://dx.doi.org/10.1371/journal.pone.0220670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369639	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900079
J	MacRae, ER; Clasen, T; Dasmohapatra, M; Caruso, BA				MacRae, Elizabeth R.; Clasen, Thomas; Dasmohapatra, Munmun; Caruso, Bethany A.			'It's like a burden on the head': Redefining adequate menstrual hygiene management throughout women's varied life stages in Odisha, India	PLOS ONE			English	Article							SANITATION EXPERIENCES; HEALTH; GIRLS; SCHOOLS	There has been growing recognition of menstrual hygiene management (MHM) as a significant public health issue. However, research has predominately focused on the experiences of adolescent girls in school settings. The purpose of this research is to examine detailed accounts of menstruation for women in rural Odisha, India at various life stages with a view toward improving international monitoring of MHM. Focus group discussions and in-depth interviews were conducted to understand women's experiences of menstruation across four life stages (unmarried women, recently married women, married women, and older women). Thematic analysis was used to identify menstruation-related challenges and needs. We found women voiced needs that aligned with those captured by the WHO/UNICEF Joint Monitoring Programme for Water Supply, Sanitation and Hygiene (JMP) definition for MHM: access to clean materials, privacy for changing materials, soap and water for bathing, and disposal facilities for materials. However, we also found women require materials that are not only clean but comfortable and reliable; soap and water for more than bathing; privacy for the full spectrum of menstruation-related practices, not just when changing; and disposal facilities that are private and safe, not just accessible. Additionally, we identified needs that extend beyond the existing definition: pain management, social support, and an enabling sociocultural environment. Overall, women representing all life stages discussed menstruation challenges, including bathing, pain, and washing, drying, and storing cloth materials. Cloth management challenges were most acute for unmarried and recently married women, who were concerned that practices could reveal their menstrual status and harm their reputations, thus informing their preference for disposable materials, if attainable. We propose a revised definition of adequate MHM for this population that more comprehensively captures their needs. This definition may also prove useful for other populations, future research, creating measures of assessment, and guiding interventions and program priorities.	[MacRae, Elizabeth R.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Clasen, Thomas; Caruso, Bethany A.] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Clasen, Thomas; Dasmohapatra, Munmun] London Sch Hyg & Trop Med, London, England	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; University of London; London School of Hygiene & Tropical Medicine	MacRae, ER (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	lizzy.macrae@gmail.com		Caruso, Bethany/0000-0001-9738-9857	Bill & Melinda Gates Foundation (BMGF); NIH/NIGMS Institutional Research and Academic Career Development Award (IRACDA) [5K12-GM000680-18]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000680] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); NIH/NIGMS Institutional Research and Academic Career Development Award (IRACDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was made possible with funding from the Bill & Melinda Gates Foundation (BMGF). The BMGF had no role in research design, data collection, analysis, interpretation of findings or the decision to submit this article. BAC was funded in part by the NIH/NIGMS Institutional Research and Academic Career Development Award (IRACDA), 5K12-GM000680-18. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MU, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015508; Alexander KT, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081682; Baker KK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188234; Borgatti SP., 1999, ELICITATION TECHNIQU, P15; Caruso B, 2013, WASH SCH EMPOWERS GI; Caruso BA, 2018, SSM-POPUL HLTH, V5, P257, DOI 10.1016/j.ssmph.2018.06.005; Caruso BA, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000414; Caruso BA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070755; Chandra-Mouli V, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0293-6; Clasen T, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-7; Crawford M, 2014, CULT HEALTH SEX, V16, P426, DOI 10.1080/13691058.2014.887147; Crofts T, 2012, J WATER SANIT HYG DE, V2, P50, DOI 10.2166/washdev.2012.067; Das P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130777; Ellis A., 2016, Waterlines, V35, P306, DOI 10.3362/1756-3488.2016.022; Farage MA., 2011, EXPERT REV OBSTET GY, V6, P127, DOI [10.1586/eog.11.1, DOI 10.1586/EOG.11.1, DOI 10.1586/eog.11.1]; Girod C, 2017, J URBAN HEALTH, V94, P835, DOI 10.1007/s11524-017-0189-3; Haver J, 2013, WASH SCH EMPOWERS GI; Hennegan J, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002803; Hennegan J, 2018, REPROD HEALTH MATTER, V26, DOI 10.1080/09688080.2018.1484220; Hennegan J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15050905; Hennegan J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012596; Hennink MM, 2007, INTERNATIONAL FOCUS GROUP RESEARCH: A HANDBOOK FOR THE HEALTH AND SOCIAL SCIENCES, P1, DOI 10.1017/CBO9780511619458; Hoffmann DE, 2001, J LAW MED ETHICS, V29, P13, DOI 10.1111/j.1748-720X.2001.tb00037.x; Hulland KRS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141883; JMP, 2012, M REP JMP POST 2015; Joshi D, 2011, ENVIRON URBAN, V23, P91, DOI 10.1177/0956247811398602; Kaur R, 2018, J ENV PUBLIC HLTH, V2018, P9; Khanna A, 2005, J HEALTH MANAG, V7, P91, DOI 10.1177/097206340400700103; Kumar A, 2011, SOC WORK PUBLIC HLTH, V26, P594, DOI 10.1080/19371918.2010.525144; Long J., 2013, WASH SCH EMPOWERS GI; Long J. L., 2015, Waterlines, V34, P68, DOI 10.3362/1756-3488.2015.007; Loughnan L., 2016, Waterlines, V35, P228, DOI 10.3362/1756-3488.2016.019; Mahon T., 2015, Waterlines, V34, P7, DOI 10.3362/1756-3488.2015.002; Mahon T., 2010, Gender and Development, V18, P99, DOI 10.1080/13552071003600083; Mason L., 2015, Waterlines, V34, P15, DOI 10.3362/1756-3488.2015.003; Mason L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079132; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Oruko K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144321; Phillips-Howard PA, 2015, J WOMENS HLTH, V24; Phillips-Howard PA, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.33032; Phillips-Howard PA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013229; Routray P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178042; Routray P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2206-3; Sahoo KC, 2015, SOC SCI MED, V139, P80, DOI 10.1016/j.socscimed.2015.06.031; Schmitt ML, 2018, WATER-SUI, V10, DOI 10.3390/w10091193; Schmitt ML, 2017, CONFL HEALTH, V11, DOI 10.1186/s13031-017-0121-1; Sclar GD, 2018, SOC SCI MED, V217, P121, DOI 10.1016/j.socscimed.2018.09.016; Sommer M., 2016, Waterlines, V35, P245, DOI 10.3362/1756-3488.2016.024; Sommer M., 2018, J INT HUMANITARIAN A, V3, P6, DOI [10.1186/S41018-018-0034-7, DOI 10.1186/S41018-018-0034-7, 10.1186/s41018-018-0034-7]; Sommer M, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000405; Sommer M, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0379-8; Sommer M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001962; Sommer M, 2015, COMPARE, V45, P589, DOI 10.1080/03057925.2013.871399; Sommer M, 2015, AM J PUBLIC HEALTH, V105, P1302, DOI 10.2105/AJPH.2014.302525; Sommer M, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0009-8; Sommer M, 2013, J WATER SANIT HYG DE, V3, P283, DOI 10.2166/washdev.2013.101; Sommer M, 2013, AM J PUBLIC HEALTH, V103, P1556, DOI 10.2105/AJPH.2013.301374; Sommer M, 2010, J ADOLESCENCE, V33, P521, DOI 10.1016/j.adolescence.2009.03.008; Sumpter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062004; Thakur H, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00072; Trinies V, 2015, WATERLINES, V34; UNICEF, 2015, WASH SCH EMP GIRLS E; UNICEF, 2014, WASH SCH EMP GIRLS E; UNICEF Columbia University, 2014, MHM 10 ADV MHM AG WA; UNICEF Columbia University, 2014, WASH SCH EMP GIRLS E; UNICEF University E, 2013, WASH SCH EMP GIRLS E; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290; VanLeeuwen C, 2018, INT J WOMENS HEALTH, V10, P169, DOI 10.2147/IJWH.S135587; WB, 2016, OD POV GROWTH IN IND; WB, 2016, OD GEND IND STAT BRE; Wilson E, 2018, LANCET CHILD ADOLESC, V2, pE17, DOI 10.1016/S2352-4642(18)30209-8	71	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220114	10.1371/journal.pone.0220114	http://dx.doi.org/10.1371/journal.pone.0220114			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369595	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000484987900024
J	Ruhl, JB; Posner, SM; Ricketts, TH				Ruhl, J. B.; Posner, Stephen M.; Ricketts, Taylor H.			Engaging policy in science writing: Patterns and strategies	PLOS ONE			English	Article								Many scientific researchers aspire to engage policy in their writing, but translating scientific research and findings into policy discussion often requires an understanding of the institutional complexities of legal and policy processes and actors. To examine how researchers have undertaken that challenge, we developed a set of metrics and applied them to articles published in one of the principal academic publication venues for science and policy-Science magazine's Policy Forum. We reviewed each Policy Forum article published over a five-year period (2011-15), 220 in all. For each article, we assessed the level of policy content based on presence of a stated policy proposal or position and identification of the relevant policy actors and actions, and recorded attributes such as field of science, field of policy, number of references to legal and policy sources, number of authors from law and policy institutions, and number of citations. We find that a handful of science fields dominate publication frequency, but that all fields have produced publications with high policy engagement. Of the attributes, number of references to law and policy sources is correlated positively with level of engagement, whereas number of law and policy authors was fairly constant across all depths of engagement. Surprisingly, level of policy engagement was negatively correlated with the number of citations an article subsequently received. We offer possible explanations for these results and thoughts for authors, editors, and research institutions interested in facilitating robust engagement of policy in scientific writing.	[Ruhl, J. B.] Vanderbilt Univ, Law Sch, 221 Kirkland Hall, Nashville, TN 37235 USA; [Posner, Stephen M.] COMPASS, Silver Spring, MD USA; [Posner, Stephen M.; Ricketts, Taylor H.] Univ Vermont, Gund Inst Environm, Burlington, VT USA; [Ricketts, Taylor H.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA	Vanderbilt University; University of Vermont; University of Vermont	Ruhl, JB (corresponding author), Vanderbilt Univ, Law Sch, 221 Kirkland Hall, Nashville, TN 37235 USA.	jb.ruhl@vanderbilt.edu		Ruhl, J.B./0000-0003-3866-733X				Arnaud-Haond S, 2011, SCIENCE, V331, P1521, DOI 10.1126/science.1200783; Bednarek AT, 2016, SCI PUBL POLICY, V43, P291, DOI 10.1093/scipol/scv008; Boswell C, 2017, PALGR COMMUN, V3, DOI 10.1057/s41599-017-0042-z; Brandt AR, 2014, SCIENCE, V343, P733, DOI 10.1126/science.1247045; Cvitanovic C, 2016, J ENVIRON MANAGE, V183, P864, DOI 10.1016/j.jenvman.2016.09.038; GIERYN TF, 1983, AM SOCIOL REV, V48, P781, DOI 10.2307/2095325; Guzman J, 2015, SCIENCE, V347, P606, DOI 10.1126/science.aaa0201; Kennel C, 2014, SCIENCE, V343, P140, DOI 10.1126/science.1244231; King G, 2017, SCIENCE, V358, P776, DOI 10.1126/science.aao1100; Lacetera N, 2013, SCIENCE, V340, P927, DOI 10.1126/science.1232280; Malakoff D, 2017, SCIENCE, V355, P562, DOI 10.1126/science.355.6325.562; Marston G., 2003, DRAWING BOARD AUST R, V3, P143; Michel-Kerjan E, 2011, SCIENCE, V333, P408, DOI 10.1126/science.1202616; Penfield T, 2014, RES EVALUAT, V23, P21, DOI 10.1093/reseval/rvt021; Pielke R. A, 2013, HONEST BROKER MAKING; Posner SM, 2019, ENVIRON SCI POLICY, V92, P141, DOI 10.1016/j.envsci.2018.11.006; Reed M. S., 2018, RES ALL, V2, P143, DOI DOI 10.18546/RFA.02.1.13; Reed MS, 2018, EVID POLICY, V14, P431, DOI 10.1332/174426418X15326967547242; Singh GG, 2014, FRONT ECOL ENVIRON, V12, P161, DOI 10.1890/130011; Sutherland WJ, 2013, PLOS ONE, V7; Vardon M, 2016, ECOL ECON, V124, P145, DOI 10.1016/j.ecolecon.2016.01.021	21	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220497	10.1371/journal.pone.0220497	http://dx.doi.org/10.1371/journal.pone.0220497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369620	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900059
J	Vickman, O; Erives, A				Vickman, Oliver; Erives, Albert			Episodic evolution of a eukaryotic NADK repertoire of ancient provenance	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; ORGANELLES; MRBAYES; KINASE; SPORULATION; MITOSOMES; BIOLOGY; ORIGIN; MODEL	NAD kinase (NADK) is the sole enzyme that phosphorylates nicotinamide adenine dinucleotide (NAD+/NADH) into NADP+/NADPH, which provides the chemical reducing power in anabolic (biosynthetic) pathways. While prokaryotes typically encode a single NADK, eukaryotes encode multiple NADKs. How these different NADK genes are all related to each other and those of prokaryotes is not known. Here we conduct phylogenetic analysis of NADK genes and identify major clade-defining patterns of NADK evolution. First, almost all eukaryotic NADK genes belong to one of two ancient eukaryotic sister clades corresponding to cytosolic ("cyto") and mitochondrial ("mito") clades. Secondly, we find that the cyto-clade NADK gene is duplicated in connection with loss of the mito-clade NADK gene in several eukaryotic clades or with acquisition of plastids in Archaeplastida. Thirdly, we find that horizontal gene transfers from proteobacteria have replaced mitochondrial NADK genes in only a few rare cases. Last, we find that the eukaryotic cyto and mito paralogs are unrelated to independent duplications that occurred in sporulating bacteria, once in mycelial Actinobacteria and once in aerobic endospore-forming Firmicutes. Altogether these findings show that the eukaryotic NADK gene repertoire is ancient and evolves episodically with major evolutionary transitions.	[Vickman, Oliver; Erives, Albert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Erives, A (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	albert-erives@uiowa.edu		Vickman, Oliver/0000-0002-1221-8408				Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1; Ando T, 2011, J BIOL CHEM, V286, P29984, DOI 10.1074/jbc.M111.249011; Bergey DH., 2001, BERGEYS MANUAL SYSTE; Blaxter M, 2015, PARASITOLOGY, V142, pS26, DOI 10.1017/S0031182014000791; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Chai MF, 2005, PLANT MOL BIOL, V59, P553, DOI 10.1007/s11103-005-6802-y; Chandra G, 2014, FEMS MICROBIOL REV, V38, P345, DOI 10.1111/1574-6976.12047; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Erives AJ, 2015, DEV GENES EVOL, V225, P259, DOI 10.1007/s00427-015-0508-1; Fontecilla-Camps JC, 2019, ANGEW CHEM INT EDIT, V58, P42, DOI 10.1002/anie.201808438; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Hashida SN, 2009, ANN BOT-LONDON, V103, P819, DOI 10.1093/aob/mcp019; Huang KY, 2019, J MICROBIOL IMMUNOL, V52, P630, DOI 10.1016/j.jmii.2017.10.005; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Kawai S, 2001, EUR J BIOCHEM, V268, P4359, DOI 10.1046/j.1432-1327.2001.02358.x; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lerner F, 2001, BIOCHEM BIOPH RES CO, V288, P69, DOI 10.1006/bbrc.2001.5735; Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7; Li BB, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00379; Li J, 2009, PROTEOMICS, V9, P4539, DOI 10.1002/pmic.200900101; Ling C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060667; Makiuchi T, 2014, BIOCHIMIE, V100, P3, DOI 10.1016/j.biochi.2013.11.018; Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5; Martincova E, 2015, MOL CELL BIOL, V35, P2864, DOI 10.1128/MCB.00448-15; MCGUINNESS ET, 1985, INT J BIOCHEM, V17, P1, DOI 10.1016/0020-711X(85)90079-5; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Tocheva EI, 2016, NAT REV MICROBIOL, V14, P535, DOI 10.1038/nrmicro.2016.85; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Waller JC, 2010, PLANTA, V231, P305, DOI 10.1007/s00425-009-1047-7; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep07949; Weiss MC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.116, 10.1038/nmicrobiol.2016.116]; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Williams CF, 2013, TRENDS PARASITOL, V29, P311, DOI 10.1016/j.pt.2013.04.004; Yague P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086296; Yague P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060665; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Zhang R, 2015, J CELL PHYSIOL, V230, P1697, DOI 10.1002/jcp.24926	49	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220447	10.1371/journal.pone.0220447	http://dx.doi.org/10.1371/journal.pone.0220447			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369599	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900050
J	Ihara, N; Wakaizumi, K; Nishimura, D; Kato, J; Yamada, T; Suzuki, T; Hashiguchi, S; Terasawa, Y; Kosugi, S; Morisaki, H				Ihara, Naho; Wakaizumi, Kenta; Nishimura, Daisuke; Kato, Jungo; Yamada, Takashige; Suzuki, Takeshi; Hashiguchi, Saori; Terasawa, Yuri; Kosugi, Shizuko; Morisaki, Hiroshi			Aberrant resting-state functional connectivity of the dorsolateral prefrontal cortex to the anterior insula and its association with fear avoidance belief in chronic neck pain patients	PLOS ONE			English	Article							LOW-BACK-PAIN; SURFACE-BASED ANALYSIS; PSYCHOMETRIC PROPERTIES; TAMPA SCALE; POSTTRAUMATIC STRESS; POSTERIOR CINGULATE; GLOBAL BURDEN; DISABILITY; KINESIOPHOBIA; ACTIVATION	Chronic neck pain (CNP), a global health problem, involves a large amount of psychological and socioeconomic burdens. Not only physical causes but also behavioral disorders such as a fear-avoidance belief (FAB) can associate with the chronicity of neck pain. However, functional brain mechanisms underlying CNP and its related behavioral disorders remain unknown. The aim of the current resting-state functional magnetic resonance imaging (fMRI) study was to explore how the functional brain networks differed between CNP patients and age- and sex-matched healthy, pain-free controls (HCs). We also investigated whether these possible brain network changes in CNP patients were associated with fear avoidance belief (FAB) and the intensity of pain. We analyzed the resting-state fMRI data of 20 CNP patients and 20 HCs. FAB and the intensity of pain were assessed by Tampa Scale for Kinesiophobia (TSK) and Visual Analog Scale (VAS) of pain. The whole brain analysis showed that CNP patients had significant different functional connectivity (FC) compared with HCs, and the right dorsolateral prefrontal cortex (DLPFC) was a core hub of these altered functional networks. Furthermore, general linear model analyses showed that, in CNP patients, the increased FC between the right DLPFC and the right anterior insular cortex (aIC) significantly associated with increased TSK (p = 0.01, statistical significance after Bonferroni correction: p<0.025), and the FC between the right DLPFC and dorsal posterior cingulate cortex had a trend of inverse association with VAS (p = 0.04). Our findings suggest that aberrant FCs between the right DLPFC and aIC associated with CNP and its related FAB.	[Ihara, Naho; Wakaizumi, Kenta; Nishimura, Daisuke; Kato, Jungo; Yamada, Takashige; Suzuki, Takeshi; Hashiguchi, Saori; Kosugi, Shizuko; Morisaki, Hiroshi] Keio Univ, Dept Anesthesiol, Sch Med, Tokyo, Japan; [Terasawa, Yuri] Keio Univ, Dept Psychol, Tokyo, Japan	Keio University; Keio University	Kosugi, S (corresponding author), Keio Univ, Dept Anesthesiol, Sch Med, Tokyo, Japan.	shizuko.kosugi@gmail.com	Terasawa, Yuri/HGA-1834-2022; Wakaizumi, Kenta/AAM-5030-2021	Terasawa, Yuri/0000-0002-2812-0544; Wakaizumi, Kenta/0000-0003-4884-6251	Keio University Academic Development Funds for Multidisciplinary Research2017.	Keio University Academic Development Funds for Multidisciplinary Research2017.	SK received the Keio University Academic Development Funds for Multidisciplinary Research2017.	Andersen TE, 2016, EUR J PAIN, V20, P1241, DOI 10.1002/ejp.848; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Balenzuela Pablo, 2010, Front Neuroinform, V4, P116, DOI 10.3389/fninf.2010.00116; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Boersma K, 2006, EUR J PAIN, V10, P551, DOI 10.1016/j.ejpain.2005.08.004; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Brascher AK, 2016, J NEUROSCI, V36, P5013, DOI 10.1523/JNEUROSCI.1954-15.2016; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Buitenhuis J, 2006, CLIN J PAIN, V22, P272, DOI 10.1097/01.ajp.0000173180.54261.0a; Ceko M, 2015, HUM BRAIN MAPP, V36, P2075, DOI 10.1002/hbm.22757; Chen J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00900; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Cieslik EC, 2013, CEREB CORTEX, V23, P2677, DOI 10.1093/cercor/bhs256; Cottam WJ, 2018, PAIN, V159, P929, DOI 10.1097/j.pain.0000000000001209; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis KD, 2013, J NEUROIMMUNE PHARM, V8, P518, DOI 10.1007/s11481-012-9386-8; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Freund W, 2009, SOMATOSENS MOT RES, V26, P1, DOI 10.1080/08990220902738243; Gu XS, 2012, BRAIN, V135, P2726, DOI 10.1093/brain/aws199; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hashmi JA, 2012, PAIN, V153, P2393, DOI 10.1016/j.pain.2012.08.008; HERSCOVITCH J, 1981, SLEEP, V4, P83, DOI 10.1093/sleep/4.1.83; Hogg-Johnson S, 2009, J MANIP PHYSIOL THER, V32, pS46, DOI 10.1016/j.jmpt.2008.11.010; Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431; Hubbard CS, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0006-14.2014; Karels CH, 2007, J CLIN EPIDEMIOL, V60, P839, DOI 10.1016/j.jclinepi.2006.11.012; Kikuchi N, 2015, J ORTHOP SCI, V20, P985, DOI 10.1007/s00776-015-0751-3; Kobayashi Yoshitaka, 2009, Spine (Phila Pa 1976), V34, P2431, DOI 10.1097/BRS.0b013e3181b1fb76; Kregel J, 2015, SEMIN ARTHRITIS RHEU, V45, P229, DOI 10.1016/j.semarthrit.2015.05.002; Lee J, 2018, ARTHRITIS RHEUMATOL, V70, P1308, DOI 10.1002/art.40507; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Linnman C, 2010, PAIN, V149, P64, DOI 10.1016/j.pain.2010.01.008; Lloyd DM, 2016, J PAIN, V17, P577, DOI 10.1016/j.jpain.2016.01.470; Lloyd DM, 2014, PSYCHOSOM MED, V76, P413, DOI 10.1097/PSY.0000000000000076; Loggia ML, 2013, PAIN, V154, P24, DOI 10.1016/j.pain.2012.07.029; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lu CB, 2016, NEUROSCI BULL, V32, P191, DOI 10.1007/s12264-016-0016-y; Mansour A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34853; Meier ML, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00386; Meier ML, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000601; Michel V, 2012, PATTERN RECOGN, V45, P2041, DOI 10.1016/j.patcog.2011.04.006; Mintken PE, 2010, ARCH PHYS MED REHAB, V91, P1128, DOI 10.1016/j.apmr.2010.04.009; Motomura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056578; Nederhand MJ, 2004, ARCH PHYS MED REHAB, V85, P496, DOI 10.1016/j.apmr.2003.06.019; Ng SK, 2018, CLIN J PAIN, V34, P237, DOI 10.1097/AJP.0000000000000534; Pedler A, 2016, PAIN, V157, P1645, DOI 10.1097/j.pain.0000000000000564; Raij TT, 2009, HUM BRAIN MAPP, V30, P2890, DOI 10.1002/hbm.20716; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Seminowicz DA, 2006, PAIN, V120, P297, DOI 10.1016/j.pain.2005.11.008; Seminowicz DA, 2007, J NEUROPHYSIOL, V97, P3651, DOI 10.1152/jn.01210.2006; Seminowicz DA, 2011, J NEUROSCI, V31, P7540, DOI 10.1523/JNEUROSCI.5280-10.2011; Smallwood RF, 2013, J PAIN, V14, P663, DOI 10.1016/j.jpain.2013.03.001; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wakaizumi K, 2017, J ANESTH, V31, P255, DOI 10.1007/s00540-016-2303-1; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yu CX, 2017, J INT MED RES, V45, P182, DOI 10.1177/0300060516679345; Zimmermann J, 2018, J NEUROSCI, V38, P9658, DOI 10.1523/JNEUROSCI.0900-18.2018	68	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221023	10.1371/journal.pone.0221023	http://dx.doi.org/10.1371/journal.pone.0221023			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404104	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800047
J	Ioerger, M; Machia, LV; Turk, MA				Ioerger, Michael; Machia, Laura, V; Turk, Margaret A.			Self-other overlap: A unique predictor of willingness to work with people with disability as part of one's career	PLOS ONE			English	Article							MEDICAL-STUDENTS ATTITUDES; PERSPECTIVE-TAKING; MODERATING ROLE; ALTRUISM; EMPATHY; MOTIVATIONS; PROFESSIONALS; CLOSENESS; INGROUP; PERCEPTIONS	Background People with disability (PWD) often rely on others, both for direct support and for the creation of enabling environments to meet their needs. This need makes it crucial for professionals to be willing to work with PWD, and for people to pursue careers that focus on supporting PWD. Objectives To explore self-other overlap as a unique predictor of willingness to work with PWD as part of one's career, using three studies. Methods Studies 1 and 2 used cross-sectional surveys of college undergraduates to explore: 1. whether an association between self-other overlap and willingness to work with PWD exists, and 2. whether self-other overlap is a unique predictor, controlling for attitudes and empathy. Study 3 investigated whether self-other overlap is associated with the groups with whom the students indicated they want (and do not want) to work as part of their career. Results Across the three studies, self-other overlap was uniquely associated with students' willingness to work with PWD as part of one's profession, even when controlling for attitudes and empathy. Conclusions Self-other overlap may be an important additional factor to take into consideration when developing interventions targeted toward promoting working with PWD.	[Ioerger, Michael; Machia, Laura, V] Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA; [Ioerger, Michael; Turk, Margaret A.] SUNY Upstate Med Univ, Dept Phys Med & Rehabil, Syracuse, NY 13210 USA	Syracuse University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Ioerger, M (corresponding author), Syracuse Univ, Dept Psychol, Syracuse, NY 13244 USA.; Ioerger, M (corresponding author), SUNY Upstate Med Univ, Dept Phys Med & Rehabil, Syracuse, NY 13210 USA.	michael.ioerger@osumc.edu	Ioerger, Michael/G-5074-2017	Ioerger, Michael/0000-0002-2282-4022; Machia, Laura/0000-0001-8725-1395	NCBDD CDC HHS [U19 DD001218] Funding Source: Medline	NCBDD CDC HHS		Ajuwon PM, 2015, INT J DISABIL HUM DE, V14, P131, DOI DOI 10.1515/IJDHD-2014-0017; Antonak R.F., 1988, MEASUREMENT ATTITUDE; Antonak R. F., 1981, DEV PSYCHOMETRIC ANA; Antonak RF, 2000, DISABIL REHABIL, V22, P211; Aron A, 1999, SOC COGNITION, V17, P140, DOI 10.1521/soco.1999.17.2.140; Aron A, 1997, PERS SOC PSYCHOL B, V23, P363, DOI 10.1177/0146167297234003; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; ARON A, 1991, J PERS SOC PSYCHOL, V60, P241, DOI 10.1037/0022-3514.60.2.241; Batson CD, 2007, J PERS SOC PSYCHOL, V93, P65, DOI 10.1037/0022-3514.93.1.65; Batson CD, 1997, J PERS SOC PSYCHOL, V73, P495, DOI 10.1037/0022-3514.73.3.495; Batson CD, 1997, J PERS SOC PSYCHOL, V73, P517; Batson CD, 1997, J PERS SOC PSYCHOL, V72, P105, DOI 10.1037/0022-3514.72.1.105; Branas-Garza P, 2018, ECON LETT, V170, P19, DOI 10.1016/j.econlet.2018.05.022; BURNSTEIN E, 1994, J PERS SOC PSYCHOL, V67, P773, DOI 10.1037/0022-3514.67.5.773; Byron M, 2000, J ROY SOC MED, V93, P397, DOI 10.1177/014107680009300801; Cameron L, 2006, CHILD DEV, V77, P1208, DOI 10.1111/j.1467-8624.2006.00929.x; Capraro V, 2018, JUDGM DECIS MAK, V13, P99; Chen HN, 2010, COMMUN STAT-SIMUL C, V39, P860, DOI 10.1080/03610911003650383; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Clary EG, 1998, J PERS SOC PSYCHOL, V74, P1516, DOI 10.1037/0022-3514.74.6.1516; Clary EG, 1999, CURR DIR PSYCHOL SCI, V8, P156, DOI 10.1111/1467-8721.00037; COKE JS, 1978, J PERS SOC PSYCHOL, V36, P752, DOI 10.1037/0022-3514.36.7.752; Coret A, 2018, TEACH LEARN MED, V30, P317, DOI 10.1080/10401334.2017.1398653; Crisp RJ, 2009, AM PSYCHOL, V64, P231, DOI 10.1037/a0014718; Crotty M, 2000, MED EDUC, V34, P659, DOI 10.1046/j.1365-2923.2000.00621.x; Cummings SM, 2005, EDUC GERONTOL, V31, P643, DOI 10.1080/03601270591003382; Cunningham M.R., 1986, HUMBOLDT J SOCIAL RE, V13, P35; Curl AL, 2005, J SOC WORK EDUC, V41, P393, DOI 10.5175/JSWE.2005.200303100; DARLEY JM, 1973, J PERS SOC PSYCHOL, V27, P100, DOI 10.1037/h0034449; Drum CE., 2009, DISABILITY PUBLIC HL; Fraley B, 2004, PERS RELATIONSHIP, V11, P61, DOI 10.1111/j.1475-6811.2004.00071.x; Fredheim T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002283; Iezzoni LI, 2012, DISABIL HEALTH J, V5, P136, DOI 10.1016/j.dhjo.2012.03.003; Karl R, 2013, INTELLECT DEV DISAB, V51, P237, DOI 10.1352/1934-9556-51.4.237; Mallen MJ, 2003, PSYCHOTHERAPY, V40, P155, DOI 10.1037/0033-3204.40.1-2.155; Maner JK, 2002, PERS SOC PSYCHOL B, V28, P1601, DOI 10.1177/014616702237586; Maner JK, 2007, EUR J SOC PSYCHOL, V37, P347, DOI 10.1002/ejsp.364; Medina-Walpole A, 2012, TEACH LEARN MED, V24, P117, DOI 10.1080/10401334.2012.664533; Minihan PM, 2011, ACAD MED, V86, P1171, DOI 10.1097/ACM.0b013e3182264a25; Morrison EH, 2008, FAM MED, V40, P645; Myers MW, 2014, MOTIV EMOTION, V38, P224, DOI 10.1007/s11031-013-9377-y; Neuberg SL, 1997, J PERS SOC PSYCHOL, V73, P510; Omoto AM, 2016, J SOC PSYCHOL, V156, P272, DOI 10.1080/00224545.2015.1105777; OMOTO AM, 1995, J PERS SOC PSYCHOL, V68, P671, DOI 10.1037/0022-3514.68.4.671; Omoto AM, 2002, AM BEHAV SCI, V45, P846, DOI 10.1177/0002764202045005007; Otten S, 2006, PERS SOC PSYCHOL B, V32, P957, DOI 10.1177/0146167206287254; Oveis C, 2010, J PERS SOC PSYCHOL, V98, P618, DOI 10.1037/a0017628; PARIS MJ, 1993, ARCH PHYS MED REHAB, V74, P818, DOI 10.1016/0003-9993(93)90007-W; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; RUSHTON JP, 1989, BEHAV BRAIN SCI, V12, P503, DOI 10.1017/S0140525X00057320; Ryan TA, 2014, RES DEV DISABIL, V35, P2316, DOI 10.1016/j.ridd.2014.05.019; Sahin H, 2010, J CLIN NURS, V19, P2271, DOI 10.1111/j.1365-2702.2009.03088.x; Satchidanand N, 2012, AM J PHYS MED REHAB, V91, P533, DOI 10.1097/PHM.0b013e3182555ea4; Schubert TW, 2002, SELF IDENTITY, V1, P353, DOI 10.1080/152988602760328012; Shakespeare T, 2009, LANCET, V374, P1815, DOI 10.1016/S0140-6736(09)62050-X; Smith DL, 2009, DISABIL HEALTH J, V2, P206, DOI 10.1016/j.dhjo.2009.06.002; Sprecher S, 2013, J EXP SOC PSYCHOL, V49, P860, DOI 10.1016/j.jesp.2013.03.017; Spreng RN, 2009, J PERS ASSESS, V91, P62, DOI 10.1080/00223890802484381; Sturmer S, 2006, PERS SOC PSYCHOL B, V32, P943, DOI 10.1177/0146167206287363; Sturmer S, 2005, J PERS SOC PSYCHOL, V88, P532, DOI 10.1037/0022-3514.88.3.532; Symons AB, 2014, DISABIL HEALTH J, V7, P88, DOI 10.1016/j.dhjo.2013.08.006; Symons AB, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-78; Tappin B, 2018, J EXP SOC PSYCHOL, V79, P64, DOI 10.1016/j.jesp.2018.06.005; Tervo RC, 2004, CLIN REHABIL, V18, P908, DOI 10.1191/0269215504cr820oa; Tervo RC, 2002, ARCH PHYS MED REHAB, V83, P1537, DOI 10.1053/apmr.2002.34620; Tropp LR, 2001, PERS SOC PSYCHOL B, V27, P585, DOI 10.1177/0146167201275007; Vezzali L, 2012, PSYCHOL SCHOOLS, V49, P148, DOI 10.1002/pits.20621; Wilkinson J, 2012, INTELLECT DEV DISAB, V50, P243, DOI 10.1352/1934-9556-50.3.243; World Health Organization, 2017, DISABILITIES; YUKER HE, 1987, REHABIL PSYCHOL, V32, P145, DOI 10.1037//0090-5550.32.3.145	72	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220722	10.1371/journal.pone.0220722	http://dx.doi.org/10.1371/journal.pone.0220722			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404107	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800028
J	Liang, D; McHugh, KM; Brophy, PD; Shaikh, N; Manak, JR; Andrews, P; Hakker, I; Wang, ZH; Schwaderer, AL; Hains, DS				Liang, Dong; McHugh, Kirk M.; Brophy, Pat D.; Shaikh, Nader; Manak, J. Robert; Andrews, Peter; Hakker, Inessa; Wang, Zihua; Schwaderer, Andrew L.; Hains, David S.			DNA copy number variations in children with vesicoureteral reflux and urinary tract infections	PLOS ONE			English	Article							GENOME SCAN; KIDNEY; LINKAGE; GENE; ASSOCIATION; MUTATIONS; ANOMALIES; TYPE-1; FAMILY; LOCUS	Vesicoureteral reflux (VUR) is a complex, heritable disorder. Genome-wide linkage analyses of families affected by VUR have revealed multiple genomic loci linked to VUR. These loci normally harbor a number of genes whose biologically functional variant is yet to be identified. DNA copy number variations (CNVs) have not been extensively studied at high resolution in VUR patients. In this study, we performed array comparative genomic hybridization (aCGH) on a cohort of patients with a history of both VUR and urinary tract infection (UTI) with the objective of identifying genetic variations responsible for VUR and/or UTI susceptibility. UTI/VUR-associated CNVs were identified by aCGH results from the 192 Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) patients compared to 683 controls. Rare, large CNVs that are likely pathogenic and lead to VUR development were identified using stringent analysis criteria. Because UTI is a common affliction with multiple risk factors, we utilized standard analysis to identify potential disease-modifying CNVs that can contribute to UTI risk. Gene ontology analysis identified that CNVs in innate immunity and development genes were enriched in RIVUR patients. CNVs affecting innate immune genes may contribute to UTI susceptibility in VUR patients and may provide the first step in assisting clinical medicine in determining adverse outcome risk in children with VUR.	[Liang, Dong; Schwaderer, Andrew L.; Hains, David S.] Indiana Univ, Dept Pediat, Indianapolis, IN 46204 USA; [Liang, Dong; Schwaderer, Andrew L.; Hains, David S.] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [McHugh, Kirk M.] Ohio State Univ, Div Anat, Columbus, OH 43210 USA; [Brophy, Pat D.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA; [Shaikh, Nader] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15260 USA; [Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Manak, J. Robert] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Andrews, Peter; Hakker, Inessa; Wang, Zihua] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Schwaderer, Andrew L.; Hains, David S.] Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN 46290 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; University System of Ohio; Ohio State University; University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Iowa; Cold Spring Harbor Laboratory; Indiana University System; James Whitcomb Riley Hospital Children	Schwaderer, AL; Hains, DS (corresponding author), Indiana Univ, Dept Pediat, Indianapolis, IN 46204 USA.; Schwaderer, AL; Hains, DS (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.; Schwaderer, AL; Hains, DS (corresponding author), Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN 46290 USA.	schwadea@iu.edu; dhains@iu.edu	Wang, Zhiquan/HHS-6768-2022; Hains, David/AAR-1112-2020	Liang, Dong/0000-0003-2494-1537; Manak, John/0000-0002-6562-7694	National Institutes of Health (NIH) [1RC4DK090937-01];  [1R01DK106286-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106286] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.L.S., P.D.B., K.M.M., N.S., J.R.M., and D.S.H. were all funded by National Institutes of Health (NIH) grant 1RC4DK090937-01. A.L.S. and D.S.H are also supported by 1R01DK106286-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A.L.S., P.D.B., K.M.M., N.S., J.R.M., and D.S.H. were all funded by National Institutes of Health (NIH) grant 1RC4DK090937-01. A.L.S. and D.S.H are also supported by 1R01DK106286-01. D.S.H. and A.L.S. initiated this project at Nationwide Children's Hospital in Columbus, OH. D. L. and D.S.H. also continued work on this project at Le Bonheur Children's Hospital in Memphis, TN.	Briggs CE, 2010, EUR J HUM GENET, V18, P245, DOI 10.1038/ejhg.2009.142; Brophy PD, 2013, HUM GENET, V132, P1339, DOI 10.1007/s00439-013-1338-8; Carpenter MA, 2013, PEDIATRICS, V132, pE34, DOI 10.1542/peds.2012-2301; Carvas F, 2010, CURR OPIN UROL, V20, P336, DOI 10.1097/MOU.0b013e328339b739; Chauvet V, 2002, AM J PATHOL, V160, P973, DOI 10.1016/S0002-9440(10)64919-X; Colonna M, 2007, NAT IMMUNOL, V8, P554, DOI 10.1038/ni0607-554; Conte ML, 2008, PEDIATR NEPHROL, V23, P587, DOI 10.1007/s00467-007-0675-z; Cordell HJ, 2010, J AM SOC NEPHROL, V21, P113, DOI 10.1681/ASN.2009060624; Darlow JM, 2014, MOL GENET GENOM MED, V2, P7, DOI 10.1002/mgg3.22; Feather SA, 2000, AM J HUM GENET, V66, P1420, DOI 10.1086/302864; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Gbadegesin RA, 2013, J AM SOC NEPHROL, V24, P1313, DOI 10.1681/ASN.2012121148; Hains DS, 2010, J UROLOGY, V183, P2077, DOI 10.1016/j.juro.2009.12.095; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Hoberman A, 2014, NEW ENGL J MED, V370, P2367, DOI 10.1056/NEJMoa1401811; Hollox EJ, 2014, HUM GENET, V133, P1217, DOI 10.1007/s00439-014-1457-x; Kamath BM, 2012, AM J MED GENET A, V158A, P85, DOI 10.1002/ajmg.a.34369; Kelly H, 2007, J MED GENET, V44, P710, DOI 10.1136/jmg.2007.051086; Lee WC, 2010, AM J PHYSIOL-RENAL, V299, pF740, DOI 10.1152/ajprenal.00148.2010; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Madsen J, 2003, EUR J IMMUNOL, V33, P2327, DOI 10.1002/eji.200323972; Malaviya R, 2004, IMMUNOL LETT, V91, P103, DOI 10.1016/j.imlet.2003.10.005; McCabe D, 2002, J BIOL CHEM, V277, P27477, DOI 10.1074/jbc.M201586200; Neirijnck Y, 2018, KIDNEY INT, V93, P1142, DOI 10.1016/j.kint.2017.11.026; Nino F, 2016, CURR GENOMICS, V17, P70, DOI 10.2174/1389202916666151014223507; Prontera P, 2006, GENET COUNSEL, V17, P407; Puri P, 2011, NAT REV UROL, V8, P539, DOI 10.1038/nrurol.2011.113; Sanna-Cherchi S, 2005, J AM SOC NEPHROL, V16, P1781, DOI 10.1681/ASN.2004121034; Sanna-Cherchi S, 2013, NEW ENGL J MED, V369, P621, DOI 10.1056/NEJMoa1214479; Schwaderer AL, 2016, J AM SOC NEPHROL, V27, P3175, DOI 10.1681/ASN.2015060700; Sencan A, 2014, J PEDIATR UROL, V10, P1008, DOI 10.1016/j.jpurol.2014.04.001; Sharma M, 2018, CELL SIGNAL, V47, P52, DOI 10.1016/j.cellsig.2018.03.004; Shen YP, 2009, CLIN CHEM, V55, P659, DOI 10.1373/clinchem.2008.112821; Shirley MD, 2012, HUM MUTAT, V33, P1075, DOI 10.1002/humu.22062; Stromberg N, 2017, EBIOMEDICINE, V26, P38, DOI 10.1016/j.ebiom.2017.11.019; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Verbitsky M, 2015, J CLIN INVEST, V125, P2171, DOI 10.1172/JCI80877; Walker KA, 2016, PEDIATR NEPHROL, V31, P885, DOI 10.1007/s00467-015-3151-1; Wang ZH, 2016, GENOME RES, V26, P844, DOI 10.1101/gr.201491.115; Weng PL, 2009, J AM SOC NEPHROL, V20, P1633, DOI 10.1681/ASN.2008111199; Williams G, 2016, PROCEEDINGS OF THE XVII EURALEX INTERNATIONAL CONGRESS, P847; Zhang YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11720-0	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220617	10.1371/journal.pone.0220617	http://dx.doi.org/10.1371/journal.pone.0220617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404082	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000485006800020
J	Zhang, MB; Guo, C; Li, M; Lv, YH; Fan, YD; Wang, ZL				Zhang, Ming-Bo; Guo, Chen; Li, Min; Lv, Yong-Hui; Fan, Yu-Dong; Wang, Zhi-Lu			Comparison of early and delayed invasive strategies in short-medium term among patients with non-ST segment elevation acute coronary syndrome: A systematic review and meta-analysis	PLOS ONE			English	Review							MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; INTERVENTION; RISK; IMMEDIATE; REVASCULARIZATION; ANGIOPLASTY; ANGIOGRAPHY; MORTALITY; TRIAL	Background and objectives An invasive approach is recommended as the treatment of patients with non-ST elevated acute coronary syndromes (NSTE-ACS). However, it remains unclear that the optimal time of angiography and intervention for patients with NSTE-ACS at present. This study was designed to compare the effect of early and delayed invasive strategies on short-medium term prognosis in patients with those. Methods Pubmed, Cochrane Library and Embase were searched up to Dec-30-2018. Randomized clinical trials comparing an early versus a delayed invasive strategy in patients with NSTE-ACS were included. The primary endpoint (all-cause death and recurrent myocardial infarction) and secondary endpoint (major bleeding and recurrent revascularization), as well as composite endpoint were assessed by random or fixed effected meta-analysis with software RevMan 5.3 version after short-medium term follow up. Result A total of six randomized clinical trials involving 4,277 early or delayed invasive strategies patients with NSTE-ACS were included in the meta-analysis. Time to coronary angiography varied from 0.5 to 24 h in the early invasive strategy and from 18.6 to 72 h in the delayed invasive strategy. There was a statistical difference in the primary endpoint of all-cause death among patients with NSTE-ACS between early and delayed invasive strategies (4.6% vs 6%; OR: 0.76; 95% CI: 0.58 to 1.00; P = 0.05; I-2 = 0%), but not for recurrent myocardial infarction (6.0% vs 6.3%; OR: 0.94; 95% CI: 0.55 to 1.61; P = 0.82; I-2 = 60%). The major bleeding in patients with NSTE-ACS was similar between both invasive strategies (2.7% vs 3.1%; OR: 0.88; 95% CI: 0.59 to 1.31; P = 0.54; I-2 = 0%). However, the composite endpoint in the early invasive strategy patients with NSTE-ACS was significantly lower than that of the delayed invasive strategy (10.9% vs 13.9%; OR: 0.76; 95% CI: 0.63 to 0.92; P = 0.006; I-2 = 0%), and the recurrent revascularization between both strategies was just the opposite (8.7% vs 5.9%; OR: 1.5; 95% CI: 1.15 to 1.97; P = 0.003; I-2 = 0%). Conclusion The systematic review and meta-analysis demonstrated that the early invasive strategy had a beneficial trend on all-cause death and significantly reduced the composite endpoint in patients with NSTE-ACS, but increased the rate of revascularization. These data could provide a solution for patients with those.	[Zhang, Ming-Bo; Guo, Chen; Li, Min; Lv, Yong-Hui; Wang, Zhi-Lu] Lanzhou Univ, Med Clin Coll 1, Lanzhou, Gansu, Peoples R China; [Fan, Yu-Dong] Emergency Gen Hosp, Dept Cardiol, Beijing, Peoples R China; [Wang, Zhi-Lu] Lanzhou Univ, Hosp 1, Dept Cardiol, Lanzhou, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Wang, ZL (corresponding author), Lanzhou Univ, Med Clin Coll 1, Lanzhou, Gansu, Peoples R China.; Wang, ZL (corresponding author), Lanzhou Univ, Hosp 1, Dept Cardiol, Lanzhou, Gansu, Peoples R China.	wangzhl@lzu.edu.cn	min, Li/GQQ-2169-2022					Badimon L, 2016, INT J CARDIOL, V222, P1105, DOI 10.1016/j.ijcard.2016.07.205; Badings EA, 2013, EUROINTERVENTION, V9, P54, DOI 10.4244/EIJV9I1A9; Bonello L, 2016, JACC-CARDIOVASC INTE, V9, P2267, DOI 10.1016/j.jcin.2016.09.017; Damman P, 2017, LANCET, V390, P717, DOI 10.1016/S0140-6736(17)31632-X; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fox KAA, 2010, J AM COLL CARDIOL, V55, P2435, DOI 10.1016/j.jacc.2010.03.007; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hochholzer W, 2016, DEUT MED WOCHENSCHR, V141, P782, DOI 10.1055/s-0042-107115; Jobs A, 2017, LANCET, V390, P737, DOI 10.1016/S0140-6736(17)31490-3; Katritsis DG, 2011, EUR HEART J, V32, P32, DOI 10.1093/eurheartj/ehq276; Kim MC, 2018, AM J CARDIOL, V121, P1285, DOI 10.1016/j.amjcard.2018.01.051; Li YD, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00952; Lindholm D, 2017, EUR HEART J, V3, P53, DOI 10.1093/ehjqcco/qcw044; Mahmoud KD, 2014, INT J CARDIOL, V177, P23, DOI 10.1016/j.ijcard.2014.09.057; McManus DD, 2011, AM J MED, V124, P40, DOI 10.1016/j.amjmed.2010.07.023; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Milasinovic D, 2015, ATHEROSCLEROSIS, V241, P48, DOI 10.1016/j.atherosclerosis.2015.04.808; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Oosterwerff EFJ, 2016, NETH HEART J, V24, P173, DOI 10.1007/s12471-016-0803-0; Rajpurohit N, 2013, CATHETER CARDIO INTE, V81, P223, DOI 10.1002/ccd.24439; Reuter PG, 2015, INT J CARDIOL, V182, P414, DOI 10.1016/j.ijcard.2014.12.089; Riezebos RK, 2009, HEART, V95, P807, DOI 10.1136/hrt.2008.154815; Ronner E, 2002, J AM COLL CARDIOL, V39, P1924, DOI 10.1016/S0735-1097(02)01897-1; Sciahbasi A, 2010, CLIN CARDIOL, V33, P650, DOI 10.1002/clc.20785; Stone GW, 2004, AM HEART J, V148, P764, DOI 10.1016/j.ahj.2004.04.036; Tekin K, 2013, KOREAN CIRC J, V43, P725, DOI 10.4070/kcj.2013.43.11.725; Terkelsen CJ, 2005, EUR HEART J, V26, P18, DOI 10.1093/eurheartj/ehi002; Testa L, 2009, AM J CARDIOL, V103, P1622, DOI 10.1016/j.amjcard.2009.03.008; Thiele H, 2012, EUR HEART J, V33, P2035, DOI 10.1093/eurheartj/ehr418	31	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220847	10.1371/journal.pone.0220847	http://dx.doi.org/10.1371/journal.pone.0220847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404097	Green Published, Green Submitted			2022-12-27	WOS:000485006800038
J	Thu, TNP; Hernandez, AI; Costet, N; Patural, H; Pichot, V; Carrault, G; Beuchee, A				Trang Nguyen Phuc Thu; Hernandez, Alfredo I.; Costet, Nathalie; Patural, Hugues; Pichot, Vincent; Carrault, Guy; Beuchee, Alain			Improving methodology in heart rate variability analysis for the premature infants: Impact of the time length	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; POINCARE PLOT; CARDIORESPIRATORY EVENTS; SAMPLE ENTROPY; INDEXES; IMMUNIZATION; MATURATION; FEATURES	Background Heart rate variability (HRV) has been emerging in neonatal medicine. It may help for the early diagnosis of pathology and estimation of autonomous maturation. There is a lack of standardization and automation in the selection of the sequences to analyze and some features have not been explored in this specific population. The main objective of this study was to analyze the impact of the time length of the sequences on the estimation of linear and non-linear HRV features, including horizontal visibility graphs (HVG). Methods HRV features were repeatedly measured with linear and non-linear methods on 2-, 5-, 10-minute sequences selected from the longest 15-min sequence and recorded on a weekly basis in 39 infants less than 31 weeks at birth. The associations between HRV measurements were analyzed through principal component analysis and k-means clustering. The effects of the time lengths on HRV measurements and post-menstrual age (PMA) were analyzed by linear mixed effect model for repeated measures. Results The domains of analysis were concordant for their descriptive parameters of short (rMSSD, SD1 and HF) and long-term (SD, SD2 and LF) variability. alpha(1) was correlated with the LF/HF and SD2/SD1. DC and AC were correlated with short-term variability estimates and significantly increased with GA and PMA. Shortening the windows of analysis increased the random measurement error for all the features and increased the bias for all but short term features and HVGs. Conclusion The linear and non-linear measurements of HRV are correlated each other. Shortening the windows of analysis increased the random error for all the features and increased the bias for all but short term features and HVGs. Short-term HRV can be an index for evaluating the maturation in whatever sequence length.	[Trang Nguyen Phuc Thu; Hernandez, Alfredo I.; Costet, Nathalie; Carrault, Guy; Beuchee, Alain] Univ Rennes 1, INSERM, UMR 1099, CHU Rennes,LTSI, Rennes, France; [Patural, Hugues] CHU St Etienne, Pole Mere Enfants, Reanimat Neonatale Hop Nord, St Etienne, France; [Patural, Hugues; Pichot, Vincent] Univ Jean Monnet, SNA EPIS 4607, St Etienne, France	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU de St Etienne	Thu, TNP (corresponding author), Univ Rennes 1, INSERM, UMR 1099, CHU Rennes,LTSI, Rennes, France.	nguyenphucthutrang@gmail.com	HUGUES, PATURAL/ABD-4569-2020; Beuchée, Alain/AAB-7024-2021; Hernández, Alfredo I/K-4933-2015; carrault, guy/ABC-4463-2020	Beuchée, Alain/0000-0003-0064-7085; Hernández, Alfredo I/0000-0003-0765-2311; carrault, guy/0000-0003-1482-2067; Nguyen Phuc Thu, Trang/0000-0002-0471-1569; Costet, Nathalie/0000-0002-3706-4812	European Union [689260]	European Union(European Commission)	This work is part of European DigiNewB Project and has received the funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 689260 (Digi-NewB project). Further information about this project can be found at http://www.digi-newb.eu.	Bauer A, 2006, PHYSICA A, V364, P423, DOI 10.1016/j.physa.2005.08.080; Ben Jmaa W, 2017, PEDIATR INFECT DIS J, V36, P988, DOI [10.1097/inf.0000000000001647, 10.1097/INF.0000000000001647]; Beuchee A, 2009, NEONATOLOGY, V96, P109, DOI 10.1159/000208792; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Camm AJ, 1996, EUR HEART J, V17, P354; CHATOW U, 1995, PEDIATR RES, V37, P294, DOI 10.1203/00006450-199503000-00008; Ciccone AB, 2017, MUSCLE NERVE, V56, P674, DOI 10.1002/mus.25573; Cong XM, 2012, J PAIN, V13, P636, DOI 10.1016/j.jpain.2012.02.008; DEHAAN R, 1977, AM J OBSTET GYNECOL, V127, P753, DOI 10.1016/0002-9378(77)90251-4; Delane A, 2016, IEEE ENG MED BIO, P944, DOI 10.1109/EMBC.2016.7590857; Dumont J, 2010, IEEE T BIO-MED ENG, V57, P607, DOI 10.1109/TBME.2008.2002157; Fairchild KD, 2013, PEDIATR RES, V74, P570, DOI 10.1038/pr.2013.136; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Guzik P, 2007, J PHYSIOL SCI, V57, P63, DOI 10.2170/physiolsci.RP005506; HEDMAN AE, 1995, ACTA PHYSIOL SCAND, V155, P205, DOI 10.1111/j.1748-1716.1995.tb09965.x; Hoshi RA, 2013, AUTON NEUROSCI-BASIC, V177, P271, DOI 10.1016/j.autneu.2013.05.004; Iacovacci J, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.042309; Kassambara A, 2017, FACTOEXTRA EXTRACT V, V5, P1; Kommers DR, 2017, J PEDIATR-US, V182, P92, DOI 10.1016/j.jpeds.2016.11.059; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lin DH, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.052705; Longin E, 2005, EARLY HUM DEV, V81, P663, DOI 10.1016/j.earlhumdev.2005.03.015; Longin E, 2006, J PERINAT MED, V34, P303, DOI 10.1515/JPM.2006.058; Luque B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046103; Madl T, 2016, COMPUT CARDIOL CONF, V43, P733; Maechler M., 2016, CLUSTER CLUSTERANALY; Malliani A, 1997, CIRCULATION, V96, P4143; Mattei J, 2011, AUTON NEUROSCI-BASIC, V162, P77, DOI 10.1016/j.autneu.2011.03.003; Mialet-Marty T, 2013, NEONATOLOGY, V104, P151, DOI 10.1159/000351035; Montano N, 2000, HYPERTENSION, V36, P1029, DOI 10.1161/01.HYP.36.6.1029; Munoz ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138921; Nakamura T, 2005, BIOSYSTEMS, V79, P117, DOI 10.1016/j.biosystems.2004.09.006; Parker RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168321; Patural H, 2008, EARLY HUM DEV, V84, P681, DOI 10.1016/j.earlhumdev.2008.04.010; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pinheiro J., 2020, PACKAGE NLME LINEAR, DOI DOI 10.1016/S0006-3207(01)00201-4; Pyetan E, 2003, IEEE T BIO-MED ENG, V50, P777, DOI 10.1109/TBME.2003.812158; R Core Team, 2020, R LANG ENV STAT COMP; Rosenstock EG, 1999, ACTA PAEDIATR, V88, P477, DOI 10.1080/08035259950169422; Shaffer F, 2016, BIOFEEDBACK, V44, P229, DOI [10.5298/1081-5937-44.3.09, DOI 10.5298/1081-5937-44.3.09]; Wang YP, 2016, EUR J APPL PHYSIOL, V116, P1281, DOI 10.1007/s00421-016-3332-z; Weippert M, 2014, ENTROPY-SWITZ, V16, P5698, DOI 10.3390/e16115698	44	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220692	10.1371/journal.pone.0220692	http://dx.doi.org/10.1371/journal.pone.0220692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398196	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000012
J	Ueno, K; Otani, Y; Yanagihara, N; Nakamura, T; Shimizu, K; Yamagoe, S; Miyazaki, Y				Ueno, Keigo; Otani, Yoshiko; Yanagihara, Nao; Nakamura, Takumi; Shimizu, Kiminori; Yamagoe, Satoshi; Miyazaki, Yoshitsugu			Cryptococcus gattii alters immunostimulatory potential in response to the environment	PLOS ONE			English	Article							C-TYPE LECTIN; PULMONARY INFECTION; DECTIN-1; RECOGNITION; NEOFORMANS; RECEPTOR; MATURATION; DEFENSE; GROWTH; YEAST	Cryptococcus gattii is a capsular fungal pathogen, which causes life-threatening cryptococcosis in immunocompetent individuals. This emerging pathogen is less likely to be recognized by innate immunity compared to traditional Cryptococcus neoformans strains. Previous studies indicate that C-type lectin receptors (CLRs), including dectin-1 and dectin-2, play a role in recognizing cryptococcal cells; however, it remains to be elucidated whether the receptors physically associate with C. gattii yeast cell surfaces. Based on the previous findings, we hypothesized that culture conditions influence the expression or exposure of CLR ligands on C. gattii. Therefore, in the present study, we first investigated the culture conditions that induce exposure of CLR ligands on C. gattii yeast cells via the binding assay using recombinant fusion proteins of mouse CLR and IgG Fc, Fc dectin-1 and Fc dectin-2. Common fungal culture media, such as yeast extract peptone dextrose (YPD) broth, Sabouraud broth, and potato dextrose agar, did not induce the exposure of dectin-1 ligands, including beta-1,3-glucan, on both capsular and acapsular C. gattiistrains, in contrast to Fc dectin-1 and Fc dectin-2 bound to C. gattii cells growing in the conventional synthetic dextrose (SD) medium [may also be referred to as a yeast nitrogen base with glucose medium]. The medium also induced the exposure of dectin-1 ligands on C. neoformans, whereas all tested media induced dectin-1 and dectin-2 ligands in a control fungus Candida albicans. Notably, C. gattii did not expose dectin-1 ligands in SD medium supplemented with yeast extract or neutral buffer. In addition, compared to YPD medium-induced C. gattii, SD medium-induced C. gattii more efficiently induced the phosphorylation of Syk, Akt, and Erk1/2 in murine dendritic cells (DCs). Afterwards, the cells were considerably engulfed by DCs and remarkably induced DCs to secrete the inflammatory cytokines. Overall, the findings suggest that C. gattii alters its immunostimulatory potential in response to the environment.	[Ueno, Keigo; Otani, Yoshiko; Yanagihara, Nao; Nakamura, Takumi; Yamagoe, Satoshi; Miyazaki, Yoshitsugu] Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, Toyama, Tokyo, Japan; [Otani, Yoshiko; Yanagihara, Nao; Nakamura, Takumi; Shimizu, Kiminori] Tokyo Univ Sci, Dept Biol Sci & Technol, Fac Ind Sci & Technol, Katsushika Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); Tokyo University of Science	Ueno, K (corresponding author), Natl Inst Infect Dis, Dept Chemotherapy & Mycoses, Shinjuku Ku, Toyama, Tokyo, Japan.	keigo-u@niid.go.jp		miyazaki, yoshitsugu/0000-0001-8942-0869; Ueno, Keigo/0000-0003-0671-0049	Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 17K10040, KAKENHI 17K18385]; Takeda Science Foundation; Tomy Digital Biology Co. Ltd; Japan Agency for Medical Research and Development, AMED [JP19fk0108045, JP19fk0108094]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Tomy Digital Biology Co. Ltd; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This work was supported by: Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 17K18385], Takeda Science Foundation, Tomy Digital Biology Co. Ltd [LEGEND Research Grant Program 2015] to Keigo Ueno; and by Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 17K10040], Japan Agency for Medical Research and Development, AMED [JP19fk0108045 and JP19fk0108094] to Yoshitsugu Miyazaki. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199; Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Ballou ER, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.238; Blanco-Menendez N, 2015, J IMMUNOL, V195, P4466, DOI 10.4049/jimmunol.1402874; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Brown GD, 2018, NAT REV IMMUNOL, V18, P374, DOI 10.1038/s41577-018-0004-8; Campuzano A, 2018, J FUNGI, V4, DOI 10.3390/jof4010033; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Chiba S, 2014, ELIFE, V3, DOI 10.7554/eLife.04177; CROSS CE, 1995, INFECT IMMUN, V63, P2604, DOI 10.1128/IAI.63.7.2604-2611.1995; Deng ZH, 2015, NAT IMMUNOL, V16, P642, DOI 10.1038/ni.3155; Esher SK, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007126; Farkas V, 2009, FEMS YEAST RES, V9, P311, DOI 10.1111/j.1567-1364.2008.00478.x; Frank D, 2018, MBIO, V9, DOI [10.1128/mBio.00782-18, 10.1128/mbio.00782-18]; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gilbert NM, 2012, MBIO, V3, DOI 10.1128/mBio.00007-12; Giles SS, 2009, INFECT IMMUN, V77, P3491, DOI 10.1128/IAI.00334-09; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Huston SM, 2016, J IMMUNOL, V196, P1259, DOI 10.4049/jimmunol.1501089; JAMES PG, 1990, CARBOHYD RES, V198, P23, DOI 10.1016/0008-6215(90)84273-W; JOHNSON BF, 1967, J BACTERIOL, V94, P192, DOI 10.1128/JB.94.1.192-195.1967; Leongson K, 2013, INFECT IMMUN, V81, P1100, DOI 10.1128/IAI.01339-12; Lim J, 2018, J IMMUNOL, V200, P3539, DOI 10.4049/jimmunol.1700790; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Matsuo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059887; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mukaremera Liliane, 2018, Cell Surf, V1, P15, DOI 10.1016/j.tcsw.2017.12.001; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115, DOI 10.1111/j.1348-0421.2007.tb04007.x; Nakamura Y, 2015, INFECT IMMUN, V83, P671, DOI 10.1128/IAI.02835-14; Nishino K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141796; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; O'Meara TR, 2013, MBIO, V4, DOI 10.1128/mBio.00522-12; Okubo Y, 2013, JPN J INFECT DIS, V66, P216, DOI 10.7883/yoken.66.216; Ostrop J, 2017, J IMMUNOL, V198, P1403, DOI 10.4049/jimmunol.1601665; Patin EC, 2019, SEMIN CELL DEV BIOL, V89, P24, DOI 10.1016/j.semcdb.2018.03.003; Rachini A, 2007, INFECT IMMUN, V75, P5085, DOI 10.1128/IAI.00278-07; Rapaka RR, 2007, J IMMUNOL, V178, P3702, DOI 10.4049/jimmunol.178.6.3702; Springer DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010978; Stanton BC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000860; Strijbis K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003446; Tarumoto N, 2014, J INFECT DIS, V209, P799, DOI 10.1093/infdis/jit534; Thiagarajan PS, 2013, CARDIOVASC RES, V99, P494, DOI 10.1093/cvr/cvt117; Ueno K, 2019, MED MYCOL, V57, P1046, DOI 10.1093/mmy/myy153; Ueno K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35699-4; Ueno K, 2019, MUCOSAL IMMUNOL, V12, P265, DOI 10.1038/s41385-018-0094-4; Ueno K, 2015, INFECT IMMUN, V83, P1577, DOI 10.1128/IAI.02827-14; Ueno K, 2013, MED MYCOL, V51, P385, DOI 10.3109/13693786.2012.733892; Urai M, 2016, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00101; Walsh NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173866; Wang HF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006568; Wright WF, 2011, LABMEDICINE, V42, P679, DOI 10.1309/LM8BW8QNV7NZBROG	52	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220989	10.1371/journal.pone.0220989	http://dx.doi.org/10.1371/journal.pone.0220989			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398236	Green Published, gold, Green Submitted			2022-12-27	WOS:000485004000036
J	Eiteljoerge, SFV; Adam, M; Elsner, B; Mani, N				Eiteljoerge, Sarah F. V.; Adam, Maurits; Elsner, Birgit; Mani, Nivedita			Word-object and action-object association learning across early development	PLOS ONE			English	Article							MULTIMODAL MOTHERESE; INFANTS; ACQUISITION; SELECTION; CHILDREN; ACCESS; MOTION	Successful communication often involves comprehension of both spoken language and observed actions with and without objects. Even very young infants can learn associations between actions and objects as well as between words and objects. However, in daily life, children are usually confronted with both kinds of input simultaneously. Choosing the critical information to attend to in such situations might help children structure the input, and thereby, allow for successful learning. In the current study, we therefore, investigated the developmental time course of children's and adults' word and action learning when given the opportunity to learn both word-object and action-object associations for the same object. All participants went through a learning phase and a test phase. In the learning phase, they were presented with two novel objects which were associated with a distinct novel name (e.g., "Look, a Tanu") and a distinct novel action (e.g., moving up and down while tilting sideways). In the test phase, participants were presented with both objects on screen in a baseline phase, then either heard one of the two labels or saw one of the two actions in a prime phase, and then saw the two objects again on screen in a recognition phase. Throughout the trial, participants' target looking was recorded to investigate whether participants looked at the target object upon hearing its label or seeing its action, and thus, would show learning of the word-object and action-object associations. Growth curve analyses revealed that 12-month-olds showed modest learning of action-object associations, 36-month-olds learned word-object associations, and adults learned word-object and action-object associations. These results highlight how children attend to the different information types from the two modalities through which communication is addressed to them. Over time, with increased exposure to systematic word-object mappings, children attend less to action-object mappings, with the latter potentially being mediated by word-object learning even in adulthood. Thus, choosing between different kinds of input that may be more relevant in their rich environment encompassing different modalities might help learning at different points in development.	[Eiteljoerge, Sarah F. V.; Mani, Nivedita] Univ Goettingen, Psychol Language, Gottingen, Germany; [Eiteljoerge, Sarah F. V.; Mani, Nivedita] Leibniz Sci Campus Primate Cognit, Gottingen, Germany; [Adam, Maurits; Elsner, Birgit] Univ Potsdam, Dev Psychol, Potsdam, Germany	University of Gottingen; University of Potsdam	Eiteljoerge, SFV (corresponding author), Univ Goettingen, Psychol Language, Gottingen, Germany.; Eiteljoerge, SFV (corresponding author), Leibniz Sci Campus Primate Cognit, Gottingen, Germany.	sarah.eiteljoerge@psych.uni-goettingen.de	ARSLAN, Okan/AAA-3232-2020; Eiteljoerge, Sarah/AAY-1570-2021; Elsner, Birgit/AAC-3264-2019	Elsner, Birgit/0000-0003-3441-2436; Eiteljoerge, Sarah/0000-0001-6141-7924	Deutsche Forschungsgemeinschaft (German Research Foundation) [FOR 2253, EL 253/7-1]; German Research Foundation; Gottingen University	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Gottingen University	This study was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation), research unit "Crossing the borders: The interplay of language, cognition, and the brain in early human development" (Project: FOR 2253, Grants: EL 253/7-1). We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Bahrick LE, 2002, CHILD DEV, V73, P1629, DOI 10.1111/1467-8624.00495; Bayley N., 2019, BAYLEY SCALES INFANT; BENEDICT H, 1979, J CHILD LANG, V6, P183, DOI 10.1017/S0305000900002245; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Chainay H, 2002, PSYCHON B REV, V9, P348, DOI 10.3758/BF03196292; Childers JB, 2003, DEVELOPMENTAL SCI, V6, P185, DOI 10.1111/1467-7687.00270; Dysart EL, 2018, PARALLELS WORD ACTIO; Dysart EL, 2016, J EXP CHILD PSYCHOL, V146, P231, DOI 10.1016/j.jecp.2016.01.003; Fulkerson AL, 2007, COGNITION, V105, P218, DOI 10.1016/j.cognition.2006.09.005; Gogate L, 2017, J SPEECH LANG HEAR R, V60, P3538, DOI 10.1044/2017_JSLHR-L-17-0085; Gogate L, 2016, DEV NEUROPSYCHOL, V41, P293, DOI 10.1080/87565641.2016.1243112; Gogate L, 2015, J EXP CHILD PSYCHOL, V129, P110, DOI 10.1016/j.jecp.2014.09.002; Gogate LJ, 2010, PSYCHOL REV, V117, P496, DOI 10.1037/a0019049; Gogate LJ, 2009, J EXP PSYCHOL HUMAN, V35, P508, DOI 10.1037/a0013623; Gogate LJ, 2000, CHILD DEV, V71, P878, DOI 10.1111/1467-8624.00197; Gogate LJ, 1998, J EXP CHILD PSYCHOL, V69, P133, DOI 10.1006/jecp.1998.2438; Grimm H, 2006, ELTERNFRAGEBOGEN FRU; Hahn ER, 2010, LANG LEARN DEV, V6, P283, DOI 10.1080/15475441003635315; Hunnius S, 2010, DEV PSYCHOL, V46, P446, DOI 10.1037/a0016543; Junge C, 2009, NEUROBILINGUALISM BI; Matatyaho DJ, 2008, INFANCY, V13, P172, DOI 10.1080/15250000701795655; Matatyaho-Bullaro DJ, 2014, J EXP CHILD PSYCHOL, V118, P27, DOI 10.1016/j.jecp.2013.09.010; May L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00222; Mirman D., 2016, GROWTH CURVE ANAL VI, V1st ed.; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; Namy LL, 2004, J COGN DEV, V5, P37, DOI 10.1207/s15327647jcd0501_3; Namy LL, 1998, CHILD DEV, V69, P295, DOI 10.2307/1132165; Puccini D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00101; Riggs KJ, 2016, COGNITIVE SCI, V40, P992, DOI 10.1111/cogs.12262; Robinson CW, 2004, CHILD DEV, V75, P1387, DOI 10.1111/j.1467-8624.2004.00747.x; Roembke TC, 2016, J MEM LANG, V87, P105, DOI 10.1016/j.jml.2015.09.005; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sloutsky VM, 2003, CHILD DEV, V74, P822, DOI 10.1111/1467-8624.00570; Swingley D, 1999, COGNITION, V71, P73, DOI 10.1016/S0010-0277(99)00021-9; Szagun G., 2009, FRAKIS FRAGEBOGEN FR; Taxitari L, ONLY COWS HORSES LIM; Tincoff R, 2018, LANGUAGE LEARNING DE, P1; Tincoff R, 2012, INFANCY, V17, P432, DOI 10.1111/j.1532-7078.2011.00084.x; Verbruggen SW, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0593; Von Holzen K, 2012, J EXP CHILD PSYCHOL, V113, P569, DOI 10.1016/j.jecp.2012.08.001; Waxman S, 2013, CHILD DEV PERSPECT, V7, P155, DOI 10.1111/cdep.12032; Waxman SR, 2009, TRENDS COGN SCI, V13, P258, DOI 10.1016/j.tics.2009.03.006; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Westermann G., 2017, EARLY WORD LEARNING; Yoon EY, 2002, VIS COGN, V9, P615, DOI 10.1080/13506280143000601	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220317	10.1371/journal.pone.0220317	http://dx.doi.org/10.1371/journal.pone.0220317			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393901	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500026
J	Malila, Y; Thanatsang, K; Arayamethakorn, S; Uengwetwanit, T; Srimarut, Y; Petracci, M; Strasburg, GM; Rungrassamee, W; Visessanguan, W				Malila, Yuwares; Thanatsang, Krittaporn; Arayamethakorn, Sopacha; Uengwetwanit, Tanaporn; Srimarut, Yanee; Petracci, Massimiliano; Strasburg, Gale M.; Rungrassamee, Wanilada; Visessanguan, Wonnop			Absolute expressions of hypoxia-inducible factor-1 alpha (HIF1A) transcript and the associated genes in chicken skeletal muscle with white striping and wooden breast myopathies	PLOS ONE			English	Article							PECTORALIS-MAJOR MUSCLE; LIGHT-CHAIN KINASE; MEAT QUALITY; SARCOGLYCAN COMPLEX; GLUTATHIONE TRANSFERASE; COMMERCIAL CONDITIONS; MUSCULAR-DYSTROPHY; OXIDATIVE STRESS; BROILER-CHICKENS; DOWN-REGULATION	Development of white striping (WS) and wooden breast (WB) in broiler breast meat have been linked to hypoxia, but their etiologies are not fully understood. This study aimed at investigating absolute expression of hypoxia-inducible factor-1 alpha subunit (HIF1A) and genes involved in stress responses and muscle repair using a droplet digital polymerase chain reaction. Total RNA was isolated from pectoralis major collected from male 6-week-old medium (carcass weight <= 2.5 kg) and heavy (carcass weight >2.5 kg) broilers. Samples were classified as "non-defective" (n = 4), "medium-WS" (n = 6), "heavy-WS" (n = 7) and "heavy-WS+ WB" (n = 3) based on abnormality scores. The HIF1A transcript was upregulated in all of the abnormal groups. Transcript abundances of genes encoding 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4), lactate dehydrogenase-A (LDHA), and phosphorylase kinase beta subunit (PHKB) were increased in heavy-WS but decreased in heavy-WS+WB. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was up-regulated in non-defective samples. The muscle-specific mu-2 isoform of glutathione Stransferases (GSTM2) was up-regulated in the abnormal samples, particularly in the heavy groups. The genes encoding myogenic differentiation (MYOD1) and myosin light chain kinase (MYLK) exhibited similar expression pattern, of which medium-WS and heavy-WS significantly increased compared to non-defective whereas expression in heavy-WS+WB was not different from either non-defective or WS-affected group. The greatest and the lowest levels of calpain-3 (CAPN3) and delta-sarcoglycan (SCGD) were observed in heavy-WS and heavy-WS+ WB, respectively. Based on micrographs, the abnormal muscles primarily comprised fibers with cross-sectional areas ranging from 2,000 to 3,000 mu m(2). Despite induced glycolysis at the transcriptional level, lower stored glycogen in the abnormal muscles corresponded with the reduced lactate and higher pH within their meats. The findings support hypoxia within the abnormal breasts, potentially associated with oversized muscle fibers. Between WS and WB, divergent glucose metabolism, cellular detoxification and myoregeneration at the transcriptional level could be anticipated.	[Malila, Yuwares; Thanatsang, Krittaporn; Arayamethakorn, Sopacha; Uengwetwanit, Tanaporn; Srimarut, Yanee; Rungrassamee, Wanilada; Visessanguan, Wonnop] Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand; [Petracci, Massimiliano] Univ Bologna, Dept Agr & Food Sci, Alma Mater Studiorum, Cesena, FC, Italy; [Strasburg, Gale M.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Bologna; Michigan State University	Malila, Y (corresponding author), Natl Ctr Genet Engn & Biotechnol BIOTEC, Khlong Luang, Pathum Thani, Thailand.	yuwares.mal@biotec.or.th	Uengwetwanit, Tanaporn/AFV-0013-2022; Malila, Yuwares/AAF-1353-2020; Rungrassamee, Wanilada/E-1718-2011; Petracci, Massimiliano/K-4169-2015	Uengwetwanit, Tanaporn/0000-0003-4710-2613; Malila, Yuwares/0000-0001-5950-5319; Rungrassamee, Wanilada/0000-0002-5802-4342; Petracci, Massimiliano/0000-0002-5671-5676; Strasburg, Gale/0000-0002-3897-4340	Cluster and Program Management (CPM), National Science and Technology Development Agency (NTSDA, Thailand) [P15-50668]; Thailand Research Fund (TRF) [TRG 5980007]	Cluster and Program Management (CPM), National Science and Technology Development Agency (NTSDA, Thailand); Thailand Research Fund (TRF)(Thailand Research Fund (TRF))	This research was financially supported by Cluster and Program Management (CPM), National Science and Technology Development Agency (NTSDA, Thailand, https://www.nstda.or.th/th/industrial-research) towards YM, YS, TU, SA, WR and WV (Grant number P15-50668) and by Thailand Research Fund (TRF, http://academics.trf.or. th/) towards YM and WV (Grant number TRG 5980007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153750; Abdellatif Y, 2007, CELL CALCIUM, V41, P429, DOI 10.1016/j.ceca.2006.08.004; Alnahhas N, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0369-2; Apidianakis Y, 2012, FASEB J, V26, P730, DOI 10.1096/fj.11-192484; Araishi K, 1999, HUM MOL GENET, V8, P1589, DOI 10.1093/hmg/8.9.1589; Bailey RA, 2015, POULTRY SCI, V94, P2870, DOI 10.3382/ps/pev304; Baldi G, 2018, ANIMAL, V12, P164, DOI 10.1017/S1751731117001069; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Berri C, 2007, J ANIM SCI, V85, P2005, DOI 10.2527/jas.2006-398; Blue EK, 2002, AM J PHYSIOL-CELL PH, V282, pC451, DOI 10.1152/ajpcell.00333.2001; Boerboom G, 2018, POULTRY SCI, V97, P3977, DOI 10.3382/ps/pey266; Chesney J, 2014, ONCOTARGET, V5, P6670, DOI 10.18632/oncotarget.2213; Cirillo F, 2017, FASEB J, V31, P2146, DOI 10.1096/fj.201600878R; Clark DL, 2016, POULTRY SCI, V95, P2930, DOI 10.3382/ps/pew243; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; Daughtry MR, 2017, POULTRY SCI, V96, P3457, DOI 10.3382/ps/pex068; Eadmusik S, 2011, BRIT POULTRY SCI, V52, P177, DOI 10.1080/00071668.2011.554798; Ehmsen J, 2002, J CELL SCI, V115, P2801; Favier FB, 2015, CELL MOL LIFE SCI, V72, P4681, DOI 10.1007/s00018-015-2025-9; FIRTH JD, 1995, J BIOL CHEM, V270, P21021, DOI 10.1074/jbc.270.36.21021; Gan H., 2016, MUSCULOSKELET REGEN, V2, pe1193, DOI [10.14800/mr.1193, DOI 10.14800/MR.1193]; Griffin JR, 2018, AVIAN PATHOL, V47, P2, DOI 10.1080/03079457.2017.1356908; Groh S, 2009, J BIOL CHEM, V284, P19178, DOI 10.1074/jbc.C109.010728; Hack AA, 1998, J CELL BIOL, V142, P1279, DOI 10.1083/jcb.142.5.1279; Hauerslev S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-43; Hernandez-Hernandez M, 2017, SEMIN CELL DEV BIOL, V72, P10, DOI 10.1016/j.semcdb.2017.11.010; Herring BP, 2000, AM J PHYSIOL-CELL PH, V279, pC1656, DOI 10.1152/ajpcell.2000.279.5.C1656; Higashimura Y, 2011, ARCH BIOCHEM BIOPHYS, V509, P1, DOI 10.1016/j.abb.2011.02.011; Hou XW, 2017, FASEB J, V31, P3179, DOI 10.1096/fj.201601082R; Houddane A, 2017, CELL SIGNAL, V34, P23, DOI 10.1016/j.cellsig.2017.02.019; Huenchuguala S, 2014, AUTOPHAGY, V10, P618, DOI 10.4161/auto.27720; Karalaki M, 2009, IN VIVO, V23, P779; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; KETTERER B, 1983, ENVIRON HEALTH PERSP, V49, P59, DOI 10.2307/3429581; KHAN AW, 1971, CAN INST F SCI TEC J, V4, P139, DOI 10.1016/S0008-3860(71)74218-4; Kindlein L., 2017, J VET SCI TECHNOLOGY, V8, P1000478, DOI [10.4172/2157-7579.1000478, DOI 10.4172/2157-7579.1000478]; Kravchenko-Balasha N, 2009, J BIOL CHEM, V284, P11717, DOI 10.1074/jbc.M900217200; Kuttappan VA, 2017, POULTRY SCI, V96, P3005, DOI 10.3382/ps/pex072; Kuttappan VA, 2013, POULTRY SCI, V92, P811, DOI 10.3382/ps.2012-02506; Kuttappan VA, 2013, POULTRY SCI, V92, P339, DOI 10.3382/ps.2012-02647; Kuttappan VA, 2012, POULTRY SCI, V91, P2677, DOI 10.3382/ps.2012-02259; Kuttappan VA, 2012, POULTRY SCI, V91, P1240, DOI 10.3382/ps.2011-01947; Kuttappan VA, 2017, POULTRY SCI, V96, P2992, DOI 10.3382/ps/pex069; Le Bihan-Duval E, 2008, BMC GENET, V10, DOI 10.1186/1471-2156-9-53; Lee DC, 2015, CELL, V161, P595, DOI 10.1016/j.cell.2015.03.011; Li YJ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt408; Liu C, 2005, POULTRY SCI, V84, P376, DOI 10.1093/ps/84.3.376; Lorenzi M, 2014, J APPL POULTRY RES, V23, P754, DOI 10.3382/japr.2014-00968; Lundby C, 2009, CELL MOL LIFE SCI, V66, P3615, DOI 10.1007/s00018-009-0146-8; Macrae VE, 2006, BRIT POULTRY SCI, V47, P264, DOI 10.1080/00071660600753615; Maftouh M, 2014, BRIT J CANCER, V110, P172, DOI 10.1038/bjc.2013.681; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Malila Y, 2013, POULTRY SCI, V92, P1621, DOI 10.3382/ps.2012-02778; Malila Y, 2018, ASIAN AUSTRAL J ANIM, V31, P1807, DOI 10.5713/ajas.18.0355; Marchesi JAP, 2019, POULTRY SCI, V98, P590, DOI 10.3382/ps/pey429; Masson N, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-3; Mazzoni M, 2015, POULTRY SCI, V94, P123, DOI 10.3382/ps/peu043; Minchenko O, 2004, FEBS LETT, V576, P14, DOI 10.1016/j.febslet.2004.08.053; Minchenko O, 2003, FEBS LETT, V554, P264, DOI 10.1016/S0014-5793(03)01179-7; Minchenko OH, 2014, WORLD J GASTROENTERO, V20, P13705, DOI 10.3748/wjg.v20.i38.13705; Mudalal S, 2015, ANIMAL, V9, P728, DOI 10.1017/S175173111400295X; Mudalal S, 2014, POULTRY SCI, V93, P2108, DOI 10.3382/ps.2014-03911; MURPHY ME, 1986, BIOCHEM BIOPH RES CO, V134, P550, DOI 10.1016/S0006-291X(86)80455-7; Mutryn MF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1623-0; NUNNALLY MH, 1985, J BIOL CHEM, V260, P1020; Pampouille E, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4598-9; Papah MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207346; Petracci M, 2015, WORLD POULTRY SCI J, V71, P363, DOI 10.1017/S0043933915000367; Petracci M, 2013, POULTRY SCI, V92, P2438, DOI 10.3382/ps.2013-03087; Petracci M, 2013, POULTRY SCI, V92, P1670, DOI 10.3382/ps.2012-03001; Petracci M, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3138; Petracci M, 2012, NUTRIENTS, V4, P1, DOI 10.3390/nu4010001; Phadke MS, 2009, J PHARMACOL EXP THER, V331, P77, DOI 10.1124/jpet.109.155671; Pisani DF, 2005, J GEN PHYSIOL, V126, P173, DOI 10.1085/jgp.200509265; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Radaelli G, 2017, POULTRY SCI, V96, P309, DOI 10.3382/ps/pew270; Ramirez-Sanchez I, 2014, FEBS J, V281, P5567, DOI 10.1111/febs.13098; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720; Ryu YC, 2005, MEAT SCI, V71, P351, DOI 10.1016/j.meatsci.2005.04.015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenza GL, 2017, EMBO J, V36, P252, DOI 10.15252/embj.201695204; Sihvo HK, 2018, J COMP PATHOL, V161, P1, DOI 10.1016/j.jcpa.2018.04.002; Sihvo HK, 2017, VET PATHOL, V54, P119, DOI 10.1177/0300985816658099; Sihvo HK, 2014, VET PATHOL, V51, P619, DOI 10.1177/0300985813497488; Soglia F, 2016, POULTRY SCI, V95, P651, DOI 10.3382/ps/pev353; Solares-Perez A, 2010, BBA-GEN SUBJECTS, V1800, P373, DOI 10.1016/j.bbagen.2009.11.011; SOSNICKI AA, 1991, FOOD STRUCT, V10, P317; Straub V, 1998, AM J PATHOL, V153, P1623, DOI 10.1016/S0002-9440(10)65751-3; Stuelsatz P, 2010, J BIOL CHEM, V285, P12670, DOI 10.1074/jbc.M109.063966; Tallentire CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19231-2; Tarakci H, 2016, FRONT BIOSCI-LANDMRK, V21, P744, DOI 10.2741/4418; Thomas MP, 2015, CELL REP, V11, P1079, DOI 10.1016/j.celrep.2015.04.026; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Trocino A, 2015, POULTRY SCI, V94, P2996, DOI 10.3382/ps/pev296; Velleman SG, 2015, AVIAN DIS, V59, P410, DOI 10.1637/11097-042015-Reg.1; Wattanachant S, 2005, POULTRY SCI, V84, P328, DOI 10.1093/ps/84.2.328; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu Y, 2003, J MUSCLE RES CELL M, V24, P499, DOI 10.1023/B:JURE.0000009810.36038.53; Xue Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173824; Yang X, 2017, J BIOL CHEM, V292, P5981, DOI 10.1074/jbc.M116.756312; Zambonelli P, 2016, POULTRY SCI, V95, P2771, DOI 10.3382/ps/pew268; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4; Zhu XL, 2001, J BIOL CHEM, V276, P21785, DOI 10.1074/jbc.M101877200; Zimniak L, 1997, TOXICOL APPL PHARM, V143, P221, DOI 10.1006/taap.1996.8070; Zuidhof MJ, 2014, POULTRY SCI, V93, P2970, DOI 10.3382/ps.2014-04291	106	27	29	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220904	10.1371/journal.pone.0220904	http://dx.doi.org/10.1371/journal.pone.0220904			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393948	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500080
J	Shakibfar, S; Krause, O; Lund-Andersen, C; Strycko, F; Moll, J; Andersen, TO; Petersen, HH; Svendsen, JH; Igel, C				Shakibfar, Saeed; Krause, Oswin; Lund-Andersen, Casper; Strycko, Filip; Moll, Jonas; Andersen, Tariq Osman; Petersen, Helen Hogh; Svendsen, Jesper Hastrup; Igel, Christian			Impact of device programming on the success of the first anti-tachycardia pacing therapy: An anonymized large-scale study	PLOS ONE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; RAPID VENTRICULAR-TACHYCARDIA; SHOCKS	Background Antitachycardia pacing (ATP) is an effective treatment for ventricular tachycardia (VT). We evaluated the efficacy of different ATP programs based on a large remote monitoring data set from patients with implantable cardioverter-defibrillators (ICDs). Methods A dataset from 18,679 ICD patients was used to evaluate the first delivered ATP treatment. We considered all device programs that were used for at least 50 patients, leaving us with 7 different programs and a total of 32,045 episodes. We used the two-proportions z-test (alpha = 0.01) to compare the probability of success and the probability for acceleration in each group with the corresponding values of the default setting. Results Overall, the first ATP treatment terminated in 78.4%-97.5% of episodes with slow VT and 81.5%-91.1% of episodes with fast VT. The default setting of the ATP programs with the number of sequences S = 3 was applied to treat 30.1% of the slow and 36.6% of the fast episodes. Reducing the maximum number of sequences to S = 2 decreased the success rate for slow VT (P < 0.0001, h = 0.38), while the setting S = 4 resulted in the highest success rate of 97.5% (P < 0.0001, h = 0.27). Conclusion While the default programs performed well, we found that increasing the number of sequences from 3 to 4 was a promising option to improve the overall ATP performance.	[Shakibfar, Saeed; Krause, Oswin; Strycko, Filip; Moll, Jonas; Andersen, Tariq Osman; Igel, Christian] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark; [Lund-Andersen, Casper; Petersen, Helen Hogh; Svendsen, Jesper Hastrup] Univ Copenhagen, Rigshosp, Heart Ctr, Dept Cardiol, Copenhagen, Denmark; [Svendsen, Jesper Hastrup] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Igel, C (corresponding author), Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark.	igel@diku.dk	Svendsen, Jesper Hastrup/G-8573-2017; Lund-Andersen, Casper/AAV-9915-2021; Andersen, Tariq Osman/O-6884-2015; Shakibfar, Saeed/M-2613-2016	Svendsen, Jesper Hastrup/0000-0001-8466-8515; Lund-Andersen, Casper/0000-0003-1111-0734; Andersen, Tariq Osman/0000-0002-9342-5520; Shakibfar, Saeed/0000-0001-8399-0318; Krause, Oswin/0000-0002-0990-559X	Innovation Fund Denmark [72-2014-1]	Innovation Fund Denmark	This work was supported by the Innovation Fund Denmark under grant #72-2014-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099418; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Grimm W, 2006, PACE, V29, P759, DOI 10.1111/j.1540-8159.2006.00431.x; Mansour F, 2011, PACE, V34, P506, DOI 10.1111/j.1540-8159.2011.03037.x; Nauffal V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175205; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Shakibfar S, 2019, EUROPACE, V21, P268, DOI 10.1093/europace/euy257; Wathen M, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2007.01.020; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4; Wilkoff BL, 2008, J AM COLL CARDIOL, V52, P541, DOI 10.1016/j.jacc.2008.05.011; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	11	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219533	10.1371/journal.pone.0219533	http://dx.doi.org/10.1371/journal.pone.0219533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393871	Green Published, gold			2022-12-27	WOS:000485002500012
J	Wu, BC; Cai, Q; Sheehan, JJ; Benson, C; Connolly, N; Alphs, L				Wu, Bingcao; Cai, Qian; Sheehan, John J.; Benson, Carmela; Connolly, Nancy; Alphs, Larry			An episode level evaluation of the treatment journey of patients with major depressive disorder and treatment-resistant depression	PLOS ONE			English	Article							BURDEN	Background Many patients with major depressive disorder (MDD) fail to respond to antidepressant (AD) pharmacotherapy. The objectives of this study were to characterize MDD and treatment-resistant depression (TRD) at the level of pharmacologically treated episodes and to describe the sequential treatment patterns by lines of therapy (LOT) in the first two episodes. Methods Adults (>= 18 years of age) with continuous enrollment. 12 months before and after the first MDD diagnosis and treated with an AD, with or without an MDD-indicated antipsychotic (AP), were identified (1/1/2010-12/31/2015). The MDD episode started on the date of MDD diagnosis that was preceded by a clean period without any MDD diagnosis. The MDD episode ended on the last MDD diagnosis or the end of the days' supply of AD/AP medication, whichever came last. TRD was defined as an MDD episode with. 3 AD/AP regimens. Measured outcomes included episode duration, number of LOT, relapse hospitalization, and sequential treatment patterns of MDD episode stratified by TRD and non-TRD episodes. Results Of 48,440 patients who received AD/AP in the 1 st MDD episode, 3,317 (6.8%) of episodes were considered TRD. Mean duration of 1 st TRD episodes was 571 days, mean number of AD/AP LOTs was 3.47, and 13.7% involved relapse hospitalization. Mean duration of 1 st non-TRD episodes was 200 days, mean number of AD/AP LOTs was 1.21, and 9.6% involved relapse hospitalization. Among 1 st MDD episodes, 25.5% had a second LOT; 7.3% had a third LOT. Most patients received selective serotonin reuptake inhibitors (SSRIs) as the first LOT (63.0%), and the plurality of regimens were SSRIs in second (44.9%) and third LOT (41.1%). Conclusions Compared to non-TRD episodes, TRD episodes were longer and more often involved relapse hospitalizations. SSRIs were the most common treatment; treatment changes and potential treatment unresponsiveness were frequent among MDD patients.	[Wu, Bingcao; Cai, Qian; Sheehan, John J.; Benson, Carmela; Connolly, Nancy; Alphs, Larry] Janssen Sci Affairs LLC, Titusville, NJ 08560 USA	Johnson & Johnson; Janssen Pharmaceuticals	Sheehan, JJ (corresponding author), Janssen Sci Affairs LLC, Titusville, NJ 08560 USA.	jsheeha2@its.jnj.com		Sheehan, Jack/0000-0002-5045-5025	Janssen Scientific Affairs, LLC	Janssen Scientific Affairs, LLC	This research and preparation of this manuscript were supported by Janssen Scientific Affairs, LLC. The funder provided support in the form of salaries for authors BW, QC, JJS, CB, NC, and LA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amos TB, 2018, J CLIN PSYCHIAT, V79, DOI 10.4088/JCP.17m11725; Bauer M, 2019, PHARMACOPSYCHIATRY, V52, P117, DOI 10.1055/a-0643-4830; Coryell W, 2005, J CLIN PSYCHIAT, V66, P412, DOI 10.4088/JCP.v66n0401; Crown WH, 2002, J CLIN PSYCHIAT, V63, P963, DOI 10.4088/JCP.v63n1102; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Gaynes BN., 2018, DEFINITION TREATMENT; Greenberg PE, 2015, J CLIN PSYCHIAT, V76, P155, DOI 10.4088/JCP.14m09298; Johnston KM, 2019, J AFFECT DISORDERS, V242, P195, DOI 10.1016/j.jad.2018.06.045; Kubitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076882; Mrazek DA, 2014, PSYCHIAT SERV, V65, P977, DOI 10.1176/appi.ps.201300059; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nemeroff CB, 2007, J CLIN PSYCHIAT, V68, P17; Olfson M, 2018, J MANAG CARE SPEC PH, V24, P226, DOI 10.18553/jmcp.2018.24.3.226; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Vergunst FK, 2013, PSYCHIAT RES, V207, P143, DOI 10.1016/j.psychres.2013.03.022	15	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220763	10.1371/journal.pone.0220763	http://dx.doi.org/10.1371/journal.pone.0220763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393922	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500059
J	Wu, HC; Wu, C; Lu, QB; Ding, ZY; Xue, M; Lin, JF				Wu, Haocheng; Wu, Chen; Lu, Qinbao; Ding, Zheyuan; Xue, Ming; Lin, Junfen			Evaluating the effects of control interventions and estimating the inapparent infections for dengue outbreak in Hangzhou, China	PLOS ONE			English	Article							VECTOR CONTROL; CONTROL STRATEGIES; ZHEJIANG PROVINCE; MODEL; TRANSMISSION; EPIDEMIOLOGY; SCHOOLS; BURDEN; FEVER	Background The number of dengue fever (DF) cases and the number of dengue outbreaks have increased in recent years in Zhejiang Province, China. An unexpected dengue outbreak was reported in Hangzhou in 2017 and caused more than one thousand dengue cases. This study was undertaken to evaluate the effectiveness of the actual control measures, estimate the proportion of inapparent infections during this outbreak and simulate epidemic development based on different levels of control measures taking inapparent infections into consideration. Methods The epidemic data of dengue cases in Hangzhou, Zhejiang Province, in 2017 and the number of the people exposed to the outbreaks were obtained from the China Information Network System of Disease Prevention and Control. The epidemic without intervention measures was used to estimate the unknown parameters. A susceptible-exposed-infectious/inapparent-recovered (SEIAR) model was used to estimate the effectiveness of the control interventions. The inapparent infections were also evaluated at the same time. Results In total, 1137 indigenous dengue cases were reported in Hangzhou in 2017. The number of indigenous dengue cases was estimated by the SEIAR model. This number was predicted to reach 6090 by the end of November 2, 2017, if no control measures were implemented. The total number of reported cases was reduced by 81.33% in contrast to the estimated incidence without intervention. The number of average daily inapparent cases was 10.18 times higher than the number of symptomatic cases. The earlier and more rigorously the vector control interventions were implemented, the more effective they were. The results showed that implementing vector control continuously for more than twenty days was more effective than every few days of implementation. Case isolation is not sufficient enough for epidemic control and only reduced the incidence by 38.10% in contrast to the estimated incidence without intervention, even if case isolation began seven days after the onset of the first case. Conclusions The practical control interventions in the outbreaks that occurred in Hangzhou City were highly effective. The proportion of inapparent infections was large, and it played an important role in transmitting the disease during this epidemic. Early, continuous and high efficacy vector control interventions are necessary to limit the development of a dengue epidemic. Timely diagnosis and case reporting are important in the intervention at an early stage of the epidemic.	[Wu, Haocheng; Wu, Chen; Lu, Qinbao; Ding, Zheyuan; Lin, Junfen] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wu, Haocheng; Lin, Junfen] Key Lab Vaccine Prevent & Control Infect Dis Zhej, Hangzhou, Zhejiang, Peoples R China; [Xue, Ming] Hangzhou Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Lin, JF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Lin, JF (corresponding author), Key Lab Vaccine Prevent & Control Infect Dis Zhej, Hangzhou, Zhejiang, Peoples R China.	hchwu@cdc.zj.cn			Provincial Medical Research Fund of Zhejiang, China [2017RC018, 2017KY131, 2017KY034]	Provincial Medical Research Fund of Zhejiang, China	This work was supported by grants from the Provincial Medical Research Fund of Zhejiang, China (No. 2017RC018, No. 2017KY131 and No. 2017KY034). The document in website was http://www.zjwjw.gov.cn/art/2016/12/5/art_1208235_4006055.html. The funders were not involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001; [Anonymous], 2013, GLOB STRAT DENG PREV; [Anonymous], LANCET, DOI 10.1016/S0140-6736(14)60572-9; Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Burattini MN, 2008, EPIDEMIOL INFECT, V136, P309, DOI 10.1017/S0950268807008667; Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027; Chen SL, 2017, EPIDEMIOL INFECT, V145, P368, DOI 10.1017/S0950268816002338; Chen TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177672; Chen TM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3716-3; Chen TM, 2014, TRAVEL MED INFECT DI, V12, P650, DOI 10.1016/j.tmaid.2014.10.015; Chen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095006; Chen TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148487; Cheng Q, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004417; Dewan AM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001998; Ding ZY, 2018, AM J TROP MED HYG, V98, P913, DOI 10.4269/ajtmh.17-0284; Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112; Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036; Esteva L, 2000, MATH BIOSCI, V167, P51, DOI 10.1016/S0025-5564(00)00024-9; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Fu CC, 2018, ENVIRON SCI POLLUT R, V25, P52, DOI 10.1007/s11356-016-7882-8; Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280; GUBLER DJ, 1981, AM J TROP MED HYG, V30, P1094, DOI 10.4269/ajtmh.1981.30.1094; Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55; Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447; Li ZH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005354; Liu KK, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006318; Liu RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132588; Liu T, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4616-x; Liu XN, 2008, SPATIAL ANAL THEORIE; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033; NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709; Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/eid1206.051210; Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005; Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y; Pang XJ, 2017, VIROL SIN, V32, P16, DOI 10.1007/s12250-016-3855-9; Ren HY, 2015, J INFECT DEV COUNTR, V9, P970, DOI 10.3855/jidc.5998; Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396; Tang B, 2016, J THEOR BIOL, V410, P65, DOI 10.1016/j.jtbi.2016.09.012; Wang C, 2015, GROUP GEOM DYNAM, V9, P1001, DOI 10.4171/GGD/334; Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182; Xu WT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184527; Yan H, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00216; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357; Zhang Y, 2018, WATER RESOURCES AND ECOLOGICAL CARRYING CAPACITY, P1; ZHAO J, 2015, CHIN J EPIDEMIOL, V36, P125, DOI DOI 10.3760/CMA.J.ISSN.0254-6450.2015.11.014	49	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220391	10.1371/journal.pone.0220391	http://dx.doi.org/10.1371/journal.pone.0220391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393899	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500030
J	Ciasca, G; Pagliei, V; Minelli, E; Palermo, F; Nardini, M; Pastore, V; Papi, M; Caporossi, A; De Spirito, M; Minnella, AM				Ciasca, Gabriele; Pagliei, Valeria; Minelli, Eleonora; Palermo, Francesca; Nardini, Matteo; Pastore, Valentina; Papi, Massimiliano; Caporossi, Aldo; De Spirito, Marco; Minnella, Angelo Maria			Nanomechanical mapping helps explain differences in outcomes of eye microsurgery: A comparative study of macular pathologies	PLOS ONE			English	Article							INTERNAL LIMITING MEMBRANE; BIOMECHANICAL PROPERTIES; CELLS; TUMOR	Many ocular diseases are associated with an alteration of the mechanical and the material properties of the eye. These mechanically-related diseases include macular hole and pucker, two ocular conditions due to the presence of abnormal physical tractions acting on the retina. A complete relief of these tractions can be obtained through a challenging microsurgical procedure, which requires the mechanical peeling of the internal limiting membrane of the retina (ILM). In this paper, we provide the first comparative study of the nanoscale morphological and mechanical properties of the ILM in macular hole and macular pucker. Our nanoscale elastic measurements unveil a different bio-mechanical response of the ILM in the two pathologies, which correlates well to significant differences occurring during microsurgery. The results here presented pave the way to the development of novel dedicated microsurgical protocols based on the material ILM properties in macular hole or pucker. Moreover, they contribute to clarify why, despite a common aetiology, a patient might develop one disease or the other, an issue which is still debated in literature.	[Ciasca, Gabriele; Pagliei, Valeria; Minelli, Eleonora; Palermo, Francesca; Nardini, Matteo; Papi, Massimiliano; Caporossi, Aldo; De Spirito, Marco; Minnella, Angelo Maria] Fdn Policlin A Gemelli IRCCS, Rome, Italy; [Ciasca, Gabriele; Minelli, Eleonora; Palermo, Francesca; Nardini, Matteo; Papi, Massimiliano; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy; [Pagliei, Valeria; Caporossi, Aldo; Minnella, Angelo Maria] Univ Cattolica Sacro Cuore, Ist Oftalmol, Rome, Italy; [Pastore, Valentina] Univ Bari A Moro, Dept Med Sci Neurosci & Sense Organs, Eye Clin, Bari, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Universita degli Studi di Bari Aldo Moro	Ciasca, G; De Spirito, M (corresponding author), Fdn Policlin A Gemelli IRCCS, Rome, Italy.; Ciasca, G; De Spirito, M (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	gabriele.ciasca@unicatt.it; marco.despirito@unicatt.it	Papi, Massimiliano/AAC-3657-2022; minnella, angelo maria/AAQ-6250-2020; Ciasca, Gabriele/D-2447-2013; De Spirito, Marco/U-3817-2019; Ciasca, Gabriele/AAL-4677-2020	Papi, Massimiliano/0000-0002-0029-1309; minnella, angelo maria/0000-0001-5896-5313; De Spirito, Marco/0000-0003-4260-5107; Ciasca, Gabriele/0000-0002-3694-8229; Nardini, Matteo/0000-0002-0122-9347				Bottos Juliana, 2012, J Ophthalmic Vis Res, V7, P148; Bu SC, 2015, INVEST OPHTH VIS SCI, V56, P5974, DOI 10.1167/iovs.14-15969; Campbell IC, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026286; Campi G, 2015, ACTA BIOMATER, V23, P309, DOI 10.1016/j.actbio.2015.05.033; Campi G, 2014, CURR PROTEIN PEPT SC, V15, P394, DOI 10.2174/1389203715666140327104023; Candiello J, 2007, FEBS J, V274, P2897, DOI 10.1111/j.1742-4658.2007.05823.x; Ciasca G, 2015, NANOSCALE, V7, P17030, DOI 10.1039/c5nr03145a; Ciasca G, 2016, NANOSCALE, V8, P19629, DOI 10.1039/c6nr06840e; Ciasca G, 2016, WORLD J GASTROENTERO, V22, P7203, DOI 10.3748/wjg.v22.i32.7203; De-giorgio F., 2019, INT J LEGAL MED, P1; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Dvorak HF, 2011, J SURG ONCOL, V103, P468, DOI 10.1002/jso.21709; Feuillie C, 2018, NANO LETT, V18, P5821, DOI 10.1021/acs.nanolett.8b02463; Girasole M, 1998, APPL PHYS A-MATER, V67, P219, DOI 10.1007/s003390050761; Halfter W, 2014, VITREOUS HLTH DIS, P165, DOI [10.1007/978-1-4939-1086-1_11, DOI 10.1007/978-1-4939-1086-1_11]; Halfter W, 2015, FEBS J, V282, P4466, DOI 10.1111/febs.13495; Haritoglou C, 2013, EYE, V27, P1308, DOI 10.1038/eye.2013.178; Haritoglou C, 2004, AM J OPHTHALMOL, V137, P345, DOI 10.1016/S0002-9394(03)00845-6; Henrich PB, 2013, OPHTHALMOLOGICA, V230, P11, DOI 10.1159/000353866; Henrich Paul B, 2012, Invest Ophthalmol Vis Sci, V53, P2561, DOI 10.1167/iovs.11-8502; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Kotecha A, 2007, SURV OPHTHALMOL, V52, pS109, DOI 10.1016/j.survophthal.2007.08.004; Krieg M, 2018, NATURE REV PHYS; Lekka M, 2009, NAT NANOTECHNOL, V4, P72, DOI 10.1038/nnano.2009.004; Lekka M, 2012, ARCH BIOCHEM BIOPHYS, V518, P151, DOI 10.1016/j.abb.2011.12.013; Maiorana A, 2014, MICROSCOPIE, V22, P37; Malucelli E, 2014, ANAL CHEM, V86, P5108, DOI 10.1021/ac5008909; Minelli E, 2017, APPL PHYS LETT, V111, DOI 10.1063/1.4996300; Palmieri V, 2015, SOFT MATTER, V11, P5719, DOI 10.1039/c5sm01089f; Palmieri V, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896161; Papi M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868388; Papi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045696; Schmitz J, 2008, BIOPHYS J, V95, P1448, DOI 10.1529/biophysj.107.124289; Sibillano T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06985; Steel DHW, 2013, EYE, V27, pS1, DOI 10.1038/eye.2013.212; Stylianou A, 2018, NANOSCALE, V10, P20930, DOI 10.1039/c8nr06146g; Valentin-Rodriguez C, 2010, LANGMUIR, V26, P12810, DOI 10.1021/la101797e; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015	39	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220571	10.1371/journal.pone.0220571	http://dx.doi.org/10.1371/journal.pone.0220571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390353	Green Submitted, Green Published, gold			2022-12-27	WOS:000484999400021
J	Brand, GD; Ramada, MHS; Manickchand, JR; Correa, R; Ribeiro, DJS; Santos, MA; Vasconcelos, AG; Abrao, FY; Prates, MV; Murad, AM; Fh, JLC; Leite, JRSA; Magalhaes, KG; Oliveira, AL; Bloch, C				Brand, Guilherme D.; Ramada, Marcelo H. S.; Manickchand, Julia R.; Correa, Rafael; Ribeiro, Dalila J. S.; Santos, Michele A.; Vasconcelos, Andreanne G.; Abrao, Fernando Y.; Prates, Maura, V; Murad, Andre M.; Cardozo Fh, Jose L.; Leite, Jose Roberto S. A.; Magalhaes, Kelly G.; Oliveira, Aline L.; Bloch Jr, Carlos			Intragenic antimicrobial peptides (IAPs) from human proteins with potent antimicrobial and anti-inflammatory activity	PLOS ONE			English	Article							FROG; ULTRAVIOLET; IMMUNITY; INNATE; MODEL; LL-37	Following the treads of our previous works on the unveiling of bioactive peptides encrypted in plant proteins from diverse species, the present manuscript reports the occurrence of four proof-of-concept intragenic antimicrobial peptides in human proteins, named Hs IAPs. These IAPs were prospected using the software Kamal, synthesized by solid phase chemistry, and had their interactions with model phospholipid vesicles investigated by differential scanning calorimetry and circular dichroism. Their antimicrobial activity against bacteria, yeasts and filamentous fungi was determined, along with their cytotoxicity towards erythrocytes. Our data demonstrates that Hs IAPs are capable to bind model membranes while attaining alpha-helical structure, and to inhibit the growth of microorganisms at concentrations as low as 1 mu M. Hs02, a novel sixteen residue long internal peptide (KWAVRIIRKFIKGFIS-NH2) derived from the unconventional myosin 1h protein, was further investigated in its capacity to inhibit lipopolysaccharide-induced release of TNF-alpha in murine macrophages. Hs02 presented potent anti-inflammatory activity, inhibiting the release of TNF-alpha in LPS-primed cells at the lowest assayed concentration, 0.1 mu M. A three-dimensional solution structure of Hs02 bound to DPC micelles was determined by Nuclear Magnetic Resonance. Our work exemplifies how the human genome can be mined for molecules with biotechnological potential in human health and demonstrates that IAPs are actual alternatives to antimicrobial peptides as pharmaceutical agents or in their many other putative applications.	[Brand, Guilherme D.; Manickchand, Julia R.] Univ Brasilia, Inst Quim, LSAB, Brasilia, DF, Brazil; [Ramada, Marcelo H. S.] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, Brasilia, DF, Brazil; [Ramada, Marcelo H. S.] Univ Catolica Brasilia, Programa Posgrad Gerontol, Brasilia, DF, Brazil; [Ramada, Marcelo H. S.; Prates, Maura, V; Murad, Andre M.; Cardozo Fh, Jose L.; Bloch Jr, Carlos] Embrapa Recursos Genet & Biotecnol, LEM, Brasilia, DF, Brazil; [Correa, Rafael; Ribeiro, Dalila J. S.; Magalhaes, Kelly G.] Univ Brasilia, Inst Biol, Lab Imunol & Inflamacao, LIMI, Brasilia, DF, Brazil; [Santos, Michele A.; Oliveira, Aline L.] Univ Brasilia, Inst Quim, LRMN, Brasilia, DF, Brazil; [Vasconcelos, Andreanne G.; Leite, Jose Roberto S. A.] Univ Brasilia, Fac Med, NuPMIA, Nucleo Pesquisa Morfol & Imunol Aplicada, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil; [Abrao, Fernando Y.] FacUnicamps, Fac Farm, Goiania, Go, Brazil; [Cardozo Fh, Jose L.] Inst Matogrossense Algodao, Dept Fitopatol, Primavera Do Leste, MT, Brazil	Universidade de Brasilia; Universidade Catolica de Brasilia; Universidade Catolica de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	Brand, GD (corresponding author), Univ Brasilia, Inst Quim, LSAB, Brasilia, DF, Brazil.	gdbrand@unb.br	Brand, Guilherme/B-5603-2015; Oliveira, Aline L/D-2953-2012; Ramada, Marcelo H.S./G-7543-2015; Prates, Maura/S-8399-2019; Murad, Andre M/C-4459-2017; Bloch, Carlos/S-8375-2019; Abrão, Fernando/AGY-2416-2022; Magalhaes, Kelly G/A-6966-2010; Leite, Jose Roberto/H-9065-2013	Brand, Guilherme/0000-0002-1615-0009; Oliveira, Aline L/0000-0002-6928-078X; Ramada, Marcelo H.S./0000-0001-9738-3412; Prates, Maura/0000-0002-0206-5890; Murad, Andre M/0000-0002-7055-9462; Abrão, Fernando/0000-0002-0553-0946; Magalhaes, Kelly G/0000-0002-7435-5272; Manickchand, Julia/0000-0002-3225-2072; Gomes Vasconcelos, Andreanne/0000-0002-9651-1598; Correa, Rafael/0000-0003-2989-2383; Bloch Jr, Carlos/0000-0003-2799-6883; Leite, Jose Roberto/0000-0002-1096-3236	Fundacao de amparo a pesquisa do DF (FAP-DF) [0193.000866/2015, 0193.001566/2017]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [563712/2010-4, 557761/2009-3]; Financiadora de Estudos e Projetos (FINEP) [0110073600]	Fundacao de amparo a pesquisa do DF (FAP-DF); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	This work was supported by: GDB Fundacao de amparo a pesquisa do DF (FAP-DF, www.fap.df.gov.br/) grant 0193.000866/2015; ALO - Fundacao de amparo a pesquisa do DF (FAP-DF, www.fap.df.gov.br/) grant 0193.001566/2017; MAS - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES, www.capes. gov. br/pt/) - Finance Code 001; CB Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br/) grants 563712/2010-4 and 557761/2009-3, Financiadora de Estudos e Projetos (FINEP, http://www.finep.gov.br/) grant 0110073600. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript..	[Anonymous], 2008, M38A2 CLSI, V28, P29; [Anonymous], [No title captured]; Barbosa EA, 2015, RAPID COMMUN MASS SP, V29, P2061, DOI 10.1002/rcm.7313; Bjorstad A, 2005, ANTIMICROB AGENTS CH, V49, P3889, DOI 10.1128/AAC.49.9.3889-3895.2005; Brand GD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19566-w; Brand GD, 2002, J BIOL CHEM, V277, P49332, DOI 10.1074/jbc.M209289200; Brand GD, 2007, ESTRATEGIAS PROSPECC; Brand GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045848; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chan WC, 2000, FMOC SOLID PHASE PEP; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Clinical and Laboratory Standards Institute, 2008, M27A3 CLSI, V28, P1; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Conlon JM, 2004, BIOCHEM BIOPH RES CO, V320, P170, DOI 10.1016/j.bbrc.2004.05.141; Dale CS, 2005, MEM I OSWALDO CRUZ, V100, P105, DOI 10.1590/S0074-02762005000900017; den Brok MH, 2018, TRENDS IMMUNOL, V39, P380, DOI 10.1016/j.it.2018.01.012; dos Santos RC, 2018, FOOD RES INT, V105, P184, DOI 10.1016/j.foodres.2017.10.045; Duplantier AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00143; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-167; Giuliani A, 2010, METHODS MOL BIOL, V618, P137, DOI 10.1007/978-1-60761-594-1_10; Gronberg A, 2014, WOUND REPAIR REGEN, V22, P613, DOI 10.1111/wrr.12211; Hancock REW, 2016, NAT REV IMMUNOL, V16, P321, DOI 10.1038/nri.2016.29; Iorga A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051018; Ivanov VT, 1997, BIOPOLYMERS, V43, P171; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; KIRSCHENBAUM DM, 1975, ANAL BIOCHEM, V64, P186, DOI 10.1016/0003-2697(75)90420-0; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Li LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182057; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Norris M, 2016, J BIOMOL NMR, V65, P205, DOI 10.1007/s10858-016-0049-6; Pahlman LI, 2013, THROMB HAEMOSTASIS, V109, P930, DOI 10.1160/TH12-10-0739; Phelan M, 2009, INT DAIRY J, V19, P643, DOI 10.1016/j.idairyj.2009.06.001; Ramada MHS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13685-6; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Sato A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153130; Seto GWJ, 2007, BBA-BIOMEMBRANES, V1768, P2787, DOI 10.1016/j.bbamem.2007.07.018; Skinner SP, 2015, ACTA CRYSTALLOGR D, V71, P154, DOI 10.1107/S1399004714026662; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Taylor D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081224; Tsai C-J, 2008, PROTEIN SCI, V6, P24, DOI DOI 10.1002/PR0.5560060104; Tsai CJ, 1998, FOLD DES, V3, pR71, DOI 10.1016/S1359-0278(98)00032-7; Tsai CJ, 2000, P NATL ACAD SCI USA, V97, P12038, DOI 10.1073/pnas.97.22.12038; Tsai CJ, 1997, PROTEIN SCI, V6, P1426, DOI 10.1002/pro.5560060707; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wang GS, 2014, PHARMACEUTICALS-BASE, V7, P545, DOI 10.3390/ph7050545; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, NMR PROTEINS NUCL AC; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021; Zhao G, 2006, PROTEIN SCI, V15, P1987, DOI 10.1110/ps.062286306	55	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220656	10.1371/journal.pone.0220656	http://dx.doi.org/10.1371/journal.pone.0220656			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386688	Green Submitted, Green Published, gold			2022-12-27	WOS:000484997100029
J	Berkowic, D; Markman, S				Berkowic, Daniel; Markman, Shai			Weighing density and kinship: Aggressive behavior and time allocation in fire salamander (Salamandra infraimmaculata)	PLOS ONE			English	Article							KIN RECOGNITION; GROUP-SIZE; CANNIBALISM; LARVAE; EVOLUTION; DYNAMICS; PATTERNS; FITNESS; FOOD	Kin-biased behavior (that is responding differentially to kin and non-kin) is thought to be adaptive in many social interactions. One example of this kin bias is behaving less aggressively toward a relative than a non-relative, a behavior which yields inclusive fitness benefits. However, data are lacking about the ability of animals to weigh their preference for kinship and the density of conspecifics simultaneously and to respond accordingly. Fire salamanders (Salamandra infraimmaculata) larviposit in high densities in ponds. Thus, larvae of different females confront competition and predation by other larvae. We studied whether larvae prefer their kin over particular density or vice versa. We experimentally used a transparent glass aquarium with inner chambers to test the responses of a focal larva toward its siblings and non-siblings. Specifically, we quantified the time a focal larva spent near its siblings or non-siblings, presented in varying densities, and the aggression level it demonstrated. We found that focal larvae spent more time near non-siblings if non-sibling and sibling groups were of equal density. The focal larvae were also more aggressive toward non-siblings. The results may be explained by the cannibalistic nature of these larvae: high density may provide more opportunities for food, especially when non-siblings are present. Further explanations for these findings may include other advantages of staying in a larger group and/or the stronger olfactory and visual stimulation offered by groups compared to a single individual. These findings suggest that larvae make differential responses toward conspecifics depending simultaneously on the level of relatedness and the density of the group. Such responses have important implications for social-aggregation decisions and may especially affect the fitness of cannibalistic species.	[Berkowic, Daniel; Markman, Shai] Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Tivon, Israel	University of Haifa	Markman, S (corresponding author), Univ Haifa, Fac Nat Sci, Dept Biol & Environm, Tivon, Israel.	markmans@research.haifa.ac.il		Markman, Shai/0000-0002-0484-3801				Alon A., 1984, REPTILES AMPHIBANS, V5; Anderson TL, 2017, OECOLOGIA, V185, P475, DOI 10.1007/s00442-017-3954-9; Bateson P., 1983, MATE CHOICE; Bilde T, 2007, J EVOLUTION BIOL, V20, P2412, DOI 10.1111/j.1420-9101.2007.01407.x; Blaustein L, 1996, OIKOS, V76, P392, DOI 10.2307/3546211; Caspers BA, 2011, AMPHIBIA-REPTILIA, V32, P503, DOI 10.1163/156853811X603265; DEGANI G, 1980, HYDROBIOLOGIA, V75, P123, DOI 10.1007/BF00007425; DEGANI G, 1993, ISRAEL J ZOOL, V39, P125; Degani G, 1996, SALAMANDER SO LIMIT; Di Maggio R, 2013, J ORNITHOL, V154, P901, DOI 10.1007/s10336-013-0954-3; Ebensperger LA, 2012, J ANIM ECOL, V81, P1013, DOI 10.1111/j.1365-2656.2012.01973.x; Eitam A, 2005, OECOLOGIA, V146, P36, DOI 10.1007/s00442-005-0185-2; Gibbons ME, 2003, HERPETOLOGICA, V59, P322, DOI 10.1655/02-53; Gramapurohit NP, 2004, J HERPETOL, V38, P594, DOI 10.1670/53-03N; GREIGSMITH PW, 1988, IBIS, V130, P1, DOI 10.1111/j.1474-919X.1988.tb00950.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hepper PG., 1991, KIN RECOGNITION; Ibanez A, 2014, AMPHIBIA-REPTILIA, V35, P189, DOI 10.1163/15685381-00002941; Kimball RT, 2003, AUK, V120, P717, DOI 10.1642/0004-8038(2003)120[0717:OAEOCB]2.0.CO;2; Markman S, 2009, BEHAV ECOL SOCIOBIOL, V63, P1149, DOI 10.1007/s00265-009-0765-y; Michimae H, 2001, BEHAV ECOL SOCIOBIOL, V50, P339, DOI 10.1007/s002650100368; PFENNIG DW, 1993, NATURE, V362, P836, DOI 10.1038/362836a0; Pfennig DW, 1997, BIOSCIENCE, V47, P667, DOI 10.2307/1313207; PFENNIG DW, 1994, BEHAV ECOL, V5, P225, DOI 10.1093/beheco/5.2.225; Quirici V, 2013, ACTA ETHOL, V16, P1, DOI 10.1007/s10211-012-0131-3; Reques R, 1996, HERPETOL J, V6, P15; Ricci L, 2013, ANIM BEHAV, V86, P245, DOI 10.1016/j.anbehav.2013.04.011; RICHNER H, 1992, ECOLOGY, V73, P330, DOI 10.2307/1938744; Roberts SJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P1995, DOI 10.1007/s00265-013-1607-5; Sadeh A, 2015, OECOLOGIA, V179, P425, DOI 10.1007/s00442-015-3366-7; Sadeh A, 2012, EVOL ECOL RES, V14, P113; Sadeh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015602; Sadeh A, 2009, ECOL LETT, V12, P1158, DOI 10.1111/j.1461-0248.2009.01371.x; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Sorato E, 2012, ANIM BEHAV, V84, P823, DOI 10.1016/j.anbehav.2012.07.003; Switzer PV, 2000, BEHAVIOUR, V137, P401, DOI 10.1163/156853900502141; Templeton A.R., 1986, P105; Thornhill N.W., 1993, NATURAL HIST INBREED; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; WALLS SC, 1991, AM NAT, V138, P1027, DOI 10.1086/285266; WALLS SC, 1987, CAN J ZOOL, V65, P2938, DOI 10.1139/z87-446; WARBURG MR, 1992, HERPETOL J, V2, P54; Wildy EL, 2001, OECOLOGIA, V128, P202, DOI 10.1007/s004420100641; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x	44	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220499	10.1371/journal.pone.0220499	http://dx.doi.org/10.1371/journal.pone.0220499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381581	Green Published, gold, Green Submitted			2022-12-27	WOS:000484993600018
J	Jaworek, H; Kubanova, K; Koudelakova, V; Slavkovsky, R; Drabek, J; Hajduch, M				Jaworek, Hana; Kubanova, Katerina; Koudelakova, Vladimira; Slavkovsky, Rastislav; Drabek, Jiri; Hajduch, Marian			Pitfalls of commercially available HPV tests in HPV68a detection	PLOS ONE			English	Article							CERVICAL-CANCER; GENOTYPES; IMPACT	Background Human papillomavirus 68 (HPV68) is a probable carcinogenic HPV genotype which is included in almost all HPV screening assays and exists as two genetically variable subtypes (HPV68a and HPV68b). Routine HPV sample testing has shown that the cobas 4800 HPV Test (Roche) provides higher false-negative rates for HPV68 status than PapilloCheck HPV-Screening (Greiner Bio-One). The aim of our study was to evaluate the efficacy of cobas 4800 in HPV68 detection. Methods A total of 2,145 cervical/cervicovaginal samples from women aged 17-88 were tested for HPV68 status using the cobas 4800 and PapilloCheck HPV tests. Viral load was assessed by quantitative PCR in all of the HPV68-positive cases. HPV68a/b subtyping was performed with real-time PCR followed by high resolution melting curve analysis, and was subsequently confirmed by Sanger sequencing. Results Cobas 4800 detected HPV positivity in only 13/33 HPV68 single-genotype infection cases. Viral load was comparable across both tested subgroups. HRM analysis and Sanger sequencing identified the HPV68a subtype in all of the 20 instances of cobas 4800 false negatives. HPV68a and HPV68b were detected in 3/13 and 10/13 cases identified as other HPV-positive by cobas 4800. Conclusion The HPV68a subtype was missed by cobas 4800 in more than 85% of all HPV68a-positive cases. Therefore, commercially available assays may underestimate HPV68 prevalence.	[Jaworek, Hana; Kubanova, Katerina; Koudelakova, Vladimira; Slavkovsky, Rastislav; Drabek, Jiri; Hajduch, Marian] Palacky Univ Olomouc, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic; [Drabek, Jiri; Hajduch, Marian] Canc Res Czech Republ, Olomouc, Czech Republic	Palacky University Olomouc	Koudelakova, V; Hajduch, M (corresponding author), Palacky Univ Olomouc, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic.; Hajduch, M (corresponding author), Canc Res Czech Republ, Olomouc, Czech Republic.	vladimira.koudelakova@upol.cz; marian.hajduch@upol.cz	Hajduch, Marian/J-4015-2014; Drabek, Jiri/A-6135-2008	Hajduch, Marian/0000-0002-4834-908X; Koudelakova, Vladimira/0000-0001-5842-7478; Drabek, Jiri/0000-0002-5747-6478; Kubanova, Katerina/0000-0002-9489-9998; Jaworek, Hana/0000-0001-6263-0049	Czech Ministry of Education, Youth and Sports [NPS I LO1304, CZ.02.1.01/0.0/0.0/16_019/0000868, LM2015064]; Technological Agency of the Czech Republic [TE02000058]; charity Cancer Research Czech Republic	Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Technological Agency of the Czech Republic; charity Cancer Research Czech Republic	This study was supported by the Czech Ministry of Education, Youth and Sports grant NPS I LO1304 (JD, RS, VK, MH), CZ.02.1.01/0.0/0.0/16_019/0000868 (VK) and LM2015064 (MH), Technological Agency of the Czech Republic TE02000058 (VK, HJ) and charity Cancer Research Czech Republic (MH, JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista JE, 2017, INT J INFECT DIS, V55, P51, DOI 10.1016/j.ijid.2017.01.001; BOUVARD V, 2009, LANCET ONCOL, V10, P321, DOI [DOI 10.1016/S1470-2045(09)70096-8, 10.1016/s1470-2045(09)70096-8]; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dwight ZL, 2014, HUM MUTAT, V35, P278, DOI 10.1002/humu.22494; Eklund C, 2014, J CLIN MICROBIOL, V52, P449, DOI 10.1128/JCM.02453-13; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; Estrade C, 2014, J CLIN MICROBIOL, V52, P4033, DOI 10.1128/JCM.01950-14; Greiner Bio-One, 2012, PAPILLOCHECK HIGH RI; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Halec G, 2014, J PATHOL, V234, P441, DOI 10.1002/path.4405; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P9; Jaworek H, 2020, BIOMED PAP, V164, P71, DOI 10.5507/bp.2018.079; Jaworek H, 2018, J MOL DIAGN, V20, P849, DOI 10.1016/j.jmoldx.2018.07.004; Kim Na Rae, 2014, Korean J Pathol, V48, P43, DOI 10.4132/KoreanJPathol.2014.48.1.43; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Longuet M, 1996, J CLIN MICROBIOL, V34, P738, DOI 10.1128/JCM.34.3.738-744.1996; Monsonego J, 2015, GYNECOL ONCOL, V137, P47, DOI 10.1016/j.ygyno.2015.01.551; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nadace pro Vyzkum Rakoviny, LETS COMB CANC TOG; Rao A, 2013, J CLIN MICROBIOL, V51, P1478, DOI 10.1128/JCM.03386-12; Schiffman M, 2005, J NATL CANCER I, V97, P147, DOI 10.1093/jnci/dji014; Nascimento MDSB, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-017-0499-3; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; Xu L, 2018, J CLIN VIROL, V98, P37, DOI 10.1016/j.jcv.2017.12.001	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220373	10.1371/journal.pone.0220373	http://dx.doi.org/10.1371/journal.pone.0220373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381580	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600016
J	Milanovic, V; Osimani, A; Cardinali, F; Litta-Mulondo, A; Vignaroli, C; Citterio, B; Mangiaterra, G; Aquilanti, L; Garofalo, C; Biavasco, F; Cocolin, L; Ferrocino, I; Di Cagno, R; Turroni, S; Lazzi, C; Pellegrini, N; Clementi, F				Milanovic, Vesna; Osimani, Andrea; Cardinali, Federica; Litta-Mulondo, Alice; Vignaroli, Carla; Citterio, Barbara; Mangiaterra, Gianmarco; Aquilanti, Lucia; Garofalo, Cristiana; Biavasco, Francesca; Cocolin, Luca; Ferrocino, Ilario; Di Cagno, Raffaella; Turroni, Silvia; Lazzi, Camilla; Pellegrini, Nicoletta; Clementi, Francesca			Erythromycin-resistant lactic acid bacteria in the healthy gut of vegans, ovo-lacto vegetarians and omnivores	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ENTEROCOCCUS-FAECIUM; ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANT; VIRULENCE FACTORS; GENES; FOOD; MICROBIOTA; DIVERSITY; CHAIN	Diet can affect the diversity and composition of gut microbiota. Usage of antibiotics in food production and in human or veterinary medicine has resulted in the emergence of commensal antibiotic resistant bacteria in the human gut. The incidence of erythromycin-resistant lactic acid bacteria (LAB) in the feces of healthy vegans, ovo-lacto vegetarians and omnivores was analyzed. Overall, 155 LAB were isolated and characterized for their phenotypic and genotypic resistance to erythromycin. The isolates belonged to 11 different species within the Enterococcus and Streptococcus genera. Enterococcus faecium was the dominant species in isolates from all the dietary categories. Only 97 out of 155 isolates were resistant to erythromycin after Minimum Inhibitory Concentration (MIC) determination; among them, 19 isolates (7 from vegans, 4 from ovo-lacto vegetarians and 8 from omnivores) carried the erm(B) gene. The copresence of erm(B) and erm(A) genes was only observed in Enterococcus avium from omnivores. Moreover, the transferability of erythromycin resistance genes using multidrug-resistant (MDR) cultures selected from the three groups was assessed, and four out of six isolates were able to transfer the erm(B) gene. Overall, isolates obtained from the omnivore samples showed resistance to a greater number of antibiotics and carried more tested antibiotic resistance genes compared to the isolates from ovo-lacto vegetarians and vegans. In conclusion, our results show that diet does not significantly affect the occurrence of erythromycin-resistant bacteria and that commensal strains may act as a reservoir of antibiotic resistance (AR) genes and as a source of antibiotic resistance spreading.	[Milanovic, Vesna; Osimani, Andrea; Cardinali, Federica; Litta-Mulondo, Alice; Aquilanti, Lucia; Garofalo, Cristiana; Clementi, Francesca] Univ Politecn Marche, Dipartimento Sci Agr Alimentari Ambientali, Ancona, Italy; [Litta-Mulondo, Alice; Vignaroli, Carla; Mangiaterra, Gianmarco; Biavasco, Francesca] Univ Politecn Marche, Dipartimento Sci Vitae & Ambiente, Ancona, Italy; [Citterio, Barbara] Univ Urbino Carlo Bo, Dept Biomol Sci, Biotechnol Sect, Urbino, Italy; [Cocolin, Luca; Ferrocino, Ilario] Univ Turin, Dept Agr Forest & Food Sci DISAFA, Grugliasco, Italy; [Di Cagno, Raffaella] Libera Univ Bolzano, Fac Sci & Technol, Bolzano, Italy; [Turroni, Silvia] Univ Bologna, Dept Pharm & Biotechnol, Alma Mater Studiorum, Bologna, Italy; [Lazzi, Camilla; Pellegrini, Nicoletta] Univ Parma, Dept Food Sci, Parma, Italy	Marche Polytechnic University; Marche Polytechnic University; University of Urbino; University of Turin; Free University of Bozen-Bolzano; University of Bologna; University of Parma	Aquilanti, L (corresponding author), Univ Politecn Marche, Dipartimento Sci Agr Alimentari Ambientali, Ancona, Italy.	l.aquilanti@univpm.it	Cocolin, Luca/H-5091-2012; Citterio, Barbara/AAB-2237-2019; Turroni, Silvia/J-7195-2016	Cocolin, Luca/0000-0003-4799-7074; Citterio, Barbara/0000-0003-3346-6379; Turroni, Silvia/0000-0003-2345-9482; Mangiaterra, Gianmarco/0000-0001-5035-5879; FERROCINO, ILARIO/0000-0002-1657-0054; Milanovic, Vesna/0000-0001-8548-366X	Italian Ministry of University and Research (MIUR) PRIN 2010-2011 program (project: "Microorganisms in foods and in humans: study of the microbiota and the related metabolome as affected by omnivore, vegetarian or vegan diets")	Italian Ministry of University and Research (MIUR) PRIN 2010-2011 program (project: "Microorganisms in foods and in humans: study of the microbiota and the related metabolome as affected by omnivore, vegetarian or vegan diets")	This study was funded by the Italian Ministry of University and Research (MIUR) PRIN 2010-2011 program (project: "Microorganisms in foods and in humans: study of the microbiota and the related metabolome as affected by omnivore, vegetarian or vegan diets"). The funders played no role in the design of the study, the data collection and analysis, the decision to publish or in the preparation of the manuscript.	Aarts H, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00754; Abriouel H, 2008, INT J FOOD MICROBIOL, V123, P38, DOI 10.1016/j.ijfoodmicro.2007.11.067; Acar JF, 2006, REV SCI TECH OIE, V25, P775, DOI 10.20506/rst.25.2.1695; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aquilanti L, 2004, SOIL BIOL BIOCHEM, V36, P1475, DOI 10.1016/j.soilbio.2004.04.024; Badosa E, 2008, J SCI FOOD AGR, V88, P605, DOI 10.1002/jsfa.3124; Bailey JK, 2010, J MED MICROBIOL, V59, P1331, DOI 10.1099/jmm.0.022475-0; Bengtsson-Palme J, 2017, CURR OPIN FOOD SCI, V14, P66, DOI 10.1016/j.cofs.2017.01.010; Brenciani A, 2014, J ANTIMICROB CHEMOTH, V69, P1197, DOI 10.1093/jac/dkt495; Card RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086428; Cittterio B, 2017, FOOD CONTROL, V82, P184, DOI 10.1016/j.foodcont.2017.06.022; CLEWELL DB, 1995, TRENDS MICROBIOL, V3, P229, DOI 10.1016/S0966-842X(00)88930-1; CLSI, 2020, PERF STAND ANT SUSC, V40; CLSI, 2015, METHODS FOR DILUTION; COYKENDALL AL, 1989, CLIN MICROBIOL REV, V2, P315, DOI 10.1128/CMR.2.3.315-328.1989; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; de Vries LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021644; Devarajan N, 2015, ENVIRON SCI TECHNOL, V49, P6528, DOI 10.1021/acs.est.5b01031; Devirgiliis C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00301; Di Sante L, 2017, J ANTIMICROB CHEMOTH, V72, P2447, DOI 10.1093/jac/dkx197; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Economou V, 2015, INFECT DRUG RESIST, V8, P49, DOI 10.2147/IDR.S55778; Ferrocino I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128669; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Garofalo C, 2007, INT J FOOD MICROBIOL, V113, P75, DOI 10.1016/j.ijfoodmicro.2006.07.015; Gomes BC, 2008, FOOD MICROBIOL, V25, P668, DOI 10.1016/j.fm.2008.03.008; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Harmsen HJM, 2016, ADV EXP MED BIOL, V902, P95, DOI 10.1007/978-3-319-31248-4_7; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Huddleston JR, 2014, INFECT DRUG RESIST, V7, P167, DOI 10.2147/IDR.S48820; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kim MS, 2013, ENV MICROBIOL REP, V5, P765, DOI 10.1111/1758-2229.12079; Lebreton F., 2014, ENTEROCOCCI COMMENSA, P5; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Losasso C, 2018, INT J ANTIMICROB AG, V52, P702, DOI 10.1016/j.ijantimicag.2018.07.023; Macovei L, 2007, APPL ENVIRON MICROB, V73, P6740, DOI 10.1128/AEM.01444-07; Matijasic BB, 2014, EUR J NUTR, V53, P1051, DOI 10.1007/s00394-013-0607-6; Milanovic V, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601098; Morroni G, 2019, J ANTIMICROB CHEMOTH, V74, P843, DOI 10.1093/jac/dky549; Osimani A, 2015, INT J FOOD MICROBIOL, V194, P62, DOI 10.1016/j.ijfoodmicro.2014.11.011; Pagadala S, 2015, INT J FOOD MICROBIOL, V196, P98, DOI 10.1016/j.ijfoodmicro.2014.12.005; Perez-Pulido R, 2006, FOOD CHEM TOXICOL, V44, P2070, DOI 10.1016/j.fct.2006.07.008; Portillo A, 2000, ANTIMICROB AGENTS CH, V44, P967, DOI 10.1128/AAC.44.4.967-971.2000; Riboldi GP, 2008, J BASIC MICROB, V48, P31, DOI 10.1002/jobm.200700226; Rolain JM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00173; San Millan A, 2018, TRENDS MICROBIOL, V26, P978, DOI 10.1016/j.tim.2018.06.007; Valenzuela AS, 2013, FOODBORNE PATHOG DIS, V10, P143, DOI 10.1089/fpd.2012.1279; Schwarz FV, 2001, PLASMID, V46, P170, DOI 10.1006/plas.2001.1544; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Stoll C, 2012, ENVIRON SCI TECHNOL, V46, P9716, DOI 10.1021/es302020s; Trivedi K, 2011, VET MED-CZECH, V56, P352, DOI 10.17221/1584-VETMED; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; vandenBraak N, 1997, LANCET, V350, P146, DOI 10.1016/S0140-6736(05)61856-9; Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643; Vignaroli C, 2013, ENVIRON SCI TECHNOL, V47, P13772, DOI 10.1021/es4019139; Vignaroli C, 2011, CURR MICROBIOL, V62, P1438, DOI 10.1007/s00284-011-9880-x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; World Health Organization, 2014, GLOBAL REPORT ON SUR; Wu GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24030; Young VB, 2012, CURR OPIN GASTROEN, V28, P63, DOI 10.1097/MOG.0b013e32834d61e9	63	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220549	10.1371/journal.pone.0220549	http://dx.doi.org/10.1371/journal.pone.0220549			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374082	Green Published, gold			2022-12-27	WOS:000484991500017
J	Broman, ME; Hansson, F; Vincent, JL; Bodelsson, M				Broman, Marcus E.; Hansson, Fredrik; Vincent, Jean-Louis; Bodelsson, Mikael			Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study	PLOS ONE			English	Article							POLYMYXIN-B HEMOPERFUSION; SEVERE SEPSIS; HEMOFILTRATION; REMOVAL	Background Endotoxin induces an inflammatory response, with secondary release of cytokines, which can progress to shock and multiple organ failure. We explored whether continuous renal replacement therapy (CRRT) using a modified membrane (oXiris) capable of adsorption could reduce endotoxin and cytokine levels in septic patients. Methods Sixteen patients requiring CRRT for septic shock-associated acute renal failure and who had endotoxin levels >03 EU/ml were prospectively randomized in a crossover double-blind design to receive CRRT with an oXiris filter or with a standard filter. Endotoxin and cytokine levels were measured at baseline and 1, 3, 8, 16 and 24 hours after the start of CRRT. Norepinephrine infusion rate and blood lactate levels were monitored. Results During the first filter treatment period, endotoxin levels decreased in 7 of 9 (77.8%) oXiris filter patients, but in only 1 of 6 (16.7%) standard filter patients (P = 0.02). Levels of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-8 and interferon (IFN)gamma decreased more with the oXiris filter than with the standard filter. Lactate concentration decreased with oXiris (-1.3[-2.2 to -1.1] mmol/l, P = 0.02), but not with the standard filter (+0.15[-0.95 to 0.6]). The norepinephrine infusion rate was reduced during oXiris CRRT, but not during standard filter CRRT. In the second filter treatment period, there was no significant reduction in endotoxin or cytokine levels in either group. Conclusions CRRT with the oXiris filter seemed to allow effective removal of endotoxin and TNF-alpha, IL-6, IL-8 and IFN gamma in patients with septic shock-associated acute renal failure. This may be associated with beneficial hemodynamic effects.	[Broman, Marcus E.; Bodelsson, Mikael] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Anaesthesiol & Intens Care, Lund, Sweden; [Hansson, Fredrik] Dag Hammarskjolds Vag, Uppsala, Sweden; [Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium	Lund University; Skane University Hospital; Universite Libre de Bruxelles	Vincent, JL (corresponding author), Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium.	jlvincent@intensive.org		Vincent, Jean-Louis/0000-0001-6011-6951	Skane University Hospital Research Funds, Sweden; Skane County Council's Research and Development Foundation, Sweden; Anna and Edwin Berger Foundation, Sweden; Baxter Healthcare, Chicago, USA	Skane University Hospital Research Funds, Sweden; Skane County Council's Research and Development Foundation, Sweden; Anna and Edwin Berger Foundation, Sweden; Baxter Healthcare, Chicago, USA	This study was funded by Skane University Hospital Research Funds, the Skane County Council's Research and Development Foundation, the Anna and Edwin Berger Foundation, all Sweden, and a research grant was provided by Baxter Healthcare, Chicago, USA to authors MEB and MB. All data and the results were solely analyzed and processed by the authors.Baxter Healthcare, Chicago, USA had no involvement in study design, in the collection, analysis and interpretation of data, in the writing of the report, or in the decision to submit the article for publication.	Ala-Kokko TI, 2011, BLOOD PURIFICAT, V32, P303, DOI 10.1159/000330323; Ankawi G, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2181-z; Atan R, 2013, RENAL FAILURE, V35, P1061, DOI 10.3109/0886022X.2013.815089; Beutler B, 2000, CURR OPIN MICROBIOL, V3, P23, DOI 10.1016/S1369-5274(99)00046-6; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cruz DN, 2009, JAMA-J AM MED ASSOC, V301, P2445, DOI 10.1001/jama.2009.856; DANNER RL, 1991, CHEST, V99, P169, DOI 10.1378/chest.99.1.169; De Vriese AS, 1999, J AM SOC NEPHROL, V10, P846; Dellinger RP, 2018, JAMA-J AM MED ASSOC, V320, P1455, DOI 10.1001/jama.2018.14618; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Honore PM, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0530-y; Hurley JC, 2003, J ENDOTOXIN RES, V9, P271, DOI 10.1179/096805103225002511; Joannes-Boyau O, 2013, INTENS CARE MED, V39, P1535, DOI 10.1007/s00134-013-2967-z; KAMBAYASHI J, 1991, J BIOCHEM BIOPH METH, V22, P93, DOI 10.1016/0165-022X(91)90022-O; Lin E., 1998, Sepsis, V2, P255, DOI 10.1023/A:1009890031293; Malard B, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0177-2; Marshall JC, 2004, J INFECT DIS, V190, P527, DOI 10.1086/422254; Payen D, 2009, CRIT CARE MED, V37, P803, DOI 10.1097/CCM.0b013e3181962316; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rimmele T, 2011, CRIT CARE, V15, DOI 10.1186/cc9411; ROTH RI, 1990, J LAB CLIN MED, V116, P153; Schadler D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187015; Vaishnavi C, 2013, INDIAN J MED MICROBI, V31, P334, DOI 10.4103/0255-0857.118870; Venet C, 2000, INTENS CARE MED, V26, P538, DOI 10.1007/s001340051201	25	65	75	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220444	10.1371/journal.pone.0220444	http://dx.doi.org/10.1371/journal.pone.0220444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369593	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900048
J	Gebremariam, A; Addissie, A; Worku, A; Assefa, M; Kantelhardt, EJ; Jemal, A				Gebremariam, Alem; Addissie, Adamu; Worku, Alemayehu; Assefa, Mathewos; Kantelhardt, Eva Johanna; Jemal, Ahmedin			Perspectives of patients, family members, and health care providers on late diagnosis of breast cancer in Ethiopia: A qualitative study	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; WOMEN; INDIA; DELAY	Background Most women with breast cancer in Ethiopia are diagnosed at an advanced stage of the disease, but the reasons for this have not been systematically investigated. This study, therefore, aimed to explore the main reasons for diagnosis of advanced stage breast cancer from the perspective of patients, family members, and health care providers. Methods A qualitative study with in-depth interviews was conducted with 23 selected participants at Tikur Anbessa Specialized Hospital, Oncology Clinic using a semi-structured interview guide. These participants were 13 breast cancer patients, 5 family members, and 5 health care providers. Data were transcribed into English, coded and analyzed using thematic analysis. Results Awareness about the causes, risk, initial symptoms, early detection methods, and treatment of breast cancer were uncommon, and misconceptions about the disease prevailed among breast cancer patients and family members. There was a sense of hopelessness and uncertainty about the effectiveness of conventional medicine amongst patients and family members. Consequently, performing spiritual acts (using holy water) or seeking care from traditional healers recurred amongst the interviewees. Not taking initial symptoms of breast cancer seriously by the patients, reliance on traditional medicines, competing priorities, financial hardship, older age, fear of diagnosis of cancer, and weak health systems (e.g., delay in referral and long waiting period for consultation) were noted as the main contributors to late diagnosis. In contrast, persuasion by family members and friends, higher educational attainment, and prior experience of neighboring women with breast cancer were mentioned to be facilitators of early diagnosis of breast cancer. Conclusions The causes of late diagnosis of breast cancer in Ethiopia are multi-factorial and include individual, cultural, and health system factors. Interventions targeting these factors could alleviate the misconceptions and knowledge gap about breast cancer in the community, and shorten waiting time between symptom recognition and diagnosis of breast cancer.	[Gebremariam, Alem] Adigrat Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Adigrat, Ethiopia; [Gebremariam, Alem; Addissie, Adamu; Worku, Alemayehu] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Assefa, Mathewos] Addis Ababa Univ, Radiotherapy Ctr, Sch Med, Addis Ababa, Ethiopia; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany; [Jemal, Ahmedin] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA	Addis Ababa University; Addis Ababa University; Martin Luther University Halle Wittenberg; American Cancer Society	Gebremariam, A (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Adigrat, Ethiopia.; Gebremariam, A (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia.	alemg25@gmail.com		Gebremariam, Alem/0000-0003-2173-6685	Intramural Research Department of the American Cancer Society	Intramural Research Department of the American Cancer Society	This project is supported by the Intramural Research Department of the American Cancer Society. The funder has no role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.	Abeje S, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-018-0695-9; Astalin PK, 2013, INT J SOC SCI INTERD, V2, P118; Atuhairwe C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5183-5; Awas T, 2009, P 16 INT C ETH STUD, V3, P711; Begashaw B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161014; Birhan W, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-39; Birhanu Z, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-83; Black E, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-018-0446-6; Bodapati SL, 2013, ASIAN PAC J CANCER P, V14, P5817, DOI 10.7314/APJCP.2013.14.10.5817; Bonsu AB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212806; Clegg-Lamptey J N A, 2009, West Afr J Med, V28, P114; Deressa BT, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5612-6; Dye TD, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/908547; Dye TD, 2010, CANCER-AM CANCER SOC, V116, P577, DOI 10.1002/cncr.24776; Dye TD, 2011, GLOB PUBLIC HEALTH, V6, P719, DOI 10.1080/17441692.2010.510479; El Saghir NS, 2011, BREAST, V20, pS3, DOI 10.1016/j.breast.2011.02.006; Espina C, 2017, ANN EPIDEMIOL, V27, P659, DOI 10.1016/j.annepidem.2017.09.007; Federal Ministry of Health Ethiopia, NAT CANC CONTR PLAN; Frie KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207928; Frie KG, 2018, BREAST CARE, V13, P39, DOI 10.1159/000481087; Gebremariam A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027034; Hammarberg K, 2016, HUM REPROD, V31, P498, DOI 10.1093/humrep/dev334; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Joffe M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192071; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Kisuya J, 2015, HEALTH EDUC RES, V30, P786, DOI 10.1093/her/cyv043; Magana-Valladares L, 2018, J CANCER EDUC, V33, P160, DOI 10.1007/s13187-016-1065-7; Maghous A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2394-y; Manglona Rosa Duenas, 2010, Calif J Health Promot, V8, P90; McQueen A, 2008, HEALTH PSYCHOL, V27, P68, DOI 10.1037/0278-6133.27.1.68; Montazeri A, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-32; Pace LE, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00098; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Park E, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3965-2; Poum A, 2014, J EPIDEMIOL, V24, P102, DOI 10.2188/jea.JE20130090; Rastad H, 2012, ASIAN PAC J CANCER P, V13, P4511, DOI 10.7314/APJCP.2012.13.9.4511; Reeler AV, 2008, CLIN ONCOL-UK, V20, P191, DOI 10.1016/j.clon.2007.11.012; Sathwara JA, 2017, INDIAN J MED PAEDIAT, V38, P277, DOI 10.4103/ijmpo.ijmpo_15_16; Sharma K, 2013, J ONCOL, V2013, DOI 10.1155/2013/206367; Smit A, 2019, SOC SCI MED, V222, P231, DOI 10.1016/j.socscimed.2019.01.020; Smith MA, 2016, CLIN J ONCOL NURS, V20, P427, DOI 10.1188/16.CJON.427-432; Timotewos G, 2018, CANCER EPIDEMIOL, V53, P93, DOI 10.1016/j.canep.2018.01.008; Trotter RT, 2012, PREV MED, V55, P398, DOI 10.1016/j.ypmed.2012.07.003; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; World Health Organization, 2011, GLOB STAT REP ALC HL; Yi M, 2012, J ADV NURS, V68, P1100, DOI 10.1111/j.1365-2648.2011.05815.x; Yusoff N, 2011, ASIAN PAC J CANCER P, V12, P2563	47	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220769	10.1371/journal.pone.0220769	http://dx.doi.org/10.1371/journal.pone.0220769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369640	Green Submitted, gold, Green Published			2022-12-27	WOS:000484987900086
J	Kamali, AM; Saadi, ZK; Yahyavi, SS; Zarifkar, A; Aligholi, H; Nami, M				Kamali, Ali-Mohammad; Saadi, Zahra Kheradmand; Yahyavi, Seyedeh-Saeedeh; Zarifkar, Asadollah; Aligholi, Hadi; Nami, Mohammad			Transcranial direct current stimulation to enhance athletic performance outcome in experienced bodybuilders	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; ISOMETRIC STRENGTH; BRAIN-STIMULATION; WORKING-MEMORY; MODULATION; EXCITABILITY; ACTIVATION; TASK; TDCS; MECHANISMS	Transcranial direct current stimulation (tDCS) is currently under investigation as a promising technique for enhancement of athletic performance through modulating cortical excitability. Through consecutive randomization, 12 experienced bodybuilders were randomly assigned to two arms receiving either sham or real tDCS over the primary motor cortex (leg area) and left temporal cortex (T3) for 13 minutes in the first session. After 72 hours, both groups received the inverse stimulation. After the brain stimulation, cerebral hemodynamic response (using frontopolar hemoencephalography) was examined upon taking three computer-based cognitive tasks i.e. reasoning, memory and verbal ability using the Cambridge Brain Science-Cognitive Platform. Subsequently, the bodybuilders performed knee extension exercise while performance indicators including one-repetition maximum (1RM), muscular endurance (SEI), heart rate (ECG), motivation (VAS), surface electromyography over quadriceps femoris muscle (sEMG) and perceived exertion (RPE) were evaluated. The real tDCS vs. sham group showed decreased RPE and HR mean scores by 14.2% and 4.9%, respectively. Regarding muscular strength, endurance, and electrical activity, the 1RM, SEI, and sEMG factors improved by 4.4%, 16.9%, and % 5.8, respectively. Meanwhile, compared to sham, real tDCS did not affect the athletes' motivation. Incidentally, it turned out that subjects who underwent T3 anodal stimulation outperformed in memory (p = 0.02) and verbal functions (0.02) as well as their corresponding frontopolar hemodynamic response [(memory HEG (p = 0.001) and verbal HEG (p = 0.003)]. Our findings suggest that simultaneous tDCS-induced excitation over the M1 leg area and left temporal area may potentially improve the overall athletic performance in experienced bodybuilders.	[Kamali, Ali-Mohammad; Yahyavi, Seyedeh-Saeedeh; Zarifkar, Asadollah; Aligholi, Hadi; Nami, Mohammad] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Shiraz, Iran; [Kamali, Ali-Mohammad; Saadi, Zahra Kheradmand; Yahyavi, Seyedeh-Saeedeh; Aligholi, Hadi; Nami, Mohammad] Iranian Neurosci Soc, DANA Brain Hlth Inst, Fars Branch, Shiraz, Iran; [Kamali, Ali-Mohammad; Saadi, Zahra Kheradmand; Yahyavi, Seyedeh-Saeedeh; Nami, Mohammad] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Neurosci Lab,NSL Brain Cognit & Behav, Shiraz, Iran; [Kamali, Ali-Mohammad; Yahyavi, Seyedeh-Saeedeh] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran; [Saadi, Zahra Kheradmand] Shiraz Univ, Dept Foreign Languages & Literature, Shiraz, Iran; [Zarifkar, Asadollah] Shiraz Univ Med Sci, Dept Physiol, Sch Med, Shiraz, Iran; [Nami, Mohammad] Senses Cultural Fdn, Acad Hlth, Sacramento, CA 95826 USA	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University; Shiraz University of Medical Science	Nami, M (corresponding author), Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Shiraz, Iran.; Nami, M (corresponding author), Iranian Neurosci Soc, DANA Brain Hlth Inst, Fars Branch, Shiraz, Iran.; Nami, M (corresponding author), Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Neurosci, Neurosci Lab,NSL Brain Cognit & Behav, Shiraz, Iran.; Nami, M (corresponding author), Senses Cultural Fdn, Acad Hlth, Sacramento, CA 95826 USA.	torabinami@sums.ac.ir	zarifkar, asadollah/U-6873-2017; Nami, Mohammad/AAL-6280-2021	zarifkar, asadollah/0000-0002-2684-6712; Nami, Mohammad/0000-0003-1410-5340; Leo, TJ/0000-0002-9525-6572	Shiraz University of Medical Sciences [1396-01-74-14298]	Shiraz University of Medical Sciences	This work was supported by Shiraz University of Medical Sciences under the grant No. 1396-01-74-14298.	Angius L, 2016, NEUROSCIENCE, V339, P363, DOI 10.1016/j.neuroscience.2016.10.028; Angius L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00090; Baudewig J, 2001, MAGN RESON MED, V45, P196, DOI 10.1002/1522-2594(200102)45:2<196::AID-MRM1026>3.0.CO;2-1; Bigliassi M, 2016, PHYSIOL BEHAV, V158, P128, DOI 10.1016/j.physbeh.2016.03.001; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Borducchi DMM, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00183; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; Colzato LS, 2017, J COGN ENHANCE, V1, P73, DOI 10.1007/s41465-016-0003-2; Davis NJ, 2013, SPORTS MED, V43, P649, DOI 10.1007/s40279-013-0027-z; Devinsky Orrin, 2004, Epilepsy Curr, V4, P43, DOI 10.1111/j.1535-7597.2004.42001.x; Dutta A, 2014, NEUROREHABILITATION, V34, P789, DOI 10.3233/NRE-141077; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Furley PA, 2012, J SPORT EXERCISE PSY, V34, P322, DOI 10.1123/jsep.34.3.322; Furuya S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-35; Geiger M, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2219-6; Grospretre S, 2016, EUR J SPORT SCI, V16, P317, DOI 10.1080/17461391.2015.1024756; Hall JE, 2015, GUYTON HALL TXB MED; Hampshire A, 2012, NEURON, V76, P1225, DOI 10.1016/j.neuron.2012.06.022; Hazime FA, 2017, INT J SPORTS PHYS TH, V12, P402; Hermens HJ, 1999, EUROPEAN RECOMMENDAT, V8, P13, DOI [10.1016/S1050-6411(00)00027-4, DOI 10.1016/S1050-6411(00)00027-4]; Hilz MJ, 2002, BRAIN, V125, P985, DOI 10.1093/brain/awf092; Jang SH, 2009, NEUROSCI LETT, V460, P117, DOI 10.1016/j.neulet.2009.05.037; Kamali A-M, 2018, CEREBELLUM, P1, DOI [10.1007/s12311-018-0919-4, DOI 10.1007/S12311-018-0919-4]; Kamali AM, 2019, CEREBELLUM, V18, P119, DOI 10.1007/s12311-018-0967-9; Kaminski E, 2016, CLIN NEUROPHYSIOL, V127, P2455, DOI 10.1016/j.clinph.2016.03.018; Kan B, 2013, APPL PHYSIOL NUTR ME, V38, P734, DOI 10.1139/apnm-2012-0412; Kaski D, 2014, NEUROSCI LETT, V568, P39, DOI 10.1016/j.neulet.2014.03.043; Kelsey JL., 1996, METHODS OBSERVATIONA; Krishnan C, 2014, BRAIN STIMUL, V7, P443, DOI 10.1016/j.brs.2014.01.057; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; LeSuer DA, 1997, J STRENGTH COND RES, V11, P211; Lewthwaite R, 2017, CURR OPIN PSYCHOL, V16, P38, DOI 10.1016/j.copsyc.2017.04.005; Medeiros L. F., 2012, NEUROBIOLOGICAL EFFE; Meinzer M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00253; Montenegro RA, 2011, NEUROSCI LETT, V497, P32, DOI 10.1016/j.neulet.2011.04.019; Moran A.P., 2016, PSYCHOL CONCENTRATIO; Muthalib M, 2013, ADV EXP MED BIOL, V789, P73, DOI 10.1007/978-1-4614-7411-1_11; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Noakes TD, 2011, SPORTS MED, V41, P263, DOI 10.2165/11583950-000000000-00000; Okano AH, 2013, BRIT J SPORT MED; Okano AH, 2015, BRIT J SPORT MED, V49, P1213, DOI 10.1136/bjsports-2012-091658; Oki K, 2001, J GERIATRIC PHYS THE; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Rroji O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127270; Serra-Sala M., 2012, J NEUROTHER, V16, P183, DOI [10.1080/10874208.2012.705754, DOI 10.1080/10874208.2012.705754]; Simons HD, 1999, J COLL STUDENT DEV, V40, P151; Sloan RP, 2009, AM J PUBLIC HEALTH, V99, P921, DOI 10.2105/AJPH.2007.133165; Sohn MK, 2013, ANN REHABIL MED-ARM, V37, P759, DOI 10.5535/arm.2013.37.6.759; Soutschek A, 2018, BIOL PSYCHIAT, V84, P38, DOI 10.1016/j.biopsych.2017.11.007; Stagg CJ, 2011, J PHYSIOL-LONDON, V589, P5845, DOI 10.1113/jphysiol.2011.216978; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Tanaka S, 2009, EXP BRAIN RES, V196, P459, DOI 10.1007/s00221-009-1863-9; Toomim H., 2005, J NEUROTHER, V8, P5, DOI DOI 10.1300/J184V08N03_; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH424, DOI 10.1152/ajpheart.1998.274.2.H424; Vitor-Costa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144916; Williams PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081418; Wulf G, 2016, PSYCHON B REV, V23, P1382, DOI 10.3758/s13423-015-0999-9; Zhou JH, 2014, EUR J NEUROSCI, V39, P1343, DOI 10.1111/ejn.12492; Zhou P, 2004, J NEUROPHYSIOL, V92, P2878, DOI 10.1152/jn.00367.2004; Zhu FF, 2015, BRAIN STIMUL, V8, P784, DOI 10.1016/j.brs.2015.02.005; Ziemann U, 1998, J NEUROSCI, V18, P7000	66	22	22	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220363	10.1371/journal.pone.0220363	http://dx.doi.org/10.1371/journal.pone.0220363			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369607	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900043
J	Schenk, M; Kropfl, JM; Hoermann-Kroepfl, M; Weiss, G				Schenk, Michael; Kropfl, Julia Maria; Hoermann-Kroepfl, Martina; Weiss, Gregor			Endometriosis accelerates synchronization of early embryo cell divisions but does not change morphokinetic dynamics in endometriosis patients	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTION; BLASTOCYST FORMATION; OOCYTE QUALITY; CLEAVAGE; IMPACT; IMPLANTATION; PREDICTORS; WOMEN	Objective The pathology of endometriosis and its impact on embryo development is still a black box in reproductive medicine. In this time-lapse study we investigated the influence of endometriosis on morphokinetic parameters of embryo development, taking variables of dynamic monitoring into account. Furthermore we evaluated reproductive medicine treatment outcome such as fetal heartbeat and live birth rate. Methods 1148 embryos (control: n = 596, endometriosis: n = 552) were retrospectively analyzed. Patients were stimulated with GnRH antagonist protocol. After fertilization, embryos were incubated in a time-lapse system (EmbryoScope). Results The mixed-model analysis revealed a significant main effect of time (p< 0.001), with posthoc tests showing that any time needed to reach a specific developmental stage was significantly different from all the others (all p< 0.001). Embryos of endometriosis patients showed the same absolute morphokinetic time parameters as the control group, however, synchronization of early embryo cell divisions (s2) was faster in endometriosis patients compared to the control group. Conclusion In general, endometriosis does not induce changes in early embryo morphokinetics. However, observed acceleration in cell cycle synchronization of embryo cleavage patterns might be a missing explanation for contradicting results in literature regarding the impairments in reproductive medicine treatment outcome of endometriosis patients.	[Schenk, Michael; Hoermann-Kroepfl, Martina; Weiss, Gregor] Kinderwunsch Inst Schenk GmbH, Dobl, Austria; [Schenk, Michael] Med Univ Graz, Inst Human Genet, Graz, Austria; [Kropfl, Julia Maria] Swiss Fed Inst Technol, Exercise Physiol Lab, Inst Human Movement Sci & Sport, Zurich, Switzerland	Medical University of Graz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Weiss, G (corresponding author), Kinderwunsch Inst Schenk GmbH, Dobl, Austria.	gregor.weiss@kinderwunsch-institut.at	Kröpfl, Julia Maria/ABE-5570-2020	Kröpfl, Julia Maria/0000-0002-9613-7268				Alviggi C, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-9; Armstrong S, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011320.pub3; Balaban B, 2011, HUM REPROD, V26, pI24; Barbosa MAP, 2014, ULTRASOUND OBST GYN, V44, P261, DOI 10.1002/uog.13366; Boynukalin FK, 2019, SYST BIOL REPROD MED, V65, P250, DOI 10.1080/19396368.2019.1573275; Burney RO, 2012, FERTIL STERIL, V98; Cetinkaya M, 2015, J ASSIST REPROD GEN, V32, P27, DOI 10.1007/s10815-014-0341-x; Chawla M, 2015, J ASSIST REPROD GEN, V32, P69, DOI 10.1007/s10815-014-0372-3; Ciray HN, 2014, HUM REPROD, V29, P2650, DOI 10.1093/humrep/deu278; Fauser BCJM, 2008, HUM REPROD UPDATE, V14, P1, DOI 10.1093/humupd/dmm034; Freis A, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0307-9; Goud PT, 2014, FERTIL STERIL, V102, P151, DOI 10.1016/j.fertnstert.2014.03.053; Gupta S, 2008, FERTIL STERIL, V90, P247, DOI 10.1016/j.fertnstert.2008.02.093; Huppertz B, 2016, OPEN J BIORESOUR, V3; Johnson NP, 2016, HUM REPROD OXF ENGL; Liu E, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012019; Lundin K, 2001, HUM REPROD, V16, P2652, DOI 10.1093/humrep/16.12.2652; Martins WP, 2017, ULTRASOUND OBST GYN, V49, P583, DOI 10.1002/uog.17327; Milewski R, 2015, J ASSIST REPROD GEN, V32, P571, DOI 10.1007/s10815-015-0440-3; Nisenblat V, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012179; Pop-Trajkovic S, 2014, TAIWAN J OBSTET GYNE, V53, P224, DOI 10.1016/j.tjog.2013.10.040; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031; Rogers PAW, 2009, REPROD SCI, V16, P335, DOI 10.1177/1933719108330568; Rubio I, 2012, FERTIL STERIL, V98, P1458, DOI 10.1016/j.fertnstert.2012.07.1135; Sanchez AM, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0341-4; Schenk M, 2016, J ASSIST REPROD GENE; Schenk M, 2017, J ASSIST REPROD GENE; SIMON C, 1994, HUM REPROD, V9, P725, DOI 10.1093/oxfordjournals.humrep.a138578; VerMilyea MD, 2014, REPROD BIOMED ONLINE, V29, P729, DOI 10.1016/j.rbmo.2014.09.005; Wissing ML, 2014, REPROD BIOMED ONLINE, V28, P508, DOI 10.1016/j.rbmo.2013.11.017; Xu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10779; Yland J, 2019, HUM REPROD, V34, P549, DOI 10.1093/humrep/dey374	32	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220529	10.1371/journal.pone.0220529	http://dx.doi.org/10.1371/journal.pone.0220529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369616	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900062
J	Szczurek, L; Juszkat, R; Szczurek, J; Turek, I; Sosnowski, P				Szczurek, Lukasz; Juszkat, Robert; Szczurek, Jolanta; Turek, Ilona; Sosnowski, Piotr			Pre-treatment 2D and 3D dosimetric verification of volumetric arc therapy. A correlation study between gamma index passing rate and clinical dose volume histogram	PLOS ONE			English	Article							QUALITY-ASSURANCE; PER-BEAM; IMRT; QA; VALIDATION; ALGORITHM; SYSTEM; HEAD	Objectives To evaluate methods for the pre-treatment verification of volumetric modulated arc therapy (VMAT) based on the percentage gamma passing rate (%GP) and its correlation and sensitivity with percentage dosimetric errors (%DE). Methods A total of 25 patients with prostate cancer and 15 with endometrial cancer were analysed. The %GP values of 2D and 3D verifications with different acceptance criteria (1%/1 mm, 2%/2 mm, and 3%/3 mm) were obtained using OmniPro and Compass. The %DE was calculated using a planned dose volume histogram (DVH) created in Monaco's treatment planning system (TPS), which relates radiation dose to tissue and the patient's predicted dose volume histogram in Compass. Statistical correlation between %GP and %DE was verified using Pearson's correlation coefficient. Sensitivity was calculated based on the receiver operating characteristics (ROC) curve. Plans were calculated using Collapsed Cone Convolution and the Monte Carlo algorithm. Results The t-test results of the planned and estimated DVH showed that the mean values were comparable (P > 0.05). For the 3%/3 mm criterion, the average %GP was acceptable for the prostate and endometrial cancer groups, with average rates of 99.68 +/- 0.49% and 99.03 +/- 0.59% for 2D and 99.86 +/- 0.39% and 99.53 +/- 0.44% for 3D, respectively. The number of correlations was poor for all analysed data. The mean Pearson's R-values for prostate and endometrial cancer were < 0.45 and < 0.43, respectively. The area under the ROC curve for the prostate and endometrial cancer groups, was lower than 0.667. Conclusions Analysis of the %GP versus %DE values revealed only weak correlations between 2D and 3D verifications. DVH results obtained using the Compass system will be helpful in confirming that the analysed plans respect dosimetric constraints.	[Szczurek, Lukasz] Poznan Univ Med Sci, Dept Med 1, Poznan, Poland; [Szczurek, Lukasz] Int Oncol Ctr Affidea, Dept Med Phys, Poznan, Poland; [Juszkat, Robert; Sosnowski, Piotr] Poznan Univ Med Sci, Dept Gen & Intervent Radiol, Poznan, Poland; [Szczurek, Jolanta] Affidea, Dept Diagnost Imaging, Poznan, Poland; [Szczurek, Jolanta] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland; [Turek, Ilona] La Trobe Univ, Dept Pharm & Biomed Sci, Bendigo, Australia	Poznan University of Medical Sciences; Poznan University of Medical Sciences; Poznan University of Medical Sciences; La Trobe University	Juszkat, R (corresponding author), Poznan Univ Med Sci, Dept Gen & Intervent Radiol, Poznan, Poland.	radiol@ump.edu.pl		Turek, Ilona/0000-0001-6457-7456				AHNESJO A, 1989, MED PHYS, V16, P577, DOI 10.1118/1.596360; Bentzen SM, 2010, INT J RADIAT ONCOL, V76, pS3, DOI 10.1016/j.ijrobp.2009.09.040; Boggula R, 2010, PHYS MED BIOL, V55, P5619, DOI 10.1088/0031-9155/55/19/001; Carrasco P, 2012, MED PHYS, V39, P5040, DOI 10.1118/1.4736949; Clivio L, 2014, RADIOTHER ONCOL, V9, P286; Cozzolino M, 2014, PHYS MEDICA, V30, P462, DOI 10.1016/j.ejmp.2014.01.003; Crijns W, 2016, MED PHYS, V43, DOI 10.1118/1.4945024; Delaby N, 2017, PHYS MED, V44, P19, DOI [10.1016/j.ejmp.2017.10.065, DOI 10.1016/J.EJMP.2017.10.065]; ESTRO, 2008, GUIDELINES VERIFICAT; Ezzell GA, 2003, MED PHYS, V30, P2089, DOI 10.1118/1.1591194; Ezzell GA, 2009, MED PHYS, V36, P5359, DOI 10.1118/1.3238104; Fodor E, 2018, BIOMED J SCI TECH RE, V6, P2; Hussein M, 2013, RADIOTHER ONCOL, V109, P370, DOI 10.1016/j.radonc.2013.08.048; International Commission on Radiation Units and Measurements, 2010, J ICRU, V10, P1; Jin X, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140577; Jornet N, 2014, RADIOTHER ONCOL, V112, P381, DOI 10.1016/j.radonc.2014.06.016; Korevaar EW, 2011, RADIOTHER ONCOL, V100, P446, DOI 10.1016/j.radonc.2011.09.007; Lawton CAF, 2009, INT J RADIAT ONCOL, V74, P383, DOI 10.1016/j.ijrobp.2008.08.002; Low DA, 2003, MED PHYS, V30, P2455, DOI 10.1118/1.1598711; Nelms BE, 2011, MED PHYS, V38, P1037, DOI 10.1118/1.3544657; Nisbet A, 2004, RADIOTHER ONCOL, V73, P79, DOI 10.1016/j.radonc.2004.06.007; Palanisamy M, 2019, REP PRACT ONCOL RADI, V24, P188, DOI 10.1016/j.rpor.2019.01.005; Pasler M, 2018, PHYS IMAG RADIAT ONC, V5, P76, DOI 10.1016/j.phro.2018.03.002; Pimthong J, 2015, J PHYS C SER, V694, P1; Schreibmann E, 2009, MED PHYS, V36, P4530, DOI 10.1118/1.3213085; Seema S, 2018, INT J CANC THER ONCO, V6; Stasi M, 2012, MED PHYS, V39, P7626, DOI 10.1118/1.4767763; Subcommittee Netherlands Commission on Radiation Dosimetry. IMRT QA, 2013, 22 NCS; Tanha K, 2014, J RADIOTHER PRACT, V13, P447, DOI 10.1017/S1460396914000211; Teoh M, 2011, BRIT J RADIOL, V84, P967, DOI 10.1259/bjr/22373346; The Radiation Therapy Oncology Group, 2011, RTOG 0822 PROT PHAS; The Radiation Therapy Oncology Group, 2014, RTOG 0126 PROT PHAS; Visser R, 2014, RADIOTHER ONCOL, V112, P389, DOI 10.1016/j.radonc.2014.08.002; Zhao YQ, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0287-2; Zhen HM, 2011, MED PHYS, V38, P5477, DOI 10.1118/1.3633904	35	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221086	10.1371/journal.pone.0221086	http://dx.doi.org/10.1371/journal.pone.0221086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408486	Green Published, Green Submitted, gold			2022-12-27	WOS:000485009500037
J	Hafke-Dys, H; Breborowicz, A; Kleka, P; Kocinski, J; Biniakowski, A				Hafke-Dys, Honorata; Breborowicz, Anna; Kleka, Pawel; Kocinski, Jedrzej; Biniakowski, Adam			The accuracy of lung auscultation in the practice of physicians and medical students	PLOS ONE			English	Article								Background Auscultation is one of the first examinations that a patient is subjected to in a GP's office, especially in relation to diseases of the respiratory system. However it is a highly subjective process and depends on the physician's ability to interpret the sounds as determined by his/her psychoacoustical characteristics. Here, we present a cross-sectional assessment of the skills of physicians of different specializations and medical students in the classification of respiratory sounds in children. Methods and findings 185 participants representing different medical specializations took part in the experiment. The experiment comprised 24 respiratory system auscultation sounds. The participants were tasked with listening to, and matching the sounds with provided descriptions of specific sound classes. The results revealed difficulties in both the recognition and description of respiratory sounds. The pulmonologist group was found to perform significantly better than other groups in terms of number of correct answers. We also found that performance significantly improved when similar sound classes were grouped together into wider, more general classes. Conclusions These results confirm that ambiguous identification and interpretation of sounds in auscultation is a generic issue which should not be neglected as it can potentially lead to inaccurate diagnosis and mistreatment. Our results lend further support to the already widespread acknowledgment of the need to standardize the nomenclature of auscultation sounds (according to European Respiratory Society, International Lung Sounds Association and American Thoracic Society). In particular, our findings point towards important educational challenges in both theory (nomenclature) and practice (training).	[Hafke-Dys, Honorata; Kocinski, Jedrzej] Uniwersytetu Poznanskiego, Fac Phys, Inst Acoust, Adam Mickiewicz Univ Poznan, Poznan, Poland; [Hafke-Dys, Honorata; Kocinski, Jedrzej; Biniakowski, Adam] StethoMe, Winogrady, Poland; [Breborowicz, Anna] Poznan Univ Med Sci, K Jonscher Clin Hosp Poznan, Dept Pediat Pneumonol Allergol & Clin Immunol, Szpitalna, Poland; [Kleka, Pawel] Adam Mickiewicz Univ, Inst Psychol, Wieniawskiego, Poland	Adam Mickiewicz University; Poznan University of Medical Sciences; Adam Mickiewicz University	Hafke-Dys, H (corresponding author), Uniwersytetu Poznanskiego, Fac Phys, Inst Acoust, Adam Mickiewicz Univ Poznan, Poznan, Poland.; Hafke-Dys, H (corresponding author), StethoMe, Winogrady, Poland.	h.hafke@amu.edu.pl	Hafke-Dys, Honorata/AAB-3887-2020	Hafke-Dys, Honorata/0000-0002-3417-5402; Kleka, Pawel/0000-0003-0841-0015	National Centre of Research and Development (NCRD) in Poland; European Union under Sub-Measure 1.1.1 of the Operational Programme Smart Growth (PO IR) "Industrial R&D carried out by enterprises" (Fast Track) [POIR.01.01.01-00-0528/16-00]	National Centre of Research and Development (NCRD) in Poland; European Union under Sub-Measure 1.1.1 of the Operational Programme Smart Growth (PO IR) "Industrial R&D carried out by enterprises" (Fast Track)	This work was supported by a grant from The National Centre of Research and Development (NCRD) in Poland and the European Union under Sub-Measure 1.1.1 of the Operational Programme Smart Growth (PO IR) "Industrial R&D carried out by enterprises" (Fast Track), agreement no. POIR.01.01.01-00-0528/16-00. All authors were paid for their work by StethoMe, which is the grantee. The funder provided support in the form of salaries for authors HH-D, ABr, PK, JK, ABi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The commercial affiliation of HH-D, JK, ABi did not play a role in our study.	Aviles-Solis JC, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2017-000250; BUNIN NJ, 1979, CHEST, V76, P690, DOI 10.1378/chest.76.6.690; CUGELL DW, 1987, AM REV RESPIR DIS, V136, P1016, DOI 10.1164/ajrccm/136.4.1016; Francis NA, 2013, EUR J GEN PRACT, V19, P77, DOI 10.3109/13814788.2012.733690; Mangione S, 1999, AM J RESP CRIT CARE, V159, P1119, DOI 10.1164/ajrccm.159.4.9806083; Melbye H, 2016, BMJ OPEN RESPIR RES, V3, DOI 10.1136/bmjresp-2016-000136; PASTERKAMP H, 1987, CHEST, V92, P346, DOI 10.1378/chest.92.2.346; Pasterkamp H, 2016, EUR RESPIR J, V47, P724, DOI 10.1183/13993003.01132-2015; Priftis KN, 2018, BASIC SCI CLIN PRACT; Rowinska-Zakrzewska E, 2004, POLISH RESPIRATORY S; Szczeklik E, 1979, POLISH DIAGNOSTYKA O; Turnbull S, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0716-7; Wilkins R.L., 2004, FUNDAMENTALS LUNG HE; WILKINS RL, 1990, CHEST, V98, P886, DOI 10.1378/chest.98.4.886	14	15	17	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220606	10.1371/journal.pone.0220606	http://dx.doi.org/10.1371/journal.pone.0220606			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404066	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800018
J	Koech, WA; Rudisill, TM; Rockett, IRH				Koech, Wilson A.; Rudisill, Toni M.; Rockett, Ian R. H.			Maternal characteristics associated with injury-related infant death in West Virginia, 2010-2014	PLOS ONE			English	Article							UNITED-STATES; MORTALITY; CHILD; MALTREATMENT	Although injury-related deaths have been documented among children and adult populations, insufficient attention has been directed towards injury-related infant deaths. The objective of this retrospective study was to investigate maternal and infant characteristics associated with injury-related infant deaths in West Virginia. Birth and infant mortality data for 2010-2014 were sourced from the West Virginia Bureau for Public Health, Charleston. Relative risk was calculated using log-binomial regression utilizing generalized estimating equations. Maternal characteristics associated with injury-related infant mortality in West Virginia were race/ethnicity (X-df=2(2) = 7.48, p = .03), and smoking during pregnancy (X-df=1(2) = 13.1, p < .00). Risk of a Black Non-Hispanic infant suffering an injury-related death was 4.0 (95% CL 1.7, 9.3) times that of infants of other races/ethnicities. Risk of an infant dying from an injury-related cause, if the mother smoked during pregnancy, was 2.9 (95% CL 1.6, 5.0) times the risk of such a death if maternal smoking status during pregnancy is unknown or no smoking, controlling for race/ethnicity. This study provides important information to public health stakeholders at both the state and local levels in designing interventions for partial reduction or prevention of injury-related infant mortality in West Virginia.	[Koech, Wilson A.; Rudisill, Toni M.; Rockett, Ian R. H.] West Virginia Univ, Dept Epidemiol, Sch Publ Hlth, Morgantown, WV 26506 USA; [Rockett, Ian R. H.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA	West Virginia University; University of Rochester	Koech, WA (corresponding author), West Virginia Univ, Dept Epidemiol, Sch Publ Hlth, Morgantown, WV 26506 USA.	wakoech@mix.wvu.edu		Rudisill, Toni/0000-0002-2019-4274	NIGMS NIH HHS [U54 GM104942] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahrens KA, 2017, AM J PREV MED, V53, P412, DOI 10.1016/j.amepre.2017.04.018; Annest J, 2014, PROPOSED FRAMEWORK P, P1; Arbogast KB, 2012, TRAFFIC INJ PREV, V13, P172, DOI 10.1080/15389588.2011.642834; Arthur M, 2008, MED CARE, V46, P192, DOI 10.1097/MLR.0b013e31815b9d8e; Bernard Stephanie J., 2007, Morbidity and Mortality Weekly Report, V56, P1; Black D. A., 2004, LABOR MARKET PERFORM; Borse NN, 2013, J SAFETY RES, V45, P127, DOI 10.1016/j.jsr.2013.02.001; Bruckner TA, 2008, ACCIDENT ANAL PREV, V40, P1797, DOI 10.1016/j.aap.2008.07.011; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1137; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; Fowler K, 2017, PEDIATRICS, V140, P1; Gilchrist Julie, 2012, Morbidity and Mortality Weekly Report, V61, P270; Heerman WJ, 2016, AM J PREV MED, V51, P411, DOI 10.1016/j.amepre.2016.04.020; Jain A, 2001, Inj Prev, V7, P135; Khan SQ, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.3317; King AJ, 2015, CHILD MALTREATMENT, V20, P151, DOI 10.1177/1077559514567176; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Lai SH, 2000, J ADDICT DIS, V19, P11, DOI 10.1300/J069v19n04_02; Matthews T J, 2015, Natl Vital Stat Rep, V64, P1; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Northam S, 2006, JOGNN-J OBST GYN NEO, V35, P3, DOI 10.1111/J.1552-6909.2006.00016.x; Rao C., 2001, IMS LECT NOTES MONOG, V38; Rockett Ian R H, 2012, Am J Public Health, V102, pe84, DOI 10.2105/AJPH.2012.300960; SAS Institute, 2012, SAS STAT SOFTW SAS; Smith DK, 2007, CHILD MALTREATMENT, V12, P150, DOI 10.1177/1077559507300129; The United States Cancer Statistics, 2004, NAT CTR HLTH STAT ST; [West Virginia Bureau for Public Health Resources WVDoHaH], 2016, W VIRG VIT STAT 2014, P184	27	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220801	10.1371/journal.pone.0220801	http://dx.doi.org/10.1371/journal.pone.0220801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404105	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800032
J	Shimizu, H; Lu, Y; Vella, KR; Damilano, F; Astapova, I; Amano, I; Ritter, M; Gallop, MR; Rosenzweig, AN; Cohen, RN; Hollenberg, AN				Shimizu, Hiroaki; Lu, Yu; Vella, Kristen R.; Damilano, Federico; Astapova, Inna; Amano, Izuki; Ritter, Megan; Gallop, Molly R.; Rosenzweig, Anthony N.; Cohen, Ronald N.; Hollenberg, Anthony N.			Nuclear corepressor SMRT is a strong regulator of body weight independently of its ability to regulate thyroid hormone action	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; NCOR1; TRANSCRIPTION; RECEPTORS; OBESITY; PHOSPHORYLATION; SENSITIVITY; EXPRESSION; REPRESSION	Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) and the nuclear receptor co-repressor1 (NCoR1) are paralogs and regulate nuclear receptor (NR) function through the recruitment of a multiprotein complex that includes histone deacetylase activity. Previous genetic strategies which deleted SMRT in a specific tissue or which altered the interaction between SMRT and NRs have suggested that it may regulate adiposity and insulin sensitivity. However, the full role of SMRT in adult mice has been difficult to establish because its complete deletion during embryogenesis is lethal. To elucidate the specific roles of SMRT in mouse target tissues especially in the context of thyroid hormone (TH) signaling, we used a tamoxifen-inducible post-natal disruption strategy. We found that global SMRT deletion causes dramatic obesity even though mice were fed a standard chow diet and exhibited normal food intake. This weight gain was associated with a decrease in energy expenditure. Interestingly, the deletion of SMRT had no effect on TH action in any tissue but did regulate retinoic acid receptor (RAR) function in the liver. We also demonstrate that the deletion of SMRT leads to profound hepatic steatosis in the setting of obesity. This is unlike NCoR1 deletion, which results in hepatic steatosis due to the upregulation of lipogenic gene expression. Taken together, our data demonstrate that SMRT plays a unique and CoR specific role in the regulation of body weight and has no role in TH action. This raises the possibility that additional role of CoRs besides NCoR1 and SMRT may exist to regulate TH action.	[Shimizu, Hiroaki; Lu, Yu; Vella, Kristen R.; Astapova, Inna; Amano, Izuki; Ritter, Megan; Gallop, Molly R.; Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Shimizu, Hiroaki; Lu, Yu; Vella, Kristen R.; Astapova, Inna; Amano, Izuki; Ritter, Megan; Gallop, Molly R.; Hollenberg, Anthony N.] Harvard Med Sch, Boston, MA 02115 USA; [Vella, Kristen R.; Amano, Izuki; Ritter, Megan; Hollenberg, Anthony N.] Weill Cornell Med, Div Endocrinol Diabet & Metab, New York, NY 10065 USA; [Damilano, Federico; Rosenzweig, Anthony N.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Cohen, Ronald N.] Univ Chicago, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University; Harvard University; Massachusetts General Hospital; University of Chicago	Hollenberg, AN (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.; Hollenberg, AN (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Hollenberg, AN (corresponding author), Weill Cornell Med, Div Endocrinol Diabet & Metab, New York, NY 10065 USA.	thollenb@med.cornell.edu	Rosenzweig, Anthony/AAD-7893-2019		National Institutes of Health [R01 DK056123]; Japan Society for the Proportion of Science, JSPS KAKENHI [18K08486]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Proportion of Science, JSPS KAKENHI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (https://www.nih.gov), grant no. R01 DK056123 to ANH and by the Japan Society for the Proportion of Science, JSPS KAKENHI, (https://www.jsps.go.jp/index.html), grant number 18K08486. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amengual J, 2010, CELL PHYSIOL BIOCHEM, V25, P657, DOI 10.1159/000315085; Astapova I, 2016, J MOL ENDOCRINOL, V56, pR73, DOI 10.1530/JME-15-0246; Astapova I, 2011, MOL ENDOCRINOL, V25, P212, DOI 10.1210/me.2010-0462; Astapova I, 2014, J CLIN INVEST, V124, P1976, DOI 10.1172/JCI73419; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Cohen RN, 2000, MOL ENDOCRINOL, V14, P900, DOI 10.1210/me.14.6.900; Costa-e-Sousa RH, 2012, ENDOCRINOLOGY, V153, P5049, DOI 10.1210/en.2012-1504; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; FOLCH J, 1957, J BIOL CHEM, V226, P497; He YQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-575; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hollenberg AN, 2012, NEW ENGL J MED, V366, P1345, DOI 10.1056/NEJMcibr1114529; Hong SH, 2018, P NATL ACAD SCI USA, V115, P10381, DOI 10.1073/pnas.1809480115; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Kiefer FW, 2012, ENDOCRINOLOGY, V153, P3089, DOI 10.1210/en.2011-2104; Kim SC, 2014, HEPATOLOGY, V59, P1750, DOI 10.1002/hep.26699; Kiss M, 2017, P NATL ACAD SCI USA, V114, P10725, DOI 10.1073/pnas.1700785114; Kumar S, 2016, DEV BIOL, V418, P204, DOI 10.1016/j.ydbio.2016.08.005; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Matsuzaka T, 2004, DIABETES, V53, P560, DOI 10.2337/diabetes.53.3.560; Mendoza A, 2017, P NATL ACAD SCI USA, V114, pE8458, DOI 10.1073/pnas.1706917114; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Palou A, 2000, EUR J NUTR, V39, P127, DOI 10.1007/s003940070017; Sanchez-Gurmaches J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5099; Shimizu H, 2015, MOL CELL BIOL, V35, P555, DOI 10.1128/MCB.01208-14; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Stanya KJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-7; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Sutanto MM, 2010, J BIOL CHEM, V285, P18485, DOI 10.1074/jbc.M110.107680; Trasino SE, 2016, DIABETES OBES METAB, V18, P142, DOI 10.1111/dom.12590; Vella KR, 2014, MOL CELL BIOL, V34, P1564, DOI 10.1128/MCB.00129-14; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220717	10.1371/journal.pone.0220717	http://dx.doi.org/10.1371/journal.pone.0220717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404087	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800027
J	Boffel, C; Mussler, J				Boeffel, Christian; Muessler, Jochen			Action effect consistency and body ownership in the avatar-Simon task	PLOS ONE			English	Article							SPATIAL PERSPECTIVE-TAKING; EFFECT COMPATIBILITY; INTENTION; INTEGRATION; IMPACT; SELF; TEC	Putting oneself in the shoes of a digital alter ego becomes an increasingly relevant part of our everyday experience. In modern day psychology, these interactions can be examined within the frameworks of visual perspective taking and body ownership. Both target similar questions: What does it take, to become one with the avatar? When do we show the same behavior and make the same experiences, as if we were in its place? In this study, we want to address the role of action effect consistency for these concepts. We manipulated the participants' sense of agency over a task-irrelevant avatar in a Simon task by providing either corresponding or random action effects. These effects could be either embodied and therefore linked to the avatar (Experiment 1) or independent of it (Experiment 2). We used stimulus-response compatibility effects from the avatar's point of view as a measure for spontaneous visual perspective taking and a questionnaire to measure the perceived body ownership of the avatar. The results showed that corresponding action effects lead to increased spontaneous perspective taking of the avatar, regardless of whether the effect was linked to the avatar or not. Though the avatar compatibility effects were overall more pronounced in the embodied action effect condition. However, significant differences in perceived body ownership were only observed if the effects were linked to the avatar. The results might prove useful to further our understanding of subjective and objective measurements of interactions with avatars.	[Boeffel, Christian; Muessler, Jochen] Rhein Westfal TH Aachen, Inst Psychol, Work & Cognit Psychol, Aachen, Germany	RWTH Aachen University	Boffel, C (corresponding author), Rhein Westfal TH Aachen, Inst Psychol, Work & Cognit Psychol, Aachen, Germany.	boeffel@psych.rwth-aachen.de	Böffel, Christian/AFN-5916-2022	Böffel, Christian/0000-0003-3623-3140	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [DFG MU 1298/11]; DFG [DFG SPP 2134]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This study was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation: DFG MU 1298/11) awarded to Jochen Musseler and is associated with the DFG Priority Program "The Active Self" (DFG SPP 2134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim Z, 2016, ATTEN PERCEPT PSYCHO, V78, P707, DOI 10.3758/s13414-015-1016-0; Ansorge U, 2002, ACTA PSYCHOL, V109, P285, DOI 10.1016/S0001-6918(01)00062-2; Beckers T, 2002, PSYCHOL RES-PSYCH FO, V66, P166, DOI 10.1007/s00426-002-0090-9; Boffel C, 2019, ATTEN PERCEPT PSYCHO, V81, P158, DOI 10.3758/s13414-018-1573-0; Boffel C, 2018, FRONT PSYCHOL, V9, P1, DOI [10.3389/fpsyg.2018.00001, DOI 10.3389/FPSYG.2018.00001]; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Deutsche Forschungsgemeinschaft, 2009, FAQ INFORMATIONEN FU; Dolk T, 2013, J EXP PSYCHOL HUMAN, V39, P1248, DOI 10.1037/a0031031; Dutzi IB, 2009, PSYCHOL RES-PSYCH FO, V73, P425, DOI 10.1007/s00426-008-0161-7; Elsner B, 2004, PSYCHOL RES-PSYCH FO, V68, P138, DOI 10.1007/s00426-003-0151-8; Elsner B, 2001, J EXP PSYCHOL HUMAN, V27, P229, DOI 10.1037/0096-1523.27.1.229; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; HEDGE A, 1975, ACTA PSYCHOL, V39, P427, DOI 10.1016/0001-6918(75)90041-4; Herwig A, 2007, Q J EXP PSYCHOL, V60, P1540, DOI 10.1080/17470210601119134; Herwig A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00444; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P208, DOI 10.1007/BF00419608; HOMMEL B, 1993, PSYCHOL RES-PSYCH FO, V55, P270, DOI 10.1007/BF00419687; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Kessler K, 2012, SPAT COGN COMPUT, V12, P133, DOI 10.1080/13875868.2011.634533; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kunde W, 2004, Q J EXP PSYCHOL-A, V57, P87, DOI 10.1080/02724980343000143; Kunde W, 2003, PSYCHOL RES-PSYCH FO, V67, P153, DOI 10.1007/s00426-002-0114-5; Kunde W, 2001, J EXP PSYCHOL HUMAN, V27, P387, DOI 10.1037//0096-1523.27.2.387; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Ma K, 2015, CONSCIOUS COGN, V36, P277, DOI 10.1016/j.concog.2015.07.008; Ma K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00604; May J, 2011, SOUTHERN J PHILOS, V49, P25, DOI 10.1111/j.2041-6962.2011.00055.x; Michelon P, 2006, PERCEPT PSYCHOPHYS, V68, P327, DOI 10.3758/BF03193680; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Musseler J, 2019, Q J EXP PSYCHOL, V72, P1539, DOI 10.1177/1747021818799240; Musseler J, 2011, HUM FACTORS, V53, P383, DOI 10.1177/0018720811408599; Ottoboni G, 2005, J EXP PSYCHOL HUMAN, V31, P778, DOI 10.1037/0096-1523.31.4.778; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pfister R, 2017, ATTEN PERCEPT PSYCHO, V79, P2132, DOI 10.3758/s13414-017-1371-0; Proctor R.W., 2006, STIMULUS RESPONSE CO; Schurz M, 2015, NEUROIMAGE, V117, P386, DOI 10.1016/j.neuroimage.2015.04.031; Surtees A, 2013, COGNITION, V129, P426, DOI 10.1016/j.cognition.2013.06.008; Waltemate T, 2018, IEEE T VIS COMPUT GR, V24, P1643, DOI 10.1109/TVCG.2018.2794629	42	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220817	10.1371/journal.pone.0220817	http://dx.doi.org/10.1371/journal.pone.0220817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398233	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000023
J	Chanvatik, S; Kosiyaporn, H; Lekagul, A; Kaewkhankhaeng, W; Vongmongkol, V; Thunyahan, A; Tangcharoensathien, V				Chanvatik, Sunicha; Kosiyaporn, Hathairat; Lekagul, Angkana; Kaewkhankhaeng, Wanwisa; Vongmongkol, Vuthiphan; Thunyahan, Apichart; Tangcharoensathien, Viroj			Knowledge and use of antibiotics in Thailand: A 2017 national household survey	PLOS ONE			English	Article							PUBLICS KNOWLEDGE; SELF-MEDICATION; ATTITUDES; POPULATION; RESISTANCE; COMMUNITY; BEHAVIOR; INTERNET; BELIEFS	Background The Thailand National Strategic Plan on Antimicrobial Resistance (AMR) 2017-2021, endorsed by the Thai Cabinet in 2016, aims to increase public knowledge about antibiotics and AMR awareness by 20% by 2021. This study assesses the prevalence of antibiotics use, clinical indications and sources; knowledge and access to information related to antibiotics and AMR; and factors related to level of knowledge and access to information among Thai adult population. Methods An AMR module was developed and embedded into the 2017 Health and Welfare Survey; a cross-sectional, two-stage stratified sampling, nationally representative household survey carried out biannually by National Statistical Office. The survey applied a structured interview questionnaire. The survey was conducted in March 2017 where 27,762 Thai adults were interviewed of the AMR module. Data were analyzed using descriptive and inferential statistics. Results The one-month prevalence of antibiotic use was 7.9% for three common conditions; flu (27.0%), fever (19.2%) and sore throat (16.8%). The majority of antibiotics (70.3%) were provided by public or private healthcare facilities, and 26.7% by pharmacies. Thai adults have low levels of knowledge about antibiotics; only 2.6 gave correct answers to all six statements related to antibiotics, while 13.5% gave wrong answers to all six statements. A few factors associated with knowledge and having received information on antibiotics were assessed. People who have higher education levels, and belong to richer wealth quintiles, and receive antibiotics and AMR information have significantly higher levels of knowledge about antibiotics. In the last 12 months, only 17.8% of respondents had heard information about the proper use of antibiotics and AMR; mostly from doctors (36.1%), health workers (24.8%) and pharmacists (17.7%). Conclusions There is a large gap of public knowledge about the use of antibiotics. The main communication channel is through healthcare professionals, which indicates they are key persons in communicating information about the proper use of antibiotics to the public.	[Chanvatik, Sunicha; Kosiyaporn, Hathairat; Lekagul, Angkana; Kaewkhankhaeng, Wanwisa; Vongmongkol, Vuthiphan; Tangcharoensathien, Viroj] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand; [Thunyahan, Apichart] Minist Informat & Commun Technol, Natl Stat Off, Bangkok, Thailand	Ministry of Public Health - Thailand	Chanvatik, S (corresponding author), Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand.	sunicha.c@gmail.com		Vongmongkol, Vuthiphan/0000-0002-7603-2557; Lekagul, Angkana/0000-0002-7335-9028; Chanvatik, Sunicha/0000-0001-8645-5097	International Health Policy Program, Ministry of Public Health, Thailand	International Health Policy Program, Ministry of Public Health, Thailand	Funded studies: The core funding was from International Health Policy Program, Ministry of Public Health, Thailand, which support staff costs and the preparation of antimicrobial resistance module in Health and Welfare Survey and data analysis. http://www.ihppthaigov.net/.	Anderson A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204878; Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; [Anonymous], 2017, THAIL NAT STRAT PLAN; Auta A, 2013, TROP J PHARM RES, V12, P1087, DOI 10.4314/tjpr.v12i6.33; Bassoum O, 2018, PHARMACY-BASEL, V6, DOI 10.3390/pharmacy6040103; Bert F, 2017, EUR J PUBLIC HEALTH, V27, P506, DOI 10.1093/eurpub/ckw209; Cals JWL, 2007, BRIT J GEN PRACT, V57, P942, DOI 10.3399/096016407782605027; Chan YH, 2012, AM J INFECT CONTROL, V40, P113, DOI 10.1016/j.ajic.2011.03.017; European Commission, 2016, FLASH EUR 444 SEPT O; European Commission, 2018, SPEC EUR 478 NOV 201; European Commission, 2016, SPEC EUR 445 APR 201; European Commission, 2010, SPEC EUR 338 APR 201; Lescure D, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00370; Lim Ka Keat, 2012, South Med Rev, V5, P26; Limaye D, 2017, ANN MED HEALTH SCI R, V7, P1; Mazinska B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172146; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; McNulty CAM, 2010, J ANTIMICROB CHEMOTH, V65, P1526, DOI 10.1093/jac/dkq126; Mouhieddine TH, 2015, J INFECT PUBLIC HEAL, V8, P20, DOI 10.1016/j.jiph.2014.07.010; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; Nepal G, 2018, CUREUS, V10, DOI 10.7759/cureus.2428; Oyindamola J., 2016, THESIS; Pavyde E, 2015, INT J ENV RES PUB HE, V12, P7002, DOI 10.3390/ijerph120607002; Raupach-Rosin H, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00776; Salm F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193336; Shehadeh M, 2012, SAUDI PHARM J, V20, P125, DOI 10.1016/j.jsps.2011.11.005; Taha AA, 2013, ZOONOSES PUBLIC HLTH, V12, P1087; Tangcharoensathien V, 2018, LANCET, V391, P1205, DOI 10.1016/S0140-6736(18)30198-3; WHO, 2017, WHO GUID ETH ISS PUB; WHO, 2015, ANT RES MULT PUBL AW; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; World Health Organization, 2017, STRATEGIC FRAMEWORK; Zucco R, 2018, INT J MED INFORM, V111, P131, DOI 10.1016/j.ijmedinf.2017.12.005	33	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220990	10.1371/journal.pone.0220990	http://dx.doi.org/10.1371/journal.pone.0220990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398242	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000485004000037
J	Jarvis, JD; Woods, H; Bali, A; Oronsaye, E; Persaud, N				Jarvis, Jordan D.; Woods, Hannah; Bali, Anjli; Oronsaye, Efosa; Persaud, Nav			Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists	PLOS ONE			English	Article							COUNTRIES	Background Non-communicable diseases (NCDs) are the leading cause of death worldwide. Inadequate and inequitable access to essential NCD medicines is a major concern, particularly in low and middle-income countries. National Essential Medicines Lists (EMLs) are important policy tools that indicate which medicines are prioritized as essential within a country's health system. This study sought to analyze a wide range of national essential medicines lists (EMLs) for their inclusion of priority non communicable disease (NCD) interventions recommended by the World Health Organization (WHO). Methods Three lists of WHO endorsed priority NCD interventions were included. A database with 137 national EMLs and the WHO EML was created from the WHO Repository and these EMLs were compared for listing of priority NCD interventions. Results Across 137 countries with national EMLs, the median percentage of 20 Best Buys interventions listed was 90% (IQR 80-95) and 31 Package of essential noncommunicable disease interventions (PEN) interventions listed was 94% (IQR 90-97), of 9 HEARTS interventions was 100% (IQR 89-100), and of the 43 unique interventions across the three priority lists was 88% (IQR 84-93). Less than 80% of the 43 interventions were listed by 22 (16%) countries and less than half of the interventions were listed by 2 countries: Angola (35%) and Cambodia (23%). Interventions listed on the fewest number of national EMLs were: influenza vaccine, HPV vaccine, hepatitis B vaccine, cervical cancer chemotherapy, codeine, promethazine, senna, and oxygen. Conclusion Most NCD interventions have been prioritized in national policy in most cases. The majority of priority medicines for NCDs described within key WHO NCD technical packages are listed on nearly all national EMLs across 137 countries of all income levels. Most NCD interventions have been prioritized in national policy in most cases, but in some countries and for select interventions such as the HPV vaccine, prioritization may be reviewed.	[Jarvis, Jordan D.] London Sch Hyg & Trop Med, London, England; [Jarvis, Jordan D.; Woods, Hannah; Bali, Anjli; Oronsaye, Efosa; Persaud, Nav] St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada; [Persaud, Nav] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada	University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Persaud, N (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Toronto, ON, Canada.; Persaud, N (corresponding author), St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada.	nav.persaud@utoronto.ca		Jarvis, Jordan/0000-0001-9994-1748	Canadian Institutes of Health Research [381409]; Ontario SPOR (Strategy for Patient Oriented Research) Support Unit	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario SPOR (Strategy for Patient Oriented Research) Support Unit	The authors received funding from Canadian Institutes of Health Research (grant 381409 to NP) and Ontario SPOR (Strategy for Patient Oriented Research) Support Unit (http://www.cihr-irsc.gc.ca/e/45859.html). The funding sources were all governmental. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors (JJ, HW, AB, EO, NP) have not entered into any agreement with the funder that may have limited their ability to complete the research as planned. The authors (JJ, HW, AB, EO, NP) have full access and control of all primary data.	[Anonymous], 2017, BAS LIN SURV REP SOI; [Anonymous], 2017, NAT ESS MED LISTS NE; Bazargani YT, 2014, THORAX, V69, P1149, DOI 10.1136/thoraxjnl-2014-205249; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106072; Bazargani YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087576; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Chido-Amajuoyi OG, 2019, CALL INTRO GEN NEUTR, V7; Chivukula Meenakshi V, 2018, WHO South East Asia J Public Health, V7, P90, DOI 10.4103/2224-3151.239420; Cuomo RE, 2017, J Cancer Policy, V12, P49, DOI 10.1016/j.jcpo.2017.03.010; Ewen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171284; Gallagher KE, 2018, VACCINE, V36, P4761, DOI 10.1016/j.vaccine.2018.02.003; Graham JE, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-27; Knaul FM, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00190; Mehrtash H, 2018, E MEDITERR HEALTH J, V24, P427, DOI 10.26719/2018.24.5.427; Neuzil KM, 2017, VACCINE, V35, P5734, DOI 10.1016/j.vaccine.2017.08.088; Parkhurst JO, 2019, CERVICAL CANC GLOBAL, V8, DOI [10.1080/17441692.2013.850524, DOI 10.1080/17441692.2013.850524]; Persaud N, 2019, B WHO; Persaud N, WHO B UNPUB; Rowlands A, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000114; Tsu VD, 2019, INVESTMENT CASE CERV, V138, P69; US Food and Drug Administration, 2009, GARD VACC SAF; WHO Collaborating Centre for Drugs Statistics Methodology, 2018, ATC DDD IND 2018; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization, 2019, WORLD MED SITUATION; World Health Organization, 2019, GLOB ACT PLAN PREV C; World Health Organization, 2018, GLOB HLTH OBS GHO DA; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; World Health Organization, 2018, HLTH FIN UN COV, P1; World Health Organization, 2018, WORLD HLTH STAT 2018; World Health Organization, 2019, AFF VACC KEY SCAL HP; World Health Organization, 2019, PACK ESS NONC PEN DI; World Health Organization, 2018, ESS MED	34	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220781	10.1371/journal.pone.0220781	http://dx.doi.org/10.1371/journal.pone.0220781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398195	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000485004000018
J	Zhang, K; Yun, SD; Triphan, SMF; Sturm, VJ; Buschle, LR; Hahn, A; Heiland, S; Bendszus, M; Schlemmer, HP; Shah, NJ; Ziener, CH; Kurz, FT				Zhang, Ke; Yun, Seong Dae; Triphan, Simon M. F.; Sturm, Volker J.; Buschle, Lukas R.; Hahn, Artur; Heiland, Sabine; Bendszus, Martin; Schlemmer, Heinz-Peter; Shah, N. Jon; Ziener, Christian H.; Kurz, Felix T.			Vessel architecture imaging using multiband gradient-echo/spin-echo EPI	PLOS ONE			English	Article							SPIN-ECHO; CONTRAST; PERFUSION; SIZE; EXCITATION; DIFFUSION; IMPACT; GRADE	Objectives To apply the MB (multiband) excitation and blipped-CAIPI (blipped-controlled aliasing in parallel imaging) techniques in a spin and gradient-echo (SAGE) EPI sequence to improve the slice coverage for vessel architecture imaging (VAI). Materials and methods Both MB excitation and blipped-CAIPI with in-plane parallel imaging were incorporated into a gradient-echo (GE)/spin-echo (SE) EPI sequence for simultaneous tracking of the dynamic MR signal changes in both GE and SE contrasts after the injection of contrast agent. MB and singleband (SB) excitation were compared using a 20-channel head coil at 3 Tesla, and high-resolution MB VAI could be performed in 32 glioma patients. Results Whole-brain covered high resolution VAI can be achieved after applying multiband excitation with a factor of 2 and in-plane parallel imaging with a factor of 3. The quality of the images resulting from MB acceleration was comparable to those from the SB method: images were reconstructed without any loss of spatial resolution or severe distortions. In addition, MB and SB signal-to-noise ratios (SNR) were similar. A relative low g-factor induced from the MB acceleration method was achieved after using a blipped-CAIPI technique (1.35 for GE and 1.33 for SE imaging). Performing quantitative VAI, we found that, among all VAI parametric maps, microvessel type indicator (MTI), distance map (I) and vascular-induced bolus peak-time shift (VIPS) were highly correlated. Likewise, VAI parametric maps of slope, slope length and short axis were highly correlated. Conclusions Multiband accelerated SAGE successfully doubles the number of readout slices in the same measurement time when compared to conventional readout sequences. The corresponding VAI parametric maps provide insights into the complexity and heterogeneity of vascular changes in glioma.	[Zhang, Ke; Sturm, Volker J.; Buschle, Lukas R.; Schlemmer, Heinz-Peter; Ziener, Christian H.; Kurz, Felix T.] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Zhang, Ke; Sturm, Volker J.; Buschle, Lukas R.; Hahn, Artur; Heiland, Sabine; Bendszus, Martin; Ziener, Christian H.; Kurz, Felix T.] Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany; [Yun, Seong Dae; Shah, N. Jon] Forschungszentrum Julich, Inst Neurosci & Med 4, Med Imaging Phys, Julich, Germany; [Triphan, Simon M. F.] Heidelberg Univ Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Hahn, Artur] Heidelberg Univ, Dept Phys & Astron, Heidelberg, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Fac Med, JARA, Aachen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; Research Center Julich; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; RWTH Aachen University	Kurz, FT (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.; Kurz, FT (corresponding author), Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany.	felix.kurz@med.uni-heidelberg.de	Hahn, Artur/AAV-2513-2020; Ziener, Christian/AAN-8411-2021; Shah, N. Jon/H-5849-2013	Hahn, Artur/0000-0002-4493-3887; Shah, N. Jon/0000-0002-8151-6169; Yun, Seong Dae/0000-0001-7398-1899; Ziener, Christian/0000-0001-8854-7358	Deutsche Forschungsgemeinschaft [DFG ZI 1295/2-1, DFG KU 3555/1-1]; medical faculty of Heidelberg University; Hoffmann-Klose foundation of Heidelberg University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); medical faculty of Heidelberg University; Hoffmann-Klose foundation of Heidelberg University	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Contract Grant number: DFG ZI 1295/2-1 and DFG KU 3555/1-1). F. T. Kurz was supported by a postdoctoral fellowship from the medical faculty of Heidelberg University and the Hoffmann-Klose foundation of Heidelberg University.	Auerbach EJ, 2013, MAGN RESON MED, V69, P1261, DOI 10.1002/mrm.24719; Bonekamp D, 2017, J CEREBR BLOOD F MET, V37, P485, DOI 10.1177/0271678X16630322; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Buschle LR, 2018, MAGN RESON MATER PHY, V31, P531, DOI 10.1007/s10334-018-0677-9; Chiacchiaretta P, 2013, NEUROIMAGE, V82, P35, DOI 10.1016/j.neuroimage.2013.05.069; Eichner C, 2014, MAGN RESON MED, V72, P949, DOI 10.1002/mrm.25389; Eichner C, 2014, MAGN RESON MED, V72, P770, DOI 10.1002/mrm.24960; Emblem KE, 2013, NAT MED, V19, P1178, DOI 10.1038/nm.3289; Firbank MJ, 1999, PHYS MED BIOL, V44, pN261, DOI 10.1088/0031-9155/44/12/403; Helenius J, 2002, AM J NEURORADIOL, V23, P194; Hsu YY, 2009, J MAGN RESON IMAGING, V30, P1078, DOI 10.1002/jmri.21960; Khatamian YB, 2016, BRAIN CONNECT, V6, P283, DOI 10.1089/brain.2015.0365; Kickingereder P, 2014, RADIOLOGY, V272, P843, DOI 10.1148/radiol.14132740; Kim T, 2013, MAGN RESON MED, V70, P1653, DOI 10.1002/mrm.24880; Kiselev VG, 2005, MAGNET RESON MED, V53, P553, DOI 10.1002/mrm.20383; Kurz FT, 2016, J MAGN RESON, V273, P83, DOI 10.1016/j.jmr.2016.10.012; Kurz FT, 2016, MAGN RESON IMAGING, V34, P875, DOI 10.1016/j.mri.2016.03.016; Larkman DJ, 2001, J MAGN RESON IMAGING, V13, P313, DOI 10.1002/1522-2586(200102)13:2<313::AID-JMRI1045>3.3.CO;2-N; Lu H, 2008, AM J NEURORADIOL, V29, P373, DOI 10.3174/ajnr.A0794; Rausch M, 2000, MAGN RESON IMAGING, V18, P1235, DOI 10.1016/S0730-725X(00)00219-8; Schmiedeskamp H, 2012, MAGN RESON MED, V68, P30, DOI 10.1002/mrm.23195; Schwarzbauer C, 2010, NEUROIMAGE, V49, P316, DOI 10.1016/j.neuroimage.2009.08.032; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Sigfridsson A, 2015, MAGN RESON MED, V73, P1713, DOI 10.1002/mrm.25294; Stadlbauer A, 2017, RADIOLOGY, V283, P798, DOI 10.1148/radiol.2016161422; Stadlbauer A, 2017, J CEREBR BLOOD F MET, V37, P632, DOI 10.1177/0271678X16655549; Wong E., 2012, P ISMRM, P2209; Wu JJ, 2019, MAGN RESON MED, V81, P1755, DOI 10.1002/mrm.27532; Xu C, 2013, MAGN RESON MED, V69, P981, DOI 10.1002/mrm.24326; Xu C, 2011, J CEREBR BLOOD F MET, V31, P1687, DOI 10.1038/jcbfm.2011.38; Zhang K, 2019, MAGN RESON IMAGING, V57, P359, DOI 10.1016/j.mri.2018.11.018	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220939	10.1371/journal.pone.0220939	http://dx.doi.org/10.1371/journal.pone.0220939			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398234	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000029
J	Begum, T; Nababan, H; Rahman, A; Islam, MR; Adams, A; Anwar, I				Begum, Tahmina; Nababan, Herfina; Rahman, Aminur; Islam, Md Rajibul; Adams, Alayne; Anwar, Iqbal			Monitoring caesarean births using the Robson ten group classification system: A cross-sectional survey of private for-profit facilities in urban Bangladesh	PLOS ONE			English	Article							NEONATAL-MORTALITY; DELIVERY RATES; COUNTRIES; TRENDS; HEALTH	Background Globally, Caesarean section (CS) rates are mounting and currently exceed the safe upper limit of 15%. Monitoring CS rates using clinical indications and obstetric sub-group analysis could confirm that women in need have been served. In Bangladesh, the reported CS rate was 31% in 2016, and almost twice that rate in urban settings. Delivering in the private healthcare sector was a strong determinant. This study uses Robson Ten Group Classification System (TGCS) to report CS rates in urban Bangladesh. The clinical causes and determining factors for CS births have also been examined. Methods This record linkage cross-sectional survey was undertaken in 34 urban for-profit private hospitals having CS facilities during the period June to August 2015. Data were supplied by inpatient case records and operation theatre registers. Descriptive analyses were performed to calculate the relative size of each group; the group-specific CS rate, and group contribution to total CS and overall CS rate. CS indications were grouped into eleven categories using ICD 10 codes. Binary logistic regression was performed to explore the determinants of CS. Results Out of 1307 births, delivery by CS occurred in 1077 (82%). Three obstetric groups contributed the most to overall CS rate: previous CS (24%), preterm (23%) and term elective groups (22%). The major clinical indications for CS were previous CS (35%), prolonged and obstructed labor (15%), fetal distress (11%) and amniotic fluid disorder (11%). Multiple gestation, non-cephalic presentation, previous bad obstetric history were positive predictors while oxytocin used for labour induction and increased parity were negative predictors of CS. Conclusions As the first ever study in urban private for-profit health facilities in Bangladesh, this study usefully identifies the burden of CS and where to intervene. Engagement of multiple stakeholders including the private sector is crucial in planning effective strategies for safe reduction of CS.	[Begum, Tahmina; Rahman, Aminur; Islam, Md Rajibul; Adams, Alayne; Anwar, Iqbal] Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Begum, Tahmina] Univ Queensland, Inst Social Sci Res, Brisbane, Qld, Australia; [Nababan, Herfina] Univ Melbourne, Sch Populat & Global Hlth, Nossal Inst Global Hlth, Melbourne, Vic, Australia; [Adams, Alayne] Georgetown Univ, Dept Int Hlth, Washington, DC USA; [Adams, Alayne] James P Grant Sch Publ Hlth, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); University of Queensland; University of Melbourne; Georgetown University	Begum, T (corresponding author), Icddr B, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh.; Begum, T (corresponding author), Univ Queensland, Inst Social Sci Res, Brisbane, Qld, Australia.	tbegum@icddrb.org	Begum, Tahmina/AAD-5258-2021; Rahman, Aminur/AAG-5391-2020	Begum, Tahmina/0000-0001-8106-2454; Rahman, Aminur/0000-0003-1434-3883; Adams, Alayne/0000-0002-0961-9825; Nababan, Herfina/0000-0002-7818-4132	Medical Research Council, UK [MR/M001717/1]; Department for International Development (DFID); MRC [MR/M001717/1] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development (DFID); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This manuscript used data from private sector phase 2 project. The funding of the phase two project came through competitive research grant from Medical Research Council, UK against the grant number MR/M001717/1. Dr Iqbal Anwar was the grant recipient and Dr Tahmina Begum was the focal person of that private sector phase 2 project. The Private sector phase one project was funded by the Department for International Development (DFID) and Dr Alayne Adams was the grant recipient of that project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2014, MAPPING HLTH FACILIT; Ahsan KA S, BANGLADESH MATERNAL; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; [Anonymous], 2010, INT STAT CLASS DIS R; Barber EL, 2011, OBSTET GYNECOL, V118, P29, DOI 10.1097/AOG.0b013e31821e5f65; Barrett JFR, 2013, NEW ENGL J MED, V369, P1295, DOI 10.1056/NEJMoa1214939; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Begum T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188074; Betran AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097769; BETRAN AP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148343; Betran AP, 2009, REPROD HLTH, V6, P1; Brennan DJ, 2009, AM J OBSTET GYNECOL, V200, pE8, DOI 10.1016/j.ajog.2008.09.004; Bugg GJ, 2013, OXYTOCIN VERSUS TREA; Chong C, 2012, ACTA OBSTET GYN SCAN, V91, P1422, DOI 10.1111/j.1600-0412.2012.01529.x; Chung WH, 2017, HONG KONG MED J, V23, P340, DOI 10.12809/hkmj176217; Easter SR, 2018, AM J PERINAT, V35, P345, DOI 10.1055/s-0037-1607316; Ferreira EC, 2015, INT J GYNECOL OBSTET, V129, P236, DOI 10.1016/j.ijgo.2014.11.026; Gholitabar M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7108; Hoffmann E, 2012, ACTA OBSTET GYN SCAN, V91, P463, DOI 10.1111/j.1600-0412.2011.01356.x; Hogle KL, 2003, AM J OBSTET GYNECOL, V188, P220, DOI 10.1067/mob.2003.64; Impey LWM, 2017, BJOG-INT J OBSTET GY, V124, pE152, DOI 10.1111/1471-0528.14465; Jayatillake R. V., 2011, J NATL SCI FDN SRI L, V39; Khawaja M, 2004, HEALTH POLICY, V69, P273, DOI 10.1016/j.healthpol.2004.05.006; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Lauer JA, 2010, DETERMINANTS CAESARE, P29; Malloy MH, 2008, PEDIATRICS, V122, P285, DOI 10.1542/peds.2007-2620; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; Neuman M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005982; NIPORT Mitra and Associates & ICF International, 2014, BANGL DEM HLTH SURV; OECD, OECD IND; Rahman MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202879; Rebelo F, 2010, ACTA OBSTET GYN SCAN, V89, P903, DOI 10.3109/00016349.2010.484044; Robson M, 2013, BEST PRACT RES CL OB, V27, P297, DOI 10.1016/j.bpobgyn.2012.09.004; Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156; Robson MS, 2001, FETAL MATERN MED REV, V12, P23, DOI [DOI 10.1017/S0965539501000122, 10.1017/S0965539501000122]; Sepehri A, 2017, BIRTH-ISS PERINAT C, V44, P11, DOI 10.1111/birt.12265; Singh P, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5533-3; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; Walker R, 2002, BIRTH-ISS PERINAT C, V29, P28, DOI 10.1046/j.1523-536X.2002.00153.x; Werner EF, 2011, ULTRASOUND OBST GYN, V38, P32, DOI 10.1002/uog.8911; Western Australian Data Linkage Branch, 2017, QUEENSL DAT LINK FRA; WHO, 2015, GUID TREATM MAL; Yadav RG, 2016, J OBSTET GYN INDIA, V66, P1, DOI 10.1007/s13224-015-0738-1	45	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220693	10.1371/journal.pone.0220693	http://dx.doi.org/10.1371/journal.pone.0220693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393926	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500051
J	Matsushita, K; Sang, YY; Yang, C; Ballew, SH; Grams, ME; Coresh, J; Molnar, MZ				Matsushita, Kunihiro; Sang, Yingying; Yang, Chao; Ballew, Shoshana H.; Grams, Morgan E.; Coresh, Josef; Molnar, Miklos Z.			Dyskalemia, its patterns, and prognosis among patients with incident heart failure: A nationwide study of US veterans	PLOS ONE			English	Article							SERUM POTASSIUM LEVELS; ATHEROSCLEROSIS RISK; MORTALITY; HYPERKALEMIA; ASSOCIATION; PREDICTORS; OUTCOMES; DISEASE; EVENTS; RACE	Background Although hypokalemia has been viewed as a significant concern among patients with heart failure (HF), recent advances in HF management tend to increase the risk of hyperkalemia. Objective To characterize contemporary data regarding correlates and prognostic values of dyskalemia in patients with HF. Design, setting, and participants In cross-sectional and longitudinal analyses, we studied 142,087 patients with newly diagnosed HF in US nationwide Veterans Administration database from 2005 through 2013. Exposures Demographic characteristics, laboratory variables, comorbidities, and medication use for the analysis of correlates of dyskalemia as well as potassium level in the analysis of mortality. Main Outcomes and Measures Dyskalemia and mortality. Results Hypokalemia (<3.5 mmol/L) at baseline was observed in 3.0% of the population, whereas hyperkalemia (>= 5.5 mmol/L) was seen in 0.9%. An additional 20.4% and 5.7% had mild hypokalemia (3.5-3.9 mmol/L) and mild hyperkalemia (5.0-5.4 mmol/L). Key correlates were black race, higher blood pressure, and use of potassium-wasting diuretics for hypokalemia, and lower kidney function for hyperkalemia. Baseline potassium levels showed a U-shaped association with mortality, with the lowest risk between 4.0-4.5 mmol/L. With respect to potassium levels over a year after HF diagnosis, persistent (>50% of measurements), intermittent (> 1 occurrence but <= 50%), and transient (1 occurrence) hypo- and hyperkalemia were also related to increased mortality in a graded fashion regardless of the aforementioned thresholds for dyskalemia. These dyskalemic patterns were also related to other clinical actions and demands such as emergency room visit. Conclusions Potassium levels below 4 mmol/L and above 5 mmol/L at and after HF diagnosis were associated with poor prognosis and the clinical actions. HF patients (particularly with risk factors for dyskalemia like black race and kidney dysfunction) may require special attention for both hypo- and hyperkalemia.	[Matsushita, Kunihiro; Sang, Yingying; Yang, Chao; Ballew, Shoshana H.; Grams, Morgan E.; Coresh, Josef] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Molnar, Miklos Z.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA	Johns Hopkins University; University of Tennessee System; University of Tennessee Health Science Center	Matsushita, K (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	kuni.matsushita@jhu.edu	Yang, Chao/AGR-0453-2022; Matsushita, Kunihiro/AAJ-5817-2020	Matsushita, Kunihiro/0000-0002-7179-718X	National Kidney Foundation; (Relypsa); National Institute of Diabetes and Digestive and Kidney Diseases [R01DK100446-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100446] Funding Source: NIH RePORTER	National Kidney Foundation; (Relypsa); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Kidney Foundation (funding sources include Relypsa) as well as the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK100446-01) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK., 2014, CIRCULATION, V129, pAP024; Ahmed A, 2007, EUR HEART J, V28, P1334, DOI 10.1093/eurheartj/ehm091; Ahmed MI, 2010, INT J CARDIOL, V144, P383, DOI 10.1016/j.ijcard.2009.04.041; Bielecka-Dabrowa A, 2012, INT J CARDIOL, V158, P12, DOI 10.1016/j.ijcard.2011.06.121; Camplain R, 2017, PHARMACOEPIDEM DR S, V26, P421, DOI 10.1002/pds.4162; Chang AR, 2016, HYPERTENSION, V67, P1181, DOI 10.1161/HYPERTENSIONAHA.116.07363; Chen Y, 2017, AM J KIDNEY DIS, V70, P244, DOI 10.1053/j.ajkd.2017.01.044; CLELAND JGF, 1987, BRIT HEART J, V58, P572; Cooper HA, 1999, CIRCULATION, V100, P1311, DOI 10.1161/01.CIR.100.12.1311; Desai AS, 2007, J AM COLL CARDIOL, V50, P1959, DOI 10.1016/j.jacc.2007.07.067; Gerber Y, 2015, JAMA INTERN MED, V175, P996, DOI 10.1001/jamainternmed.2015.0924; Gosmanova EO, 2014, HYPERTENSION, V64, P951, DOI 10.1161/HYPERTENSIONAHA.114.03805; Heerspink HJL, 2014, EUR J PREV CARDIOL, V21, P299, DOI 10.1177/2047487313510678; Hoss S, 2016, AM J CARDIOL, V118, P1868, DOI 10.1016/j.amjcard.2016.08.078; Kovesdy CP, 2015, CIRCULATION, V132, P1538, DOI 10.1161/CIRCULATIONAHA.114.015124; Kovesdy CP, 2013, ANN INTERN MED, V159, P233, DOI 10.7326/0003-4819-159-4-201308200-00004; Krogager ML, 2015, EUR HEART J-CARD PHA, V1, P245, DOI 10.1093/ehjcvp/pvv026; Leto L, 2014, HEART FAIL REV, V19, P237, DOI 10.1007/s10741-012-9354-7; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Macdonald JE, 2004, J AM COLL CARDIOL, V43, P155, DOI 10.1016/j.jacc.2003.06.021; Nehler MR, 2014, J VASC SURG, V60, P686, DOI 10.1016/j.jvs.2014.03.290; NORDREHAUG JE, 1985, CIRCULATION, V71, P645, DOI 10.1161/01.CIR.71.4.645; Poggio R, 2010, POSTGRAD MED J, V86, P136, DOI 10.1136/pgmj.2008.072058; Quach S, 2010, CAN J CARDIOL, V26, pE306, DOI 10.1016/S0828-282X(10)70438-4; Rosamond WD, 2012, CIRC-HEART FAIL, V5, P152, DOI 10.1161/CIRCHEARTFAILURE.111.963199; Sumida K, 2017, J AM SOC NEPHROL, V28, P1248, DOI 10.1681/ASN.2016060656; Vardeny O, 2014, CIRC-HEART FAIL, V7, P573, DOI 10.1161/CIRCHEARTFAILURE.114.001104	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219899	10.1371/journal.pone.0219899	http://dx.doi.org/10.1371/journal.pone.0219899			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393910	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500019
J	de Arellano, ER; Diez-Fuertes, F; Aguilar, F; Tarazona, HED; Sanchez-Lara, S; Lao, Y; Vicario, JL; Garcia, F; Gonzalez-Garcia, J; Pulido, F; Gutierrez-Rodero, FPL; Moreno, S; Iribarren, JA; Viciana, P; Vilches, C; Ramos, M; Capa, L; Alcami, J; Del Val, M				Ramirez de Arellano, Eva; Diez-Fuertes, Francisco; Aguilar, Francisco; de la Torre Tarazona, Humberto Erick; Sanchez-Lara, Susana; Lao, Yolanda; Luis Vicario, Jose; Garcia, Felipe; Gonzalez-Garcia, Juan; Pulido, Federico; Gutierrez-Rodero, Felix; Moreno, Santiago; Antonio Iribarren, Jose; Viciana, Pompeyo; Vilches, Carlos; Ramos, Manuel; Capa, Laura; Alcami, Jose; Del Val, Margarita			Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CLASS-I ALLELES; GENETIC RESTRICTION; INFECTION; AIDS; POLYMORPHISM; REPLICATION; COHORT; SUSCEPTIBILITY; NONPROGRESSION	Certain host genetic variants, especially in the human leucocyte antigen (HLA) region, are associated with different progression of HIV-1-induced diseases and AIDS. Long term non progressors (LTNP) represent only the 2% of infected patients but are especially relevant because of their efficient HIV control. In this work we present a global analysis of genetic data in the large national multicenter cohort of Spanish LTNP, which is compared with seronegative individuals and HIV-positive patients. We have analyzed whether several single-nucleotide polymorphisms (SNPs) including in key genes and certain HLA-A and B alleles could be associated with a specific HIV phenotype. A total of 846 individuals, 398 HIV-1-positive patients (213 typical progressors, 55 AIDS patients, and 130 LTNPs) and 448 HIV-negative controls, were genotyped for 15 polymorphisms and HLA-A and B alleles. Significant differences in the allele frequencies among the studied populations identified 16 LTNP-associated genetic factors, 5 of which were defined for the first time as related to LTNP phenotype: the protective effect of HLA-B39, and the detrimental impact of HLA-B18, -A24, -B08 and -A29. The remaining eleven polymorphisms confirmed previous publications, including the protective alleles HLA-B57, rs2395029 (HCP5), HLA bw4 homozygosity, HLA-B52, HLA-B27, CCR2 V64I, rs9264942 (HLA-C) and HLA-A03; and the risk allele HLA bw6 homozygosity. Notably, individual Spanish HIV-negative individuals had an average of 0.12 protective HLA alleles and SNPs, compared with an average of 1.43 protective alleles per LTNP patient, strongly suggesting positive selection of LTNP. Finally, stratification of LTNP according to viral load showed a proportional relationship between the frequency of protective alleles with control of viral load. Interestingly, no differences in the frequency of protection/risk polymorphisms were found between elite controllers and LTNPs maintaining viral loads <2.000 copies/mL throughout the follow-up.	[Ramirez de Arellano, Eva; Diez-Fuertes, Francisco; Aguilar, Francisco; de la Torre Tarazona, Humberto Erick; Sanchez-Lara, Susana; Lao, Yolanda; Ramos, Manuel; Capa, Laura; Alcami, Jose; Del Val, Margarita] Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain; [Diez-Fuertes, Francisco; Garcia, Felipe; Gonzalez-Garcia, Juan; Alcami, Jose] Univ Barcelona, Hosp Clin, IBIDAPS, Infect Dis Unit, Barcelona, Spain; [Sanchez-Lara, Susana; Ramos, Manuel; Del Val, Margarita] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Viral Immunol, Madrid, Spain; [Luis Vicario, Jose] Ctr Transfus Madrid, Dept Histocompatibilidad, Madrid, Spain; [Gonzalez-Garcia, Juan] Hosp Univ La Paz, Madrid, Spain; [Pulido, Federico] Inst Invest Hosp 12 Octubre I 12, HIV Unit, Madrid, Spain; [Gutierrez-Rodero, Felix] Hosp Gen Univ Elche, Serv Med Interna, Unidad Enfermedades Infecciosas, Alicante, Spain; [Moreno, Santiago] Hosp Ramon & Cajal, Infect Dis, Madrid, Spain; [Antonio Iribarren, Jose] Hosp Univ Donostia, San Sebastian, Spain; [Viciana, Pompeyo] Univ Seville, Virgen Rocio Univ Hosp, IBIS CSIC SAS,Lab Immunovirol, Biomed Inst Sevilla,Clin Unit Infect Dis Microbio, Seville, Spain; [Vilches, Carlos] Inst Invest Sanitaria Puerta Hierro, Inmunogenet & Histocompatibilidad, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario La Paz; Hospital Universitario 12 de Octubre; Hospital Universitario Ramon y Cajal; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Puerta de Hierro-Majadahonda	de Arellano, ER (corresponding author), Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain.	erarellano75@gmail.com	Del Val, Margarita/E-4769-2010; Ramos, Manuel/F-5076-2016; Díez-Fuertes, Francisco/AAA-9427-2019; Vilches, Carlos/AAG-9203-2021; , Felipe/F-4242-2014; Iribarren, José/AAK-5528-2021; Pulido, Federico/B-8417-2009; Vilches, Carlos/G-1471-2012; Alcami, Pepe/T-2242-2018; Gutierrez, Felix/Q-7880-2018	Del Val, Margarita/0000-0001-6769-4279; Ramos, Manuel/0000-0002-0404-7936; Díez-Fuertes, Francisco/0000-0003-2413-9229; , Felipe/0000-0001-7658-5832; Pulido, Federico/0000-0002-7414-8812; Vilches, Carlos/0000-0002-0300-9225; Alcami, Pepe/0000-0003-0023-7377; De La Torre Tarazona, Humberto Erick/0000-0003-0325-3735; Gutierrez, Felix/0000-0002-9485-6867; Sanchez Lara, Susana/0000-0002-7391-2081; Capa, Laura/0000-0002-0234-331X; Gonzalez-Garcia, Juan/0000-0002-3652-002X	Instituto de Salud Carlos III from the Spanish Ministry of Health, through Red Tematica de Investigacion Cooperativa en SIDA (RIS) [G03/173(2), PI050528, RD06/0006/0033, RD06/0006/0035, RD12/0017/0037, C03/173, RD12/0017/0018]; ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER); Plan Nacional I+ D+ I from the Spanish Ministry of Science and Technology [SAF2007-60934, SAF2010-18917, SAF201348754-C2-1-R]; Instituto de Salud Carlos III [Intrasalud PI12/0056]; Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Fundacion Ramon Areces; Banco de Santander; Spanish Government's "Sara Borrell" postdoctoral program [CD12/00515]	Instituto de Salud Carlos III from the Spanish Ministry of Health, through Red Tematica de Investigacion Cooperativa en SIDA (RIS); ISCIII-Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Plan Nacional I+ D+ I from the Spanish Ministry of Science and Technology; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE); Fundacion Ramon Areces; Banco de Santander; Spanish Government's "Sara Borrell" postdoctoral program	This work was supported by Instituto de Salud Carlos III from the Spanish Ministry of Health, through Red Tematica de Investigacion Cooperativa en SIDA (RIS) [G03/173(2), PI050528 and RD06/0006/0033 to MDV, RD06/0006/0035 and RD12/0017/0037 to the HIV BioBank, and C03/173 and RD12/0017/0018 to CoRIS], cofinanced by ISCIII-Subdireccion General de Evaluacion and Fondo Europeo de Desarrollo Regional (FEDER), and also financed by Plan Nacional I+ D+ I from the Spanish Ministry of Science and Technology [SAF2007-60934, SAF2010-18917 and SAF201348754-C2-1-R to MDV], by Instituto de Salud Carlos III [Intrasalud PI12/0056 to JA] and by Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE) [to HIV Biobank]. Institutional grants from the Fundacion Ramon Areces and Banco de Santander to the CBMSO are also acknowledged. FDF is supported by the Spanish Government's "Sara Borrell" postdoctoral program CD12/00515. The funders had no role in study design, decision to publish, analysis and preparation of the manuscript.	Balas A, 2011, TISSUE ANTIGENS, V77, P45, DOI 10.1111/j.1399-0039.2010.01578.x; Ballana E, 2012, IMMUNOBIOLOGY, V217, P889, DOI 10.1016/j.imbio.2011.12.012; Ballana E, 2010, CLIN INFECT DIS, V50, P1022, DOI 10.1086/651114; Bartha I, 2013, ELIFE, V2, DOI 10.7554/eLife.01123; Caro-Murillo AM, 2007, ENFERM INFEC MICR CL, V25, P23, DOI 10.1157/13096749; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Casado C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011079; Chaudhari DV, 2013, IMMUNOL LETT, V156, P1, DOI 10.1016/j.imlet.2013.09.002; Chikata T, 2017, J INFECT DIS, V216, P1415, DOI 10.1093/infdis/jix483; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Sorrentino AH, 2000, J INFECT DIS, V182, P1523, DOI 10.1086/315854; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Farquhar C, 2004, AIDS RES HUM RETROV, V20, P692, DOI 10.1089/0889222041524616; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Furutsuki T, 2004, J VIROL, V78, P8437, DOI 10.1128/JVI.78.16.8437-8445.2004; Gao XJ, 2010, AIDS, V24, P1835, DOI 10.1097/QAD.0b013e32833c3219; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Ghezzi S, 2013, AIDS, V27, P2335, DOI 10.1097/01.aids.0000432474.76873.5f; Goulder PJR, 1997, AIDS, V11, P1883, DOI 10.1097/00002030-199715000-00015; Guergnon J, 2012, J INFECT DIS, V205, P718, DOI 10.1093/infdis/jir833; KASLOW RA, 1990, LANCET, V335, P927, DOI 10.1016/0140-6736(90)90995-H; Keet IPM, 1999, J INFECT DIS, V180, P299, DOI 10.1086/314862; KILPATRICK DC, 1991, DIS MARKERS, V9, P21; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu HL, 1999, P NATL ACAD SCI USA, V96, P4581, DOI 10.1073/pnas.96.8.4581; Machmach K, 2013, J INFECT DIS, V207, P651, DOI 10.1093/infdis/jis717; Magierowska M, 1999, BLOOD, V93, P936, DOI 10.1182/blood.V93.3.936.403k08_936_941; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; McNeil AJ, 1996, QJM-INT J MED, V89, P177; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959; Tang JM, 2002, J VIROL, V76, P8276, DOI 10.1128/JVI.76.16.8276-8284.2002; Teixeira SLM, 2014, GENES IMMUN, V15, P256, DOI 10.1038/gene.2014.14; Thomas R, 2009, NAT GENET, V41, P1290, DOI 10.1038/ng.486; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Wilson CC, 1997, J VIROL, V71, P1256, DOI 10.1128/JVI.71.2.1256-1264.1997; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Yindom LM, 2010, J VIROL, V84, P8202, DOI 10.1128/JVI.00116-10; Zhang WL, 2013, SCI CHINA LIFE SCI, V56, P1014, DOI 10.1007/s11427-013-4555-4	51	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220459	10.1371/journal.pone.0220459	http://dx.doi.org/10.1371/journal.pone.0220459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393887	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500034
J	Uhl, P; Awanbor, O; Schulz, RS; Bruhl, CA				Uhl, Philipp; Awanbor, Osarobo; Schulz, Robert S.; Bruehl, Carsten A.			Is Osmia bicornis an adequate regulatory surrogate? Comparing its acute contact sensitivity to Apis mellifera	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDE; POLLINATING INSECTS; HONEY-BEES; PESTICIDE; EXPOSURE; MORTALITY; SEEDS	Bees provide essential ecosystem services and help maintain floral biodiversity. However, there is an ongoing decline of wild and domesticated bee species. Since agricultural pesticide use is a key driver of this process, there is a need for a protective risk assessment. To achieve a more protective registration process, two bee species, Osmia bicornis/Osmia cornuta and Bombus terrestris, were proposed by the European Food Safety Authority as additional test surrogates to the honey bee Apis mellifera. We investigated the acute toxicity (median lethal dose, LD50) of multiple commercial insecticide formulations towards the red mason bee (O. bicornis) and compared these values to honey bee regulatory endpoints. In two thirds of all cases, O. bicornis was less sensitive than the honey bee. By applying an assessment factor of 10 on the honey bee endpoint, a protective level was achieved for 87% (13 out 15) of all evaluated products. Our results show that O. bicornis is rarely an adequate additional surrogate species for lower tier risk assessment since it is less sensitive than the honey bee for the majority of investigated products. Given the currently limited database on bee species sensitivity, the honey bee seems sufficiently protective in acute scenarios as long as a reasonable assessment factor is applied. However, additional surrogate species can still be relevant for ecologically meaningful higher tier studies.	[Uhl, Philipp; Awanbor, Osarobo; Schulz, Robert S.; Bruehl, Carsten A.] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Schulz, Robert S.] Fed Inst Hydrol, Koblenz, Germany	University of Koblenz & Landau	Uhl, P (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	uhl@uni-landau.de	Bruhl, Carsten A/F-3385-2012	Uhl, Philipp/0000-0003-4697-5949; Bruhl, Carsten A./0000-0003-1332-535X				Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Dmochowska-Slezak K, 2015, APIDOLOGIE, V46, P432, DOI 10.1007/s13592-014-0333-y; Elias-Neto M, 2014, APIDOLOGIE, V45, P397, DOI 10.1007/s13592-013-0254-1; Fine JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep40499; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gradish AE, 2019, ENVIRON ENTOMOL, V48, P12, DOI 10.1093/ee/nvy168; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Heard MS, 2017, SCI TOTAL ENVIRON, V578, P357, DOI 10.1016/j.scitotenv.2016.10.180; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Ollerton J, 2017, ANNU REV ECOL EVOL S, V48, P353, DOI 10.1146/annurev-ecolsys-110316-022919; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Peters B, 2016, ECOTOXICOLOGY, V25, P1679, DOI 10.1007/s10646-016-1729-4; R Core Team, 2017, LANG ENV STAT COMP; Rader R, 2015, P NATL ACAD SCI USA; Ritz C, 2005, J STAT SOFTW, V12, P1; Robinson KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185000; Roessink I., 2016, SOLITARY BEE ACUTE C; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Sanchez-Bayo F, 2019, BIOL CONSERV, V232, P8, DOI 10.1016/j.biocon.2019.01.020; Sattler C, 2007, AGR ECOSYST ENVIRON, V119, P299, DOI 10.1016/j.agee.2006.07.017; Sgolastra F, 2019, ENVIRON ENTOMOL, V48, P22, DOI 10.1093/ee/nvy105; Sgolastra F, 2017, PEST MANAG SCI, V73, P1236, DOI 10.1002/ps.4449; Slowinska M, 2016, APIDOLOGIE, V47, P227, DOI 10.1007/s13592-015-0391-9; SMIRLE MJ, 1988, CAN J ZOOL, V66, P1938, DOI 10.1139/z88-283; Sterk G, 2016, ECOTOXICOLOGY, V25, P1666, DOI 10.1007/s10646-016-1730-y; Uhl P, 2016, SCI REP-UK, V6, DOI 10.1038/srep34439; van der Sluijs JP, 2015, ENVIRON SCI POLLUT R, V22, P148, DOI 10.1007/s11356-014-3229-5; Wood T, 2017, ENV RISKS NEONICOTIN; 2013, EFSA J, V11, DOI DOI 10.2903/J.EFSA.2013.3295	33	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0201081	10.1371/journal.pone.0201081	http://dx.doi.org/10.1371/journal.pone.0201081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393875	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500001
J	Yeh, PS; Lee, YW; Chang, WH; Wang, W; Wang, JL; Liu, SH; Chen, RM				Yeh, Poh-Shiow; Lee, Yuan-Wen; Chang, Wei-Hui; Wang, Weu; Wang, Jaw-Lin; Liu, Shing-Hwa; Chen, Ruei-Ming			Biomechanical and tomographic differences in the microarchitecture and strength of trabecular and cortical bone in the early stage of male osteoporosis	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; SUBSEQUENT FRACTURE; BENDING STRENGTH; CANCELLOUS BONE; MALE-RATS; MEN; TESTOSTERONE; MODEL; MORTALITY; STIFFNESS	Osteoporosis is a continuous process of loss of bone tissue. Compared to women, osteoporosis in men is associated with greater morbidity and mortality. In this study, we conducted tomographic and biomechanical evaluations of trabecular and cortical bone in the early stage of male osteoporosis. Male Wistar rats were subjected to orchiectomy and sham operation. Four weeks after being castrated, decreased levels of testosterone in plasma were found and resulted in concurrent bone loss. Separately, the orchiectomy led to significant tomographic alterations in the trabecular bone number, trabecular separation, and trabecular pattern factor. Data of a mechanistic compression test further showed that the orchiectomy diminished the maximum loading force, displacement at maximum load, energy at maximum load, and ultimate stress. Interestingly, orchiectomy-triggered changes in the maximum loading force and tomographic parameters were highly correlated. In contrast, tomographic and biomechanical analyses showed that 4 weeks after rats were orchiectomized, the thickness, area, maximum loading force, bone stiffness, energy at maximum load, and ultimate stress of the cortical bone were not changed. Taken together, this study showed specific differences in the microarchitecture and strength of trabecular bone in the early stage of male osteoporosis.	[Yeh, Poh-Shiow] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Yeh, Poh-Shiow; Chang, Wei-Hui; Chen, Ruei-Ming] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Lee, Yuan-Wen] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Lee, Yuan-Wen; Chen, Ruei-Ming] Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan; [Lee, Yuan-Wen; Chen, Ruei-Ming] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Wang, Weu] Taipei Med Univ Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Wang, Jaw-Lin] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei, Taiwan; [Chen, Ruei-Ming] Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei, Taiwan	Chi Mei Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University; Taipei Medical University; Taipei Municipal WanFang Hospital	Chen, RM (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Chen, RM (corresponding author), Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan.; Chen, RM (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.; Chen, RM (corresponding author), Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei, Taiwan.	rmchen@tmu.edu.tw		LIU, SHING-HWA/0000-0002-9976-1197; Chen, Ruei-Ming/0000-0002-5728-0571	Chi-Mei Medical Center, Taipei, Taiwan [102CM-TMU-14-4]; Wan Fang Hospital, Taipei, Taiwan [108-wf-eva-04]; Ministry of Science and Technology, Taipei, Taiwan [MOST107-2314-B-038-036-MY3]	Chi-Mei Medical Center, Taipei, Taiwan; Wan Fang Hospital, Taipei, Taiwan; Ministry of Science and Technology, Taipei, Taiwan	This study was supported by grants from the Chi-Mei Medical Center (102CM-TMU-14-4), Wan Fang Hospital (108-wf-eva-04), and the Ministry of Science and Technology (MOST107-2314-B-038-036-MY3), Taipei, Taiwan.	AARON JE, 1987, CLIN ORTHOP RELAT R, P260; Abdulai-Saiku S, 2017, BRAIN BEHAV IMMUN, V65, P95, DOI 10.1016/j.bbi.2017.04.005; Almeida M, 2017, PHYSIOL REV, V97, P135, DOI 10.1152/physrev.00033.2015; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Blouin S, 2007, OSTEOPOROSIS INT, V18, P85, DOI 10.1007/s00198-006-0197-8; Cauley JA, 2018, J BONE MINER RES, V33, P1859, DOI 10.1002/jbmr.3468; Cefalu CA, 2004, CURR MED RES OPIN, V20, P341, DOI 10.1185/030079903125003062; Chin KY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120808; Eastell R, 2018, EUR J ENDOCRINOL, V178, pR19, DOI 10.1530/EJE-17-0585; Gartlehner G, 2017, JAMA-J AM MED ASSOC, V318, P2234, DOI 10.1001/jama.2017.16952; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Jayusman PA, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070799; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Jiang HX, 2005, J BONE MINER RES, V20, P494, DOI 10.1359/JBMR.041133; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; KELLER TS, 1990, J ORTHOPAED RES, V8, P592, DOI 10.1002/jor.1100080416; Kovacs CS, 2017, J BONE MINER RES, V32, P676, DOI 10.1002/jbmr.3090; Lee JH, 2016, OSTEOPOROSIS INT, V27, P1691, DOI 10.1007/s00198-015-3436-z; Lee YE, 2014, J ETHNOPHARMACOL, V158, P94, DOI 10.1016/j.jep.2014.10.016; Liao MH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.182; Lim SJ, 2018, OSTEOPOROSIS INT, V29, P2427, DOI 10.1007/s00198-018-4640-4; Mohamad NV, 2018, INT J MED SCI, V15, P300, DOI 10.7150/ijms.22732; Mohamad NV, 2016, CLIN INTERV AGING, V11, P1317, DOI 10.2147/CIA.S115472; Nayak S, 2017, J AM GERIATR SOC, V65, P490, DOI 10.1111/jgs.14668; Nazarian A, 2008, CALCIFIED TISSUE INT, V83, P368, DOI 10.1007/s00223-008-9174-x; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rejnmark L, 2013, OSTEOPOROSIS INT, V24, P1529, DOI 10.1007/s00198-012-2230-4; Riggs BL, 2008, J BONE MINER RES, V23, P205, DOI 10.1359/JBMR.071020; Savaridas T, 2015, BONE JOINT RES, V4, P99, DOI 10.1302/2046-3758.46.2000311; Schmidt C, 2003, J BONE MINER RES, V18, P1486, DOI 10.1359/jbmr.2003.18.8.1486; Sidlauskas KM, 2014, CLIN INTERV AGING, V9, P593, DOI 10.2147/CIA.S51940; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Sinnesael M, 2013, CURR OPIN ENDOCRINOL, V20, P240, DOI 10.1097/MED.0b013e32835f7d04; Swift JM, 1985, J APPL PHYSIOL, V109, P1600; Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639; Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185; VAHEY JW, 1987, J BIOMECH, V20, P29, DOI 10.1016/0021-9290(87)90264-8; Vandenput L, 2002, J BONE MINER RES, V17, P2080, DOI 10.1359/jbmr.2002.17.11.2080; VANDERSCHUEREN D, 1992, ENDOCRINOLOGY, V130, P2906, DOI 10.1210/en.130.5.2906; Viswanathan M, 2018, JAMA-J AM MED ASSOC, V319, P2532, DOI 10.1001/jama.2018.6537; Vorland CJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44415-9; Wang J, 2016, BONE, V88, P39, DOI 10.1016/j.bone.2016.04.003; Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55; WEINSTEIN RS, 1987, BONE, V8, P137, DOI 10.1016/8756-3282(87)90012-3; WINK CS, 1980, CALCIFIED TISSUE INT, V32, P77, DOI 10.1007/BF02408524	46	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219718	10.1371/journal.pone.0219718	http://dx.doi.org/10.1371/journal.pone.0219718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393911	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500015
J	Lo Iacono, S				Lo Iacono, Sergio			Law-breaking, fairness, and generalized trust: The mediating role of trust in institutions	PLOS ONE			English	Article							SOCIAL TRUST; POLITICAL CORRUPTION; DIVERSITY; STATE; CRIME	Institution-centered accounts of generalized trust rely on the idea that law-breaking and state's unfairness lower individuals' propensity to trust fellow citizens because of a weaker confidence in the state. Despite the theoretical relevance attributed to this mediation mechanism, no empirical analysis in the literature has focused on examining its correlational validity. Using data from the European Social Survey (2010), the Quality of Government EU Regional data, and EUROSTAT, this paper assesses the intervening role of institutional trust on the relationship between crime rates, state's fairness, and generalized trust. Results from a Multilevel SEM (MSEM) mediation analysis indicate that trust in institutions strongly mediates the relationship between violent crimes (i.e. homicide) and generalized trust but not the one between property crimes (i.e. vehicle thefts and robberies) and generalized trust. On the other hand, indicators of fairness (i.e. impartiality and corruption) are all mediated by institutional trust, though impartiality maintains a significant direct effect. Overall, findings support the institutional approach, confirming that the negative relationship between ineffective and unfair institutions and generalized trust passes mostly through people's lost faith in the state.	[Lo Iacono, Sergio] European Univ Inst, Dept Polit & Social Sci, Florence, Italy	European University Institute	Lo Iacono, S (corresponding author), European Univ Inst, Dept Polit & Social Sci, Florence, Italy.	Sergio.Loiacono@EUI.eu		Lo Iacono, Sergio/0000-0001-7316-5162	Economic and Social Research Council [ES/J500045/1]	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	S.L.I. acknowledges the financial support of the Economic and Social Research Council (ES/J500045/1). https://esrc.ukri.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal M, 2015, AM J SOCIOL, V121, P722, DOI 10.1086/683144; Alesina A, 2002, J PUBLIC ECON, V85, P207, DOI 10.1016/S0047-2727(01)00084-6; Allum N, 2010, UNDERST POPUL TRENDS, V2, P199, DOI 10.1007/978-90-481-8750-8_13; [Anonymous], 1998, TRUST GOVERNANCE; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bjornskov C, 2007, PUBLIC CHOICE, V130, P1, DOI 10.1007/s11127-006-9069-1; Brehm J, 1997, AM J POLIT SCI, V41, P999, DOI 10.2307/2111684; Charron N., 2016, QUALITY GOVT EU REGI; Charron N, 2014, REG STUD, V48, P68, DOI 10.1080/00343404.2013.770141; Fieldhouse E, 2010, CAN J POLIT SCI, V43, P289, DOI 10.1017/S0008423910000065; Freitag M, 2009, COMP POLIT STUD, V42, P1537, DOI 10.1177/0010414009332151; Galea S, 2002, SOC SCI MED, V55, P1373, DOI 10.1016/S0277-9536(01)00274-X; Herreros F, 2004, POLIT EVOL INST CHAN, P1, DOI 10.1057/9781403978806; Herreros F, 2008, INT POLIT SCI REV, V29, P53, DOI 10.1177/0192512107083447; Hooghe M., 2011, POLITICAL TRUST WHY, P1, DOI DOI 10.1177/1532673X09341531; Hooghe M, 2009, COMP POLIT STUD, V42, P198, DOI 10.1177/0010414008325286; Kawachi I, 1999, SOC SCI MED, V48, P719, DOI 10.1016/S0277-9536(98)00400-6; Kennedy BP, 1998, SOC SCI MED, V47, P7, DOI 10.1016/S0277-9536(98)00097-5; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Lederman D, 2002, ECON DEV CULT CHANGE, V50, P509, DOI 10.1086/342422; Luhmann, 1979, TRUST POWER CHICHEST; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Messner SF, 2004, AM SOCIOL REV, V69, P882, DOI 10.1177/000312240406900607; Muthen L, 1998, COMPREHENSIVE MODELL, V5; Phan M.B., 2008, ANAL SOCIAL ISSUES P, V8, P23, DOI DOI 10.1111/J.1530-2415.2008.00151.X; PREACHER KJ, 2015, ANNU REV PSYCHOL, V66, DOI DOI 10.1086/683144; Preacher KJ, 2011, MULTIVAR BEHAV RES, V46, P691, DOI 10.1080/00273171.2011.589280; Preacher KJ, 2011, STRUCT EQU MODELING, V18, P161, DOI 10.1080/10705511.2011.557329; Preacher KJ, 2010, PSYCHOL METHODS, V15, P209, DOI 10.1037/a0020141; Putnam R.D., 1994, MAKING DEMOCRACY WOR; Putnam R. D., 2001, BOWLING ALONE COLLAP; Putnam RD, 2007, SCAND POLIT STUD, V30, P137, DOI 10.1111/j.1467-9477.2007.00176.x; Richey S, 2010, AM POLIT RES, V38, P676, DOI 10.1177/1532673X09341531; Robbins BG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035120; Rothstein B, 2008, COMP POLIT, V40, P441; Rothstein B, 2009, RATION SOC, V21, P81, DOI 10.1177/1043463108099349; Sonderskov KM, 2016, POLIT BEHAV, V38, P179, DOI 10.1007/s11109-015-9322-8; Tao R, 2014, INT POLIT SCI REV, V35, P237, DOI 10.1177/0192512113492599; van der Meer Tom, 2011, POLITICAL TRUST WHY, P95; You J- S., 2005, CORRUPTION INEQUALIT; You JS, 2012, POLIT PSYCHOL, V33, P701, DOI 10.1111/j.1467-9221.2012.00893.x; Zak PJ, 2001, ECON J, V111, P295, DOI 10.1111/1468-0297.00609; Ziller C, 2015, J ELECT PUBLIC OPIN, V25, P368, DOI 10.1080/17457289.2014.1002792; 2018, OXFORD HDB SOCIAL PO, P473, DOI DOI 10.1007/978-90-481-8750-8_13	44	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220160	10.1371/journal.pone.0220160	http://dx.doi.org/10.1371/journal.pone.0220160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390348	Green Published, gold			2022-12-27	WOS:000484999400012
J	Tierney, NJ; Mira, A; Reinhold, HJ; Arbia, G; Clifford, S; Auricchio, A; Moccetti, T; Peluso, S; Mengersen, KL				Tierney, Nicholas J.; Mira, Antonietta; Reinhold, H. Jost; Arbia, Giuseppe; Clifford, Samuel; Auricchio, Angelo; Moccetti, Tiziano; Peluso, Stefano; Mengersen, Kerrie L.			Evaluating health facility access using Bayesian spatial models and location analysis methods	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; AUTOMATED EXTERNAL DEFIBRILLATORS; CARDIOPULMONARY-RESUSCITATION; SURVIVAL	Background Floating catchment methods have recently been applied to identify priority regions for Automated External Defibrillator (AED) deployment, to aid in improving Out of Hospital Cardiac Arrest (OHCA) survival. This approach models access as a supply-to-demand ratio for each area, targeting areas with high demand and low supply for AED placement. These methods incorporate spatial covariates on OHCA occurrence, but do not provide precise AED locations, which are critical to the initial intent of such location analysis research. Exact AED locations can be determined using optimisation methods, but they do not incorporate known spatial risk factors for OHCA, such as income and demographics. Combining these two approaches would evaluate AED placement impact, describe drivers of OHCA occurrence, and identify areas that may not be appropriately covered by AED placement strategies. There are two aims in this paper. First, to develop geospatial models of OHCA that account for and display uncertainty. Second, to evaluate the AED placement methods using geospatial models of accessibility. We first identify communities with the greatest gap between demand and supply for allocating AEDs. We then use this information to evaluate models for precise AED location deployment. Methods Case study data set consisted of 2802 OHCA events and 719 AEDs. Spatial OHCA occurrence was described using a geospatial model, with possible spatial correlation accommodated by introducing a conditional autoregressive (CAR) prior on the municipality-level spatial random effect. This model was fit with Integrated Nested Laplacian Approximation (INLA), using covariates for population density, proportion male, proportion over 65 years, financial strength, and the proportion of land used for transport, commercial, buildings, recreation, and urban areas. Optimisation methods for AED locations were applied to find the top 100 AED placement locations. AED access was calculated for current access and 100 AED placements. Priority rankings were then given for each area based on their access score and predicted number of OHCA events. Results Of the 2802 OHCA events, 64.28% occurred in rural areas, and 35.72% in urban areas. Additionally, over 70% of individuals were aged over 65. Supply of AEDs was less than demand in most areas. Priority regions for AED placement were identified, and access scores were evaluated for AED placement methodology by ranking the access scores and the predicted OHCA count. AED placement methodology placed AEDs in areas with the highest priority, but placed more AEDs in areas with more predicted OHCA events in each grid cell. Conclusion The methods in this paper incorporate OHCA spatial risk factors and OHCA coverage to identify spatial regions most in need of resources. These methods can be used to help understand how AED allocation methods affect OHCA accessibility, which is of significant practical value for communities when deciding AED placements.	[Tierney, Nicholas J.; Clifford, Samuel; Mengersen, Kerrie L.] Queensland Univ Technol, Sci & Engn Fac, Dept Stat Sci, Math Sci, Brisbane, Qld, Australia; [Tierney, Nicholas J.; Clifford, Samuel; Mengersen, Kerrie L.] ARC Ctr Excellence Math & Stat Frontiers ACEMS, Brisbane, Qld, Australia; [Tierney, Nicholas J.] Monash Univ, Dept Econometr & Business Stat, Melbourne, Vic, Australia; [Mira, Antonietta; Reinhold, H. Jost; Arbia, Giuseppe; Peluso, Stefano] Univ Svizzera Italiana, Data Sci Ctr, Inst Computat Sci, Lugano, Switzerland; [Mira, Antonietta] Univ Insubria, Dept Sci & High Technol, Como, Italy; [Arbia, Giuseppe; Peluso, Stefano] Univ Cattolica Sacro Cuore, Dept Stat Sci, Milan, Italy; [Clifford, Samuel] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Clifford, Samuel] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Auricchio, Angelo; Moccetti, Tiziano] Fdn Ticino Cuore, Lugano, Switzerland; [Auricchio, Angelo] Fdn Cardioctr Ticino, Div Cardiol, Lugano, Switzerland; [Auricchio, Angelo] Univ Svizzera Ltaliana, Ctr Computat Med Cardiol, Lugano, Switzerland	Queensland University of Technology (QUT); Monash University; Universita della Svizzera Italiana; University of Insubria; Catholic University of the Sacred Heart; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Universita della Svizzera Italiana	Tierney, NJ (corresponding author), Queensland Univ Technol, Sci & Engn Fac, Dept Stat Sci, Math Sci, Brisbane, Qld, Australia.; Tierney, NJ (corresponding author), ARC Ctr Excellence Math & Stat Frontiers ACEMS, Brisbane, Qld, Australia.; Tierney, NJ (corresponding author), Monash Univ, Dept Econometr & Business Stat, Melbourne, Vic, Australia.	nicholas.berney@gmail.com	Mengersen, Kerrie/AHC-4096-2022; arbia, giuseppe/AAD-1772-2022; Clifford, Samuel/AAE-7344-2021	Clifford, Samuel/0000-0002-3774-3882; Tierney, Nicholas/0000-0003-1460-8722; Mira, Antonietta/0000-0002-5609-7935	Fondazione Fratelli Agostino Enrico Rocca; SNF [105218_166504]; Swiss Heart Foundation "Lay people involvement in out-of-hospital cardiac arrest resuscitation: strategies for improvement and impact on survival"; Australian Government; QUT	Fondazione Fratelli Agostino Enrico Rocca; SNF; Swiss Heart Foundation "Lay people involvement in out-of-hospital cardiac arrest resuscitation: strategies for improvement and impact on survival"; Australian Government(Australian GovernmentCGIAR); QUT	One of the authors (NJT) wishes to acknowledge the receipt of an Australian Postgraduate Award from the Australian Government and QUT. Financial support from Fondazione Fratelli Agostino Enrico Rocca is acknowledged. The author Antonietta Mira was partially supported by SNF grant 105218_166504. The study was supported by a grant of the Swiss Heart Foundation "Lay people involvement in out-of-hospital cardiac arrest resuscitation: strategies for improvement and impact on survival".	Allaire J., 2017, RMARKDOWN DYNAMIC DO; Arbia G, 2006, ADV SPAT SCI, P1; Arbia G., 2014, PRIMER SPATIAL ECONO, DOI DOI 10.1057/9781137317940; Becker L, 1998, CIRCULATION, V97, P2106, DOI 10.1161/01.CIR.97.21.2106; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Bivand R, 2015, J STAT SOFTW, V63, P1; Caputo ML, 2017, RESUSCITATION, V114, P73, DOI 10.1016/j.resuscitation.2017.03.003; Chan TCY, 2016, MANAGE SCI, V62, P3617, DOI 10.1287/mnsc.2015.2312; Chan TCY, 2013, CIRCULATION, V127, P1801, DOI 10.1161/CIRCULATIONAHA.113.001953; Church R., 1974, PAP REG SCI ASS, V32, P101, DOI DOI 10.1007/BF01942293; Claesson A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0313-5; Engdahl J, 2005, RESUSCITATION, V64, P171, DOI 10.1016/j.resuscitation.2004.08.006; Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Lin BC, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0046-8; Link MS, 2010, CIRCULATION, V122, pS706, DOI 10.1161/CIRCULATIONAHA.110.970954; Marenco JP, 2001, JAMA-J AM MED ASSOC, V285, P1193, DOI 10.1001/jama.285.9.1193; Mauri R, 2016, EUROPACE, V18, P398, DOI 10.1093/europace/euv218; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Murray AT, 2015, MAXIMAL COVERAGE LOC; Ong MEH, 2008, RESUSCITATION, V76, P388, DOI 10.1016/j.resuscitation.2007.09.006; Padgham M, 2019, TRANSPORT FINDINGS; Pulver A, 2016, PREHOSP EMERG CARE, V20, P378, DOI 10.3109/10903127.2015.1115932; R Core Team, 2018, R LANG ENV STAT COMP; Ringh M, 2018, J INTERN MED, V283, P238, DOI 10.1111/joim.12730; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sun CLF, 2016, J AM COLL CARDIOL, V68, P836, DOI 10.1016/j.jacc.2016.03.609; Tierney N, 2017, MAXCOVR SET TOOLS SO; Tierney NJ, 2018, RESUSCITATION, V125, P83, DOI 10.1016/j.resuscitation.2018.01.055; Wei R, 2015, COMPUT OPER RES, V62, P325, DOI 10.1016/j.cor.2014.04.010; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; White N, 2016, J R STAT SOC C-APPL, V65, P145, DOI 10.1111/rssc.12111; Xie Y., 2015, DYNAMIC DOCUMENTS R, VSecond edition	34	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0218310	10.1371/journal.pone.0218310	http://dx.doi.org/10.1371/journal.pone.0218310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390366	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000484999400003
J	Lee, CB; Liao, CM; Peng, LH; Lin, CM				Lee, Chiachi Bonnie; Liao, Chen-Mao; Peng, Li-Hsin; Lin, Chih-Ming			Economic fluctuations and cardiovascular diseases: A multiple-input time series analysis	PLOS ONE			English	Article							LONG WORKING HOURS; HEART-DISEASE; RISK-FACTORS; BUSINESS CYCLES; GREAT RECESSION; AIR-POLLUTION; HEALTH; MORTALITY; ASSOCIATION; HYPERTENSION	Objectives Little is known about the gender and age differences associated with the effects of economic fluctuations on hospitalization for cardiovascular diseases. This paper investigates the impact of economic fluctuations on hospitalization for ischemic heart disease (IHD), stroke, and hypertension by age and gender between January 1996 and December 2012 in Taiwan. Methods We adopted a multiple-input time series analysis to examine the strength of the immediate and latent effects of the 17-year quarterly unemployment rates (UR), air pollution exposure (APE), gross domestic product (GDP), per capita consumption expenditure in cigarette and alcohol (ECA), and per capita healthcare expenditure (HE) on the adjusted quarterly incidence rate of hospitalization. The data used in this paper were retrieved from the National Health Insurance Research Database and the website of the Directorate-General of Budget, Accounting and Statistics (DGBAS), Executive Yuan. Results Our findings indicate that higher UR increased IHD hospitalization in young men and women and middle-aged women but reduced stroke hospitalization in young men. Higher APE increased IHD hospitalization in young men but reduced it for young women, increased stroke hospitalization in old men and middle-aged women but reduced it for young men, and increased hypertension hospitalization in middle-aged men and young women. Higher ECA reduced IHD hospitalization in middle-aged men, increased stoke hospitalization in middle-aged and old men and middle-aged women. Higher HE reduced IHD hospitalization in old men, young and old women, reduced stroke hospitalization in old women, and reduced hypertension hospitalization in young and middle-aged women. Conclusions Overall, we found that the economic fluctuations caused increased harmful effects in certain population subgroups but also brought some soothing effects to some groups.	[Lee, Chiachi Bonnie] China Med Univ, Coll Publ Hlth, Dept Hlth Serv Adm, Taichung, Taiwan; [Liao, Chen-Mao; Peng, Li-Hsin] Ming Chuan Univ, Dept Appl Stat & Informat Sci, Taoyuan, Taiwan; [Lin, Chih-Ming] Ming Chuan Univ, Dept Healthcare Informat & Management, Taoyuan, Taiwan	China Medical University Taiwan; Ming Chuan University; Ming Chuan University	Lin, CM (corresponding author), Ming Chuan Univ, Dept Healthcare Informat & Management, Taoyuan, Taiwan.	cmlin@mail.mcu.edu.tw		Lin, Chih-Ming/0000-0001-9637-395X	Ministry of Science and Technology [MOST 105-2410-H-130-052]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by a grant from the Ministry of Science and Technology MOST 105-2410-H-130-052) https://www.most.gov.tw/? l= en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The interpretation and conclusions contained herein do not represent those of National Health Insurance Administration, Ministry of Health and Welfare and National Health Research Institutes.; This study was supported by a grant from the Ministry of Science and Technology (MOST 105-2410-H-130-052), and was based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by National Health Research Institutes.	Alliance NCD, 2016, CALL ACT WOM NONC DI; Asgeirsdottir TL, 2014, BLOOD PRESSURE, V23, P213, DOI 10.3109/08037051.2013.862913; Birgisdottir KH, 2017, DEMOGR RES, V37, P769, DOI 10.4054/DemRes.2017.37.25; Box G, 1970, STAT MODELS FORECAST; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Braendle T, 2016, HEALTH POLICY, V120, P1051, DOI 10.1016/j.healthpol.2016.07.009; Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007; Cuadra G, 2008, WORKING PAPERS; Dai XT, 2018, ATMOS ENVIRON, V186, P129, DOI 10.1016/j.atmosenv.2018.05.033; Davis ME, 2012, AM J PUBLIC HEALTH, V102, P1951, DOI 10.2105/AJPH.2012.300658; Davis ME, 2010, ENVIRON HEALTH PERSP, V118, P614, DOI 10.1289/ehp.0901145; DGBAS, 2018, UN RAT DIR GEN BUDG; DGBAS, 2010, 2010 REP MANP UT SUR; Eliason M, 2009, J HUM RESOUR, V44, P277, DOI 10.1353/jhr.2009.0020; Gan Y, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0371-z; Gerdtham UG, 2006, ECON HUM BIOL, V4, P298, DOI 10.1016/j.ehb.2006.04.001; Giorginia P, 2016, CURR PHARM DESIGN, V22, P28, DOI 10.2174/1381612822666151109111712; Hackshaw A, 2018, BMJ-BRIT MED J, V360, DOI [10.1136/bmj.j5855, 10.1136/bmj.k1611]; HPA, 2017, 2016 ANN REP HLTH PR; Jofre-Bonet M, 2018, SOC SCI MED, V197, P213, DOI 10.1016/j.socscimed.2017.12.010; Kamceva Gordana, 2016, Open Access Maced J Med Sci, V4, P636, DOI 10.3889/oamjms.2016.117; Kang MY, 2012, J OCCUP ENVIRON MED, V54, P532, DOI 10.1097/JOM.0b013e31824fe192; Karagiannis R, 2017, GREEK EC OUTLOOK, V2017, P73; Khubchandani J, 2017, J COMMUN HEALTH, V42, P242, DOI 10.1007/s10900-016-0249-8; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Laliotis I, 2016, LANCET PUBLIC HEALTH, V1, pE56, DOI 10.1016/S2468-2667(16)30018-4; Lam JP, 2017, HEALTH ECON, V26, P164, DOI 10.1002/hec.3285; Lee CB, 2017, J AFFECT DISORDERS, V221, P65, DOI 10.1016/j.jad.2017.06.028; Lin RT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00198-5; Lin SJ, 2009, APPL ECON, V41, P519, DOI 10.1080/00036840701720754; LIU LM, 1982, COMMUN STAT A-THEOR, V11, P297, DOI 10.1080/03610928208828236; Margerison-Zilko Claire, 2016, Curr Epidemiol Rep, V3, P81; Markbreiter J., 2016, CVD ADVOCACY TOOLKIT; Ministry of Labor, 2018, INT LAB STAT 2018; Ministry of Labor, 2016, REP GEND LAB STAT 20; Ministry of Labor, 2016, ANN WORK HOURS AR IN; MOWH, 2017, 2016 STAT RES CAUS D; Natioanl Statistics, 2018, STAT NAT INC TAIW 20; National Statistics, 2018, NAT INC STAT NAT STA; OECD, 2018, AV ANN HOURS ACT WOR; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Peter D, 2012, 30 INT C MATH METH E; Quast T, 2014, SOC SCI MED, V109, P19, DOI 10.1016/j.socscimed.2014.03.013; Reeves A, 2014, HEALTH POLICY, V115, P1, DOI 10.1016/j.healthpol.2013.11.008; Ricci C, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k934; ROTH GA, 2017, J AM COLL CARDIOL, V70, P1, DOI [DOI 10.1016/J.JACC.2017.04.052, DOI 10.1016/j.jacc.2017.04.052]; Ruhm CJ, 2007, DEMOGRAPHY, V44, P829, DOI 10.1007/BF03208384; Ruhm CJ, 2015, J HEALTH ECON, V42, P17, DOI 10.1016/j.jhealeco.2015.03.004; Ruhm CJ, 2003, J HEALTH ECON, V22, P637, DOI 10.1016/S0167-6296(03)00041-9; Shah ASV, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.i4851, 10.1136/bmj.h1295]; Siervo M, 2014, PUBLIC HEALTH NUTR, V17, P587, DOI 10.1017/S1368980013000141; Sposato LA, 2012, STROKE, V43, P170, DOI 10.1161/STROKEAHA.111.632158; Stock JH, 2001, J ECON PERSPECT, V15, P101, DOI 10.1257/jep.15.4.101; Strumpf EC, 2017, SOC SCI MED, V189, P11, DOI 10.1016/j.socscimed.2017.07.016; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Su SY, 2017, HEART ASIA, V9, DOI 10.1136/heartasia-2017-010905; Svensson M, 2007, SOC SCI MED, V65, P833, DOI 10.1016/j.socscimed.2007.04.015; Virtanen M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4746; Vlachadis N, 2014, INT J CARDIOL, V176, P1367, DOI 10.1016/j.ijcard.2014.07.275; Wang DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep33960; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; World Health Organization, 2017, WORLD HEART DAY 2017; Xu AY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020168; Yang BY, 2018, ENVIRON POLLUT, V235, P576, DOI 10.1016/j.envpol.2018.01.001	64	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219358	10.1371/journal.pone.0219358	http://dx.doi.org/10.1371/journal.pone.0219358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5CU	31386665	gold, Green Submitted, Green Published			2022-12-27	WOS:000484997100005
J	Grossman, C; Grossman, E; Goldbourt, U				Grossman, Chagai; Grossman, Ehud; Goldbourt, Uri			Uric acid variability at midlife as an independent predictor of coronary heart disease and all-cause mortality	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; LONG-TERM MORTALITY; CARDIOVASCULAR-DISEASE; ESSENTIAL-HYPERTENSION; BODY-WEIGHT; RISK-FACTOR; SERUM; OUTCOMES; FLUCTUATIONS; DEATH	Background Serum uric acid (SUA) has long been associated with cardiovascular disease. Variability of serum uric acid (SUA) has seldom been examined in association with long-term morbidity and mortality. Therefore, we aimed to investigate the association between SUA variability and long-term all-cause and specific-cause mortality. Methods Among 10,059 men, aged 40-65, tenured civil servants and municipal employees in Israel, 8822 participants who were examined in 1963, 1965 and 1968 had assessment of diabetic and coronary morbidity status and SUA levels. We conducted analysis examining whether the standard deviations (SD) of Z-scores of SUA across study visits predicted coronary heart disease (CHD) and mortality. Hazard ratios (HR) associated with the SD of SUA-Z were calculated for stroke, CHD mortality and all-cause mortality associated with quartiles of the above variability. Results Multivariate analysis of 18-year CHD mortality yielded a significant association with the 1963-1968 SD of SUA-Z with age adjusted HR of CHD mortality of 0.97 (95% CI, 0.8-1.19), 1.05 (95% CI, 0.87-1.28) and 1.37 (95% CI, 1.15-1.65) for quartiles 2 to 4 respectively). The results of all-cause mortality similarly and strongly indicated increasing age-adjusted mortality risk with increasing SD of SUA-Z: HR = 1.08 (95% CI, 0.97-1.21), 1.15 (1.03-1.28) and 1.37 (1.23-1.51). No association was observed between the SD of SUA-Z and stroke mortality. Conclusion In this cohort of tenured male workers, with diverse occupations, higher variability of SUA measurement taken over 5 years was clearly predictive of 18-year CHD and all-cause mortality, above and beyond the SUA levels proper.	[Grossman, Chagai] Chaim Sheba Med Ctr, Dept Internal Med F, Tel Hashomer, Israel; [Grossman, Chagai] Chaim Sheba Med Ctr, Rheumatol Unit, Tel Hashomer, Israel; [Grossman, Chagai; Grossman, Ehud] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Grossman, Ehud] Chaim Sheba Med Ctr, Dept Internal Med D, Tel Hashomer, Israel; [Grossman, Ehud] Chaim Sheba Med Ctr, Hypertens Unit, Tel Hashomer, Israel; [Goldbourt, Uri] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Tel Aviv, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Grossman, C (corresponding author), Chaim Sheba Med Ctr, Dept Internal Med F, Tel Hashomer, Israel.; Grossman, C (corresponding author), Chaim Sheba Med Ctr, Rheumatol Unit, Tel Hashomer, Israel.; Grossman, C (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	chagaigr@gmail.com						Alderman M, 2004, CURR MED RES OPIN, V20, P369, DOI 10.1185/030079904125002982; Alderman MH, 2002, CURR OPIN PHARMACOL, V2, P126, DOI 10.1016/S1471-4892(02)00143-1; ANDERSON JT, 1956, CLIN CHEM, V2, P145; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Bangalore S, 2017, NEW ENGL J MED, V376, P1332, DOI 10.1056/NEJMoa1606148; Cavarretta E, 2017, AM J HYPERTENS, V30, P550, DOI 10.1093/ajh/hpx055; Ceriello A, 2017, DIABETES OBES METAB, V19, P1570, DOI 10.1111/dom.12976; Ceriello A, 2013, DIABETES CARE, V36, pS272, DOI 10.2337/dcS13-2030; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Frontoni S, 2013, DIABETES RES CLIN PR, V102, P86, DOI 10.1016/j.diabres.2013.09.007; Gerber Y, 2006, EUR J CARDIOV PREV R, V13, P193, DOI 10.1097/01.hjr.0000192745.26973.00; GERTLER MM, 1951, ANN INTERN MED, V34, P1421, DOI 10.7326/0003-4819-34-6-1421; GROEN JJ, 1968, ISRAEL J MED SCI, V4, P177; Grossman C, 2014, J CLIN HYPERTENS, V16, P424, DOI 10.1111/jch.12313; HAMM P, 1989, AM J EPIDEMIOL, V129, P312, DOI 10.1093/oxfordjournals.aje.a115135; Johnson RJ, 2005, J AM SOC NEPHROL, V16, P1909, DOI 10.1681/ASN.2005010063; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kivity S, 2013, AM J CARDIOL, V111, P1146, DOI 10.1016/j.amjcard.2012.12.034; Kuo CF, 2013, RHEUMATOLOGY, V52, P127, DOI 10.1093/rheumatology/kes223; Lytvyn Y, 2015, CAN J DIABETES, V39, P239, DOI 10.1016/j.jcjd.2014.10.013; Mayer FJ, 2015, J STROKE CEREBROVASC, V24, P354, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.035; MEDALIE JH, 1973, J CHRON DIS, V26, P63, DOI 10.1016/0021-9681(73)90006-4; Ndrepepa G, 2013, CLIN SCI, V124, P259, DOI 10.1042/CS20120336; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Strasak A, 2008, CLIN CHEM, V54, P273, DOI 10.1373/clinchem.2007.094425; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Waring WS, 2000, QJM-INT J MED, V93, P707, DOI 10.1093/qjmed/93.11.707; Xu QY, 2017, SAUDI MED J, V38, P577, DOI 10.15537/smj.2017.6.17190	32	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220532	10.1371/journal.pone.0220532	http://dx.doi.org/10.1371/journal.pone.0220532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381584	gold, Green Published, Green Submitted			2022-12-27	WOS:000484993600023
J	Valente, RS; de Almeida, TG; Alves, MF; de Camargo, J; Basso, AC; Belaz, KRA; Eberlin, MN; Landim-Alvarenga, FD; Fontes, PK; Nogueira, MFG; Sudano, MJ				Valente, Roniele Santana; de Almeida, Tamie Guibu; Alves, Mayra Fernanda; de Camargo, Janine; Basso, Andrea Cristina; Anacleto Belaz, Katia Roberta; Eberlin, Marcos Nogueira; da Cruz Landim-Alvarenga, Fernanda; Fontes, Patricia Kubo; Gouveia Nogueira, Marcelo Fabio; Sudano, Mateus Jose			Modulation of long-chain Acyl-CoA synthetase on the development, lipid deposit and cryosurvival of in vitro produced bovine embryos	PLOS ONE			English	Article							LIVER-X-RECEPTOR; FATTY-ACID; L-CARNITINE; CULTURE; ACTIVATION; GENE; CRYOTOLERANCE; VITRIFICATION; ACCUMULATION; INHIBITION	In this study, we evaluated the modulation effect of long-chain Acyl-CoA synthetase during early embryo development. Bovine embryos were cultured in four groups: positive modulation (ACS+) with GW3965 hydrochloride, negative modulation (ACS-) with Triacsin C, association of both modulators (ACS +/-), and control. Embryo development rates were not altered (P>0.05) by treatments. Embryonic cytoplasmic lipid content increased in ACS+ but reduced in ACS- compared to the control (P < 0.05), whereas the membrane phospholipids profile was not altered by treatments. The total number of blastomeres did not differ (P > 0.05) between groups; however, an increased apoptotic cells percentage was found in ACS- compared to control. Twenty-four hours after warming, ACS+ and control grade I embryos presented the best hatching rates, whereas the ACS+ group equaled the hatching rates between their embryos of grades I, II and III 48 hours after warming. The relative abundance of transcripts for genes associated with lipid metabolism (ACSL3, ACSL6, ACAT1, SCD, and AUH), heatshock (HSP90AA1 and HSF1), oxidative stress (GPX4), and angiogenesis (VEGF), among other important genes for embryo development were affected by at least one of the treatments. The treatments were effective in modulating the level of transcripts for ACSL3 and the cytoplasmic lipid content. The ACS- was not effective in increasing embryonic cryosurvival, whereas ACS+ restored survival rates after vitrification of embryos with low quality, making them equivalent to embryos of excellent quality.	[Valente, Roniele Santana; de Camargo, Janine; Sudano, Mateus Jose] Fed Univ Pampa, Sch Vet Med, Uruguaiana, RS, Brazil; [Valente, Roniele Santana; Sudano, Mateus Jose] Fed Univ ABC, Ctr Nat & Human Sci, Santo Andre, SP, Brazil; [de Almeida, Tamie Guibu] Univ Sao Paulo, Dept Anim Reprod, Sao Paulo, SP, Brazil; [Alves, Mayra Fernanda; Basso, Andrea Cristina] ABS Pecplan, In Vitro Brasil, Mogi Mirim, SP, Brazil; [Anacleto Belaz, Katia Roberta] Univ Fed Uberlandia, Dept Chem, Uberlandia, MG, Brazil; [Eberlin, Marcos Nogueira] Univ Prebiteriana Mackenzie, Sch Engn, Sao Paulo, SP, Brazil; [da Cruz Landim-Alvarenga, Fernanda] Sao Paulo State Univ, Dept Anim Reprod, Botucatu, SP, Brazil; [Fontes, Patricia Kubo; Gouveia Nogueira, Marcelo Fabio] Sao Paulo State Univ, Dept Biol Sci, Assis, SP, Brazil	Universidade Federal do Pampa; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade Presbiteriana Mackenzie; Universidade Estadual Paulista; Universidade Estadual Paulista	Sudano, MJ (corresponding author), Fed Univ Pampa, Sch Vet Med, Uruguaiana, RS, Brazil.; Sudano, MJ (corresponding author), Fed Univ ABC, Ctr Nat & Human Sci, Santo Andre, SP, Brazil.	mjsudano@gmail.com	Nogueira, Marcelo Fábio Gouveia/D-9801-2012; Cristina Basso, Andrea/AHC-5589-2022; Fontes, Patricia Kubo/R-8362-2017; , M/AAZ-7804-2020; Alizadeh/AAK-1398-2021; Sudano, Mateus J/D-7614-2013	Nogueira, Marcelo Fábio Gouveia/0000-0002-2239-9652; Fontes, Patricia Kubo/0000-0002-4280-9575; , M/0000-0002-7699-4449; Sudano, Mateus J/0000-0002-7699-4449; Belaz, Katia Roberta A/0000-0003-0626-1992; Landim-Alvarenga, Fernanda/0000-0002-2420-2550; de Camargo, Janine/0000-0002-0575-056X; , Andrea Cristina Basso/0000-0002-8679-5232; Eberlin, Marcos Nogueira/0000-0003-4868-0618	CNPq, National Council of Scientific and Technological Development - Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [1, 2012/50533-2, 2019/16239-9]; Sao Paulo Research Foundation (FAPESP)	CNPq, National Council of Scientific and Technological Development - Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The present work was carried out with the support of CNPq, National Council of Scientific and Technological Development - Brazil, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) - financial code 1, and grant 2012/50533-2 and 2019/16239-9, Sao Paulo Research Foundation (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Dong B, 2013, J LIPID RES; Edidin M, 2003, NAT REV MOL CELL BIO, V4, P414, DOI 10.1038/nrm1102; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Gomez E, 2017, REPROD FERT DEVELOP, V29, P1932, DOI 10.1071/RD16213; Gutierrez-Adan A, 2015, REPROD FERT DEVELOP, V27, P765, DOI 10.1071/RD14216; Held-Hoelker E, 2017, THERIOGENOLOGY, V96, P145, DOI 10.1016/j.theriogenology.2017.03.014; Igal RA, 1997, BIOCHEM J, V324, P529, DOI 10.1042/bj3240529; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kim JH, 2001, J BIOL CHEM, V276, P24667, DOI 10.1074/jbc.M010793200; Knitlova D, 2017, THERIOGENOLOGY, V102, P16, DOI 10.1016/j.theriogenology.2017.06.025; Krussell JS, 2001, MOL HUM REPROD, V7, P57, DOI 10.1093/molehr/7.1.57; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Kuzmany A, 2011, THERIOGENOLOGY, V75, P482, DOI 10.1016/j.theriogenology.2010.09.016; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Murillo A, 2017, REPROD BIOL, V17, P162, DOI 10.1016/j.repbio.2017.04.002; NAKAGAWA J, 1995, P NATL ACAD SCI USA, V92, P2051, DOI 10.1073/pnas.92.6.2051; Panyaboriban S, 2018, CRYOBIOLOGY, V84, P46, DOI 10.1016/j.cryobiol.2018.08.003; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Patel MB, 2008, INDIAN J PHARM SCI, V70, P135, DOI 10.4103/0250-474X.41445; Lopez-Damian EP, 2018, ANAT HISTOL EMBRYOL, V47, P435, DOI 10.1111/ahe.12382; Peck B, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0146-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pomar FJR, 2005, THERIOGENOLOGY, V63, P2254, DOI 10.1016/j.theriogenology.2004.10.015; Rizos D, 2008, REPROD DOMEST ANIM, V43, P44, DOI 10.1111/j.1439-0531.2008.01230.x; Sanches BV, 2013, THERIOGENOLOGY, V80, P372, DOI 10.1016/j.theriogenology.2013.04.026; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Stringfellow D, 1998, MANUAL SOC INT GERAI, V3, P180; Sudano MJ, 2013, ANIM REPROD, V10, P160; Sudano MJ, 2016, THERIOGENOLOGY, V86, P472, DOI 10.1016/j.theriogenology.2016.03.025; Sudano MJ, 2014, REPROD FERT DEVELOP, V26, P1129, DOI 10.1071/RD13099; Sudano MJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102897; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Tang Y, 2018, ONCOL LETT, V16, P1390, DOI 10.3892/ol.2018.8843; Tian GP, 2012, BIOCHIMIE, V94, P2749, DOI 10.1016/j.biochi.2012.08.018; TOMODA H, 1991, J BIOL CHEM, V266, P4214; Ufer C, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00012; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Weedon-Fekjaer MS, 2010, J LIPID RES; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Zhang Y, 2011, ROLE HEAT SHOCK FACT, P21; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	46	11	11	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220731	10.1371/journal.pone.0220731	http://dx.doi.org/10.1371/journal.pone.0220731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381602	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600032
J	Black, SA; McConnell, EL; McKerr, L; McClelland, JF; Little, JA; Dillenburger, K; Jackson, AJ; Anketell, PM; Saunders, KJ				Black, S. A.; McConnell, E. L.; McKerr, L.; McClelland, J. F.; Little, J. A.; Dillenburger, K.; Jackson, A. J.; Anketell, P. M.; Saunders, K. J.			In-school eyecare in special education settings has measurable benefits for children's vision and behaviour	PLOS ONE			English	Article							CEREBRAL VISUAL IMPAIRMENT; OCULAR DISORDERS; DEVELOPMENTAL DELAY; DISABILITIES; DYSFUNCTIONS; INVENTORY; BURDEN; NEEDS	Objectives To determine whether implementation of comprehensive in-school eyecare results in measurable benefits for children and young people in terms of visual status, classroom behaviours and how well their visual needs are met. Design School-based observational study. Participants & Methods 200 pupils [mean age 10 years 9 months, 70% male, majority moderate (40%) or severe (35%) learning difficulty] of a special education school in the UK. A sector-agreed in-school eyecare framework including full eye examination and cycloplegic refraction, dispensing of spectacles (as appropriate) and written reporting of outcomes to parents/teachers was applied. Classroom behaviours were observed and recorded prior to, and after, the in-school eyecare. Surveys were employed to obtain visual histories from parents/teachers. School records and statutory documents were reviewed for diagnostic and learning disability classifications. Visual function and ocular health were profiled at baseline and significant visual deficits identified. Where such deficits were previously unrecognised, untreated or not compensated for (e.g. correction of refractive error, enlargement of educational material) they were recorded as 'unmet visual need'. At follow-up, 2-5 months after initial (baseline) measures, eye examinations, parent/teacher surveys and behaviour observations were repeated. Follow-up measures were used to determine if measurable improvements were evident in visual function, ocular health, the level of unmet need and classroom behaviour following implementation of in-school eyecare. Results 199 participants completed baseline and follow-up measures. 122 (61%) participants presented with at least one significant visual or ocular health deficit and 90 (45%) participants had at least one unmet visual need. Younger pupils and those with no previous history of eyecare were more likely to demonstrate unmet visual needs at baseline (OR 1.12 95% CI 1.03 to 1.21) p = 0.012; (OR 4.44 95% CI 1.38 to 14.29 p = 0.007 respectively). On followup, the number of pupils with unmet visual needs dropped significantly to 36 (18%) (McNemar's test p< 0.001). Visual and behavioural metrics of participants without significant visual deficits or whose visual needs were adequately addressed at baseline remained relatively unchanged between baseline and follow-up (Wilcoxon signed rank p> 0.05). Where significant refractive deficits were corrected at follow-up, near visual acuity improved significantly (Wilcoxon signed rank p = 0.013), however, poor spectacle compliance was a persistent cause of unmet visual need. Off-task behaviour reduced significantly after actions to address unmet visual needs were communicated to parents and teachers (Wilcoxon signed rank p = 0.035). Conclusions The present study demonstrates for the first time measurable visual and behaviour benefits to children in special education settings when they receive comprehensive in-school eye examinations, on-site spectacle dispensing and jargon-free reporting of outcomes to teachers and parents.	[Black, S. A.; McConnell, E. L.; McClelland, J. F.; Little, J. A.; Saunders, K. J.] Ulster Univ, Sch Biomed Sci Optometry & Vis Sci, Coleraine, Londonderry, North Ireland; [McKerr, L.; Dillenburger, K.] Queens Univ, Sch Social Sci Educ & Social Work, Belfast, Antrim, North Ireland; [Jackson, A. J.; Anketell, P. M.] Hlth & Social Care Trust, Belfast, Antrim, North Ireland	Ulster University; Queens University Belfast	Black, SA (corresponding author), Ulster Univ, Sch Biomed Sci Optometry & Vis Sci, Coleraine, Londonderry, North Ireland.	sa.black@ulster.ac.uk	Jackson, Jonathan/ABH-1264-2021	Jackson, Jonathan/0000-0003-4675-0272; Little, Julie-Anne/0000-0001-5242-8066; Black, Shelley/0000-0002-3930-6483; McConnell, Emma/0000-0002-6180-418X; Dillenburger, Karola/0000-0002-3410-5949	Action Medical research [GN2429]; Department for the Economy; Vision Translational Research Group NI HSC RD	Action Medical research; Department for the Economy; Vision Translational Research Group NI HSC RD	This research was supported by Action Medical research (GN2429 to K.J.S.), the Department for the Economy to S.A.B., and the Vision Translational Research Group NI HSC R&D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2002, OPHTHAL PHYSL OPT, V22, P565, DOI 10.1046/j.1475-1313.2002.00080.x; Al-Bagdady M, 2009, OPHTHAL PHYSL OPT, V29, P416, DOI 10.1111/j.1475-1313.2009.00646.x; Anketell PM, 2018, OPTOMETRY VISION SCI, V95, P193, DOI 10.1097/OPX.0000000000001190; [Anonymous], 2012, E J MED; BADER D, 1980, AM J OPTOM PHYS OPT, V57, P447; Barbareza R, 2008, OPHTHALMIC PHYSL OPT, V17; Bax M., 2010, VISUAL IMPAIRMENT CH; Coyle C., 2018, ACAD J ED RES, V5, P1; Cumberland PM, 2016, JAMA OPHTHALMOL, V134, P959, DOI 10.1001/jamaophthalmol.2016.1778; CUMMINGS MF, 1988, BEHAV BRAIN RES, V29, P7, DOI 10.1016/0166-4328(88)90047-2; Das M, 2010, ARCH DIS CHILD, V95, P888, DOI 10.1136/adc.2009.159053; Dekker MJ, 2012, STRABISMUS, V20, P49, DOI 10.3109/09273972.2012.680233; Department of Health, 2010, HLTH LIV HLTH FUT FR; Department of Health, 2016, HLTH WELLBEING 2026; Donaldson LA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212733; Dutton G N, 2001, Semin Neonatol, V6, P477, DOI 10.1053/siny.2001.0078; Elliman D., 2006, HLTH ALL CHILDREN; GILLIGAN MB, 1981, AM J OCCUP THER, V35, P249, DOI 10.5014/ajot.35.4.249; Gogate P, 2011, INDIAN J OPHTHALMOL, V59, P223, DOI 10.4103/0301-4738.81036; Kaur G, 2016, J CLIN DIAGN RES, V10, pNC1, DOI 10.7860/JCDR/2016/23615.8742; Little JA, 2015, PUBLIC HEALTH, V129, P143, DOI 10.1016/j.puhe.2014.12.009; Loew S. J., 2017, J PSYCHOL ED, V12, P85; Ludlow AK, 2016, RES DEV DISABIL, V56, P108, DOI 10.1016/j.ridd.2016.05.019; Lueck AH, 2010, J VISUAL IMPAIR BLIN, V104, P585, DOI 10.1177/0145482X1010401003; Macintyre-Beon C, 2012, EYE, V26, P1393, DOI 10.1038/eye.2012.154; Martin D, 2007, TLS-TIMES LIT SUPPL, P3; McClelland JF, 2004, OPTOMETRY VISION SCI, V81, P929; McClelland JF, 2006, INVEST OPHTH VIS SCI, V47, P1824, DOI 10.1167/iovs.05-0825; McCulloch DL, 2007, DEV MED CHILD NEUROL, V49, P757, DOI 10.1111/j.1469-8749.2007.00757.x; McKillop E., 2008, BRIT IRISH ORTHOPTIC, V5, P8; Nandakumar K, 2011, CLIN EXP OPTOM, V94, P575, DOI 10.1111/j.1444-0938.2011.00650.x; Nielsen LS, 2007, ACTA OPHTHALMOL SCAN, V85, P419, DOI 10.1111/j.1600-0420.2007.00881.x; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1155, DOI 10.1136/bjo.2009.176040; Philip SS, 2014, CLIN EXP OPTOM, V97, P196, DOI 10.1111/cxo.12155; Pilling R, 2017, BRIT J OPHTHALMOLOGY, V101; Pilling RF, 2016, BRIT J OPHTHALMOL, V100, P1118, DOI 10.1136/bjophthalmol-2015-307558; Public Health England, CHILD VIS SCREEN GUI; Puri S, 2015, ARCH DIS CHILD, V100, P834, DOI 10.1136/archdischild-2014-308131; Salt A, 2014, ARCH DIS CHILD, V99, P1163, DOI 10.1136/archdischild-2013-305267; Nielsen LS, 2007, ACTA OPHTHALMOL SCAN, V85, P149, DOI 10.1111/j.1600-0420.2006.00867.x; SeeAbility, 2016, DEL EQ RIGHT SIGHT; Stoica L, 2016, RIVER PUBL SER CIRC, P3; The Royal College of Ophthalmologists, 2016, FRAM PROV EYE CAR SP; van Genderen M, 2012, STRABISMUS, V20, P78, DOI 10.3109/09273972.2012.680232; Wallace DK, 2018, OPHTHALMOLOGY, V125, P1961, DOI 10.1016/j.ophtha.2018.05.001; Winterbottom M, 2009, J ENVIRON PSYCHOL, V29, P63, DOI 10.1016/j.jenvp.2008.11.007; Woodhouse JM, 2014, ARCH DIS CHILD, V99, P500, DOI 10.1136/archdischild-2013-304866; WOODHOUSE JM, 1993, INVEST OPHTH VIS SCI, V34, P2382; World Health Organisation, 2018, ICD 11 MORT MORB STA	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220480	10.1371/journal.pone.0220480	http://dx.doi.org/10.1371/journal.pone.0220480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369627	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900056
J	Lee, HS; Thanh, TL; Ly, NK; Hung, NV; Thakur, KK; Grace, D				Hu Suk Lee; To Long Thanh; Nguyen Khanh Ly; Hung Nguyen-Viet; Thakur, Krishna K.; Grace, Delia			Seroprevalence of leptospirosis and Japanese encephalitis in swine in ten provinces of Vietnam	PLOS ONE			English	Article							MEKONG DELTA; RISK-FACTORS; WILD BOARS; VIRUS; PREVALENCE; INFECTION; PIGS; ANTIBODIES; SEROPOSITIVITY; SURVEILLANCE	Background Leptospirosis is an important zoonotic disease with a global distribution, affecting a wide range of mammalian animals and humans. Japanese encephalitis (JE) virus is the major vector-borne zoonotic disease in the Asia-Pacific region. The main objective of this study was to evaluate the seroprevalence of serovar-specific Leptospira and JE in swine from 10 provinces in Vietnam. Methods Samples were initially collected for swine influenza surveillance from March to April 2017 at large-scale farms (with at least 50 sows and/or 250 fattening pigs) with pigs that tested positive for influenza in the previous surveillance period (2015-16). Findings A total of 2,000 sera samples were analyzed from 10 provinces. Overall, the seroprevalence of leptospirosis was 21.05% (95% CI: 19.28-22.90) using a cut-off titer of >= 1:100. The apparent prevalence of JE was 73.45% (95% CI: 71.46-75.37) while the true prevalence was slightly higher (74.46%, 95% credible interval: 73.73-86.41). We found a relatively high presence of leptospirosis and JE in pigs kept on large farms. Prevalence was comparable with other studies suggesting opportunistic testing of samples collected for other surveillance purposes can be a valuable tool to better understand and prevent the potential transmission of these zoonotic diseases from pigs to people in Vietnam. Conclusion Our study provides evidence to veterinarians and animal health professionals for evidence-based practice such as diagnosis, vaccination and zoonotic control. Further investigation into the possible role of different domestic animals, wildlife species or environmental factors is needed to identify the potential risk factors and transmission routes in Vietnam.	[Hu Suk Lee; Hung Nguyen-Viet] Int Livestock Res Inst, Hanoi, Vietnam; [To Long Thanh; Nguyen Khanh Ly] Natl Ctr Vet Diag, 15-78 Duong Giai Phong Phuong Mai Dong Hanoi, Hanoi, Vietnam; [Thakur, Krishna K.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE, Canada; [Grace, Delia] Int Livestock Res Inst, Nairobi, Kenya	University of Prince Edward Island; CGIAR; International Livestock Research Institute (ILRI)	Lee, HS (corresponding author), Int Livestock Res Inst, Hanoi, Vietnam.	H.S.Lee@cgiar.org	Nguyen-Viet, Hung/AHH-2981-2022; Thakur, Krishna/H-8736-2019; Nguyen-Viet, Hung/F-6498-2012	Nguyen-Viet, Hung/0000-0003-1549-2733; Thakur, Krishna/0000-0002-9964-4273; Nguyen-Viet, Hung/0000-0001-9877-0596; Lee, Hu Suk/0000-0002-8731-9836; Grace, Delia/0000-0002-0195-9489	CGIAR Trust Fund [1111]; Australian Centre for International Agricultural Research; European Union; International Fund for Agricultural Development; government of the Netherlands; government of the New Zealand; government of the Switzerland; government of the United Kingdom; government of the United States of America; government of the Thailand; CGIAR Research Program on Agriculture for Nutrition and Health; Irish Aid	CGIAR Trust Fund(CGIAR); Australian Centre for International Agricultural Research; European Union(European Commission); International Fund for Agricultural Development; government of the Netherlands(Netherlands Government); government of the New Zealand; government of the Switzerland; government of the United Kingdom; government of the United States of America; government of the Thailand; CGIAR Research Program on Agriculture for Nutrition and Health(CGIAR); Irish Aid(CGIAR)	We acknowledge the CGIAR Trust Fund, grant no. 1111 to DG (https://www.cgiar.org/funders), the Australian Centre for International Agricultural Research, Irish Aid, the European Union, the International Fund for Agricultural Development and the governments of the Netherlands, New Zealand, Switzerland, the United Kingdom, the United States of America and Thailand for funding to the CGIAR Research Program on Climate Change, Agriculture and Food Security. The study was also supported by the CGIAR Research Program on Agriculture for Nutrition and Health, led by the International Food Policy Research Institute.	Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bolin C A, 1991, J Vet Diagn Invest, V3, P152; Boqvist S, 2005, TROP ANIM HEALTH PRO, V37, P443, DOI 10.1007/s11250-005-0300-8; Boqvist S, 2003, VET MICROBIOL, V93, P361, DOI 10.1016/S0378-1135(03)00042-7; Boqvist S, 2002, PREV VET MED, V53, P233, DOI 10.1016/S0167-5877(01)00263-X; Brown CA, 1996, J AM VET MED ASSOC, V209, P1265; BURNSTEIN T, 1954, J INFECT DIS, V94, P53, DOI 10.1093/infdis/94.1.53; Cachay E R, 2005, J Postgrad Med, V51, P174; Chang Kwo-Jiing, 2002, Journal of Microbiology Immunology and Infection, V35, P12; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Conlan JV, 2012, AM J TROP MED HYG, V86, P1077, DOI 10.4269/ajtmh.2012.11-0195; Devleesschauwer B, 2015, PACKAGE PREVALENCE; Dinh XT, 2017, OVERVIEW AGR POLLUTI; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Duong V, 2011, ACTA TROP, V120, P146, DOI 10.1016/j.actatropica.2011.07.008; ELLIS WA, 1986, VET REC, V118, P63, DOI 10.1136/vr.118.3.63; ENGLISH RV, 1993, J VIROL, V67, P5175, DOI 10.1128/JVI.67.9.5175-5186.1993; FERESU SB, 1994, INT J SYST BACTERIOL, V44, P541, DOI 10.1099/00207713-44-3-541; HANSON LE, 1982, J AM VET MED ASSOC, V181, P1505; Loan HK, 2015, VECTOR-BORNE ZOONOT, V15, P56, DOI 10.1089/vbz.2014.1613; Jansen A, 2007, EMERG INFECT DIS, V13, P739, DOI 10.3201/eid1305.061302; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Kuwata R, 2013, AM J TROP MED HYG, V88, P681, DOI 10.4269/ajtmh.12-0407; Lapar M. L., 2003, IDENTIFYING BARRIERS; Laras K, 2002, AM J TROP MED HYG, V67, P278, DOI 10.4269/ajtmh.2002.67.278; Lee HS, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1044-1; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Mackenzie JS, 2007, PERSP MED V, V16, P201, DOI 10.1016/S0168-7069(06)16010-3; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Martins G, 2015, EPIDEMIOL INFECT, V143, P1538, DOI 10.1017/S0950268814002416; McGOWAN J. E., 1965, CAN VETERINARY J, V6, P243; Messam Locksley L. McV., 2008, Animal Health Research Reviews, V9, P1, DOI 10.1017/S1466252307001314; Mikaelian I, 1997, CAN VET J, V38, P440; Nations D of E and SAPDU, 2006, NAT D E SAPDU WORLD; Nguyen H., 1995, SE ASIAN J TROP ME S, V26, P47; Nguyen TY, 2010, AM J TROP MED HYG, V83, P816, DOI 10.4269/ajtmh.2010.10-0262; Okuno T, 1978, World Health Stat Q, V31, P120; Pant GR, 2006, ANN NY ACAD SCI, V1081, P124, DOI 10.1196/annals.1373.013; Patel JM, 2014, VET WORLD, V7, P999, DOI 10.14202/vetworld.2014.999-1003; Plummer M., 2004, JAGS JUST ANOTHER GI; Rocha T., 1990, VET RECORD, P126; Ruget A, 2018, TRANSBOUNDARY EMERGI; Ryan TJ, 1976, ISOLATION LEPTOSPIRE; SCHERER WF, 1959, J IMMUNOL, V83, P620; SCHERER WF, 1959, AM J TROP MED HYG, V8, P665, DOI 10.4269/ajtmh.1959.8.665; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; Tarantola A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002533; Thakur KK, 2012, ZOONOSES PUBLIC HLTH, V59, P393, DOI 10.1111/j.1863-2378.2012.01456.x; THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39; Trautwein G, 1994, Tierarztl Prax, V22, P63; Vale-Goncalves HM, 2015, EPIDEMIOL INFECT, V143, P2126, DOI 10.1017/S0950268814003331; Van CTB, 1998, T ROY SOC TROP MED H, V92, P625, DOI 10.1016/S0035-9203(98)90787-8; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; World Health Organization (WHO), JAPANESE ENCEPHALITI; WPRO, 2019, QUEST ANSW JAP ENC; Yamanaka A, 2010, JPN J INFECT DIS, V63, P58	57	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0214701	10.1371/journal.pone.0214701	http://dx.doi.org/10.1371/journal.pone.0214701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369564	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900006
J	Lin, S; Zhang, HY; Hou, YL; Liu, L; Li, WH; Jiang, JP; Han, B; Zhang, SL; Sun, DX				Lin, Shan; Zhang, Hongyan; Hou, Yali; Liu, Lin; Li, Wenhui; Jiang, Jianping; Han, Bo; Zhang, Shengli; Sun, Dongxiao			SNV discovery and functional candidate gene identification for milk composition based on whole genome resequencing of Holstein bulls with extremely high and low breeding values	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DAIRY-CATTLE; ENRICHMENT ANALYSIS; CELL PROLIFERATION; WIDE ASSOCIATION; EXPRESSION; QTL; SCAN; METABOLISM; DISSECTION	We have sequenced the whole genomes of eight proven Holstein bulls from the four half-sib or full-sib families with extremely high and low estimated breeding values (EBV) for milk protein percentage (PP) and fat percentage (FP) using Illumina re-sequencing technology. Consequently, 2.3 billion raw reads were obtained with an average effective depth of 8.1x. After single nucleotide variant (SNV) calling, total 10,961,243 SNVs were identified, and 57,451 of them showed opposite fixed sites between the bulls with high and low EBVs within each family (called as common differential SNVs). Next, we annotated the common differential SNVs based on the bovine reference genome, and observed that 45,188 SNVs (78.70%) were located in the intergenic region of genes and merely 11,871 SNVs (20.67%) located within the protein-coding genes. Of them, 13,099 common differential SNVs that were within or close to protein-coding genes with less than 5 kb were chosen for identification of candidate genes for milk compositions in dairy cattle. By integrated analysis of the 2,657 genes with the GO terms and pathways related to protein and fat metabolism, and the known quantitative trait loci (QTLs) for milk protein and fat traits, we identified 17 promising candidate genes: ALG14, ATP2C1, PLD1, C3H1orf85, SNX7, MTHFD2L, CDKN2D, COL5A3, FDX1L, PIN1, FIG4, EXOC7, LASP1, PGS1, SAO, GPLD1 and MGEA5. Our findings provided an important foundation for further study and a prompt for molecular breeding of dairy cattle.	[Lin, Shan; Zhang, Hongyan; Li, Wenhui; Jiang, Jianping; Han, Bo; Zhang, Shengli; Sun, Dongxiao] China Agr Univ, Dept Anim Genet & Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Natl Engn Lab Anim Breeding,Coll Anim Sci & Techn, Beijing, Peoples R China; [Hou, Yali] Chinese Acad Sci, Beijing Inst Genom, Lab Dis Genom & Individualized Med, Beijing, Peoples R China; [Liu, Lin] Beijing Dairy Cattle Ctr, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Sun, DX (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Key Lab Anim Genet & Breeding,Minist Agr, Natl Engn Lab Anim Breeding,Coll Anim Sci & Techn, Beijing, Peoples R China.	sundx@cau.edu.cn			National Natural Science Foundation of China [31872330, 31802041]; Beijing Dairy Industry Innovation Team [BAIC06-2017/2018]; Beijing Science and Technology Program [D171100002417001]; National Science and Technology Programs of China [2013AA102504]; earmarked fund for Modern Agro-industry Technology Research System [CARS-36]; Program for Changjiang Scholar and Innovation Research Team in University [IRT_15R62]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Dairy Industry Innovation Team; Beijing Science and Technology Program; National Science and Technology Programs of China; earmarked fund for Modern Agro-industry Technology Research System; Program for Changjiang Scholar and Innovation Research Team in University	This work was financially supported by the National Natural Science Foundation of China (31872330, 31802041), Beijing Dairy Industry Innovation Team (BAIC06-2017/2018), Beijing Science and Technology Program (D171100002417001), National Science and Technology Programs of China (2013AA102504), earmarked fund for Modern Agro-industry Technology Research System (CARS-36), and the Program for Changjiang Scholar and Innovation Research Team in University (IRT_15R62).	Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; Ashwell MS, 2004, J DAIRY SCI, V87, P468, DOI 10.3168/jds.S0022-0302(04)73186-0; Bennewitz J, 2004, GENETICS, V168, P1019, DOI 10.1534/genetics.104.030296; Blott S, 2003, GENETICS, V163, P253; Boichard D, 2003, GENET SEL EVOL, V35, P77, DOI 10.1051/gse:2002037; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Clark AGHM, 2005, GENOME RES, V15; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Cottarel J, 2016, J GEN VIROL, V97, P69, DOI 10.1099/jgv.0.000331; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Deng YQ, 2018, DEV CELL, V47, P464, DOI 10.1016/j.devcel.2018.10.012; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Dzugasova V, 1998, CURR GENET, V34, P297, DOI 10.1007/s002940050399; Feng Zhan, 2014, Sheng Wu Gong Cheng Xue Bao, V30, P1436; Gao XD, 2008, J BIOL CHEM, V283, P32534, DOI 10.1074/jbc.M804060200; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gao YH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3636-3; GEORGES M, 1995, GENETICS, V139, P907; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Han Y, 2016, MOL CELL ENDOCRINOL, V436, P150, DOI 10.1016/j.mce.2016.07.030; Hoffmann HH, 2017, CELL HOST MICROBE, V22, P460, DOI 10.1016/j.chom.2017.09.002; Huang GR, 2011, J CLIN INVEST, V121, P769, DOI 10.1172/JCI45096; Jiang JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168946; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kong XY, 2016, ARCH PHYSIOL BIOCHEM, V122, P36, DOI 10.3109/13813455.2015.1120752; Kong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129402; Kotze-Horstmann LM, 2017, ENDOCRINE, V55, P153, DOI 10.1007/s12020-016-1089-0; Larkin DM, 2012, P NATL ACAD SCI USA, V109, P7693, DOI 10.1073/pnas.1114546109; Lebigot E, 2017, MOL GENET METAB, V122, P85, DOI 10.1016/j.ymgme.2017.08.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang RB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06634-w; Liu Y, 2018, BIOMED PHARMACOTHER, V108, P845, DOI 10.1016/j.biopha.2018.09.068; Lu D MS, 2013, J ANIM SCI, V91; Lu JS, 2012, GLYCOBIOLOGY, V22, P504, DOI 10.1093/glycob/cwr162; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Marete AG, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00522; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Meuwissen THE, 2001, GENETICS, V157, P1819; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Minozzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080219; Mitchell KJ, 2004, DIABETES, V53, P393, DOI 10.2337/diabetes.53.2.393; Morota G, 2015, ANIM GENET, V46, P381, DOI 10.1111/age.12307; Morota G, 2016, G3-GENES GENOM GENET, V6, P2447, DOI 10.1534/g3.116.031096; Mukhopadhyay S, 2015, J BIOL CHEM, V290, P6986, DOI 10.1074/jbc.M114.622571; Nadesalingam J, 2001, MAMM GENOME, V12, P27, DOI 10.1007/s003350010232; Nakagawa H, 2017, BIOCHEM BIOPH RES CO, V490, P895, DOI 10.1016/j.bbrc.2017.06.137; Nakatsu Y, 2017, J BIOL CHEM, V292, P11886, DOI 10.1074/jbc.M117.780726; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Olsen HG, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0257-2; Park ST, 2016, INT NEUROUROL J, V20, P76, DOI 10.5213/inj.1632742.371; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peyta L, 2015, BBA-MOL CELL BIOL L, V1851, P1490, DOI 10.1016/j.bbalip.2015.08.008; Plante Y, 2001, J DAIRY SCI, V84, P1516, DOI 10.3168/jds.S0022-0302(01)70185-3; Raikwar NS, 2006, AM J PHYSIOL-ENDOC M, V290, P463, DOI 10.1152/ajpendo.00593.2004; Reinhardt TA, 2014, BIOCHEM BIOPH RES CO, V445, P417, DOI 10.1016/j.bbrc.2014.02.020; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Ron M, 2004, J DAIRY SCI, V87, P476, DOI 10.3168/jds.S0022-0302(04)73187-2; Russo V, 2012, ANIM GENET, V43, P72, DOI 10.1111/j.1365-2052.2012.02353.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schnabel RD, 2005, ANIM GENET, V36, P408, DOI 10.1111/j.1365-2052.2005.01337.x; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Suchyta SP, 2003, PHYSIOL GENOMICS, V16, P8, DOI 10.1152/physiolgenomics.00028.2003; Sui YM, 2018, ONCOL REP, V39, P473, DOI 10.3892/or.2017.6114; Utsunomiya YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064280; Viera JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157607; Viitala SM, 2003, J DAIRY SCI, V86, P1828, DOI 10.3168/jds.S0022-0302(03)73769-2; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xiong XH, 2012, MOL BIOL CELL, V23, P87, DOI 10.1091/mbc.E11-05-0449; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093017; Zhou Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4699-5	78	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220629	10.1371/journal.pone.0220629	http://dx.doi.org/10.1371/journal.pone.0220629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369641	Green Submitted, gold, Green Published			2022-12-27	WOS:000484987900071
J	Wei, SC; Messina, L; Hood, J; Hughes, A; Jaenicke, T; Johnson, K; Mena, L; Scheer, S; Udeagu, CC; Wohl, A; Robertson, M; Prejean, J; Chen, M; Tang, T; Bertolli, J; Johnson, CH; Skarbinski, J				Wei, Stanley C.; Messina, Lauren; Hood, Julia; Hughes, Alison; Jaenicke, Thomas; Johnson, Kendra; Mena, Leandro; Scheer, Susan; Udeagu, Chi-Chi; Wohl, Amy; Robertson, McKaylee; Prejean, Joseph; Chen, Mi; Tang, Tian; Bertolli, Jeanne; Johnson, Christopher H.; Skarbinski, Jacek			Methods to include persons living with HIV not receiving HIV care in the Medical Monitoring Project	PLOS ONE			English	Article							UNITED-STATES; SURVEILLANCE DATA; INFECTION; SUPPRESSION; RETENTION; SYSTEM	The Medical Monitoring Project (MMP) is an HIV surveillance system that provides national estimates of HIV-related behaviors and clinical outcomes. When first implemented, MMP excluded persons living with HIV not receiving HIV care. This analysis will describe new case-surveillance-based methods to identify and recruit persons living with HIV who are out of care and at elevated risk for mortality and ongoing HIV transmission. Stratified random samples of all persons living with HIV were selected from the National HIV Surveillance System in five public health jurisdictions from 2012-2014. Sampled persons were located and contacted through seven different data sources and five methods of contact to collect interviews and medical record abstractions. Data were weighted for non-response and case reporting delay. The modified sampling methodology yielded 1159 interviews (adjusted response rate, 44.5%) and matching medical record abstractions for 1087 (93.8%). Of persons with both interview and medical record data, 264 (24.3%) would not have been included using prior MMP methods. Significant predictors were identified for successful contact (e.g., retention in care, adjusted Odds Ratio [aOR] 5.02; 95% Confidence Interval [CI] 1.98-12.73), interview (e.g. moving out of jurisdiction, aOR 0.24; 95% CI: 0.12-0.46) and case reporting delay (e.g. rural residence, aOR 3.18; 95% CI: 2.09-4.85). Case-surveillance-based sampling resulted in a comparable response rate to existing MMP methods while providing information on an important new population. These methods have since been adopted by the nationally representative MMP surveillance system, offering a model for public health program, research and surveillance endeavors seeking inclusion of all persons living with HIV.	[Wei, Stanley C.; Messina, Lauren; Robertson, McKaylee; Prejean, Joseph; Chen, Mi; Tang, Tian; Bertolli, Jeanne; Johnson, Christopher H.; Skarbinski, Jacek] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Messina, Lauren; Robertson, McKaylee] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Hood, Julia] Publ Hlth Seattle & King Cty, Prevent Div, Seattle, WA USA; [Hughes, Alison; Scheer, Susan] San Francisco Dept Publ Hlth, HIV Epidemiol & Surveillance Sect, San Francisco, CA USA; [Jaenicke, Thomas] Washington State Dept Hlth, Off Infect Dis, Tumwater, WA USA; [Johnson, Kendra; Mena, Leandro] Mississippi Dept Hlth, STD HIV Off, Jackson, MS USA; [Udeagu, Chi-Chi] New York City Dept Hlth & Mental Hyg, Bur HIV AIDS Prevent & Control, New York, NY USA; [Wohl, Amy] Los Angeles Cty Dept Publ Hlth, Program Evaluat Unit, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; San Francisco Department of Public Health; New York City Department of Health & Mental Hygiene; Los Angeles County Department of Public Health	Wei, SC (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	bge3@cdc.gov	Robertson, McKaylee/GLU-4343-2022	Robertson, McKaylee/0000-0002-8426-6572	 [5U62PS001597-02]		These public health surveillance activities were funded through CDC cooperative agreement 5U62PS001597-02.	American Association for Public Opinion Research (AAPOR), 2016, STAND DEF FIN DISP C; [Anonymous], 2019, HIV SURVEILL REP SPE; Blair JM, 2014, MMWR SURVEILL SUMM, V63, P1; Buchacz Kate, 2015, Open AIDS J, V9, P123, DOI 10.2174/1874613601509010123; Bureau of AIDS Tuberculosis and Sexually Transmitted Infections Department of Disease Control Ministry of Public Health, 2019, THAIL NAT GUID HIV A; Buskin S. E., 2011, J HIV AIDS SURVEILLA, V3, P3; Buskin SE, 2014, SEX TRANSM DIS, V41, P35, DOI 10.1097/OLQ.0000000000000072; Centers for Disease Control and Prevention, 2019, BEH CLIN CHAR PERS D; Centers for Disease Control and Prevention, HIV SURV REP 2017; Centers for Disease Control and Prevention, 2018, HIV SURVEILL REP SPE; Chowdhury S, 2007, P JOINT STAT M SECT; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen SM, 2014, PUBLIC HEALTH REP, V129, P335, DOI 10.1177/003335491412900408; Dean BB, 2015, JAIDS-J ACQ IMM DEF, V68, P133, DOI 10.1097/QAI.0000000000000406; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Giordano TP, 2007, CLIN INFECT DIS, V44, P1493, DOI 10.1086/516778; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084318; Health Resources and Services Administration, 2013, HAB HIV COR CLIN PER; Horberg MA, 2013, AIDS PATIENT CARE ST, V27, P442, DOI 10.1089/apc.2013.0073; Institute of Medicine, 2012, MONITORING HIV CARE; Institute of Medicine, 2012, MON HIV CAR US STRAT; Magnus M, 2014, AIDS CARE, V26, P367, DOI 10.1080/09540121.2013.824537; McNaghten AD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000550; Mokotoff E, 2004, DEV POPULATION BASED; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Osborne J. W., 2011, PRACTICAL ASSESSMENT, V16, P1; Padilla M, 2018, PUBLIC HEALTH REP, V133, P147, DOI 10.1177/0033354918754541; Sabharwal CJ, 2014, JAIDS-J ACQ IMM DEF, V65, P571, DOI 10.1097/QAI.0000000000000077; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Selik RM, 2014, MMWR RECOMM REP, V63; Song RG, 2012, JP J BIOSTAT, V7, P1; Sullivan PS, 2011, AIDS CARE, V23, P1314, DOI 10.1080/09540121.2011.555746; Sweeney P, 2013, MILBANK Q, V91, P558, DOI 10.1111/milq.12018; Wohl AR, 2017, JAIDS-J ACQ IMM DEF, V76, P158, DOI 10.1097/QAI.0000000000001482	35	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219996	10.1371/journal.pone.0219996	http://dx.doi.org/10.1371/journal.pone.0219996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369574	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900020
J	Urzua, A; Leiva-Gutierrez, J; Caqueo-Urizar, A; Vera-Villarroel, P				Urzua, Alfonso; Leiva-Gutierrez, Jose; Caqueo-Urizar, Alejandro; Vera-Villarroel, Pablo			Rooting mediates the effect of stress by acculturation on the psychological well-being of immigrants living in Chile	PLOS ONE			English	Article							AMERICAN IMMIGRANTS; MENTAL-HEALTH; SCALES	Migration is a social phenomenon that has an impact both on the lives of the people who migrate, and on the societies who receive them; with psychological well-being being one of the most affected variables. The objective of this research is to analyze the possible mediating role of rooting in the host location on the negative effect that acculturation stress has on the level of well-being. Data for this study were collected using 699 Colombian and Peruvian immigrants who have been permanently residing in Chile for more than six months. Participants were assessed by using Riff's Psychological Well-being Scale, rooting of Torrente et al., and Ruiz et al. scales of stress. The results demonstrated the mediating role of settling down within the host country in relation to stress and psychological well-being, except for the sub-dimension of autonomy. It is concluded that the need for rooting in the host country is a protective factor against the negative effects of stress on perceived well-being.	[Urzua, Alfonso; Leiva-Gutierrez, Jose] Univ Catolica Norte, Sch Psychol, Antofagasta, Chile; [Caqueo-Urizar, Alejandro] Univ Tarapace, Dept Psychol & Philosophy, Arica, Chile; [Vera-Villarroel, Pablo] Univ Santiago Chile, Santiago, Chile	Universidad Catolica del Norte; Universidad de Santiago de Chile	Urzua, A (corresponding author), Univ Catolica Norte, Sch Psychol, Antofagasta, Chile.	alurzua@ucn.cl	Vera-Villarroel, Pablo/AAQ-8476-2020; Leiva-Gutiérrez, Jose/AAP-6813-2020; Vera-Villarroel, Pablo/A-1134-2011; Urzúa, Alfonso/A-1208-2012	Leiva-Gutiérrez, Jose/0000-0002-0460-8350; Vera-Villarroel, Pablo/0000-0001-9187-8414; Urzúa, Alfonso/0000-0002-0882-2194	Comision Nacional de Investigacion Cientifica y Tecnologica, FONDECYT [1140843, 1180315]	Comision Nacional de Investigacion Cientifica y Tecnologica, FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This research was supported by the Comision Nacional de Investigacion Cientifica y Tecnologica, FONDECYT 1140843 and 1180315 to AU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Urzua MA, 2016, REV MED CHILE, V144, P563, DOI 10.4067/S0034-98872016000500002; Barra Almagia Enrique, 2012, Divers.: Perspect. Psicol., V8, P29; Castro A., 2000, REV INTERUNIVERSITAR, V66, P43; Chitgian-Urzua V, 2013, REV ARGENT CLIN PSIC, V22, P5; Diaz D, 2006, PSICOTHEMA, V18, P572; Dodge R., 2012, INT J WELLBEING, V2, P222, DOI [DOI 10.5502/IJW.V2I3.4, 10.5502/ijw.v2i3.4, 10.5502/ijw10.5502/ijw.v2i310.5502/ijw.v2i3.4]; Instituto Nacional de Estadisticas, 2018, SINT RES CENS 2017; Kitchen Peter, 2015, BMC Psychol, V3, P28, DOI 10.1186/s40359-015-0085-0; Melendez J, 2008, REV GERIATRIA GERONT, V43, P67; Organizacion Internacional para las Migraciones, 2013, PERFIL MIGRATORIO CH; Quezada M., 2007, REV ELECT CIENCIAS S, V2; Rogers-Sirin L, 2013, GLOBAL PERSPECTIVES, P11; Ross Nancy, 2002, Health Rep, V13, P33; Hernandez JAR, 2011, SPAN J PSYCHOL, V14, P227, DOI 10.5209/rev_SJOP.2011.v14.n1.20; Ryff CD, 2014, PSYCHOTHER PSYCHOSOM, V83, P10, DOI 10.1159/000353263; RYFF CD, 1995, J PERS SOC PSYCHOL, V69, P719; Ryff CD, 1996, PSYCHOTHER PSYCHOSOM, V65, P14, DOI 10.1159/000289026; Silva J, 2016, INTERCIENCIA, V41, P804; Torrente G, 2011, AN PSICOL-SPAIN, V27, P843; Urzua A, 2019, PSYCHIAT RES, V271, P187, DOI 10.1016/j.psychres.2018.11.028; Urzua A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198413; Urzua A, 2017, UNIV PSYCHOL, V16, DOI [10.11144/Javeriana.upsy16-5.aeai, 10.11144/javeriana.upsy16-5.aeai]; Urzua Morales A, 2017, INTERCIENCIA, V42, P818; van Dierendonck D, 2004, PERS INDIV DIFFER, V36, P629, DOI 10.1016/S0191-8869(03)00122-3; Véliz Burgos Alex, 2012, Psicoperspectivas, V11, P143, DOI 10.5027/psicoperspectivas-Vol11-Issue2-fulltext-196; Vera-Villarroel P, 2013, PSICOL-REFLEX CRIT, V26, P106, DOI 10.1590/S0102-79722013000100012; Williams A., 2008, SENSE PLACE HLTH QUA; WILLIAMS CL, 1991, AM PSYCHOL, V46, P632, DOI 10.1037/0003-066X.46.6.632	29	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0219485	10.1371/journal.pone.0219485	http://dx.doi.org/10.1371/journal.pone.0219485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408469	Green Published, gold, Green Submitted			2022-12-27	WOS:000485009500004
J	Haque, MI; Chowdhury, ABMA; Hassan, MS; Khan, HTA; Harun, MGD				Haque, Md Imdadul; Chowdhury, A. B. M. Alauddin; Hassan, Muhammad Shaikh; Khan, Hafiz T. A.; Harun, Md Golam Dostogir			Prevailing familial, social and cultural obstacles in keeping tobacco-free homes in urban areas of Bangladesh: A mixed-method study	PLOS ONE			English	Article							SMOKING; INITIATION; RELIGION	Background Millions of children and others across the world are being dangerously exposed to tobacco smoke and toxins in their own homes. Whilst there is limited interest in laws and interventions controlling tobacco use in public places in Bangladesh, no attention has been given to preventing tobacco-use inside homes. This study explores the familial and socio-cultural factors that provide obstacles for ensuring tobacco-free homes in Bangladesh. Materials and methods A mixed-method design was adopted and from among the 1,436 tobacco users identified in a population of 11,853, 400 (tobacco users) were selected for cross-sectional survey. This survey involved a probability proportional sampling procedure, and 24 In-Depth Interviews. Multivariate logistic regression was performed to explore the association of familial and socio-cultural factors with tobacco-use at home adjusted by other demographic characteristics. Thematic content analysis was done on the qualitative data, and then inferences were drawn out collectively. Results This study revealed that the prevalence of tobacco-use in the home was 25.7% in urban residential areas in Bangladesh. Multivariate logistic regression analysis identified that familial and socio-cultural factors were significantly associated with tobacco-use at home: marital status (OR 3.23, 95% CI: 1.37-6.61), education (OR 2.14, 95% CI: 1.15-3.99), smoking habits of older family members (OR 1.81 95% CI: 0.91-2.89), tobacco being offered as hospitality and for entertainment (OR 1.85, 95% CI: .94-2.95) and lack of religiosity practice (OR 2.39, 95% CI: 1.27-4.54). Qualitative findings indicated that social customs, lack of religious practice, tobacco-use of older family members, and lack of family guidance were key obstacles for enabling tobacco-free homes in urban areas. Conclusion Use of tobacco at home is continuing as part of established familial and socio-cultural traditions. If tobacco-use at home is not addressed seriously by the authorities then the emerging threat of second-hand smoke exposure and harmful consequences of tobacco-use will be exacerbated.	[Haque, Md Imdadul; Chowdhury, A. B. M. Alauddin; Harun, Md Golam Dostogir] Daffodil Int Univ, Fac Allied Hlth Sci, Dept Publ Hlth, Dhaka, Bangladesh; [Hassan, Muhammad Shaikh] BRAC Univ, Ctr Excellence Hlth Syst & Universal Hlth Coverag, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Khan, Hafiz T. A.] Univ West London, Grad Sch, London, England	Daffodil International University; Bangladesh Rural Advancement Committee BRAC; BRAC University	Haque, MI (corresponding author), Daffodil Int Univ, Fac Allied Hlth Sci, Dept Publ Hlth, Dhaka, Bangladesh.	imdadul.ph@diu.edu.bd		Haque, Md. Imdadul/0000-0003-4822-9157; Haque, Mohammad/0000-0001-5980-3877; Khan, Hafiz/0000-0002-1817-3730	Bangladesh Center for Communication Programs (BCCP); Institute for Global Tobacco Control (IGTC, USA)	Bangladesh Center for Communication Programs (BCCP); Institute for Global Tobacco Control (IGTC, USA)	This study was funded by the Bangladesh Center for Communication Programs (BCCP) in collaboration with the Institute for Global Tobacco Control (IGTC, USA, URL: www.bangladesh-ccp.org/). The study sponsor had no role in the in study design, data collection, analysis, interpretation, or writing of the report. The corresponding author had full access to all the data in the study and the final responsibility to submit for publication.	Afghari AP, 2018, ANAL METHODS ACCID R, V18, P1, DOI 10.1016/j.amar.2018.03.002; [Anonymous], 2010, GENDER WOMEN TOBACCO; [Anonymous], 2010, TOBACCO USE A CROSS; Azam MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156887; Bangladesh Bureau of Statistics, 2010, HOUS INC EXP SURV; Bonnie RJ, 1994, GROWING TOBACCO FREE; Chadda RK, 2003, TOBINDUC DIS, V1, P8, DOI DOI 10.1186/1617-9625-1-8; Charlton A, 2004, J ROY SOC MED, V97, P292, DOI 10.1258/jrsm.97.6.292; Choudhury K, 2007, J HEALTH POPUL NUTR, V25, P456; Dey S, 2015, TIMES INDIA; Dozier AM, 2014, REV PANAM SALUD PUBL, V35, P30; EVANS RI, 1978, J APPL SOC PSYCHOL, V8, P126, DOI 10.1111/j.1559-1816.1978.tb00771.x; Ferrante G, 2013, Monaldi Arch Chest Dis, V79, P38; Gilman SE, 2009, PEDIATRICS, V123, pE274, DOI 10.1542/peds.2008-2251; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Hawkins SS, 2011, PREV MED, V53, P61, DOI 10.1016/j.ypmed.2011.05.016; Hossain A, 2015, UNIVERS J PUBLIC HLT, V3, P241; Hossain MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084470; Hosseinpoor AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042843; Idris BI, 2007, HEALTH PLACE, V13, P702, DOI 10.1016/j.healthplace.2006.11.001; Jabbour S, 2004, B WORLD HEALTH ORGAN, V82, P923; Jarvis MJ, 2004, BRIT MED J, V328, P277, DOI 10.1136/bmj.328.7434.277; Khor YL, 2005, FACTORS ASS TOBACCO; Koenig H. G., 2001, HDB RELIG HLTH CENTU; Matt GE, 2011, ENVIRON HEALTH PERSP, V119, P1218, DOI 10.1289/ehp.1103500; McCullough ME, 2009, PSYCHOL BULL, V135, P69, DOI 10.1037/a0014213; Ministry of Health and Family Welfare, 2009, GLOBAL ADULT TOBACCO; Nargis, 2012, EC TOBACCO TOBACCO T; Pampel F, 2008, SOC SCI MED, V66, P1772, DOI 10.1016/j.socscimed.2007.12.003; Proescholdbell R J, 2000, Nicotine Tob Res, V2, P159, DOI 10.1080/713688125; Rahman MA, 2015, ASIA-PAC J PUBLIC HE, V27, pNP2197, DOI 10.1177/1010539512446957; Rugg M, 2013, EUREK ALERT J ADOLES, V143, P120; Scalici F, 2017, SUBST ABUSE TREAT PR, V12, DOI 10.1186/s13011-017-0089-2; Schick S, 2005, TOB CONTROL, V14, P396, DOI 10.1136/tc.2005.011288; Schick S, 2006, TOB CONTROL, V15, P424, DOI 10.1136/tc.2006.016162; Shahjahan M, 2017, INT Q COMMUNITY HEAL, V37, P181, DOI [10.1177/0272684X17736244, 10.1177/0272684x17736244]; Simons-Morton BG, 2010, J PRIM PREV, V31, P191, DOI 10.1007/s10935-010-0220-x; Skinner ML, 2009, NICOTINE TOB RES, V11, P558, DOI 10.1093/ntr/ntp034; Tsoh JY, 2011, ADDICT BEHAV, V36, P294, DOI 10.1016/j.addbeh.2010.11.009; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; UDDIN G, 2009, BANGLADESH MED J, V38, P48, DOI DOI 10.3329/BMJ.V38I2.3573; Ullah AZ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003059; WHO, 2009, REP GLOB TOB EP; World Health Organization, 2017, TOB ITS ENV IMP OV	44	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220777	10.1371/journal.pone.0220777	http://dx.doi.org/10.1371/journal.pone.0220777			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404115	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000485006800031
J	Matos, SRD; Cunha, MLR; Podgaec, S; Weltman, E; Centrone, AFY; Mafra, ACCN				de Lima Matos, Sabrina Rosa; Rocha Cunha, Mariana Lucas; Podgaec, Sergio; Weltman, Eduardo; Yamazaki Centrone, Ana Fernanda; Cintra Nunes Mafra, Ana Carolina			Consensus for vaginal stenosis prevention in patients submitted to pelvic radiotherapy	PLOS ONE			English	Article							SEXUAL REHABILITATION; DILATOR USE; INTERVENTION; RADIATION	Objective To propose a consensus for prevention of vaginal stenosis in patients submitted to pelvic radiotherapy. Method In this methodological study, Delphi technique was applied for content validation on vaginal stenosis prevention. Data regarding content validation were collected from 32 specialists practicing in the oncology profession. The content validity index of items in the consensus was calculated based on the evaluations by the specialists. Results In the first round, of the 38 items evaluated, 29 items reached a Content Validity Index (CVI-I) greater than 80%, and 9 items had a CVI lower than 80%. Of the items that did not obtain agreement, 2 items were excluded, and 7 were reformulated and included in the second round. In the second round, all 7 items obtained a CVI-I greater than 80%. The final instrument consisted of 29 items validated in the first round, plus 7 items reformulated and consolidated in the second round. The judges agreed that it is the responsibility of the health professionals to consult the patients undergoing radiation therapy in the area of sexuality to patients. The radiation oncologist should be the first professional to address this issue and the nurse oncologist in the follow-up consultation should pass the guidelines to the patients as comprehensively as possible. Patients should be informed about vaginal dilation, regardless of whether they are sexually active or have a partner. They should also be informed of when they can resume sexual activity. The procedure of vaginal dilation should be individualized. The prescribed vaginal dilators should be used with a lubricant for a duration of at least 5-10 minutes, 2-3 times a week, as per the need of each patient (sexual activity and/or clinical follow-up) for an indefinite time. Patients should seek medical help in case they experience pain, discomfort, or bleeding during dilation. Conclusion The Brazilian version of the consensus for vaginal stenosis prevention in patients submitted to pelvic radiotherapy was validated with 36 items in 7 categories related to Responsibility; Target population; Rationale; Vaginal dilator; Content instructions; Information provision; and Patient support. In Brazil, the educational practices on vaginal dilation for patients submitted to radiotherapy partly revealed similar difficulties as identified in other studies as well as countries with reference to specific guidelines for the start and duration of vaginal dilation. The final consensus developed in this study could strengthen the guidelines for education of patients in Brazil and provide a future scope to establish a single and safe guideline.	[de Lima Matos, Sabrina Rosa; Weltman, Eduardo] Hosp Israelita Albert Einstein, Radiat Oncol Dept, Sao Paulo, SP, Brazil; [Rocha Cunha, Mariana Lucas] Fac Israelita Ciencias Saude Albert Einstein, Nursing Sch, Sao Paulo, SP, Brazil; [Podgaec, Sergio] Hosp Israelita Albert Einstein, Womens Hlth Dept, Sao Paulo, SP, Brazil; [Yamazaki Centrone, Ana Fernanda] Hosp Israelita Albert Einstein, Oncol Ctr, Sao Paulo, SP, Brazil; [Cintra Nunes Mafra, Ana Carolina] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	Matos, SRD (corresponding author), Hosp Israelita Albert Einstein, Radiat Oncol Dept, Sao Paulo, SP, Brazil.	sabrina.rlmatos@gmail.com	Mafra, Ana Carolina CN/H-1030-2015	Mafra, Ana Carolina CN/0000-0001-9004-7176; Rosa de Lima Matos, Sabrina/0000-0001-8452-8491; Weltman, Eduardo/0000-0002-7964-2051; Podgaec, Sergio/0000-0002-9760-6003				Baiocchi Neto G, 2013, ONCOLOGIA GRADUACAO, P464; Bakker RM, 2017, SUPPORT CARE CANCER, V25, P729, DOI 10.1007/s00520-016-3453-2; Bakker RM, 2014, INT J GYNECOL CANCER, V24, P1499, DOI 10.1097/IGC.0000000000000253; BEATON D, 2002, RECOMMENDATIONS CROS; Bonner C, 2012, SUPPORT CARE CANCER, V20, P2305, DOI 10.1007/s00520-011-1337-z; Brand AH, 2012, INT J GYNECOL CANCER, V22, P897, DOI 10.1097/IGC.0b013e31824d7243; Brasil. Ministerio da Saude. Instituto Nacional de Cancer, 2017, EST 2018 INC CANC BR, P25; Brasil. Ministerio da Saude. Instituto Nacional de Cancer, 2017, EST 2018 INC CANC BR, P38; BRUNER DW, 1993, INT J RADIAT ONCOL, V27, P825, DOI 10.1016/0360-3016(93)90455-5; Carvalho HA, 2013, RADIOTERAPIA ONCOLOG, P939; Ferreira SMD, 2015, REV LAT-AM ENFERM, V23, P82, DOI 10.1590/0104-1169.3602.2528; Gwet K. L., 2014, HDB INTERRATER RELIA; International Clinical Guideline Group, 2012, INT GUID VAG DIL PEL; Jeffries SA, 2006, INT J RADIAT ONCOL, V65, P404, DOI 10.1016/j.ijrobp.2005.12.009; Lancaster Letitia, 2004, Eur J Oncol Nurs, V8, P30, DOI 10.1016/S1462-3889(03)00059-0; Martins J, 2017, ARCH GYNECOL OBSTET, V296, P1125, DOI 10.1007/s00404-017-4553-z; Miles T, 2014, COCHRANE DB SYST REV, V12, P1; Mirabeau-Beale K, 2015, PRACT RADIAT ONCOL, V5, pE113, DOI 10.1016/j.prro.2014.09.003; Novaes PE, 2011, RADIOTERAPIA BASEADA, P273; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Santos SD, 2011, FISIOTERAPIA SER, V6, P25; Scarparo AF, 2012, REV RENE, V13, P242, DOI DOI 10.15253/REVRENE.V13I1.3803; Team RC., 2013, R LANG ENV STAT COMP; Vinuto J., 2014, TEMATICAS CAMPINAS S, V44, P203, DOI [10.20396/tematicas.v22i44.10977, DOI 10.20396/TEMATICAS.V22I44.10977]; White ID, 2006, INT J GYNECOL CANCER, V16, P1140, DOI 10.1111/j.1525-1438.2006.00452.x	25	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221054	10.1371/journal.pone.0221054	http://dx.doi.org/10.1371/journal.pone.0221054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398239	Green Published, gold, Green Submitted			2022-12-27	WOS:000485004000045
J	Santini, CD; Imakawa, TD; Duarte, G; Quintana, SM; Moises, ECD				Santini, Cibele de Oliveira; Imakawa, Thiago dos Santos; Duarte, Geraldo; Quintana, Silvana Maria; Dantas Moises, Elaine Christine			Do the body mass index and the diagnosis of gestational diabetes mellitus influence the level of physical activity during pregnancy and postpartum?	PLOS ONE			English	Article							EXERCISE; RISK; INACTIVITY; BEHAVIORS; PATTERNS; WOMEN; COMPENDIUM; BENEFITS; BARRIERS; BELIEFS	Obesity and lack of physical exercise are associated with the increase of diabetes mellitus in women of reproductive age and during the gestational period. The objective of the present study was to evaluate physical activity levels during the pregnancy and postpartum periods and the influence of body mass index (BMI) in women with gestational diabetes mellitus (GDM) or low risk pregnancy. The Pregnancy Physical Activity Questionnaire (PPAQ), translated and validated for Portuguese, was used for the evaluation of physical activity (PA) level. The sample was stratified according to preconception BMI and the presence or absence of diagnosis of GDM, resulting in four groups with 66 participants each: low risk pregnancy (LRP) with normal weight (BMI >= 18.5 and <= 24 kg/m(2)), LRP and overweight/obese (BMI >= 25 kg/m(2)), GDM with normal weight and GDM with overweight/obese. The level of PA of each participant was measured as Metabolic Equivalent of Task (MET) during the preconceptional period (T0), in the third trimester of gestation (T1), and three months after delivery (T2). The comparison of the MET values showed that the values found in the evaluation three months after delivery (T2) were higher than 1.00 (1.10 MET for the LRP-normal weight, 1.06 MET for LRP-overweight/obese, 1.02 MET for the GDM-normal weight, 1.07 MET for the GDM-overweight/obese). On the pre-gestational (T0) and third trimester (T1) analyzes, the values were less than 1.00 MET. The analysis between groups in relation to BMI and diagnosis of GDM showed no difference.	[Santini, Cibele de Oliveira; Duarte, Geraldo; Quintana, Silvana Maria; Dantas Moises, Elaine Christine] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, Sao Paulo, Brazil; [Imakawa, Thiago dos Santos] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Moises, ECD (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Gynecol & Obstet, Sao Paulo, Brazil.	elainemoises@fmrp.usp.br	Moisés, Elaine C/A-5708-2015	Moisés, Elaine C/0000-0001-9099-4544; Santini de Oliveira Imakawa, Cibele/0000-0003-3244-2930	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1538886/2015-2017]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), wich provided a master scholarship to CSO (1538886/2015-2017). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Aune D, 2014, EPIDEMIOLOGY, V25, P331, DOI 10.1097/EDE.0000000000000036; Bloom D.E, 2011, GLOBAL EC BURDEN NON; Borodulin Katja, 2009, BMC Womens Health, V9, P32, DOI 10.1186/1472-6874-9-32; Borodulin KM, 2008, MED SCI SPORT EXER, V40, P1901, DOI 10.1249/MSS.0b013e31817f1957; Brown W, 2002, J SCI MED SPORT, V5, P37, DOI 10.1016/S1440-2440(02)80296-1; Bueno DR, 2016, CIENC SAUDE COLETIVA, V21, P1001, DOI 10.1590/1413-81232015214.09082015; Byrne NM, 2005, J APPL PHYSIOL, V99, P1112, DOI 10.1152/japplphysiol.00023.2004; Cerin E, 2008, SOC SCI MED, V66, P2596, DOI 10.1016/j.socscimed.2008.02.012; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Chasan-Taber L, 2008, J WOMENS HEALTH, V17, P999, DOI 10.1089/jwh.2007.0560; Colberg SR, 2016, DIABETES CARE, V39, P2065, DOI 10.2337/dc16-1728; Colberg SR, 2013, WORLD J DIABETES, V4, P256, DOI 10.4239/wjd.v4.i6.256; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; Di Mascio D, 2016, AM J OBSTET GYNECOL, V215, P561, DOI 10.1016/j.ajog.2016.06.014; Dias-da-Costa Juvenal Soares, 2005, Cad. Saúde Pública, V21, P275, DOI 10.1590/S0102-311X2005000100030; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; do Nascimento SL, 2012, REV BRAS GINECOL OBS, V36, P423; Downs DS, 2004, J MIDWIFERY WOM HEAL, V49, P138, DOI 10.1016/j.jmwh.2003.11.009; Eaton SB, 2017, RES Q EXERCISE SPORT, V88, P1, DOI 10.1080/02701367.2016.1268519; Ehrlich SF, 2017, DIABETES METAB, V43, P416, DOI 10.1016/j.diabet.2017.01.006; Eime RM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1796-0; Evenson KR, 2009, J WOMENS HEALTH, V18, P1925, DOI 10.1089/jwh.2008.1309; Evenson KR, 2009, MATERN CHILD HLTH J, V13, P364, DOI 10.1007/s10995-008-0359-8; Fazzi C, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0485-z; Feghali MN, 2018, DIABETES RES CLIN PR, V138, P177, DOI 10.1016/j.diabres.2018.02.004; Gaston A, 2011, J SCI MED SPORT, V14, P299, DOI 10.1016/j.jsams.2011.02.006; Gavard JA, 2008, CLIN OBSTET GYNECOL, V51, P467, DOI 10.1097/GRF.0b013e31816feb1d; Hallal Pedro C., 2005, Cad. Saúde Pública, V21, P573, DOI 10.1590/S0102-311X2005000200024; Harrison Cheryce L, 2016, Semin Reprod Med, V34, pe28, DOI 10.1055/s-0036-1583530; Hayman M, 2016, J SCI MED SPORT, V19, P664, DOI 10.1016/j.jsams.2015.09.004; Instituto Brasileiro de Geografia e Estatistica, 2014, SINT IND POP BRAS; King AC, 2000, HEALTH PSYCHOL, V19, P354, DOI 10.1037//0278-6133.19.4.354; Knuth AG, 2010, J EPIDEMIOL COMMUN H, V64, P591, DOI 10.1136/jech.2009.088526; Lynch KE, 2012, AM J PREV MED, V43, P434, DOI 10.1016/j.amepre.2012.06.020; Magro-Malosso ER, 2017, ACTA OBSTET GYN SCAN, V96, P921, DOI 10.1111/aogs.13151; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-41; Coll CDN, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4036-y; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Padmapriya N, 2015, MATERN CHILD HLTH J, V19, P2523, DOI 10.1007/s10995-015-1773-3; Perales M, 2017, JAMA-J AM MED ASSOC, V317, P1113, DOI 10.1001/jama.2017.0593; Prather H, 2012, PM&R, V4, P845, DOI 10.1016/j.pmrj.2012.07.012; Russo LM, 2015, OBSTET GYNECOL, V125, P576, DOI 10.1097/AOG.0000000000000691; Salles-Costa Rosana, 2003, Cad. Saúde Pública, V19, P1095, DOI 10.1590/S0102-311X2003000400031; Shepherd E, 2017, COCHRANE DATABASE SY; Silva F T, 2015, Ceska Gynekol, V80, P290; Sklempe Kokic I, 2018, SCAND J MED SCI SPOR; Teh WT, 2011, AUST NZ J OBSTET GYN, V51, P26, DOI 10.1111/j.1479-828X.2011.01292.x; Tobias DK, 2011, DIABETES CARE, V34, P223, DOI 10.2337/dc10-1368; 2002, OBSTET GYNECOL, V99, P869	53	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220947	10.1371/journal.pone.0220947	http://dx.doi.org/10.1371/journal.pone.0220947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398219	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000030
J	Andaleon, A; Mogil, LS; Wheeler, HE				Andaleon, Angela; Mogil, Lauren S.; Wheeler, Heather E.			Genetically regulated gene expression underlies lipid traits in Hispanic cohorts	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; ANCESTRY; POPULATION; CETP; ATHEROSCLEROSIS; INFERENCE; RISK; STATISTICS; DIVERSITY	Plasma lipid levels are risk factors for cardiovascular disease, a leading cause of death worldwide. While many studies have been conducted in genetic variation underlying lipid levels, they mainly comprise individuals of European ancestry and thus their transferability to non-European populations is unclear. We performed genome-wide (GWAS) and imputed transcriptome-wide association studies of four lipid traits in the Hispanic Community Health Study/Study of Latinos cohort (HCHS/SoL, n = 11,103), replicated top hits in the Multi-Ethnic Study of Atherosclerosis (MESA, n = 3,855), and compared the results to the larger, predominantly European ancestry meta-analysis by the Global Lipids Genetics Consortium (GLGC, n = 196,475). In our GWAS, we found significant SNP associations in regions within or near known lipid genes, but in our admixture mapping analysis, we did not find significant associations between local ancestry and lipid phenotypes. In the imputed transcriptomewide association study in multiple tissues and in different ethnicities, we found 59 significant gene-tissue-phenotype associations (P < 3.61x10(-8)) with 14 unique significant genes, many of which occurred across multiple phenotypes, tissues, and ethnicities and replicated in MESA (45/59) and in GLGC (44/59). These include well-studied lipid genes such as SORT1, CETP, and PSRC1, as well as genes that have been implicated in cardiovascular phenotypes, such as CCL22 and ICAM1. The majority (40/59) of significant associations colocalized with expression quantitative trait loci (eQTLs), indicating a possible mechanism of gene regulation in lipid level variation. To fully characterize the genetic architecture of lipid traits in diverse populations, larger studies in non-European ancestry populations are needed.	[Andaleon, Angela; Mogil, Lauren S.; Wheeler, Heather E.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA; [Andaleon, Angela; Wheeler, Heather E.] Loyola Univ, Program Bioinformat, Chicago, IL 60611 USA; [Wheeler, Heather E.] Loyola Univ, Dept Comp Sci, Chicago, IL 60611 USA; [Wheeler, Heather E.] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Wheeler, HE (corresponding author), Loyola Univ, Dept Biol, Chicago, IL 60626 USA.; Wheeler, HE (corresponding author), Loyola Univ, Program Bioinformat, Chicago, IL 60611 USA.; Wheeler, HE (corresponding author), Loyola Univ, Dept Comp Sci, Chicago, IL 60611 USA.; Wheeler, HE (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA.	hwheeler1@luc.edu	; Wheeler, Heather/I-9279-2019	Andaleon, Angela/0000-0003-4459-6398; Wheeler, Heather/0000-0003-1365-9667	NIH National Human Genome Research Institute Academic Research Enhancement Award [R15 HG009569]; Loyola University Chicago; Loyola Carbon Undergraduate Research Fellowship; Loyola MS Bioinformatics Research Assistant Fellowship; National Heart, Lung, and Blood Institute (NHLBI) [N01HC65233, N01-HC65234, N01HC65235, N01HC65236, N01HC65237]; National Center on Minority Health and Health Disparities; National Institute of Deafness and Other Communications Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke; Office of Dietary Supplements; National Heart, Lung, and Blood Institute (NHLBI); NHLBI [N02HL-64278];  [N01-HC95159];  [N01-HC-95160];  [N01-HC95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC95164];  [N01-HC-95165];  [N01-HC95166];  [N01-HC95167];  [N01-HC-95168];  [N01-HC-95169];  [UL1-RR025005];  [UL1-TR-000040]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG009569] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute Academic Research Enhancement Award; Loyola University Chicago; Loyola Carbon Undergraduate Research Fellowship; Loyola MS Bioinformatics Research Assistant Fellowship; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Deafness and Other Communications Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by the NIH National Human Genome Research Institute Academic Research Enhancement Award R15 HG009569 (HEW), start-up funds from Loyola University Chicago (HEW), the Loyola Carbon Undergraduate Research Fellowship (AA), and the Loyola MS Bioinformatics Research Assistant Fellowship (AA). The Hispanic Community Health Study/Study of Latinos is supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01HC65235), Northwestern University (N01HC65236), and San Diego State University (N01HC65237). The following Institutes/Centers/Offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Center on Minority Health and Health Disparities, the National Institute of Deafness and Other Communications Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements. The authors thank the staff and participants of the HCHS/SOL study for their important contributions. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC95159, N01-HC-95160, N01-HC95161, N01-HC-95162, N01-HC-95163, N01-HC95164, N01-HC-95165, N01-HC95166, N01-HC95167, N01-HC-95168, N01-HC-95169, UL1-RR025005, and UL1-TR-000040. Funding for SHARe genotyping was provided by NHLBI Contract N02HL-64278. Genotyping was performed at Affymetrix (Santa Clara, California, USA) and the Broad Institute of Harvard and MIT (Boston, Massachusetts, USA) using the Affymetrix Genome-Wide Human SNP Array 6.0. The authors thank the other investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at mesa-nhlbi. org. The following datasets were downloaded from dbGaP: phs000810. v1.p1 and phs000209. v13.p3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andaleon A, 2018, PEERJ, V6, DOI 10.7717/peerj.4314; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arvind P, 2014, J CARDIOL, V64, P339, DOI 10.1016/j.jjcc.2014.02.012; Barbeira AN, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007889; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Belbin GM, 2018, CURR OPIN GENET DEV, V53, P98, DOI 10.1016/j.gde.2018.07.006; Below JE, 2016, SCI REP-UK, V6, DOI 10.1038/srep19429; Bhatti JS, 2018, ANN HUM GENET, V82, P448, DOI 10.1111/ahg.12274; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Brown LA, 2017, J AM SOC NEPHROL, V28, P2211, DOI 10.1681/ASN.2016091010; Browning SR, 2016, G3-GENES GENOM GENET, V6, P1525, DOI 10.1534/g3.116.028779; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; Conomos MP, 2015, GENET EPIDEMIOL, V39, P276, DOI 10.1002/gepi.21896; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Daviglus ML, 2012, JAMA-J AM MED ASSOC, V308, P1775, DOI 10.1001/jama.2012.14517; de Grooth GJ, 2004, J LIPID RES, V45, P1967, DOI 10.1194/jlr.R400007-JLR200; Feingold KR, 2000, INTRO LIPIDS LIPOPRO; Fotis L, 2012, IN VIVO, V26, P243; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Graff M, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0591-6; Guo K, 2018, J MOL CELL CARDIOL, V116, P69, DOI 10.1016/j.yjmcc.2018.01.013; Keys K.L, 2019, CROSS POPULATION GEN, DOI [10.1101/552042, DOI 10.1101/552042]; Kimura S, 2015, J ATHEROSCLER THROMB, V22, P599, DOI 10.5551/jat.27417; Kimura S, 2012, PATHOL INT, V62, P675, DOI 10.1111/j.1440-1827.2012.02854.x; Klarin D, 2018, NAT GENET, V50, P1514, DOI 10.1038/s41588-018-0222-9; Kosmas CE, 2016, CLIN MED INSIGHTS-CA, V10, P37, DOI 10.4137/CMC.S32667; Kramer HJ, 2017, J AM SOC NEPHROL, V28, P915, DOI 10.1681/ASN.2016030357; Langefeld CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16021; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Liu BX, 2019, NAT GENET, V51, P768, DOI 10.1038/s41588-019-0404-0; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Mikhaylova AV, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00261; Mogil LS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007586; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nielsen JL, 2011, CAN J FISH AQUAT SCI, V68, P1, DOI 10.1139/F10-124; Paththinige CS, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0488-4; Petty LE, 2019, HUM MOL GENET, V28, P1212, DOI 10.1093/hmg/ddy435; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodrigues DA, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019101; Rodriguez CJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001867; Rosenson RS, 2016, NAT REV CARDIOL, V13, P48, DOI 10.1038/nrcardio.2015.124; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sofer T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188400; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Strong A, 2014, CURR OPIN LIPIDOL, V25, P350, DOI 10.1097/MOL.0000000000000110; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Tall AR, 2018, CIRC RES, V122, P106, DOI 10.1161/CIRCRESAHA.117.311978; Thompson JF, 2003, ATHEROSCLEROSIS, V167, P195, DOI 10.1016/S0021-9150(03)00005-4; Vijai J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6751; Wainberg M, 2019, NATURE GENETICS, V51; Weissglas-Volkov D, 2013, J MED GENET, V50, P298, DOI 10.1136/jmedgenet-2012-101461; Wheeler HE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006423; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhong YZ, 2019, AM J HUM GENET, V104, P1097, DOI 10.1016/j.ajhg.2019.04.009; Zhou L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082420; Zhou X, 2017, ANN APPL STAT, V11, P2027, DOI 10.1214/17-AOAS1052; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	77	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220827	10.1371/journal.pone.0220827	http://dx.doi.org/10.1371/journal.pone.0220827			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393916	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500066
J	Falcon, A; Montano, U; Tavira, M; Dominguez-Gallegos, O				Falcon, Alberto; Montano, Ulianov; Tavira, Mariel; Dominguez-Gallegos, Osmara			Haptic sound-symbolism in young Spanish-speaking children	PLOS ONE			English	Article							CROSSMODAL CORRESPONDENCES; ASSOCIATIONS; ODORS; SHAPE; INTEGRATION; BOUBA; TOUCH; KIKI	Haptic sound symbolism has been found in adults, between ideophones and various textures, between words and shape, and between written words and texture. However, associations between the sound of nonwords and features other than shape and in early stages of development have been less explored. The present study investigates the haptic manifestation of sound symbolism in an early developmental stage. We examined associations between nonwords and the rough-smooth tactile dimension in 3.5-to-4.5-year-old children. Two experiments were conducted: a pointing selection task and a naming task. Sound symbolic associations were found in the naming task, but not in the pointing task. On the other hand an unexpected bias towards smoothness was found in the pointing task. We explain these results by suggesting that the articulation of nonwords may facilitate or intensify sound symbolism, and that hedonic biases are manifested in the pointing task.	[Falcon, Alberto; Montano, Ulianov; Tavira, Mariel; Dominguez-Gallegos, Osmara] Univ Autonoma Estado Morelos, Lab Comunicac Humana & Cognic, Fac Comunicac Humana, Cuernavaca, Morelos, Mexico	Universidad Autonoma del Estado de Morelos	Falcon, A (corresponding author), Univ Autonoma Estado Morelos, Lab Comunicac Humana & Cognic, Fac Comunicac Humana, Cuernavaca, Morelos, Mexico.	falcon@uaem.mx		FALCON, ALBERTO/0000-0003-4884-6518				[Anonymous], P ANN M PHONOLOGY; Aoki H., 1994, SOUND SYMBOLISM, P15; Asano M, 2015, CORTEX, V63, P196, DOI 10.1016/j.cortex.2014.08.025; Bremner AJ, 2013, COGNITION, V126, P165, DOI 10.1016/j.cognition.2012.09.007; Crisinel AS, 2012, CHEMOSENS PERCEPT, V5, P266, DOI 10.1007/s12078-012-9133-9; Crisinel AS, 2012, CHEM SENSES, V37, P151, DOI 10.1093/chemse/bjr085; DAVIS R, 1961, BRIT J PSYCHOL, V52, P259, DOI 10.1111/j.2044-8295.1961.tb00788.x; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Dominguez-Gallegos, 2014, THESIS; Eitan Z, 2011, PSYCHOL MUSIC, V39, P449, DOI 10.1177/0305735610377592; Etzi R, 2016, MULTISENS RES, V29, P133, DOI 10.1163/22134808-00002497; Evans KK, 2010, J VISION, V10, DOI 10.1167/10.1.6; Fort M., 2013, P 12 INT C AUD VIS S, P71; Fryer L, 2014, COGNITION, V132, P164, DOI 10.1016/j.cognition.2014.03.015; Gallace A, 2006, PERCEPT PSYCHOPHYS, V68, P1191, DOI 10.3758/BF03193720; Gallace A, 2011, SOC SEMIOT, V21, P569, DOI 10.1080/10350330.2011.591998; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; Hanson-Vaux G, 2013, CHEM SENSES, V38, P161, DOI 10.1093/chemse/bjs087; Hinton L., 1994, SOUND SYMBOLISM, P40; Hubbard TL, 1996, AM J PSYCHOL, V109, P219, DOI 10.2307/1423274; Hunter-Smith S., 2007, UNDERSTANDING BABBLE; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Kantartzis K, 2011, COGNITIVE SCI, V35, P575, DOI 10.1111/j.1551-6709.2010.01169.x; Kohler W., 1929, GESTALT PSYCHOL; Langdon M., 1994, SOUND SYMBOLISM, P94; LEDERMAN SJ, 1993, ACTA PSYCHOL, V84, P29, DOI 10.1016/0001-6918(93)90070-8; Lockwood G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00933; Ludwig VU, 2013, CORTEX, V49, P1089, DOI 10.1016/j.cortex.2012.04.004; Martino G, 2000, PERCEPTION, V29, P745, DOI 10.1068/p2984; Masuda K., 2007, INSISTENT IMAGES, V5, P57; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Ngo MK, 2011, FOOD QUAL PREFER, V22, P567, DOI 10.1016/j.foodqual.2011.03.009; Nielsen A, 2012, LANG COGN, V4, P115, DOI 10.1515/langcog-2012-0007; Oda Hiromi, 2000, EMBODIED SEMANTIC ME; Ohala JJ, 2006, SOUND SYMBOLISM, P325; Ohala John J., 1983, PRODUCTION SPEECH, P189, DOI DOI 10.1007/978-1-4613-8202-7_9; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; Perry LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137147; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Sakamoto M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00295; Sapir E, 1929, J EXP PSYCHOL, V12, P225, DOI 10.1037/h0070931; Seo HS, 2010, NEUROSCI LETT, V478, P175, DOI 10.1016/j.neulet.2010.05.011; Tzeng CY, 2017, J EXP CHILD PSYCHOL, V160, P107, DOI 10.1016/j.jecp.2017.03.004; von Humboldt WF, 1836, KONIGL AKAD WISS; Watanbe J, 2012, P ANN M COGN SCI SOC	48	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220618	10.1371/journal.pone.0220618	http://dx.doi.org/10.1371/journal.pone.0220618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393921	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500047
J	Sanchez-Quinto, A; Falcon, LI				Sanchez-Quinto, Andres; Falcon, Luisa I.			Metagenome of Acropora palmata coral rubble: Potential metabolic pathways and diversity in the reef ecosystem	PLOS ONE			English	Article							FRINGING-REEF; MARINE FUNGI; NITROGEN; METAMORPHOSIS; ECOLOGY; GENOME; DMSP	Over the past 30 years, the stony coral Acropora palmata has experienced an excessive loss of individuals showing few signs of recovery throughout the Mexican Caribbean, resulting in long stretches of coral rubble structures. When the coral dies, the skeleton begins to be colonized by algae, sponges, virus, bacteria and other microorganisms, forming a new community. Here we analyze, using a metagenomic approach, the diversity and biogeochemical cycles associated to coral rubble in La Bocana (Puerto Morelos, QRoo, Mexico). This study provides the first broad characterization of coral rubble associated communities and their role in biogeochemical cycling, suggesting a potential view of a world where coral reefs are no longer dominated by corals.	[Sanchez-Quinto, Andres] Univ Nacl Autonoma Mexico, Posgrad Ciencias Mar & Limnol, Mexico City, DF, Mexico; [Sanchez-Quinto, Andres; Falcon, Luisa I.] Univ Nacl Autonoma Mexico, Inst Ecol, Lab Ecol Bacteriana, Mexico City, DF, Mexico; [Falcon, Luisa I.] UNAM, Parque Cient & Tecnol Yucatan, Sierra Papacal, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Falcon, LI (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Lab Ecol Bacteriana, Mexico City, DF, Mexico.; Falcon, LI (corresponding author), UNAM, Parque Cient & Tecnol Yucatan, Sierra Papacal, Mexico.	falcon@ecologia.unam.mx		Falcon, Luisa I/0000-0002-7210-6483	SEP-CONACyT (La Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia) [254962]; PAPIIT-UNAM [IN 202016-3]	SEP-CONACyT (La Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	Funding for this project was granted through SEP-CONACyT (https://www.conacyt.gob.mx/) (La Secretaria de Educacion Publica-Consejo Nacional de Ciencia y Tecnologia) No. 254962 (L.I.F.) and PAPIIT-UNAM No. IN 202016-3 (https://www.gob.mx/sep) (L.I. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Aloisi G, 2006, GEOLOGY, V34, P1017, DOI 10.1130/G22986A.1; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Amend AS, 2012, ISME J, V6, P1291, DOI 10.1038/ismej.2011.193; Anandan R, 2016, ACTINOBACTERIA BASIC, V2, P1; Andrews S, 2010, FASTQC QUALITY CONTR; Arp G, 2001, SCIENCE, V292, P1701, DOI 10.1126/science.1057204; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Baker DM, 2013, CORAL REEFS, V32, P691, DOI 10.1007/s00338-013-1040-2; Beltran Y, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv162; Blanchon P, 1997, J SEDIMENT RES, V67, P1; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bourne DG, 2012, PROKARYOTES PROKARYO, P163; Broadbent AD, 2004, MAR FRESHWATER RES, V55, P849, DOI 10.1071/MF04114; Capone D.G., 1993, HDB METHODS AQUATIC, P621, DOI 10.1201/9780203752746-74; Coronado C, 2007, CORAL REEFS, V26, P149, DOI 10.1007/s00338-006-0175-9; Eric Jordan-Dahlgren, 2003, LATIN AM CORAL REEFS, V508; Falcon LI, 2007, MICROB ECOL, V54, P363, DOI 10.1007/s00248-007-9240-3; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Grasshoff K, 1999, METHODS SEAWATER ANA; Grober-Dunsmore R, 2006, MAR ECOL PROG SER, V321, P123, DOI 10.3354/meps321123; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hassan R., 2005, ECOSYSTEMS HUMAN WEL, P331; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Instituto Nacional de Ecologia, 2000, PROGR MAN PARQ NAC A, P224; Ivarez-Filip L, 2014, DIAGNOSTICO ESTADO C; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jordan-Dahlgren E., 1993, REV SOC MEXICANA HIS, V44, P157; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Keegan KP, 2016, METHODS MOL BIOL, V1399, P207, DOI 10.1007/978-1-4939-3369-3_13; Kimes NE, 2010, ENVIRON MICROBIOL, V12, P541, DOI 10.1111/j.1462-2920.2009.02113.x; Kirkwood D.S, 1994, SEAWATER ANAL; KURSAR TA, 1983, PLANT PHYSIOL, V72, P409, DOI 10.1104/pp.72.2.409; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mukherjee S, 2015, STAND GENOMIC SCI, V10; Mulhall M, 2009, DUKE ENV LAW POLICY, V19, P321; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Perry CT, 2008, EARTH-SCI REV, V86, P106, DOI 10.1016/j.earscirev.2007.08.006; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Rasser MW, 2002, CORAL REEFS, V21, P57, DOI 10.1007/s00338-001-0206-5; Richards TA, 2012, ANNU REV MAR SCI, V4, P495, DOI 10.1146/annurev-marine-120710-100802; Riding R., 1991, CALCAREOUS ALGAE STR, DOI DOI 10.1007/978-3-642-52335-9_2; Riding R., 2000, MICROBIAL SEDIMENTS; Riding Robert, 2011, P911; Rodriguez-Martinez RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096140; SEBENS KP, 1994, AM ZOOL, V34, P115; Sumich JL, 2004, INTRO BIOL MARINE LI, V8, P1; Thompson A, 2011, REP AIMS ACT CORAL R, V128; Turchyn A V., 2005, OXYGEN ISOTOPES MARI, P1; VALDERRAMA JC, 1981, MAR CHEM, V10, P109, DOI 10.1016/0304-4203(81)90027-X; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Witzany G., 2017, BIOCOMMUNICATION ARC, P1; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Young CN, 2012, B MAR SCI, V88, P1075, DOI 10.5343/bms.2011.1143; Zhu TT, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00004	61	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220117	10.1371/journal.pone.0220117	http://dx.doi.org/10.1371/journal.pone.0220117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31394568	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500022
J	Yamashita, H; Katai, H; Kawaguchi, L; Nagano, AJ; Nakamura, Y; Morita, A; Ikka, T				Yamashita, Hiroto; Katai, Hideyuki; Kawaguchi, Lina; Nagano, Atsushi J.; Nakamura, Yoriyuki; Morita, Akio; Ikka, Takashi			Analyses of single nucleotide polymorphisms identified by ddRAD-seq reveal genetic structure of tea germplasm and Japanese landraces for tea breeding	PLOS ONE			English	Article							POPULATION-STRUCTURE; QUANTITATIVE-EVALUATION; SHAPE; DIFFERENTIATION; DIVERSITY; CULTIVARS; INFERENCE	To obtain genetic information about the germplasm of tea (Camellia sinensis L.) in Japan, 167 accessions including 138 var. sinensis (96 Japanese var. sinensis and 42 exotic var. sinensis) and 29 Assam hybrids were analyzed using single nucleotide polymorphisms (SNPs) markers identified by double-digest restriction-site-associated DNA sequencing (ddRAD-seq) analysis. Approximately 10,000 SNPs were identified by ddRAD-seq and were mapped across the whole genome. The 167 tea accessions were classified into three genetic subgroups: (1) Japanese var. sinensis; (2) Japanese and exotic var. sinensis; (3) Assam hybrids and exotic var. sinensis. Leaf morphology varied widely within each genetic subgroups. The 96 Japanese var. sinensis were classified into four genetic subgroups as follows; two subgroups of Shizuoka (the largest tea production region) landraces, Uji (most ancient tea production region) landraces, and the pedigree of 'Yabukita', the leading green tea cultivar in Japan. These results indicated that the SNP markers obtained from ddRAD-seq are a useful tool to investigate the geographical background and breeding history of Japanese tea. This genetic information revealed the ancestral admixture situation of the 'Yabukita' pedigree, and showed that the genome structure of 'Yabukita' is clearly different from those of other Japanese accessions.	[Yamashita, Hiroto; Morita, Akio; Ikka, Takashi] Shizuoka Univ, Fac Agr, Shizuoka, Japan; [Yamashita, Hiroto] Gifu Univ, United Grad Sch Agr Sci, Gifu, Japan; [Katai, Hideyuki] Shizuoka Prefectural Res Inst Agr & Forestry, Tea Res Ctr, Shizuoka, Japan; [Kawaguchi, Lina; Nagano, Atsushi J.] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Nakamura, Yoriyuki] Univ Shizuoka, Sch Food & Nutr Sci, Yada, Shizuoka, Japan	Shizuoka University; Gifu University; Ryukoku University; University of Shizuoka	Ikka, T (corresponding author), Shizuoka Univ, Fac Agr, Shizuoka, Japan.	ikka.takashi@shizuoka.ac.jp	Nagano, Atsushi J./A-2957-2019	Nagano, Atsushi J./0000-0001-7891-5049; Ikka, Takashi/0000-0002-1845-5658	ICHIMURA Foundation For New Technology	ICHIMURA Foundation For New Technology	This work partly supported by The 27th and the 28th Botanical Research Grant of ICHIMURA Foundation For New Technology (http://www.sgkz.or.jp/project/plant/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Freeman H., 1974, Computing Surveys, V6, P57, DOI 10.1145/356625.356627; FURUTA N, 1995, BREEDING SCI, V45, P315; Gunasekare MTK, 2012, TEA PLANT CAMELLIA S, P125; HASHIMOTO M., 1971, Japanese Journal of Tropical Agriculture, V15, P158; HASIMOTO M, 1978, JPN J TROP AGR, V21, P93; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Kubo N, 2019, GENET RESOUR CROP EV, V66, P441, DOI 10.1007/s10722-018-0722-6; Lin C, 2018, INT J STROKE, V13, P8; MATSUMOTO S, 1994, THEOR APPL GENET, V89, P671, DOI 10.1007/BF00223703; Matsumoto S, 2002, THEOR APPL GENET, V104, P998, DOI 10.1007/s00122-001-0806-z; Namita P., 2012, GLOBAL J PHARM, V6, P52; Penjor T, 2016, BREEDING SCI, V66, P797, DOI 10.1270/jsbbs.16059; Peterson BK, 2012, DOUBLE DIGEST RADSEQ, V7, DOI [10.1371/JOURNAL.PONE.0037135, DOI 10.1371/JOURNAL.PONE.0037135]; Pritchard JK, 2000, GENETICS, V155, P945; Raina SN, 2012, GENET RESOUR CROP EV, V59, P1527, DOI 10.1007/s10722-011-9782-6; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Sakaguchi S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0944-0; Sealy JR, 1958, REVISION GENUS CAMEL, P111; Shirasawa K, 2017, SCI REP-UK, V7, DOI 10.1038/srep44207; Shirasawa K, 2016, DNA RES, V23, P145, DOI 10.1093/dnares/dsw004; Stekhoven DJ, 2012, BIOINFORMATICS, V28, P112, DOI 10.1093/bioinformatics/btr597; Tamaki I, 2016, GENET RESOUR CROP EV, V63, P823, DOI 10.1007/s10722-015-0286-7; Tanaka Y, 2012, INTED PROC, P227; Taniguchi F, 2014, TREE GENET GENOMES, V10, P1555, DOI 10.1007/s11295-014-0779-0; Toyao T, 1999, TEA RES J, V87, P39; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wachira F, 2001, J HORTIC SCI BIOTECH, V76, P557; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wei CL, 2018, P NATL ACAD SCI USA, V115, pE4151, DOI 10.1073/pnas.1719622115; Yang HW, 2016, SOC MEDIA SOC, V2, DOI 10.1177/2056305115623802	35	9	9	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220981	10.1371/journal.pone.0220981	http://dx.doi.org/10.1371/journal.pone.0220981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393947	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500089
J	Perez-Benito, FJ; Saez, C; Conejero, JA; Tortajada, S; Valdivieso, B; Garcia-Gomez, JM				Javier Perez-Benito, Francisco; Saez, Carlos; Alberto Conejero, J.; Tortajada, Salvador; Valdivieso, Bernardo; Garcia-Gomez, Juan M.			Temporal variability analysis reveals biases in electronic health records due to hospital process reengineering interventions over seven years	PLOS ONE			English	Article							DATA QUALITY ASSESSMENT; REQUIREMENTS; MORTALITY; FRAMEWORK; TOOL	Objective To evaluate the effects of Process-Reengineering interventions on the Electronic Health Records (EHR) of a hospital over 7 years. Materials and methods Temporal Variability Assessment (TVA) based on probabilistic data quality assessment was applied to the historic monthly-batched admission data of Hospital La Fe Valencia, Spain from 2010 to 2016. Routine healthcare data with a complete EHR was expanded by processed variables such as the Charlson Comorbidity Index. Results Four Process-Reengineering interventions were detected by quantifiable effects on the EHR: (1) the hospital relocation in 2011 involved progressive reduction of admissions during the next four months, (2) the hospital services re-configuration incremented the number of inter-services transfers, (3) the care-services re-distribution led to transfers between facilities (4) the assignment to the hospital of a new area with 80,000 patients in 2015 inspired the discharge to home for follow up and the update of the pre-surgery planned admissions protocol that produced a significant decrease of the patient length of stay. Discussion TVA provides an indicator of the effect of process re-engineering interventions on healthcare practice. Evaluating the effect of facilities' relocation and increment of citizens (findings 1, 3-4), the impact of strategies (findings 2-3), and gradual changes in protocols (finding 4)may help on the hospital management by optimizing interventions based on their effect on EHRs or on data reuse. Conclusions The effects on hospitals EHR due to process re-engineering interventions can be evaluated using the TVA methodology. Being aware of conditioned variations in EHR is of the utmost importance for the reliable reuse of routine hospitalization data.	[Javier Perez-Benito, Francisco; Saez, Carlos; Tortajada, Salvador; Garcia-Gomez, Juan M.] Univ Politecn Valencia, Inst Univ Tecnol Informac & Comunicac Avanzadas I, Biomed Data Sci Lab, Valencia, Spain; [Javier Perez-Benito, Francisco; Alberto Conejero, J.] Univ Politecn Valencia, Inst Univ Matemat Pura & Aplicada, Valencia, Spain; [Tortajada, Salvador; Valdivieso, Bernardo; Garcia-Gomez, Juan M.] Hosp Univ Fe, Inst Invest Sanitaria La Fe, Unidad Conjunta Invest Reingn Proc Sociosanitario, Valencia, Spain; [Tortajada, Salvador; Garcia-Gomez, Juan M.] Red Invest Serv Salud Enfermedades Cron REDISSEC, Valencia, Spain	Universitat Politecnica de Valencia; Universitat Politecnica de Valencia	Conejero, JA (corresponding author), Univ Politecn Valencia, Inst Univ Matemat Pura & Aplicada, Valencia, Spain.	aconejero@upv.es	Martinez, Bernardo Valdivieso/AAB-2922-2019; Pérez-Benito, Francisco Javier/S-2301-2019; Conejero, J. Alberto/A-8589-2008; Sáez, Carlos/AAZ-3748-2020; Sáez, Carlos/AAZ-3935-2020; Tortajada, Salvador/AAB-6037-2020; Garcia-Gomez, Juan M/G-2681-2016	Pérez-Benito, Francisco Javier/0000-0002-6290-5644; Conejero, J. Alberto/0000-0003-3681-7533; Sáez, Carlos/0000-0003-2678-8249; Tortajada, Salvador/0000-0001-7426-2407; Garcia-Gomez, Juan M/0000-0002-3851-1557; Valdivieso, Bernardo/0000-0003-3344-2369	Ministerio de Economia y Competitividad of Spain through MTS4up project (National Plan for Scientific and Technical Research and Innovation 2013-2016) [DPI2016-80054-R]; European Commission project H2020-SC1-2016-CNECT [727560]; European Commission project H2020-SC1-BHC-2018-2020 [825750]; Universitat Politecnica de Valencia, project "ANALISIS DE LA CALIDAD Y VARIABILIDAD DE DATOS MEDICOS"	Ministerio de Economia y Competitividad of Spain through MTS4up project (National Plan for Scientific and Technical Research and Innovation 2013-2016); European Commission project H2020-SC1-2016-CNECT(European CommissionEuropean Commission Joint Research Centre); European Commission project H2020-SC1-BHC-2018-2020(European CommissionEuropean Commission Joint Research Centre); Universitat Politecnica de Valencia, project "ANALISIS DE LA CALIDAD Y VARIABILIDAD DE DATOS MEDICOS"	F.J.P.B, C.S., J.M.G.G. and J.A.C. were funded Universitat Politecnica de Valencia, project "ANALISIS DE LA CALIDAD Y VARIABILIDAD DE DATOS MEDICOS". www.upv.es. J.M.G.G.is also partially supported by: Ministerio de Economia y Competitividad of Spain through MTS4up project (National Plan for Scientific and Technical Research and Innovation 2013-2016, No. DPI2016-80054-R); and European Commission projects H2020-SC1-2016-CNECT Project (No. 727560) and H2020-SC1-BHC-2018-2020 (No. 825750). The funders did not play any role in the study design, data collection and analysis, decision to publish, nor preparation of the manuscript.	Abdulrahman Jabour RM, 2016, CANC REPORTING TIMEL; Aguilar-Saven RS, 2004, INT J PROD ECON, V90, P129, DOI 10.1016/S0925-5273(03)00102-6; Amari S. I., 2000, METHODS INFORM GEOME; Amour  E.A.E.H., 2017, P 18 INT C PAR DISTR, P230, DOI 10.1109/PDCAT.2017.00045; [Anonymous], 2009, INT ETH GUID EP STUD; Anyanwu K, 2003, J RES PRACT INF TECH, V35, P83; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; Ferreira GSA, 2018, BUS PROCESS MANAG J, V24, P400, DOI 10.1108/BPMJ-06-2016-0115; Batini Carlo, 2009, ACM Computing Surveys, V41, DOI 10.1145/1541880.1541883; Brandes U, 2007, LECT NOTES COMPUT SC, V4372, P42; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chou YC, 2012, J MED SYST, V36, P893, DOI 10.1007/s10916-010-9553-5; Dadam P, 2000, BIS 2000, P36; Dale Compton W, 2005, BUILDING BETTER DELI, DOI [10.17226/11378, DOI 10.17226/11378]; Daszykowski M, 2009, COMPREHENSIVE CHEMOMETRICS: CHEMICAL AND BIOCHEMICAL DATA ANALYSIS, VOLS 1-4, pA635; Davison ML, 1983, MULTIDIMENSIONAL SCA, DOI [10.1002/0470018860.s00585, DOI 10.1002/0470018860.S00585]; de Medeiros AK, 2006, LECT NOTES COMPUT SC, V3812, P203; Donaldson MS., 2000, ERR IS HUMAN BUILDIN, P287; Fernandez-Llatas C, 2019, LECT NOTES BUSINESS, P214, DOI [10.1007/978-3-030-11641-5_17, DOI 10.1007/978-3-030-11641-5_17]; Fernandez-Llatas C, 2015, SENSORS-BASEL, V15, P29821, DOI 10.3390/s151229769; Gand K, 2017, CONF BUS INFORM, V1, P471, DOI 10.1109/CBI.2017.36; Heinrich B., 2009, J DATA INFORM QUALIT, V1, P1, DOI [10.1145/1515693.1515697, DOI 10.1145/1515693.1515697]; Hewitt ME, 2000, ENHANCING DATA SYSTE; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Jolliffe IT., 2002, PRINCIPAL COMPONENT, DOI DOI 10.1007/B98835; Kahn MG, 2016, EGEMS GENERATING EVI, V4, DOI DOI 10.13063/2327-9214.1244; Kahn MG, 2012, MED CARE, V50, pS21, DOI 10.1097/MLR.0b013e318257dd67; Lenz R, 2007, DATA KNOWL ENG, V61, P39, DOI 10.1016/j.datak.2006.04.007; Leu JD, 2011, J MED SYST, V35, P409, DOI 10.1007/s10916-009-9376-4; Liaw ST, 2013, INT J MED INFORM, V82, P10, DOI 10.1016/j.ijmedinf.2012.10.001; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Parkin DM, 2009, EUR J CANCER, V45, P756, DOI 10.1016/j.ejca.2008.11.033; Poulymenopoulou M, 2003, J Med Syst, V27, P325, DOI 10.1023/A:1023701219563; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rebuge A, 2012, INFORM SYST, V37, P99, DOI 10.1016/j.is.2011.01.003; Saez C, 2017, STAT METHODS MED RES, V26, P312, DOI 10.1177/0962280214545122; Saez C, 2016, J AM MED INFORM ASSN, V23, P1085, DOI 10.1093/jamia/ocw010; Saez C, 2015, DATA MIN KNOWL DISC, V29, P950, DOI 10.1007/s10618-014-0378-6; Saez C, 2013, IEEE ENG MED BIO, P3226, DOI 10.1109/EMBC.2013.6610228; Saez C, 2012, STUD HEALTH TECHNOL, V180, P721, DOI 10.3233/978-1-61499-101-4-721; Saez Silvestre C, 2016, THESIS, DOI [10.4995/Thesis/10251/62188, DOI 10.4995/THESIS/10251/62188]; Schneeweiss S, 2003, HEALTH SERV RES, V38, P1103, DOI 10.1111/1475-6773.00165; Shim SJ, 2010, BUS PROCESS MANAG J, V16, P795, DOI 10.1108/14637151011076476; Sirgo G, 2018, INT J MED INFORM, V112, P166, DOI 10.1016/j.ijmedinf.2018.02.007; Svolba G, 1999, CONTROL CLIN TRIALS, V20, P519, DOI 10.1016/S0197-2456(99)00029-X; Thomas MC, 2006, ELEMENTS INFORM THEO; Turlach B.A., 1993, BANDWIDTH SELECTION; van der Aalst W, 2004, IEEE T KNOWL DATA EN, V16, P1128, DOI 10.1109/TKDE.2004.47; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Dongen BF, 2005, LECT NOTES COMPUT SC, V3536, P444; Weijters AJMM, PROCESS MINING WITH; Weinberger K. Q., 2004, P 21 INT C MACH LEAR, P106, DOI 10.1145/1015330.1015345; Weiskopf NG, 2013, J AM MED INFORM ASSN, V20, P144, DOI 10.1136/amiajnl-2011-000681	55	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220369	10.1371/journal.pone.0220369	http://dx.doi.org/10.1371/journal.pone.0220369			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390350	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400017
J	Schakel, L; Veldhuijzen, DS; van Middendorp, H; Manai, M; Meeuwis, SH; Van Dessel, P; Evers, AWM				Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Manai, Meriem; Meeuwis, Stefanie H.; Van Dessel, Pieter; Evers, Andrea W. M.			Can verbal suggestions strengthen the effects of a relaxation intervention?	PLOS ONE			English	Article							STRESS-MANAGEMENT INTERVENTION; RESPONSES; PLACEBO; REACTIVITY; REDUCTION; PANAS	Short stress management interventions such as relaxation therapy have demonstrated preliminary effectiveness in reducing stress-related problems. A promising tool to strengthen the effectiveness of relaxation-based interventions is the use of verbal suggestions, as previous research provided evidence that verbal suggestions can induce positive outcome expectancies, facilitate adaptive responses to stress and improve health outcomes. The present experimental proof-of-concept study aimed to investigate the effects of a brief relaxation intervention and specifically the role of verbal suggestions on stress-related outcomes assessed by self-report questionnaires and psychophysiological data. 120 participants (mean age = 22.1 years) were randomized to one of four intervention conditions: a brief relaxation intervention plus verbal suggestions condition, a brief relaxation intervention only condition, a verbal suggestions only condition, and a control condition. Afterwards, participants were subjected to a psychosocial stress challenge to assess reactivity to a stressful event. Immediately after both relaxation interventions (with and without verbal suggestions), lower self-reported state anxiety was found compared to the control condition, but no differences were observed in response to the stressor. The verbal suggestions only condition did not impact state anxiety. No significant effects were found for verbal suggestion interventions on cortisol, alpha amylase, heart rate and skin conductance. This is the first study investigating the role of verbal suggestions in the effectiveness of a brief relaxation intervention. Although this experimental proof-of-concept study provides support for the effectiveness of a brief relaxation intervention in lowering state anxiety directly after the intervention, the effects did not impact the response to a subsequent stressor and we did not observe any evidence for the add-on effectiveness of verbal suggestions. The effectiveness of brief relaxation interventions on stress responses should be investigated further in future research by incorporating interventions that are tailored to the specific stress challenge and various types of verbal suggestions.	[Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Manai, Meriem; Meeuwis, Stefanie H.; Evers, Andrea W. M.] Leiden Univ, Inst Psychol, Fac Social & Behav Sci, Hlth Med & Neu Ropsychol Unit, Leiden, Netherlands; [Schakel, Lemmy; Veldhuijzen, Dieuwke S.; van Middendorp, Henriet; Manai, Meriem; Meeuwis, Stefanie H.; Evers, Andrea W. M.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [Van Dessel, Pieter] Univ Ghent, Dept Expt Clin & Hlth Psychol, Ghent, Belgium; [Evers, Andrea W. M.] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ghent University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schakel, L (corresponding author), Leiden Univ, Inst Psychol, Fac Social & Behav Sci, Hlth Med & Neu Ropsychol Unit, Leiden, Netherlands.; Schakel, L (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	l.schakel@fsw.leidenuniv.nl	Van Dessel, Pieter/Q-1917-2019; Evers, Andrea/GWV-9705-2022	Van Dessel, Pieter/0000-0002-3401-780X; Manai, Meriem/0000-0002-4684-9224; Veldhuijzen, Dieuwke S. (Judy)/0000-0001-9046-1019	European Research Council [ERC-2013-CoG-617700_EXPECT HEAL-TH]; NWO Vici Grant [016.Vici.170.152]	European Research Council(European Research Council (ERC)European Commission); NWO Vici Grant(Netherlands Organization for Scientific Research (NWO))	This study was funded by a European Research Council Consolidator Grant (ERC-2013-CoG-617700_EXPECT HEAL-TH) and a NWO Vici Grant (016.Vici.170.152), both granted to AWME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2014, NEUROSCI BIOBEHAV R, V38, P94, DOI 10.1016/j.neubiorev.2013.11.005; [Anonymous], 1982, TIJDSCHR PSYCHIAT; Bartels DJP, 2016, EUR J PAIN, V20, P8, DOI 10.1002/ejp.750; Blease C, 2016, BIOETHICS, V30, P407, DOI 10.1111/bioe.12245; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 2002, PSYCHOSOM MED, V64, P302, DOI 10.1097/00006842-200203000-00014; Cohen S., 1988, PERCEIVED STRESS PRO; Colloca L, 2011, PHILOS T R SOC B, V366, P1859, DOI 10.1098/rstb.2010.0398; Colloca L, 2011, CURR OPIN PSYCHIATR, V24, P149, DOI 10.1097/YCO.0b013e328343803b; Creswell JD, 2014, PSYCHONEUROENDOCRINO, V44, P1, DOI 10.1016/j.psyneuen.2014.02.007; Cruess DG, 2015, INT J STRESS MANAGE, V22, P270, DOI 10.1037/a0039130; Evers AWM, 2018, PSYCHOTHER PSYCHOSOM, V87, P204, DOI 10.1159/000490354; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Gaab J, 2003, PSYCHONEUROENDOCRINO, V28, P767, DOI 10.1016/S0306-4530(02)00069-0; Hartrick Craig T, 2003, Pain Pract, V3, P310; KERCHER K, 1992, RES AGING, V14, P131, DOI 10.1177/0164027592142001; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McRae AL, 2006, HUM PSYCHOPHARM CLIN, V21, P377, DOI 10.1002/hup.778; Nagele E, 2014, J HYPERTENS, V32, P1936, DOI 10.1097/HJH.0000000000000298; Peerdeman KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139563; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; Richardson KM, 2008, J OCCUP HEALTH PSYCH, V13, P69, DOI 10.1037/1076-8998.13.1.69; Rohrmann S, 2002, PSYCHOL HEALTH, V17, P583, DOI 10.1080/08870440290025795; Rohrmann S, 1999, INT J PSYCHOPHYSIOL, V33, P149, DOI 10.1016/S0167-8760(99)00036-7; Schakel L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201309; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sharma M, 2014, J EVID-BASED INTEGR, V19, P271, DOI 10.1177/2156587214543143; Sjak-Shie EE, 2016, PHYSIODATA TOOLBOX V; Skvortsova A, 2018, PSYCHOSOM MED, V80, P353, DOI 10.1097/PSY.0000000000000571; van Dixhoorn J J, 1999, J Cardiopulm Rehabil, V19, P178, DOI 10.1097/00008483-199905000-00005; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yamakawa K, 2009, BIOL PSYCHOL, V82, P25, DOI 10.1016/j.biopsycho.2009.05.001	33	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220112	10.1371/journal.pone.0220112	http://dx.doi.org/10.1371/journal.pone.0220112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390349	Green Published, gold			2022-12-27	WOS:000484999400011
J	Lee, S; Kang, D				Lee, Sanghoon; Kang, Daekook			Development of interval-valued fuzzy GRA with SERVPERF based on subjective and objective weights for evaluation of airline service quality: A case study of Korea low-cost carriers	PLOS ONE			English	Article							GREY RELATION; CONSUMER PERCEPTIONS; ENTROPY MEASURE; TOPSIS METHOD; VIKOR METHOD; SELECTION; EXTENSION; MODEL; SETS; EXPECTATIONS	As the airline industry has become ever-more competitive and profitability more tenuous, airline service quality management has grown more important to airlines. Although many studies have focused on the evaluation of airline service quality, some common limitations need to be noted. First, traditional fuzzy logics were utilized to present linguistic variables as fuzzy numbers. However, precise quantification of lower and upper bounds with a single number is often difficult; thus, interval-valued fuzzy sets that represent the lower and upper bounds in the fuzzy number as an interval form should be applied instead. Second, while some studies have applied various multiple-criteria decision-making method [MCDM] and the service quality (SERVQUAL) method for evaluation of airline service quality, few have utilized grey relational analysis (GRA, a simple and data-driven MCDM method applicable to environments with incomplete information) and the service performance (SERVPERF), a performance-based measure that can resolve the ambiguity issue of the expectations construct in SERVQUAL. Third, extant studies dealing with the issue of weighting criteria in the evaluation of airline service quality have focused only on either subjective or objective weights, though weighting criteria based on a combined objective/subjective approach would be much better than those just considering the subjective approach. The present study endeavored to fill these literature gaps by developing, for evaluation of airline service quality, interval-valued fuzzy GRA with SERVPERF based on both subjective and objective weights. It contributes to the field by incorporating the 22 criteria from SERVPERF to effectively account for the various characteristics of airline service. Additionally, it is the first study to utilize interval-valued fuzzy GRA together with a novel technique that combines a subjective/objective weighting method for integration of objective decision-matrix-derived information with subjective decision-maker preferences. The supplemental empirical case study of airline service evaluation, further, provides researchers and practitioners with a means of better understanding the proposed approach in the practical perspectives.	[Lee, Sanghoon] Hannam Univ, Coll Business & Econ, Dept Business Adm, Daejeon, South Korea; [Kang, Daekook] Inje Univ, Dept Ind & Management Engn, Gimhae Si, Gyeongsangnam D, South Korea	Hannam University; Inje University	Kang, D (corresponding author), Inje Univ, Dept Ind & Management Engn, Gimhae Si, Gyeongsangnam D, South Korea.	dkkang@inje.ac.kr			2019 Hannam University Research Fund	2019 Hannam University Research Fund	This work was supported by 2019 Hannam University Research Fund.	Abdullah K., 2012, INT J ENG MANAG SCI, V3, P134; Ashtiani B, 2009, APPL SOFT COMPUT, V9, P457, DOI 10.1016/j.asoc.2008.05.005; Awasthi A, 2011, COMPUT IND ENG, V61, P637, DOI 10.1016/j.cie.2011.04.019; Aydin K, 2012, SERB J MANAG, V7, P219, DOI 10.5937/sjm7-1317; BABAKUS E, 1992, J BUS RES, V24, P253, DOI 10.1016/0148-2963(92)90022-4; Bigand A, 2010, FUZZY SET SYST, V161, P96, DOI 10.1016/j.fss.2009.03.010; Bustince H, 2000, FUZZY SET SYST, V113, P205, DOI 10.1016/S0165-0114(98)00020-7; Chen CF, 2008, TRANSPORT RES A-POL, V42, P709, DOI 10.1016/j.tra.2008.01.007; Chen MF, 2004, MATH COMPUT MODEL, V40, P1473, DOI 10.1016/j.mcm.2005.01.006; Chen VYC, 2011, APPL SOFT COMPUT, V11, P265, DOI 10.1016/j.asoc.2009.11.017; Ching-Liang Chang, 1999, Kybernetes, V28, P1072, DOI 10.1108/03684929910300295; Chou CC, 2011, APPL SOFT COMPUT, V11, P2117, DOI 10.1016/j.asoc.2010.07.010; Cornelis C, 2006, FUZZY SET SYST, V157, P622, DOI 10.1016/j.fss.2005.10.007; CRONIN JJ, 1992, J MARKETING, V56, P55, DOI 10.2307/1252296; CRONIN JJ, 1994, J MARKETING, V58, P125, DOI 10.2307/1252256; DENG JL, 1982, SYST CONTROL LETT, V1, P288, DOI 10.1016/S0167-6911(82)80025-X; Deng Julong, 1989, Journal of Grey Systems, V1, P1; Geum Y, 2011, MATH COMPUT MODEL, V54, P3126, DOI 10.1016/j.mcm.2011.07.042; GORZALCZANY MB, 1987, FUZZY SET SYST, V21, P1, DOI 10.1016/0165-0114(87)90148-5; Grzegorzewski P, 2004, FUZZY SET SYST, V148, P319, DOI 10.1016/j.fss.2003.08.005; Guh YY, 2009, COMPUT MATH APPL, V57, P841, DOI 10.1016/j.camwa.2008.09.054; Hong DH, 2002, INFORM SCIENCES, V148, P1, DOI 10.1016/S0020-0255(02)00265-7; Hsu CC, 2013, EXPERT SYST APPL, V40, P2297, DOI 10.1016/j.eswa.2012.10.040; Huang JT, 2003, INT J PROD RES, V41, P1707, DOI 10.1080/1352816031000074973; Jain S. K., 2004, VIKALPA, V29, P25, DOI [10.1177/0256090920040203, DOI 10.1177/0256090920040203]; Kaiquan S, 1990, UNC MOD AN 1990 P 1; Karnik NN, 2001, FUZZY SET SYST, V122, P327, DOI 10.1016/S0165-0114(00)00079-8; Kim YK, 2011, TOURISM MANAGE, V32, P235, DOI 10.1016/j.tourman.2009.12.008; Korenius T, 2007, INFORM SCIENCES, V177, P4893, DOI 10.1016/j.ins.2007.05.027; Kouatli I, 2008, KYBERNETES, V37, P166, DOI 10.1108/03684920810851069; Kuo Y, 2008, COMPUT IND ENG, V55, P80, DOI 10.1016/j.cie.2007.12.002; Lee H, 2014, EXPERT SYST APPL, V41, P3761, DOI 10.1016/j.eswa.2013.12.008; Lee PTW, 2012, EXPERT SYST APPL, V39, P5649, DOI 10.1016/j.eswa.2011.11.052; Li GD, 2007, MATH COMPUT MODEL, V46, P573, DOI 10.1016/j.mcm.2006.11.021; Li XX, 2011, PROCEDIA ENGINEER, V26, DOI 10.1016/j.proeng.2011.11.2410; Liou JJH, 2007, J AIR TRANSP MANAG, V13, P131, DOI 10.1016/j.jairtraman.2006.12.002; Liou JJH, 2011, TOURISM MANAGE, V32, P1381, DOI 10.1016/j.tourman.2011.01.013; Liou JJH, 2011, J AIR TRANSP MANAG, V17, P57, DOI 10.1016/j.jairtraman.2010.03.004; Liu S, 2016, EXPERT SYST APPL, V55, P37, DOI 10.1016/j.eswa.2016.01.059; Mi CM, 2014, KYBERNETES, V43, P601, DOI 10.1108/K-06-2013-0123; Mohsen O, 2017, SAFETY SCI, V92, P160, DOI 10.1016/j.ssci.2016.10.006; PARASURAMAN A, 1988, J RETAILING, V64, P12; PARASURAMAN A, 1994, J MARKETING, V58, P111, DOI 10.1177/002224299405800109; PARASURAMAN A, 1985, J MARKETING, V49, P41, DOI 10.2307/1251430; Quiros P, 2017, INFORM SCIENCES, V418, P421, DOI 10.1016/j.ins.2017.08.041; Shemshadi A, 2011, EXPERT SYST APPL, V38, P12160, DOI 10.1016/j.eswa.2011.03.027; Torlak G, 2011, EXPERT SYST APPL, V38, P3396, DOI 10.1016/j.eswa.2010.08.125; Tsaur SH, 2002, TOURISM MANAGE, V23, P107, DOI 10.1016/S0261-5177(01)00050-4; Vahdani B, 2013, APPL SOFT COMPUT, V13, P165, DOI 10.1016/j.asoc.2012.08.020; VanDyke TP, 1997, MIS QUART, V21, P195, DOI 10.2307/249419; Wang GJ, 1998, FUZZY SET SYST, V98, P331, DOI 10.1016/S0165-0114(96)00368-5; Wang HH, 2012, KYBERNETES, V41, P736, DOI 10.1108/03684921211243383; Wang Q, 2015, J AIR TRANSP MANAG, V42, P55, DOI 10.1016/j.jairtraman.2014.08.003; Wang TC, 2009, EXPERT SYST APPL, V36, P8980, DOI 10.1016/j.eswa.2008.11.035; Wu -H.-H., 2002, QUAL ENG, V15, DOI [10.1081/QEN-120015853, DOI 10.1081/QEN-120015853]; Yager RR, 2008, INFORM SCIENCES, V178, P3565, DOI 10.1016/j.ins.2008.05.022; Yang CC, 2006, J MANUF TECHNOL MANA, V17, P926, DOI 10.1108/17410380610688241; ZADEH LA, 1975, INFORM SCIENCES, V8, P199, DOI [10.1016/0020-0255(75)90036-5, 10.1016/0020-0255(75)90046-8]; Zeithaml V., 1990, DELIVERING QUALITY S; Zhao R, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8010079; Zitnick CL, 2004, P 20 C UNC ART INT	61	4	4	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219739	10.1371/journal.pone.0219739	http://dx.doi.org/10.1371/journal.pone.0219739			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5CU	31386667	gold, Green Published, Green Submitted			2022-12-27	WOS:000484997100007
J	Ren, JC; Cui, JP; Luo, MK; Liu, H; Hao, PF; Wang, X; Zhang, GH				Ren, Jingchao; Cui, Jun-peng; Luo, Mengkai; Liu, Huan; Hao, Pengfei; Wang, Xiao; Zhang, Guang-hui			The prevalence and persistence of aberrant promoter DNA methylation in benzene-exposed Chinese workers	PLOS ONE			English	Article							REPAIR GENES; MICRONUCLEUS FREQUENCIES; HYPOMETHYLATION; RISK; MGMT; LEUKEMIA; DAMAGE; LEVEL; HMLH1; GENOTOXICITY	Aberrant DNA methylation patterns are common in cancers and environmental pollutant exposed subjects. Up to date, few studies have examined the aberrant DNA methylation patterns in benzene exposed workers. We recruited 141 benzene-exposed workers, including 83 benzene-exposed workers from a shoe factory in Wenzhou and 58 workers from a painting workshop in Wuhu, 35 workers in Wuhu were followed from 2009 to 2013, and 48 indoor workers as controls from Wenzhou. We used high-resolution melting (HRM) to quantitate human samples of DNA methylation in long interspersed nuclear element-1 (LINE-1), (6)-methylguanine-DNA methyltransferase (MGMT), and DNA mismatch repair gene human mutator L homologue 1 (hMLH1). AML-5 cells were treated with benzoquinone (BQ) and hydroquinone (HQ), and the promoter methylation of MGMT and hMLH1 was detected using the bisulfite sequencing PCR method. The degree of LINE-1 methylation in benzene-exposed workers was significantly lower than that of the controls (p<0.001), and the degree of MGMT (p<0.001) and hMLH1 (p = 0.01) methylation was significantly higher than that of the controls. The in vitro study validated the aberrant hypermethylation of hMLH1 after treatment with BQ. Among the cohort workers who were followed from 2009 to 2013, the LINE1 methylation elevated in 2013 than 2009 (p = 0.004), and premotor methylation in hMLH1 reduced in 2013 than 2009 (p = 0.045) with the reduction of the benzene exposure. This study provides evidence that benzene exposure can induce LINE-1 hypomethylation and DNA repair gene hypermethylation.	[Ren, Jingchao; Cui, Jun-peng; Luo, Mengkai; Liu, Huan; Wang, Xiao; Zhang, Guang-hui] Xinxiang Med Univ, Sch Publ Hlth, Henan Int Collaborat Lab Hlth Effects & Intervent, Med, Xinxiang, Henan, Peoples R China; [Hao, Pengfei] Xinxiang Ctr Dis Control & Prevent, Xinxiang, Henan, Peoples R China	Xinxiang Medical University	Wang, X; Zhang, GH (corresponding author), Xinxiang Med Univ, Sch Publ Hlth, Henan Int Collaborat Lab Hlth Effects & Intervent, Med, Xinxiang, Henan, Peoples R China.	whz@xxmu.edu.cn; zhgh221@163.com			National Natural Science Foundation of China [NSFC 81602836]; Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine [XTCX-2015-PY3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine	This work was supported by the National Natural Science Foundation of China (NSFC 81602836), and the Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine (XTCX-2015-PY3).; We sincerely thank Professor Xia Zhao-lin for his help on this work! This work was supported by the National Natural Science Foundation of China (NSFC 81602836), the Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine (XTCX-2015-PY3).	Aporntewan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017934; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Candiloro ILM, 2011, EPIGENETICS-US, V6, P501, DOI 10.4161/epi.6.4.14853; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Deng GR, 1999, CANCER RES, V59, P2029; Derks S, 2006, CELL ONCOL, V28, P247; Duan HW, 2013, ARCH TOXICOL, V87, P2013, DOI 10.1007/s00204-013-1046-0; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Esteller M, 2004, ONCOGENE, V23, P1, DOI 10.1038/sj.onc.1207316; Felsberg J, 2011, INT J CANCER, V129, P659, DOI 10.1002/ijc.26083; Fenech M, 2005, METH MOLEC MED, V111, P3; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; FENECH M, 1993, MUTAT RES, V285, P35, DOI 10.1016/0027-5107(93)90049-L; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Glass DC, 2003, EPIDEMIOLOGY, V14, P569, DOI 10.1097/01.ede.0000082001.05563.e0; Goethel G, 2014, MUTAT RES-GEN TOX EN, V770, P61, DOI 10.1016/j.mrgentox.2014.05.008; Hornung R W, 1989, Toxicol Ind Health, V5, P1153; Hu JJ, 2014, ENVIRON TOXICOL, V29, P108, DOI 10.1002/tox.20777; Ji F, 2010, CARCINOGENESIS, V31, P648, DOI 10.1093/carcin/bgq015; Ji Z, 2010, LEUKEMIA, V24, P986, DOI 10.1038/leu.2010.43; Kristensen LS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn113; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Lewis C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202462; Li J, 2017, BIOMARKERS, V22, P470, DOI 10.1080/1354750X.2016.1274335; Lovreglio P, 2014, MUTAT RES-GEN TOX EN, V770, P55, DOI 10.1016/j.mrgentox.2014.04.022; Malentacchi F, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp383; McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Psofaki V, 2010, WORLD J GASTROENTERO, V16, P3553, DOI 10.3748/wjg.v16.i28.3553; Rinsky RA, 2002, AM J IND MED, V42, P474, DOI 10.1002/ajim.10138; RINSKY RA, 1987, NEW ENGL J MED, V316, P1044, DOI 10.1056/NEJM198704233161702; Rota F, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040735; Schiffman C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205427; Seow WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050471; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Toyooka S, 2003, CLIN CANCER RES, V9, P3034; Tse M Yat, 2011, BMC Res Notes, V4, P565, DOI 10.1186/1756-0500-4-565; Vlaanderen J, 2011, ENVIRON HEALTH PERSP, V119, P159, DOI 10.1289/ehp.1002318; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013; Wojdacz TK, 2010, EXPERT REV MOL DIAGN, V10, P575, DOI [10.1586/erm.10.46, 10.1586/ERM.10.46]; Wu F, 2013, INT J OCCUP MED ENV, V26, P173, DOI 10.2478/S13382-013-0079-1; Zhang C, 2013, TOXICOL APPL PHARM, V271, P78, DOI 10.1016/j.taap.2013.04.025; Zhang GH, 2017, ENVIRON MOL MUTAGEN, V58, P678, DOI 10.1002/em.22136; Zhang GH, 2016, J OCCUP ENVIRON MED, V58, pE39, DOI 10.1097/JOM.0000000000000639; Zhang GH, 2014, INT J HYG ENVIR HEAL, V217, P726, DOI 10.1016/j.ijheh.2014.03.003; Zhang HG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199689	48	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220500	10.1371/journal.pone.0220500	http://dx.doi.org/10.1371/journal.pone.0220500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381583	Green Submitted, gold, Green Published			2022-12-27	WOS:000484993600019
J	Adams, B; Fidler, K; Demoes, N; Aguiar, EJ; Ducharme, SW; McCullough, AK; Moore, CC; Tudor-Locke, C; Thomas, D				Adams, Bryan; Fidler, Katie; Demoes, Noah; Aguiar, Elroy J.; Ducharme, Scott W.; McCullough, Aston K.; Moore, Christopher C.; Tudor-Locke, Catrine; Thomas, Diana			Cardiometabolic thresholds for peak 30-min cadence and steps/day	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; METABOLIC SYNDROME; STEPPING CADENCE; RISK; ACCUMULATION; ADULTS; HEALTH	Purpose To provide empirically-supported thresholds for step-based intensity (i.e., peak 30-min cadence; average of the top 30 steps/min in a day) and steps/day in relation to cardiometabolic health outcomes. Methods Receiver operating characteristic curve analysis was applied to the National Health and Nutrition Examination Survey (NHANES) 2005-2006 accelerometer-derived step data to determine steps/day and peak 30-min cadence as risk screening values (i.e., thresholds) for fasting glucose, body mass index, waist circumference, high blood pressure, triglycerides, and HDL cholesterol. Thresholds for peak 30-min cadence and steps/day were derived that, when exceeded, classify the absence of each cardiometabolic risk factor. Additionally, logistic regression models that included the influence of age and smoking were developed using the sample weights, primary sampling units (PSUs), and stratification variables provided by the NHANES survey. Finally, a decision tree analysis was performed to delineate criteria for at-risk versus healthy populations using cadence bands. Results Peak 30-min cadence thresholds across cardiometabolic outcomes ranged from 66-72 steps/min. Steps/day thresholds ranged from 4325-6192 steps/day. Higher thresholds were observed in men compared to women. In men, higher steps/day thresholds were observed in age ranges of 30- 39, while in women, higher thresholds were observed in the age-range 50-59 years. Decision trees for classifying being at low risk for metabolic syndrome contained one risk-free leaf at higher cadence bands, specifically for any time accumulated at >= 120 steps/min. Conclusions Minimum thresholds representing absence of cardiometabolic risk range from 4325-6192 steps/day and 66-72 steps/min for peak 30-min cadence. Any time accumulated at >= 120 steps/min was associated with an absence of cardiometabolic risk. Although based on cross-sectional data, these thresholds represent potentially important and clinically interpretable daily physical activity goals.	[Adams, Bryan; Fidler, Katie; Demoes, Noah; Thomas, Diana] US Mil Acad, Dept Math Sci, West Point, NY 10996 USA; [Aguiar, Elroy J.; Ducharme, Scott W.; McCullough, Aston K.; Moore, Christopher C.; Tudor-Locke, Catrine] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Dept Kinesiol, Amherst, MA 01003 USA	United States Department of Defense; United States Army; United States Military Academy; University of Massachusetts System; University of Massachusetts Amherst	Thomas, D (corresponding author), US Mil Acad, Dept Math Sci, West Point, NY 10996 USA.	diana.thomas@usma.edu	Tudor-Locke, Catrine/AAC-2829-2021	Aguiar, Elroy/0000-0003-4763-0491; Moore, Christopher/0000-0001-6027-1732; Thomas, Diana/0000-0003-2641-9304				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; [Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; [Anonymous], 2018, INTRO RECURSIVE PART; [Anonymous], 2018, 2018 PHYSICAL ACTIVI; Barreira TV, 2016, J SCI MED SPORT, V19, P227, DOI 10.1016/j.jsams.2015.01.008; Breiman L, 1993, CLASSIFICATION REGRE; Centers for Disease Control and Prevention, 2020, ADOLESCENT HEALTH; Dall PM, 2013, MED SCI SPORT EXER, V45, P1995, DOI 10.1249/MSS.0b013e3182955780; Fuzeki E, 2017, SPORTS MED, V47, P1769, DOI 10.1007/s40279-017-0724-0; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gennuso KP, 2015, DIABETOLOGIA, V58, P485, DOI 10.1007/s00125-014-3453-z; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Lee IM, 2019, JAMA INTERN MED, V179, P1105, DOI 10.1001/jamainternmed.2019.0899; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; National Health and Nutrition Examination Survey (NHANES), 2016, ANTHR PROC MAN; Rowlands AV, 2007, MED SCI SPORT EXER, V39, P716, DOI 10.1249/mss.0b013e318031126c; Schuna JM, 2013, MED SCI SPORT EXER, V45, P914, DOI 10.1249/MSS.0b013e31827e47ac; Sisson SB, 2010, AM J PREV MED, V38, P575, DOI 10.1016/j.amepre.2010.02.015; Toth LP, 2018, MED SCI SPORT EXER, V50, P1315, DOI 10.1249/MSS.0000000000001569; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2008, J PHYS ACT HEALTH, V5, pS126, DOI 10.1123/jpah.5.s1.s126; Tudor-Locke C, 2017, MED SCI SPORT EXER, V49, P283, DOI 10.1249/MSS.0000000000001100; Tudor-Locke C, 2012, J PHYS ACT HEALTH, V9, P1125, DOI 10.1123/jpah.9.8.1125; Tudor-Locke C, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110332; Tudor-Locke C, 2012, SPORTS MED, V42, P381, DOI 10.2165/11599170-000000000-00000; Tudor-Locke C, 2011, PREV MED, V53, P178, DOI 10.1016/j.ypmed.2011.06.004; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c; Westerterp KR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00090; Williams PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078777; 2000, OBESITY PREVENTING M	34	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0219933	10.1371/journal.pone.0219933	http://dx.doi.org/10.1371/journal.pone.0219933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374078	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500003
J	Sharma, S; Tomar, S; Dharne, M; Ganesan, V; Smith, A; Yang, YF; Waggoner, L; Wang, YH; Hogan, SP				Sharma, Sribava; Tomar, Sunil; Dharne, Mayuri; Ganesan, Varsha; Smith, Andrew; Yang, Yanfen; Waggoner, Lisa; Wang, Yui-Hsi; Hogan, Simon P.			Deletion of Delta dblGata motif leads to increased predisposition and severity of IgE-mediated food-induced anaphylaxis response	PLOS ONE			English	Article							FC-EPSILON-RI; ERYTHROID TRANSCRIPTION FACTOR; MAST-CELL DIFFERENTIATION; FACTOR GATA-1; EXPRESSION; EOSINOPHILS; RECEPTOR; ALLERGY; PROMOTER; ROLES	Background Previous studies have revealed an important role for the transcription factor GATA-1 in mast cell maturation and degranulation. However, there have been conflicting reports with respect to the requirement of GATA-1 function in mast cell dependent inflammatory processes. Herein, we examine the requirement of GATA-1 signaling in mast cell effector function and IgE-mast cell-dependent anaphylaxis. Objective To study the requirement of GATA-1 dependent signaling in the development and severity of IgE-mast cell-dependent anaphylaxis in mice. Methods Wild type (Balb/c) and mutant Delta dblGata (Balb/c) mice were employed to study the role of GATA-1 signaling in in vitro IgE-mediated activation of bone marrow derived mast cells (BMMCs). Murine models of passive IgE-mediated and oral antigen-induced IgE-mediated anaphylaxis were employed in mice. Frequency of steady state mast cells in various tissues (duodenum, ear, and tongue), peritoneal cavity, and clinical symptoms (diarrhea, shock, and mast cell activation) and intestinal Type 2 immune cell analysis including CD4(+) Th-2 cells, type 2 innate lymphoid cells (ILC2), and IL-9 secreting mucosal mast cells (MMC9) were assessed Results In vitro analysis revealed that Delta dblGata BMMCs exhibit a reduced maturation rate, decreased expression of Fc epsilon RI alpha, and degranulation capacity when compared to their wildtype (WT) counterparts. These in vitro differences did not impact tissue resident mast cell numbers, total IgE, and susceptibility to or severity of IgE-mediated passive anaphylaxis. Surprisingly, Delta dblGata mice were more susceptible to IgE-mast cell-mediated oral antigen induced anaphylaxis. The increased allergic response was associated with increased Type 2 immunity (antigen-specific IgE, and CD4(+) T(H)2 cells), MMC9 cells and small intestine (SI) mast cell load. Conclusion Diminished GATA-1 activity results in reduced in vitro mast cell Fc epsilon RI alpha expression, proliferation, and degranulation activity. However, in vivo, diminished GATA-1 activity results in normal homeostatic tissue mast cell levels and increased antigen-induced CD4(+) Th2 and iMMC9 cell levels and heightened IgE-mast cell mediated reactions.	[Sharma, Sribava; Tomar, Sunil; Dharne, Mayuri; Ganesan, Varsha; Smith, Andrew; Yang, Yanfen; Waggoner, Lisa; Wang, Yui-Hsi; Hogan, Simon P.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol,Coll Med, Cincinnati, OH 45221 USA; [Sharma, Sribava] Univ Cincinnati, Dept Pediat, Immunobiol Grad Program, Div Immunobiol,Coll Med, Cincinnati, OH USA; [Tomar, Sunil; Ganesan, Varsha; Hogan, Simon P.] Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, Michigan Med, Ann Arbor, MI 48109 USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; University of Cincinnati; University of Michigan System; University of Michigan	Hogan, SP (corresponding author), Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol,Coll Med, Cincinnati, OH 45221 USA.; Hogan, SP (corresponding author), Univ Michigan, Dept Pathol, Mary H Weiser Food Allergy Ctr, Michigan Med, Ann Arbor, MI 48109 USA.	sihogan@med.umich.edu		Sharma, Sribava/0000-0001-5562-1179	DoD [W81XWH-15-1-051730]; NIH [R01 AI073553, DK090119]; Mary H Weiser Food Allergy Center; MFARA; Food Allergy Research Education	DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary H Weiser Food Allergy Center; MFARA; Food Allergy Research Education	This work was supported by DoD W81XWH-15-1-051730, NIH R01 AI073553 and DK090119, Mary H Weiser Food Allergy Center, MFARA and Food Allergy Research & Education (S.P.H.).	Ahrens R, 2012, AM J PATHOL, V180, P1535, DOI 10.1016/j.ajpath.2011.12.036; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Baba Y, 2012, ALLERGOL INT, V61, P461, DOI 10.2332/allergolint.12-OA-0424; Barnstein BO, 2006, J IMMUNOL, V177, P3421, DOI 10.4049/jimmunol.177.5.3421; Bartnikas LM, 2013, J ALLERGY CLIN IMMUN, V131, P451, DOI 10.1016/j.jaci.2012.11.032; Benede S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190453; Berin MC, 2015, CLIN EXP ALLERGY, V45, P1483, DOI 10.1111/cea.12598; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Brown SGA, 2013, J ALLERGY CLIN IMMUN, V132, P1141, DOI 10.1016/j.jaci.2013.06.015; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Deo SS, 2010, LUNG INDIA, V27, P66, DOI 10.4103/0970-2113.63609; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Elishmereni M, 2013, ALLERGY, V68, P171, DOI 10.1111/all.12059; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Forbes E, 2004, GASTROENTEROLOGY, V127, P105, DOI 10.1053/j.gastro.2004.03.057; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gupta R, 2013, JAMA PEDIATR, V167, P1026, DOI 10.1001/jamapediatrics.2013.2376; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hogan SP, 2012, SEMIN IMMUNOPATHOL, V34, P643, DOI 10.1007/s00281-012-0320-1; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Hussain M, 2018, J ALLERGY CLIN IMMUN, V141, P223, DOI 10.1016/j.jaci.2017.02.035; Inage E, 2014, J IMMUNOL, V192, P3936, DOI 10.4049/jimmunol.1302366; Khodoun MV, 2013, J ALLERGY CLIN IMMUN, V131, P1555, DOI 10.1016/j.jaci.2013.02.043; Koyasu S, 2011, IMMUNOLOGY, V132, P475, DOI 10.1111/j.1365-2567.2011.03413.x; Kuehn Hye Sun, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0738s91; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Kweon MN, 2000, J CLIN INVEST, V106, P199, DOI 10.1172/JCI8490; Li XM, 1999, J ALLERGY CLIN IMMUN, V103, P206, DOI 10.1016/S0091-6749(99)70492-6; Li Y, 2017, J ALLERGY CLIN IMMUN, V24, P32917; Li YP, 2018, J ALLERGY CLIN IMMUN, V142, P1173, DOI 10.1016/j.jaci.2017.10.043; MacGlashan D, 2008, CURR OPIN IMMUNOL, V20, P717, DOI 10.1016/j.coi.2008.08.004; Maeda K, 2003, J IMMUNOL, V170, P334, DOI 10.4049/jimmunol.170.1.334; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Minai-Fleminger Y, 2010, CELL TISSUE RES, V341, P405, DOI 10.1007/s00441-010-1010-8; Morii E, 2004, BLOOD, V104, P1656, DOI 10.1182/blood-2004-01-0247; Nei Y, 2013, P NATL ACAD SCI USA, V110, P18620, DOI 10.1073/pnas.1311668110; Nishiyama C, 1999, J IMMUNOL, V163, P623; Nishiyama C, 2005, INT IMMUNOL, V17, P847, DOI 10.1093/intimm/dxh278; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, P1390, DOI 10.1016/j.jaci.2014.01.021; Ohmori S, 2015, BLOOD, V125, P3306, DOI 10.1182/blood-2014-11-612465; Ohneda K, 2014, MOL CELL BIOL, V34, P1812, DOI 10.1128/MCB.01524-13; Osterfeld H, 2010, J ALLERGY CLIN IMMUN, V125, P469, DOI 10.1016/j.jaci.2009.09.054; Piliponsky AM, 2001, J ALLERGY CLIN IMMUN, V107, P993, DOI 10.1067/mai.2001.114656; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Strait RT, 2003, J IMMUNOL, V170, P3835, DOI 10.4049/jimmunol.170.7.3835; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Wakabayashi J, 2003, GENES CELLS, V8, P619, DOI 10.1046/j.1365-2443.2003.00658.x; Yamani A, 2018, J ALLERGY CLIN IMMUN, V142, P1159, DOI 10.1016/j.jaci.2017.08.046; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; ZON LI, 1991, J BIOL CHEM, V266, P22948	61	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219375	10.1371/journal.pone.0219375	http://dx.doi.org/10.1371/journal.pone.0219375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369572	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900013
J	Leader, CJ; Moharram, M; Coffey, S; Sammut, IA; Wilkins, GW; Walker, RJ				Leader, Catherine J.; Moharram, Mohammed; Coffey, Sean; Sammut, Ivan A.; Wilkins, Gerard W.; Walker, Robert J.			Myocardial global longitudinal strain: An early indicator of cardiac interstitial fibrosis modified by spironolactone, in a unique hypertensive rat model	PLOS ONE			English	Article							SPECKLE TRACKING ECHOCARDIOGRAPHY; LEFT-VENTRICULAR HYPERTROPHY; PRESERVED EJECTION FRACTION; HEART-FAILURE; MINERALOCORTICOID RECEPTOR; TRANSGENIC RATS; CARDIOVASCULAR-DISEASE; SYSTOLIC FUNCTION; ANGIOTENSIN-II; ALDOSTERONE	Objectives Is global longitudinal strain (GLS) a more accurate non-invasive measure of histological myocardial fibrosis than left ventricular ejection fraction (LVEF) in a hypertensive rodent model. Background Hypertension results in left ventricular hypertrophy and cardiac dysfunction. Speckle-tracking echocardiography has emerged as a robust technique to evaluate cardiac function in humans compared with standard echocardiography. However, its use in animal studies is less clearly defined. Methods Cyp1a1Ren2 transgenic rats were randomly assigned to three groups; normotensive, untreated hypertensive or hypertensive with daily administration of spironolactone (human equivalent dose of 50 mg/day). Cardiac function and interstitial fibrosis development were monitored for three months. Results The lower limit of normal LVEF was calculated to be 75%. After three months hypertensive animals (196 +/- 21 mmHg systolic blood pressure (SBP)) showed increased cardiac fibrosis (8.8 +/- 3.2% compared with 2.4 +/- 0.7% % in normals), reduced LVEF (from 81 +/- 2% to 67 +/- 7%) and impaired myocardial GLS (from -17 +/- 2% to -11 +/- 2) (all p<0.001). Myocardial GLS demonstrated a stronger correlation with cardiac interstitial fibrosis (r(2) = 0.58, p<0.0001) than LVEF (r(2) = 0.37, p<0.006). Spironolactone significantly blunted SBP elevation (184 +/- 15, p<0.01), slowed the progression of cardiac fibrosis (4.9 +/- 1.4%, p<0.001), reduced the decline in LVEF (72 +/- 4%, p<0.05) and the degree of impaired myocardial GLS (-13 +/- 1%, p<0.01) compared to hypertensive animals. Conclusions This study has demonstrated that, myocardial GLS is a more accurate non-invasive measure of histological myocardial fibrosis compared to standard echocardiography, in an animal model of both treated and untreated hypertension. Spironolactone blunted the progression of cardiac fibrosis and deterioration of myocardial GLS.	[Leader, Catherine J.; Moharram, Mohammed; Coffey, Sean; Wilkins, Gerard W.; Walker, Robert J.] Univ Otago, Dept Med, Dunedin, New Zealand; [Sammut, Ivan A.] Univ Otago, Dept Pharmacol, Dunedin, New Zealand	University of Otago; University of Otago	Walker, RJ (corresponding author), Univ Otago, Dept Med, Dunedin, New Zealand.	rob.walker@otago.ac.nz	Walker, Robert J/B-1498-2010; Moharram, Mohammed/AAR-1999-2021	Walker, Robert J/0000-0003-3366-0956; Sammut, Ivan/0000-0002-9217-9452; Coffey, Sean/0000-0003-2312-4666	Department of Medicine University of Otago, New Zealand; Otago Medical Research Foundation Otago, New Zealand; Healthcare Otago Charitable Trust Otago, New Zealand; New Zealand Lottery Grants Board; Maurice and Phyllis Paykel Trust New Zealand	Department of Medicine University of Otago, New Zealand; Otago Medical Research Foundation Otago, New Zealand; Healthcare Otago Charitable Trust Otago, New Zealand; New Zealand Lottery Grants Board; Maurice and Phyllis Paykel Trust New Zealand	Funding was provided by the Department of Medicine University of Otago, New Zealand (CL), a Laurenson Award from the Otago Medical Research Foundation Otago, New Zealand (IS, RW), the Healthcare Otago Charitable Trust Otago, New Zealand (RW), the New Zealand Lottery Grants Board (IS, GW, RW) and the Maurice and Phyllis Paykel Trust New Zealand (CL, RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachner-Hinenzon N, 2010, AM J PHYSIOL-HEART C, V299, pH664, DOI 10.1152/ajpheart.00017.2010; Bader M, 2000, EXP PHYSIOL, V85, P713; Baldo MP, 2011, PHARMACOL REP, V63, P975, DOI 10.1016/S1734-1140(11)70613-2; Bauer M, 2011, CIRC RES, V108, P908, DOI 10.1161/CIRCRESAHA.110.239574; Bauersachs J, 2015, HYPERTENSION, V65, P257, DOI 10.1161/HYPERTENSIONAHA.114.04488; Bhan A, 2014, AM J PHYSIOL-HEART C, V306, pH1371, DOI 10.1152/ajpheart.00553.2013; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; BRILLA CG, 1993, J MOL CELL CARDIOL, V25, P563, DOI 10.1006/jmcc.1993.1066; BRILLA CG, 1993, AM J CARDIOL, V71, pA12, DOI 10.1016/0002-9149(93)90239-9; Catena C, 2012, AM J CARDIOVASC DIS, V2, P50; Colussi G, 2013, J HYPERTENS, V31, P3, DOI 10.1097/HJH.0b013e3283599b6a; CRAWFORD DC, 1994, CIRC RES, V74, P727, DOI 10.1161/01.RES.74.4.727; Gomes AC, 2013, HEART FAIL REV, V18, P219, DOI 10.1007/s10741-012-9305-3; Gonzalez A, 2004, MED CLIN N AM, V88, P83, DOI 10.1016/S0025-7125(03)00125-1; Howard CG, 2012, AM J PHYSIOL-RENAL, V302, pF52, DOI 10.1152/ajprenal.00187.2011; Howard CG, 2010, AM J MED SCI, V339, P543, DOI 10.1097/MAJ.0b013e3181d82a62; Ishizu T, 2014, HYPERTENSION, V63, P500, DOI 10.1161/HYPERTENSIONAHA.113.02149; Kahan T, 2005, HEART, V91, P250, DOI 10.1136/hrt.2004.042473; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Kantachuvesiri S, 2001, J BIOL CHEM, V276, P36727, DOI 10.1074/jbc.M103296200; Koshizuka R, 2013, J AM SOC ECHOCARDIOG, V26, P316, DOI 10.1016/j.echo.2012.11.015; Krieger EM, 2018, HYPERTENSION, V71, P681, DOI 10.1161/HYPERTENSIONAHA.117.10662; Krishnasamy R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127044; Kuroda K, 2015, J MOD POWER SYST CLE, V3, P41, DOI 10.1007/s40565-015-0096-0; Lacolley P, 2001, J AM COLL CARDIOL, V37, P662, DOI 10.1016/S0735-1097(00)01129-3; Lal A, 2005, J MOL CELL CARDIOL, V39, P521, DOI 10.1016/j.yjmcc.2005.05.002; Leader C., 2018, COMPARATIVE MED, V68, P1; Markowitz M, 2012, CLIN CARDIOL, V35, P605, DOI 10.1002/clc.22025; Matyas C, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-017-0645-0; Medvedofsky D, 2018, JACC-CARDIOVASC IMAG, V11, P1569, DOI 10.1016/j.jcmg.2017.08.023; Messaoudi S, 2012, MOL CELL ENDOCRINOL, V350, P266, DOI 10.1016/j.mce.2011.06.038; Mitchell KD, 2006, J RENIN-ANGIO-ALDO S, V7, P74, DOI 10.3317/jraas.2006.013; Mulder P, 2008, EUR HEART J, V29, P2171, DOI 10.1093/eurheartj/ehn277; Nagata K, 2006, HYPERTENSION, V47, P656, DOI 10.1161/01.HYP.0000203772.78696.67; Nagata K, 2008, CURR HYPERTENS REP, V10, P216, DOI 10.1007/s11906-008-0041-y; Oktay AA, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0545-9; Peters B, 2008, J HYPERTENS, V26, P102, DOI 10.1097/HJH.0b013e3282f0ab66; Peters BS, 2010, J CELL MOL MED, V14, P1318, DOI 10.1111/j.1582-4934.2009.00778.x; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 2014, NEW ENGL J MED, V370, P1383, DOI 10.1056/NEJMoa1313731; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; ROBERT V, 1994, HYPERTENSION, V24, P30, DOI 10.1161/01.HYP.24.1.30; Rocha R, 1998, HYPERTENSION, V31, P451, DOI 10.1161/01.HYP.31.1.451; Shah AM, 2015, CIRCULATION, V132, P402, DOI 10.1161/CIRCULATIONAHA.115.015884; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Stokke TM, 2017, J AM COLL CARDIOL, V70, P942, DOI 10.1016/j.jacc.2017.06.046; Sun Y, 1997, CARDIOVASC RES, V35, P138, DOI 10.1016/S0008-6363(97)00097-7; Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9; Tanaka-Esposito C, 2014, J CARDIOVASC ELECTR, V25, P537, DOI 10.1111/jce.12379; Tesch GH, 2017, FRONT PHARMACOL, V8, P1; Valero-Munoz Maria, 2017, JACC Basic Transl Sci, V2, P770, DOI 10.1016/j.jacbts.2017.07.013; Voigt JU, 2015, EUR HEART J-CARD IMG, V16, P1, DOI 10.1093/ehjci/jeu184; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; WEBER KT, 1994, HYPERTENSION, V23, P869, DOI 10.1161/01.HYP.23.6.869; Whalley GA, 2018, JACC-CARDIOVASC IMAG, V11, P1580, DOI 10.1016/j.jcmg.2017.11.003; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492	58	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220837	10.1371/journal.pone.0220837	http://dx.doi.org/10.1371/journal.pone.0220837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404095	gold, Green Published, Green Submitted			2022-12-27	WOS:000485006800036
J	White, Z; Milad, N; Tehrani, AY; Chen, WWH; Donen, G; Sellers, SL; Bernatchez, P				White, Zoe; Milad, Nadia; Tehrani, Arash Y.; Chen, William Wei-Han; Donen, Graham; Sellers, Stephanie L.; Bernatchez, Pascal			Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B	PLOS ONE			English	Article							SKELETAL-MUSCLE; GROWTH-FACTOR; MIYOSHI MYOPATHY; LIPID PROFILE; DYSFUNCTION; MICE; PROGRESSION; GENE; DIFFERENTIATION; HYPERTENSION	There is no cure or beneficial management option for Limb-Girdle muscular dystrophy (MD) type 2B (LGMD2B). Losartan, a blood pressure (BP) lowering angiotensin II (AngII) receptor type 1 (ATR1) blocker (ARB) with unique anti-transforming growth factor-beta (TGF-beta) properties, can protect muscles in various types of MD such as Duchenne MD, suggesting a potential benefit for LGMD2B patients. Herein, we show in a mild, dysferlin-null mouse model of LGMD2B that losartan increased quadriceps muscle fibrosis (142%; P<0.0001). In a severe, atherogenic diet-fed model of LGMD2B recently described by our group, losartan further exacerbated dysferlin-null mouse muscle wasting in quadriceps and triceps brachii, two muscles typically affected by LGMD2B, by 40% and 51%, respectively (P<0.05). Lower TGF-beta signalling was not observed with losartan, therefore plasma levels of atherogenic lipids known to aggravate LGMD2B severity were investigated. We report that losartan increased both plasma triglycerides and cholesterol concentrations in dysferlin-null mice. Other protective properties of losartan, such as increased nitric oxide release and BP lowering, were also reduced in the absence of dysferlin expression. Our data suggest that LGMD2B patients may show some resistance to the primary BP-lowering effects of losartan along with accelerated muscle wasting and dyslipidemia. Hence, we urge caution on the use of ARBs in this population as their ATR1 pathway may be dysfunctional.	[White, Zoe; Milad, Nadia; Tehrani, Arash Y.; Chen, William Wei-Han; Donen, Graham; Sellers, Stephanie L.; Bernatchez, Pascal] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [White, Zoe; Milad, Nadia; Tehrani, Arash Y.; Chen, William Wei-Han; Donen, Graham; Sellers, Stephanie L.; Bernatchez, Pascal] UBC Ctr Heart Lung Innovat, Vancouver, BC, Canada; [White, Zoe; Milad, Nadia; Tehrani, Arash Y.; Chen, William Wei-Han; Donen, Graham; Sellers, Stephanie L.; Bernatchez, Pascal] St Pauls Hosp, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan	White, Z; Bernatchez, P (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada.; White, Z; Bernatchez, P (corresponding author), UBC Ctr Heart Lung Innovat, Vancouver, BC, Canada.; White, Z; Bernatchez, P (corresponding author), St Pauls Hosp, Vancouver, BC, Canada.	zoe.white@hli.ubc.ca; pascal.bematchez@ubc.ca		Sellers, Stephanie/0000-0002-3539-5730; Chen, William Wei-Han/0000-0002-9755-1428; Milad, Nadia/0000-0002-1497-8224	Jain Foundation; Canadian Institutes of Health Research; Canadian Foundation For Innovation; British Columbia Knowledge Development Fund; Heart & Stroke Foundation; MITACS Canada; Pacific Airways Centre	Jain Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation For Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Heart & Stroke Foundation(Heart & Stroke Foundation of Canada); MITACS Canada; Pacific Airways Centre	This work was supported by grants from the Jain Foundation, the Canadian Institutes of Health Research, the Canadian Foundation For Innovation, the British Columbia Knowledge Development Fund, the Heart & Stroke Foundation (PNB), MITACS Canada and the Pacific Airways Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HD, 2013, PLOS CURR US, V5; ALLEN RE, 1987, J CELL PHYSIOL, V133, P567, DOI 10.1002/jcp.1041330319; Araujo KPC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061367; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Begam M, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13727; BEJAOUI K, 1995, NEUROLOGY, V45, P768, DOI 10.1212/WNL.45.4.768; Bish LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020856; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Cardenas AM, 2016, EXP NEUROL, V283, P246, DOI 10.1016/j.expneurol.2016.06.026; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Castets P, 2013, AUTOPHAGY, V9, P1435, DOI 10.4161/auto.25722; Ceco E, 2013, FEBS J, V280, P4198, DOI 10.1111/febs.12266; Chung AWY, 2007, BRIT J PHARMACOL, V150, P1075, DOI 10.1038/sj.bjp.0707181; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Collier AF, 2018, J PHARMACOL EXP THER, V364, P409, DOI 10.1124/jpet.117.244244; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Dabire H, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0240-6; Derosa G, 2004, CLIN THER, V26, P1228, DOI 10.1016/S0149-2918(04)80049-3; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; Goldstein JA, 2014, HUM MOL GENET, V23, P6722, DOI 10.1093/hmg/ddu390; Grounds MD, 2014, AM J PATHOL, V184, P1668, DOI 10.1016/j.ajpath.2014.02.005; Han R., 2011, PROTOC EXCH; Han WQ, 2016, HYPERTENS RES, V39, P227, DOI 10.1038/hr.2015.144; Kalikar M, 2017, J PHARMACOL PHARMACO, V8, P106, DOI 10.4103/jpp.JPP_39_17; Kyvelou Stella-Maria G, 2006, Hellenic J Cardiol, V47, P21; Lee EM, 2015, LIFE SCI, V143, P35, DOI 10.1016/j.lfs.2015.10.023; Lerch M, 1998, J CARDIOVASC PHARM, V31, P576, DOI 10.1097/00005344-199804000-00016; Leung C, 2011, BIOCHEM BIOPH RES CO, V415, P263, DOI 10.1016/j.bbrc.2011.10.031; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Loufrani L, 2001, CIRCULATION, V103, P864, DOI 10.1161/01.CIR.103.6.864; Meinen S, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-18; Milad N, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0135-9; Miura S, 2011, J RENIN-ANGIO-ALDO S, V12, P1, DOI 10.1177/1470320310370852; Mueller AL, 2014, MUSCLE NERVE, V50, P286, DOI 10.1002/mus.24220; Onofre-Oliveira PCG, 2012, NEUROMOL MED, V14, P74, DOI 10.1007/s12017-012-8172-3; Palladino M, 2013, ARTERIOSCL THROM VAS, V33, P2867, DOI 10.1161/ATVBAHA.112.301172; PENNINGTON RJT, 1980, BRIT MED BULL, V36, P123, DOI 10.1093/oxfordjournals.bmb.a071625; Rando TA, 1998, NEUROMUSCULAR DISORD, V8, P14, DOI 10.1016/S0960-8966(97)00124-7; Rodriguez-Iturbe B, 2005, KIDNEY INT, V68, P1041, DOI 10.1111/j.1523-1755.2005.00496.x; Sellers SL, 2018, AM J PATHOL, V188, P574, DOI 10.1016/j.ajpath.2017.11.006; Sellers SL, 2018, J LIPID RES, V59, P261, DOI 10.1194/jlr.M079459; Sharma A, 2015, DIABETES, V64, P3937, DOI 10.2337/db15-0472; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; Srivastava A, 2016, J INVEST MED, V64, P1102, DOI 10.1136/jim-2016-000102; Srivastava NK, 2010, NMR BIOMED, V23, P13, DOI 10.1002/nbm.1419; Sun G, 2008, J NEUROL SCI, V267, P48, DOI 10.1016/j.jns.2007.09.043; Suzuki N, 2005, NEUROSCI RES, V52, P47, DOI 10.1016/j.neures.2005.01.006; Terrill JR, 2013, FEBS J, V280, P4149, DOI 10.1111/febs.12142; Tershakovec AM, 2008, DIABETES CARE, V31, P445, DOI 10.2337/dc07-0196; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Walter MC, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-26; Wenzel K, 2007, J MOL MED, V85, P1203, DOI 10.1007/s00109-007-0253-7; White Z, 2017, SKELET MUSCLE, V7, DOI [10.1186/s13395-017-0120-3, 10.1186/s13395-016-0117-3]; White Z, 2016, INT J BIOCHEM CELL B, V78, P10, DOI 10.1016/j.biocel.2016.06.012; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x; Wiktorowicz T, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0057-3; ZATZ M, 1991, J NEUROL SCI, V102, P190, DOI 10.1016/0022-510X(91)90068-I	60	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220903	10.1371/journal.pone.0220903	http://dx.doi.org/10.1371/journal.pone.0220903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404091	Green Submitted, Green Published, gold			2022-12-27	WOS:000485006800041
J	Xu, LY; Lee, JR; Hao, SY; Ling, XB; Brooks, JD; Wang, SX; Gambhir, SS				Xu, Lingyun; Lee, Jung-Rok; Hao, Shiying; Ling, Xuefeng Bruce; Brooks, James D.; Wang, Shan X.; Gambhir, Sanjiv Sam			Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies	PLOS ONE			English	Article							TOTAL PSA RATIO; COLORECTAL-CANCER; BIOMARKERS; ANTIGEN; IDENTIFICATION; SIGNATURE; MORTALITY; CALDESMON; BLADDER; CELLS	Purpose To develop a magneto-nanosensor (MNS) based multiplex assay to measure protein and autoantibody biomarkers from human serum for prostate cancer (CaP) diagnosis. Materials and methods A 4-panel MNS autoantibody assay and a MNS protein assay were developed and optimized in our labs. Using these assays, serum concentration of six biomarkers including prostate-specific antigen (PSA) protein, free/total PSA ratio, as well as four autoantibodies against Parkinson disease 7 (PARK7), TAR DNA-binding protein 43 (TARDBP), Talin 1 (TLN1), and Caldesmon 1 (CALD1) and were analyzed. Human serum samples from 99 patients (50 with non-cancer and 49 with clinically localized CaP) were evaluated. Results The MNS assay showed excellent performance characteristics and no cross-reactivity. All autoantibody assays showed a statistically significant difference between CaP and non-cancer samples except for PARK7. The most significant difference was the combination of the four autoantibodies as a panel in addition to the free/total PSA ratio. This combination had the highest area under the curve (AUC)-0.916 in ROC analysis. Conclusions Our results suggest that this autoantibody panel along with PSA and free PSA have potential to segregate patients without cancer from those with prostate cancer with higher sensitivity and specificity than PSA alone.	[Xu, Lingyun; Gambhir, Sanjiv Sam] Stanford Univ, Dept Radiol, Bio X Program, Mol Imaging Program Stanford,Sch Med, Stanford, CA 94305 USA; [Lee, Jung-Rok] Ewha Womans Univ, Div Mech & Biomed Engn, Seoul, South Korea; [Hao, Shiying; Ling, Xuefeng Bruce] Lucile Packard Childrens Hosp, Betty Irene Moore Childrens Heart Ctr, Clin & Translat Res Program, Palo Alto, CA USA; [Hao, Shiying; Ling, Xuefeng Bruce] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Brooks, James D.] Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA; [Wang, Shan X.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Wang, Shan X.; Gambhir, Sanjiv Sam] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Wang, Shan X.] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA; [Gambhir, Sanjiv Sam] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Ewha Womans University; Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Gambhir, SS (corresponding author), Stanford Univ, Dept Radiol, Bio X Program, Mol Imaging Program Stanford,Sch Med, Stanford, CA 94305 USA.; Gambhir, SS (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.; Gambhir, SS (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	sgambhir@stanford.edu		Ling, Bruce/0000-0002-5386-3884; Hao, Shiying/0000-0002-7527-2460	Early Detection Research Network (EDRN) of the National Cancer Institute (NCI) [NCI U01 CA152737]; Canary Foundation	Early Detection Research Network (EDRN) of the National Cancer Institute (NCI); Canary Foundation	This work was supported by the Early Detection Research Network (EDRN) of the National Cancer Institute (NCI), grant number: NCI U01 CA152737 (https://edrn.nci.nih.gov) to LX and the Canary Foundation (https://www.canaryfoundation.org) to SSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Aslan G, 2005, INT UROL NEPHROL, V37, P511, DOI 10.1007/s11255-005-0921-x; Bertoli G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030421; Brooks JD, 2013, CANCER-AM CANCER SOC, V119, P3906, DOI 10.1002/cncr.28301; Chen HD, 2016, ONCOTARGET, V7, P16420, DOI 10.18632/oncotarget.7500; Chen Y, 2012, J CANCER RES CLIN, V138, P1463, DOI 10.1007/s00432-012-1205-3; Dumstrei K, 2016, ONCOTARGET, V7, P11151, DOI 10.18632/oncotarget.7098; Erol B, 2014, KAOHSIUNG J MED SCI, V30, P545, DOI 10.1016/j.kjms.2014.03.008; Fabris L, 2016, EUR UROL, V70, P312, DOI 10.1016/j.eururo.2015.12.054; Gaster RS, 2009, NAT MED, V15, P1327, DOI 10.1038/nm.2032; Hall DA, 2010, BIOSENS BIOELECTRON, V25, P2177, DOI 10.1016/j.bios.2010.01.039; Heck MM, 2016, PROSTATE, V76, P1160, DOI 10.1002/pros.23202; Heo CK, 2012, BMB REP, V45, P677, DOI 10.5483/BMBRep.2012.45.12.236; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Huang CC, 2014, J CELL SCI, V127, P3024, DOI 10.1242/jcs.136150; Huangfu MM, 2016, TUMOR BIOL, V37, P8709, DOI 10.1007/s13277-015-4472-1; Jia J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095444; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Jokerst JV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139484; Kim D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02234; Kim Y, 2012, MOL CELL PROTEOMICS, V11, P1870, DOI 10.1074/mcp.M112.017889; Kuriyama M, 1998, JPN J CLIN ONCOL, V28, P661, DOI 10.1093/jjco/28.11.661; Lee JR, 2017, NANO LETT, V17, P6644, DOI 10.1021/acs.nanolett.7b02591; Lee JR, 2016, ACS NANO, V10, P10652, DOI 10.1021/acsnano.6b03786; Lee JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12220; Lee JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep18692; Lee MS, 2015, ONCOTARGET, V6, P40370, DOI 10.18632/oncotarget.5458; Little J, 2016, GENET MED, V18, P535, DOI 10.1038/gim.2015.125; Loeb S, 2007, CANCER LETT, V249, P30, DOI 10.1016/j.canlet.2006.12.022; McDonald ML, 2016, UROL CLIN N AM, V43, P39, DOI 10.1016/j.ucl.2015.08.004; Nam RK, 2007, J CLIN ONCOL, V25, P3582, DOI 10.1200/JCO.2007.10.6450; O'Rourke DJ, 2012, CLIN CHIM ACTA, V413, P561, DOI 10.1016/j.cca.2011.11.027; Osterfeld SJ, 2008, P NATL ACAD SCI USA, V105, P20637, DOI 10.1073/pnas.0810822105; Park YY, 2013, HEPATOLOGY, V58, P182, DOI 10.1002/hep.26310; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Trivedi R, 2016, EUR J PHARMACOL, V784, P99, DOI 10.1016/j.ejphar.2016.04.014; Werner S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25467; Xu YW, 2014, AM J GASTROENTEROL, V109, P36, DOI 10.1038/ajg.2013.384; Zaenker P, 2013, CANCER EPIDEM BIOMAR, V22, P2161, DOI 10.1158/1055-9965.EPI-13-0621; Zayakin P, 2013, INT J CANCER, V132, P137, DOI 10.1002/ijc.27667; Zhang GQ, 2015, INT J CLIN EXP PATHO, V8, P6944; Zheng PP, 2005, J PATHOL, V205, P408, DOI 10.1002/path.1700	45	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221051	10.1371/journal.pone.0221051	http://dx.doi.org/10.1371/journal.pone.0221051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404106	gold, Green Published, Green Submitted			2022-12-27	WOS:000485006800049
J	Zhang, JJ; Sha, QY; Liu, GF; Wang, XX				Zhang, Jianjun; Sha, Qiuying; Liu, Guanfu; Wang, Xuexia			A gene based approach to test genetic association based on an optimally weighted combination of multiple traits	PLOS ONE			English	Article							DETECTING ASSOCIATION; COMMON VARIANTS; RARE VARIANTS; SUSCEPTIBILITY; HERITABILITY; PHENOTYPES; DISEASE	There is increasing evidence showing that pleiotropy is a widespread phenomenon in complex diseases for which multiple correlated traits are often measured. Joint analysis of multiple traits could increase statistical power by aggregating multiple weak effects. Existing methods for multiple trait association tests usually study each of the multiple traits separately and then combine the univariate test statistics or combine p-values of the univariate tests for identifying disease associated genetic variants. However, ignoring correlation between phenotypes may cause power loss. Additionally, the genetic variants in one gene (including common and rare variants) are often viewed as a whole that affects the underlying disease since the basic functional unit of inheritance is a gene rather than a genetic variant. Thus, results from gene level association tests can be more readily integrated with downstream functional and pathogenic investigation, whereas many existing methods for multiple trait association tests only focus on testing a single common variant rather than a gene. In this article, we propose a statistical method by Testing an Optimally Weighted Combination of Multiple traits (TOW-CM) to test the association between multiple traits and multiple variants in a genomic region (a gene or pathway). We investigate the performance of the proposed method through extensive simulation studies. Our simulation studies show that the proposed method has correct type I error rates and is either the most powerful test or comparable with the most powerful tests. Additionally, we illustrate the usefulness of TOW-CM based on a COPDGene study.	[Zhang, Jianjun; Wang, Xuexia] Univ North Texas, Dept Math, Denton, TX 76203 USA; [Sha, Qiuying] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA; [Liu, Guanfu] Shanghai Univ Int Business & Econ, Sch Stat & Informat, Shanghai, Peoples R China	University of North Texas System; University of North Texas Denton; Michigan Technological University; Shanghai University of International Business & Economics	Wang, XX (corresponding author), Univ North Texas, Dept Math, Denton, TX 76203 USA.	Xuexia.Wang@unt.edu			National Human Genome Research Institute of the National Institutes of Health [R15HG008209]; University of North Texas Foundation; NIH from the National Institute of General Medical Sciences [R01 GM031575]; NIH [R01 MH059490, U01HL089856, U01HL089897]; COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856, U01HL089897] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG008209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); University of North Texas Foundation; NIH from the National Institute of General Medical Sciences(General Electric); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R15HG008209 to QS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. X Wang was supported by the University of North Texas Foundation which was contributed by Dr. Linda Truitt Creagh. The content is solely the responsibility of the authors and does not necessarily represent the views of the University of North Texas Foundation and Dr. Linda Truitt Creagh. The Genetic Analysis workshops are supported by NIH grant R01 GM031575 from the National Institute of General Medical Sciences. Preparation of the Genetic Analysis Workshop 17 Simulated Exome Data Set was supported in part by NIH R01 MH059490 and used sequencing data from the 1000 Genomes Project (www.1000genomes.org).This research used data generated by the COPDGene study, which was supported by NIH grants U01HL089856 and U01HL089897. The COPDGene project is also supported by the COPD Foundation through contributions made by an Industry Advisory Board comprised of Pfizer, AstraZeneca, Boehringer Ingelheim, Novartis, and Sunovion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt A, 2012, EMBO MOL MED, V4, P1144, DOI 10.1002/emmm.201100627; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Chu JH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-78; COLE DA, 1994, PSYCHOL BULL, V115, P465, DOI 10.1037/0033-2909.115.3.465; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kim J, 2015, GENET EPIDEMIOL, V39, P651, DOI 10.1002/gepi.21931; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34323; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Murphy TF, 2002, DRUG AGING, V19, P761, DOI 10.2165/00002512-200219100-00005; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Ott J, 1999, HUM HERED, V49, P106, DOI 10.1159/000022854; Pan W, 2014, GENETICS, V197, P1081, DOI 10.1534/genetics.114.165035; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Yang Q, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/652569; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Sha QY, 2012, GENET EPIDEMIOL, V36, P561, DOI 10.1002/gepi.21649; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stephens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065245; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wu BL, 2016, GENET EPIDEMIOL, V40, P91, DOI 10.1002/gepi.21945; Wu BL, 2015, ANN HUM GENET, V79, P282, DOI 10.1111/ahg.12110; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Yang XL, 2017, GENET EPIDEMIOL, V41, P233, DOI 10.1002/gepi.22034; Zabaneh D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011961	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220914	10.1371/journal.pone.0220914	http://dx.doi.org/10.1371/journal.pone.0220914			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398229	Green Published, gold, Green Submitted			2022-12-27	WOS:000485004000026
J	Cho, BJ; Bae, SH; Park, SM; Shin, MC; Park, IW; Kim, HK; Kwon, S				Cho, Bum-Joo; Bae, So Hyun; Park, Sang Min; Shin, Min Chul; Park, In Won; Kim, Ha Kyoung; Kwon, Soonil			Comparison of systemic conditions at diagnosis between central retinal vein occlusion and branch retinal vein occlusion	PLOS ONE			English	Article							RISK-FACTORS; LYMPHOCYTE RATIO; HOMOCYSTEINE; ABNORMALITIES; HYPERHOMOCYSTEINEMIA; ASSOCIATION; PREVALENCE; NEUTROPHIL; MECHANISMS; CREATININE	Objective To compare systemic conditions at the time of diagnosis between patients with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). Design This study included patients diagnosed with CRVO or BRVO between February 2009 and August 2017 at three branch hospitals of Hallym University Medical Center. Demographic and anthropometric variables, systemic comorbidity profiles, and laboratory findings at diagnosis were collected from a clinical data warehouse system, and were compared between the CRVO and BRVO groups. Result Four hundred and seventeen patients with CRVO and 1,511 patients with BRVO were included. The mean age was 61.8 +/- 13.9 years, which was comparable between two groups (P = .332). Female proportion was higher in the BRVO group (55.0%) than in the CRVO group (48.0%; P = .013). Diabetes mellitus (P =.017) and chronic kidney disease (P = .004) were more prevalent in the CRVO group. Serum homocysteine level was abnormally high in 23.5% of CRVO patients and in 8.4% of BRVO patients (P < .001). Blood urea nitrogen and serum creatinine levels were abnormally elevated in more subjects with CRVO (P = .002). Conclusion CRVO is associated with higher prevalence of diabetes mellitus and chronic kidney disease, as well as with elevated serum homocysteine level. These results might suggest a difference between the pathophysiologies of CRVO and BRVO.	[Cho, Bum-Joo; Park, In Won; Kwon, Soonil] Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Ophthalmol, Anyang, South Korea; [Bae, So Hyun; Kim, Ha Kyoung] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Park, Sang Min] Hallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Cardiovasc Ctr, Chunchon, South Korea; [Shin, Min Chul] Hallym Univ, Chuncheon Sacred Heart, Coll Med, Dept Ophthalmol, Chunchon, South Korea	Hallym University; Hallym University; Hallym University; Hallym University	Kwon, S (corresponding author), Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Ophthalmol, Anyang, South Korea.	magicham@hallym.or.kr	Park, Sang Min/AAJ-7415-2021; Kwon, Soonil/AAH-2251-2019	Park, Sang Min/0000-0001-6521-303X; Kwon, Soonil/0000-0003-1543-981X; Cho, Bum-Joo/0000-0002-0244-388X	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT) [NRF-2017M3A9E8033207]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT)	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) and funded by the Korean government (MSIT) (No. NRF-2017M3A9E8033207) to B-JC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 2002, OPHTHALMOLOGY, V109, P287, DOI 10.1016/S0161-6420(01)00923-X; Chelico John D, 2016, AMIA Annu Symp Proc, V2016, P381; Chen YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184016; Chua B, 2005, AM J OPHTHALMOL, V139, P181, DOI 10.1016/j.ajo.2004.06.084; DODSON PM, 1981, T OPHTHAL SOC UK, V101, P17; Duffy BK, 2006, AM J CARDIOL, V97, P993, DOI 10.1016/j.amjcard.2005.10.034; Dursun A, 2015, EUR J OPHTHALMOL, V25, P343, DOI 10.5301/ejo.5000570; Eye Disease Case-Control Study Group, 1996, ARCH OPHTHALMOL-CHIC, V114, P545, DOI DOI 10.1001/ARCHOPHT.1996.01100130537006; Hayreh SS, 2014, PROG RETIN EYE RES, V41, P1, DOI 10.1016/j.preteyeres.2014.04.001; Hayreh SS, 2002, GRAEF ARCH CLIN EXP, V240, P180, DOI 10.1007/s00417-001-0421-3; Hayreh SS, 2001, AM J OPHTHALMOL, V131, P61, DOI 10.1016/S0002-9394(00)00709-1; Ho M, 2016, RETINA-J RET VIT DIS, V36, P432, DOI 10.1097/IAE.0000000000000843; Incorvaia C, 2001, GRAEF ARCH CLIN EXP, V239, P251, DOI 10.1007/s004170100266; Jakubowski H, 2006, J NUTR, V136, p1741S, DOI 10.1093/jn/136.6.1741S; Jaulim A, 2013, RETINA-J RET VIT DIS, V33, P901, DOI 10.1097/IAE.0b013e3182870c15; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Klein R, 2000, T AM OPHTHAL SOC, V98, P133; Koh V, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3322-x; Kolar P, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/724780; Lee SH, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00526; Lentz SR, 2005, J THROMB HAEMOST, V3, P1646, DOI 10.1111/j.1538-7836.2005.01364.x; McAllister IL, 2012, CLIN EXP OPHTHALMOL, V40, P48, DOI 10.1111/j.1442-9071.2011.02713.x; McGimpsey SJ, 2009, OPHTHALMOLOGY, V116, P1778, DOI 10.1016/j.ophtha.2009.02.033; Michalska-Malecka K, 2016, CLIN HEMORHEOL MICRO, V63, P69, DOI 10.3233/CH-162056; O'Mahoney PRA, 2008, ARCH OPHTHALMOL-CHIC, V126, P692, DOI 10.1001/archopht.126.5.692; Park SJ, 2014, OPHTHALMOLOGY, V121, P1274, DOI 10.1016/j.ophtha.2013.12.024; Pellizzon GG, 2003, AM J CARDIOL, V91, P729, DOI 10.1016/S0002-9149(02)03416-1; Pinna A, 2006, INVEST OPHTH VIS SCI, V47, P4067, DOI 10.1167/iovs.06-0290; Ponto KA, 2015, J THROMB HAEMOST, V13, P1254, DOI 10.1111/jth.12982; Rim TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34708; Rim TH, 2015, OPHTHALMOLOGY, V122, P1187, DOI 10.1016/j.ophtha.2015.01.020; Saxena S, 2017, RETINA-J RET VIT DIS, V37, P344, DOI 10.1097/IAE.0000000000001163; Sinawat S, 2017, CLIN OPHTHALMOL, V11, P441, DOI 10.2147/OPTH.S128341; Srivastav K, 2015, BIOMARKERS, V20, P470, DOI 10.3109/1354750X.2015.1094142; Undas A, 2005, THROMB HAEMOSTASIS, V94, P907, DOI 10.1160/TH05-05-0313; Uthamalingam S, 2011, AM J CARDIOL, V107, P433, DOI 10.1016/j.amjcard.2010.09.039; Vine AK, 2000, AM J OPHTHALMOL, V129, P640, DOI 10.1016/S0002-9394(99)00476-6; Weiss N, 2005, CURR DRUG METAB, V6, P27, DOI 10.2174/1389200052997357; YANNUZZI LA, 1993, AM J OPHTHALMOL, V116, P286; Yau JWY, 2008, INTERN MED J, V38, P904, DOI 10.1111/j.1445-5994.2008.01720.x	40	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220880	10.1371/journal.pone.0220880	http://dx.doi.org/10.1371/journal.pone.0220880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393915	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500076
J	Kadayakkara, DK; Balasubramanian, P; Araque, K; Davis, K; Javed, F; Niaki, P; Majumdar, S; Buller, G				Kadayakkara, Deepak Kana; Balasubramanian, Priyadarshini; Araque, Katherine; Davis, Karri; Javed, Fahad; Niaki, Pontea; Majumdar, Sachin; Buller, Gregory			Multidisciplinary strategies to treat severe hypoglycemia in hospitalized patients with diabetes mellitus reduce inpatient mortality rate: Experience from an academic community hospital	PLOS ONE			English	Article							LENGTH; IMPACT; STAY	Objective Severe hypoglycemia (blood glucose < 50 mg/dl) in hospitalized patients with diabetes mellitus is associated with poor outcomes such as increased mortality and readmission rates. We study the effects of system based interventions in managing severe hypoglycemia and its impact on outcomes. Research design and methods We performed retrospective review of pre- and post-intervention study to quantify severe hypoglycemia in patients admitted in the general internal medicine wards with primary or secondary diagnosis of diabetes mellitus based on ICD-9 and ICD-10 codes. We implemented multidisciplinary interventions including standardization of treatment, education of in-patient medical teams and physician notification and feedback immediately after severe hypoglycemia. The endpoints were the comparative analysis of incidence of severe hypoglycemia, in-patient mortality rate, 30-day mortality rate, 30-day readmission rate, recovery time from hypoglycemia, time to next glucose measurements, use of standardized treatment and physician notification rate pre- and post-intervention. Results The incidence of severe hypoglycemia per patient with diabetes was reduced from 9.6% (233/2416) to 5.6% (202/3607) (p<0.001) post-intervention. The in-patient mortality rate in patients with severe hypoglycemia reduced from 4.1% to 0% (p = 0.019), 30-day mortality rate reduced from 9.8% to 3.8% (p = 0.058) post-intervention. 30-day readmission rate was comparable between pre-intervention (31.7%) and post-intervention (29%) (p = 0.60). In comparison, the mortality and readmission rates of all diabetic patients did not reduce during the same observation periods. Recovery time reduced from 116 (83-161) to 75 (57-102) min (p<0.01), time to next glucose measurement reduced from 39.5 (34-48) to 32 (28-35) min (p<0.01), use of standardized treatment improved from 22.7% (53/233) to 72.2% (146/202) (p<0.001) and physician notification rate increased from 29.2 (68/233) to 84.7% (171/202) post-intervention. Conclusions Our study shows that multidisciplinary strategies improves the process of early detection and management of severe hypoglycemia and reduce incidence and in-patient mortality rate.	[Kadayakkara, Deepak Kana; Balasubramanian, Priyadarshini; Araque, Katherine; Davis, Karri; Javed, Fahad; Niaki, Pontea; Majumdar, Sachin; Buller, Gregory] Bridgeport Hosp Yale New Haven Hlth, Dept Med, Bridgeport, CT 06610 USA; [Kadayakkara, Deepak Kana; Majumdar, Sachin; Buller, Gregory] Yale Sch Med, Dept Med, New Haven, CT 06520 USA; [Araque, Katherine] NIDDK, Adult Endocrinol Dept, NIH, Bethesda, MD 20892 USA	Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kadayakkara, DK (corresponding author), Bridgeport Hosp Yale New Haven Hlth, Dept Med, Bridgeport, CT 06610 USA.; Kadayakkara, DK (corresponding author), Yale Sch Med, Dept Med, New Haven, CT 06520 USA.	deepak.kanakadayakkara@bpthosp.org		Araque, katherine/0000-0002-2098-2027; Kana Kadayakkara, Deepak/0000-0002-4325-7557				Araque Katherine A, 2018, BMJ Open Qual, V7, pe000120, DOI 10.1136/bmjoq-2017-000120; Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Braithwaite Susan S, 2004, Endocr Pract, V10 Suppl 2, P89; Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744; Deusenberry CM, 2012, PHARMACOTHERAPY, V32, P613, DOI 10.1002/j.1875-9114.2011.01088.x; Farrokhi Farnoosh, 2012, J Diabetes Sci Technol, V6, P1022; Feinkohl I, 2014, DIABETES CARE, V37, P507, DOI 10.2337/dc13-1384; Garg R, 2013, DIABETES CARE, V36, P1107, DOI 10.2337/dc12-1296; Maynard G, 2015, ENDOCR PRACT, V21, P355, DOI 10.4158/EP14367.OR; Reno CM, 2018, AM J PHYSIOL-ENDOC M, V315, pE240, DOI 10.1152/ajpendo.00442.2017; Turchin A, 2009, DIABETES CARE, V32, P1153, DOI 10.2337/dc08-2127; Varghese P, 2007, J HOSP MED, V2, P234, DOI 10.1002/jhm.212; Varlamov Elena V, 2014, Hosp Pract (1995), V42, P163, DOI 10.3810/hp.2014.10.1153; Zapatero A, 2014, ENDOCR PRACT, V20, P870, DOI 10.4158/EP14006.OR	14	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220956	10.1371/journal.pone.0220956	http://dx.doi.org/10.1371/journal.pone.0220956			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393971	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500086
J	Li, W; Cho, MY; Lee, S; Jang, M; Park, J; Park, R				Li, Wanlu; Cho, Mee-Yon; Lee, Suji; Jang, Mirae; Park, Junsoo; Park, Rackhyun			CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; EMT	We previously reported that CD133, as a putative cancer stem cell marker, plays an important role in cell proliferation and invasion in colon cancer. To understand the role of CD133 expression in colon cancer, we evaluated the inhibitory effect of CD133 in colon cancer cells. In this study, we generated CD133(knockout) colon cancer cells (LoVo) using the CRISPR-Cas9 gene editing system. CD133(+) colon cancer cells (LoVo) were infected with the lentiviral vector carrying CD133 gRNA and purified cell by culturing single cell colonies. CD133(knockout) cells was validated by western blot and flow cytometry analysis. In functional study, we observed a significant reduction in cell proliferation and colony formation in CRISPR-Cas9 mediated CD133(knockout) cells in compare with control (P < 0.001). We also found the anticancer effect of stattic was dependent on CD133 expression in colon cancer cells. Although CD133(knockout) cells could not completely block the tumorigenic property, they showed remarkable inhibitory effects on the ability of cell migration and invasion (P < 0.001). In addition, we examined the epithelial mesenchymal transition (EMT)-related protein expression by western blot. The result clearly showed a loss of vimentin expression in CD133(knockout) cells. Therefore, CRISPR-Cas9 mediated CD133 knockout can be an effective treatment modality for CD133(+) colon cancer through reducing the characteristics of cancer stem cells.	[Li, Wanlu; Cho, Mee-Yon; Lee, Suji; Jang, Mirae] Yonsei Univ, Wonju Coll Med, Dept Pathol, Wonju, South Korea; [Park, Junsoo; Park, Rackhyun] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea	Yonsei University; Yonsei University	Cho, MY (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Pathol, Wonju, South Korea.	meeyon@yonsei.ac.kr		Cho, Mee Yon/0000-0002-7955-4211	National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1A09918958]	National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, No. 2016R1D1A1A09918958 (https://www.nrf.re.kr/index).; This work was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2016R1D1A1A09918958).	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Dinicola S, 2018, J CELL PHYSIOL, V233, P4935, DOI 10.1002/jcp.26323; Feng HL, 2018, BRIT J CANCER, V118, P224, DOI 10.1038/bjc.2017.363; Gheldof A, 2013, PROG MOL BIOL TRANSL, V116, P317, DOI 10.1016/B978-0-12-394311-8.00014-5; Glumac PM, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0198-1; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Karimian A, 2019, J CELL PHYSIOL, V234, P12267, DOI 10.1002/jcp.27972; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Kim EJ, 2017, KOREAN J INTERN MED, V32, P42, DOI 10.3904/kjim.2016.198; Kusoglu A, 2019, GENE, V681, P80, DOI 10.1016/j.gene.2018.09.052; Lee MR, 2015, BIOCHEM BIOPH RES CO, V463, P229, DOI 10.1016/j.bbrc.2015.05.031; Li WL, 2016, BIOCHEM BIOPH RES CO, V471, P309, DOI 10.1016/j.bbrc.2016.02.009; Li W, 2018, BIOCHEM BIOPH RES CO, V497, P354, DOI 10.1016/j.bbrc.2018.02.084; Li W, 2017, J PATHOL TRANSL MED, V51, P17, DOI 10.4132/jptm.2016.09.23; Ottaiano A, 2005, CANCER IMMUNOL IMMUN, V54, P781, DOI 10.1007/s00262-004-0636-3; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; TOMASZ M, 1995, CHEM BIOL, V2, P575, DOI 10.1016/1074-5521(95)90120-5; Turano M, 2018, INT J ONCOL, V53, P2379, DOI 10.3892/ijo.2018.4565; Wang BB, 2016, HISTOL HISTOPATHOL, V31, P299, DOI 10.14670/HH-11-676; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhou Yujuan, 2018, Oncotarget, V9, P33403, DOI 10.18632/oncotarget.23607	24	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220860	10.1371/journal.pone.0220860	http://dx.doi.org/10.1371/journal.pone.0220860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393941	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500073
J	Olmo, L; Reichel, MP; Nampanya, S; Khounsy, S; Wahl, LC; Clark, BA; Thomson, PC; Windsor, PA; Bush, RD				Olmo, Luisa; Reichel, Michael P.; Nampanya, Sonevilay; Khounsy, Syseng; Wahl, Lloyd C.; Clark, Bethanie A.; Thomson, Peter C.; Windsor, Peter A.; Bush, Russell D.			Risk factors for Neospora caninum, bovine viral diarrhoea virus, and Leptospira interrogans serovar Hardjo infection in smallholder cattle and buffalo in Lao PDR	PLOS ONE			English	Article							BUBALUS-BUBALIS; FOOD SECURITY; DAIRY-CATTLE; NORTHERN-TERRITORY; BEEF-CATTLE; SEROPREVALENCE; BVDV; BRUCELLOSIS; COMMUNITIES; ERADICATION	Smallholder large ruminant production in Lao People's Democratic Republic (Laos) is characterised by low reproductive efficiency. To determine if common abortifacient bovid infectious diseases are involved, a serological investigation was conducted. Sera was collected from stored and fresh cattle (n = 390) and buffalo (n = 130) samples from 2016-18 from, and then examined for associations in a retrospective risk factor study of 71 herds. The sera were assayed for antibodies to Neospora caninum, bovine viral diarrhoea virus (BVDV), Leptospira interrogans serovar Hardjo and Brucella abortus using commercially available enzyme-linked immunosorbent assay kits. These pathogens were detected in buffalo samples at 78.5% (95% CI 71.4-85.6), 0%, 2.3% (95% CI 0-4.9) and 0%, respectively, and in cattle at 4.4% (95% CI 2.4-6.4), 7.7% (95% CI 3.1-12.3), 12.8% (95% CI 9.5-16.1) and 0.26% (95% CI 0-0.8), respectively. Exposure of buffalo to N. caninum was positively associated with buffalo age, with a predicted seropositivity at birth of 52.8%, increasing to 97.2% by 12 years of age (p = 0.037). Exposure of cattle to L. interrogans serovar Hardjo was more prevalent in females compared to males, was associated with higher titres of BVDV, and was more prevalent in the wet season compared to the dry season. Exposure of cattle to BVDV was more prevalent in males compared to females, the wet and dry seasons were comparable, and was associated with rising antibody titres against N. caninum and L. interrogans serovar Hardjo. The risk factor survey identified that the probability of herds being N. caninum positive increased with farmer age, if farmers believed there were rodents on farm, and if farmers weren't aware that canids or rodents could contaminate bovid feed on their farm. The probability of a herd being positive to L. interrogans serovar Hardjo increased on farms where multiple cows shared the same bull, where farmers had lower husbandry knowledge, and on farms that used water troughs. The probability of a herd being BVDV seropositive increased with increasing herd size and increasing titres to N. caninum. The benchmarking of bovid exposure to emerging abortifacient pathogens and identification of their risk factors potentially informs disease prevention strategies, supporting efforts to establish a biosecure beef supply for enhanced smallholder livestock productivity, public health and food security in Laos and surrounding countries.	[Olmo, Luisa; Nampanya, Sonevilay; Clark, Bethanie A.; Windsor, Peter A.; Bush, Russell D.] Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia; [Reichel, Michael P.; Wahl, Lloyd C.] City Univ Hong Kong, Jockey Club Coll Vet Med & Life Sci, Kowloon, Tat Chee Ave, Hong Kong, Peoples R China; [Nampanya, Sonevilay; Khounsy, Syseng] Minist Agr & Forestry, Dept Livestock & Fisheries, Viangchan, Laos; [Thomson, Peter C.] Univ Sydney, Sch Life & Environm Sci, Camden, NSW, Australia	University of Sydney; City University of Hong Kong; University of Sydney	Olmo, L (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia.	luisa.olmo@sydney.edu.au	Reichel, Michael/AAJ-5329-2020; Thomson, Peter/V-7290-2019	Reichel, Michael/0000-0002-9792-8336; Thomson, Peter/0000-0003-4428-444X	Australian Centre for International Agricultural Research (ACIAR) [AH/2012/067]	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res)	The study was funded by the Australian Centre for International Agricultural Research (ACIAR, http://aciar.gov.au/), project AH/2012/067, 'Enhancing transboundary livestock disease risk management in Lao PDR'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIAR, 2016, ENH TRANSB LIV DIS R; Almeria Sonia, 2013, ISRN Parasitol, V2013, P947347, DOI 10.5402/2013/947347; [Anonymous], 2018, GDAM MAPS DAT; Arif S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173365; Barratt J, 2008, MOL CELL PROBE, V22, P228, DOI 10.1016/j.mcp.2008.03.001; Bartley PM, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-38; BonDurant RH, 2005, VET CLIN N AM-FOOD A, V21, P383, DOI 10.1016/j.cvfa.2005.03.002; Brown PR, 2010, CROP PROT, V29, P577, DOI 10.1016/j.cropro.2009.12.025; Brown PR, 2007, INTEGR ZOOL, V2, P165, DOI 10.1111/j.1749-4877.2007.00055.x; Butler D.G., 2017, ASREML R REFERENCE M; Chase CCL, 2013, BIOLOGICALS, V41, P52, DOI 10.1016/j.biologicals.2012.09.009; Dacre I, 2019, P 3 INT C AN HLTH SU, P203; Dhandapani K, 2017, Vet Parasitol Reg Stud Reports, V7, P36, DOI 10.1016/j.vprsr.2016.12.004; Douangngeun B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005609; Douangngeun B, 2016, AM J TROP MED HYG, V95, P558, DOI 10.4269/ajtmh.15-0913; Dubey JP, 2007, CLIN MICROBIOL REV, V20, P323, DOI 10.1128/CMR.00031-06; ELLIS WA, 1994, VET CLIN N AM-FOOD A, V10, P463, DOI 10.1016/S0749-0720(15)30532-6; Evans CA, 2016, AUST VET J, V94, P423, DOI 10.1111/avj.12517; FAO, 2011, MAPP SUPPL DEM AN SO; Ferroglio E, 2007, VET PARASITOL, V148, P346, DOI 10.1016/j.vetpar.2007.06.031; Glynn MK, 2008, JAVMA-J AM VET MED A, V233, P900, DOI 10.2460/javma.233.6.900; Graham DA, 2013, PREV VET MED, V112, P99, DOI 10.1016/j.prevetmed.2013.07.011; Grooms DL, 2004, VET CLIN N AM-FOOD A, V20, P5, DOI 10.1016/j.cvfa.2003.11.006; Kampa J, 2011, THAI J VET MED, V41, P409; Kawaguchi L, 2008, AM J TROP MED HYG, V78, P957, DOI 10.4269/ajtmh.2008.78.957; King JS, 2011, VET J, V188, P24, DOI 10.1016/j.tvjl.2010.03.002; Koiwai M, 2006, VET PARASITOL, V135, P175, DOI 10.1016/j.vetpar.2005.08.014; Lanyon SR, 2014, VET J, V199, P201, DOI 10.1016/j.tvjl.2013.07.024; Ledien J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181044; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lilenbaum W, 2014, TRANSBOUND EMERG DIS, V61, P63, DOI 10.1111/tbed.12233; Lindberg ALE, 1999, VET MICROBIOL, V64, P197, DOI 10.1016/S0378-1135(98)00270-3; Matsumoto N, 2017, TROP ANIM HEALTH PRO, V49, P87, DOI 10.1007/s11250-016-1162-y; Meays CL, 2005, RANGELAND ECOL MANAG, V58, P279, DOI 10.2111/1551-5028(2005)58[279:SOECIB]2.0.CO;2; Nampanya S, 2014, ANIM PROD SCI, V54, P899, DOI 10.1071/AN13180; Nampanya S, 2013, TRANSBOUND EMERG DIS, V60, P315, DOI 10.1111/j.1865-1682.2012.01350.x; Nampanya S, 2015, TROP ANIM HEALTH PRO, V47, P681, DOI 10.1007/s11250-015-0778-7; Nasir A, 2011, J PARASITOL, V97, P541, DOI 10.1645/GE-2687.1; Neta AVC, 2010, VET J, V184, P146, DOI 10.1016/j.tvjl.2009.04.010; Neverauskas CE, 2015, PARASITOL INT, V64, P392, DOI 10.1016/j.parint.2015.05.009; Olmo L, 2018, ACTA TROP, V177, P118, DOI 10.1016/j.actatropica.2017.10.007; Reichel MP, 2015, VET PARASITOL, V212, P75, DOI 10.1016/j.vetpar.2015.08.008; Reichel MP, 2013, INT J PARASITOL, V43, P133, DOI 10.1016/j.ijpara.2012.10.022; Reichel MP, 2002, VET PARASITOL, V107, P197, DOI 10.1016/S0304-4017(02)00086-9; Rodrigues AAR, 2005, VET PARASITOL, V129, P21, DOI 10.1016/j.vetpar.2004.12.024; Roushan MRH, 2011, T ROY SOC TROP MED H, V105, P540, DOI 10.1016/j.trstmh.2011.06.003; Sanhueza JM, 2013, PREV VET MED, V112, P90, DOI 10.1016/j.prevetmed.2013.07.009; Selim AM, 2018, VET WORLD, V11, P259, DOI 10.14202/vetworld.2018.259-267; Seng Heng, 2007, Journal of the Medical Association of Thailand, V90, P546; Smith P., 2015, MOVEMENT PATHWAYS MA; Sraboni E, 2014, WORLD DEV, V61, P11, DOI 10.1016/j.worlddev.2014.03.025; Str W.W., 2002, REV LIVESTOCK SECTOR; Suwancharoen D, 2013, EPIDEMIOL INFECT, V141, P2269, DOI 10.1017/S0950268812002981; Suzuki K, 2006, RES VET SCI, V81, P177, DOI 10.1016/j.rvsc.2005.12.002; Vongxay K, 2012, VECTOR-BORNE ZOONOT, V12, P861, DOI 10.1089/vbz.2011.0850; World Bank Group, 2020, CLIM CHANG KNOWL POR; World Meteorological Organization Standard Normals, 2018, UNDATA; Yu JH, 2007, VET PARASITOL, V143, P79, DOI 10.1016/j.vetpar.2006.07.031	58	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220335	10.1371/journal.pone.0220335	http://dx.doi.org/10.1371/journal.pone.0220335			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393897	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500027
J	Abdin, E; Subramaniam, M; Chan, A; Chen, JA; Chong, CL; Wang, C; Lee, M; Gan, SL				Abdin, Edimansyah; Subramaniam, Mythily; Chan, Angelina; Chen, Jo-Ann; Chong, Chee Leong; Wang, Cheryl; Lee, Michelle; Gan, Siok Lin			iWorkHealth: An instrument to identify workplace psychosocial risk factors for a multi-ethnic Asian working population	PLOS ONE			English	Article							ENVIRONMENT; DISEASES; INDEXES; TOOL	Objective The current study aimed to develop iWorkHealth, a valid and reliable self-administered instrument which identifies workplace psychosocial risk factors in Singapore. Methods The survey was conducted among 2718 employees who were primarily salaried workers and working in five companies from the healthcare, banking and finance, and legal sectors in Singapore. Factor extraction and item reduction were conducted using exploratory factor analysis (EFA) and Mokken scale analysis (MSA). Construct validity, internal consistency and convergent validity of the final scale were confirmed using confirmatory factor analysis (CFA), Cronbach's alpha and Pearson correlation coefficients, respectively. Multiple Indicators Multiple Causes model was used to detect Differential Item Functioning (DIF). Results EFA and MSA identified a five-factor solution (job demand, job control, employee and management engagement, supervisor support and colleague support) for the 27 items iWorkHealth instrument. CFA demonstrated that the five-factor model fitted the data with high internal consistency (Cronbach's alpha ranged from 0.79 to 0.92). The convergent validity was shown through significant association with existing scales-high job demand was significantly associated with high burnout and depression, while high job control, employee and management engagement, supervisor support and coworker support were significantly associated with low burnout and depression. Ten items were detected with significant DIF, but impact was minimal on the associations between socio-demographics factors and iWorkHealth subscales. Conclusions The findings provided evidence that the iWorkHealth instrument which comprises 27 items in five domains of psychosocial risk at the workplace is a reliable and valid instrument that could be used to measure and compare the level of psychosocial risk factors across companies and industries in Singapore.	[Abdin, Edimansyah; Subramaniam, Mythily] Inst Mental Hlth, Singapore, Singapore; [Chan, Angelina] Changi Gen Hosp, Singapore, Singapore; [Chen, Jo-Ann; Gan, Siok Lin] Minist Manpower, Singapore, Singapore; [Chong, Chee Leong] Clanworks, Singapore, Singapore; [Wang, Cheryl] Work Safety & Hlth Council, Singapore, Singapore; [Lee, Michelle] Hlth Promot Board, Singapore, Singapore	Changi General Hospital	Abdin, E (corresponding author), Inst Mental Hlth, Singapore, Singapore.	Edimansyah_Abdin@imh.com.sg	Abdin, Edimansyah/E-6451-2011	Abdin, Edimansyah/0000-0002-1016-3298				Abdin E, 2017, QUAL LIFE RES, V26, P823, DOI 10.1007/s11136-016-1418-z; Bailey TS, PSYCHOSOCIAL FACTORS; Browne MW., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Fishta A, 2015, INT ARCH OCC ENV HEA, V88, P997, DOI 10.1007/s00420-015-1019-0; Houtman I, 2007, RAISING AWARENESS ST; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; International Labour Organization (ILO), 1986, OCC SAF HLTH SER, V56; Iwata N, PSYCHOSOCIAL FACTORS; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R., 1990, HLTH WORK STRESS PRO; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kline P., 1979, PSYCHOMETRICS PSYCHO; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Leka S, PSYCHOSOCIAL FACTORS; Ministry of Manpower, 2018, LAB FORC SING 2018; Orhede E, 2000, SCAND J WORK ENV HEA, V26, P263, DOI 10.5271/sjweh.541; Rugulies R, 2006, AM J EPIDEMIOL, V163, P877, DOI 10.1093/aje/kwj119; Siegrist J, 2010, INT J OCCUP MED ENV, V23, P279, DOI 10.2478/v10001-010-0013-8; Sijtsma K., 2002, INTRO NONPARAMETRIC, VVol. 5; Singapore Department of Statistics, 2018, YB STAT SING 2018; Yu YF, 2007, MED CARE, V45, P851, DOI 10.1097/MLR.0b013e318074ce4c; Zhumbo BD., 1999, HDB THEORY METHODS D	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220566	10.1371/journal.pone.0220566	http://dx.doi.org/10.1371/journal.pone.0220566			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390355	Green Published, gold, Green Submitted			2022-12-27	WOS:000484999400020
J	Di Cosimo, S; La Verde, N; Moretti, A; Cazzaniga, ME; Generali, D; Bianchi, GV; Mariani, L; Torri, V; Crippa, F; Paolini, B; Scaperrotta, G; De Santis, MC; Di Nicola, M; Apolone, G; Gulino, A; Tripodo, C; Colombo, MP; Folli, S; de Braud, F				Di Cosimo, Serena; La Verde, Nicla; Moretti, Anna; Cazzaniga, Marina Elena; Generali, Daniele; Bianchi, Giulia Valeria; Mariani, Luigi; Torri, Valter; Crippa, Flavio; Paolini, Biagio; Scaperrotta, Gianfranco; De Santis, Maria Carmen; Di Nicola, Massimo; Apolone, Giovanni; Gulino, Alessandro; Tripodo, Claudio; Colombo, Mario Paolo; Folli, Secondo; de Braud, Filippo			Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study	PLOS ONE			English	Article							HALICHONDRIN B ANALOG; PHASE-II; ADJUVANT CHEMOTHERAPY; NAB-PACLITAXEL; TUMOR RESPONSE; CLINICAL-TRIAL; OPEN-LABEL; WOMEN; CYCLOPHOSPHAMIDE; FLUOROURACIL	Background Eribulin mesylate (E) is indicated for metastatic breast cancer patients previously treated with anthracycline and taxane. We argued that E could also benefit patients eligible for neoadjuvant chemotherapy. Methods Patients with primary triple negative breast cancer >= 2 cm received doxorubicin 60 mg/m(2) and paclitaxel 200 mg/m(2) x 4 cycles (AT) followed by E 1.4 mg/m(2) x 4 cycles. Primary endpoint was pathological complete response (pCR) rate; secondary and explorative endpoints included clinical/metabolic response rates and safety, and biomarker analysis, respectively. Using a two-stage Simon design, 43 patients were to be included provided that 4 of 13 patients had achieved pCR in the first stage of the study. Results In stage I of the study 13 women were enrolled, median age 43 years, tumor size 2-5 cm in 9/13 (69%), positive nodal status in 8/13 (61%). Main grade 3 adverse event was neutropenia (related to AT and E in 4 and 2 cases, respectively). AT followed by E induced clinical complete + partial responses in 11/13 patients (85%), pCR in 3/13 (23%). Median measurements of maximum standardized uptake value (SUVmax) resulted 13, 3, and 1.9 at baseline, after AT and E, respectively. Complete metabolic response (CMR) occurred after AT and after E in 2 and 3 cases, respectively. Notably, 2 of the 5 (40%) patients with CMR achieved pCR at surgery. Immunostaining of paired pre-/post-treatment tumor specimens showed a reduction of beta-catenin, CyclinD1, Zeb-1, and c-myc expression, in the absence of N-cadherin modulation. The study was interrupted at stage I due to the lack of the required patients with pCR. Conclusions Despite the early study closure, preoperative E following AT showed clinical and biological activity in triple negative breast cancer patients. Furthermore, the modulation of beta-catenin pathway core proteins, supposedly outside the domain of epithelial-mesenchymal transition, claims for further investigation.	[Di Cosimo, Serena; Bianchi, Giulia Valeria; Mariani, Luigi; Crippa, Flavio; Paolini, Biagio; Scaperrotta, Gianfranco; De Santis, Maria Carmen; Di Nicola, Massimo; Apolone, Giovanni; Colombo, Mario Paolo; Folli, Secondo; de Braud, Filippo] Fdn IRCCS Ist Nazl Tumori Milano, Milan, Italy; [La Verde, Nicla] ASST Fatebenefratelli Sacco, PO Sacco, Milan, Italy; [Moretti, Anna] ASST Fatebenefratelli Sacco, PO Fatebenefratelli, Milan, Italy; [Cazzaniga, Marina Elena] ASST Monza, Ctr Ric Fase 1, Monza, Italy; [Generali, Daniele] ASST Cremona, Cremona, Italy; [Torri, Valter] IRCCS Ist Ric Farmacol Mario Negri, Milan, Italy; [Gulino, Alessandro; Tripodo, Claudio] Univ Palermo, Sch Med, Palermo, Italy; [de Braud, Filippo] Univ Milan, Sch Med, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Palermo; University of Milan	Di Cosimo, S (corresponding author), Fdn IRCCS Ist Nazl Tumori Milano, Milan, Italy.	serena.dicosimo@istitutotumori.mi.it	cazzaniga, marina/AAB-9950-2022; , Di Cosimo Serena/E-9418-2017; Folli, Secondo/AAB-2227-2020; Torri, Valter/H-7550-2015; Mariani, Luigi/AAB-9464-2019; Tripodo, Claudio/AAB-6004-2022; Mariani, Luigi/C-2580-2017; la verde, nicla/AAW-9398-2020; Colombo, Mario P./V-7166-2017; Apolone, Giovanni/R-9799-2016; Paolini, Biagio/E-9240-2017; BIANCHI, GIULIA VALERIA/C-4553-2017	, Di Cosimo Serena/0000-0002-4666-8052; Folli, Secondo/0000-0003-3465-3010; Torri, Valter/0000-0001-9541-9354; Tripodo, Claudio/0000-0002-0821-6231; Mariani, Luigi/0000-0001-6208-4084; la verde, nicla/0000-0002-2884-1632; Colombo, Mario P./0000-0003-0042-7955; Apolone, Giovanni/0000-0001-5179-104X; GENERALI, DANIELE/0000-0003-2480-3855; Paolini, Biagio/0000-0001-7535-7715; BIANCHI, GIULIA VALERIA/0000-0003-3630-4527	EISAI	EISAI(Eisai Co Ltd)	The HOPE study is an Investigator Initiated Trial supported by EISAI; Eribulin is an asset of EISAI. EISAI had no role in study design, enrollment, biological sample collection; data management, analysis, and interpretation, preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.	Abraham J, 2015, BREAST CANCER RES TR, V152, P399, DOI 10.1007/s10549-015-3466-4; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Alberro JA, 2018, LANCET ONCOL, V19, P27, DOI 10.1016/S1470-2045(17)30777-5; [Anonymous], CLIN BREAST CANC; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chang HR, 2010, CANCER-AM CANCER SOC, V116, P4227, DOI 10.1002/cncr.25309; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Cortes J, 2011, LANCET, V377, P914, DOI 10.1016/S0140-6736(11)60070-6; Cortes J, 2010, J CLIN ONCOL, V28, P3922, DOI 10.1200/JCO.2009.25.8467; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gianni L, 2005, CLIN CANCER RES, V11, P8715, DOI 10.1158/1078-0432.CCR-05-0539; Gianni L, 2018, JAMA ONCOL, V4, P302, DOI 10.1001/jamaoncol.2017.4612; Gianni L, 2009, J CLIN ONCOL, V27, P2474, DOI 10.1200/JCO.2008.19.2567; Gray R, 2018, CANCER RES, V78; Jordan MA, 2005, MOL CANCER THER, V4, P1086, DOI 10.1158/1535-7163.MCT-04-0345; Kaklamani VG, 2015, BREAST CANCER RES TR, V151, P629, DOI 10.1007/s10549-015-3435-y; Kuznetsov G, 2004, CANCER RES, V64, P5760, DOI 10.1158/0008-5472.CAN-04-1169; Locatelli MA, 2017, BREAST CARE, V12, P152, DOI 10.1159/000478087; Loibl S, 2018, LANCET ONCOL, V19, P497, DOI 10.1016/S1470-2045(18)30111-6; Malorni L, 2012, BREAST CANCER RES TR, V136, P795, DOI 10.1007/s10549-012-2315-y; Naito Y, EUR J CANC S3, V92, pS17; Okouneva T, 2008, MOL CANCER THER, V7, P2003, DOI 10.1158/1535-7163.MCT-08-0095; Shien T, 2016, ANN ONCOL, V27; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Torrisi R, 2008, CANCER CHEMOTH PHARM, V62, P667, DOI 10.1007/s00280-007-0652-z; Twelves C, 2016, BREAST CANCER-BASIC, V10, P77, DOI 10.4137/BCBCR.S39615; Twelves C, 2014, BREAST CANCER RES TR, V148, P553, DOI 10.1007/s10549-014-3144-y; Untch M, 2016, LANCET ONCOL, V17, P345, DOI 10.1016/S1470-2045(15)00542-2; Vahdat LT, 2009, J CLIN ONCOL, V27, P2954, DOI 10.1200/JCO.2008.17.7618; Yardley DA, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-P1-12-04; Yardley DA, 2015 SAN ANT BREAST; Yoshida T, 2014, BRIT J CANCER, V110, P1497, DOI 10.1038/bjc.2014.80; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4; Zoltan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106131	35	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220644	10.1371/journal.pone.0220644	http://dx.doi.org/10.1371/journal.pone.0220644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390375	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400025
J	Wallace, RVS; Martinez, R; Rowe, T				Wallace, Rachel V. S.; Martinez, Ricardo; Rowe, Timothy			First record of a basal mammaliamorph from the early Late Triassic Ischigualasto Formation of Argentina	PLOS ONE			English	Article							GRANDE-DO-SUL; FOSSIL EVIDENCE; CYNODONT; BRAZIL; THERAPSIDA; EVOLUTION; EUCYNODONTIA; MAMMALIAFORM; ORIGIN; TRITHELEDONTIDAE	We describe a new probainognathian cynodont, Pseudotherium argentinus, from the early Late Triassic Ischigualasto Formation of Argentina. Pseudotherium adds to a growing assemblage of small Triassic cynodonts that offers new insight into events leading up to the origin of crown Mammalia and the successively more inclusive Mammaliaformes and Mammaliamorpha. Using high-resolution X-ray computed tomography, we illustrate and describe the holotype and only known specimen, which consists of a well-preserved isolated skull. It preserves apomorphic features of the orbit and braincase. Prefrontal and vestigial postorbital bones are present, despite the absence of an ossified postorbital bar. As in Brasilitherium riograndensis, thin turbinal-like bones are present in the nasopharyngeal passage, and we discuss impediments to establishing their identity and function. Compared to more basal cynodonts, the cochlea is elongated but uncoiled and in this and other features it resembles basal mammaliamorphs. Our analysis found weak support for Pseudotherium as the sister taxon of Tritylodontidae. However, a broader assessment of its relationships in light of additional character data from the literature and unpublished computed tomography data suggest that it may be more realistic to view the relationships of Pseudotherium as an unresolved polytomy with tritylodontids, and the taxa referred to as tritheledontids and brasilodontids (groups of variable membership and questionable monophyly). Thus, Pseudotherium may lie just inside or just outside of Mammaliamorpha, and there is also weak character support for its sister taxon relationship with Brasilitherium. Our results amplify previous conclusions that phylogenetic relationships in this adaptive radiation of small cynodonts will remain somewhat uncertain until more complete specimens are recovered, and until high-resolution CT scans of existing specimens become available to the larger community. Toward that goal, we make the CT dataset for the holotype of Pseudotherium argentinus publically available under a Creative Commons license at www.DigiMorph.org.	[Wallace, Rachel V. S.; Rowe, Timothy] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Martinez, Ricardo] Univ Nacl San Juan, Inst & Museo Ciencias Nat, Div Paleontol Vertebrados, San Juan, Argentina; [Wallace, Rachel V. S.] Univ Texas Austin, Dept Med Educ, Dell Med Sch, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Universidad Nacional de San Juan; University of Texas System; University of Texas Austin	Wallace, RVS (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.; Wallace, RVS (corresponding author), Univ Texas Austin, Dept Med Educ, Dell Med Sch, Austin, TX 78712 USA.	Rachel.Wallace@austin.utexas.edu		Wallace, Rachel/0000-0003-3160-5865	National Science Foundation Division of Earth Sciences [EAR 1258878]; Geology Foundation of the Jackson School of Geosciences	National Science Foundation Division of Earth Sciences(National Science Foundation (NSF)); Geology Foundation of the Jackson School of Geosciences	TBR received funding for scanning from the National Science Foundation Division of Earth Sciences (EAR 1258878) (https://www.nsf.gov/div/index.jsp?div=EAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TBR and RVSW received funding for scanning and computing resources from the Geology Foundation of the Jackson School of Geosciences (http://www.jsg.utexas.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2007, PALAEONTOLOGY, V50, P591, DOI 10.1111/j.1475-4983.2007.00646.x; Barghusen HR, 1986, ECOLOGY BIOL MAMMAL, P256; Benoit J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25604; Bonaparte J.F., 1980, 2 C ARG PAL BIOESTR, P123; BONAPARTE JF, 1975, J PALEONTOL, V49, P931; Bonaparte JF, 2001, PALAEONTOLOGY, V44, P623, DOI 10.1111/1475-4983.00194; Bonaparte JF, 2006, B N M MUS NAT HIST S, V37, P533; Bonaparte JF, 2001, B MUS COMP ZOOL HARV, V156, P37; Bonaparte JF, 2013, HIST NAT, V2, P5; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte Jose F., 2003, Revista Brasileira de Paleontologia, V5, P5; Bonaparte JF, 2013, HIST BIOL, V25, P643, DOI 10.1080/08912963.2012.731154; Bonaparte JF, 2010, REV BRAS PALEONTOLOG, V13, P233, DOI 10.4072/rbp.2010.3.07; Broom, 1932, MAMMAL LIKE REPTILES; Broom R., 1936, Annals of the Transvaal Museum, V18, P349; Broom R, 1929, P LINN SOC, P688; Broom R., 1912, ANN S AFR MUS, V7, P334; Cantino P.D., 2003, PHYLOCODE PHYLOGENET; Carlson WD, 2003, GEOL SOC SPEC PUBL, V215, P7, DOI 10.1144/GSL.SP.2003.215.01.02; Crompton AW, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1269116; CROMPTON AW, 1993, MAMMAL PHYLOGENY, P30; CROMPTON AW, 1985, ZOOL J LINN SOC-LOND, V85, P99, DOI 10.1111/j.1096-3642.1985.tb01500.x; Crompton AW, 1955, RES NASIONALE MUSEUM, V1, P150; Currie BS, 2009, J S AM EARTH SCI, V27, P74, DOI 10.1016/j.jsames.2008.10.004; Davies TG, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0194; de Beer G., 1937, DEV VERTEBRATE SKULL; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; Estes R., 1961, Bulletin of the Museum of Comparative Zoology, V125, P165; FOURIE S, 1974, Annals of the South African Museum, V65, P337; Garrett EC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2828; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; HAUGHTON S. H., 1954, PALEONTOL AFRICANA, V2, P1; Hopson JA, 1986, ANAL RAPSID RELATION, P83; Hopson James A., 2001, Bulletin of the Museum of Comparative Zoology, V156, P5; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; Kemp T.S, 1982, MAMMAL LIKE REPTILES; KEMP TS, 1983, ZOOL J LINN SOC-LOND, V77, P353, DOI 10.1111/j.1096-3642.1983.tb00859.x; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KERMACK KA, 1981, ZOOL J LINN SOC-LOND, V71, P1, DOI 10.1111/j.1096-3642.1981.tb01127.x; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Lillegraven JA, 1979, MESOZOIC MAMMALS 1 2; Liu J, 2010, J MAMM EVOL, V17, P151, DOI 10.1007/s10914-010-9136-8; Lucas Spencer G., 1993, Journal of Vertebrate Paleontology, V13, P309; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2016, SPRINGER HANDB AUDIT, V59, P139, DOI 10.1007/978-3-319-46661-3_6; Luo ZX, 2015, P NATL ACAD SCI USA, V112, pE7101, DOI 10.1073/pnas.1519387112; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P113, DOI 10.1080/02724634.1995.10011211; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinelli AG, 2017, CONTRIBUICAO CONHECI; Martinelli AG, 2007, J VERTEBR PALEONTOL, V27, P442, DOI 10.1671/0272-4634(2007)27[442:OCMETF]2.0.CO;2; Martinelli AG, 2017, PAP PALAEONTOL, V3, P401, DOI 10.1002/spp2.1081; Martinelli AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162945; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P271, DOI 10.1080/02724634.1996.10011314; Oliveira T.V., 2011, PALAEONTOL Z, V85, P67, DOI DOI 10.1007/S12542-010-0078-5; Rodrigues PG, 2014, PALAEONTOL Z, V88, P329, DOI 10.1007/s12542-013-0200-6; Rodrigues PG, 2013, J MAMM EVOL, V20, P291, DOI 10.1007/s10914-012-9221-2; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Romer A. S., 1970, Breviora, VNo. 344, P1; Romer A.S, 1956, OSTEOLOGY REPTILIA; Rougier G.W., 1992, Journal of Vertebrate Paleontology, V12, P188; ROWE T, 1992, SYST BIOL, V41, P372, DOI 10.2307/2992573; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Rowe T, 1997, GEOTIMES, V42, P23; ROWE T, 1993, MAMMAL PHYLOGENY, P129; Rowe T, 1995, THRINAXODON DIGITAL, P547; Rowe T.B., 2017, EVOLUTION NERVOUS SY, P1; Rowe TB, 1986, OSTEOLOGICAL DIAGNOS; Rowe Timothy, 1996, Memoirs of the California Academy of Sciences, V20, P71; Rowe Timothy B., 2005, Journal of Mammalian Evolution, V12, P303, DOI 10.1007/s10914-005-5731-5; Rowe TB, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.40; Rowe TB, 2016, J COMP NEUROL, V524, P471, DOI 10.1002/cne.23802; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; Ruf I, 2014, ANAT REC, V297, P2018, DOI 10.1002/ar.23022; Shepherd GM, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00100; SHUBIN NH, 1991, SCIENCE, V251, P1063, DOI 10.1126/science.251.4997.1063; Sidor CA, 2006, J PALEONTOL, V80, P10; Silva JEMR, 2018, OCCUPATIONAL SAFETY AND HYGIENE VI, P1; Soares M. H. F. B., 2004, THESIS; Soares MB, 2014, AN ACAD BRAS CIENC, V86, P1673, DOI 10.1590/0001-3765201420140455; Soares MB, 2011, AN ACAD BRAS CIENC, V83, P329, DOI 10.1590/S0001-37652011000100021; SUES H-D, 1986, Bulletin of the Museum of Comparative Zoology, V151, P217; Sues Hans-Dieter, 2001, Bulletin of the Museum of Comparative Zoology, V156, P37; Swofford D.L., 2003, PAUP VERSION 40 B10; Tatarinov L.P., 1963, PALEONTOL ZH, V4, P46; van Bemmelen JF, 1901, DENKSCHR MEDNATURW G, V3, P729; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Watson D. M. S., 1913, Geological Magazine London (5), V10; Wible J.R., 1991, Journal of Vertebrate Paleontology, V11, P1; Zander R. H., 2004, PHYLOINFORMATICS, V2, P1	100	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0218791	10.1371/journal.pone.0218791	http://dx.doi.org/10.1371/journal.pone.0218791			56	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390368	Green Submitted, Green Published, gold			2022-12-27	WOS:000484999400004
J	Nair, AV; Wei, YH; Paunescu, TG; Bouley, R; Brown, D				Nair, Anil, V; Wei Yanhong; Paunescu, Teodor G.; Bouley, Richard; Brown, Dennis			Sex-dependent differences in water homeostasis in wild-type and V-ATPase B1-subunit deficient mice	PLOS ONE			English	Article							CONSENSUS DEVELOPMENT CONFERENCE; RENAL INTERCALATED CELLS; BODY-FLUID; EXPRESSION; HYPONATREMIA; VASOPRESSIN; PHYSIOLOGY; STATEMENT; INSIGHTS; HORMONES	Men tend to dehydrate more than women after prolonged exercise, possibly due to lower water intake and higher perspiration rate. Women are prone to exercise-associated hyponatremia, primarily attributed to the higher water consumption causing hypervolemia. Since aquaporin-2 (AQP2) water channels in the kidney collecting duct (CD) principal cells (PCs) are involved in maintaining water balance, we investigated their role in sex-dependent water homeostasis in wild-type (WT) C57BL/6 mice. Because CD intercalated cells (ICs) may also be involved in water balance, we also assessed the urine concentrating ability of V-ATPase B1 subunit-deficient (Atp6v1b1(-/-)) mice. Upon 12-hour water deprivation, urine osmolality increased by 59% in WT female mice and by only 28% in males. This difference was abolished in Atp6v1b1(-/-) mice, in which dehydration induced a similar to 30% increase in urine osmolarity in both sexes. AQP2 levels were highest in WT females; female Atp6v1b1(-/-) mice had substantially lower AQP2 expression than WT females, comparable to the low AQP2 levels seen in both Atp6v1b1(-/-) and WT males. After dehydration, AQP2 relocates towards the PC apical pole, especially in the inner stripe and inner medulla, and to a greater extent in WT females than in WT males. This apparent sex-dependent concentrating advantage was absent in Atp6v1b1(-/-) females, whose reduced AQP2 apical relocation was similar to WT males. Accordingly, female mice concentrate urine better than males upon dehydration due to increased AQP2 expression and mobilization. Moreover, our data support the involvement of ICs in water homeostasis, at least partly mediated by V-ATPase, in a sex-dependent manner.	[Nair, Anil, V; Wei Yanhong; Paunescu, Teodor G.; Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA; [Nair, Anil, V; Wei Yanhong; Paunescu, Teodor G.; Bouley, Richard; Brown, Dennis] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Nair, Anil, V; Wei Yanhong; Paunescu, Teodor G.; Bouley, Richard; Brown, Dennis] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Nair, AV (corresponding author), Massachusetts Gen Hosp, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA.	avnair@mgh.harvard.edu	Paunescu, Teodor/AAX-7533-2020	Paunescu, Teodor/0000-0003-0227-9028	Centre for the Study of Inflammatory Bowel Disease [DK043351 NIH]; Boston Area Diabetes and Endocrinology Research Center [DK057521 NIH];  [5R01DK096586 NIH];  [R56DK042956 NIH];  [S10 OD021577-01 NIH]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK042956, R01DK096586] Funding Source: NIH RePORTER	Centre for the Study of Inflammatory Bowel Disease; Boston Area Diabetes and Endocrinology Research Center; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 5R01DK096586 NIH, R56DK042956 NIH, S10 OD021577-01 NIH to DB, Centre for the Study of Inflammatory Bowel Disease DK043351 NIH, and Boston Area Diabetes and Endocrinology Research Center DK057521 NIH.r The Microscopy core facility of the Massachusetts General Hospital (MGH) Program in Membrane Biology receives support by a Centre for the Study of Inflammatory Bowel Disease and a Boston Area Diabetes and Endocrinology Research Center.	Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Dickinson H, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-21; Eijsvogels TMH, 2013, SCAND J MED SCI SPOR, V23, P198, DOI 10.1111/j.1600-0838.2011.01371.x; Eladari D, 2012, ANNU REV PHYSIOL, V74, P325, DOI 10.1146/annurev-physiol-020911-153225; Fenton RA, 2013, CURR OPIN NEPHROL HY, V22, P551, DOI 10.1097/MNH.0b013e328364000d; Finberg KE, 2005, P NATL ACAD SCI USA, V102, P13616, DOI 10.1073/pnas.0506769102; Gueutin V, 2013, J CLIN INVEST, V123, P4219, DOI 10.1172/JCI63492; Hatano R, 2012, AM J PHYSIOL-RENAL, V302, pF342, DOI 10.1152/ajprenal.00366.2011; HAYLOR J, 1980, J PHYSIOL-LONDON, V298, P383, DOI 10.1113/jphysiol.1980.sp013088; Herak-Kramberger CM, 2015, AM J PHYSIOL-RENAL, V308, pF809, DOI 10.1152/ajprenal.00368.2014; Hew-Butler T, 2008, CLIN J SPORT MED, V18, P111, DOI 10.1097/JSM.0b013e318168ff31; Hew-Butler T, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00021; Hew-Butler T, 2015, CLIN J SPORT MED, V25, P303, DOI 10.1097/JSM.0000000000000221; Knepper MA, 1997, AM J PHYSIOL-RENAL, V272, pF3, DOI 10.1152/ajprenal.1997.272.1.F3; Liu J, 2011, AM J PHYSIOL-RENAL, V300, pF433, DOI 10.1152/ajprenal.00199.2010; Nair AV, 2015, ACS NANO, V9, P3641, DOI 10.1021/acsnano.5b00428; Olesen ETB, 2013, J AM SOC NEPHROL, V24, P169, DOI 10.1681/ASN.2012020217; Paunescu TG, 2008, AM J PHYSIOL-RENAL, V294, pF130, DOI 10.1152/ajprenal.00406.2007; Paunescu TG, 2007, AM J PHYSIOL-RENAL, V293, pF1915, DOI 10.1152/ajprenal.00160.2007; Paunescu TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045395; Rosner MH, 2007, CLIN J AM SOC NEPHRO, V2, P151, DOI 10.2215/CJN.02730806; Sasaki S, 2012, MOL ASPECTS MED, V33, P535, DOI 10.1016/j.mam.2012.03.004; Soleimani M, 2015, NEPHROL DIAL TRANSPL, V30, P1257, DOI 10.1093/ndt/gfu307; Stachenfeld NS, 2009, J APPL PHYSIOL, V107, P864, DOI 10.1152/japplphysiol.91211.2008; Stachenfeld NS, 2001, J APPL PHYSIOL, V91, P1893, DOI 10.1152/jappl.2001.91.4.1893; Vedovelli L, 2013, AM J PHYSIOL-RENAL, V304, pF522, DOI 10.1152/ajprenal.00394.2012; Wall SM, 2017, KIDNEY RES CLIN PRAC, V36, P305, DOI 10.23876/j.krcp.2017.36.4.305; Wang YX, 1997, AM J PHYSIOL-REG I, V272, pR370, DOI 10.1152/ajpregu.1997.272.1.R370; WEBER PC, 1979, KLIN WOCHENSCHR, V57, P1021, DOI 10.1007/BF01479987	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219940	10.1371/journal.pone.0219940	http://dx.doi.org/10.1371/journal.pone.0219940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386675	Green Submitted, gold, Green Published			2022-12-27	WOS:000484997100012
J	Villasenor-Altamirano, AB; Watson, JD; Prokopec, SD; Yao, CQ; Boutros, PC; Pohjanvirta, R; Valdes-Flores, J; Elizondo, G				Villasenor-Altamirano, Ana B.; Watson, John D.; Prokopec, Stephenie D.; Yao, Cindy Q.; Boutros, Paul C.; Pohjanvirta, Raimo; Valdes-Flores, Jesus; Elizondo, Guillermo			2,3,7,8-Tetrachlorodibenzo-p-dioxin modifies alternative splicing in mouse liver	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; AH RECEPTOR; BINDING DOMAIN; EXPRESSION; TCDD; EXON; IDENTIFICATION; DISRUPTION; MECHANISMS; REPRESSOR	Alternative splicing is a co-transcriptional mechanism that generates protein diversity by including or excluding exons in different combinations, thereby expanding the diversity of protein isoforms of a single gene. Abnormalities in this process can result in deleterious effects to human health, and several xenobiotics are known to interfere with splicing regulation through multiple mechanisms. These changes could lead to human diseases such as cancer, neurological disorders, autoimmune diseases, and developmental disorders. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is an environmental contaminant generated as a byproduct of various industrial activities. Exposure to this dioxin has been linked to a wide range of pathologies through the alteration of multiple cellular processes. However, the effects of TCDD exposure on alternative splicing have not yet been studied. Here, we investigated whether a single po. dose of 5 mu g/kg or 500 mu g/kg TCDD influence hepatic alternative splicing in adult male C57BL/6Kou mouse. We identified several genes whose alternative splicing of precursor messenger RNAs was modified following TCDD exposure. In particular, we demonstrated that alternative splicing of Cyp1a1, Ahrr, and Actn1 was significantly altered after TCDD treatment. These findings show that the exposure to TCDD has an impact on alternative-splicing, and suggest a new avenue for understanding TCDD-mediated toxicity and pathogenesis.	[Villasenor-Altamirano, Ana B.; Elizondo, Guillermo] IPN, CINVESTAN, Natl Polytech Inst, Cell Biol Dept,Ctr Res & Adv Studies, Mexico City, DF, Mexico; [Villasenor-Altamirano, Ana B.] Univ Nacl Autonoma Mexico, Int Lab Human Genome Res, Queretaro, Mexico; [Watson, John D.; Prokopec, Stephenie D.; Yao, Cindy Q.; Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Yao, Cindy Q.; Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Pohjanvirta, Raimo] Natl Inst Hlth & Welf, Lab Toxicol, Kuopio, Finland; [Pohjanvirta, Raimo] Univ Helsinki, Dept Food Hyg & Environm Hlth, Helsinki, Finland; [Valdes-Flores, Jesus] IPN, CINVESTAV, Natl Polytech Inst, Biochem Dept,Ctr Res & Adv Studies, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; University of Helsinki; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Elizondo, G (corresponding author), IPN, CINVESTAN, Natl Polytech Inst, Cell Biol Dept,Ctr Res & Adv Studies, Mexico City, DF, Mexico.	gazuela@cinvestav.mx		Pohjanvirta, Raimo/0000-0003-0952-5746; Villasenor Altamirano, Ana Beatriz/0000-0002-3940-5617	Terry Fox Research Institute; CIHR New Investigator Awards; Consejo Nacional de Ciencia y Tecnologia [153377, 280897]	Terry Fox Research Institute; CIHR New Investigator Awards(Canadian Institutes of Health Research (CIHR)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by Terry Fox Research Institute and CIHR New Investigator Awards, to PCB; and Consejo Nacional de Ciencia y Tecnologia grant 153377 and 280897, GE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward LL, 2002, J EXPO ANAL ENV EPID, V12, P319, DOI 10.1038/sj.jea.7500233; Boutros PC, 2011, TOXICOL APPL PHARM, V251, P119, DOI 10.1016/j.taap.2010.12.010; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen R, 2017, METAB BRAIN DIS, V32, P667, DOI 10.1007/s11011-017-0007-3; Chopra M, 2011, CRIT REV TOXICOL, V41, P292, DOI 10.3109/10408444.2010.524635; Enan E, 1996, BIOCHEM PHARMACOL, V52, P1599, DOI 10.1016/S0006-2952(96)00566-7; Falahatpisheh MH, 2003, ONCOGENE, V22, P2160, DOI 10.1038/sj.onc.1206238; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gonzalez FJ, 1998, DRUG METAB DISPOS, V26, P1194; Hsu LC, 1996, GENE EXPRESSION, V6, P87; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karchner SI, 2009, MOL CELL BIOL, V29, P3465, DOI 10.1128/MCB.00206-09; Kommaddi RP, 2007, J NEUROCHEM, V102, P867, DOI 10.1111/j.1471-4159.2007.04599.x; Kumar MB, 1999, J BIOL CHEM, V274, P22155, DOI 10.1074/jbc.274.32.22155; Leung YK, 2005, CANCER RES, V65, P3726, DOI 10.1158/0008-5472.CAN-04-3771; MANZ A, 1991, LANCET, V338, P959, DOI 10.1016/0140-6736(91)91835-I; Martin EA, 2015, ELIFE, V4, DOI 10.7554/eLife.09395; Moffat ID, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-263; Murphy ACH, 2016, FEBS LETT, V590, P685, DOI 10.1002/1873-3468.12101; Nazarov PV, 2017, BMC GENOMICS, V18, P1, DOI [10.1186/s12864-016-3406-7, DOI 10.1186/S12864-016-3406-7]; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; P'ng C, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2610-2; Patel RD, 2009, LAB INVEST, V89, P695, DOI 10.1038/labinvest.2009.24; Placencio VR, 2015, CANCER RES, V75, P2969, DOI 10.1158/0008-5472.CAN-15-0876; POHJANVIRTA R, 1994, PHARMACOL REV, V46, P483; Powers BE, 2005, GENES BRAIN BEHAV, V4, P51, DOI 10.1111/j.1601-183X.2004.00098.x; Prochazkova J, 2011, TOXICOL SCI, V122, P349, DOI 10.1093/toxsci/kfr129; Prokopec SD, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3446-z; Puga A, 1997, BIOCHEM PHARMACOL, V54, P1287, DOI 10.1016/S0006-2952(97)00417-6; Rasche A, 2010, BIOINFORMATICS, V26, P84, DOI 10.1093/bioinformatics/btp626; Rawson RL, 2017, CURR OPIN NEUROBIOL, V45, P39, DOI 10.1016/j.conb.2017.03.006; Rowlands JC, 1997, CRIT REV TOXICOL, V27, P109, DOI 10.3109/10408449709021615; Scotti MM, 2016, NAT REV GENET, V17, P19, DOI 10.1038/nrg.2015.3; Southby J, 1999, MOL CELL BIOL, V19, P2699; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; WAITES GT, 1992, J BIOL CHEM, V267, P6263; Wang C, 2017, J CRANIO MAXILL SURG, V45, P678, DOI 10.1016/j.jcms.2017.02.004; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; White SS, 2009, J ENVIRON SCI HEAL C, V27, P197, DOI 10.1080/10590500903310047; Wu YG, 2013, MOL CELL BIOL, V33, P2817, DOI 10.1128/MCB.00011-13; Yan CL, 2010, MUTAT RES-FUND MOL M, V686, P47, DOI 10.1016/j.mrfmmm.2010.01.015; Yuan XG, 2016, MOL MED REP, V14, P1139, DOI 10.3892/mmr.2016.5348; Zaharieva E, 2012, TOXICOLOGY, V296, P1, DOI 10.1016/j.tox.2012.01.014	48	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219747	10.1371/journal.pone.0219747	http://dx.doi.org/10.1371/journal.pone.0219747			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386671	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100009
J	Morato, GO; Rocha, AG; Chung, DG; da Conceicao, MEBAM; Minto, BW; Padilha, JG; Dias, LGGG				Morato, Glaucia O.; Rocha, Artur G.; Chung, Denise G.; da Conceicao, Maria E. B. A. M.; Minto, Bruno W.; Padilha Filho, Joao G.; Dias, Luis G. G. G.			Lyophilized and gamma-sterilized allogeneic bone implant used as a spacer for advancement of a modified tibial tuberosity in the treatment of cranial cruciate ligament disease in dogs	PLOS ONE			English	Article							PLATEAU LEVELING OSTEOTOMY; COMPLICATIONS	The objective of this study was to evaluate the use of a lyophilized and gamma-sterilized allogeneic freeze-dried bone wedge as a spacer for advancement of a modified tibial tuberosity (mTTA) in 16 knees that were clinically diagnosed with cranial cruciate ligament disease. Patients underwent radiography before the surgical procedure as well as immediately after surgery and at 30, 60, 90 and 120 days post-surgery, and their locomotion was evaluated at the same time points except for the immediate postoperative period. The surgical wounds were evaluated for signs of infection and rejection of the bone implant. Locomotion was graded on a scale of 0-5, with 0 indicating no limping and 5 indicating limb functional impotence. The "tibial-tibial bone-tibial implant" interfaces were evaluated radiographically, and each interface was assigned scores of 0-3, with 0 indicating no contact between the implant and adjacent bone and 3 indicating a bone bridge throughout the interface. The patients showed good clinical and radiographic recovery. The lyophilized bone spacer allowed for easy storage and transport and rapid and satisfactory execution of mTTA while showing resistance to drilling and fixation with screws in 87.5% of cases and a mean surgical time of 45.9 minutes. No immunogenic reactions were observed in 93.7% of the cases. One patient presented infection of the surgical focus, which showed remission after antimicrobial therapy. All patients showed functional recovery of the operated limb, with the number of clinically healthy patients being higher than those with claudication at 120 days (p <= 0.05). In all patients, it was possible to verify the incorporation of the bone implant into the tibia. Bone union occurred progressively, and the degrees of bone union observed on radiographs at postoperative days 60, 90, and 120 were significantly greater (p < 0.05) than those observed in the immediate postoperative period and at 30 days.	[Morato, Glaucia O.; Chung, Denise G.] Autonomus Vet Med, Descalvado, SP, Brazil; [Rocha, Artur G.] Ctr Univ Cent Paulista Unicep, Hosp Vet Univ, Sao Carlos, SP, Brazil; [da Conceicao, Maria E. B. A. M.; Minto, Bruno W.; Padilha Filho, Joao G.; Dias, Luis G. G. G.] Sao Paulo State Univ Julio de Mesquite Filho, Coll Agr Sci & Vet Med, Dept Clin & Anim Surg, Div Vet Surg, Jaboticabal Campus, Sao Paulo, Brazil	Centro Universitario Central Paulista; Universidade Estadual Paulista	Dias, LGGG (corresponding author), Sao Paulo State Univ Julio de Mesquite Filho, Coll Agr Sci & Vet Med, Dept Clin & Anim Surg, Div Vet Surg, Jaboticabal Campus, Sao Paulo, Brazil.	gustavogosuen@gmail.com	Dias, Luís Gustavo Gosuen Gonçalves/AGM-6576-2022; minto, bruno w/G-1186-2012	Dias, Luís Gustavo Gosuen Gonçalves/0000-0003-3993-1649; minto, bruno w/0000-0002-8808-4127; Bastos Andrade Moutinho da Conceicao, Maria Eduarda/0000-0002-6939-2183	National Council for Scientific and Technological Development (CNPq)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author of this paper (GOM) had recived a salary of National Council for Scientific and Technological Development (CNPq), which promoted an additional bank rate to by stuffs related to the project or pay some personal or institutional service.	Bander NB, 2018, J AM ANIM HOSP ASSOC, V54, P85, DOI [10.5326/JAAHA-MS-6532, 10.5326/jaaha-ms-6532]; Boudrieau RJ, 2011, VET SURG, V40, P641, DOI 10.1111/j.1532-950X.2011.00845.x; Christopher SA, 2013, VET SURG, V42, P329, DOI 10.1111/j.1532-950X.2013.12001.x; Costa M, 2017, VET SURG, V46, P494, DOI 10.1111/vsu.12649; Dal-Bo IS, 2013, ACTA SCI VET, V41, P1; Finkemeier CG., 2002, J BONE JOINT SURG, V84, P649; Gallagher AD, 2012, VET SURG, V41, P705, DOI 10.1111/j.1532-950X.2012.00971.x; Hedeiros RM, 2018, ARQ BRAS MED VET ZOO, V70, P1053, DOI 10.1590/1678-4162-9594; Innes JF, 2010, VET COMP ORTHOPAED, V23, P393, DOI 10.3415/VCOT-10-02-0022; Kim SE, 2009, VET SURG, V38, P23, DOI 10.1111/j.1532-950X.2008.00470.x; Lafaver S, 2007, VET SURG, V36, P573, DOI 10.1111/j.1532-950X.2007.00307.x; Medeiros RM, 2016, VET MED-CZECH, V61, P382, DOI 10.17221/168/2015-VETMED; Minier K, 2014, VET COMP ORTHOPAED, V27, P411, DOI 10.3415/VCOT-14-03-0036; Montavon P. M., 2002, 1st World Orthopaedic Veterinary Congress Proceedings, Munich, Germany, 5-8 September 2002, P152; Morato GO, 2012, BRA J AN SCI, V5, P346; Morato GO, 2017, INVESTIGACAO, V16, P1; Quinn MM, 2007, VET SURG, V36, P360, DOI 10.1111/j.1532-950X.2007.00276.x; Robinson D, 2017, VET SURG SMALL ANIMA, P2185; Rocha AG, 2012, WORLD ORTH VET C BOL, V16, P454; Tepic S., 2002, 1st World Orthopaedic Veterinary Congress Proceedings, Munich, Germany, 5-8 September 2002, P189; Wang Hong, 2015, Zhonghua Kou Qiang Yi Xue Za Zhi, V50, P720	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220291	10.1371/journal.pone.0220291	http://dx.doi.org/10.1371/journal.pone.0220291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381582	gold, Green Published, Green Submitted			2022-12-27	WOS:000484993600015
J	Hamaneh, MB; Yu, YK				Hamaneh, Mehdi B.; Yu, Yi-Kuo			Exploring induced pluripotency in human fibroblasts via construction, validation, and application of a gene regulatory network	PLOS ONE			English	Article							HUMAN SOMATIC-CELLS; STEM-CELLS; TRANSCRIPTIONAL REGULATION; SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; OCT4; INDUCTION; SOX2; KLF4	Reprogramming of somatic cells to induced pluripotent stem cells, by overexpressing certain factors referred to as the reprogramming factors, can revolutionize regenerative medicine. To provide a coherent description of induced pluripotency from the gene regulation perspective, we use 35 microarray datasets to construct a reprogramming gene regulatory network. Comprising 276 nodes and 4471 links, the resulting network is, to the best of our knowledge, the largest gene regulatory network constructed for human fibroblast reprogramming and it is the only one built using a large number of experimental datasets. To build the network, a model that relates the expression profiles of the initial (fibroblast) and final (induced pluripotent stem cell) states is proposed and the model parameters (link strengths) are fitted using the experimental data. Twenty nine additional experimental datasets are collectively used to test the model/network, and good agreement between experimental and predicted gene expression profiles is found. We show that the model in conjunction with the constructed network can make useful predictions. For example, we demonstrate that our approach can incorporate the effect of reprogramming factor stoichiometry and that its predictions are consistent with the experimentally observed trends in reprogramming efficiency when the stoichiometric ratios vary. Using our model/network, we also suggest new (not used in training of the model) candidate sets of reprogramming factors, many of which have already been experimentally verified. These results suggest our model/network can potentially be used in devising new recipes for induced pluripotency with higher efficiencies. Additionally, we classify the links of the network into three classes of different importance, prioritizing them for experimental verification. We show that many of the links in the top ranked class are experimentally known to be important in reprogramming. Finally, comparing with other methods, we show that using our model is advantageous.	[Hamaneh, Mehdi B.; Yu, Yi-Kuo] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Yu, YK (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.	yyu@ncbi.nlm.nih.gov		Yu, Yi-Kuo/0000-0002-6213-7665	National Institutes of Health [ZIA LM092404]; NATIONAL LIBRARY OF MEDICINE [ZIALM092404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was supported by the intramural research program of the National Institutes of Health through the grant ZIA LM092404 awarded to YKY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2010, GENES CELLS, V15, P455, DOI 10.1111/j.1365-2443.2010.01400.x; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Chai LE, 2014, COMPUT BIOL MED, V48, P55, DOI 10.1016/j.compbiomed.2014.02.011; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chang R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002300; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Declercq J, 2013, STEM CELLS DEV, V22, P2017, DOI 10.1089/scd.2012.0651; Duren ZN, 2012, CHIN CONTR CONF, P7437; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gracio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060240; Ho R, 2013, CELL REP, V3, P2113, DOI 10.1016/j.celrep.2013.05.015; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jones E., 2001, SCIPY OPEN SOURCE SC; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kim SI, 2015, STEM CELL REP, V4, P727, DOI 10.1016/j.stemcr.2015.02.004; Kumar A, 2012, J MOL CELL BIOL, V4, P252, DOI 10.1093/jmcb/mjs015; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lim LS, 2007, MOL BIOL CELL, V18, P1348, DOI 10.1091/mbc.E06-07-0624; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; MacArthur BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003086; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Marbach D, 2016, NAT METHODS, V13, P366, DOI [10.1038/NMETH.3799, 10.1038/nmeth.3799]; Mitra MK, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0706; Miyamoto T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004476; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Nakaki F, 2014, TRENDS BIOCHEM SCI, V39, P289, DOI 10.1016/j.tibs.2014.04.003; Nishimura K, 2014, STEM CELL REP, V3, P915, DOI 10.1016/j.stemcr.2014.08.014; Ohnuki M, 2014, P NATL ACAD SCI USA, V111, P12426, DOI 10.1073/pnas.1413299111; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi K, 2016, NAT REV MOL CELL BIO, V17, P183, DOI 10.1038/nrm.2016.8; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yamaguchi S, 2011, STEM CELL RES, V6, P177, DOI 10.1016/j.scr.2010.09.004; Yang HM, 2007, J CELL BIOCHEM, V101, P1198, DOI 10.1002/jcb.21244; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang B, 2014, P NATL ACAD SCI USA, V111, P10185, DOI 10.1073/pnas.1408561111; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220742	10.1371/journal.pone.0220742	http://dx.doi.org/10.1371/journal.pone.0220742			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374103	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500030
J	Harada, A; Taniguchi, F; Amano, H; Kurozawa, Y; Ideno, Y; Hayashi, K; Harada, T; Kawamoto, T; Ohya, Y; Kishi, R; Yaegashi, N; Hashimoto, K; Inadera, H; Yamagata, Z; Mori, C; Ito, S; Kamijima, M; Nakayama, T; Iso, H; Shima, M; Hirooka, Y; Suganuma, N; Kusuhara, K; Katoh, T				Harada, Akashi; Taniguchi, Fuminori; Amano, Hiroki; Kurozawa, Youichi; Ideno, Yuki; Hayashi, Kunihiko; Harada, Tasuku; Kawamoto, Toshihiro; Ohya, Yukihiro; Kishi, Reiko; Yaegashi, Nobuo; Hashimoto, Koichi; Inadera, Hidekuni; Yamagata, Zentaro; Mori, Chisato; Ito, Shuichi; Kamijima, Michihiro; Nakayama, Takeo; Iso, Hiroyasu; Shima, Masayuki; Hirooka, Yasuaki; Suganuma, Narufumi; Kusuhara, Koichi; Katoh, Takahiko		Japan Environm Childrens Study Grp	Adverse obstetrical outcomes for women with endometriosis and adenomyosis: A large cohort of the Japan Environment and Children's Study	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; PREGNANCY OUTCOMES; UTERINE ADENOMYOSIS; PERINATAL OUTCOMES; SPIRAL ARTERIES; INFERTILITY; SUBFERTILITY; ASSOCIATION; PREVALENCE	Background Because of the increased number of diagnosed cases of endometriosis or adenomyosis resulting in infertility, many women require assisted reproductive technology (ART) to become pregnant. However, incidences of obstetric complications are increased for women who conceive using ART. There has been no prospective cohort study examining the influence of endometriosis and adenomyosis on obstetric outcomes after adjusting for the confounding influence of ART therapy. Objective This study evaluated the impact of endometriosis and adenomyosis on the incidence of adverse pregnancy outcomes. Study design Data were obtained from a prospective cohort study, known as the Japan Environment and Children's Study (JECS), of the incidence of obstetric complications for women with endometriosis and adenomyosis. The data of 103,099 pregnancies that resulted in live birth or stillbirth or that were terminated through abortion between February 2011 and July 2014 in Japan were included. Results Women with endometriosis or adenomyosis were at increased risk for complications during pregnancy compared to those without a medical history of endometriosis (odds ratio [OR], 1.32; 95% confidence interval [CI], 1.23 to 1.41) or adenomyosis (OR, 1.72; 95% CI, 1.37 to 2.16). Our analysis showed that the adjusted ORs for obstetric complications of pregnant women who conceived naturally or after infertility treatment that did not involve ART therapy were 1.26 (CI, 1.17 to 1.35) for pregnant women with a history of endometriosis and 1.52 (CI, 1.19 to 1.94) for those with a history of adenomyosis. Conclusions The presence of endometriosis and adenomyosis significantly increased the prevalence of obstetric complications after adjusting for the influence of ART outcomes.	[Harada, Akashi; Taniguchi, Fuminori; Harada, Tasuku] Tottori Univ, Fac Med, Dept Obstet & Gynecol, Yonago, Tottori, Japan; [Amano, Hiroki; Kurozawa, Youichi] Tottori Univ, Fac Med, Dept Publ Hlth, Yonago, Tottori, Japan; [Ideno, Yuki; Hayashi, Kunihiko] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci & Environm Hlth Sci, Maebashi, Gunma, Japan; [Ohya, Yukihiro] Med Support Ctr, Tokyo, Japan; [Kishi, Reiko] Hokkaido Reg Ctr, Sapporo, Hokkaido, Japan; [Yaegashi, Nobuo] Miyagi Reg Ctr, Sendai, Miyagi, Japan; [Hashimoto, Koichi] Fukushima Reg Ctr, Fukushima, Japan; [Inadera, Hidekuni] Toyama Reg Ctr, Toyama, Japan; [Yamagata, Zentaro] Koushin Reg Ctr, Tokyo, Japan; [Mori, Chisato] Chiba Reg Ctr, Chiba, Japan; [Ito, Shuichi] Kanagawa Reg Ctr, Yokohama, Kanagawa, Japan; [Kamijima, Michihiro] Aichi Reg Ctr, Nagoya, Aichi, Japan; [Nakayama, Takeo] Kyoto Reg Ctr, Kyoto, Japan; [Iso, Hiroyasu] Osaka Reg Ctr, Osaka, Japan; [Shima, Masayuki] Hyogo Reg Ctr, Kobe, Hyogo, Japan; [Hirooka, Yasuaki] Tottori Reg Ctr, Tottori, Japan; [Suganuma, Narufumi] Kochi Reg Ctr, Kochi, Japan; [Kusuhara, Koichi] Fukuoka Reg Ctr, Fukuoka, Fukuoka, Japan; [Katoh, Takahiko] South Kyushu Okinawa Reg Ctr, Naha, Okinawa, Japan	Tottori University; Tottori University; Gunma University	Harada, T (corresponding author), Tottori Univ, Fac Med, Dept Obstet & Gynecol, Yonago, Tottori, Japan.	tasuku@med.tottori-u.ac.jp	NAKAYAMA, Takeo/HCH-0537-2022	Hayashi, Kunihiko/0000-0003-4648-3936				Aguilar HN, 2010, HUM REPROD UPDATE, V16, P725, DOI 10.1093/humupd/dmq016; Aris A, 2014, GYNECOL ENDOCRINOL, V30, P34, DOI 10.3109/09513590.2013.848425; Benagiano G, 2014, HUM REPROD UPDATE, V20, P386, DOI 10.1093/humupd/dmt052; Brosens I, 2013, PLACENTA, V34, P100, DOI 10.1016/j.placenta.2012.11.017; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; D'Hooghe TM, 2003, SEMIN REPROD MED, V21, P243; DOMMISSE J, 1992, BRIT J OBSTET GYNAEC, V99, P651, DOI 10.1111/j.1471-0528.1992.tb13848.x; Dueholm M, 2017, ACTA OBSTET GYN SCAN, V96, P715, DOI 10.1111/aogs.13158; Harada T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168476; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Juang CM, 2007, BJOG-INT J OBSTET GY, V114, P165, DOI 10.1111/j.1471-0528.2006.01186.x; Kanatani KT, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004863; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Khine Yin Mon, 2016, Reproductive Medicine and Biology, V15, P217, DOI 10.1007/s12522-016-0237-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; Kramer MS, 1997, OBSTET GYNECOL, V89, P221, DOI 10.1016/S0029-7844(96)00478-4; Larsen SB, 2011, EUR J OBSTET GYN R B, V157, P206, DOI 10.1016/j.ejogrb.2011.03.003; Levy G, 2013, J RADIOL DIAGN INTER, V94, P3, DOI 10.1016/j.diii.2012.10.012; Maggiore ULR, 2016, HUM REPROD UPDATE, V22, P70, DOI 10.1093/humupd/dmv045; Maheshwari A, 2012, HUM REPROD UPDATE, V18, P374, DOI 10.1093/humupd/dms006; MAJOR CA, 1995, AM J OBSTET GYNECOL, V172, P672, DOI 10.1016/0002-9378(95)90591-X; Martinez-Conejero JA, 2011, FERTIL STERIL, V96, P943, DOI 10.1016/j.fertnstert.2011.07.1088; Michikawa T, 2018, J EPIDEMIOL, V28, P99, DOI 10.2188/jea.JE20170018; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Mochimaru A, 2015, J OBSTET GYNAECOL RE, V41, P529, DOI 10.1111/jog.12604; Naftalin J, 2012, HUM REPROD, V27, P3432, DOI 10.1093/humrep/des332; Osteen KG, 1996, SEMIN REPROD ENDOCR, V14, P247, DOI 10.1055/s-2007-1016334; Pierce BT, 2000, AM J OBSTET GYNECOL, V183, P863, DOI 10.1067/mob.2000.108887; Reddy UM, 2007, OBSTET GYNECOL, V109, P967, DOI 10.1097/01.AOG.0000259316.04136.30; Reinhold C, 1999, RADIOGRAPHICS, V19, pS147, DOI 10.1148/radiographics.19.suppl_1.g99oc13s147; ROSSMAN F, 1983, OBSTET GYNECOL, V62, P519; Stephansson O, 2009, HUM REPROD, V24, P2341, DOI 10.1093/humrep/dep186; Wu Y, 2006, ENDOCRINOLOGY, V147, P232, DOI 10.1210/en.2005-0426; Yorifuji T, 2013, J OBSTET GYNAECOL RE, V39, P1480, DOI 10.1111/jog.12088	39	24	31	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220256	10.1371/journal.pone.0220256	http://dx.doi.org/10.1371/journal.pone.0220256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374085	Green Published, gold, Green Submitted			2022-12-27	WOS:000484991500006
J	Abba, C; Campanelli, R; Catarsi, P; Villani, L; Abbonante, V; Sesta, MA; Barosi, G; Rosti, V; Massa, M				Abba, Carlotta; Campanelli, Rita; Catarsi, Paolo; Villani, Laura; Abbonante, Vittorio; Sesta, Melanie Antonietta; Barosi, Giovanni; Rosti, Vittorio; Massa, Margherita			Constitutive STAT5 phosphorylation in CD34(+) cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity	PLOS ONE			English	Article							INTERNATIONAL WORKING GROUP; HEMATOPOIETIC STEM; INTERFERON-GAMMA; MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; PATHWAY ACTIVATION; POLYCYTHEMIA-VERA; JAK2 MUTATION; EXPRESSION; CONTRIBUTES	Primary Myelofibrosis (PMF) is a myeloproliferative disorder associated with JAK2V617F, Calreticulin (CALR) indels, and MPLW515L/K mutations activating the tyrosine kinase JAK2 and its downstream signaling pathway. The nature of signaling abnormalities in primary cells from PMF patients is poorly understood, since most of the work has been performed in cell lines or animal models. By flow cytometry we measured constitutive and cytokine induced phosphorylation of STAT5, STAT3, and ERK1/2 in circulating CD34(+) cells from 57 patients with PMF (20 with prefibrotic-PMF) and 13 healthy controls (CTRLs). Levels of constitutive and TPO induced p-STAT5, and IL6 induced p-STAT3 were higher in patients than in CTRLs. Constitutive p-STAT5 values were lower in CALR than homozygous JAK2V617F mutated CD34(+) cells from PMF patients. Moreover, constitutive p-STAT5 and IL6 induced p-STAT3 values correlated directly with circulating CD34(+) cell number/L, and inversely with the frequency of circulating CD34(+) cells expressing CXCR4. Constitutive p-STAT5 values of CD34(+) cells were also inversely correlated with hemoglobin levels. When the patients were divided according with presence/absence of JAK2V617F mutation, all the correlations described characterized the JAK2V617F+ patients with prefibrotic-PMF (P-PMF). In conclusion, increased constitutive p-STAT5 and IL6 induced p-STAT3 values in circulating CD34(+) cells characterize patients with PMF. Constitutive p-STAT5 and IL6 induced p-STAT3 values correlate with circulating CD34(+) cell number/L, the frequency of circulating CD34(+) cells expressing CXCR4 and hemoglobin levels within the prefibrotic JAK2V617F(+) patient population. Our data point toward a complex activation of STAT5-dependent pathways in the stem/progenitor cell compartment, that characterize the phenotypic diversity of PMF.	[Abba, Carlotta; Campanelli, Rita; Catarsi, Paolo; Villani, Laura; Barosi, Giovanni; Rosti, Vittorio] IRCCS, Ctr Study Myelofibrosis, Lab Biochem Biotechnol & Adv Diag, Policlin San Matteo Fdn, Pavia, Italy; [Abbonante, Vittorio; Sesta, Melanie Antonietta; Massa, Margherita] IRCCS, Lab Biochem Biotechnol & Adv Diag, Policlin San Matteo Fdn, Pavia, Italy; [Abbonante, Vittorio] Univ Pavia, Dept Mol Med, Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; University of Pavia	Massa, M (corresponding author), IRCCS, Lab Biochem Biotechnol & Adv Diag, Policlin San Matteo Fdn, Pavia, Italy.	m.massa@smatteo.pv.it	Rosti, Vittorio/K-1743-2018; Massa, Margherita/K-4682-2016; Catarsi, Paolo/J-4463-2016; Villani, Laura/K-1794-2018; Abbonante, Vittorio/AAA-9303-2020; Barosi, Giovanni/AAI-1714-2019; Abbà, Carlotta/Y-9169-2019; Campanelli, Rita/K-4686-2016	Rosti, Vittorio/0000-0003-4195-2289; Massa, Margherita/0000-0001-8037-0439; Catarsi, Paolo/0000-0002-1862-8168; Villani, Laura/0000-0003-4199-5633; Abbonante, Vittorio/0000-0001-8066-9895; Abbà, Carlotta/0000-0002-4173-7055; Campanelli, Rita/0000-0003-4923-2761	Associazione Italiana Ricerca sul Cancro (AIRC) [10005]; Ricerca Corrente Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo [874, 08054517]; Ricerca Finalizzata Italian Ministry of Health [GR-2016-02363136]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ricerca Corrente Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo; Ricerca Finalizzata Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by: Associazione Italiana Ricerca sul Cancro (AIRC) project number 10005 "Special Program Molecular Clinical Oncology 5x1000" to Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative (AGIMM) (A detailed description of the AGIMM project is available at http://www. progettoagimm. it), received by GB; by Ricerca Corrente Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, project number 874, code number 08054517, received by VR (Vittorio Rosti) (www.sanmatteo.org); and by Ricerca Finalizzata Italian Ministry of Health, project number GR-2016-02363136, received by VA (Vittorio Abbonante). The funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.	Akada H, 2010, BLOOD, V115, P3589, DOI 10.1182/blood-2009-04-215848; Anand S, 2011, BLOOD, V118, P1610, DOI 10.1182/blood-2011-02-335042; Anand S, 2011, BLOOD, V118, P177, DOI 10.1182/blood-2010-12-327593; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; Barosi G, 2017, LEUKEMIA RES, V60, P18, DOI 10.1016/j.leukres.2017.06.004; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; Glembotsky AC, 2010, EUR J HAEMATOL, V84, P398, DOI 10.1111/j.1600-0609.2010.01421.x; Grimwade LF, 2009, BRIT J HAEMATOL, V147, P495, DOI 10.1111/j.1365-2141.2009.07870.x; Hamilton A, 2006, LEUKEMIA, V20, P1035, DOI 10.1038/sj.leu.2404189; Hasselbalch HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112786; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kleppe M, 2015, CANCER DISCOV, V5, P316, DOI 10.1158/2159-8290.CD-14-0736; Kota J, 2008, LEUKEMIA, V22, P1828, DOI 10.1038/leu.2008.236; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Mesa RA, 2006, LEUKEMIA, V20, P1800, DOI 10.1038/sj.leu.2404338; Morales-Mantilla DE, 2018, CURR STEM CELL REP, V4, P264, DOI 10.1007/s40778-018-0139-3; Moucadel V, 2005, J BIOL CHEM, V280, P13364, DOI 10.1074/jbc.M407326200; Nangalia J, 2017, BLOOD, V130, P2475, DOI 10.1182/blood-2017-06-782037; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Poletto V, 2012, BLOOD, V120, P3112, DOI 10.1182/blood-2012-05-433466; Rampal R, 2014, BLOOD, V123, pE123, DOI 10.1182/blood-2014-02-554634; Roder S, 2001, EXP HEMATOL, V29, P694, DOI 10.1016/S0301-472X(01)00637-3; Rosti V, 2007, BLOOD CELL MOL DIS, V38, P280, DOI 10.1016/j.bcmd.2007.01.003; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Selleri C, 1996, BLOOD, V87, P4149, DOI 10.1182/blood.V87.10.4149.bloodjournal87104149; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Teofili L, 2007, BLOOD, V110, P354, DOI 10.1182/blood-2007-01-069237; Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699; Tvorogov D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat3834; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zeng WH, 2006, BLOOD, V107, P167, DOI 10.1182/blood-2005-05-1884	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220189	10.1371/journal.pone.0220189	http://dx.doi.org/10.1371/journal.pone.0220189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369569	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900035
J	Siebers, N; Kruse, J				Siebers, Nina; Kruse, Jens			Short-term impacts of forest clear-cut on soil structure and consequences for organic matter composition and nutrient speciation: A case study	PLOS ONE			English	Article							SULFUR SPECIATION; LAND-USE; SEQUENTIAL EXTRACTION; DENSITY FRACTIONS; NEW-ZEALAND; PHOSPHORUS; CARBON; STABILITY; NITROGEN; SPECTROSCOPY	Clear-cuts of forests severely affect soil structure and thus soil organic matter (SOM) and nutrient cycling dynamics therein, though with yet unknown consequences for SOM composition as well as phosphorus (P) and sulfur (S) chemical form within the soil microaggregate size fraction. To determine the effects of conventional clear-cutting on soil chemistry in a Cambisol of the Wu <spacing diaeresis> stebach Forest (northwestern Germany), we sampled the mineral Aand B-horizons prior to clear-cut as well as 10 and 24 month thereafter. We measured the SOM composition of soil microaggregates using pyrolysis field ionization mass spectrometry (Py-FIMS), as well as P and S chemical form and speciation using wet-chemical extractions and X-ray absorption near edge structure (XANES) spectroscopy. We found that clear-cut led to an increase of the microaggregate size fraction up to 6% due to break-down of macroaggregates and initially significantly increased total elemental concentrations (C, N, P, S) due to the introduction of slash-residues. The SOM of slash-residues consisted to a substantial amount of sterols and was generally found to be of low thermal stability and probably did not contribute to aggregate stability. Deterioration of the aggregate structure probably led to an exposure of originally inaccessible sites within aggregates to the attack by soil microorganisms and thus to an increased P and S turnover as reflected in a significantly reduction of available P proportions (4 to 7%) and a reduction of the most reduced S forms (5%). A probable increased microbial activity and contribution to SOM after clear-cut is also reflected in the significantly increasing hexose: pentose ratio by 0.25 between 10 and 24 month after clear-cut, significantly increasing the general thermal stability of SOM in the microaggregate size fraction and believed to contribute to aggregate stability. This indicated that a first deterioration of the aggregate structure after clear-cut might in the long-term be remediated with time.	[Siebers, Nina; Kruse, Jens] Forschungszentrum Julich, Inst Bio & Geosci IBG 3, Agrosphere Inst, Julich, Germany; [Kruse, Jens] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Soil Sci & Soil Ecol, Bonn, Germany	Helmholtz Association; Research Center Julich; University of Bonn	Siebers, N (corresponding author), Forschungszentrum Julich, Inst Bio & Geosci IBG 3, Agrosphere Inst, Julich, Germany.	n.siebers@fz-juelich.de		Kruse, Jens/0000-0003-1011-3298; Siebers, Nina/0000-0002-6431-0046	Helmholtz-Post-doctorate Program "Bioaccessibility of soil nutrients in relation to aggregate microstructure" [PD-122]; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research	Helmholtz-Post-doctorate Program "Bioaccessibility of soil nutrients in relation to aggregate microstructure"; Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	NS received fundings for this study from the Helmholtz-Post-doctorate Program "Bioaccessibility of soil nutrients in relation to aggregate microstructure", PD-122. The funders did not play a role for the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.r We gratefully acknowledge Inge Wiekenkamp, Hela Brixius, and Werner Kupper (FZJ) for helping with soil sampling. We thank Kai-Uwe Eckhardt and Peter Leinweber (Soil Science Group, University of Rostock) for providing and discussing Py-FIMS data. Additionally, special thanks to Stephanie Sosada (FZJ) for helping with P and S fractionation. The P and S Kedge XANES research described in this paper was performed at the Canadian Light Source (CLS), which is supported by the Canadian Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research. The authors would like to thank one of the best beamline scientist team, i. e., Yongfeng Hu, Qunfeng Xiao, and Aimee Maclennan at CLS for technical support. We would also like to thank Pee Narf.	Al-Kaisi MM, 2014, J SOIL WATER CONSERV, V69, P574, DOI 10.2489/jswc.69.6.574; Amelung W., 2018, SCHEFFERSCHACHTSCHAB, P491, DOI [10.1007/978-3-662-55871-3, DOI 10.1007/978-3-662-55871-3, 10.1007/978-3-662-55871-3_9, DOI 10.1007/978-3-662-55871-3_9]; AUTRY AR, 1990, CAN J FOREST RES, V20, P337, DOI 10.1139/x90-049; BEYER L, 1993, J ANAL APPL PYROL, V27, P169, DOI 10.1016/0165-2370(93)80007-M; Bhupinderpal-Singh, 2004, EUR J SOIL SCI, V55, P79, DOI [10.1046/j.1365-2389.2003.00552.x, 10.1046/j.1351-0754.2003.0552.x]; Blanco J.A., 2018, SOIL MANAGEMENT CLIM, P237, DOI [10.1016/B978-0-12-812128-3.00016-1, DOI 10.1016/B978-0-12-812128-3.00016-1]; Bogena HR, 2015, SCI CHINA EARTH SCI, V58, P61, DOI 10.1007/s11430-014-4911-7; Bogena HR, 2010, VADOSE ZONE J, V9, P1002, DOI 10.2136/vzj2009.0173; Boyle JR, 1976, TAPPI ANNUAL MEETING, P29; Calvin S, 2018, XAFS FOR EVERYONE, DOI [10.1201/b14843, DOI 10.1201/B14843]; Chen B, 1997, FRESEN J ANAL CHEM, V357, P941, DOI 10.1007/s002160050278; Chen CM, 2018, SOIL SYST, V2, DOI 10.3390/soilsystems2010016; CORNELL RM, 1979, CLAY CLAY MINER, V27, P402, DOI 10.1346/CCMN.1979.0270602; CORTINA J, 1994, FOREST ECOL MANAG, V70, P299, DOI 10.1016/0378-1127(94)90095-7; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Etmann M., 2009, DENDROLOGISCHE AUFNA; Finer L, 2003, FOREST ECOL MANAG, V174, P51, DOI 10.1016/S0378-1127(02)00019-1; FRENEY J R, 1971, Soil Biology and Biochemistry, V3, P133, DOI 10.1016/0038-0717(71)90006-X; FRENEY JR, 1969, J SCI FOOD AGR, V20, P440, DOI 10.1002/jsfa.2740200718; FRENEY JR, 1961, AUST J AGR RES, V12, P424, DOI 10.1071/AR9610424; Gerard F, 2016, GEODERMA, V262, P213, DOI 10.1016/j.geoderma.2015.08.036; Gottselig N, 2017, GLOBAL BIOGEOCHEM CY, V31, P1592, DOI 10.1002/2017GB005657; Groenendijk FM, 2002, GEODERMA, V108, P91, DOI 10.1016/S0016-7061(02)00125-8; GUGGENBERGER G, 1994, EUR J SOIL SCI, V45, P449, DOI 10.1111/j.1365-2389.1994.tb00530.x; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; HEMPFLING R, 1989, SCI TOTAL ENVIRON, V81-2, P31, DOI 10.1016/0048-9697(89)90108-3; HEMPFLING R, 1991, BIOGEOCHEMISTRY, V13, P27; Hempfling R., 1988, CHARAKTERISIERUNG VE; Hu YF, 2010, AIP CONF PROC, V1234, P343, DOI 10.1063/1.3463208; HUNTINGTON TG, 1990, FOREST ECOL MANAG, V31, P193, DOI 10.1016/0378-1127(90)90067-L; Julich D, 2017, FORESTS, V8, DOI 10.3390/f8010019; Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5; Knuti LL, 1984, PRENTICE HALL AGR SE; Kruse J, 2015, J PLANT NUTR SOIL SC, V178, P43, DOI 10.1002/jpln.201400327; Lacroix EM, 2016, SOIL SCI, V181, P202, DOI 10.1097/SS.0000000000000147; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lang F, 2017, BIOGEOCHEMISTRY, V136, P5, DOI 10.1007/s10533-017-0375-0; LeBissonnais Y, 1996, EUR J SOIL SCI, V47, P425, DOI 10.1111/j.1365-2389.1996.tb01843.x; Leemans R., 2003, MILLENNIUM ECOSYSTEM; Lilienfein J, 2000, GEODERMA, V96, P31, DOI 10.1016/S0016-7061(00)00002-1; Lobe I, 2011, GEODERMA, V162, P251, DOI 10.1016/j.geoderma.2011.02.001; Ludwig M, 2015, SOIL BIOL BIOCHEM, V81, P311, DOI 10.1016/j.soilbio.2014.12.002; McDowell RW, 2006, GEODERMA, V130, P176, DOI 10.1016/j.geoderma.2005.01.020; MENGEL K, 1994, Z PFLANZ BODENKUNDE, V157, P233, DOI 10.1002/jpln.19941570311; Nave LE, 2010, FOREST ECOL MANAG, V259, P857, DOI 10.1016/j.foreco.2009.12.009; Negassa W, 2009, J PLANT NUTR SOIL SC, V172, P305, DOI 10.1002/jpln.200800223; Nieminen Mika, 1998, Boreal Environment Research, V3, P9; OADES JM, 1991, AUST J SOIL RES, V29, P815, DOI 10.1071/SR9910815; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Ohlinger R, 1996, SOIL SAMPLING SAMPLE, P7; Olsson BA, 1996, FOREST ECOL MANAG, V82, P19, DOI 10.1016/0378-1127(95)03697-0; Pennock DJ, 1997, CAN J SOIL SCI, V77, P211, DOI 10.4141/S96-112; Piirainen S, 2004, BIOGEOCHEMISTRY, V69, P405, DOI 10.1023/B:BIOG.0000031061.80421.1b; Prietzel J, 2008, EUR J SOIL SCI, V59, P730, DOI 10.1111/j.1365-2389.2008.01034.x; Prietzel J, 2016, J PLANT NUTR SOIL SC, V179, P168, DOI 10.1002/jpln.201500472; Prietzel J, 2009, J PLANT NUTR SOIL SC, V172, P393, DOI 10.1002/jpln.200800054; QUEVAUVILLER P, 2002, METHODOLOGIES SOIL S, P21, DOI DOI 10.1039/9781847551412-00028; Ranius T, 2018, J ENVIRON MANAGE, V209, P409, DOI 10.1016/j.jenvman.2017.12.048; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rosenqvist L, 2007, ENV EFFECTS AFFOREST, P79, DOI DOI 10.1007/1-4020-4568-94; Scherer HW, 2009, J PLANT NUTR SOIL SC, V172, P326, DOI 10.1002/jpln.200900037; Schnitzer M, 1995, ADV AGRON, V55, P167, DOI 10.1016/S0065-2113(08)60540-4; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Schulten H.-R., 1998, Biology and Fertility of Soils, V26, P1, DOI 10.1007/s003740050335; Schulten HR, 1999, EUR J SOIL SCI, V50, P237, DOI 10.1046/j.1365-2389.1999.00241.x; Schulten HR, 1998, STRUCTURE SURFACE RE; Shan XQ, 1997, SCI TOTAL ENVIRON, V199, P237, DOI 10.1016/S0048-9697(97)05465-X; Siebers N, 2018, GEODERMA, V313, P163, DOI [10., 10.1016/j.geoderma.2017.10.028]; Siebers N, 2018, GEODERMA, V315, P59, DOI 10.1016/j.geoderma.2017.11.024; Six J, 2006, SOIL SCI SOC AM J, V70, P555, DOI 10.2136/sssaj2004.0347; Six J, 2000, SOIL SCI SOC AM J, V64, P1042, DOI 10.2136/sssaj2000.6431042x; Six J, 2016, ENCY ENV MANAGEMENT, P1872, DOI [10.1081/e-eem-120001812, DOI 10.1081/E-EEM-120001812]; Sleutel S, 2008, BIOGEOCHEMISTRY, V89, P253, DOI 10.1007/s10533-008-9217-4; Smolander A, 2001, BIOL FERT SOILS, V33, P190, DOI 10.1007/s003740000307; Solomon D, 2003, SOIL SCI SOC AM J, V67, P1721, DOI 10.2136/sssaj2003.1721; SPAANS EJA, 1989, HYDROL PROCESS, V3, P383, DOI 10.1002/hyp.3360030409; Spielvogel S, 2006, SOIL SCI SOC AM J, V70, P2130, DOI 10.2136/sssaj2005.0027; Stutter MI, 2015, GEODERMA, V257, P29, DOI 10.1016/j.geoderma.2015.03.020; Thomas D, 2016, J ENVIRON MANAGE, V165, P243, DOI 10.1016/j.jenvman.2015.09.039; Tiessen H., 1993, SOIL SAMPLING METHOD, P75, DOI [10.1201/9781420005271.ch25, DOI 10.1201/9781420005271.CH25]; Totsche KU, 2018, J PLANT NUTR SOIL SC, V181, P104, DOI 10.1002/jpln.201600451; Virto I, 2008, GEODERMA, V146, P326, DOI 10.1016/j.geoderma.2008.05.021; Vitousek P. M., 1981, Ecological Bulletins, V33, P631; Vodyanitskii YN, 2016, EURASIAN SOIL SCI+, V49, P796, DOI 10.1134/S1064229316070127; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wu B, 2017, J ENVIRON QUAL, V46, P1510, DOI 10.2134/jeq2017.05.0193; Xu JM, 2006, SOIL BIOL BIOCHEM, V38, P709, DOI 10.1016/j.soilbio.2005.06.022; Yanai RD, 1998, FOREST ECOL MANAG, V104, P281, DOI 10.1016/S0378-1127(97)00256-9; Zacharias S, 2011, VADOSE ZONE J, V10, P955, DOI 10.2136/vzj2010.0139	89	14	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220476	10.1371/journal.pone.0220476	http://dx.doi.org/10.1371/journal.pone.0220476			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369652	Green Submitted, gold, Green Published			2022-12-27	WOS:000484987900055
J	Brown, RT; Guzman, D; Kaplan, LM; Ponath, C; Lee, CT; Kushel, MB				Brown, Rebecca T.; Guzman, David; Kaplan, Lauren M.; Ponath, Claudia; Lee, Christopher T.; Kushel, Margot B.			Trajectories of functional impairment in homeless older adults: Results from the HOPE HOME study	PLOS ONE			English	Article							PHYSICAL PERFORMANCE; GERIATRIC SYNDROMES; CASE-MANAGEMENT; RISK-FACTORS; DISABILITY; MORTALITY; PATTERNS; DECLINE; INDEPENDENCE; STABILITY	Difficulty performing activities of daily living ("functional impairment") is common in homeless adults aged 50 and older. However, little is known about the trajectory of these impairments, nor the extent to which these trajectories are similar to those of older adults in the general population. We identified trajectories of functional impairment in homeless adults aged 50 and older, and risk factors for differing trajectories. We conducted a prospective cohort study of 350 homeless adults, aged 50 and older, recruited via population-based sampling in Oakland, California and interviewed at 6-month intervals for up to 3 years. We assessed functional trajectories based on self-reported difficulty performing 5 activities of daily living. We used multivariable multinomial logistic regression to identify baseline risk factors for each trajectory. At baseline, participants' mean age was 58 years (SD, 5.3), 24.1% were women, 80.9% were African American, and 38.6% had difficulty performing 1 or more activities of daily living. We identified 4 distinct functional trajectories: minimal impairment in 136 participants (41.1%); persistent impairment in 81 (25.4%); partial improvement in 74 (23.5%); and decline in 28 (10.0%). Risk factors for persistent impairment included falls in the 6 months before baseline, depressive symptoms, and low physical performance. Although functional impairment improved in some homeless adults, it persisted or worsened in many others. These findings suggest that, similar to older adults in the general population, functional impairment among older homeless persons is not a transient phenomenon, but instead a chronic issue requiring long-term solutions.	[Brown, Rebecca T.] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Brown, Rebecca T.] Univ Penn, Div Geriatr Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Brown, Rebecca T.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Guzman, David; Kaplan, Lauren M.; Ponath, Claudia; Kushel, Margot B.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Guzman, David; Kaplan, Lauren M.; Ponath, Claudia; Kushel, Margot B.] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA USA; [Guzman, David; Kaplan, Lauren M.; Ponath, Claudia; Kushel, Margot B.] UCSF Ctr Vulnerable Populat, San Francisco, CA USA; [Lee, Christopher T.] Resolve Save Lives, New York, NY USA	University of California System; University of California San Francisco; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco	Brown, RT (corresponding author), Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA.; Brown, RT (corresponding author), Univ Penn, Div Geriatr Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Brown, RT (corresponding author), Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.	rebecca.brown@ucsf.edu		Brown, Rebecca/0000-0001-7483-4137	National Institute on Aging at the National Institutes of Health [K23AG045290, K76AG057016, K24AG046372, R01AG041860, P30AG044281]; National Institutes of Health National Center for Advancing Translational Sciences through the University of California, San Francisco, Clinical and Translational Science Institute [KL2TR000143]; American Federation for Aging Research [K76AG057016]; NATIONAL INSTITUTE ON AGING [P30AG044281, K76AG057016, K24AG046372, K23AG045290, R01AG041860] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health National Center for Advancing Translational Sciences through the University of California, San Francisco, Clinical and Translational Science Institute; American Federation for Aging Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute on Aging at the National Institutes of Health, https://www.nia.nih.gov/, [grant numbers K23AG045290 to R.T.B., K76AG057016 to R.T.B., K24AG046372 to M.B.K., R01AG041860 to M.B.K., P30AG044281 to R.T.B. and M.B.K.]; the National Institutes of Health National Center for Advancing Translational Sciences through the University of California, San Francisco, Clinical and Translational Science Institute, https://ncats.nih.gov/, [grant number KL2TR000143 to R.T.B.]; and the American Federation for Aging Research, https://www.afar.org/, [grant number K76AG057016 to R.T.B.].	Al-Delaimy WK., 2008, CALIFORNIA TOBACCO S; ANESHENSEL CS, 1984, J HEALTH SOC BEHAV, V25, P350, DOI 10.2307/2136376; [Anonymous], FED STRAT PLAN PREV; Babor T.F., 2001, AUDIT ALCOHOL USE DI, V2nd ed., P41; Bamberger J, LONG TERM COST EFFEC; Bland RC, 2001, CAN J PSYCHIAT, V46, P506, DOI 10.1177/070674370104600604; Brown RT, 2019, JAMA INTERN MED, V179, P668, DOI 10.1001/jamainternmed.2019.0008; Brown RT, 2017, ANN INTERN MED, V167, P761, DOI 10.7326/M17-0496; Brown Rebecca T, 2013, Seniors Hous Care J, V21, P126; Brown RT, 2017, GERONTOLOGIST, V57, P757, DOI 10.1093/geront/gnw011; Brown RT, 2013, J HEALTH CARE POOR U, V24, P456, DOI 10.1353/hpu.2013.0077; Brown RT, 2012, J GEN INTERN MED, V27, P16, DOI 10.1007/s11606-011-1848-9; BURNAM MA, 1988, EVALUATION REV, V12, P117, DOI 10.1177/0193841X8801200202; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Calonge N, 2009, ANN INTERN MED, V151, P37, DOI 10.7326/0003-4819-151-1-200907070-00007; CHEN TY, 2016, SCI REP UK, V6; Cohen CI, 1999, GERONTOLOGIST, V39, P5, DOI 10.1093/geront/39.1.5; Covinsky KE, 1999, ANN INTERN MED, V130, P563, DOI 10.7326/0003-4819-130-7-199904060-00004; CRIMMINS EM, 1993, J ING HLTH, V0005; Culhane DP, 2013, ANAL SOC ISS PUB POL, V13, P228, DOI 10.1111/asap.12004; Dunn LB, 2001, NEUROPSYCHOPHARMACOL, V24, P595, DOI 10.1016/S0893-133X(00)00218-9; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Ferrucci L, 1998, GERONTOLOGIST, V38, P286, DOI 10.1093/geront/38.3.286; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; GELBERG L, 1990, J AM GERIATR SOC, V38, P1220, DOI 10.1111/j.1532-5415.1990.tb01503.x; Gill TM, 2009, J AM GERIATR SOC, V57, P1850, DOI 10.1111/j.1532-5415.2009.02443.x; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hahn JA, 2006, J GEN INTERN MED, V21, P775, DOI 10.1111/j.1525-1497.2006.00493.x; Hair J.F., 2015, MULTIVARIATE DATA AN, V7th; Hardy SE, 2005, ARCH INTERN MED, V165, P106, DOI 10.1001/archinte.165.1.106; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; Humeniuk R. E., 2010, ALCOHOL SMOKING SUBS; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Karvonen-Gutierrez Carrie A, 2015, Womens Midlife Health, V1, P10, DOI 10.1186/s40695-015-0011-x; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Kohn HF, 2010, PSYCHOL METHODS, V15, P87, DOI 10.1037/a0018535; Kushel M, 2012, J GEN INTERN MED, V27, P5, DOI 10.1007/s11606-011-1925-0; Lee CT, 2016, SOC SCI MED, V153, P131, DOI 10.1016/j.socscimed.2016.02.004; Lundstrom M, 2016, THE SACRAMENTO BEE; MOR V, 1994, AM J PUBLIC HEALTH, V84, P1274, DOI 10.2105/AJPH.84.8.1274; Moyer VA, 2012, ANN INTERN MED, V157, P655, DOI 10.7326/0003-4819-157-9-201211060-00526; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Patanwala M, 2018, J GEN INTERN MED, V33, P635, DOI 10.1007/s11606-017-4229-1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Riley ED, 2014, AM J PUBLIC HEALTH, V104, P1657, DOI 10.2105/AJPH.2014.301958; Roach MJ, 1998, ARCH INTERN MED, V158, P397, DOI 10.1001/archinte.158.4.397; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; STERGIOPOULOS V, 2015, JAMA-J AM MED ASSOC, V313, P905, DOI DOI 10.1001/JAMA.2015.1163; Stergiopoulos V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130281; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Sullivan G, 2001, PSYCHIATR SERV, V52, P1097, DOI 10.1176/appi.ps.52.8.1097; Sun VK, 2012, J GEN INTERN MED, V27, P541, DOI 10.1007/s11606-011-1943-y; Szanton SL, 2016, HEALTH AFFAIR, V35, P1558, DOI 10.1377/hlthaff.2016.0140; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; Tsemberis S, 2007, J COMMUNITY PSYCHOL, V35, P29, DOI 10.1002/jcop.20132; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Wang Emily A, 2012, Am J Public Health, V102, pe22, DOI 10.2105/AJPH.2012.300894; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	62	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221020	10.1371/journal.pone.0221020	http://dx.doi.org/10.1371/journal.pone.0221020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408488	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500033
J	Cardona-Arias, JA; Velez-Quintero, C; Calle-Gonzalez, OV; Florez-Duque, J; Zapata, JC				Cardona-Arias, Jaiberth Antonio; Velez-Quintero, Carolina; Calle-Gonzalez, Olga Victoria; Florez-Duque, Jennifer; Zapata, Juan Carlos			Seroprevalence of human T-lymphotropic virus HTLV and its associated factors in donors of a blood bank of Medellin-Colombia, 2014-2018	PLOS ONE			English	Article							CURRENT PREVALENCE; INFECTION; RISK	Background Research on HTLV in Colombia is limited; despite being an endemic country there are few studies on the magnitude of this infection. The aim of this study was to determine the seroprevalence of HTLV I/II and its associated factors in donors to a blood bank of Medellin Colombia, 2014-2018. Methods This is a cross-sectional study of 52,159 donors with a secondary information source. Seroprevalence of HTLV I/II was determined with its confidence interval and the population characteristics were described by frequency and summary measures. To explore the associated factors, Pearson's Chi square test, Mann-Whitney U test, crude odds ratios were used and they were adjusted by logistic regression in SPSS 25.0. Results 88% of the population lived in the metropolitan area, 68.5% belonged to the University. 76.2% were altruistic donors (unpaid donors who did not donate to a specific patient). 24.5% were repetitive (paid) donors. 75% of the donors were under 41 years old. The seroprevalence of HTLV I/II was 0.176% (95% CI = 0.139% -0.213%), being statistically lower in repetitive donors and men. Conclusion The seroprevalence of HTLV I/II infection in the studied blood bank is lower than that reported in other blood banks at the departmental and national levels. In Medellin, it was associated with the frequency of donation and gender, which is useful information for the hemovigilance programs of the city.	[Cardona-Arias, Jaiberth Antonio] Univ Antioquia, Fac Med, Sch Microbiol, Medellin, Colombia; [Cardona-Arias, Jaiberth Antonio] Univ Cooperat Colombia, Bogota, Colombia; [Velez-Quintero, Carolina; Calle-Gonzalez, Olga Victoria] Univ Antioquia, Sch Microbiol, Medellin, Colombia; [Florez-Duque, Jennifer] Univ Antioquia, Sch Microbiol, Blood Bank, Medellin, Colombia; [Zapata, Juan Carlos] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA	Universidad de Antioquia; Universidad Cooperativa de Colombia; Universidad de Antioquia; Universidad de Antioquia; University System of Maryland; University of Maryland Baltimore	Zapata, JC (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	jczapata@ihv.umaryland.edu	Zapata, Juan/L-5095-2019; Cardona, Jaiberth/GZL-3892-2022	Zapata, Juan/0000-0003-1931-6147; Cardona Arias, Jaiberth/0000-0002-7101-929X	University of Antioquia; Cooperative University of Colombia; Institute of Human Virology (IHV), University of Maryland School of Medicine	University of Antioquia; Cooperative University of Colombia; Institute of Human Virology (IHV), University of Maryland School of Medicine	This research relies upon salary support for the authors. JAC-A was supported by University of Antioquia and Cooperative University of Colombia. CV-Q, OVC-G, and JF-D were supported, as students, by the University of Antioquia. JCZ salary was supported by the Institute of Human Virology (IHV), University of Maryland School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcón Villaverde Jorge, 2011, Rev. perú. med. exp. salud publica, V28, P101, DOI 10.1590/s1726-46342011000100016; Alessio Loredana, 2018, PLoS Negl Trop Dis, V12, pe0006601, DOI 10.1371/journal.pntd.0006601; Bermudez M, 2017, INFORM ANUAL RED NAC; Biglione MM, 2013, ASEI, V21, P84; Bonfante M, 2017, FACTORES ASOCIADOS S; Brun RO, 2004, MEDICINA-BUENOS AIRE, V64, P125; Carrascal E., 2004, Colombia Medica, V35, P12; Catalan-Soares BC., 2001, REV BRAS EPIDEMIOL, V4, P81, DOI [10.1590/S1415-790X2001000200003, DOI 10.1590/S1415-790X2001000200003]; Cortes A, 1999, COLUMBIA MED, V30, P19; Cortes A, 1999, COLOMB MEDICA, V30, P13; Cruz Bermúdez Harold, 2014, Salud, Barranquilla, V30, P95; Cruz Bermúdez Harold Fabián, 2013, Revista médica Risaralda, V19, P10; Davison KL, 2009, TRANSFUSION MED, V19, P24, DOI 10.1111/j.1365-3148.2008.00902.x; Daza Bolaño Nelson, 2016, Medicas UIS, V29, P55, DOI 10.18273/revmed.v29n3-2016006; Demontis MA, 2015, J MED VIROL, V87, P2130, DOI 10.1002/jmv.24264; Djuicy DD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006832; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Espejo J., 2014, SEROPREVALENCIA MARC; Garcia Z, 2006, REV COSTARRIC CIENC, V27, P11; Gessain A, 2011, Bull Soc Pathol Exot, V104, P167, DOI 10.1007/s13149-011-0174-4; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Gotuzzo E, 2004, INFECT ETIOLOGY CHRO, DOI [10.17226/11026, DOI 10.17226/11026]; Gotuzzo E, 2010, ACTA MED PERU, V27, P96; Gotuzzo H Eduardo, 2004, Rev. perú. med. exp. salud publica, V21, P253; Hlela C, 2009, AIDS REV, V11, P205; IARC Working group on the evaluation of carcinogenic risks to humans, 2012, IARC MONOGR EVAL CAR, V100; Instituto Nacional de Salud, 2014, INF NAC IND RED NAC, P1; Instituto Nacional de Salud Republica de Colombia, 0082 I NAC SAL; Bermudez-Forero MI, 2016, BIOMEDICA, V36, P194, DOI 10.7705/biomedica.v36i0.2943; Lubian A, 1998, REV CUBANA MED, V37, P199; Macia C, 2016, BIOMEDICA, V36, P108, DOI [10.7705/biomedica.v36i0.2942, 10.7705/biomedica.v3610.2942]; Mantilla C, 2012, MED LAB, V18, P459; Martin F, 2018, LANCET, V391, P1893, DOI 10.1016/S0140-6736(18)30974-7; Martínez-Nieto Oscar, 2007, Rev. salud pública, V9, P253, DOI 10.1590/S0124-00642007000200009; Mueller N, 1996, J ACQ IMMUN DEF SYND, V13, pS2, DOI 10.1097/00042560-199600001-00002; Munoz M, 2018, BIOMEDICA, V38, P37, DOI 10.7705/biomedica.v38i0.3417; Murphy EL, 1999, J INFECT DIS, V180, P1777, DOI 10.1086/315139; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Bedoya JAP, 2012, REV SAUDE PUBL, V46, P950, DOI 10.1590/S0034-89102012000600004; Polizzotto MN, 2008, TRANSFUSION, V48, P55, DOI 10.1111/j.1537-2995.2007.01482.x; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Real Delor Raúl, 2016, Rev. Méd. La Paz, V22, P5; Satake M, 2012, J MED VIROL, V84, P327, DOI 10.1002/jmv.23181; Tagaya Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01425; Vasquez TP, 2003, REV CHIL INFECTOL, V20, P34; Willems L, 2017, ANTIVIR RES, V137, P41, DOI 10.1016/j.antiviral.2016.10.015	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221060	10.1371/journal.pone.0221060	http://dx.doi.org/10.1371/journal.pone.0221060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404110	gold, Green Published, Green Submitted			2022-12-27	WOS:000485006800051
J	Modchalingam, S; Vachon, CM; 't Hart, BM; Henriques, DYP				Modchalingam, Shanaathanan; Vachon, Chad Michael; 't Hart, Bernard Marius; Henriques, Denise Y. P.			The effects of awareness of the perturbation during motor adaptation on hand localization	PLOS ONE			English	Article							VISUOMOTOR ADAPTATION; PROPRIOCEPTIVE RECALIBRATION; SENSORY PREDICTION; EXPLICIT STRATEGY; REACH ADAPTATION; CEREBELLUM; IMPLICIT; ERROR; CONSEQUENCES; MOVEMENT	Awareness of task demands is often used during rehabilitation and sports training by providing instructions which appears to accelerate learning and improve performance through explicit motor learning. However, the effects of awareness of perturbations on the changes in estimates of hand position resulting from motor learning are not well understood. In this study, people adapted their reaches to a visuomotor rotation while either receiving instructions on the nature of the perturbation, experiencing a large rotation, or both to generate awareness of the perturbation and increase the contribution of explicit learning. We found that instructions and/or larger rotations allowed people to activate or deactivate part of the learned strategy at will and elicited explicit changes in open-loop reaches, while a small rotation without instructions did not. However, these differences in awareness, and even manipulations of awareness and perturbation size, did not appear to affect learning-induced changes in hand-localization estimates. This was true when estimates of the adapted hand location reflected changes in proprioception, produced when the hand was displaced by a robot, and also when hand location estimates were based on efferent-based predictions of self-generated hand movements. In other words, visuomotor adaptation led to significant shifts in predicted and perceived hand location that were not modulated by either instruction or perturbation size. Our results indicate that not all outcomes of motor learning benefit from an explicit awareness of the task. Particularly, proprioceptive recalibration and the updating of predicted sensory consequences appear to be largely implicit.	[Modchalingam, Shanaathanan; Vachon, Chad Michael; 't Hart, Bernard Marius; Henriques, Denise Y. P.] York Univ, Ctr Vis Res, Toronto, ON, Canada; [Modchalingam, Shanaathanan; Henriques, Denise Y. P.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Vachon, Chad Michael] York Univ, Dept Psychol, Toronto, ON, Canada	York University - Canada; York University - Canada; York University - Canada	Modchalingam, S (corresponding author), York Univ, Ctr Vis Res, Toronto, ON, Canada.; Modchalingam, S (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada.	s.modcha@gmail.com	't Hart, Bernard/AHD-9519-2022	't Hart, Bernard/0000-0002-0045-3769; Modchalingam, Shanaathanan/0000-0002-8274-6724	Natural Science and Engineering Research Council of Canada; Deutsche Forschungsgemeinschaft [HA 6861/2-1]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Natural Science and Engineering Research Council of Canada Discovery Grant to DYPH and BM'tH was partially funded by the Deutsche Forschungsgemeinschaft: HA 6861/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Benson BL, 2011, J NEUROPHYSIOL, V105, P2843, DOI 10.1152/jn.00002.2011; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Block HJ, 2012, NEUROPSYCHOLOGIA, V50, P1766, DOI 10.1016/j.neuropsychologia.2012.03.034; Bond KM, 2015, J NEUROPHYSIOL, V113, P3836, DOI 10.1152/jn.00009.2015; Butcher PA, 2017, J NEUROPHYSIOL, V118, P1622, DOI 10.1152/jn.00451.2017; Cameron BD, 2012, CONSCIOUS COGN, V21, P4, DOI 10.1016/j.concog.2010.11.006; Cressman EK, 2015, J NEUROPHYSIOL, V114, P354, DOI 10.1152/jn.00415.2014; Cressman EK, 2010, EXP BRAIN RES, V205, P533, DOI 10.1007/s00221-010-2392-2; Cressman EK, 2009, J NEUROPHYSIOL, V102, P3505, DOI 10.1152/jn.00514.2009; ERIKSEN CW, 1960, PSYCHOL REV, V67, P279, DOI 10.1037/h0041622; Haith AM, 2016, J NEUROSCI, V36, P3007, DOI 10.1523/JNEUROSCI.3245-15.2016; Hegele M, 2013, PSYCHOL AGING, V28, P333, DOI 10.1037/a0031914; Hegele M, 2010, CONSCIOUS COGN, V19, P906, DOI 10.1016/j.concog.2010.05.005; Henriques DYP, 2014, NEUROPSYCHOLOGIA, V64, P195, DOI 10.1016/j.neuropsychologia.2014.09.029; Henriques DYP, 2012, J MOTOR BEHAV, V44, P435, DOI 10.1080/00222895.2012.659232; Heuer H, 2008, PSYCHOL AGING, V23, P190, DOI 10.1037/0882-7974.23.1.190; Heuer H, 2011, EXP BRAIN RES, V211, P97, DOI 10.1007/s00221-011-2656-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Izawa J, 2012, J NEUROSCI, V32, P4230, DOI 10.1523/JNEUROSCI.6353-11.2012; Kong GQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13889-w; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McDougle SD, 2016, TRENDS COGN SCI, V20, P535, DOI 10.1016/j.tics.2016.05.002; McDougle SD, 2015, J NEUROSCI, V35, P9568, DOI 10.1523/JNEUROSCI.5061-14.2015; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Modchalingam S, 2018, OPEN SCI FRAMEWORK, DOI [10.17605/OSF.IO/MX5U2, DOI 10.17605/OSF.IO/MX5U2]; Neville KM, 2018, EXP BRAIN RES, V236, P2047, DOI 10.1007/s00221-018-5282-7; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; R Core Team, 2018, R LANG ENV STAT COMP; Redding GM, 2000, J MOTOR BEHAV, V32, P83, DOI 10.1080/00222890009601362; Ruttle JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163695; Salomonczyk D, 2013, EXP BRAIN RES, V228, P313, DOI 10.1007/s00221-013-3564-7; Salomonczyk D, 2011, NEUROPSYCHOLOGIA, V49, P3053, DOI 10.1016/j.neuropsychologia.2011.07.006; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; 't Hart BM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163556; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Thomas M, 2012, EXP BRAIN RES, V221, P85, DOI 10.1007/s00221-012-3150-4; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Van Rossum G., 1995, PYTHON TUTORIAL, V620; Werner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123321; Wilke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054925	46	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220884	10.1371/journal.pone.0220884	http://dx.doi.org/10.1371/journal.pone.0220884			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398227	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000025
J	Shah, S; Christianson, AL; Verma, P; Meganathan, K; Leonard, AC; Schauer, DP; Thakar, CV				Shah, Silvi; Christianson, Annette L.; Verma, Prasoon; Meganathan, Karthikeyan; Leonard, Anthony C.; Schauer, Daniel P.; Thakar, Charuhas V.			Racial disparities and factors associated with pregnancy in kidney transplant recipients in the United States	PLOS ONE			English	Article							REPLACEMENT THERAPY; HYPERTENSION; OUTCOMES; WOMEN	Background Although kidney transplant improves reproductive function in women with end-stage kidney disease (ESKD), pregnancy in kidney transplant recipients' remains challenging due to the risk of adverse maternal and fetal outcomes. Methods We evaluated a retrospective cohort of 7,966 women who were aged 15-45 years and received a kidney transplant between January 1, 2005 and December 31, 2011 from the United States Renal Data System with Medicare as the primary payer for the entire three years after the date of transplantation. Unadjusted and adjusted rates of pregnancy in the first three post-transplant years were calculated, using Poisson regression for the adjustment. Factors associated with pregnancy, including race, were examined using logistic regression. Results Overall, 293 pregnancies were identified in 7966 women. The unadjusted pregnancy rate was 13.8 per thousand person-years (PTPY) (95% confidence interval (CI), 12.3-15.5). Pregnancy rates were roughly constant in the years 2005-2011 except in 2005 and 2010. The rate of pregnancy was highest in Hispanic women (21.4 PTPY; 95% CI, 17.2-26.4) and Hispanic women had a higher likelihood of pregnancy as compared to white women (OR, 1.56; CI, 1.12-2.16). Pregnancy rates were lowest in women aged 30-34 years and 35-45 years at transplant, and women aged 30-34 years and 35-45 years at transplant were less likely to ever become pregnant during the follow-up (odds ratio [OR], 0.69; CI, 0.49-0.98 and OR, 0.14; CI 0.09-0.21 respectively) as compared to women aged 25-29 years at time of transplant. Women had higher rates of pregnancy in the second and third-year post-transplant (16.0 PTPY, CI 13.2-19.2 and 16.9 PTPY, CI 14.0-20.4) than in the first-year post-transplant (9.0 PTPY, CI 7.0-11.4). In transplant recipients, pregnancy was more likely in women with ESKD due to cystic disease (OR, 2.42; CI, 1.02-5.74) or glomerulonephritis (OR, 2.14; CI, 1.07-4.31) as compared to women with ESKD due to diabetes. Conclusion Hispanic race, younger age, and ESKD cause due to cystic disease or glomerulonephritis are significant factors associated with a higher likelihood of pregnancy. Pregnancy rates have been fairly constant over the last decade. This study improves our understanding of factors associated with pregnancy in kidney transplant recipients.	[Shah, Silvi; Thakar, Charuhas V.] Univ Cincinnati, Div Nephrol, Kidney CARE Program, Cincinnati, OH 45220 USA; [Christianson, Annette L.; Meganathan, Karthikeyan] Univ Cincinnati, Dept Biomed Informat, Cincinnati, OH USA; [Verma, Prasoon] Cincinnati Childrens Hosp & Med Ctr, Div Neonatol, Cincinnati, OH USA; [Leonard, Anthony C.] Univ Cincinnati, Dept Family & Community Med, Cincinnati, OH USA; [Schauer, Daniel P.] Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA; [Thakar, Charuhas V.] VA Med Ctr, Div Nephrol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Shah, S (corresponding author), Univ Cincinnati, Div Nephrol, Kidney CARE Program, Cincinnati, OH 45220 USA.	shah2sv@ucmail.uc.edu						Abraido-Lanza AF, 1999, AM J PUBLIC HEALTH, V89, P1543, DOI 10.2105/AJPH.89.10.1543; [Anonymous], 2015, 2015 RES GUID USRDS; Blotiere PO, 2018, PHARMACOEPIDEM DR S, V27, P763, DOI 10.1002/pds.4556; Bramham K, 2013, CLIN J AM SOC NEPHRO, V8, P290, DOI 10.2215/CJN.06170612; Chapman AB, 2010, ADV CHRONIC KIDNEY D, V17, P153, DOI 10.1053/j.ackd.2010.01.001; Combs J, 2018, AM J TRANSPLANT, V18, P2079, DOI 10.1111/ajt.14911; Coscia Lisa A, 2010, Clin Transpl, P65; Coscia LA, 2014, BEST PRACT RES CL OB, V28, P1174, DOI 10.1016/j.bpobgyn.2014.07.020; Lemini MCC, 2007, INT J GYNECOL OBSTET, V96, P76, DOI 10.1016/j.ijgo.2006.11.006; DAVISON JM, 1985, KIDNEY INT, V27, P74, DOI 10.1038/ki.1985.12; Davison JM, 1997, BRIT J OBSTET GYNAEC, V104, P1106, DOI 10.1111/j.1471-0528.1997.tb10930.x; Deshpande NA, 2011, AM J TRANSPLANT, V11, P2388, DOI 10.1111/j.1600-6143.2011.03656.x; EBPG Expert Group on Renal Transplantation, 2002, NEPHROL DIAL TRAN S4, V17, P50; Gill J, 2009, AM J TRANSPLANT, V9, P1541, DOI 10.1111/j.1600-6143.2009.02662.x; Holley JL, 2013, ADV CHRONIC KIDNEY D, V20, P240, DOI 10.1053/j.ackd.2013.01.003; Hornbrook MC, 2007, HEALTH SERV RES, V42, P908, DOI 10.1111/j.1475-6773.2006.00635.x; Keitel E, 2004, TRANSPL P, V36, P870, DOI 10.1016/j.transproceed.2004.03.089; Kshirsagar AV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186651; Levidiotis V, 2009, J AM SOC NEPHROL, V20, P2433, DOI 10.1681/ASN.2008121241; Liao YL, 1998, AM J PUBLIC HEALTH, V88, P227, DOI 10.2105/AJPH.88.2.227; Little MA, 2000, IRISH J MED SCI, V169, P19, DOI 10.1007/BF03170477; MacDorman M, 2015, NATL VITAL STAT REP, V64, P8; Majak GB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173420; McKay DB, 2006, NEW ENGL J MED, V354, P1281, DOI 10.1056/NEJMra050431; McKay DB, 2005, AM J TRANSPLANT, V5, P1592, DOI 10.1111/j.1600-6143.2005.00969.x; Mckay DB, 2008, CLIN J AM SOC NEPHRO, V3, pS117, DOI 10.2215/CJN.02980707; OROFINO L, 1987, NEPHRON, V45, P22, DOI 10.1159/000184065; Palmer BF, 2003, ADV RENAL REPLACE TH, V10, P48, DOI 10.1053/jarr.2003.50003; Piccoli GB, 2010, CLIN J AM SOC NEPHRO, V5, P844, DOI 10.2215/CJN.07911109; RIZZONI G, 1992, NEPHROL DIAL TRANSPL, V7, P279, DOI 10.1093/oxfordjournals.ndt.a092129; Saha MT, 2002, NEPHRON, V92, P735, DOI 10.1159/000064079; Shah S, 2016, INT J NEPHROL, V2016, P1; Shah S, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1213-5; Stratta P, 2003, J NEPHROL, V16, P792; Ventura Stephanie J, 2012, Natl Vital Stat Rep, V60, P1	35	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220916	10.1371/journal.pone.0220916	http://dx.doi.org/10.1371/journal.pone.0220916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398243	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000027
J	Arnold, RJ; Ochoa, A; Kerth, CR; Miller, RK; Murray, SC				Arnold, Robert J.; Ochoa, Alejandra; Kerth, Chris R.; Miller, Rhonda K.; Murray, Seth C.			Assessing the impact of corn variety and Texas terroir on flavor and alcohol yield in new-make bourbon whiskey	PLOS ONE			English	Article							KEY AROMA COMPOUNDS; WHEAT-VARIETIES; SPIRIT YIELD; MAIZE; BARLEY; GRAIN; VARIABILITY; SELECTION; BRANDIES; RELEASE	The whiskey industry is dominated by whiskey styles with recipes that contain corn as the primary grain. However, little research has been conducted to investigate whiskey specific distinctions arising from different corn varieties and growing environments (i. e. terroir). Further, no studies have investigated the aroma or flavor impacts of different varieties and terroirs. Here, three different commodity yellow dent hybrid corn varieties were grown on different farms in Texas, spanning from the Texas Panhandle to the Mexico-United States border. Using novel small-batch mashing techniques, a newly developed new-make (i. e. unaged whiskey, immediate by-product of distillation) bourbon sensory lexicon, a trained sensory panel, high-performance liquid chromatography, and gas chromatography-mass spectrometry/olfactometry (GC-MS/O), we report for the first time a method for evaluating sample effects on alcohol yield and flavor in new-make bourbon whiskey. We discover that variety, terroir and their interactions, previously ignored, can substantially affect valuable sensory aspects of whiskey, suggesting the importance of scientifically evaluating corn genetics and agronomy for developing better whiskey. Excitingly, our data suggest milled corn with higher levels of benzadehyde, readily measured by GC-MS/O, correlates with improved sensory aspects of distillate, which must be expensively evaluated using a trained human sensory panel.	[Arnold, Robert J.; Murray, Seth C.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Arnold, Robert J.; Ochoa, Alejandra] Firestone & Robertson Distilling Co, Ft Worth, TX 76119 USA; [Ochoa, Alejandra; Kerth, Chris R.; Miller, Rhonda K.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Arnold, RJ (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.; Arnold, RJ (corresponding author), Firestone & Robertson Distilling Co, Ft Worth, TX 76119 USA.	robsoc7@tamu.edu	Ochoa, Alejandra/GWC-2509-2022	Kerth, Chris/0000-0002-9183-7919; Murray, Seth/0000-0002-2960-8226	Firestone & Robertson Distilling Co.	Firestone & Robertson Distilling Co.	This research was directly funded by the Firestone & Robertson Distilling Co. Resources leveraged in this study were made possible by USDA-NIFA, the Texas Corn Producers Board, and Texas A& M AgriLife support. Thanks to Dennis Pietsch, Katrina Horn and the TAMU Crop Testing Program for corn samples; thanks to David Rooney for FT-NIRS support. Thank you to the Scotch Whisky Research Institute for guidance on the lab-scale whiskey production methods. Thank you to Kayley Wall for guidance with MS statistical analysis.	Adhikari K, 2011, J SENS STUD, V26, P413, DOI 10.1111/j.1745-459X.2011.00356.x; Agu RC, 2006, J I BREWING, V112, P314, DOI 10.1002/j.2050-0416.2006.tb00737.x; Agu RC, 2008, J I BREWING, V114, P39, DOI 10.1002/j.2050-0416.2008.tb00304.x; Balcerek M, 2016, MOLECULES, V21, DOI 10.3390/molecules21101320; Basso L.C., 2011, BIOFUEL PRODUCTION R; Belsito A., 2004, THESIS; Bettenhausen HM, 2018, FOOD RES INT, V113, P487, DOI 10.1016/j.foodres.2018.07.024; Boothroyd E, 2014, J I BREWING, V120, P16, DOI 10.1002/jib.103; Bringhurst TA, 2015, J I BREWING, V121, P1, DOI 10.1002/jib.192; Bringhurst TA, 2008, PRODUCTION TECHNOLOG, P51; Brosnan J.M., 1999, P 5 AV C MALT BREW D, P225; Brouwer BO, 2016, AGRON J, V108, P939, DOI 10.2134/agronj2015.0385; Brouwer BO, 2016, RENEW AGR FOOD SYST, V31, P172, DOI 10.1017/S1742170515000198; Burdock G. A, 2010, FENAROLIS HDB FLAVOR, V6th, DOI DOI 10.1201/9781439847503; BUTTERY RG, 1994, J AGR FOOD CHEM, V42, P791, DOI 10.1021/jf00039a038; Buttery RG, 1997, J AGR FOOD CHEM, V45, P837, DOI 10.1021/jf9604807; Conner J., 2001, ACS SYM SER, V782, P113, DOI DOI 10.1021/BK-2001-0782.CH010; Conner JM, 1999, J SCI FOOD AGR, V79, P1015, DOI 10.1002/(SICI)1097-0010(19990515)79:7<1015::AID-JSFA321>3.3.CO;2-I; Dawson J. C., 2018, Plant Breeding Reviews, V41, P215; DOEBLEY J, 1988, ECON BOT, V42, P120, DOI 10.1007/BF02859042; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Ferrari G, 2004, J AGR FOOD CHEM, V52, P5670, DOI 10.1021/jf049512d; Franitza L, 2016, J AGR FOOD CHEM, V64, P637, DOI 10.1021/acs.jafc.5b05426; Goodman M. M., 1988, Corn and corn improvement. Third edition., P33; Green DIG, 2015, J I BREWING, V121, P332, DOI 10.1002/jib.236; Halloran A., 2015, NEW BREAD BASKET NEW; Harrison B, 2011, J I BREWING, V117, P106, DOI 10.1002/j.2050-0416.2011.tb00450.x; Haze S., 2001, J INVESTIGATIVE DERM, V116; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Herb D, 2017, J AM SOC BREW CHEM, V75, P345, DOI 10.1094/ASBCJ-2017-4860-01; Herb D, 2017, J AM SOC BREW CHEM, V75, P354, DOI 10.1094/ASBCJ-2017-4976-01; Herb DW, 2017, THESIS; Jack F, 2003, J I BREWING, V109, P114, DOI 10.1002/j.2050-0416.2003.tb00139.x; Jacques K. A., 2003, ALCOHOL TXB REFERENC; Jaradat AA, 2013, CROP SCI, V53, P956, DOI 10.2135/cropsci2012.07.0437; Kindred DR, 2008, J CEREAL SCI, V48, P46, DOI 10.1016/j.jcs.2007.07.010; Kurtz B, 2016, CROP SCI, V56, P931, DOI 10.2135/cropsci2015.07.0439; Lee KYM, 2000, J I BREWING, V106, P287, DOI 10.1002/j.2050-0416.2000.tb00068.x; Lee KYM, 2000, J I BREWING, V106, P203, DOI 10.1002/j.2050-0416.2000.tb00058.x; Li Q, 2016, MICROB ECOL, V71, P409, DOI 10.1007/s00248-015-0673-9; LONG A, 1989, RADIOCARBON, V31, P1035; Malfondet N, 2016, FLAVOUR FRAG J, V31, P361, DOI 10.1002/ffj.3325; Martin GE, 1974, J ASS OFF ANAL CHEM; Mason SC, 2012, INPROCEEDINGS 47TH C, V24, P31; Mc Donnell E, 2001, J SENS STUD, V16, P425, DOI 10.1111/j.1745-459X.2001.tb00311.x; Meng QC, 2015, CROP SCI, V55, P2234, DOI 10.2135/cropsci2014.11.0767; Nykanen L, 1963, TEKNILLISEN KEMIAN A, V20, P789; PIGGOTT JR, 1979, J I BREWING, V85, P82, DOI 10.1002/j.2050-0416.1979.tb06830.x; Poisson L, 2008, J AGR FOOD CHEM, V56, P5820, DOI 10.1021/jf800383v; Poisson L, 2008, J AGR FOOD CHEM, V56, P5813, DOI 10.1021/jf800382m; Schnell R., 2016, CORN PERFORMANCE TES; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Singh AK, 2011, CROP SCI, V51, P75, DOI 10.2135/cropsci2010.06.0378; Swanston JS, 2007, J SCI FOOD AGR, V87, P676, DOI 10.1002/jsfa.2767; Swanston JS, 2014, J SCI FOOD AGR, V94, P3234, DOI 10.1002/jsfa.6675; Swanston JS, 2005, J CEREAL SCI, V42, P127, DOI 10.1016/j.jcs.2005.02.001; Swanston JS, 2000, J I BREWING, V106, P53, DOI 10.1002/j.2050-0416.2000.tb00040.x; Swanston JS, 1999, MOL BREEDING, V5, P103, DOI 10.1023/A:1009606705925; Sylvester-Bradley R., 2010, 468 HGCA; Teixeira JEC, 2015, HEREDITY, V114, P229, DOI 10.1038/hdy.2014.90; Thomas Y., 2002, COFFEE FLAVOR CHEM; Troyer AF, 1999, CROP SCI, V39, P601, DOI 10.2135/cropsci1999.0011183X003900020001x; Vanbeneden N, 2007, J AGR FOOD CHEM, V55, P11002, DOI 10.1021/jf072340a; Willner B, 2013, J AGR FOOD CHEM, V61, P9583, DOI 10.1021/jf403024t; World Coffee Research, 2016, WORLD COFF RES SENS; Zoeller KM, 2008, THESIS, DOI [10.18297/etd/1652, DOI 10.18297/ETD/1652]	66	6	6	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220787	10.1371/journal.pone.0220787	http://dx.doi.org/10.1371/journal.pone.0220787			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393929	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500062
J	Beck, S; Borutta, B; Walter, U; Dreier, M				Beck, Simone; Borutta, Birgit; Walter, Ulla; Dreier, Maren			Systematic evaluation of written health information on PSA based screening in Germany	PLOS ONE			English	Article							PROSTATE-CANCER MORTALITY; PATIENT DECISION AID; QUALITY; MEN; COMPLICATIONS; OVERDETECTION; INSTRUMENT; KNOWLEDGE; BENEFITS; SUPPORT	Background Prostate-specific antigen (PSA) based screening for early detection of prostate cancer is common although it is associated with both benefits and potential harms (e.g., the risk of overdiagnosis). Evidence-based health information could help individuals make informed decisions about whether to undergo PSA testing or not. This evaluation aimed to determine whether the written health information materials available in Germany provide appropriate information for informed decision-making on PSA based screening. Methods A list of criteria was developed and used to systematically assess the quality of information on the benefits and harms of prostate cancer screening included in written health information materials. Fourteen information materials identified by information requests and online searches were evaluated independently by two of three reviewers. Consensus was achieved with a third reviewer. Results Of the 14 information materials evaluated, 10 (71%) list the ability to reduce the absolute risk of death from prostate cancer as a benefit of PSA testing, 9 (64%) point out the risks of follow-up diagnostics, 13 (93%) describe the risks of the available prostate cancer treatments, and all 14 specify the risk of overdiagnosis. The minority provide numerical data on benefits and risks. Partially mismatched framing was identified in four cases: two information materials report only the relative frequencies of benefits, and two report only the absolute frequencies of harms. Half of the materials encouraged participation using downplaying or frightening language. Conclusions The majority of health information materials in Germany describe the benefits and harms of PSA based screening, including overdiagnosis, but often lack adequate balance, neutrality and numbers.	[Beck, Simone; Borutta, Birgit; Walter, Ulla; Dreier, Maren] Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany	Hannover Medical School	Dreier, M (corresponding author), Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany.	Dreier.maren@mh-hannover.de		Dreier, Maren/0000-0003-2861-0284	German Research Foundation (DFG); Hannover Medical School (MHH)	German Research Foundation (DFG)(German Research Foundation (DFG)); Hannover Medical School (MHH)	We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Hannover Medical School (MHH).	Akl EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006466; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Carter SM, 2016, CANCER FORUM, V40, P105; Chan Evelyn C Y, 2011, Patient Educ Couns, V84, pe44, DOI 10.1016/j.pec.2010.07.033; Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Costanza ME, 2011, PATIENT EDUC COUNS, V82, P193, DOI 10.1016/j.pec.2010.05.011; Deutsches Netzwerk Evidenzbasierte Medizin e. V, 2016, GUT PRAX GES VERS 2; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Dreier M, 2014, BUNDESGESUNDHEITSBLA, V57, P356, DOI 10.1007/s00103-013-1906-z; Dreier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107575; Dreier M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-843; Ecke TH, 2008, UROL ONCOL-SEMIN ORI, V26, P474, DOI 10.1016/j.urolonc.2007.12.003; Elwyn G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004705; Fenton JJ, 2017, 154 AHRQ; Fenton JJ, 2018, JAMA-J AM MED ASSOC, V319, P1914, DOI 10.1001/jama.2018.3712; Frosch DL, 2008, ARCH INTERN MED, V168, P363, DOI 10.1001/archinternmed.2007.111; General Medical Council, 2008, CONS PAT DOCT MAK DE; German Society of Urology (DGU), 2016, INT S3 GUID SCREEN D; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; Greenland S, 2001, Biostatistics, V2, P463, DOI 10.1093/biostatistics/2.4.463; Helou A, 2014, BUNDESGESUNDHEITSBLA, V57, P288, DOI 10.1007/s00103-013-1902-3; Hofmann J, 2015, Z EVIDENZ FORTBILD Q, V109, P350, DOI 10.1016/j.zefq.2015.06.014; Ilic D, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3519; Ilic D, 2015, PSYCHO-ONCOLOGY, V24, P1303, DOI 10.1002/pon.3815; International Patient Decision Aid Standards (IPDAS) Collaboration, 2005, IPDAS 2005 CRIT JUDG; Jorgensen KJ, 2009, J MED ETHICS, V35, P268, DOI 10.1136/jme.2008.027961; Koch K, 2008, STELLUNGNAHME KRITER; Korfage IJ, 2010, EUR J CANCER, V46, P3073, DOI 10.1016/j.ejca.2010.09.011; Loeb S, 2013, EUR UROL, V64, P876, DOI 10.1016/j.eururo.2013.05.049; Luhnen J., 2017, LEITLINIE EVIDENZBAS; Lumen N, 2012, INT J UROL, V19, P100, DOI 10.1111/j.1442-2042.2011.02912.x; Marckmann G, 2014, BUNDESGESUNDHEITSBLA, V57, P327, DOI 10.1007/s00103-013-1913-0; OCEBM Levels of Evidence Working Group, 2011, OXFORD LEVELS EVIDEN; Pignone MP, 2013, JAMA INTERN MED, V173, P362, DOI 10.1001/jamainternmed.2013.2651; Robert Koch-Institut (RKI), KREBS DEUTSCHL 2013; Sanger S, 2004, CHECK IN INSTRUMENT; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Sheridan SL, 2004, PATIENT EDUC COUNS, V54, P345, DOI 10.1016/j.pec.2003.12.003; Sheridan SL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-130; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Steckelberg Anke, 2005, Z Arztl Fortbild Qualitatssich, V99, P343; Strobelberger M, 2011, WIEN MED WOCHENSCHR, V161, P89, DOI 10.1007/s10354-010-0855-5; Taylor KL, 2013, JAMA INTERN MED, V173, P1704, DOI 10.1001/jamainternmed.2013.9253; van Vugt HA, 2010, EUR J CANCER, V46, P669, DOI 10.1016/j.ejca.2009.11.022; Volk RJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S1; Watson E, 2006, PATIENT EDUC COUNS, V63, P367, DOI 10.1016/j.pec.2006.05.005; Williams RM, 2013, PATIENT EDUC COUNS, V91, P329, DOI 10.1016/j.pec.2012.12.013; Witteman HO, 2016, MED DECIS MAKING, V36, P760, DOI 10.1177/0272989X16634085; Wu GHM, 2012, INT J CANCER, V131, P1367, DOI 10.1002/ijc.27340	53	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220745	10.1371/journal.pone.0220745	http://dx.doi.org/10.1371/journal.pone.0220745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393928	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500058
J	Lezama-Ochoa, N; Hall, MA; Pennino, MG; Stewart, JD; Lopez, J; Murua, H				Lezama-Ochoa, Nerea; Hall, Martin A.; Pennino, Maria Grazia; Stewart, Joshua D.; Lopez, Jon; Murua, Hilario			Environmental characteristics associated with the presence of the Spinetail devil ray (Mobula mobular) in the eastern tropical Pacific	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; SPATIOTEMPORAL DISTRIBUTION; SPECIES DISTRIBUTIONS; INCIDENTAL CATCH; DIVING BEHAVIOR; MANTA-BIROSTRIS; BY-CATCH; TUNA; PREDICTION; FISHERIES	In the eastern Pacific Ocean, the tropical tuna purse-seine fishery incidentally captures high numbers of five mobulid bycatch species; all of which are classified as mortalities by the Inter-American Tropical Tuna Commission due to uncertainties in post-release mortality rates. To date, the factors (operational or environmental) leading to the capture of these species by the fishery have not been well studied. Here, we developed Generalized Additive Models for fisheries observer data to analyze the relationships between the presence/absence of Mobula mobular bycatch and oceanographic conditions, the spatial and temporal variability in fishing location, and the set type (associated with dolphins, free-swimming tuna schools or floating objects). Our results suggest that chlorophyll concentration and sea surface height are the most important variables to describe the presence of M. mobular in conjunction with geographic location (latitude and longitude) and set type. Presence of the species was predicted in waters with chlorophyll concentrations between 0.5-1 mg.m(-3) and with sea surface height values close to 0; which indicates direct relationships with productive upwelling systems. Seasonally, M. mobular was observed more frequently during December-January and August-September. We also found the highest probability of presence observed in School sets, followed by Dolphin sets. Three areas were observed as important hotspots: the area close to the coastal upwelling of northern Peru, the area west to Islands Colon Archipelago (Galapagos) and the area close to the Costa Rica Dome. This information is crucial to identify the mobulids habitat and hotspots that could be managed and protected under dynamic spatial management measures to reduce the mortality of mobulid rays in the eastern Pacific purse-seine fishery and, hence, ensure the sustainability of the populations of these iconic species.	[Lezama-Ochoa, Nerea; Hall, Martin A.; Lopez, Jon] Interamer Trop Tuna Commiss, Bycatch Program, San Diego, CA 92121 USA; [Lezama-Ochoa, Nerea; Murua, Hilario] AZTI Tecnalia, Marine Res Div, Pasaia, Spain; [Pennino, Maria Grazia] IEO, Vigo, Spain; [Stewart, Joshua D.] Scripps Inst Oceanog, San Diego, CA USA; [Stewart, Joshua D.] Manta Trust, Dorchester, Dorset, England; [Murua, Hilario] ISSF, Washington, DC USA	AZTI; Spanish Institute of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography	Lezama-Ochoa, N (corresponding author), Interamer Trop Tuna Commiss, Bycatch Program, San Diego, CA 92121 USA.; Lezama-Ochoa, N (corresponding author), AZTI Tecnalia, Marine Res Div, Pasaia, Spain.	nlezamaochoa@gmail.com	Johnson, Jeannie/AAD-1971-2021	Stewart, Joshua/0000-0001-6851-2289; pennino, maria grazia/0000-0002-7577-2617; Lopez, Jon/0000-0002-4172-4094	Basque Government ("Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor")	Basque Government ("Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor")(Basque Government)	This work is funded by the Basque Government ("Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor") to NLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes JMV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161444; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bigelow K, 2006, FISH RES, V77, P173, DOI 10.1016/j.fishres.2005.10.010; Bivand R, 2009, MGCV 1 3 R PACKAGE; BIVAND R, SPDEP SPATIAL DEPEND, DOI DOI 10.1007/978-3-319-02769-2_2; Borrell A, 2011, ICES J MAR SCI, V68, P547, DOI 10.1093/icesjms/fsq170; BRAUN CD, 2015, MAR BIOL, V162, P12; Braun CD, 2015, FAO FISHERIES AQUACU, V162; BRAUN CD, 2014, PLOS ONE, V9, P2, DOI DOI 10.1111/FOG.12005; Brodie S, 2015, FISH OCEANOGR, V24, P463, DOI 10.1111/fog.12122; BURGESS K, 2017, FEEDING ECOLOGY AND; Canese Simonepietro, 2011, Endangered Species Research, V14, P171, DOI 10.3354/esr00349; Carvalho FC, 2011, ICES J MAR SCI, V68, P890, DOI 10.1093/icesjms/fsr047; CELONA A, 2004, ANN SER HIST NAT, P1788; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Clark TB, 2010, PLOS ONE; CLARK TB, 2010, ABUNDANCE HOME RANGE, P2010, DOI DOI 10.1016/J.DSR2.2006.03.004; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; CROLL DA, MARINE ECOLOGY PROGR, DOI DOI 10.1111/J.1365-2419.2011.00571.X; Croll DA, 2016, VULNERABILITIES AND; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; DUFFY C, 2003, SIGHTINGS OF MOBULID, DOI DOI 10.1007/978-94-017-7499-4_3; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Escalle L, 2016, FISH OCEANOGR, V25, P433, DOI 10.1111/fog.12163; EVESON JP, 2018, DEEP SEA RESEARCH PA, DOI DOI 10.1111/FOG.12130; Fiedler PC, 2017, CORAL REEFS WORLD, V8, P59, DOI 10.1007/978-94-017-7499-4_3; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fortuna CM, 2014, SCI MAR, V78, P227, DOI 10.3989/scimar.03920.30D; FRANCIS MP, 2016, AQUAT CONSERV, DOI DOI 10.1111/FOG.12122; FREEMAN E, 2012, R PACKAGE VERSION, V1, P9, DOI DOI 10.3354/ESR00251; Gadig OBF, 2003, J MAR BIOL ASSOC UK, V83, P869, DOI 10.1017/S0025315403007914h; Giannoulaki M, 2013, FISH OCEANOGR, V22, P69, DOI 10.1111/fog.12005; Gilly WF, 2013, ANNU REV MAR SCI, V5, P393, DOI 10.1146/annurev-marine-120710-100849; Girondot M, 2015, J MAR BIOL ASSOC UK, V95, P153, DOI 10.1017/S0025315414001398; GRIFFITHS S, DOCUMENT SAC 08 07D, P8; Griffiths TL, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P9; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hacohen-Domene A, 2015, INFLUENCIA DE FACTOR, P1; Hacohen-Domene A, 2006, CYBIUM, V30, P99; HACOHENDOMENE P, MARINE, DOI DOI 10.3354/MEPS10910; Hahlbeck N, 2017, FISH RES, V191, P154, DOI 10.1016/j.fishres.2017.03.011; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.1093/ZOOLINNEAN/ZLX018; HALL MA, 2007, FAO FISHERIES AQUACU; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.1016/J.POCEAN.2009.07.032; HALL MA, 2010, FAO FISHERIES AQUACU, V90, P969; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.1371/JOURNAL.PONE.0036834; HALL MA, 2012, FAO FISHERIES AQUACU, V465, P193, DOI DOI 10.1146/ANNUREV.ECOLSYS.110308.120159; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.3354/ESR00349; Hall MA, 2013, FAO FISHERIES AND AQ, P568; HALL MA, FAO FISHERIES AQUACU, DOI DOI 10.1016/J.ZOOL.2016.05.010; Hearn AR, 2014, SOC ECOL INTERACT GA, P23, DOI 10.1007/978-3-319-02769-2_2; Heinrichs S, 2011, MANTA RAY OF HOPE GL; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hijmans RJ, 2012, PLOS ONE, V1, P9; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Hobday AJ, 2011, DEEP-SEA RES PT II, V58, P734, DOI 10.1016/j.dsr2.2010.10.006; IATTC, 2015, ROYAL SOC OPEN SCI; *IATTC, 2009, FISHERY STATUS REPOR, V8, P133; *IATTC, DOCUMENT IATTC 89 04, P89, DOI DOI 10.3354/MEPS09900; *ISSF, 2014, SKIPPERS GUIDEBOOK T; Jaine F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046170; Jaine FRA, 2014, MAR ECOL PROG SER, V510, P73, DOI 10.3354/meps10910; JIMENEZ JA, 2017, THE THERMAL DOME OF, V106, DOI DOI 10.3354/MEPS12304; Jimenez JA, 2017, FISH RES; Jones AR, 2014, PROG OCEANOGR, V128, P30, DOI 10.1016/j.pocean.2014.08.002; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; KOHAVI R, 1995, A STUDY OF CROSS VAL, DOI DOI 10.1038/NCLIMATE1304; Lawson JM, 2017, PEERJ, V5, DOI 10.7717/peerj.3027; Lezama-Ochoa N, 2015, BIODIVERS CONSERV, V24, P2647, DOI 10.1007/s10531-015-0951-3; Lezama-Ochoa N, 2018, FAO FISHERIES AQUACU; Lezama-Ochoa N, 2018, FISH RES; LEZAMAOCHOA N, 2017, FRONTIERS IN MARINE, DOI DOI 10.3989/SCIMAR.03920.30D; LEZAMAOCHOA N, 2018, MARINE ECOLOGY, DOI DOI 10.1017/S0025315414001398; Lopez J, 2017, DEEP-SEA RES PT II, V140, P127, DOI 10.1016/j.dsr2.2017.02.007; Martinez-Rincon RO, 2015, MAR FRESHWATER RES, V66, P644, DOI 10.1071/MF14062; Martinez-Rincon RO, 2012, ECOL MODEL, V233, P20, DOI 10.1016/j.ecolmodel.2012.03.006; Mas F, 2015, MAR FRESHWATER RES, V66, P767, DOI 10.1071/MF14180; MASANGCAY SIG, 2018, FEEDING HABITS OF MO, V30, P1; Montero JT, 2016, FISH OCEANOGR, V25, P1, DOI 10.1111/fog.12130; NOTARBARTOLODISCIARA G, 1989, COPEIA, P607; NOTARBARTOLODISCIARA G, 1988, FISH B-NOAA, V86, P45; O'Malley MP, 2017, AQUAT CONSERV, V27, P394, DOI 10.1002/aqc.2670; OCHOA NHL, 2018, ENVIRONMENTAL BIOLOG, DOI DOI 10.1016/J.MARPOL.2013.09.025; OCHOA NL, 2016, FRONT MAR SCI, V3, P34; Palacios DM, 2006, DEEP-SEA RES PT II, V53, P250, DOI 10.1016/j.dsr2.2006.03.004; Pardo SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33745; PAYNE MR, 2015, ICEJ MARINE SCI J, V231; Payne MR, 2015, ECOLOGY; PEARSON RG, 2007, SYNTHESIS AMERICAN M, V50, DOI DOI 10.1146/ANNUREV-MARINE-120710-100849; PERRYMAN HA, 2017, COLLECT VOL SCI PAP, V73, P1778, DOI DOI 10.1111/FOG.12163; Perryman HA, 2017, FISHERIES OCEANOGRAP, V73, P1778; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Poisson F, 2014, MAR POLICY, V44, P312, DOI 10.1016/j.marpol.2013.09.025; RINCO ROM, 2012, THESIS, DOI DOI 10.1016/J.DSR2.2017.02.007; ROHNER CA, 2017, PEER J PREPRINTS, P2167; Sampson L, 2010, J MAR BIOL ASSOC UK, V90, P969, DOI 10.1017/S0025315410000548; Shillinger George L., 2010, Endangered Species Research, V10, P215, DOI 10.3354/esr00251; SOBRAL AFL, 2013, BIOLOGY ECOLOGY AND; STEWART JD, 2018, FRONTIERS IN MARINE, DOI DOI 10.1071/MF14180; Stewart JD, 2018, FAO FISHERIES AQUACU; Stewart JD, 2018, FAO FISHERIES AQUACU; Stewart JD, 2017, MAR ECOL PROG SER, V580, P131, DOI 10.3354/meps12304; Stewart JD, 2016, ZOOLOGY, V119, P406, DOI 10.1016/j.zool.2016.05.010; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Team R. C., 2017, R LANG ENV STAT COMP, P2016; Thorrold S.R., 2014, FAO FISHERIES AQUACU, V5, P4274; Thorrold SR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5274; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Wang L, 2018, HABITAT SUITABILITY; WANG L, 2018, FISHERIES OCEANOGRAP; White WT, 2018, ZOOL J LINN SOC-LOND, V182, P50, DOI 10.1093/zoolinnean/zlx018; WOOD S, 2006, GENERALIZED ADDITIVE, DOI DOI 10.1016/J.DSR2.2010.10.006; WOOD S, THE MGCV PACKAGE; Wood S, 2007, MODELLING THE OCEANI; Zuur A, 2009, HABITAT MODEL TO PRE; Zuur Alain F., 2009, P1	121	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220854	10.1371/journal.pone.0220854	http://dx.doi.org/10.1371/journal.pone.0220854			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390369	gold, Green Published, Green Submitted			2022-12-27	WOS:000484999400032
J	Daun, S; Mantziaris, C; Toth, T; Buschges, A; Rosjat, N				Daun, Silvia; Mantziaris, Charalampos; Toth, Tibor; Bueschges, Ansgar; Rosjat, Nils			Unravelling intra- and intersegmental neuronal connectivity between central pattern generating networks in a multi-legged locomotor system	PLOS ONE			English	Article							STICK INSECT; SPECTRAL RESPONSES; PHASE-LOCKING; WALKING; COORDINATION; MOVEMENTS; BEHAVIOR; LEGS; BRAIN; MODEL	Animal walking results from a complex interplay of central pattern generating networks (CPGs), local sensory signals expressing position, velocity and forces generated in the legs, and coordinating signals between neighboring legs. In particular, the CPGs control the activity of motoneuron (MN) pools which drive the muscles of the individual legs and are thereby responsible for the generation of rhythmic leg movements. The rhythmic activity of the CPGs as well as their connectivity can be modified by the aforementioned sensory signals. However, the precise nature of the interaction between the CPGs and these sensory signals has remained generally largely unknown. Experimental methods aiming at finding out details of these interactions often apply cholinergic agonists such as pilocarpine in order to induce rhythmic activity in the CPGs. Using this general approach, we removed the influence of sensory signals and investigated the putative connections between CPGs controlling the upward/downward movement in the different legs of the stick insect. The experimental data, i.e. the measured MN activities, underwent connectivity analysis using Dynamic Causal Modelling (DCM). This method can uncover the underlying coupling structure and strength between pairs of segmental CPGs. For the analysis we set up different coupling schemes (models) for DCM and compared them using Bayesian Model Selection (BMS). Models with contralateral connections in each segment and ipsilateral connections on both sides, as well as the coupling from the meta-to the ipsilateral prothoracic ganglion were preferred by BMS to all other types of models tested. Moreover, the intrasegmental coupling strength in the mesothoracic ganglion was the strongest and most stable in all three ganglia.	[Daun, Silvia; Toth, Tibor; Rosjat, Nils] Univ Cologne, Inst Zool, Heisenberg Res Grp Computat Neurosci Modelling Ne, Cologne, Germany; [Daun, Silvia; Rosjat, Nils] Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany; [Mantziaris, Charalampos; Bueschges, Ansgar] Univ Cologne, Inst Zool, Dept Anim Physiol, Cologne, Germany	University of Cologne; Helmholtz Association; Research Center Julich; University of Cologne	Rosjat, N (corresponding author), Univ Cologne, Inst Zool, Heisenberg Res Grp Computat Neurosci Modelling Ne, Cologne, Germany.; Rosjat, N (corresponding author), Res Ctr Julich, Inst Neurosci & Med INM 3, Cognit Neurosci, Julich, Germany.	n.rosjat@fz-juelich.de		Daun, Silvia/0000-0001-7342-1015; Mantziaris, Charalampos/0000-0003-2280-1733; Buschges, Ansgar/0000-0003-2123-1900	Deutsche Forschungsgemeinschaft [DA1953/5-2, RTG1960]; University of Cologne: CONNECT; University of Cologne Emerging Groups Initiative (CONNECT); German Excellence Initiative; German Research Foundation, Germany [DA1953/5-2]; DFG [RTG1960]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Cologne: CONNECT; University of Cologne Emerging Groups Initiative (CONNECT); German Excellence Initiative; German Research Foundation, Germany(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	SD was supported by Deutsche Forschungsgemeinschaft: DA1953/5-2 (http://www.dfg.de/); SD and AB were supported by Deutsche Forschungsgemeinschaft and University of Cologne: CONNECT (http://www.dfg.de/); CM was supported by Deutsche Forschungsgemeinschaft: RTG1960 (http://www.dfg.de/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Anke Borgmann for useful discussions on the analysis. This study was funded by the University of Cologne Emerging Groups Initiative (CONNECT) within the framework of the Institutional Strategy of the University of Cologne and the German Excellence Initiative. SD gratefully acknowledges additional support from the German Research Foundation, Germany (DA1953/5-2). CM was an associate member of the RTG1960 "Neural Circuit Analysis on the Cellular and Subcellular Level" funded by the DFG.	[Anonymous], [No title captured]; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Borgmann A, 2007, J NEUROPHYSIOL, V98, P1685, DOI 10.1152/jn.00291.2007; Brunner von Wattenwyl K, 1908, INSEKTENFAMILIE PHAS; Buschges A, 2008, BRAIN RES REV, V57, P162, DOI 10.1016/j.brainresrev.2007.06.028; BUSCHGES A, 1995, J EXP BIOL, V198, P435; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; Chen CC, 2009, NEUROIMAGE, V45, P453, DOI 10.1016/j.neuroimage.2008.12.041; CRUSE H, 1990, TRENDS NEUROSCI, V13, P15, DOI 10.1016/0166-2236(90)90057-H; CRUSE H, 1976, J COMP PHYSIOL, V112, P235, DOI 10.1007/BF00606541; Daido H, 1997, INT J BIFURCAT CHAOS, V7, P807, DOI 10.1142/S0218127497000601; Daun-Gruhn S, 2011, BIOL CYBERN, V105, P71, DOI 10.1007/s00422-011-0446-6; Daun-Gruhn S, 2011, J COMPUT NEUROSCI, V31, P43, DOI 10.1007/s10827-010-0300-1; David I, 2016, BIOL OPEN, V5, P1229, DOI 10.1242/bio.018705; DEAN J, 1989, J EXP BIOL, V145, P103; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; FOTH E, 1985, BIOL CYBERN, V51, P313, DOI 10.1007/BF00336918; Friston KJ, 2012, NEUROIMAGE, V59, P439, DOI 10.1016/j.neuroimage.2011.07.048; Fuchs E, 2011, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00125; Grabowska M, 2012, J EXP BIOL, V215, P4255, DOI 10.1242/jeb.073643; GRAHAM D, 1985, J EXP BIOL, V118, P287; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Hess D, 1997, J NEUROBIOL, V33, P891; Johnston Rebecca M., 2002, Invertebrate Neuroscience, V4, P175, DOI 10.1007/s10158-002-0019-4; Kiebel SJ, 2008, COGN NEURODYNAMICS, V2, P121, DOI 10.1007/s11571-008-9038-0; Knebel D, 2017, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00112; Ludwar BC, 2005, J NEUROPHYSIOL, V93, P1255, DOI 10.1152/jn.00727.2004; MacQueen J., 1967, P 5 BERK S MATH STAT, V1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mallada E, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/50/505101; Mantziaris C, 2017, J NEUROPHYSIOL, V118, P2296, DOI 10.1152/jn.00321.2017; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marple SL, 1999, IEEE T SIGNAL PROCES, V47, P2600, DOI 10.1109/78.782222; Moran RJ, 2008, NEUROIMAGE, V42, P272, DOI 10.1016/j.neuroimage.2008.01.025; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; Moran RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022790; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Penny WD, 2009, J NEUROSCI METH, V183, P19, DOI 10.1016/j.jneumeth.2009.06.029; Rigoux L, 2014, NEUROIMAGE, V84, P971, DOI 10.1016/j.neuroimage.2013.08.065; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; RYCKEBUSCH S, 1994, J NEUROPHYSIOL, V72, P2771, DOI 10.1152/jn.1994.72.6.2771; SCHMITZ J, 1986, BIOL CYBERN, V55, P25, DOI 10.1007/BF00363975; SCHMITZ J, 1988, COMP BIOCHEM PHYS A, V91, P769, DOI 10.1016/0300-9629(88)90963-2; SILLAR KT, 1987, J EXP BIOL, V131, P245; Szczecinski NS, 2018, BIORXIV; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Walz JM, 2013, J NEUROSCI, V33, P19212, DOI 10.1523/JNEUROSCI.2649-13.2013	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220767	10.1371/journal.pone.0220767	http://dx.doi.org/10.1371/journal.pone.0220767			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386699	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100036
J	Husain, B; Feltus, FA				Husain, Benafsh; Feltus, F. Alex			EdgeScaping: Mapping the spatial distribution of pairwise gene expression intensities	PLOS ONE			English	Article							COEXPRESSION NETWORK; CANCER; VALIDATION; ALGORITHM; RELEVANCE	Gene co-expression networks (GCNs) are constructed from Gene Expression Matrices (GEMs) in a bottom up approach where all gene pairs are tested for correlation within the context of the input sample set. This approach is computationally intensive for many current GEMs and may not be scalable to millions of samples. Further, traditional GCNs do not detect non-linear relationships missed by correlation tests and do not place genetic relationships in a gene expression intensity context. In this report, we propose EdgeScaping, which constructs and analyzes the pairwise gene intensity network in a holistic, top down approach where no edges are filtered. EdgeScaping uses a novel technique to convert traditional pairwise gene expression data to an image based format. This conversion not only performs feature compression, making our algorithm highly scalable, but it also allows for exploring non-linear relationships between genes by leveraging deep learning image analysis algorithms. Using the learned embedded feature space we implement a fast, efficient algorithm to cluster the entire space of gene expression relationships while retaining gene expression intensity. Since EdgeScaping does not eliminate conventionally noisy edges, it extends the identification of co-expression relationships beyond classically correlated edges to facilitate the discovery of novel or unusual expression patterns within the network. We applied EdgeScaping to a human tumor GEM to identify sets of genes that exhibit conventional and nonconventional interdependent non-linear behavior associated with brain specific tumor subtypes that would be eliminated in conventional bottom-up construction of GCNs. Edgescaping source code is available at https://github.com/bhusain/EdgeScaping under the MIT license.	[Husain, Benafsh; Feltus, F. Alex] Clemson Univ, Biomed Data Sci & Informat Program, Clemson, SC 29634 USA; [Feltus, F. Alex] Clemson Univ, Genet & Biochem Dept, Clemson, SC 29634 USA; [Feltus, F. Alex] Clemson Univ, Ctr Human Genet, Clemson, SC 29634 USA	Clemson University; Clemson University; Clemson University	Feltus, FA (corresponding author), Clemson Univ, Biomed Data Sci & Informat Program, Clemson, SC 29634 USA.; Feltus, FA (corresponding author), Clemson Univ, Genet & Biochem Dept, Clemson, SC 29634 USA.; Feltus, FA (corresponding author), Clemson Univ, Ctr Human Genet, Clemson, SC 29634 USA.	ffeltus@clemson.edu		Husain, Benafsh/0000-0002-5542-5992; Feltus, Frank/0000-0002-2123-6114	National Science Foundation Directorate for Computer and Information Science and Engineering [1659300]	National Science Foundation Directorate for Computer and Information Science and Engineering	This work was supported by National Science Foundation Directorate for Computer and Information Science and Engineering, 1659300, Dr. Frank Alexander Feltus.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen JQ, 2013, J PROTEOME RES, V12, P2354, DOI 10.1021/pr400162t; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Ficklin SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09094-4; Gibson SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055871; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Guo XF, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1753; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Krizhevsky A., P 25 INT C NEUR INF, P1097; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liang MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116776; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Petereit J, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0298-8; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Srihari S, 2013, BIOINFORMATICS, V29, P1553, DOI 10.1093/bioinformatics/btt191; Vempati UD, 2014, J BIOMOL SCREEN, V19, P803, DOI 10.1177/1087057114522514; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220279	10.1371/journal.pone.0220279	http://dx.doi.org/10.1371/journal.pone.0220279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386677	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100017
J	Zuo, JP; Hong, ZJ; Peng, SP; Shi, Y; Song, HQ; Li, M; Zhang, ZS				Zuo, Jianping; Hong, Zijie; Peng, Suping; Shi, Yue; Song, Hongqiang; Li, Meng; Zhang, Zishan			Investigation on failure behavior of collapse column in China's coal mine based on discontinuous deformation numerical method	PLOS ONE			English	Article							KARST COLLAPSE; ENVIRONMENTS; PREDICTION; HAZARDS	Karst collapse column is a serious geological disaster in China's coal mines. There are various karst collapse columns in coal mine areas, such as Huainan, Huaibei, Xingtai, Lu'an. And they have seriously affected mining safety and geological environment. The present research is focused on analyzing subsidence mechanism and dynamic collapse process. Based on mechanical analysis of thin plate theory, a detailed model of collapse column slipping and bending fracture is constructed to gather the critical conditions of the collapse column roof. The sensitivity parameters analysis shows that both the radius and roof thickness of cave have a great influence on the sliding instability and bending fracture. Meanwhile, the buried depth also affects bending failure. The discontinuous deformation analysis (DDA) method is used to simulate and analyze the collapse process. The numerical results indicate that the stability of inverted funnel collapse column is dominated by the bending stress of roof strata. The movement of columnar collapse column is mainly caused by sliding instability. However, the funnel collapse column is relatively stable, and does not change in the same condition. The displacement field analysis shows that the collapse range of inverted funnel collapse column is obviously larger than that of columnar collapse column, in which its maximum displacement is approximately 1.5 times that of the columnar collapse column. There is no large area collapse on the upper part of the funnel collapse column, and the block system is relatively stable. The principal stress field analysis proves the above results.	[Zuo, Jianping; Hong, Zijie; Shi, Yue; Song, Hongqiang; Li, Meng; Zhang, Zishan] China Univ Min & Technol, Sch Mech & Civil Engn, Beijing, Peoples R China; [Zuo, Jianping; Peng, Suping] China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Beijing, Peoples R China; [Peng, Suping] China Univ Min & Technol, Beijing, Peoples R China	China University of Mining & Technology; China University of Mining & Technology; China University of Mining & Technology	Zuo, JP (corresponding author), China Univ Min & Technol, Sch Mech & Civil Engn, Beijing, Peoples R China.; Zuo, JP (corresponding author), China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Beijing, Peoples R China.	zjp@cumtb.edu.cn	Zhang, zs/GXN-3521-2022		National Natural Science Foundation of China [51622404, 11572343]; State Key Research Development Program of China [2016YFC0801404]; Outstanding Young Talents of Ten Thousand People Plan [W02070044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Research Development Program of China(State Key Development Program for Basic Research of China); Outstanding Young Talents of Ten Thousand People Plan	This study was supported by the National Natural Science Foundation of China, grant numbers 51622404 and 11572343 to JPZ, the State Key Research Development Program of China, grant number 2016YFC0801404 to JPZ, and by the Outstanding Young Talents of Ten Thousand People Plan, grant number W02070044 to JPZ. The had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achari G, 1999, CAN GEOTECH J, V36, P783, DOI 10.1139/cgj-36-5-783; Chen SP, 1993, CARSOLOGICA SIN, V12, P233; Feng XY, 2017, COAL GEOLOGY CHINA, V29, P70; Galve JP, 2015, GEOMORPHOLOGY, V229, P30, DOI 10.1016/j.geomorph.2014.07.035; He KQ, 2007, ENVIRON GEOL, V52, P449, DOI 10.1007/s00254-006-0478-8; He KQ, 2005, KARST COLLAPSE N CHI, P4; Hu RL, 2001, CHIN J ROCK MECH ENG, V25, P189; Intrieri E, 2015, GEOMORPHOLOGY, V241, P304, DOI 10.1016/j.geomorph.2015.04.018; Ju Y, 2007, P 8 INT C AN DISC DE, P39; Kong HL, 2018, ARAB J GEOSCI, V11, DOI 10.1007/s12517-018-3881-z; Ma D, 2015, NAT HAZARDS, V76, P1319, DOI 10.1007/s11069-014-1551-3; Nicieza CG, 2005, INT J ROCK MECH MIN, V42, P372, DOI 10.1016/j.ijrmms.2004.12.003; Peng SP, 2008, CHINESE J ROCK MECH, V27, P2762; Qian MG, 2010, GROUND PRESSURE STRA, P15; Shi G.H., 1988, THESIS; Shi J, 1998, GEOL MIN RES N CHINA, V13, P264; Sun XF., 2008, MECH MAT; Tharp TM, 2002, ENVIRON GEOL, V42, P447, DOI 10.1007/s00254-001-0504-9; Thierry P, 2005, B ENG GEOL ENVIRON, V64, P139, DOI 10.1007/s10064-004-0247-4; Troitzky GM, 1993, SINKHOLE DANGER ENG, P231; Wang HT, 1997, ENG GEOL, V48, P135, DOI 10.1016/S0013-7952(97)81918-7; Wang J. C., 2009, J MIN SAFE ENG, V26, P140; Xu ZL, 2001, CONCISE COURSE ELAST; Yin SX, 2004, J CHINA COAL SOC, V29, P183; Youssef AM, 2016, HYDROGEOL J, V24, P625, DOI 10.1007/s10040-015-1336-0; Yuan DX, 1994, KARST CHINA, P21; Yuan DX., 2002, KARST DYNAMIC SYSTEM, P185; Zhang YF, 2011, PROGR GEOPHYS, V26, P1432; Zuo JP, 2017, ARAB J GEOSCI, V10, DOI 10.1007/s12517-017-3190-y; Zuo JP, 2009, INT J COAL GEOL, V78, P276, DOI 10.1016/j.coal.2009.02.003; Zuo JP, 2017, J CHINA U MINING TEC, V46, P19	31	4	4	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219733	10.1371/journal.pone.0219733	http://dx.doi.org/10.1371/journal.pone.0219733			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386674	Green Published, gold, Green Submitted			2022-12-27	WOS:000484997100006
J	Reiss, S; Klackl, J; Proulx, T; Jonas, E				Reiss, Stefan; Klackl, Johannes; Proulx, Travis; Jonas, Eva			Strength of socio-political attitudes moderates electrophysiological responses to perceptual anomalies	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ALPHA OSCILLATIONS; POLITICAL-IDEOLOGY; MORTALITY SALIENCE; ATTENTION; AFFIRMATION; INCREASES; EXPOSURE; THREAT; SIMILARITIES	People with strong (vs. moderate) political attitudes have been shown to exhibit less phasic reactivity to perceptual anomalies, presumably to prevent their committed meaning systems from being challenged by novel experiences. Several researchers have proposed that (but not tested whether) firmly committed individuals also engage in more attentional suppression of anomalies, likely mediated by prestimulus alpha power. We expected participants with strong (vs. moderate) political attitudes to display increased pre-stimulus alpha power when processing perceptual anomalies. We recorded electrophysiological activity during the presentation of normal cards (control group) or both normal and anomalous playing cards (experimental group; total N = 191). In line with our predictions, the presence of anomalous playing cards in the stimulus set increased prestimulus alpha power only among individuals with strong but not moderate political attitudes. As potential markers of phasic reactivity, we also analyzed the late positive potential (LPP) and earlier components of the event-related potential, namely P1, N1, and P300. The moderating effect of extreme attitudes on ERP amplitudes remained inconclusive. Altogether, our findings support the idea that ideological conviction is related to increased tonic responses to perceptual anomalies.	[Reiss, Stefan; Klackl, Johannes; Jonas, Eva] Univ Salzburg, Dept Psychol, Salzburg, Austria; [Proulx, Travis] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales	Salzburg University; Cardiff University	Reiss, S (corresponding author), Univ Salzburg, Dept Psychol, Salzburg, Austria.	stefan.reiss@sbg.ac.at	delete, Doctoral College Imaging the Mind - to/E-5040-2018; cohorts, Doctoral College Imaging the Mind - all/I-4689-2018; Reiss, Stefan/AAA-6155-2021	Reiss, Stefan/0000-0001-8188-6664; Klackl, Johannes/0000-0003-2619-4715	Austrian Science Fund [FWF-P27457]; Doctoral College "Imaging the Mind" of the Austrian Science Fund [FWF-W1233-G17]	Austrian Science Fund(Austrian Science Fund (FWF)); Doctoral College "Imaging the Mind" of the Austrian Science Fund	Research was supported by the Austrian Science Fund (FWF-P27457). SR has been supported by the Doctoral College "Imaging the Mind" of the Austrian Science Fund (FWF-W1233-G17).	Agroskin D, 2013, J EXP SOC PSYCHOL, V49, P1144, DOI 10.1016/j.jesp.2013.05.014; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Bizumic B, 2009, EUR J SOC PSYCHOL, V39, P871, DOI 10.1002/ejsp.589; Brandt MJ, 2014, BEHAV BRAIN SCI, V37, P307, DOI 10.1017/S0140525X13002513; Brandt MJ, 2014, CURR DIR PSYCHOL SCI, V23, P27, DOI 10.1177/0963721413510932; BRANDT ME, 1991, INT J NEUROSCI, V61, P261, DOI 10.3109/00207459108990744; BRUNER JS, 1949, J PERS, V18, P206, DOI 10.1111/j.1467-6494.1949.tb01241.x; Codispoti M, 2007, J COGNITIVE NEUROSCI, V19, P577, DOI 10.1162/jocn.2007.19.4.577; Cohen F, 2017, ANAL SOC ISS PUB POL, V17, P339, DOI 10.1111/asap.12143; Dandeneau SD, 2007, J PERS SOC PSYCHOL, V93, P651, DOI 10.1037/0022-3514.93.4.651; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dennis TA, 2009, J CHILD PSYCHOL PSYC, V50, P1373, DOI 10.1111/j.1469-7610.2009.02168.x; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ferrari V, 2016, BIOL PSYCHOL, V113, P75, DOI 10.1016/j.biopsycho.2015.11.008; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Gratton G, 1983, ELECTROENCEPHALOGR C, V116, P717; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Hanslmayr S, 2005, NEUROSCI LETT, V375, P64, DOI 10.1016/j.neulet.2004.10.092; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Hibbing JR, 2014, BEHAV BRAIN SCI, V37, P297, DOI 10.1017/S0140525X13001192; Hirsh JB, 2012, PSYCHOL REV, V119, P304, DOI 10.1037/a0026767; Hong LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091321; Inzlicht M, 2010, PSYCHOL SCI, V21, P1184, DOI 10.1177/0956797610375451; Inzlicht M, 2009, PSYCHOL SCI, V20, P385, DOI 10.1111/j.1467-9280.2009.02305.x; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jonas E, 2014, ADV EXP SOC PSYCHOL, V49, P219, DOI 10.1016/B978-0-12-800052-6.00004-4; Jonas E, 2008, J PERS SOC PSYCHOL, V95, P1239, DOI 10.1037/a0013593; Jost JT, 2014, POLIT PSYCHOL, V35, P3, DOI 10.1111/pops.12162; Jost JT, 2012, MOTIV EMOTION, V36, P55, DOI 10.1007/s11031-011-9260-7; Kamp SM, 2015, PSYCHOPHYSIOLOGY, V52, P460, DOI 10.1111/psyp.12378; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Klackl J, 2014, SOC COGN AFFECT NEUR, V9, P1754, DOI 10.1093/scan/nst167; Klackl J, 2018, SOC NEUROSCI-UK, V13, P355, DOI 10.1080/17470919.2017.1308880; Klackl J, 2013, SOC COGN AFFECT NEUR, V8, P333, DOI 10.1093/scan/nss003; Klimesch W, 2004, COGNITIVE BRAIN RES, V19, P302, DOI 10.1016/j.cogbrainres.2003.11.016; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Klimesch W, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00118; Ludeke SG, 2014, BEHAV BRAIN SCI, V37, P319, DOI 10.1017/S0140525X13002641; Lueders A, 2019, EUR J SOC PSYCHOL, V49, P1471, DOI 10.1002/ejsp.2580; Millisecond Software LLC, 2014, INQ 4 0 8 0, DOI [10.1002/ejsp.589, DOI 10.1002/EJSP.589]; Mouffe C, 1998, SOUNDINGS, V9, P11; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Proulx T., 2013, EXPERIENCE MEANING L, P47, DOI [10.1007/978-94-007-6527-6_4, DOI 10.1007/978-94-007-6527-6_4]; Proulx T, 2006, PSYCHOL INQ, V17, P309, DOI 10.1080/10478400701366985; Proulx T, 2017, SOC COGNITION, V35, P313, DOI 10.1521/soco.2017.35.4.313; Proulx T, 2017, J EXP SOC PSYCHOL, V70, P69, DOI 10.1016/j.jesp.2016.12.003; Proulx T, 2013, J SOC ISSUES, V69, P455, DOI 10.1111/josi.12024; Proulx T, 2012, PSYCHOL INQ, V23, P317, DOI 10.1080/1047840X.2012.702372; Proulx T, 2010, PERS SOC PSYCHOL B, V36, P817, DOI 10.1177/0146167210369896; Proulx T, 2009, PSYCHOL SCI, V20, P1125, DOI 10.1111/j.1467-9280.2009.02414.x; Proulx T, 2008, PSYCHOL SCI, V19, P1294, DOI 10.1111/j.1467-9280.2008.02238.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Randles D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204640; Randles D, 2011, J EXP SOC PSYCHOL, V47, P246, DOI 10.1016/j.jesp.2010.07.020; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reiss S., 2018, HDB TERROR MANAGEMEN, P449, DOI [10.1016/B978-0-12-811844-3.00019-6, DOI 10.1016/B978-0-12-811844-3.00019-6]; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Sleegers W., 2015, FRONT PSYCHOL, V5, P1568, DOI [10.3389/fpsyg.2015.01568, DOI 10.3389/FPSYG.2015.01568]; Sleegers WWA, 2015, BIOL PSYCHOL, V108, P126, DOI 10.1016/j.biopsycho.2015.03.012; TAYLOR IA, 1960, PSYCHOL MONOGR, V74, P1; Tritt SM, 2016, EMOTION, V16, P1172, DOI 10.1037/emo0000150; Tritt SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083333; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008	70	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220732	10.1371/journal.pone.0220732	http://dx.doi.org/10.1371/journal.pone.0220732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381605	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000484993600033
J	Valbusa, F; Angheben, A; Mantovani, A; Zerbato, V; Chiampan, A; Bonapace, S; Rodari, P; Agnoletti, D; Arcaro, G; Fava, C; Bisoffi, Z; Targher, G				Valbusa, Filippo; Angheben, Andrea; Mantovani, Alessandro; Zerbato, Verena; Chiampan, Andrea; Bonapace, Stefano; Rodari, Paola; Agnoletti, Davide; Arcaro, Guido; Fava, Cristiano; Bisoffi, Zeno; Targher, Giovanni			Increased aortic stiffness in adults with chronic indeterminate Chagas disease	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; TRYPANOSOMA-CRUZI INFECTION; ARTERIAL STIFFNESS; HEART-DISEASE; PATHOGENESIS; PRESSURE	An ever-increasing number of patients with chronic indeterminate Chagas disease are diagnosed with early vascular and cardiac abnormalities, as cardiovascular imaging becomes more sensitive. However, the currently available information on aortic stiffness (a prognostic marker for adverse cardiovascular outcomes) in these patients is scarce. In this study, we consecutively recruited 21 asymptomatic Bolivian adult patients with chronic indeterminate Chagas disease and 14 Bolivian adults, who were seronegative for Trypanosoma cruzi infection. No participants had a prior history of heart disease, hypertension, diabetes, chronic kidney disease or atrial fibrillation. Carotid-femoral pulse wave velocity (cf-PWV), carotid-radial PWV (cr-PWV), carotid intima-media thickness and conventional echocardiographic measurements were recorded in all participants. Patients with chronic indeterminate Chagas disease had significantly higher cf-PWV (7.9 +/- 1.3 vs. 6.4 +/- 1.1 m/s, p = 0.003) and greater HOMA-estimated insulin resistance than subjects without Chagas disease. The two groups did not significantly differ in terms of age, sex, smoking, adiposity measures, blood pressure, plasma lipids, fasting glucose levels as well as cr-PWV, carotid intima-media thickness measurements, left ventricular mass and function. Presence of chronic indeterminate Chagas disease was significantly associated with increasing cf-PWV values (beta coefficient: 1.31, 95% coefficient interval 0.44 to 2.18, p = 0.005), even after adjustment for age, sex, heart rate, systolic blood pressure and insulin resistance. In conclusion, asymptomatic Bolivian adult patients with chronic indeterminate Chagas disease have an early and marked increase in aortic stiffness, as measured by cf-PWV, when compared to Bolivian adults who were seronegative for Trypanosoma cruzi infection.	[Valbusa, Filippo; Agnoletti, Davide; Arcaro, Guido] IRCCS Sacro Cuore Don Calabria Hosp, Div Internal Med, Verona, Italy; [Angheben, Andrea; Zerbato, Verena; Rodari, Paola; Bisoffi, Zeno] IRCCS Sacro Cuore Don Calabria Hosp, Dept Infect & Trop Dis, Verona, Italy; [Mantovani, Alessandro; Targher, Giovanni] Univ & Azienda Osped Univ Integrate Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy; [Chiampan, Andrea; Bonapace, Stefano] IRCCS Sacro Cuore Don Calabria Hosp, Div Cardiol, Verona, Italy; [Fava, Cristiano] Univ Verona, Dept Med, Sect Gen Med & Hypertens, Verona, Italy; [Bisoffi, Zeno] Univ Verona, Dept Diagnost & Publ Hlth, Verona, Italy	IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; IRCCS Sacro Cuore Don Calabria; University of Verona; University of Verona	Targher, G (corresponding author), Univ & Azienda Osped Univ Integrate Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy.	giovanni.targher@univr.it	Targher, Giovanni/AAB-9008-2019; Agnoletti, Davide/K-1441-2016; Mantovani, Alessandro/AAB-9015-2019; Fava, Cristiano/K-9590-2015; Rodari, Paola/D-6871-2019; Bisoffi, Zeno/B-6438-2013	Targher, Giovanni/0000-0002-4325-3900; Agnoletti, Davide/0000-0001-8108-7133; Mantovani, Alessandro/0000-0002-7271-6329; Fava, Cristiano/0000-0002-8910-7378; Rodari, Paola/0000-0001-8853-8443; Bisoffi, Zeno/0000-0001-9530-8742; Bonapace, Stefano/0000-0001-9122-2642	Italian Ministry of Health "Fondi Ricerca Corrente - Linea 3, progetto 9"	Italian Ministry of Health "Fondi Ricerca Corrente - Linea 3, progetto 9"	This work was supported by the Italian Ministry of Health "Fondi Ricerca Corrente - Linea 3, progetto 9" to IRCCS Sacro Cuore-Don Calabria Hospital of Negrar (VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angheben A, 2011, EUROSURVEILLANCE, V16, P2; Benetos A, 2010, J HYPERTENS, V28, P41, DOI 10.1097/HJH.0b013e328332b879; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bonney KM, 2008, CURR MOL MED, V8, P510, DOI 10.2174/156652408785748004; Burgos JM, 2010, CLIN INFECT DIS, V51, P485, DOI 10.1086/655680; Gornik HL, 2008, CIRCULATION, V117, P3039, DOI 10.1161/CIRCULATIONAHA.107.760686; Hofmann B, 2014, J CLIN HYPERTENS, V16, P629, DOI 10.1111/jch.12382; Jerrard-Dunne P, 2008, J HYPERTENS, V26, P529, DOI 10.1097/HJH.0b013e3282f35265; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lopez M, 2018, CURR CLIN MICROBIOL, V5, P45, DOI 10.1007/s40588-018-0081-2; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Millasseau SC, 2005, HYPERTENSION, V45, P222, DOI 10.1161/01.HYP.0000154229.97341.d2; Nagajyothi F, 2008, OBESITY, V16, P1992, DOI 10.1038/oby.2008.331; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nunes MCP, 2018, EUR HEART J-CARD IMG, V19, P459, DOI 10.1093/ehjci/jex154; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Rajzer MW, 2008, J HYPERTENS, V26, P2001, DOI 10.1097/HJH.0b013e32830a4a25; Regueiro A, 2013, INT J CARDIOL, V165, P107, DOI 10.1016/j.ijcard.2011.07.089; Repetto Ernestina Carla, 2015, PLoS Negl Trop Dis, V9, pe0004103, DOI 10.1371/journal.pntd.0004103; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Requena-Mendez A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003245; Salvi P, 2004, J HYPERTENS, V22, P2285, DOI 10.1097/00004872-200412000-00010; Silva JF, 2016, VASC PHARMACOL, V82, P73, DOI 10.1016/j.vph.2016.03.002; Sunnemark D, 1998, SCAND J IMMUNOL, V48, P480; Tanowitz HB, 2011, ADV PARASIT, V76, P235, DOI 10.1016/B978-0-12-385895-5.00010-4; Villacorta H, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-9; Zhang Y, 2014, J HYPERTENS, V32, P1572, DOI 10.1097/HJH.0000000000000187	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220689	10.1371/journal.pone.0220689	http://dx.doi.org/10.1371/journal.pone.0220689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374101	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500025
J	Choi, AN; Jang, IS; Son, SA; Jung, KH; Park, JK				Choi, An-Na; Jang, II-Seok; Son, Sung-Ae; Jung, Kyoung-Hwa; Park, Jeong-Kil			Effect of erosive and abrasive stress on sealing ability of different desensitizers: In-vitro study	PLOS ONE			English	Article							DENTIN HYPERSENSITIVITY; POTASSIUM OXALATE; TUBULE OCCLUSION; FLUORIDE VARNISH; PERMEABILITY; ADHESIVES; EFFICACY; AGENTS	This in vitro study examined the sealing ability of different desensitizing agents under a chemo-mechanical stress condition. For the study, a total of 144 extracted, caries-free human third molars were used to produce 1 mm-thick dentin discs. The specimens were divided randomly into four groups: Superseal (SS), Gluma (GL), Gluma Self-etch (GS), and Tooth Coat (TC). For each group, the permeability was measured before and after applying the desensitizer, after being exposed to Coca Cola for 5 minutes, and after 3150 strokes of a brushing abrasion. The decrease in permeability after the erosive and abrasive stress was analyzed by ANOVA and Tukey post hoc test. As a result, the dentin permeability decreased significantly for all desensitizers immediately after application (p < 0.05). SS and GS showed a significant difference in permeability reduction observed immediately after application and after acid action with Coca Cola (p < 0.05). After brushing abrasion, the permeability reduction decreased significantly for all desensitizers tested in this study (p < 0.05). TC showed the largest decrease in dentinal permeability compared to that of the other desensitizers and the differences were significant after brushing abrasion (p < 0.05). All tested desensitizers were effective in reducing dentin permeability. The behavioral characteristics under erosive and abrasive stress varied according to the products used. TC exhibited excellent sealing ability among the other desensitizers.	[Choi, An-Na; Son, Sung-Ae; Jung, Kyoung-Hwa; Park, Jeong-Kil] Pusan Natl Univ, Sch Dent, Dent Res Inst, Dept Conservat Dent, Yangsan, South Korea; [Jang, II-Seok] Pusan Natl Univ, Sch Nat Sci, Dept Microbiol, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University	Park, JK (corresponding author), Pusan Natl Univ, Sch Dent, Dent Res Inst, Dept Conservat Dent, Yangsan, South Korea.	jeongkil@pusan.ac.kr		Park, Jeongkil/0000-0001-6333-8138; An-na, Choi/0000-0003-0364-4621				ABSI EG, 1987, J CLIN PERIODONTOL, V14, P280, DOI 10.1111/j.1600-051X.1987.tb01533.x; ADDY M, 1994, ARCH ORAL BIOL, V39, pS33, DOI 10.1016/0003-9969(94)90186-4; Andrew D, 2000, J PHYSIOL-LONDON, V529, P791, DOI 10.1111/j.1469-7793.2000.00791.x; [Anonymous], J CAN DENT ASS; Arrais César Augusto Galvão, 2004, J. Appl. Oral Sci., V12, P144, DOI 10.1590/S1678-77572004000200012; Atta AM, 2011, J APPL POLYM SCI, V122, P183, DOI 10.1002/app.34052; Bacelar-Sa R, 2017, J ADHES DENT, V19, P357, DOI 10.3290/j.jad.a38866; Banomyong D, 2013, J INVESTIG CLIN DENT, V4, DOI 10.1111/j.2041-1626.2012.00144.x; Brannstrom M, 1969, Odontol Revy, V20, P15; Brunton PA, 2000, DENT MATER, V16, P351, DOI 10.1016/S0109-5641(00)00027-0; Camps J, 1998, AM J DENT, V11, P286; Canakci CF, 2007, J AM DENT ASSOC, V138, P1563, DOI 10.14219/jada.archive.2007.0105; De Munck J, 2005, J DENT RES, V84, P118, DOI 10.1177/154405910508400204; Fu B, 2007, OPER DENT, V32, P496, DOI 10.2341/06-143; Giannini Marcelo, 2015, Braz. Dent. J., V26, P3, DOI 10.1590/0103-6440201302442; Gillam D G, 1997, Adv Dent Res, V11, P487; Gillam DG, 2001, J ORAL REHABIL, V28, P1037, DOI 10.1046/j.1365-2842.2001.00775.x; Gillam DG, 2006, ENDOD TOPICS, V13, P13, DOI [10.1111/j.1601-1546.2006.00209.x, DOI 10.1111/J.1601-1546.2006.00209.X]; Guentsch A, 2012, DENT MATER, V28, P457, DOI 10.1016/j.dental.2012.01.003; HANSEN EK, 1992, SCAND J DENT RES, V100, P305; Hashimoto M, 2004, J DENT RES, V83, P843, DOI 10.1177/154405910408301104; Haywood VB, 2001, QUINTESSENCE INT, V32, P105; Hoang-Dao BT, 2009, J ORAL REHABIL, V36, P124, DOI 10.1111/j.1365-2842.2008.01907.x; Ide M, 1998, J CLIN PERIODONTOL, V25, P286, DOI 10.1111/j.1600-051X.1998.tb02442.x; Ishihata H, 2011, J APPL ORAL SCI, V19, P147, DOI 10.1590/S1678-77572011000200011; Jacobsen P L, 2001, J Contemp Dent Pract, V2, P1; Kolker Justine L, 2002, J Adhes Dent, V4, P211; Leonard Ralph H Jr, 2004, J Esthet Restor Dent, V16, P49, DOI 10.1111/j.1708-8240.2004.tb00452.x; March J., 1992, ADVANCED ORGANIC CHE; Markowitz K, 2007, J DENT RES, V86, P292, DOI 10.1177/154405910708600401; Mehta D, 2014, ACTA ODONTOL SCAND, V72, P936, DOI 10.3109/00016357.2014.923112; Morris MF, 1999, AM J DENT, V12, P72; Moszner N, 2005, DENT MATER, V21, P895, DOI 10.1016/j.dental.2005.05.001; MUZZIN KB, 1989, J PERIODONTOL, V60, P151, DOI 10.1902/jop.1989.60.3.151; Orchardson R, 2006, J AM DENT ASSOC, V137, P990, DOI 10.14219/jada.archive.2006.0321; PASHLEY DH, 1978, ARCH ORAL BIOL, V23, P1127, DOI 10.1016/0003-9969(78)90119-X; PASHLEY DH, 1985, ARCH ORAL BIOL, V30, P731, DOI 10.1016/0003-9969(85)90185-2; PASHLEY DH, 1978, ARCH ORAL BIOL, V23, P807, DOI 10.1016/0003-9969(78)90159-0; PASHLEY DH, 1986, J ENDODONT, V12, P465, DOI 10.1016/S0099-2399(86)80201-1; Paul SJ, 1999, J DENT, V27, P209, DOI 10.1016/S0300-5712(98)00042-6; Petersson LG, 2013, CLIN ORAL INVEST, V17, pS63, DOI 10.1007/s00784-012-0916-9; Pillon FL, 2004, J PERIODONTOL, V75, P1461, DOI 10.1902/jop.2004.75.11.1461; Qin CY, 2006, EUR J ORAL SCI, V114, P354, DOI 10.1111/j.1600-0722.2006.00382.x; Schmalz G, 2017, OPER DENT, V42, pE35, DOI 10.2341/16-068-L; Schupbach P, 1997, EUR J ORAL SCI, V105, P414, DOI 10.1111/j.1600-0722.1997.tb02138.x; Sidhu SK, 2004, AM J DENT, V17, P211; Silva SMA, 2010, OPER DENT, V35, P610, DOI 10.2341/09-202-L; Splieth CH, 2013, CLIN ORAL INVEST, V17, pS3, DOI 10.1007/s00784-012-0889-8; Talioti E, 2014, ISRN Dent, V2014, P865761, DOI 10.1155/2014/865761; Tay FR, 2003, AM J DENT, V16, P6; Van Landuyt KL, 2007, BIOMATERIALS, V28, P3757, DOI 10.1016/j.biomaterials.2007.04.044; West N, 1998, J ORAL REHABIL, V25, P885, DOI 10.1046/j.1365-2842.1998.00339.x; West NX, 2013, CLIN ORAL INVEST, V17, pS9, DOI 10.1007/s00784-012-0887-x; Yilmaz HG, 2011, PHOTOMED LASER SURG, V29, P721, DOI 10.1089/pho.2010.2974; Yilmaz NA, 2017, OPEN DENT J, V11, P15, DOI 10.2174/1874210601711010015; Yiu CKY, 2005, BIOMATERIALS, V26, P6863, DOI 10.1016/j.biomaterials.2005.05.011; Zhang Y, 1998, J CLIN PERIODONTOL, V25, P884, DOI 10.1111/j.1600-051X.1998.tb02386.x; Zhou JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158400; DG	59	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220823	10.1371/journal.pone.0220823	http://dx.doi.org/10.1371/journal.pone.0220823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369650	gold, Green Published, Green Submitted			2022-12-27	WOS:000484987900088
J	Coletta, AM; Marquez, G; Thomas, P; Thoman, W; Bevers, T; Brewster, AM; Hawk, E; Basen-Engquist, K; Gilchrist, SC				Coletta, Adriana M.; Marquez, Guillermo; Thomas, Parijatham; Thoman, Whittney; Bevers, Therese; Brewster, Abenaa M.; Hawk, Ernest; Basen-Engquist, Karen; Gilchrist, Susan C.			Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors	PLOS ONE			English	Article							BREAST-CANCER; CARDIORESPIRATORY FITNESS; RISK; MORTALITY; EXERCISE; HEALTH; STRENGTH; PARADIGM; PROSTATE	Physical activity (PA) is a known behavior to reduce cancer risk and improve cancer survivorship, yet adherence to PA guidelines is poor among the general population and cancer survivors. The purpose of this study was to determine the extent to which patients referred for exercise consultation within a clinical cancer prevention setting were meeting aerobic and resistance physical activity (PA) guidelines and to identify factors associated with guideline adherence. Between 2013 and 2015, cancer prevention patients and cancer survivors were interviewed by an exercise physiologist within an Integrative Health Program at The University of Texas MD Anderson Cancer Prevention Center. PA adherence was defined as at least 150-minutes of moderate-intensity or 75-minutes of vigorous-intensity PA per week, along with resistance training at least 2 days per week. Logistic regression was used to determine factors associated with meeting or not meeting PA guidelines for aerobic exercise, resistance exercise, and aerobic and resistance exercise combined. Among 1,024 cancer prevention patients and survivors, 9% of patients adhered to guideline-based PA. Adherence to aerobic and resistance guidelines were 20% and 12%, respectively. Overweight or obesity was associated with not meeting guideline-based PA in both cancer prevention patients and cancer survivors. Among breast cancer survivors, combination treatment with surgery, radiation, and chemotherapy ('multimodal therapy') was robustly associated with not meeting aerobic guidelines (OR 2.20, 95% CI: 1.17 to 4.16). BMI and breast cancer treatment history are key determinants of PA behavior among cancer prevention patients and survivors. Poor adherence to PA guidelines is a key issue for cancer prevention patients and survivors, particularly obese patients and women who receive multimodal therapy for breast cancer. Identifying and connecting patients at highest risk of poor PA adherence with exercise programs is needed to improve PA, a key modifiable cancer risk factor.	[Coletta, Adriana M.] Huntsman Canc Inst, Canc Control & Populat Sci Program, Salt Lake City, UT USA; [Coletta, Adriana M.] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT USA; [Marquez, Guillermo; Thomas, Parijatham; Thoman, Whittney; Bevers, Therese; Brewster, Abenaa M.; Gilchrist, Susan C.] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Hawk, Ernest] Univ Texas MD Anderson Canc Ctr, Div OVP Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Basen-Engquist, Karen] Univ Texas MD Anderson Canc Ctr, Dept Behav Sci, Houston, TX 77030 USA; [Gilchrist, Susan C.] Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gilchrist, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA.; Gilchrist, SC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA.	sgilchrist@mdanderson.org		Coletta, Adriana/0000-0002-2503-2792	Duncan Family; Center for Energy Balance in Cancer Prevention and Survivorship, Duncan Family Institute; National Cancer Institute of the National Institutes of Health [R25CA057730]; NATIONAL CANCER INSTITUTE [R25CA057730, P30CA016672] Funding Source: NIH RePORTER	Duncan Family; Center for Energy Balance in Cancer Prevention and Survivorship, Duncan Family Institute; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a gift from the Duncan Family to the University of Texas MD Anderson Cancer Center Duncan Family Institute for Cancer Prevention and Risk Assessment. This study was also supported by the Center for Energy Balance in Cancer Prevention and Survivorship, Duncan Family Institute. We would like to thank the National Cancer Institute of the National Institutes of Health under Award Number R25CA057730 (PI: Shine Chang, PhD) for supporting AMC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All funders had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abioye AI, 2015, BRIT J SPORT MED, V49, P224, DOI 10.1136/bjsports-2013-092778; ALBANES D, 1989, AM J PUBLIC HEALTH, V79, P744, DOI 10.2105/AJPH.79.6.744; [Anonymous], 2018, 2018 PHYSICAL ACTIVI; Crawford JJ, 2016, SUPPORT CARE CANCER, V24, P3533, DOI 10.1007/s00520-016-3173-7; Farrell SW, 2007, OBESITY, V15, P3140, DOI 10.1038/oby.2007.374; Fisher A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006853; Fong DYT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e70; Forbes CC, 2015, ONCOL NURS FORUM, V42, P118, DOI 10.1188/15.ONF.42-02AP; Friedenreich CM, 2016, EUR UROL, V70, P576, DOI 10.1016/j.eururo.2015.12.032; Inoue-Choi M, 2013, CANCER EPIDEM BIOMAR, V22, P792, DOI 10.1158/1055-9965.EPI-13-0054; Irwin ML, 2008, J CLIN ONCOL, V26, P3958, DOI 10.1200/JCO.2007.15.9822; Irwin ML, 2004, MED SCI SPORT EXER, V36, P1484, DOI 10.1249/01.MSS.0000074670.03001.98; Jones LW, 2004, ANN BEHAV MED, V28, P105, DOI 10.1207/s15324796abm2802_5; Kabat GC, 2015, AM J CLIN NUTR, V101, P558, DOI 10.3945/ajcn.114.094854; Lahart IM, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011292.pub2; Lakoski SG, 2015, JAMA ONCOL, V1, P231, DOI 10.1001/jamaoncol.2015.0226; Lakoski SG, 2013, BREAST CANCER RES TR, V138, P909, DOI 10.1007/s10549-013-2478-1; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Loprinzi P, 2014, N AM J MED SCI, V6, P295, DOI 10.4103/1947-2714.136901; Mazzilli KM, 2019, MED SCI SPORT EXER, V51, P1845, DOI 10.1249/MSS.0000000000001987; McCullough ML, 2011, CANCER EPIDEM BIOMAR, V20, P1089, DOI 10.1158/1055-9965.EPI-10-1173; McTiernan A, 2003, JAMA-J AM MED ASSOC, V290, P1331, DOI 10.1001/jama.290.10.1331; Mishra SI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007566.pub2; Nayak P, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140067; Ottenbacher A, 2015, J PHYS ACT HEALTH, V12, P675, DOI 10.1123/jpah.2014-0003; Peel AB, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000432; Pescatello LS, 2013, ACSMS GUIDELINES FOR; Sanchis-Gomar F, 2015, CANCER PREV RES, V8, P105, DOI 10.1158/1940-6207.CAPR-14-0320; Short CE, 2014, SUPPORT CARE CANCER, V22, P2757, DOI 10.1007/s00520-014-2273-5; Smith SG, 2010, AM SURGEON, V76, P962; Tarasenko YN, 2018, CANCER CAUSE CONTROL, V29, P475, DOI 10.1007/s10552-018-1017-0; Tarasenko YN, 2017, PREV MED, V99, P211, DOI 10.1016/j.ypmed.2017.01.010; Thune I, 1997, NEW ENGL J MED, V336, P1269, DOI 10.1056/NEJM199705013361801; Thune I, 2001, MED SCI SPORT EXER, V33, pS530, DOI 10.1097/00005768-200106001-00025; Trinh L, 2018, PSYCHO-ONCOLOGY, V27, P2419, DOI 10.1002/pon.4844; Vallerand JR, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0498-7; van Vulpen JK, 2016, MATURITAS, V85, P104, DOI 10.1016/j.maturitas.2015.12.007; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7	38	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220814	10.1371/journal.pone.0220814	http://dx.doi.org/10.1371/journal.pone.0220814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369653	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900087
J	Eves, FF; Puig-Ribera, A				Eves, Frank F.; Puig-Ribera, Anna			Learnt effects of environmental cues on transport-related walking; disrupting habits with health promotion?	PLOS ONE			English	Article							OF-CHOICE PROMPTS; STAIR-RISER BANNERS; PHYSICAL-ACTIVITY; CLIMBING INTERVENTION; EVERYDAY LIFE; BEHAVIOR; EXERCISE; IMPLICIT; CONTEXT; TOLERANCE	Background In Ecological models, physical environments can be important determinants of transport-related walking. With repeated exposure to the same environment, learning of a linkage between the cues in the environment and walking should occur. Subsequent encounters with the cues can prompt the behaviour relatively automatically. No studies have experimentally tested the potential learning of this linkage between cues and behaviour. Choices between stairs and escalators in public access settings were employed to test this premise for transport-related walking. Methods Three studies investigated the effects of visual cues on stair/escalator choices (combined n = 115,062). In quasi-experimental, interrupted time-series designs, observers audited choices in public access settings. Design alone phases with art or coloured backgrounds were compared with design plus message phases in which verbal health promotion messages were superimposed on the visual cues. Analyses used bootstrapped logistic regression. Results In initial studies, the design alone phases had no effect whereas subsequent design plus message phases reduced escalator choice. In two further studies, a 5-6 week design plus message phase that reduced escalator choice preceded a design alone phase. The visual background behind the successful health promotion message was reintroduced four weeks after the intervention was removed. The visual cue of design alone reduced escalator choice after it had been paired with the verbal health promotion message. There were no differences between art and coloured backgrounds. Conclusion These studies demonstrate for the first time a learnt linkage between transport-related walking and environmental cues. Discussion focuses on the mechanisms that may underlie this learning and cues in the environment that are relevant to transport-related walking.	[Eves, Frank F.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Puig-Ribera, Anna] Univ Vic Univ Cent Catalunya, Dept Ciencies Activitat Fis, Vic, Spain	University of Birmingham; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Eves, FF (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England.	F.F.Eves@bham.ac.uk		Eves, Frank/0000-0002-4921-7169				Aarts, 2007, HLTH PSYCHOL REV, V1, P53, DOI [https://doi.org/10.1080/17437190701485852, DOI 10.1080/17437190701485852]; Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Allison MK, 2017, MED SCI SPORT EXER, V49, P298, DOI 10.1249/MSS.0000000000001188; Bargh J.A., 1994, HDB SOCIAL COGNITION, P1; Bauman A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012459; Bellicha A, 2015, PREV MED, V70, P3, DOI 10.1016/j.ypmed.2014.11.001; Birak KS, 2011, ALCOHOL ALCOHOLISM, V46, P686, DOI 10.1093/alcalc/agr084; BLAMEY A, 1995, BRIT MED J, V311, P289, DOI 10.1136/bmj.311.7000.289; Boreham CAG, 2005, BRIT J SPORT MED, V39, P590, DOI 10.1136/bjsm.2002.001131; Boreham CAG, 2000, PREV MED, V30, P277, DOI 10.1006/pmed.2000.0634; Boutelle KN, 2001, AM J PUBLIC HEALTH, V91, P2004, DOI 10.2105/AJPH.91.12.2004; Bouton ME, 2000, HEALTH PSYCHOL, V19, P57, DOI 10.1037/0278-6133.19.Suppl1.57; Brockmole JR, 2006, VIS COGN, V13, P99, DOI 10.1080/13506280500165188; Chun MM, 2003, J EXP PSYCHOL LEARN, V29, P224, DOI 10.1037/0278-7393.29.2.224; Danner UN, 2008, BRIT J SOC PSYCHOL, V47, P245, DOI 10.1348/014466607X230876; DICKINSON A, 1985, PHILOS T ROY SOC B, V308, P67, DOI 10.1098/rstb.1985.0010; Eves FF, 2008, MED SCI SPORT EXER, V40, P965, DOI 10.1249/MSS.0b013e3181659c68; Eves FF, 2008, OBES REV, V9, P83, DOI 10.1111/j.1467-789X.2007.00372.x; Eves FF, 2006, OBESITY, V14, P2210, DOI 10.1038/oby.2006.259; Eves FF, 2006, INT J EPIDEMIOL, V35, P1286, DOI 10.1093/ije/dyl141; Eves FF, 2006, PREV MED, V43, P4, DOI 10.1016/j.ypmed.2006.03.011; Eves FF, 2014, PSYCHON B REV, V21, P71, DOI 10.3758/s13423-013-0463-7; Eves FF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-423; Eves FF, 2010, AM J PREV MED, V38, P573, DOI 10.1016/j.amepre.2010.02.004; Eves FF, 2009, J ENVIRON PSYCHOL, V29, P300, DOI 10.1016/j.jenvp.2008.10.002; Gardner B, 2019, BRIT J HEALTH PSYCH, V24, P241, DOI 10.1111/bjhp.12369; Gardner B, 2015, HEALTH PSYCHOL REV, V9, P277, DOI 10.1080/17437199.2013.876238; Gardner B, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-102; Holland RW, 2006, J EXP SOC PSYCHOL, V42, P776, DOI 10.1016/j.jesp.2005.11.006; Jimenez L, 1999, J EXP PSYCHOL LEARN, V25, P236, DOI 10.1037/0278-7393.25.1.236; Jimenez L, 2001, Q J EXP PSYCHOL-A, V54, P345, DOI 10.1080/02724980042000200; Kennedy RA, 2007, J SPORT SCI MED, V6, P448; Kerr J, 2001, PREV MED, V33, P422, DOI 10.1006/pmed.2001.0908; Kerr J, 2001, AM J PUBLIC HEALTH, V91, P1192, DOI 10.2105/AJPH.91.8.1192; Kerr J., 2003, PERSPECTIVES HLTH EX, P203; Kerr NA, 2004, AM J HEALTH PROMOT, V18, P312, DOI 10.4278/0890-1171-18.4.312; Lally P, 2011, PSYCHOL HEALTH MED, V16, P484, DOI 10.1080/13548506.2011.555774; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Lewis AL, 2012, PSYCHOL SPORT EXERC, V13, P126, DOI 10.1016/j.psychsport.2011.10.001; Lewis AL, 2011, ANN BEHAV MED, V42, P257, DOI 10.1007/s12160-011-9283-z; Meyer P, 2010, EUR J CARDIOV PREV R, V17, P569, DOI 10.1097/HJR.0b013e328338a4dd; MULLEN B, 1990, PERS SOC PSYCHOL B, V16, P320, DOI 10.1177/0146167290162012; Neal DT, 2012, J EXP SOC PSYCHOL, V48, P492, DOI 10.1016/j.jesp.2011.10.011; Neal DT, 2011, PERS SOC PSYCHOL B, V37, P1428, DOI 10.1177/0146167211419863; Nocon M, 2010, SCAND J PUBLIC HEALT, V38, P633, DOI 10.1177/1403494810375865; Olander EK, 2008, PREV MED, V46, P308, DOI 10.1016/j.ypmed.2007.11.009; Orbell S, 2010, HEALTH PSYCHOL, V29, P374, DOI 10.1037/a0019596; Organisation for Economic Cooperation and Development, 2014, EMPL LAB MARK STAT E; Ouellette JA, 1998, PSYCHOL BULL, V124, P54, DOI 10.1037/0033-2909.124.1.54; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Phillips LA, 2016, HEALTH PSYCHOL, V35, P69, DOI 10.1037/hea0000249; Puig-Ribera A, 2010, EUR J PUBLIC HEALTH, V20, P100, DOI 10.1093/eurpub/ckp059; Reynolds R, 2014, PREV MED, V67, P46, DOI 10.1016/j.ypmed.2014.06.023; SHAPIRO AP, 1986, PSYCHOPHARMACOLOGY, V88, P90, DOI 10.1007/BF00310519; Srinivasan M, 2009, CHAOS, V19, DOI 10.1063/1.3141428; Teh KC, 2002, MED SCI SPORT EXER, V34, P695, DOI 10.1097/00005768-200204000-00021; Tobias R, 2009, PSYCHOL REV, V116, P408, DOI 10.1037/a0015512; Tolman E. C., 1930, U CALIF PUBL PSYCHOL, V4, P257; US Department of Health and Human Services, 2015, STEP IT SURG GEN CAL; Verplanken B, 1997, EUR J SOC PSYCHOL, V27, P539, DOI 10.1002/(SICI)1099-0992(199709/10)27:5<539::AID-EJSP831>3.0.CO;2-A; Verplanken B., 1999, EUR REV SOC PSYCHOL, V10, P101, DOI [10.1080/14792779943000035, DOI 10.1080/14792779943000035PLEASE, DOI 10.1080/14792779943000035]; Webb OJ, 2005, AM J PUBLIC HEALTH, V95, P1543, DOI 10.2105/AJPH.2004.046235; Webb OJ, 2007, AM J HEALTH PROMOT, V22, P114, DOI 10.4278/0890-1171-22.2.114; Webb OJ, 2007, AM J HEALTH PROMOT, V22, P38, DOI 10.4278/0890-1171-22.1.38; Webb OJ, 2011, J PHYS ACT HEALTH, V8, P558, DOI 10.1123/jpah.8.4.558; Webb OJ, 2011, BRIT J HEALTH PSYCH, V16, P373, DOI 10.1348/135910710X510395; Wood W, 2002, J PERS SOC PSYCHOL, V83, P1281, DOI 10.1037/0022-3514.83.6.1281; Wood W, 2007, PSYCHOL REV, V114, P843, DOI 10.1037/0033-295X.114.4.843; Yu S, 2003, HEART, V89, P502, DOI 10.1136/heart.89.5.502	71	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220308	10.1371/journal.pone.0220308	http://dx.doi.org/10.1371/journal.pone.0220308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369609	Green Submitted, gold, Green Published			2022-12-27	WOS:000484987900041
J	Yoo, J; Chong, S; Lim, C; Heo, M; Hwang, IG				Yoo, Jeongin; Chong, Semin; Lim, Changwon; Heo, Miyoung; Hwang, In Gyu			Assessment of spatial tumor heterogeneity using CT growth patterns estimated by tumor tracking on 3D CT volumetry of multiple pulmonary metastatic nodules	PLOS ONE			English	Article								Purpose Our purpose was to assess the differences in growth rates of multiple pulmonary metastatic nodules using three-dimensional (3D) computed tomography (CT) volumetry and propose a concept of CT spatial tumor heterogeneity. Materials and methods We manually measured the largest diameter of metastatic pulmonary nodules on chest CT scans, and calculated the 3D maximum diameter and the volume using a semi-automated 3D CT volumetry of each nodule. The tumor response was assessed according to the revised RECIST 1.1. We defined a nodule as an outlier based on 1.5 times growth during follow-up. The CT spatial tumor heterogeneity was statistically analyzed by the "minimum combination t-test method" devised in our study. Results On manual measurement, the tumor response category was stable disease (SD) in all 10 patients. Of them, total 155 metastatic nodules (4-52 nodules per patient) were segmented using the 3D CT volumetry. In the 3D maximum diameter, 9 patients had SD except for one patient with partial response in the two selected nodules; for the volume, all 10 patients were SD. For the 3D maximum diameter, six patients had at least one outlier; whereas five patients had the outlier on the volume measurement. Six patients were proven to have overall CT spatial tumor heterogeneity. Conclusions The spatial tumor heterogeneity determined in a CT parametric approach could be statistically assessed. In patients with CT spatial heterogeneity, tumors with different growth rates may be neglected when the nodules are assessed according to the current guideline.	[Yoo, Jeongin] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Chong, Semin] Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea; [Lim, Changwon; Heo, Miyoung] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea; [Hwang, In Gyu] Chung Ang Univ, Dept Internal Med, Chung Ang Univ Hosp, Div Hematol Oncol,Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Chung Ang University; Chung Ang University; Chung Ang University Hospital	Chong, S (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea.	smchong337@gmail.com		Chong, Semin/0000-0002-7429-2566				[Anonymous], 2011, PREC MED BUILD KNOWL; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; CROW J, 1981, CANCER, V47, P2595, DOI 10.1002/1097-0142(19810601)47:11<2595::AID-CNCR2820471114>3.0.CO;2-Q; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Martelotto LG, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3658; Marten K, 2007, EUR RADIOL, V17, P2561, DOI 10.1007/s00330-007-0642-x; MURATA K, 1992, RADIOLOGY, V182, P331, DOI 10.1148/radiology.182.2.1732945; Suzuki C, 2008, RADIOGRAPHICS, V28, P329, DOI 10.1148/rg.282075068; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7	11	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220550	10.1371/journal.pone.0220550	http://dx.doi.org/10.1371/journal.pone.0220550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369602	gold, Green Published, Green Submitted			2022-12-27	WOS:000484987900063
J	Su, XJ; Deng, C				Su, Xiaojian; Deng, Chao			The heterogeneous effects of exchange rate and stock market on CO2 emission allowance price in China: A panel quantile regression approach	PLOS ONE			English	Article							CARBON; ENERGY; DEPENDENCE; RISK	This paper studies the heterogeneous effects of exchange rate and stock market on carbon emission allowance price in four emissions trading scheme pilots in China. We employ a panel quantile regression model, which can describe both individual and distributional heterogeneity. The empirical results illustrate that the effects of explanatory variables on carbon emission allowance price is heterogeneous along the whole quantiles. Specifically, exchange rate has a negative effect on carbon emission allowance price at lower quantiles, while becomes a positive effect at higher quantiles. In addition, a negative effect exists between domestic stock market and carbon emission allowance price, and the intensity decreasing along with the increase of quantile. By contrast, an increasing positive effect is discovered between European stock market and domestic carbon emission allowance prices. Finally, heterogeneous effects on carbon emission allowance price can also be proved in European Union Emission Trading Scheme (EU-ETS).	[Su, Xiaojian; Deng, Chao] Guangdong Univ Foreign Studies, Sch Finance, Guangzhou, Guangdong, Peoples R China; [Deng, Chao] Southern China Inst Fortune Management Res IFMR G, Guangzhou, Guangdong, Peoples R China	Guangdong University of Foreign Studies	Deng, C (corresponding author), Guangdong Univ Foreign Studies, Sch Finance, Guangzhou, Guangdong, Peoples R China.; Deng, C (corresponding author), Southern China Inst Fortune Management Res IFMR G, Guangzhou, Guangdong, Peoples R China.	dengchaohunan@163.com			National Natural Science Foundation of China [11801099]; Ministry of education of Humanities and Social Science project of China [18YJC910005]; Natural Science Foundation of Guangdong Province of China [2017A030310575]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of education of Humanities and Social Science project of China; Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province)	This work is partially supported by National Natural Science Foundation of China (Grant No. 11801099), the Ministry of education of Humanities and Social Science project of China (Grant No. 18YJC910005), and by the Natural Science Foundation of Guangdong Province of China (Grant No. 2017A030310575) to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola E, 2008, ENERG POLICY, V36, P787, DOI 10.1016/j.enpol.2007.10.029; Barros CP, 2016, ENVIRON RESOUR ECON, V63, P45, DOI 10.1007/s10640-014-9835-3; Boutabba MA, 2017, ANN OPER RES, V255, P47, DOI 10.1007/s10479-016-2246-9; Canay IA, 2011, ECONOMET J, V14, P368, DOI 10.1111/j.1368-423X.2011.00349.x; Chevallier J, 2009, ENERG ECON, V31, P614, DOI 10.1016/j.eneco.2009.02.008; Daskalakis G, 2009, J BANK FINANC, V33, P1230, DOI 10.1016/j.jbankfin.2009.01.001; Gil-Alana LA, 2016, RENEW SUST ENERG REV, V55, P221, DOI 10.1016/j.rser.2015.10.056; Hammoudeh S, 2014, ENERG ECON, V46, P122, DOI 10.1016/j.eneco.2014.07.020; Koenker R, 2004, J MULTIVARIATE ANAL, V91, P74, DOI 10.1016/j.jmva.2004.05.006; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Lancaster T, 2000, J ECONOMETRICS, V95, P391, DOI 10.1016/S0304-4076(99)00044-5; Liu GQ, 2018, PHYSICA A, V499, P288, DOI 10.1016/j.physa.2018.02.033; Mansanet-Bataller M, 2009, J ENERGY MARKETS, V2, P75; Mensi W, 2017, J BANK FINANC, V75, P258, DOI 10.1016/j.jbankfin.2016.11.017; Mukaka MM, 2012, MALAWI MED J, V24, P69; Ren C, 2017, APPL ENERG, V193, P414, DOI 10.1016/j.apenergy.2017.02.037; Soliman AM, 2019, RESOUR POLICY, V61, P369, DOI 10.1016/j.resourpol.2018.12.005; Sun CW, 2019, ENERGY, V169, P637, DOI 10.1016/j.energy.2018.12.032; Wang NL, 2018, J CLEAN PROD, V194, P54, DOI 10.1016/j.jclepro.2018.05.092; Zeng SH, 2017, ENERG POLICY, V106, P111, DOI 10.1016/j.enpol.2017.03.046; ZHANG J, 2016, SUSTAINABILITY-BASEL, V8, DOI DOI 10.3390/SU8111195; Zhu BZ, 2019, ENERG ECON, V78, P202, DOI 10.1016/j.eneco.2018.11.007; Zhu HM, 2018, CARBON MANAG, V9, P277, DOI 10.1080/17583004.2018.1475802; Zhu HM, 2018, ENVIRON SCI POLLUT R, V25, P17176, DOI 10.1007/s11356-018-1900-y	25	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220808	10.1371/journal.pone.0220808	http://dx.doi.org/10.1371/journal.pone.0220808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408472	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500018
J	Badr, AM; EL-Orabi, NF; Ali, RA				Badr, Amira M.; EL-Orabi, Naglaa F.; Ali, Rehab A.			The implication of the crosstalk of Nrf2 with NOXs, and HMGB1 in ethanol-induced gastric ulcer: Potential protective effect is afforded by Raspberry Ketone	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASE; IN-VITRO; APOPTOSIS; RATS; NECROSIS; INJURY; DAMAGE; REDOX	Ethanol consumption is one of the common causative agents implicated in gastric ulcer development. Oxidative stress plays a major role in the induction and development of gastric ulceration. NADPH oxidases (NOXs) and Nuclear factor erythroid 2-related factor 2 (Nrf2) are key players in ethanol-induced ulcers. High-mobility group box 1 (HMGB1), a ubiquitous nuclear protein, mediates various inflammation functions. However, the role of HMGB1 in ethanol-induced gastric ulcer is not yet elucidated. Raspberry Ketone (RK) is a natural phenolic compound with antioxidant and anti-inflammatory properties. In the present study, absolute ethanol (7.5 ml/kg) was used to induce gastric ulceration in rats. Raspberry Ketone (RK) (50 mg/kg) was given orally one hour before the administration of absolute ethanol. Interestingly, ethanol-induced gastric ulcer was associated with Nrf2 downregulation, which was correlated with NOX-1, 2 NOX-4, and HMGB1 upregulation, and was significantly reversed by RK pre-treatment. RK pre-treatment provided 80% gastroprotection. Gastroprotective properties of RK were mediated via antioxidant, anti-inflammatory (suppression of NF-kB and tumor necrosis factor-a), and antiapoptotic activities (reduction of Bax/Bcl2 ratio). Gastroprotective properties of RK were confirmed by histopathological examination. In conclusion, this study is the first to provide evidence to the role of HMGB1 in ethanol-induced gastric ulcer, and the crosstalk of Nrf2, NOXs and HMGB1. It also demonstrates that RK represents a promising gastroprotective activity comparable to omeprazole.	[Badr, Amira M.; EL-Orabi, Naglaa F.; Ali, Rehab A.] King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia; [Badr, Amira M.] Ain Shams Univ, Coll Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [EL-Orabi, Naglaa F.] Suez Canal Univ, Fac Pharm, Dept Pharmacol & Toxicol, Ismailia, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Suez Canal University	Badr, AM (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmacol & Toxicol, Riyadh, Saudi Arabia.; Badr, AM (corresponding author), Ain Shams Univ, Coll Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	AmiBadr@ksu.edu.sa	Badr, Amira/U-5840-2019; Badr, Amira/AAA-7683-2022	Badr, Amira/0000-0003-3983-868X; 	Deanship of Scientific Research at King Saud University [RG-1440-033]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding this work through the research group project number RG-1440-033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SI, 2013, INT J NANOMED, V8, P2163, DOI 10.2147/IJN.S44108; Abebaw Mastewal, 2017, J Exp Pharmacol, V9, P1, DOI 10.2147/JEP.S125383; Al-Sayed E, 2015, PHYTOMEDICINE, V22, P5, DOI 10.1016/j.phymed.2014.10.002; Albaayit SFA, 2016, DRUG DES DEV THER, V10, DOI 10.2147/DDDT.S103993; Arab HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122417; Attia RT, 2019, BIOMED PHARMACOTHER, V110, P500, DOI 10.1016/j.biopha.2018.11.079; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Bhattamisra SK, 2019, J TRADIT COMPL MED, V9, P206, DOI 10.1016/j.jtcme.2018.05.001; Biglar M., 2012, African Journal of Biotechnology, V11, P6619; Brewer AC, 2011, FREE RADICAL BIO MED, V51, P205, DOI 10.1016/j.freeradbiomed.2011.04.022; Burtenshaw D, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040090; Alfredo SIC, 2018, PHARMACOL RES, V134, P92, DOI 10.1016/j.phrs.2018.06.013; Chen H, 2014, GUT, V63, P711, DOI 10.1136/gutjnl-2012-303731; Chen NN, 2016, NEUROCHEM RES, V41, P3052, DOI 10.1007/s11064-016-2024-8; Choi YJ, 2016, GUT LIVER, V10, P348, DOI 10.5009/gnl14509; Correia C, 2015, BBA-MOL CELL RES, V1853, P1658, DOI 10.1016/j.bbamcr.2015.03.012; Drury R.A.B., 1980, CARLETON HISTOLOGICA; El-Naga RN, 2015, CHEM-BIOL INTERACT, V242, P317, DOI 10.1016/j.cbi.2015.10.018; Guzman-Gomez O, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060763; Hristova M, 2018, MOLECULES, V23, DOI 10.3390/molecules23040749; Ibrahim MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26819; Joseph SV, 2016, CRIT REV FOOD SCI, V56, P419, DOI 10.1080/10408398.2013.767221; Khan V, 2018, LIFE SCI, V194, P205, DOI 10.1016/j.lfs.2017.12.013; Kovac S, 2015, BBA-GEN SUBJECTS, V1850, P794, DOI 10.1016/j.bbagen.2014.11.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Li WF, 2014, CHEM-BIOL INTERACT, V208, P18, DOI 10.1016/j.cbi.2013.11.011; Li WF, 2017, FUND CLIN PHARMACOL, V31, P174, DOI 10.1111/fcp.12255; Li WF, 2015, IMMUNOBIOLOGY, V220, P798, DOI 10.1016/j.imbio.2014.12.014; Li WF, 2013, TOXICOL APPL PHARM, V272, P21, DOI 10.1016/j.taap.2013.05.035; Lin HJ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00341; Lin VCH, 2011, INT J MOL SCI, V12, P4819, DOI 10.3390/ijms12084819; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Magna M, 2014, MOL MED, V20, P138, DOI 10.2119/molmed.2013.00164; Mehanna ET, 2018, EUR J PHARMACOL, V832, P81, DOI 10.1016/j.ejphar.2018.05.028; Nadatani Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080130; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park SW, 2008, J GASTROEN HEPATOL, V23, P976, DOI 10.1111/j.1440-1746.2008.05333.x; Perez S, 2017, FREE RADICAL BIO MED, V104, P75, DOI 10.1016/j.freeradbiomed.2016.12.048; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Qu J, 2019, J CELL PHYSIOL, V234, P8862, DOI 10.1002/jcp.27548; Radin JN, 2011, INFECT IMMUN, V79, P2535, DOI 10.1128/IAI.01370-10; Shukla S, 2015, PESTIC BIOCHEM PHYS, V123, P74, DOI 10.1016/j.pestbp.2015.03.007; Tarafdar A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123824; Tayeby F, 2017, INT J MED SCI, V14, P1317, DOI 10.7150/ijms.20984; Wang LL, 2012, J MED FOOD, V15, P495, DOI 10.1089/jmf.2011.1717; Wu CZ, 2018, ONCOTARGETS THER, V11, P4501, DOI 10.2147/OTT.S167197; Yadav SK, 2012, FREE RADICAL BIO MED, V52, P1175, DOI 10.1016/j.freeradbiomed.2011.12.023; Yanaka A, 2018, J CLIN BIOCHEM NUTR, V63, P18, DOI 10.3164/jcbn.17-139; Yang SM, 2019, AM J CHINESE MED, V47, P613, DOI 10.1142/S0192415X19500320; Yu Y, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00093; Yu Y, 2019, INT IMMUNOPHARMACOL, V69, P11, DOI 10.1016/j.intimp.2019.01.022; Zhang T, 2017, PHARMACOL REP, V69, P1154, DOI 10.1016/j.pharep.2017.07.004; Zhang YK, 2016, J PHARM PHARMACOL, V68, P514, DOI 10.1111/jphp.12532; Zhao HR, 2015, NEUROCHEM RES, V40, P854, DOI 10.1007/s11064-015-1536-y	56	29	30	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220548	10.1371/journal.pone.0220548	http://dx.doi.org/10.1371/journal.pone.0220548			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404064	gold, Green Submitted, Green Published			2022-12-27	WOS:000485006800016
J	Meszaros, VA; Miller-Dickson, MD; Ogbunugafor, CB				Meszaros, Victor A.; Miller-Dickson, Miles D.; Ogbunugafor, C. Brandon			Lexical Landscapes as large in silico data for examining advanced properties of fitness landscapes	PLOS ONE			English	Article							HIGHER-ORDER EPISTASIS; EVOLUTION; RESISTANCE	In silico approaches have served a central role in the development of evolutionary theory for generations. This especially applies to the concept of the fitness landscape, one of the most important abstractions in evolutionary genetics, and one which has benefited from the presence of large empirical data sets only in the last decade or so. In this study, we propose a method that allows us to generate enormous data sets that walk the line between in silico and empirical: word usage frequencies as catalogued by the Google ngram corpora. These data can be codified or analogized in terms of a multidimensional empirical fitness landscape towards the examination of advanced concepts-adaptive landscape by environment interactions, clonal competition, higher-order epistasis and countless others. We argue that the greater Lexical Landscapes approach can serve as a platform that offers an astronomical number of fitness landscapes for exploration (at least) or theoretical formalism (potentially) in evolutionary biology.	[Meszaros, Victor A.; Miller-Dickson, Miles D.; Ogbunugafor, C. Brandon] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Ogbunugafor, CB (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	brandon_ogbunu@brown.edu		Ogbunugafor, C. Brandon/0000-0002-1581-8345	NSF RII Track-2 FEC [1736253]	NSF RII Track-2 FEC(National Science Foundation (NSF)NSF - Office of the Director (OD))	CBO was funded by NSF RII Track-2 FEC (Award Number: 1736253).	Aguilar-Rodriguez J, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0045; Baeza-Centurion P, 2019, CELL, V176, P549, DOI 10.1016/j.cell.2018.12.010; Brouillet S, 2015, MAGELLAN TOOL EXPLOR, DOI 10.1101/031583; Crawford L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006869; de Visser JAGM, 2014, NAT REV GENET, V15, P480, DOI 10.1038/nrg3744; Eppstein MJ, 2016, DARPS; Flynn KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003426; Gavrilets S., 2004, FITNESS LANDSCAPES O, P41; Guerrero RF, 2019, GENETICS, V212, P565, DOI 10.1534/genetics.119.302138; Iwasa Y, 2004, GENETICS, V166, P1571, DOI 10.1534/genetics.166.3.1571; Lin Y, 2012, CONTEMP SYST THINK, P169, DOI 10.1007/978-1-4614-2311-9_8; Lozovsky ER, 2009, P NATL ACAD SCI USA, V106, P12025, DOI 10.1073/pnas.0905922106; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Nichol D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004493; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Ogbunugafor CB, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0064; Ogbunugafor CB, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005046; Otwinowski J, 2018, P NATL ACAD SCI USA, V115, pE7550, DOI 10.1073/pnas.1804015115; Palmer AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8385; Palmer AC, 2013, NAT REV GENET, V14, P243, DOI 10.1038/nrg3351; Poelwijk FJ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004771; Provine WB., 2001, ORIGINS THEORETICAL; Sackton TB, 2016, CELL, V166, P279, DOI 10.1016/j.cell.2016.06.047; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Weinreich DM, 2018, J STAT PHYS, V172, P208, DOI 10.1007/s10955-018-1975-3; Weinreich DM, 2013, CURR OPIN GENET DEV, V23, P700, DOI 10.1016/j.gde.2013.10.007; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220891	10.1371/journal.pone.0220891	http://dx.doi.org/10.1371/journal.pone.0220891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404101	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800040
J	Agustin-Panadero, R; Serra-Pastor, B; Roig-Vanaclocha, A; Fons-Font, A; Sola-Ruiz, MF				Agustin-Panadero, Ruben; Serra-Pastor, Blanca; Roig-Vanaclocha, Ana; Fons-Font, Antonio; Fernanda Sola-Ruiz, Maria			Fracture resistance and the mode of failure produced in metal-free crowns cemented onto zirconia abutments in dental implants	PLOS ONE			English	Article							BITE FORCE; TITANIUM; MORPHOLOGY; FATIGUE; DESIGN	The purpose of the investigation was to analyze fracture resistance and mode of failure of zirconium oxide (zirconia) abutments placed on dental implants bearing crowns of different esthetic materials: zirconia, lithium disilicate (LDS), and nano-ceramic resin, for replacing single teeth in the anterior sector. Eighty implant-abutment-crown units were divided into four groups: Group T-MC (control): 20 metal-ceramic crowns cemented onto titanium abutments; Group Z-Z: 20 zirconia crowns on zirconia abutments; Group Z-LD: 20 lithium disilicate crowns on zirconia abutments; and Group Z-NCR: 20 nano-ceramic resin crowns on zirconia abutments. Specimens underwent a fatiguing process (dynamic loading and thermocycling), followed by static loading to evaluate mechanical fracture resistance, and the mode of failure produced. Mean fracture resistance values were: Control Group T-MC, 575.85 +/- 120.01 N; Group Z-Z 459.64 +/- 66.52 N; Group Z-LD, 531.77 +/- 34.10 N; and Group Z-NCR, 587.05 +/- 59.27 N. In Group T-MC, fracture occurred in the prosthetic fixing screw in 100% of specimens. In Group Z-Z, 80% of fractures occurred in the fixing screw, 15% in the abutment, and 5% in the abutment and crown. In Group Z-LD, 60% of fractures were produced in the fixing screw and 40% in the abutment. In Group Z-NCR, 70% of fractures were produced in the fixing screw and 30% in the abutment. All the abutments and crowns analyzed have the potential to withstand the physiological occlusal forces to which they would be subject in the anterior region. Lithium disilicate and nano-ceramic resin crowns cemented onto zirconia abutments are a good restoration alternative for single implants in the anterior sector.	[Agustin-Panadero, Ruben; Serra-Pastor, Blanca; Roig-Vanaclocha, Ana; Fons-Font, Antonio; Fernanda Sola-Ruiz, Maria] Univ Valencia, Fac Med & Dent, Dept Dent Med, Valencia, Spain	University of Valencia	Sola-Ruiz, MF (corresponding author), Univ Valencia, Fac Med & Dent, Dept Dent Med, Valencia, Spain.	m.fernanda.sola@uv.es	Agustín-Panadero, Rubén/R-9296-2018; Sola-Ruiz/L-5653-2014	Agustín-Panadero, Rubén/0000-0003-2757-6619; Sola-Ruiz/0000-0002-7946-6932				Agustin-Panadero R, 2015, MED ORAL PATOL ORAL, V20, pE94, DOI 10.4317/medoral.19958; Agustin-Panadero R, 2012, INT J PROSTHODONT, V25, P294; Att W, 2006, J PROSTHET DENT, V95, P111, DOI 10.1016/j.prosdent.2005.12.003; Att W, 2012, CLIN IMPLANT DENT R, V14, pe196, DOI 10.1111/j.1708-8208.2011.00428.x; Canullo L, 2013, J APPL ORAL SCI, V21, P20, DOI 10.1590/1678-7757201302124; Elsayed A, 2018, CLIN ORAL IMPLAN RES, V29, P20, DOI 10.1111/clr.13034; Ferrario VF, 2004, J ORAL REHABIL, V31, P18, DOI 10.1046/j.0305-182X.2003.01179.x; Foong JKW, 2013, J PROSTHET DENT, V109, P304, DOI 10.1016/S0022-3913(13)60306-6; Gehrke P, 2015, INT J ORAL MAX IMPL, V30, P546, DOI 10.11607/jomi.3942; GIBBS CH, 1981, J PROSTHET DENT, V46, P443, DOI 10.1016/0022-3913(81)90455-8; Jimenez- Melendo M, 2014, J CLIN EXP DENT, V6, P485; Joo HS, 2015, J ADV PROSTHODONT, V7, P183, DOI 10.4047/jap.2015.7.3.183; Jung RE, 2012, CLIN ORAL IMPLAN RES, V23, P2, DOI 10.1111/j.1600-0501.2012.02547.x; KILIARIDIS S, 1993, ACTA ODONTOL SCAND, V51, P323, DOI 10.3109/00016359309040583; Kim JS, 2013, J PROSTHET DENT, V109, P255, DOI 10.1016/S0022-3913(13)60054-2; Kim S, 2009, J PROSTHET DENT, V101, P226, DOI 10.1016/S0022-3913(09)60043-3; Martinez-Rus F, 2012, INT J ORAL MAX IMPL, V27, P1448; Muhlemann S, 2014, CLIN ORAL IMPLAN RES, V25, P74, DOI 10.1111/clr.12192; Prestipino V, 1993, J Esthet Dent, V5, P29, DOI 10.1111/j.1708-8240.1993.tb00741.x; Protopapadaki M, 2013, J PROSTHET DENT, V110, P389, DOI 10.1016/j.prosdent.2013.06.004; Sailer I, 2009, CLIN ORAL IMPLAN RES, V20, P4, DOI 10.1111/j.1600-0501.2009.01787.x; Sanchez-Perez A, 2010, MED ORAL PATOL ORAL, V15, pE504, DOI 10.4317/medoral.15.e504; Sghaireen MG, 2015, CLIN IMPLANT DENT R, V17, P554, DOI 10.1111/cid.12160; Spies BC, 2016, J MECH BEHAV BIOMED, V53, P1, DOI 10.1016/j.jmbbm.2015.07.005; Studart AR, 2007, DENT MATER, V23, P106, DOI 10.1016/j.dental.2005.12.008; Sung M, 2014, J PROSTHODONT, V23, P534, DOI 10.1111/jopr.12147; WALTIMO A, 1993, SCAND J DENT RES, V101, P171; WALTIMO A, 1994, SCAND J DENT RES, V102, P92	28	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220551	10.1371/journal.pone.0220551	http://dx.doi.org/10.1371/journal.pone.0220551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393888	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500038
J	Glatter, M; Borewicz, K; van den Bogert, B; Wensch-Dorendorf, M; Bochnia, M; Greef, JM; Bachmann, M; Smidt, H; Breves, G; Zeyner, A				Glatter, M.; Borewicz, K.; van den Bogert, B.; Wensch-Dorendorf, M.; Bochnia, M.; Greef, J. M.; Bachmann, M.; Smidt, H.; Breves, G.; Zeyner, A.			Modification of the equine gastrointestinal microbiota by Jerusalem artichoke meal supplementation	PLOS ONE			English	Article							HORSES; STOMACH; HINDGUT; TRACT; DIET; FERMENTATION; MICROFLORA; DIVERSITY; LAMINITIS; COMMUNITY	The objective of this study was to investigate the impact of natural prebiotic active compounds on the microbial composition in different regions of the equine gastrointestinal tract. Twelve adult horses (body weight [bwt] 534 +/- 64.5 kg; age 14 +/- 7.5 years) were randomly divided into two feeding groups. Six horses received a basal diet consisting of 1.5 kg hay/100 kg bwt x d(-1) and oat grains equal to 1.19 g starch/kg bwt x d(-1), supplemented with Jerusalem artichoke meal providing prebiotic fructooligosaccharides + inulin in a quantity of 0.15 g/kg bwt x d(-1). The remaining horses received a placebo added to the basal diet. The horses were fed for 21 d and euthanized at the end of the feeding period. Digesta samples from different parts of the gastrointestinal tract were taken, DNA extracted and the V1-V2 region of the 16S rRNA gene amplified. Supplementation with the prebiotic increased the relative abundance of Lactobacillus (P < 0.05), with a concurrent reduction of the relative abundance of Streptococcus mainly in the stomach (P < 0.05). In the hindgut, the supplemental prebiotic also increased the relative abundance of Lactobacillus but further reduced the relative abundance of fibrolytic bacteria, specifically the unclassified members of the families Lachnospiraceae (P < 0.05) and Ruminococcaceae. The relative abundance of the genus Ruminococcus increased solely in the caecum and colon transversum. Overall, the addition of the prebiotic significantly increased the diversity in nearly all parts of the gastrointestinal tract (P < 0.05). The feeding of this natural prebiotic compound to horses had an impact on the microbial community in the entire gastrointestinal tract. Furthermore, the effect on the bacterial community in the foregut (especially the stomach) was more pronounced in comparison to the effect in the hindgut. Therefore, the impact on stomach health should be carefully considered.	[Glatter, M.; Bochnia, M.; Bachmann, M.; Zeyner, A.] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Grp Anim Nutr, Halle, Saale, Germany; [Borewicz, K.; van den Bogert, B.; Smidt, H.] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Wensch-Dorendorf, M.] Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Biometr & Informat Agr Grp, Halle, Saale, Germany; [Greef, J. M.] Julius Kuehn Inst, Fed Res Ctr Cultivated Plants Crop & Soil Sci, Braunschweig, Germany; [Breves, G.] Univ Vet Med, Inst Physiol & Cell Biol, Hannover, Germany	Martin Luther University Halle Wittenberg; Wageningen University & Research; Martin Luther University Halle Wittenberg; Julius Kuhn-Institut; University of Veterinary Medicine Hannover, Foundation	Glatter, M (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Agr & Nutr Sci, Grp Anim Nutr, Halle, Saale, Germany.	maren.glatter@landw.uni-halle.de	Breves, Gerhard/ABI-1315-2020; Bachmann, Martin/W-5190-2019; Smidt, Hauke/D-7054-2014	Bachmann, Martin/0000-0002-1264-997X; Smidt, Hauke/0000-0002-6138-5026	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	We acknowledge the financial support within the funding programme Open Access Publishing by the German Research Foundation (DFG).	Al Jassim RAM, 2009, VET CLIN N AM-EQUINE, V25, P199, DOI 10.1016/j.cveq.2009.04.005; Al Jassim RAM, 2005, FEMS MICROBIOL LETT, V248, P75, DOI 10.1016/j.femsle.2005.05.023; [Anonymous], 2013, HORSE HLTH NUTR; Bachmann M, 2019, LIVEST SCI, V223, P16, DOI 10.1016/j.livsci.2019.02.015; Biddle A., 2013, DIVERSITY-BASEL, V5, P627, DOI [10.3390/d5030627, DOI 10.3390/d5030627]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cehak A, 2019, RES VET SCI, V124, P303, DOI 10.1016/j.rvsc.2019.04.008; Coenen M, 2011, J EQUINE VET SCI, V31, P219, DOI 10.1016/j.jevs.2011.03.204; Coenen M, 2006, J NUTR, V136, p2108S, DOI 10.1093/jn/136.7.2108S; Costa MC, 2015, VET J, V205, P74, DOI 10.1016/j.tvjl.2015.03.018; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Costa Marcio C., 2012, Animal Health Research Reviews, V13, P121, DOI 10.1017/S1466252312000035; Destrez A, 2015, PHYSIOL BEHAV, V149, P159, DOI 10.1016/j.physbeh.2015.05.039; Dicks LMT, 2014, LIVEST SCI, V160, P69, DOI 10.1016/j.livsci.2013.11.025; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Gesellschaft fur Ernahrungsphysiologie, 2014, EN NAHRST LANDW NUTZ, V11; Glatter M, 2016, J ANIMAL NUTR, V1, P1, DOI DOI 10.21767/2572-5459.100; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen Naja C. K., 2015, Microbial Ecology in Health and Disease, V26, P27216, DOI 10.3402/mehd.v26.27216; Ince JC, 2014, GRASS FORAGE SCI, V69, P514, DOI 10.1111/gfs.12061; Julliand V, 2016, J ANIM SCI, V94, P2262, DOI 10.2527/jas.2015-0198; Julliand V, 2017, J EQUINE VET SCI, V52, P23, DOI 10.1016/j.jevs.2017.03.002; Kienzle E, 2010, J ANIM PHYSIOL AN N, V94, pE231, DOI 10.1111/j.1439-0396.2010.01015.x; Longland AC, 2006, J NUTR, V136, p2099S, DOI 10.1093/jn/136.7.2099S; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Luthersson N, 2009, EQUINE VET J, V41, P625, DOI 10.2746/042516409X441929; MACKIE RI, 1988, APPL ENVIRON MICROB, V54, P2155, DOI 10.1128/AEM.54.9.2155-2160.1988; Milinovich GJ, 2010, VET CLIN N AM-EQUINE, V26, P79, DOI 10.1016/j.cveq.2010.01.007; Milinovich GJ, 2006, ENVIRON MICROBIOL, V8, P885, DOI 10.1111/j.1462-2920.2005.00975.x; Nadeau JA, 2000, AM J VET RES, V61, P784, DOI 10.2460/ajvr.2000.61.784; Nadeau JA, 2003, AM J VET RES, V64, P404, DOI 10.2460/ajvr.2003.64.404; Naumann K, 1976, METHODENBUCH, V3; Pavis N, 2001, NEW PHYTOL, V150, P83, DOI 10.1046/j.1469-8137.2001.00069.x; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Proudman CJ, 2015, EQUINE VET J, V47, P580, DOI 10.1111/evj.12324; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Respondek F, 2008, J ANIM SCI, V86, P316, DOI 10.2527/jas.2006-782; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Sadet-Bourgeteau S., 2010, The impact of nutrition on the health and welfare of horses. 5th European Workshop on Equine Nutrition, Cirencester, UK, 19-22 September, 2010, P161; Santos AS, 2011, ANIMAL, V5, P48, DOI 10.1017/S1751731110001588; Schoster A, 2016, EQUINE VET J, V48, P595, DOI 10.1111/evj.12479; Schoster Angelika, 2013, BMC Res Notes, V6, P91, DOI 10.1186/1756-0500-6-91; Strauch S, 2017, J ANIM PHYSIOL AN N, V101, P51, DOI 10.1111/jpn.12635; Sykes BW, 2015, J VET INTERN MED, V29, P1288, DOI 10.1111/jvim.13578; Tian LM, 2016, MOL NUTR FOOD RES, V60, P2256, DOI 10.1002/mnfr.201600149; van de Wiele T, 2007, J APPL MICROBIOL, V102, P452, DOI 10.1111/j.1365-2672.2006.03084.x; van Eps AW, 2006, EQUINE VET J, V38, P203, DOI 10.2746/042516406776866327; Vosmer J, 2012, J ANIM PHYSIOL AN N, V96, P860, DOI 10.1111/j.1439-0396.2011.01269.x; Yuki N, 2000, APPL ENVIRON MICROB, V66, P5030, DOI 10.1128/AEM.66.11.5030-5034.2000; Zeyner A., 2015, INT J SCI RES SCI TE, V1, P74	54	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220553	10.1371/journal.pone.0220553	http://dx.doi.org/10.1371/journal.pone.0220553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393892	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500039
J	Piper, AJ; Clark, JL; Mercado-Matos, J; Matthew-Onabanjo, AN; Hsieh, CC; Akalin, A; Shaw, LM				Piper, Andrew J.; Clark, Jennifer L.; Mercado-Matos, Jose; Matthew-Onabanjo, Asia N.; Hsieh, Chung-Cheng; Akalin, Ali; Shaw, Leslie M.			Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)	PLOS ONE			English	Article							DOWN-REGULATION; EGFR; INSULIN-RECEPTOR-SUBSTRATE-1; RESISTANCE; MUTATIONS; IGF-1R; IGF1R	The insulin-like growth factor-1 (IGF-1) signaling pathway has been implicated in non-small cell lung cancer (NSCLC) outcomes and resistance to targeted therapies. However, little is known regarding the molecular mechanisms by which this pathway contributes to the biology of NSCLC. The insulin receptor substrate (IRS) proteins are cytoplasmic adaptor proteins that signal downstream of the IGF-1R and determine the functional outcomes of this signaling pathway. In this study, we assessed the expression patterns of IRS-1 and IRS-2 in NSCLC to identify associations between IRS-1 and IRS-2 expression levels and survival outcomes in the two major histological subtypes of NSCLC, adenocarcinoma (ADC) and squamous cell carcinoma (SCC). High IRS-2 expression was significantly associated with decreased overall survival in adenocarcinoma (ADC) patients, whereas low IRS-1 cytoplasmic expression showed a trend toward association with decreased overall survival in squamous cell carcinoma (SCC) patients. Tumors with low IRS-1 and high IRS-2 expression were found to be associated with poor outcomes in ADC and SCC, indicating a potential role for IRS-2 in the aggressive behavior of NSCLC. Our results suggest distinct contributions of IRS-1 and IRS-2 to the biology of ADC and SCC that impact disease progression.	[Piper, Andrew J.; Mercado-Matos, Jose; Matthew-Onabanjo, Asia N.; Hsieh, Chung-Cheng; Shaw, Leslie M.] Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Clark, Jennifer L.; Akalin, Ali] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Piper, Andrew J.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Beth Israel Deaconess Medical Center	Shaw, LM (corresponding author), Univ Massachusetts, Med Sch, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.	leslie.shaw@umassmed.edu	Akalin, Ali/GMW-6237-2022; Akalin, Ali/AAH-1266-2019	Clark, Jennifer/0000-0001-9114-4285; Piper-Vallillo, Andrew J./0000-0003-0742-0350	National Institute of Health (NIH) [CA142782]; NIH F31 Predoctoral fellowship [CA180706]; NATIONAL CANCER INSTITUTE [F31CA180706] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH F31 Predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health (NIH) grant CA142782 (LMS) and NIH F31 Predoctoral fellowship CA180706 (JMM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Clark JL, 2011, BREAST CANCER RES TR, V130, P759, DOI 10.1007/s10549-011-1353-1; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fukushima T, 2011, BIOCHEM BIOPH RES CO, V404, P767, DOI 10.1016/j.bbrc.2010.12.045; Gately K, 2014, CLIN LUNG CANCER, V15, P58, DOI 10.1016/j.cllc.2013.08.005; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Gorgisen G, 2019, GENET MOL BIOL, V42, P15, DOI [10.1590/1678-4685-GMB-2017-0307, 10.1590/1678-4685-gmb-2017-0307]; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han CH, 2006, ONCOL REP, V16, P1205; Heni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050953; Korpanty GJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00204; Kuo AH, 2007, ONCOGENE, V26, P859, DOI 10.1038/sj.onc.1209840; Lovly CM, 2014, NAT MED, V20, P1027, DOI 10.1038/nm.3667; Ludovini V, 2013, CANCER CHEMOTH PHARM, V71, P671, DOI 10.1007/s00280-012-2056-y; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Metz HE, 2016, P NATL ACAD SCI USA, V113, P8795, DOI 10.1073/pnas.1601989113; Murakami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086459; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Porter HA, 2013, CANCER LETT, V338, P239, DOI 10.1016/j.canlet.2013.03.030; Rotow J, 2017, NAT REV CANCER, V17, P637, DOI 10.1038/nrc.2017.84; Schnarr B, 2000, INT J CANCER, V89, P506, DOI 10.1002/1097-0215(20001120)89:6<506::AID-IJC7>3.0.CO;2-F; Shaw CM, 2012, ANTICANCER RES, V32, P439; Shi J, 2009, CANCER RES, V69, P7180, DOI 10.1158/0008-5472.CAN-08-4470; Sisci D, 2007, J CLIN PATHOL, V60, P633, DOI 10.1136/jcp.2006.039107; Suda K, 2014, INT J CANCER, V135, P1002, DOI 10.1002/ijc.28737; Szabolcs M, 2009, AM J PATHOL, V174, P276, DOI 10.2353/ajpath.2009.080086; Yeo CD, 2015, LUNG CANCER, V87, P311, DOI 10.1016/j.lungcan.2015.01.004; Zhao J, 2017, CELL PHYSIOL BIOCHEM, V43, P697, DOI 10.1159/000480655	35	13	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220567	10.1371/journal.pone.0220567	http://dx.doi.org/10.1371/journal.pone.0220567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393907	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500041
J	Babu, BK; Mathur, RK; Ravichandran, G; Anitha, P; Venu, MVB				Babu, B. Kalyana; Mathur, R. K.; Ravichandran, G.; Anitha, P.; Venu, M. V. B.			Genome-wide association study for leaf area, rachis length and total dry weight in oil palm (Eleaeisguineensis) using genotyping by sequencing	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; AGRONOMIC TRAITS; SNP; RICE; MAP	The marker-trait association for complex traits using genotyping by sequencing (GBS) method is being widely spread in plants. The study aimed to identify significant single nucleotide polymorphism (SNP) associations for rachis length (RL), leaf area (LA) and total dry weight (TrDW) in oil palm among diverse African germplasm. The Illumina NextSeq platform has been used for SNP genotyping and retained 4031 fully informative SNPs after applying the filter criterion. These 4031 SNPs were used for genome wide association study for the above three traits. The LD decay rates of the African germplasm using GBS data of SNP is observed to be 25 Kb at 0.45 of average pair wise correlation coefficient (r(2)). Association mapping led to the identification of seven significant associations for three traits using MLM approach at a P value of <= 0.001. Three associations were identified for total dry weight, two each for leaf area index and rachis length. The qtlLA1 was found to be highly significant at a P value of 7.39E(-05) (18.4% phenotypic variance) which is located on chromosome 4. Two QTLs (qtlLA2 and qtlRL1) were located on chromosome 1, which explained 11.9% and 12.4% of phenotypic variance respectively. Three QTLs for total dry weight were located on chromosome 2, 14 and 16, all-together explained 40% phenotypic variance. The results showed that the SNP-trait associations identified in the present study could be used in selection of elite oil palm germplasm for higher yields.	[Babu, B. Kalyana; Mathur, R. K.; Ravichandran, G.; Anitha, P.; Venu, M. V. B.] ICAR Indian Inst Oil Palm Res, Pedavegi, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Oil Palm Research	Babu, BK (corresponding author), ICAR Indian Inst Oil Palm Res, Pedavegi, Andhra Pradesh, India.	kalyan_biotek@yahoo.co.in						[Anonymous], 2011, FURTHER ADV OIL PALM; [Anonymous], [No title captured]; Babu BK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171933; Bai B, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1045-z; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; Billotte N, 2010, THEOR APPL GENET, V120, P1673, DOI 10.1007/s00122-010-1284-y; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chuenpoma, 2016, THAI SCI TECH, V6, P2560; CORLEY RHV, 1971, EUPHYTICA, V20, P307, DOI 10.1007/BF00056093; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fukuoka S, 2001, THEOR APPL GENET, V103, P185, DOI 10.1007/s001220100611; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ithnin M, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1185-1; Jeennor S, 2014, TREE GENET GENOMES, V10, P1, DOI 10.1007/s11295-013-0655-3; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jin JJ, 2016, DNA RES, V23, P527, DOI 10.1093/dnares/dsw036; Kainer D, 2015, THEOR APPL GENET, V128, P2351, DOI 10.1007/s00122-015-2591-0; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Mathew LS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-285; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Murphy DJ, 2014, J OIL PALM RES, V26, P1; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Okoye M. N., 2007, 8th African Crop Science Society Conference, El-Minia, Egypt, 27-31 October 2007, P723; Pootakham W, 2015, GENOMICS, V105, P288, DOI 10.1016/j.ygeno.2015.02.002; Pritchard J, 2003, DOCUMENTATION STRUCT; Rance KA, 2001, THEOR APPL GENET, V103, P1302, DOI 10.1007/s122-001-8204-z; Singh R, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-114; Teh CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19075; Ting NC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-309; Ukoskit K, 2014, MOL BREEDING, V33, P415, DOI 10.1007/s11032-013-9959-0; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220626	10.1371/journal.pone.0220626	http://dx.doi.org/10.1371/journal.pone.0220626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390382	gold, Green Published, Green Submitted			2022-12-27	WOS:000484999400023
J	Han, SF; Liu, GX; Zhang, TW				Han, Sufang; Liu, Guoxin; Zhang, Tianwei			Mean almost periodicity and moment exponential stability of semi-discrete random cellular neural networks with fuzzy operations	PLOS ONE			English	Article							STOCHASTIC STABILITY; GLOBAL ATTRACTIVITY; SEQUENCE SOLUTION; NEUTRAL SYSTEMS; CONTINUOUS-TIME; FISHING MODEL; DISCRETE; EXISTENCE; DELAYS; DISSIPATIVITY	By using the semi-discretization technique of differential equations, the discrete analogue of a kind of cellular neural networks with stochastic perturbations and fuzzy operations is formulated, which gives a more accurate characterization for continuous-time models than that by Euler scheme. Firstly, the existence of at least one p-th mean almost periodic sequence solution of the semi-discrete stochastic models with almost periodic coefficients is investigated by using Minkowski inequality, Holder inequality and Krasnoselskii's fixed point theorem. Secondly, the p-th moment global exponential stability of the semi-discrete stochastic models is also studied by using some analytical skills and the proof of contradiction. Finally, a problem of stochastic stabilization for discrete cellular neural networks is studied.	[Han, Sufang; Liu, Guoxin] Cent S Univ, Sch Math & Stat, Changsha, Hunan, Peoples R China; [Zhang, Tianwei] Kunming Univ Sci & Technol, City Coll, Kunming, Yunnan, Peoples R China	Central South University; Kunming University of Science & Technology	Zhang, TW (corresponding author), Kunming Univ Sci & Technol, City Coll, Kunming, Yunnan, Peoples R China.	zhang@kmust.edu.cn	Zhang, Tianwei/AAV-8818-2020	Zhang, Tianwei/0000-0001-6777-1668	National Nature Science Foundation of China [11461082]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Nature Science Foundation of China (No. 11461082 to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, GEORGIANMATHEMATICAL, DOI DOI 10.1007/BF02280009; [Anonymous], 1980, FIXED POINT THEOREMS; Arnold L., 1998, STOCHASTICS STOCHAST, V64, P177; Arunkumar A, 2014, ISA T, V53, P1006, DOI 10.1016/j.isatra.2014.05.002; Bezandry PH, 2010, ALMOST PERIODIC STOC; Chen AP, 2003, APPL MATH COMPUT, V134, P125, DOI 10.1016/S0096-3003(01)00274-0; Chen WH, 2006, PHYS LETT A, V358, P186, DOI 10.1016/j.physleta.2006.05.014; CHUA LO, 1988, IEEE T CIRCUITS SYST, V35, P1257, DOI 10.1109/31.7600; Diagana T, 2007, J DIFFER EQU APPL, V13, P239, DOI 10.1080/10236190601079035; Feng ZG, 2004, APPL MATH COMPUT, V154, P683; Gao S, 2019, PHYS LETT A, V383, P414, DOI 10.1016/j.physleta.2018.11.016; Han SF, 2019, OPEN MATH, V17, P385, DOI 10.1515/math-2019-0030; Hsu CF, 2016, NEUROCOMPUTING, V173, P734, DOI 10.1016/j.neucom.2015.08.024; Hu MF, 2014, NEUROCOMPUTING, V129, P476, DOI 10.1016/j.neucom.2013.09.011; Hu S., 2008, STOCHASTIC DIFFERENT; Huang ZK, 2007, NONLINEAR DYNAM, V50, P13, DOI 10.1007/s11071-006-9139-4; Huang ZK, 2014, MATH COMPUT SIMULAT, V101, P43, DOI 10.1016/j.matcom.2013.05.017; Huang ZK, 2010, MATH COMPUT MODEL, V52, P1521, DOI 10.1016/j.mcm.2010.06.013; Huang ZK, 2006, PHYS LETT A, V350, P182, DOI 10.1016/j.physleta.2005.10.022; Ji Y, 2011, ARAB J SCI ENG, V36, P1447, DOI 10.1007/s13369-011-0109-x; Kim EH, 2018, NEUROCOMPUTING, V303, P20, DOI 10.1016/j.neucom.2018.04.003; Kong FC, 2018, APPL INTELL, V48, P3332, DOI 10.1007/s10489-018-1146-x; Kuang JC, 2012, APPL INEQUALITIES, V4; Li YK, 2015, NEURAL COMPUT APPL, V26, P1073, DOI 10.1007/s00521-014-1784-9; Li YK, 2013, FUZZY SET SYST, V217, P62, DOI 10.1016/j.fss.2012.11.009; Li YK, 2012, APPL MATH MODEL, V36, P1173, DOI 10.1016/j.apm.2011.07.090; Liu D, 2017, NONLINEAR DYNAM, V90, P915, DOI 10.1007/s11071-017-3702-z; Meng FR, 2019, NEUROCOMPUTING, V325, P254, DOI 10.1016/j.neucom.2018.10.038; Mohamad S, 2000, MATH COMPUT SIMULAT, V53, P1, DOI 10.1016/S0378-4754(00)00168-3; Mohamad S, 2003, APPL MATH COMPUT, V135, P17, DOI 10.1016/S0096-3003(01)00299-5; Ramasamy S, 2016, NONLINEAR DYNAM, V85, P2777, DOI 10.1007/s11071-016-2862-6; Ren Y, 2018, STAT PROBABIL LETT, V143, P56, DOI 10.1016/j.spl.2018.07.024; Selvaraj P, 2018, NEURAL NETWORKS, V105, P154, DOI 10.1016/j.neunet.2018.05.004; Sun KY, 2015, NEURAL NETWORKS, V61, P68, DOI 10.1016/j.neunet.2014.10.002; Tudor C., 1992, STOCHASTICS STOCHAST, V38, P251, DOI DOI 10.1080/17442509208833758; Wang C, 2018, NEUROCOMPUTING, V282, P1, DOI 10.1016/j.neucom.2017.12.008; Wang C, 2014, APPL MATH COMPUT, V248, P101, DOI 10.1016/j.amc.2014.09.046; Wang JL, 2014, NEUROCOMPUTING, V142, P542, DOI 10.1016/j.neucom.2014.02.056; Wang P, 2015, NEUROCOMPUTING, V167, P76, DOI 10.1016/j.neucom.2015.04.089; Wu T, 2019, INT J ROBUST NONLIN, V29, P2525, DOI 10.1002/rnc.4510; Xiong LL, 2018, APPL MATH COMPUT, V321, P672, DOI 10.1016/j.amc.2017.11.020; Xiong LL, 2016, NONLINEAR ANAL-HYBRI, V19, P13, DOI 10.1016/j.nahs.2015.07.005; Xiong LL, 2012, J FRANKLIN I, V349, P2193, DOI 10.1016/j.jfranklin.2012.04.003; Xu C, 2016, ELECTRON J DIFFER EQ, V2016, P1; Xu CJ, 2017, NONLINEAR ANAL-MODEL, V22, P531, DOI 10.15388/NA.2017.4.8; Xu CJ, 2016, NEURAL COMPUT, V28, P2726, DOI 10.1162/NECO_a_00895; Yang T, 1996, IEEE T CIRCUITS-I, V43, P880, DOI 10.1109/81.538999; Yang XS, 2010, J FRANKLIN I, V347, P559, DOI 10.1016/j.jfranklin.2009.12.004; Zhang HY, 2019, INT J SYST SCI, V50, P970, DOI 10.1080/00207721.2019.1586005; Zhang HY, 2019, NEUROCOMPUTING, V333, P395, DOI 10.1016/j.neucom.2018.12.028; Zhang TW, 2020, INT J CONTROL, V93, P1442, DOI 10.1080/00207179.2018.1513165; Zhang TW, 2017, KYBERNETIKA, V53, P612, DOI 10.14736/kyb-2017-4-0612; Zhang TW, 2014, COMMUN NONLINEAR SCI, V19, P150, DOI 10.1016/j.cnsns.2013.06.019; Zhang TW, 2012, COMMUN NONLINEAR SCI, V17, P1408, DOI 10.1016/j.cnsns.2011.08.008; Zhang XM, 2018, IEEE T CYBERNETICS, V48, P1660, DOI 10.1109/TCYB.2017.2776283; Zhang ZQ, 2010, J FRANKLIN I, V347, P763, DOI 10.1016/j.jfranklin.2010.02.007; Zhao HY, 2007, NEUROCOMPUTING, V70, P2924, DOI 10.1016/j.neucom.2006.11.010; Zhou LQ, 2014, NONLINEAR DYNAM, V77, P41, DOI 10.1007/s11071-014-1271-y	58	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220861	10.1371/journal.pone.0220861	http://dx.doi.org/10.1371/journal.pone.0220861			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390372	gold, Green Published, Green Submitted			2022-12-27	WOS:000484999400034
J	Chaudhury, A; Dalal, AD; Sheoran, NT				Chaudhury, Ashok; Dalal, Anita Devi; Sheoran, Nayan Tara			Isolation, cloning and expression of CCA1 gene in transgenic progeny plants of Japonica rice exhibiting altered morphological traits	PLOS ONE			English	Article							CIRCADIAN CLOCK; TRANSFORMATION EFFICIENCY; MEDIATED TRANSFORMATION; PHOTOPERIODIC CONTROL; TRANSCRIPTION FACTOR; REGENERATION; L.	Circadian clock genes holds tremendous potential for breeding crops better adapted to environmental fluctuations inherent to climate change. Endogenous TOC1 promoter and CCA1 gene from rice were isolated, cloned and mobilized into pCAMBIA1300 vectors and RNAi constructs A, B and C. Embryogenic calli of varying ages derived from mature seeds of Taipei 309 were employed for Agrobacterium-mediated genetic transformation generating T0, T1 and T2 independent transgenic lines were analyzed for over-expression and repression of CCA1 gene along with various morphological traits. Six hundred and thirty two T0 transgenic plants were generated from rice calli using constructs A, B and C. T0 progeny plants derived from constructs A, B and C did not show any considerable difference in morphological traits. T1and T2 progeny plants derived from construct A exhibited over-expression of CCA1 gene, on the contrary, progeny plants derived from RNAi constructs B and C exhibited repression of CCA1 gene in qRT-PCR analysis at different time points and showed rhythmicity peaking at dawn (6: 00 AM) and lowest expression at 12: 00 Noon. T1 and T2 progeny plants derived from construct A, namely, A-17 and A-45 exhibited reduced number of tillers/panicles (6-8), reduced thousand seed weight (10.1-16.6g), decreased seed length (4.98 to 6.58mm), decreased seed width (1.1-1.8mm) as compared to wild type plants. T1 and T2 progeny plants of construct B and C showed increased number of tillers/panicles (8-19), better seed yield (4.98-28.9g), increased thousand seed weight (15.6-29.03g), slightly increased seed length (5.7-7.43mm) and slightly increased seed width (1.7-2.98mm) as compared to wild type plants. Chlorophyll content in T1 and T2 progeny plants did not show any significant difference among the three constructs, however, rhythmicity was observed over the period of time in conjunction to CCA1 gene expression. Evidence has been presented which demonstrates that endogenous repression of CCA1 gene resulted in improved morphological traits: increased number of tillers/panicle, thousand seed weight, seed size; whereas, over-expression leads to diminution in morphological traits: decreased number of tillers/panicle, thousand seed weight, seed size as compared to the wild type in T1 and T2 progeny plants. This is first report of successful regulation of endogenous CCA1 gene under control of TOC1 promoter and its effect on improved growth vigor in Japonica rice.	[Chaudhury, Ashok; Dalal, Anita Devi; Sheoran, Nayan Tara] Guru Jambheshwar Univ Sci & Technol, Bio & Nano Technol Ctr, Dept Bio & Nano Technol, Plant Mol Biol Lab, Hisar, Haryana, India	Guru Jambheshwar University of Science & Technology	Chaudhury, A (corresponding author), Guru Jambheshwar Univ Sci & Technol, Bio & Nano Technol Ctr, Dept Bio & Nano Technol, Plant Mol Biol Lab, Hisar, Haryana, India.	ashokchaudhury@hotmail.com		chaudhury, ashok/0000-0002-0383-1497	USIEF (The United States-India Educational Foundation) New Delhi [1510/FN-SR/2011]; Bureau of Educational and Cultural Affairs, U S Department of State, USA [1510/FN-SR/2011]; International Educational Exchange Program, USA [1510/FN-SR/2011]; Department of Science & Technology, Ministry of Science & Technology, Government of India, New Delhi, India [SR/FST/LSI-153/2003]; University Grants Commission, New Delhi [3-18/2009, F.3-4/2016/DRS-II (SAP-II), DBNT146299]	USIEF (The United States-India Educational Foundation) New Delhi; Bureau of Educational and Cultural Affairs, U S Department of State, USA; International Educational Exchange Program, USA; Department of Science & Technology, Ministry of Science & Technology, Government of India, New Delhi, India; University Grants Commission, New Delhi(University Grants Commission, India)	This work was supported by: 1. The Award of Fulbright Nehru Senior Research Fellowship to Prof A. Chaudhury by the USIEF (The United States-India Educational Foundation) New Delhi; Bureau of Educational and Cultural Affairs, U S Department of State, USA; International Educational Exchange Program, USA vide letter 1510/FN-SR/2011 Dated May 17, 2011; 2. FIST program, sanctioned to Prof. A. Chaudhury by the Department of Science & Technology, Ministry of Science & Technology, Government of India, New Delhi, India Vide Letter #No SR/FST/LSI-153/2003 Dated July 01, 2004; 3. SAP DRS-I and SAP DRS-II, sanctioned to Prof. A. Chaudhury by the University Grants Commission, New Delhi Vide Letter no. 3-18/2009 dated March 31, 2009 and Letter No F.3-4/2016/DRS-II (SAP-II) dated March 18, 2016; 4. JRF/SRF under Basic Scientific Research (BSR) to Ms. Anita Devi Dalal by the University Grants Commission, New Delhi Vide Letter no. DBNT146299 dated August 01, 2014.	Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bendix C, 2015, MOL PLANT, V8, P1135, DOI 10.1016/j.molp.2015.03.003; Chaudhury A, 2000, PLANT CELL TISS ORG, V60, P113, DOI 10.1023/A:1006456005961; Chaudhury Abed, 1999, Plant Cell, V11, P1817; CHU CC, 1975, SCI SINICA, V18, P659; Farinas B, 2011, PLANT J, V66, P318, DOI 10.1111/j.1365-313X.2011.04484.x; Han JL, 2005, PLANT SCI, V168, P73, DOI 10.1016/j.plantsci.2004.07.020; Hayama R, 2003, CURR OPIN PLANT BIOL, V6, P13, DOI 10.1016/S1369-5266(02)00011-0; Heilersig HJB, 2006, PLANT MOL BIOL, V60, P647, DOI 10.1007/s11103-005-5280-6; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hsu PY, 2014, TRENDS PLANT SCI, V19, P240, DOI 10.1016/j.tplants.2013.11.007; Htwe Nwe Nwe, 2014, Pak J Biol Sci, V17, P472, DOI 10.3923/pjbs.2014.472.481; Huang W, 2012, SCIENCE, V336, P75, DOI 10.1126/science.1219075; Huang X, 2016, NAT GENET; Karthikeyan A, 2011, PLANT SCI, V181, P258, DOI 10.1016/j.plantsci.2011.05.011; Kumari A, 2015, PLOS ONE, P1932; Kuno N, 2003, PLANT CELL, V15, P2476, DOI 10.1105/tpc.014217; Lai AG, 2012, P NATL ACAD SCI USA, V109, P17129, DOI 10.1073/pnas.1209148109; Lee HG, 2016, SCI REP-UK, V6, DOI 10.1038/srep17754; LI XQ, 1995, TRANSGENIC RES, V4, P349, DOI 10.1007/BF01972532; Liu JF, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.43; Livak KJ, 2001, METHOD; Lucca P, 2001, MOL BREEDING, V7, P43, DOI 10.1023/A:1009661014167; Meiru L, 2011, PLANT CELL TISSUE OR, P363; Mohanty A, 1999, PLANT SCI, V147, P127, DOI 10.1016/S0168-9452(99)00103-X; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Ng, 2014, PLANT CELL, P2430, DOI [10.1105/tpc.113.115980, DOI 10.1105/TPC.113.115980]; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Patel M, 2013, PLANT CELL TISS ORG, V114, P19, DOI 10.1007/s11240-013-0301-7; Pravin J., 2011, J CELL PLANT SCI, V2, P24; Rawat R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001350; Rawat R, 2009, P NATL ACAD SCI USA, V106, P16883, DOI 10.1073/pnas.0813035106; Rosato E., 2007, CIRCADIAN RHYTHMS ME, V362; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Shalit Kaneh A, 2018, P NATL ACAD SCI USA; Tan J, 2018, PLANT CELL REP, V37, P993, DOI 10.1007/s00299-018-2284-7; Tyagi AK, 1999, CRIT REV BIOTECHNOL, V19, P41, DOI 10.1080/0738-859991229198; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wang XT, 2011, PLANT CELL REP, V30, P1261, DOI 10.1007/s00299-011-1036-8; Wang ZY, 1988, CELL, P1207; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Zhang XB, 2007, PLANT J, V51, P512, DOI 10.1111/j.1365-313X.2007.03156.x	45	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220140	10.1371/journal.pone.0220140	http://dx.doi.org/10.1371/journal.pone.0220140			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381594	Green Published, gold, Green Submitted			2022-12-27	WOS:000484993600011
J	Kimmann, M; Tergast, TL; Schultalbers, M; Laser, H; Gerbel, S; Manns, MP; Cornberg, M; Maasoumy, B				Kimmann, Markus; Tergast, Tammo Lambert; Schultalbers, Marie; Laser, Hans; Gerbel, Svetlana; Manns, Michael Peter; Cornberg, Markus; Maasoumy, Benjamin			Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis	PLOS ONE			English	Article							INFECTIONS; NORFLOXACIN; PROPHYLAXIS; FAILURE; DIAGNOSIS; INCREASE; MODEL	Background & aims Bacterial infections, in particular a spontaneous bacterial peritonitis (SBP), are a major threat in patients with liver cirrhosis. Recently, it has been shown that the impact on mortality might be underestimated by established risk-scores. Onset of infection was suggested to define a distinct stage of cirrhosis. However, it remains unclear whether all stages of decompensated cirrhosis are equally affected. Moreover, if there is such a distinct stage, it must be determined whether it is reversible after the infection has resolved. In this study we aimed to further analyze the impact of a current as well as a resolved SBP in different stages of decompensated liver cirrhosis. Methods A number of 579 patients with liver cirrhosis and ascites were included. MELD-score was used to determine the stage of liver disease. Low (<15), intermediate (15-25) and high (>25) MELD-groups were compared. Patients were followed up for 90 days. Primary end-point was overall mortality. Statistical analyses were performed using the log-rank test, Cox regression and competing risk analysis. Results Mortality was significantly higher in patients with nosocomial-acquired SBP (nSBP) compared to patients without SBP (p<0.001; HR = 2.05). However, the most prominent difference in mortality was documented in the intermediate MELD-group (nSBP: p = 0.02; HR = 2.10). Importantly, mortality in nSBP patients remained increased even after the initial nSBP episode had resolved (p<0.01; HR = 1.90). Again, this was only significant in those with intermediate MELD-scores (p = 0.02; HR = 2.28). While a current as well as a resolved nSBP were significantly linked to a higher mortality, neither of them did increase the likelihood for liver transplantation. Conclusions Development of nSBP is independently associated with increased mortality supporting the concept of a distinct status of cirrhosis. Importantly, the prognosis remains unfavorable even after resolution of nSBP. This could be particularly relevant for patients with intermediate MELD-scores, who have limited chances for a donor liver.	[Kimmann, Markus; Tergast, Tammo Lambert; Schultalbers, Marie; Manns, Michael Peter; Cornberg, Markus; Maasoumy, Benjamin] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Laser, Hans; Gerbel, Svetlana] Hannover Med Sch, Ctr Informat Management ZIMT, Hannover, Germany; [Manns, Michael Peter; Cornberg, Markus; Maasoumy, Benjamin] German Ctr Infect Res, DZIF, Partner Site Hannover Braunschweig, Hannover, Germany; [Manns, Michael Peter; Cornberg, Markus] CIIM, Hannover, Germany	Hannover Medical School; Hannover Medical School; German Center for Infection Research	Maasoumy, B (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.; Maasoumy, B (corresponding author), German Ctr Infect Res, DZIF, Partner Site Hannover Braunschweig, Hannover, Germany.	maasoumy.benjamin@mh-hannover.de	Cornberg, Markus/AAN-6939-2021	Cornberg, Markus/0000-0002-9141-8001; Maasoumy, Benjamin/0000-0002-3250-3177; Kimmann, Markus/0000-0002-6403-7094	Else Kroner-Fresenius Foundation	Else Kroner-Fresenius Foundation	T.L.T. and this study were supported by the `KlinStrucMed' Programme funded by the Else Kroner-Fresenius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo J, 2013, HEPATOL INT, V7, P72, DOI 10.1007/s12072-012-9396-x; Albillos A, 2014, J HEPATOL, V61, P1385, DOI 10.1016/j.jhep.2014.08.010; Arroyo V, 2016, SEMIN LIVER DIS, V36, P109, DOI 10.1055/s-0036-1583202; Arvaniti V, 2010, GASTROENTEROLOGY, V139, P1246, DOI 10.1053/j.gastro.2010.06.019; Cheong HS, 2009, CLIN INFECT DIS, V48, P1230, DOI 10.1086/597585; Cholongitas E, 2017, ANN HEPATOL, V16, P584, DOI 10.5604/01.3001.0010.0298; D'Amico G, 2018, J HEPATOL, V68, P563, DOI 10.1016/j.jhep.2017.10.020; Dionigi E, 2017, AM J GASTROENTEROL, V112, P588, DOI 10.1038/ajg.2017.19; European Association for the Study of the Liver, 2018, J HEPATOL; Fernandez J, 2002, HEPATOLOGY, V35, P140, DOI 10.1053/jhep.2002.30082; Fernandez J, 2017, GUT; Fernandez J, 2006, GASTROENTEROLOGY, V131, P1049, DOI 10.1053/j.gastro.2006.07.010; Fernandez J, 2016, HEPATOLOGY, V63, P2019, DOI 10.1002/hep.28330; Fernandez J, 2012, HEPATOLOGY, V55, P1551, DOI 10.1002/hep.25532; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gerbes AL, 2011, Z GASTROENTEROL, V49, P780, DOI 10.1055/s-0031-1273404; GINES P, 1990, HEPATOLOGY, V12, P716, DOI 10.1002/hep.1840120416; Gustot T, 2015, HEPATOLOGY, V62, P243, DOI 10.1002/hep.27849; Gustot T, 2014, J HEPATOL, V61, P725, DOI 10.1016/j.jhep.2014.06.028; Jalan R, 2014, J HEPATOL, V60, P1310, DOI 10.1016/j.jhep.2014.01.024; Jochmans I, 2017, TRANSPLANTATION, V101, P1542, DOI 10.1097/TP.0000000000001631; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042; Mucke MM, 2018, LIVER INT, V38, P645, DOI 10.1111/liv.13568; Park YH, 2003, J GASTROEN HEPATOL, V18, P927, DOI 10.1046/j.1440-1746.2003.03086.x; Piano S, 2016, HEPATOLOGY, V63, P1299, DOI 10.1002/hep.27941; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Soriano G, 2011, ALIMENT PHARM THER, V33, P275, DOI 10.1111/j.1365-2036.2010.04506.x; Tergast TL, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0053-0; Tergast TL, 2018, LIVER INT; Zapater P, 2015, WORLD J GASTROENTERO, V21, P11493, DOI 10.3748/wjg.v21.i41.11493	32	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220666	10.1371/journal.pone.0220666	http://dx.doi.org/10.1371/journal.pone.0220666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374111	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500024
J	Verma, R; Pandit, SB				Verma, Rivi; Pandit, Shashi Bhushan			Unraveling the structural landscape of intra-chain domain interfaces: Implication in the evolution of domain-domain interactions	PLOS ONE			English	Article							MULTIDOMAIN PROTEINS; CLASSIFICATION; CONSERVATION; ORIENTATION; DIVERGENCE; SEQUENCES; FAMILIES; GEOMETRY; DATABASE; LINKERS	Intra-chain domain interactions are known to play a significant role in the function and stability of multidomain proteins. These interactions are mediated through a physical interaction at domain-domain interfaces (DDIs). With a motivation to understand evolution of interfaces, we have investigated similarities among DDIs. Even though interfaces of protein-protein interactions (PPIs) have been previously studied by structurally aligning interfaces, similar analyses have not yet been performed on DDIs of either multidomain proteins or PPIs. For studying the structural landscape of DDIs, we have used iAlign to structurally align intra-chain domain interfaces of domains. The interface alignment of spatially constrained domains (due to inter-domain linkers) showed that similar to 88% of these could identify a structural matching interface having similar C-alpha geometry and contact pattern despite that aligned domain pairs are not structurally related. Moreover, the mean interface similarity score (IS-score) is 0.307, which is higher compared to the average random IS-score (0.207) suggesting domain interfaces are not random. The structural space of DDIs is highly connected as similar to 84% of all possible directed edges among interfaces are found to have at most path length of 8 when 0.26 is IS-score threshold. At this threshold, similar to 83% of interfaces form the largest strongly connected component. Thus, suggesting that structural space of intra-chain domain interfaces is degenerate and highly connected, as has been found in PPI interfaces. Interestingly, searching for structural neighbors of inter-chain interfaces among intra-chain interfaces showed that similar to 86% could find a statistically significant match to intra-chain interface with a mean IS-score of 0.311. This implies that domain interfaces are degenerate whether formed within a protein or between proteins. The interface degeneracy is most likely due to limited possible ways of packing secondary structures. In principle, interface similarities can be exploited to accurately model domain interfaces in structure prediction of multidomain proteins.	[Verma, Rivi; Pandit, Shashi Bhushan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, India	Indian Institute of Science Education & Research (IISER) - Mohali	Pandit, SB (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, India.	shashibp@iisermohali.ac.in		Pandit, Shashi/0000-0002-1362-5136	Ministry of Human Resource Development [MHRD-140064]; Science and Engineering Research Board, Department of Science and Technology [EMR/2017/005450]; Council of Scientific and Industrial ResearchUniversity Grants Commission, Government of India; Indian Institute of Science Education and Research Mohali startup funds; Center of excellence in frontier areas of science and technology (Ministry of Human Resource Development) grant from Government of India [MHRD-14-0064]; SERB grant from Government of India [EMR/2017/005450]; Council of Scientific and Industrial Research-University Grants Commission, Government of India	Ministry of Human Resource Development; Science and Engineering Research Board, Department of Science and Technology; Council of Scientific and Industrial ResearchUniversity Grants Commission, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); Indian Institute of Science Education and Research Mohali startup funds; Center of excellence in frontier areas of science and technology (Ministry of Human Resource Development) grant from Government of India; SERB grant from Government of India; Council of Scientific and Industrial Research-University Grants Commission, Government of India(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India)	This work was supported by MHRD-140064: Shashi Bhushan Pandit, Ministry of Human Resource Development, www.mhrd.gov.in; EMR/2017/005450: Shashi Bhushan Pandit, Science and Engineering Research Board, Department of Science and Technology, http://www.serb.gov.in/home.php.RV is supported by fellowship from the Council of Scientific and Industrial ResearchUniversity Grants Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Indian Institute of Science Education and Research Mohali startup funds, and followings grants: Center of excellence in frontier areas of science and technology grant [MHRD-14-0064] (Ministry of Human Resource Development), and SERB grant [EMR/2017/005450] both from Government of India grants. RV is supported by fellowship from the Council of Scientific and Industrial Research-University Grants Commission, Government of India. We thank Dr. Nidhi for her help in editing the manuscript.	Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic G, 2001, Bioinformatics, V17 Suppl 1, pS83; Apic G, 2001, J MOL BIOL, V310, P311, DOI 10.1006/jmbi.2001.4776; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Arviv O, 2012, PROTEINS, V80, P2780, DOI 10.1002/prot.24161; Bashton M, 2002, J MOL BIOL, V315, P927, DOI 10.1006/jmbi.2001.5288; Basu MK, 2009, BRIEF BIOINFORM, V10, P205, DOI 10.1093/bib/bbn057; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bhaskara RM, 2013, J BIOMOL STRUCT DYN, V31, P1467, DOI 10.1080/07391102.2012.743438; Bhaskara RM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00040; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Cui XF, 2015, BIOINFORMATICS, V31, P133, DOI 10.1093/bioinformatics/btv242; Ekman D, 2005, J MOL BIOL, V348, P231, DOI 10.1016/j.jmb.2005.02.007; FINKELSTEIN AV, 1987, PROG BIOPHYS MOL BIO, V50, P171, DOI 10.1016/0079-6107(87)90013-7; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Gao M, 2011, PROTEINS, V79, P1623, DOI 10.1002/prot.22987; Gao M, 2010, P NATL ACAD SCI USA, V107, P22517, DOI 10.1073/pnas.1012820107; Gao M, 2010, BIOINFORMATICS, V26, P2259, DOI 10.1093/bioinformatics/btq404; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Han JH, 2006, STRUCTURE, V14, P935, DOI 10.1016/j.str.2006.01.016; Huang J, 2008, P NATL ACAD SCI USA, V105, P6578, DOI 10.1073/pnas.0801097105; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Kim WK, 2006, PLOS COMPUT BIOL, V2, P1151, DOI 10.1371/journal.pcbi.0020124; Kim WK, 2005, PROTEINS, V61, P1075, DOI 10.1002/prot.20693; Kolodny R, 2013, ANNU REV BIOPHYS, V42, P559, DOI 10.1146/annurev-biophys-083012-130432; Levy Y, 2017, BIOCHEMISTRY-US, V56, P5040, DOI 10.1021/acs.biochem.7b00666; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Littler SJ, 2005, J MOL BIOL, V345, P1265, DOI 10.1016/j.jmb.2004.11.011; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Lu H, 2003, BIOPHYS J, V84, P1895, DOI 10.1016/S0006-3495(03)74997-2; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Maheshwari S, 2015, J MOL RECOGNIT, V28, P35, DOI 10.1002/jmr.2410; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Mikami B, 2006, J MOL BIOL, V359, P690, DOI 10.1016/j.jmb.2006.03.058; Moore AD, 2008, TRENDS BIOCHEM SCI, V33, P444, DOI 10.1016/j.tibs.2008.05.008; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Rodgers TL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001651; Sadreyev RI, 2009, CURR OPIN STRUC BIOL, V19, P321, DOI 10.1016/j.sbi.2009.04.009; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Valas RE, 2009, CURR OPIN STRUC BIOL, V19, P329, DOI 10.1016/j.sbi.2009.03.011; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Vogel C, 2005, J MOL BIOL, V346, P355, DOI 10.1016/j.jmb.2004.11.050; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Wolff P, 2014, J MED CHEM, V57, P7565, DOI 10.1021/jm500467a; Zhang QC, 2010, P NATL ACAD SCI USA, V107, P10896, DOI 10.1073/pnas.1005894107; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P2605, DOI 10.1073/pnas.0509379103; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	53	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220336	10.1371/journal.pone.0220336	http://dx.doi.org/10.1371/journal.pone.0220336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374091	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500011
J	Corrigan, AM; Karlsson, J; Wildenhain, J; Knerr, L; Olwegard-Halvarsson, M; Karlsson, M; Lunse, S; Wang, YH				Corrigan, Adam M.; Karlsson, Johan; Wildenhain, Jan; Knerr, Laurent; Olwegard-Halvarsson, Maria; Karlsson, Maria; Lunse, Svenja; Wang, Yinhai			IA-Lab: A MATLAB framework for efficient microscopy image analysis development, applied to quantifying intracellular transport of internalized peptide-drug conjugate	PLOS ONE			English	Article							SOFTWARE; DELIVERY; PLATFORM	This work presents a MATLAB-based software package for high-throughput microscopy image analysis development, making such development more accessible for a large user community. The toolbox provides a GUI and a number of analysis workflows, and can serve as a general framework designed to allow for easy extension. For a new application, only a minor part of the object-oriented code needs to be replaced by new components, making development efficient. This makes it possible to quickly develop solutions for analysis not available in existing tools. We show its use in making a tool for quantifying intracellular transport of internalized peptide-drug conjugates.	[Corrigan, Adam M.; Wildenhain, Jan; Wang, Yinhai] AstraZeneca, Discovery Sci R&D, Cambridge, England; [Karlsson, Johan; Lunse, Svenja] AstraZeneca, Discovery Sci R&D, Gothenburg, Sweden; [Knerr, Laurent; Olwegard-Halvarsson, Maria] AstraZeneca, Res & Early Dev Cardiovasc Renal & Metab BioPharm, Gothenburg, Sweden; [Karlsson, Maria] AstraZeneca, Res & Early Dev Resp Inflammat & Autoimmune BioPh, Gothenburg, Sweden; [Wildenhain, Jan] Syngenta, Jealotts Hill Res Ctr, Bracknell, Berks, England	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Syngenta	Corrigan, AM (corresponding author), AstraZeneca, Discovery Sci R&D, Cambridge, England.	adam.corrigan@astrazeneca.com	Wildenhain, Jan/E-5597-2011	Wildenhain, Jan/0000-0002-5461-3828; Corrigan, Adam/0000-0001-5142-6579	AstraZeneca	AstraZeneca(AstraZeneca)	All authors are or were employees of AstraZeneca. AstraZeneca provided the funding for this research and provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Caicedo JC, 2017, NAT METHODS, V14, P849, DOI [10.1038/nmeth.4397, 10.1038/NMETH.4397]; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Du C-J, 2011, BIOMEDICAL IMAGING N; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Georgescu W, 2012, BIOINFORMATICS, V28, P138, DOI 10.1093/bioinformatics/btr633; Gilad Y, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4020011; Hodneland E, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-16; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Lelle M, 2015, MOL PHARMACEUT, V12, P4290, DOI 10.1021/acs.molpharmaceut.5b00487; Li HY, 2002, MED RES REV, V22, P225, DOI 10.1002/med.10008; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Majumdar S, 2012, MED RES REV, V32, P637, DOI 10.1002/med.20225; Ogier A, 2012, BIOINFORMATICS, V28, P1945, DOI 10.1093/bioinformatics/bts288; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Valeur E, 2017, ANGEW CHEM INT EDIT, V56, P10294, DOI 10.1002/anie.201611914; Wang Q, 2005, CELLTRACER SOFTWARE; Williams E, 2017, NAT METHODS, V14, P775, DOI [10.1038/NMETH.4326, 10.1038/nmeth.4326]	21	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220627	10.1371/journal.pone.0220627	http://dx.doi.org/10.1371/journal.pone.0220627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369634	gold, Green Submitted, Green Published			2022-12-27	WOS:000484987900069
J	van der Linden, M; Imoehl, M; Perniciaro, S				van der Linden, Mark; Imoehl, Matthias; Perniciaro, Stephanie			Limited indirect effects of an infant pneumococcal vaccination program in an aging population	PLOS ONE			English	Article							CONJUGATE VACCINE; POLYSACCHARIDE VACCINATION; ADULTS; DISEASE; 13-VALENT; CARRIAGE; HYPORESPONSIVENESS; GERMANY; OLDER	Background A general recommendation for adult pneumococcal vaccination with 23-valent polysaccharide vaccine (PPV23) for adults 60 and older has been in place in Germany since 1998, but uptake has been low. Just over a decade after the implementation of an infant pneumococcal conjugate vaccine recommendation, we examined indirect protection effects on adult invasive pneumococcal disease (IPD) in Germany. Methods and findings Reported IPD cases decreased in children under two years of age from 11.09 per 100,000 in 2003-2006 to 5.94 per 100,000 in 2017/18, while in adult age groups, reported IPD cases rose across the board, most dramatically in adults 60 years of age and over, from 1.64 to 10.08 cases per 100,000. PCV13-type IPD represents 31% of all cases in this age group, the lion's share of which is due to the rapid increase of serotype 3 IPD, which, by itself, has reached 2.11 reported cases per 100,000 and makes up 21% of all IPD cases in this age group. The two vaccine formulations currently in development (PCV15 and PCV20) would increase current (PCV13) coverage by 8.5% points and 28.0% points in children, while in adults coverage would increase by 10.4% points and 21.9% points, respectively. Conclusions While original models predicted that indirect effects of childhood vaccination would suffice for adults, it seems that the herd protection effect has reached its limit, with vaccine serotypes 4, 19F, and 19A IPD persisting in adults after initial reductions, and serotype 3 IPD not showing any herd protection effect at all.	[van der Linden, Mark; Imoehl, Matthias; Perniciaro, Stephanie] Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	van der Linden, M (corresponding author), Univ Hosp RWTH, Natl Reference Ctr Streptococci, Dept Med Microbiol, Aachen, Germany.	mlinden@ukaachen.de	van der Linden, Mark/B-9305-2009	van der Linden, Mark/0000-0002-6574-4313	Pfizer Pharma GmbH; Robert Koch Institute, Berlin, Germany	Pfizer Pharma GmbH(Pfizer); Robert Koch Institute, Berlin, Germany	Pneumococcal surveillance is funded in part by Pfizer Pharma GmbH and PneumoWeb is maintained and supported by the Robert Koch Institute, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090974; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Balsells E, 2018, J INFECTION, V77, P368, DOI 10.1016/j.jinf.2018.06.004; Betsch C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5787-9; Bewick T, 2012, THORAX, V67, P540, DOI 10.1136/thoraxjnl-2011-201092; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Choi EH, 2016, CLIN VACCINE IMMUNOL, V23, P162, DOI 10.1128/CVI.00591-15; Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428; de Celles MD, 2019, P NATL ACAD SCI USA, V116, P1802, DOI 10.1073/pnas.1812388116; de Waroux OL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086136; Djennad A, 2018, ECLINICALMEDICINE, V6, P42, DOI 10.1016/j.eclinm.2018.12.007; Domenech M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125636; Dominguez A, 2016, HUM VACC IMMUNOTHER, V12, P1891, DOI 10.1080/21645515.2016.1149661; Donkor ES, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00007; Falconer MA, 2013, HUM VACC IMMUNOTHER, V9, P1368, DOI 10.4161/hv.24695; Falkenhorst G, 2016, BUNDESGESUNDHEITSBLA, V59, P1623, DOI 10.1007/s00103-016-2466-9; Fedson DS, 2011, EXPERT REV VACCINES, V10, P1143, DOI [10.1586/ERV.11.99, 10.1586/erv.11.99]; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Gladstone RA, 2015, VACCINE, V33, P2015, DOI 10.1016/j.vaccine.2015.03.012; Greenberg D, 2018, VACCINE, V36, P6883, DOI 10.1016/j.vaccine.2018.02.113; Hanquet G, 2019, THORAX, V74, P473, DOI 10.1136/thoraxjnl-2018-211767; Htar MTT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177985; Institute RK, 2016, EPIDEMIOL B, V36; Izurieta P, 2018, EXPERT REV VACCINES, V17, P479, DOI 10.1080/14760584.2018.1413354; Kobayashi M, 2015, MMWR-MORBID MORTAL W, V64, P944, DOI 10.15585/mmwr.mm6434a4; Koch-Institute R., 2014, EPID B, V34, P305; Kuhlmann A, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-4; Maruyama T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1004; McLaughlin JM, 2018, CLIN INFECT DIS, V67, P1498, DOI 10.1093/cid/ciy312; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; Ojal J, 2017, VACCINE, V35, P4652, DOI 10.1016/j.vaccine.2017.05.088; Orsi A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071140; Pilishvili T, 2015, VACCINE, V33, pD60, DOI 10.1016/j.vaccine.2015.05.102; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P845, DOI 10.1007/s00103-013-1693-6; Poolman J, 2011, EXPERT REV VACCINES, V10, P307, DOI [10.1586/ERV.11.8, 10.1586/erv.11.8]; Prevention CfDCa, 2017, PNEUM DIS SURV REP; Reinert RR, 2005, CLIN MICROBIOL INFEC, V11, P985, DOI 10.1111/j.1469-0691.2005.01282.x; Robert Koch Institut, 2018, EPIDEMIOL B, P335; Robert Koch-Institut (RKI), 1998, EPID B, V15, P101; Salm F, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0432-z; Selva L, 2012, EUR J CLIN MICROBIOL, V31, P1487, DOI 10.1007/s10096-011-1468-7; Siber G, 2008, PNEUMOCOCCAL VACCINE; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Sings HL, 2019, CLIN INFECT DIS, V68, P2135, DOI 10.1093/cid/ciy920; Southern J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195799; Standige Impfkommission (STIKO), 2015, EPIDEMIOL B, P339; Stoecker C, 2016, J GEN INTERN MED, V31, P901, DOI 10.1007/s11606-016-3651-0; Van der Linden M, 2010, 7 INT S PNEUM PNEUM; van der Linden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161257; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; van der Linden M, 2012, VACCINE, V30, P5880, DOI 10.1016/j.vaccine.2012.06.068; van Deursen AMM, 2018, CLIN INFECT DIS, V67, P42, DOI 10.1093/cid/ciy009; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476; Weiss S, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21057; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yang XQ, 2018, VACCINE, V36, P7574, DOI 10.1016/j.vaccine.2018.10.015	60	34	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220453	10.1371/journal.pone.0220453	http://dx.doi.org/10.1371/journal.pone.0220453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369597	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900051
J	Wu, L; Xie, BG				Wu, Li; Xie, Binggeng			The variation differences of cultivated land ecological security between flatland and mountainous areas based on LUCC	PLOS ONE			English	Article							INTEGRATED EVALUATION; LANDSCAPE; NETWORK; PATTERN; REGION; COVER	The purpose of this study was to explore the correlations between land use/cover change and cultivated land ecological security in flatland and mountainous areas. Firstly, the spatiotemporal variation characteristics of land use/cover change are described in conjunction with ArcGIS10.5 software based on remote sensing images of 2005 and 2015. Then, by establishing a pressure-support framework as an assessment indicator system and developing an improved BP neural network model via a genetic algorithm with the help of MATLAB2016a, the spatiotemporal dynamic changes of cultivated land ecological security in Yuxi City from 2005 to 2015 are evaluated. The results showed that the transformation of farmland area accounted for a large proportion of increased constructive land and land use/cover spatial variations were significantly different among counties, which manifested the changes in farmland and the construction land in flatland areas but also facilitated a mutual transformation of forest and grass in mountainous areas. Moreover, ecological security status presented a clear difference among counties due to their different land use/cover changes. The ecological security state of the flatland expressed a higher ecological pressure and lower ecological support, so the security grade was IV. Otherwise, the ecological security was superior and the security grade was level II or I in the mountainous areas. Thus, protection strategies for ecological security should be differentiated in the flatland areas and mountainous areas due to their different ecological security status brought by land use/cover change.	[Wu, Li; Xie, Binggeng] Hunan Normal Univ, Dept Resources & Environm Sci, Changsha, Hunan, Peoples R China; [Wu, Li] Yuxi Normal Univ, Dept Geog & Land Engn, Yuxi, Peoples R China	Hunan Normal University; Yuxi Normal University	Xie, BG (corresponding author), Hunan Normal Univ, Dept Resources & Environm Sci, Changsha, Hunan, Peoples R China.	xbgyb@sina.com		Xie, Binggeng/0000-0001-8083-8556; wu, li/0000-0002-7832-9936	Applied Basic Research Foundation of Yunnan Province [2017FH001-045]; Scientific research foundation of Yunnan Province Education Department [2017ZDX134]	Applied Basic Research Foundation of Yunnan Province; Scientific research foundation of Yunnan Province Education Department	This work was supported by the Applied Basic Research Foundation of Yunnan Province, No. 2017FH001-045 to LW and a Scientific research foundation of Yunnan Province Education Department, No. 2017ZDX134 to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenby B, 1998, J IND ECOL, V2, P45, DOI DOI 10.1162/JIEC.1998.2.1.45; Cen XT, 2015, SUSTAINABILITY-BASEL, V7, P1459, DOI 10.3390/su7021459; Chen HS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020136; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Fang YP, 2016, J MT SCI-ENGL, V13, P1120, DOI 10.1007/s11629-015-3714-4; Fattahi H, 2017, TUNN UNDERGR SP TECH, V70, P114, DOI 10.1016/j.tust.2017.07.017; Feng YJ, 2017, STOCH ENV RES RISK A, V31, P2235, DOI 10.1007/s00477-016-1330-7; Franceschini S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211445; Gao Y, 2012, ENVIRON MONIT ASSESS, V184, P2307, DOI 10.1007/s10661-011-2119-2; Gao YF, 2017, ALGORITHMS, V10, DOI 10.3390/a10010002; Ge YW, 2019, SCI TOTAL ENVIRON, V650, P2906, DOI 10.1016/j.scitotenv.2018.10.058; [龚巧灵 Gong Qiaoling], 2017, [水土保持研究, Research of Soil and Water Conservation], V24, P292; Gworek B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204852; HOLDEN C, 1977, SCIENCE, V198, P807, DOI 10.1126/science.72414; Huang YH, 2013, LAND ECOLOGY; Huang Y, 2019, ECOL INDIC, V98, P149, DOI 10.1016/j.ecolind.2018.10.065; Li FZ, 2015, SUSTAINABILITY-BASEL, V7, P13631, DOI 10.3390/su71013631; Li M., 2011, ECON GEOGR, V31, P289; Li W, 2012, ENVIRON MANAGE, V49, P483, DOI 10.1007/s00267-011-9794-1; Li XB, 2014, ECOL INDIC, V39, P153, DOI 10.1016/j.ecolind.2013.12.014; Li YF, 2010, ECOL MODEL, V221, P2251, DOI 10.1016/j.ecolmodel.2010.04.016; Li ZK, 2017, OPT COMMUN, V385, P219, DOI 10.1016/j.optcom.2016.10.037; Li ZG, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010123; Lin Q, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8020172; Lou F, 2017, HENAN PROVINCE EC GE, V37, P158; Lu XC, 2014, J MT SCI-ENGL, V11, P86, DOI 10.1007/s11629-013-2293-5; Mao XY, 2013, ENVIRON EARTH SCI, V70, P269, DOI 10.1007/s12665-012-2125-x; Qian H., 2001, CHINA L SCI, V15, P14, DOI [10.13708/j.cnki.cn11-2640.2001.02.004, DOI 10.13708/J.CNKI.CN11-2640.2001.02.004, 10.3969/j.issn.1001-8158.2001.02.004, DOI 10.3969/J.ISSN.1001-8158.2001.02.004]; Shao C, 2014, INT J ENVIRON RES, V8, P765; Shao CF, 2013, INT J ENV RES PUB HE, V10, P2084, DOI 10.3390/ijerph10052084; Shi YH, 2018, ECOL INDIC, V85, P729, DOI 10.1016/j.ecolind.2017.11.033; Wang JJ, 2012, OMEGA-INT J MANAGE S, V40, P758, DOI 10.1016/j.omega.2011.07.008; Wang L, 2014, EARTH SCI RES J, V18, P181; Xie Zhen, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P255; Xu CY, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8080816; Yang WT, 2019, J HYDROL, V570, P201, DOI 10.1016/j.jhydrol.2018.12.055; [喻锋 Yu Feng], 2015, [生态学报, Acta Ecologica Sinica], V35, P4931; Yu GM, 2014, STOCH ENV RES RISK A, V28, P307, DOI 10.1007/s00477-013-0750-x; [于海洋 Yu Haiyang], 2017, [生态学报, Acta Ecologica Sinica], V37, P6355; Yu K., 1995, GEOGR INFO SCI, V1, P88, DOI [10.1080/10824009509480474, DOI 10.1080/10824009509480474]; Zhang F, 2019, SCI TOTAL ENVIRON, V656, P1133, DOI 10.1016/j.scitotenv.2018.11.444; Zhang YJ, 2015, J ENVIRON ENG LANDSC, V23, P192, DOI 10.3846/16486897.2015.1036872; Zhao XQ, 2015, RUSS J ECOL+, V46, P59, DOI 10.1134/S106741361501018X; Zhou W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205680; Zuo W, 2005, PEDOSPHERE, V15, P456	45	7	7	10	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220747	10.1371/journal.pone.0220747	http://dx.doi.org/10.1371/journal.pone.0220747			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369632	gold, Green Published, Green Submitted			2022-12-27	WOS:000484987900084
J	Fukasawa, T; Takahashi, H; Kameyama, N; Fukuda, R; Furuhata, S; Tanemura, N; Amagai, M; Urushihara, H				Fukasawa, Toshiki; Takahashi, Hayato; Kameyama, Norin; Fukuda, Risa; Furuhata, Shihori; Tanemura, Nanae; Amagai, Masayuki; Urushihara, Hisashi			Development of an electronic medical record-based algorithm to identify patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; DIAGNOSTIC CODE; VALIDATION; HLA-A-ASTERISK-3101; VALIDITY; DATABASE; STROKE; RATIO	Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), severe drug reactions, are often misdiagnosed due to their rarity and lack of information on differential diagnosis. The objective of the study was to develop an electronic medical record (EMR)-based algorithm to identify patients with SJS/TEN for future application in database studies. From the EMRs of a university hospital, two dermatologists identified all 13 patients with SJS/TEN seen at the Department of Dermatology as the case group. Another 1472 patients who visited the Department of Dermatology were identified using the ICD-10 codes for diseases requiring differentiation from SJS/TEN. One hundred of these patients were then randomly sampled as controls. Based on clinical guidelines for SJS/TEN and the experience of the dermatologists, we tested 128 algorithms based on the use of ICD-10 codes, clinical courses for SJS/TEN, medical encounters for mucocutaneous lesions from SJS/TEN, and items to exclude paraneoplastic pemphigus. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic odds ratio (DOR) of each algorithm were calculated, and the optimal algorithm was defined as that with high PPV and maximal sensitivity and specificity. One algorithm, consisting of a combination of clinical course for SJS/TEN, medical encounters for mucocutaneous lesions from SJS/TEN, and items to exclude paraneoplastic pemphigus, but not ICD-10 codes, showed a sensitivity of 76.9%, specificity of 99.0%, PPV of 40.5%, NPV of 99.8%, and DOR of 330.00. We developed a potentially optimized algorithm for identifying SJS/TEN based on clinical practice records. The almost perfect specificity of this algorithm will prevent bias in estimating relative risks of SJS/TEN in database studies. Considering the small sample size, this algorithm should be further tested in different settings.	[Fukasawa, Toshiki; Kameyama, Norin; Furuhata, Shihori; Tanemura, Nanae; Urushihara, Hisashi] Keio Univ, Grad Sch Pharmaceut Sci, Div Drug Dev & Regulatory Sci, Minato Ku, Tokyo, Japan; [Takahashi, Hayato; Fukuda, Risa; Amagai, Masayuki] Keio Univ, Dept Dermatol, Sch Med, Shinjuku Ku, Tokyo, Japan	Keio University; Keio University	Urushihara, H (corresponding author), Keio Univ, Grad Sch Pharmaceut Sci, Div Drug Dev & Regulatory Sci, Minato Ku, Tokyo, Japan.	urushihara.hisashi@keio.jp	Amagai, Masayuki/K-5325-2013; Fukasawa, Toshiki/I-6282-2018; Fukasawa, Toshiki/ABA-3798-2021; Takahashi, Hayato/AAV-7707-2021	Amagai, Masayuki/0000-0003-3314-7052; Fukasawa, Toshiki/0000-0001-7147-0737; Fukasawa, Toshiki/0000-0001-7147-0737; Takahashi, Hayato/0000-0001-6768-8821; Urushihara, Hisashi/0000-0001-6913-9930; Fukuda, Risa/0000-0002-0500-8453	Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan [H29-Nanchitou(Zatsu)-Ippan028]; Division of Drug Development and Regulatory Science at Faculty of Pharmacy, Keio University	Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan; Division of Drug Development and Regulatory Science at Faculty of Pharmacy, Keio University	This work was partly supported by Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan (H29-Nanchitou(Zatsu)-Ippan028; https://mhlw-grants.niph.go.jp/) to HT, and self-funded by the Division of Drug Development and Regulatory Science at Faculty of Pharmacy, Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboa-Eboule C, 2013, J NEUROL, V260, P605, DOI 10.1007/s00415-012-6686-0; Aihara M, 2015, J DERMATOL, V42, P768, DOI 10.1111/1346-8138.12925; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Amagai M, 1998, J CLIN INVEST, V102, P775, DOI 10.1172/JCI3647; Ando T, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3727-0; Araki Y, 2009, AM J OPHTHALMOL, V147, P1004, DOI 10.1016/j.ajo.2008.12.040; Chan SL, 2017, CLIN PHARMACOL THER, V101, P667, DOI 10.1002/cpt.526; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Davis RL, 2015, PHARMACOEPIDEM DR S, V24, P684, DOI 10.1002/pds.3778; Eisenberg DF, 2012, PHARMACOEPIDEM DR S, V21, P760, DOI 10.1002/pds.3276; Elston DM, 2016, J AM ACAD DERMATOL, V74, P1, DOI 10.1016/j.jaad.2015.06.033; Elwood JM, 2013, INT J EPIDEMIOL, V42, P1014, DOI 10.1093/ije/dyt101; Fletcher RH, 2012, CLIN EPIDEMIOLOGY ES, P108; Frey N, 2017, PHARMACOEPIDEM DR S, V26, P429, DOI 10.1002/pds.4124; Furlan JC, 2011, NEUROEPIDEMIOLOGY, V37, P96, DOI 10.1159/000330835; Gerull R, 2011, CRIT CARE MED, V39, P1521, DOI 10.1097/CCM.0b013e31821201ed; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Goldinger SM, 2016, CLIN CANCER RES, V22, P4023, DOI 10.1158/1078-0432.CCR-15-2872; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Hung Shuen-Iu, 2005, Per Med, V2, P225, DOI 10.2217/17410541.2.3.225; Kim GE, 2014, BRIT J DERMATOL, V171, P338, DOI 10.1111/bjd.13041; Kitami A., 2011, J DERMATOL, V121, P2467, DOI 10.14924/dermatol.121.2467; Kobayashi M, 2002, J DERMATOL SCI, V30, P224, DOI 10.1016/S0923-1811(02)00109-3; Lash, 2008, MODERN EPIDEMIOLOGY, P345; MacFarlane LA, 2016, PHARMACOEPIDEM DR S, V25, P820, DOI 10.1002/pds.4044; McCormack Mark, 2011, N Engl J Med, V364, P1134, DOI 10.1056/NEJMoa1013297; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Sato I, 2015, BIOL PHARM BULL, V38, P53, DOI 10.1248/bpb.b14-00543; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Schneider G, 2012, PHARMACOEPIDEM DR S, V21, P236, DOI 10.1002/pds.2331; Singh JA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4425; Sotozono C, 2009, OPHTHALMOLOGY, V116, P685, DOI 10.1016/j.ophtha.2008.12.048; The Japanese Research Committee on Severe Cutaneous Adverse Reaction (J-SCAR) supported by the Ministry of Health Labor and Welfare of Japan, 2016, JPN J DERMATOL, V126, P1637; Yamada H, 1998, Ther Apher, V2, P153, DOI 10.1111/j.1744-9987.1998.tb00094.x; Yamane Yumiko, 2007, Allergol Int, V56, P419, DOI 10.2332/allergolint.O-07-483	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0221130	10.1371/journal.pone.0221130	http://dx.doi.org/10.1371/journal.pone.0221130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408480	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500045
J	Barnas, AF; Darby, BJ; Vandeberg, GS; Rockwell, RF; Ellis-Felege, SN				Barnas, Andrew F.; Darby, Brian J.; Vandeberg, Gregory S.; Rockwell, Robert F.; Ellis-Felege, Susan N.			A comparison of drone imagery and ground-based methods for estimating the extent of habitat destruction by lesser snow geese (Anser caerulescens caerulescens) in La Perouse Bay	PLOS ONE			English	Article							UNMANNED AERIAL VEHICLES; RESOLUTION SATELLITE IMAGERY; OBJECT-BASED CLASSIFICATION; AIRCRAFT SYSTEM; WILDLIFE RESEARCH; VEGETATION COVER; BETA REGRESSION; NESTING COLONY; RANDOM FOREST; POLAR BEARS	Lesser snow goose (Anser caerulescens caerulescens) populations have dramatically altered vegetation communities through increased foraging pressure. In remote regions, regular habitat assessments are logistically challenging and time consuming. Drones are increasingly being used by ecologists to conduct habitat assessments, but reliance on georeferenced data as ground truth may not always be feasible. We estimated goose habitat degradation using photointerpretation of drone imagery and compared estimates to those made with ground-based linear transects. In July 2016, we surveyed five study plots in La Perouse Bay, Manitoba, to evaluate the effectiveness of a fixed-wing drone with simple Red Green Blue (RGB) imagery for evaluating habitat degradation by snow geese. Ground-based land cover data was collected and grouped into barren, shrub, or non-shrub categories. We compared estimates between ground-based transects and those made from unsupervised classification of drone imagery collected at altitudes of 75, 100, and 120 m above ground level (ground sampling distances of 2.4, 3.2, and 3.8 cm respectively). We found large time savings during the data collection step of drone surveys, but these savings were ultimately lost during imagery processing. Based on photointerpretation, overall accuracy of drone imagery was generally high (88.8% to 92.0%) and Kappa coefficients were similar to previously published habitat assessments from drone imagery. Mixed model estimates indicated 75m drone imagery overestimated barren (F-2,F-182 = 100.03, P < 0.0001) and shrub classes (F-2,F-182 = 160.16, P < 0.0001) compared to ground estimates. Inconspicuous graminoid and forb species (non-shrubs) were difficult to detect from drone imagery and were underestimated compared to ground-based transects (F-2,F-182 = 843.77, P < 0.0001). Our findings corroborate previous findings, and that simple RGB imagery is useful for evaluating broad scale goose damage, and may play an important role in measuring habitat destruction by geese and other agents of environmental change.	[Barnas, Andrew F.; Darby, Brian J.; Ellis-Felege, Susan N.] Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Vandeberg, Gregory S.] Univ North Dakota, Dept Geog & Geog Informat Sci, Grand Forks, ND 58201 USA; [Rockwell, Robert F.] Amer Museum Nat Hist, Vertebrate Zool, New York, NY 10024 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks; American Museum of Natural History (AMNH)	Barnas, AF (corresponding author), Univ North Dakota, Dept Biol, Grand Forks, ND 58202 USA.	andrew.barnas@und.edu		Barnas, Andrew/0000-0003-0990-4666	North Dakota EPSCOR [IIA-1355466]; Arctic Goose Joint Venture; Central Flyway Council; Mississippi Flyway Council; North Dakota View Scholarship; UND Intercollegiate Academics Fund; North Dakota EPSCoR Infrastructure Improvement Program-Doctoral Dissertation Assistantship [OIA-1355466]; UND College of Arts and Sciences; UND Biology; North Dakota Department of Commerce	North Dakota EPSCOR; Arctic Goose Joint Venture; Central Flyway Council; Mississippi Flyway Council; North Dakota View Scholarship; UND Intercollegiate Academics Fund; North Dakota EPSCoR Infrastructure Improvement Program-Doctoral Dissertation Assistantship; UND College of Arts and Sciences; UND Biology; North Dakota Department of Commerce	This work was supported by North Dakota EPSCOR #IIA-1355466 (https://www.ndepscor.ndus.edu/) to SNE; Arctic Goose Joint Venture (https://www.agjv.ca/) to RFR; Central (https://centralflyway.org/) and Mississippi Flyway Councils (http://mississippi.flyways.us/) to RFR; North Dakota View Scholarship (https://arts-sciences.und.edu/academics/geography/) and UND Intercollegiate Academics Fund (https://www1.und.edu/research/about/division-offices/grants-and-funding/intercollegiate-academics-fund.cfm) to AFB; North Dakota EPSCoR Infrastructure Improvement Program-Doctoral Dissertation Assistantship #OIA-1355466 (https://www.ndepscor.ndus.edu/) to SNE and AFB; UND College of Arts and Sciences (https://arts-sciences.und.edu/), and UND Biology (https://arts-sciences.und.edu/biology/) to SNE and AFB. North Dakota Department of Commerce (https://www.commerce.nd.gov/): awarded to Susan Ellis-Felege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KF, 2005, GLOBAL CHANGE BIOL, V11, P841, DOI 10.1111/j.1365-2486.2005.00943.x; Abraham KF, 1999, CAN FIELD NAT, V113, P245; ABRAHAM KF, 2014, GOOSE FORAGING ARCTI; Aguera F, 2011, INT ARCH PHOTOGRAMM, V38-1, P33; Ahmed OS, 2017, INT J REMOTE SENS, V38, P2037, DOI 10.1080/01431161.2017.1294781; Alisauskas RT, 2011, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.5; Alisauskas RT, 2006, ARCTIC, V59, P201; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; Ankney CD, 1996, J WILDLIFE MANAGE, V60, P217, DOI 10.2307/3802219; [Anonymous], 2012, EVALUATION SPECIAL M; Arnold LL, 2011, COMPUT GEOSCI-UK, V37, P883, DOI 10.1016/j.cageo.2010.12.011; Barnas AF, 2018, POLAR BIOL, V41, P1055, DOI 10.1007/s00300-018-2270-0; Berra EF, 2017, IEEE T GEOSCI REMOTE, V55, P4878, DOI 10.1109/TGRS.2017.2655365; Breckenridge RP, 2012, RANGELAND ECOL MANAG, V65, P362, DOI 10.2111/REM-D-10-00031.1; Burgess RM, 2017, WATERBIRDS, V40, P11; Chabot D, 2013, J UNMANNED VEH SYST, V1, P15, DOI 10.1139/juvs-2013-0014; Chabot D, 2015, J UNMANNED VEH SYST, V3, P137, DOI 10.1139/juvs-2015-0021; Chabot D, 2014, WETLANDS, V34, P527, DOI 10.1007/s13157-014-0518-1; Chapman A, 2014, J UNMANNED VEH SYST, V2, pIII, DOI 10.1139/juvs-2014-0009; Christie KS, 2016, FRONT ECOL ENVIRON, V14, P242, DOI 10.1002/fee.1281; Cruzan MB, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600041; Eskelson BNI, 2011, FOREST SCI, V57, P212; ESRI, 2018, SCAL NOT GIV; EVANS R. A., 1957, Journal of Range Management, V10, P208, DOI 10.2307/3894015; Feng QL, 2015, REMOTE SENS-BASEL, V7, P1074, DOI 10.3390/rs70101074; Ferguson MC, 2018, J UNMANNED VEH SYST, V6, P128, DOI 10.1139/juvs-2018-0002; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Flemming SA, 2016, ENVIRON REV, V24, P393, DOI 10.1139/er-2016-0007; Fortune SME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186156; Fraser RH, 2016, ARCT SCI, V2, P79, DOI 10.1139/as-2016-0008; Hanson L, 2014, 20141205 US GEOL SUR; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; Hogrefe KR, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9121234; Jano AP, 1998, J ECOL, V86, P93, DOI 10.1046/j.1365-2745.1998.00232.x; Jefferies R. L., 2003, Environmental Reviews, V11, P193, DOI 10.1139/a04-002; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; Jefferies RL, 2004, INTEGR COMP BIOL, V44, P130, DOI 10.1093/icb/44.2.130; Jefferies RL, 2002, APPL VEG SCI, V5, P7, DOI 10.1111/j.1654-109X.2002.tb00531.x; Knoth C, 2013, APPL VEG SCI, V16, P509, DOI 10.1111/avsc.12024; Koski WR, 2015, J UNMANNED VEH SYST, V3, P22, DOI 10.1139/juvs-2014-0014; Laliberte AS, 2010, PHOTOGRAMM ENG REM S, V76, P661, DOI 10.14358/PERS.76.6.661; LaRue MA, 2018, POLAR BIOL, V41, P2621, DOI 10.1007/s00300-018-2384-4; LaRue MA, 2015, WILDLIFE SOC B, V39, P772, DOI 10.1002/wsb.596; Lillesand T., 2014, REMOTE SENSING IMAGE; Linchant J, 2015, MAMMAL REV, V45, P239, DOI 10.1111/mam.12046; Loarie SR, 2007, TRENDS ECOL EVOL, V22, P630, DOI 10.1016/j.tree.2007.08.018; Lucieer A, 2014, INT J APPL EARTH OBS, V27, P53, DOI 10.1016/j.jag.2013.05.011; Malenovsky Z, 2017, METHODS ECOL EVOL, V8, P1842, DOI 10.1111/2041-210X.12833; Mallory ML, 2018, ARCT SCI, V4, P624, DOI 10.1139/as-2017-0019; Marcaccio JV, 2016, J UNMANNED VEH SYST, V4, P193, DOI 10.1139/juvs-2015-0016; Mathews AJ, 2013, REMOTE SENS-BASEL, V5, P2164, DOI 10.3390/rs5052164; Milakovic B, 2003, ECOSCIENCE, V10, P57, DOI 10.1080/11956860.2003.11682751; Milakovic B, 2001, ECOSCIENCE, V8, P58, DOI 10.1080/11956860.2001.11682631; Mora C, 2015, GEOGR ANN A, V97, P473, DOI 10.1111/geoa.12088; Moreland EE, 2015, J UNMANNED VEH SYST, V3, P114, DOI 10.1139/juvs-2015-0012; OWENSBY CE, 1973, J RANGE MANAGE, V26, P302, DOI 10.2307/3896585; Pande-Chhetri R, 2017, EUR J REMOTE SENS, V50, P564, DOI 10.1080/22797254.2017.1373602; Patterson C, 2016, J UNMANNED VEH SYST, V4, P53, DOI 10.1139/juvs-2015-0014; Peterson SL, 2014, CONDOR, V116, P527, DOI 10.1650/CONDOR-14-45.1; Peterson SL, 2013, ARCT ANTARCT ALP RES, V45, P575, DOI 10.1657/1938-4246.45.4.575; Polonen I, 2013, PROC SPIE, V8887, DOI 10.1117/12.2028624; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Rockwell RF, 2003, ECOSCIENCE, V10, P33, DOI 10.1080/11956860.2003.11682747; Rummler MC, 2016, POLAR BIOL, V39, P1329, DOI 10.1007/s00300-015-1838-1; Samelius G, 2009, CAN J ZOOL, V87, P95, DOI 10.1139/Z08-140; Sarda-Palomera F, 2017, J AVIAN BIOL, V48, P1273, DOI 10.1111/jav.01535; Shilts W.W., 1987, GEOMORPHIC SYSTEMS N, V2, P119, DOI DOI 10.1130/DNAG-CENT-V2.119; Smithson M, 2006, PSYCHOL METHODS, V11, P54, DOI 10.1037/1082-989X.11.1.54; Strecha C., 2012, ISPRS ANN PHOTOGRAMM, VI, P311, DOI DOI 10.5194/ISPRSANNALS-I-3-311-2012; Su LH, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9020159; Sykora-Bodie ST, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17719-x; Tay JYL, 2018, PLANT ECOL, V219, P1139, DOI 10.1007/s11258-018-0865-8; Turner D, 2018, INT J APPL EARTH OBS, V68, P168, DOI 10.1016/j.jag.2018.01.004; Vermeulen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054700; Weatherhead PJ, 1979, ECOLOGICAL CORRELATE, P391; Wing MG, 2005, J FOREST, V103, P169, DOI 10.1093/jof/103.4.169; Zarco-Tejada PJ, 2012, REMOTE SENS ENVIRON, V117, P322, DOI 10.1016/j.rse.2011.10.007; Zmarz A, 2018, REMOTE SENS ENVIRON, V217, P375, DOI 10.1016/j.rse.2018.08.031; Zweig CL, 2015, WETLANDS, V35, P303, DOI 10.1007/s13157-014-0612-4	79	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0217049	10.1371/journal.pone.0217049	http://dx.doi.org/10.1371/journal.pone.0217049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398201	Green Published, gold			2022-12-27	WOS:000485004000004
J	Bafna, K; Narayanan, C; Chennubhotla, SC; Doucet, N; Agarwal, PK				Bafna, Khushboo; Narayanan, Chitra; Chennubhotla, S. Chakra; Doucet, Nicolas; Agarwal, Pratul K.			Nucleotide substrate binding characterization in human pancreatic-type ribonucleases	PLOS ONE			English	Article							EOSINOPHIL CATIONIC PROTEIN; CYCLOPHILIN-A INSIGHTS; UNIQUE BASIC RESIDUES; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; HUMAN ANGIOGENIN; LIGAND-BINDING; RNASE; NEUROTOXIN; CATALYSIS	Human genome contains a group of more than a dozen similar genes with diverse biological functions including antiviral, antibacterial and angiogenesis activities. The characterized gene products of this group show significant sequence similarity and a common structural fold associated with binding and cleavage of ribonucleic acid (RNA) substrates. Therefore, these proteins have been categorized as members of human pancreatic-type ribonucleases (hRNases). hRNases differ in cell/tissue localization and display distinct substrate binding preferences and a wide range of ribonucleolytic catalytic efficiencies. Limited information is available about structural and dynamical properties that influence this diversity among these homologous RNases. Here, we use computer simulations to characterize substrate interactions, electrostatics and dynamical properties of hRNases 1-7 associated with binding to two nucleotide substrates (ACAC and AUAU). Results indicate that even with complete conservation of active-site catalytic triad associated with ribonucleolytic activity, these enzymes show significant differences in substrate interactions. Detailed characterization suggests that in addition to binding site electrostatic and van der Waals interactions, dynamics of distal regions may also play a role in binding. Another key insight is that a small difference in temperature of 300 K (used in experimental studies) and 310 K (physiological temperature) shows significant changes in enzyme-substrate interactions.	[Bafna, Khushboo] Univ Tennessee, Genome Sci & Technol, Knoxville, TN USA; [Narayanan, Chitra; Doucet, Nicolas] Univ Quebec, INRS, Inst Armand Frappier, Laval, PQ, Canada; [Chennubhotla, S. Chakra] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Doucet, Nicolas] Univ Laval, Quebec Network Res Prot Funct Struct & Engn, PROTEO, Quebec City, PQ, Canada; [Agarwal, Pratul K.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Quebec; Institut national de la recherche scientifique (INRS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Laval University; University of Tennessee System; University of Tennessee Knoxville	Agarwal, PK (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	pratul@agarwal-lab.org	Bafna, Khushboo/AGK-9642-2022	Agarwal, Pratul/0000-0002-3848-9492; Bafna, Khushboo/0000-0002-1893-1175	National Institute of General Medical Sciences of the National Institutes of Health USA [GM105978]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05557]; Foundation Armand-Frappier; CAS Dissertation Fellowship from University of Tennessee, Knoxville; National Science Foundation [ACI-1548562];  [MCB-180199];  [MCB-190044]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105978] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health USA; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Foundation Armand-Frappier; CAS Dissertation Fellowship from University of Tennessee, Knoxville; National Science Foundation(National Science Foundation (NSF)); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences of the National Institutes of Health USA under award number GM105978, and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN-2016-05557 to N. D.). C. N. received a Postdoctoral Fellowship from the Foundation Armand-Frappier. N. D. holds a Fonds de Recherche Queebec -Sante (FRQS) Research Scholar Junior 2 Career Award. PKA designed the study with inputs from SCC and ND. KB performed the simulations. KB, CN and PKA analyzed the data, created the tables and figures. All authors wrote and reviewed the manuscript.; We thank Dr. Elizabeth Howell, Dr. Donald Gagne and Shantanu Shukla for discussions and feedback. This work was supported by a grant from the National Institute of General Medical Sciences of the National Institutes of Health USA under award number GM105978, and a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN-2016-05557 to N. D.). C. N. received a Postdoctoral Fellowship from the Foundation Armand-Frappier. N. D. holds a Fonds de Recherche Quebec-Sante (FRQS) Research Scholar Junior 2 Career Award. K. B. acknowledges receipt of the CAS Dissertation Fellowship from University of Tennessee, Knoxville. This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by National Science Foundation grant number ACI-1548562. XSEDE computing allocation awards to P.K.A. (MCB-180199 and MCB-190044).	ACHARYA KR, 1994, P NATL ACAD SCI USA, V91, P2915, DOI 10.1073/pnas.91.8.2915; Acharya KR, 1998, NATO ADV SCI I A-LIF, V298, P165; Agarwal PK, 2004, PROTEINS, V56, P449, DOI 10.1002/prot.20135; Agarwal PK, 2012, J PHYS CHEM LETT, V3, P1142, DOI 10.1021/jz201675m; ANDERSON DG, 1968, BIOCHEMISTRY-US, V7, P1637, DOI 10.1021/bi00845a004; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beck DAC, 2004, METHODS, V34, P112, DOI 10.1016/j.ymeth.2004.03.008; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Boix E, 1999, BIOCHEMISTRY-US, V38, P16794, DOI 10.1021/bi9919145; Boix E, 2001, METHOD ENZYMOL, V341, P287, DOI 10.1016/S0076-6879(01)41159-1; Boix E, 2013, BIOCHIMIE, V95, P1087, DOI 10.1016/j.biochi.2012.12.015; Case D.A., 2022, AMBER; Chang CS, 2002, J MOL BIOL, V317, P119, DOI 10.1006/jmbi.2002.5406; Chatani E, 2001, J BIOSCI BIOENG, V92, P98, DOI 10.1263/jbb.92.98; Cho S, 2005, GENOMICS, V85, P208, DOI 10.1016/j.ygeno.2004.10.008; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELCARDAYRE SB, 1994, BIOCHEMISTRY-US, V33, P6031, DOI 10.1021/bi00186a001; Dey P, 2007, BIOCHEM BIOPH RES CO, V360, P809, DOI 10.1016/j.bbrc.2007.06.141; Doucet N., 2018, HUMAN RNASE 6 UNPUB; Doucet N, 2011, BIOCHEMISTRY-US, V50, P1723, DOI 10.1021/bi1018539; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; Duff MR, 2018, BIOCHEMISTRY-US, V57, P4263, DOI 10.1021/acs.biochem.8b00424; Elsasser B, 2014, J AM CHEM SOC, V136, P927, DOI 10.1021/ja406122c; Fisher BM, 1998, BIOCHEMISTRY-US, V37, P17386, DOI 10.1021/bi981369s; FLOGEL M, 1975, BIOCHEMISTRY-US, V14, P2616, DOI 10.1021/bi00683a009; FONTECILLACAMPS JC, 1994, J BIOL CHEM, V269, P21526; Gagne D, 2016, BIOCHEMISTRY-US, V55, P4184, DOI 10.1021/acs.biochem.6b00130; Gagne D, 2015, PROTEIN SCI, V24, P525, DOI 10.1002/pro.2613; Gagne D, 2013, FEBS J, V280, P5596, DOI 10.1111/febs.12371; Gaur D, 2005, MOL CELL BIOCHEM, V275, P95, DOI 10.1007/s11010-005-0997-8; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; HERRIES DG, 1962, BIOCHEM J, V85, P127, DOI 10.1042/bj0850127; Hofsteenge J, 1998, BIOCHEMISTRY-US, V37, P9250, DOI 10.1021/bi9803832; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; Jardine AM, 2001, BIOCHEMISTRY-US, V40, P10262, DOI 10.1021/bi010888j; Kelemen BR, 2000, BIOCHEMISTRY-US, V39, P14487, DOI 10.1021/bi001862f; Klink TA, 2000, EUR J BIOCHEM, V267, P566, DOI 10.1046/j.1432-1327.2000.01037.x; Koczera P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081278; Kover KE, 2008, J MOL BIOL, V379, P953, DOI 10.1016/j.jmb.2008.04.042; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Li L, 2017, BIOCHEMISTRY-US, V56, P5328, DOI 10.1021/acs.biochem.7b00657; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; Narayanan C, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00054; Narayanan C, 2018, STRUCTURE, V26, P426, DOI 10.1016/j.str.2018.01.015; Panov KI, 1996, FEBS LETT, V398, P57, DOI 10.1016/S0014-5793(96)01173-8; Prats-Ejarque G, 2016, BIOCHEM J, V473, P1523, DOI 10.1042/BCJ20160245; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ramanathan A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001193; Ramanathan A, 2010, J COMPUT BIOL, V17, P309, DOI 10.1089/cmb.2009.0167; Ramanathan A, 2009, J PHYS CHEM B, V113, P16669, DOI 10.1021/jp9077213; Rosenberg HF, 1996, NUCLEIC ACIDS RES, V24, P3507, DOI 10.1093/nar/24.18.3507; ROSENBERG HF, 1995, J BIOL CHEM, V270, P21539, DOI 10.1074/jbc.270.37.21539; Russo N, 1996, P NATL ACAD SCI USA, V93, P3243, DOI 10.1073/pnas.93.8.3243; Russo N, 1996, P NATL ACAD SCI USA, V93, P804, DOI 10.1073/pnas.93.2.804; Rutkoski TJ, 2008, ENG RIBONUCLEASE BAS; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shapiro R, 1998, BIOCHEMISTRY-US, V37, P6847, DOI 10.1021/bi9800146; Shukla S, 2018, BIOCHEMISTRY-US, V57, P5864, DOI 10.1021/acs.biochem.8b00783; Sikriwal D, 2012, J CELL BIOCHEM, V113, P3104, DOI 10.1002/jcb.24187; Sikriwal D, 2009, BIOL CHEM, V390, P225, DOI 10.1515/BC.2009.025; Singh A, 2011, BIOL CHEM, V392, P337, DOI 10.1515/BC.2011.037; SORRENTINO S, 1991, FEBS LETT, V288, P23, DOI 10.1016/0014-5793(91)80994-E; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018; Swaminathan GJ, 2002, BIOCHEMISTRY-US, V41, P3341, DOI 10.1021/bi015911f; Terzyan SS, 1999, J MOL BIOL, V285, P205, DOI 10.1006/jmbi.1998.2288; WLODAWER A, 1988, BIOCHEMISTRY-US, V27, P2705, DOI 10.1021/bi00408a010	67	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220037	10.1371/journal.pone.0220037	http://dx.doi.org/10.1371/journal.pone.0220037			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393891	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500020
J	Dekker, LH; de Borst, MH; Meems, LMG; de Boer, RA; Bakker, SJL; Navis, GJ				Dekker, Louise H.; de Borst, Martin H.; Meems, Laura M. G.; de Boer, Rudolf A.; Bakker, Stephan J. L.; Navis, Gerjan J.			The association of multimorbidity within cardio-metabolic disease domains with dietary patterns: A cross-sectional study in 129 369 men and women from the Lifelines cohort	PLOS ONE			English	Article							HEALTH-CARE; CLUSTER-ANALYSIS; RISK; PREVALENCE; METAANALYSIS; NUTRITION; QUALITY; BURDEN; INDEX; FOOD	Background Multimorbidity is considered a major challenge for current health care. Lifestyle interventions, as a broad and generic approach, may have the potential to improve the management of care among patients with multimorbidity. The objective of this study was to evaluate the association of multimorbidity defined within the cardiometabolic disease domains with dietary patterns, representing habitual dietary intake. Design We studied 129 369 participants from the Lifelines Cohort study (42% male, 45 +/- 13 years (range 18-93)) in which diet was assessed using a 110-item food frequency questionnaire. A composite morbidity score was applied in multivariable ordered logistic regression to test the association with dietary patterns derived by principal components analysis, based on sex-specific dietary pattern scores. Results Four dietary patterns were retained, accounting for 26.6% of the variation in overall diet. After control for potential confounders, men and women in the highest quintile of "meat, alcohol and potato pattern" and "snack pattern" had a higher likelihood of having higher morbidity scores than those in the lowest quintile (e.g. men: OR = 1.83(95% CI: 1.71-1.97), OR = 1.18(95% CI 1.11-1.27 respectively). The opposite was observed with respect to the "bread and sweets pattern" and "vegetable, fish and fruit pattern" (e.g. women: OR = 0.88 (95% CI: 0.81-0.96), OR = 0.86(95% CI 0.81-0.92 respectively). The association partially attenuated after adjusting for BMI, but the associations remained significant among men. Conclusions Robust associations between dietary patterns and multimorbidity within the cardiometabolic domain, in particular a "meat, alcohol and potato pattern", suggest an important opportunity of dietary interventions in multimobidity prevention. Generic prevention strategies based on population derived dietary patterns may have the potential to enhance lifestyle management among people with multimorbidity.	[Dekker, Louise H.; de Borst, Martin H.; Bakker, Stephan J. L.; Navis, Gerjan J.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Meems, Laura M. G.; de Boer, Rudolf A.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands	University of Groningen; University of Groningen	Dekker, LH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands.	l.h.dekker@umcg.nl	Meems, Laura M.G./J-7979-2016; de Boer, Rudolf/ABE-9879-2020; Bakker, Stephan/J-4023-2015	Meems, Laura M.G./0000-0001-8627-7139; De Borst, Martin/0000-0002-4127-8733; Bakker, Stephan/0000-0003-3356-6791	FES (Fonds Economische Structuurversterking); SNN (Samenwerkingsverband Noord Nederland); REP (Ruimtelijk Economisch Programma); De Friesland Zorgverzekeraar	FES (Fonds Economische Structuurversterking); SNN (Samenwerkingsverband Noord Nederland); REP (Ruimtelijk Economisch Programma); De Friesland Zorgverzekeraar	The Lifelines Biobank initiative has been made possible by funds from FES (Fonds Economische Structuurversterking), SNN (Samenwerkingsverband Noord Nederland) and REP (Ruimtelijk Economisch Programma). LHD participates in projects funded by De Friesland Zorgverzekeraar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agborsangaya CB, 2015, OBESITY, V23, P707, DOI 10.1002/oby.21008; Ammerman AS, 2002, PREV MED, V35, P25, DOI 10.1006/pmed.2002.1028; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Boeckxstaens P, 2015, J CLIN EPIDEMIOL, V68, P220, DOI 10.1016/j.jclinepi.2014.08.010; Booth HP, 2014, FAM PRACT, V31, P38, DOI 10.1093/fampra/cmt061; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dekker LH, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0622-8; Di Angelantonio E, 2015, JAMA-J AM MED ASSOC, V314, P52, DOI 10.1001/jama.2015.7008; Fabbri E, 2015, J AM MED DIR ASSOC, V16, P640, DOI 10.1016/j.jamda.2015.03.013; Floegel A, 2014, INT J OBESITY, V38, P1388, DOI 10.1038/ijo.2014.39; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hulshof K F, 2001, Public Health Nutr, V4, P667; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Jannasch F, 2017, J NUTR, V147, P1174, DOI 10.3945/jn.116.242552; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091; Klijs B, 2015, PLOS ONE, V10, P1180, DOI [10.1093/ije/dyu229, DOI 10.1093/IJE/DYU229]; Krauss RM, 2000, STROKE, V31, P2751, DOI 10.1161/01.STR.31.11.2751; Li F, 2015, BRIT J NUTR, V113, P16, DOI 10.1017/S000711451400289X; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Meems LMG, 2015, ANN MED, V47, P474, DOI 10.3109/07853890.2015.1073347; Molag ML, 2010, BRIT J NUTR, V104, P446, DOI 10.1017/S0007114510000401; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Palmer K, 2018, HEALTH POLICY, V122, P4, DOI 10.1016/j.healthpol.2017.09.006; Reedy J, 2010, AM J EPIDEMIOL, V171, P479, DOI 10.1093/aje/kwp393; Rodriguez-Monforte M, 2015, BRIT J NUTR, V114, P1341, DOI 10.1017/S0007114515003177; Ruel G, 2014, CLIN NUTR, V33, P513, DOI 10.1016/j.clnu.2013.07.009; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Tapsell LC, 2016, ADV NUTR, V7, P445, DOI 10.3945/an.115.011718; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Trijsburg L, 2017, PUBLIC HEALTH NUTR, V20, P598, DOI 10.1017/S1368980016002743; von Ruesten A, 2013, EUR J CLIN NUTR, V67, P412, DOI 10.1038/ejcn.2013.7; Wardle J, 2004, ANN BEHAV MED, V27, P107, DOI 10.1207/s15324796abm2702_5; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; WHO, 2018, MULT TECHN SER SAF P; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Xu SH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040180; Xu XL, 2017, AGEING RES REV, V37, P53, DOI 10.1016/j.arr.2017.05.003	45	9	9	10	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220368	10.1371/journal.pone.0220368	http://dx.doi.org/10.1371/journal.pone.0220368			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393962	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500029
J	Nilsson, OR; Kari, L; Steele-Mortimer, O				Nilsson, Olof R.; Kari, Laszlo; Steele-Mortimer, Olivia			Foodborne infection of mice with Salmonella Typhimurium	PLOS ONE			English	Article							ORAL GAVAGE; INDUCED COLITIS; NRAMP1; RESISTANCE; PATHOGEN; DISEASE; ILLNESS; DRIVES; LOCUS	The bacterial pathogen Salmonella enterica serovar Typhimurium is one of the most common causes of foodborne disease in humans and is also an important model system for bacterial pathogenesis. Oral inoculation of C57Bl/6 mice, which are genetically susceptible to Salmonella, results in systemic infection but the murine intestine is not efficiently colonized unless the intestinal microbiota is disrupted. Pretreatment of C57Bl/6 mice with streptomycin, followed by oral inoculation with Salmonella Typhimurium results in colitis resembling human intestinal Salmonellosis. The predominant method of delivery of bacteria is oral gavage, during which organisms are deposited directly into the stomach via a feeding needle. Although convenient, this method can be stressful for mice, and may lead to unwanted tracheal or systemic introduction of bacteria. Here, we developed a method for oral infection of mice by voluntary consumption of regular mouse chow inoculated with bacteria. Mice readily ate chow fragments containing up to 10(8) CFU Salmonella, allowing for a wide range of infectious doses. In mice pretreated with streptomycin, infection with inoculated chow resulted in reproducible infections with doses as low as 10(3) CFU. Mice not treated with streptomycin, as well as resistant Nramp1 reconstituted C57Bl/6J mice, were also readily infected using this method. In summary, voluntary consumption of chow inoculated with Salmonella represents a natural route of infection for foodborne salmonellosis and a viable alternative to oral gavage.	[Nilsson, Olof R.; Kari, Laszlo; Steele-Mortimer, Olivia] NIAID, Lab Bacteriol, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Steele-Mortimer, O (corresponding author), NIAID, Lab Bacteriol, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	omortimer@niaid.nih.gov			Intramural Research Program of the NIH, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001199] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the Intramural Research Program of the NIH, NIAID to OSM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arantes-Rodrigues R, 2012, LAB ANIMAL, V41, P129, DOI 10.1038/laban0512-129; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bauler TJ, 2017, AM J PATHOL, V187, P187, DOI 10.1016/j.ajpath.2016.09.002; Blackwell JM, 2001, CELL MICROBIOL, V3, P773, DOI 10.1046/j.1462-5822.2001.00150.x; BOHNHOFF M, 1962, J INFECT DIS, V111, P117, DOI 10.1093/infdis/111.2.117; Bollaerts K, 2008, RISK ANAL, V28, P427, DOI 10.1111/j.1539-6924.2008.01038.x; Bou Ghanem EN, 2012, PLOS PATHOG, V8; Bou Ghanem EN, 2013, JOVE-J VIS EXP, DOI [10.3791/, DOI 10.3791/]; Brown AP, 2000, CONTEMP TOP LAB ANIM, V39, P17; Brown DE, 2013, VET PATHOL, V50, P867, DOI 10.1177/0300985813478213; Damsch S, 2011, TOXICOL PATHOL, V39, P348, DOI 10.1177/0192623310388431; Gopinath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003408; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hoggatt AF, 2010, J AM ASSOC LAB ANIM, V49, P329; Jacobson A, 2018, CELL HOST MICROBE, V24, P296, DOI 10.1016/j.chom.2018.07.002; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Jones CP, 2016, J AM ASSOC LAB ANIM, V55, P805; Lamas A, 2018, MICROBIOL RES, V206, P60, DOI 10.1016/j.micres.2017.09.010; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; MILLER CP, 1962, J INFECT DIS, V111, P107, DOI 10.1093/infdis/111.2.107; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Nanton MR, 2012, J IMMUNOL, V189, P5503, DOI 10.4049/jimmunol.1201413; O' Donnell H, 2015, FUTURE MICROBIOL, V10, P1615, DOI 10.2217/fmb.15.93; PLANT J, 1976, J INFECT DIS, V133, P72, DOI 10.1093/infdis/133.1.72; QUE JU, 1985, INFECT IMMUN, V48, P169, DOI 10.1128/IAI.48.1.169-174.1985; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; Roy MF, 2002, GENES IMMUN, V3, P381, DOI 10.1038/sj.gene.6363924; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Spiga L, 2017, CELL HOST MICROBE, V22, P291, DOI 10.1016/j.chom.2017.07.018; Stecher B, 2006, INFECT IMMUN, V74, P5047, DOI 10.1128/IAI.00072-06; Todd ECD, 2008, J FOOD PROTECT, V71, P2339, DOI 10.4315/0362-028X-71.11.2339; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; Valdez Y, 2009, CELL MICROBIOL, V11, P351, DOI 10.1111/j.1462-5822.2008.01258.x; Vandenberg LN, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-46; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Walker MK, 2012, TOXICOL APPL PHARM, V260, P65, DOI 10.1016/j.taap.2012.01.025; Wessling-Resnick M, 2015, J BIOL CHEM, V290, P18984, DOI 10.1074/jbc.R115.643973	41	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0215190	10.1371/journal.pone.0215190	http://dx.doi.org/10.1371/journal.pone.0215190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393874	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500003
J	Vicovaro, M; Ruta, K; Vidotto, G				Vicovaro, Michele; Ruta, Katia; Vidotto, Giulio			Influence of visually perceived shape and brightness on perceived size, expected weight, and perceived weight of 3D objects	PLOS ONE			English	Article							CONJOINT-MEASUREMENT; APPARENT WEIGHT; FIXED SET; PERCEPTION; ILLUSION; HEAVINESS; EXPECTANCIES; JUDGMENT; HEAVIER; VISION	In the size-weight illusion, when two objects of identical weight but different volume are lifted, the smaller object is typically perceived to weigh more than the larger object. A well-known explanation for this and other weight illusions is provided by the hypothesis that perceived weight results from the contrast between actual and expected weight. More recently, it has been suggested that an object's size may exert a direct and automatic effect on its perceived weight, independently of expected weight. Here we test these two hypotheses by exploring two illusions that have been known for a long time but have remained relatively underexplored, namely the shape-weight and brightness-weight illusions. Specifically, we measured the influence of visually perceived shape and brightness on the perceived size, the expected weight, and the perceived weight of 3D plastic objects. A numerical rating task was used in Experiment 1, and a paired comparison task was used in Experiment 2. The results showed that spheres were perceived to be heavier than tetrahedrons and cubes, and cubes were perceived to be heavier than tetrahedrons. We did not find any consistent relationship between brightness and perceived weight. A systematic comparison between perceived size, expected weight, and perceived weight showed that the visual shape-weight and brightness-weight illusions are partially inconsistent with the hypothesis that perceived weight results from the contrast between actual and expected weight and with the hypothesis that perceived weight results from the contrast between actual weight and perceived size. The results appear to suggest that there may be a dissociation between the processing of variables that contribute to the conscious experience of size, such as brightness and vertical height, and the processing of variables that contribute to perceived weight, such as surface area.	[Vicovaro, Michele; Ruta, Katia; Vidotto, Giulio] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Vicovaro, M (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	michele.vicovaro@unipd.it	Vidotto, Giulio/B-9314-2009	Vidotto, Giulio/0000-0002-3854-5087; VICOVARO, MICHELE/0000-0002-9656-1640	Ministero dell'Istruzione, dell'Universita e della Ricerca [262]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	The study was supported by a grant form Ministero dell'Istruzione, dell'Universita e della Ricerca (Dipartimenti di Eccellenza DM 11/05/2017 n. 262) to the Department of General Psychology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KR, 1976, PERCEPT PSYCHOPHYS, V19, P72, DOI 10.3758/BF03199388; Amazeen EL, 1996, J EXP PSYCHOL HUMAN, V22, P213, DOI 10.1037/0096-1523.22.1.213; Anderson N. H., 1982, METHODS INFORM INTEG; Anderson N. H., 1981, FDN INFORM INTEGRATI; ANDERSON NH, 1970, PERCEPT PSYCHOPHYS, V8, P1, DOI 10.3758/BF03208919; Bates D, 2013, J STAT SOFTW, V52, P1, DOI 10.18637/jss.v052.i05; Buckingham G, 2016, Q J EXP PSYCHOL, V69, P1831, DOI 10.1080/17470218.2015.1100642; Buckingham G, 2014, EXP BRAIN RES, V232, P1623, DOI 10.1007/s00221-014-3926-9; Buckingham G, 2011, ATTEN PERCEPT PSYCHO, V73, P36, DOI 10.3758/s13414-010-0007-4; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; De Camp JE, 1917, J EXP PSYCHOL, V2, P347, DOI 10.1037/h0075903; Dijker AJM, 2008, COGNITION, V106, P1109, DOI 10.1016/j.cognition.2007.05.009; Dijker AJM, 2014, PSYCHON B REV, V21, P1404, DOI 10.3758/s13423-014-0634-1; Dresslar F.B., 1894, AM J PSYCHOL, V6, P313, DOI [10.2307/1411644, DOI 10.2307/1411644]; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; Ellis RR, 1998, PERCEPTION, V27, P193, DOI 10.1068/p270193; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; FALMAGNE JC, 1976, PSYCHOL REV, V83, P65, DOI 10.1037/0033-295X.83.1.65; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; FRAYMAN BJ, 1981, PERCEPT PSYCHOPHYS, V29, P56, DOI 10.3758/BF03198840; HARSHFIELD SP, 1970, PSYCHON SCI, V20, P365, DOI 10.3758/BF03335692; He RQ, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/4790174; HELLSTROM A, 1985, PSYCHOL BULL, V97, P35, DOI 10.1037/0033-2909.97.1.35; Ho YX, 2008, PSYCHOL SCI, V19, P196, DOI 10.1111/j.1467-9280.2008.02067.x; JONES LA, 1986, PSYCHOL BULL, V100, P29, DOI 10.1037/0033-2909.100.1.29; Kahrimanovic M, 2011, IEEE T HAPTICS, V4, P316, DOI [10.1109/TOH.2011.22, 10.1109/ToH.2011.22]; Kahrimanovic M, 2010, LECT NOTES COMPUT SC, V6191, P17, DOI 10.1007/978-3-642-14064-8_3; Kahrimanovic M, 2010, ACTA PSYCHOL, V134, P385, DOI 10.1016/j.actpsy.2010.03.011; Knoblauch K., 2012, MODELING PSYCHOPHYSI, DOI [10.1007/978-1-4614-4475-6, DOI 10.1007/978-1-4614-4475-6]; Krishna A, 2006, J CONSUM RES, V32, P557, DOI 10.1086/500486; MASIN SC, 1988, PERCEPT PSYCHOPHYS, V44, P309, DOI 10.3758/BF03210411; NAKATANI K, 1985, PSYCHOL RES-PSYCH FO, V47, P223, DOI 10.1007/BF00309450; NAKATANI K, 1989, PERCEPT MOTOR SKILL, V68, P415, DOI 10.2466/pms.1989.68.2.415; Nicolas S, 2012, PERCEPT MOTOR SKILL, V115, P120, DOI 10.2466/24.22.27.PMS.115.4.120-141; Oyama T, 1960, JAPANESE PSYCHOL RES, V2, P13, DOI 10.4992/psycholres1954.2.13; PAYNE MC, 1958, AM J PSYCHOL, V71, P725, DOI 10.2307/1420330; Plaisier MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17719; ROSS HE, 1969, Q J EXP PSYCHOL, V21, P346, DOI 10.1080/14640746908400230; Saccone EJ, 2019, PSYCHON B REV, V26, P77, DOI 10.3758/s13423-018-1519-5; STANEK RJ, 1969, PERCEPT PSYCHOPHYS, V6, P16, DOI 10.3758/BF03210668; Streit M, 2007, PSYCHON B REV, V14, P363, DOI 10.3758/BF03194078; Taylor CD, 1930, J GEN PSYCHOL, V4, P229, DOI 10.1080/00221309.1930.9918312; Trewartha KM, 2017, COGNITION, V163, P121, DOI 10.1016/j.cognition.2017.02.014; Vicovaro M, 2019, ACTA PSYCHOL, V194, P51, DOI 10.1016/j.actpsy.2019.02.001; Vicovaro M, 2017, ATTEN PERCEPT PSYCHO, V79, P306, DOI 10.3758/s13414-016-1212-6; Vicovaro M, 2014, ACTA PSYCHOL, V149, P52, DOI 10.1016/j.actpsy.2014.03.001; Walker P, 2017, PERCEPTION, V46, P772, DOI 10.1177/0301006616684369; Walker P, 2010, EXP PSYCHOL, V57, P462, DOI 10.1027/1618-3169/a000057; Wallis WA, 1935, J GEN PSYCHOL, V13, P193, DOI 10.1080/00221309.1935.9917877; Wolf C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190624; Zago M, 2005, NEUROPSYCHOLOGIA, V43, P178, DOI 10.1016/j.neuropsychologia.2004.11.005	52	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220149	10.1371/journal.pone.0220149	http://dx.doi.org/10.1371/journal.pone.0220149			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393903	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500024
J	de Lara, CMR; Navas, JF; Perales, JC				Ruiz de Lara, Cristian M.; Navas, Juan F.; Perales, Jose C.			The paradoxical relationship between emotion regulation and gambling-related cognitive biases	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; PATHOLOGICAL GAMBLERS; SUBSTANCE-USE; CLASSIFICATION ACCURACY; PSYCHOMETRIC PROPERTIES; EXTERNALIZING BEHAVIOR; NEGATIVE URGENCY; SPANISH VERSION; RISK-FACTORS; RASH ACTION	Background Gambling behavior presents substantial individual variability regarding its severity, manifestations, and psychological correlates. Specifically, differences in emotion regulation, impulsivity, and cognitive distortions have been identified as crucial to describe individual profiles with implications for the prevention, prognosis, and treatment of gambling disorder (GD). Aims and method The aim of the present study was to investigate the associations of gambling-related cognitions (measured according to the GRCS model) with impulsivity (UPPS-P model) and emotion regulation (CERQ model), in a sample of 246 gamblers with different levels of gambling involvement, using mixed-effects modelling to isolate theoretically relevant associations while controlling for the potentially confounding effects of sociodemographic and clinical covariates. Results Affective/motivational dimensions of UPPS-P impulsivity positive urgency and sensation seeking, on the one hand, and CERQ emotion regulation strategies reappraisal, rumination and blaming others, on the other, independently and significantly predicted distorted gambling-related cognitions. Conclusions These results (a) reinforce the ones of previous studies stressing the relevance of emotional and motivational processes in the emergence of gambling-related cognitive distortions; and (b) replicate the seemingly paradoxical finding that gamblers use emotion regulation strategies customarily considered as adaptive (i.e. reappraisal) to strengthen and justify their biased beliefs about gambling outcomes and controllability.	[Ruiz de Lara, Cristian M.; Navas, Juan F.; Perales, Jose C.] Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain	University of Granada	Navas, JF (corresponding author), Univ Granada, Mind Brain & Behav Res Ctr CIMCYC, Granada, Spain.	jfnavas@ugr.es	Navas, Juan/AAD-3302-2019	Navas, Juan. F./0000-0002-9521-6642; Perales, Jose C./0000-0001-5163-8811	Spanish Government (Ministerio de Economia y Competitividad, Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Convocatoria 2017 de Proyectos I + D de Excelencia, Spain); Fondo Europeo de Desarrollo Regional, FEDER, European Union [PSI2017-85488-P]	Spanish Government (Ministerio de Economia y Competitividad, Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Convocatoria 2017 de Proyectos I + D de Excelencia, Spain); Fondo Europeo de Desarrollo Regional, FEDER, European Union	This work is supported by a grant from the Spanish Government (Ministerio de Economia y Competitividad, Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Convocatoria 2017 de Proyectos I + D de Excelencia, Spain; co-funded by the Fondo Europeo de Desarrollo Regional, FEDER, European Union), with reference number PSI2017-85488-P. The funding agency is public and played no role in planning or executing this work, nor interfered with the collection and interpretation of data.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Albein-Urios N, 2014, ADDICT BIOL, V19, P415, DOI 10.1111/j.1369-1600.2012.00497.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; [Anonymous], 2007, INT GAMBL STUD, DOI DOI 10.1080/14459790701387428; Aragay N, 2015, COMPR PSYCHIAT, V57, P58, DOI 10.1016/j.comppsych.2014.10.009; Barrada JR, 2019, PLOS ONE, V14, P1; Billieux J, 2012, PSYCHIAT RES, V198, P291, DOI 10.1016/j.psychres.2012.01.001; Blain B, 2015, INT GAMBL STUD, V15, P239, DOI 10.1080/14459795.2015.1029960; Blanco C, 2012, PSYCHOL MED, V42, P497, DOI 10.1017/S0033291711001401; Blanco C, 2015, ADDICTION, V110, P1340, DOI 10.1111/add.12946; Blanco C, 2009, PSYCHIAT RES, V167, P161, DOI 10.1016/j.psychres.2008.04.023; Blaszczynski A, 2002, ADDICTION, V97, P487, DOI 10.1046/j.1360-0443.2002.00015.x; Brooks SJ, 2017, PROG BRAIN RES, V235, P177, DOI 10.1016/bs.pbr.2017.08.002; Calado F, 2016, J BEHAV ADDICT, V5, P592, DOI 10.1556/2006.5.2016.073; Canale N, 2016, ADDICTION, V112, P370, DOI [10.1111/add.13599, DOI 10.1111/ADD.13599]; Canale N, 2017, ADDICTION, V112, P372, DOI 10.1111/add.13641; Candido A., 2012, TRASTORNOS ADICTIVOS, V14, P73, DOI DOI 10.1016/S1575-0973(12)70048-X; Carlson SR, 2013, PERS INDIV DIFFER, V54, P202, DOI 10.1016/j.paid.2012.08.039; Carver CS, 2017, CLIN PSYCHOL SCI, V5, P880, DOI 10.1177/2167702617710037; Chamberlain SR, 2017, ADDICT BEHAV, V72, P79, DOI 10.1016/j.addbeh.2017.03.020; Cheetham A, 2010, CLIN PSYCHOL REV, V30, P621, DOI 10.1016/j.cpr.2010.04.005; Chu S, 2015, CAN J ADDICT, V6, P62; Ciccarelli M, 2017, J BEHAV THER EXP PSY, V54, P204, DOI 10.1016/j.jbtep.2016.08.012; Clark L, 2019, MOL PSYCHIATR, V24, P674, DOI 10.1038/s41380-018-0230-2; Clark L, 2014, ANN NY ACAD SCI, V1327, P46, DOI 10.1111/nyas.12558; Clark L, 2013, CURR OPIN NEUROBIOL, V23, P655, DOI 10.1016/j.conb.2013.01.004; Cosenza M, 2015, J ADOLESCENCE, V45, P56, DOI 10.1016/j.adolescence.2015.08.015; Cosenza M, 2014, COGN COMPUT, V6, P652, DOI 10.1007/s12559-014-9274-z; Cunningham JA, 2014, J GAMBL ISSUES, DOI 10.4309/jgi.2014.29.2; Cyders MA., 2016, DARK SIDE PERSONALIT, P157, DOI [DOI 10.1037/14854-009, 10.1037/14854-009]; Cyders MA, 2008, PSYCHOL BULL, V134, P807, DOI 10.1037/a0013341; Cyders MA, 2007, PERS INDIV DIFFER, V43, P839, DOI 10.1016/j.paid.2007.02.008; de Castro V, 2007, ADDICT BEHAV, V32, P1555, DOI 10.1016/j.addbeh.2006.11.014; Del Prete F, 2017, J BEHAV ADDICT, V6, P51, DOI 10.1556/2006.6.2017.001; Dominguez-Sanchez FJ, 2013, ASSESSMENT, V20, P253, DOI 10.1177/1073191110397274; Donati MA, 2015, ADDICT BEHAV, V45, P1, DOI 10.1016/j.addbeh.2015.01.001; Echeburua E., 1994, AN LISIS MODIFICACI, V20, P769, DOI DOI 10.1037/T03938-000; French MT, 2008, DRUG ALCOHOL DEPEN, V96, P155, DOI 10.1016/j.drugalcdep.2008.02.011; GABOURY A, 1989, J SOC BEHAV PERS, V4, P411; Garnefski N, 2007, EUR J PSYCHOL ASSESS, V23, P141, DOI 10.1027/1015-5759.23.3.141; Goodie AS, 2013, PSYCHOL ADDICT BEHAV, V27, P730, DOI 10.1037/a0031892; Grant JE, 2011, ANN CLIN PSYCHIATRY, V23, P3; Griffiths M, 2009, CYBERPSYCHOL BEHAV, V12, P199, DOI 10.1089/cpb.2008.0196; Gross J. J., 2006, EMOTION REGULATION C, P13, DOI [10.1037/11468-001, DOI 10.1037/11468-001]; Gross JJ, 2013, EMOTION, V13, P359, DOI 10.1037/a0032135; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hodgins DC, 2012, PSYCHOL MED, V42, P2433, DOI 10.1017/S0033291712000724; Hodgins DC, 2009, PSYCHOL ADDICT BEHAV, V23, P122, DOI 10.1037/a0013010; Ibanez A, 2001, AM J PSYCHIAT, V158, P1733, DOI 10.1176/appi.ajp.158.10.1733; Jara-Rizzo MF, 2019, ADICCIONES, V31, P147, DOI 10.20882/adicciones.1041; Jara-Rizzo MF, J GAMBL STUD; Jimenez-Murcia S, 2009, J GAMBL STUD, V25, P93, DOI 10.1007/s10899-008-9104-x; Jimenez-Murcia S, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00173; Johansson A, 2009, J GAMBL STUD, V25, P67, DOI 10.1007/s10899-008-9088-6; Johnson SL, 2017, BRIT J CLIN PSYCHOL, V56, P235, DOI 10.1111/bjc.12135; Joukhador J, 2003, PSYCHOL REP, V92, P1203, DOI 10.2466/PR0.92.3.1203-1214; Lee HP, 2007, PSYCHIAT RES, V150, P21, DOI 10.1016/j.psychres.2006.04.005; Lee NK, 1999, ADDICT BEHAV, V24, P359, DOI 10.1016/S0306-4603(98)00091-4; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Lobo DSS, 2009, ADDICTION, V104, P1454, DOI 10.1111/j.1360-0443.2009.02671.x; MacKay TL, 2014, COMPUT HUM BEHAV, V31, P419, DOI 10.1016/j.chb.2013.11.006; MacKillop J, 2014, EXP CLIN PSYCHOPHARM, V22, P176, DOI 10.1037/a0035874; MacLaren VV, 2011, CLIN PSYCHOL REV, V31, P1057, DOI 10.1016/j.cpr.2011.02.002; Maniaci G, 2017, J GAMBL STUD, V33, P633, DOI 10.1007/s10899-016-9636-4; Michalczuk R, 2011, PSYCHOL MED, V41, P2625, DOI 10.1017/S003329171100095X; Miller NV, 2008, J GAMBL STUD, V24, P257, DOI 10.1007/s10899-008-9089-5; Morasco BJ, 2006, PSYCHOSOM MED, V68, P976, DOI 10.1097/01.psy.0000238466.76172.cd; Myrseth H, 2010, J GAMBL STUD, V26, P561, DOI 10.1007/s10899-010-9180-6; Nautiyal KM, 2017, ANN NY ACAD SCI, V1394, P106, DOI 10.1111/nyas.13356; Navas JF., 2019, HARM REDUCTION PROBL; Navas JF, 2017, ADDICTION, V112, P1086, DOI 10.1111/add.13751; Navas JF, 2017, INT GAMBL STUD, V17, P102, DOI 10.1080/14459795.2016.1275739; Navas JF, 2016, J BEHAV ADDICT, V5, P271, DOI 10.1556/2006.5.2016.040; Pace U, 2015, CLIN NEUROPSYCHIATR, V12, P111; Perales JC, 2017, J GAMBL STUD, V33, P705, DOI 10.1007/s10899-016-9634-6; Petry NM, 2005, PSYCHOL ADDICT BEHAV, V19, P226, DOI 10.1037/0893-164X.19.2.226; Petry NM, 2005, J CLIN PSYCHIAT, V66, P564, DOI 10.4088/JCP.v66n0504; Petry NM, 2002, ADDICTION, V97, P745, DOI 10.1046/j.1360-0443.2002.00163.x; Pinheiro J., 2020, PACKAGE NLME LINEAR, DOI DOI 10.1016/S0006-3207(01)00201-4; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Raylu N, 2004, ADDICTION, V99, P757, DOI 10.1111/j.1360-0443.2004.00753.x; Raylu N, 2002, CLIN PSYCHOL REV, V22, P1009, DOI 10.1016/S0272-7358(02)00101-0; Rogier G, 2018, J BEHAV ADDICT, V7, P239, DOI 10.1556/2006.7.2018.52; de Lara CMR, 2018, INT GAMBL STUD, V18, P195, DOI 10.1080/14459795.2018.1448427; Scholes-Balog KE, 2014, J ADOLESCENCE, V37, P215, DOI 10.1016/j.adolescence.2013.12.006; Settles RE, 2012, J ABNORM PSYCHOL, V121, P160, DOI 10.1037/a0024948; Shaffer HJ, 2002, ANNU REV PUBL HEALTH, V23, P171, DOI 10.1146/annurev.publhealth.23.100901.140532; Slutske WS, 2010, ARCH GEN PSYCHIAT, V67, P624, DOI 10.1001/archgenpsychiatry.2010.51; Smith GT, 2016, DRUG ALCOHOL DEPEN, V163, pS3, DOI 10.1016/j.drugalcdep.2015.08.038; Stewart SH, 2008, ADDICTION, V103, P1110, DOI 10.1111/j.1360-0443.2008.02235.x; Stewart SH, 2008, PSYCHOL ADDICT BEHAV, V22, P257, DOI 10.1037/0893-164X.22.2.257; Stinchfield R, 2002, ADDICT BEHAV, V27, P1, DOI 10.1016/S0306-4603(00)00158-1; Taylor RN, 2014, J GAMBL STUD, V30, P453, DOI 10.1007/s10899-013-9368-7; Toneatto T, 1997, J Gambl Stud, V13, P253, DOI 10.1023/A:1024983300428; Tran J, 2018, AM J DRUG ALCOHOL AB, V44, P695, DOI 10.1080/00952990.2018.1503280; van Holst RJ, 2010, NEUROSCI BIOBEHAV R, V34, P87, DOI 10.1016/j.neubiorev.2009.07.007; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Volberg RA, 2001, ACTA PSYCHIAT SCAND, V104, P250, DOI 10.1034/j.1600-0447.2001.00336.x; Welte JW, 2004, ADDICT BEHAV, V29, P323, DOI 10.1016/j.addbeh.2003.08.007; Williams AD, 2012, BRIT J CLIN PSYCHOL, V51, P223, DOI 10.1111/j.2044-8260.2011.02022.x; Wood RTA, 2007, PSYCHOL PSYCHOTHER-T, V80, P107, DOI 10.1348/147608306X107881; Wood RT, 2011, NEW MEDIA SOC, V13, P1123, DOI 10.1177/1461444810397650; Xian H, 2008, PSYCHIAT RES, V160, P300, DOI 10.1016/j.psychres.2007.08.007; Xuan YH, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02121	104	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220668	10.1371/journal.pone.0220668	http://dx.doi.org/10.1371/journal.pone.0220668			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381598	Green Published, gold, Green Submitted			2022-12-27	WOS:000484993600028
J	Sodergren, A; Karp, K; Bengtsson, C; Moller, B; Rantapaa-Dahlqvist, S; Wallberg-Jonsson, S				Sodergren, Anna; Karp, Kjell; Bengtsson, Christine; Moller, Bozena; Rantapaa-Dahlqvist, Solbritt; Wallberg-Jonsson, Solveig			Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; RISK-FACTORS; ATHEROSCLEROSIS; INFLAMMATION; METAANALYSIS; VALIDATION; MORTALITY; EVENTS; EXTENT	Objectives Patients with rheumatoid arthritis (RA) have an increased mortality and morbidity due to cardiovascular disease (CVD). In this prospective 5-year follow up of patients with RA, we analysed several biomarkers, known to be associated with atherosclerosis and/or inflammation in the general population. The aim of this study was to find out whether the RA-disease per se affect these biomarkers and if those could be associated with the progression of atherosclerosis, as measured by intima media thickness (IMT) among patients with early RA. Methods Patients from northern Sweden diagnosed with early RA, are consecutively recruited into an ongoing prospective study on CVD comorbidity. A subgroup of patients, aged <= 60 years (n = 71) was included for ultrasound measurements of IMT at inclusion (T0) and after 5 years (T5) together with age-sex-matched controls (n = 40). The patients were clinically assessed. Blood was analysed for lipids, ESR and CRP and several biomarkers known to be associated with atherosclerosis in the general population. Results At T0, the patients with RA had significantly lower levels of MIF and significantly higher levels of interleukin (IL)-18 and MIC-1 compared with controls. At T5, the patients with RA had significantly higher levels of pentraxin3, MIC-1, TNF-R2, ICAM-1, VCAM-1 and endostatin compared with controls. At T0 the levels of MPO correlated with DAS28, sCD40L with CRP and IL-18 with systolic blood pressure and Reynolds risk score. Using PLSR on a CVD-panel analysed with multiplex immunoassay, the patients with RA could be correctly classified into those who had a worsening in their IMT over the five years or not. Here, MMP3 was identified as influential. Conclusions This study indicates that the RA disease itself could affect several of the biomarkers in this study, and possibly also the processes involved in the development of atherosclerosis.	[Sodergren, Anna; Bengtsson, Christine; Rantapaa-Dahlqvist, Solbritt; Wallberg-Jonsson, Solveig] Univ Umea, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden; [Sodergren, Anna] Umea Univ, WCMM, Umea, Sweden; [Karp, Kjell] Univ Umea, Dept Surg & Perioperat Sci, Umea, Sweden; [Bengtsson, Christine] Kristianstad Hosp, Dept Rheumatol, Kristianstad, Sweden; [Moller, Bozena] Sunderby Hosp, Dept Rheumatol, Lulea, Sweden	Umea University; Umea University; Umea University; Sunderby Hospital	Sodergren, A (corresponding author), Univ Umea, Dept Publ Hlth & Clin Med Rheumatol, Umea, Sweden.; Sodergren, A (corresponding author), Umea Univ, WCMM, Umea, Sweden.	anna.sodergren@umu.se			Swedish Research Council [K 2007-52X-20307-01-3]; Swedish Rheumatism Association; Swedish Rheumatism Association in the Vasterbotten County; Visare Norr, Norrlandstingens regionforbund (Northern County Councils); Swedish Heart-Lung Foundation; King Gustaf V's 80-Year Fund, Sweden; Swedish Society for Medical Research (SSMF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; Swedish Rheumatism Association in the Vasterbotten County; Visare Norr, Norrlandstingens regionforbund (Northern County Councils); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Gustaf V's 80-Year Fund, Sweden; Swedish Society for Medical Research (SSMF)	This work was supported by grants from the Swedish Research Council (grant number K 2007-52X-20307-01-3); the Swedish Rheumatism Association; the Swedish Rheumatism Association in the Vasterbotten County; Visare Norr, Norrlandstingens regionforbund (Northern County Councils); the Swedish Heart-Lung Foundation; the King Gustaf V's 80-Year Fund, Sweden; and the Swedish Society for Medical Research (SSMF).	Ambrosino P, 2015, THROMB HAEMOSTASIS, V113, P916, DOI 10.1160/TH14-11-0921; Arlestig L, 2012, J RHEUMATOL, V39, P939, DOI 10.3899/jrheum.111336; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Avina-Zubieta JA, 2008, ARTHRIT RHEUM-ARTHR, V59, P1690, DOI 10.1002/art.24092; Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726; Brown DA, 2007, ARTHRITIS RHEUM, V56, P753, DOI 10.1002/art.22410; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; Dessein PH, 2005, J RHEUMATOL, V32, P435; Evans MR, 2011, ARTHRITIS RHEUM-US, V63, P1211, DOI 10.1002/art.30265; Galil SMA, 2016, INT J RHEUM DIS, V19, P377, DOI 10.1111/1756-185X.12434; Giles JT, 2011, ARTHRITIS RHEUM-US, V63, P3216, DOI 10.1002/art.30542; Jonsson SW, 2001, J RHEUMATOL, V28, P2597; Klingenberg R, 2015, EUR HEART J, V36, P3423, DOI 10.1093/eurheartj/ehv489; Kozera L, 2011, RHEUMATOLOGY, V50, P1944, DOI 10.1093/rheumatology/ker232; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mamehara Akira, 2010, Kobe J Med Sci, V56, pE98; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Pamuk GE, 2008, PLATELETS, V19, P146, DOI 10.1080/09537100701210057; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; Sellam J, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2833; Sodergren A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/673018; Sodergren A, 2015, J RHEUMATOL, V42, P935, DOI 10.3899/jrheum.140694; Sodergren A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3116; Tyrrell PN, 2010, ARTERIOSCL THROM VAS, V30, P1014, DOI 10.1161/ATVBAHA.109.198424; van Sijl AM, 2011, SEMIN ARTHRITIS RHEU, V40, P389, DOI 10.1016/j.semarthrit.2010.06.006; Volin MV, 2011, J INTERF CYTOK RES, V31, P745, DOI 10.1089/jir.2011.0050; Wallberg-Jonsson S, 1999, J RHEUMATOL, V26, P2562; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220531	10.1371/journal.pone.0220531	http://dx.doi.org/10.1371/journal.pone.0220531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381601	Green Submitted, gold, Green Published			2022-12-27	WOS:000484993600022
J	Nadal-Serrano, JM; de la Pedrosa, EGG; Lopez-Vallejo, M; Gonzalez, ADF; Lopez-Barrio, C				Nadal-Serrano, Jose M.; de la Pedrosa, Elia Gomez G.; Lopez-Vallejo, Marisa; Fernandez Gonzalez, Alvaro de Guzman; Lopez-Barrio, Carlos			Simple method to generate calibrated synthetic smoke-like atmospheres at microscopic scale	PLOS ONE			English	Article							FRACTAL AGGREGATE; SOOT; SCATTERING; PARTICLES; VESSEL; MODEL	Artificial smokes focusing on macroscopic or fluid properties of smoke have been available for a long time. This paper presents a simple method to generate fully customizable smoke-like atmospheres at microscopic scale (i.e. considering their constituent particles as discrete elements) using a different approach. Synthetic, reproducible media can be generated combining monodisperse microspheres with known geometrical and optical properties conveniently parameterized. The method is presented as a proof-of-concept, highlighting the design decisions along with their implications. Practical issues such as aerosol nebulization, particle carrier selection or the features of the medium chamber where the smoke-like atmosphere is to be tested are analyzed. A comparison between methanol and ethanol as carriers for polystyrene microsphere nebulization is also made. The method could be the seed for the obtention of standard reference media for calibration or standardized characterization of not only smoke detectors and exhaust smoke sensors but also other instruments relying on optical properties of dispersive media (dust in PV panels, public lighting, etc.).	[Nadal-Serrano, Jose M.; Lopez-Vallejo, Marisa; Fernandez Gonzalez, Alvaro de Guzman; Lopez-Barrio, Carlos] Univ Politecn Madrid, ETSI Telecomunicac, Madrid, Spain; [de la Pedrosa, Elia Gomez G.] Hosp Univ Ramon y Cajal, Madrid, Spain	Universidad Politecnica de Madrid; Hospital Universitario Ramon y Cajal	Nadal-Serrano, JM (corresponding author), Univ Politecn Madrid, ETSI Telecomunicac, Madrid, Spain.	jmnadal@ieee.org	Lopez-Vallejo, Marisa/K-9456-2014; Barrio, Carlos A. López/I-1311-2015	Lopez-Vallejo, Marisa/0000-0002-3833-524X; Barrio, Carlos A. López/0000-0002-2423-5272				BANKSTON CP, 1981, COMBUST FLAME, V41, P273, DOI 10.1016/0010-2180(81)90062-6; Baumgardner D, 2012, ATMOS MEAS TECH, V5, P1869, DOI 10.5194/amt-5-1869-2012; Black JD, 2017, SOOT GENERATING DEVI; Brandrup J., 1975, POLYM HDB, V2nd ed.; Bryan JL, SMOKE DETERMINANT HU; CHRISTOFORIDIS AJ, 1971, CHEST, V59, P629, DOI 10.1378/chest.59.6.629; Davies NW, 2018, ACCURACY AEROSOL PHO; Deng XY, 2004, APPL OPTICS, V43, P2925, DOI 10.1364/AO.43.002925; Di Sarli V, 2014, J LOSS PREVENT PROC, V27, P8, DOI 10.1016/j.jlp.2013.10.015; DOBBINS RA, 1994, ATMOS ENVIRON, V28, P889, DOI 10.1016/1352-2310(94)90247-X; Doner N, 2017, J QUANT SPECTROSC RA, V187, P10, DOI 10.1016/j.jqsrt.2016.09.005; Frank SR, 2004, RESP INFECT TREATMEN; Hinds WC, 2022, AEROSOL TECHNOLOGY P, V3; Hull P, 2004, APPL OPTICS, V43, P3433, DOI 10.1364/AO.43.003433; Ishii K, 1998, APPL OPTICS, V37, P5014, DOI 10.1364/AO.37.005014; Jiang H, 2014, SCI REP-UK, V4, DOI 10.1038/srep07114; Kashef A, 2004, 5 INT C TUNN FIR LON, P185; Kobes M, 2010, FIRE SAFETY J, V45, P1, DOI 10.1016/j.firesaf.2009.08.005; Kou L., 1996, BLACK CARBON ATMOSPH; Labs B, 2013, MICR AGGR; Labs B, 2013, DRYING RES MICR; Ma XY, 2003, PHYS MED BIOL, V48, P4165, DOI 10.1088/0031-9155/48/24/013; MERCER TT, 1968, AM IND HYG ASSOC J, V29, P66, DOI 10.1080/00028896809342983; Middleton N, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9061053; Moallemi A, 2019, J AEROSOL SCI, V135, P46, DOI 10.1016/j.jaerosci.2019.05.004; Mulholland GW, 1995, SFPE HDB FIRE PROTEC; Nadal-Serrano JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187219; Nadal-Serrano JM, 2015, FIRE SAFETY J, V71, P299, DOI 10.1016/j.firesaf.2014.11.029; NIST, 2013, SRM 2975 DIES PART M; OCallaghan C, 1997, THORAX, V52, pS31, DOI 10.1136/thx.52.2008.S31; PHIPPS PR, 1990, CHEST, V97, P1327, DOI 10.1378/chest.97.6.1327; Prahl S., 2012, MIE SCATTERING; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Seinfeld J.H., 2016, ENVIRONMENT, DOI [10.1080/00139157.1999.10544295, DOI 10.1080/00139157.1999.10544295]; SPANNER G, 1994, J AEROSOL SCI, V25, P265, DOI 10.1016/0021-8502(94)90078-7; Tan S, 2019, RELIAB ENG SYST SAFE, V188, P233, DOI 10.1016/j.ress.2019.03.012; Tumolva L, 2010, AEROSOL SCI TECH, V44, P202, DOI 10.1080/02786820903518907; Webb AK, 2006, FDS MODELLING HOT SM; Weinert D. W., 2002, FIR SAF SCI P 7 INT, P209; Wu WW, 2017, J LOSS PREVENT PROC, V49, P299, DOI 10.1016/j.jlp.2017.07.012	40	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220700	10.1371/journal.pone.0220700	http://dx.doi.org/10.1371/journal.pone.0220700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374105	gold, Green Published, Green Submitted			2022-12-27	WOS:000484991500027
J	Absi, M; Eid, BG; Ashton, N; Hart, G; Gurney, AM				Absi, Mais; Eid, Basma G.; Ashton, Nick; Hart, George; Gurney, Alison M.			Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE; RHO-KINASES; RAT; INHIBITION; HYPERTENSION; STATINS; CELLS; ECHOCARDIOGRAPHY; SENSITIZATION	Simvastatin reduces pulmonary arterial pressure and right ventricular hypertrophy in animal models of pulmonary arterial hypertension (PAH) and is thought to restore endothelial dysfunction. In vivo effects of drugs are complicated by several factors and little is known of the direct effects of statins on pulmonary arteries. This study investigated the direct effects of simvastatin on pulmonary arteries isolated from rats with or without monocrotaline-induced PAH. Simvastatin suppressed contractions evoked by the thromboxane A2 receptor agonist U46619 (30 nM), the alpha(1)-adrenergic agonist phenylephrine (5 mu M) and KCl (50 mM) by similar to 50% in healthy and diseased arteries, but did not reduce contraction evoked by sarco/endoplasmic reticulum ATPase blockers. It relaxed hypertensive arteries in the absence of stimulation. Removing the endothelium or inhibiting eNOS did not prevent the inhibition by simvastatin. Inhibiting RhoA/rho kinase (ROCK) with Y27632 (10 mu M) suppressed contractions to U46619 and phenylephrine by similar to 80% and prevented their inhibition by simvastatin. Y27632 reduced KCl-induced contraction by similar to 30%, but did not prevent simvastatin inhibition. Simvastatin suppressed Ca2+ entry into smooth muscle cells, as detected by Mn2+ quench of fura-2 fluorescence. The calcium antagonist, nifedipine (1 mu M), almost abolished K+-induced contraction with less effect against U46619 and phenylephrine. We conclude that simvastatin relaxes pulmonary arteries by acting on smooth muscle to interfere with signalling through G-protein coupled receptors and voltage-dependent Ca2+ entry. Its actions likely include inhibition of ROCK-dependent Ca2+ sensitisation and voltage-gated Ca2+ channels. These are likely to contribute to the beneficial effects of simvastatin in animal models of PAH.	[Absi, Mais; Eid, Basma G.; Ashton, Nick; Hart, George; Gurney, Alison M.] Univ Manchester, Fac Biol Med & Hlth, Core Technol Facil Level, Manchester, Lancs, England; [Absi, Mais] Kings Coll London, Cardiovasc Sci, London, England; [Eid, Basma G.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah, Saudi Arabia	University of Manchester; University of London; King's College London; King Abdulaziz University	Gurney, AM (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Core Technol Facil Level, Manchester, Lancs, England.	Alison.gurney@manchester.ac.uk		Ashton, Nicholas/0000-0002-3579-8804; Ashton, Nick/0000-0003-3366-1617	British Heart Foundation [PG/14/22/30714]; European Respiratory Society; King Abdulaziz University; Saudi Ministry of Higher Education	British Heart Foundation(British Heart Foundation); European Respiratory Society; King Abdulaziz University; Saudi Ministry of Higher Education	This work was supported by: British Heart Foundation, PG/14/22/30714 to AG and GH (www.bhf.org.uk); European Respiratory Society travel grant to MA (www.ersnet.org), King Abdulaziz University (www.kau.edu.sa) and Saudi Ministry of Higher Education (www.moe.gov.sa) scholarship to BE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348; Aoki C, 2012, INT J CARDIOL, V156, P55, DOI 10.1016/j.ijcard.2010.10.029; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bergdahl A, 2003, PHARMACOL TOXICOL, V93, P128, DOI 10.1034/j.1600-0773.2003.930304.x; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; CLAPP LH, 1991, EXP PHYSIOL, V76, P677, DOI 10.1113/expphysiol.1991.sp003535; CLAPP LH, 1991, PFLUG ARCH EUR J PHY, V418, P462, DOI 10.1007/BF00497774; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Dhaliwal JS, 2007, AM J PHYSIOL-LUNG C, V293, pL1306, DOI 10.1152/ajplung.00189.2007; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Girgis RE, 2003, AM J PHYSIOL-HEART C, V285, pH938, DOI 10.1152/ajpheart.01097.2002; Ito KM, 2000, AM J PHYSIOL-HEART C, V279, pH1786, DOI 10.1152/ajpheart.2000.279.4.H1786; Jernigan NL, 2014, MICROCIRCULATION, V21, P259, DOI 10.1111/micc.12096; Kang S, 2014, TOXICOL SCI, V138, P446, DOI 10.1093/toxsci/kfu011; Khalil RA, 2010, C SERIES INTEGRATED, DOI [10.4199/c00012ed1v01y201005isp007, DOI 10.4199/C00012ED1V01Y201005ISP007]; Knipe RS, 2015, PHARMACOL REV, V67, P103, DOI 10.1124/pr.114.009381; Koskenvuo JW, 2010, INT J CARDIOVAS IMAG, V26, P509, DOI 10.1007/s10554-010-9596-1; Laufs U, 1997, J BIOL CHEM, V272, P31725, DOI 10.1074/jbc.272.50.31725; Li XL, 2012, J CARDIOVASC PHARM, V60, P219, DOI 10.1097/FJC.0b013e31825cce63; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; Mraiche F, 2005, BRIT J PHARMACOL, V144, P715, DOI 10.1038/sj.bjp.0706114; Muck W, 2000, CLIN PHARMACOKINET, V39, P99; Nagaoka T, 2004, AM J PHYSIOL-LUNG C, V287, pL665, DOI 10.1152/ajplung.00050.2003; Nakagami H, 2003, ANN MED, V35, P398, DOI 10.1080/07853890310001294; Ng LC, 2001, CIRC RES, V89, P923, DOI 10.1161/hh2201.100315; NG LL, 1994, CIRC RES, V74, P173, DOI 10.1161/01.RES.74.2.173; Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37; Oesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537; OKA M, 1993, AM J PHYSIOL, V264, pL587, DOI 10.1152/ajplung.1993.264.6.L587; Omori H, 2002, BRIT J CLIN PHARMACO, V54, P395, DOI 10.1046/j.1365-2125.2002.01677.x; Robertson TP, 2000, BRIT J PHARMACOL, V131, P5, DOI 10.1038/sj.bjp.0703537; Rossoni LV, 2011, CLIN SCI, V121, P449, DOI 10.1042/CS20110259; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Steeds RP, 1997, BRIT J PHARMACOL, V122, P99, DOI 10.1038/sj.bjp.0701356; Taraseviciene-Stewart L, 2006, AM J PHYSIOL-LUNG C, V291, pL668, DOI 10.1152/ajplung.00491.2005; Temple IP, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.115.003432; Tennakoon M, 2019, MOL PHARMACOL, V95, P361, DOI 10.1124/mol.118.114710; Tesfamariam B, 1999, J CARDIOVASC PHARM, V34, P95, DOI 10.1097/00005344-199907000-00016; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Urboniene D, 2010, AM J PHYSIOL-LUNG C, V299, pL401, DOI 10.1152/ajplung.00114.2010; Vaquero M, 2007, J MOL CELL CARDIOL, V42, P931, DOI 10.1016/j.yjmcc.2007.03.807; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; WANSTALL JC, 1995, BRIT J PHARMACOL, V114, P109, DOI 10.1111/j.1476-5381.1995.tb14913.x; Yada T, 1999, BRIT J PHARMACOL, V126, P1205, DOI 10.1038/sj.bjp.0702397; Yi SL, 2006, FREE RADICAL BIO MED, V41, P942, DOI 10.1016/j.freeradbiomed.2006.05.035; Zhao L, 2009, EUR RESPIR J, V34, P948, DOI 10.1183/09031936.00143508	48	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220473	10.1371/journal.pone.0220473	http://dx.doi.org/10.1371/journal.pone.0220473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369604	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900053
J	Antol, A; Rojek, W; Singh, S; Piekarski, D; Czarnoleski, M				Antol, Andrzej; Rojek, Wiktoria; Singh, Sanjeev; Piekarski, Damian; Czarnoleski, Marcin			Hypoxia causes woodlice (Porcellio scaber) to select lower temperatures and impairs their thermal performance and heat tolerance	PLOS ONE			English	Article							OXYGEN LIMITATION; TERRESTRIAL ISOPODS; CLIMATE-CHANGE; CRUSTACEA; PHYSIOLOGY; ARTHROPOD; LIMITS; METABOLISM; ADAPTATION; LOCOMOTION	Environmental temperatures and oxygen availability are important for the balance between oxygen supply and demand. Terrestrial organisms are generally perceived to be less limited by access to oxygen than their aquatic counterparts. Nevertheless, even terrestrial environments can be deficient in oxygen, especially for organisms occurring in soil, litter, wood, rotten fruit or at high elevations. While isopods are the best adapted to a terrestrial lifestyle among crustaceans, many species, including woodlice, occupy environmental gradients of temperature and oxygen. To investigate whether mismatches between oxygen supply and demand can result in a loss of performance in a terrestrial organism, we studied the effects of atmospheric oxygen concentration on the thermal performance of the common rough woodlouse (Porcellio scaber). We compared the thermal preference, thermal sensitivity of running speed, and tolerance to extreme temperatures of woodlice exposed to one of two oxygen concentrations (21% - normoxia, 7% - hypoxia). Under hypoxia, P. scaber preferred microhabitats with temperatures that were on average 3 degrees C lower than those preferred under normoxia. The running speed tended to reach its maximum at a lower temperature under hypoxia than under normoxia (25.13 degrees C vs 28.87 degrees C, respectively, although p was equal to 0.09), and normoxic woodlice ran approximately 1.5-fold faster than hypoxic woodlice at the point of maximum speed. Heat tolerance was significantly lower under hypoxia (38.9 degrees C) than under normoxia (40.7 degrees C), but there was no difference in cold tolerance (5.81 degrees C under normoxia and 5.44 degrees C under hypoxia). Overall, our results indicate that environmental gradients of temperature and oxygen may shape the physiological performance of terrestrial ectotherms, likely via their effects on the balance between oxygen supply and demand, which may have fitness consequences for these organisms in nature.	[Antol, Andrzej; Rojek, Wiktoria; Singh, Sanjeev; Piekarski, Damian; Czarnoleski, Marcin] Jagiellonian Univ, Inst Environm Sci, Ul Gronostajowa, Krakow, Poland	Jagiellonian University	Antol, A (corresponding author), Jagiellonian Univ, Inst Environm Sci, Ul Gronostajowa, Krakow, Poland.	andrzejantol@gmail.com	Czarnoleski, Marcin/H-2893-2015; Antoł, Andrzej/W-6110-2019	Czarnoleski, Marcin/0000-0003-2645-0360; Antoł, Andrzej/0000-0002-9730-7417; Rojek, Wiktoria/0000-0003-1300-5372	National Science Center in Poland [ETIUDA 2018/28/T/NZ8/00217]; NSC research grant [OPUS 2016/21/B/NZ8/00303]; Jagiellonian University [DS/WBiNoZ/INoS/757/2018, DS/MND/WBiNoZ/INoS/3/2016]	National Science Center in Poland(National Science Centre, Poland); NSC research grant; Jagiellonian University	AA was supported by a doctoral stipend provided by the National Science Center in Poland (ETIUDA 2018/28/T/NZ8/00217). MC and the conceptual part of the study were supported by an NSC research grant (OPUS 2016/21/B/NZ8/00303). Additional funds were provided by Jagiellonian University (DS/WBiNoZ/INoS/757/2018 and DS/MND/WBiNoZ/INoS/3/2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Antol A, 2018, J ETHOL, V36, P199, DOI 10.1007/s10164-018-0540-5; Atkinson D, 2006, EVOL DEV, V8, P202, DOI 10.1111/j.1525-142X.2006.00090.x; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Beron P., 2008, HIGH ALTITUDE ISOPOD; Boardman L, 2015, J EXP BIOL, V218, P1677, DOI 10.1242/jeb.120261; Broly P, 2013, EVOL ECOL, V27, P461, DOI 10.1007/s10682-012-9625-8; Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006; Cadena V, 2009, J EXP BIOL, V212, P137, DOI 10.1242/jeb.023531; Carbines GD., 1992, INT J COMP PSYCHOL, V5, P138; Castaneda LE, 2005, J INSECT PHYSIOL, V51, P1346, DOI 10.1016/j.jinsphys.2005.08.005; Castaneda LE, 2004, EVOL ECOL RES, V6, P579; Clark TD, 2013, J EXP BIOL, V216, P2771, DOI 10.1242/jeb.084251; Csonka D, 2013, ARTHROPOD STRUCT DEV, V42, P229, DOI 10.1016/j.asd.2013.01.002; Currie RJ, 1998, ENVIRON BIOL FISH, V51, P187, DOI 10.1023/A:1007447417546; Czarnoleski M, 2005, EVOL ECOL RES, V7, P821; Czarnoleski M, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00024.1; Dailey TM, 2009, COMP BIOCHEM PHYS A, V153, P162, DOI 10.1016/j.cbpa.2009.02.005; DuBois PM, 2017, J THERM BIOL, V68, P170, DOI 10.1016/j.jtherbio.2017.02.008; Fox J, 2018, J STAT SOFTW, V87, P1, DOI 10.18637/jss.v087.i09; Gudowska A, 2018, J INSECT PHYSIOL, V107, P7, DOI 10.1016/j.jinsphys.2018.02.004; Gudowska A, 2017, J THERM BIOL, V68, P89, DOI 10.1016/j.jtherbio.2016.11.009; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; HICKS JW, 1985, AM J PHYSIOL, V248, pR595, DOI 10.1152/ajpregu.1985.248.5.R595; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hoefnagel KN, 2015, J THERM BIOL, V54, P56, DOI 10.1016/j.jtherbio.2014.12.003; Hornung Elisabeth, 2011, Terrestrial Arthropod Reviews, V4, P95, DOI 10.1163/187498311X576262; Horvathova T, 2017, J EXP BIOL, V220, P1563, DOI 10.1242/jeb.156661; Jumbam KR, 2008, J INSECT PHYSIOL, V54, P1008, DOI 10.1016/j.jinsphys.2008.03.011; Klok CJ, 2004, J EXP BIOL, V207, P2361, DOI 10.1242/jeb.01023; Kozlowski J, 2004, INTEGR COMP BIOL, V44, P480, DOI 10.1093/icb/44.6.480; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; Lighton JRB, 2007, J THERM BIOL, V32, P134, DOI 10.1016/j.jtherbio.2007.01.009; Lins LSF, 2017, ORG DIVERS EVOL, V17, P813, DOI 10.1007/s13127-017-0346-2; Neven LG, 2014, J THERM BIOL, V42, P9, DOI 10.1016/j.jtherbio.2014.02.017; PAIM U, 1964, CAN J ZOOLOG, V42, P59, DOI 10.1139/z64-006; Peacock AJ, 1998, BRIT MED J, V317, P1063; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; POLLARD SD, 1995, ETHOL ECOL EVOL, V7, P271, DOI 10.1080/08927014.1995.9522957; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; R Core Team, 2018, R LANG ENV STAT COMP; Schmalfuss H., 2003, STUTTGARTER BEITR A, V654, P341; Schmidt C, 2001, ACTA ZOOL-STOCKHOLM, V82, P315, DOI 10.1046/j.1463-6395.2001.00092.x; Schuler MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020905; SCHURMANN H, 1992, J FISH BIOL, V41, P927, DOI 10.1111/j.1095-8649.1992.tb02720.x; SCHURMANN H, 1991, J EXP BIOL, V157, P75; Sepulveda R, 2014, J ARACHNOL, V42, P299, DOI 10.1636/B13-87.1; Stevens MM, 2010, J EXP BIOL, V213, P2209, DOI 10.1242/jeb.040170; SUNDERLAND KD, 1980, J ANIM ECOL, V49, P987, DOI 10.2307/4240; Verberk WCEP, 2013, INTEGR COMP BIOL, V53, P609, DOI 10.1093/icb/ict015; Verberk WCEP, 2018, FUNCT ECOL, V32, P926, DOI 10.1111/1365-2435.13050; Verberk WCEP, 2016, COMP BIOCHEM PHYS A, V192, P64, DOI 10.1016/j.cbpa.2015.10.020; Verberk WCEP, 2015, J EXP BIOL, V218, P2083, DOI 10.1242/jeb.119560; Verberk WCEP, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0473; Verberk WCEP, 2013, FUNCT ECOL, V27, P1275, DOI 10.1111/1365-2435.12152; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Walczynska A, 2015, J THERM BIOL, V54, P78, DOI 10.1016/j.jtherbio.2014.11.002; Wang YJ, 2010, MAR BIOL, V157, P747, DOI 10.1007/s00227-009-1358-z; Ward P, 2006, P NATL ACAD SCI USA, V103, P16818, DOI 10.1073/pnas.0607824103; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wood SC, 1996, COMP BIOCHEM PHYS B, V113, P37, DOI 10.1016/0305-0491(95)02045-4; Wright JC, 2006, COMP BIOCHEM PHYS A, V145, P235, DOI 10.1016/j.cbpa.2006.06.020	63	10	10	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220647	10.1371/journal.pone.0220647	http://dx.doi.org/10.1371/journal.pone.0220647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369635	gold, Green Published, Green Submitted			2022-12-27	WOS:000484987900075
J	Choi, B; Crisp, MD; Cook, LG; Meusemann, K; Edwards, RD; Toon, A; Kulheim, C				Choi, Bokyung; Crisp, Michael D.; Cook, Lyn G.; Meusemann, Karen; Edwards, Robert D.; Toon, Alicia; Kulheim, Carsten			Identifying genetic markers for a range of phylogenetic utility-From species to family level	PLOS ONE			English	Article							MODEL SELECTION; NUCLEAR LOCI; DNA; MYRTACEAE; TREE; ENRICHMENT; ALGORITHM; EVOLUTION; SEQUENCES; EUCALYPTS	Resolving the phylogenetic relationships of closely related species using a small set of loci is challenging as sufficient information may not be captured from a limited sample of the genome. Relying on few loci can also be problematic when conflict between gene-trees arises from incomplete lineage sorting and/or ongoing hybridization, problems especially likely in recently diverged lineages. Here, we developed a method using limited genomic resources that allows identification of many low copy candidate loci from across the nuclear and chloroplast genomes, design probes for target capture and sequence the captured loci. To validate our method we present data from Eucalyptus and Melaleuca, two large and phylogenetically problematic genera within the Myrtaceae family. With one annotated genome, one transcriptome and two whole-genome shotgun sequences of one Eucalyptus and four Melaleuca species, respectively, we identified 212 loci representing 263 kbp for targeted sequence capture and sequencing. Of these, 209 were successfully tested from 47 samples across five related genera of Myrtaceae. The average percentage of reads mapped back to the reference was 57.6% with coverage of more than 20 reads per position across 83.5% of the data. The methods developed here should be applicable across a large range of taxa across all kingdoms. The core methods are very flexible, providing a platform for various genomic resource availabilities and are useful from shallow to deep phylogenies.	[Choi, Bokyung; Crisp, Michael D.; Kulheim, Carsten] Australian Natl Univ, Res Sch Biol, Div Ecol & Evolut, Canberra, ACT, Australia; [Cook, Lyn G.; Edwards, Robert D.; Toon, Alicia] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Meusemann, Karen] Univ Freiburg, Inst Biol, Evolutionary Biol & Ecol, Freiburg, Germany; [Meusemann, Karen] CSIRO, Australian Natl Inset Collect, Natl Res Collect Australia, Canberra, ACT, Australia; [Edwards, Robert D.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kulheim, Carsten] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Australian National University; University of Queensland; University of Freiburg; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan Technological University	Kulheim, C (corresponding author), Australian Natl Univ, Res Sch Biol, Div Ecol & Evolut, Canberra, ACT, Australia.; Kulheim, C (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	ckulheim@mtu.edu	Cook, Lyn/G-7336-2012; Kulheim, Carsten/AAR-2734-2021	Cook, Lyn/0000-0002-3172-4920; Edwards, Robert/0000-0002-4993-2453; Kulheim, Carsten/0000-0002-0798-3324	Australian Research Council [DP130101141]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council (https://www.arc.gov.au/) grant to LGC and MDC (DP130101141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Akhani H, 2013, BOT J LINN SOC, V171, P519, DOI 10.1111/boj.12015; Bayly MJ, 2013, MOL PHYLOGENET EVOL, V69, P704, DOI 10.1016/j.ympev.2013.07.006; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; Biffin E, 2007, MOL PHYLOGENET EVOL, V43, P124, DOI 10.1016/j.ympev.2006.08.013; Boekhorst J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-356; Bragg JG, 2016, MOL ECOL RESOUR, V16, P1059, DOI 10.1111/1755-0998.12449; Chernomor O, 2016, SYST BIOL, V65, P997, DOI 10.1093/sysbio/syw037; Cook LG, 2008, MOL PHYLOGENET EVOL, V47, P506, DOI 10.1016/j.ympev.2008.02.012; Craven LA, 2014, TAXON, V63, P663, DOI 10.12705/633.38; Crisp MD, 2012, NATURE COMM, V2, P193; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; Edwards RD, 2010, TAXON, V59, P744, DOI 10.1002/tax.593007; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; Hsieh JF, 2018, PHYTOPATHOLOGY, V108, P495, DOI 10.1094/PHYTO-09-17-0307-R; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jermiin LS, 2004, SYST BIOL, V53, P638, DOI 10.1080/10635150490468648; Kadlec M, 2017, PEERJ, V5, DOI 10.7717/peerj.3569; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Klopfstein S, 2017, SYST BIOL, V66, P769, DOI 10.1093/sysbio/syx051; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lemmon AR, 2012, SYST BIOL, V61, P745, DOI 10.1093/sysbio/sys051; Lemmon EM, 2013, ANNU REV ECOL EVOL S, V44, P99, DOI 10.1146/annurev-ecolsys-110512-135822; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lucas EJ, 2007, TAXON, V56, P1105, DOI 10.2307/25065906; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Myburg AA, 2013, NATURE; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Paiva JAP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-137; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Penalba JV, 2014, MOL ECOL RESOUR, V14, P1000, DOI 10.1111/1755-0998.12249; Portik DM, 2016, MOL ECOL RESOUR, V16, P1069, DOI 10.1111/1755-0998.12541; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Schmickl R, 2016, MOL ECOL RESOUR, V16, P1124, DOI 10.1111/1755-0998.12487; Schuster TM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195034; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Smith DR, 2015, GENOME BIOL EVOL, V7, P1227, DOI 10.1093/gbe/evv069; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tekaia F, 2016, GENOMICS INSIGHTS, V9, DOI [10.4137/gei.s37925, DOI 10.4137/GEI.S37925]; Thornhill AH, 2019, AUST SYST BOT, V32, P29, DOI 10.1071/SB18015; Thornhill AH, 2015, MOL PHYLOGENET EVOL, V93, P29, DOI 10.1016/j.ympev.2015.07.007; Thornhill AH, 2012, AUST SYST BOT, V25, P171, DOI 10.1071/SB11019; Tonnabel J, 2014, MOL PHYLOGENET EVOL, V70, P37, DOI 10.1016/j.ympev.2013.07.027; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Weitemier K, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400042; Wilson PG, 2001, AM J BOT, V88, P2013, DOI 10.2307/3558428; Xiang QP, 2015, MOL PHYLOGENET EVOL, V82, P1, DOI 10.1016/j.ympev.2014.10.008; Zhu WD, 2013, BOT J LINN SOC, V171, P377, DOI 10.1111/j.1095-8339.2012.01318.x	66	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218995	10.1371/journal.pone.0218995	http://dx.doi.org/10.1371/journal.pone.0218995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369563	Green Published, gold			2022-12-27	WOS:000484987900012
J	Navarro-Torres, A; Alastruey-Benede, J; Ibanez-Marin, P; Vinals-Yufera, V				Navarro-Torres, Agustin; Alastruey-Benede, Jesus; Ibanez-Marin, Pablo; Vinals-Yufera, Victor			Memory hierarchy characterization of SPEC CPU2006 and SPEC CPU2017 on the Intel Xeon Skylake-SP	PLOS ONE			English	Article								SPEC CPU is one of the most common benchmark suites used in computer architecture research. CPU2017 has recently been released to replace CPU2006. In this paper we present a detailed evaluation of the memory hierarchy performance for both the CPU2006 and single-threaded CPU2017 benchmarks. The experiments were executed on an Intel Xeon Skylake-SP, which is the first Intel processor to implement a mostly non-inclusive last-level cache (LLC). We present a classification of the benchmarks according to their memory pressure and analyze the performance impact of different LLC sizes. We also test all the hardware prefetchers showing they improve performance in most of the benchmarks. After comprehensive experimentation, we can highlight the following conclusions: i) almost half of SPEC CPU benchmarks have very low miss ratios in the second and third level caches, even with small LLC sizes and without hardware prefetching, ii) overall, the SPEC CPU2017 benchmarks demand even less memory hierarchy resources than the SPEC CPU2006 ones, iii) hardware prefetching is very effective in reducing LLC misses for most benchmarks, even with the smallest LLC size, and iv) from the memory hierarchy standpoint the methodologies commonly used to select benchmarks or simulation points do not guarantee representative workloads.	[Navarro-Torres, Agustin; Alastruey-Benede, Jesus; Ibanez-Marin, Pablo; Vinals-Yufera, Victor] Univ Zaragoza, Dept Informat & Ingn Sistemas, Aragon Inst Engn Res I3A, Zaragoza, Spain	University of Zaragoza	Alastruey-Benede, J (corresponding author), Univ Zaragoza, Dept Informat & Ingn Sistemas, Aragon Inst Engn Res I3A, Zaragoza, Spain.	jalastru@unizar.es	Ibáñez, Pablo/F-4214-2016; Alastruey-Benedé, Jesús/AAA-1773-2019	Ibáñez, Pablo/0000-0002-5916-7898; Alastruey-Benedé, Jesús/0000-0003-4164-5078; Navarro Torrres, Agustin/0000-0002-3556-2244	Agencia Estatal de Investigacion [TIN2016-76635-C2-1-R]; European Regional Development Fund (ERDF); Aragon Goverment [gaZ: T58_17R]; European Social Fund (ESF)	Agencia Estatal de Investigacion; European Regional Development Fund (ERDF)(European Commission); Aragon Goverment; European Social Fund (ESF)(European Social Fund (ESF))	All authors acknowledge support in part from grants (1) TIN2016-76635-C2-1-R from Agencia Estatal de Investigacion (AEI, http://www.ciencia.gob.es/portal/site/MICINN/aei) and European Regional Development Fund (ERDF, https://ec.europa.eu/regional_policy/en/funding/erdf/), and (2) gaZ: T58_17R research group from Aragon Goverment (http://www.aragon.es/) and European Social Fund (ESF, http://ec.europa.eu/esf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests:	Cook Jeanine, 2011, Performance Evaluation Review, V38, P75, DOI 10.1145/1964218.1964231; Corporation SPE, SPEC CPU BENCHM SUIT; De Melo A. C, 2010, LIN K, V18; Falk H, 2016, TACLEBENCH BENCHMARK, V55; Ferdman M, 2012, ACM SIGPLAN NOTICES, V47, P37, DOI 10.1145/2248487.2150982; Hennessy J. L., 2017, COMPUTER ARCHITECTUR, V6th; Jain A, 2016, CONF PROC INT SYMP C, P78, DOI 10.1109/ISCA.2016.17; Jaleel A., 2010, MEMORY CHARACTERIZAT; Kanter D., 2017, MICROPROCESSOR REPOR, P6; Korn W., 2007, Computer Architecture News, V35, P97, DOI 10.1145/1241601.1241620; Kumar T, ISAST T COMPUT SOFTW, V2, P36; Limaye A, 2018, INT SYM PERFORM ANAL, P149, DOI 10.1109/ISPASS.2018.00028; McCurdy C., 2005, SIGARCH COMPUT ARCHI, V33, P39, DOI [10.1145/1127577.1127586, DOI 10.1145/1127577.1127586]; Panda R, 2018, INT S HIGH PERF COMP, P271, DOI 10.1109/HPCA.2018.00032; Perelman E., 2003, Performance Evaluation Review, V31, P318, DOI 10.1145/885651.781076; Wenisch TF, 2006, IEEE MICRO, V26, P18, DOI 10.1109/MM.2006.79	16	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220135	10.1371/journal.pone.0220135	http://dx.doi.org/10.1371/journal.pone.0220135			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369592	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900029
J	Fronteau, C; Pare, M; Benoit, P; Tollec, S; Hamon, C; Schwiertz, V; Maillarce, C; Cransac, A; Volteau, C; Huon, JF; Burgeot, V; Tching-Sin, M; Guerin, C; Flet, L				Fronteau, Clementine; Pare, Maxime; Benoit, Philippe; Tollec, Sophie; Hamon, Catherine; Schwiertz, Verane; Maillarce, Christian; Cransac, Amelie; Volteau, Christelle; Huon, Jean-Francois; Burgeot, Veronique; Tching-Sin, Martine; Guerin, Corinne; Flet, Laurent			What do adult outpatients included in clinical trials know about the investigational drugs being assessed: A cross-sectional study in France	PLOS ONE			English	Article							INFORMED-CONSENT; MEDICATION ADHERENCE; PATIENT KNOWLEDGE; LITERACY; COMPREHENSION; PARTICIPANTS; INFORMATION	This study aimed to assess patient investigational medication knowledge and to identify factors associated with medication understanding by adult outpatients included in clinical trials. A cross-sectional prospectively designed survey was conducted on consecutive volunteers at 21 university teaching hospitals (in France) from February to December 2014. Investigational medication understanding was assessed at the time of the first dispensing using a structured interviewer-administered questionnaire based on information obtained from the literature that provided an 8-point score. Demographic and other baseline data were collected using structured interviews. Of the 236 participants, 139 (58.9%) of the respondents were male, and the median age was 54.9 years (range: 18-83 years). The mean understanding score was 6.24 and 72.5% of the patients had a score of 6 or higher. In univariate analysis, the medication understanding score was negatively correlated with age (r = -0.15, p = 0.0247) and positively correlated with the level of education (r = 0.25, p = 0.0002). In multivariate analysis, prognostic factors of a higher medication understanding score were: graduation from high school or a higher level of education; HIV infection; phase II/III/IV studies; mention of the drug on the prescription form, and the dispensing of a single investigational medication. Only a quarter of the adult outpatients included in clinical trials had a maximum possible investigational medication understanding score. Being old and having a low level of education were found to be important risk factors for inadequate medication understanding. This and other data suggest that sponsors should encourage initiatives aimed at improving investigational medication understanding in adults enrolled in clinical trials.	[Fronteau, Clementine; Pare, Maxime; Huon, Jean-Francois; Burgeot, Veronique; Tching-Sin, Martine; Flet, Laurent] Nantes Univ Hosp, Dept Pharm, Nantes, France; [Benoit, Philippe] Reims Univ Hosp, Dept Pharm, Reims, France; [Tollec, Sophie] Orleans Reg Hosp, Dept Pharm, Orleans, France; [Hamon, Catherine] Rennes Univ Hosp, Dept Pharm, Rennes, France; [Schwiertz, Verane] Hosp Civils Lyon, Dept Pharm, Lyon, France; [Maillarce, Christian] Nimes Univ Hosp, Dept Pharm, Nimes, France; [Cransac, Amelie] Dijon Univ Hosp, Dept Pharm, Dijon, France; [Cransac, Amelie] LNC UMR1231, Dijon, France; [Volteau, Christelle] Nantes Univ Hosp, Clin Res Unit, Nantes, France; [Huon, Jean-Francois] Nantes Univ, EA3826 Lab, Nantes, France; [Huon, Jean-Francois] Nantes Univ, UFR Sci Pharmaceut, Nantes, France; [Guerin, Corinne] Cochin Hosp, AP HP, Dept Pharm, Paris, France	Nantes Universite; CHU de Nantes; CHU de Reims; Universite de Reims Champagne-Ardenne; Centre Hospitalier Regional d'Orleans; CHU Rennes; Universite de Rennes; CHU Lyon; Universite de Montpellier; CHU de Nimes; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Flet, L (corresponding author), Nantes Univ Hosp, Dept Pharm, Nantes, France.	laurent.flet@chu-nantes.fr	CRANSAC, Amélie/AAH-5651-2020; FLET, Laurent/X-1192-2019; HUON, Jean-François/GYJ-3989-2022	CRANSAC, Amélie/0000-0003-1836-2619; FLET, Laurent/0000-0001-8305-7085; 	University Hospital of Nantes	University Hospital of Nantes	The authors wish to thank: (i) all of the participants who volunteered to participate in this survey; (ii) the COMQUEST team: Valerie Daniel, Francoise Renon-Caron, Marie-Claude Saux, Stephanie Tamisier, Audrey Castet-Nicolas, Christine Pivot, Isabelle Princet, Anne HuttClauss, Pierre Chauvet, Anne-Marie Caminondo, Isabelle Madelaine, Melanie Dumas, and Maxime Lebeaupin. The regulatory and ethics submissions for this work were sponsored by the University Hospital of Nantes.	Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Bergenmar M, 2011, CLIN TRIALS, V8, P77, DOI 10.1177/1740774510384516; Breckenridge A, 2017, NAT REV DRUG DISCOV, V16, P149, DOI 10.1038/nrd.2017.1; Burge S, 2005, FAM MED, V37, P712; Burkhart PV, 2003, J NURS SCHOLARSHIP, V35, P207; Cameron P, 2013, CURR ONCOL, V20, pE193, DOI 10.3747/co.20.1323; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; Davis TC, 2009, J GEN INTERN MED, V24, P57, DOI 10.1007/s11606-008-0833-4; Dollinger C, 2016, INT J QUAL HEALTH C, V28, P311, DOI 10.1093/intqhc/mzw025; Falagas ME, 2009, AM J SURG, V198, P420, DOI 10.1016/j.amjsurg.2009.02.010; Delgado PG, 2009, ATEN PRIM, V41, P661, DOI 10.1016/j.aprim.2009.03.011; MacLaughlin EJ, 2005, DRUG AGING, V22, P231, DOI 10.2165/00002512-200522030-00005; Marvanova M, 2011, J HOSP MED, V6, P488, DOI 10.1002/jhm.925; Mexas F, 2014, CLIN TRIALS, V11, P70, DOI 10.1177/1740774513509316; Mohan A, 2014, AM J MANAG CARE, V20, pE547; Ng AWY, 2017, APPL ERGON, V58, P167, DOI 10.1016/j.apergo.2016.06.005; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; Pentz RD, 2012, CANCER-AM CANCER SOC, V118, P4571, DOI 10.1002/cncr.27397; Shrank W, 2007, ANN PHARMACOTHER, V41, P783, DOI 10.1345/aph.1H582; SPANDORFER JM, 1995, ANN EMERG MED, V25, P71, DOI 10.1016/S0196-0644(95)70358-6; Wolf MS, 2007, PATIENT EDUC COUNS, V67, P293, DOI 10.1016/j.pec.2007.03.024; Zheng F, 2017, J INT MED RES, V45, P303, DOI 10.1177/0300060516676726	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220383	10.1371/journal.pone.0220383	http://dx.doi.org/10.1371/journal.pone.0220383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5HO	31408456	Green Published, gold, Green Submitted			2022-12-27	WOS:000485009500014
J	Ndikumana, A; Ullah, A; Kim, D; Hong, CS				Ndikumana, Anselme; Ullah, Aeed; Kim, Do Hyeon; Hong, Choong Seon			DeepAuC: Joint deep learning and auction for congestion-aware caching in Named Data Networking	PLOS ONE			English	Article							MECHANISM	Over the last few decades, the Internet has experienced tremendous growth in data traffic. This continuous growth due to the increase in the number of connected devices and platforms has dramatically boosted content consumption. However, retrieving content from the servers of Content Providers (CPs) can increase network traffic and incur high network delay and congestion. To address these challenges, we propose a joint deep learning and auction-based approach for congestion-aware caching in Named Data Networking (NDN), which aims to prevent congestion and minimize the content downloading delays. First, using recorded network traffic data on the Internet Service Provider (ISP) network, we propose a deep learning model to predict future traffic over transit links. Second, to prevent congestion and avoid high latency on transit links, which may experience congestion in the future; we propose a caching model that helps the ISP to cache content that has a high predicted future demand. Paid-content requires payment to be downloaded and cached. Therefore, we propose an auction mechanism to obtain paid-content at an optimal price. The simulation results show that our proposal prevents congestion and increases the profits of both ISPs and CPs.	[Ndikumana, Anselme; Ullah, Aeed; Kim, Do Hyeon; Hong, Choong Seon] Kyung Hee Univ, Dept Comp Sci & Engn, Yongin, Gyeonggi Do, South Korea	Kyung Hee University	Hong, CS (corresponding author), Kyung Hee Univ, Dept Comp Sci & Engn, Yongin, Gyeonggi Do, South Korea.	cshong@khu.ac.kr	Ndikumana, Anselme/W-8289-2018; Hong, Choong Seon/ABF-5527-2020	Ndikumana, Anselme/0000-0003-3328-3695; Hong, Choong Seon/0000-0003-3484-7333; Ullah, Saeed/0000-0001-8946-7640	MSIT (Ministry of Science and ICT), Korea, under the Grand Information Technology Research Center support program [IITP-2018-2015-0-00742]; IITP grant - Korea MSIT [2019-001287]	MSIT (Ministry of Science and ICT), Korea, under the Grand Information Technology Research Center support program; IITP grant - Korea MSIT	This research was supported by the MSIT (Ministry of Science and ICT), Korea, under the Grand Information Technology Research Center support program (IITP-2018-2015-0-00742) supervised by the IITP (Institute for Information & communications Technology Promotion) and IITP grant funded by the Korea MSIT (No. 2019-001287, Evolvable Deep Learning Model Generation Platform for Edge Computing).	Alom M.Z., 2018, 180301164 ARXIV; [Anonymous], 2017, P GLOBECOM IEEE GLOB; [Anonymous], 2018, ARXIV181001548; Araldo A, 2016, IEEE T PARALL DISTR, V27, P1316, DOI 10.1109/TPDS.2015.2433296; Aubr E., 2015, P 1 IEEE C NETW SOFT, P1, DOI DOI 10.1109/NETSOFT.2015.7116130; Azzouni A., 2017, ARXIV171006799; Blumrosen L., 2007, ALGORITHMIC GAME THE, V267, P300; Bruck P. A, 2006, E CONTENT TECHNOLOGI; Caminati M., 2015, VICKREY CLARKE GROVE; Chavoosh Ghasemi K.G.S., 2018, P IEEE C COMP COMM W, P1; Chollet F, 2018, ASTROPHYS SOURCE COD, P1806; Cui Y, 2016, P IEEE GLOB COMM C G, P1; DANTE C, UK GEANT TOPOLOGY; Evans D., INTERNET THINGS NEXT; Giustolisi O, 2005, HYDROLOG SCI J, V50, P439, DOI 10.1623/hysj.50.3.439.65025; Gurvich V, 1999, DISCRETE APPL MATH, V97, P363, DOI 10.1016/S0166-218X(99)00099-2; Hannay Alastair., 2014, CONCEPT ANXIETY; Kamiyama N, 2015, IEEE T NETW SERV MAN, V12, P176, DOI 10.1109/TNSM.2015.2432011; Kesidis G., 2012, IEEE International Conference on Communications (ICC 2012), P2785, DOI 10.1109/ICC.2012.6364113; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Kocak F, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P45, DOI 10.1109/SocialCom.2013.13; Kreuzer E., 2002, US Patent App, Patent No. [10/219,958, 10219958]; Luce L., 2019, ARTIFICIAL INTELLIGE, P155; Ma R. T., 2015, P 11 ACM C EM NETW E, P8; Mahdian M, 2016, PROCEEDINGS OF THE 2016 3RD ACM CONFERENCE ON INFORMATION-CENTRIC NETWORKING (ACM-ICN '16), P1, DOI 10.1145/2984356.2984365; Mastorakis S., 2016, NDN0028 U CAL DEP CO; Mastorakis S., 2017, ACM COMPUTER COMMUNI; McKinney W., 2011, PYTHON HIGH PERFORMA, P1; Ndikumana A., DEEP CACHE; Ndikumana A., 2016, P 18 IEEE AS PAC NET, P1; Ndikumana A, 2020, IEEE T MOBILE COMPUT, V19, P1359, DOI 10.1109/TMC.2019.2908403; Ndikumana A, 2019, 33RD INTERNATIONAL CONFERENCE ON INFORMATION NETWORKING (ICOIN 2019), P49, DOI 10.1109/ICOIN.2019.8718113; Ndikumana A, 2018, IEEE ACCESS, V6, P33702, DOI 10.1109/ACCESS.2018.2848231; Ndikumana A, 2017, IEEE ACCESS, V5, P27691, DOI 10.1109/ACCESS.2017.2778339; Ndikumana A, 2017, ASIA-PAC NETW OPER M, P366, DOI 10.1109/APNOMS.2017.8094149; Ndikumana A, 2015, ASIA-PAC NETW OPER M, P464, DOI 10.1109/APNOMS.2015.7275367; Norton William. B, 2002, BUSINESS CASE ISP PE; Peng G., 2004, CS0411069 ARXIV; Quan W, 2014, 2014 IFIP NETWORKING CONFERENCE; Quan W, 2014, IEEE COMMUN LETT, V18, P102, DOI 10.1109/LCOMM.2013.112413.132231; Shumway R.H., 2017, TIME SERIES ANAL ITS, P75; Ullah S, 2017, MULTIMED TOOLS APPL, V76, P21519, DOI 10.1007/s11042-016-4008-8; Woeginger Gerhard J, 2003, EXACT ALGORITHMS NP, P185, DOI DOI 10.1007/3-540-36478-1_17; Xu CQ, 2017, COMPUT COMMUN, V99, P93, DOI 10.1016/j.comcom.2016.07.014; Yeh E., 2014, P 1 ACM C INF CTR NE, P117, DOI DOI 10.1145/2660129.2660151; Zhang LX, 2014, ACM SIGCOMM COMP COM, V44, P66, DOI 10.1145/2656877.2656887	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220813	10.1371/journal.pone.0220813	http://dx.doi.org/10.1371/journal.pone.0220813			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408477	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500020
J	Mitrenga, KJ; Alderson-Day, B; May, L; Moffatt, J; Moseley, P; Fernyhough, C				Mitrenga, Kaja Julia; Alderson-Day, Ben; May, Lucy; Moffatt, Jamie; Moseley, Peter; Fernyhough, Charles			Reading characters in voices: Ratings of personality characteristics from voices predict proneness to auditory verbal hallucinations	PLOS ONE			English	Article							MENTAL-IMAGERY; EMOTION RECOGNITION; VOCAL ATTRACTIVENESS; PARANOID THINKING; SCHIZOPHRENIA; PERCEPTION; DISCRIMINATION; CONCLUSIONS; FEATURES; GENDER	People rapidly make first impressions of others, often based on very little information-minimal exposure to faces or voices is sufficient for humans to make up their mind about personality of others. While there has been considerable research on voice personality perception, much less is known about its relevance to hallucination-proneness, despite auditory hallucinations being frequently perceived as personified social agents. The present paper reports two studies investigating the relation between voice personality perception and hallucination-proneness in non-clinical samples. A voice personality perception task was created, in which participants rated short voice recordings on four personality characteristics, relating to dimensions of the voice's perceived Valence and Dominance. Hierarchical regression was used to assess contributions of Valence and Dominance voice personality ratings to hallucination-proneness scores, controlling for paranoia-proneness and vividness of mental imagery. Results from Study 1 suggested that high ratings of voices as dominant might be related to high hallucination-proneness; however, this relation seemed to be dependent on reported levels of paranoid thinking. In Study 2, we show that hallucination-proneness was associated with high ratings of voice dominance, and this was independent of paranoia and imagery abilities scores, both of which were found to be significant predictors of hallucination-proneness. Results from Study 2 suggest an interaction between gender of participants and the gender of the voice actor, where only ratings of own gender voices on Dominance characteristics are related to hallucination-proneness scores. These results are important for understanding the perception of characterful features of voices and its significance for psychopathology.	[Mitrenga, Kaja Julia; Alderson-Day, Ben; Moffatt, Jamie; Moseley, Peter; Fernyhough, Charles] Univ Durham, Dept Psychol, Durham, England; [May, Lucy] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Moffatt, Jamie] Univ Sussex, Sch Psychol, Falmer, England; [Moseley, Peter] Univ Cent Lancashire, Dept Psychol, Preston, Lancs, England	Durham University; University of Reading; University of Sussex; University of Central Lancashire	Mitrenga, KJ (corresponding author), Univ Durham, Dept Psychol, Durham, England.	kaja.j.mitrenga@durham.ac.uk	Fernyhough, Charles/A-1057-2010; Moffatt, Jamie/AAJ-4434-2021	Fernyhough, Charles/0000-0002-3822-710X; Mitrenga, Kaja/0000-0003-0033-9998; Moffatt, Jamie/0000-0003-4778-6066; Moseley, Peter/0000-0002-9284-2509	Wellcome Trust [WT098455, WT108720, WT209513]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by the Wellcome Trust, grants WT098455, WT108720 and WT209513 (https://wellcome.ac.uk/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Ferrara L, 2012, J NERV MENT DIS, V200, P784, DOI 10.1097/NMD.0b013e318266f835; Alderson-Day B, 2017, CONSCIOUS COGN, V49, P98, DOI 10.1016/j.concog.2017.01.003; Aleman A, 2000, J NERV MENT DIS, V188, P830, DOI 10.1097/00005053-200012000-00007; Andrade J, 2014, BRIT J PSYCHOL, V105, P547, DOI 10.1111/bjop.12050; Badcock JC, 2016, REV PHILOS PSYCHOL, V7, P631, DOI 10.1007/s13164-015-0270-3; Badcock JC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00114; Bailey T, 2018, SCHIZOPHRENIA BULL, V44, P1111, DOI 10.1093/schbul/sbx161; BARRETT TR, 1992, APPL COGNITIVE PSYCH, V6, P379, DOI 10.1002/acp.2350060503; BARRETT TR, 1993, PERS INDIV DIFFER, V15, P61, DOI 10.1016/0191-8869(93)90041-Z; Belin P, 2008, BEHAV RES METHODS, V40, P531, DOI 10.3758/BRM.40.2.531; Belin P, 2011, BRIT J PSYCHOL, V102, P711, DOI 10.1111/j.2044-8295.2011.02041.x; BERRY DS, 1990, J NONVERBAL BEHAV, V14, P141, DOI 10.1007/BF00996223; Bocker KBE, 2000, BRIT J CLIN PSYCHOL, V39, P397; CHADWICK P, 1994, BRIT J PSYCHIAT, V164, P190, DOI 10.1192/bjp.164.2.190; Chhabra S, 2014, COGN NEUROPSYCHIATRY, V19, P305, DOI 10.1080/13546805.2013.865512; Daalman K, 2011, J CLIN PSYCHIAT, V72, P320, DOI 10.4088/JCP.09m05797yel; Evans SL, 2015, NEUROPSYCH DIS TREAT, V11, P1615, DOI 10.2147/NDT.S56870; Feingold D, 2016, PSYCHIAT RES, V240, P60, DOI 10.1016/j.psychres.2016.04.015; Freeman D, 2008, SCHIZOPHR RES, V102, P254, DOI 10.1016/j.schres.2008.03.020; Freeman D, 2013, SCHIZOPHRENIA BULL, V39, P1281, DOI 10.1093/schbul/sbs145; GARETY P, 1991, BRIT J PSYCHIAT, V159, P14, DOI 10.1192/S0007125000296426; Gold R, 2012, AM J PSYCHIAT, V169, P424, DOI 10.1176/appi.ajp.2011.11081230; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Hartigan N, 2014, BEHAV COGN PSYCHOTH, V42, P117, DOI 10.1017/S1352465813000611; Herlitz A, 2013, VIS COGN, V21, P1306, DOI 10.1080/13506285.2013.823140; Hughes SM, 2004, EVOL HUM BEHAV, V25, P295, DOI 10.1016/j.evolhumbehav.2004.06.001; Hughes SM, 2010, J SOC EVOL CULT PSYC, V4, P290, DOI DOI 10.1037/H0099282; Jack A, 2016, INT J SOC PSYCHIATR, V62, P123, DOI 10.1177/0020764015599998; Johns Louise C, 2005, Curr Psychiatry Rep, V7, P162, DOI 10.1007/s11920-005-0049-9; Johns LC, 2014, SCHIZOPHRENIA BULL, V40, pS255, DOI 10.1093/schbul/sbu005; Krakvik B, 2015, SCAND J PSYCHOL, V56, P508, DOI 10.1111/sjop.12236; Krauss RM, 2002, J EXP SOC PSYCHOL, V38, P618, DOI 10.1016/S0022-1031(02)00510-3; Laroi F, 2012, SCHIZOPHRENIA BULL, V38, P724, DOI 10.1093/schbul/sbs061; Legg L, 2006, PSYCHOL PSYCHOTHER-T, V79, P517, DOI 10.1348/147608305X70955; Leszczynska A, 2015, PSYCHIATR POL, V49, P1159, DOI 10.12740/PP/38919; Lima CF, 2019, EMOTION, V19, P219, DOI 10.1037/emo0000429; Lima CF, 2013, BEHAV RES METHODS, V45, P1234, DOI 10.3758/s13428-013-0324-3; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Rubio JL, 2011, SCHIZOPHR RES, V133, P199, DOI 10.1016/j.schres.2011.08.008; Martinez A., 2010, J VISUAL-JAPAN, V10, P607, DOI [10.1167/10.7.607, DOI 10.1167/10.7.607]; McAleer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090779; McCarthy-Jones S, 2014, SCHIZOPHRENIA BULL, V40, P225, DOI 10.1093/schbul/sbs156; McCarthy-Jones S, 2011, CONSCIOUS COGN, V20, P1586, DOI 10.1016/j.concog.2011.08.005; Melo S, 2009, PSYCHOL PSYCHOTHER-T, V82, P247, DOI 10.1348/147608308X398337; Morrison AP, 2000, BRIT J CLIN PSYCHOL, V39, P67, DOI 10.1348/014466500163112; Parviainen T, 2005, CEREB CORTEX, V15, P1054, DOI 10.1093/cercor/bhh206; Pell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027256; Pinheiro AP, 2016, COGN NEUROPSYCHIATRY, V21, P335, DOI 10.1080/13546805.2016.1208611; Pinkham AE, 2011, SCHIZOPHR RES, V125, P174, DOI 10.1016/j.schres.2010.11.006; Plante-Hebert J, 2017, INTERSPEECH, P3907, DOI 10.21437/Interspeech.2017-1392; Read J, 2003, PSYCHOL PSYCHOTHER-T, V76, P1, DOI 10.1348/14760830260569210; Sack AT, 2005, SCHIZOPHRENIA BULL, V31, P97, DOI 10.1093/schbul/sbi011; SCHERER KR, 1972, J PERS, V40, P191, DOI 10.1111/j.1467-6494.1972.tb00998.x; Sullivan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080055; Tinti C, 1997, EUR J COGN PSYCHOL, V9, P417, DOI 10.1080/713752569; Todorov A, 2009, SOC COGNITION, V27, P813, DOI 10.1521/soco.2009.27.6.813; Turetsky BI, 2007, SCHIZOPHR RES, V94, P253, DOI 10.1016/j.schres.2007.05.001; Vellante M, 2012, J NERV MENT DIS, V200, P310, DOI 10.1097/NMD.0b013e31824cb2ba; Wilkinson S, 2016, MIND LANG, V31, P104, DOI 10.1111/mila.12096; Williams LM, 2007, PSYCHIAT RES-NEUROIM, V155, P29, DOI 10.1016/j.pscychresns.2006.12.018; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Zhang ZJ, 2008, ACTA PSYCHIAT SCAND, V118, P272, DOI 10.1111/j.1600-0447.2008.01243.x; ZUCKERMAN M, 1989, J NONVERBAL BEHAV, V13, P67	63	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221127	10.1371/journal.pone.0221127	http://dx.doi.org/10.1371/journal.pone.0221127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404114	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800055
J	Wang, XD; Sun, YF; Li, SY; Wang, HX				Wang, Xuedong; Sun, Yanfeng; Li, Shiyu; Wang, Hanxi			Spatial distribution and ecological risk assessment of heavy metals in soil from the Raoyanghe Wetland, China	PLOS ONE			English	Article							SOURCE IDENTIFICATION; SURFACE SEDIMENTS; POLLUTION ASSESSMENT; AGRICULTURAL SOILS; MANGROVE WETLAND; HEALTH-RISK; CONTAMINATION; PROVINCE; URBAN; CITY	Wetlands are recognized as one of the most important natural environments for humans. At the same time, heavy metal pollution has an important impact on wetlands. China's Raoyanghe Wetland is one of the most important natural wild species gene banks in China. Eight heavy metal elements (As, Cd, Cr, Cu, Hg, Ni, Pb, and Zn) in surface layer and deep layer soils were analyzed using statistical-, pollution index-, and Nemerow index-based methods, the Hakanson potential ecological risk index method, and principal component and cluster analyses. The results showed that the maximum concentrations of heavy metals exceeded the background values in the core area and buffer zone of the wetland, but the heavy metal content of the soils was generally low and did not exceed 30%. With the exception of Hg, heavy metal concentrations showed strong spatial differentiation. The differences between the surface layer and deep layer soils of the core area were smaller than in the buffer zone. With the exception of Cd, a clear vertical zonation in the buffer zone soils was observed, showing greater evidence of external influences in this zone than the core. With the exception of partial surface soils, which indicated a safe level of pollution in the core area, all other soils were classified as having a 'mild' level of pollution. Thus, the wetland is moderately polluted, with both the core area and the buffer zone presenting a low level of potential ecological risk. According to the results of the present study, heavy metal contaminants in the wetland soils were found to be derived mainly from the natural sources.	[Wang, Xuedong; Sun, Yanfeng; Li, Shiyu] Liaoning Tech Univ, Coll Min, Fuxing, Peoples R China; [Wang, Xuedong] Liaoning Tech Univ, Res Stn Mech Postdoctoral Fellows, Fuxing, Peoples R China; [Wang, Hanxi] Northeast Normal Univ, State Environm Protect Key Lab Wetland Ecol & Veg, Sch Environm, Changchun, Jilin, Peoples R China	Liaoning Technical University; Liaoning Technical University; Northeast Normal University - China	Wang, HX (corresponding author), Northeast Normal Univ, State Environm Protect Key Lab Wetland Ecol & Veg, Sch Environm, Changchun, Jilin, Peoples R China.	wanghanxizs1982@126.com	wang, xuedong/AAA-3358-2019	wang, xuedong/0000-0003-0555-4814; Wang, Hanxi/0000-0003-4130-6981; LI, SHIYU/0000-0002-4272-3958	National Natural Science Fund of China [51604140]; Natural Science Fund in Liaoning Province of China [20170540423]; Open Projects of Research Center of Coal Resources Safe Mining and Clean Utilization, LNTU [LNTU17KF09]; China Postdoctoral Science Foundation [2018M631815]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund in Liaoning Province of China; Open Projects of Research Center of Coal Resources Safe Mining and Clean Utilization, LNTU; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Fund of China (Grant No. 51604140) to XW, Natural Science Fund in Liaoning Province of China (Grant No. 20170540423) to XW, Open Projects of Research Center of Coal Resources Safe Mining and Clean Utilization, LNTU (Grant No. LNTU17KF09) to XW, and a project funded by China Postdoctoral Science Foundation (Grant No. 2018M631815) to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah MAM, 2015, ENVIRON EARTH SCI, V73, P3603, DOI 10.1007/s12665-014-3646-2; Akcay H, 2003, WATER RES, V37, P813, DOI 10.1016/S0043-1354(02)00392-5; Alam AKMR, 2018, POLLUTION, V4, P129, DOI 10.22059/poll.2017.234867.284; Bai JH, 2016, ENVIRON POLLUT, V219, P379, DOI 10.1016/j.envpol.2016.05.016; Boruvka L, 2005, GEODERMA, V128, P289, DOI 10.1016/j.geoderma.2005.04.010; Cai C, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2620-2; Cai LM, 2012, ECOTOX ENVIRON SAFE, V78, P2, DOI 10.1016/j.ecoenv.2011.07.004; Chai Y, 2015, CHEMOSPHERE, V134, P67, DOI 10.1016/j.chemosphere.2015.04.008; Chen CY, 2000, LIMNOL OCEANOGR, V45, P1525, DOI 10.4319/lo.2000.45.7.1525; Chen Quan, 2017, Chinese Journal of Plant Ecology, V41, P409, DOI 10.17521/cjpe.2016.0338; Chen TB, 2005, CHEMOSPHERE, V60, P542, DOI 10.1016/j.chemosphere.2004.12.072; Cheng QL, 2015, ENVIRON SCI POLLUT R, V22, P8586, DOI 10.1007/s11356-014-4041-y; Cui LQ, 2017, CHEM SPEC BIOAVAILAB, V29, P15, DOI 10.1080/09542299.2016.1252692; Das SS, 2019, INDIA POLLUTION, V5, P161, DOI [10.22059/poll.2018.263546.493, DOI 10.22059/POLL.2018.263546.493]; Esmaeilzadeh M, 2016, ACTA OCEANOL SIN, V35, P28, DOI 10.1007/s13131-016-0920-z; Fang HD, 2015, INT J SUST DEV WORLD, V22, P117, DOI 10.1080/13504509.2014.918908; [高静湉 Gao Jingtian], 2016, [农业环境科学学报, Journal of Agro-Environment Science], V35, P2180; Gao WH, 2016, J SOIL SEDIMENT, V16, P1093, DOI 10.1007/s11368-015-1314-0; [葛晓颖 Ge Xiaoying], 2019, [环境科学学报, Acta Scientiae Circumstantiae], V39, P1979; He JY, 2019, GEODERMA, V337, P359, DOI 10.1016/j.geoderma.2018.09.038; Hu B, 2017, J CIRCUIT SYST COMP, V26, DOI 10.1142/S0218126617501596; Hu BF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040710; Hu J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189295; Hua L, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10093115; Huang JH, 2016, SCI TOTAL ENVIRON, V541, P969, DOI 10.1016/j.scitotenv.2015.09.139; Huang SS, 2007, CHEMOSPHERE, V67, P2148, DOI 10.1016/j.chemosphere.2006.12.043; Jamshidi-Zanjani A, 2013, ENVIRON EARTH SCI, V70, P1791, DOI 10.1007/s12665-013-2267-5; Jiang XL, 2017, ENVIRON SCI POLLUT R, V24, P436, DOI 10.1007/s11356-016-7775-x; Khosheghbal MZ, 2018, WATER SCI TECHNOL, V78, P1276, DOI 10.2166/wst.2018.396; Lee CS, 2006, SCI TOTAL ENVIRON, V356, P45, DOI 10.1016/j.scitotenv.2005.03.024; Li F, 2018, SCI TOTAL ENVIRON, V644, P649, DOI 10.1016/j.scitotenv.2018.06.366; Li F, 2017, ENVIRON GEOCHEM HLTH, V39, P923, DOI 10.1007/s10653-016-9864-7; Li F, 2013, J GEOCHEM EXPLOR, V132, P75, DOI 10.1016/j.gexplo.2013.05.007; [李吉锋 Li Jifeng], 2013, [广东农业科学, Guangdong Agricultural Sciences], V40, P164; Li LF, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8122561; Li SY, 2010, J HAZARD MATER, V181, P1051, DOI 10.1016/j.jhazmat.2010.05.120; [李卫平 Li Weiping], 2017, [生态环境学报, Ecology and Environmental Sciences], V26, P1977; Liang J, 2016, ENVIRON SCI POLLUT R, V23, P11806, DOI 10.1007/s11356-016-6372-3; Liu Li, 2018, Chinese Journal of Zoology, V53, P628, DOI 10.13859/j.cjz.201804014; [刘娜 Liu Na], 2015, [农业现代化研究, Research of Agricultural Modernization], V36, P901; LIU P, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/su11020419; Liu Zezheng, 2018, Journal of Beijing Normal University (Natural Science), V54, P144, DOI 10.16360/j.cnki.jbnuns.2018.01.020; [罗松英 Luo Songying], 2018, [生态环境学报, Ecology and Environmental Sciences], V27, P1547; Luo Ting, 2018, Huanjing Huaxue-Environmental Chemistry, V37, P984, DOI 10.7524/j.issn.0254-6108.2017072404; [麦麦提吐尔逊·艾则孜 Mamattursun Eziz], 2018, [土壤, Soils], V50, P369; Mungai TM, 2016, ENVIRON SCI POLLUT R, V23, P18533, DOI 10.1007/s11356-016-7042-1; Leguizamo MAO, 2017, CHEMOSPHERE, V168, P1230, DOI 10.1016/j.chemosphere.2016.10.075; Peng CY, 2017, SPECTROSC SPECT ANAL, V37, P1980, DOI 10.3964/j.issn.1000-0593(2017)06-1980-07; Qiu GL, 2006, ENVIRON POLLUT, V142, P549, DOI 10.1016/j.envpol.2005.10.015; Ramachandra TV, 2018, J ENVIRON MANAGE, V206, P1204, DOI 10.1016/j.jenvman.2017.10.014; Romic M, 2003, ENVIRON GEOL, V43, P795, DOI 10.1007/s00254-002-0694-9; Sandilyan S, 2014, OCEAN COAST MANAGE, V102, P161, DOI 10.1016/j.ocecoaman.2014.09.025; Sun CJ, 2010, ANAL LETT, V43, P1989, DOI 10.1080/00032711003687070; [孙海燕 Sun Haiyan], 2015, [水土保持学报, Journal of Soil and Water Conservation], V29, P289; Varol M, 2011, J HAZARD MATER, V195, P355, DOI 10.1016/j.jhazmat.2011.08.051; Wang HX, 2019, ENERGY, V173, P263, DOI 10.1016/j.energy.2019.02.081; Wang HX, 2018, ENVIRON SCI POLLUT R, V25, P4435, DOI 10.1007/s11356-017-0751-2; Wang HX, 2015, RENEW SUST ENERG REV, V52, P1881, DOI 10.1016/j.rser.2015.08.038; Wang JunGuang, 2018, Southwest China Journal of Agricultural Sciences, V31, P611; Wang LF, 2014, J GEOCHEM EXPLOR, V140, P87, DOI 10.1016/j.gexplo.2014.02.008; [王萌 Wang Meng], 2018, [地学前缘, Earth Science Frontiers], V25, P305; Wu J.Y., 2014, ENVIRON SCI TECHNOL, V37, P268; Xiao Q, 2015, ECOTOX ENVIRON SAFE, V120, P377, DOI 10.1016/j.ecoenv.2015.06.019; Xiao R, 2017, ECOTOX ENVIRON SAFE, V141, P17, DOI 10.1016/j.ecoenv.2017.03.002; Xu JL, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5093-x; Xu Ya-yan, 2012, Huanjing Kexue, V33, P732; Ye SJ, 2019, APPL CATAL B-ENVIRON, V250, P78, DOI 10.1016/j.apcatb.2019.03.004; Ye SJ, 2019, RESOUR CONSERV RECY, V140, P278, DOI 10.1016/j.resconrec.2018.10.004; Ye SJ, 2017, CRIT REV ENV SCI TEC, V47, P1528, DOI 10.1080/10643389.2017.1386951; Ye SJ, 2017, CRIT REV BIOTECHNOL, V37, P1062, DOI 10.1080/07388551.2017.1304357; Yu L, 2016, NAT HAZARDS, V81, P1435, DOI 10.1007/s11069-015-2130-y; [袁红明 Yuan Hongming], 2018, [海洋地质前沿, Marine Geology Letters], V34, P51; Zeng YanYi, 2018, Environmental Science & Technology (China), V41, P190; Zhang GL, 2016, ECOL INDIC, V69, P331, DOI 10.1016/j.ecolind.2016.04.042; Zhang HuiJuan, 2017, Journal of Yunnan University - Natural Sciences Edition, V39, P494; Zhang Y, 2014, ENVIRON MONIT ASSESS, V186, P1219, DOI 10.1007/s10661-013-3451-5	76	16	19	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220409	10.1371/journal.pone.0220409	http://dx.doi.org/10.1371/journal.pone.0220409			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398209	gold, Green Published, Green Submitted			2022-12-27	WOS:000485004000010
J	Cohen, YZ; Butler, AL; Millard, K; Witmer-Pack, M; Levin, R; Unson-O'Brien, C; Patel, R; Shimeliovich, I; Lorenzi, JCC; Horowitz, J; Walsh, SR; Lin, S; Weiner, JA; Tse, A; Sato, A; Bennett, C; Mayer, B; Seaton, KE; Yates, NL; Baden, LR; deCamp, AC; Ackerman, ME; Seaman, MS; Tomaras, GD; Nussenzweig, MC; Caskey, M				Cohen, Yehuda Z.; Butler, Allison L.; Millard, Katrina; Witmer-Pack, Maggi; Levin, Rebeka; Unson-O'Brien, Cecilia; Patel, Roshni; Shimeliovich, Irina; Lorenzi, Julio C. C.; Horowitz, Jill; Walsh, Stephen R.; Lin, Shu; Weiner, Joshua A.; Tse, Anna; Sato, Alicia; Bennett, Chelsey; Mayer, Bryan; Seaton, Kelly E.; Yates, Nicole L.; Baden, Lindsey R.; deCamp, Allan C.; Ackerman, Margaret E.; Seaman, Michael S.; Tomaras, Georgia D.; Nussenzweig, Michel C.; Caskey, Marina			Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; MONOCLONAL-ANTIBODY; HIV-INFECTION; POTENT; THERAPY; VIREMIA	Background Additional forms of pre-exposure prophylaxis are needed to prevent HIV-1 infection. 3BNC117 and 10-1074 are broadly neutralizing anti-HIV-1 antibodies that target non-overlapping epitopes on the HIV-1 envelope. We investigated the safety, tolerability, pharmacokinetics, and immunogenicity of the intravenous administration of the combination of 3BNC117 and 10-1074 in healthy adults. Methods This randomized, double-blind, placebo-controlled, single center, phase 1 study enrolled healthy adults aged 18-65 years to receive one infusion of 3BNC117 immediately followed by 10-1074 at 10 mg/kg, three infusions of 3BNC117 followed by 10-1074 at 3 mg/kg or 10 mg/kg every 8 weeks, or placebo infusions. The primary outcomes were safety and pharmacokinetics. This trial is registered with ClinicalTrials.gov, number NCT02824536. Findings Twenty-four participants were enrolled in a 3: 1 ratio to receive the study products or placebo. The combination of 3BNC117 and 10-1074 was safe and generally well tolerated. There were no serious adverse events considered related to the infusions. The mean elimination half-lives of 3BNC117 and 10-1074 were 16.4 +/- 4.6 days and 23.0 +/- 5.4 days, respectively, similar to what was observed in previous studies in which each antibody was administered alone. Anti-drug antibody responses were rare and without evidence of related adverse events or impact on elimination kinetics. Interpretation Single and repeated doses of the combination of 3BNC117 and 10-1074 were well tolerated in healthy adults. These data support the further development of the combination of 3BNC117 and 10-1074 as a long-acting injectable form of pre-exposure prophylaxis for the prevention of HIV-1 infection.	[Cohen, Yehuda Z.; Butler, Allison L.; Millard, Katrina; Witmer-Pack, Maggi; Levin, Rebeka; Unson-O'Brien, Cecilia; Patel, Roshni; Shimeliovich, Irina; Lorenzi, Julio C. C.; Horowitz, Jill; Nussenzweig, Michel C.; Caskey, Marina] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA; [Walsh, Stephen R.; Baden, Lindsey R.] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Lin, Shu; Weiner, Joshua A.; Ackerman, Margaret E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Tse, Anna; Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Sato, Alicia; Bennett, Chelsey; Mayer, Bryan; deCamp, Allan C.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Sato, Alicia; Bennett, Chelsey; Mayer, Bryan; deCamp, Allan C.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1124 Columbia St, Seattle, WA 98104 USA; [Seaton, Kelly E.; Yates, Nicole L.; Tomaras, Georgia D.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Tomaras, Georgia D.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Tomaras, Georgia D.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Tomaras, Georgia D.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Nussenzweig, Michel C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Rockefeller University; Harvard University; Brigham & Women's Hospital; Dartmouth College; Harvard University; Beth Israel Deaconess Medical Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Caskey, M (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	mcaskey@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019	Weiner, Joshua/0000-0003-1054-0628; Walsh, Stephen/0000-0002-0817-9370	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) [OPP1092074, CAVIMC OPP1146996]; Robertson Fund of The Rockefeller University; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K23AI136578]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI136578] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD); Robertson Fund of The Rockefeller University; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grants OPP1092074 (MCN), CAVIMC OPP1146996 (MEA, GDT, MSS) (https://www.gatesfoundation.org), and the Robertson Fund of The Rockefeller University (https://www.rockefeller.edu/technology-transfer/resources/robertsonfund). YZC was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number K23AI136578 (https://www.niaid.nih.gov). MCN is a Howard Hughes Medical Institute Investigator (https://www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all study participants who devoted time to our research. We also thank Hongmei Gao, Kelli Greene, Michelle Chung, and Eva Chung for project management, Shad Mosher, Sam McMillan for expert technical assistance, Marcella Sarzotti-Kelsoe for quality assurance oversight, David Beaumont and Sahill Patel for data management, Harriet Park and Pat Fast for study monitoring and helpful discussions, and Sarah Schlesinger for input on study design. This work was supported by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery (CAVD) grants OPP1092074 (MCN), CAVIMC OPP1146996 (MEA, GDT, MSS), and the Robertson Fund of The Rockefeller University. YZC was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number K23AI136578. MCN is a Howard Hughes Medical Institute Investigator.	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bar-On Y, 2018, NAT MED, V24, P1701, DOI 10.1038/s41591-018-0186-4; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Cohen YZ, 2018, CURR OPIN HIV AIDS, V13, P366, DOI 10.1097/COH.0000000000000475; Cohen YZ, 2018, J VIROL, V92, DOI 10.1128/JVI.01883-17; Davda JP, 2014, MABS-AUSTIN, V6, P1094, DOI 10.4161/mabs.29095; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Gaudinski MR, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002493; Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Heyndrickx L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036438; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Huang YD, 2017, MABS-AUSTIN, V9, P792, DOI 10.1080/19420862.2017.1311435; Karim QA, 2017, JAIDS-J ACQ IMM DEF, V75, pS17, DOI [10.1097/QAI.0000000000001316, 10.1097/qai.0000000000001316]; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mayer KH, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002435; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mendoza P, NATURE; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Provine NM, 2012, VIROLOGY, V427, P25, DOI 10.1016/j.virol.2012.02.001; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Siedner MJ, 2018, AIDS, V32, P1541, DOI [10.1097/QAD.0000000000001859, 10.1097/qad.0000000000001859]; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	34	36	36	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219142	10.1371/journal.pone.0219142	http://dx.doi.org/10.1371/journal.pone.0219142			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393868	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500006
J	D'Angeli, IM; Ghezzi, D; Leuko, S; Firrincieli, A; Parise, M; Fiorucci, A; Vigna, B; Addesso, R; Baldantoni, D; Carbone, C; Miller, AZ; Jurado, V; Saiz-Jimenez, C; De Waele, J; Cappelletti, M				D'Angeli, Ilenia M.; Ghezzi, Daniele; Leuko, Stefan; Firrincieli, Andrea; Parise, Mario; Fiorucci, Adriano; Vigna, Bartolomeo; Addesso, Rosangela; Baldantoni, Daniela; Carbone, Cristina; Miller, Ana Zelia; Jurado, Valme; Saiz-Jimenez, Cesareo; De Waele, Jo; Cappelletti, Martina			Geomicrobiology of a seawater-influenced active sulfuric acid cave	PLOS ONE			English	Article							MOONMILK DEPOSITS; BACTERIAL DIVERSITY; ACQUASANTA TERME; GENOME SEQUENCE; MICROBIAL MATS; CESAREA-TERME; MOVILE CAVE; GEN. NOV.; FAM. NOV; COMMUNITY	Fetida Cave is an active sulfuric acid cave influenced by seawater, showing abundant microbial communities that organize themselves under three main different morphologies: water filaments, vermiculations and moonmilk deposits. These biofilms/deposits have different cave distribution, pH, macro-and microelement and mineralogical composition, carbon and nitrogen content. In particular, water filaments and vermiculations had circumneutral and slightly acidic pH, respectively, both had abundant organic carbon and high microbial diversity. They were rich in macro- and microelements, deriving from mineral dissolution, and, in the case of water filaments, from seawater composition. Vermiculations had different color, partly associated with their mineralogy, and unusual minerals probably due to trapping capacities. Moonmilk was composed of gypsum, poor in organic matter, had an extremely low pH (0-1) and low microbial diversity. Based on 16S rRNA gene analysis, the microbial composition of the biofilms/deposits included autotrophic taxa associated with sulfur and nitrogen cycles and biomineralization processes. In particular, water filaments communities were characterized by bacterial taxa involved in sulfur oxidation and reduction in aquatic, aphotic, microaerophilic/anoxic environments (Campylobacterales, Thiotrichales, Arenicellales, Desulfobacterales, Desulforomonadales) and in chemolithotrophy in marine habitats (Oceanospirillales, Chromatiales). Their biodiversity was linked to the morphology of the water filaments and their collection site. Microbial communities within vermiculations were partly related to their color and showed high abundance of unclassified Betaproteobacteria and sulfur-oxidizing Hydrogenophilales (including Sulfuriferula), and Acidiferrobacterales (including Sulfurifustis), sulfur-reducing Desulfurellales, and ammonia-oxidizing Planctomycetes and Nitrospirae. The microbial community associated with gypsum moonmilk showed the strong dominance (>60%) of the archaeal genus Thermoplasma and lower abundance of chemolithotrophic Acidithiobacillus, metal-oxidizing Metallibacterium, Sulfobacillus, and Acidibacillus. This study describes the geomicrobiology of water filaments, vermiculations and gypsum moonmilk from Fetida Cave, providing insights into the microbial taxa that characterize each morphology and contribute to biogeochemical cycles and speleogenesis of this peculiar seawater-influenced sulfuric acid cave.	[D'Angeli, Ilenia M.; De Waele, Jo] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Ghezzi, Daniele; Cappelletti, Martina] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Leuko, Stefan] DLR Inst Aerosp Med, Radiat Biol, Cologne, Germany; [Firrincieli, Andrea] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Parise, Mario] Univ Bari Aldo Moro, Dept Geol & Environm Sci, Bari, Italy; [Fiorucci, Adriano; Vigna, Bartolomeo] Polytech Univ Turin, Dept Environm Land & Infrastruct Engn, Turin, Italy; [Addesso, Rosangela; Baldantoni, Daniela] Univ Salerno, Dept Chem & Biol Adolfo Zambelli, Fisciano, SA, Italy; [Carbone, Cristina] Univ Genoa, Dept Geol Environm & Biol Sci, DISTAV, Genoa, Italy; [Miller, Ana Zelia] Univ Evora, HERCULES Lab, Evora, Portugal; [Jurado, Valme; Saiz-Jimenez, Cesareo] CSIC, IRNAS, Inst Recursos Nat & Agrobiol, Seville, Spain	University of Bologna; University of Bologna; Helmholtz Association; German Aerospace Centre (DLR); University of Washington; University of Washington Seattle; Universita degli Studi di Bari Aldo Moro; Polytechnic University of Turin; University of Salerno; University of Genoa; University of Evora; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS)	Cappelletti, M (corresponding author), Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy.	martina.cappelletti2@unibo.it	Miller, Ana Zélia/H-8140-2012; CAPPELLETTI, MARTINA/H-5414-2019; Ghezzi, Daniele/AAE-1774-2020; Cappelletti, Martina/I-4952-2012; Miller, Ana Zélia/AAD-1117-2019; Baldantoni, Daniela/ABA-4273-2020; De Waele, Jo/A-7509-2008	Miller, Ana Zélia/0000-0002-0553-8470; CAPPELLETTI, MARTINA/0000-0002-6238-8296; Ghezzi, Daniele/0000-0002-9358-1566; Cappelletti, Martina/0000-0002-6238-8296; Miller, Ana Zélia/0000-0002-0553-8470; De Waele, Jo/0000-0001-5325-5208; Firrincieli, Andrea/0000-0001-5768-3170; D'Angeli, Ilenia M./0000-0002-2471-6236; Addesso, Rosangela/0000-0002-0300-8337	University of Bologna (UNIBO); Lions Club Napoli Megaride district 108 YA; UNIBO; Europlanet 2020 [15-EPN1-029, 17-EPN3-021]; European Union [654208]; Spanish project MINECO [CGL2016-75590-P]; ERDF; UNIBO (Ricerca Fondamentale e Orientata-RFO); Rectorate of UNIBO; Medical University of Graz (Austria)	University of Bologna (UNIBO); Lions Club Napoli Megaride district 108 YA; UNIBO; Europlanet 2020; European Union(European Commission); Spanish project MINECO(Spanish Government); ERDF(European Commission); UNIBO (Ricerca Fondamentale e Orientata-RFO); Rectorate of UNIBO; Medical University of Graz (Austria)	IMDA was supported by University of Bologna (UNIBO) and by the award from Lions Club Napoli Megaride district 108 YA. DG and MC's work was supported by the UNIBO. Funding for microbial analyses was provided by Europlanet 2020 15-EPN1-029 and 17-EPN3-021 grants. Europlanet 2020 RI has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 654208. Further funding was provided by the Spanish project MINECO CGL2016-75590-P with ERDF funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Santa Cesarea Terme spa for the availability during the intense sampling campaigns, Maria Luisa Garberi, Giovanni Belvederi, and Federazione Speleologica Emilia-Romagna for the gas measurements. IMDA was supported by University of Bologna (UNIBO) and by the award from Lions Club Napoli Megaride district 108 YA. DG and MC work was supported by UNIBO (Ricerca Fondamentale e Orientata-RFO) and the Rectorate of UNIBO. Funding for microbial analyses was provided by Europlanet 2020 15-EPN1-029 and 17-EPN3-021 grants. Europlanet 2020 RI has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 654208. Further funding was provided by the Spanish project MINECO CGL2016-75590-P with ERDF funds. MC, DG and IMDA are grateful to Prof. Christine Moissl Eichinger, Dr Kaisa Koskinen and Dr Alexander Mahnert from the Medical University of Graz (Austria), for their help with sample preparation for Illumina sequencing and data analysis with QIIME2 software. The authors thank Paolo Costantini for his support with the figures drawing and adjustments. Finally, we gratefully acknowledge the valuable comments of Dr Jarrod J. Scott, Dr Satoshi Kawaichi and one additional anonymous reviewer that helped to improve the initial submission of the manuscript.	Addesso R, 2019, CATENA, V182, DOI 10.1016/j.catena.2019.104178; Amato A, 2014, J GEODYN, V82, P125, DOI 10.1016/j.jog.2014.09.007; Baker BJ, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0077-6; Banerjee S, 2013, P NATL A SCI INDIA B, V83, P277, DOI 10.1007/s40011-012-0149-3; Barton HA, 2004, GEOMICROBIOL J, V21, P11, DOI 10.1080/01490450490253428; BINI A, 1978, INT J SPELEOL, V10, P11, DOI 10.5038/1827-806X.10.1.2; Bolyen E, 2018, EERJ; Borsato A, 2010, J SEDIMENT RES, V70, P1179; Boston PJ, 2001, ASTROBIOLOGY, V1, P25, DOI 10.1089/153110701750137413; Burlet C, 2015, COMPUT GEOSCI-UK, V74, P50, DOI 10.1016/j.cageo.2014.10.009; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; CALO GC, 1995, J HYDROL, V165, P185; Camejo PY, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00059-17; Canganella Francesco, 2007, Reviews in Environmental Science and Bio/Technology, V6, P61, DOI 10.1007/s11157-006-9103-2; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cappelletti M, 2016, MICROBES ENVIRON, V31, P369, DOI 10.1264/jsme2.ME16087; Chirienco M., 2004, ACTA CARSOLOGICA, V17, P257; Cirigliano A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34134-y; Clarke KR, 2015, PRIMER V7 USER MANUA; D'Angeli IM, 2018, INT J SPELEOL, V47, P271, DOI 10.5038/1827-806X.47.3.2175; D'Angeli IM, 2017, CAVE KARST SYSTEMS, P161, DOI 10.1007/978-3-319-53348-3_9; da Cunha AR, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4458-x; De Waele J, 2016, GEOMORPHOLOGY, V253, P452, DOI 10.1016/j.geomorph.2015.10.019; Delmont TO, 2018, NAT MICROBIOL, V3, P804, DOI 10.1038/s41564-018-0176-9; Engel AS, 2007, J CAVE KARST STUD, V69, P187; Engel AS, 2013, INT J SPELEOL, V42, P181, DOI 10.5038/1827-806X.42.3.2; Engel AS, 2010, ISME J, V4, P98, DOI 10.1038/ismej.2009.91; Engel AS, 2004, GEOLOGY, V32, P369, DOI 10.1130/G20288.1; Engel AS, 2003, APPL ENVIRON MICROB, V69, P5503, DOI 10.1128/AEM.69.9.5503-5511.2003; Florentino AP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00222; GALDENZI S, 1995, ENVIRON GEOL, V26, P39, DOI 10.1007/BF00776030; Galdenzi Sandro, 2003, Journal of Cave and Karst Studies, V65, P111; Galdenzi S, 2010, J CAVE KARST STUD, V72, P43, DOI 10.4311/jcks2008es0056; Ghosh S, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9030036; Golyshina OV, 2005, ENVIRON MICROBIOL, V7, P1277, DOI 10.1111/j.1462-2920.2005.00861.x; Golyshina OV, 2017, SCI REP, V7, P997, DOI [10.1038/s41598-017-00810-8, DOI 10.1038/S41598-017-00810-8]; Hamilton TL, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00756; Han YC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00989; Hathaway JJM, 2014, GEOMICROBIOL J, V31, P205, DOI 10.1080/01490451.2013.777491; Hester ER, 2018, MSYSTEMS, V3, DOI [10.1128/msystems.00214-17, 10.1128/mSystems.00214-17]; Hill CA, 1997, CAVE MINERALS WORLD, P221; Hirano H, 2003, ENVIRON MICROBIOL, V5, P503, DOI 10.1046/j.1462-2920.2003.00444.x; Hose L, 2004, J CAVE KARST STUD, V66, P112; Hose LD, 2000, CHEM GEOL, V169, P399, DOI 10.1016/S0009-2541(00)00217-5; Hose Louise D., 1999, Journal of Caves and Karst Studies, V61, P13; Ionescu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038319; Issotta F, 2018, RES MICROBIOL, V169, P608, DOI 10.1016/j.resmic.2018.08.001; Jones DS, 2010, APPL ENVIRON MICROB, V76, P5902, DOI 10.1128/AEM.00647-10; Jones DS, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00673-17; Jones DS, 2016, ADV ENV MICROBIOLOGY, V1, P203, DOI 10.1007/978-3-319-28071-4_5; Jones DS, 2016, ISME J, V10, P2879, DOI 10.1038/ismej.2016.74; Jones DS, 2015, APPL ENVIRON MICROB, V81, P3142, DOI 10.1128/AEM.00039-15; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Jones DS, 2008, J CAVE KARST STUD, V70, P78; Justice NB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1107; Kang I, 2018, MAR GENOM, V37, P176, DOI 10.1016/j.margen.2017.11.005; Keller AH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01396; Klimchouk A, 2017, CAVE KARST SYSTEMS, P1, DOI 10.1007/978-3-319-53348-3_1; Koch H, 2019, APPL MICROBIOL BIOT, V103, P177, DOI 10.1007/s00253-018-9486-3; Kojima H, 2015, INT J SYST EVOL MICR, V65, P3709, DOI 10.1099/ijsem.0.000479; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumaresan D, 2014, GEOMICROBIOL J, V31, P186, DOI 10.1080/01490451.2013.839764; Lavoie K.H., 2010, GEOMICROBIOL J, P1; Li YF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02718; Liu JL, 2019, ENVIRON POLLUT, V247, P98, DOI 10.1016/j.envpol.2018.12.045; Macalady JL, 2008, ISME J, V2, P590, DOI 10.1038/ismej.2008.25; Macalady JL, 2007, ENVIRON MICROBIOL, V9, P1402, DOI 10.1111/j.1462-2920.2007.01256.x; Macalady JL, 2006, APPL ENVIRON MICROB, V72, P5596, DOI 10.1128/AEM.00715-06; Mackey E.A., 2004, J RES, DOI [10.6028/nist.sp.260-156, DOI 10.6028/NIST.SP.260-156]; Marques ELS, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7020029; Martin-Cuadrado AB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000914; Mattison RG, 1998, MICROBIAL ECOL, V35, P58, DOI 10.1007/s002489900060; Mcllroy SJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01134; Miller AZ, 2012, CHEM GEOL, V322, P181, DOI 10.1016/j.chemgeo.2012.07.005; Miller AZ, 2018, SEDIMENTOLOGY, V65, P1482, DOI 10.1111/sed.12431; Mugge RL, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00048; Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750; Onac B.-P., 1993, CAVE SCI, V20, P107; Pascual J, 2015, SYST APPL MICROBIOL, V38, P534, DOI 10.1016/j.syapm.2015.08.001; Portillo MC, 2011, MICROB ECOL, V61, P182, DOI 10.1007/s00248-010-9731-5; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Riquelme C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01342; Rohwerder T, 2003, ACTA BIOTECHNOL, V23, P101, DOI 10.1002/abio.200390000; Ruffel V, 2018, ENVIRON MICROBIOL, V20, P3717, DOI 10.1111/1462-2920.14374; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; Sauro F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35532-y; Teramoto M, 2015, INT J SYST EVOL MICR, V65, P353, DOI 10.1099/ijs.0.064683-0; Tisato N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15525; Tomczyk-Zak K, 2016, GEOMICROBIOL J, V33, P20, DOI 10.1080/01490451.2014.1003341; Trembath-Reichert E, 2016, PEERJ, V4, P1913; Umezawa K, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0196-0; Velaj T., 2015, PETROLEUM, V1, P269; Wei HW, 2017, BIORESOURCE TECHNOL, V243, P1149, DOI 10.1016/j.biortech.2017.07.077; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Wright KE, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00063; Ye RW, 2001, CURR OPIN MICROBIOL, V4, P307, DOI 10.1016/S1369-5274(00)00208-3	97	22	22	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220706	10.1371/journal.pone.0220706	http://dx.doi.org/10.1371/journal.pone.0220706			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393920	gold, Green Published, Green Accepted			2022-12-27	WOS:000485002500053
J	Dyr, B; Boomer, T; Almasri, EA; Wardrop, JL; Rafalko, J; Chibuk, J; McCullough, RM				Dyr, Brittany; Boomer, Theresa; Almasri, Eyad A.; Wardrop, Jenna L.; Rafalko, Jill; Chibuk, Jason; McCullough, Ron M.			y A new era in aneuploidy screening: cfDNA testing in > 30,000 multifetal gestations: Experience at one clinical laboratory	PLOS ONE			English	Article							CELL-FREE DNA; MATERNAL PLASMA DNA; TWIN PREGNANCIES; DOWN-SYNDROME; FETAL DNA; POSITION STATEMENT; TRISOMIES 21; ABNORMALITIES; BLOOD; AGE	Since introducing cell-free DNA screening, Sequenom Laboratories has analyzed over 1 million clinical samples. More than 30,000 of these samples were from multifetal gestations (including twins, triplets and higher-order multiples). The clinical laboratory experience with the first 30,000 multifetal samples will be discussed. Maternal plasma samples from multifetal gestations were subjected to DNA extraction and library preparation followed by massively parallel sequencing. Sequencing data were analyzed to identify autosomal trisomies and other subchromosomal events. Fetal fraction requirements were adjusted in proportion to fetal number. Outcome data, when voluntarily received from the ordering provider, were collected from internal case notes. Feedback was received in 50 cases. The positivity rate in multifetal samples for trisomy 21 was 1.50%, 0.47% for trisomy 18, and 0.21% for trisomy 13. Average total sample fetal fraction was 12.2% at a mean gestational age of 13 weeks 6 days. Total non-reportable rate was 5.95%. Estimated performance based on ad hoc clinical feedback demonstrates that possible maximum sensitivity and specificity meet or exceed the original performance from clinical validation studies. Cell-free DNA (cfDNA) screening provides certain advantages over that of conventional screening in multifetal gestations and is available in higher-order multiples.	[Dyr, Brittany; Rafalko, Jill; Chibuk, Jason] Sequenom Inc, Dept Med Affairs, San Diego, CA 92121 USA; [Boomer, Theresa; Almasri, Eyad A.; Wardrop, Jenna L.; McCullough, Ron M.] Sequenom Inc, Dept Clin Sci, San Diego, CA USA	Sequenom; Sequenom	Dyr, B (corresponding author), Sequenom Inc, Dept Med Affairs, San Diego, CA 92121 USA.	dyrb@labcorp.com		Chibuk, Jason/0000-0003-1903-8829				American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; [Anonymous], 2014, Obstet Gynecol, V123, P1118, DOI 10.1097/01.AOG.0000446856.51061.3e; [Anonymous], 2015, CELL FREE DNA SCREEN; Benachi A, 2015, OBSTET GYNECOL, V125, P1330, DOI 10.1097/AOG.0000000000000874; Bender W, 2018, OBSTET GYN CLIN N AM, V45, P41, DOI 10.1016/j.ogc.2017.10.004; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Bevilacqua E, 2015, ULTRASOUND OBST GYN, V45, P61, DOI 10.1002/uog.14690; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Canick JA, 2012, PRENATAL DIAG, V32, P730, DOI 10.1002/pd.3892; Garchet-Beaudron A, 2008, PRENATAL DIAG, V28, P1105, DOI 10.1002/pd.2145; Gil MD, 2014, FETAL DIAGN THER, V35, P204, DOI 10.1159/000356495; Gregg AR, 2016, GENET MED, V18, P1056, DOI 10.1038/gim.2016.97; Huang X, 2014, PRENATAL DIAG, V34, P335, DOI 10.1002/pd.4303; Jensen TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057381; Kim SK, 2015, PRENATAL DIAG, V35, P810, DOI 10.1002/pd.4615; Lau TK, 2013, J MATERN-FETAL NEO M, V26, P434, DOI 10.3109/14767058.2012.733768; Le Conte G, 2018, ULTRASOUND OBST GYN, V52, P318, DOI 10.1002/uog.18838; Mackie FL, 2017, BJOG-INT J OBSTET GY, V124, P32, DOI 10.1111/1471-0528.14050; Martin Joyce A, 2012, NCHS Data Brief, P1; Mazloom AR, 2013, PRENATAL DIAG, V33, P591, DOI 10.1002/pd.4127; McCullough RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109173; Meyers C, 1997, OBSTET GYNECOL, V89, P248, DOI 10.1016/S0029-7844(96)00424-3; NIEBUHR E, 1978, HUM GENET, V44, P227, DOI 10.1007/BF00394291; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Reynolds MA, 2003, PEDIATRICS, V111, P1159; Sarno L, 2016, ULTRASOUND OBST GYN, V47, P705, DOI 10.1002/uog.15913; Sebire NJ, 1996, BRIT J OBSTET GYNAEC, V103, P999, DOI 10.1111/j.1471-0528.1996.tb09550.x; Tan YQ, 2016, PRENATAL DIAG, V36, P672, DOI 10.1002/pd.4837; WALD N, 1991, BRIT J OBSTET GYNAEC, V98, P905, DOI 10.1111/j.1471-0528.1991.tb13513.x; Wilson KL, 2013, J GENET COUNS, V22, P4, DOI 10.1007/s10897-012-9545-3; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792; Zhao C, 2015, CLIN CHEM, V61, P608, DOI 10.1373/clinchem.2014.233312	36	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220979	10.1371/journal.pone.0220979	http://dx.doi.org/10.1371/journal.pone.0220979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393959	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500088
J	El Moussawi, L; Chakkour, M; Kreydiyyeh, S				El Moussawi, Layla; Chakkour, Mohamed; Kreydiyyeh, Sawsan			The epinephrine-induced PGE2 reduces Na+/K+ ATPase activity in Caco-2 cells via PKC, NF-kappa B and NO	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NA+,K+-ATPASE ACTIVITY; K+-ATPASE; ALPHA; PHOSPHORYLATION; NA,K-ATPASE; INHIBITION; EXPRESSION; MECHANISM; COLON	We showed previously an epinephrine-induced inhibition of the Na+/K+ ATPase in Caco-2 cells mediated via PGE2. This work is an attempt to further elucidate mediators downstream of PGE2 and involved in the observed inhibitory effect. The activity of the Na+/K+ ATPase was assayed by measuring the amount of inorganic phosphate liberated in presence and absence of ouabain, a specific inhibitor of the enzyme. Changes in the protein expression of the Na+/K+ ATPase were investigated by western blot analysis which revealed a significant decrease in the abundance of the ATPase in plasma membranes. Treating the cells with epinephrine or PGE2 in presence of SC19220, a blocker of EP1 receptors abolished completely the effect of the hormone and the prostaglandin while the effect was maintained unaltered in presence of antagonists to all other receptors. Treatment with calphostin C, PTIO, ODQ or KT5823, respective inhibitors of PKC, NO, soluble guanylate cyclase and PKG, abrogated completely the effect of epinephrine and PGE2, suggesting an involvement of these mediators. A significant inhibition of the ATPase was observed when cells were treated with PMA, an activator of PKC or with 8-Br-cGMP, a cell permeable cGMP analogue. PMA did reduce the protein expression of I kappa B, as shown by western blot analysis, and its effect on the ATPase was not manifested in presence of an inhibitor of NF-kappa B while that of SNAP, a nitric oxide donor, was not affected. The results infer that NF-kappa B is downstream PKC and upstream NO. The data support a pathway in which epinephrine induces the production of PGE2 which binds to EP1 receptors and activates PKC and NF-kappa B leading to NO synthesis. The latter activates soluble guanylate cyclase resulting in cGMP production and activation of PKG which through direct or indirect phosphorylation inhibits the Na+/K+ ATPase by inducing its internalization.	[El Moussawi, Layla; Chakkour, Mohamed; Kreydiyyeh, Sawsan] Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut, Lebanon	American University of Beirut	Kreydiyyeh, S (corresponding author), Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut, Lebanon.	Sawkreyd@aub.edu.lb			SK University Research Board	SK University Research Board	This work was funded by SK University Research Board. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Alam N, 2017, J CELL COMMUN SIGNAL, V11, P309, DOI 10.1007/s12079-016-0369-z; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; Beltowski J, 2003, J PHYSIOL PHARMACOL, V54, P191; Beltowski J, 2007, CLIN EXP HYPERTENS, V29, P189, DOI 10.1080/10641960701361585; BERTORELLO AM, 1991, P NATL ACAD SCI USA, V88, P11359, DOI 10.1073/pnas.88.24.11359; Boldyrev AA, 1997, BBA-BIOENERGETICS, V1321, P243, DOI 10.1016/S0005-2728(97)00053-4; Bos CL, 2004, INT J BIOCHEM CELL B, V36, P1187, DOI 10.1016/j.biocel.2003.08.006; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; Dey I, 2006, BRIT J PHARMACOL, V149, P611, DOI 10.1038/sj.bjp.0706923; Esmann M., 1988, METHODS ENZYMOLOGY P, P105; FESCHENKO MS, 1995, J BIOL CHEM, V270, P14072, DOI 10.1074/jbc.270.23.14072; Fotis H, 1999, EUR J BIOCHEM, V260, P904, DOI 10.1046/j.1432-1327.1999.00237.x; Fujii S, 2016, SCI REPORTS, V6; GUZMAN NJ, 1995, J CLIN INVEST, V95, P2083, DOI 10.1172/JCI117895; Hatano E, 2001, GASTROENTEROLOGY, V120, P1251, DOI 10.1053/gast.2001.23239; Hsieh YH, 2007, BIOCHEM BIOPH RES CO, V359, P643, DOI 10.1016/j.bbrc.2007.05.154; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Jia JH, 2013, INVEST OPHTH VIS SCI, V54, P5070, DOI 10.1167/iovs.13-11796; Kostic TS, 1999, J ENDOCRINOL, V163, P409, DOI 10.1677/joe.0.1630409; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Li D, 1995, AM J PHYSL RENAL PHY, V269; Liang MY, 1999, KIDNEY INT, V56, P627, DOI 10.1046/j.1523-1755.1999.00583.x; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lucas KA, 2000, PHARMACOL REV, V52, P375; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; MEISTER B, 1989, P NATL ACAD SCI USA, V86, P8068, DOI 10.1073/pnas.86.20.8068; Moussawi LE, 2018, PLOS ONE, V13; Oliveira MS, 2009, J NEUROCHEM, V109, P416, DOI 10.1111/j.1471-4159.2009.05961.x; Olivenza R, 2000, J NEUROCHEM, V74, P785, DOI 10.1046/j.1471-4159.2000.740785.x; Oussaief L, 2011, J VIROL, V85, P6502, DOI 10.1128/JVI.02560-10; Rida R, 2018, LIFE SCI, V215, P198, DOI 10.1016/j.lfs.2018.11.026; Sandle GI, 1998, GUT, V43, P294, DOI 10.1136/gut.43.2.294; Shahidullah M, 2013, J CELLULAR PHYSL, V229, P343; Shahidullah M, 2006, BRIT J PHARMACOL, V148, P871, DOI 10.1038/sj.bjp.0706795; Taussky H, 1959, MICROCHEM J, V3, P587; Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9; Wood JS, 1996, J BIOL CHEM, V271, P174, DOI 10.1074/jbc.271.1.174; Wu ZQ, 2005, MOL PHARM; Yoon Hyun-Ju, 1994, Neuroimmunomodulation, V1, P377, DOI 10.1159/000097191	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220987	10.1371/journal.pone.0220987	http://dx.doi.org/10.1371/journal.pone.0220987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393950	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500091
J	Snyder, BM; Nam, SM; Khunsongkiet, P; Ausayakhun, S; Leeungurasatien, T; Leiter, MR; Sevastopolsky, A; Joye, AS; Berlinberg, EJ; Liu, YN; Ramirez, DA; Moe, CA; Ausayakhun, S; Stamper, RL; Keenan, JD				Snyder, Blake M.; Nam, Sang Min; Khunsongkiet, Preeyanuch; Ausayakhun, Sakarin; Leeungurasatien, Thidarat; Leiter, Maxwell R.; Sevastopolsky, Artem; Joye, Ashlin S.; Berlinberg, Elyse J.; Liu, Yingna; Ramirez, David A.; Moe, Caitlin A.; Ausayakhun, Somsanguan; Stamper, Robert L.; Keenan, Jeremy D.			Accuracy of computer-assisted vertical cup-to-disk ratio grading for glaucoma screening	PLOS ONE			English	Article							OPTIC NEUROPATHY EVALUATION; DIABETIC-RETINOPATHY; EVALUATION PROJECT; REPRODUCIBILITY	Purpose Glaucoma screening can be performed by assessing the vertical-cup-to-disk ratio (VCDR) of the optic nerve head from fundus photography, but VCDR grading is inherently subjective. This study investigated whether computer software could improve the accuracy and repeatability of VCDR assessment. Methods In this cross-sectional diagnostic accuracy study, 5 ophthalmologists independently assessed the VCDR from a set of 200 optic disk images, with the median grade used as the reference standard for subsequent analyses. Eight non-ophthalmologists graded each image by two different methods: by visual inspection and with assistance from a custom-made publicly available software program. Agreement with the reference standard grade was assessed for each method by calculating the intraclass correlation coefficient (ICC), and the sensitivity and specificity determined relative to a median ophthalmologist grade of >= 0.7. Results VCDR grades ranged from 0.1 to 0.9 for visual assessment and from 0.1 to 1.0 for software-assisted grading, with a median grade of 0.4 for each. Agreement between each of the 8 graders and the reference standard was higher for visual inspection (median ICC 0.65, interquartile range 0.57 to 0.82) than for software-assisted grading (median ICC 0.59, IQR 0.44 to 0.71); P = 0.02, Wilcoxon signed-rank test). Visual inspection and software assistance had similar sensitivity and specificity for detecting glaucomatous cupping. Conclusion The computer software used in this study did not improve the reproducibility or validity of VCDR grading from fundus photographs compared with simple visual inspection. More clinical experience was correlated with higher agreement with the ophthalmologist VCDR reference standard.	[Snyder, Blake M.] Univ Colorado, Sch Med, Aurora, CO USA; [Snyder, Blake M.; Leiter, Maxwell R.; Joye, Ashlin S.; Berlinberg, Elyse J.; Liu, Yingna; Ramirez, David A.; Moe, Caitlin A.; Keenan, Jeremy D.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Nam, Sang Min; Stamper, Robert L.; Keenan, Jeremy D.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Nam, Sang Min] CHA Univ, CHA Bundang Med Ctr, Dept Ophthalmol, Seongnam, South Korea; [Khunsongkiet, Preeyanuch; Ausayakhun, Sakarin; Leeungurasatien, Thidarat; Ausayakhun, Somsanguan] Chiang Mai Univ, Fac Med, Dept Ophthalmol, Chiang Mai, Thailand; [Sevastopolsky, Artem] Youth Labs LLC, Moscow, Russia; [Sevastopolsky, Artem] Skolkovo Inst Sci & Technol, Moscow, Russia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Pochon Cha University; Chiang Mai University; Skolkovo Institute of Science & Technology	Keenan, JD (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA.; Keenan, JD (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	jeremy.keenan@ucsf.edu	Solodushenkova, Anastasia/H-1732-2019; Keenan, Jeremy David/AAO-5882-2020; Moe, Caitlin/GYA-1601-2022	Keenan, Jeremy David/0000-0002-7118-1457; Moe, Caitlin/0000-0002-9318-2514; Berlinberg, Elyse/0000-0001-5308-1383; Ramirez, David/0000-0003-0357-917X; Snyder, Blake/0000-0002-0049-3111	Doris Duke Charitable Foundation through Doris Duke International Clinical Research Fellows Program at the University of California San Francisco School of Medicine; Fortisure Foundation; JaMel and Tom Perkins Family Foundation; That Man May See; Research to Prevent Blindness	Doris Duke Charitable Foundation through Doris Duke International Clinical Research Fellows Program at the University of California San Francisco School of Medicine; Fortisure Foundation; JaMel and Tom Perkins Family Foundation; That Man May See; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported in part by the Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at the University of California San Francisco School of Medicine. Blake M. Snyder is a Doris Duke International Clinical Research Fellow. Additional support came from the Fortisure Foundation, the JaMel and Tom Perkins Family Foundation, That Man May See, and Research to Prevent Blindness. The funders provided support in the form of salaries for authors [AS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Addis V, 2019, EYE, V33, P838, DOI 10.1038/s41433-018-0332-8; Almazroa A, 2017, INT J BIOMED IMAGING, V2017, DOI 10.1155/2017/4826385; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bhaskaranand Malavika, 2016, J Diabetes Sci Technol, V10, P254, DOI 10.1177/1932296816628546; Chan HHL, 2014, AM J OPHTHALMOL, V157, P936, DOI 10.1016/j.ajo.2014.01.024; Feuer WJ, 2002, AM J OPHTHALMOL, V133, P19, DOI 10.1016/S0002-9394(01)01338-1; Fumero F, 2011, COMP MED SY; Grisolia ABD, 2017, ARQ BRAS OFTALMOL, V80, P401, DOI 10.5935/0004-2749.20170099; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Haleem MS, 2018, J MED SYST, V42, DOI 10.1007/s10916-017-0859-4; Hu M, 2017, BIOENGINEERED, V8, P21, DOI 10.1080/21655979.2016.1227144; Kaiser-Kupfer M I, 1980, Trans Am Ophthalmol Soc, V78, P896; Kong YXG, 2011, CLIN EXP OPHTHALMOL, V39, P308, DOI 10.1111/j.1442-9071.2010.02462.x; Lamminen H, 2003, ACTA OPHTHALMOL SCAN, V81, P105, DOI 10.1034/j.1600-0420.2003.00045.x; Li ZX, 2018, OPHTHALMOLOGY, V125, P1199, DOI 10.1016/j.ophtha.2018.01.023; Lichter P R, 1976, Trans Am Ophthalmol Soc, V74, P532; Lowell J, 2004, IEEE T MED IMAGING, V23; Matimba A, 2016, J TELEMED TELECARE, V22, P311, DOI 10.1177/1357633X15604083; Morgan JE, 2005, BRIT J OPHTHALMOL, V89, P879, DOI 10.1136/bjo.2004.046169; Muttuvelu DV, 2012, ACTA OPHTHALMOL, V90, P322, DOI 10.1111/j.1755-3768.2010.01987.x; Norgaard MF, 2018, OPHTHALMIC RES, V60, P9, DOI 10.1159/000486284; O'Neill EC, 2014, JAMA OPHTHALMOL, V132, P560, DOI 10.1001/jamaophthalmol.2014.96; Parkin B, 2001, BRIT J OPHTHALMOL, V85, P1347, DOI 10.1136/bjo.85.11.1347; Sevastopolsky A., 2017, [Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications), Pattern Recognition and Image Analysis. (Advances in Mathematical Theory and Applications)], V27, P618, DOI 10.1134/S1054661817030269; Soorya M, 2018, INT J MED INFORM, V110, P52, DOI 10.1016/j.ijmedinf.2017.11.015; Team RDC, 2008, COMP RFFS; Tham YC, 2013, CLIN EXP OPHTHALMOL, V41, P842, DOI 10.1111/ceo.12112; Zilly J, 2017, COMPUT MED IMAG GRAP, V55, P28, DOI 10.1016/j.compmedimag.2016.07.012; Zimmer-Galler IE, 2015, CURR OPIN OPHTHALMOL, V26, P167, DOI 10.1097/ICU.0000000000000142	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220362	10.1371/journal.pone.0220362	http://dx.doi.org/10.1371/journal.pone.0220362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393904	gold, Green Submitted, Green Published			2022-12-27	WOS:000485002500028
J	Miton, H; Morin, O				Miton, Helena; Morin, Olivier			When iconicity stands in the way of abbreviation: No Zipfian effect for figurative signals	PLOS ONE			English	Article							VISUAL COMPLEXITY; WORD-LENGTH; CHINESE; DISCRIMINATION; RECOGNITION; PATTERNS; BREVITY; FLUENCY; LEXICON	Zipf's law of abbreviation, relating more frequent signals to shorter signal lengths, applies to sounds in a variety of communication systems, both human and non-human. It also applies to writing systems: more frequent words tend to be encoded by less complex graphemes, even when grapheme complexity is decoupled from word length. This study documents an exception to this law of abbreviation. Observing European heraldic motifs, whose frequency of use was documented for the whole continent and over two large corpora (total N = 25115), one medieval, one early modern, we found that they do not obey a robust law of abbreviation. In our early modern corpus, motif complexity and motif frequency are positively, not negatively, correlated, a result driven by iconic motifs. In both our corpora, iconic motifs tend to be more frequent when more complex. They grew in popularity after the invention of printing. Our results suggest that lacking iconicity may be a precondition for a graphic code to exhibit Zipf's Law of Abbreviation.	[Miton, Helena] Cent European Univ, Dept Cognit Sci, Budapest, Hungary; [Miton, Helena; Morin, Olivier] Max Planck Sci Human Hist, Minds & Tradit Res Grp, Jena, Germany	Central European University	Miton, H (corresponding author), Cent European Univ, Dept Cognit Sci, Budapest, Hungary.; Miton, H (corresponding author), Max Planck Sci Human Hist, Minds & Tradit Res Grp, Jena, Germany.	helena.miton@gmail.com		Miton, Helena/0000-0003-0896-1167	European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013); ERC [609819]	European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013); ERC(European Research Council (ERC)European Commission)	HM was supported by the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) and ERC grant agreement no. 609819 (SOMICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREND U, 1987, BEHAV INFORM TECHNOL, V6, P411, DOI 10.1080/01449298708901853; ARNOULT MD, 1960, PERCEPT MOTOR SKILL, V11, P259; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Bentz C, 2016, PROCEEDINGS OF THE L; Bezerra BM, 2011, BIOL LETTERS, V7, P23, DOI 10.1098/rsbl.2010.0455; BYRNE MD, 1993, HUMAN FACTORS IN COMPUTING SYSTEMS, P446; Caldwell CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043807; Clemmensen S, 2017, ARMORIAL DK A MEDIEV; Cohen MA, 2009, P NATL ACAD SCI USA, V106, P6008, DOI 10.1073/pnas.0811884106; CONNER RN, 1985, CONDOR, V87, P379, DOI 10.2307/1367219; Donderi DC, 2006, PSYCHOL BULL, V132, P73, DOI 10.1037/0033-2909.132.1.73; Donderi DC, 2005, DISPLAYS, V26, P71, DOI 10.1016/j.displa.2005.02.002; Ferrer-i-Cancho R., 2013, GLOTTOTHEORY, V4, P45, DOI [10.1524/glot.2013.0004, DOI 10.1524/GLOT.2013.0004]; Ferrer-I-Cancho R, 2009, COMPLEXITY, V14, P23, DOI 10.1002/cplx.20266; Fox-Davies AC., 1900, HERALDRY EXPLAINED; GARCIA M, 1994, INTERACT COMPUT, V6, P191, DOI 10.1016/0953-5438(94)90024-8; Garrod S, 2007, COGNITIVE SCI, V31, P961, DOI 10.1080/03640210701703659; Green A, 1990, P INTERACT, P457; HUFFMAN DA, 1952, P IRE, V40, P1098, DOI 10.1109/JRPROC.1952.273898; Jappy T, 2013, INTRODUCTION TO PEIR; Kanwal J, 2017, COGNITION, V165, P45, DOI 10.1016/j.cognition.2017.05.001; Luo B, 2013, J COMP PHYSIOL A, V199, P325, DOI 10.1007/s00359-013-0793-y; MAVRIDES CM, 1969, PERCEPT PSYCHOPHYS, V6, P276, DOI 10.3758/BF03210098; Metcalf A., 2010, OK THE IMPROBABLE ST; Morin O, 2019, TOP COGN SCI; Morin O, 2018, EVOL HUM BEHAV, V39, P392, DOI 10.1016/j.evolhumbehav.2018.03.004; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; New B, 2006, PSYCHON B REV, V13, P45, DOI 10.3758/BF03193811; Pastoureau M., 2007, TRAITE DHERALDIQUE; Peirce CS., 1974, COLLECTED PAPERS OF; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Piantadosi ST, 2011, P NATL ACAD SCI USA, V108, P3526, DOI 10.1073/pnas.1012551108; Priva UC, 2017, LANGUAGE, V93, P569, DOI 10.1353/lan.2017.0037; R Core Team, 2018, R A LANGUAGE AND ENV; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Renesse T, 1894, DICTIONNAIRE DES FIG; Rietstap J-B., 1884, ARMORIAL GENERAL PRE; ROGERS Y, 1989, INT REV ERGON, V3, P129; ROGERS Y, 1987, BRIT J PSYCHOL, V78, P99, DOI 10.1111/j.2044-8295.1987.tb02229.x; Rogers Y., 1986, PEOPLE COMPUTERS DES, P586; Rohr G, 1984, HUMAN FACTORS ORG DE, P269; Rolland V, 1969, SUPPLEMENT TO THE AR; Rolland V., 1909, PLANCHES DE LARMORIA; Rovenchak A, 2009, GLOTTOMETRICS, V18, P1; Rovenchak A, 2011, MANDENKAN, P77; Schmandt-Besserat D., 2010, HOW WRITING CAME ABO; Selinger P, 2003, POTRACE A POLYGON BA; Semple S, 2010, BIOL LETTERS, V6, P469, DOI 10.1098/rsbl.2009.1062; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; Sigurd B, 2004, STUD LINGUISTICA, V58, P37, DOI 10.1111/j.0039-3193.2004.00109.x; STAMMERS RB, 1991, P HUM FACT SOC 35, P354, DOI DOI 10.1177/154193129103500525; Strauss U., 2007, CONTRIBUTIONS SCI TE, V31, P277, DOI DOI 10.1007/978-1-4020-4068-9_13; Tamaoka K, 2013, READ WRIT, V26, P205, DOI 10.1007/s11145-012-9363-x; Tamariz M, 2015, COGNITIVE SCI, V39, P171, DOI 10.1111/cogs.12144; THOMAS H, 1968, AM J PSYCHOL, V81, P551, DOI 10.2307/1421059; Trudgill P, 2011, SOCIOLINGUISTIC TYPO; Watson A. B., 2012, MATH J, V14, P1, DOI DOI 10.3888/TMJ.14-5; Wengrow D, 2008, CURR ANTHROPOL, V49, P7, DOI 10.1086/523676; Winters J, 2018, COGNITION, V176, P15, DOI 10.1016/j.cognition.2018.03.002; Wray A, 2007, LINGUA, V117, P543, DOI 10.1016/j.lingua.2005.05.005; Xiao W, 2012, BEHAV RES METHODS, V44, P954, DOI 10.3758/s13428-012-0191-3; Zhang JY, 2007, INVEST OPHTH VIS SCI, V48, P2383, DOI 10.1167/iovs.06-1195; ZIPF G. K., 1949, HUMAN BEHAVIOR AND T	64	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220793	10.1371/journal.pone.0220793	http://dx.doi.org/10.1371/journal.pone.0220793			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390374	gold, Green Published, Green Submitted			2022-12-27	WOS:000484999400028
J	Johnsen, SAL; Bollmann, J; Gebuehr, C; Herrle, JO				Johnsen, Simen Alexander Linge; Bollmann, Jorg; Gebuehr, Christina; Herrle, Jens O.			Relationship between coccolith length and thickness in the coccolithophore species Emiliania huxleyi and Gephyrocapsa oceanica	PLOS ONE			English	Article							SEAWATER CARBONATE CHEMISTRY; CALCIUM-CARBONATE; CO2 CONCENTRATION; CALCIFICATION; MORPHOLOGY; PRYMNESIOPHYCEAE; TEMPERATURE; SEA; CALIBRATION; SATURATION	Coccolith mass is an important parameter for estimating coccolithophore contribution to carbonate sedimentation, organic carbon ballasting and coccolithophore calcification. Single coccolith mass is often estimated based on the k(s) model, which assumes that length and thickness increase proportionally. To evaluate this assumption, this study compared coccolith length, thickness, and mass of seven Emiliania huxleyi strains and one Gephyrocapsa oceanica strain grown in 25, 34, and 44 salinity artificial seawater. While coccolith length increased with salinity in four E. huxleyi strains, thickness did not increase significantly with salinity in three of these strains. Only G. oceanica showed a consistent increase in length with salinity that was accompanied by an increase in thickness. Coccolith length and thickness was also not correlated in 14 of 24 individual experiments, and in the experiments in which there was a positive relationship r(2) was low (<0.4). Because thickness did not increase with length in E. huxleyi, the increase in mass was less than expected from the ks model, and thus, mass can not be accurately estimated from coccolith length alone.	[Johnsen, Simen Alexander Linge; Bollmann, Jorg] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada; [Gebuehr, Christina; Herrle, Jens O.] Goethe Univ Frankfurt, Inst Geosci, Frankfurt, Germany; [Gebuehr, Christina] Biodivers & Climate Res Ctr BIK F, Frankfurt, Germany	University of Toronto; Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Johnsen, SAL (corresponding author), Univ Toronto, Dept Earth Sci, Toronto, ON, Canada.	simen.johnsen@mail.utoronto.ca	Herrle, Jens O/B-9088-2008		NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by NSERC through J. B.'s NSERC Discovery Grant [http://www.nserccrsng.gc.ca]. NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP; Armstrong RA, 2001, DEEP-SEA RES PT II, V49, P219, DOI 10.1016/S0967-0645(01)00101-1; Batvik H, 1997, EUR J PHYCOL, V32, P155, DOI 10.1017/S0967026297001212; Baumann KH, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P367; Beaufort L, 2005, MICROPALEONTOLOGY, V51, P289, DOI 10.2113/gsmicropal.51.4.289; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beaufort L, 1999, DEEP-SEA RES PT II, V46, P2147, DOI 10.1016/S0967-0645(99)00058-2; Bell, 1999, MEASUREMENT GOOD PRA, V11, P1; Berger WH, 1985, CO2 INCREASE CLIMATE; Bollmann J, 1997, MAR MICROPALEONTOL, V29, P319, DOI 10.1016/S0377-8398(96)00028-X; Bollmann J, 2014, BIOGEOSCIENCES, V11, P1899, DOI 10.5194/bg-11-1899-2014; Bollmann J., 2013, BIOGEOSCIENCES DISCU, V10, P11155, DOI [DOI 10.5194/BGD-10-11155-2013, 10.5194/bgd-10-11155-2013]; Bollmann J., 2013, BIOGEOSCIENCES DISCU, V10, pC6961; Bollmann J, 2007, EARTH PLANET SC LETT, V255, P273, DOI 10.1016/j.epsl.2006.12.029; Bollmann J, 2010, PROTIST, V161, P78, DOI 10.1016/j.protis.2009.08.002; Bollmann J, 2009, EARTH PLANET SC LETT, V284, P320, DOI 10.1016/j.epsl.2009.05.003; Buitenhuis E, 1996, MAR ECOL PROG SER, V143, P271, DOI 10.3354/meps143271; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Charalampopoulou A, 2016, BIOGEOSCIENCES, V13, P5917, DOI 10.5194/bg-13-5917-2016; CRAIG DB, 1961, AM MINERAL, V46, P757; DERICHE R, 1987, INT J COMPUT VISION, V1, P167, DOI 10.1007/BF00123164; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Fabry V. L., 2010, GUIDE BEST PRACTICES, P201, DOI DOI 10.2777/66906; Fielding SR, 2009, LIMNOL OCEANOGR, V54, P1475, DOI 10.4319/lo.2009.54.5.1475; Fiorini S, 2011, J PHYCOL, V47, P1281, DOI 10.1111/j.1529-8817.2011.01080.x; Fox J., 2019, R COMPANION APPL REG, V.; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gibbs SJ, 2013, NAT GEOSCI, V6, P218, DOI 10.1038/ngeo1719; Gonzalez-Lemos S, 2018, BIOGEOSCIENCES, V15, P1079, DOI 10.5194/bg-15-1079-2018; Green JC, 1998, PHYCOLOGIA, V37, P121, DOI 10.2216/i0031-8884-37-2-121.1; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hagino K, 2011, J PHYCOL, V47, P1164, DOI 10.1111/j.1529-8817.2011.01053.x; Hansen E. W., 1988, Proceedings of the SPIE - The International Society for Optical Engineering, V891, P190, DOI 10.1117/12.944306; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Johnsen SAL, 2018, J MICROSC-OXFORD, V269, P321, DOI 10.1111/jmi.12641; Jones BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061868; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Langer Gerald, 2011, Journal of Nannoplankton Research, V32, P29; Langer Gerald, 2009, Journal of Nannoplankton Research, V30, P77; Leon P, 2018, ESTUAR COAST SHELF S, V202, P302, DOI 10.1016/j.ecss.2018.01.011; Lochte A.A., 2014, THESIS; McClelland HLO, 2016, SCI REP-UK, V6, DOI 10.1038/srep34263; Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; O'Dea SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6363; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Oviedo AM, 2017, ESTUAR COAST SHELF S, V186, P58, DOI 10.1016/j.ecss.2015.12.007; Paasche E, 1996, PHYCOLOGIA, V35, P394, DOI 10.2216/i0031-8884-35-5-394.1; Paasche E, 1998, EUR J PHYCOL, V33, P33, DOI 10.1017/S0967026297001480; Pena EA, 2006, J AM STAT ASSOC, V101, P341, DOI 10.1198/016214505000000637; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Rosas-Navarro A, 2016, BIOGEOSCIENCES, V13, P2913, DOI 10.5194/bg-13-2913-2016; Rost B, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P99; Saruwatari K, 2016, BIOGEOSCIENCES, V13, P2743, DOI 10.5194/bg-13-2743-2016; Schroeder DC, 2005, J PHYCOL, V41, P874, DOI 10.1111/j.1529-8817.2005.04188.x; Smith HEK, 2012, P NATL ACAD SCI USA, V109, P8845, DOI 10.1073/pnas.1117508109; Sucheras-Marx B, 2014, GLOBAL PLANET CHANGE, V123, P97, DOI 10.1016/j.gloplacha.2014.10.015; SWANN MM, 1950, J EXP BIOL, V27, P226; von Dassow P, 2018, BIOGEOSCIENCES, V15, P1515, DOI 10.5194/bg-15-1515-2018; Waldbusser GG, 2015, NAT CLIM CHANGE, V5, P273, DOI 10.1038/NCLIMATE2479; WATABE N, 1966, LIMNOL OCEANOGR, V11, P567, DOI 10.4319/lo.1966.11.4.0567; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; Young JR, 2014, BIOGEOSCIENCES, V11, P4771, DOI 10.5194/bg-11-4771-2014; Young J. R, 2003, GUIDE EXTANT COCCOLI; YOUNG JR, 1991, MAR MICROPALEONTOL, V18, P5, DOI 10.1016/0377-8398(91)90004-P; Young JR, 2000, DEEP-SEA RES PT II, V47, P1679, DOI 10.1016/S0967-0645(00)00003-5; Zeebe RE, 2012, ANNU REV EARTH PL SC, V40, P141, DOI 10.1146/annurev-earth-042711-105521; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0	70	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220725	10.1371/journal.pone.0220725	http://dx.doi.org/10.1371/journal.pone.0220725			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381588	Green Submitted, Green Published, gold			2022-12-27	WOS:000484993600031
J	Kazemian, N; Pakpour, S; Milani, AS; Klironomos, J				Kazemian, Negin; Pakpour, Sepideh; Milani, Abbas S.; Klironomos, John			Environmental factors influencing fungal growth on gypsum boards and their structural biodeterioration: A university campus case study	PLOS ONE			English	Article							BUILDING-MATERIALS; MOLD GROWTH; HEALTH; CONTAMINATION; MOISTURE; AEROSOLIZATION; ASSOCIATIONS; MYCOTOXINS; FILTRATION; PARTICLES	The new era in the design of modern healthy buildings necessitates multidisciplinary research efforts that link principles of engineering and material sciences with those of building biology, in order to better comprehend and apply underlying interactions among design criteria. As part of this effort, there have been an array of studies in relation to the effects of building characteristics on indoor microbiota and their propensity to cause health issues. Despite the abundance of scientific inquiries, limited studies have been dedicated to concomitantly link these effects to the deterioration of 'structural integrity' in the building materials. This study focuses on the observed biodeteriorative capabilities of indoor fungi upon the ubiquitous gypsum board material as a function of building age and room functionality within a university campus. We observed that the fungal growth significantly affected the physical (weight loss) and mechanical (tensile strength) properties of moisture-exposed gypsum board samples; in some cases, tensile strength and weight decreased by more than 80%. Such intertwined associations between the biodeterioration of building material properties due to viable indoor fungi, and as a function of building characteristics, would suggest a critical need towards multi-criteria design and optimization of next-generation healthy buildings. Next to structural integrity measures, with a better understanding of what factors and environmental conditions trigger fungal growth in built environment materials, we can also optimize the design of indoor living spaces, cleaning strategies, as well as emergency management measures during probable events such as flooding or water damage.	[Kazemian, Negin; Klironomos, John] Univ British Columbia, Dept Biol, Kelowna, BC, Canada; [Kazemian, Negin; Pakpour, Sepideh; Milani, Abbas S.] Univ British Columbia, Sch Engn, Kelowna, BC, Canada; [Pakpour, Sepideh] Broad Inst, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA; [Milani, Abbas S.] Okanagan Node, Composites Res Network, Kelowna, BC, Canada	University of British Columbia; University of British Columbia; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Klironomos, J (corresponding author), Univ British Columbia, Dept Biol, Kelowna, BC, Canada.; Pakpour, S; Milani, AS (corresponding author), Univ British Columbia, Sch Engn, Kelowna, BC, Canada.; Pakpour, S (corresponding author), Broad Inst, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA.; Milani, AS (corresponding author), Okanagan Node, Composites Res Network, Kelowna, BC, Canada.	sepideh.pakpour@ubc.ca; abbas.milani@ubc.ca; john.klironomos@ubc.ca	Kazemian, Negin/ABF-4238-2021	Kazemian, Negin/0000-0001-6974-5201	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work received support from Natural Sciences and Engineering Research Council of Canada; Discover Grants (A.S.M & J.K). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the University of British Columbia Okanagan campus for providing the necessary facilities for dust sample collection and the support received from different research laboratories. The financial support from the Natural Sciences and Engineering Research Council of Canada is greatly acknowledged.	Adams RI, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0112-7; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Adan OCG, 2011, FUNDAMENTALS OF MOLD GROWTH IN INDOOR ENVIRONMENTS AND STRATEGIES FOR HEALTHY LIVING, P1, DOI 10.3921/978-90-8686-722-6; Andersen B, 2017, INDOOR AIR, V27, P6, DOI 10.1111/ina.12298; Andersen B, 2002, MYCOLOGIA, V94, P392, DOI 10.2307/3761773; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; [Anonymous], 2018, INSTALL HANG DRYWALL; [Anonymous], 2018, IMAGEJ; [Anonymous], 2018, COST REMOVE DRYWALL; Baxi SN, 2016, J ALLER CL IMM-PRACT, V4, P396, DOI 10.1016/j.jaip.2016.01.008; Betancourt DA, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-283; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Cabral JPS, 2010, SCI TOTAL ENVIRON, V408, P4285, DOI 10.1016/j.scitotenv.2010.07.005; Canada Housing and Mortgage Association, REL MOIST CONT MECH; Chen Z, 2010, J MATER SCI, V45, P4444, DOI 10.1007/s10853-010-4527-z; Chew GL, 2003, ALLERGY, V58, P13, DOI 10.1034/j.1398-9995.2003.00013.x; Crawford B, 2017, MATERIALS, V10, DOI 10.3390/ma10111252; Dacarro C, 2003, J APPL MICROBIOL, V95, P904, DOI 10.1046/j.1365-2672.2003.02044.x; Dannemiller KC, 2016, INDOOR AIR, V26, P179, DOI 10.1111/ina.12205; Dedesko S, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0137-y; Drews K, 2008, MOULD GROWS; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Fisk WJ, 2007, INDOOR AIR, V17, P284, DOI 10.1111/j.1600-0668.2007.00475.x; Flannigan B, 2001, MICROORGANISMS IN HO; Flannigan B, 2011, MICROORGANISMS IN HOME AND INDOOR WORK ENVIRONMENTS: DIVERSITY, HEALTH IMPACTS, INVESTIGATION AND CONTROL, 2ND EDITION; Foarde K, 2004, J EXPO ANAL ENV EPID, V14, pS41, DOI 10.1038/sj.jea.7500357; Frankel M, 2014, INDOOR AIR, V24, P16, DOI 10.1111/ina.12055; Fromme H, 2016, INT J HYG ENVIR HEAL, V219, P143, DOI 10.1016/j.ijheh.2015.11.004; Gadd G. M., 2004, Mycologist, V18, P60, DOI 10.1017/S0269915X04002022; Genuis SJ, 2007, EUR J INTERN MED, V18, P516, DOI 10.1016/j.ejim.2007.05.005; Ghazi Wakili K, 2015, FIRE MATER, V39, P85, DOI 10.1002/fam.2234; GRANT C, 1989, INT BIODETERIOR, V25, P259, DOI 10.1016/0265-3036(89)90002-X; Guggemos AA, 2005, J INFRASTRUCT SYST, V11, P93, DOI 10.1061/(ASCE)1076-0342(2005)11:2(93); Haugland R., 2002, METHOD IDENTIFYING Q, Patent No. [6,387,652, 6387652]; Hicks JB, 2005, J OCCUP ENVIRON HYG, V2, P481, DOI 10.1080/15459620500252860; Hope J, 2013, SCI WORLD J, DOI 10.1155/2013/767482; Hyvarinen A, 2002, INT BIODETER BIODEGR, V49, P27, DOI 10.1016/S0964-8305(01)00103-2; Iino H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7828; Jamriska M, 2000, INDOOR AIR, V10, P19, DOI 10.1034/j.1600-0668.2000.010001019.x; Karunasena E, 2001, MYCOPATHOLOGIA, V150, P91, DOI 10.1023/A:1010920611811; Karunasena E, 2010, MYCOPATHOLOGIA, V170, P377, DOI 10.1007/s11046-010-9330-5; Kemp PC, 2002, INDOOR BUILT ENVIRON, V11, P214, DOI 10.1159/000066011; Khan AAH, 2012, SAUDI J BIOL SCI, V19, P405, DOI 10.1016/j.sjbs.2012.06.002; Kolarkar P, 2014, FIRE MATER, V38, P13, DOI 10.1002/fam.2155; Krause M, 2006, J OCCUP ENVIRON HYG, V3, P435, DOI 10.1080/15459620600798663; Mankowski M, 2000, WOOD FIBER SCI, V32, P340; McMullin DR, 2013, MYCOTOXIN RES, V29, P47, DOI 10.1007/s12550-012-0144-9; Mihinova D, 2012, BRATISL MED J, V113, P314, DOI 10.4149/BLL_2012_073; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; Mudarri DH, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/2386596; Muilenberg ML., 1995, THE OUTDOOR AEROSOL; Nielsen KF, 2004, INT BIODETER BIODEGR, V54, P325, DOI 10.1016/j.ibiod.2004.05.002; Nielsen KF, 1998, INT BIODETER BIODEGR, V42, P9, DOI 10.1016/S0964-8305(98)00038-9; Pasanen P, 1997, ENVIRON INT, V23, P425, DOI 10.1016/S0160-4120(97)00027-5; Pekhtasheva E, 2012, CHEM TECHNOL, V6; Phelka AD, 2012, CRIT REV TOXICOL, V42, P1, DOI 10.3109/10408444.2011.613067; Portnoy JM, 2004, J ALLERGY CLIN IMMUN, V113, P189, DOI 10.1016/j.jaci.2003.11.021; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ratnaseelan AM, 2018, CLIN THER, V40, P903, DOI 10.1016/j.clinthera.2018.05.004; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Rogers CA, 2003, IMMUNOL ALLERGY CLIN, V23, P501, DOI 10.1016/S0889-8561(03)00061-4; Sanchez-Silva M, 2008, J MATER CIVIL ENG, V20, P352, DOI 10.1061/(ASCE)0899-1561(2008)20:5(352); Sharpe R, 2014, CLIN EXP ALLERGY, V44, P631, DOI 10.1111/cea.12281; Sivasubramani SK, 2004, INDOOR AIR, V14, P405, DOI 10.1111/j.1600-0668.2004.00262.x; Tischer C, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.OA3319; Vacher S, 2010, BUILD ENVIRON, V45, P916, DOI 10.1016/j.buildenv.2009.09.011; Verdier T, 2014, BUILD ENVIRON, V80, P136, DOI 10.1016/j.buildenv.2014.05.030; Viitanen H, 2010, J BUILD PHYS, V33, P201, DOI 10.1177/1744259109343511; Wani KA, 2014, INDOOR BUILT ENVIRON, V23, P724, DOI 10.1177/1420326X13480374; Webb JS, 2000, APPL ENVIRON MICROB, V66, P3194, DOI 10.1128/AEM.66.8.3194-3200.2000; Yan L, 2015, FOREST PROD J, V65, P272, DOI 10.13073/FPJ-D-14-00085; Zhao D, 2015, INT J ENV RES PUB HE, V12, P8448, DOI 10.3390/ijerph120708448	72	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220556	10.1371/journal.pone.0220556	http://dx.doi.org/10.1371/journal.pone.0220556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374095	Green Submitted, Green Published, gold			2022-12-27	WOS:000484991500018
J	Bricout, H; Torcel-Pagnon, L; Lecomte, C; Almas, MF; Matthews, I; Lu, XY; Wheelock, A; Sevdalis, N				Bricout, Helene; Torcel-Pagnon, Laurence; Lecomte, Coralie; Almas, Mariana F.; Matthews, Ian; Lu, Xiaoyan; Wheelock, Ana; Sevdalis, Nick			Determinants of shingles vaccine acceptance in the United Kingdom	PLOS ONE			English	Article							HERPES-ZOSTER VACCINATION; POSTHERPETIC NEURALGIA; INFLUENZA VACCINATION; PUBLIC AWARENESS; BARRIERS; PREDICTORS; DECISION; COVERAGE; ENGLAND; PROGRAM	Background The United Kingdom (UK) was the first European country to introduce a national immunisation program for shingles (2013-2014). That year, vaccination coverage ranged from 50 to 64% across the UK, but uptake has declined ever since. This study explored determinants of the acceptance of the shingles vaccine in the UK. Methods Vaccinated and unvaccinated individuals, who were eligible for the last catch-up cohort of the 2014-2015 shingles vaccination campaign, were identified using the Clinical Practice Research Datalink (the National Health Service data research service) and invited to participate by their general practitioner (GP). An anonymised self-administered questionnaire was developed using the Health Belief Model as a theoretical framework, to collect data on demographic and socio-economic characteristics, health status, knowledge, influences, experiences and attitudes to shingles and the shingles vaccine. Multivariable logistic regression was used to identify the factors associated with vaccination. Physicians' views concerning perceived barriers to vaccination were also assessed. Results Of the 2,530 questionnaires distributed, 536 were returned (21.2%) from 69 general practices throughout the UK. The majority of responders were female (58%), lived in care homes (56%) and had completed secondary or higher education (88%). There were no differences between vaccinated and unvaccinated responders. Being offered the shingles vaccine by a GP/nurse (odds ratio (OR) = 2.3), and self-efficacy (OR = 1.2) were associated with being vaccinated (p<0.05). In contrast, previous shingles history (OR = 0.4), perceived barriers to vaccination (OR = 0.7) and perceived control of the disease (OR = 0.7) were associated with not being vaccinated against shingles (p<0.05). Less than half (44.0%) of GPs were aware of the local communication campaigns regarding shingles and the shingles vaccine. Conclusions Socio-psychological factors largely influence shingles vaccination acceptance in this study. The results add to existing evidence that healthcare providers (HCPs) have a pivotal role against vaccine hesitancy. Campaigns focusing on GPs and accessible information offered to eligible members of the public can further enhance shingles vaccine uptake.	[Bricout, Helene; Torcel-Pagnon, Laurence] Sanofi Pasteur, Lyon, France; [Lecomte, Coralie] IQVIA, Ouen, France; [Almas, Mariana F.] IQVIA, Slough, Berks, England; [Matthews, Ian] MSD Ltd, Maidenhead, Berks, England; [Lu, Xiaoyan] MSD Vaccins, Lyon, France; [Wheelock, Ana] Imperial Coll London, Natl Inst Hlth Res, Dept Surg & Canc, Imperial Patient Safety Translat Res Ctr, London, England; [Sevdalis, Nick] Kings Coll London, Ctr Implementat Sci, London, England	Sanofi-Aventis; Sanofi France; IQVIA; IQVIA; Merck & Company; Imperial College London; University of London; King's College London	Lu, XY (corresponding author), MSD Vaccins, Lyon, France.	xiaoyan.lu@msd.com	Sevdalis, Nick/AAJ-6280-2020; Wheelock, Ana/AAE-9248-2019	Sevdalis, Nick/0000-0001-7560-8924; Wheelock, Ana/0000-0003-0855-7252; Lu, Xiaoyan/0000-0002-5592-7239; Helene, BRICOUT/0000-0002-5439-8064; Matthews, Ian/0000-0001-6175-6512	Sanofi Pasteur MSD; MSD	Sanofi Pasteur MSD; MSD	This work was funded initially by Sanofi Pasteur MSD and lately by MSD from January 2017. Bricout H, Torcel-Pagnon L, Wheelock A and Sevdalis N contributed to the conception/design of the study. Matthews I, Lu X, Lecomte C and Almas MF drafted the initial manuscript. Bricout H and Torcel-Pagnon L were employee of Sanofi Pasteur MSD. Matthews I and Lu X are employed by MDS. Wheelock A and Sevdalis N have received consultancy fees from of Sanofi Pasteur MSD and MDS. Lecomte C and Almas M are employed by IQVIA which received funds from Sanofi Pasteur MSD and MSD to conduct the study. The funder provided support in the form of salaries for authors Bricout H, Torcel-Pagnon L, Matthews I, and Lu X, but did not have any additional role in the study design, data collection of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Amirthalingam G, 2018, LANCET PUBLIC HEALTH, V3, pE82, DOI 10.1016/S2468-2667(17)30234-7; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Eid Deeb D, 2015, Consult Pharm, V30, P459, DOI 10.4140/TCP.n.2015.459; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Health Protection Scotland, SHINGL HERP ZOST VAC; Hurley LP, 2010, ANN INTERN MED, V152, P555, DOI 10.7326/0003-4819-152-9-201005040-00005; Javed Saba, 2012, Dermatol Online J, V18, P2; Kohlhammer Y, 2007, PUBLIC HEALTH, V121, P742, DOI 10.1016/j.puhe.2007.02.011; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lehmann BA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-547; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; Matthews I, 2018, VACCINE, V36, P7105, DOI 10.1016/j.vaccine.2018.08.037; Mick G, 2013, J CLIN GERONTOL GERI, V4, P102, DOI DOI 10.1016/j.jcgg.2013.03.001; Nexoe J, 1999, SCAND J PRIM HEALTH, V17, P105, DOI 10.1080/028134399750002737; Nunnally J. C., 1978, PSYCHOMETRIC THEORY, V2nd; Opstelten W, 2009, VACCINE, V27, P192, DOI 10.1016/j.vaccine.2008.10.047; Paek E, 2010, GERONTOLOGY, V56, P20, DOI 10.1159/000240046; Preston CC, 2000, ACTA PSYCHOL, V104, P1, DOI 10.1016/S0001-6918(99)00050-5; Public Health Agency, ANN IMM VACC PREV DI; Public Health England, HERP ZOST SHINGL IMM; Public Health England, 2014, HERP ZOST SHINGL IMM; Public Health Wales, SHINGL IMM UPT DAT; Robinson A, 2001, QUAL HEALTH CARE, V10, pI34; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Rubin D. B., 2004, MULTIPLE IMPUTATION; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Sheldon H., INCREASING RESPONSE; Shim E, 2012, J R SOC INTERFACE, V9, P2234, DOI 10.1098/rsif.2012.0115; Shiraki K, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx007; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Teeter BS, 2014, VACCINE, V32, P5749, DOI 10.1016/j.vaccine.2014.08.040; Valente N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011539; Walker JL, 2018, VACCINE, V36, P2371, DOI 10.1016/j.vaccine.2018.02.021; Ward C, 2017, VACCINE, V35, P2372, DOI 10.1016/j.vaccine.2017.03.042; Wheelock A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014668; Wheelock A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113503; World Health Organization (WHO), REP SAGE WORK GROUP; Yang TU, 2015, HUM VACC IMMUNOTHER, V11, P719, DOI 10.1080/21645515.2015.1008885; Zhang DM, 2017, AM J PREV MED, V52, pE17, DOI 10.1016/j.amepre.2016.08.029	42	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220230	10.1371/journal.pone.0220230	http://dx.doi.org/10.1371/journal.pone.0220230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369608	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900037
J	Choi, M; Youn, H; Kim, D; Lee, S; Suh, S; Seong, JK; Jeong, HG; Han, CE				Choi, Myungwon; Youn, HyunChul; Kim, Daegyeom; Lee, Suji; Suh, Sangil; Seong, Joon-Kyung; Jeong, Hyun-Ghang; Han, Cheol E.			Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; CORTICAL THICKNESS; NEUROPSYCHOLOGICAL ASSESSMENT; NEUROFIBRILLARY TANGLES; DISEASE; DECLINE; VOLUME; CERAD; AREA	Several metrics of analysis of magnetic resonance imaging (MRI) have been used to assess Alzheimer's disease (AD)-related neurodegeneration. We compared four structural brain MRI analysis metrics, cortical thickness, volume, surface area, and local gyrification index (LGI), in different stages of AD-related cognitive decline. Participants with normal cognition, mild cognitive impairment, and AD were included (34 participants per group). All undertook the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) battery of neuropsychological tests and brain MRI scanning. We analyzed associations between morphometric measures and CERAD total/Mini Mental State Examination (MMSE) scores for the regions of interest (ROIs), identifying three types of curves: U-shaped, inverted U-shaped, and linear. Cortical thickness and volume analyses showed linear types in most of the significant ROIs. Significant ROIs for the cortical thickness analysis were located in the temporal and limbic lobes, whereas those for volume and surface area were distributed over more diffuse areas of the brain. LGI analysis showed few significant ROIs. CERAD total scores were more sensitive to early changes of cortical structures than MMSE scores. Cortical thickness analysis may be preferable in assessing brain structural MRI changes during AD-related cognitive decline, whereas LGI analysis may have limited capability to reflect the cognitive decrease. Our findings may provide a reference for future studies and help to establish optimal analytical approaches to brain structural MRI in neurodegenerative diseases.	[Choi, Myungwon; Kim, Daegyeom; Han, Cheol E.] Korea Univ, Dept Elect & Informat Engn, Sejong, South Korea; [Youn, HyunChul; Jeong, Hyun-Ghang] Korea Univ, Guro Hosp, Dept Psychiat, Coll Med, Seoul, South Korea; [Lee, Suji] Korea Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea; [Suh, Sangil] Korea Univ, Guro Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Seong, Joon-Kyung] Korea Univ, Dept Bioconvergence Engn, Seoul, South Korea; [Jeong, Hyun-Ghang] Korea Univ, Res Inst Mental Hlth, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University; Korea University Medicine (KU Medicine)	Han, CE (corresponding author), Korea Univ, Dept Elect & Informat Engn, Sejong, South Korea.; Jeong, HG (corresponding author), Korea Univ, Guro Hosp, Dept Psychiat, Coll Med, Seoul, South Korea.; Jeong, HG (corresponding author), Korea Univ, Res Inst Mental Hlth, Seoul, South Korea.	jeonghg@korea.ac.kr; cheolhan@korea.ac.kr	Han, Cheol/AAR-9212-2021	Jeong, Hyun-Ghang/0000-0002-0318-5069	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C1509]; National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT, MSIT) [NRF-2015R1C1A1A01052172]; National Research Foundation (NRF) of Korea - Ministry of Education [2016R1D1A1B03934990]; ICT R&D program of MSIP/IITP [R7124-16-0004]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT, MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation (NRF) of Korea - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); ICT R&D program of MSIP/IITP(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea)	This work was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) that was funded by the Ministry of Health & Welfare, Republic of Korea (HC15C1509 to HG Jeong) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) granted funded by the Korea government (Ministry of Science and ICT, MSIT) (NRF-2015R1C1A1A01052172 to HG Jeong). The URLs are https://www.khidi.or.kr/kps and http://nrf.re.kr/index, respectively. Additional funding came from the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (2016R1D1A1B03934990 to CE Han), and by ICT R&D program of MSIP/IITP (R7124-16-0004 to CE Han, Development of Intelligent Interaction Technology Based on Context Awareness and Human Intention Understanding). The URL is http://nrf.re.kr/index. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2000, ARCH GEN PSYCHIAT, V57, P47, DOI 10.1001/archpsyc.57.1.47; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Bilello M, 2015, J ALZHEIMERS DIS, V48, P987, DOI 10.3233/JAD-150400; Braak H, 2000, ANN NY ACAD SCI, V924, P53; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chandler MJ, 2005, NEUROLOGY, V65, P102, DOI 10.1212/01.wnl.0000167607.63000.38; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gautam P, 2015, BEHAV BRAIN RES, V287, P331, DOI 10.1016/j.bbr.2015.03.018; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Jubault T, 2011, NEUROIMAGE, V55, P462, DOI 10.1016/j.neuroimage.2010.12.043; Kemper TL, 1994, NEUROANATOMICAL NEUR, P3; Lebed E, 2013, IEEE T MED IMAGING, V32, P660, DOI 10.1109/TMI.2012.2230640; Lee JH, 2002, J GERONTOL B-PSYCHOL, V57, pP47, DOI 10.1093/geronb/57.1.P47; 이동영, 2002, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V41, P508; Lee SB, 2009, DEMENT GERIATR COGN, V28, P23, DOI 10.1159/000228841; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Li SY, 2014, J NEUROSCI, V34, P10541, DOI 10.1523/JNEUROSCI.4356-13.2014; Liu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031083; Liu YW, 2010, NEUROBIOL AGING, V31, P1375, DOI 10.1016/j.neurobiolaging.2010.01.022; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miller BL, 2017, BEHAV NEUROLOGY DEME; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Narr KL, 2004, BIOL PSYCHIAT, V55, P859, DOI 10.1016/j.biopsych.2003.12.027; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pini L, 2016, AGEING RES REV, V30, P25, DOI 10.1016/j.arr.2016.01.002; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2004, SCIENCE, V303, P1983, DOI 10.1126/science.1096414; Rettmann ME, 2006, CEREB CORTEX, V16, P1584, DOI 10.1093/cercor/bhj095; Risacher SL, 2017, NEUROLOGY, V89, P2176, DOI 10.1212/WNL.0000000000004670; de Miras JR, 2017, HUM BRAIN MAPP, V38, P5905, DOI 10.1002/hbm.23773; Salat DH, 2011, NEUROIMAGE, V54, P1795, DOI 10.1016/j.neuroimage.2010.10.034; Schaer M, 2008, IEEE T MED IMAGING, V27, P161, DOI 10.1109/TMI.2007.903576; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; SVENNERHOLM L, 1994, J NEUROCHEM, V62, P1039; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Velayudhan L, 2013, J ALZHEIMERS DIS, V33, P755, DOI 10.3233/JAD-2012-121408; Westlye LT, 2009, NEUROIMAGE, V47, P1545, DOI 10.1016/j.neuroimage.2009.05.084; Winkler AM, 2018, CEREB CORTEX, V28, P738, DOI 10.1093/cercor/bhx308	56	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220739	10.1371/journal.pone.0220739	http://dx.doi.org/10.1371/journal.pone.0220739			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369629	gold, Green Published, Green Submitted			2022-12-27	WOS:000484987900082
J	Dolan, M; Mastri, M; Tracz, A; Christensen, JG; Chatta, G; Ebos, JML				Dolan, Melissa; Mastri, Michalis; Tracz, Amanda; Christensen, James G.; Chatta, Gurkamal; Ebos, John M. L.			Enhanced efficacy of sitravatinib in metastatic models of antiangiogenic therapy resistance	PLOS ONE			English	Article							TARGETED THERAPY; TUMOR-GROWTH; ANGIOGENESIS; INHIBITOR; VEGF; RECEPTORS; SUNITINIB; EPHRIN-B2; CANCER; MET	Tyrosine kinase inhibitors (TKIs) that primarily target angiogenesis are approved to treat several cancers in the metastatic setting; however, resistance is common. Sequential treatment or 'switching' from one TKI to another following failure can be effective, but predicting which drugs will have cross-over sensitivity remains a challenge. Here we examined sitravatinib (MGCD516), a spectrum-selective TKI able to block MET, TAM (TYRO3, AXL, MerTK) and multiple receptor families (including PDGFRs, VEGFRs, and Ephs). Transcriptomic analysis of several mouse and human cell lines revealed diverse molecular changes after resistance to two TKIs (sunitinib and axitinib) with multiple sitravatinib targets found to be upregulated. Sitravatinib treatment in vitro resulted in enhanced anti-proliferative effects in resistant cells and was improved compared to TKIs with similar target profiles. In vivo, primary tumor growth inhibition after sitravatinib treatment in mice was enhanced in resistant tumors and metastasis suppression improved when tumors were surgically removed. Together, these results suggest that the diverse and often inconsistent compensatory signaling mechanisms found to contribute to TKI resistance may paradoxically improve the tumor-inhibiting effects of broad-spectrum TKIs such as sitravatinib that are able to block multiple signaling pathways. Sitravatinib in the second-line setting following antiangiogenic TKI treatment may have enhanced inhibitory effects in local and disseminated disease, and improve outcomes in patients with refractory disease.	[Dolan, Melissa; Ebos, John M. L.] Roswell Pk Comprehens Canc Ctr, Dept Expt Therapeut, Buffalo, NY 14203 USA; [Mastri, Michalis; Tracz, Amanda; Ebos, John M. L.] Roswell Pk Comprehens Canc Ctr, Dept Canc Genet & Genom, Buffalo, NY 14203 USA; [Chatta, Gurkamal; Ebos, John M. L.] Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY 14203 USA; [Christensen, James G.] Mirati Therapeut, San Diego, CA USA		Ebos, JML (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Expt Therapeut, Buffalo, NY 14203 USA.; Ebos, JML (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Canc Genet & Genom, Buffalo, NY 14203 USA.; Ebos, JML (corresponding author), Roswell Pk Comprehens Canc Ctr, Dept Med, Buffalo, NY 14203 USA.	John.Ebos@RoswellPark.org		Dolan, Melissa/0000-0002-8425-7780; Ebos, John/0000-0002-7175-9044	Roswell Park Cancer Institute (RPCI) Support Grant from the National Cancer Institute (NCI) [P30CA016056]; Roswell Park Alliance Foundation (RPAF); American Cancer Society (ACS) [RSG-18-064-01 - TBG]; Department of Defense (DoD) through the Peer Reviewed Cancer Research Program [W81XWH-14-1-0210]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Roswell Park Cancer Institute (RPCI) Support Grant from the National Cancer Institute (NCI); Roswell Park Alliance Foundation (RPAF); American Cancer Society (ACS)(American Cancer Society); Department of Defense (DoD) through the Peer Reviewed Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work used shared resources supported by Roswell Park Cancer Institute (RPCI) Support Grant from the National Cancer Institute (NCI) (P30CA016056) and was supported by the Roswell Park Alliance Foundation (RPAF); the American Cancer Society (ACS) via a Research Scholar Grant (RSG-18-064-01 - TBG); and, the Department of Defense (DoD) through the Peer Reviewed Cancer Research Program (Award No. W81XWH-14-1-0210), all to JMLE. Mirati Therapeutics also provided support in the form of salaries (AT) via a sponsored research agreement to JMLE, with roles articulated in the 'Author Contribution' sections. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marrawi MY, 2013, TARGET ONCOL, V8, P203, DOI 10.1007/s11523-012-0252-7; Azad NS, 2008, J CLIN ONCOL, V26, P3709, DOI 10.1200/JCO.2007.10.8332; Benzekry S, 2016, CANCER RES, V76, P535, DOI 10.1158/0008-5472.CAN-15-1389; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Chowdhury S, 2017, P AN M AM SOC CLIN, V35, P4506, DOI DOI 10.1200/JC0.2017.35.15_; Cook RS, 2013, J CLIN INVEST, V123, P3231, DOI 10.1172/JCI67655; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du WT, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124184; Ebos J, 2016, CURR DRUG TARGETS; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; Ebos JML, 2014, EMBO MOL MED, V6, P1561, DOI 10.15252/emmm.201403989; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Gacche RN, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.14; Gacche RN, 2018, DRUG RESIST UPDATE, V36, P47, DOI 10.1016/j.drup.2018.01.002; Gao YA, 2018, TOXINS, V10, DOI 10.3390/toxins10010013; Germain S, 2010, NAT MED, V16, P752, DOI 10.1038/nm0710-752; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Guerin E, 2013, CANCER RES, V73, P2743, DOI 10.1158/0008-5472.CAN-12-4183; Jimenez-Valerio G, 2016, CURR DRUG TARGETS, V17, P1728, DOI 10.2174/1389450117666160301101425; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Kasikara C, 2017, MOL CANCER RES, V15, P753, DOI 10.1158/1541-7786.MCR-16-0350; Ko B, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.09; Kuczynski EA, 2013, NAT REV CLIN ONCOL, V10, P571, DOI 10.1038/nrclinonc.2013.158; Lai YC, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0530-2; Leal TA, 2017, J THORAC ONCOL, V12, pS1567, DOI 10.1016/j.jtho.2017.09.046; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JL, 2011, CANCER RES, V71, P6073, DOI 10.1158/0008-5472.CAN-11-1704; Ma Shaolin, 2018, F1000Res, V7, P326, DOI 10.12688/f1000research.11771.1; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mastri M, 2018, CELL REP, V25, P3706, DOI 10.1016/j.celrep.2018.12.017; Mastri M, 2018, MOL CANCER THER, V17, P1602, DOI 10.1158/1535-7163.MCT-17-1066; Mastri M, 2016, CURR DRUG TARGETS, V17, P1747, DOI 10.2174/1389450117666151209123544; Motzer RJ, 2019, NEW ENGL J MED, V380, P1103, DOI 10.1056/NEJMoa1816047; Msaouel P, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.6_suppl.TPS708; Pant S, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.4568; Paolino M, 2016, CANCERS, V8, DOI 10.3390/cancers8100097; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Patwardhan PP, 2016, ONCOTARGET, V7, P4093, DOI 10.18632/oncotarget.6547; Rini BI, 2019, NEW ENGL J MED, V380, P1116, DOI 10.1056/NEJMoa1816714; Rini BI, 2010, J CLIN ONCOL, V28, pE284, DOI 10.1200/JCO.2009.27.1759; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Schmidinger Manuela, 2013, EJC Suppl, V11, P172, DOI 10.1016/j.ejcsup.2013.07.016; Shojaei F, 2012, CANCER LETT, V320, P48, DOI 10.1016/j.canlet.2012.01.026; Spina A, 2015, BIOMEDICINES, V3, P71, DOI 10.3390/biomedicines3010071; Tracz A, 2014, JOVE-J VIS EXP, DOI 10.3791/51485; Uhl C, 2018, ANGIOGENESIS, V21, P873, DOI 10.1007/s10456-018-9633-6; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; Zembruski NCL, 2012, ANAL BIOCHEM, V429, P79, DOI 10.1016/j.ab.2012.07.005; Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343	54	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220101	10.1371/journal.pone.0220101	http://dx.doi.org/10.1371/journal.pone.0220101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369645	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900023
J	Kumthip, K; Khamrin, P; Ushijima, H; Maneekarn, N				Kumthip, Kattareeya; Khamrin, Pattara; Ushijima, Hiroshi; Maneekarn, Niwat			Enteric and non-enteric adenoviruses associated with acute gastroenteritis in pediatric patients in Thailand, 2011 to 2017	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CHILDREN; VIRUSES; INFECTION; INFANTS	Human adenovirus (HAdV) is known to be a common cause of diarrhea in children worldwide. Infection with adenovirus is responsible for 2-10% of diarrheic cases. To increase a better understanding of the prevalence and epidemiology of HAdV infection, a large scale and long-term study was needed. We implemented a multi-year molecular detection and characterization study of HAdV in association with acute gastroenteritis in Chiang Mai, Thailand from 2011 to 2017. Out of 2,312 patients, HAdV was detected in 165 cases (7.2%). The positive rate for HAdV infection was highest in children of 1 and 2 years of age compared to other age groups. HAdV subgroup C (40.6%) was the most prevalent, followed by subgroups F (28.5%), B (20.6%), A and D (4.8% each), and E (0.6%). Of these, HAdV-F41 (22.4%), HAdV-C2 (18.2%), HAdV-B3 (15.2%), and HAdV-C1 (13.3%) were the most common genotypes detected. HAdV infection occurred throughout the year with a higher detection rate between May and July. In conclusion, our study demonstrated the infection rate, seasonal distribution and genotype diversity of HAdV infection in children with diarrhea in Chiang Mai, Thailand over a period of 7 year. Not only enteric adenovirus (F40 and F41) but also non-enteric adenovirus (B3, C1, C2) may play an important role in gastroenteritis in this area. The information will be beneficial for the prevention and control of HAdV outbreaks in the future.	[Kumthip, Kattareeya; Khamrin, Pattara; Maneekarn, Niwat] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand; [Kumthip, Kattareeya; Khamrin, Pattara; Maneekarn, Niwat] Chiang Mai Univ, Ctr Excellence Emerging & Re Emerging Diarrhea Vi, Chiang Mai, Thailand; [Ushijima, Hiroshi] Univ Tokyo, Sch Int Hlth, Grad Sch Med, Dept Dev Med Sci, Tokyo, Japan; [Ushijima, Hiroshi] Nihon Univ, Dept Pathol & Microbiol, Div Microbiol, Sch Med, Tokyo, Japan	Chiang Mai University; Chiang Mai University; University of Tokyo; Nihon University	Maneekarn, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand.; Maneekarn, N (corresponding author), Chiang Mai Univ, Ctr Excellence Emerging & Re Emerging Diarrhea Vi, Chiang Mai, Thailand.	niwat.m@cmu.ac.th			Thailand Research Fund [KKMRG6180145]	Thailand Research Fund(Thailand Research Fund (TRF))	This work was supported by the grant from the Thailand Research Fund (KKMRG6180145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2017, J MED VIROL, V89, P606, DOI 10.1002/jmv.24672; Chaimongkol N, 2012, CLIN LAB, V58, P117; Desselberger Ulrich, 2014, VirusDisease, V25, P147, DOI 10.1007/s13337-014-0223-y; Dey SK, 2013, EPIDEMIOL INFECT, V141, P958, DOI 10.1017/S0950268812001586; Dey SK, 2009, INFECT GENET EVOL, V9, P518, DOI 10.1016/j.meegid.2009.02.001; Echavarria M., 2009, Principles and practice of clinical virology, P463, DOI 10.1002/9780470741405.ch19; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; Huh JW, 2009, J CLIN VIROL, V44, P152, DOI 10.1016/j.jcv.2008.11.016; Kim JS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1602054; Kittigul L, 2009, J MED VIROL, V81, P345, DOI 10.1002/jmv.21380; Lazic G, 2015, FOOD ENV VIROL; Lee JI, 2012, MICROBIOL IMMUNOL, V56, P523, DOI 10.1111/j.1348-0421.2012.00469.x; Liu LY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088791; Moyo SJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0666-1; Nakanishi K, 2009, J CLIN VIROL, V46, P94, DOI 10.1016/j.jcv.2009.06.014; Pereira E, 2007, J MED MICROBIOL, V56, P313, DOI 10.1099/jmm.0.46685-0; Qiu FZ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3340-1; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Scott MK, 2016, EMERG INFECT DIS, V22, P1044, DOI 10.3201/eid2206.151898; Sriwanna P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-193; UHNOO I, 1984, J CLIN MICROBIOL, V20, P365, DOI 10.1128/JCM.20.3.365-372.1984; Verma H, 2009, J MED VIROL, V81, P60, DOI 10.1002/jmv.21331; Yan Hainian, 2004, Kansenshogaku Zasshi, V78, P699	24	30	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220263	10.1371/journal.pone.0220263	http://dx.doi.org/10.1371/journal.pone.0220263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369615	Green Submitted, gold, Green Published			2022-12-27	WOS:000484987900039
J	Soontararak, S; Chow, L; Johnson, V; Coy, J; Webb, C; Wennogle, S; Dow, S				Soontararak, Sirikul; Chow, Lyndah; Johnson, Valerie; Coy, Jonathan; Webb, Craig; Wennogle, Sara; Dow, Steven			Humoral immune responses against gut bacteria in dogs with inflammatory bowel disease	PLOS ONE			English	Article							IMMUNOGLOBULIN-A; CHRONIC ENTEROPATHIES; DUODENAL BIOPSIES; FECAL BACTERIA; EXPRESSION; ANTIBODIES; MICROBIOTA; COLITIS; CATS	Inflammatory bowel disease (IBD) in dogs is associated with clinical signs of intestinal dysfunction, as well as abnormal lymphocytic and myeloid cell infiltrates in the small and/or large intestine. Thus, in many respects IBD in dogs resembles IBD in humans. However, the factors that trigger intestinal inflammation in dogs with IBD are not well understood and have been variously attributed to immune responses against dietary antigens or intestinal antigens. Previous studies in humans with IBD have documented increased production of IgG and IgA antibodies specific to intestinal bacteria, and this abnormal immune response has been linked to disease pathogenesis. Therefore, we investigated the humoral immune response against gut bacteria in dogs with IBD, using flow cytometry to quantitate IgG and IgA binding. Studies were also done to investigate the source of these antibodies (locally produced versus systemic production) and whether greater antibody binding to bacteria is associated with increased inflammatory responses. We found that dogs with IBD had significantly higher percentages and overall amounts of IgG bound to their intestinal bacteria compared to healthy dogs. Similarly, significantly higher percentages of bacteria were IgA(+) bacteria were also found in dogs with IBD. Serum antibody recognition of gut bacteria was not different between healthy dogs and dogs with IBD, suggesting that anti-bacterial antibodies were primarily produced locally in the gut rather than systemically. Importantly, bacteria in the Actinobacteria phylum and in particular the genus Collinsella had significantly greater levels of antibody binding in dogs with IBD. Based on these findings, we concluded that antibody binding to commensal gut bacteria was significantly increased in dogs with IBD, that particular phyla were preferential targets for gut antibodies, and that anti-bacterial antibody responses may play an important role in regulating gut inflammation.	[Soontararak, Sirikul; Chow, Lyndah; Johnson, Valerie; Coy, Jonathan; Webb, Craig; Wennogle, Sara; Dow, Steven] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA	Colorado State University	Dow, S (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Clin Sci, Ft Collins, CO 80523 USA.	sdow@colostate.edu		Soontararak, Sirikul/0000-0003-2042-7848; Jablonski, Sara/0000-0002-6486-3644	Shipley Foundation; Kasetsart Veterinary Development Fund of Thailand	Shipley Foundation; Kasetsart Veterinary Development Fund of Thailand	This study was supported by the Shipley Foundation (SD), and by the Kasetsart Veterinary Development Fund of Thailand (salary support for SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; AlShawaqfeh MK, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix136; [Anonymous], 2017, Journal of Veterinary Internal Medicine, V31, P1225, DOI 10.1111/jvim.14778; Armstrong H, 2019, MICROBIOME, V7, DOI 10.1186/s40168-018-0604-3; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; BoseDasgupta S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003879; Brandtzaeg P, 2006, ADV EXP MED BIOL, V579, P149; Brandtzaeg P, 2010, CURR OPIN GASTROEN, V26, P554, DOI 10.1097/MOG.0b013e32833dccf8; Burgener IA, 2008, J VET INTERN MED, V22, P553, DOI 10.1111/j.1939-1676.2008.0093.x; Cao XY, 2006, INT J ANTIMICROB AG, V27, P431, DOI 10.1016/j.ijantimicag.2005.12.010; Chiodini RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134382; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Frehn L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106750; Furrie E, 2004, GUT, V53, P91, DOI 10.1136/gut.53.1.91; German AJ, 2003, J VET INTERN MED, V17, P8, DOI 10.1111/j.1939-1676.2003.tb01318.x; German AJ, 2001, J VET INTERN MED, V15, P14, DOI 10.1892/0891-6640(2001)015&lt;0014:ICPWTD&gt;2.3.CO;2; GROVE DI, 1977, INT ARCH ALLER A IMM, V54, P422, DOI 10.1159/000231857; Gunawardana SC, 1997, J AM VET MED ASSOC, V211, P318; Haas A, 2011, GUT, V60, P1506, DOI 10.1136/gut.2010.224774; Harmsen HJM, 2012, CLIN VACCINE IMMUNOL, V19, P515, DOI 10.1128/CVI.05517-11; Hartley G, 2017, VET COMP ONCOL, V15, P534, DOI 10.1111/vco.12197; Heilmann RM, 2018, J VET INTERN MED; Heilmann RM, 2014, VET IMMUNOL IMMUNOP, V158, P156, DOI 10.1016/j.vetimm.2014.01.006; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hullar MAJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197686; Iltanen S, 2006, INFLAMM BOWEL DIS, V12, P389, DOI 10.1097/01.MIB.0000218765.84087.42; Jergens AE, 2003, J VET INTERN MED, V17, P291, DOI 10.1892/0891-6640(2003)017&lt;0291:ASIFDA&gt;2.3.CO;2; Jergens Albert E, 2012, Front Biosci (Elite Ed), V4, P1404; Jergens AE, 2009, COMPARATIVE MED, V59, P153; Lin RT, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1723-0; Littler RM, 2006, VET REC, V158, P334, DOI 10.1136/vr.158.10.334; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; Maeda S, 2013, J VET INTERN MED, V27, P47, DOI 10.1111/jvim.12023; Marks SL, 2011, J VET INTERN MED, V25, P1195, DOI 10.1111/j.1939-1676.2011.00821.x; McMahon LA, 2010, VET IMMUNOL IMMUNOP, V135, P158, DOI 10.1016/j.vetimm.2009.11.012; Morikawa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163607; Olsson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133844; Otoni CC, 2018, J VET INTERN MED; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Pascal V., 2017, GUT, DOI [10.1136/gutjnl-2016-313235, DOI 10.1136/GUTJNL-2016-313235]; Peiravan A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200685; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ramadan Z, 2014, J VET INTERN MED, V28, P59, DOI 10.1111/jvim.12261; Schmitz S, 2016, VET MED SCI, V2, P71, DOI 10.1002/vms3.17; Simpson KW, 2006, INFECT IMMUN, V74, P4778, DOI 10.1128/IAI.00067-06; Soontararak S, 2018, STEM CELLS TRANSL ME; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051907; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Suchodolski JS, 2010, VET MICROBIOL, V142, P394, DOI 10.1016/j.vetmic.2009.11.002; van der Waaij LA, 2004, EUR J GASTROEN HEPAT, V16, P669, DOI 10.1097/01.meg.0000108346.41221.19; van der Waaij LA, 2003, THESIS; Vazquez-Baeza Y, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.177, 10.1038/nmicrobiol.2016.177]; Walker D, 2013, J VET INTERN MED, V27, P862, DOI 10.1111/jvim.12093; Washabau RJ, 2010, J VET INTERN MED, V24, P10, DOI 10.1111/j.1939-1676.2009.0443.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xenoulis PG, 2008, FEMS MICROBIOL ECOL, V66, P579, DOI 10.1111/j.1574-6941.2008.00556.x	59	9	9	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220522	10.1371/journal.pone.0220522	http://dx.doi.org/10.1371/journal.pone.0220522			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369623	gold, Green Submitted, Green Published			2022-12-27	WOS:000484987900061
J	Utermoehlen, O; Jakobshagen, K; Blissenbach, B; Wiegmann, K; Merz, T; Hefti, JP; Kronke, M				Utermoehlen, Olaf; Jakobshagen, Kristin; Blissenbach, Birgit; Wiegmann, Katja; Merz, Tobias; Hefti, Jacqueline Pichler; Kroenke, Martin			Emergence of AnnexinV(pos) CD31(neg) CD42b(low/neg) extracellular vesicles in plasma of humans at extreme altitude	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; VE-CADHERIN; ENDOTHELIAL MICROPARTICLES; ADHESION MOLECULE-1; OXIDATIVE STRESS; PLATELETS; ADHERENCE; JUNCTIONS; DISTINCT; RELEASE	Background Hypobaric hypoxia has been reported to cause endothelial cell and platelet dysfunction implicated in the formation of microvascular lesions, and in its extremes may contribute to vascular leakage in high altitude pulmonary edema or blood brain barrier disruption leading to cerebral micro-hemorrhage (MH). Platelet function in the development of microvascular lesions remained ill defined, and is still incompletely understood. In this study platelet-and endothelial cell-derived extracellular vesicles (PEV and EEV, respectively) and cell adhesion molecules were characterized in plasma samples of members of a high altitude expedition to delineate the contribution of platelets and endothelial cells to hypobaric hypoxiainduced vascular dysfunction. Methods and findings In this observational study, platelet and endothelial cell-derived extracellular vesicles were analysed by flow-cytometry in plasma samples from 39 mountaineers participating in a medical research climbing expedition to Himlung Himal, Nepal, 7,050m asl. Megakaryocyte/platelet-derived AnnexinV(pos), PECAM-1 (CD31) and glycoprotein-1b (GP1b, CD42b) positive extracellular vesicles (PEV) constituted the predominant fraction of EV in plasma samples up to 6,050m asl. Exposure to an altitude of 7,050m led to a marked decline of CD31(pos) CD42(neg) EEV as well as of CD31(pos) CD42b(pos) PEV at the same time giving rise to a quantitatively prevailing CD31(neg) CD42b(low/neg) subpopulation of AnnexinV(pos) EV. An almost hundredfold increase in the numbers of this previously unrecognized population of CD31 neg CD42b(low/neg) EV was observed in all participants reaching 7,050m asl. Conclusions The emergence of CD31(neg) CD42b(low/neg) EV was observed in all participants and thus represents an early hypoxic marker at extreme altitude. Since CD31 and CD42b are required for platelet-endothelial cell interactions, these hypobaric hypoxia-dependent quantitative and phenotypic changes of AnnexinV(pos) EV subpopulations may serve as early and sensitive indicators of compromised vascular homeostasis.	[Utermoehlen, Olaf; Jakobshagen, Kristin; Blissenbach, Birgit; Wiegmann, Katja; Kroenke, Martin] Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Utermoehlen, Olaf; Kroenke, Martin] CMMC, Cologne, Germany; [Blissenbach, Birgit; Wiegmann, Katja; Kroenke, Martin] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Merz, Tobias; Hefti, Jacqueline Pichler] Univ Hosp, Dept Intens Care Med, Bern, Switzerland; [Merz, Tobias; Hefti, Jacqueline Pichler] Univ Bern, Bern, Switzerland; [Merz, Tobias] Auckland City Hosp, Cardiovasc Intens Care Unit, Auckland, New Zealand; [Hefti, Jacqueline Pichler] Univ Hosp, Dept Pneumol, Bern, Switzerland; [Blissenbach, Birgit] Paul Ehrlich Inst, Div Microbiol, Langen, Germany	University of Cologne; University of Cologne; University of Cologne; University of Bern; University Hospital of Bern; University of Bern; Auckland City Hospital; University of Bern; University Hospital of Bern; Paul Ehrlich Institute	Kronke, M (corresponding author), Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany.; Kronke, M (corresponding author), CMMC, Cologne, Germany.; Kronke, M (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.; Hefti, JP (corresponding author), Univ Hosp, Dept Intens Care Med, Bern, Switzerland.; Hefti, JP (corresponding author), Univ Bern, Bern, Switzerland.; Hefti, JP (corresponding author), Univ Hosp, Dept Pneumol, Bern, Switzerland.	Jacqueline.Pichler@insel.ch; M.Kroenke@uni-koeln.de	Merz, Tobias/AAE-8323-2020					Barthelmes D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0011532; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Blissenbach B, 2018, AM J PHYSIOL-LUNG C, V314, pL157, DOI 10.1152/ajplung.00146.2017; Bravi L, 2014, CELL TISSUE RES, V355, P515, DOI 10.1007/s00441-014-1843-7; Brill A, 2009, CARDIOVASC RES, V84, P137, DOI 10.1093/cvr/cvp176; Cointe S, 2017, J THROMB HAEMOST, V15, P187, DOI 10.1111/jth.13514; Dey-Hazra E, 2010, VASC HEALTH RISK MAN, V6, P1125, DOI 10.2147/VHRM.S13236; Dinkla S, 2013, NANOMEDICINE-UK, V8, P1657, DOI [10.2217/NNM.13.149, 10.2217/nnm.13.149]; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Evans PC, 2001, TRANSPLANTATION, V71, P457, DOI 10.1097/00007890-200102150-00020; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; Fong KP, 2011, BLOOD, V117, pE15, DOI 10.1182/blood-2010-05-283838; Gao CJ, 2003, BLOOD, V102, P169, DOI 10.1182/blood-2003-01-0003; Gavard Julie, 2014, Cell Adh Migr, V8, P158; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hefti JP, 2016, EUR J APPL PHYSIOL, V116, P739, DOI 10.1007/s00421-015-3309-3; Hefti JP, 2010, SWISS MED WKLY, V140, P111, DOI smw-12910; Ilan N, 2001, FASEB J, V15, P362, DOI 10.1096/fj.00-0372com; Kottke R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141097; Lanza F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-46; Latham SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16314; Levi M, 2016, SEMIN THROMB HEMOST, V42, P252, DOI 10.1055/s-0035-1570080; Luks AM, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0096-2016; Marfella R, 2000, CIRCULATION, V101, P2247, DOI 10.1161/01.CIR.101.19.2247; MCFADDEN DM, 1981, JAMA-J AM MED ASSOC, V245, P581, DOI 10.1001/jama.245.6.581; Meigs JB, 2006, DIABETES, V55, P530, DOI 10.2337/diabetes.55.02.06.db05-1041; POBER JS, 1986, J IMMUNOL, V136, P1680; Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649; Reiners KS, 2013, BLOOD, V121, P3658, DOI 10.1182/blood-2013-01-476606; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; Shai E, 2012, J PROTEOMICS, V76, P287, DOI 10.1016/j.jprot.2012.02.030; Singh RJR, 2005, CARDIOVASC RES, V67, P39, DOI 10.1016/j.cardiores.2005.02.020; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Sun J, 2000, J CELL SCI, V113, P1459; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; van der Pol E, 2018, J THROMB HAEMOST, V16, P1236, DOI 10.1111/jth.14009; Vince RV, 2009, OXID MED CELL LONGEV, V2, P2, DOI 10.4161/oxim.2.1.7611; West JB, 2012, AM J RESP CRIT CARE, V186, P1229, DOI 10.1164/rccm.201207-1323CI; Zharikov S, 2013, BIOCHEM SOC T, V41, P118, DOI 10.1042/BST20120327	45	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220133	10.1371/journal.pone.0220133	http://dx.doi.org/10.1371/journal.pone.0220133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369589	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900028
J	van Hoof, SJM; Quanjel, TCC; Kroese, MEAL; Spreeuwenberg, MD; Ruwaard, D				van Hoof, Sofie J. M.; Quanjel, Tessa C. C.; Kroese, Marielle E. A. L.; Spreeuwenberg, Marieke D.; Ruwaard, Dirk			Substitution of outpatient hospital care with specialist care in the primary care setting: A systematic review on quality of care, health and costs	PLOS ONE			English	Review							GENERAL-PRACTITIONERS; OUTREACH CLINICS; COMMUNITY; DISEASE; PROGRAMS	Rationale, aims and objective Substituting outpatient hospital care with primary care is seen as a solution to decrease unnecessary referrals to outpatient hospital care and decrease rising healthcare costs. This systematic review aimed to evaluate the effects on quality of care, health and costs outcomes of substituting outpatient hospital care with primary care-based interventions, which are performed by medical specialists in face-to-face consultations in a primary care setting. Method The systematic review was performed using the PICO framework. Original papers in which the premise of the intervention was to substitute outpatient hospital care with primary care through the involvement of a medical specialist in a primary care setting were eligible. Results A total of 14 papers were included. A substitution intervention in general practitioner (GP) practices was described in 11 papers, three described a joint consultation intervention in which GPs see patients together with a medical specialist. This study showed that substitution initiatives result mostly in favourable outcomes compared to outpatient hospital care. The initiatives resulted mostly in shorter waiting lists, shorter clinic waiting times and higher patient satisfaction. Costs for treating one extra patient seemed to be higher in the intervention settings. This was mainly caused by inefficient planning of consultation hours and lower patient numbers. Conclusions Despite the fact that internationally a lot has been written about the importance of performing substitution interventions in which preventing unnecessary referrals to outpatient hospital care was the aim, only 14 papers were included. Future systematic reviews should focus on the effects on the Triple Aim of substitution initiatives in which other healthcare professions than medical specialists are involved along with new technologies, such as e-consults. Additionally, to gain more insight into the effects of substitution initiatives operating in a dynamic healthcare context, it is important to keep evaluating the interventions in a longitudinal study design.	[van Hoof, Sofie J. M.; Quanjel, Tessa C. C.; Kroese, Marielle E. A. L.; Spreeuwenberg, Marieke D.; Ruwaard, Dirk] Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands; [Spreeuwenberg, Marieke D.] Zuyd Univ Appl Sci, Res Ctr Technol Care, Heerlen, Netherlands	Maastricht University	van Hoof, SJM; Quanjel, TCC (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Care & Publ Hlth Res Inst CAPHRI, Dept Hlth Serv Res, Maastricht, Netherlands.	s.vanhoof@maastrichtuniversity.nl; t.quanjel@maastrichtuniversity.nl		Ruwaard, Dirk/0000-0003-4887-8413				Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Black M, 1997, BRIT J GEN PRACT, V47, P558; Bond M, 2000, J EPIDEMIOL COMMUN H, V54, P149, DOI 10.1136/jech.54.2.149; Bowling A, 2001, BRIT J GEN PRACT, V51, P264; Bowling A, 1997, J EPIDEMIOL COMMUN H, V51, P52, DOI 10.1136/jech.51.1.52; Clements B., 2012, EC PUBLIC HLTH CARE; DART JKG, 1986, BRIT MED J, V293, P1477, DOI 10.1136/bmj.293.6560.1477; Deeks J J, 2003, Health Technol Assess, V7, piii; Faulkner A, 2003, BRIT J GEN PRACT, V53, P878; GILLAM SJ, 1995, BRIT J GEN PRACT, V45, P649; Gosden T, 1997, J Health Serv Res Policy, V2, P174; Gruen R L, 2004, Cochrane Database Syst Rev, pCD003798, DOI 10.1002/14651858.CD003798.pub2; Helliwell PS, 1996, BRIT J RHEUMATOL, V35, P385; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS8, DOI 10.1016/j.apmr.2005.08.116; Institute of Medicine, 2001, CROSSING QUALITY CHA; Korda H, 2011, INQUIRY-J HEALTH CAR, V48, P277, DOI 10.5034/inquiryjrnl_48.04.01; Kringos D, 2013, BRIT J GEN PRACT, V63, pE742, DOI 10.3399/bjgp13X674422; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; LITTLE BC, 1993, EYE, V7, P180, DOI 10.1038/eye.1993.38; Martinez-Gonzalez NA, 2015, MED CARE RES REV, V72, P395, DOI 10.1177/1077558715586297; Martinez-Gonzalez NA, 2014, INT J QUAL HEALTH C, V26, P561, DOI 10.1093/intqhc/mzu071; Methley AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0579-0; Norris SL, 2002, AM J PREV MED, V22, P15, DOI 10.1016/S0749-3797(02)00423-3; OECD, 2015, FISCAL SUSTAINABILIT; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Powell John, 2002, J Health Serv Res Policy, V7, P177, DOI 10.1258/135581902760082490; Prisma, 2017, PRISM TRANSP REP SYS; Schulpen G J C, 2003, Ned Tijdschr Geneeskd, V147, P447; Schut FT, 2017, HEALTH POLICY, V121, P126, DOI 10.1016/j.healthpol.2016.11.002; Sibbald B, 2008, J HEALTH SERV RES PO, V13, P233, DOI 10.1258/jhsrp.2008.008049; Struijs JN, 2011, NEW ENGL J MED, V364, P990, DOI 10.1056/NEJMp1011849; Suris X, 2007, J RHEUMATOL, V34, P1328; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Tsiachristas A, 2014, COST EFFECT RESOUR A, V12, DOI 10.1186/1478-7547-12-17; van Hoof SJM, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0498-8; van Hoof SJM, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2446; VIERHOUT WPM, 1995, LANCET, V346, P990, DOI 10.1016/S0140-6736(95)91686-5; Villagra V, 2004, MED CARE, V42, P24, DOI 10.1097/01.mlr.0000119395.13327.e9; Wallace PG, 2002, J TELEMED TELECARE, V8, P94, DOI 10.1258/135763302320302208; Warner MM, 1997, REDESIGNING HLTH SER; Westra D, 2017, Ned Tijdschr Geneeskd, V161, pD1354; WHO, 2010, WOR HEALT REP, P1; Winpenny EM, 2017, J HEALTH SERV RES PO, V22, P53, DOI 10.1177/1355819616648982	43	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219957	10.1371/journal.pone.0219957	http://dx.doi.org/10.1371/journal.pone.0219957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369567	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900019
J	Pathak, S; Chaudhary, N; Dhakal, P; Shakya, D; Dhungel, P; Neupane, G; Shrestha, S; Regmi, S; Kurmi, OP				Pathak, Santosh; Chaudhary, Nagendra; Dhakal, Prativa; Shakya, Disuja; Dhungel, Prativa; Neupane, Gagan; Shrestha, Sandeep; Regmi, Shanti; Kurmi, Om P.			Clinical profile, complications and outcome of scrub typhus in children: A hospital based observational study in central Nepal	PLOS ONE			English	Article							FEATURES; FEVER	Background Scrub typhus, an important cause of unexplained fever, is grossly neglected and often misdiagnosed in low and middle income countries like Nepal. The main aim of this study was to report on the clinical profile and complications of scrub typhus and its outcome in Nepalese children. Methods A prospective observational study was carried out in children aged 1-16 years, admitted to a tertiary care hospital of central Nepal in between July 2016-Aug 2017. Scrub typhus was diagnosed with IgM ELISA. Results All cases of scrub typhus (n = 76) presented with fever and commonly had other symptoms such as headache (75%), myalgia (68.4%), vomiting (64.5%), nausea (59.2%), abdominal pain (57.9%), cough (35.5%), shortness of breath (22.4%), altered sensorium (14.5%), rashes (13.2%) and seizures (11.8%). Important clinical signs noticed were lymphadenopathy (60.5%), hepatomegaly (47.4%), edema (26.3%), jaundice (26.3%), and splenomegaly (15.8%). About 12% (n = 9) had necrotic eschar. Similarly, thrombocytopenia, raised liver enzymes and raised creatinine values were seen in 36.9%, 34.2% and 65.8% respectively. The most common complications were myocarditis (72.4%), hypoalbuminemia (71.1%), severe thrombocytopenia (22.4%), renal impairment (65.8%), hyponatremia (48.7%) and hepatitis (34.2%). Over two-thirds (69.70%) of the cases were treated with doxycycline followed by combination with azithromycin in the remaining 18.4%. Overall, mortality rate in this group was 3.9%. Conclusions Scrub typhus should be considered as a differential in any community acquired acute undifferentiated febrile illness regardless of the presence of an eschar. Myocarditis and acute kidney injury are important complications which when addressed early can prevent mortality. Use of doxycycline showed a favorable outcome.	[Pathak, Santosh; Shakya, Disuja; Dhungel, Prativa; Regmi, Shanti] Chitwan Med Coll, Dept Pediat, Bharatpur, Nepal; [Chaudhary, Nagendra; Shrestha, Sandeep] Universal Coll Med Sci, Dept Pediat, Bhairahawa, Nepal; [Dhakal, Prativa] Chitwan Med Coll, Sch Nursing, Dept Womans Hlth & Dev, Bharatpur, Nepal; [Neupane, Gagan] Shreegaun Primary Hlth Care Ctr, Dang, Nepal; [Kurmi, Om P.] McMaster Univ, Populat Hlth Res Inst, Dept Med, Hamilton, ON, Canada; [Kurmi, Om P.] McMaster Univ, Dept Med, Div Respirol, Hamilton, ON, Canada	McMaster University; Population Health Research Institute; McMaster University	Chaudhary, N (corresponding author), Universal Coll Med Sci, Dept Pediat, Bhairahawa, Nepal.	enagendra@hotmail.com	Yue, Yuhang/AAW-9279-2021; Dhakal, Prativa/J-7868-2019; Chaudhary, Nagendra/D-9723-2017	Dhakal, Prativa/0000-0002-1559-0686; Chaudhary, Nagendra/0000-0002-3216-8671; Neupane, Gagan/0000-0002-8194-7794; Kurmi, Om Prakash/0000-0002-9518-4716; Shrestha, Sandeep/0000-0002-0365-3299				Bal M, 2019, INDIAN PEDIATR, V56, P304, DOI 10.1007/s13312-019-1519-1; Chanta Chulapong, 2005, Journal of the Medical Association of Thailand, V88, P1867; De Silva N, 2012, AM J TROP MED HYG, V87, P342, DOI 10.4269/ajtmh.2012.12-0170; El Sayed I, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002150.pub2; Phuong HL, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-123; Huang CT, 2009, SE ASIAN J TROP MED, V40, P789; Kamarasu K, 2007, INDIAN J MED RES, V126, P128; Kumar Manish, 2012, J Infect Public Health, V5, P82, DOI 10.1016/j.jiph.2011.11.001; Kumar Ritesh, 2016, J Assoc Physicians India, V64, P30; Kumar V, 2014, INT J AP MAT COM-POL, V24, P387, DOI 10.2478/amcs-2014-0029; Lee CS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-216; Mahajan SK, 2008, INDIAN J PEDIATR, V75, P947, DOI 10.1007/s12098-008-0198-z; Murali N, 2001, Indian Pediatr, V38, P1393; Murdoch DR, 2004, AM J TROP MED HYG, V70, P670, DOI 10.4269/ajtmh.2004.70.670; Palanivel S, 2012, INDIAN J PEDIATR, V79, P1459, DOI 10.1007/s12098-012-0721-0; Panpanich R, 2002, COCHRANE DB SYST REV; Pavithran Sreeja, 2004, Indian Pediatr, V41, P1254; Rathi NB, 2011, INDIAN PEDIATR, V48, P867, DOI 10.1007/s13312-011-0141-7; Silpapojakul Khachornsakdi, 1997, Annals Academy of Medicine Singapore, V26, P794; Sirisanthana V, 2003, PEDIATR INFECT DIS J, V22, P341, DOI 10.1097/00006454-200304000-00010; Sivarajan S, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0186-x; Somashekar HR, 2006, J TROP PEDIATRICS, V52, P228, DOI 10.1093/tropej/fmi096; Upadhyaya B P, 2016, J Nepal Health Res Counc, V14, P122; Vivekanandan M, 2010, J Assoc Physicians India, V58, P24	24	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220905	10.1371/journal.pone.0220905	http://dx.doi.org/10.1371/journal.pone.0220905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408484	Green Published, gold, Green Submitted			2022-12-27	WOS:000485009500051
J	Balogh, SG; Zagyva, D; Pollner, P; Palla, G				Balogh, Samuel G.; Zagyva, Daniel; Pollner, Peter; Palla, Gergely			Time evolution of the hierarchical networks between PubMed MeSH terms	PLOS ONE			English	Article							PREFERENTIAL ATTACHMENT; EMERGENCE	Hierarchical organisation is a prevalent feature of many complex networks appearing in nature and society. A relating interesting, yet less studied question is how does a hierarchical network evolve over time? Here we take a data driven approach and examine the time evolution of the network between the Medical Subject Headings (MeSH) provided by the National Center for Biotechnology Information (NCBI, part of the U. S. National Library of Medicine). The network between the MeSH terms is organised into 16 different, yearly updated hierarchies such as "Anatomy", "Diseases", "Chemicals and Drugs", etc. The natural representation of these hierarchies is given by directed acyclic graphs, composed of links pointing from nodes higher in the hierarchy towards nodes in lower levels. Due to the yearly updates, the structure of these networks is subject to constant evolution: new MeSH terms can appear, terms becoming obsolete can be deleted or be merged with other terms, and also already existing parts of the network may be rewired. We examine various statistical properties of the time evolution, with a special focus on the attachment and detachment mechanisms of the links, and find a few general features that are characteristic for all MeSH hierarchies. According to the results, the hierarchies investigated display an interesting interplay between non-uniform preference with respect to multiple different topological and hierarchical properties.	[Balogh, Samuel G.; Zagyva, Daniel] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Pollner, Peter; Palla, Gergely] MTA ELTE Stat & Biol Phys Res Grp, Budapest, Hungary	Eotvos Lorand University	Balogh, SG (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.	balogh@hal.elte.hu	Pollner, Peter/N-3975-2016; Palla, Gergely/H-1767-2016	Pollner, Peter/0000-0003-0464-4893; Palla, Gergely/0000-0002-3406-4200; Balogh, Samuel Gaspar/0000-0003-3417-2655	European Union [740688-RED-Alert-H2020-SEC-2016-2017/H2020-SEC-2016-2017-1]; Hungarian National Research, Development and Innovation Office [K 128780]	European Union(European Commission); Hungarian National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	The research was partially supported by the European Union through projects 'RED-Alert' (grant no.: 740688-RED-Alert-H2020-SEC-2016-2017/H2020-SEC-2016-2017-1) and by the Hungarian National Research, Development and Innovation Office (grant no. K 128780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alvial-Palavicino C, 2019, FUTURES, V109, P192, DOI 10.1016/j.futures.2018.10.008; [Anonymous], 1985, UNFINISHED SYNSIS; Asllani M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau9403; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batty M., 1994, FRACTAL CITIES; Chen C, 2017, SCI MAPPING TOOLS AP; Chen CM, 2017, J DATA INFO SCI, V2, P1, DOI 10.1515/jdis-2017-0006; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Corominas-Murtra B, 2013, P NATL ACAD SCI USA, V110, P13316, DOI 10.1073/pnas.1300832110; Corominas-Murtra B, 2011, CHAOS, V21, DOI 10.1063/1.3562548; Czegel D, 2015, SCI REP-UK, V5, DOI 10.1038/srep17994; De Leenheer P, 2008, SEMAT WEB BEYOND-COM, V7, P131; Fushing H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017817; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Gupte Mangesh, 2011, P 20 INT C WORLD WID, P557, DOI DOI 10.1145/1963405.1963484; HIRATA H, 1985, J THEOR BIOL, V116, P321, DOI 10.1016/S0022-5193(85)80271-X; Jeong H, 2003, EUROPHYS LETT, V61, P567, DOI 10.1209/epl/i2003-00166-9; Kaiser Marcus, 2010, Front Neuroinform, V4, DOI 10.3389/fninf.2010.00112; Katchanov YL, 2017, SCIENTOMETRICS, V113, P313, DOI 10.1007/s11192-017-2471-2; Krugman P, 1996, J JPN INT ECON, V10, P399, DOI 10.1006/jjie.1996.0023; Letizia E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191604; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; McCray AT, 2013, TAXONOMIC CHANGE REF, P189; McShea DW, 2001, PALEOBIOLOGY, V27, P405, DOI 10.1666/0094-8373(2001)027<0405:THSOOA>2.0.CO;2; Mengistu H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004829; Mones E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033799; Nagy M, 2013, P NATL ACAD SCI USA, V110, P13049, DOI 10.1073/pnas.1305552110; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131; Ozogany K, 2015, J STAT PHYS, V158, P628, DOI 10.1007/s10955-014-1131-7; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Palla G, 2015, PALGR COMMUN, V1, DOI 10.1057/palcomms.2015.16; Pollner P, 2006, EUROPHYS LETT, V73, P478, DOI 10.1209/epl/i2005-10414-6; Pumain D, 2006, METHODS SER, V3, P1, DOI 10.1007/1-4020-4127-6; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Shan W, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10030597; Tibely G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165728; Toth BJ, 2018, 2018 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM), P1184; Trusina A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178702; Tsatsaronis G, 2013, TEMPORAL CLASSIFIERS, P98; Tsatsaronis George, 2012, J Biomed Semantics, V3 Suppl 1, pS2, DOI 10.1186/2041-1480-3-S1-S2; Valverde S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046118; WICKEN JS, 1988, J SOC BIOL STRUCT, V11, P369, DOI 10.1016/0140-1750(88)90066-8; Zafeiris A., 2018, WHY WE LIVE HIERARCH; Zafeiris A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3484; Zamani M, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aaa8ca; Zamani M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01503-y	50	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220648	10.1371/journal.pone.0220648	http://dx.doi.org/10.1371/journal.pone.0220648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404084	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800022
J	Eslami, B; Rosa, M; Barros, H; Torres-Gonzalez, F; Stankunas, M; Ioannidi-Kapolou, E; Lindert, J; Soares, JJF; Lamura, G; Melchiorre, MG				Eslami, Bahareh; Di Rosa, Mirko; Barros, Henrique; Torres-Gonzalez, Francisco; Stankunas, Mindaugas; Ioannidi-Kapolou, Elisabeth; Lindert, Jutta; Soares, Joaquim J. F.; Lamura, Giovanni; Melchiorre, Maria Gabriella			Lifetime abuse and somatic symptoms among older women and men in Europe	PLOS ONE			English	Article							ELDER ABUSE; CARE PROGRAMS; CHRONIC PAIN; PREVALENCE; ASSOCIATION; DEPRESSION; COMMUNITY; STRESS; TRAUMA; ADULTS	Background Research suggests that survivors of interpersonal violence have an increasing experience of bodily symptoms. This study aims to scrutinise the association between lifetime abuse and somatic symptoms among older women and men, considering demographics/socioeconomic, social support and health variables. Methods A sample of 4,467 community-dwelling persons aged 60-84 years (57.3% women) living in seven European countries (Germany, Greece, Italy, Lithuania, Portugal, Spain, Sweden) was recruited for this cross-sectional study. Lifetime abuse (psychological, physical, sexual, financial and injury) was assessed on the basis of the UK study of elder abuse and the Conflict Tactics Scale-2, while somatic symptoms were assessed by the Giessen Complaint List short version. Results Women reported somatic symptoms more frequently than men. Multiple regression analyses revealed that lifetime exposure to psychological abuse was associated with higher levels of somatic symptoms among both women and men, while experiencing lifetime sexual abuse was associated with somatic symptoms only among older women, after adjusting for other demographic and socio-economic variables. Country of residence, older age, and low socio-economic status were other independent factors contributing to a higher level of somatic symptoms. Conclusions The positive association between the experience of abuse during lifetime and the reporting of higher levels of somatic symptoms, in particular among older women, seems to suggest that such complaints in later life might also be related to the experience of mistreatment and not only to ageing and related diseases. Violence prevention throughout lifetime could help to prevent somatic symptoms in later life.	[Eslami, Bahareh] Univ Gavle, Dept Occupat & Publ Hlth Sci, Gavle, Sweden; [Eslami, Bahareh; Soares, Joaquim J. F.] Mid Sweden Univ, Dept Hlth Sci, Div Publ Hlth Sci, Sundsvall, Sweden; [Di Rosa, Mirko] IRCCS INRCA, Natl Inst Hlth & Sci Aging, Lab Geriatr Pharmacoepidemiol, Ancona, Italy; [Barros, Henrique] Univ Porto, Inst Saude Publ, EPIUnit, Porto, Portugal; [Torres-Gonzalez, Francisco] Univ Granada, Dept Psychiat, Fac Med, Granada, Spain; [Stankunas, Mindaugas] Lithuanian Univ Hlth Sci, Dept Hlth Management, Kaunas, Lithuania; [Stankunas, Mindaugas] Griffith Univ, Sch Med, Hlth Serv Management Dept, Gold Coast, Qld, Australia; [Ioannidi-Kapolou, Elisabeth] Natl Sch Publ Hlth, Dept Sociol, Athens, Greece; [Lindert, Jutta] Univ Emden, Dept Publ Hlth, Emden, Germany; [Lindert, Jutta] Brandeis Univ, Womens Studies Res Ctr, Waltham, MA USA; [Lamura, Giovanni; Melchiorre, Maria Gabriella] IRCCS INRCA, Natl Inst Hlth & Sci Aging, Ctr Socioecon Res Ageing, Ancona, Italy	University of Gavle; Mid-Sweden University; IRCCS INRCA; Universidade do Porto; University of Granada; Lithuanian University of Health Sciences; Griffith University; National & Kapodistrian University of Athens; Brandeis University; IRCCS INRCA	Rosa, M (corresponding author), IRCCS INRCA, Natl Inst Hlth & Sci Aging, Lab Geriatr Pharmacoepidemiol, Ancona, Italy.	m.dirosa@inrca.it	Barros, Henrique/Q-8609-2019; Barros, Henrique/A-5488-2008; Di Rosa, Mirko/J-5974-2016	Barros, Henrique/0000-0003-4699-6571; Di Rosa, Mirko/0000-0002-1862-4159; Fernandes Soares, Joaquim Jorge/0000-0001-5221-9504	CHAFEA, Consumers, Health, Agriculture and Food Executive Agency [2007123]; IRCCS INRCA, by Ricerca Corrente from Italian Ministry of Health	CHAFEA, Consumers, Health, Agriculture and Food Executive Agency; IRCCS INRCA, by Ricerca Corrente from Italian Ministry of Health	This research was funded by grant support from the European Commission, through the Executive Agency for Health and Consumers (EAHC, currently CHAFEA, Consumers, Health, Agriculture and Food Executive Agency, http://ec.europa.eu/chafea/index_en.htm Public Health Programme 2008-2010), Grant Agreement n. 2007123, which made possible the realisation of the ABUEL Project, "Elder Abuse: A multinational prevalence survey." This study was partially supported, only for authors from IRCCS INRCA, by Ricerca Corrente funding from Italian Ministry of Health to IRCCS INRCA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afari N, 2014, PSYCHOSOM MED, V76, P2, DOI 10.1097/PSY.0000000000000010; Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; Bohn D, 2013, J TRAUMA DISSOCIATIO, V14, P342, DOI 10.1080/15299732.2012.736930; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Creed FH, 2012, J PSYCHOSOM RES, V72, P311, DOI 10.1016/j.jpsychores.2012.01.009; Davidov E, 2014, ANNU REV SOCIOL, V40, P55, DOI 10.1146/annurev-soc-071913-043137; de Bruin SR, 2012, HEALTH POLICY, V107, P108, DOI [10.1016/j.healthpo1.2012.06.006, 10.1016/j.healthpol.2012.06.006]; Eberhard-Gran M, 2007, J GEN INTERN MED, V22, P1668, DOI 10.1007/s11606-007-0389-8; Eslami B, 2017, EUR J PUBLIC HEALTH, V27, P686, DOI 10.1093/eurpub/ckx047; Eslami B, 2016, INT J PUBLIC HEALTH, V61, P891, DOI 10.1007/s00038-016-0816-x; Fisher BS, 2006, GERONTOLOGIST, V46, P200, DOI 10.1093/geront/46.2.200; Giraldo-Rodriguez L, 2015, J AM GERIATR SOC, V63, P1594, DOI 10.1111/jgs.13552; Hanel G, 2009, J PSYCHOSOM RES, V67, P189, DOI 10.1016/j.jpsychores.2009.04.013; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hobfoll SE, 2001, APPL PSYCHOL-INT REV, V50, P337, DOI 10.1111/1464-0597.00062; Hofelmann DA, 2018, EUR J PUBLIC HEALTH, V28, P603, DOI 10.1093/eurpub/ckx224; Johnston MC, 2019, EUR J PUBLIC HEALTH, V29, P182, DOI 10.1093/eurpub/cky098; Lindert J, 2012, EUR J PUBLIC HEALTH, V22, P662, DOI 10.1093/eurpub/ckr079; Logan JG, 2008, J CLIN NURS, V17, P201, DOI 10.1111/j.1365-2702.2008.02347.x; McCall-Hosenfeld JS, 2014, J PSYCHOSOM RES, V77, P196, DOI 10.1016/j.jpsychores.2014.07.011; Melchiorre MG, 2018, HEALTH POLICY, V122, P53, DOI 10.1016/j.healthpol.2017.08.006; Melchiorre MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146425; Melchiorre MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054856; Mladovsky P., 2009, HLTH EUROPEAN UNION; O'Keeffe M, 2007, NURSING OLDER PEOPLE, DOI DOI 10.7748/NOP2007.10.19.8.24.C6268; Penninx Brenda W J H, 2010, Ned Tijdschr Geneeskd, V154, pA1784; Pillemer K, 2016, GERONTOLOGIST, V56, pS194, DOI 10.1093/geront/gnw004; Rijken M., 2013, Eurohealth, V19, P29; Rodrigues R., 2012, FACTS FIGURES HLTH A; Scheer, 1995, GIESSENER BESCHWERDE; Soares JJF, 2014, J ADULT PROT, V16, P213, DOI 10.1108/JAP-08-2013-0034; Stickley A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191651; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Tomenson B, 2013, BRIT J PSYCHIAT, V203, P373, DOI 10.1192/bjp.bp.112.114405; Tredal I, 2013, DRUG-EDUC PREV POLIC, V20, P96, DOI 10.3109/09687637.2012.751087; Winnersjo Rocio, 2012, J Inj Violence Res, V4, P87, DOI 10.5249/jivr.v4i2.122; Wuest J, 2008, J PAIN, V9, P1049, DOI 10.1016/j.jpain.2008.06.009; Yan E, 2012, INT PSYCHOGERIATR, V24, P1437, DOI 10.1017/S1041610212000294; Yi QQZ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206640; Yon YJ, 2017, LANCET GLOB HEALTH, V5, pE147, DOI 10.1016/S2214-109X(17)30006-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	43	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220741	10.1371/journal.pone.0220741	http://dx.doi.org/10.1371/journal.pone.0220741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393925	Green Published, gold			2022-12-27	WOS:000485002500057
J	Palekar, R; Rodriguez, A; Avila, C; Barrera, G; Barrera, M; Brenes, H; Bruno, A; El Omeiri, N; Fasce, R; de Almeida, WF; Franco, D; Huaringa, M; Lara, J; Loayza, R; Lopez-Martinez, I; de Paiva, TM; Medina, J; Ojeda, J; Ropero, AM; Sotomayor, V; Vazquez, C; Von Horoch, M				Palekar, Rakhee; Rodriguez, Angel; Avila, Cinthia; Barrera, Gisela; Barrera, Miriam; Brenes, Hebleen; Bruno, Alfedo; El Omeiri, Nathalie; Fasce, Rodrigo; Ferreira de Almeida, Walquiria; Franco, Danilo; Huaringa, Maribel; Lara, Jenny; Loayza, Roxana; Lopez-Martinez, Irma; Maria de Paiva, Terezinha; Medina, Jose; Ojeda, Jenny; Maria Ropero, Alba; Sotomayor, Viviana; Vazquez, Cynthia; Von Horoch, Marta			Patterns of influenza B circulation in Latin America and the Caribbean, 2010-2017	PLOS ONE			English	Article							AUSTRALIA	Objective There are limited published data about the circulation of influenza B/Victoria and B/Yamagata in Latin America and the Caribbean (LAC) and most countries have a vaccine policy that includes the use of the trivalent influenza vaccine. We analyzed influenza surveillance data to inform decision-making in LAC about prevention strategies, such as the use of the quadrivalent influenza vaccine. Methods There are a total of 28 reference laboratories and National Influenza Centers in LAC that conduct influenza virologic surveillance according to global standards, and on a weekly basis upload their surveillance data to the open-access World Health Organization (WHO) platform FluNet. These data include the number of specimens tested for influenza and the number of specimens positive for influenza by type, subtype and lineage, all by the epidemiologic week of specimen collection. We invited these laboratories to provide additional epidemiologic data about the hospitalized influenza B cases. We conducted descriptive analyses of patterns of influenza circulation and characteristics of hospitalized cases. We compared the predominant B lineage each season to the lineage in the vaccine applied, to determine vaccine mismatch. A Chi-square and Wilcoxan statistic were used to assess the statistical significance of differences in proportions and medians at the P<0.05 level. Findings During 2010-2017, the annual number of influenza B cases in LAC was similar to 4500 to 7000 cases. Since 2011, among the LAC-laboratories reporting influenza B lineage using molecular methods, both B/Victoria and B/Yamagata were detected annually. Among the hospitalized influenza B cases, there were statistically significant differences observed between B/Victoria and B/Yamagata cases when comparing age and the proportion with underlying co-morbid conditions and with history of oseltamivir treatment (P<0.001). The proportion deceased among B/Victoria and B/Yamagata hospitalized cases did not differ significantly. When comparing the predominant influenza B lineage detected, as part of surveillance activities during 63 seasons among 19 countries, to the lineage of the influenza B virus included in the trivalent influenza vaccine used during that season, there was a vaccine mismatch noted during 32% of the seasons analyzed. Conclusions Influenza B is important in LAC with both B/Victoria and B/Yamagata circulating annually in all sub regions. During approximately one-third of the seasons, an influenza B vaccine mismatch was identified. Further analyses are needed to better characterize the medical and economic burden of each influenza B lineage, to examine the potential cross-protection of one vaccine lineage against the other circulating virus lineage, and to determine the potential impact and cost-effectiveness of using the quadrivalent vaccine rather than the trivalent influenza vaccine.	[Palekar, Rakhee; Rodriguez, Angel; El Omeiri, Nathalie; Maria Ropero, Alba] WHO, PAHO, Washington, DC USA; [Avila, Cinthia; Loayza, Roxana] Ctr Nacl Enfermedades Trop CENETROP, Santa Cruz, CA, Bolivia; [Barrera, Gisela; Lopez-Martinez, Irma] Inst Diagnost & Referencia Epidemiol InDRE, Mexico City, DF, Mexico; [Barrera, Miriam] LNS, Guatemala City, Guatemala; [Brenes, Hebleen; Lara, Jenny] Inst Costarricense Invest & Ensenanza Nutr & Salu, San Jose, Costa Rica; [Bruno, Alfedo] Univ Agraria Ecuador, Inst Nacl Invest Salud Publ INSPI, Guayaquil, Ecuador; [Fasce, Rodrigo] Inst Salud Publ Chile, Santiago, Chile; [Ferreira de Almeida, Walquiria] Minist Salud, Brasilia, DF, Brazil; [Franco, Danilo] Inst Conmemorat Gorgas Estudios Salud, Panama City, Panama; [Huaringa, Maribel; Medina, Jose] INS, Lima, Peru; [Maria de Paiva, Terezinha] Adolfo Lutz Inst, Sao Paulo, Brazil; [Ojeda, Jenny] Minist Salud Publ, Quito, Ecuador; [Sotomayor, Viviana] Minist Salud, Santiago, Chile; [Vazquez, Cynthia] LCSP, Asuncion, Paraguay; [Von Horoch, Marta] Minist Salud Publ & Bienestar Social, Asuncion, Paraguay	Pan American Health Organization; World Health Organization; Instituto Conmemorativo Gorgas de Estudios de la Salud; Instituto Adolfo Lutz; Ministerio de Salud Publica y Bienstar Social	Palekar, R (corresponding author), WHO, PAHO, Washington, DC USA.	rpalekar@gmail.com	BRUNO, ALFREDO/AAW-8354-2020	BRUNO, ALFREDO/0000-0002-9678-4203; HUARINGA, MARIBEL/0000-0001-9247-4040				Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; [Anonymous], 2014, INFL VIR INF HUM; Caini S, 2017, EUROSURVEILLANCE, V22, P7, DOI [10.2807/1560-7917.ES.2017.22.35.30606, 10.2807/1560-7917.es.2017.22.35.30606]; Caini S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174592; Caini S, 2015, INFLUENZA OTHER RESP, V9, P3, DOI 10.1111/irv.12319; El Omeiri N, 2018, VACCINE, V36, P3555, DOI 10.1016/j.vaccine.2017.06.036; Fielding JE, 2016, VACCINE, V34, P4905, DOI 10.1016/j.vaccine.2016.08.067; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Hannoun C, 2013, EXPERT REV VACCINES, V12, P1085, DOI 10.1586/14760584.2013.824709; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Moa AM, 2017, INFLUENZA OTHER RESP, V11, P102, DOI 10.1111/irv.12432; PAHO/ WHO, 2016, COUNTR REP PAHO WEBS; Pan American Health Organization, EXP PROGR IMM VACC P; Pan American Health Organization, IMM AM 2017 SUMM; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; WHO, WHO GUID PHARM MAN P; WHO, 2011, MAN LAB DIAGN VIR SU; World Health Organization, GLOB EP SURV STAND I; World Health Organization, FLUNET VIR SURV DAT; World Health Organization, GLOB INFL SURV RESP	21	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219595	10.1371/journal.pone.0219595	http://dx.doi.org/10.1371/journal.pone.0219595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393886	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500014
J	Bovin, MJ; Meyer, EC; Kimbrel, NA; Kleiman, SE; Green, JD; Morissette, SB; Marx, BP				Bovin, Michelle J.; Meyer, Eric C.; Kimbrel, Nathan A.; Kleiman, Sarah E.; Green, Jonathan D.; Morissette, Sandra B.; Marx, Brian P.			Using the World Health Organization Disability Assessment Schedule 2.0 to assess disability in veterans with posttraumatic stress disorder	PLOS ONE			English	Article							PSYCHOMETRIC PROPERTIES; PTSD CHECKLIST; DSM-5; DIAGNOSIS; 12-ITEM	The introduction of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) was accompanied by the elimination of the Global Assessment of Functioning (GAF) scale, which was previously used to assess functioning. Although the World Health Organization Disability Assessment Schedule, Version 2.0 (WHODAS 2.0) was offered as a measure for further study, widespread adoption of the WHODAS 2.0 has yet to occur. The lack of a standardized instrument for assessing posttraumatic stress disorder (PTSD)-related disability has important implications for disability compensation. Accordingly, this study was designed to determine and codify the utility of the WHODAS 2.0 for assessing PTSD-related disability. Veterans from several VA medical centers (N = 1109) were included. We examined PTSD using several definitions and modalities and considered results by gender and age. Across definitions and modalities, veterans with PTSD reported significantly greater WHODAS 2.0 total (large effects; all ts > 6.00; all ps <.01; all Cohen's ds > 1.03) and subscale (medium-to-large effects; all ts > 2.29; all ps <.05; all Cohen's ds >.39) scores than those without PTSD. WHODAS 2.0 scores did not vary by gender; however, younger veterans reported less disability than older veterans (small effects; all Fs > 4.30; all ps <.05; all eta(2)s <.05). We identified 32 as the optimally efficient cutoff score for discriminating veterans with and without PTSD-related disability, although this varied somewhat by age and gender. Findings support the utility of the WHODAS 2.0 in assessing PTSD-related disability.	[Bovin, Michelle J.; Kleiman, Sarah E.; Green, Jonathan D.; Marx, Brian P.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA; [Bovin, Michelle J.; Kleiman, Sarah E.; Green, Jonathan D.; Marx, Brian P.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Meyer, Eric C.] VISN 17 Ctr Excellence Res Returning War Vet, Dept Vet Affairs, Waco, TX USA; [Meyer, Eric C.] Cent Texas Vet Healthcare Syst, Waco, TX USA; [Meyer, Eric C.] Texas A&M Univ, Coll Med, Hlth Sci Ctr, College Stn, TX 77843 USA; [Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Kimbrel, Nathan A.] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Morissette, Sandra B.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Green, Jonathan D.] OConnor Profess Grp, Boston, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of Texas System; University of Texas at San Antonio (UTSA)	Bovin, MJ (corresponding author), VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA 02130 USA.; Bovin, MJ (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	michelle.bovin@va.gov	Marx, Brian/AAK-5072-2020; Meyer, Eric C/GYV-3448-2022; Bovin, Michelle/AEW-4717-2022	Bovin, Michelle/0000-0002-3296-4360	VA Merit Award from the Rehabilitation Research and Development (R& D) Service of the VA Office of Research and Development (ORD) [I01RX000304, I01RX000304-04]; Department of Defense [W81XWH-08-2-0028]	VA Merit Award from the Rehabilitation Research and Development (R& D) Service of the VA Office of Research and Development (ORD)(US Department of Veterans Affairs); Department of Defense(United States Department of Defense)	This research was supported by VA Merit Award I01RX000304 to SBM and #I01RX000304-04 to ECM and SBM from the Rehabilitation Research and Development (R& D) Service of the VA Office of Research and Development (ORD; https://www.research.va.gov/services/rrd.cfm), and by Award W81XWH-08-2-0028 from the Department of Defense (https://www.defense.gov/) to BPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bovin MJ, 2018, PSYCHOL SERV, V15, P216, DOI 10.1037/ser0000220; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Campbell SB, 2018, CLIN PSYCHOL REV, V65, P152, DOI 10.1016/j.cpr.2018.08.003; Carlozzi NE, 2015, QUAL LIFE RES, V24, P1963, DOI 10.1007/s11136-015-0930-x; Cicchetti D.V., 1994, PSYCHOL ASSESSMENT, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Clark LA, 2017, PSYCHOL SCI PUBL INT, V18, P72, DOI 10.1177/1529100617727266; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Creechi SK, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01101; Fang SC, 2015, J WOMENS HEALTH, V24, P1038, DOI 10.1089/jwh.2014.5096; Gore KL, 2013, PSYCHOL ASSESSMENT, V25, P1032, DOI 10.1037/a0033325; Gspandl S, 2018, PSYCHIAT RES, V259, P251, DOI 10.1016/j.psychres.2017.10.033; Hildebrandt A, 2011, PSYCHOL AGING, V26, P701, DOI 10.1037/a0023056; HOLM S, 1979, SCAND J STAT, V6, P65; Kennedy C, 2002, DYNAMICS DISABILITY, P241; Khanjani Z, 2015, AUST PSYCHOL, V50, P80, DOI 10.1111/ap.12099; Konecky B, 2014, AM J PSYCHIAT, V171, P818, DOI 10.1176/appi.ajp.2014.14050587; KRAEMER HC, 1992, EVALUATING MED TESTS; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Marx BP, 2015, PSYCHIAT SERV, V66, P1312, DOI 10.1176/appi.ps.201400400; Ro E, 2009, PSYCHOL ASSESSMENT, V21, P313, DOI 10.1037/a0016611; Sjonnesen K, 2016, CAN J PSYCHIAT, V61, P227, DOI 10.1177/0706743716632514; Speroff T, 2012, J TRAUMA STRESS, V25, P607, DOI 10.1002/jts.21759; U. S. Department of Veteran Affairs VA Office of Inspector General, 2006, REV STAT VAR VA DIS; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); Veterans Benefits Administration (VBA), 2013, ANN BEN REP; Weathers F.W., 2013, CLIN ADM PTSD SCALE; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Weathers F. W., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220806	10.1371/journal.pone.0220806	http://dx.doi.org/10.1371/journal.pone.0220806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5DR	31390376	Green Submitted, Green Published, gold			2022-12-27	WOS:000484999400030
J	Moodley, J; Scott, SE; Mwaka, AD; Constant, D; Githaiga, JN; Stewart, TS; Payne, A; Cairncross, L; Somdyala, NIM; Walter, FM				Moodley, J.; Scott, S. E.; Mwaka, A. D.; Constant, D.; Githaiga, J. N.; Stewart, T. S.; Payne, A.; Cairncross, L.; Somdyala, N. I. M.; Walter, F. M.			Development and validation of the African Women Awareness of CANcer (AWACAN) tool for breast and cervical cancer	PLOS ONE			English	Article							DELAYED PRESENTATION; PATIENT DELAY; DIAGNOSIS; KNOWLEDGE; SURVIVAL; SYMPTOMS; QUALITY; STAGE	Background Measuring factors influencing time to presentation is important in developing and evaluating interventions to promote timely cancer diagnosis, yet there is a lack of validated, culturally relevant measurement tools. This study aimed to develop and validate the African Women Awareness of CANcer (AWACAN) tool to measure awareness of breast and cervical cancer in Sub-Saharan Africa (SSA). Methods Development of the AWACAN tool followed 4 steps: 1) Item generation based on existing measures and relevant literature. 2) Refinement of items via assessment of content and face validity using cancer experts' ratings and think aloud interviews with community participants in Uganda and South Africa. 3) Administration of the tool to community participants, university staff and cancer experts for assessment of validity using test-retest reliability (using Intra-Class Correlation (ICC) and adjusted Kappa coefficients), construct validity (comparing expert and community participant responses using t-tests) and internal reliability (using the Kuder-Richarson (KR-20) coefficient). 4) Translation of the final AWACAN tool into isiXhosa and Acholi. Results ICC scores indicated good test-retest reliability (>= 0.7) for all breast cancer knowledge domains and cervical cancer risk factor and lay belief domains. Experts had higher knowledge of breast cancer risk factors (p < 0.001), and cervical cancer risk factors (p = 0.003) and symptoms (p = 0.001) than community participants, but similar knowledge of breast cancer symptoms (p = 0.066). Internal reliability for breast cancer risk factors, lay beliefs and symptom and cervical cancer symptom subscales was good with KR-20 values > 0.7, and lower (0.6) for the cervical cancer risk subscale. Conclusion The final AWACAN tool includes items on socio-demographic details; breast and cervical cancer symptom awareness, risk factor awareness, lay beliefs, anticipated help-seeking behaviour; and barriers to seeking care. The tools showed evidence of content, face, construct and internal validity and test-retrest reliability and are available for use in SSA in three languages.	[Moodley, J.; Constant, D.; Githaiga, J. N.] Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa; [Moodley, J.; Payne, A.] Univ Cape Town, Fac Hlth Sci, Canc Res Initiat, Cape Town, South Africa; [Moodley, J.] Univ Cape Town, Fac Hlth Sci, SAMRC Gynaecol Canc Res Ctr, Cape Town, South Africa; [Scott, S. E.] Kings Coll London, Fac Dent Oral & Craniofacial Sci, Ctr Oral Clin & Translat Sci, London, England; [Mwaka, A. D.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda; [Stewart, T. S.] Plymouth Hosp NHS Trust, Derriford Hosp, Dept Obstet & Gynaecol, Plymouth, Devon, England; [Cairncross, L.] Univ Cape Town, Dept Surg, Div Gen Surg, Surg Endocrine Oncol Unit, Cape Town, South Africa; [Somdyala, N. I. M.] South African Med Res Council, Burden Dis Res Unit, Eastern Cape Canc Registry, Tygerberg, South Africa; [Walter, F. M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England	University of Cape Town; University of Cape Town; University of Cape Town; University of London; King's College London; Makerere University; Derriford Hospital; University of Plymouth; University of Cape Town; South African Medical Research Council; University of Cambridge	Moodley, J (corresponding author), Univ Cape Town, Fac Hlth Sci, Sch Publ Hlth & Family Med, Womens Hlth Res Unit, Cape Town, South Africa.; Moodley, J (corresponding author), Univ Cape Town, Fac Hlth Sci, Canc Res Initiat, Cape Town, South Africa.; Moodley, J (corresponding author), Univ Cape Town, Fac Hlth Sci, SAMRC Gynaecol Canc Res Ctr, Cape Town, South Africa.	Jennifer.moodley@uct.ac.za	Walter, Fiona/F-3054-2014; Walter, Fiona/GYR-1347-2022; Scott, Suzanne/A-4697-2009	Walter, Fiona/0000-0002-7191-6476; Scott, Suzanne/0000-0001-5536-9612; Moodley, Jennifer/0000-0002-9398-5202; Githaiga, Jennifer/0000-0002-4511-9393; Constant, Deborah/0000-0002-7176-9963; Payne, Alexandra/0000-0001-6770-1846; Somdyala, Nontuthuzelo Iris Muriel/0000-0001-6564-8754	Cancer Association of South Africa (CANSA); University of Cape Town; South African Medical Research Council; South African National Department of Health; GlaxoSmithKline (GSK) Africa Non-Communicable Disease Open Lab [023]; United Kingdom Medical Research Council (Newton Fund); Cancer Research UK [C8640/A23385]; MRC [MC_PC_16098] Funding Source: UKRI	Cancer Association of South Africa (CANSA); University of Cape Town; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African National Department of Health; GlaxoSmithKline (GSK) Africa Non-Communicable Disease Open Lab; United Kingdom Medical Research Council (Newton Fund); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research reported in this article was jointly supported by the Cancer Association of South Africa (CANSA), the University of Cape Town and the South African Medical Research Council with funds received from the South African National Department of Health, GlaxoSmithKline (GSK) Africa Non-Communicable Disease Open Lab (via a supporting grant Project Number: 023), the United Kingdom Medical Research Council (via the Newton Fund). GSK provided in-kind scientific and statistical support as part of capacity strengthening. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the participants for sharing their experiences and participating in the validation processes; the providers and managers of the primary health care clinics and our students for support in the data collection process and the University of Cape Town human resources department for facilitating access to non-medical staff. This research is linked to the CanTest Collaborative, which is funded by Cancer Research UK [C8640/A23385], of which FionaMWalter is Director.	Amone C., 2015, AFRICAN IDENTITIES, V13, P129; [Anonymous], 2009, BREAST MOD CANC AW M; Anthoine Emmanuelle, 2014, Health Qual Life Outcomes, V12, P176, DOI 10.1186/s12955-014-0176-2; Arndt V, 2002, BRIT J CANCER, V86, P1034, DOI 10.1038/sj.bjc.6600209; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; BRENNAN RL, 1981, EDUC PSYCHOL MEAS, V41, P687, DOI 10.1177/001316448104100307; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; D'Alonzo KT, 2011, REV LAT-AM ENFERM, V19, P1255, DOI 10.1590/S0104-11692011000500025; Demment MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134618; Devi BCR, 2007, ANN ONCOL, V18, P1172, DOI 10.1093/annonc/mdm105; El-Shinawi M, 2013, BREAST, V22, P1210, DOI 10.1016/j.breast.2013.08.010; Ericsson KA, PROTOCOL ANAL VERBAL; Fox MC, 2011, PSYCHOL BULL, V137, P316, DOI 10.1037/a0021663; Fregene A, 2005, CANCER-AM CANCER SOC, V103, P1540, DOI 10.1002/cncr.20978; Frenk J, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-42; Ginsburg OM, 2013, J CANCER POLICY, V1, pE35, DOI 10.1016/j.jcpo.2013.07.002; Gyenwali D, 2013, ASIAN PAC J CANCER P, V14, P4373, DOI 10.7314/APJCP.2013.14.7.4373; Jones CEL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004076; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kuder GF, 1937, PSYCHOMETRIKA, V2, P151, DOI 10.1007/BF02288391; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee JW, 2002, RES NURS HEALTH, V25, P295, DOI 10.1002/nur.10041; Linn R.L., 2000, MEASUREMENT ASSESSME; Lynn MR, 1986, NURS RES; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Moodley J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4219-7; Moodley J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009905; Mwaka AD, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0167-4; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Norsa'adah B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-141; Ramathuba DU, 2015, CURATIONIS, V38, P1, DOI DOI 10.4102/curationis.v38i1.1551; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; Richards MA, 1999, LANCET, V353, P1119, DOI 10.1016/S0140-6736(99)02143-1; Robb K, 2009, BRIT J CANC, V101; Sainsbury R, 1999, LANCET, V353, P1132; Sankaranarayanan R, 2010, ANN ONCOL, V21, P1935, DOI 10.1093/annonc/mdq049; Simon AE, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001758; Simon AE, 2012, J FAM PLAN REPROD H, V38, P167, DOI 10.1136/jfprhc-2011-100118; Simon AE, 2010, CANCER EPIDEM BIOMAR, V19, P2272, DOI 10.1158/1055-9965.EPI-10-0219; Statistics South Africa, 2012, STAT S AFR CONS 2011; Streiner D. L., 2015, HLTH MEASUREMENT SCA, V5<feminine, DOI [10.1093/med/9780199685219.001.0001, DOI 10.1093/MED/9780199685219.001.0001, 10.1093/MED/9780199685219.001.0001]; Stubbings S, 2009, BRIT J CANC, V101; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; UCL Health Behaviour Research Centre, 2007, CERV CANC AW MEAS CA; Unger-Saldana K, 2014, WORLD J CLIN ONCOL, V5, P465, DOI 10.5306/wjco.v5.i3.465; Wachira J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2058-x	48	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220545	10.1371/journal.pone.0220545	http://dx.doi.org/10.1371/journal.pone.0220545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5CU	31386684	Green Published, gold, Green Submitted			2022-12-27	WOS:000484997100024
J	Nostedt, JJ; Churchill, T; Ghosh, S; Thiesen, A; Hopkins, J; Lees, MC; Adam, B; Freed, DH; Shapiro, AMJ; Bigam, DL				Nostedt, Jordan J.; Churchill, Tom; Ghosh, Sunita; Thiesen, Aducio; Hopkins, Jessica; Lees, Mackenzie C.; Adam, Benjamin; Freed, Darren H.; Shapiro, A. M. James; Bigam, David L.			Avoiding initial hypothermia does not improve liver graft quality in a porcine donation after circulatory death (DCD) model of normothermic perfusion	PLOS ONE			English	Article							MACHINE PERFUSION; CARDIAC DEATH; COLD-STORAGE; TRANSPLANTATION; PRESERVATION; REPERFUSION; DONORS; INJURY; ISCHEMIA	Background Normothermic machine perfusion (NMP) of liver grafts donated after circulatory death (DCD) has shown promise in large animal and clinical trials. Following procurement, initial flush with a cold preservation solution is the standard of care. There is concern that initial cooling followed by warming may exacerbate liver injury, and the optimal initial flush temperature has yet to be identified. We hypothesize that avoidance of the initial cold flush will yield better quality liver grafts. Methods Twenty-four anaesthetized pigs were withdrawn from mechanical ventilation and allowed to arrest. After 60-minutes of warm ischemia to simulate a DCD procurement, livers were flushed with histidine-tryptophan-ketoglutarate (HTK) at 4 degrees C, 25 degrees C or 35 degrees C (n = 4 per group). For comparison, an adenosine-lidocaine crystalloid solution (AD), shown to have benefit at warm temperatures in heart perfusions, was also used (n = 4 per group). During 12-hours of NMP, adenosine triphosphate (ATP), lactate, transaminase levels, and histological injury were determined. Bile production and hemodynamics were monitored continuously. Results ATP levels recovered substantially following 1-hour of NMP reaching pre-ischemic levels by the end of NMP with no difference between groups. There was no difference in peak aspartate aminotransferase (AST) or in lactate dehydrogenase (LDH). Portal vein resistance was lowest in the 4 degrees C group reaching significance after 2 hours (0.13 CI -0.01,0.277, p = 0.025). Lactate levels recovered promptly with no difference between groups. Comparison to AD groups showed no statistical difference in the abovementioned parameters. On electron microscopy the HTK4 degrees C group had the least edema with mean cell thickness of 2.92 mu m (p = 0.41) while also having the least sinusoidal dilatation with a mean diameter of 5.36 mu m (p = 0.04). For AD, the 25 degrees C group had the lowest mean cell thickness at 3.14 mu m (p = 0.09). Conclusions Avoidance of the initial cold flush failed to demonstrate added benefit over standard 4 degrees C HTK in this DCD model of liver perfusion.	[Nostedt, Jordan J.; Hopkins, Jessica; Lees, Mackenzie C.; Shapiro, A. M. James; Bigam, David L.] Univ Alberta, Dept Surg, Div Gen Surg, Edmonton, AB, Canada; [Churchill, Tom] Univ Alberta, Dept Surg, Div Surg Res, Edmonton, AB, Canada; [Ghosh, Sunita] Univ Alberta, Dept Math & Stat Sci, Edmonton, AB, Canada; [Thiesen, Aducio; Adam, Benjamin] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Freed, Darren H.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Freed, Darren H.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Freed, Darren H.] Univ Alberta, Dept Surg, Div Cardiac Surg, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Nostedt, JJ; Bigam, DL (corresponding author), Univ Alberta, Dept Surg, Div Gen Surg, Edmonton, AB, Canada.	nostedt@ualberta.ca; david.bigam@albertahealthservices.ca		Freed, Darren/0000-0002-6239-1444; Nostedt, Jordan/0000-0002-3984-5700; Adam, Benjamin/0000-0003-1908-1739	University of Alberta Clinician Investigator Program	University of Alberta Clinician Investigator Program	JN was funded by the University of Alberta Clinician Investigator Program. The funder provided support in the form of salaries for JN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Berendsen TA, 2011, TRANSPL P, V43, P1484, DOI 10.1016/j.transproceed.2010.12.066; Bhogal RH, 2018, SEMIN LIVER DIS, V38, P252, DOI 10.1055/s-0038-1661371; Boehnert MU, 2013, AM J TRANSPLANT, V13, P1441, DOI 10.1111/ajt.12224; Bral M, 2017, AM J TRANSPLANT, V17, P1071, DOI 10.1111/ajt.14049; Brockmann J, 2009, ANN SURG, V250, P1, DOI 10.1097/SLA.0b013e3181a63c10; Bruinsma BG, 2017, TRANSPLANTATION, V101, P1637, DOI 10.1097/TP.0000000000001699; Busuttil RW, 2003, LIVER TRANSPLANT, V9, P651, DOI 10.1053/jlts.2003.50105; Carini R, 1999, EXP CELL RES, V248, P280, DOI 10.1006/excr.1999.4408; CLAVIEN PA, 1992, TRANSPLANTATION, V53, P957, DOI 10.1097/00007890-199205000-00001; Coffey JC, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13068; Foley DP, 2005, ANN SURG, V242, P724, DOI 10.1097/01.sla.0000186178.07110.92; Hashimoto K, 2010, AM J TRANSPLANT, V10, P2665, DOI 10.1111/j.1600-6143.2010.03337.x; Janssen H, 2003, TRANSPLANT INT, V16, P515, DOI 10.1007/s00147-003-0583-5; Kim WR, 2018, AM J TRANSPLANT, V18, P172, DOI 10.1111/ajt.14559; Liu Q, 2016, AM J TRANSPLANT, V16, P794, DOI 10.1111/ajt.13546; Liu Q, 2014, LIVER TRANSPLANT, V20, P987, DOI 10.1002/lt.23906; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu TF, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e24; Mergental H, 2018, LIVER TRANSPLANT, V24, P1453, DOI 10.1002/lt.25291; Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9; Nassar A, 2016, ARTIF ORGANS, V40, P999, DOI 10.1111/aor.12699; Passonneau JV, 1993, ENZYMATID ANAL PRACT; Peralta C, 2013, J HEPATOL, V59, P1094, DOI 10.1016/j.jhep.2013.06.017; Perera MTPR, 2014, BRIT J SURG, V101, P775, DOI 10.1002/bjs.9478; Radi ZA, 2011, AM J PATHOL, V179, P240, DOI 10.1016/j.ajpath.2011.03.029; Ravikumar R, 2016, AM J TRANSPLANT, V16, P1779, DOI 10.1111/ajt.13708; Reddy S, 2005, LIVER TRANSPLANT, V11, P35, DOI 10.1002/lt.20287; Reinders ME, 1996, TRANSPLANT INT, V9, P446, DOI 10.1111/j.1432-2277.1996.tb00987.x; Schon MR, 2001, ANN SURG, V233, P114, DOI 10.1097/00000658-200101000-00017; Selzner M, 2016, LIVER TRANSPLANT, V22, P1501, DOI 10.1002/lt.24499; van Golen RF, 2012, FREE RADICAL BIO MED, V52, P1382, DOI 10.1016/j.freeradbiomed.2012.01.013; Watson CJE, 2019, AM J TRANSPLANT, V19, P1745, DOI 10.1111/ajt.15241; Watson Christopher J E, 2018, Curr Transplant Rep, V5, P72, DOI 10.1007/s40472-018-0178-9; Watson CJE, 2017, TRANSPLANTATION, V101, P1084, DOI 10.1097/TP.0000000000001661; White CW, 2016, AM J TRANSPLANT, V16, P773, DOI 10.1111/ajt.13574; Xu HZ, 2012, J SURG RES, V173, pE83, DOI 10.1016/j.jss.2011.09.057	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220786	10.1371/journal.pone.0220786	http://dx.doi.org/10.1371/journal.pone.0220786			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386697	Green Published, gold, Green Submitted			2022-12-27	WOS:000484997100037
J	Guillen, S; Prieto, L; de Ory, SJ; Gonzalez-Tome, MI; Rojo, P; Navarro, ML; Mellado, MJ; Escosa, L; Sainz, T; Francisco, L; Munoz-Fernandez, MA; Ramos, JT; Hortelano, MG; Blazquez, D; Epalza, C; Saavedra, J; Santos, M; Munoz, MA; Santiago, B; Carrasco, I; Roa, MA; Beceiro, J; Penin, M; Martinez, J; Badillo, K; Apilanez, M; Pocheville, I; Garrote, E; Colino, E; Sirvent, JG; Garzon, M; Roman, V; Munoz, MJ; Angulo, R; Neth, O; Falcon, L; Terol, P; Santos, JL; Moreno, D; Lendinez, F; Peromingo, E; Montero, M; Grande, A; Romero, FJ; Perez, C; Martinez, M; Lillo, M; Losada, B; Herranz, M; Bustillo, M; Guerrero, C; Collado, P; Couceiro, JA; Vila, L; Calvino, C; Piqueras, AI; Breton, R; Oltra, M; Lopez, E; Segarra, I; Gavilan, C; Montesinos, E; Dapena, M; Alvarez, C; Jimenez, B; Andres, AG; Marugan, V; Ochoa, C; Alfayate, S; Menasalvas, AI; del Prado, YR; Soler-Palacin, P; Frick, MA; Mur, A; Lopez, N; Mendez, M; Mayol, L; Vallmanya, T; Calavia, O; Garcia, L; Pineda, V; Rius, N; Duenas, J; Fortuny, C; Noguera-Julian, A				Guillen, Sara; Prieto, Luis; Jimenez de Ory, Santiago; Isabel Gonzalez-Tome, Maria; Rojo, Pablo; Luisa Navarro, Maria; Jose Mellado, Maria; Escosa, Luis; Sainz, Talia; Francisco, Laura; Angeles Munoz-Fernandez, Maria; Tomas Ramos, Jose; Garcia Hortelano, Milagros; Blazquez, Daniel; Epalza, Cristina; Saavedra, Jesus; Santos, Mar; Angeles Munoz, Ma; Santiago, Begona; Carrasco, Itziar; Angel Roa, Miguel; Beceiro, Jose; Penin, Maria; Martinez, Jorge; Badillo, Katie; Apilanez, Miren; Pocheville, Itziar; Garrote, Elisa; Colino, Elena; Gomez Sirvent, Jorge; Garzon, Monica; Roman, Vicente; Jose Munoz, Maria; Angulo, Raquel; Neth, Olaf; Falcon, Lola; Terol, Pedro; Luis Santos, Juan; Moreno, David; Lendinez, Francisco; Peromingo, Estrella; Montero, Maria; Grande, Ana; Jose Romero, Francisco; Perez, Carlos; Martinez, Maria; Lillo, Miguel; Losada, Begona; Herranz, Mercedes; Bustillo, Matilde; Guerrero, Carmelo; Collado, Pilar; Antonio Couceiro, Jose; Vila, Leticia; Calvino, Consuelo; Isabel Piqueras, Ana; Breton, Rafael; Oltra, Manuel; Lopez, Eva; Segarra, Inmaculada; Gavilan, Cesar; Montesinos, Elena; Dapena, Marta; Alvarez, Cristina; Jimenez, Beatriz; Gloria Andres, Ana; Marugan, Victor; Ochoa, Carlos; Alfayate, Santiago; Isabel Menasalvas, Ana; Ruiz del Prado, Yolanda; Soler-Palacin, Pere; Antoinette Frick, Maria; Mur, Antonio; Lopez, Nuria; Mendez, Maria; Mayol, Lluis; Vallmanya, Teresa; Calavia, Olga; Garcia, Lourdes; Pineda, Valenti; Rius, Neus; Duenas, Joaquin; Fortuny, Claudia; Noguera-Julian, Antoni		CoRISpe Cohorte Nacl VIH Pediat RE	Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; T-CELL-ACTIVATION; IMMUNE RECONSTITUTION; 1-INFECTED CHILDREN; HIV-1-INFECTED CHILDREN; THYMIC OUTPUT; AGE; RECOVERY; NORMALIZATION; INDIVIDUALS	Background Combination antiretroviral therapy (cART) is associated with marked immune reconstitution. Although a long term viral suppression is achievable, not all children however, attain complete immunological recovery due to persistent immune activation. We use CD4/CD8 ratio like a marker of immune reconstitution. Methods Perinatal HIV-infected children who underwent a first-line cART, achieved viral suppression in the first year and maintained it for more than 5 years, with no viral rebound were included. Logistic models were applied to estimate the prognostic factors, clinical characteristics at cART start, of a lower CD4/CD8 ratio at the last visit. Results 146 HIV-infected children were included: 77% Caucasian, 45% male and 28% CDC C. Median age at cART initiation was 2.3 years (IQR: 0.5-6.2). 42 (30%) children received mono-dual therapy previously to cART. Time of undetectable viral load was 9.5 years (IQR: 7.8, 12.5). 33% of the children not achieved CD4/CD8 ratio >1. Univariate analysis showed an association between CD4/CD8 <1 with lower CD4 nadir and baseline CD4; older age at diagnosis and at cART initiation; and a previous exposure to mono-dual therapy. Multivariate analysis also revealed relationship between CD4/CD8 <1 and lower CD4 nadir (OR: 1.002, CI 95% 1.000-1.004) as well as previous exposure to mono-dual therapy (OR: 0.16, CI 95% 0.003-0.720). Conclusions CD4/CD8 > 1 was not achieved in 33% of the children. Lower CD4 nadir and previous exposure to suboptimal therapy, before initiating cART, are factors showing independently association with a worse immune recovery (CD4/CD8 < 1).	[Guillen, Sara] Hosp Univ Getafe, Dept Pediat, Madrid, Spain; [Prieto, Luis; Isabel Gonzalez-Tome, Maria; Rojo, Pablo] Hosp Univ 12 Octubre Madrid, Dept Pediat, Madrid, Spain; [Jimenez de Ory, Santiago; Angeles Munoz-Fernandez, Maria] Hosp Univ Gregorio Maranon, Dept Immunol, Madrid, Spain; [Luisa Navarro, Maria] Hosp Univ Gregorio Maranon, Dept Pediat, Madrid, Spain; [Jose Mellado, Maria; Escosa, Luis; Sainz, Talia] Hosp Univ La Paz, Dept Pediat, Madrid, Spain; [Francisco, Laura; Tomas Ramos, Jose] Hosp Clin Univ San Carlos, Dept Pediat, Madrid, Spain; [Jose Mellado, Maria; Escosa, Luis; Sainz, Talia; Garcia Hortelano, Milagros] Hosp La Paz, Madrid, Spain; [Isabel Gonzalez-Tome, Maria; Rojo, Pablo; Blazquez, Daniel; Epalza, Cristina] Hosp Doce Octubre, Madrid, Spain; [Tomas Ramos, Jose] Hosp Clin San Carlos, Madrid, Spain; [Guillen, Sara; Prieto, Luis] Hosp Getafe, Getafe, Spain; [Jimenez de Ory, Santiago; Luisa Navarro, Maria; Saavedra, Jesus; Santos, Mar; Angeles Munoz, Ma; Santiago, Begona; Carrasco, Itziar] Hosp Gregorio Maranon, Madrid, Spain; [Angel Roa, Miguel] Hosp Mostoles, Madrid, Spain; [Beceiro, Jose; Penin, Maria] Hosp Principe Asturias, Alcala De Henares, Spain; [Martinez, Jorge] Hosp Nino Jesus, Madrid, Spain; [Badillo, Katie] Hosp Torrejon, Torrejon de Ardoz, Spain; [Apilanez, Miren] Hosp Donostia, San Sebastian, Spain; [Pocheville, Itziar] Hosp Cruces, Bilbao, Spain; [Garrote, Elisa] Hosp Basurto, Bilbao, Spain; [Colino, Elena] Hosp Insular Materno Infantil, Las Palmas Gran Canaria, Spain; [Gomez Sirvent, Jorge] Hosp Virgen de laCandelaria, Santa Cruz De Tenerife, Spain; [Garzon, Monica; Roman, Vicente] Hosp Lanzarote, Arrecife, Spain; [Jose Munoz, Maria; Angulo, Raquel] Hosp Poniente, El Ejido, Spain; [Neth, Olaf; Falcon, Lola] Hosp Virgen de Rocio, Seville, Spain; [Terol, Pedro] Hosp Virgen de la Macarena, Seville, Spain; [Luis Santos, Juan] Hosp Virgen de las Nieves, Granada, Spain; [Moreno, David] Hosp Carlos Haya, Malaga, Spain; [Lendinez, Francisco] Hosp Torrecardenas, Almeria, Spain; [Peromingo, Estrella; Montero, Maria] Hosp Puerta Mar, Cadiz, Spain; [Grande, Ana] Complejo Hosp Univ Infanta Cristina, Badajoz, Spain; [Jose Romero, Francisco] Complejo Hosp Caceres, Caceres, Spain; [Perez, Carlos] Hosp Cabuenes, Gijon, Spain; [Martinez, Maria] Hosp Univ Cent Asturias, Oviedo, Spain; [Lillo, Miguel] Hosp Albacete, Albacete, Spain; [Losada, Begona] Hosp Virgen de la Salud, Toledo, Spain; [Herranz, Mercedes] Hosp Virgen del Camino, Pamplona, Spain; [Bustillo, Matilde; Guerrero, Carmelo] Hosp Miguel Servet, Zaragoza, Spain; [Collado, Pilar] Hosp Clin Lozano Blesa, Zaragoza, Spain; [Antonio Couceiro, Jose] Complejo Hosp Pontevedra, Pontevedra, Spain; [Vila, Leticia] Complejo Hosp Univ La Coruna, La Coruna, Spain; [Calvino, Consuelo] Hosp Univ Lucus Augusti Lugo, Lugo, Spain; [Isabel Piqueras, Ana; Breton, Rafael; Oltra, Manuel; Lopez, Eva; Segarra, Inmaculada] Hosp La Fe, Valencia, Spain; [Gavilan, Cesar] Hosp San Juan Alicante, Alicante, Spain; [Montesinos, Elena] Hosp Gen Valencia, Valencia, Spain; [Dapena, Marta] Hosp Castellon, Castellon de La Plana, Spain; [Alvarez, Cristina; Jimenez, Beatriz] Hosp Marques Valdecilla, Santander, Spain; [Gloria Andres, Ana] Hosp Leon, Leon, Spain; [Marugan, Victor; Ochoa, Carlos] Hosp Zamora, Zamora, Spain; [Alfayate, Santiago; Isabel Menasalvas, Ana] Hosp Virgen Arrixaca, Murcia, Spain; [Ruiz del Prado, Yolanda] Complejo Hosp San Millan San Pedro, Logrono, Spain; [Soler-Palacin, Pere; Antoinette Frick, Maria] Hosp Univ Vall dHebron, Barcelona, Spain; [Mur, Antonio; Lopez, Nuria] Hosp Univ Mar, Barcelona, Spain; [Mendez, Maria] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Mayol, Lluis] Hosp Univ Josep Trueta, Girona, Spain; [Vallmanya, Teresa] Hosp Arnau Vilanova, Lleida, Spain; [Calavia, Olga] Hosp Univ Joan XXIII, Tarragona, Spain; [Garcia, Lourdes] Consorci Sanitari Maresme, Mataro, Spain; [Garcia, Lourdes] Hosp Gen Granollers, Granollers, Spain; [Pineda, Valenti] Corp Sanitaria Parc Tauli, Sabadell, Spain; [Rius, Neus] Hosp Univ St Joan, Reus, Spain; [Duenas, Joaquin] Hosp Son Espases, Mallorca, Spain; [Fortuny, Claudia; Noguera-Julian, Antoni] Hosp St Joan de Deu, Esplugues, Spain	Hospital Universitario de Getafe; Hospital Universitario 12 de Octubre; General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario 12 de Octubre; Hospital Clinico San Carlos; Hospital Universitario de Getafe; General University Gregorio Maranon Hospital; Prince of Asturias University Hospital; University Hospital Donostia; Hospital Universitario Cruces; Basurto Hospital; Hospital Universitario Virgen de las Nieves; Hospital Carlos Haya; Hospital Torrecardenas; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital de Cabuenes; Central University Hospital Asturias; Complejo Hospitalario de Toledo; Hospital Virgen del Camino; Servicio Navarro de Salud - Osasunbidea; Miguel Servet University Hospital; Lozano Blesa University Clinical Hospital; Complexo Hospitalario Universitario de Pontevedra; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitari i Politecnic La Fe; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Leon; Hospital de Leon; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Universitari Vall d'Hebron; Hospital Germans Trias i Pujol; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University Hospital Arnau de Vilanova; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Hospital Universitari Son Espases	Guillen, S (corresponding author), Hosp Univ Getafe, Dept Pediat, Madrid, Spain.; Guillen, S (corresponding author), Hosp Getafe, Getafe, Spain.	sguillenmartin@hotmail.com	Escosa-Garcia, Luis/AFZ-2323-2022; Moreno, David/J-2969-2012; Soler-Palacin, Pere/N-2373-2014; Villanueva, Rita Guadalupe Angulo/I-8399-2017; Carrasco, Itziar/O-1724-2018; Prieto, Luis Enrique/HFZ-7903-2022; García, Lourdes/GZK-6681-2022	Moreno, David/0000-0002-7017-4095; Soler-Palacin, Pere/0000-0002-0346-5570; Villanueva, Rita Guadalupe Angulo/0000-0003-2694-3501; ROJO, PABLO/0000-0002-0197-5462; DUENAS MORALES, JOAQUIN/0000-0001-6500-0042; Munoz-Fernandez/0000-0002-0813-4500; Guillen, Sara/0000-0001-8204-1858; Mellado Pena, Maria Jose/0000-0003-2251-9666				Caby F, 2017, AIDS, V31, P1685, DOI [10.1097/QAD.0000000000001533, 10.1097/qad.0000000000001533]; Caby F, 2016, CLIN INFECT DIS, V62, P1297, DOI 10.1093/cid/ciw076; Cohen S, 2015, JAIDS-J ACQ IMM DEF, V68, P178, DOI 10.1097/QAI.0000000000000431; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, 2008, AIDS, V22, P1463, DOI 10.1097/QAD.0b013e3282f88d02; Collins IJ, 2013, 7 IAS C HIV PATH TRE; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; De Biasi S, 2016, AIDS, V30, P2599, DOI 10.1097/QAD.0000000000001247; De Rossi A, 2002, J INFECT DIS, V186, P312, DOI 10.1086/341657; Diaz L, 2012, JAIDS-J ACQ IMM DEF, V60, P447, DOI 10.1097/QAI.0b013e318259254f; Gibb DM, 2000, LANCET, V355, P1331, DOI 10.1016/S0140-6736(00)02117-6; Hainaut M, 2003, PEDIATR INFECT DIS J, V22, P62, DOI 10.1097/00006454-200301000-00016; Krogstad P, 2015, AIDS, V29, P683, DOI 10.1097/QAD.0000000000000598; Lewis J, 2012, J INFECT DIS, V205, P548, DOI 10.1093/infdis/jir787; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Newell ML, 2006, J INFECT DIS, V193, P954, DOI 10.1086/500842; Patel K, 2008, CLIN INFECT DIS, V46, P1751, DOI 10.1086/587900; Petoumenos K, 2017, ANTIVIR THER, V22, P659, DOI 10.3851/IMP3155; Phongsamart W, 2014, INT J INFECT DIS, V22, P19, DOI 10.1016/j.ijid.2013.12.011; Puthanakit T, 2009, PEDIATR INFECT DIS J, V28, P488, DOI 10.1097/INF.0b013e318194eea6; Rainwater-Lovett K, 2014, JAIDS-J ACQ IMM DEF, V67, P455, DOI 10.1097/QAI.0000000000000342; Resino S, 2006, CLIN INFECT DIS, V42, P862, DOI 10.1086/500412; Resino S, 2006, PEDIATR INFECT DIS J, V25, P365, DOI 10.1097/01.inf.0000207419.50016.5e; Sainz T, 2013, AIDS, V27, P1513, DOI 10.1097/QAD.0b013e32835faa72; Sandgaard KS, 2014, AIDS, V28, P209, DOI 10.1097/QAD.0000000000000063; Sauter R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005094; Serrano-Villar S, 2017, J ANTIMICROB CHEMOTH, V72, P235, DOI 10.1093/jac/dkw375; Serrano-Villar S, 2013, J INFECTION, V66, P57, DOI 10.1016/j.jinf.2012.09.013; Soh CH, 2003, LANCET, V362, P2045, DOI 10.1016/S0140-6736(03)15098-2; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Van Dyke RB, 2011, JAIDS-J ACQ IMM DEF, V57, P165, DOI 10.1097/QAI.0b013e318215c7b1; van Rossum AMC, 2001, AIDS, V15, P2267, DOI 10.1097/00002030-200111230-00008; Walker AS, 2004, AIDS, V18, P1915, DOI 10.1097/00002030-200409240-00007	33	3	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220552	10.1371/journal.pone.0220552	http://dx.doi.org/10.1371/journal.pone.0220552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381604	Green Published, gold			2022-12-27	WOS:000484993600024
J	Pitini, E; D'Andrea, E; De Vito, C; Rosso, A; Unim, B; Marzuillo, C; Federici, A; Di Maria, E; Villari, P				Pitini, Erica; D'Andrea, Elvira; De Vito, Corrado; Rosso, Annalisa; Unim, Brigid; Marzuillo, Carolina; Federici, Antonio; Di Maria, Emilio; Villari, Paolo			A proposal of a new evaluation framework towards implementation of genetic tests	PLOS ONE			English	Article							HEALTH TECHNOLOGY-ASSESSMENT; CLINICAL UTILITY; PERSONAL UTILITY; PROGRAMS; WOMEN	Background The existing frameworks for the evaluation of genetic and genomic applications clearly address the technical and clinical value of a test, but are less concerned with the way genetic services are delivered and organized. We therefore aimed to develop a comprehensive new framework that includes an assessment of service delivery. Methods A new framework was built on the evaluation dimensions identified through a systematic review of the existing frameworks and a Delphi survey of Italian experts in public health genomics. Results Our framework has four sections. The first two sections, respectively, guide the evidence collection process for the genetic test (analytic validity; clinical validity; clinical utility; personal utility) and its delivery models (organizational aspects; economic evaluation; ethical, legal and social implications; patient perspective). The third section guides the formulation of the research priorities to be addressed in future research. Finally, the fourth section suggests three criteria to summarize the collected evidence (net benefit, cost-effectiveness, feasibility). Conclusion We have successfully developed an evaluation framework for the evaluation of genetic tests that includes an assessment of service delivery. It also introduces some neglected evaluation dimensions such as personal utility and patient perspective.	[Pitini, Erica; D'Andrea, Elvira; De Vito, Corrado; Rosso, Annalisa; Unim, Brigid; Marzuillo, Carolina; Villari, Paolo] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [D'Andrea, Elvira] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [D'Andrea, Elvira] Harvard Med Sch, Boston, MA 02115 USA; [Federici, Antonio] Minist Hlth, Rome, Italy; [Di Maria, Emilio] Univ Genoa, Dept Hlth Sci, Div Med Genet, Galliera Hosp, Genoa, Italy	Sapienza University Rome; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ente Ospedaliero Ospedali Galliera; University of Genoa	Pitini, E (corresponding author), Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.	erica.pitini@uniroma1.it	Rosso, Annalisa/AAC-3957-2022; Di Maria, Emilio/AFK-2153-2022; D'Andrea, Elvira/ABA-7631-2020	Rosso, Annalisa/0000-0002-0537-5130; Di Maria, Emilio/0000-0002-8357-2658; DE VITO, CORRADO/0000-0002-7846-672X; MARZUILLO, CAROLINA/0000-0002-7299-5727; Unim, Brigid/0000-0002-6522-9098; Pitini, Erica/0000-0003-2018-3679; villari, paolo/0000-0002-3139-0668	Italian Ministry of Health; European Union [645740]	Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission)	EP, ED, CDV, AR, BU, CM, PV report grants from Italian Ministry of Health, project "Definizione e promozione di programmi per il sostegno all'attuazione del Piano d'Intesa del 13/3/13 recante Linee di indirizzo su La Genomica in Sanita Pubblica": http://www.ccm-network.it/progetto.jsp? id=node/1914& idP=740; European Union Horizon 2020 research and innovation programme MSCA-RISE-2014 (Marie Sklodowska-Curie Research and Innovation Staff Exchange) under grant agreement No 645740, project "Personalized pREvention of Chronic Diseases consortium PRECeDI": http://www.precedi.eu/site/index.php.EDM reports a grant from Italian Ministry of Health, project "Definizione e promozione di programmi per il sostegno all'attuazione del Piano d'Intesa del 13/3/13 recante Linee di indirizzo su La Genomica in Sanita Pubblica": http://www.ccm-network.it/progetto.jsp? id= node/1914& idP= 740. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews L. B., 1994, ASSESSING GENETIC RI, P247; [Anonymous], 2011, ADDRESSING CHALLENGE; Arslan-Kirchner M, 2016, EUR J HUM GENET, V24, P146, DOI 10.1038/ejhg.2015.225; Bakos AD, 2008, HEALTH EXPECT, V11, P220, DOI 10.1111/j.1369-7625.2008.00494.x; Battista RN, 2012, PUBLIC HEALTH GENOM, V15, P34, DOI 10.1159/000328846; Battista RN, 2006, INT J TECHNOL ASSESS, V22, P275; Becker F, 2011, EUR J HUM GENET, V19, pS6, DOI 10.1038/ejhg.2010.249; Boccia S., 2017, EPIDEMIOL BIOSTAT PU, V14; Bunnik EM, 2015, J MED ETHICS, V41, P322, DOI 10.1136/medethics-2013-101887; Burke W., 2007, MOVING ACCE EXPANDED; Burke Wylie, 2014, Curr Protoc Hum Genet, V81, DOI 10.1002/0471142905.hg0915s81; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; D'Andrea E, 2018, EUR J HUM GENET, V26, P518, DOI 10.1038/s41431-017-0083-1; D'Andrea E, 2016, GENET MED, V18, P1171, DOI 10.1038/gim.2016.29; Di Marco M, 2018, GENET MED, V20, P1131, DOI 10.1038/gim.2017.244; Dotson WD, 2016, GENET MED, V18, P672, DOI 10.1038/gim.2015.153; Drummond MF, 2015, METHODS EC EVALUATIO, V4th; EUnetHTA Joint Action 2 WP 8, 2013, HTA COR MOD VERS 3 0; Ferreira-Gonzalez A, 2008, PERS MED, V5, P521, DOI 10.2217/17410541.5.5.521; Gagnon MP, 2011, INT J TECHNOL ASSESS, V27, P31, DOI 10.1017/S0266462310001315; Grosse SD, 2006, GENET MED, V8, P448, DOI 10.1097/01.gim.0000227935.26763.c6; Gu YL, 2011, GENET MED, V13, P26, DOI 10.1097/GIM.0b013e3181f9648a; Haddow JE, 2004, HUMAN GENOME EPIDEMI, P217; Hornberger J, 2012, GENET TEST MOL BIOMA, V16, P605, DOI 10.1089/gtmb.2011.0177; Hoskins LM, 2013, J GENET COUNS, V22, P27, DOI 10.1007/s10897-012-9521-y; Khoury MJ, 2008, HEALTH AFFAIR, V27, P1600, DOI 10.1377/hlthaff.27.6.1600; Khoury MJ, 2017, JAMA-J AM MED ASSOC, V318, P27, DOI 10.1001/jama.2017.6315; Kohler JN, 2017, CLIN GENET, V92, P290, DOI 10.1111/cge.12998; Kohler JN, 2017, EUR J HUM GENET, V25, P662, DOI 10.1038/ejhg.2017.10; Krahn MD, 2019, S CADTH ALB CAN 2019; Kroese M, 2007, EUR J HUM GENET, V15, P917, DOI 10.1038/sj.ejhg.5201867; Marzuillo C, 2014, QJM-INT J MED, V107, P93, DOI 10.1093/qjmed/hct190; Mazzucco W, 2016, EUR J PUBLIC HEALTH, V27, P155; Pitini E, 2018, EUR J HUM GENET, V26, P605, DOI 10.1038/s41431-018-0095-5; Ricciardi W, 2007, EUROHEALTH, V13, P4; Schmidtke J, 2010, EUR J HUM GENET, V18, P1068, DOI 10.1038/ejhg.2010.85; Simone B, 2013, HEALTH POLICY, V110, P214, DOI 10.1016/j.healthpol.2013.01.015; The New York-Mid-Atlantic Consortium for Genetic and Newborn Screening Services, 2010, ETH LEG SOC ISS UND; UK Genetic testing Network, 2017, 5 UK GEN TEST NETW; Unim B, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00223; Zimmern RL, 2007, J PUBLIC HEALTH-UK, V29, P246, DOI 10.1093/pubmed/fdm028	41	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0219755	10.1371/journal.pone.0219755	http://dx.doi.org/10.1371/journal.pone.0219755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5BL	31381569	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600007
J	Esmaeili, S; Hemami, MR; Goheen, JR				Esmaeili, Saeideh; Hemami, Mahmoud-Reza; Goheen, Jacob R.			Human dimensions of wildlife conservation in Iran: Assessment of human-wildlife conflict in restoring a wide-ranging endangered species	PLOS ONE			English	Article							MANAGEMENT; PERFORMANCE; EXTINCTION; INTERESTS; DIVERSITY; ATTITUDES	Human-wildlife conflicts restrict conservation efforts, especially for wide-ranging animals whose home ranges overlap with human activities. We conducted a study to understand conflicts with, and factors influencing the perceived value of an expanding population of onagers (Equus hemionus onager) in local communities in southern Iran. We asked about locals' perceptions of six potential management strategies intended to lessen human-onager conflict. We found that human-onager conflict was restricted to 45% of respondents within the Bahram-e-Goor Protected Area, all of whom were involved in farming or herding activities. Locals within the protected area were more knowledgeable about onagers and valued onagers more than those living outside the protected area. The perceived value of onagers increased with level of education, total annual income, and perceptions of onager population trends; the perceived value of onagers decreased with the magnitude of conflict between onagers and locals. To tolerate or avoid conflicts with onagers, locals were supportive of monetary compensation and changing from a traditional lifestyle to industrialized farming (for farmers) or livestock production (for herders) with the help of government; locals did not support selling land to the government. Our study is among the first in human-wildlife conflict and local attitudes towards an endangered species and its recovery in Iran. We conclude that current levels of human-onager conflict are relatively low and perceived value of onagers is still relatively high. Therefore, wildlife authorities should consider the development of mitigation strategies with local communities before conflicts intensify.	[Esmaeili, Saeideh; Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Hemami, Mahmoud-Reza] Isfahan Univ Technol, Dept Nat Resources, Esfahan, Iran	University of Wyoming; Isfahan University of Technology	Esmaeili, S (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.	saeideh.esmaeili@uwyo.edu	Hemami, Mahmoud-Reza/AAH-2553-2022; Hemami, Mahmoud-Reza/AFM-0224-2022	Esmaeili, Saeideh/0000-0002-8678-7048	Cleveland Metroparks Zoo; Eva Mayr-Stihl Stiftung	Cleveland Metroparks Zoo; Eva Mayr-Stihl Stiftung	This work was funded by: 1-Cleveland Metroparks Zoo, https://www.clevelandmetroparks.com/zoo to MRH, SE; and 2Eva Mayr-Stihl Stiftung: http://www.eva-mayr-stihlstiftung.de/en to MRH, SE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams W., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; [Anonymous], 2009, IRAN 2006 CENSUS; Beck, 1998, YALE SCH FORESTRY EN, V103, P58; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Bulte EH, 2005, J WILDLIFE MANAGE, V69, P14, DOI 10.2193/0022-541X(2005)069&lt;0014:WCWDMB&gt;2.0.CO;2; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Decker DJ, 1997, WILDLIFE SOC B, V25, P788; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dickman AJ, 2011, P NATL ACAD SCI USA, V108, P13937, DOI 10.1073/pnas.1012972108; Farhadinia MS, 2017, BIOL CONSERV, V213, P210, DOI 10.1016/j.biocon.2017.07.011; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Ghoshtasb H, 2012, J NAT ENV IRANINAN J, V65, P247; Gliem J.A., 2003, MIDWEST RES TO PRACT, DOI [10.1016/j.encep.2016.05.011, DOI 10.1109/PROC.1975.9792]; Goldberg EJ, 2018, ABBASID CAROLINGIAN, P73; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Gusset M, 2008, BIODIVERS CONSERV, V17, P83, DOI 10.1007/s10531-007-9232-0; Harrell FE, 2018, PACKAGE RMS CRAN; Hemami MR, 2013, ORYX, V47, P266, DOI 10.1017/S0030605311001827; Hemami P, 2015, IUCN RED LIST THREAT; Hobbs NT, 2012, ECOL APPL, V22, P1640, DOI 10.1890/11-1309.1; Hosseini-Zavarei F, 2013, J ZOOL, V290, P127, DOI 10.1111/jzo.12022; Kaczensky P., 2015, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T7951A45171204.EN]; Kaczensky P., 2006, MONGOLIA DISCUSSION; Kansky R, 2014, BIOL CONSERV, V179, P93, DOI 10.1016/j.biocon.2014.09.008; Kolahi M, 2013, ENVIRON MANAGE, V52, P514, DOI 10.1007/s00267-013-0061-5; Lele S, 2010, CURR OPIN ENV SUST, V2, P94, DOI 10.1016/j.cosust.2010.03.006; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Maclennan SD, 2009, BIOL CONSERV, V142, P2419, DOI 10.1016/j.biocon.2008.12.003; Manfredo MJ, 2008, WHO CARES WILDLIFE E; Marshall K, 2007, BIODIVERS CONSERV, V16, P3129, DOI 10.1007/s10531-007-9167-5; Martin-Lopez B, 2009, BIOL CONSERV, V142, P1370, DOI 10.1016/j.biocon.2009.01.030; Mohammadi A, 2016, HUM-WILDL INTERACT, V10, P103; Nyhus PJ, 2005, CONSERV BIOL SER, V9, P107; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Santos J.R.A., 1999, J EXT, V37, P1; Schwerdtner K, 2007, BIOL CONSERV, V134, P354, DOI 10.1016/j.biocon.2006.08.010; Seddon PJ, 2014, SCIENCE, V345, P406, DOI 10.1126/science.1251818; Tatin L, 2003, ORYX, V37, P488; Teel TL, 2010, CONSERV BIOL, V24, P128, DOI 10.1111/j.1523-1739.2009.01374.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wingard J, 2014, GUIDELINES ADDRESSIN; Woodroffe R, 2005, CONSERV BIOL SER, V9, P1; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Yackulic CB, 2011, P NATL ACAD SCI USA, V108, P4024, DOI 10.1073/pnas.1015097108; Yasmi Y, 2006, ENVIRON SCI POLICY, V9, P538, DOI 10.1016/j.envsci.2006.04.003; Zeileis A, 2016, PACKAGE BETAREG CRAN	52	8	8	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220702	10.1371/journal.pone.0220702	http://dx.doi.org/10.1371/journal.pone.0220702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374100	Green Published, gold			2022-12-27	WOS:000484991500028
J	Huth, S; Sindt, S; Selhuber-Unkel, C				Huth, Steven; Sindt, Sandra; Selhuber-Unkel, Christine			Automated analysis of soft hydrogel microindentation: Impact of various indentation parameters on the measurement of Young's modulus	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; SUBSTRATE STIFFNESS; MATRIX; ELASTICITY; ROUGHNESS; MIGRATION; FRICTION; GRADIENT; CONTACT	Measurements of Young's moduli are mostly evaluated using strong assumptions, such as sample homogeneity and isotropy. At the same time, descriptions of measurement parameters often lack detailed specifications. Many of these assumptions are, for soft hydrogels especially, not completely valid and the complexity of hydrogel microindentation demands more sophisticated experimental procedures in order to describe their elastic properties more accurately. We created an algorithm that automates indentation data analysis as a basis for the evaluation of large data sets with consideration of the influence of indentation depth on the measured Young's modulus. The algorithm automatically determines the Young's modulus in indentation regions where it becomes independent of the indentation depth and furthermore minimizes the error from fitting an elastic model to the data. This approach is independent of the chosen elastic fitting model and indentation device. With this, we are able to evaluate large amounts of indentation curves recorded on many different sample positions and can therefore apply statistical methods to overcome deviations due to sample inhomogeneities. To prove the applicability of our algorithm, we carried out a systematic analysis of how the indentation speed, indenter size and sample thickness affect the determination of Young's modulus from atomic force microscope (AFM) indentation curves on polyacrylamide (PAAm) samples. We chose the Hertz model as the elastic fitting model for this proof of principle of our algorithm and found that all of these parameters influence the measured Young's moduli to a certain extent. Hence, it is essential to clearly state the experimental parameters used in microindentation experiments to ensure reproducibility and comparability of data.	[Huth, Steven; Sindt, Sandra; Selhuber-Unkel, Christine] Univ Kiel, Inst Mat Sci, Biocompatible Nanomat, Kiel, Germany	University of Kiel	Selhuber-Unkel, C (corresponding author), Univ Kiel, Inst Mat Sci, Biocompatible Nanomat, Kiel, Germany.	cse@tf.uni-kiel.de	Selhuber-Unkel, Christine/D-9715-2016	Selhuber-Unkel, Christine/0000-0002-5051-4822	ERC [336104, 768740, RTG 2154]; German Research Foundation	ERC(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG))	C. S. and S. H. acknowledge support through the ERC (Starting grant no. 336104, Proof of Concept Grant no. 768740). S. S. is a doctoral researcher in the Research Training Group RTG 2154 "Materials for Brain," which is funded by the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w; Barthel E, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/16/163001; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647; Burmistrova A, 2011, COLLOID POLYM SCI, V289, P613, DOI 10.1007/s00396-011-2383-2; Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116; Chaudhri MM, 1996, PHILOS MAG A, V74, P1213, DOI 10.1080/01418619608239721; COHEN Y, 1992, J POLYM SCI POL PHYS, V30, P1055, DOI 10.1002/polb.1992.090300913; Crick SL, 2007, BIOMECH MODEL MECHAN, V6, P199, DOI 10.1007/S10237-006-0046-x; Denisin AK, 2016, ACS APPL MATER INTER, V8, P21893, DOI 10.1021/acsami.5b09344; Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doerner MF, 1986, J MATER RES, V1, P601, DOI 10.1557/JMR.1986.0601; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2004, SURF SCI, V570, P142, DOI 10.1016/j.susc.2004.06.179; FIELD JS, 1995, J MATER RES, V10, P101, DOI 10.1557/JMR.1995.0101; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Galluzzi M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05902-1; Gavara N, 2016, SCI REP-UK, V6, DOI 10.1038/srep21267; Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI 10.2217/NNM.10.12; Gross W, 2017, SOFT MATTER, V13, P1048, DOI 10.1039/c6sm02470j; Gutekunst SB, 2019, ACS BIOMATER SCI ENG, V5, P1784, DOI 10.1021/acsbiomaterials.8b01009; Guz N, 2014, BIOPHYS J, V107, P564, DOI 10.1016/j.bpj.2014.06.033; Hadden WJ, 2017, P NATL ACAD SCI USA, V114, P5647, DOI 10.1073/pnas.1618239114; Hagel V, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-36; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Krieg M, 2019, NAT REV PHYS, V1, P41, DOI 10.1038/s42254-018-0001-7; Kronenberg NM, 2017, NAT CELL BIOL, V19, P864, DOI 10.1038/ncb3561; Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; Moshayedi P, 2014, BIOMATERIALS, V35, P3919, DOI 10.1016/j.biomaterials.2014.01.038; Platzman I, 2013, RSC ADV, V3, P13293, DOI [10.1039/C3RA41579A, 10.1039/c3ra41579a]; Pratt JR, 2010, J APPL PHYS, V107, DOI 10.1063/1.3284957; Rico F, 2008, NANOSCI TECHNOL, P89, DOI 10.1007/978-3-540-74083-4_4; RUCHEL R, 1975, ANAL BIOCHEM, V68, P415, DOI 10.1016/0003-2697(75)90637-5; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stiernstedt J, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2006407; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]; Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978; van Zwol PJ, 2008, LANGMUIR, V24, P7528, DOI 10.1021/la800664f; Wang JHC, 2007, ADVANCED BIOIMAGING TECHNOLOGIES IN ASSESSMENT OF THE QUALITY OF BONE AND SCAFFOLD MATERIALS: TECHNIQUES AND APPLICATIONS, P227, DOI 10.1007/978-3-540-45456-4_14; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Xu LN, 2008, J CENT SOUTH UNIV T, V15, P443, DOI 10.1007/s11771-008-0396-x; Yashima S, 2014, SOFT MATTER, V10, P3192, DOI 10.1039/c3sm52883a	46	20	20	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220281	10.1371/journal.pone.0220281	http://dx.doi.org/10.1371/journal.pone.0220281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374079	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500007
J	Multini, LC; de Souza, ALD; Marrelli, MT; Wilke, ABB				Multini, Laura Cristina; da Silva de Souza, Ana Leticia; Marrelli, Mauro Toledo; Bruno Wilke, Andre Barretto			Population structuring of the invasive mosquito Aedes albopictus (Diptera: Culicidae) on a microgeographic scale	PLOS ONE			English	Article							ASIAN TIGER MOSQUITO; SAO-PAULO; GENETIC DIVERSITY; GLOBAL RISK; R-PACKAGE; VIRUS; SOFTWARE; AEGYPTI; VECTOR; BRAZIL	Aedes albopictus is an invasive mosquito species that has spread globally and can transmit several arboviruses, including dengue, chikungunya and yellow fever. The species was first reported in Brazil in 1986 and since then has been found in 24 of the 27 Brazilian states, often in peri-urban environments close to highly urbanized areas. To date, population genetics of this important mosquito in areas in the city of Sao Paulo has not been investigated. In this study, we used 12 microsatellite loci to investigate the microgeographic population genetics of Ae. albopictus, which is present throughout the city of Sao Paulo. All the analyses revealed structuring of the populations studied, divided into two groups with restricted gene flow between them and without evidence of isolation by distance. We propose two hypotheses to explain the results: (i) low dispersal capability-limited gene flow between populations is due to the low dispersal capability inherent to Ae. albopictus; and (ii) multiple introductions-the structure identified here results from multiple introductions, which led to different dispersal patterns within the city and more genetic heterogeneity. The ability of Ae. albopictus to invade new areas and expand may explain why these mosquito populations appear to be well established and thriving in the city of Sao Paulo.	[Multini, Laura Cristina; Marrelli, Mauro Toledo] Univ Sao Paulo, Fac Publ Hlth, Dept Epidemiol, Sao Paulo, SP, Brazil; [da Silva de Souza, Ana Leticia; Marrelli, Mauro Toledo] Univ Sao Paulo, Sao Paulo Inst Trop Med, Sao Paulo, SP, Brazil; [Bruno Wilke, Andre Barretto] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Miami	Multini, LC (corresponding author), Univ Sao Paulo, Fac Publ Hlth, Dept Epidemiol, Sao Paulo, SP, Brazil.	lauramultini@usp.br	Wilke, Andre B B/J-9973-2014; Marrelli, Mauro/AHB-7335-2022	Wilke, Andre B B/0000-0002-6629-7666; Multini, Laura Cristina/0000-0002-1322-9889	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/15313-4]; FAPESP fellowship [2015/23386-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant 2013/15313-4. LCM is the recipient of a FAPESP fellowship (grant 2015/23386-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5; Amraoui F, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.39.30361; [Anonymous], 2002, CULICIDOLOGIA MED; Ayllon T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195014; Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Wilke ABB, 2017, J MED ENTOMOL, V54, P1582, DOI 10.1093/jme/tjx149; Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150; Buhaug H, 2013, GLOBAL ENVIRON CHANG, V23, P1, DOI 10.1016/j.gloenvcha.2012.10.016; Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Ceretti W, 2015, J AM MOSQUITO CONTR, V31, P172, DOI 10.2987/14-6457R; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Conn JE, 2006, AM J TROP MED HYG, V74, P798, DOI 10.4269/ajtmh.2006.74.798; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105; Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111; Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009; Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866; GOMES AD, 1985, REV SAUDE PUBL, V19, P190, DOI 10.1590/S0034-89101985000200009; Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35; Hill MP, 2014, AUSTRAL ECOL, V39, P469, DOI 10.1111/aec.12105; Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kamgang Basile, 2018, Wellcome Open Res, V3, P79, DOI 10.12688/wellcomeopenres.14659.1; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kivela M, 2015, MOL ECOL RESOUR, V15, P117, DOI 10.1111/1755-0998.12290; Knop E, 2016, GLOBAL CHANGE BIOL, V22, P228, DOI 10.1111/gcb.13091; Kotsakiozi P, 2017, ECOL EVOL, V7, P10143, DOI 10.1002/ece3.3514; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851; Lourenco AF, 2017, ESTUDOS, V44, P72; Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624; Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332; Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5; Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x; Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014; Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167; Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328; NASCI RS, 1981, MOSQ NEWS, V41, P808; Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691; Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x; Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2017, LANG ENV STAT COMP, P1; Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rissler LJ, 2016, P NATL ACAD SCI USA, V113, P8079, DOI 10.1073/pnas.1601073113; Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schmidt TL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006009; SERUFO JC, 1993, MEM I OSWALDO CRUZ, V88, P503, DOI 10.1590/S0074-02761993000300025; Sherpa S, 2018, INFECT GENET EVOL, V58, P145, DOI 10.1016/j.meegid.2017.12.018; Martins WFS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005917; Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058; United Nations Department of Economic and Social Affairs Population Division. United Nations, 2015, WORLD URB PROSP 2014; Vazeille M, 2001, AM J TROP MED HYG, V65, P491, DOI 10.4269/ajtmh.2001.65.491; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; WHO, 2018, YELL FEV BRAZ; Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003; Wilke ABB, 2018, INFECT GENET EVOL, V65, P333, DOI 10.1016/j.meegid.2018.08.017; Zielke DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099093	76	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220773	10.1371/journal.pone.0220773	http://dx.doi.org/10.1371/journal.pone.0220773			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374109	Green Published, gold, Green Submitted			2022-12-27	WOS:000484991500032
J	Mahmood, T; Younas, A; Akrim, F; Andleeb, S; Hamid, A; Nadeem, MS				Mahmood, Tariq; Younas, Ayesha; Akrim, Faraz; Andleeb, Shaista; Hamid, Abdul; Nadeem, Muhammad Sajid			Range contraction of snow leopard (Panthera uncia)	PLOS ONE			English	Article								Snow Leopard (Panthera uncia) is native to mountain ranges of Central and South Asia, where it occurs from 3,000-4500 m elevation. The species is enlisted as "Endangered" by IUCN and its populations are reportedly declining. In the current study, we compared the past and current distribution ranges of the species using spatial analysis. We used Quantum Geographical Information System (QGIS) software to reconstruct and quantify its past distribution range and compare with its current one. Snow leopard was found more widely distributed in the past having a distribution range of approximately 10.47 million km(2) against the current 3.20 million km(2). Range contraction of the species approximates 69%. A total of 719 terrestrial protected areas of Asia (out of total 7209) had this species in the past whereas at current, only 311 protected areas support this species. The results emphasize escalating conservation efforts to save its remaining distribution range.	[Mahmood, Tariq; Younas, Ayesha; Akrim, Faraz; Andleeb, Shaista; Hamid, Abdul] Pir Mehr Ali Shah Arid Agr Univ, Dept Wildlife Management, Rawalpindi, Pakistan; [Akrim, Faraz] Univ Kotli, Dept Zool, Kotli, Azad Jammu & Ka, Pakistan; [Nadeem, Muhammad Sajid] Pir Mehr Ali Shah Arid Agr Univ, Dept Zool, Rawalpindi, Pakistan	Arid Agriculture University; Arid Agriculture University	Akrim, F (corresponding author), Pir Mehr Ali Shah Arid Agr Univ, Dept Wildlife Management, Rawalpindi, Pakistan.; Akrim, F (corresponding author), Univ Kotli, Dept Zool, Kotli, Azad Jammu & Ka, Pakistan.	farazakrim@hotmail.com	Akrim, Faraz/C-5032-2013	Akrim, Faraz/0000-0001-9313-0637; Nadeem, Muhammad/0000-0002-2839-6989				Anwar MB, 2014, EUROPEAN J WILDLIFE, V57, P1077; CBD, 2008, PROT AR TOD WORLD TH, P96; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Dewas M, 2012, MAMMAL REV, V42, P144, DOI 10.1111/j.1365-2907.2011.00196.x; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Fox J L, 1994, P 7 INT SNOW LEOP S, P315; Fox JL, 1989, REV STATUS ECOLOGY S, P40; Ghoshal A, 2017, ORYX, V53, P1, DOI [10.1017/S0030605317001107, DOI 10.1017/S0030605317001107]; IUCN U-Wa, 2015, PROT PLAN WORLD DAT; Jackson R, 2008, IUCN RED LIST THREAT, V2008, DOI [DOI 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.EN, 10.2305/IUCN.UK.2008.RLTS.T22732A9381126.en]; Jackson R, 1992, SNOW LEOPARD UNPUB; Jackson RM, 1996, THESIS, P233; Janecka JE, 2008, ANIM CONSERV, V11, P401, DOI 10.1111/j.1469-1795.2008.00195.x; Kachel S, 2014, THESIS, P98; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Li J, 2016, CHALLENGES SNOW LEOP; Licht DS, 2010, BIOSCIENCE, V60, P147, DOI 10.1525/bio.2010.60.2.9; Mallon DP, 2014, SNOW LEOPARD SURVIVA, P135; Manij U, 2010, THESIS, P90; McCarthy T., 2017, PANTHERA UNCIA IUCN; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Riordan P, 2010, SNOW LEOPARD CHINA, P14; Sanderson E., 2006, SETTING PRIORITIES C; Sechrest W.W., 2003, THESIS; Soberon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019359; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; Sukumar R., 2003, LIVING ELEPHANTS EVO; Suryawanshi KR, 2013, J APPL ECOL, V50, P550, DOI 10.1111/1365-2664.12061; Taubmann J, 2016, ORYX, V50, P220, DOI 10.1017/S0030605315000502; Theile S, 2003, FADING FOOTPRINTS KI; Thinley P, 2014, ESTIMATING SNOW LEOP, P45; Thinley P., 2016, NATL SNOW LEOPARD SU; Thinley P. Dendup T. Rajaratnam R. Vernes K. Tempa K. Chophel T. & Norbu L., 2015, COUNTING TIGERS BHUT; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Worm B, 2011, P NATL ACAD SCI USA, V108, P11942, DOI 10.1073/pnas.1102353108	36	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218460	10.1371/journal.pone.0218460	http://dx.doi.org/10.1371/journal.pone.0218460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369579	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900010
J	Akter, R; Zhyvoloup, A; Zheng, BQ; Bhatia, SR; Raleigh, DP				Akter, Rehana; Zhyvoloup, Alexander; Zheng, Bingqian; Bhatia, Surita R.; Raleigh, Daniel P.			The triphenylmethane dye brilliant blue G is only moderately effective at inhibiting amyloid formation by human amylin or at disaggregating amylin amyloid fibrils, but interferes with amyloid assays; Implications for inhibitor design	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; THIOFLAVIN-T; BETA FIBRILS; POLYPEPTIDE; IAPP; BINDING; PEPTIDE; AGGREGATION; TOXICITY	The development of inhibitors of islet amyloid formation is important as pancreatic amyloid deposition contributes to type-2 diabetes and islet transplant failure. The Alzheimer's A beta peptide and human amylin (h-amylin), the polypeptide responsible for amyloid formation in type-2 diabetes, share common physio-chemical features and some inhibitors of A beta also inhibit amyloid formation by h-amylin and vice versa. Thus, a popular and potentially useful strategy to find lead compounds for anti-amylin amyloid agents is to examine compounds that have effects on A beta amyloid formation. The triphenylmethane dye, brilliant blue G (BBG, Sodium; 3-[[4-[(E)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene] methyl]-N-ethyl-3-methylanilino] methyl] benzenesulfonate) has been shown to modulate A beta amyloid formation and inhibit A beta induced toxicity. However, the effects of BBG on h-amylin have not been examined, although other triphenylmethane derivatives inhibit h-amylin amyloid formation. The compound has only a modest impact on h-amylin amyloid formation unless it is added in significant excess. BBG also remodels preformed h-amylin amyloid fibrils if added in excess, however BBG has no significant effect on h-amylin induced toxicity towards cultured beta-cells or cultured CHO-T cells except at high concentrations. BBG is shown to interfere with standard thioflavin-T assays of h-amylin amyloid formation and disaggregation, highlighting the difficulty of interpreting such experiments in the absence of other measurements. BBG also interferes with ANS based assays of h-amylin amyloid formation. The work highlights the differences between inhibition of A beta and h-amylin amyloid formation, illustrates the limitation of using A beta inhibitors as leads for h-amylin amyloid inhibitors, and reinforces the difficulties in interpreting dye binding assays of amyloid formation.	[Akter, Rehana; Zheng, Bingqian; Bhatia, Surita R.; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Zhyvoloup, Alexander; Raleigh, Daniel P.] UCL, Inst Struct & Mol Biol, Gower St, London, England	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of London; Birkbeck University London; University College London	Raleigh, DP (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.; Raleigh, DP (corresponding author), UCL, Inst Struct & Mol Biol, Gower St, London, England.	d.raleigh@ucl.ac.uk	Bhatia, Surita R/B-4536-2008	raleigh, daniel/0000-0003-3248-7493	Wellcome Trust [107927/Z/15/Z]; National Science Foundation [CBET-1335787]; American Chemical Society PRF grant [55729-ND9]; U.S. Department of Education GAANN Fellowship [P200A160163]; U.S. National Institutes of Health; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DESC0012704]	Wellcome Trust(Wellcome TrustEuropean Commission); National Science Foundation(National Science Foundation (NSF)); American Chemical Society PRF grant(American Chemical Society); U.S. Department of Education GAANN Fellowship(US Department of Education); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by Wellcome Trust senior investigator award 107927/Z/15/Z (https://wellcome.ac.uk/) to DPR; Support for B. Z. was provided by National Science Foundation award CBET-1335787 (http://www.nsf.org/) to SB, American Chemical Society PRF grant 55729-ND9 (https://www.acs.org/) to SB, and a U.S. Department of Education GAANN Fellowship (Award P200A160163) (https://www.ed.gov/) to BZ. The LiX beamline is part of the Advanced Beamlines for Biological Investigations using Xrays (ABBIX) project funded by the U.S. National Institutes of Health. NSLS-II is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DESC0012704 (https://www.energy.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2005, ORG LETT, V7, P693, DOI 10.1021/ol047480+; Abedini A, 2018, J CLIN INVEST, V128, P682, DOI 10.1172/JCI85210; Abedini A, 2016, ELIFE, V5, DOI 10.7554/eLife.12977; Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017; Akter R, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2798269; Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cao P, 2013, FEBS LETT, V587, P1106, DOI 10.1016/j.febslet.2013.01.046; Cao P, 2013, CURR OPIN STRUC BIOL, V23, P82, DOI 10.1016/j.sbi.2012.11.003; Chandel TI, 2019, J MOL LIQ, V278, P553, DOI 10.1016/j.molliq.2018.12.127; Chen MS, 2013, CHEM COMMUN, V49, P1799, DOI 10.1039/c2cc33432a; Chen X, 2014, NEUROSCIENCE, V279, P94, DOI 10.1016/j.neuroscience.2014.08.036; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cooper GJS, 2010, DIABETOLOGIA, V53, P1011, DOI 10.1007/s00125-010-1715-y; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Dubey R, 2019, BIOCHEM J, V476, P889, DOI 10.1042/BCJ20180820; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Gong GH, 2019, J BIOL INORG CHEM, V24, P179, DOI 10.1007/s00775-019-01637-6; Hammouda B, 2004, MACROMOLECULES, V37, P6932, DOI 10.1021/ma049623d; Haney CM, 2017, BIOCHEMISTRY-US, V56, P683, DOI 10.1021/acs.biochem.6b01060; HOBBS JR, 1963, J PATHOL BACTERIOL, V86, P437, DOI 10.1002/path.1700860218; Irwin JA, 2013, BIOMACROMOLECULES, V14, P264, DOI 10.1021/bm3016994; Jana MK, 2016, ACS CHEM NEUROSCI, V7, P1141, DOI 10.1021/acschemneuro.6b00108; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Marek P, 2010, ORG LETT, V12, P4848, DOI 10.1021/ol101981b; Meng FL, 2011, J MOL BIOL, V406, P491, DOI 10.1016/j.jmb.2010.12.028; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Meng FL, 2010, J MOL BIOL, V400, P555, DOI 10.1016/j.jmb.2010.05.001; Miklossy J, 2010, NEUROBIOL AGING, V31, P1503, DOI 10.1016/j.neurobiolaging.2008.08.019; Montane J, 2012, DIABETES OBES METAB, V14, P68, DOI 10.1111/j.1463-1326.2012.01657.x; Ninomiya T, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0487-z; Noor H, 2012, PROTEIN SCI, V21, P373, DOI 10.1002/pro.2023; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Oskarsson ME, 2015, AM J PATHOL, V185, P834, DOI 10.1016/j.ajpath.2014.11.016; Potter KJ, 2010, P NATL ACAD SCI USA, V107, P4305, DOI 10.1073/pnas.0909024107; Pujols J, 2018, P NATL ACAD SCI USA, V115, P10481, DOI 10.1073/pnas.1804198115; Qiu WQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088063; Quittot N, 2018, BIOCONJUGATE CHEM, V29, P517, DOI 10.1021/acs.bioconjchem.7b00827; Sulatskaya AI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015385; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wong HE, 2011, ACS CHEM NEUROSCI, V2, P645, DOI 10.1021/cn200056g; Wu C, 2009, J MOL BIOL, V394, P627, DOI 10.1016/j.jmb.2009.09.056; Wu C, 2008, J MOL BIOL, V384, P718, DOI 10.1016/j.jmb.2008.09.062; Yan LM, 2013, ANGEW CHEM INT EDIT, V52, P10378, DOI 10.1002/anie.201302840; Yang L, 2013, J SYNCHROTRON RADIAT, V20, P211, DOI 10.1107/S0909049512048984; Yang Y, 2013, NEUROSCIENCE, V250, P140, DOI 10.1016/j.neuroscience.2013.07.009	52	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0219130	10.1371/journal.pone.0219130	http://dx.doi.org/10.1371/journal.pone.0219130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404073	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800007
J	Lee, K; Lee, SJ; Yoon, S; Ryoo, BY; Kim, SW; Choi, SH; Lee, SM; Chae, EJ; Park, Y; Jang, SJ; Park, SY; Yoon, YK; Park, SH; Kim, TW				Lee, Kyoungmin; Lee, So Jung; Yoon, Shinkyo; Ryoo, Baek-Yeol; Kim, Sang-We; Choi, Sang Hyun; Lee, Sang Min; Chae, Eun Jin; Park, Yangsoon; Jang, Se-Jin; Park, Soo-Yeon; Yoon, Young-Kwang; Park, Seong Ho; Kim, Tae Won			Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center	PLOS ONE			English	Article							NEEDLE-ASPIRATION BIOPSY; TUMOR HETEROGENEITY; SUCCESS	Objective Research biopsies are an essential component of cancer clinical trials for studying drug efficacy and identifying biomarkers. Site-level clinical investigators, however, do not have access to results on the adequacy of research biopsies for histological or molecular assays, because samples are sent to central labs and the test results are seldom reported back to site-level investigators unless requested. We evaluated the feasibility, safety, and adequacy of research biopsies performed at an academic medical center. Materials and methods We retrospectively reviewed the data on 122 research biopsy sessions conducted in 99 patients via percutaneous core needle biopsy for 39 clinical trials from January 2017 to February 2018 at a single institute. We asked the sponsors of each clinical trial for the adequacy of the biopsy samples for histological or molecular assays. Results The biopsy success rate was 93.4% (113/122), with nine samples categorized as inadequate for obtaining pathologic diagnosis. Post-biopsy complications occurred in 9.8% (12/122) of biopsies, all of which were mild and completely recovered by the day after the biopsy. The sponsors of clinical trials provided feedbacks on the adequacy of 76 biopsy samples, and noted that a total of 8 biopsy samples from 7 patients were inadequate for analysis, resulting in an adequacy rate of 89.5% (68/76): the reasons for inadequacy were insufficient tumor content for immunohistochemistry (n = 3) and low RNA yield for sequencing (n = 5). Conclusion Research biopsies performed at an experienced, multidisciplinary center had acceptable safety for patients as well as practicality in terms of obtaining adequate tissue samples for molecular studies.	[Lee, Kyoungmin; Yoon, Shinkyo; Ryoo, Baek-Yeol; Kim, Sang-We; Kim, Tae Won] Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea; [Lee, So Jung; Choi, Sang Hyun; Lee, Sang Min; Chae, Eun Jin; Park, Seong Ho] Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea; [Park, Yangsoon; Jang, Se-Jin] Univ Ulsan, Asan Med Ctr, Dept Pathol, Coll Med, Seoul, South Korea; [Park, Soo-Yeon; Yoon, Young-Kwang] Asan Med Ctr, Clin Trial Ctr, Asan Inst Life Sci, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, TW (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea.; Park, SH (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea.	parksh.radiology@gmail.com; tw-kimmd@amc.seoul.kr	Choi, Sang Hyun/AAE-4828-2022	Choi, Sang Hyun/0000-0002-6898-6617; Lee, Kyoungmin/0000-0002-6578-7671	National Research Foundation of Korea (NRF) [2016R1C1B2013126]; Bio & Medical Technology Development Program of the NRF - Korean government, Ministry of Science and ICT(MSIT) [2017M3A9B6061815]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Bio & Medical Technology Development Program of the NRF - Korean government, Ministry of Science and ICT(MSIT)	This research was supported by the National Research Foundation of Korea (NRF) grant (grant number 2016R1C1B2013126) and the Bio & Medical Technology Development Program of the NRF (grant number 2017M3A9B6061815) funded by the Korean government, Ministry of Science and ICT(MSIT).	Beslic S, 2012, RADIOL ONCOL, V46, P19, DOI 10.2478/v10019-012-0004-4; Bradley E, 2012, NAT BIOTECHNOL, V30, P596, DOI 10.1038/nbt.2296; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Choi Y, 2017, J BREAST CANCER, V20, P393, DOI 10.4048/jbc.2017.20.4.393; Chung JY, 2008, J HISTOCHEM CYTOCHEM, V56, P1033, DOI 10.1369/jhc.2008.951863; El-Osta H, 2011, ONCOLOGIST, V16, P1292, DOI 10.1634/theoncologist.2011-0043; Ferry-Galow KV, 2018, J ONCOL PRACT, V14, P690, DOI 10.1200/JOP.18.00092; Guimaraes MD, 2010, CLINICS, V65, P847, DOI 10.1590/S1807-59322010000900006; Gupta S, 2004, CARDIOVASC INTER RAD, V27, P91, DOI 10.1007/s00270-003-0056-3; illumina, 2019, TRUSIGHT TUM 170 REF; Marshall D, 2013, J VASC INTERV RADIOL, V24, P1094, DOI 10.1016/j.jvir.2013.04.027; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Mills M, 2017, CLIN RADIOL, V72, P1038, DOI 10.1016/j.crad.2017.07.023; Otto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124947; Overman MJ, 2013, J CLIN ONCOL, V31, P17, DOI 10.1200/JCO.2012.43.1718; Pentz Rebecca D, 2012, IRB, V34, P1; Peppercorn J, 2013, J CLIN ONCOL, V31, P1, DOI 10.1200/JCO.2012.44.8589; Peppercorn J, 2010, J CLIN ONCOL, V28, P2635, DOI 10.1200/JCO.2009.27.2443; Sabir SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189651; Saltman D, 2014, REPORT CARD CANC CAN, V15, P19; Schneider F, 2015, AM J CLIN PATHOL, V143, P193, DOI 10.1309/AJCPMY8UI7WSFSYY; Sparchez Z, 2018, WORLD J HEPATOL, V10, P452, DOI 10.4254/wjh.v10.i7.452; Tacher V, 2016, EUR J CANCER, V59, P79, DOI 10.1016/j.ejca.2016.02.006; Tokaca N, 2018, J THORAC ONCOL, V13, P63, DOI 10.1016/j.jtho.2017.09.1958; Yu SC, 1997, CLIN RADIOL, V52, P907, DOI 10.1016/S0009-9260(97)80222-X	25	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221065	10.1371/journal.pone.0221065	http://dx.doi.org/10.1371/journal.pone.0221065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404103	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800053
J	Xiong, JS; Zhao, P; Yang, PF; Yan, QL; Jiang, LF				Xiong, Jiasheng; Zhao, Ping; Yang, Pengfei; Yan, Qingli; Jiang, Lufang			Evolutionary dynamics of the H7N9 avian influenza virus based on large-scale sequence analysis	PLOS ONE			English	Article							HEMAGGLUTININ GENE; POSITIVE SELECTION; HUMAN INFECTION; ORIGIN; SITES; H5N1; PATHOGENICITY; EPIDEMIOLOGY; SUBSTITUTION; VIRULENCE	Since 2013, epidemics caused by novel H7N9 avian influenza A viruses (AIVs) have become a considerable public health issue. This study investigated the evolution of these viruses at the population level. Compared to H7 and N9 before 2013, there were 18 and 24 substitutions in the majority of novel H7N9 AIVs, respectively. Nine of these in HA and six in NA were rare before 2013, and four of these in HA and two in NA displayed host tropism. S136(128) N and A143(135) V are located on the receptor binding sites of the HA1 subunit and might be important factors in determining the host species of novel H7N9 AIV. On an overall scale, the evolution of H7 and N9, both in terms of time distribution and host species, is under negative selection. However, both in HA and NA, several sites were under positive selection. In both the overall epidemics and the human-derived H7N9 AIVs, eight positive selection sites were identified in HA1, with some located within the known antigen epitopes or the receptor binding site(RBS) domain. This may induce variations in H7N9 AIV with positive selection. It is necessary to strengthen the surveillance of novel H7N9 AIVs, both in human and bird population to determine whether a new virus has emerged through selection pressure and to prevent future epidemics from occurring.	[Xiong, Jiasheng] Shandong Univ Weihai, Coll Marine Sci, Weihai, Peoples R China; [Zhao, Ping; Jiang, Lufang] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China; [Zhao, Ping; Jiang, Lufang] Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Yang, Pengfei; Yan, Qingli] Huaian Ctr Dis Control & Prevent, Huaian, Peoples R China	Shandong University; Fudan University	Jiang, LF (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai, Peoples R China.; Jiang, LF (corresponding author), Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China.	jianglufang@fudan.edu.cn		Xiong, Jiasheng/0000-0002-3335-5364	National Natural Science Foundation of China [81872673]; National Key Research and Development Program of China [2017YFC1200203]; Original Research Support Project of Fudan University [IDF201011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Original Research Support Project of Fudan University	This research was funded by the National Natural Science Foundation of China (grant No. 81872673), the National Key Research and Development Program of China (grant No. 2017YFC1200203), the Original Research Support Project of Fudan University (grant No. IDF201011) to LJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangaru S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04704-9; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Fang SS, 2016, ARCH VIROL, V161, P2117, DOI 10.1007/s00705-016-2872-1; Furuse Y, 2010, VIROLOGY, V405, P314, DOI 10.1016/j.virol.2010.06.018; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Hu J, 2019, ARCH VIROL, V164, P807, DOI 10.1007/s00705-018-04142-4; Huang KYA, 2019, NAT MICROBIOL, V4, P306, DOI 10.1038/s41564-018-0303-7; Lan Yu, 2013, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V27, P177; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu Q, 2013, MICROBES INFECT, V15, P432, DOI 10.1016/j.micinf.2013.04.004; Lu J, 2018, EMERG INFECT DIS, V24, P1795, DOI 10.3201/eid2410.171063; Ma W, 2009, ZOONOSES PUBLIC HLTH, V56, P326, DOI 10.1111/j.1863-2378.2008.01217.x; Munoz ET, 2005, VACCINE, V23, P1144, DOI 10.1016/j.vaccine.2004.08.028; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Oshansky CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021183; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pu ZQ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00414; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Qin JR, 2019, VIROL J, V16, DOI 10.1186/s12985-018-1109-1; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Schrauwen EJA, 2014, EUR J CLIN MICROBIOL, V33, P479, DOI 10.1007/s10096-013-1984-8; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Su S, 2017, TRENDS MICROBIOL, V25, P713, DOI 10.1016/j.tim.2017.06.008; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Wang WB, 2014, J CLIN VIROL, V60, P305, DOI 10.1016/j.jcv.2014.04.006; Wang XL, 2017, LANCET INFECT DIS, V17, P822, DOI [10.1016/s1473-3099(17)30323-7, 10.1016/S1473-3099(17)30323-7]; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Webby RJ, 2017, LANCET INFECT DIS, V17, P783, DOI 10.1016/S1473-3099(17)30337-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wei KF, 2012, VIRUS GENES, V44, P450, DOI 10.1007/s11262-012-0717-x; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wu Y, 2013, CELL RES, V23, P1347, DOI 10.1038/cr.2013.144; Xiang D, 2018, J INFECT DIS, V217, P1699, DOI 10.1093/infdis/jiy082; Xu Hui-lin, 2006, Fudan Xuebao (Yixueban), V33, P642; Yang H, 2012, J VIROL, V86, P8645, DOI 10.1128/JVI.00281-12; Zeng XY, 2018, SCI CHINA LIFE SCI, V61, P1465, DOI 10.1007/s11427-018-9420-1; Zhang Wen-tong, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P843	48	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220249	10.1371/journal.pone.0220249	http://dx.doi.org/10.1371/journal.pone.0220249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404069	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800010
J	Semeniak, D; Faber, K; Oftering, P; Manukjan, G; Schulze, H				Semeniak, Daniela; Faber, Kristina; Oftering, Patricia; Manukjan, Georgi; Schulze, Harald			Impact of Itga2-Gp6-double collagen receptor deficient mice for bone marrow megakaryocytes and platelets	PLOS ONE			English	Article							GLYCOPROTEIN-VI; INTRACELLULAR CALCIUM; PROPLATELET FORMATION; MOUSE MEGAKARYOCYTES; INTEGRIN; GPVI; ALPHA(2)BETA(1); ADHESION; SYK; THROMBOPOIESIS	The two main collagen receptors on platelets, GPVI and integrin alpha 2 beta 1, play an important role for the recognition of exposed collagen at sites of vessel injury, which leads to platelet activation and subsequently stable thrombus formation. Both receptors are already expressed on megakaryocytes, the platelet forming cells within the bone marrow. Megakaryocytes are in permanent contact with collagen filaments in the marrow cavity and at the basal lamina of sinusoids without obvious preactivation. The role of both collagen receptors for megakaryocyte maturation and thrombopoiesis is still poorly understood. To investigate the function of both collagen receptors, we generated mice that are double deficient for Gp6 and Itga2. Flow cytometric analyses revealed that the deficiency of both receptors had no impact on platelet number and led to the expected lack in GPVI responsiveness. Integrin activation and degranulation ability was comparable to wildtype mice. By immunofluorescence microscopy, we could demonstrate that both wildtype and double-deficient megakaryocytes were overall normally distributed within the bone marrow. We found megakaryocyte count and size to be normal, the localization within the bone marrow, the degree of maturation, as well as their association to sinusoids were also unaltered. However, the contact of megakaryocytes to collagen type I filaments was decreased at sinusoids compared to wild-type mice, while the interaction to type IV collagen was unaffected. Our results imply that GPVI and alpha 2 beta 1 have no influence on the localization of megakaryocytes within the bone marrow, their association to the sinusoids or their maturation. The decreased contact of megakaryocytes to collagen type I might at least partially explain the unaltered platelet phenotype in these mice, since proplatelet formation is mediated by these receptors and their interaction to collagen. It is rather likely that other compensatory signaling pathways and receptors play a role that needs to be elucidated.	[Semeniak, Daniela; Faber, Kristina; Oftering, Patricia; Manukjan, Georgi; Schulze, Harald] Univ Hosp Wurzburg, Dept Expt Biomed, Chair 1, Wurzburg, Germany	University of Wurzburg	Schulze, H (corresponding author), Univ Hosp Wurzburg, Dept Expt Biomed, Chair 1, Wurzburg, Germany.	harald.schulze@uni-wuerzburg.de		Schulze, Harald/0000-0003-1285-6407; Oftering, Patricia/0000-0002-0967-0049	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [374031971 - TRR 240]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	The study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Projektnummer 374031971 - TRR 240 to HS. (https://www.dfg.de) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbonante V, 2013, J BIOL CHEM, V288, P16738, DOI 10.1074/jbc.M112.431528; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Bender M, 2011, J THROMB HAEMOST, V9, P1423, DOI 10.1111/j.1538-7836.2011.04328.x; Briddon SJ, 1999, BLOOD, V93, P3847, DOI 10.1182/blood.V93.11.3847.411k17_3847_3855; Chen JC, 2002, AM J PATHOL, V161, P337, DOI 10.1016/S0002-9440(10)64185-5; Dutting S, 2012, TRENDS PHARMACOL SCI, V33, P583, DOI 10.1016/j.tips.2012.07.004; Eckly A, 2012, METHODS MOL BIOL, V788, P175, DOI 10.1007/978-1-61779-307-3_13; Gruner S, 2004, CIRCULATION, V110, P2946, DOI 10.1161/01.CIR.0000146341.63677.3C; Gruner S, 2003, BLOOD, V102, P4021, DOI 10.1182/blood-2003-05-1391; Gupta S, 2018, BLOOD, V131, P1106, DOI 10.1182/blood-2017-08-800136; Habart D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055094; He L, 2003, BLOOD, V102, P3652, DOI 10.1182/blood-2003-04-1323; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Italiano JE, 1999, J CELL BIOL, V147, P1299, DOI 10.1083/jcb.147.6.1299; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kunicki TJ, 2012, CURR OPIN HEMATOL, V19, P371, DOI 10.1097/MOH.0b013e3283567526; Kunicki TJ, 2012, ARTERIOSCL THROM VAS, V32, P147, DOI 10.1161/ATVBAHA.111.239392; Kunicki TJ, 2010, BLOOD, V116, P2627, DOI 10.1182/blood-2010-04-262048; Malara A, 2014, STEM CELLS, V32, P926, DOI 10.1002/stem.1626; Marjoram RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114035; Mazharian A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002936; Melford SK, 1997, J BIOL CHEM, V272, P27539, DOI 10.1074/jbc.272.44.27539; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Moog S, 2001, BLOOD, V98, P1038, DOI 10.1182/blood.V98.4.1038; Munzer P, 2017, BLOOD, V130, P2774, DOI 10.1182/blood-2017-05-784413; Nagy Z, 2019, BLOOD, V133, P331, DOI 10.1182/blood-2018-09-877787; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sarratt KL, 2005, BLOOD, V106, P1268, DOI 10.1182/blood-2004-11-4434; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulze H, 2018, RES PRACT THROMB HAE, V2, P461, DOI 10.1002/rth2.12112; Semeniak D, 2016, J CELL SCI, V129, P3473, DOI 10.1242/jcs.187971; Shivdasani R, 2005, CURRENT PROTOCOLS IM; Smith CW, 2017, ARTERIOSCL THROM VAS, V37, P823, DOI 10.1161/ATVBAHA.117.309253; Spindler M, 2018, BLOOD, V132, P635, DOI 10.1182/blood-2018-01-829259; Steevels TAM, 2010, HAEMATOL-HEMATOL J, V95, P2005, DOI 10.3324/haematol.2010.026120; Stegner D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00201-7; Strassel C, 2012, EXP CELL RES, V318, P25, DOI 10.1016/j.yexcr.2011.10.003; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; Xue JN, 2011, BIOCHEM BIOPH RES CO, V405, P128, DOI 10.1016/j.bbrc.2010.12.140; Zeltz C, 2016, J CELL SCI, V129, P653, DOI 10.1242/jcs.180992	43	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0216839	10.1371/journal.pone.0216839	http://dx.doi.org/10.1371/journal.pone.0216839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398205	gold, Green Submitted, Green Published			2022-12-27	WOS:000485004000003
J	Woo, HG; Chang, Y; Ryu, DR; Song, TJ				Woo, Ho Geol; Chang, Yoonkyung; Ryu, Dong-Ryeol; Song, Tae-Jin			Plasma Klotho concentration is associated with the presence, burden and progression of cerebral small vessel disease in patients with acute ischaemic stroke	PLOS ONE			English	Article							DIETARY GLYCEMIC LOAD; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; MORTALITY; SEVERITY; MICROBLEEDS; PROTECTS; SUBTYPE; MRI	Klotho is a soluble or membrane-bound anti-aging protein, whose protective actions are important for a prudential function of many organs. Because Klotho and cerebral small vessel disease (SVD) are associated with ageing process and endothelial dysfunction, it is possible that Klotho has an association with cerebral SVD. We aimed to investigate the association of plasma Klotho concentration with the presence, burden and progression of cerebral SVD. We prospectively enrolled 262 patients with first-ever acute cerebral infarction, performed brain MRI and collected their blood samples within 24 hours of admission. An enzyme-linked immunosorbent assay was used for evaluating plasma Klotho concentration. We estimated the total SVD score of each patient after determining the presence and burden of high-grade white matter hyperintensities (HWMHs), cerebral microbleeds (CMBs), high-grade perivascular spaces (HPVSs) and asymptomatic lacunar infarctions (ALls). Univariate and multivariate analyses were conducted to investigate association of Klotho with cerebral SVD and the total SVD score. Of the 262 patients, 152 (58.0%) were men. The mean age of these patients was 64.7 years. The mean standard deviation of plasma Klotho concentration was 329.8 194.1 pg/mL. In multivariate analysis, plasma Klotho concentration was negatively associated with the presence of HWMHs [Odds ratio (OR): 0.13, p = 0.047], HPVSs (OR: 0.22, p = 0.024) and ALIs (OR: 0.53, p = 0.021) but not associated with the presence of CMBs (OR: 0.39, p = 0.404). Plasma Klotho concentration was also negatively related to the total SVD score (unstandardized coefficients beta: -0.895, standard error = 0.317, p = 0.005, R-2 = 0.239). Furthermore, plasma Klotho concentration was negatively related to the presence (OR: 0.75, 95% CI: 0.59-0.96, p = 0.025) and severity of cerebral SVD progression (OR: 0.72, 95% CI: 0.56-0.92, p = 0.009). In conclusion, plasma Klotho concentration was negatively associated with the presence, burden and progression of cerebral SVD.	[Woo, Ho Geol] Ewha Womans Univ, Coll Med, Seoul Hosp, Dept Neurol, Seoul, South Korea; [Chang, Yoonkyung; Song, Tae-Jin] Ewha Womans Univ, Coll Med, Dept Neurol, Mokdong Hosp, Seoul, South Korea; [Ryu, Dong-Ryeol] Ewha Womans Univ, Coll Med, Dept Nephrol, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Song, TJ (corresponding author), Ewha Womans Univ, Coll Med, Dept Neurol, Mokdong Hosp, Seoul, South Korea.	knstar@ewha.ac.kr	Woo, Ho Geol/ABF-1206-2020; Woo, Ho Geol/AAX-4094-2021	Woo, Ho Geol/0000-0001-6489-0100; Chang, Yoonkyung/0000-0002-0345-2278	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2018R1D1A1B07040959]; Ewha Womans University	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Ewha Womans University	This project was supported by grant from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2018R1D1A1B07040959 to T-JS). This work was supported by the Ewha Womans University Research Grant of 2018 to T-JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Brombo G, 2018, GERONTOLOGY, V64, P414, DOI 10.1159/000488318; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chang Y, 2018, J CLIN NEUROL, V14, P555, DOI 10.3988/jcn.2018.14.4.555; Chang Y, 2018, AM J HYPERTENS, V31, P35, DOI 10.1093/ajh/hpx126; Chen CD, 2015, J MOL NEUROSCI, V55, P76, DOI 10.1007/s12031-014-0336-1; Cuadrado-Godia E, 2018, J STROKE, V20, P302, DOI 10.5853/jos.2017.02922; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; Drueke TB, 2013, KIDNEY INT, V83, P13, DOI 10.1038/ki.2012.370; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Grochowski C, 2018, FREE RADICAL RES, V52, P1, DOI 10.1080/10715762.2017.1402304; Kalaria Raj N, 2006, J Clin Neurol, V2, P1, DOI 10.3988/jcn.2006.2.1.1; Kim BJ, 2013, J STROKE, V15, P153, DOI 10.5853/jos.2013.15.3.153; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Kuriyama N, 2018, J ALZHEIMERS DIS, V61, P145, DOI 10.3233/JAD-170466; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3; Marcais C, 2017, J CLIN ENDOCR METAB, V102, P3154, DOI 10.1210/jc.2017-00104; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Navarro-Gonzalez JF, 2014, HEART, V100, P34, DOI 10.1136/heartjnl-2013-304746; Nezu T, 2015, HYPERTENS RES, V38, P291, DOI 10.1038/hr.2015.4; Oh HJ, 2015, PERITON DIALYSIS INT, V35, P43, DOI 10.3747/pdi.2013.00150; Pan HC, 2018, ATHEROSCLEROSIS, V276, P83, DOI 10.1016/j.atherosclerosis.2018.07.006; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Poggesi A, 2016, J CEREBR BLOOD F MET, V36, P72, DOI 10.1038/jcbfm.2015.116; Rakugi H, 2007, ENDOCRINE, V31, P82, DOI 10.1007/s12020-007-0016-9; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Song TJ, 2014, EUR J NEUROL, V21, P463, DOI 10.1111/ene.12332; Song TJ, 2014, NEUROLOGY, V83, P1308, DOI 10.1212/WNL.0000000000000862; Song TJ, 2018, NUTR RES, V51, P93, DOI 10.1016/j.nutres.2017.12.009; Song TJ, 2018, J CLIN NEUROL, V14, P165, DOI 10.3988/jcn.2018.14.2.165; Song TJ, 2017, J CLIN NEUROL, V13, P187, DOI 10.3988/jcn.2017.13.2.187; Song TJ, 2016, J STROKE, V18, P312, DOI 10.5853/jos.2016.00171; Song TJ, 2014, THROMB HAEMOSTASIS, V112, P1312, DOI 10.1160/TH14-02-0176; Song TJ, 2012, BIOMARKERS, V17, P738, DOI 10.3109/1354750X.2012.727027; Staals J, 2014, NEUROLOGY, V83, P1228, DOI 10.1212/WNL.0000000000000837; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wei K, 2016, J NEPHROL, V29, P349, DOI 10.1007/s40620-016-0284-7; Witkowski JM, 2007, J IMMUNOL, V178, P771, DOI 10.4049/jimmunol.178.2.771; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110	43	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220796	10.1371/journal.pone.0220796	http://dx.doi.org/10.1371/journal.pone.0220796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398214	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000021
J	Garakani, R; Ng, JS				Garakani, Roya; Ng, Jason S.			Associations between macular pigment, iris color and reflectance, ethnicity, and color vision: An observational study	PLOS ONE			English	Article							FARNSWORTH-MUNSELL 100-HUE; OPTICAL-DENSITY; ZEAXANTHIN; LUTEIN; DEGENERATION; FOVEAL	Purpose Conflicting findings exist in the literature with regard to the relationship between iris color, ethnicity, macular pigment optical density (MPOD), and hue discrimination. This study re-examined these relationships, accounting for factors that may have confounded prior studies. Clinically, the relationship between MPOD and hue discrimination may impact the utility of macular pigment supplementation as a treatment for conditions such as macular degeneration. Methods Subjects (n = 30, mean/SD age = 25.1/2.5 yrs.) with normal color vision completed MPOD testing and Farnsworth-Munsell 100 hue (FM100) testing. MPOD data was derived from the average of three measurements using the QuantifEYE II device and FM100 testing included training runs. The total error score of the FM100 test was used for analysis. Iris color was determined subjectively, while iris reflectance was derived using calibrated iris images. Spearman correlations were used to determine the relationship between MPOD and FM100 test scores. Kruskal-Wallis testing was used to investigate MPOD differences among different ethnicities and iris colors. Results MPODs were normally distributed with a mean/SD = 0.38/0.13. Total error scores had a mean/SD of 10.7/9.7, but were not normally distributed. Iris reflectances had a mean/SD = 11.0/8.7. MPODs were not correlated to total error scores (p = 0.93). MPODs were also not correlated with iris reflectances (p = 0.28) even though MPODs differed significantly by iris color (brown = 0.44, hazel = 0.31, blue = 0.33, p = 0.04). Iris reflectances were not correlated with total error scores (p = 0.68). MPODs differed significantly (p = 0.003) between Asian and Caucasian subjects, 0.44 and 0.33, respectively. Conclusions This study did not find a correlation between MPOD and hue discrimination as in some previous studies. While MPOD was associated with iris color and ethnicity as found in prior studies, it was not associated with iris reflectance, which may be a better indicator of ocular pigmentation compared to either iris color or ethnicity.	[Garakani, Roya; Ng, Jason S.] Marshall B Ketchum Univ, Southern Calif Coll Optometry, Fullerton, CA 92831 USA		Ng, JS (corresponding author), Marshall B Ketchum Univ, Southern Calif Coll Optometry, Fullerton, CA 92831 USA.	jng@ketchum.edu	Ng, Jason/AAD-5574-2019	Ng, Jason/0000-0002-8579-9020				Barbur JL, 2012, J OPT SOC AM A, V29, pA27, DOI 10.1364/JOSAA.29.000A27; Bartlett H, 2010, BRIT J OPHTHALMOL, V94, P753, DOI 10.1136/bjo.2009.175901; Bernstein PS, 2010, VISION RES, V50, P716, DOI 10.1016/j.visres.2009.10.014; Bone RA, 2001, INVEST OPHTH VIS SCI, V42, P235; Breton MEF D. E., 1988, APPL OPTICS, V27, P6; Dain Stephen J, 2004, Clin Exp Optom, V87, P322; Davison P, 2011, OPTOMETRY VISION SCI, V88, P816, DOI 10.1097/OPX.0b013e31821798ec; FINE BJ, 1980, PERCEPT MOTOR SKILL, V51, P1167, DOI 10.2466/pms.1980.51.3f.1167; Garakani R, 2014, OPTOM VIS SCI, V2014; Hammond BR, 2014, INVEST OPHTH VIS SCI, V55, P8583, DOI 10.1167/iovs.14-15573; Hammond BR, 1996, EXP EYE RES, V62, P293, DOI 10.1006/exer.1996.0035; Hammond BR, 2000, INVEST OPHTH VIS SCI, V41, P1492; KILBRIDE PE, 1989, VISION RES, V29, P663, DOI 10.1016/0042-6989(89)90028-X; Kinnear PR, 2002, BRIT J OPHTHALMOL, V86, P1408, DOI 10.1136/bjo.86.12.1408; Ma L, 2012, AM J OPHTHALMOL, V154, P625, DOI 10.1016/j.ajo.2012.04.014; Mackey DA, 2011, CLIN EXP OPHTHALMOL, V39, P462, DOI 10.1111/j.1442-9071.2010.02487.x; MAHON LE, 1995, OPTOMETRY VISION SCI, V72, P547, DOI 10.1097/00006324-199508000-00002; Moreland JD, 2006, VISUAL NEUROSCI, V23, P549, DOI 10.1017/S0952523806233522; Moreland J. D., 1995, MACULAR PIGMENT CONT, P517; Murray IJ, 2013, GRAEF ARCH CLIN EXP, V251, P2355, DOI 10.1007/s00417-013-2430-4; PEASE PL, 1987, VISION RES, V27, P705, DOI 10.1016/0042-6989(87)90067-8; Roorda A, 2001, VISION RES, V41, P1291, DOI 10.1016/S0042-6989(01)00043-8; RUDDOCK KH, 1972, VISION RES, V12, P145, DOI 10.1016/0042-6989(72)90147-2; Stringham JM, 2010, J FOOD SCI, V75, pR24, DOI 10.1111/j.1750-3841.2009.01447.x; van der Veen RLP, 2009, OPHTHAL PHYSL OPT, V29, P127, DOI 10.1111/j.1475-1313.2008.00618.x; VERRIEST G, 1982, AM J OPHTHALMOL, V93, P635, DOI 10.1016/S0002-9394(14)77380-5; VINGRYS AJ, 1988, INVEST OPHTH VIS SCI, V29, P50; Werner JS, 2000, J OPT SOC AM A, V17, P1918, DOI 10.1364/JOSAA.17.001918; Wolf-Schnurrbusch UEK, 2007, INVEST OPHTH VIS SCI, V48, P3783, DOI 10.1167/iovs.06-1218; Woo George C, 2002, Clin Exp Optom, V85, P372	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220940	10.1371/journal.pone.0220940	http://dx.doi.org/10.1371/journal.pone.0220940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393943	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500085
J	Guo, J; Xiao, Y; Iyer, R; Lu, X; Lake, M; Ladror, U; Harlan, J; Samanta, T; Tomlinson, M; Bukofzer, G; Donawho, C; Shoemaker, A; Huang, TH				Guo, Jun; Xiao, Yu; Iyer, Ramesh; Lu, Xin; Lake, Marc; Ladror, Uri; Harlan, John; Samanta, Tanushree; Tomlinson, Medha; Bukofzer, Gail; Donawho, Cherrie; Shoemaker, Alex; Huang, Tzu-Hsuan			Empowering therapeutic antibodies with IFN-alpha for cancer immunotherapy	PLOS ONE			English	Article							INTERFERON-ALPHA	Type 1 IFNs stimulate secretion of IP-10 (CXCL10) which is a critical chemokine to recruit effector T cells to the tumor microenvironment and IP-10 knockout mice exhibit a phenotype with compromised effector T cell generation and trafficking. Type 1 IFNs also induce MHC class 1 upregulation on tumor cells which can enhance anti-tumor CD8 T cell effector response in the tumor microenvironment. Although type 1 IFNs show great promise in potentiating anti-tumor immune response, systemic delivery of type 1 IFNs is associated with toxicity thereby limiting clinical application. In this study, we fused tumor targeting antibodies with IFN-alpha and showed that the fusion proteins can be produced with high yields and purity. IFN fusions selectively induced IP-10 secretion from antigen positive tumor cells, which was critical in recruiting the effector T cells to the tumor microenvironment. Further, we found that treatment with the anti-PDL1-IFN-alpha fusion at concentrations as low as 1 pM exhibited potent activity in mediating OT1 CD8(+) T cell killing against OVA expressing tumor cells, while control IFN fusion did not exhibit any activity at the same concentration. Furthermore, the IFN-alpha fusion antibody was well tolerated in vivo and demonstrated anti-tumor efficacy in an anti-PD-L1 resistant syngeneic mouse tumor model. One of the potential mechanisms for the enhanced CD8 T cell killing by anti-PD-L1 IFN fusion was up-regulation of MHC class I/tumor antigen complex. Our data supports the hypothesis of targeting type 1 IFN to the tumor microenvironment may enhance effector T cell functions for anti-tumor immune response.	[Guo, Jun; Xiao, Yu; Samanta, Tanushree; Bukofzer, Gail; Donawho, Cherrie; Shoemaker, Alex; Huang, Tzu-Hsuan] AbbVie Inc, Oncol Discovery, N Chicago, IL 60064 USA; [Iyer, Ramesh; Lake, Marc; Ladror, Uri; Harlan, John] AbbVie Inc, Global Prot Sci, N Chicago, IL USA; [Lu, Xin] AbbVie Inc, Genom Res Ctr, N Chicago, IL USA; [Tomlinson, Medha] AbbVie Biores Ctr, Global Biol, Worcester, MA USA	AbbVie; AbbVie; AbbVie; AbbVie	Huang, TH (corresponding author), AbbVie Inc, Oncol Discovery, N Chicago, IL 60064 USA.	leon.huang@abbvie.com			AbbVie	AbbVie(AbbVie)	JG, YX, RI, XL, ML, UL, JH, TS, GB, AS, and TH are employees of AbbVie. MT & CD were AbbVie employees at the time of the study. The specific roles of these authors are articulated in the ` author contributions' section. The design, study conduct, and financial support for this research were provided by AbbVie. AbbVie participated in the interpretation of data, review, and approval of the publication.	Bazhin AV, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02129; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Dong YN, 2017, ONCOTARGET, V8, P2171, DOI 10.18632/oncotarget.13895; Farrar JD, 2000, NAT IMMUNOL, V1, P65, DOI 10.1038/76932; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Guo J, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-2783; Huang TH, 2007, J IMMUNOL, V179, P6881, DOI 10.4049/jimmunol.179.10.6881; Jennings RN, 2014, J VIROL, V88, P14040, DOI 10.1128/JVI.02360-14; Knudson KM, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1426519; Kwok G, 2016, HUM VACC IMMUNOTHER, V12, P2777, DOI 10.1080/21645515.2016.1199310; Liang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06890-y; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Papageorgiou A, 2007, CANCER BIOL THER, V6, P872, DOI 10.4161/cbt.6.6.4088; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Schiavoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00483; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Woo SR, 2015, TRENDS IMMUNOL, V36, P250, DOI 10.1016/j.it.2015.02.003; Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004; Zhang HC, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0397-y; Zhang L, 2017, EXP HEMATOL ONCOL, V6, DOI 10.1186/s40164-017-0081-6; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	24	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219829	10.1371/journal.pone.0219829	http://dx.doi.org/10.1371/journal.pone.0219829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393905	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500018
J	Israel, E; Cohen, N; Czamanski, D				Israel, Emil; Cohen, Nir; Czamanski, Daniel			Return on capital? Determinants of counter-migration among early career Israeli STEM researchers	PLOS ONE			English	Article							INTERNATIONAL MIGRATION; SKILLED MIGRATION; HIGHER-EDUCATION; PARENTAL WEALTH; MIDDLE-CLASS; STUDENTS; MOBILITY; BOURDIEU; SOCIALIZATION; GEOGRAPHIES	Migration studies emphasize the role of economic, social and cultural capital in shaping out-migration decisions. Yet, little attention is paid to the effect of capital endowment on return migration, particularly among the highly educated. This article examines the extent to which different forms of capital determine return decisions of early-career researchers (ECRs). We hypothesized that individuals from more privileged backgrounds would repatriate at higher rates, due to the benefits that their capital stock might offer them upon homeland reintegration at home. Drawing on a sample of 223 early career Israeli scholars in STEM (Science, Technology, Engineering and Mathematics) disciplines, we used logistic regressions to analyze the effects of material wealth, social ties, and family-oriented cultural capital on their return propensities. No significant differences were found between repatriating and non-repatriating scholars with respect to cultural capital. However, accumulating social and economic capital was positively correlated with the decision to repatriate as was marrying into academic families.	[Israel, Emil] Technion Israel Inst Technol, Fac Architecture & Town Planning, Haifa, Israel; [Israel, Emil] Technion, Samuel Neaman Inst Natl Policy Res, Haifa, Israel; [Cohen, Nir] Bar Ilan Univ, Dept Geog & Environm, Ramat Gan, Israel; [Czamanski, Daniel] Ruppin Acad Ctr, Fac Econ & Business Adm, Emek Hefer, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Bar Ilan University; Ruppin Academic Center	Israel, E (corresponding author), Technion Israel Inst Technol, Fac Architecture & Town Planning, Haifa, Israel.; Israel, E (corresponding author), Technion, Samuel Neaman Inst Natl Policy Res, Haifa, Israel.	emil.israel@technion.ac.il	Czamanski, Danny/AAB-7207-2021	Czamanski, Danny/0000-0002-3309-4475	Israel Science Foundation [319/17]; Samuel Neaman Institute for National Policy Research; Technion	Israel Science Foundation(Israel Science Foundation); Samuel Neaman Institute for National Policy Research; Technion	This research was financed by the Samuel Neaman Institute for National Policy Research (Emil Israel, Daniel Czamanski), Technion, and conducted under its auspice. Additionally, the project was partially supported by the Israel Science Foundation (grant 319/17) (Daniel Czamanski). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the Samuel Neaman Institute for National Policy Research, Technion, and conducted under its auspices. We wish to thank to Prof. Arnon Bentur, who assisted greatly in the realization of the research. Czamanski would like to thank the Israel Science Foundation (grant 319/17) for partial support of this work.	Ackers L, 2005, INT MIGR, V43, P99, DOI 10.1111/j.1468-2435.2005.00343.x; Alberts HC, 2005, INT MIGR, V43, P131, DOI 10.1111/j.1468-2435.2005.00328.x; ANHEIER HK, 1995, AM J SOCIOL, V100, P859, DOI 10.1086/230603; Austin AE, 2002, J HIGH EDUC, V73, P94, DOI 10.1353/jhe.2002.0001; Aydin D., 2014, ED SYSTEM ROJAVA KUR; BALAZ V, 2004, POPULATION SPACE PLA, V0010; Baruffaldi SH, 2012, RES POLICY, V41, P1655, DOI 10.1016/j.respol.2012.04.005; Bauder H, 2006, ANTIPODE, V38, P671, DOI 10.1111/j.1467-8330.2006.00469.x; Bauder H, 2015, INT MIGR, V53, P83, DOI 10.1111/j.1468-2435.2012.00783.x; Blechman Israel, 2008, THEORY CRITICISM, V33, P191; Bourdieu P., 1988, HOMOACADEMICUS; Bourdieu P., 2009, LOGIC PRACTICE; Bourdieu P., 2007, INVITATION REFLEXIVE; Bourdieu P., 1984, DISTINCTION SOCIAL C; Bourdieu Pierre, 1977, POWER IDEOLOGY ED, P487; Bourdieu Pierre, 1986, DISTINCTION SOCIAL C; Brooks R, 2010, GLOB SOC EDUC, V8, P143, DOI 10.1080/14767720903574132; Byram M., 2009, STUDENTS STAFF ACAD, P31; Carlson S, 2013, POPUL SPACE PLACE, V19, P168, DOI 10.1002/psp.1749; Carpiano RM, 2006, SOC SCI MED, V62, P165, DOI 10.1016/j.socscimed.2005.05.020; Castles S, 2000, INT SOC SCI J, V52, P269, DOI 10.1111/1468-2451.00258; CHE (The Council for Higher Education) and MST (Ministry of Science and Technology MST), 2015, COMM ADV REPR WOM I; Cohen N, 2015, J ETHN MIGR STUD, V41, P795, DOI 10.1080/1369183X.2014.948392; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Crescenzi R, 2017, ANN REGIONAL SCI, V59, P603, DOI 10.1007/s00168-016-0762-9; Czaika M, 2017, POPUL SPACE PLACE, V23, P1; Department of Trade and Industry (DTI) Knowledge Migrants, 2002, MOT EXP PROF UK WORK; Erel U, 2010, SOCIOLOGY, V44, P642, DOI 10.1177/0038038510369363; Fernandez RM, 1997, AM SOCIOL REV, V62, P883, DOI 10.2307/2657345; Friesen MR, 2011, ENG STUD, V3, P79, DOI 10.1080/19378629.2011.571260; Garip F, 2008, DEMOGRAPHY, V45, P591, DOI 10.1353/dem.0.0016; Geddie K, 2013, POPUL SPACE PLACE, V19, P196, DOI 10.1002/psp.1751; Granovetter M. S., 1992, NETWORKS ORG STRUCTU, V25, P25; Granovetter Mark., 1995, GETTING JOB STUDY CO, V2nd; Gruber N., 2014, 201408 TAUB CTR; Halfacree K., 2004, POPUL SPACE PLACE, V10, P239, DOI DOI 10.1002/PSP.326; Harvey WS, 2009, POPUL SPACE PLACE, V15, P493, DOI 10.1002/psp.526; Hazen HD, 2006, POPUL SPACE PLACE, V12, P201, DOI 10.1002/psp.409; Holloway SL, 2012, T I BRIT GEOGR, V37, P482, DOI 10.1111/j.1475-5661.2012.00542.x; Hunt J.D., 1994, TRANSPORT RES REC, V1466, P79; Israel E, 2010, TRANSPORT RES A-POL, V44, P523, DOI 10.1016/j.tra.2010.03.021; Jaeger MM, 2007, SOC SCI RES, V36, P719, DOI 10.1016/j.ssresearch.2006.11.003; Kamphuis CBM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130695; Kaplan K, 2010, NATURE, V468, P1135, DOI 10.1038/nj7327-1135a; Keister LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168043; Kellogg RP, 2012, J CHIN OVERSEAS, V8, P83, DOI 10.1163/179325412X634319; Khoo SE, 2008, INT MIGR REV, V42, P193, DOI 10.1111/j.1747-7379.2007.00118.x; King R, 2013, POPUL SPACE PLACE, V19, P127, DOI 10.1002/psp.1746; Labrianidis L, 2013, POPUL SPACE PLACE, V19, P472, DOI 10.1002/psp.1726; Laudel G, 2008, HIGH EDUC, V55, P387, DOI 10.1007/s10734-007-9063-7; Lin N., 2002, SOCIAL CAPITAL THEOR, V19; Lynn CD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203500; Madge C, 2015, PROG HUM GEOG, V39, P681, DOI 10.1177/0309132514526442; Mahroum S, 2000, R&D MANAGE, V30, P23, DOI 10.1111/1467-9310.00154; Mahroum S., 1998, IPTS REPORT, V29, P21; Marom N, 2013, URBAN STUD, V50, P2826, DOI 10.1177/0042098013477699; MASSEY DS, 1993, POPUL DEV REV, V19, P431, DOI 10.2307/2938462; McAlpine L, 2012, HIGH EDUC Q, V66, P174, DOI 10.1111/j.1468-2273.2012.00514.x; Musselin C, 2004, HIGH EDUC, V48, P55, DOI 10.1023/B:HIGH.0000033770.24848.41; Pelizon C., 2002, SCI NEXT WAVE, V10, P1; Pinheiro DL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176977; Portes A, 1998, ANNU REV SOCIOL, V24, P1, DOI 10.1146/annurev.soc.24.1.1; Scellato G., 2014, INNOVATION POLICY EC; Scott S, 2006, J ETHN MIGR STUD, V32, P1105, DOI 10.1080/13691830600821802; Senor Dan, 2009, START UP NATION STOR; Shachar A, 2006, NEW YORK U LAW REV, V81, P148; Silvey R, 2004, PROG HUM GEOG, V28, P490, DOI 10.1191/0309132504ph490oa; Spilerman S, 2004, AM J SOCIOL, V110, P92, DOI 10.1086/424943; Spilerman S, 2012, SOC SCI RES, V41, P207, DOI 10.1016/j.ssresearch.2011.08.002; Sretenova N., 2003, S SCI POL MOB BRAIN; STARK O, 1985, AM ECON REV, V75, P173; Tharenou P., 2014, INT STUD MANAG ORG, V44, P55, DOI [10.2753/IMO0020-8825440203, DOI 10.2753/IMO0020-8825440203]; The Israeli Young Academy, 2017, SUMM REP SURV RES BE; Thorn K, 2008, INT MOBILITY TALENT, P145; Tubin D, 2008, HIGH EDUC, V55, P203, DOI 10.1007/s10734-006-9049-x; Vertovec S., 2002, LAD DISK MIGR C GOTT; Wadhwa V, 2009, AM LOSS IS WORLDS GA; Wadhwa V., 2011, GRASS IS INDEED GREE; Wang QF, 2015, POPUL SPACE PLACE, V21, P771, DOI 10.1002/psp.1855; Waters J, 2013, POPUL SPACE PLACE, V19, P155, DOI 10.1002/psp.1748; Waters JL, 2006, T I BRIT GEOGR, V31, P179, DOI 10.1111/j.1475-5661.2006.00202.x; Waters JL, 2009, ENVIRON PLANN A, V41, P1865, DOI 10.1068/a40319; Weidman JC, 2003, RES HIGH EDUC, V44, P641, DOI 10.1023/A:1026123508335; Weiss H, 2014, CULT ANTHROPOL, V29, P128, DOI 10.14506/ca29.1.08; Zweig D, 1997, STUD COMP INT DEV, V32, P92, DOI 10.1007/BF02696307	85	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220609	10.1371/journal.pone.0220609	http://dx.doi.org/10.1371/journal.pone.0220609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393885	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500045
J	Ugolino, J; Dziki, KM; Kim, A; Wu, JJ; Vogel, BE; Monteiro, MJ				Ugolino, Janet; Dziki, Kristina M.; Kim, Annette; Wu, Josephine J.; Vogel, Bruce E.; Monteiro, Mervyn J.			Overexpression of human Atp13a2(Isoform-1) protein protects cells against manganese and starvation-induced toxicity	PLOS ONE			English	Article							P-TYPE ATPASE; INCLUSION-BODY FORMATION; ALPHA-SYNUCLEIN; HEREDITARY PARKINSONISM; CAENORHABDITIS-ELEGANS; LYSOSOMAL DYSFUNCTION; ATP13A2; AUTOPHAGY; IDENTIFICATION; DEFICIENCY	Mutations in ATP13A2 cause Kufor-Rakeb syndrome (KRS), a juvenile form of Parkinson's disease (PD) with dementia. However, the mechanisms by which mutations in ATP13A2 cause KRS is not understood. The mutations lead to misfolding of the translated Atp13a2 protein and its premature degradation in the endoplasmic reticulum, never reaching the lysosome where the protein is thought to function. Atp13a2 is a P-type ATPase, a class of proteins that function in ion transport. Indeed, studies of human, mouse, and yeast Atp13a2 proteins suggest a possible involvement in regulation of heavy metal toxicity. Here we report on the cytoprotective function of Atp13a2 on HeLa cells and dopamine neurons of Caenorhabditis elegans (C. elegans). HeLa cells stably overexpressing V5-tagged Atp13a2(Isoform-1) protein were more resistant to elevated manganese exposure and to starvation-induced cell death compared to cells not overexpressing the protein. Because PD is characterized by loss of dopamine neurons, we generated transgenic C. elegans expressing GFP-tagged human Atp13a2 protein in dopamine neurons. The transgenic animals exhibited higher resistance to dopamine neuron degeneration after acute exposure to manganese compared to nematodes that expressed GFP alone. The results suggest Atp13a2(Isoform-1) protein confers cytoprotection against toxic insults, including those that cause PD syndromes.	[Ugolino, Janet] Univ Maryland, Sch Med, Biochem & Mol Biol Grad Program, Baltimore, MD 21201 USA; [Ugolino, Janet; Dziki, Kristina M.; Kim, Annette; Wu, Josephine J.; Vogel, Bruce E.; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Ugolino, Janet; Monteiro, Mervyn J.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Ugolino, Janet] Roanoke Coll, Dept Biol, Salem, VA 24153 USA; [Dziki, Kristina M.] Johns Hopkins Appl Phys Lab, Laurel, MD USA; [Kim, Annette] Virginia Commonwealth Univ, Richmond, VA USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Virginia Commonwealth University	Monteiro, MJ (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.; Monteiro, MJ (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	monteiro@som.umaryland.edu		Wu, Josephine/0000-0001-8740-7716; Monteiro, Mervyn/0000-0002-1740-5309	NIH [R01NS100008, R21NS095135]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100008, R21NS095135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded in part by grant to MJM by NIH R01NS100008 and NIH R21NS095135.	Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Billingsley KJ, 2018, CELL TISSUE RES, V373, P9, DOI 10.1007/s00441-018-2817-y; Chesi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034178; Cho JH, 2005, FEBS LETT, V579, P778, DOI 10.1016/j.febslet.2004.12.032; Criswell SR, 2011, NEUROLOGY, V76, P1296, DOI 10.1212/WNL.0b013e3182152830; Dehay B, 2012, P NATL ACAD SCI USA, V109, P9611, DOI 10.1073/pnas.1112368109; Demirsoy S, 2017, HUM MOL GENET, V26, P1656, DOI 10.1093/hmg/ddx070; Deng H, 2018, AGEING RES REV, V42, P72, DOI 10.1016/j.arr.2017.12.007; Dobson AW, 2004, ANN NY ACAD SCI, V1012, P115, DOI 10.1196/annals.1306.009; Fleming SM, 2018, NEUROTOXICOLOGY, V64, P256, DOI 10.1016/j.neuro.2017.06.005; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Gusdon AM, 2012, NEUROBIOL DIS, V45, P962, DOI 10.1016/j.nbd.2011.12.015; Hamamichi S, 2008, P NATL ACAD SCI USA, V105, P728, DOI 10.1073/pnas.0711018105; Janicki S, 1997, J CELL BIOL, V139, P485, DOI 10.1083/jcb.139.2.485; Kett LR, 2015, J NEUROSCI, V35, P5724, DOI 10.1523/JNEUROSCI.0632-14.2015; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kong SMY, 2014, HUM MOL GENET, V23, P2816, DOI 10.1093/hmg/ddu099; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lie PPY, 2019, NEUROBIOL DIS, V122, P94, DOI 10.1016/j.nbd.2018.05.015; Matsui H, 2013, FEBS LETT, V587, P1316, DOI 10.1016/j.febslet.2013.02.046; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Monteiro MJ, 1996, EXP CELL RES, V223, P443, DOI 10.1006/excr.1996.0100; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park JS, 2017, CURR PROTEIN PEPT SC, V18, P725, DOI 10.2174/1389203717666160311121534; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Spataro R, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0203-9; Tan JQ, 2011, J BIOL CHEM, V286, P29654, DOI 10.1074/jbc.M111.233874; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; Ugolino J, 2011, HUM MOL GENET, V20, P3565, DOI 10.1093/hmg/ddr274; Usenovic M, 2012, J NEUROSCI, V32, P4240, DOI 10.1523/JNEUROSCI.5575-11.2012; Van Baelen K, 2001, J BIOL CHEM, V276, P10683, DOI 10.1074/jbc.M010553200; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220849	10.1371/journal.pone.0220849	http://dx.doi.org/10.1371/journal.pone.0220849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393918	Green Submitted, gold, Green Published			2022-12-27	WOS:000485002500070
J	Kim, D; Jung, IH; Kim, DH; Park, SW				Kim, Do Hee; Jung, In Hye; Kim, Dong Hee; Park, Seung Woo			Knockout of longevity gene Sirt1 in zebrafish leads to oxidative injury, chronic inflammation, and reduced life span	PLOS ONE			English	Article							STRESS; PATHWAY	Sirt1, a member of the sirtuin gene family, encodes the most conserved mammalian NAD(+)-dependent deacetylase enzyme responsible for removing acetyl groups from many proteins. The Sirt1 gene is known as a longevity gene whose knockout in mice leads to decreased lifespan relative to the wild type. This study aimed to explore phenotypic changes in zebrafish Sirt1-knockouts and to investigate the function of the Sirt1 gene. Targeted knockout of Sirt1 in zebrafish (Danio rerio) was achieved using the CRISPR-Cas9 genome editing system. We created a 4-bp insertion-homozygote Sirt1-knockout zebrafish. Although there was no evident difference in appearance in the early stages of development, a significant increase in reactive oxygen species and in the extent of apoptosis in Sirt1-knockout zebrafish was observed. Sirt1 knockout caused inflammatory genes, including IL-1b, IL-6 and TNF-alpha to be highly expressed. Additionally, the lack of Sirt1 caused chronic inflammation and intestinal atrophy, thereby increasing pro-apoptotic events, which ultimately reduced the lifespan of transgenic zebrafish. Overall, our data demonstrate that lack of Sirt1 caused a significantly increased generation of reactive oxygen species that resulted in chronic inflammation and regeneration. Continuous repetition of these events played an important role in accelerating aging, thereby decreasing lifespan. Our findings using the knockout zebrafish model confirmed the association of the Sirt1 gene to aging processes and lifespan. Furthermore, the Sirt1-knockout mutant zebrafish developed in our study will surely be a valuable model to explore the mechanism of chronic inflammation.	[Kim, Do Hee; Kim, Dong Hee] Yonsei Univ, Postgrad Sch Nano Sci & Technol, Seoul, South Korea; [Jung, In Hye; Park, Seung Woo] Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med,Inst Gastroenterol, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System	Park, SW (corresponding author), Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med,Inst Gastroenterol, Seoul, South Korea.	swoopark@yuhs.ac		Park, Seung Woo/0000-0001-8230-964X	Technology Innovation Program - Ministry of Trade, Industry & Energy (MOTIE, Korea) [10063396]; Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education [2015R1D1A1A09060230]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute(KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1324]	Technology Innovation Program - Ministry of Trade, Industry & Energy (MOTIE, Korea); Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education; Korea Health Technology R&D Project through the Korea Health Industry Development Institute(KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by the Technology Innovation Program (10063396 to SWP, Zebrafish-based services in efficacy, Toxicity, and druggability) funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea), Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education(2015R1D1A1A09060230 to SWP), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute(KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HI14C1324 to SWP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Chan SH, 2017, REDOX BIOL, V13, P301, DOI 10.1016/j.redox.2017.05.027; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Haegens A, 2008, EUR RESPIR J, V31, P252, DOI 10.1183/09031936.00029307; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Halasi M, 2013, BIOCHEM J, V454, P201, DOI 10.1042/BJ20130282; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jung IH, 2015, NEOPLASIA, V17, P586, DOI 10.1016/j.neo.2015.07.005; Jung IH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027941; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Li Kai, 2011, N Am J Med Sci (Boston), V4, P104; Liu Tie Fu, 2013, Genes Cancer, V4, P135, DOI 10.1177/1947601913476948; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Salminen A, 2013, INT J MOL SCI, V14, P3834, DOI 10.3390/ijms14023834; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Zou Y, 2003, FASEB J, V17, P320, DOI 10.1096/fj.03-0849fje	24	21	21	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220581	10.1371/journal.pone.0220581	http://dx.doi.org/10.1371/journal.pone.0220581			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386694	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100025
J	At Thobari, J; Satria, CD; Ridora, Y; Watts, E; Handley, A; Samad, S; Bachtiar, NS; Bines, JE; Soenarto, Y; Buttery, JP				At Thobari, Jarir; Satria, Cahya Dewi; Ridora, Yohanes; Watts, Emma; Handley, Amanda; Samad, Samad; Bachtiar, Novilia S.; Bines, Julie E.; Soenarto, Yati; Buttery, Jim P.			Antimicrobial use in an Indonesian community cohort 0-18 months of age	PLOS ONE			English	Article							ANTIBIOTIC USE; OPHTHALMIA NEONATORUM; CHILDREN; CHLORAMPHENICOL; FORMULATIONS; ASSOCIATION; INFECTIONS; PREVENTION; EFFICACY; INFANTS	Background Antimicrobial resistance has become a global health emergency and is contributed to by inappropriate antibiotic use in community clinical settings. The aim of this study was to evaluate the antimicrobial use pattern in infants from birth until 18 months of age in Indonesia. Methods A post-hoc analysis was conducted in 1621 participants from the RV3BB Phase IIb trial conducted in Indonesia from January 2013 through July 2016. Any health events were documented in the trial as adverse events. Concomitant medication surveillance recorded all medications, including antibiotics during the 18 months of follow-up. Information included the frequency, duration of usage, formulation, classes, and their indications, including prophylactic antibiotic and perinatal use. Results Of 1621 participants, 551 (33.99%) received at least one antibiotic for treatment of infections during the 18 months observation period. Additionally, during the perinatal period, prophylactic antibiotics were used in 1244 (76.74%) participants and antibiotics consumed in 235 mothers of participants (14.50%). A total of 956 antibiotic consumptions were recorded for 18 months follow up, 67 (7.01%) as part of antimicrobial combinations. The average duration of antibiotic course was 4.92 days. Penicillin and sulfonamides were the most common antibiotic classes consumed (38.81% and 24.48%, respectively). Conclusions Despite the low community consumption rate, the overuse of antibiotic in URTIs and nonbloody diarrhea in our setting represents a major opportunity for antimicrobial stewardship, particularly in early life.	[At Thobari, Jarir; Satria, Cahya Dewi; Ridora, Yohanes; Soenarto, Yati] Univ Gadjah Mada, Pediat Res Off, Dept Pediat, Fac Med Publ Hlth & Nursing, Yogyakarta, Special Region, Indonesia; [At Thobari, Jarir] Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nursing, Yogyakarta, Special Region, Indonesia; [Watts, Emma; Handley, Amanda; Bines, Julie E.; Buttery, Jim P.] Murdoch Childrens Res Inst, RV3 Rotavirus Vaccine Program, Parkville, Vic, Australia; [Handley, Amanda] Med Dev Global Hlth, Melbourne, Vic, Australia; [Samad, Samad; Bines, Julie E.] Soeradji Tirtonegoro Gen Hosp, Klaten, Central Java, Indonesia; [Bachtiar, Novilia S.] PT Bio Farma, Bandung, West Java, Indonesia; [Bines, Julie E.; Buttery, Jim P.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Bines, Julie E.] Royal Childrens Hosp Melbourne, Dept Gastroenterol & Clin Nutr, Parkville, Vic, Australia; [Buttery, Jim P.] Monash Univ, Dept Paediat, Clayton, Vic, Australia; [Buttery, Jim P.] Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia; [Buttery, Jim P.] Monash Childrens Hosp, Dept Infect & Immun, Clayton, Vic, Australia	Gadjah Mada University; Gadjah Mada University; Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; Monash University; Monash University	At Thobari, J (corresponding author), Univ Gadjah Mada, Pediat Res Off, Dept Pediat, Fac Med Publ Hlth & Nursing, Yogyakarta, Special Region, Indonesia.; At Thobari, J (corresponding author), Univ Gadjah Mada, Dept Pharmacol & Therapy, Fac Med Publ Hlth & Nursing, Yogyakarta, Special Region, Indonesia.	j.atthobari@ugm.ac.id	At Thobari, Jarir/GOP-2379-2022	At Thobari, Jarir/0000-0002-7035-4846; Ridora, Yohanes/0000-0002-7104-9595; Bines, Julie/0000-0002-5452-6601	PT Biofarma; Murdoch Children's Research Institute	PT Biofarma; Murdoch Children's Research Institute	The vaccine company PT Bio Farma provided support for this study in the form of a salary for the author NSB. The specific role of this author is articulated in the 'author contributions' section. Additionally, PT Biofarma was one of the funders of the RV3-BB Phase IIb trial. Another funding source of the RV3-BB Phase IIb trial was Murdoch Children's Research Institute. The funders had roles in the study design, decision to publish, and preparation of the manuscript.	Ahmed AM, 2010, ANN PHARMACOTHER, V44, P1986, DOI 10.1345/aph.1P423; Allegaert Karel, 2013, World J Clin Pediatr, V2, P1, DOI 10.5409/wjcp.v2.i1.1; Altiner A, 2007, J ANTIMICROB CHEMOTH, V60, P638, DOI 10.1093/jac/dkm254; [Anonymous], 2014, WHO GLOB REP SURV AN; [Anonymous], 2011, WHO EV TECHN UPD POC; Bailey LC, 2014, JAMA PEDIATR, V168, P1063, DOI 10.1001/jamapediatrics.2014.1539; Batchelor HK, 2015, BRIT J CLIN PHARMACO, V79, P405, DOI 10.1111/bcp.12268; Biezen R, 2017, NPJ PRIM CARE RESP M, V27, P1, DOI [10.1038/s41533-016-0007-5, DOI 10.1038/S41533-016-0007-5]; Bines JE, 2018, NEW ENGL J MED, V378, P719, DOI 10.1056/NEJMoa1706804; Bramantyo T, 2015, ASIA-PAC J OPHTHALMO, V4, P180, DOI 10.1097/APO.0000000000000070; Cabral C, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-63; Clift C, 2017, VACCINE, V35, P6591, DOI 10.1016/j.vaccine.2017.09.053; Darling EK, 2010, J MIDWIFERY WOM HEAL, V55, P319, DOI 10.1016/j.jmwh.2009.09.003; De Luca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154662; de Tejada BM, 2014, INT J ENV RES PUB HE, V11, P7993, DOI 10.3390/ijerph110807993; Fuchs A, 2018, PAEDIATR INT CHILD H, V38, pS3, DOI 10.1080/20469047.2017.1408738; Grimwood K, 2016, PNEUMONIA, V8, DOI 10.1186/s41479-016-0006-x; Holstiege J, 2013, EUR J PEDIATR, V172, P787, DOI 10.1007/s00431-013-1958-y; Joseph F, 2015, ETHIOP J HEALTH SCI, V25, P73, DOI 10.4314/ejhs.v25i1.10; Kastelan S, 2018, MED SCI MONITOR, V24, P8042, DOI 10.12659/MSM.910705; Klugman KP, 2018, P NATL ACAD SCI USA, V115, P12896, DOI 10.1073/pnas.1721095115; Kuperman AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0636-0; Laporte JR, 1998, BRIT J CLIN PHARMACO, V46, P181, DOI 10.1046/j.1365-2125.1998.00773.x; Laxminarayan R, 2012, BMJ-BRIT MED J, V344, P25; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Lee ACC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001741; Lee CF, 2018, J ANTIMICROB CHEMOTH, V73, P844, DOI 10.1093/jac/dkx492; Levy Y, 2004, CLIN PEDIATR, V43, P99, DOI 10.1177/000992280404300114; Lindell A, 2011, AM FAM PHYSICIAN, V83, P747; Lipsitch M, 2016, MBIO, V7, DOI 10.1128/mBio.00428-16; Maindoka FS, 2017, PHARMACON, V6, P240; Matejcek A, 2013, CAN FAM PHYSICIAN, V59, P1187; Mensah KB, 2017, J PHARM POLICY PRACT, V10, P4; MoH Republic of Indonesia, 2010, ESS NEWB CAR TECHN G; Hoa NQ, 2011, T ROY SOC TROP MED H, V105, P628, DOI 10.1016/j.trstmh.2011.07.015; Pandey Anuja A, 2010, Indian J Community Med, V35, P70, DOI 10.4103/0970-0218.62564; Pudjiadi Antonius H, 2009, PEDOMAN PELAYANAN ME; Pujiarto PS, 2010, B WORLD HEALTH ORGAN, V87, P570; Puspitasari HP, 2011, TROP MED INT HEALTH, V16, P840, DOI 10.1111/j.1365-3156.2011.02782.x; Rahmawati F, 2006, MAJ FARM INDONES, V17, P177; Ramasethu J, 2017, SEMIN FETAL NEONAT M, V22, P278, DOI 10.1016/j.siny.2017.07.001; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Rogawski ET, 2017, B WORLD HEALTH ORGAN, V95, P49, DOI 10.2471/BLT.16.176123; Salazar ML, 2012, CLIN PEDIATR, V51, P632, DOI 10.1177/0009922812439243; Schaller UC, 2001, B WORLD HEALTH ORGAN, V79, P262; Schrag SJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2013; Stam J, 2012, ACTA PAEDIATR, V101, P929, DOI 10.1111/j.1651-2227.2012.02728.x; Turnbull SL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008615; van Riet-Nales DA, 2013, ARCH DIS CHILD, V98, P725, DOI 10.1136/archdischild-2012-303303; WHO, 2017, WHO REC NEWB HLTH; Wong DM, 2006, AM FAM PHYSICIAN, V74, P956; World Health Organization, 2014, CHART BOOKL IMCI INT; Youngster I, 2017, J PEDIATR-US, V182, P239, DOI 10.1016/j.jpeds.2016.11.027; Zuppa AA, 2011, J MATERN-FETAL NEO M, V24, P769, DOI 10.3109/14767058.2010.531326	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0219097	10.1371/journal.pone.0219097	http://dx.doi.org/10.1371/journal.pone.0219097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381611	Green Published, gold			2022-12-27	WOS:000484993600003
J	Hackett, RA; Steptoe, A; Cadar, D; Fancourt, D				Hackett, Ruth A.; Steptoe, Andrew; Cadar, Dorina; Fancourt, Daisy			Social engagement before and after dementia diagnosis in the English Longitudinal Study of Ageing	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; RISK; METAANALYSIS; DEPRESSION; SYMPTOMS; DECLINE; LIFE	Background Social engagement protects against dementia onset. Less is known about patterns of social engagement around the time of dementia diagnosis. We investigated face-to-face and telephone contact at three times (pre-diagnosis, at report of diagnosis, 2 years post-diagnosis) in individuals who developed dementia and a comparison group. Methods Social engagement was assessed at waves 2-7 of the English Longitudinal Study of Ageing in 4171 individuals aged 50 and older. Dementia was ascertained by either self-reported physician diagnosis or through an informant evaluation of a participant's functional and cognitive performance compared with a few years earlier. Generalized estimating equations were used to examine differences by group, time, and group-by-time interactions. Results The dementia group reported less face-to-face (p < 0.001) and telephone contact (p < 0.001) than the dementia-free group pre-diagnosis. The dementia group experienced greater reductions in social engagement leading up to dementia diagnosis and in the 2 years following diagnosis (p's < 0.001). Conclusion Given that social engagement reduces dementia risk and supports the lived experience of people with dementia, it is important to find ways of promoting social interaction in older adults.	[Hackett, Ruth A.; Steptoe, Andrew; Cadar, Dorina; Fancourt, Daisy] UCL, Dept Behav Sci & Hlth, London, England	University of London; University College London	Hackett, RA (corresponding author), UCL, Dept Behav Sci & Hlth, London, England.	ruth.hackett.09@ucl.ac.uk	Cadar, Dorina/D-4510-2017	Cadar, Dorina/0000-0003-1398-5841; Hackett, Ruth/0000-0002-5428-2950	National Institute on Aging [RO1AG7644]; consortium of U.K. government departments; ESRC [ES/S013830/1] Funding Source: UKRI	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); consortium of U.K. government departments; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	ELSA is funded by the National Institute on Aging (Grant RO1AG7644) and by a consortium of U.K. government departments coordinated by the Economic and Social Research Council (ESRC). Declarations of interest: None. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Banks J., 2003, SOCIOECONOMIC POSITI, P71; Bathgate D, 2001, ACTA NEUROL SCAND, V103, P367, DOI 10.1034/j.1600-0404.2001.2000236.x; Bora E, 2017, J GERIATR PSYCH NEUR, V30, P206, DOI 10.1177/0891988717710337; Bora E, 2015, J NEUROL NEUROSUR PS, V86, P714, DOI 10.1136/jnnp-2014-309445; Boss L, 2015, INT PSYCHOGERIATR, V27, P541, DOI 10.1017/S1041610214002749; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Caddell L.S., 2011, DEMENTIA, V10, P379, DOI [DOI 10.1177/1471301211408255, 10.1177/1471301211408255]; Corner L, 2004, J AGING STUD, V18, P143, DOI 10.1016/j.jaging.2004.01.007; Department of Health, 2009, LIVING WELL DEMENTIA; Fancourt D, CULTURAL ENGAGEMENT; Forbes D., 2011, ONLINE J RURAL NURS, V11, P27, DOI DOI 10.14574/OJRNHC.V11I2.18; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Gelfo F, 2018, NEUROSCIENCE, V370, P218, DOI 10.1016/j.neuroscience.2017.07.065; Hackett RA, J AM GERIATR SOC; Hsiao Y-H, 2018, J BIOMED SCI, P25, DOI [10.1186/s12929-018-0410-z, DOI 10.1186/S12929-018-0410-Z]; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Khondoker M, 2017, J ALZHEIMERS DIS, V58, P99, DOI [10.3233/JAD-161160, 10.3233/jad-161160]; Kim HK, 2016, PROG NEURO-PSYCHOPH, V67, P51, DOI 10.1016/j.pnpbp.2016.01.008; Kuiper JS, 2015, AGEING RES REV, V22, P39, DOI 10.1016/j.arr.2015.04.006; Lough S, 2006, NEUROPSYCHOLOGIA, V44, P950, DOI 10.1016/j.neuropsychologia.2005.08.009; McKeith I, 2005, LANCET NEUROL, V4, P735, DOI 10.1016/S1474-4422(05)70219-2; McMunn A, 2003, 6 HLTH HLTH WEALTH L, P207; Meek KP, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010158; Min J, 2016, AGE AGEING, V45, P838, DOI 10.1093/ageing/afw125; Peres K, 2008, J AM GERIATR SOC, V56, P37, DOI 10.1111/j.1532-5415.2007.01499.x; Port CL, 2001, GERONTOLOGIST, V41, P589, DOI 10.1093/geront/41.5.589; Prince M., 2014, DEMENTIA UK UPDATE; Quinn TJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010079.pub2; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rafnsson S. B, 2017, J GERONTOL B-PSYCHOL, DOI [10.1093/geronb/gbx087, DOI 10.1093/GERONB/GBX087]; Reeves A, 2016, SOCIOL REV, V64, P550, DOI 10.1111/1467-954X.12406; Steeman E, 2006, J ADV NURS, V54, P722, DOI 10.1111/j.1365-2648.2006.03874.x; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Ward R, 2012, DEMENTIA-LONDON, V11, P287, DOI 10.1177/1471301211421064	35	44	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220195	10.1371/journal.pone.0220195	http://dx.doi.org/10.1371/journal.pone.0220195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369590	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900036
J	Kimura, T; Ueno, T; Doi, S; Nakashima, A; Doi, T; Ashitani, A; Kawano, R; Yamane, K; Masaki, T				Kimura, Tomoe; Ueno, Toshinori; Doi, Shigehiro; Nakashima, Ayumu; Doi, Toshiki; Ashitani, Aki; Kawano, Reo; Yamane, Kiminori; Masaki, Takao			High-normal albuminuria is associated with subclinical atherosclerosis in male population with estimated glomerular filtration rate >= 60 mL/min/1.73 m(2): A cross-sectional study	PLOS ONE			English	Article							LOW-GRADE ALBUMINURIA; C-REACTIVE PROTEIN; ALL-CAUSE; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; RISK; HYPERFILTRATION; CORONARY; MICROALBUMINURIA; MORTALITY	Background Low-grade albuminuria has been considered a predictor of cardiovascular mortality. We investigated the relationship between high-normal albuminuria and subclinical atherosclerosis in non-diabetic men with estimated glomerular filtration rate (eGFR) >= 60 mL/min/1.73 m(2). Methods In this cross-sectional study, 1,756 men with eGFR >= 60 mL/min/1.73 m(2) and urine albumin-to-creatinine ratio (UACR) <30 mg/g, who attended general health checkups between April 2012 and March 2015, underwent blood sampling, urinalysis, and carotid ultrasonography. We excluded the subjects who were diabetic and/or received an anti-hypertensive drug. Carotid intima-media thickness (IMT) and the number of focal atheromatous plaques were used as indicators of subclinical atherosclerosis. Multiple linear regression analysis was performed to identify clinical factors associated with carotid IMT. Poisson regression analysis was used to assess the determinants of the carotid plaque number. Results Median UACR was 4.8 mg/g (interquartile range, 3.6-6.9 mg/g). Compared with subjects with low-normal UACR (<10.0 mg/g), subjects with high-normal UACR (10.0-29.8 mg/g) had greater IMT and higher carotid plaque number. High-normal UACR was independently associated with thickened IMT in the model adjusted for conventional cardiovascular disease risk factors. Moreover, participants with high-normal UACR were also more likely to be associated with increased plaque count (prevalence ratio: 1.06; 95% confidence interval: 1.01-1.14) after adjustment for conventional cardiovascular disease risk factors. Conclusions Our results indicate that high-normal albuminuria is associated with both carotid IMT and plaque formation in the non-diabetic male population with eGFR >= 60 mL/min/1.73 m(2).	[Kimura, Tomoe; Ueno, Toshinori; Doi, Shigehiro; Nakashima, Ayumu; Doi, Toshiki; Ashitani, Aki; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan; [Kawano, Reo] Hiroshima Univ Hosp, Ctr Integrated Med Res, Hiroshima, Japan; [Yamane, Kiminori] Nippon Telegraph & Tel West Corp, Chugoku Hlth Adm Ctr, Hiroshima, Japan	Hiroshima University; Hiroshima University	Ueno, T; Masaki, T (corresponding author), Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan.	tueno-ygc@umin.ac.jp; masakit@hiroshima-u.ac.jp	Doi, Shigehiro/AAQ-2655-2020; Nakashima, Ayumu/CAF-0274-2022; Nakashima, Ayumu/N-9158-2017; Kawano, Reo/M-2661-2018	Nakashima, Ayumu/0000-0002-7838-1494; Nakashima, Ayumu/0000-0002-7838-1494; Kawano, Reo/0000-0001-8699-3768; DOI, TOSHIKI/0000-0001-8870-5790	Nippon Telegraph and Telephone West Corporation	Nippon Telegraph and Telephone West Corporation	Nippon Telegraph and Telephone West Corporation provided support in the form of salaries for author [KY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	American Diabetes Association, 2016, DIABETES CARE, V39, pS13, DOI [10.2337/dc16-S005, DOI 10.2337/DC16-S005, DOI 10.2337/DC16-ER09]; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Cosson E, 2006, DIABETES CARE, V29, P107, DOI 10.2337/diacare.29.1.107; Elias-Smale SE, 2007, ATHEROSCLEROSIS, V195, pE195, DOI 10.1016/j.atherosclerosis.2007.07.006; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gronholdt MLM, 2001, CIRCULATION, V104, P68, DOI 10.1161/hc2601.091704; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; LOEB JN, 1972, ARTHRITIS RHEUM-US, V15, P189, DOI 10.1002/art.1780150209; Lorenz MW, 2007, STROKE, V38, P1774, DOI 10.1161/STROKEAHA.106.476135; Ma H, 2013, ATHEROSCLEROSIS, V228, P237, DOI 10.1016/j.atherosclerosis.2013.02.007; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Melsom T, 2016, CLIN J AM SOC NEPHRO, V11, P2186, DOI 10.2215/CJN.04940516; Nakashima Y, 2008, CARDIOVASC RES, V79, P14, DOI 10.1093/cvr/cvn099; Naresh CN, 2013, AM J KIDNEY DIS, V62, P1095, DOI 10.1053/j.ajkd.2013.06.016; Naya T, 2007, ANGIOLOGY, V58, P677, DOI 10.1177/0003319707303589; Ogna A, 2016, EUR J NUTR, V55, P1089, DOI 10.1007/s00394-015-0923-0; Okamura T, 2007, ATHEROSCLEROSIS, V190, P216, DOI 10.1016/j.atherosclerosis.2006.01.024; Palatini P, 2012, AM J HYPERTENS, V25, P1011, DOI 10.1038/ajh.2012.73; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; Rabelink TJ, 2015, NAT REV NEPHROL, V11, P667, DOI 10.1038/nrneph.2015.162; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; Simon A, 2002, J HYPERTENS, V20, P159, DOI 10.1097/00004872-200202000-00001; Stan RV, 2007, J AM SOC NEPHROL, V18, P2432, DOI 10.1681/ASN.2007060687; Stehouwer CDA, 2004, KIDNEY INT, V66, pS42, DOI 10.1111/j.1523-1755.2004.09211.x; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Tanaka F, 2016, J HYPERTENS, V34, P506, DOI 10.1097/HJH.0000000000000809; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tonelli M, 2012, LANCET, V380, P807, DOI 10.1016/S0140-6736(12)60572-8; Tonneijck L, 2017, J AM SOC NEPHROL, V28, P1023, DOI 10.1681/ASN.2016060666; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Wasserman BA, 2008, STROKE, V39, P329, DOI 10.1161/STROKEAHA.107.498634; Yang GK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068908, 10.1371/journal.pone.0078355]; Zhang X, 2017, TRANSL RES, V183, P14, DOI 10.1016/j.trsl.2016.12.004	40	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0218290	10.1371/journal.pone.0218290	http://dx.doi.org/10.1371/journal.pone.0218290			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369578	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900008
J	Li, XY; Pape, T; Zhang, D				Li, Xin-yu; Pape, Thomas; Zhang, Dong			Gasterophilus flavipes (Oestridae: Gasterophilinae): A horse stomach bot fly brought back from oblivion with morphological and molecular evidence	PLOS ONE			English	Article							SPECIES COMPOSITION; DIPTERA; MYIASIS; IDENTIFICATION; SARCOPHAGIDAE; BIODIVERSITY; PHYLOGENY; NASALIS; LARVAE	Species of Gasterophilus Leach are obligate parasites in domestic and wild equids and responsible for cosmopolitan gasterophilosis. Although with only eight species known so far, they have received considerable attention because of their significant veterinary and economic importance. Surprisingly, we found that G. flavipes (Olivier) is a valid species based on morphological characters from male, female and the egg, after spending half a century as a synonym of G. haemorrhoidalis (Linnaeus). In the present study, G. flavipes, G. haemorrhoidalis and G. inermis (Brauer), which are the three closely related species possessing a remarkable mixture of shared morphological characters, are diagnosed and comparatively redescribed; the key to separate adults and eggs are provided, together with a series of high-resolution photographs from all the body parts. COI barcodes do not allow for a separation of G. flavipes, G. haemorrhoidalis and G. inermis, but showed a closer relationship between G. flavipes and G. haemorrhoidalis than the other two combinations, which is consistent with the morphological evidence. Geographically, G. flavipes seems to be common and widespread in the warmer parts of the Palaearctic region. Thus, the epidemiology of gasterophilosis where G. flavipes is known or supposed to occur calls for a more careful veterinarian re-assessment. A decline in the populations of Gasterophilus spp. has been noticed in Europe, but all seven Palaearctic species of Gasterophilus appear to maintain stable populations in Xinjiang (China), which may be explained by a higher biodiversity of equids and less use of anti-parasitic treatments in Xinjiang than in Europe. Our study shows that morphological characters still provide the solid backbone in classification of Gasterophilus at species-level, and updated diagnoses and a key is provided to distinguish G. flavipes, G. haemorrhoidalis and G. inermis, and to facilitate studies of epidemiology, phylogeny and host-parasite co-evolution.	[Li, Xin-yu; Zhang, Dong] Beijing Forestry Univ, Sch Nat Conservat, Key Lab Noninvas Res Technol Endangered Species, Beijing, Peoples R China; [Li, Xin-yu; Pape, Thomas] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	Beijing Forestry University; University of Copenhagen	Zhang, D (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Key Lab Noninvas Res Technol Endangered Species, Beijing, Peoples R China.	ernest8445@163.com	Pape, Thomas/E-7520-2011; Zhang, Dong/J-2296-2014	Pape, Thomas/0000-0001-6609-0609; Zhang, Dong/0000-0001-6427-7867; LI, XINYU/0000-0001-5136-0303	National Natural Science Foundation of China [31872964, 31572305]; Fundamental Research Funds for the Central Universities [JC2015-04]; Program for New Century Excellent Talents in University [NCET-12-0783]; Beijing Higher Education Young Elite Teacher Project [YETP0771]; State Scholarship Fund of China Scholarship Council [201806510006, 201306515009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Higher Education Young Elite Teacher Project; State Scholarship Fund of China Scholarship Council(China Scholarship Council)	This study is supported by the National Natural Science Foundation of China (Nos. 31872964 and 31572305), Fundamental Research Funds for the Central Universities (No. JC2015-04), Program for New Century Excellent Talents in University (No. NCET-12-0783), Beijing Higher Education Young Elite Teacher Project (No. YETP0771), the State Scholarship Fund of China Scholarship Council (No. 201306515009) awarded to DZ, and also the State Scholarship Fund of China Scholarship Council awarded to XYL (No. 201806510006) to pursue her study in University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashtari B, 2013, B ENV PHARM LIFE SCI, V2, P169; Bezdekova B, 2007, ACTA VET HUNG, V55, P241, DOI 10.1556/AVet.55.2007.2.10; Brauer F, 1858, VERHANDLUNGEN KAIS Z, V8, P464; BRAUER F, 1863, MONOGRAPHIE OESTRIDE; Buenaventura E, 2018, ACTA TROP, V182, P291, DOI 10.1016/j.actatropica.2018.01.020; Colwell D. D., 2006, The oestrid flies: biology, host-parasite relationships, impact and management, DOI 10.1079/9780851996844.0000; Colwell DD, 2009, TRENDS PARASITOL, V25, P500, DOI 10.1016/j.pt.2009.07.011; Cumming Jeffrey M., 2009, P9; de Jong Yde, 2014, Biodivers Data J, pe4034, DOI 10.3897/BDJ.2.e4034; Felix S. R., 2007, Parasitologia Latinoamericana, V62, P122; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Getachew AM, 2012, TROP ANIM HEALTH PRO, V44, P757, DOI 10.1007/s11250-011-9961-7; Grunin K.J., 1969, Fliegen Palaearkt Reg, VNo. 279,1969, P1; Grunin KJ, 1955, FAUNA URSS INSECTA D, P1; Guimaraes JH, 1999, MYIASIS CAUSED OBLIG, P167; Guimaraes JH, 1967, FAMILY GASTEROPHILID, P1; HALL M, 1995, ADV PARASIT, V35, P257, DOI 10.1016/S0065-308X(08)60073-1; Huang Heqing, 2017, Scientia Silvae Sinicae, V53, P142; Huang HQ, 2016, PARASITE, V23, DOI 10.1051/parasite/2016036; James MT, 1974, FLIES CAUSE MYIASIS; Jordaens K, 2013, INT J LEGAL MED, V127, P491, DOI 10.1007/s00414-012-0767-6; Kaboret Y, 1986, REV ELEV MED VET PAY, V39; Kamiya T, 2014, ECOGRAPHY, V37, P689, DOI 10.1111/j.1600-0587.2013.00571.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; Lafferty KD, 2012, PHILOS T R SOC B, V367, P2814, DOI 10.1098/rstb.2012.0110; Li XY, 2018, VET PARASITOL, V262, P56, DOI 10.1016/j.vetpar.2018.09.011; Lindner E, 1999, ICZN INT CODE ZOOLOG; Liu SH, 2016, VET PARASITOL, V217, P36, DOI 10.1016/j.vetpar.2015.12.028; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meiklejohn KA, 2011, INT J LEGAL MED, V125, P27, DOI 10.1007/s00414-009-0395-y; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; Nelson LA, 2007, MED VET ENTOMOL, V21, P44, DOI 10.1111/j.1365-2915.2007.00664.x; Olivier GA., 1811, ENCY METHODIQUE HIST; Otranto D, 2005, VET PARASITOL, V133, P111, DOI 10.1016/j.vetpar.2005.05.015; Papavero N., 1977, Series Ent., V14, P1; Pape T, 2001, SYST ENTOMOL, V26, P133, DOI 10.1046/j.1365-3113.2001.00143.x; Paramonov SJ, 1940, FLIES OF THE GENUS G; PATTON W. S., 1937, Annals of Tropical Medicine and Parasitology, V31, P351; Pawlas-Opiela M, 2010, VET PARASITOL, V169, P219, DOI 10.1016/j.vetpar.2009.12.030; PEARSE BHG, 1989, AUST VET J, V66, P380, DOI 10.1111/j.1751-0813.1989.tb09745.x; Pilo C, 2015, PARASITOL RES, V114, P1693, DOI 10.1007/s00436-015-4352-z; PONT AC, 1980, CATALOGUE DIPTERA AF, P883; Pont AC, 1973, CATALOG DIPTERA ORIE, P700; Sequeira JL, 2001, VET PARASITOL, V102, P261, DOI 10.1016/S0304-4017(01)00536-2; Soos A., 1986, P237; Tavassoli Mosa, 2012, Scientia Parasitologica, V13, P83; Wood DM, 2006, OESTRID FLIES: BIOLOGY, HOST-PARASITE RELATIONSHIPS, IMPACT AND MANAGEMENT, P78, DOI 10.1079/9780851996844.0078; Wood D.M., 1987, Agriculture Canada Monograph, P1147; Xue WQ, 1996, FLIES CHINA, V2, P2207; Zhang D, 2016, INT J BIOL SCI, V12, P489, DOI 10.7150/ijbs.12148; Zumpt F., 1953, Journal of the Entomological Society of Southern Africa, V16, P59; Zumpt F., 1965, MYIASIS MAN ANIMALS	55	4	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220820	10.1371/journal.pone.0220820	http://dx.doi.org/10.1371/journal.pone.0220820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404100	Green Published, gold			2022-12-27	WOS:000485006800035
J	Soon, PGK; Lim, SK; Rampal, S; Su, TT				Soon, Peter Gan Kim; Lim, Soo Kun; Rampal, Sanjay; Su, Tin Tin			A qualitative examination of barriers and solutions to renal transplantation in Malaysia: Key-informants' perspective	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ORGAN DONATION; SYSTEMATIC ANALYSIS; AFRICAN-AMERICANS; GLOBAL BURDEN; DONOR; HEALTH; WILLINGNESS; DISPARITIES; ATTITUDES	Introduction End-stage renal disease (ESRD) is increasing globally, and renal transplantation (RT) is the preferred renal replacement therapy to treat ESRD. Internationally, there are only a few countries with RT rates above 50 per million population (pmp), while most of the countries have RT rates between 30-40 pmp. The low-and middle-income countries (LMIC) makes up the majority for the RT rates below 20 pmp in which Malaysia belongs to despite its increasing ESRD rates. There is a need to explore the barriers to access RT with targeted solutions to improve the RT rates and service in LMIC. Thus, a qualitative study was undertaken in Malaysia to address this issue. Method A qualitative methodological approach was performed between March-May 2018. Semi-structured interviews were used to explore current RT policy and service availability. Key-informants were identified from a detailed stakeholder analysis of RT system in Malaysia. Interviews were digitally audio-recorded, transcribed verbatim, coded with ATLAS.ti software and underwent thematic analysis thoroughly. Results Eight key-informants participated in the study. Barriers and related solutions were classified using the socio-ecological model (SEM). As reported, the barriers and solutions of RT in Malaysia are the results of a complex interplay of personal, cultural, and environmental factors. Key barriers are linked to public's attitude and perception towards RT and the unaccommodating practices in the healthcare fraternity for RT. Key-informants provided a systematic solution that shed light on how RT could be improved at each SEM level via effective communication, education and inter-agency collaboration. Conclusion The SEM provided a framework to foster a better understanding of current practice, barriers, and solutions to RT in Malaysia. This study is the first to explore the barriers and related solutions to RT comprehensively as a whole. Implications of these findings could prompt a policy change for a better RT service delivery model not just for Malaysia but also for other LMIC. Further stakeholder engagement and evaluation of the systems are required to provide insight into best practices that will help to improve the RT rates and service in Malaysia.	[Soon, Peter Gan Kim; Rampal, Sanjay; Su, Tin Tin] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Lim, Soo Kun] Univ Malaya, Fac Med, Dept Med, Nephrol Unit, Kuala Lumpur, Malaysia; [Su, Tin Tin] Monash Univ Malaysia, Jeffery Cheah Sch Med & Hlth Sci, SEACO, Bandar Sunway, Malaysia	Universiti Malaya; Universiti Malaya; Monash University; Monash University Sunway	Soon, PGK (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	kimsoon9@gmail.com	Rampal, Sanjay/B-9691-2010; Gan, Peter/ABE-7991-2020; Lim, Soo Kun/Q-2012-2019	Rampal, Sanjay/0000-0002-0105-6407; Lim, Soo Kun/0000-0001-7589-5150; Su, Tin Tin/0000-0003-0387-6406; Gan Kim Soon, Peter/0000-0002-6919-6182				Akabayashi A, 2018, TRANSPLANTATION P; Alvaro EM, 2008, PROG TRANSPLANT, V18, P243; [Anonymous], US RENAL DATA SYSTEM; Bavanandan S, 2015, TRANSPLANT DIRECT, V1, DOI 10.1097/TXD.0000000000000553; Becker S., 2012, UNDERSTANDING RES SO; Bjazevic J, 2015, UROL PRACT, P275, DOI [10.1016/j.urpr.2015.03.001, DOI 10.1016/J.URPR.2015.03.001]; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Bujang MA, 2016, FORECASTING INCIDENC; Butt FK, 2009, AM J TRANSPLANT, V9, P2180, DOI 10.1111/j.1600-6143.2009.02730.x; Calestani M, 2014, NEPHROL DIAL TRANSPL, V29, P2144, DOI 10.1093/ndt/gfu188; Chkhotua A, 2012, TRANSPLANTATION P; Creswell J. W., 2008, QUALITATIVE INQUIRY; Eriksson JK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012062; Formica RN, 2012, AM J KIDNEY DIS, V60, P288, DOI 10.1053/j.ajkd.2012.04.008; Gentry SE, 2009, AM J TRANSPLANT, V9, P1330, DOI 10.1111/j.1600-6143.2009.02622.x; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gordon EJ, 2012, CLIN TRANSPLANT, V26, P359, DOI 10.1111/j.1399-0012.2011.01536.x; Ha TTT, 2016, HLTH SCI J, V10, P1; Harding K, 2017, AM J NEPHROL, V46, P165, DOI 10.1159/000479480; Harrison TR, 2011, J HEALTH COMMUN, V16, P805, DOI 10.1080/10810730.2011.552001; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Irving MJ, 2012, NEPHROL DIAL TRANSPL, V27, P2526, DOI 10.1093/ndt/gfr683; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Johnson RJ, 2008, TRANSPLANTATION, V86, P1672, DOI 10.1097/TP.0b013e3181901a3d; Junchotikul P, 2015, TRANSPLANTATION P; Khazanah Research Institute, 2015, POP AG CAN WE LIV LO; Kumar K, 2018, TRANSPLANTATION, V102, pS561, DOI 10.1097/01.tp.0000543425.95491.33; Lee SW, 2011, NEPHROL DIAL TRANSPL, V26, P3975, DOI 10.1093/ndt/gfr154; Lim H, 2016, TRANSPLANTATION P; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lumsdaine JA, 2005, TRANSPLANT INT, V18, P975, DOI 10.1111/j.1432-2277.2005.00175.x; Malaysian Medical Council, 2006, ORGAN TRANSPLANTATIO; McSorley AMM, 2017, WORLD MED HEALTH POL, V9, P399, DOI 10.1002/wmh3.251; Mendelow AubreyL, 1981, ENV SCANNING IMPACT; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mills KT, 2015, KIDNEY INT, V88, P950, DOI 10.1038/ki.2015.230; Ministry of Health Malaysia, 2007, NAT ORG TISS CELL TR; Ministry of Health Malaysia, 2010, NEPHR SERV OP POL 20; Ministry of Health Malaysia, 2011, LIV ORG DON WHAT YOU; Ministry of Health Malaysia, 2011, UNR LIV ORG DON POL; Montgomery RA, 2006, LANCET, V368, P419, DOI 10.1016/S0140-6736(06)69115-0; Morad Z, 2015, AM J KIDNEY DIS, V65, P799, DOI 10.1053/j.ajkd.2014.09.031; Morgan SE, 2003, J APPL SOC PSYCHOL, V33, P693, DOI 10.1111/j.1559-1816.2003.tb01920.x; Morton RL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c112; Muda FSB, 2011, ORGAN SHORTAGE CRISI; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Rodrigue JR, 2014, TRANSPLANTATION, V98, P1025, DOI 10.1097/TP.0000000000000424; Rodrigue JR, 2012, CONTEMP CLIN TRIALS, V33, P811, DOI 10.1016/j.cct.2012.03.015; Rosenblum AM, 2012, TRANSPL INT, V25, P801, DOI 10.1111/j.1432-2277.2012.01472.x; Rubin A, 2010, PRACTICE SOCIAL RES, DOI [10.1001/jama.284.3.357, DOI 10.1001/JAMA.284.3.357]; Russell CL, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0285-8; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Schieppati A, 2005, KIDNEY INT, V68, pS7, DOI 10.1111/j.1523-1755.2005.09801.x; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Scully Tony, 2012, Nature, V485, pS2; Siebelink MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178128; Silva AN, 2016, NEPHROLOGY, V21, P938, DOI 10.1111/nep.12695; Soyama A, 2016, SURG TODAY, V46, P387, DOI 10.1007/s00595-015-1211-6; Stanifer JW, 2016, NEPHROL DIAL TRANSPL, V31, P868, DOI 10.1093/ndt/gfv466; Sultan H, 2013, PERFORMANCE MEASURES; Taber DJ, 2014, AM J NEPHROL, V40, P19, DOI 10.1159/000363393; The Ministry of Health Malaysia, 2011, ORG TRANSPL ISL PERS; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; Tong A, 2016, TRANSPLANTATION, V100, P710, DOI 10.1097/TP.0000000000001117; Tumin M, 2014, IRAN J PUBLIC HEALTH, V43, P926; Tumin M, 2014, CLIN TRANSPLANT, V28, P423, DOI 10.1111/ctr.12334; Tumin M, 2013, ANN TRANSPL, V18, P314, DOI 10.12659/AOT.883957; Tumin M, 2013, CLIN TRANSPLANT, V27, pE316, DOI 10.1111/ctr.12132; Wakefield CE, 2011, PROG TRANSPLANT, V21, P161, DOI 10.7182/prtr.21.2.2071rgn834573152; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Waterman AD, 2010, SEMINARS NEPHROLOGY; Wong H.S., 2018, 24 REPORT MALAYSIAN; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	74	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220411	10.1371/journal.pone.0220411	http://dx.doi.org/10.1371/journal.pone.0220411			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404075	Green Published, gold			2022-12-27	WOS:000485006800014
J	Ahsan, MN; Bockerman, P				Ahsan, Md Nazmul; Boeckerman, Petri			Alternative measures of body composition and wage premium: New evidence from Indonesia	PLOS ONE			English	Article							OBESITY; WEIGHT; HEIGHT; HEALTH; BMI; EARNINGS; MASS; MEN	This paper examines the relationship between body composition and earnings in a developing country setting. We use body mass index, waist circumference and hip circumference. Exploiting the panel structure of our longitudinal survey, we find that along with BMI, waist circumference is related to higher earnings in Indonesia.	[Ahsan, Md Nazmul] St Louis Univ, Dept Econ, St Louis, MO 63103 USA; [Boeckerman, Petri] Univ Jyvaskyla, Jyvaskyla, Finland; [Boeckerman, Petri] Labour Inst Econ Res, Helsinki, Finland; [Boeckerman, Petri] IZA Inst Labor Econ, Bonn, Germany	Saint Louis University; University of Jyvaskyla; IZA Institute Labor Economics	Ahsan, MN (corresponding author), St Louis Univ, Dept Econ, St Louis, MO 63103 USA.	nazmul.ahsan@slu.edu	Böckerman, Petri/M-4969-2013	Böckerman, Petri/0000-0002-5372-2985				Ahsan MN, 2018, SOUTH ECON J, V85, P121, DOI 10.1002/soej.12298; Atella V, 2008, ECON HUM BIOL, V6, P305, DOI 10.1016/j.ehb.2008.06.007; Bozoyan C, 2011, ECON HUM BIOL, V9, P356, DOI 10.1016/j.ehb.2011.07.001; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Cawley J, 2015, J HEALTH ECON, V43, P244, DOI 10.1016/j.jhealeco.2015.03.001; Dinda S, 2006, ECON HUM BIOL, V4, P342, DOI 10.1016/j.ehb.2005.10.003; Frankenfield DC, 2001, NUTRITION, V17, P26, DOI 10.1016/S0899-9007(00)00471-8; Huang W, 2013, AM ECON J-APPL ECON, V5, P86, DOI 10.1257/app.5.2.86; Johansson E, 2009, ECON HUM BIOL, V7, P36, DOI 10.1016/j.ehb.2009.01.008; Johar M, 2012, HEALTH ECON, V21, P597, DOI 10.1002/hec.1736; Kedir AM, 2013, ECON ISS, V18, P1; Lakdawalla D, 2009, ECON HUM BIOL, V7, P283, DOI 10.1016/j.ehb.2009.08.001; Machado JAF, 2019, J ECONOMETRICS, DOI [10.1016/J.JECONOM.2018.09.003, DOI 10.1016/J.JECONOM.2018.09.003]; Maluccio JA, 1998, 54 IFPRI FCND; Sabia JJ, 2012, ECON HUM BIOL, V10, P14, DOI 10.1016/j.ehb.2011.09.004; Schaner S, 2016, 2737842 SSRN; Strauss J, 1998, J ECON LIT, V36, P766; Strauss J, 5 WAVE INDONESIA FAM; Thomas D, 1997, J ECONOMETRICS, V77, P159, DOI 10.1016/S0304-4076(96)01811-8; Wada R, 2010, ECON HUM BIOL, V8, P242, DOI 10.1016/j.ehb.2010.02.001; Wooldridge J, 2017, 24003 NAT BUR EC RES	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0219438	10.1371/journal.pone.0219438	http://dx.doi.org/10.1371/journal.pone.0219438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398206	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000006
J	Kansiime, S; Mwesigire, D; Mugerwa, H				Kansiime, Sheila; Mwesigire, Doris; Mugerwa, Henry			Prevalence of non-communicable diseases among HIV positive patients on antiretroviral therapy at joint clinical research centre, Lubowa, Uganda	PLOS ONE			English	Article								Introduction Antiretroviral therapy (ART) has changed the course of HIV/AIDs by enabling patients to live longer, raising concern of the co-existence of HIV with other chronic illnesses, notably non-communicable diseases (NCDs). NCDs are on the rise in developing countries and evidence shows higher occurrence among people living with HIV (PLHIV). In Uganda, the burden of NCDs among PLHIV remains largely unquantified. Objective To determine the prevalence of hypertension, osteoporosis, diabetes mellitus, renal impairment, asthma, cardiomyopathy and multi-morbidity among HIV positive patients, receiving Anti-Retroviral Therapy at Joint Clinical Research Centre, Lubowa, Uganda. Methods This was a cross-sectional study conducted among 387 systematically sampled patients, receiving ART at the Joint Clinical Research Centre, Lubowa, between March and April 2017. The study used data extracted from routine care patient files to identify individuals with non-communicable diseases. Prevalence of the NCDs was estimated and reported with 95% confidence intervals. Prevalence was also reported at various levels of socio-demographic, behavioural and clinical factors. Results The overall prevalence of having at least one NCD was 20.7% (95% CI: 16.7-24.5). The prevalence of hypertension was 12.4% (95% CI: 9.1-15.7), osteoporosis 6.5% (95% CI: 4.0-8.9), diabetes mellitus 4.7% (95% CI: 2.6-6.8), renal impairment 1.6% (95% CI: 0.3-2.8), asthma 1.6% (95% CI: 0.3-2.8), and cardiomyopathy 1.3% (95% CI: 0.2-2.4). Prevalence of multi-morbidity was 4.7% (95% CI: 2.6-6.8). Prevalence was significantly higher among older participants, widowed participants and individuals with an opportunistic infection. Conclusion Non-communicable diseases are common among people living with HIV. There is need to encourage early diagnosis and treatment of non-communicable diseases in PLHIV in Uganda.	[Kansiime, Sheila; Mwesigire, Doris] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Kansiime, Sheila] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Mugerwa, Henry] Joint Clin Res Ctr, Luboowa, Uganda	Makerere University	Kansiime, S (corresponding author), Makerere Univ, Coll Hlth Sci, Kampala, Uganda.; Kansiime, S (corresponding author), MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda.	Kansiimesheila@yahoo.com		Kansiime, Sheila/0000-0003-3700-1501	NIMH NIH HHS [R25 MH064712, R25 MH123256] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alvarez E, 2016, CURR OPIN HIV AIDS, V11, P268, DOI 10.1097/COH.0000000000000269; Cailhol J, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-40; CDC, 2013, BACKGR BRIEF PREV BE; Dimala CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148100; Edwards J. K. B., 2015, T ROYAL SOC TROPICAL; Haregu T. N., 2012, EPIDEMIOLOGY COMORBI, V2; Hernandez-Romieu, 2016, IS DIABETES PREVALEN; Isa SE, 2016, CLIN INFECT DIS, V63, P830, DOI 10.1093/cid/ciw381; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; Kotwani P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1151; Kwarisiima D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156309; Magafu MGMD, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.84.2831; Magodoro Itai M, 2016, BMC Res Notes, V9, P379, DOI 10.1186/s13104-016-2187-z; Musoke D., 2006, UGANDAS HIV RESPONSE; Narayan K, 2014, HIV NONCOMMUNICABLE, DOI [10.1097/QAI.0000000000000267, DOI 10.1097/QAI.0000000000000267]; Onyia, 2014, PREVALENCE COMORBIDI; Struik GM, 2011, INT J STD AIDS, V22, P457, DOI 10.1258/ijsa.2011.010521; Uganda M. o. H., 2014, HIV AIDS UG COUNTR P; UNODC, 2016, HIV AIDS E AFR; Wandera B., 2014, LOW BONE MINERAL DEN; World_Health_Organization, 2018, 2018 NCVRW RES GUID	21	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221022	10.1371/journal.pone.0221022	http://dx.doi.org/10.1371/journal.pone.0221022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398244	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000042
J	Schopf, AC; Vach, W; Jakob, M; Saxer, F				Schoepf, Andrea C.; Vach, Werner; Jakob, Marcel; Saxer, Franziska			Routine patient surveys: Patients' preferences and information gained by healthcare providers	PLOS ONE			English	Article							WEB SURVEYS; SATISFACTION; QUESTIONNAIRE; EXPERIENCES; QUALITY; IMPACT	Background Patient feedback after contact with a hospital is regarded as an important source of information for the improvement of local healthcare services. Routine patient surveys are in widespread use to obtain such feedback. While general principles for the composition of this kind of surveys have been described in the literature, it is unknown which method of contact and topics of feedback are important to patients in postcontact healthcare surveys. Material and methods We invited 2931 consecutive patients who had in-or outpatient contact with the Department of Orthopaedics and Traumatology at the University Hospital Basel to an anonymous survey. They were asked whether they were generally in favor of feedback surveys. They also had the opportunity to state their preferred form of contact (text message, app, email, online or letter) and provide up to three topics that they regarded as specifically important in patient surveys. Results A total of 745 patients participated in the survey (25.4%), of these 61.9% expressed the preference to be surveyed, and 69.1% selected 'letter' as one of the preferred forms of contact. Favoring only 'letter' contact increased substantially with age. Overall 54.6% of patients stated at least one topic that they wished to give feedback on. The most frequent topics were related to treatment and rather general aspects regarding staff and overall impression. The wish to include suggestions for improvements was rarely mentioned as specific topic. Conclusions The majority of patients seem to be rather indifferent to the existence and content of patient surveys. They mention a wide range of topics from general to specific ones, but do not express interest in the opportunity to suggest changes. There is a need to effectively engage patients in healthcare planning using new approaches to obtain valuable feedback on patients' hospital stay and contact experiences. These new approaches should ideally be more informative and cost-effective than the current practice.	[Schoepf, Andrea C.] Univ Freiburg, Fac Med & Med Ctr, Sect Healthcare Res & Rehabil Res, Freiburg, Germany; [Vach, Werner; Jakob, Marcel; Saxer, Franziska] Univ Hosp Basel, Dept Orthopaed & Traumatol, Basel, Switzerland	University of Freiburg; University of Basel	Vach, W (corresponding author), Univ Hosp Basel, Dept Orthopaed & Traumatol, Basel, Switzerland.	werner.vach@usb.ch	Vach, Werner/F-2512-2011; Jakob, Marcel/AAI-6122-2021; Saxer, Franziska/AAE-7732-2021	Vach, Werner/0000-0003-1865-8399; Jakob, Marcel/0000-0002-9021-0890; Saxer, Franziska/0000-0003-4153-6795				Ahmed F, 2014, PATIENT, V7, P235, DOI 10.1007/s40271-014-0060-5; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2014, INITIATIVE 21 TNS IN; Barron DN, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-153; Beattie M, 2015, SYST REV, V4, DOI 10.1186/s13643-015-0089-0; Bjertnaes OA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-13; Bjertnaes OA, 2012, BMJ QUAL SAF, V21, P39, DOI 10.1136/bmjqs-2011-000137; Blumenberg C, 2018, INT J PUBLIC HEALTH, V63, P765, DOI 10.1007/s00038-018-1108-4; Dozier AM, 2001, RES NURS HEALTH, V24, P506, DOI 10.1002/nur.10007; Ekhtiari S, 2017, ARTHROSCOPY, V33, DOI 10.1016/j.arthro.2017.01.032; Elliott MN, 2010, HEALTH AFFAIR, V29, P2061, DOI 10.1377/hlthaff.2009.0876; Fan WM, 2010, COMPUT HUM BEHAV, V26, P132, DOI 10.1016/j.chb.2009.10.015; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; FRENCH K, 1981, INT J NURS STUD, V18, P7, DOI 10.1016/0020-7489(81)90004-3; Gasquet I, 2001, J CLIN EPIDEMIOL, V54, P1174, DOI 10.1016/S0895-4356(01)00387-0; Glickman SW, 2010, CIRC-CARDIOVASC QUAL, V3, P188, DOI 10.1161/CIRCOUTCOMES.109.900597; Halbesleben JRB, 2013, HEALTH SERV RES, V48, P913, DOI 10.1111/1475-6773.12002; Hess R, 2008, J GEN INTERN MED, V23, P476, DOI 10.1007/s11606-007-0500-1; Jenkinson C, 2002, QUAL SAF HEALTH CARE, V11, P335, DOI 10.1136/qhc.11.4.335; Jensen HI, 2010, SOC SCI MED, V70, P1882, DOI 10.1016/j.socscimed.2010.02.035; Larson Nicole, 2011, Int J Child Health Hum Dev, V4, P225; LaVela SL., 2014, PATIENT EXP J, V1, P28, DOI DOI 10.1177/237437431400100206; Manfreda KL, 2008, INT J MARKET RES, V50, P79, DOI 10.1177/147078530805000107; Mazor KM, 2002, HEALTH SERV RES, V37, P1403, DOI 10.1111/1475-6773.11194; Morrel-Samuels P, 2003, HARVARD BUS REV, V81, P16; Naidu A, 2009, INT J HEALTH CARE Q, V22, P366, DOI 10.1108/09526860910964834; Presser S, 2011, SOC SCI RES, V40, P1019, DOI 10.1016/j.ssresearch.2011.04.004; Sack C, 2011, INT J QUAL HEALTH C, V23, P278, DOI 10.1093/intqhc/mzr011; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Sitzia J, 1998, INT J QUAL HEALTH C, V10, P311, DOI 10.1093/intqhc/10.4.311; Stevens M, 2006, PATIENT EDUC COUNS, V60, P241, DOI 10.1016/j.pec.2005.01.011; Tyser AR, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1595-z; Van Eimeren B, 2011, MEDIA PERSPEKTIVEN, V7-8, P334; Wolfinger Martina, 2008, SOZIALE UNGLEICHHEIT, P132	34	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220495	10.1371/journal.pone.0220495	http://dx.doi.org/10.1371/journal.pone.0220495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369612	Green Submitted, Green Published, gold			2022-12-27	WOS:000484987900057
J	Jung, Y; Chun, H; Moon, JI				Jung, Younhea; Chun, Heejeong; Moon, Jung Il			Corneal deflection amplitude and visual field progression in primary open-angle glaucoma	PLOS ONE			English	Article							FIBER LAYER LOSS; BIOMECHANICAL PROPERTIES; PROSTAGLANDIN ANALOGS; INTRAOCULAR-PRESSURE; MATRIX METALLOPROTEINASES; HYSTERESIS; THICKNESS; EYES; DEFORMATION; LATANOPROST	Purpose To investigate the relationship between corneal deflection amplitude and visual field progression rate in patients with primary open-angle glaucoma (POAG). Methods This study included 113 eyes of 65 patients with POAG followed for an average of 4.81 +/- 1.24 years. Evaluation of visual field progression rate was performed using mean deviation of standard automated perimetry. Corneal deflection amplitude was measured using Corvis ST (Oculus Optikgerate GmbH, Wetzlar, Germany). Linear mixed models were performed to determine the relationship between corneal deflection amplitude, intraocular pressure (IOP), and visual field progression rate. Results Mean age was 56.36 +/- 14.58 years. Baseline average mean deviation was -8.20 +/- 9.12 dB and mean treated IOP was 14.38 +/- 3.08 mmHg. Average deflection amplitude was 0.90 +/- 0.13 mm. In both univariate and multivariate analysis, IOP (P = 0.028 and P < 0.001, respectively) and deflection amplitude (P = 0.034 and P < 0.001, respectively) significantly affected visual field progression rate. Eyes with high IOP and greater deflection amplitude showed faster progression rate. Conclusions Corneal deflection amplitude was significantly related with glaucoma progression. Eyes with greater corneal deflection amplitude showed faster visual field progression rate in patients with POAG.	[Jung, Younhea; Chun, Heejeong; Moon, Jung Il] Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea	Catholic University of Korea	Moon, JI (corresponding author), Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	jimoon@catholic.ac.kr			Institute of Clinical Medicine Research in the Yeouido St. Mary's hospital, Catholic University of Korea	Institute of Clinical Medicine Research in the Yeouido St. Mary's hospital, Catholic University of Korea	This research was supported by grant of the Institute of Clinical Medicine Research in the Yeouido St. Mary's hospital, Catholic University of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward WLM, 2001, OPHTHALMOLOGY, V108, P247; Aoki S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21424-8; Bolivar G, 2015, ACTA OPHTHALMOL, V93, pE495, DOI 10.1111/aos.12689; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; De Moraes CGV, 2012, J GLAUCOMA, V21, P209, DOI 10.1097/IJG.0b013e3182071b92; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P5656, DOI 10.1167/iovs.10-6927; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; Herber R, 2018, OPHTHALMOLOGE, V115, P635, DOI 10.1007/s00347-018-0716-y; Hirasawa K, 2018, AM J OPHTHALMOL, V195, P26, DOI 10.1016/j.ajo.2018.07.025; Honda N, 2010, ARCH OPHTHALMOL-CHIC, V128, P466, DOI 10.1001/archophthalmol.2010.40; Hong Y, 2016, INT J OPHTHALMOL-CHI, V9, P973, DOI 10.18240/ijo.2016.07.06; Huseynova T, 2014, AM J OPHTHALMOL, V157, P885, DOI 10.1016/j.ajo.2013.12.024; Jung Y, 2017, ACTA OPHTHALMOL, V95, pE556, DOI 10.1111/aos.13466; Jung Y, 2016, OPHTHALMOLOGY, V123, P959, DOI 10.1016/j.ophtha.2015.12.043; Kotecha A, 2006, INVEST OPHTH VIS SCI, V47, P5337, DOI 10.1167/iovs.06-0557; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Matsuura M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40798; Meda R, 2017, BRIT J OPHTHALMOL, V101, P120, DOI 10.1136/bjophthalmol-2016-308432; Medeiros FA, 2013, OPHTHALMOLOGY, V120, P1533, DOI 10.1016/j.ophtha.2013.01.032; Medeiros FA, 2009, OPHTHALMOLOGY, V116, P1125, DOI 10.1016/j.ophtha.2008.12.062; Oh DJ, 2006, INVEST OPHTH VIS SCI, V47, P3887, DOI 10.1167/iovs.06-0036; Roy AS, 2015, J MECH BEHAV BIOMED, V48, P173, DOI 10.1016/j.jmbbm.2015.04.010; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P1896, DOI 10.1167/iovs.10-5500; Steinhart MR, 2012, MOL VIS, V18, P1093; Tejwani S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097591; Tsikripis P, 2013, DRUG DES DEV THER, V7, P1149, DOI 10.2147/DDDT.S50622; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Vellara HR, 2015, INVEST OPHTH VIS SCI, V56, P6941, DOI 10.1167/iovs.15-17396; Vinciguerra R, 2016, J REFRACT SURG, V32, P803, DOI 10.3928/1081597X-20160629-01; Wu N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155527; Zhang CW, 2016, AM J OPHTHALMOL, V166, P29, DOI 10.1016/j.ajo.2016.02.034	32	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220655	10.1371/journal.pone.0220655	http://dx.doi.org/10.1371/journal.pone.0220655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404083	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800023
J	Santos, FJDA; da Silva, LS; Santo, JD; de Mesquita, TGR; de Souza, MLG; de Andrade, MC; Talhari, S; Ramasawmy, R				de Araujo Santos, Felipe Jules; da Silva, Lener Santos; Santo Junior, Jose do Espirito; Ramos de Mesquita, Tirza Gabrielle; Gomes de Souza, Mara Lucia; de Andrade Junior, Moacir Couto; Talhari, Sinesio; Ramasawmy, Rajendranath			Single nucleotide polymorphisms of the genes IL-2, IL-2RB, and JAK3 in patients with cutaneous leishmaniasis caused by Leishmania (V.) guyanensis in Manaus, Amazonas, Brazil	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; REGULATORY T-CELLS; MUCOSAL LEISHMANIASIS; SUSCEPTIBILITY; INTERLEUKIN-2; IDENTIFICATION; INHIBITION; ACTIVATION; MECHANISMS; CYTOKINES	Leishmaniasis is a disease caused by intracellular protozoan parasites of the genus Leishmania. In endemic areas, only a portion of exposed subjects develops cutaneous leishmaniasis (CL), suggesting that the genetic inheritance of the host plays a vital role in both resistance and susceptibility to the disease. Interleukin-2 (IL-2) is a cytokine that plays a central role in the regulation of the immune response in infection through the axis IL-2/IL-2R (receptor) complex, triggering a series of intracellular events, among which the signaling of Janus kinase/signal transducers and activators of transcription (JAK-STAT). The present study aimed at verifying the possible relationship between single nucleotide polymorphism (s) (SNP s) in the genes IL-2, IL-2RB, and JAK3 in subjects with CL caused by Leishmania guyanensis in the city of Manaus, state of Amazonas, Brazil. 820 patients with CL and 850 healthy subjects (control group) coming from the same endemic areas as the patients were examined. The SNPs-2425G/A (rs4833248) and-330 T/G (rs2069762), located in the IL-2 gene promoter region, seem to influence the expression of the gene and the SNP +10558G/A (rs1003694) and + 13295T/C (rs3212760) located in the 3rd intron of the IL-2RB gene and the 13th intron of the JAK3 gene, respectively, were studied by PCR-RFLP. Genotypes and alleles frequencies were obtained by direct counting. For the comparison between the two groups, the.2 test with OR (odds ratio) and the 95% confidence interval (CI) were used. Similar genotypes and alleles frequencies for the different SNPs were observed in both patients with CL and healthy controls. Comparison of genotypic and allelic frequency between patients with CL and healthy subjects did not show any difference. These polymorphisms do not predict susceptibility to, or protection against the development of CL caused by L. guyanensis in the Amazonas.	[de Araujo Santos, Felipe Jules; da Silva, Lener Santos; Ramos de Mesquita, Tirza Gabrielle; Talhari, Sinesio; Ramasawmy, Rajendranath] Univ Estado Amazonas, Programa Postgrad Med Trop, Manaus, Amazonas, Brazil; [de Araujo Santos, Felipe Jules; da Silva, Lener Santos; Ramos de Mesquita, Tirza Gabrielle; Gomes de Souza, Mara Lucia; Talhari, Sinesio; Ramasawmy, Rajendranath] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Santo Junior, Jose do Espirito; Ramasawmy, Rajendranath] Univ Fed Amazonas, Programa Postgrad Imunol Basica, Manaus, Amazonas, Brazil; [de Andrade Junior, Moacir Couto] Nilton Lins Univ, Postgrad Dept, Manaus, Amazonas, Brazil; [de Andrade Junior, Moacir Couto] INPA, Dept Food Technol, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath] Nilton Lins Univ, Fac Med, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade Federal de Amazonas; Centro Universitario Nilton Lins; Institute Nacional de Pesquisas da Amazonia; Centro Universitario Nilton Lins	Ramasawmy, R (corresponding author), Univ Estado Amazonas, Programa Postgrad Med Trop, Manaus, Amazonas, Brazil.; Ramasawmy, R (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.; Ramasawmy, R (corresponding author), Univ Fed Amazonas, Programa Postgrad Imunol Basica, Manaus, Amazonas, Brazil.; Ramasawmy, R (corresponding author), Nilton Lins Univ, Fac Med, Manaus, Amazonas, Brazil.	ramasawm@gmail.com		Ramasawmy, Rajendranath/0000-0002-0538-0773; do Espirito Santo Junior, Jose/0000-0002-7922-6090	Brazilian Council for Scientific and Technological Development (CNPq) [404181/2012-0]; Fundacao de Amparo a Pesquisa do Estado do Amazonas [062.01954/2015]	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas	This work was supported by the Brazilian Council for Scientific and Technological Development (CNPq) to RR (grant number: 404181/2012-0) and the Fundacao de Amparo a Pesquisa do Estado do Amazonas to RR (grant number: 062.01954/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKUFFO H, 1990, J INFECT DIS, V161, P775, DOI 10.1093/infdis/161.4.775; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amirzargar AA, 2008, EUR CYTOKINE NETW, V19, P104, DOI 10.1684/ecn.2008.0122; Antony PA, 2006, J IMMUNOL, V176, P5255, DOI 10.4049/jimmunol.176.9.5255; Arenas-Ramirez N, 2015, TRENDS IMMUNOL, V36, P763, DOI 10.1016/j.it.2015.10.003; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Benicio E, 2015, AM J TROP MED HYG, V93, P1208, DOI 10.4269/ajtmh.14-0164; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; Bodas M, 2006, J IMMUNOL, V177, P4636, DOI 10.4049/jimmunol.177.7.4636; Bucheton B, 2007, GENES IMMUN, V8, P79, DOI 10.1038/sj.gene.6364355; Bucheton B, 2003, AM J HUM GENET, V73, P1052, DOI 10.1086/379084; Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2; Carvalho LP, 2007, PARASITE IMMUNOL, V29, P251, DOI 10.1111/j.1365-3024.2007.00940.x; Castellucci L, 2006, J INFECT DIS, V194, P519, DOI 10.1086/505504; Castellucci LC, 2014, MEM I OSWALDO CRUZ, V109, P279, DOI 10.1590/0074-0276140028; Chauhan SB, 2019, J INFECT DIS, V220, P163, DOI 10.1093/infdis/jiz074; Dutra WO, 2011, DRUG DEVELOP RES, V72, P430, DOI 10.1002/ddr.20449; Fernandez-Figueroa EA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004570; Garcia L, 2004, J CLIN MICROBIOL, V42, P2294, DOI 10.1128/JCM.42.5.2294-2297.2004; Gollob KJ, 2014, PARASITE IMMUNOL, V36, P367, DOI 10.1111/pim.12100; Gumy A, 2006, EUR J IMMUNOL, V36, P1465, DOI 10.1002/eji.200535801; Hoffmann SC, 2001, TRANSPLANTATION, V72, P1444, DOI 10.1097/00007890-200110270-00019; Ibarra-Meneses AV, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.021; Ibarra-Meneses AV, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00200; internationalgenome. org, 2019, 1000 GEN PROJ; Kamali-Sarvestani E, 2006, CYTOKINE, V35, P159, DOI 10.1016/j.cyto.2006.07.016; Kar S, 2009, EUR J IMMUNOL, V39, P741, DOI 10.1002/eji.200838465; Kariminia A, 2005, INFECT IMMUN, V73, P5908, DOI 10.1128/IAI.73.9.5908-5914.2005; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Machado T., 2008, THESIS; Marfurt J, 2003, J CLIN MICROBIOL, V41, P3147, DOI 10.1128/JCM.41.7.3147-3153.2003; MURRAY HW, 1992, J IMMUNOL, V148, P1858; MURRAY HW, 1993, J IMMUNOL, V151, P929; NANDAN D, 1995, INFECT IMMUN, V63, P4495, DOI 10.1128/IAI.63.11.4495-4500.1995; Oliveira PRS, 2015, J IMMUNOL, V194, P2664, DOI 10.4049/jimmunol.1402047; Oliveira WN, 2014, CYTOKINE, V66, P127, DOI 10.1016/j.cyto.2013.12.016; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; Ross SH, 2018, ANNU REV IMMUNOL, V36, P411, DOI 10.1146/annurev-immunol-042617-053352; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Sambrook J, 1989, MOL CLONING LABORATO, V9, P16; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Torres-Guerrero Edoardo, 2017, F1000Res, V6, P750, DOI 10.12688/f1000research.11120.1	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220572	10.1371/journal.pone.0220572	http://dx.doi.org/10.1371/journal.pone.0220572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393896	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500042
J	Kermanizadeh, A; Brown, DM; Stone, V				Kermanizadeh, Ali; Brown, David M.; Stone, Vicki			The variances in cytokine production profiles from non- or activated THP-1, Kupffer cell and human blood derived primary macrophages following exposure to either alcohol or a panel of engineered nanomaterials	PLOS ONE			English	Article							IN-VITRO; NANOPARTICLES; INFLAMMATION; LIVER	The portfolio of cytokines is key to the function of macrophages as sentries of the innate immune system as well as being critical for the transition from innate to adaptive immunity. Cytokine bias is critical in the fate of macrophages into a continuum of inflammatory to anti-inflammatory macrophages. Due to advances in the field of toxicology, increasingly advanced multi-cellular in vitro safety assessment models are being developed in order to allow for a better predication of potential adverse effects in humans with many of these models include a macrophage population. The selection of the correct macrophage cells in these advanced in vitro models is critical for a physiologically relevant and realistic immune response. In this study we investigated cytokine response profile (IL1-beta, IL6, IL10 and TNF-alpha) of activated and non-activated THP-1 (immortalized monocyte-like cell line), primary human Kupffer cells (liver resident macrophages) and human primary peripheral blood mononuclear cells following exposure of a panel of nanomaterials or ethanol. The data demonstrated that the THP-1 cell line are not great cytokine producers. The PBMC appear to be a good in vitro surrogate for circulating/pro-inflammatory macrophages but are not a suitable replacement for Kupffer cells. The findings from this study highlight the necessity for the selection of appropriate macrophages populations to meet the specific physiological requirements of in vitro experiment.	[Kermanizadeh, Ali; Brown, David M.; Stone, Vicki] Heriot Watt Univ, Sch Engn & Phys Sci, Nano Safety Res Grp, Edinburgh, Midlothian, Scotland	Heriot Watt University	Kermanizadeh, A (corresponding author), Heriot Watt Univ, Sch Engn & Phys Sci, Nano Safety Res Grp, Edinburgh, Midlothian, Scotland.	Ali.Kermanizadeh@hw.ac.uk	Kermanizadeh, Ali/AAD-6281-2019	Kermanizadeh, Ali/0000-0002-2989-9078	H2020 [760813]	H2020	This work has been financially supported by H2020 funded project PATROLS [Grant code 760813]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2018, J IMMUNOL, V200, P3599, DOI 10.4049/jimmunol.1701552; Al-Rashed Fatema, 2019, Cell Physiol Biochem, V52, P397, DOI 10.33594/000000028; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Brock M, 2011, J BIOL CHEM, V286, P40142, DOI 10.1074/jbc.M111.251793; Brown DM, 2010, J BIOMED NANOTECHNOL, V6, P224, DOI 10.1166/jbn.2010.1117; Cao ZW, 2016, INT J NANOMED, V11, P3331, DOI 10.2147/IJN.S106912; Cruz T, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1105-z; Dabrowski MP, 2001, MEDIAT INFLAMM, V10, P101; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Franken L, 2016, CELL MICROBIOL, V18, P475, DOI 10.1111/cmi.12580; Gonnord P, 2018, SCI SIGNAL, V11, P544; Gosens I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126934; Hamilton RF, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-57; Jacobsen NR, 2015, FOOD CHEM TOXICOL, V85, P84, DOI 10.1016/j.fct.2015.08.008; Jessop F, 2015, NANOTOXICOLOGY, V9, P365, DOI 10.3109/17435390.2014.933904; Kermanizadeh A, 2019, NATURE SCI REPORTS, DOI [10.1038/s41598-019-39903-x, DOI 10.1038/S41598-019-39903-X]; Kermanizadeh A, 2017, TOXICOL SCI, V158, P176, DOI 10.1093/toxsci/kfx080; Kermanizadeh A, 2017, BASIC CLIN PHARMACOL, V120, P380, DOI 10.1111/bcpt.12692; Kermanizadeh A, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0056-2; Kermanizadeh A, 2014, NANOTOXICOLOGY, V8, P149, DOI 10.3109/17435390.2013.866284; Kermanizadeh A, 2013, NANOTOXICOLOGY, V7, P301, DOI 10.3109/17435390.2011.653416; Kochumon S, 2018, CELL PHYSIOL BIOCHEM, V46, P953, DOI 10.1159/000488824; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; MacParland SA, 2017, ACS NANO, V11, P2428, DOI 10.1021/acsnano.6b06245; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Petkov DI, 2019, J LEUKOCYTE BIOL, V106, P1241, DOI 10.1002/JLB.1A0119-017R; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Septiadi D, 2018, ADV MATER, V30, DOI 10.1002/adma.201806181; Sumner DR, 2014, CLIN ORTHOP RELAT R, V472, P3728, DOI 10.1007/s11999-014-3580-3; Tachibana S, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-6; Vranic S, 2017, ARCH TOXICOL, V91, P353, DOI 10.1007/s00204-016-1673-3; Wong CP, 2015, MOL NUTR FOOD RES, V59, P991, DOI 10.1002/mnfr.201400761	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220974	10.1371/journal.pone.0220974	http://dx.doi.org/10.1371/journal.pone.0220974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393970	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500087
J	Martin-Torrijos, L; Kokko, H; Makkonen, J; Jussila, J; Dieguez-Uribeondo, J				Martin-Torrijos, Laura; Kokko, Harri; Makkonen, Jenny; Jussila, Japo; Dieguez-Uribeondo, Javier			Mapping 15 years of crayfish plague in the Iberian Peninsula: The impact of two invasive species on the endangered native crayfish	PLOS ONE			English	Article							PATHOGEN APHANOMYCES-ASTACI; PACIFASTACUS-LENIUSCULUS; FUNGUS; POPULATIONS; DISEASE	Crayfish plague, caused by the pathogen Aphanomyces astaci, is one of the main factors responsible for the decimation of the native European crayfish species Austropotamobius pallipes. In Spain, two North American freshwater crayfish species, Procambarus clarkii and Pacifastacus leniusculus, were intentionally introduced during the 1970s for aquaculture and fishery purposes. Since then, incidences of crayfish plague have been continually reported. In this work, we evaluated more than 50 diagnosed cases of crayfish plague that have occurred in the Iberian Peninsula since 2004 by performing a microscopic examination of infected specimens and by molecularly identifying and haplotyping the pathogen. Our results showed that (i) the pathogen A. astaci has been active 45 years since the first introductions of the invasive North American crayfish species in the Iberian Peninsula, and (ii) P. clarkii and P. leniusculus are chronic reservoirs of the crayfish plague pathogen. Moreover, our data confirmed a correspondence between pathogen origin and spread and the specific haplotypes carried by the North American invasive crayfish located in the vicinity of each outbreak. We generated a crayfish plague incidence map of the Iberian Peninsula that shows (i) a northern area, mainly inhabited by alien P. leniusculus, where crayfish plague cases are associated with the b-haplotype specific to P. leniusculus, and (ii) southern, central and eastern areas that are basically inhabited by alien P. clarkii, where crayfish plague cases are associated with the d1- and d2-haplotypes specific to P. clarkii. The results presented here are evidence of the long standing and negative impact of the two invasive crayfish species on the native species, indicating the need for more extensive control measures.	[Martin-Torrijos, Laura; Dieguez-Uribeondo, Javier] CSIC, RJB, Dept Mycol, Madrid, Spain; [Kokko, Harri; Makkonen, Jenny; Jussila, Japo] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Eastern Finland	Dieguez-Uribeondo, J (corresponding author), CSIC, RJB, Dept Mycol, Madrid, Spain.	dieguez@rjb.csic.es	MARTIN-TORRIJOS, LAURA/AAH-8654-2019; dieguez-uribeondo, javier/I-2178-2015; Diéguez-Uribeondo, Javier/ABF-1130-2021	MARTIN-TORRIJOS, LAURA/0000-0002-2850-2737; dieguez-uribeondo, javier/0000-0002-4488-0658; Diéguez-Uribeondo, Javier/0000-0002-4488-0658	Spanish Ministry of Economy and Competitiveness [CGL2016-80526-R]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CGL2016-80526-R) to JDU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partially supported by a grant from the Spanish Ministry of Economy and Competitiveness (CGL2016-80526-R). We also like to thank the assistance in providing us with crayfish plague samples and information to Jokin Larumbe (Gobierno de Navarra); Fernando Alonso and Javier Valenciano (Junta de Comunidades de Castilla-La Mancha), Sara Lapesa (Gobierno de Aragon), Joan Motserrat (Parque Natural La Garrotxa, Catalunya), Lluis Benejam (CEBCAT-La Balca S. L.) Antonio Pradillo (CCEDCV-EL PALMAR, Generatlitat Valenciana), Juan Maria Herrero (Juanta de Castilla y Leon), Jon Zulaika (Diputacion de Gipuzkoa, Pais Vasco), Borja Nebot (Junta de Andalucia) and Javier Galindo (Agencia Medio Ambiente y Agua Andalucia). We also thank Jeffry Lintsen, from the University of Eastern Finland, Nina Keller from the University of Koblenz-Landau and Emilio Cano and Marta Higuera from the RJB-CSIC for their technical assistance.	Alderman DJ, 1997, SCI TECHNICAL REV, V15, P15; Alonso F, 2000, B FR PECHE PISCIC, P31, DOI 10.1051/kmae:2000003; Alonso F., 2012, BASES ECOLOGICAS PRE; [Anonymous], 2014, PREVENTION MANAGEMEN; [Anonymous], 2013, ENV NEW EU ACTION PR; Aydin H, 2014, KNOWL MANAG AQUAT EC, p03P1, DOI 10.1051/kmae/2014004; Cerenius L., 1988, P131; Clement M., 2002, P 16 INT PARALLEL DI, P7; Cornalia E., 1960, ATTI SOC ITAL SCI NA, V2, P334; Crowl TA, 2008, FRONT ECOL ENVIRON, V6, P238, DOI 10.1890/070151; Dieguez-Uribeondo J, 2006, B FR PECHE PISCIC, P1303, DOI 10.1051/kmae:2006036; Dieguez-Uribeondo J, 1997, B FR PECHE PISCIC, P753, DOI 10.1051/kmae/1997051; DIEGUEZURIBEONDO J, 1995, MYCOL RES, V99, P574, DOI 10.1016/S0953-7562(09)80716-8; Edsman L, 2015, DIS AQUAT ORGAN, V112, P219, DOI 10.3354/dao02811; Grandjean F, 2014, VET MICROBIOL, V170, P317, DOI 10.1016/j.vetmic.2014.02.020; Gutierrez-Yurrita PJ, 1999, CRUSTACEAN ISS, V11, P161; Habsburgo Lorena A.S., 1986, Freshwater Crayfish, V6, P131; Habsburgo Lorena A. S., 1979, Freshwater crayfish 4, P175; HUANG TS, 1994, AQUACULTURE, V126, P1, DOI 10.1016/0044-8486(94)90243-7; Jussila Japo, 2016, Freshwater Crayfish, V22, P53; Jussila Japo, 2014, Freshwater Crayfish, V20, P73; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kozubikova E, 2011, J INVERTEBR PATHOL, V108, P214, DOI 10.1016/j.jip.2011.08.002; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lowe S., 100 WORLDS WORST INV; Maguire I, 2016, DIS AQUAT ORGAN, V118, P45, DOI 10.3354/dao02955; Makkonen J, 2018, PARASITOLOGY, V145, P1210, DOI 10.1017/S0031182018000227; Makkonen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36089; Martin-Torrijos L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195353; Moorhouse TP, 2015, WIRES WATER, V2, P1, DOI 10.1002/wat2.1059; Oidtmann B, 2004, VET MICROBIOL, V100, P269, DOI 10.1016/j.vetmic.2004.01.019; Oidtmann B, 2006, DIS AQUAT ORGAN, V72, P53, DOI 10.3354/dao072053; Peiro DF, 2016, HYDROBIOLOGIA, V781, P181, DOI 10.1007/s10750-016-2841-4; Rezinciuc S, 2014, FUNGAL BIOL-UK, V118, P612, DOI 10.1016/j.funbio.2013.10.007; Ricciardi A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P211; Richman NI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0060; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sandstrom A, 2014, BIOL INVASIONS, V16, P1961, DOI 10.1007/s10530-014-0641-1; SILVESTRO D., 2011, ORG DIVERS EVOL, V12, P335, DOI DOI 10.1007/S13127-011-0056-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Unestam T., 1969, RESISTANCE CRAYFISH	41	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219223	10.1371/journal.pone.0219223	http://dx.doi.org/10.1371/journal.pone.0219223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393870	gold, Green Submitted, Green Published			2022-12-27	WOS:000485002500007
J	Nien, CW; Lee, CY; Wu, PH; Chen, HC; Chi, JCY; Sun, CC; Huang, JY; Lin, HY; Yang, SF				Nien, Chan-Wei; Lee, Chia-Yi; Wu, Pei-Hsuan; Chen, Hung-Chi; Chi, Jessie Chao-Yun; Sun, Chi-Chin; Huang, Jing-Yang; Lin, Hung-Yu; Yang, Shun-Fa			The development of optic neuropathy after chronic rhinosinusitis: A population-based cohort study	PLOS ONE			English	Article							ENDOSCOPIC SINUS SURGERY; ASSOCIATION; DIAGNOSIS; NEURITIS; AGE	Background To evaluate the risk of developing optic neuropathy (ON) in patient with both non-surgery and surgery-indicated chronic rhinosinusitis (CRS) via the national health insurance research database in Taiwan. Methodology/Principal findings 44,176 Patients with a diagnostic code of CRS was selected, which included 6,678 received functional endoscopic sinus surgery (FESS) regarded as the surgery-indicated CRS. Each individual in the study group was matched to two non-CRS patients by age and gender. The outcome was set as the occurrence of ON according to the diagnostic codes occurred after the index date. Poisson regression was used to calculate the adjusted relative risk (aRR) and conditional Cox proportional model was used to estimate the adjusted hazard ratio (aHR). There were 131 and 144 events of ON occurred in the study group and the control group respectively during the follow-up period. The whole study group, whether received FESS or not, demonstrated both significant aRR and aHR compared to the control group after adjusting demographic data, prominent ocular diseases, and systemic co-morbidities. In addition, both the aRR and aHR were higher in CRS patient received FESS than those with CRS but without FESS management. Conclusion The existence of CRS, especially the surgery-indicated CRS is a significant risk factor for the following ON using multivariable analysis.	[Nien, Chan-Wei; Chi, Jessie Chao-Yun; Lin, Hung-Yu; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Nien, Chan-Wei; Lee, Chia-Yi; Lin, Hung-Yu] Show Chwan Mem Hosp, Dept Ophthalmol, Changhua, Taiwan; [Lee, Chia-Yi] Chung Hwa Univ Med Technol, Coll Med & Life Sci, Dept Optometry, Tainan, Taiwan; [Wu, Pei-Hsuan] Triserv Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Chen, Hung-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Linkou, Taiwan; [Chen, Hung-Chi] Chang Gung Univ, Dept Med, Coll Med, Taoyuan, Taiwan; [Chen, Hung-Chi] Chang Gung Mem Hosp, Ctr Tissue Engn, Linkou, Taiwan; [Chi, Jessie Chao-Yun] Taichung Hosp, Dept Otorhinolaryngol Head & Neck Surg, Minist Hlth & Welf, Taichung, Taiwan; [Sun, Chi-Chin] Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan; [Sun, Chi-Chin] Chang Gung Univ, Dept Chinese Med, Taoyuan, Taiwan; [Huang, Jing-Yang; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Lin, Hung-Yu] Chung Shan Med Univ, Dept Optometry, Taichung, Taiwan; [Lin, Hung-Yu] Chung Chou Univ Sci & Technol, Dept Exercise & Hlth Promot, Changhua, Taiwan	Chung Shan Medical University; Show Chwan Memorial Hospital; Chung Hua University; Tri-Service General Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Yang, SF (corresponding author), Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Chen, Hung-Chi/0000-0002-1117-7878	Chung Shan Medical University Hospital [CSH-2018-E-001-Y2]	Chung Shan Medical University Hospital	This study was supported by a grant (CSH-2018-E-001-Y2) from Chung Shan Medical University Hospital to SY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo-Lima WT, 2007, AM J RHINOL, V21, P719, DOI 10.2500/ajr.2007.21.3102; Barac A, 2015, EUR ARCH OTO-RHINO-L, V272, P3727, DOI 10.1007/s00405-015-3511-2; Biousse V, 2016, LANCET NEUROL, V15, P1355, DOI 10.1016/S1474-4422(16)30237-X; Brooks SG, 2018, INT FORUM ALLERGY RH, V8, P668, DOI 10.1002/alr.22109; Cazzavillan A, 2010, Int J Immunopathol Pharmacol, V23, P74; Chang YS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184477; Cheng HC, 2015, OPHTHALMOLOGY, V122, P2553, DOI 10.1016/j.ophtha.2015.08.022; Constantin Farah, 2017, Rom J Ophthalmol, V61, P133; Costello Fiona, 2014, Continuum (Minneap Minn), V20, P816, DOI 10.1212/01.CON.0000453316.60013.52; Del Noce C, 2017, CASE REP OPHTHALM, V8, P421, DOI 10.1159/000476057; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Gulati SP, 2008, INDIAN J OTOLARYNGOL, V60, P152, DOI 10.1007/s12070-008-0037-6; Gurrola J, 2017, J ALLERGY CLIN IMMUN, V140, P1499, DOI 10.1016/j.jaci.2017.10.006; Jin YP, 1998, J NEUROL SCI, V159, P107, DOI 10.1016/S0022-510X(98)00141-5; Koh YN, 2017, INT MED CASE REP J, V10, P263, DOI 10.2147/IMCRJ.S124524; Kuo CL, 2017, JAMA OTOLARYNGOL, V143, P757, DOI 10.1001/jamaoto.2017.0130; Neo WL, 2018, AM J OTOLARYNG, V39, P791, DOI 10.1016/j.amjoto.2018.08.008; Olcott CM, 2016, INT FORUM ALLERGY RH, V6, P841, DOI 10.1002/alr.21745; Park DY, 2016, J CRANIOFAC SURG, V27, pE248, DOI 10.1097/SCS.0000000000002440; Petzold A, 2014, AUTOIMMUN REV, V13, P539, DOI 10.1016/j.autrev.2014.01.009; Pfeiffer Margaret L, 2018, Am J Ophthalmol Case Rep, V10, P84, DOI 10.1016/j.ajoc.2018.01.041; Poletti SC, 2017, RHINOLOGY, V55, P70, DOI [10.4193/Rhino16.194, 10.4193/Rhin16.194]; Ramakrishnan VR, 2017, AM J RHINOL ALLERGY, V31, P283, DOI 10.2500/ajra.2017.31.4457; Ramakrishnan VR, 2011, CURR ALLERGY ASTHM R, V11, P220, DOI 10.1007/s11882-011-0182-y; Ramm L, 2017, CURR EYE RES, V42, P1313, DOI 10.1080/02713683.2017.1307415; Renner M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00254; Saliba J, 2016, LARYNGOSCOPE, V126, pE174, DOI 10.1002/lary.25952; Sedaghat AR, 2017, AM FAM PHYSICIAN, V96, P500; Shin IH, 2018, RETINA-J RET VIT DIS, V38, P253, DOI 10.1097/IAE.0000000000001535; Siedek V, 2009, INT J PEDIATR OTORHI, V73, P741, DOI 10.1016/j.ijporl.2009.01.019; Soelberg K, 2017, MULT SCLER J, V23, P1893, DOI 10.1177/1352458517734070; Stunkel L, 2018, ASIA-PAC J OPHTHALMO, V7, P218, DOI 10.22608/APO.2018127; Tan BK, 2009, OTOLARYNG CLIN N AM, V42, P227, DOI 10.1016/j.otc.2009.01.012; Tong J, 2015, NEURO-OPHTHALMOLOGY, V39, P236, DOI 10.3109/01658107.2015.1056380; Welch KC, 2009, LARYNGOSCOPE, V119, P2258, DOI 10.1002/lary.20618; Wong W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196007; Woung LC, 2007, NEUROEPIDEMIOLOGY, V29, P250, DOI 10.1159/000112858; Xiong Mengfei, 2018, Eur J Case Rep Intern Med, V5, P000905, DOI 10.12890/2018_000905	38	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220286	10.1371/journal.pone.0220286	http://dx.doi.org/10.1371/journal.pone.0220286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390351	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400014
J	Liu, CL; Sun, QW; Xing, QG; Wang, SF; Tang, DL; Zhu, DH; Xing, X				Liu, Chunli; Sun, Qiwei; Xing, Qianguo; Wang, Sufen; Tang, Danling; Zhu, Donghe; Xing, Xiang			Variability in phytoplankton biomass and effects of sea surface temperature based on satellite data from the Yellow Sea, China	PLOS ONE			English	Article							CHLOROPHYLL-A; SPATIOTEMPORAL VARIABILITY; INTERANNUAL VARIABILITY; SEASONAL VARIABILITY; OCEAN COLOR; LONG-TERM; CLIMATE; PACIFIC; RECONSTRUCTION; TRENDS	A time series of satellite data on Chlorophyll-a concentration (Chl-a) that used ocean color was studied to determine mechanisms of phytoplankton variation in recent decade in the Yellow Sea, China during 2003-2015. The variability patterns on seasonal and inter-annual oscillation periods were confirmed using the Empirical Orthogonal Function (EOF), and Morlet wavelet transform analyses, respectively. The first EOF mode for Chl-a was dominated by obvious spring and fall blooms in a spatial pattern that was related to the strong mixing of the water masses from the Yellow Sea Cold Warm Mass (YSCWM) and the Yellow Sea Warm Current (YSWC) in winter. The second EOF mode for Chl-a showed an opposite spatial pattern between the northern and southern regions. The temporal coefficient showed differences in the timing of blooms. On an inter-annual scale, Chl-a indicated variation at periods of 2-4 years during 2003-2015. Chl-a showed a significantly negative correlation with the sea surface temperature (r = -0.21, p<0.01), with time lags of 4 months (Chl-a ahead). Chl-a was coupled with El Nino Southern Oscillation (ENSO) events, with a positive correlation (r = 0.46, p<0.01) at a lag of 3-5 months (ENSO ahead). The present study demonstrated that the variation in phytoplankton biomass was controlled primarily by water mass seasonally, and it was influenced by ENSO events on an inter-annual scale.	[Liu, Chunli; Xing, Xiang] Shandong Univ Weihai, Marine Coll, Weihai, Peoples R China; [Sun, Qiwei] Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China; [Sun, Qiwei] Univ Chinese Acad Sci, Coll Earth & Planetary Sci, Beijing, Peoples R China; [Xing, Qianguo] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China; [Wang, Sufen; Tang, Danling] Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangdong Key Lab Remote Sensing, Guangzhou, Guangdong, Peoples R China; [Zhu, Donghe] Zhejiang Univ, Ocean Coll, Zhoushan, Peoples R China	Shandong University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Zhejiang University	Liu, CL; Xing, X (corresponding author), Shandong Univ Weihai, Marine Coll, Weihai, Peoples R China.	chunliliu@sdu.edu.cn; xingxiang@sdu.edu.cn	Xing, Qianguo/AAR-7174-2021	Sun, Qiwei/0000-0002-7128-224X	National Natural Science Foundation of China-Shandong joint fund [U1806203]; National Science Foundation of China [41206166]; Fundamental Research Funds for the Central Universities [2019ZRJC005]; Postdoctoral Science Foundation of China [2017M622180]; Fundamental of Guangdong Key Laboratory of Ocean Remote Sensing (South China Sea Institute of Oceanology Chinese Academy of Sciences) [2017B030301005-LORS1803]	National Natural Science Foundation of China-Shandong joint fund; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Fundamental of Guangdong Key Laboratory of Ocean Remote Sensing (South China Sea Institute of Oceanology Chinese Academy of Sciences)	This study was supported by the National Natural Science Foundation of China-Shandong joint fund (U1806203), the National Science Foundation of China (41206166), the Fundamental Research Funds for the Central Universities (2019ZRJC005), the Postdoctoral Science Foundation of China (2017M622180), the Fundamental of Guangdong Key Laboratory of Ocean Remote Sensing (South China Sea Institute of Oceanology Chinese Academy of Sciences) (2017B030301005-LORS1803).	Alvera-Azcarate A, 2015, ESTUAR COAST SHELF S, V159, P28, DOI 10.1016/j.ecss.2015.03.026; Beckers JM, 2006, OCEAN SCI, V2, P183, DOI 10.5194/os-2-183-2006; Beckers JM, 2003, J ATMOS OCEAN TECH, V20, P1839, DOI 10.1175/1520-0426(2003)020<1839:ECADFF>2.0.CO;2; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Chu P, 2005, ADV ATMOS SCI, V22, P1, DOI 10.1007/BF02930865; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gao S, 2013, ACTA OCEANOL SIN, V32, P48, DOI 10.1007/s13131-013-0266-8; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Gregg WW, 2005, GEOPHYS GEOPHYS RES, V32, P259; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; He RY, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042658; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; Hou XY, 2016, J MARINE SYST, V158, P59, DOI 10.1016/j.jmarsys.2016.01.008; Huynh HNT, 2016, J OCEANOGR, V72, P707, DOI 10.1007/s10872-016-0365-1; Li YZ, 2014, REMOTE SENS ENVIRON, V144, P98, DOI 10.1016/j.rse.2014.01.019; Lie H-J, 2009, J GEOPHYS RES, V114, P362; Liu DY, 2013, PROG OCEANOGR, V116, P154, DOI 10.1016/j.pocean.2013.07.003; Liu ML, 2014, CONT SHELF RES, V75, P15, DOI 10.1016/j.csr.2013.12.010; Matsumoto K, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006845; Messie M, 2006, DEEP-SEA RES PT I, V53, P1581, DOI 10.1016/j.dsr.2006.06.007; Miles TN, 2010, CONT SHELF RES, V30, P1951, DOI 10.1016/j.csr.2010.08.016; Moradi M, 2015, MAR POLLUT BULL, V98, P14, DOI 10.1016/j.marpolbul.2015.07.018; NORTH GR, 1982, MON WEATHER REV, V110, P699, DOI 10.1175/1520-0493(1982)110<0699:SEITEO>2.0.CO;2; Olita A, 2011, OCEAN DYNAM, V61, P89, DOI 10.1007/s10236-010-0344-9; Park JY, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007056; Qiu FW, 2011, CHIN J OCEANOL LIMN, V29, P18, DOI 10.1007/s00343-011-9931-y; Racault MF, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00133; Rousseaux CS, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008083; Shi W, 2012, PROG OCEANOGR, V104, P30, DOI 10.1016/j.pocean.2012.05.001; Shiozaki T, 2013, ADV SPACE RES, V52, P668, DOI 10.1016/j.asr.2013.05.005; Siswanto E, 2011, J OCEANOGR, V67, P627, DOI 10.1007/s10872-011-0062-z; Thomas AC, 2012, DEEP-SEA RES PT II, V77-80, P99, DOI 10.1016/j.dsr2.2012.04.008; Townsend DW, 2010, CONT SHELF RES, V30, P820, DOI 10.1016/j.csr.2010.01.019; Tseng CM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038252; Volpe G, 2012, REMOTE SENS ENVIRON, V117, P223, DOI 10.1016/j.rse.2011.09.020; Wei QS, 2016, J SEA RES, V112, P1, DOI 10.1016/j.seares.2016.02.004; Wilson C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002724; Xie SP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015884; Xu M, 2016, MAR POLLUT BULL, V105, P58, DOI 10.1016/j.marpolbul.2016.02.067; Yamaguchi H, 2012, PROG OCEANOGR, V105, P22, DOI 10.1016/j.pocean.2012.04.004; Yu F, 2010, CHIN J OCEANOL LIMN, V28, P677, DOI 10.1007/s00343-010-0006-2; Zhang SW, 2008, CONT SHELF RES, V28, P442, DOI 10.1016/j.csr.2007.10.002; Zhao H, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003536	46	10	10	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220058	10.1371/journal.pone.0220058	http://dx.doi.org/10.1371/journal.pone.0220058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386653	Green Submitted, gold, Green Published			2022-12-27	WOS:000484997100015
J	Bennasrallah, C; Kacem, M; Dhouib, W; Zemni, I; Ben Fredj, M; Abroug, H; Djobbi, A; Green, A; Said, SG; Maalel, I; Stambouli, S; Zhir, W; Youssef, HBH; Belguith, AS				Bennasrallah, Cyrine; Kacem, Meriem; Dhouib, Wafa; Zemni, Imen; Ben Fredj, Manel; Abroug, Hela; Djobbi, Amira; Green, Assia; Said, Samia Grira; Maalel, Issam; Stambouli, Sarra; Zhir, Wafa; Youssef, Hichem Bel Haj; Belguith, Asma Sriha			BCG vaccination and tuberculosis prevention: A forty years cohort study, Monastir, Tunisia	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; METAANALYSIS; PROTECTION; RISK	We aimed to describe incidence, trends of tuberculosis (TB) over 18 years and to evaluate the impact of the BCG vaccine after four decades of immunization program according to three protocols. We performed a cohort study including declared cases in Monastir from January 1, 2000 to December 31, 2017. We reported 997 cases of TB. The predominant site was pulmonarylocalization (n = 486). The age standardized incidence of pulmonary and lymph node TB per 100,000 inh were 5.71 and 2.57 respectively. Trends were negative for pulmonary TB (PTB) (b = -0.82; r = -0.67; p< 10(-3)) and positive for lymph node localization (b = 1.31; r = 0.63; p< 10(-3)). We had not notified cases of HIV associated with TB. Crude incidence rate (CIR) of PTB per 100,000 inh was 8.17 in Non-Vaccinated Cohort (NVC) and 2.85 in Vaccinated Cohort (VC) (p < 0.0001). Relative risk reduction (RRR) of BCG vaccination was 65.1% (95% CI: 57.5; 71.4) for pulmonary localization and 65% (95% CI: 55; 73) for other localizations. We have not established a significant RRR of BCG vaccination on lymph node TB. Protocol 3 (at birth) had the highest effectiveness with a RRR of 96.7% (95% CI: 86.6%; 99.2%) and 86% (95% CI: 71%; 91%) in patients with PTB and other localizations TB respectively. In Cox regression model the HR was 0.061 (95% CI 0.015-0.247) for PTB and 0.395 (95% CI 0.185-0.844) for other localizations TB in patients receiving protocol 3 compared to NVC. For lymph-node TB, HR was 1.390 (95% CI 1.043-1.851) for protocol 1 and 1.849 (95% CI 1.232-2.774) for protocol 2 compared to NVC. Depending on the three protocols, the BCG vaccine had a positive impact on PTB and other TB localizations that must be kept and improved. However, protocols 1 and 2 had a reverse effect on lymph node TB.	[Bennasrallah, Cyrine; Kacem, Meriem; Dhouib, Wafa; Zemni, Imen; Ben Fredj, Manel; Abroug, Hela; Belguith, Asma Sriha] Univ Monastir, Dept Epidemiol & Prevent Med, Monastir, Tunisia; [Djobbi, Amira; Green, Assia; Said, Samia Grira; Maalel, Issam; Youssef, Hichem Bel Haj] Reg Direct Primary Hlth Monastir, Monastir, Tunisia; [Stambouli, Sarra; Zhir, Wafa] Univ Monastir, Dept Family Med, Monastir, Tunisia	Universite de Monastir; Universite de Monastir	Belguith, AS (corresponding author), Univ Monastir, Dept Epidemiol & Prevent Med, Monastir, Tunisia.	belguith_asma@yahoo.fr	Abroug, Hela/AAD-6764-2019	Abroug, Hela/0000-0002-9666-4914				Abebe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-504; [Anonymous], 2015, GLOBAL TUBERCULOSIS; Baily G V, 1980, Indian J Med Res, V72 Suppl, P1; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Boisson-Dupuis S, 2015, IMMUNOL REV, V264, P103, DOI 10.1111/imr.12272; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; De Cock K, 1994, Afr Health, V16, P8; Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8; Fader T, 2010, INT J INFECT DIS, V14, pE102, DOI 10.1016/j.ijid.2009.03.023; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Gaifer ZA, 2017, INT J MYCOBACT, V6, P356, DOI 10.4103/ijmy.ijmy_123_17; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Kacem M, 2018, REV SYSTEMATIQUE LIT, P696; Khattab MA, 2015, ADV INFECT DIS, V5, P148, DOI [DOI 10.4236/aid.2015.54018, DOI 10.1038/ni1443]; Kouni Chahed M, 2010, SANTE, V20, P87, DOI [10.1684/san.2010.0191, DOI 10.1684/SAN.2010.0191]; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Meddeb N, 2005, OSTEOPOROSIS INT, V16, P180, DOI 10.1007/s00198-004-1658-6; Meira L, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.PA2653; Moliva JI, 2015, VACCINE, V33, P5035, DOI 10.1016/j.vaccine.2015.08.033; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Newman Thomas B., GOLDMAN CECIL MED, V9, P32, DOI [10.1186/1741-7015-9-32, DOI 10.1186/1741-7015-9-32]; Reuter H, 2009, TUBERCULOSIS COMPREH, P377; Rowinska-Zakrzewska Ewa, 2013, Pneumonol Alergol Pol, V81, P121; Smaoui S, 2015, INT J MYCOBACT, V4, P196, DOI 10.1016/j.ijmyco.2015.04.004; Snow KJ, 2018, EPIDEMIOL INFECT, V146, P946, DOI 10.1017/S0950268818000821; Tatar D, 2016, IRAN J PUBLIC HEALTH, V45, P305; Tinsa Faten, 2009, Tunis Med, V87, P693; Tiwari V, 2016, INT J ADV INTEGR MED, V1, P95, DOI [10.5005/jp-journals-10050-10033, DOI 10.5005/JP-JOURNALS-10050-10033]; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; World Health Organization, 2013, GLOBALTUBERCULOSISRE; World Health Organization, WHO GLOBAL TUBERCULO; Zhang Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011732; 2014, FRAMEWORK TOWARDS TU, P1	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0219991	10.1371/journal.pone.0219991	http://dx.doi.org/10.1371/journal.pone.0219991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381577	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600008
J	Cho, YK; Lee, J; Kang, YM; Yoo, JH; Park, JY; Jung, CH; Lee, WJ				Cho, Yun Kyung; Lee, Jiwoo; Kang, Yu Mi; Yoo, Jee Hee; Park, Joong-Yeol; Jung, Chang Hee; Lee, Woo Je			Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes	PLOS ONE			English	Article							COTRANSPORTER 2 INHIBITORS; DOUBLE-BLIND; ADD-ON; SGLT2 INHIBITORS; METFORMIN; 24-WEEK; WEIGHT	We aimed to investigate the clinical factors affecting the therapeutic effectiveness of the sodium-glucose cotransporter-2 inhibitor empagliflozin in patients with type 2 diabetes mellitus (T2DM). We reviewed the medical records of 374 T2DM patients aged between 20 and 75 years who were prescribed empagliflozin 10 mg or 25 mg as add-on therapy for more than 90 consecutive days. Changes in hemoglobin A1c (HbA1c) from baseline levels and the reduction in body weights of the study participants were assessed. We found that younger patients (. 50 years), patients with the highest levels of HbA1c (> 9%) at baseline, patients with an estimated glomerular filtration rate (eGFR) of > 90 mL/min/1.73 m(2), and patients with a shorter duration of T2DM (< 10 years) were more likely to exhibit a better glycemic response. Multivariate linear regression analysis revealed that a shorter duration of T2DM, higher baseline levels of HbA1c, and higher eGFR were positively associated with HbA1c reduction. Higher BMI and lower HbA1c levels were predictors of a more significant reduction in body weight among patients taking empagliflozin. The glucose-lowering effect of empagliflozin was more evident in T2DM patients with higher baseline HbA1c levels, better renal function, and shorter duration of T2DM.	[Cho, Yun Kyung; Lee, Jiwoo; Park, Joong-Yeol; Jung, Chang Hee; Lee, Woo Je] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea; [Cho, Yun Kyung] Kangwon Natl Univ, Dept Internal Med, Sch Med, Chunchon, South Korea; [Kang, Yu Mi] Univ Ulsan, Int Healthcare Ctr, Asan Med Ctr, Coll Med, Seoul, South Korea; [Yoo, Jee Hee] Sungkyunkwan Univ, Samsung Med Ctr, Dept Internal Med, Sch Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; Kangwon National University; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WJ (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Internal Med, Coll Med, Seoul, South Korea.	lwjatlas@amc.seoul.kr	Jung, Chang Hee/AAU-7897-2020; Kang, Yu Mi/AAW-2935-2020	LEE, WOO JE/0000-0002-9605-9693				Abdul-Ghani MA, 2013, DIABETES, V62, P3324, DOI 10.2337/db13-0604; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS55, DOI 10.2337/dc18-S006; Chao EC, 2010, NAT REV DRUG DISCOV, V9, P551, DOI 10.1038/nrd3180; DeFronzo RA, 2015, DIABETES CARE, V38, P384, DOI 10.2337/dc14-2364; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Grempler R, 2012, DIABETES OBES METAB, V14, P83, DOI 10.1111/j.1463-1326.2011.01517.x; Haring HU, 2014, DIABETES CARE, V37, P1650, DOI 10.2337/dc13-2105; Haring HU, 2013, DIABETES CARE, V36, P3396, DOI 10.2337/dc12-2673; Iemitsu Kotaro, 2016, J Clin Med Res, V8, P373, DOI 10.14740/jocmr2492w; Kalra S, 2014, DIABETES THER, V5, P355, DOI 10.1007/s13300-014-0089-4; Ko SH, 2017, DIABETES METAB J, V41, P337, DOI 10.4093/dmj.2017.41.5.337; Kohan DE, 2014, KIDNEY INT, V85, P962, DOI 10.1038/ki.2013.356; Korean Diabetes Association, DIAB FACT SHEET; Korean Society for the Study of Obesity, 2017 OB FACT SHEET; Kovacs CS, 2014, DIABETES OBES METAB, V16, P147, DOI 10.1111/dom.12188; Lee JY, 2017, DIABETES METAB, V43, P191, DOI 10.1016/j.diabet.2016.11.005; Lee PC, 2018, OBES REV, V19, P1630, DOI 10.1111/obr.12755; Li J, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007201; Roden M, 2013, LANCET DIABETES ENDO, V1, P208, DOI 10.1016/S2213-8587(13)70084-6; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Yagi S, 2018, ADV THER, V35, P124, DOI 10.1007/s12325-017-0639-z; Zanoli L, 2015, ScientificWorldJournal, V2015, P317507, DOI 10.1155/2015/317507; Zhang L, 2010, DIABETES OBES METAB, V12, P510, DOI 10.1111/j.1463-1326.2010.01216.x	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220667	10.1371/journal.pone.0220667	http://dx.doi.org/10.1371/journal.pone.0220667			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369642	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900078
J	Frolich, A; Ghith, N; Schiotz, M; Jacobsen, R; Stockmarr, A				Frolich, Anne; Ghith, Nermin; Schiotz, Michaela; Jacobsen, Ramune; Stockmarr, Anders			Multimorbidity, healthcare utilization and socioeconomic status: A register-based study in Denmark	PLOS ONE			English	Article							DANISH NATIONWIDE REGISTERS; MULTIPLE CHRONIC DISEASES; NETHERLANDS DIFFERENCES; PUBLIC-HEALTH; POPULATION; PREVALENCE; EDUCATION; COMORBIDITY; COSTS; LIFE	Background People with multimorbidity have reduced functional capacity, lower quality of life, higher mortality rates and use healthcare resources more intensively than healthy people or those with a single chronic condition. Multimorbidity was defined as the coexistence of two or more chronic conditions in the same person. The aim of this study was to explore associations between multimorbidity and use of healthcare services and the impact of socioeconomic status on utilization of hospitalizations and bed days. Methods The study population included all individuals aged 16 years and older who lived in the Capital Region of Denmark on January 1st, 2012. Data on chronic conditions, use of healthcare services and demographics were obtained from Danish national administrative and health registries. Zero-inflated models were used to calculate anticipated annual use of hospitalizations and bed days. Findings The study population comprised 1,397,173 individuals; the prevalence of multimorbidity was 22%. Prevalence was inversely related to educational attainment. For people with multimorbidity, utilization of hospitalizations and bed days increased approximately linearly with the number of chronic conditions. However, a steep increase in utilization of bed days was observed between five and six or more chronic conditions. An educational gradient in hospitalization rates and use of bed days was observed regardless of the number of chronic conditions. Educational attainment was strongly associated with healthcare utilization. Conclusion Multimorbidity was associated with a significant increase in utilization of all healthcare services in Denmark. In addition, a socioeconomic gradient was observed in utilization of hospitalizations and bed days.	[Frolich, Anne] Slagelse Hosp NSR, Knowledge Ctr Multimorbid & Chron Condit, Slagelse, Region Zealand, Denmark; [Frolich, Anne] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Ghith, Nermin] Bispebjerg Frederiksberg Univ Hosp, Ctr Clin Res & Prevent, Res Unit Chron Condit, Copenhagen, Denmark; [Schiotz, Michaela] Bispebjerg Frederiksberg Univ Hosp, Ctr Clin Res & Prevent, Sect Intersectoral Hlth Serv Res, Copenhagen, Denmark; [Jacobsen, Ramune] Univ Copenhagen, Bispebjerg Frederiksberg Univ Hosp, Dept Pharm, Copenhagen, Denmark; [Stockmarr, Anders] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; Technical University of Denmark	Frolich, A (corresponding author), Slagelse Hosp NSR, Knowledge Ctr Multimorbid & Chron Condit, Slagelse, Region Zealand, Denmark.; Frolich, A (corresponding author), Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark.	Anne.Froelich@regionh.dk	Jacobsen, Ramune/AAG-1887-2019	Jacobsen, Ramune/0000-0002-8142-9807; Ghith, Nermin/0000-0002-5863-5442; Stockmarr, Anders/0000-0002-8681-2370	50 million Crown Foundation from the Capital Region of Denmark	50 million Crown Foundation from the Capital Region of Denmark	This work was supported by grants for AF from the 50 million Crown Foundation from the Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsen M, 2017, SSM-POPUL HLTH, V3, P419, DOI 10.1016/j.ssmph.2017.05.006; Agardh EE, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-60; Alimohammadian M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013548; Bahler C, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0698-2; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss Elizabeth A, 2004, Health Qual Life Outcomes, V2, P47, DOI 10.1186/1477-7525-2-47; Carstensen B, 2011, SCAND J PUBLIC HEALT, V39, P58, DOI 10.1177/1403494811404278; Caughey GE, 2010, J EPIDEMIOL COMMUN H, V64, P1036, DOI 10.1136/jech.2009.088260; Di Angelantonio E, 2015, JAMA-J AM MED ASSOC, V314, P52, DOI 10.1001/jama.2015.7008; Diderichsen F, 2001, CHALLENGING INEQUITI, P12; Erlangsen A, 2015, SCAND J PUBLIC HEALT, V43, P333, DOI 10.1177/1403494815575193; Freid Virginia M, 2012, NCHS Data Brief, P1; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Hopman P, 2016, EUR J INTERN MED, V35, P44, DOI 10.1016/j.ejim.2016.08.025; Hopman P, 2015, EUR J INTERN MED, V26, P190, DOI 10.1016/j.ejim.2015.02.006; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Jindai K, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160174; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Konig HH, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-219; Lachenbruch PA, 2002, STAT METHODS MED RES, V11, P297, DOI 10.1191/0962280202sm289ra; Lane NE, 2015, EBIOMEDICINE, V2, P2094, DOI 10.1016/j.ebiom.2015.11.018; Lau C.J., 2015, SUNDHEDSPROFIL 2013; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Abad-Diez JM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-75; McPhail SM, 2016, RISK MANAG HEALTHC P, V9, P143, DOI 10.2147/RMHP.S97248; Mercer S, 2016, MULTIMORBIDITY TECHN; Olivarius ND, 1997, DAN MED BULL, V44, P449; Palladino R, 2016, AGE AGEING, V45, P431, DOI 10.1093/ageing/afw044; Pefoyo AJK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1733-2; Robinson KM, 2011, KRONISKE SYGDOMME HV; Rzewuska M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171813; Schiotz ML, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4314-8; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Skinner HG, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1304-y; Thavorn K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017264; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P8, DOI 10.1177/1403494811409654; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van den Bussche H, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1357-y; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; van Oostrom SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160264; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; van Oostrom SH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-715; Wang HHX, 2015, ANN FAM MED, V13, P164, DOI 10.1370/afm.1757; Westert GP, 2001, EUR J PUBLIC HEALTH, V11, P365, DOI 10.1093/eurpub/11.4.365; Williams JS, 2016, AM J MED SCI, V352, P45, DOI 10.1016/j.amjms.2016.03.004; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yu W, 2004, AM J MANAG CARE, V10, P909; Zulman DM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007771	52	43	42	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0214183	10.1371/journal.pone.0214183	http://dx.doi.org/10.1371/journal.pone.0214183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369580	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900005
J	Guan, VX; Probst, YC; Neale, EP; Tapsell, LC				Guan, Vivienne X.; Probst, Yasmine C.; Neale, Elizabeth P.; Tapsell, Linda C.			Evaluation of the dietary intake data coding process in a clinical setting: Implications for research practice	PLOS ONE			English	Article							SOURCE DATA VERIFICATION; PORTION-SIZE; SELF-REPORT; RECOVERY BIOMARKERS; FOOD PHOTOGRAPHY; QUALITY-CONTROL; 5 VALIDATION; INTERVENTION; TRIALS; MANAGEMENT	Background High quality dietary intake data is required to support evidence of diet-disease relationships exposed in clinical research. Source data verification may be a useful quality assurance method in this setting. The present pilot study aimed to apply source data verification to evaluate the quality of the data coding process for dietary intake in a clinical trial and to explore potential barriers to data quality in this setting. Methods Using a sample of 20 cases from a clinical trial, source data verification was conducted between three sets of data derived documents: transcripts of audio-recorded diet history interviews, matched paper-based diet history forms and outputs from nutrition analysis software. The number of cases and rates of discrepancies between documents were calculated. A total of five in-depth interviews with dietitians collecting and coding dietary data were thematically analysed. Results Some 2024 discrepancies were identified. The highest discrepancy rate was 57.49%, and occurred between diet history interviews and nutrition analysis software outputs. Sources of the discrepancies included both quantities and frequencies of food intake. The highest discrepancy rate was for the food group "vegetable products and dishes". In-depth interviews implicated recall bias of trial participants as a cause of discrepancies, but dietitians also acknowledged a possible subconscious influence of having to code reported foods into nutrition analysis software programs. Conclusion The accuracy of dietary intake data appeared to depend on the level of detailed food data required. More support for participants on reporting consumption, and incorporating supportive tools to guide estimates of food quantities may facilitate a more consistent coding process and improve data quality. This pilot study offers a novel method and an overview of dietary intake data coding measurement errors. These findings may warrant further investigation in a larger sample.	[Guan, Vivienne X.; Probst, Yasmine C.; Neale, Elizabeth P.; Tapsell, Linda C.] Univ Wollongong, Fac Sci Med & Hlth, Sch Med, Wollongong, NSW, Australia; [Guan, Vivienne X.; Probst, Yasmine C.; Neale, Elizabeth P.; Tapsell, Linda C.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia	University of Wollongong; University of Wollongong	Guan, VX (corresponding author), Univ Wollongong, Fac Sci Med & Hlth, Sch Med, Wollongong, NSW, Australia.; Guan, VX (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	xg885@uowmail.edu.au	Probst, Yasmine/A-1342-2008	Probst, Yasmine/0000-0002-1971-173X; Guan, Vivienne/0000-0002-3162-1788; Tapsell, Linda/0000-0002-2546-6507	Illawarra Health and Medical Research Institute and California Walnut Commission	Illawarra Health and Medical Research Institute and California Walnut Commission	The HealthTrack study was funded by the Illawarra Health and Medical Research Institute and California Walnut Commission. The funding bodies had no involvement in the data analysis, data interpretation, or writing of the manuscript.	Andersen JR, 2015, BRIT J CLIN PHARMACO, V79, P660, DOI 10.1111/bcp.12531; [Anonymous], 2019, INT C HARMONISATION; Braakhuis AJ, 2003, INT J SPORT NUTR EXE, V13, P152, DOI 10.1123/ijsnem.13.2.152; Burden S, 2009, J FOOD COMPOS ANAL, V22, P130, DOI 10.1016/j.jfca.2008.10.004; Burke Bertha S., 1947, JOUR AMER DIETETIC ASSOC, V23, P1041; Chen H, 2014, INT J ENV RES PUB HE, V11, P5170, DOI 10.3390/ijerph110505170; Conway R, 2004, BRIT J NUTR, V91, P765, DOI 10.1079/BJN20041095; Copeland T, 2000, J AM DIET ASSOC, V100, P1186, DOI 10.1016/S0002-8223(00)00343-6; Cypel YS, 1997, J AM DIET ASSOC, V97, P289, DOI 10.1016/S0002-8223(97)00074-6; Dennis B, 2003, J HUM HYPERTENS, V17, P609, DOI 10.1038/sj.jhh.1001604; Espeland MA, 2001, ANN EPIDEMIOL, V11, P85, DOI 10.1016/S1047-2797(00)00173-3; Faber M, 2013, NUTRITION, V29, P1286, DOI 10.1016/j.nut.2013.03.016; Food Standards Australia New Zealand, 2010, AUSNUT 2007; Freedman LS, 2015, AM J EPIDEMIOL, V181, P473, DOI 10.1093/aje/kwu325; Freedman LS, 2014, AM J EPIDEMIOL, V180, P172, DOI 10.1093/aje/kwu116; Gibson R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012927; Greenberg C, 2009, J FOOD COMPOS ANAL, V22, pS88, DOI 10.1016/j.jfca.2009.01.011; Guan V, 2017, J FOOD COMPOS ANAL, V64, P27, DOI 10.1016/j.jfca.2017.07.010; Guan V, 2016, STUD HEALTH TECHNOL, V227, P34, DOI 10.3233/978-1-61499-666-8-34; Hebert JR, 2016, J ACAD NUTR DIET, V116, P1895, DOI 10.1016/j.jand.2016.08.007; HILNER JE, 1992, CONTROL CLIN TRIALS, V13, P156, DOI 10.1016/0197-2456(92)90021-Q; Johnson R. B., 2004, ED RES, V33, P14, DOI [10.3102/0013189X033007014, DOI 10.3102/0013189X033007014]; Kirkpatrick SI, 2014, AM J CLIN NUTR, V100, P233, DOI 10.3945/ajcn.114.083238; Lissner L, 2007, INT J OBESITY, V31, P956, DOI 10.1038/sj.ijo.0803527; Mangione-Smith R, 2002, HEALTH SERV RES, V37, P1603, DOI 10.1111/1475-6773.10482; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; Martin GS, 2003, PREV MED, V36, P420, DOI 10.1016/S0091-7435(02)00054-3; Natarajan L, 2010, AM J EPIDEMIOL, V172, P819, DOI 10.1093/aje/kwq216; NELSON M, 1994, BRIT J NUTR, V72, P649, DOI 10.1079/BJN19940069; Nelson M, 1996, BRIT J NUTR, V76, P31, DOI 10.1079/BJN19960007; O'Shea J, 2019, EUR J CLIN NUTR, V73, P801, DOI 10.1038/s41430-018-0277-9; Probst Y, 2007, J FOOD COMPOS ANAL, V20, P696, DOI 10.1016/j.jfca.2007.04.009; Probst Y, 2016, CRIT REV FOOD SCI, V56, P2069, DOI 10.1080/10408398.2013.816653; Probst Y, 2010, NUTR DIET, V67, P275, DOI 10.1111/j.1747-0080.2010.01476.x; Rampersad SE, 2013, PEDIATR ANESTH, V23, P627, DOI 10.1111/pan.12198; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; Ritchie J, 2002, ANAL QUALITATIVE DAT, P187; Saldana J., 2015, CODING MANUAL QUALIT, V3rd; Schuyl ML, 1999, DRUG INF J, V33, P789, DOI 10.1177/009286159903300319; Sheetz N, 2014, THER INNOV REGUL SCI, V48, P671, DOI 10.1177/2168479014554400; Slimani N, 2000, EUR J CLIN NUTR, V54, P900, DOI 10.1038/sj.ejcn.1601107; Slimani N, 2015, NUTR RES METHODOLOGI, VVolume 1, P48; SMITH AF, 1993, EUROPEAN J CLIN N S2, V47, pS; Stelmach-Mardas M, 2016, EUR J CLIN NUTR, V70, P700, DOI 10.1038/ejcn.2015.224; Strauss A., 1990, BASICS QUALITATIVE R; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Tantsyura V, 2010, DRUG INF J, V44, P745, DOI 10.1177/009286151004400611; Tapsell LC, 2000, J AM DIET ASSOC, V100, P818, DOI 10.1016/S0002-8223(00)00237-6; Tapsell LC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014533; Tapsell LC, 2016, ADV NUTR, V7, P445, DOI 10.3945/an.115.011718; Tapsell LC, 2015, CONTEMP CLIN TRIALS, V45, P394, DOI 10.1016/j.cct.2015.10.008; Thompson FE, 2013, NUTR PREVENTION TREA, P5, DOI DOI 10.1016/B978-0-12-391884-0.00001-9; Wirfalt E, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-3; Woodcock J, 2016, NEW ENGL J MED, V374, P2167, DOI 10.1056/NEJMe1601510; Zimmerman TP, 2009, J FOOD COMPOS ANAL, V22, pS48, DOI 10.1016/j.jfca.2009.02.003	55	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221047	10.1371/journal.pone.0221047	http://dx.doi.org/10.1371/journal.pone.0221047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404088	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800048
J	Wang, GF; Ai, XZ; Zhong, L				Wang, Ganfu; Ai, Xingzheng; Zhong, Li			Managing product variety on online platform: Consumer heterogeneity and diseconomies of scope	PLOS ONE			English	Article							COMPETITION; COORDINATION; MANAGEMENT; DECISIONS	Recent innovations in e-commerce have led to the emergence of online retailing platforms, where millions of products are sold. Most of these products are sold by third-party sellers who pay a fee for the e-retailer (called the platform owner). We investigate how the e-retailer manages the various products in the presence of consumer heterogeneity and diseconomies of scope. Our analytical results indicate that the e-retailer prefers the platform-selling mode when consumers have stronger heterogeneity or when the value of a product is high; moreover, the consumer heterogeneity benefits the e-retailer and hurts the supplier. We also analyze the effect of the relationship of among categories on the e-retailer's choice. We show that the relationship among categories can invert the existing format. In addition, we find that the e-retailer may be better off and raise the number of products under strong diseconomies of scope when the categories are complements, and the opposite is true when the categories are substitutable.	[Wang, Ganfu; Ai, Xingzheng] Hubei Univ Econ, Sch Business Adm, Wuhan, Hubei, Peoples R China; [Zhong, Li] Univ Elect Sci & Technol China, Sch Management & Econ, Chengdu, Sichuan, Peoples R China	Hubei University of Economics; University of Electronic Science & Technology of China	Zhong, L (corresponding author), Univ Elect Sci & Technol China, Sch Management & Econ, Chengdu, Sichuan, Peoples R China.	zlee04@sina.com			National Natural Science Foundation of China [71372140]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China under grant 71372140.	Armstrong M, 2006, RAND J ECON, V37, P668, DOI 10.1111/j.1756-2171.2006.tb00037.x; Cachon GP, 2007, MANAGE SCI, V53, P934, DOI 10.1287/mnsc.1060.0661; Casadesus-Masanell R, 2014, J ECON MANAGE STRAT, V23, P259, DOI 10.1111/jems.12052; DIXON HD, 1994, ECONOMICA, V61, P213, DOI 10.2307/2554958; Hagiu A., 2011, WORKING PAPER; Hagiu A, 2015, MANAGE SCI, V61, P184, DOI 10.1287/mnsc.2014.2042; Hagiu A, 2014, MIT SLOAN MANAGE REV, V55, P71; Hagiu A, 2009, J ECON MANAGE STRAT, V18, P1011, DOI 10.1111/j.1530-9134.2009.00236.x; Jiang BJ, 2011, MARKET SCI, V30, P757, DOI 10.1287/mksc.1110.0656; Kung LC, 2017, TRANSPORT RES E-LOG, V101, P1, DOI 10.1016/j.tre.2017.02.003; Mantin B, 2014, PROD OPER MANAG, V23, P1937, DOI 10.1111/poms.12203; Parker GG, 2005, MANAGE SCI, V51, P1494, DOI 10.1287/mnsc.1050.0400; Rajagopalan S, 2012, EUR J OPER RES, V217, P84, DOI 10.1016/j.ejor.2011.08.016; Reisinger M, 2014, EUR ECON REV, V68, P168, DOI 10.1016/j.euroecorev.2014.03.005; Rochet JC, 2003, J EUR ECON ASSOC, V1, DOI 10.1162/154247603322493212; Ryan JK, 2012, PROD OPER MANAG, V21, P997, DOI 10.1111/j.1937-5956.2012.01332.x; Shi HY, 2013, MANAGE SCI, V59, P1162, DOI 10.1287/mnsc.1120.1604; Smith SA, 2000, OPER RES, V48, P50, DOI 10.1287/opre.48.1.50.12443; Wang M, 2016, ROUT ADV ART VISUAL, V13, P1; Wely EG., 2010, AM ECON REV, V100, P1642; Xia N, 2009, MARKET SCI, V28, P887, DOI 10.1287/mksc.1080.0456; Xiao TJ, 2015, IEEE T ENG MANAGE, V62, P411, DOI 10.1109/TEM.2015.2429143	22	1	1	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0219177	10.1371/journal.pone.0219177	http://dx.doi.org/10.1371/journal.pone.0219177			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404071	gold, Green Published, Green Submitted			2022-12-27	WOS:000485006800008
J	Leicht, K; Jokela, J; Seppala, O				Leicht, Katja; Jokela, Jukka; Seppala, Otto			Inbreeding does not alter the response to an experimental heat wave in a freshwater snail	PLOS ONE			English	Article							CLIMATE-CHANGE; IMMUNE DEFENSE; LYMNAEA-STAGNALIS; ANTIMICROBIAL PEPTIDES; HABITAT FRAGMENTATION; EXTREME TEMPERATURES; MASS MORTALITY; DEPRESSION; DROSOPHILA; STRESS	Global climate change affects natural populations of many species by increasing the average temperature and the frequency of extreme weather events (e.g. summer heat waves). The ability of organisms to cope with these environmental changes can, however, depend on their genetic properties. For instance, genetic load owing to inbreeding could alter organisms' responses to climate change-mediated environmental changes but such effects are often overlooked. We investigated the effects of an experimental heat wave (25 degrees C versus 15 degrees C) on life history (reproduction, size) and constitutive immune defence traits (phenoloxidase-like and antibacterial activity of haemolymph) in relation to inbreeding by manipulating the mating type (outcrossing, self-fertilization) in two populations of a hermaphroditic freshwater snail, Lymnaea stagnalis. High temperature increased reproduction and size of snails but impaired their immune function. In one of the two study populations, inbreeding reduced reproductive output of snails indicating inbreeding depression. Furthermore, this effect did not depend on the temperature snails were exposed to. Our results suggest that L. stagnalis snails can be negatively affected by inbreeding but it may not alter their responses to heat waves.	[Leicht, Katja; Jokela, Jukka; Seppala, Otto] Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland; [Leicht, Katja] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Jokela, Jukka; Seppala, Otto] Swiss Fed Inst Technol, Inst Integrat Biol IBZ, Zurich, Switzerland; [Seppala, Otto] Univ Innsbruck, Res Dept Limnol, Mondsee, Austria	Swiss Federal Institute of Aquatic Science & Technology (EAWAG); University of Jyvaskyla; ETH Zurich; University of Innsbruck	Seppala, O (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland.; Seppala, O (corresponding author), Swiss Fed Inst Technol, Inst Integrat Biol IBZ, Zurich, Switzerland.; Seppala, O (corresponding author), Univ Innsbruck, Res Dept Limnol, Mondsee, Austria.	otto.seppaelae@env.ethz.ch		Seppala, Otto/0000-0001-7902-3069	Biological Interactions Doctoral Program (BIOINT); Emil Aaltonen Foundation; Swiss National Science Foundation [31003A 140876, 31003A 169531]	Biological Interactions Doctoral Program (BIOINT); Emil Aaltonen Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the Biological Interactions Doctoral Program (BIOINT) to KL, and the Emil Aaltonen Foundation and Swiss National Science Foundation (grants 31003A 140876 and 31003A 169531) to OS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Bijlsma R, 1999, J EVOLUTION BIOL, V12, P1125, DOI 10.1046/j.1420-9101.1999.00113.x; Boldt R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064489; Busch JW, 2005, HEREDITY, V94, P159, DOI 10.1038/sj.hdy.6800584; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Christidis N, 2015, NAT CLIM CHANGE, V5, P46, DOI [10.1038/nclimate2468, 10.1038/NCLIMATE2468]; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; DAHLGAARD J, 1995, HEREDITY, V74, P157, DOI 10.1038/hdy.1995.23; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; Doums C, 1996, EVOLUTION, V50, P1908, DOI [10.2307/2410749, 10.1111/j.1558-5646.1996.tb03578.x]; Enders LS, 2012, P ROY SOC B-BIOL SCI, V279, P3756, DOI 10.1098/rspb.2012.1018; Faltynkova A, 2007, PARASITE, V14, P39, DOI 10.1051/parasite/2007141039; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hou QQ, 2014, BIOL INVASIONS, V16, P2049, DOI 10.1007/s10530-014-0647-8; Hughes RN, 2009, BIOL J LINN SOC, V98, P519, DOI 10.1111/j.1095-8312.2009.01312.x; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Joubert D, 2010, CLIM RES, V43, P57, DOI 10.3354/cr00883; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953; Kopp KC, 2012, EVOL ECOL, V26, P483, DOI 10.1007/s10682-011-9504-8; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; Langeloh L, 2017, EVOLUTION, V71, P227, DOI 10.1111/evo.13148; Le Clec'h W, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1319-6; Leicht K, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0988-x; Leicht K, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-192; Leicht K, 2013, ECOL EVOL, V3, P4861, DOI 10.1002/ece3.874; Leimu R, 2010, ANN NY ACAD SCI, V1195, P84, DOI 10.1111/j.1749-6632.2010.05450.x; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; MILLER PS, 1994, ZOO BIOL, V13, P195, DOI 10.1002/zoo.1430130302; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Nakadera Y, 2017, J MOLLUS STUD, V83, P56, DOI 10.1093/mollus/eyw043; Nakadera Y, 2014, J MOLLUS STUD, V80, P1, DOI 10.1093/mollus/eyt049; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PECHENIK JA, 1995, PARASITOLOGY, V111, P373, DOI 10.1017/S0031182000081920; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Puurtinen M, 2007, J EVOLUTION BIOL, V20, P901, DOI 10.1111/j.1420-9101.2007.01312.x; Puurtinen M, 2004, EVOLUTION, V58, P2747, DOI 10.1111/j.0014-3820.2004.tb01626.x; RICH SS, 1979, EVOLUTION, V33, P579, DOI [10.2307/2407781, 10.1111/j.1558-5646.1979.tb04711.x]; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Roth O, 2010, MAR BIOL, V157, P1605, DOI 10.1007/s00227-010-1433-5; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Salo T, 2018, OIKOS, V127, P1437, DOI 10.1111/oik.05310; Salo T, 2017, FRESHWATER BIOL, V62, P1831, DOI 10.1111/fwb.12999; Schiegg K, 2002, P ROY SOC B-BIOL SCI, V269, P1153, DOI 10.1098/rspb.2002.1966; Seppala O, 2011, BIOL LETTERS, V7, P119, DOI 10.1098/rsbl.2010.0459; Seppala O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161584; Seppala O, 2013, J EXP BIOL, V216, P2902, DOI 10.1242/jeb.084947; Sminia T., 1981, INVERTEBRATE BLOOD C, P191; VAUGHN CM, 1953, AM MIDL NAT, V49, P214, DOI 10.2307/2422289; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wegner KM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-124; White JD, 2015, CAN J FISH AQUAT SCI, V72, P1221, DOI 10.1139/cjfas-2015-0064	60	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220669	10.1371/journal.pone.0220669	http://dx.doi.org/10.1371/journal.pone.0220669			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393914	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500050
J	Salinas, J; Lin, HH; Aparico, HJ; Huan, TX; Liu, CY; Rong, J; Beiser, A; Himali, JJ; Freedman, JE; Larson, MG; Rosand, J; Soreq, H; Levy, D; Seshadri, S				Salinas, Joel; Lin, Honghuang; Aparico, Hugo J.; Huan, Tianxiao; Liu, Chunyu; Rong, Jian; Beiser, Alexa; Himali, Jayandra J.; Freedman, Jane E.; Larson, Martin G.; Rosand, Jonathan; Soreq, Hermona; Levy, Daniel; Seshadri, Sudha			Whole blood microRNA expression associated with stroke: Results from the Framingham Heart Study	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ATRIAL-FIBRILLATION; CARDIOVASCULAR-DISEASE; POTENTIAL BIOMARKERS; HEPATIC STEATOSIS; ISCHEMIC-STROKE; SEVERITY; THERAPY; UPDATE; BRAIN	Emerging evidence suggests microRNAs (miRNAs) may play an important role in explaining variation in stroke risk and recovery in humans, yet there are still few longitudinal studies examining the association between whole blood miRNAs and stroke. Accounting for multiple testing and adjusting for potentially confounding technical and clinical variables, here we show that whole blood miR-574-3p expression was significantly lower in participants with chronic stroke compared to non-cases. To explore the functional relevance of our findings, we analyzed miRNA-mRNA whole blood co-expression, pathway enrichment, and brain tissue gene expression. Results suggest miR-574-3p is involved in neurometabolic and chronic neuronal injury response pathways, including brain gene expression of DBNDD2 and ELOVL1. These results suggest miR-574-3p plays a role in regulating chronic brain and systemic cellular response to stroke and thus may implicate miR-574-3p as a partial mediator of long-term stroke outcomes.	[Salinas, Joel; Lin, Honghuang; Aparico, Hugo J.; Huan, Tianxiao; Liu, Chunyu; Rong, Jian; Beiser, Alexa; Himali, Jayandra J.; Larson, Martin G.; Levy, Daniel; Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Salinas, Joel; Rosand, Jonathan] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Henry & Allison McCance Ctr Brain Hlth, Boston, MA 02115 USA; [Lin, Honghuang] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02118 USA; [Aparico, Hugo J.; Rong, Jian; Beiser, Alexa; Himali, Jayandra J.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Beiser, Alexa; Himali, Jayandra J.; Larson, Martin G.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Freedman, Jane E.] Univ Massachusetts, Med Sch, Dept Med, Worcester, MA 01605 USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Rosand, Jonathan] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Soreq, Hermona] Hebrew Univ Jerusalem, Life Sci Inst, Dept Biol Chem, Jerusalem, Israel; [Soreq, Hermona] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Levy, Daniel] NHLBI, Populat Sci Branch, Div Intramural Res, Bldg 10, Bethesda, MD 20892 USA; [Seshadri, Sudha] Univ Texas Hlth Sci Ctr San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX 78229 USA	Framingham Heart Study; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; Boston University; Boston University; University of Massachusetts System; University of Massachusetts Worcester; Boston University; Harvard University; Massachusetts General Hospital; Hebrew University of Jerusalem; Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health San Antonio	Salinas, J (corresponding author), Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA.; Salinas, J (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Henry & Allison McCance Ctr Brain Hlth, Boston, MA 02115 USA.	joelsalinas@mail.harvard.edu	Levy, Daniel/ABB-2752-2021; Salinas, Joel/AGH-5046-2022; Huan, Tianxiao/AAF-3577-2021; Levy, Daniel/ABF-6873-2021; Aparicio, Hugo/M-2051-2014	Salinas, Joel/0000-0002-3735-0018; Levy, Daniel/0000-0003-1843-8724; /0000-0003-1391-9481; Soreq, Hermona/0000-0002-0955-526X; Aparicio, Hugo/0000-0001-8584-1455; Huan, Tianxiao/0000-0001-5840-9413; Seshadri, Sudha/0000-0001-6135-2622	Robert Katzman Research Training Fellowship in Alzheimer's and Dementia Research - American Academy of Neurology; American Brain Foundation; Alzheimer's Association;  [P30AG10161];  [R01AG15819];  [R01AG17917];  [R01AG30146];  [R01AG36836];  [U01AG32984];  [U01AG46152];  [N01-HC 25195];  [HHSN268201500001I];  [75N92019D00031];  [NS017950];  [UH2NS100605];  [AG049505];  [AG052409];  [AG054076];  [AG049607];  [AG059421];  [T32NS048005];  [AG057760]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [UH2NS100605, R01NS017950, T32NS048005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG052409, RF1AG059421, U01AG032984, U01AG046152, R01AG015819, P30AG010161, R01AG030146, R01AG017917] Funding Source: NIH RePORTER	Robert Katzman Research Training Fellowship in Alzheimer's and Dementia Research - American Academy of Neurology; American Brain Foundation; Alzheimer's Association(Alzheimer's Association); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by P30AG10161, R01AG15819, R01AG17917, R01AG30146, R01AG36836, U01AG32984, and U01AG46152 to the Rush Alzheimer's Disease Center; N01-HC 25195, HHSN268201500001I, and 75N92019D00031 to the FHS; NS017950, UH2NS100605, AG049505, AG052409, AG054076, AG049607, and AG059421 to SS; T32NS048005, AG057760, and the Robert Katzman Research Training Fellowship in Alzheimer's and Dementia Research Cosponsored by the American Academy of Neurology, the American Brain Foundation, and the Alzheimer's Association to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628; Bryant RJ, 2012, BRIT J CANCER, V106, P768, DOI 10.1038/bjc.2011.595; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Dufouil C, 2017, CIRCULATION, V135, P1145, DOI 10.1161/CIRCULATIONAHA.115.021275; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Freedman JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11106; Freedman Jane E, 2012, F1000Res, V1, P50, DOI 10.12688/f1000research.1-50.v1; Hanin G, 2014, HUM MOL GENET, V23, P4569, DOI 10.1093/hmg/ddu170; Huan TX, 2015, ARTERIOSCL THROM VAS, V35, P1011, DOI 10.1161/ATVBAHA.114.305176; Huan TX, 2013, ARTERIOSCL THROM VAS, V33, P1427, DOI 10.1161/ATVBAHA.112.300112; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Lai ZM, 2018, BIOMED PHARMACOTHER, V97, P162, DOI 10.1016/j.biopha.2017.10.062; Li PF, 2015, CELL MOL NEUROBIOL, V35, P433, DOI 10.1007/s10571-014-0139-5; Li WY, 2014, J HUM HYPERTENS, V28, P288, DOI 10.1038/jhh.2013.94; Li William A, 2017, Neurol Res, P1, DOI 10.1080/01616412.2017.1327505; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lucas T, 2005, STEM CELLS DEV, V14, P556, DOI 10.1089/scd.2005.14.556; McKimmie RL, 2008, AM J GASTROENTEROL, V103, P3029, DOI 10.1111/j.1572-0241.2008.02188.x; McManus DD, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3533-9; McManus DD, 2015, HEART RHYTHM, V12, P3, DOI 10.1016/j.hrthm.2014.09.050; McManus DD, 2014, HEART RHYTHM, V11, P663, DOI 10.1016/j.hrthm.2014.01.018; Mellinger JL, 2015, J HEPATOL, V63, P470, DOI 10.1016/j.jhep.2015.02.045; Mick E, 2017, STROKE, V48, P828, DOI 10.1161/STROKEAHA.116.015140; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Rink C, 2011, PHYSIOL GENOMICS, V43, P521, DOI 10.1152/physiolgenomics.00158.2010; Schackmann MJA, 2015, BBA-MOL CELL BIOL L, V1851, P231, DOI 10.1016/j.bbalip.2014.12.005; Sepramaniam S, 2014, INT J MOL SCI, V15, P1418, DOI 10.3390/ijms15011418; Shah V, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00272; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Soreq H, 2015, TRENDS NEUROSCI, V38, P448, DOI 10.1016/j.tins.2015.05.007; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Summerer I, 2015, BRIT J CANCER, V113, P76, DOI 10.1038/bjc.2015.111; Volny O, 2015, ADV EXP MED BIOL, V888, P155, DOI 10.1007/978-3-319-22671-2_9; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang WH, 2014, J STROKE CEREBROVASC, V23, P2607, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.002; WOLF PA, 1970, NEUROLOGY, V20, P373; Yang DG, 2012, CHINESE MED J-PEKING, V125, P3479, DOI 10.3760/cma.j.issn.0366-6999.2012.19.021; Yin HS, 2006, BIOCHEMISTRY-US, V45, P5297, DOI 10.1021/bi052354e; Zhou J, 2015, J ALZHEIMERS DIS, V43, P479, DOI 10.3233/JAD-140666; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365	51	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219261	10.1371/journal.pone.0219261	http://dx.doi.org/10.1371/journal.pone.0219261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393881	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500008
J	Vossius, C; Selbaek, G; Benth, JS; Wimo, A; Engedal, K; Kirkevold, O; Rokstad, AMM				Vossius, C.; Selbaek, G.; Benth, J. Saltyte; Wimo, A.; Engedal, K.; Kirkevold, O.; Rokstad, A. M. M.			Cost analysis of day care centres in Norway	PLOS ONE			English	Article							DEMENTIA; PEOPLE; SCALE	Background Day care services aim to offer meaningful activities and a safe environment for the attendees and a respite for family caregivers while being cost effective. This study compares the use of formal and informal care in users and non-users of day care centres designed for persons with dementia. Method Users of day care designed for dementia (DC group) and non-users (NDC group) were followed over a period of 24 months or until nursing home admission (NHA) respectively death. Demographic and clinical characteristics were collected at baseline and after 12 and 24 months. The use of care was recorded by Resource Utilization in Dementia (RUD). Results A total of 257 persons with dementia participated in the study, 181 in the DC group and 76 in the NDC group. Users of day care centres cause higher costs due to the expenses for day care, while neither the use of home nursing, secondary care, informal care nor the time until NHA did show any differences between users and non-users. The overall costs were higher in the DC group at baseline and after 12 months, but this difference was no longer present at the end of the two-year study period. Conclusion Our results indicate no potential cost-saving effect of day care designed for people with dementia, as the use of day care did neither result in a reduced use of care nor in a delay of NHA. Future research should balance the non-monetary benefits of day care against its costs for a full cost-effectiveness analysis, most favourable in a RCT-design.	[Vossius, C.] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway; [Vossius, C.; Benth, J. Saltyte; Kirkevold, O.] Innlandet Hosp Trust, Res Ctr Agerelated Funct Decline & Dis, Brumunddal, Norway; [Selbaek, G.; Engedal, K.; Kirkevold, O.; Rokstad, A. M. M.] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Selbaek, G.; Benth, J. Saltyte] Univ Oslo, Inst Clin Med, Oslo, Norway; [Selbaek, G.; Engedal, K.] Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway; [Benth, J. Saltyte] Akershus Univ Hosp, Hlth Serv Res Unit, Nordbyhagen, Norway; [Wimo, A.] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Div Neurogeriatr, Stockholm, Sweden; [Wimo, A.] Uppsala Univ, Ctr Res & Dev, Cty Council Gavleborg, Gavle, Sweden; [Kirkevold, O.] Norwegian Univ Sci & Technol NTNU, Dept Hlth Sci Gjovik, Gjovik, Norway; [Rokstad, A. M. M.] Molde Univ Coll, Fac Hlth Sci & Social Care, Molde, Norway	Stavanger University Hospital; Innlandet Hospital Trust; University of Oslo; University of Oslo; University of Oslo; Karolinska Institutet; Uppsala University; Norwegian University of Science & Technology (NTNU); Molde University College	Vossius, C (corresponding author), Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway.; Vossius, C (corresponding author), Innlandet Hosp Trust, Res Ctr Agerelated Funct Decline & Dis, Brumunddal, Norway.	c.vossius@hotmail.com	Wimo, Anders/ABA-2678-2021	Selbaek, Geir/0000-0001-6511-8219; Rokstad, Anne Marie Mork/0000-0002-3713-1229	Norwegian Research Council as part of the Health, Care and Welfare Services Research (HELSEVEL) programme [222083]	Norwegian Research Council as part of the Health, Care and Welfare Services Research (HELSEVEL) programme	The study was funded by unrestricted grants from the Norwegian Research Council as part of the Health, Care and Welfare Services Research (HELSEVEL) programme, project number 222083.; We would like to thank the municipalities of Harstad and Songdalen, Innlandet Hospital Trust and SESAM-Centre for Age-Related Medicine and our colleagues at the Norwegian National Advisory Unit on Ageing and Health for assisting with the recruitment of participants and data collection.	Abramson CM, 2009, INT J AGING HUM DEV, V68, P65, DOI 10.2190/AG.68.1.d; Arksey H, 2004, REV RESPITE SERVICES; Costa N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/852368; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dahm KT, 2014, EFFECT DAY CARE CTR; ENGEDAL K, 1989, Scandinavian Journal of Primary Health Care, V7, P161, DOI 10.3109/02813438909087234; Fields NL, 2014, J APPL GERONTOL, V33, P130, DOI 10.1177/0733464812443308; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gaugler J E, 2001, J Aging Soc Policy, V12, P23, DOI 10.1300/J031v12n02_03; Greene J G, 1982, Age Ageing, V11, P121, DOI 10.1093/ageing/11.2.121; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; JOHANNESSON M, 1991, HEALTH POLICY, V18, P141, DOI 10.1016/0168-8510(91)90095-F; Landmark, 2011, EFFEKTEN TILRETTELAG; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lyketsos CG, 1999, J AM GERIATR SOC, V47, P487, DOI 10.1111/j.1532-5415.1999.tb07245.x; Mavall L., 2007, DEMENTIA, V6, P27, DOI DOI 10.1177/1471301207075627; Norwegian Ministry of Health and Care Services, 2008, DEM PLAN 2015 MAK MO; Norwegian Ministry of Health and Care Services, 2015, DEM PLAN 2020 MOR DE; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Shea E., 2000, 60 NAT COUNC AG OLD; Rokstad AM, 2014, J CLIN TRIALS, V4, P2167; Rokstad AMM, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3686-5; SBU. Dementia, 2008, 172E13 SBU; Statistics Norway, EARN; Statistics Norway, CONS PRIC IND; Tretteteig S, 2016, AGING MENT HEALTH, V20, P450, DOI 10.1080/13607863.2015.1023765; Vossius C, 2015, RESSURSBRUK SYKDOMSF, P1; WIMO A, 1994, HEALTH ECON, V3, P395, DOI 10.1002/hec.4730030607; Wimo A WB, 2003, BRAIN AGING, V3, P48; Wimo Anders, 1993, Scandinavian Journal of Primary Health Care, V11, P117, DOI 10.3109/02813439308994913; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0219568	10.1371/journal.pone.0219568	http://dx.doi.org/10.1371/journal.pone.0219568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393890	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500013
J	Kaufmann, P; Muenzner, M; Kastorf, M; Santos, K; Hartmann, T; Dienelt, A; Rehfeld, L; Bergmann, A				Kaufmann, Paul; Muenzner, Matthias; Kaestorf, Mandy; Santos, Karine; Hartmann, Tobias; Dienelt, Anke; Rehfeld, Linda; Bergmann, Andreas			A novel and highly efficient purification procedure for native human dipeptidyl peptidase 3 from human blood cell lysate	PLOS ONE			English	Article							AMINOPEPTIDASE-III; RAT-BRAIN; ASSAY	Dipeptidyl amino-peptidase 3 (DPP3) is an aminopeptidase involved in peptide degradation, including hormone peptides as angiotensin II and enkephalins. DPP3 plasma activity increases in septic patients and correlates with mortality risk. However, the exact physiological role of DPP3 remains unclear and animal studies are necessary to reveal the function of DPP3 in vivo. To this demand, we developed a two-step purification procedure for isolation of native human DPP3 from blood cell lysate (BCL) that is suitable for in vivo applications. With the use of monoclonal antibodies coupled to beads in combination with an ion-exchange chromatography, we recovered 68% of human DPP3 activity from BCL with a purity of >= 95%. Purified human DPP3 was assayed for activity and protein concentration using recently published DPP3-activity- and immunoassays. Additionally, protein stability and storage in relevant buffers were tested. Our results provide a promising strategy for fast and efficient isolation of human DPP3. The purified human DPP3 represents the native state of DPP3, suitable for future in vivo applications to investigate the physiological role of DPP3 and its involvement in pathophysiological conditions.	[Kaufmann, Paul] Sphingotec GmbH, Hennigsdorf, Germany; [Muenzner, Matthias; Kaestorf, Mandy; Santos, Karine; Hartmann, Tobias; Dienelt, Anke; Rehfeld, Linda; Bergmann, Andreas] Sphingotec Therapeut GmbH, Hennigsdorf, Germany		Kaufmann, P (corresponding author), Sphingotec GmbH, Hennigsdorf, Germany.	kaufmann@sphingotec.de		Bergmann, Andreas/0000-0002-4466-1682				ABRAMIC M, 1988, BIOL CHEM H-S, V369, P29, DOI 10.1515/bchm3.1988.369.1.29; Abramic M, 2000, BIOL CHEM, V381, P1233, DOI 10.1515/BC.2000.151; ALBA F, 1995, PEPTIDES, V16, P325, DOI 10.1016/0196-9781(94)00186-3; Baral PK, 2008, J BIOL CHEM, V283, P22316, DOI 10.1074/jbc.M803522200; Barsun M, 2007, BIOL CHEM, V388, P343, DOI 10.1515/BC.2007.039; Cicin-Sain L, 2008, NEUROPEPTIDES, V42, P435, DOI 10.1016/j.npep.2008.04.007; Dostal DE, 1997, J MOL CELL CARDIOL, V29, P2893, DOI 10.1006/jmcc.1997.0524; ELLIS S, 1967, J BIOL CHEM, V242, P4623; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; He M, 2010, CLIN CANCER RES, V16, P249, DOI 10.1158/1078-0432.CCR-09-1602; JONES THD, 1982, ANAL BIOCHEM, V119, P418, DOI 10.1016/0003-2697(82)90607-8; Kimple ME, 2013, CURR PROTOC PROTEIN, V73, DOI [10.1002/0471140864.ps0909s73, DOI 10.1002/0471140864.PS0909S73]; LEE CM, 1982, J BIOL CHEM, V257, P2043; LYNN KR, 1991, INT J BIOCHEM, V23, P47, DOI 10.1016/0020-711X(91)90007-A; Mazzocco C, 2006, FEBS J, V273, P1056, DOI 10.1111/j.1742-4658.2006.05132.x; Mazzocco C, 2001, EUR J BIOCHEM, V268, P4940, DOI 10.1046/j.1432-1327.2001.02425.x; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pang XL, 2016, HYPERTENSION, V68, P630, DOI 10.1161/HYPERTENSIONAHA.116.07357; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Prajapati SC, 2011, FEBS J, V278, P3256, DOI 10.1111/j.1742-4658.2011.08275.x; Rehfeld L, 2019, J APPL LAB MED, V3, P943, DOI 10.1373/jalm.2018.027995; Schwarz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113840; Sentandreu MA, 2001, FOOD CHEM, V75, P159, DOI 10.1016/S0308-8146(01)00145-5; SHIMAMORI Y, 1986, CHEM PHARM BULL, V34, P3333; Shukla AA, 2010, FEBS J, V277, P1861, DOI 10.1111/j.1742-4658.2010.07603.x; Simaga S, 2003, GYNECOL ONCOL, V91, P194, DOI 10.1016/S0090-8258(03)00462-1; Simaga S, 1998, EUR J CANCER, V34, P399, DOI 10.1016/S0959-8049(97)00401-2; SMYTH M, 1994, J NEUROCHEM, V63, P1439; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220866	10.1371/journal.pone.0220866	http://dx.doi.org/10.1371/journal.pone.0220866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390378	Green Published, Green Submitted, gold			2022-12-27	WOS:000484999400035
J	Beaulieu, A; zur Linden, A; Phillips, J; Arroyo, LG; Koenig, J; Monteith, G				Beaulieu, Alexandra; zur Linden, Alex; Phillips, John; Arroyo, Luis G.; Koenig, Judith; Monteith, Gabrielle			Various 3D printed materials mimic bone ultrasonographically: 3D printed models of the equine cervical articular process joints as a simulator for ultrasound guided intra-articular injections	PLOS ONE			English	Article							QUANTITATIVE ULTRASOUND; OSTEOARTHRITIS; EDUCATION; HORSE	Introduction In the equine racehorse industry, reduced athletic performance due to joint injury and lameness has been extensively reviewed. Intra-articular injections of glucocorticoids are routinely used to relieve pain and inflammation associated with osteoarthritis. Intra-articular injections of pharmaceutical agents require practice for precise needle placement and to minimize complications. Training on simulators or models is a viable alternative for developing these technical skills. The purpose of this study was to compare the qualitative ultrasonographic characteristics of three-dimensional (3D) printed models of equine cervical articular process joints to that of a dissected equine cervical spine (gold standard). Methods A randomized complete block design study was conducted in which a total of thirteen cervical articular process joint models were printed using several materials, printers, and printing technologies. Ultrasound video clips with the models immersed in water were recorded. Two board certified veterinary radiologists and three veterinary radiology residents reviewed the videos and responded to a survey assessing and comparing the ultrasonographic characteristics of the 3D printed models to those of the gold standard. Results Six 3D printed models had ultrasonographic characteristics similar to the gold standard. These six models were (material, printer, printing technology): nylon PA 12, EOS Formiga P100, selective laser sintering (P = 0.99); Onyx nylon with chopped carbon fiber, Markforged Onyx Two, fused deposition modeling (P = 0.48); polycarbonate, Ultimaker 3, fused deposition modeling (P = 0.28); gypsum, ProJet CJP 660 Pro, ColorJet Printing (P = 0.28); polylactic acid, Prusa I3, fused deposition modeling (P = 0.23); and high temperature V1 resin, Form 2, stereolithography (P = 0.22). Conclusion When assessed in water, it is possible to replicate the qualitative ultrasonographic characteristics of bone using three dimensional printed models made by combining different materials, printing technologies, and printers. However, not all models share similar qualitative ultrasonographic characteristics with bone. We suggest that the aforementioned six models be used as proxy for simulating bones or joints for use with ultrasound. In order to replicate the resistance and acoustic window provided by soft tissues, further work testing the ability of these models to withstand embedding in material such as ballistic gelatin is required.	[Beaulieu, Alexandra; zur Linden, Alex; Arroyo, Luis G.; Koenig, Judith; Monteith, Gabrielle] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON, Canada; [Phillips, John] Univ Guelph, Coll Arts, Digital Hapt Lab, Guelph, ON, Canada; [Phillips, John] Sheridan Coll, Ctr Adv Mfg & Design Technol, Brampton, ON, Canada	University of Guelph; University of Guelph	zur Linden, A (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON, Canada.	azurlind@uoguelph.ca		Beaulieu, Alexandra/0000-0002-9333-8275; zur Linden, Alex/0000-0002-5663-0197	Equine Guelph [EG2017 04]; SONAMI	Equine Guelph; SONAMI	Funding was provided to AZL by Equine Guelph, www.equineguelph.ca (EG2017 04) and SONAMI, https://www.ncinnovation.ca/sonami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Elq AH, 2010, J FAM COMMUNITY MED, V17, P35, DOI 10.4103/1319-1683.68787; Ayhan E, 2014, WORLD J ORTHOP, V5, P351, DOI 10.5312/wjo.v5.i3.351; Barkmann R, 2000, OSTEOPOROSIS INT, V11, P745, DOI 10.1007/s001980070053; Brandt KD, 2009, MED CLIN N AM, V93, P1, DOI 10.1016/j.mcna.2008.08.009; Bushberg JT, 2012, ESSENTIAL PHYS MED I, P501; Chae MP, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00025; CLARKE AJ, 1994, PHYS MED BIOL, V39, P1677, DOI 10.1088/0031-9155/39/10/011; Culjat MO, 2010, ULTRASOUND MED BIOL, V36, P861, DOI 10.1016/j.ultrasmedbio.2010.02.012; David F, 2007, EQUINE VET J, V39, P79, DOI 10.2746/042516407X153093; De Lasalle J, 2016, VET RADIOL ULTRASOUN, V57, P489, DOI 10.1111/vru.12370; deSouza MV, 2016, BRAZ ARCH BIOL TECHN, V59; Favier V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189486; Fox V, 2013, J VET MED EDUC, V40, P152, DOI 10.3138/jvme.0912-083R1; Goodrich LR, 2006, VET J, V171, P51, DOI 10.1016/j.tvjl.2004.07.008; Herdrich MRA, 2017, AM J VET RES, V78, P1077, DOI 10.2460/ajvr.78.9.1077; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; JEFFCOTT LB, 1982, EQUINE VET J, V14, P185, DOI 10.1111/j.2042-3306.1982.tb02389.x; Johnson JP, 2017, VET COMP ORTHOPAED, V30, P165, DOI [10.3415/VCOT-16-09-0139, 10.3415/vcot-16-09-0139]; Kidd JA, 2001, EQUINE VET EDUC, V13, P160, DOI 10.1111/j.2042-3292.2001.tb00082.x; Kleider N., 2013, Proceedings of the 59th Annual Convention of the American Association of Equine Practitioners, Nashville, Tennessee, USA, 7-11 December 2013, P220; Kremkau FW, 2016, SONOGRAPHY PRINCIPLE, P183; Mattoon JS, 2004, VET RADIOL ULTRASOUN, V45, P238, DOI 10.1111/j.1740-8261.2004.04042.x; McIlwraith CW, 2012, BONE JOINT RES, V1, P297, DOI 10.1302/2046-3758.111.2000132; McMenamin PG, 2014, ANAT SCI EDUC, V7, P479, DOI 10.1002/ase.1475; Mitsouras D, 2015, RADIOGRAPHICS, V35, P1966, DOI 10.1148/rg.2015140320; Motola I, 2013, MED TEACH, V35, pE1511, DOI 10.3109/0142159X.2013.818632; Mowry SE, 2015, OTOL NEUROTOL, V36, P1562, DOI 10.1097/MAO.0000000000000848; Nielsen JV, 2003, EQUINE VET J, V35, P637; RADIN EL, 1991, SEMIN ARTHRITIS RHEU, V21, P12, DOI 10.1016/0049-0172(91)90036-Y; Sorensen JL, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-016-0838-3; Takahashi K, 2017, ANN OTO RHINOL LARYN, V126, P530, DOI 10.1177/0003489417705395; Tatarinov A, 1999, MECH COMPOS MATER, V35, P147, DOI 10.1007/BF02257245; Whitcomb MB, 2016, VET RADIOL ULTRASOUN, V57, P199, DOI 10.1111/vru.12323; Ziv A, 2003, ACAD MED, V78, P783, DOI 10.1097/00001888-200308000-00006	34	7	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220332	10.1371/journal.pone.0220332	http://dx.doi.org/10.1371/journal.pone.0220332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386687	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100018
J	DiBartolomeis, M; Kegley, S; Mineau, P; Radford, R; Klein, K				DiBartolomeis, Michael; Kegley, Susan; Mineau, Pierre; Radford, Rosemarie; Klein, Kendra			An assessment of acute insecticide toxicity loading (AITL) of chemical pesticides used on agricultural land in the United States	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDES; SEED TREATMENTS; TREATED SEEDS; SOYBEAN APHID; HONEY-BEES; EXPOSURE; CONTAMINATION; POLLINATORS; MANAGEMENT	We present a method for calculating the Acute Insecticide Toxicity Loading (AITL) on US agricultural lands and surrounding areas and an assessment of the changes in AITL from 1992 through 2014. The AITL method accounts for the total mass of insecticides used in the US, acute toxicity to insects using honey bee contact and oral LD50 as reference values for arthropod toxicity, and the environmental persistence of the pesticides. This screening analysis shows that the types of synthetic insecticides applied to agricultural lands have fundamentally shifted over the last two decades from predominantly organophosphorus and N-methyl carbamate pesticides to a mix dominated by neonicotinoids and pyrethroids. The neonicotinoids are generally applied to US agricultural land at lower application rates per acre; however, they are considerably more toxic to insects and generally persist longer in the environment. We found a 48- and 4-fold increase in AITL from 1992 to 2014 for oral and contact toxicity, respectively. Neonicotinoids are primarily responsible for this increase, representing between 61 to nearly 99 percent of the total toxicity loading in 2014. The crops most responsible for the increase in AITL are corn and soybeans, with particularly large increases in relative soybean contributions to AITL between 2010 and 2014. Oral exposures are of potentially greater concern because of the relatively higher toxicity (low LD(50)s) and greater likelihood of exposure from residues in pollen, nectar, guttation water, and other environmental media. Using AITL to assess oral toxicity by class of pesticide, the neonicotinoids accounted for nearly 92 percent of total AITL from 1992 to 2014. Chlorpyrifos, the fifth most widely used insecticide during this time contributed just 1.4 percent of total AITL based on oral LD(50)s. Although we use some simplifying assumptions, our screening analysis demonstrates an increase in pesticide toxicity loading over the past 26 years, which potentially threatens the health of honey bees and other pollinators and may contribute to declines in beneficial insect populations as well as insectivorous birds and other insect consumers.	[DiBartolomeis, Michael; Kegley, Susan] Toxicol Res Int, Haiku, HI 96708 USA; [Radford, Rosemarie] Pesticide Res Inst Inc, Santa Rosa, CA USA; [Mineau, Pierre] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [Klein, Kendra] Friends Earth US, Berkeley, CA USA	Carleton University	DiBartolomeis, M (corresponding author), Toxicol Res Int, Haiku, HI 96708 USA.	mjd@toxicologistint.com			Friends of the Earth U.S. (FOE)	Friends of the Earth U.S. (FOE)	This study was funded by Friends of the Earth U.S. (FOE). MD, SK, RR, and PM received research fees as contractors to FOE. KK is a staff scientist at FOE. SK and RR are paid employees of the Pesticide Research Institute (PRI). The specific roles of these authors are articulated in the "author contributions." The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Alkassab AT, 2017, J PLANT DIS PROTECT, V124, P1, DOI 10.1007/s41348-016-0041-0; Arena M, 2014, ECOTOXICOLOGY, V23, P324, DOI 10.1007/s10646-014-1190-1; Aufauvre J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00326; Baker N. T., 2017, ESTIMATED ANN AGR PE; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Byrne FJ, 2014, PEST MANAG SCI, V70, P470, DOI 10.1002/ps.3596; CDPR, 2015, 2015 STAT REP PEST C; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; David A, 2016, ENVIRON INT, V88, P169, DOI 10.1016/j.envint.2015.12.011; Dorsey J, 2006, 2006P00028 OFF INSP; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; Douglas MR, 2015, J APPL ECOL, V52, P250, DOI 10.1111/1365-2664.12372; Gaspar AP, 2014, AGRON J, V106, P1955, DOI 10.2134/agronj14.0277; Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Goulson D, 2018, PEERJ, V6, DOI 10.7717/peerj.5255; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gustafson D, 2011, FUNDAMENTAL CONCEPTS; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Heard MS, 2017, SCI TOTAL ENVIRON, V578, P357, DOI 10.1016/j.scitotenv.2016.10.180; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Hopwood J., 2016, NEONICOTINOIDS CAN K; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2012, PESTICIDES HONEY BEE; Kaplan M, 2016, FOOD TECHNOL BIOTECH, V54, P497, DOI [10.17113/ftb.54.04.16.4635, 10.17113/ft b.54.04.16.4635]; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kurwadkar S, 2016, ENVIRON TOXICOL CHEM, V35, P1718, DOI 10.1002/etc.3335; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; Le Conte Y, 2008, REV SCI TECH OIE, V27, P485, DOI 10.20506/rst.27.2.1819; Lee-Mader E., 2013, BIRDS BEES EFFECTS N; Lewis KA, 2016, HUM ECOL RISK ASSESS, V22, P1050, DOI 10.1080/10807039.2015.1133242; Li Y, 2018, ENVIRON SCI POLLUT R, V25, P31318, DOI 10.1007/s11356-018-3121-9; Long EY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11629; Lopez JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40853; Lundgren JG, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500558; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Millot F, 2017, ENVIRON SCI POLLUT R, V24, P5469, DOI 10.1007/s11356-016-8272-y; Mineau P., 2018, NEONICOTINOID INSECT; Moffat C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24764; Mogren CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29608; Morrissey CA, 2015, ENVIRON INT, V74, P291, DOI 10.1016/j.envint.2014.10.024; Mullin CA, 2015, PESTIC BIOCHEM PHYS, V120, P27, DOI 10.1016/j.pestbp.2014.12.026; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; NPIC, 2011, IMIDACLOPRID TECHNIC; Nuyttens D, 2013, PEST MANAG SCI, V69, P564, DOI 10.1002/ps.3485; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Raimets R, 2018, PEST MANAG SCI, V74, P541, DOI 10.1002/ps.4756; Samson-Robert O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108443; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Stewart SD, 2014, ENVIRON SCI TECHNOL, V48, P9762, DOI 10.1021/es501657w; Stone W.W., 2015, US GEOLOGICAL SURVEY, V907; Stone Wesley W, 2013, US GEOLOGICAL SURVEY, V752; Turnbull LA, 2010, NATURE, V466, P36, DOI 10.1038/466036a; U.S. EPA, 2015, GUID CALC REPR HALF; United States Environmental Protection Agency, SUMM FED INS FUNG RO; University of Hertfordshire, 2017, PEST PROP DAT BAS PP; US EPA, EPA PUBL C, V7501C; US EPA, 2016, PROC REQ EXP EFF TES; US EPA, 2010, FED REGISTER, V75, P5584; USDA, 2014, 2012 CENS AGR US SUM; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Wood TJ, 2017, ENVIRON SCI POLLUT R, V24, P17285, DOI 10.1007/s11356-017-9240-x; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547; Zhu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178421; Zhu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176837	70	73	74	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220029	10.1371/journal.pone.0220029	http://dx.doi.org/10.1371/journal.pone.0220029			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386666	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100014
J	van den Berg, EH; Corsetti, JP; Bakker, SJL; Dullaart, RPF				van den Berg, Eline H.; Corsetti, James P.; Bakker, Stephan J. L.; Dullaart, Robin P. F.			Plasma ApoE elevations are associated with NAFLD: The PREVEND Study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; APOLIPOPROTEIN-E POLYMORPHISM; FATTY LIVER-DISEASE; CATALYTIC ACTIVITY CONCENTRATIONS; E GENOTYPES; HEPATIC STEATOSIS; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK; STEATOHEPATITIS	Non-alcoholic fatty liver disease (NAFLD) is featured by increased plasma very low density lipoproteins (VLDL). The extent to which plasma apolipoprotein E (ApoE) levels are elevated in NAFLD is unclear. We determined whether plasma ApoE is elevated in subjects with suspected NAFLD. Plasma ApoE and genotypes were determined in 6,762 participants of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) cohort. A Fatty Liver Index (FLI) >= 60 was used as a proxy of NAFLD. A total of 1,834 participants had a FLI >= 60, which coincided with increased triglycerides, non-HDL cholesterol, ApoB and ApoE (all P< 0.001). In multivariable linear regression analysis, plasma ApoE levels were positively associated with an elevated FLI when taking account of ApoE genotypes and other clinical and laboratory covariates (fully adjusted model: beta = 0.201, P< 0.001). Stratified analysis for ApoE genotypes (ApoE epsilon 3 epsilon 3 homozygotes, ApoE epsilon 2 carriers, and ApoE epsilon 3 epsilon 4 and epsilon 4 epsilon 4 carriers combined), also showed positive associations of plasma ApoE levels with an elevated FLI in each group (all P< 0.001). In conclusion, it is suggested that NAFLD is characterized by increased plasma ApoE levels, even when taking account of the various ApoE geno-types. Increased plasma ApoE may contribute to altered VLDL metabolism and to increased atherosclerosis susceptibility in NAFLD.	[van den Berg, Eline H.; Dullaart, Robin P. F.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [van den Berg, Eline H.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Corsetti, James P.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA; [Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Rochester; University of Groningen	van den Berg, EH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands.; van den Berg, EH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.	e.h.van.den.berg@umcg.nl		van den Berg, Eline H./0000-0003-2703-2320	Dutch Kidney Foundation [E.033]; Dade Behring; Ausam; Roche; Abbott; Dutch Heart Foundation [2001-005]	Dutch Kidney Foundation; Dade Behring; Ausam; Roche(Roche Holding); Abbott(Abbott Laboratories); Dutch Heart Foundation(Netherlands Heart Foundation)	The Dutch Kidney Foundation supported the infrastructure of the PREVEND program from 1997 to 2003 (Grant E.033). The University Medical Center Groningen supported the infrastructure from 2003 to 2006. Dade Behring, Ausam, Roche, and Abbott financed laboratory equipment and reagents by which various laboratory determinations could be performed. The Dutch Heart Foundation supported studies on lipid metabolism (Grant 2001-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; ALLAN CM, 1995, GENOMICS, V28, P291, DOI 10.1006/geno.1995.1144; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Batal R, 2000, J LIPID RES, V41, P706; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Benedict M, 2017, WORLD J HEPATOL, V9, P715, DOI 10.4254/wjh.v9.i16.715; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Blaauwwiekel EE, 1998, DIABETIC MED, V15, P1031, DOI 10.1002/(SICI)1096-9136(1998120)15:12<1031::AID-DIA705>3.0.CO;2-6; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Borggreve SE, 2005, J CLIN ENDOCR METAB, V90, P4198, DOI 10.1210/jc.2005-0182; Bril F, 2016, J CLIN ENDOCR METAB, V101, P644, DOI 10.1210/jc.2015-3111; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Cali AMG, 2007, DIABETES CARE, V30, P3093, DOI 10.2337/dc07-1088; Cohn JS, 1996, ARTERIOSCL THROM VAS, V16, P149, DOI 10.1161/01.ATV.16.1.149; Corsetti JP, 2016, J CLIN LIPIDOL, V10, P842, DOI 10.1016/j.jacl.2016.03.003; Corsetti JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039110; Corsetti JP, 2012, METABOLISM, V61, P996, DOI 10.1016/j.metabol.2011.11.010; Curtiss LK, 2000, CURR OPIN LIPIDOL, V11, P243, DOI 10.1097/00041433-200006000-00004; Davignon J, 1999, CLIN CHIM ACTA, V286, P115, DOI 10.1016/S0009-8981(99)00097-2; De Feo E, 2012, MOL BIOL REP, V39, P7381, DOI 10.1007/s11033-012-1570-7; DEMANT T, 1991, J CLIN INVEST, V88, P1490, DOI 10.1172/JCI115459; Demirag MD, 2007, DIGEST DIS SCI, V52, P3399, DOI 10.1007/s10620-007-9740-5; Dullaart RPF, 2013, ATHEROSCLEROSIS, V230, P6, DOI 10.1016/j.atherosclerosis.2013.06.019; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Fabbrini E, 2008, GASTROENTEROLOGY, V134, P424, DOI 10.1053/j.gastro.2007.11.038; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gaidukov L, 2005, BIOCHEMISTRY-US, V44, P11843, DOI 10.1021/bi050862i; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Greenow K, 2005, J MOL MED, V83, P329, DOI 10.1007/s00109-004-0631-3; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gruppen EG, 2018, AM J CLIN NUTR, V108, P1283, DOI 10.1093/ajcn/nqy217; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jiang ZG, 2016, LIVER INT, V36, P1213, DOI 10.1111/liv.13076; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Kappelle PJWH, 2011, J INTERN MED, V269, P232, DOI 10.1111/j.1365-2796.2010.02323.x; Karavia EA, 2011, FEBS J, V278, P3119, DOI 10.1111/j.1742-4658.2011.08238.x; Kunutsor SK, 2017, CLIN CHIM ACTA, V466, P54, DOI 10.1016/j.cca.2017.01.008; Lee Dong-Min, 2002, Taehan Kan Hakhoe Chi, V8, P355; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Luc G, 1997, ATHEROSCLEROSIS, V131, P257, DOI 10.1016/S0021-9150(97)00053-1; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Mooijaart SP, 2006, PLOS MED, V3, P874, DOI 10.1371/journal.pmed.0030176; MYKLEBOST O, 1988, HUM GENET, V78, P244, DOI 10.1007/BF00291670; Nass KJ, 2017, METABOLISM, V72, P37, DOI 10.1016/j.metabol.2017.04.004; Nayyar G, 2012, ATHEROSCLEROSIS, V224, P326, DOI 10.1016/j.atherosclerosis.2012.05.040; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; PLUMP AS, 1995, ANNU REV NUTR, V15, P495, DOI 10.1146/annurev.nu.15.070195.002431; Puoti C, 2017, EUR J INTERN MED, V46, P1, DOI 10.1016/j.ejim.2017.06.024; RALL SC, 1982, J BIOL CHEM, V257, P4171; Rasmussen KL, 2016, ATHEROSCLEROSIS, V246, P63, DOI 10.1016/j.atherosclerosis.2015.12.038; Riches FM, 1998, J LIPID RES, V39, P1752; Sazci A, 2008, DIGEST DIS SCI, V53, P3218, DOI 10.1007/s10620-008-0271-5; Schierwagen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12931; Schumann G, 2002, CLIN CHEM LAB MED, V40, P734, DOI 10.1515/CCLM.2002.126; Schumann G, 2002, CLIN CHEM LAB MED, V40, P725, DOI 10.1515/CCLM.2002.125; Schumann G, 2002, CLIN CHEM LAB MED, V40, P718, DOI 10.1515/CCLM.2002.124; SMIT M, 1988, HUM GENET, V80, P287, DOI 10.1007/BF01790099; Soderlund S, 2010, METABOLISM, V59, P1502, DOI 10.1016/j.metabol.2010.01.015; Stachowska E, 2013, J PHYSIOL PHARMACOL, V64, P711; van den Berg EH, 2019, J LIPID RES, V60, P168, DOI 10.1194/jlr.P088997; van den Berg EH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171502; Welty FK, 2000, ARTERIOSCL THROM VAS, V20, P1807, DOI 10.1161/01.ATV.20.7.1807; Yang MH, 2005, HEPATO-GASTROENTEROL, V52, P1832	69	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220659	10.1371/journal.pone.0220659	http://dx.doi.org/10.1371/journal.pone.0220659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386691	gold, Green Published, Green Submitted			2022-12-27	WOS:000484997100030
J	Reddy, PRK; Kumar, DS; Rao, ER; Seshiah, CV; Sateesh, K; Reddy, PK; Hyder, I				Reddy, P. Ravi Kanth; Kumar, D. Srinivasa; Rao, E. Raghava; Seshiah, Ch Venkata; Sateesh, K.; Reddy, Pradeep Kumar; Hyder, Iqbal			Assessment of eco-sustainability vis-a-vis zoo-technical attributes of soybean meal (SBM) replacement with varying levels of coated urea in Nellore sheep (Ovis aries)	PLOS ONE			English	Article							SLOW-RELEASE UREA; METABOLISM; RUMEN; RUMINANTS; CARBON; FIBER; DIETS	The contemporary environmental-stewardship programmes primarily aimed at curbing the global warming potential by adopting a multidisciplinary approach. Manipulating the feeding strategies has great potential in reducing the environmental footprints of livestock production. This study intends to assess the effect of soybean meal (SBM) replacement with varying levels of coated urea (SRU) on both zoo-technical (nutrient digestibility, heat increment, and physio-biochemical parameters) and environmental attributes. The coated urea was used to replace the SBM at 0, 25, 50, and 75 percent levels. Eight adult rams (43.02 +/- 0.76) maintained in a conventional shed were used in a replicated 4 x 4 Latin square design. Not all the physiological parameters viz. rectal temperature, pulse rate, and respiratory rate were affected (P> 0.05) f by varying levels of SRU incorporation. The SRU fed animals had higher (P< 0.05) crude protein digestibility compared to SBM fed animals; however, the replacements did not affect the nutrient digestibility coefficients of DM, OM, NFC, NDFap, ADF, and hemicellulose components. The SRU did not affect various biochemical parameters such as serum glucose, total protein, albumin, globulin, urea, creatinine, ALT, AST, Ca, P and T3, and T4 levels; however, post-prandial serum urea N (SUN) values showed a diurnal quadratic pattern (P< 0.05) with a dose-dependent relationship. Further, the SBM replacements had no effect on the calcium excretion, while the SRU incorporation decreased the faecal phosphorous content, thereby abating the eutrophication phenomenon. Although the SBM replacements did not affect in vivo water variables and faecal solid fractions, they managed to decrease the land and virtual water requirement along with global warming potential (GWP) of the entire trial. The GWP-perceptual map unveils the fact that replacement of conventional feed ingredients with NPN compounds aids in eco-friendly livestock production. Further, the conjectural analysis of the carbon footprint methodology revealed that agricultural by-products consideration could cause a huge increase in the GWP share of feed consumed, thus compelling the importance of research pertaining to feed production perspective as equal as ruminal methane amelioration.	[Reddy, P. Ravi Kanth] Sri Venkateswara Vet Univ, Coll Vet Sci, Livestock Farm Complex, Proddutur, Andhra Pradesh, India; [Kumar, D. Srinivasa] Sri Venkateswara Vet Univ, NTR Coll Vet Sci, Dept Anim Nutr, Gannavaram, Andhra Pradesh, India; [Rao, E. Raghava] Sri Venkateswara Vet Univ, Adm Bldg, Tirupati, Andhra Pradesh, India; [Seshiah, Ch Venkata] Sri Venkateswara Vet Univ, NTR Coll Vet Sci, Livestock Farm Complex, Gannavaram, Andhra Pradesh, India; [Sateesh, K.] Sri Venkateswara Vet Univ, AH Polytech Coll, Banavasi, Andhra Pradesh, India; [Reddy, Pradeep Kumar] Sri Venkateswara Vet Univ, Coll Vet Sci, Ctr Continuing Vet Educ & Commun, Tirupati, Andhra Pradesh, India; [Hyder, Iqbal] Sri Venkateswara Vet Univ, NTR Coll Vet Sci, Dept Vet Physiol, Gannavaram, Andhra Pradesh, India	Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University; Sri Venkateswara Veterinary University	Hyder, I (corresponding author), Sri Venkateswara Vet Univ, NTR Coll Vet Sci, Dept Vet Physiol, Gannavaram, Andhra Pradesh, India.	iqbvet@gmail.com	POONOORU, RAVIKANTH REDDY/AAU-5144-2020	POONOORU, RAVIKANTH REDDY/0000-0003-2451-2783				Adom F, 2012, INT J LIFE CYCLE ASS, V17, P520, DOI 10.1007/s11367-012-0386-y; Ali Y, 2018, RENEW SUST ENERG REV, V81, P1813, DOI 10.1016/j.rser.2017.05.277; Almora EGA, 2012, ANIM FEED SCI TECH, V171, P136, DOI 10.1016/j.anifeedsci.2011.10.012; [Anonymous], 2007, 200704 AOAC; [Anonymous], 1970, P 5 S EN MET; Audsley E., 2009, ESTIMATION GREENHOUS; Benedeti PDB, 2014, LIVEST SCI, V165, P51, DOI 10.1016/j.livsci.2014.04.027; Block H. C., 2004, Professional Animal Scientist, V20, P319; Capper Judith L, 2012, Animals (Basel), V2, P127, DOI 10.3390/ani2020127; Cherdthong A, 2011, LIVEST SCI, V136, P76, DOI 10.1016/j.livsci.2010.08.002; Clark JP, 2009, FOOD ENG SER, P1, DOI 10.1007/978-1-4419-0420-1_1; Constable P, 2016, TXB DIS CATTLE SHEEP; Cottle DJ, 2011, ANIM PROD SCI, V51, P491, DOI 10.1071/AN10163; Couch CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176830; Deru M, 2007, STUFF MIT ED, DOI DOI 10.2172/884990; Du TS, 2015, J EXP BOT, V66, P2253, DOI 10.1093/jxb/erv034; Favreau A, 2010, APPL ANIM BEHAV SCI, V125, P115, DOI 10.1016/j.applanim.2010.04.007; Galo E, 2003, J DAIRY SCI, V86, P2154, DOI 10.3168/jds.S0022-0302(03)73805-3; Gardinal R, 2017, ASIAN AUSTRAL J ANIM, V30, P34, DOI 10.5713/ajas.16.0058; Hall MB, 1998, ANIM FEED SCI TECH, V70, P23, DOI 10.1016/S0377-8401(97)00068-0; Highstreet A, 2010, LIVEST SCI, V129, P179, DOI 10.1016/j.livsci.2010.01.022; Hyder I, 2017, SHEEP PRODUCTION ADA, DOI [10.1007/978-981-10-4714-5_11, DOI 10.1007/978-981-10-4714-5_11]; Hyder I, 2017, HEAT SHOCK PROTEINS, V12, P3, DOI 10.1007/978-3-319-73377-7_1; Iglesias A., 2007, AD CLIM CHANG AGR SE; IPCC, 2019, REF 2006 IPCC GUID N, V5, P1; Jayaram K., 2016, THESIS; Kertz A. F., 2010, Professional Animal Scientist, V26, P257; Khattab IM, 2013, LIVEST SCI, V155, P223, DOI 10.1016/j.livsci.2013.05.024; Kitamura SS, 2010, CIENC RURAL, V40, P1779, DOI 10.1590/S0103-84782010005000131; Kohn R., 2007, P FLORIDA RUMINANT N, P1; Licitra G, 1996, ANIM FEED SCI TECH, V57, P347, DOI 10.1016/0377-8401(95)00837-3; Lizarazo AC, 2014, SMALL RUMINANT RES, V116, P28, DOI 10.1016/j.smallrumres.2013.10.009; Pinos-Rodriguez JM, 2010, ITAL J ANIM SCI, V9, P16, DOI 10.4081/ijas.2010.e4; Millen DD, 2009, J ANIM SCI, V87, P3427, DOI 10.2527/jas.2009-1880; Mynhardt H., 2017, THESIS; National Research Council, 2001, NUTR REQ BEEF CATTL; NRC, 2007, NUTR REQ SMALL RUM, DOI [10.17226/11654, DOI 10.17226/11654]; OWENS FN, 1980, J ANIM SCI, V50, P527, DOI 10.2527/jas1980.503527x; Patra A, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0145-9; Pretty J, 2014, ANN BOT-LONDON, V114, P1571, DOI 10.1093/aob/mcu205; Rahardja DP, 2011, ANIMAL, V5, P1587, DOI 10.1017/S1751731111000577; Schwalfenberg GK, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/727630; Sejian V, 2010, INT J BIOMETEOROL, V54, P653, DOI 10.1007/s00484-010-0341-1; Sharma SK, 2016, RES REV J VET SCI, V3, P1; Sinclair LA, 2012, ANIMAL, V6, P920, DOI 10.1017/S1751731111002485; SNIFFEN CJ, 1992, J ANIM SCI, V70, P3562, DOI 10.2527/1992.70113562x; STORM E, 1983, BRIT J NUTR, V50, P463, DOI 10.1079/BJN19830114; Sudarman A, 2000, ASIAN AUSTRAL J ANIM, V13, P1523, DOI 10.5713/ajas.2000.1523; Swainson N, 2018, ANIM PROD SCI, V58, P973, DOI 10.1071/AN15766; Thornton PK, 2010, 5178 WPS WORLD BANK; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Varma VS, 2018, FRONT SUSTAIN FOOD S, V2, DOI 10.3389/fsufs.2018.00033; Wallerstein I, 2012, J WORLD SYST RES, V18, P6; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Zhang SJ, 2016, J APPL ANIM RES, V44, P1, DOI 10.1080/09712119.2014.978779; Zheng G., 2011, AIS T HUMAN COMPUTER, V3, P82	56	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220252	10.1371/journal.pone.0220252	http://dx.doi.org/10.1371/journal.pone.0220252			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408459	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500010
J	Almerekova, S; Sariev, B; Abugalieva, A; Chudinov, V; Sereda, G; Tokhetova, L; Ortaev, A; Tsygankov, V; Blake, T; Chao, S; Genievskaya, Y; Abugalieva, S; Turuspekov, Y				Almerekova, Shyryn; Sariev, Burabai; Abugalieva, Aigul; Chudinov, Vladimir; Sereda, Grigoriy; Tokhetova, Laura; Ortaev, Anarbai; Tsygankov, Vladimir; Blake, Thomas; Chao, Shiaoman; Genievskaya, Yuliya; Abugalieva, Saule; Turuspekov, Yerlan			Association mapping for agronomic traits in six-rowed spring barley from the USA harvested in Kazakhstan	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENVIRONMENT INTERACTION; GENETIC-ANALYSIS; GRAIN-YIELD; SOFTWARE; GENOTYPE; QUALITY; LOCI; POPULATIONS; QTL	In barley, six-rowed barley is advantageous over two-rowed barley for feed due to the larger number of seeds per spike and the higher seed protein content. The growth of six-rowed barley is potentially important for breeding in agriculturally oriented countries, such as Kazakhstan. Nevertheless, until recently, very little attention was given to six-rowed barley in breeding projects in Kazakhstan, one of the largest countries in the world. In this study, phenotyping and single nucleotide polymorphism (SNP) genotyping data were generated from 275 accessions originating from six different breeding organizations in the USA as well as 9 accessions from Kazakhstan in field trials at six breeding institutions. The USA six-rowed barley was tested in comparison to local accessions over three years (2009-2011) based on analyses of key agronomic traits. It was determined that the average yield in the USA accessions in comparison to local lines showed heavier yield in all six tested sites. Principal Coordinate Analysis based on 1618 polymorphic SNP markers separated Kazakh lines from six USA barley origin groups based on PC1 (77.9%), and Montana lines from the remaining five USA groups based on PC2 (15.1%). A genome-wide association study based on eighteen field trials allowed the identification of 47 stable marker-trait associations (MTA) for ten agronomic traits, including key yield related characters such as yield per square meter, thousand grain weight, number of kernels per spike, and productive tillers. The comparison of chromosomal positions of identified MTA with positions of known genes and quantitative trait loci suggests that 25 out of those 47 MTAs are presumably novel. The analysis of 42 SNPs associated with 47 MTAs in the Ensemble genome annotation system (http://ensemblgenomes.org) suggested that 40 SNPs were in genic positions of the genome, as their sequences successfully aligned with corresponding Gen ID.	[Almerekova, Shyryn; Genievskaya, Yuliya; Abugalieva, Saule; Turuspekov, Yerlan] Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan; [Sariev, Burabai; Abugalieva, Aigul] Kazakh Res Inst Agr & Plant Ind, Almalybak, Almaty Region, Kazakhstan; [Chudinov, Vladimir] Karabalyk Breeding Stn, Nauchnyi, Kostanai Region, Kazakhstan; [Sereda, Grigoriy] Karaganda Breeding Stn, Tsentralnoe, Karaganda Regio, Kazakhstan; [Tokhetova, Laura] Kazakh Res Inst Rice, Kyzylorda, Kazakhstan; [Ortaev, Anarbai] Krasnovodopad Breeding Stn, Sarkyrama, Turkestan Regio, Kazakhstan; [Tsygankov, Vladimir] Aktobe Breeding Stn, Aktobe, Aktobe Region, Kazakhstan; [Blake, Thomas] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Chao, Shiaoman] USDA ARS, Biosci Res Lab, Fargo, ND 58105 USA; [Abugalieva, Saule; Turuspekov, Yerlan] Al Farabi Kazakh Natl Univ, Dept Biodivers & Bioresources, Alma Ata, Kazakhstan	Institute of Plant Biology & Biotechnology in Kazakhstan; Kazakh Scientific Research Institute of Plant Protection & Quarantine of Zh.Zhienbaev; Montana State University System; Montana State University Bozeman; United States Department of Agriculture (USDA); Al-Farabi Kazakh National University	Turuspekov, Y (corresponding author), Inst Plant Biol & Biotechnol, Alma Ata, Kazakhstan.; Turuspekov, Y (corresponding author), Al Farabi Kazakh Natl Univ, Dept Biodivers & Bioresources, Alma Ata, Kazakhstan.	yerlant@yahoo.com	Genievskaya, Yuliya/AAF-2410-2019; Turuspekov, Yerlan/C-3458-2011; Almerekova, Shyryn/AAO-1157-2020; Tokhetova, Laura/AAC-6892-2021; Abugalieva, Saule/M-6690-2015	Genievskaya, Yuliya/0000-0001-5987-2952; Turuspekov, Yerlan/0000-0001-8590-1745; Tokhetova, Laura/0000-0003-2053-6956; Abugalieva, Saule/0000-0002-9748-507X; Almerekova, Shyryn/0000-0002-6079-264X	Ministry of Education and Sciences of the Republic of Kazakhstan [0109PK00329]	Ministry of Education and Sciences of the Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This work was supported by the grant 0109PK00329 funded by the Ministry of Education and Sciences of the Republic of Kazakhstan (2009-2011), (http://edu.gov.kz/kz/) to TY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD RW, 1988, J HERED, V79, P225, DOI 10.1093/oxfordjournals.jhered.a110503; Alqudah AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113120; Aw-Hassan A, 2003, CROP VARIETY IMPROVE, P242; Bayer MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01792; Bellucci A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173313; Berger GL, 2013, THEOR APPL GENET, V126, P693, DOI 10.1007/s00122-012-2011-7; Blake VC, 2012, PLANT GENOME-US, V5, P81, DOI 10.3835/plantgenome2012.03.0002; Bowman JGP, 2001, CROP SCI, V41, P863, DOI 10.2135/cropsci2001.413863x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Cockram J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045307; Costa JM, 2001, THEOR APPL GENET, V103, P415, DOI 10.1007/s001220100622; Casao MC, 2011, J EXP BOT, V62, P1939, DOI 10.1093/jxb/erq382; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Franckowiak J.D., 1997, BARLEY GENET NEWSL, V26, P9; Genievskaya Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205421; Hayes PM, 2003, DEV PL GEN, V7, P201, DOI 10.1016/S0168-7972(03)80012-9; Hu X, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01683; IBSC, 2016, HIGH RES GBS MAP MOR, DOI [10.5447/ipk/2016/29, DOI 10.5447/IPK/2016/29]; Igartua E, 2013, GENET RESOUR CROP EV, V60, P251, DOI 10.1007/s10722-012-9831-9; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Liller CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140246; Mangini G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190162; Mohammadi M, 2015, THEOR APPL GENET, V128, P705, DOI 10.1007/s00122-015-2465-5; Munoz-Amatriain M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094688; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pauli D., 2014, PLANT GENOME, V7, P3, DOI DOI 10.3835/PLANTGEN0ME2013.11.0037; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pswarayi A, 2008, EUPHYTICA, V163, P435, DOI 10.1007/s10681-008-9726-1; Reynolds MP, 2002, FIELD CROP RES, V75, P139, DOI 10.1016/S0378-4290(02)00023-0; RIGGS TJ, 1978, J AGR SCI, V91, P199, DOI 10.1017/S0021859600056768; Rode J, 2012, MOL BREEDING, V30, P831, DOI 10.1007/s11032-011-9667-6; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Saade S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32586; Sameri M, 2006, BREEDING SCI, V56, P243, DOI 10.1270/jsbbs.56.243; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Sharma R, 2018, J EXP BOT, V69, P3811, DOI 10.1093/jxb/ery178; TAKAHASHI R, 1951, BER OHARA I LANDWIRT, V9, P399; Turuspekov Y, 2008, CEREAL CHEM, V85, P817, DOI 10.1094/CCHEM-85-6-0817; Turuspekov Y, 2005, PLANT BREEDING, V124, P542, DOI 10.1111/j.1439-0523.2005.01161.x; Turuspekov Y, 2013, RUSS J GENET+, V49, P196, DOI 10.1134/S1022795413020129; Turuspekov Y, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0686-z; Turuspekov Y, 2014, BREEDING SCI, V64, P399, DOI 10.1270/jsbbs.64.399; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Xu X, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.08.0073; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	53	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0221064	10.1371/journal.pone.0221064	http://dx.doi.org/10.1371/journal.pone.0221064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404111	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800052
J	Cao, XS; Li, SC				Cao, Xiaoshu; Li, Shengchao			Spatio-temporal evolution of port opening in China's 40 years of reform and opening-up period	PLOS ONE			English	Article							SPATIAL DATA; BORDER; LOGISTICS	In the past 40 years of reform and opening-up, China has developed from an economically closed country to a country that is highly dependent on foreign trade. From the perspective of spatiotemporal evolution, we analyze how port opening promoted China's reform and opening-up process. First, the port development process is divided into four periods. In the start-up period, the pilot open port policy created a platform for foreign cooperation and exchange. During the expansion period, port openings promoted the continuous optimization of the trade structure. In the cooperation period, port openings corresponded with the adjustment of China's overall industrial structure. During the optimization period, port openings provided guarantees for the implementation of a national development strategy. Second, we analyze the distribution of ports and their relationship with cross-border logistics and passenger flow. Based on data of foreign trade and passenger flow, a port openness degree measurement model includes port logistics intensity, passenger flow intensity and port city foreign-trade volume is constructed. There are significant types, geographical differences and grade differences of ports' openness.	[Cao, Xiaoshu; Li, Shengchao] Sun Yat Sen Univ, Sch Geog & Planning, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Li, SC (corresponding author), Sun Yat Sen Univ, Sch Geog & Planning, Guangzhou, Guangdong, Peoples R China.	lishengchao@qq.com		Li, Shengchao/0000-0002-5947-3457	National Natural Science Foundation of China [41671160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Natural Science Foundation of China, No. 41671160, to X. Cao.	Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Anselin L, 2004, ECONOMETRICS SPATIAL, P1; Baldwin RobertE., 1988, TRADE POLICY ISSUES, P147; Brunet-Jailly E., 2010, EURASIAN BORD REV, V1, P1; Chen S., 2002, WORLD REGIONAL STUDI, P50, DOI [10.3969/j.issn.1004-9479.2002.03.008, DOI 10.3969/J.ISSN.1004-9479.2002.03.008]; [陈威 Chen Wei], 2016, [地理与地理信息科学, Geography and Geo-information Science], V32, P53; Chen XQ, 2019, J NAVIGATION, V72, P176, DOI 10.1017/S0373463318000504; CHENG KL, 2001, WORLD REGIONAL STUDI, P91, DOI DOI 10.3969/J.ISSN.1004-9479.2001.02.014; China Association of Port-of-Entry, 2001, CHIN PORTS OF ENTRY; Cong Z., 2010, ECON GEOGR, V30, P1937, DOI [10.15957/j.cnki.jjdl.2010.12.010, DOI 10.15957/J.CNKI.JJDL.2010.12.010]; Dai A., 2005, FUDAN J SOC SCI, V4, P71, DOI DOI 10.3969/J.ISSN.0257-0289.2005.04.009; Demsar U, 2013, ANN ASSOC AM GEOGR, V103, P106, DOI 10.1080/00045608.2012.689236; [邓锋 DENG Feng], 2006, [干旱区地理, Arid Land Geography], V29, P422; DING X, 1994, AUTOMATIC CONTROL - WORLD CONGRESS 1993, VOL 5, P383; Dinu O, 2017, IOP CONF SER-MAT SCI, V227, DOI 10.1088/1757-899X/227/1/012038; DOLLAR D, 1992, ECON DEV CULT CHANGE, V40, P523, DOI 10.1086/451959; Edwards S, 1998, ECON J, V108, P383, DOI 10.1111/1468-0297.00293; Fang S, 2006, J YUNNAN U SOCIAL SC, DOI [10.3969/j.issn.1671-7511.2006.04.007, DOI 10.3969/J.ISSN.1671-7511.2006.04.007]; Feng G., 2005, WORLD REG STUD, V14, P53, DOI [DOI 10.3969/J.ISSN.1004-9479.2005.01.009, 10.3969/j.issn.1004-9479.2005.01.009]; Fremont A, 2007, J TRANSP GEOGR, V15, P431, DOI 10.1016/j.jtrangeo.2007.01.005; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 2016, COD PORTS OTH LOC PE; Gu XS, 2000, ASIAN SURV, V40, P1042; [郭建科 Guo Jianke], 2010, [地理科学进展, Progress in Geography], V29, P1490; Ha MH, 2017, TRANSPORT RES E-LOG, V103, P1, DOI 10.1016/j.tre.2017.04.008; Hilmola OP, 2015, RES TRANSP BUS MANAG, V14, P72, DOI 10.1016/j.rtbm.2014.10.010; Hu Z, 1993, URBAN PROBLEMS, DOI [10.13239/j.bjsshkxy.cswt.1993.03.011, DOI 10.13239/J.BJSSHKXY.CSWT.1993.03.011]; Johnson C, 2011, POLIT GEOGR, V30, P61, DOI 10.1016/j.polgeo.2011.01.002; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; Liang Z, 2012, WORLD REGIONAL STUDI, P97, DOI [10.3969/j.issn.1004-9479.2012.02.012, DOI 10.3969/J.ISSN.1004-9479.2012.02.012]; Mao L, 2005, J HIST SCI, P37, DOI [10.3969/j.issn.0583-0214.2005.12.009, DOI 10.3969/J.ISSN.0583-0214.2005.12.009]; Monios J, 2012, MARIT POLICY MANAG, V39, P207, DOI 10.1080/03088839.2011.650720; Notteboom T. E., 2005, MARIT POL MANAG, V32, P297, DOI DOI 10.1080/03088830500139885; Rodrigue JP, 2010, J TRANSP GEOGR, V18, P497, DOI 10.1016/j.jtrangeo.2010.03.006; Rodrigue JP, 2009, MARIT POLICY MANAG, V36, P165, DOI 10.1080/03088830902861086; Sachs J, 1995, HARVARD I EC RES WOR, V35, P1, DOI [10.2307/2534573, DOI 10.2307/2534573]; [宋长青 Song Changqing], 2018, [地理研究, Geographical Research], V37, P3; [宋周莺 Song Zhouying], 2015, [地理科学进展, Progress in Geography], V34, P589; Stewart TP, 1999, DRAKE J AGR LAW, V4, P243; Tavasszy L, 2011, J TRANSP GEOGR, V19, P1163, DOI 10.1016/j.jtrangeo.2011.05.005; Veenstra AW., 2005, J TRANSP GEOGR, V13, P295, DOI [10.1016/j.jtrangeo.2004.07.006, DOI 10.1016/J.JTRANGEO.2004.07.006]; Wang JE, 2014, SUSTAINABILITY-BASEL, V6, P7089, DOI 10.3390/su6107089; Wang JF, 2016, ECOL INDIC, V67, P250, DOI 10.1016/j.ecolind.2016.02.052; Wang JF, 2012, POPUL ENVIRON, V33, P186, DOI 10.1007/s11111-011-0142-4; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang L, 1999, ECON GEOGR, DOI [10.15957/j.cnki.jjdl.1999.05.005, DOI 10.15957/J.CNKI.JJDL.1999.05.005]; [王伟 Wang Wei], 2016, [地理学报, Acta Geographica Sinica], V71, P1752; Wang Y, 2014, MODERN URBAN RES, P55, DOI [10.3969/j.issn.1009-6000.2014.07.009, DOI 10.3969/J.ISSN.1009-6000.2014.07.009]; Wei HR, 2018, MARIT POLICY MANAG, V45, P53, DOI 10.1080/03088839.2017.1403052; Xia Q, 1994, INT EC COOPERATION, P10; Xu L, 2017, J NW NORMAL U SOCIAL, P76, DOI [10.16783/j.cnki.nwnus.2017.03.010, DOI 10.16783/J.CNKI.NWNUS.2017.03.010]; [于晓华 Yu Xiaohua], 2016, [干旱区地理, Arid Land Geography], V39, P967; Zhang B, 2013, CHEMOTHERAPY, V2, P108, DOI DOI 10.13727/J.CNKI.53-1191/C.2013.02.020; Zhang G, 2003, JILIN NORMAL U J NAT, P57, DOI [10.16862/j.cnki.issn1674-3873.2003.03.019, DOI 10.16862/J.CNKI.ISSN1674-3873.2003.03.019]; Zhang L, 2016, J MINZU U CHINA PHIL, P109, DOI [10.15970/j.cnki.1005-8575.2016.01.015, DOI 10.15970/J.CNKI.1005-8575.2016.01.015]; Zhang PY, 2002, CHINESE GEOGR SCI, V12, P315, DOI 10.1007/s11769-002-0035-7; ZHOU J, 2001, SCI GEOGRAPHICA SINI, P481, DOI DOI 10.13249/J.CNKI.SGS.2001.06.001	56	1	1	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220912	10.1371/journal.pone.0220912	http://dx.doi.org/10.1371/journal.pone.0220912			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404093	gold, Green Published			2022-12-27	WOS:000485006800042
J	Ledezma, CA; Zhou, X; Rodriguez, B; Tan, PJ; Diaz-Zuccarini, V				Ledezma, Carlos A.; Zhou, Xin; Rodriguez, Blanca; Tan, P. J.; Diaz-Zuccarini, Vanessa			A modeling and machine learning approach to ECG feature engineering for the detection of ischemia using pseudo-ECG	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; ELECTROPHYSIOLOGICAL PROPERTIES; MYOCARDIAL-INFARCTION; HEART-DISEASE; QT INTERVAL; REPOLARIZATION; VARIABILITY; REFRACTORINESS; POPULATIONS; DISPERSION	Early detection of coronary heart disease (CHD) has the potential to prevent the millions of deaths that this disease causes worldwide every year. However, there exist few automatic methods to detect CHD at an early stage. A challenge in the development of these methods is the absence of relevant datasets for their training and validation. Here, the ten Tusscher-Panfilov 2006 model and the O'Hara-Rudy model for human myocytes were used to create two populations of models that were in concordance with data obtained from healthy individuals (control populations) and included inter-subject variability. The effects of ischemia were subsequently included in the control populations to simulate the effects of mild and severe ischemic events on single cells, full ischemic cables of cells and cables of cells with various sizes of ischemic regions. Action potential and pseudo-ECG biomarkers were measured to assess how the evolution of ischemia could be quantified. Finally, two neural network classifiers were trained to identify the different degrees of ischemia using the pseudo-ECG biomarkers. The control populations showed action potential and pseudo-ECG biomarkers within the physiological ranges and the trends in the biomarkers commonly identified in ischemic patients were observed in the ischemic populations. On the one hand, inter-subject variability in the ischemic pseudo-ECGs precluded the detection and classification of early ischemic events using any single biomarker. On the other hand, the neural networks showed sensitivity and positive predictive value above 95%. Additionally, the neural networks revealed that the biomarkers that were relevant for the detection of ischemia were different from those relevant for its classification. This work showed that a computational approach could be used, when data is scarce, to validate proof-of-concept machine learning methods to detect ischemic events.	[Ledezma, Carlos A.; Tan, P. J.; Diaz-Zuccarini, Vanessa] UCL, Dept Mech Engn, London, England; [Zhou, Xin; Rodriguez, Blanca] Univ Oxford, Dept Comp Sci, Oxford, England; [Diaz-Zuccarini, Vanessa] UCL, Wellcome EPSRC Ctr Intervent & Surg Sci WEISS, Dept Med Phys & Biomed Engn, London W1W 7TS, England	University of London; University College London; University of Oxford; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of London; University College London	Diaz-Zuccarini, V (corresponding author), UCL, Dept Mech Engn, London, England.; Diaz-Zuccarini, V (corresponding author), UCL, Wellcome EPSRC Ctr Intervent & Surg Sci WEISS, Dept Med Phys & Biomed Engn, London W1W 7TS, England.	v.diaz@ucl.ac.uk	Zhou, Xin/AAR-3098-2021	Zhou, Xin/0000-0003-2814-3399; Tan, P.J./0000-0001-8098-8837; Rodriguez, Blanca/0000-0001-6361-3339	European Union [642612, 675451]; Leverhulme Trust [RF-2015-482]; Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS) [203145Z/16/Z]; Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences	European Union(European Commission); Leverhulme Trust(Leverhulme Trust); Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences(Wellcome Trust)	CL and VD received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 642612 under the VPH-CaSE ITN framework (http://vphcase.eu). VD received funding from the Leverhulme Trust through the Senior Research Fellowship "Exploring the Unknowable Using Simulation: Structural Uncertainty in Multiscale Models" (Fellowship number RF-2015-482). VD is also supported by the Wellcome/EPSRC Centre for Interventional and Surgical Sciences (WEISS) (203145Z/16/Z). BR and XZ are supported by BR's Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences and the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 675451 (CompBioMed project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CL and VD received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 642612 under the VPH-CaSE ITN framework (http://vph-case.eu). VD also received funding from the Leverhulme Trust through the Senior Research Fellowship "Exploring the Unknowable Using Simulation: Structural Uncertainty in Multiscale Models" (Fellowship number RF-2015-482). BR and XZ are supported by BR's Wellcome Trust Senior Research Fellowship in Basic Biomedical Sciences and the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 675451 (CompBioMed project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2017, INFORM SCIENCES, V415, P190, DOI 10.1016/j.ins.2017.06.027; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Britton OJ, 2017, ELECTROGENIC NA K PU; Britton OJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00597; CINCA J, 1981, AM J CARDIOL, V48, P1023, DOI 10.1016/0002-9149(81)90315-5; Coronel R, 2012, HEART RHYTHM, V9, P977, DOI 10.1016/j.hrthm.2012.01.021; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Datta S, 2017, INT CONF SOFT COMP, P1; De Bacquer D, 1998, HEART, V80, P570, DOI 10.1136/hrt.80.6.570; Dutta AMS, 2013, COMPUT CARDIOL CONF, V40, P691; Dutta S, 2017, PROG BIOPHYS MOL BIO, V129, P40, DOI 10.1016/j.pbiomolbio.2017.02.007; Dutta S, 2016, PROG BIOPHYS MOL BIO, V120, P236, DOI 10.1016/j.pbiomolbio.2016.01.008; Garson G.D., 1991, AI EXPERT, V6, P46; Gemmell P, 2016, PROG BIOPHYS MOL BIO, V121, P169, DOI 10.1016/j.pbiomolbio.2016.06.003; Gima K, 2002, CIRC RES, V90, P889, DOI 10.1161/01.RES.0000016960.61087.86; GOH ATC, 1995, ARTIF INTELL ENG, V9, P143, DOI 10.1016/0954-1810(94)00011-S; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goodfellow I., 2016, DEEP LEARNING, DOI DOI 10.4258/HIR.2016.22.4.351; Hong S. J., 2017, P COMP CARD CINC 201, P1; Lines GT, 2017, IEEE T BIO-MED ENG, V64, P1305, DOI 10.1109/TBME.2016.2600198; Loewe A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/530352; Lu WG, 2010, COMPUT CARDIOL CONF, V37, P185; Lyon A, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0821; MAEDA T, 1992, CLIN CARDIOL, V15, P525, DOI 10.1002/clc.4960150710; Martinez JP, 2017, COMPUTING, V44, P1; Mckay MD, 2000, TECHNOMETRICS, V42, P55, DOI 10.2307/1271432; Michailova A, 2005, BIOPHYS J, V88, P2234, DOI 10.1529/biophysj.104.046284; Michelucci A, 1996, PACE, V19, P1905, DOI 10.1111/j.1540-8159.1996.tb03250.x; Moller CS, 2007, HEART; MORGAN JM, 1992, J AM COLL CARDIOL, V19, P1244, DOI 10.1016/0735-1097(92)90331-G; Muszkiewicz A, 2018, AM J PHYSIOL-HEART C, V314, pH895, DOI 10.1152/ajpheart.00477.2017; Muszkiewicz A, 2016, PROG BIOPHYS MOL BIO, V120, P115, DOI 10.1016/j.pbiomolbio.2015.12.002; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Passini E, 2016, J MOL CELL CARDIOL, V96, P72, DOI 10.1016/j.yjmcc.2015.09.003; Pettersson J, 2000, AM HEART J, V139, P352, DOI 10.1016/S0002-8703(00)90246-1; Plonsey R., 2007, BIOELECTRICITY QUANT; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Sanchez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105897; Schiesser W., 2012, NUMERICAL METHOD LIN; Shaw RM, 1997, CIRC RES, V80, P124, DOI 10.1161/01.RES.80.1.124; Sutton PMI, 2000, HEART, V84, P365, DOI 10.1136/heart.84.4.365; Taggart P, 2001, CARDIOVASC RES, V50, P454, DOI 10.1016/S0008-6363(01)00223-1; Teijeiro T, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.166-054; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Wilhelms M, 2011, IEEE T BIO-MED ENG, V58, P2961, DOI 10.1109/TBME.2011.2159381; Wood G, 2014, MED DECIS MAKING, V34, P75, DOI 10.1177/0272989X13492016; Zabihi M, 2017, COMPUT CARDIOL CONF, V44, DOI 10.22489/CinC.2017.069-336; Zhou X, 2016, CIRC RES, V118, P266, DOI 10.1161/CIRCRESAHA.115.307836	49	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220294	10.1371/journal.pone.0220294	http://dx.doi.org/10.1371/journal.pone.0220294			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404081	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800011
J	Ruoff, P; Agafonov, O; Tveit, DM; Thorsen, K; Drengstig, T				Ruoff, Peter; Agafonov, Oleg; Tveit, Daniel M.; Thorsen, Kristian; Drengstig, Tormod			Homeostatic controllers compensating for growth and perturbations	PLOS ONE			English	Article							ROBUST PERFECT ADAPTATION; FEEDBACK; PRINCIPLE; KINETICS; SIGNAL	Cells and organisms have developed homeostatic mechanisms which protect them against a changing environment. How growth and homeostasis interact is still not well understood, but of increasing interest to the molecular and synthetic biology community to recognize and design control circuits which can oppose the diluting effects of cell growth. In this paper we describe the performance of selected negative feedback controllers in response to different applied growth laws and time dependent outflow perturbations of a controlled variable. The approach taken here is based on deterministic mass action kinetics assuming that cell content is instantaneously mixed. All controllers behave ideal in the sense that they for stepwise perturbations in volume and a controlled compound A are able to drive A precisely back to the controllers' theoretical set-points. The applied growth kinetics reflect experimentally observed growth laws, which range from surface to volume ratio growth to linear and exponential growth. Our results show that the kinetic implementation of integral control and the structure of the negative feedback loop are two properties which affect controller performance. Best performance is observed for controllers based on derepression kinetics and controllers with an autocatalytic implementation of integral control. Both are able to defend exponential growth and perturbations, although the autocatalytic controller shows an offset from its theoretical set-point. Controllers with activating signaling using zero-order or bimolecular (antithetic) kinetics for integral control behave very similar but less well. Their performance can be improved by implementing negative feedback structures having repression/derepression steps or by increasing controller aggressiveness. Our results provide a guide what type of feedback structures and integral control kinetics are suitable to oppose the dilution effects by different growth laws and time dependent perturbations on a deterministic level.	[Ruoff, Peter; Agafonov, Oleg] Univ Stavanger, Ctr Organelle Res, Stavanger, Norway; [Tveit, Daniel M.; Thorsen, Kristian; Drengstig, Tormod] Univ Stavanger, Dept Elect Engn & Comp Sci, Stavanger, Norway; [Agafonov, Oleg] Oslo Univ Hosp, Inst Canc Res, Oslo, Norway	Universitetet i Stavanger; Universitetet i Stavanger; University of Oslo	Ruoff, P (corresponding author), Univ Stavanger, Ctr Organelle Res, Stavanger, Norway.	peter.ruoff@uis.no			University of Stavanger	University of Stavanger	This research was financed in part by Program Area Funds from the University of Stavanger to PR and TD. There was no additional external funding received for this study. The University of Stavanger (funder) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bernard C., 1957, INTRO LIT CORRES TON; Briat C, 2016, ACS SYNTH BIOL, V5, P1108, DOI 10.1021/acssynbio.6b00014; Briat C, 2016, CELL SYST, V2, P15, DOI [10.1016/j.cels.2016.02.010, 10.1016/j.cels.2016.01.004]; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; DEANGELIS DL, 1980, POSITIVE FEEDBACK NA; Drengstig T, 2012, BIOPHYS J, V103, P2000, DOI 10.1016/j.bpj.2012.09.033; Drengstig T, 2012, J PHYS CHEM B, V116, P5355, DOI 10.1021/jp3004568; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Ferrell JE, 2016, CELL SYST, V2, P62, DOI 10.1016/j.cels.2016.02.006; Fjeld G, 2017, J PHYS CHEM B, V121, P6097, DOI 10.1021/acs.jpcb.7b01989; Forger DB, 2017, BIOL CLOCKS RHYTHMS; FRANCIS BA, 1976, AUTOMATICA, V12, P457, DOI 10.1016/0005-1098(76)90006-6; FROMME P, 2008, PHOTOSYNTHETIC PROTE; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Gomez-Schiavon M, 2018, CURR OPIN MICROBIOL, V45, P47, DOI 10.1016/j.mib.2018.01.004; Goodwin B., 1963, TEMPORAL ORG CELLS; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; ISIDORI A, 1990, IEEE T AUTOMAT CONTR, V35, P131, DOI 10.1109/9.45168; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Jacques-Silva MC, 2010, P NATL ACAD SCI USA, V107, P6465, DOI 10.1073/pnas.0908935107; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Langley L. L., 1973, HOMEOSTASIS ORIGINS; Leibiger IB, 2002, FEBS LETT, V532, P1, DOI 10.1016/S0014-5793(02)03627-X; Lim B, 2013, P NATL ACAD SCI USA, V110, P10330, DOI 10.1073/pnas.1303635110; Mrosovsky N., 1990, RHEOSTASIS PHYSL CHA; Ni XY, 2009, BIOPHYS J, V97, P1244, DOI 10.1016/j.bpj.2009.06.030; Peters A, 2007, AM J PHYSIOL-REG I, V293, pR83, DOI 10.1152/ajpregu.00907.2006; Poza-Carrion C, 2014, J BACTERIOL, V196, P595, DOI 10.1128/JB.00942-13; Qian YL, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0902; Radhakrishnan K., 1993, NASA REFERENCE PUBLI; Risvoll GB, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13408; Schmalhausen I, 1930, Wilhelm Roux Arch Entwickl Mech Org, V121, P726, DOI 10.1007/BF00583349; Selye H, 1938, AM J PHYSIOL, V123, P758, DOI 10.1152/ajplegacy.1938.123.3.758; Selye H, 1975, STRESS LIFE, DOI [10.1016/j.cels.2016.02.006, DOI 10.1016/J.CELS.2016.02.006]; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Smith JH, 1924, NEW PHYTOL, V2, P65, DOI [DOI 10.1111/J.1469-8137.1924.TB06621.X, 10.1111/j.1469-8137.1924.tb06621.x]; Sontag ED, 2003, SYST CONTROL LETT, V50, P119, DOI 10.1016/S0167-6911(03)00136-1; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Thorsen K, 2018, BIORXIV; Thorsen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107766; UMBARGER HE, 1961, COLD SPRING HARB SYM, V26, P301, DOI 10.1101/SQB.1961.026.01.036; von Bertalanffy L., 1960, FUNDAMENTAL ASPECTS, P137, DOI 10.1016/b978-0-408-10638-2.50012-4; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; VONBERTALANFFY L, 1951, AM NAT, V85, P111, DOI 10.1086/281659; Wilkie J, 2002, CONTROL ENG INTRODUC; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	50	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0207831	10.1371/journal.pone.0207831	http://dx.doi.org/10.1371/journal.pone.0207831			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404092	Green Published, Green Submitted, gold			2022-12-27	WOS:000485006800001
J	Starks, MA; Sanders, GD; Coeytaux, RR; Riley, IL; Jackson, LR; Brooks, AM; Thomas, KL; Choudhury, KR; Califf, RM; Hernandez, AF				Starks, Monique Anderson; Sanders, Gillian D.; Coeytaux, Remy Rene; Riley, Isaretta L.; Jackson, Larry R., II; Brooks, Amanda McBroom; Thomas, Kevin L.; Choudhury, Kingshuk Roy; Califf, Robert M.; Hernandez, Adrian F.			Assessing heterogeneity of treatment effect analyses in health-related cluster randomized trials: A systematic review	PLOS ONE			English	Review							ACUTE CORONARY SYNDROMES; PRIMARY-CARE; PHARMACIST INTERVENTION; REGULATORY ISSUES; ASTHMA; MANAGEMENT; PROGRAM	Background Cluster-randomized trials (CRTs) are being increasingly used to test a range of interventions, including medical interventions commonly used in clinical practice. Policies created by the NIH and the Food and Drug Administration (FDA) require the reporting of demographics and the examination of demographic heterogeneity of treatment effect (HTE) for individually randomized trials. Little is known about how frequent demographics are reported and HTE analyses are conducted in CRTs. Objectives We sought to understand the prevalence of HTE analyses and the statistical methods used to conduct them in CRTs focused on treating cardiovascular disease, cancer, and chronic lower respiratory diseases. Additionally, we also report on the proportion of CRTs that reported on baseline demographics of its populations and conducted demographic HTE analyses. Data sources We searched PubMed and Embase for CRTs published between 1/1/2010 and 3/29/2016 that focused on treating the top 3 Center for Disease Control causes of death (cardiovascular disease, chronic lower respiratory disease, and cancer). Evidence Screening And Review: Of 1,682 unique titles, 117 abstracts were screened. After excluding 53 articles, we included 64 CRT publications and abstracted information on study characteristics and demographic information, statistical analysis, HTE analysis, and study quality. Results Age and sex were reported in greater than 95.3% of CRTs, while race and ethnicity were reported in only 20.3% of CRTs. HTE analyses were conducted in 28.1% (n = 18) of included CRTs and 77.8% (n = 12) were prespecified analyses. Four CRTs conducted a demographic subgroup analysis. Only 6/ 18 CRTs used interaction testing to determine whether HTE existed. Conclusions Baseline demographic reporting was high for age and sex in CRTs, but was uncommon for race and ethnicity. HTE analyses were uncommon and was rare for demographic subgroups, which limits the ability to examine the extent of benefits or risks for treatments tested with CRT designs.	[Starks, Monique Anderson; Sanders, Gillian D.; Jackson, Larry R., II; Brooks, Amanda McBroom; Thomas, Kevin L.; Califf, Robert M.; Hernandez, Adrian F.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27708 USA; [Starks, Monique Anderson; Sanders, Gillian D.; Jackson, Larry R., II; Thomas, Kevin L.; Califf, Robert M.; Hernandez, Adrian F.] Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA; [Coeytaux, Remy Rene] Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC USA; [Riley, Isaretta L.] Duke Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care, Durham, NC 27706 USA; [Choudhury, Kingshuk Roy] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA	Duke University; Duke University; Wake Forest University; Duke University; Duke University	Starks, MA (corresponding author), Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC 27708 USA.; Starks, MA (corresponding author), Duke Univ, Sch Med, Dept Med, Div Cardiol, Durham, NC 27706 USA.	monique.starks@duke.edu			National Institutes of Health [3U54AT007748-02S1]; Health Care Systems Research Collaboratory Coordinating Center from the National Institutes of Health [1U54AT007748-01]; National Center for Complementary & Integrative Health [U54AT007748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Care Systems Research Collaboratory Coordinating Center from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported primarily by the National Institutes of Health Common Fund research supplements to promote diversity in health-related research under award number 3U54AT007748-02S1, and the Health Care Systems Research Collaboratory Coordinating Center under award number 1U54AT007748-01 from the National Institutes of Health. The views presented here are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in the authoring or revision of this manuscript.	Anderson ML, 2015, CLIN TRIALS, V12, P276, DOI 10.1177/1740774515571140; [Anonymous], 1998, Fed Regist, V63, P6854; Berwanger O, 2012, JAMA-J AM MED ASSOC, V307, P2041, DOI 10.1001/jama.2012.413; Califf RM, 2015, CLIN TRIALS, V12, P436, DOI 10.1177/1740774515598334; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Casey D, 2013, THORAX, V68, P922, DOI 10.1136/thoraxjnl-2012-203103; Costantini M, 2014, LANCET, V383, P226, DOI 10.1016/S0140-6736(13)61725-0; Du X, 2014, CIRC-CARDIOVASC QUAL, V7, P217, DOI 10.1161/CIRCOUTCOMES.113.000526; Eldridge Sandra M, 2004, Clin Trials, V1, P80, DOI 10.1191/1740774504cn006rr; Flather MD, 2011, AM HEART J, V162, P700, DOI 10.1016/j.ahj.2011.07.027; Garbutt JM, 2015, J ALLERGY CLIN IMMUN, V135, P1163, DOI 10.1016/j.jaci.2014.09.033; Garcia-Cardenas V, 2013, RESP MED, V107, P1346, DOI 10.1016/j.rmed.2013.05.014; Hemming K, 2018, STAT MED, V37, P883, DOI 10.1002/sim.7553; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hostler David, 2011, BMJ, V342, pd512, DOI 10.1136/bmj.d512; Kruis AL, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5392; Lowrie R, 2012, EUR HEART J, V33, P314, DOI 10.1093/eurheartj/ehr433; Nichol G, 2015, NEW ENGL J MED, V373, P2203, DOI 10.1056/NEJMoa1509139; Office of Extramural Research National Institutes of Health, 2001, NIH POL GUID INCL WO; Perkins GD, 2015, LANCET, V385, P947, DOI 10.1016/S0140-6736(14)61886-9; Smith JR, 2012, THORAX, V67, P1052, DOI 10.1136/thoraxjnl-2012-202093; Stiell IG, 2011, NEW ENGL J MED, V365, P787, DOI 10.1056/NEJMoa1010076; Tamblyn R, 2015, J AM MED INFORM ASSN, V22, P773, DOI 10.1093/jamia/ocu009; U.S. Office of Management and Budget, 1997, REVISIONS TO THE STA; US FDA, 2013, FDA REP COLL AN AV D; US Food and Drug Administration (US FDA), 2005, GUID IND COLL RAC ET; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0219894	10.1371/journal.pone.0219894	http://dx.doi.org/10.1371/journal.pone.0219894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404063	Green Submitted, Green Published, gold			2022-12-27	WOS:000485006800009
J	Wang, C; Li, XF; Xiong, ZQ; Wang, C; Su, CD; Zhang, YH				Wang, Cheng; Li, Xuefeng; Xiong, Zuqiang; Wang, Chun; Su, Chengdong; Zhang, Yaohui			Experimental study on the effect of grouting reinforcement on the shear strength of a fractured rock mass	PLOS ONE			English	Article								To study the strengthening mechanism and effect underlying the reinforcement of a fractured rock mass with grouting, compressive shear tests were conducted with an RMT-150B rock mechanics test system. Prefabricated structural surfaces were strengthened with a new inorganic dual-liquid grouting material at five water-cement ratios (0.6-1.5). The effects of these water-cement ratios of the grouting on the deformation, strength, and failure characteristics of the prefabricated structural surface were analyzed. The results show that reinforcement with grouting significantly influenced the bearing capacity of the structural surface. The shear strength of the structure was significantly improved and the deformation resistance of the structural surface was enhanced. The shear stress-displacement curves, generated in compressive shear tests of the grouting-reinforced structures, were all nonlinear. The shearing process comprised three stages: elasticity, yield, and failure. Decreasing the water-cement ratio of the grouting material weakened the plasticity of the grouted structural surface and enhanced its brittleness. The deformation type changed from plastic slip to brittle shear. The shear strength, cohesion, and angle of internal friction of the grouting-reinforced structural surface increased with decreasing water-cement ratio.	[Wang, Cheng; Li, Xuefeng; Xiong, Zuqiang; Wang, Chun; Su, Chengdong] Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China; [Wang, Cheng; Xiong, Zuqiang; Wang, Chun; Su, Chengdong] Henan Collaborat Innovat Ctr Coal Work Safety, Jiaozuo, Henan, Peoples R China; [Zhang, Yaohui] Henan Coll Ind & Informat Technol, Jiaozuo, Henan, Peoples R China; [Zhang, Yaohui] Henan Polytech Univ, Dept Energy Sci & Engn, Jiaozuo, Henan, Peoples R China	Henan Polytechnic University; Henan Polytechnic University	Li, XF; Xiong, ZQ (corresponding author), Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China.; Xiong, ZQ (corresponding author), Henan Collaborat Innovat Ctr Coal Work Safety, Jiaozuo, Henan, Peoples R China.	wangchengcumt@163.com; xzqjzit@163.com		Wang, Cheng/0000-0001-7168-1921	Henan University Science and Technology Innovative Talents Program [17HASTIT032]; Program for Innovative Research Team of Ningbo Novel Photoelectric Materials and Devices (CN) [CXTD2017088]	Henan University Science and Technology Innovative Talents Program; Program for Innovative Research Team of Ningbo Novel Photoelectric Materials and Devices (CN)	The specific grant numbers are Henan University Science and Technology Innovative Talents Program and Program for Innovative Research Team of Ningbo Novel Photoelectric Materials and Devices (CN), the award number are 17HASTIT032 and CXTD2017088, respectively. Initials of authors who received each award is CW. The funders (other than the named authors) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El Aziz MA, 2012, CONSTR BUILD MATER, V26, P310, DOI 10.1016/j.conbuildmat.2011.06.026; BANDIS S, 1981, INT J ROCK MECH MIN, V18, P1, DOI 10.1016/0148-9062(81)90262-X; Guo GL, 2000, J CHINA U MINING TEC, V29, P293; Han LJ, 2011, ROCK SOIL MECH, V32, P2570; He Man-chao, 2001, CHINESE J ROCK MECH, V20, P225; [李世海 Li Shihai], 2006, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V25, P1125; Li TY, 2012, CHINESE J ROCK MECH, V31, P3936; Lin P, 2016, ROCK MECH ROCK ENG, V49, P115, DOI 10.1007/s00603-015-0732-z; Liu QS., 2017, CHIN J ROCK MECH ENG, V36, P3140; Liu QS, 2018, ROCK MECH ROCK ENG, V51, P613, DOI 10.1007/s00603-017-1340-x; Pantelidis L, 2009, INT J ROCK MECH MIN, V46, P315, DOI 10.1016/j.ijrmms.2008.06.003; SHEN Ming-rong, 2010, CHINESE J UNDERGROUN, V6, P38; Soler JM, 2011, APPL GEOCHEM, V26, P1115, DOI 10.1016/j.apgeochem.2011.04.001; Tremblay D, 2007, P OTTAWAGEO, P2011; [吴文平 Wu Wenping], 2011, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V30, P1782; Xuan DY, 2015, ROCK MECH ROCK ENG, V48, P2435, DOI 10.1007/s00603-015-0710-5; Yin JH, 2009, J GEOTECH GEOENVIRON, V135, P1198, DOI 10.1061/(ASCE)GT.1943-5606.0000045; Zhang FS, 2010, TUNN UNDERGR SP TECH, V25, P99, DOI 10.1016/j.tust.2009.09.006; [赵宇飞 Zhao Yufei], 2013, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V32, P1229; Zong Y.J., 2013, J MIN SAF ENG, V4, P483	20	4	4	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0220643	10.1371/journal.pone.0220643	http://dx.doi.org/10.1371/journal.pone.0220643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5GN	31404074	gold, Green Published, Green Submitted			2022-12-27	WOS:000485006800021
J	Wyper, GMA; Grant, I; Fletcher, E; McCartney, G; Stockton, DL				Wyper, Grant M. A.; Grant, Ian; Fletcher, Eilidh; McCartney, Gerry; Stockton, Diane L.			The impact of worldwide, national and sub-national severity distributions in Burden of Disease studies: A case study of cancers in Scotland	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN	Background Increasingly Burden of Disease (BOD) measures are being used to influence policy decisions because they summarise the complete effects of morbidity and mortality in an equitable manner. An important element of producing non-fatal BOD estimates are severity distributions. The Global Burden of Disease (GBD) study use the same severity distributions across countries due to a lack of available country-specific data. In the Scottish BOD (SBOD) study we developed national severity distributions for cancer types. The main aim of this study was to consider the extent to which the use of worldwide severity distributions in BOD studies are influencing cross-country comparisons, by comparing weighted-average disability weights (DW) based on GBD severity distributions with nationally derived severity distributions in Scotland for cancer types. Methods We obtained individual records from the Scottish Cancer Registry for 21 cancer types and linked these to registered deaths. We estimated prevalent cancer cases for 2016 and assigned each case to sequelae using GBD 2016 study definitions. We compared the impact of using severity distributions based on GBD 2016, a Scotland-wide distribution, and distributions specific to deprivation strata in Scotland, on the weighted-average DW for each cancer type. Results The relative difference in point estimates of weighted-average DW based on GBD 2016 worldwide severity distributions compared with Scottish national severity distributions resulted in overestimates in the majority of cancers (17 out of 21 cancer types). The largest overestimates were for gallbladder and biliary tract cancer (70.8%), oesophageal cancer (31.6%) and pancreatic cancer (31.2%). Furthermore, the use of weighted-average DW based on Scottish national severity distributions rather than sub-national Scottish severity distributions stratified by deprivation quintile overestimated weighted-average DW in the least deprived areas (16 out of 18 cancer types), and underestimated in the most deprived areas (16 out of 18 cancer types). Conclusion Our findings illustrate a bias in point estimates of weighted-average DW created using worldwide severity distributions. This bias would have led to the misrepresentation of non-fatal estimates of the burden of individual cancers, and underestimated the scale of socioeconomic inequality in this non-fatal burden. This highlights the importance of not interpreting non-fatal estimates of burden of disease too precisely, especially for sub-national estimates and those comparing populations when relying on data inputs from other countries. It is essential to ensure that any estimates are based upon country-specific data as far as possible.	[Wyper, Grant M. A.; McCartney, Gerry; Stockton, Diane L.] NHS Hlth Scotland, Publ Hlth Sci Directorate, Glasgow, Lanark, Scotland; [Grant, Ian; Fletcher, Eilidh] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland	NHS National Services Scotland	Wyper, GMA (corresponding author), NHS Hlth Scotland, Publ Hlth Sci Directorate, Glasgow, Lanark, Scotland.	gwyper@nhs.net	Wyper, Grant/AAF-2382-2020	Wyper, Grant/0000-0003-2854-5822; McCartney, Gerry/0000-0001-6341-3521	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	We would like to acknowledge the GBD 2016 cancer collaborators for making detailed and transparent model definitions publically available as part of the GBD 2016 technical appendix. Additionally, we would like to thank members of the European Commission funded 'Joint Action on Health Information (InfAct)' workshop in Paris in April 2019 for productive discussions on the use of severity distributions in BOD studies.	AbouZahr C, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1299978; Burstein R, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0064-y; Devleesschauwer B, 2018, EUR J PUBLIC HEALTH, V28, P283; Global Burden of Disease Collaborative Network, 2017, GLOB BURD DIS STUD 2; Grant I, 2018, SCOTLANDS POPULATION; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Information Services Division Scotland, COLORECTAL CANC; Information Services Division Scotland, LUNG CANC MES; Information Services Division Scotland, SCOTT CANC REG; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; King NB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195338; Leyland AH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-172; Marinho F, 2018, LANCET, V392, P760, DOI 10.1016/S0140-6736(18)31221-2; Mesalles-Naranjo O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196906; Murray C.J, 1996, GLOBAL BURDEN DIS CO; National Center for Health Statistics Centers for Disease Control and Prevention, US MORT FIL 61 YEAR; National Records of Scotland, VIT EV DEATHS; O'Donovan MR, 2018, EUR J PUBLIC HEALTH, V28, P773, DOI 10.1093/eurpub/cky060; Ock M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2904-5; Rommel A, 2018, BUNDESGESUNDHEITSBLA, V61, P1159, DOI 10.1007/s00103-018-2793-0; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Sankaranarayanan R, 2011, CANC SURVIVAL AFRICA; Scottish Government, 2016, SCOTT IND MULT DEPR; Scottish Government, LONG TERM MON HLTH I; Spasoff RA, 1986, P WORKSH COMP LINK H; Steel N, 2018, LANCET, V392, P1647, DOI [10.1016/S0140-6736(18)32207-4, 10.1016/s0140-6736(18)32207-4]; Turan JM, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1246-9; United States Department of Health & Human Services, INT CLASS DIS 9 REV; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	29	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221026	10.1371/journal.pone.0221026	http://dx.doi.org/10.1371/journal.pone.0221026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398232	Green Published, gold, Green Submitted			2022-12-27	WOS:000485004000043
J	Criado-Mesas, L; Ballester, M; Crespo-Piazuelo, D; Castello, A; Benitez, R; Fernandez, AI; Folch, JM				Criado-Mesas, Lourdes; Ballester, Maria; Crespo-Piazuelo, Daniel; Castello, Anna; Benitez, Rita; Isabel Fernandez, Ana; Folch, Josep M.			Analysis of porcine IGF2 gene expression in adipose tissue and its effect on fatty acid composition	PLOS ONE			English	Article							GROWTH-FACTOR-II; IGF2-INTRON3-G3072A SUBSTITUTION; IMPRINTED QTL; MEAT QUALITY; MUSCLE MASS; SKELETAL; POPULATION; METABOLISM; DEPOSITION; VARIANTS	IGF2:g.3072G>A polymorphism has been described as the causal mutation of a maternally imprinted QTL for muscle growth and fat deposition in pigs. The objective of the current work was to study the association between the IGF2:g.3072G>A polymorphism and the IGF2 gene expression and its effect on fatty acid composition in adipose tissue in different pig genetic backgrounds. A cis-eQTL region associated with the IGF2 mRNA expression in adipose tissue was identified in an eGWAS with 355 animals. The IGF2 gene was located in this genomic interval and IGF2g.3072G>A was the most significant SNP, explaining a 25% of the gene expression variance. Significant associations between IGF2:g.3072G>A polymorphism and oleic (C18:1(n-9); p-value = 4.18x10(-07)), hexadecanoic (C16:1(n-9); p-value = 4.04x10(-07)), linoleic (C18:2(n-6); p-value = 6.44x10(-09)), alpha-linoleic (C18:3(n-3); p-value = 3.30x10(-06)), arachidonic (C20:4(n-6); p-value = 9.82x10(-08)) FAs and the MUFA/PUFA ratio (p-value = 2.51x10(-9)) measured in backfat were identified. Animals carrying the A allele showed an increase in IGF2 gene expression and higher PUFA and lower MUFA content. However, in additional studies was observed that there could be other proximal genetic variants affecting FA composition in adipose tissue. Finally, no differences in the IGF2 gene expression in adipose tissue were found between heterozygous animals classified according to the IGF2:g.3072G>A allele inherited from the father (A(P)G(M) or A(M)G(P)). However, pyrosequencing analysis revealed that there is imprinting of the IGF2 gene in muscle and adipose tissues, with stronger differences among the paternally and maternally inherited alleles in muscle. Our results suggested that IGF2:g.3072G>A polymorphism plays an important role in the regulation of IGF2 gene expression and can be involved in the fatty acid composition in adipose tissue. In both cases, further studies are still needed to deepen the mechanism of regulation of IGF2 gene expression in adipose tissue and the IGF2 role in FA composition.	[Criado-Mesas, Lourdes; Crespo-Piazuelo, Daniel; Castello, Anna; Folch, Josep M.] UB, UAB, IRTA, Dept Genom Anim,Ctr Recerca Agrigenom CRAG,CSIC, Barcelona, Spain; [Ballester, Maria] IRTA, Dept Genet & Millora Anim, Caldes De Montbui, Spain; [Crespo-Piazuelo, Daniel; Castello, Anna; Folch, Josep M.] UAB, Fac Vet, Dept Ciencia Anim & Aliments, Bellaterra, Spain; [Benitez, Rita; Isabel Fernandez, Ana] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Mejora Genet Anim, Madrid, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; IRTA; Autonomous University of Barcelona; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Criado-Mesas, L (corresponding author), UB, UAB, IRTA, Dept Genom Anim,Ctr Recerca Agrigenom CRAG,CSIC, Barcelona, Spain.	lourdes.criado@cragenomica.es	Fernández, Ana Isabel/J-3265-2012; Benítez, Rita/AAL-6381-2020; Ballester, Maria/E-7201-2016; Crespo-Piazuelo, Daniel/K-2280-2015; Farré, Anna Castelló/K-9637-2015; Folch, Josep M/I-4738-2015	Fernández, Ana Isabel/0000-0002-1509-5191; Ballester, Maria/0000-0002-5413-4640; Crespo-Piazuelo, Daniel/0000-0001-7896-2507; Farré, Anna Castelló/0000-0001-8497-6251; Criado Mesas, Lourdes/0000-0002-1115-4131; BENITEZ, RITA/0000-0001-7459-2836; Folch, Josep M/0000-0003-3689-1303	Spanish Ministerio de Economia y Competitividad (MINECO); Fondo Europeo de Desarrollo Regional (FEDER) [AGL2014-56369-C2, AGL2017-82641-R]; FPI grant [AGL2014-56369-C2]; "Ramon y Cajal" contract from the Spanish Ministerio de Economia y Competitividad [RYC-2013-12573]; "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya [ECO/1788/2014]; Spanish Ministerio de Economia y Competitividad [SEV-2015-0533]	Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); FPI grant; "Ramon y Cajal" contract from the Spanish Ministerio de Economia y Competitividad; "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya; Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO) and the Fondo Europeo de Desarrollo Regional (FEDER) with project references: AGL2014-56369-C2 and AGL2017-82641-R (http://www.mineco.gob.es/portal/site/mineco/and http://ec.europa.eu/regional_policy/es/funding/erdf/). LCM was financially supported by a FPI grant from the AGL2014-56369-C2 project. MB was funded with a "Ramon y Cajal" contract (RYC-2013-12573) from the Spanish Ministerio de Economia y Competitividad. DCP was funded by a "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya (ECO/1788/2014). We acknowledge the support of the Spanish Ministerio de Economia y Competitividad for the "Severo Ochoa Programme for Centres of Excellence in R&D" 2016-2019 (SEV-2015-0533) to the Centre for Research in Agricultural Genomics and the CERCA Programme/Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfares MN, 2018, AM J PHYSIOL-ENDOC M, V315, pE1098, DOI 10.1152/ajpendo.00409.2017; Martinez JA, 2014, ADV NUTR, V5, P71, DOI 10.3945/an.113.004705; Amaya I, 2005, SOCIETY, V11, P1405; Aslan O, 2012, MOL BIOL REP, V39, P4101, DOI 10.1007/s11033-011-1192-5; Ballester M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080385; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braunschweig MH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-47; Braunschweig MH, 2004, GENOMICS, V84, P1021, DOI 10.1016/j.ygeno.2004.09.006; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cianfarani Stefano, 2012, Front Endocrinol (Lausanne), V3, P118, DOI 10.3389/fendo.2012.00118; Estelle J, 2005, J ANIM SCI, V83, P2723; Faisal M, 2014, GENE, V533, P434, DOI 10.1016/j.gene.2013.10.006; Gardan D, 2008, DOMEST ANIM ENDOCRIN, V34, P45, DOI 10.1016/j.domaniend.2006.10.001; Hong J, 2015, MEAT SCI, V110, P46, DOI 10.1016/j.meatsci.2015.06.011; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; JANSEN GR, 1966, BIOCHEM J, V99, P323, DOI 10.1042/bj0990323; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Jungerius BJ, 2004, GENET RES, V84, P95, DOI 10.1017/S0016672304007098; Laggai S, 2014, J LIPID RES, V55, P1087, DOI 10.1194/jlr.M045500; Li C, 2008, ANIM BIOTECHNOL, V19, P22, DOI 10.1080/10495390701758563; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livingstone C, 2014, CLIN ENDOCRINOL, V80, P773, DOI 10.1111/cen.12446; Lopez-Buesa P, 2013, JOINT ANAL ADDITIVE, P133, DOI [10.1111/age.12091, DOI 10.1111/AGE.12091]; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Pavelic K, 2002, MOL MED, V8, P771, DOI 10.1007/BF03402082; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Puig-Oliveras A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31803; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramayo-Caldas Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-232; Ruan WJ, 2010, ACTA DIABETOL, V47, P5, DOI 10.1007/s00592-009-0142-3; Sambrook J., MOL CLONING LAB MANU; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Van Wyk JJ, 1999, J CLIN ENDOCR METAB, V84, P4349, DOI 10.1210/jc.84.12.4349; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	41	8	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220708	10.1371/journal.pone.0220708	http://dx.doi.org/10.1371/journal.pone.0220708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393967	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500055
J	Karuga, RN; Kok, M; Mbindyo, P; Hilverda, F; Otiso, L; Kavoo, D; Broerse, J; Dieleman, M				Karuga, Robinson Njoroge; Kok, Maryse; Mbindyo, Patrick; Hilverda, Femke; Otiso, Lilian; Kavoo, Daniel; Broerse, Jaqueline; Dieleman, Marjolein			"It's like these CHCs don't exist, are they featured anywhere?": Social network analysis of community health committees in a rural and urban setting in Kenya	PLOS ONE			English	Article							PARTICIPATION; SYSTEMS; POLICY; CARE	Background In Kenya, Community Health Committees (CHC) were established to enhance community participation in health services. Their role is to provide leadership, oversight in delivery of community health services, promote social accountability and mobilize resources for community health. CHCs form social networks with other actors, with whom they exchange health information for decision-making and accountability. This case study aimed to explore the structure of a rural and an urban CHC network and to analyze how health-related information flowed in these networks. Understanding the pathways of information in community settings may provide recommendations for strategies to improve the role and functioning of CHCs. Methods In 2017, we conducted 4 focus group discussions with 27 community discussants and 10 semi-structured interviews with health professionals in a rural area and an urban slum. Using social network analysis, we determined the structure of their social networks and how health related information flowed in these networks. Results Both CHCs were composed of respected persons nominated by their communities. Each social network had 12 actors that represented both community and government institutions. CHCs were not central actors in the exchange of health-related information. Health workers, community health volunteers and local Chiefs in the urban slum often passed information between the different groups of actors, while CHCs hardly did this. Therefore, CHCs had little control over the flow of health-related information. Although CHC members were respected persons who served in multiple roles within their communities, this did not enhance their centrality. It emerged that CHCs were often left out in the flow of health-related information and decision-making, which led to demotivation. Community health volunteers were more involved by other actors such as health managers and non-governmental organizations as a conduit for health-related information. Conclusion Social network analysis demonstrated how CHCs played a peripheral role in the flow of health-related information. Their perception of being left out of the information flow led to demotivation, which hampered their ability to facilitate community participation in community health services; hence challenging effective participation through CHCs.	[Karuga, Robinson Njoroge; Otiso, Lilian] LVCT Hlth, Nairobi, Kenya; [Karuga, Robinson Njoroge; Broerse, Jaqueline; Dieleman, Marjolein] Vrije Univ, Athena Inst, Amsterdam, Netherlands; [Kok, Maryse; Dieleman, Marjolein] Royal Trop Inst KIT, Amsterdam, Netherlands; [Mbindyo, Patrick] Jomo Kenyatta Univ Agr & Technol, Juja, Kenya; [Hilverda, Femke] Erasmus Univ, Sch Hlth Policy & Management, Rotterdam, Netherlands; [Kavoo, Daniel] Minist Hlth, Community Hlth & Dev Unit, Nairobi, Kenya; [Broerse, Jaqueline] Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Jomo Kenyatta University of Agriculture & Technology; Erasmus University Rotterdam; Vrije Universiteit Amsterdam	Karuga, RN (corresponding author), LVCT Hlth, Nairobi, Kenya.; Karuga, RN (corresponding author), Vrije Univ, Athena Inst, Amsterdam, Netherlands.	robinson.karuga@lvcthealth.org		Hilverda, Femke/0000-0002-7542-4508; Karuga, Robinson/0000-0003-3249-5047; Mbindyo, Patrick/0000-0003-0388-0026; Otiso, Lilian/0000-0003-0164-154X	European Commission (Seventh Framework Programme)	European Commission (Seventh Framework Programme)	Funding for this study was provided by the European Commission (Seventh Framework Programme), LO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abimbola S, 2016, HEALTH POLICY PLANN, V31, P332, DOI 10.1093/heapol/czv066; Akintola O, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0151-6; Blanchet K, 2013, HEALTH POLICY PLANN, V28, P143, DOI 10.1093/heapol/czs031; Blanchet K, 2012, HEALTH POLICY PLANN, V27, P438, DOI 10.1093/heapol/czr055; Borgatti S. P., 2002, UCINET 6 WINDOWS SOF; Borgatti SP, 2009, SCIENCE, V323, P892, DOI 10.1126/science.1165821; Crossley N., 2010, SOCIOLOGICA; Equinet Tarsc, 2014, HLTH CTR COMM VEH SO; Finnegan J, 1999, BETTER ENV DECISIONS; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; George A, 2015, SOC SCI MED, V133, P159, DOI 10.1016/j.socscimed.2015.03.049; Gilmore B, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011885; Goldsmith EB, 2015, INT SER CONSUM SCI, P3, DOI 10.1007/978-3-319-20738-4_1; Goodman C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-229; Gopalan SS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001557; Haricharan H., 2014, EXTENDING PARTICIPAT; Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P971, DOI 10.1136/jech.2003.014530; Kapiriri L, 2003, HEALTH POLICY PLANN, V18, P205, DOI 10.1093/heapol/czg025; Kilewo EG, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26461; Lazarsfeld P. F., 1948, PEOPLES CHOICE VOTER, V2nd; Li J, 2016, SOCIAL NETWORK ANAL; Lunsford SS, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0006-6; Ministry of Health, 2013, STRAT COMM HLTH 2014; Ministry Of Health, 2012, HDB COMM HLTH COMM; Ministry Of Health, 2015, KEN QUAL MOD COMM HL; Mubyazi GM, 2007, J PUBLIC HEALTH-UK, V29, P147, DOI 10.1093/pubmed/fdm016; Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373; Nathan S, 2011, HEALTH EXPECT, V14, P272, DOI 10.1111/j.1369-7625.2010.00628.x; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; O'Meara WP, 2011, HEALTH POLICY, V99, P234, DOI 10.1016/j.healthpol.2010.08.027; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; QSR International Pty Ltd, 2018, NVIVO; RCCT, 1999, STRAT PEOPL BAS CONS; Rifkin SB, 2014, HEALTH POLICY PLANN, V29, P98, DOI 10.1093/heapol/czu076; Rodriguez-Garcia R, 2012, J EPIDEMIOL COMMUN H, V66, pII7, DOI 10.1136/jech-2012-201298; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Sah K, 2013, PERFORMANCE VILLAGE; Sandstrom A, 2008, POLICY STUD J, V36, P497, DOI 10.1111/j.1541-0072.2008.00281.x; Seiyefa F, 2014, NIGERIAN HLTH J, V14; Singh D, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0051-1; Srivastava A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2699-4; Strachan DL, 2012, AM J TROP MED HYG, V87, P111, DOI 10.4269/ajtmh.2012.12-0030; Villalonga-Olives E, 2016, SSM POPUL HLTH, V2, P613; Waweru E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-404; WHO (World Health Organization), 1978, PRIM HLTH CAR REP IN; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; World Health Organization (WHO), 2012, HLTH POLICY SYSTEMS; Young N, 2010, SOCIOL RURALIS, V50, P392, DOI 10.1111/j.1467-9523.2010.00521.x	48	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220836	10.1371/journal.pone.0220836	http://dx.doi.org/10.1371/journal.pone.0220836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393923	Green Published, Green Submitted, gold			2022-12-27	WOS:000485002500067
J	Lang, AY; Hall, JA; Boyle, JA; Harrison, CL; Teede, H; Moran, LJ; Barrett, G				Lang, Adina Y.; Hall, Jennifer A.; Boyle, Jacqueline A.; Harrison, Cheryce L.; Teede, Helena; Moran, Lisa J.; Barrett, Geraldine			Validation of the London Measure of Unplanned Pregnancy among pregnant Australian women	PLOS ONE			English	Article							UNINTENDED PREGNANCIES; PRECONCEPTION HEALTH; CONSENSUS; INTENTION; URBAN	Introduction Globally, over half of pregnancies in developed countries are unplanned. Identifying and understanding the prevalence and complexity surrounding pregnancy preparation among Australian women is vital to enable sensitive, responsive approaches to addressing preconception and long-term health improvements for these women with varying motivation levels. Aim This study evaluated the reliability and validity of a comprehensive pregnancy planning/intention measure (London Measure of Unplanned Pregnancy) in a population of pregnant women (over 18 years of age) in Australia. Methods A psychometric evaluation, within a cross-sectional study comprising cognitive interviews (to assess comprehension and acceptability) and a field test. Pregnant women aged over 18 years were recruited in early pregnancy (approximately 12 weeks' gestation). Reliability (internal consistency) was assessed using Cronbach's alpha, corrected item-total correlations and inter-item correlations, and stability via a test-retest. Construct validity was assessed using principal components analysis and hypothesis testing. Results Six women participated in cognitive interviews and 317 in the field test. The London Measure of Unplanned Pregnancy was acceptable and well comprehended. Reliability testing demonstrated good internal consistency (alpha = 0.81, all corrected item-total correlations >0.20, all inter-item correlations positive) and excellent stability (weighted kappa = 0.92). Validity testing confirmed the unidimensional structure of the measure and all hypotheses were confirmed. Conclusions The London Measure of Unplanned Pregnancy is a valid and reliable measure of pregnancy planning/intention for the Australian population. Implementation of this measure into all maternity healthcare, research and policy settings will provide accurate population-level pregnancy planning estimates to inform, monitor and evaluate interventions to improve preconception health in Australia.	[Lang, Adina Y.; Boyle, Jacqueline A.; Harrison, Cheryce L.; Teede, Helena; Moran, Lisa J.] Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia; [Hall, Jennifer A.; Barrett, Geraldine] UCL, UCL EGA Inst Womens Hlth, Res Dept Reprod Hlth, London, England	Monash University; University of London; University College London	Boyle, JA (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia.	jacqueline.boyle@monash.edu	Boyle, Jacqueline/AAD-3246-2019; Lang, Adina/GWU-9274-2022; Harrison, Cheryce/AAC-3675-2019	Lang, Adina/0000-0002-2923-0016; Harrison, Cheryce/0000-0002-3154-4946; Barrett, Geraldine/0000-0002-9738-1051; Boyle, Jacqueline/0000-0002-3616-1637				Almaghaslah E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185433; [Anonymous], 2018, 2033 0 55 001 CENS P; Australian Bureau of Statistics, 2016, 3301 0 BIRTHS; Australian Institute of Health and Welfare, 2018, AUSTRALIAS MOTHERS B; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Barrett G, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0672-3; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Centers for Disease Control and Prevention, 2018, PRAMS QUEST; Cheney K, 2016, AUST NZ J OBSTET GYN, V56, P426, DOI 10.1111/ajo.12466; Cheng TS, 2016, PREV SCI, V17, P960, DOI 10.1007/s11121-016-0694-8; Children By Choice Association Incorporated, 2020, OUR WORK; Delissaint D, 2011, HEALTH EDUC BEHAV, V38, P603, DOI 10.1177/1090198110389709; DONNER A, 1987, STAT MED, V6, P441, DOI 10.1002/sim.4780060404; Frayne DJ, 2016, OBSTET GYNECOL, V127, P863, DOI 10.1097/AOG.0000000000001379; Goossens J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194033; Habib MA, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1339-z; Hall J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-200; Hall JA, 2017, PATIENT-RELAT OUTCOM, V8, P43, DOI 10.2147/PROM.S122420; Hall JA, 2017, MATERN CHILD HLTH J, V21, P670, DOI 10.1007/s10995-016-2237-0; Hewitt B, 2010, POPUL REV, V49, P36, DOI 10.1353/prv.2010.0000; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lang AY, 2018, MINERVA GINECOL, V70, P99, DOI 10.23736/S0026-4784.17.04140-5; Lowenthal K, 2001, INTRO PSHYCHOL TESTS; Michelson J, 2007, SEX HEALTH, V4, P297, DOI 10.1071/SHv4n4Ab33; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; Moos MK, 2004, J PERINAT NEONAT NUR, V18, P2, DOI 10.1097/00005237-200401000-00002; Morof D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035381; National Health and Medical Research Council, 2010, IOD SUPPL PREGN LACT; Practitioners TRACoG, 2016, GUID PREV ACT GEN PR; Presser S, 2004, PUBLIC OPIN QUART, V68, P109, DOI 10.1093/poq/nfh008; Rassi A, 2013, AUST NZ J PUBL HEAL, V37, P568, DOI 10.1111/1753-6405.12098; Rocca CH, 2010, DEMOGR RES, V23, P293, DOI 10.4054/DemRes.2010.23.11; Roscoe J., 1975, FUNDAMENTAL RES STAT, DOI [10.1002/sim.4780060404, DOI 10.1002/SIM.4780060404]; Roshanaei S, 2015, E MEDITERR HEALTH J, V21, P572, DOI 10.26719/2015.21.8.572; Rowe H, 2016, AUST NZ J PUBL HEAL, V40, P104, DOI 10.1111/1753-6405.12461; Scheil W, 2017, PREGNANCY OUTCOME S; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Stephenson J, 2018, LANCET, V391, P1830, DOI [10.1016/S0140-6736(18)30311-8, 10.1016/s0140-6736(18)30311-8]; Streiner D. L., 2003, HLTH MEASUREMENT SCA; STREINER DL, 1994, PERCEPT MOTOR SKILL, V78, P275, DOI 10.2466/pms.1994.78.1.275; Tuomainen H, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002977; Borges ALV, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1037-2; Willis G.B, 2004, COGNITIVE INTERVIEWI	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220774	10.1371/journal.pone.0220774	http://dx.doi.org/10.1371/journal.pone.0220774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5EW	31393966	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500061
J	Luchniak, A; Mahamdeh, M; Howard, J				Luchniak, Anna; Mahamdeh, Mohammed; Howard, Jonathon			Nicotinamide adenine dinucleotides and their precursor NMN have no direct effect on microtubule dynamics in purified brain tubulin	PLOS ONE			English	Article							WALLERIAN DEGENERATION; NAD; REVEALS; INJURY; ACTIVATION; MECHANISMS; SYNAPSES; SIRT1; AXONS; ASSAY	Microtubules are dynamic cytoskeletal polymers that provide mechanical support for cellular structures, and play important roles in cell division, migration, and intracellular transport. Their intrinsic dynamic instability, primarily controlled by polymerization-dependent GTP hydrolysis, allows for rapid rearrangements of microtubule arrays in response to signaling cues. In neurons, increases in intracellular levels of nicotinamide adenine dinucleotide (NAD(+)) can protect against microtubule loss and axonal degeneration elicited by axonal transection. The protective effects of NAD(+) on microtubule loss have been shown to be indirect in some systems, for example through the sirtuin-3 pathway. However, it is still possible that NAD(+) and related metabolites have direct effects on microtubule dynamics to promote assembly or inhibit disassembly. To address this question, we reconstituted microtubule dynamics in an in vitro assay with purified bovine brain tubulin and examined the effects of NAD(+), NADH, and NMN. We found that the compounds had only small effects on the dynamics at the plus and minus ends of the microtubules. Furthermore, these effects were not statistically significant. Consequently, our data support earlier findings that NADs and their precursors influence microtubule growth through indirect mechanisms.	[Luchniak, Anna; Mahamdeh, Mohammed; Howard, Jonathon] Yale Univ, Dept Mol Biophys & Biochem, Yale Sch Med, New Haven, CT 06520 USA; [Mahamdeh, Mohammed] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA	Yale University; Harvard University; Massachusetts General Hospital	Howard, J (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Yale Sch Med, New Haven, CT 06520 USA.	jonathon.howard@yale.edu	Luchniak, Anna/AAW-6834-2020; Mahamdeh, Mohammed/AAG-6530-2019		National Institutes of Health [R01 GM110386, DP1 M110065]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH110065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JH (R01 GM110386 and DP1 M110065) received funding from the National Institutes of Health, www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; [Anonymous], R LANG ENV STAT COMP; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Babetto E, 2010, J NEUROSCI, V30, P13291, DOI 10.1523/JNEUROSCI.1189-10.2010; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chang JH, 2002, J BIOL CHEM, V277, P34489, DOI 10.1074/jbc.M205460200; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen L, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006503; Chini CCS, 2017, MOL CELL ENDOCRINOL, V455, P62, DOI 10.1016/j.mce.2016.11.003; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; D'Angelo I, 2000, STRUCTURE, V8, P993, DOI 10.1016/S0969-2126(00)00190-8; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Di Stefano M, 2017, CURR BIOL, V27, P784, DOI 10.1016/j.cub.2017.01.070; Fanara P, 2007, J BIOL CHEM, V282, P23465, DOI 10.1074/jbc.M703434200; Fang YS, 2012, CURR BIOL, V22, P590, DOI 10.1016/j.cub.2012.01.065; Gell C, 2010, METHOD CELL BIOL, V95, P221, DOI 10.1016/S0091-679X(10)95013-9; Gilley J, 2015, CELL REP, V10, P1974, DOI 10.1016/j.celrep.2015.02.060; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Gupta RS, 1996, BIOCHEM MOL BIOL INT, V38, P1211; Harkcom WT, 2014, P NATL ACAD SCI USA, V111, pE2443, DOI 10.1073/pnas.1404269111; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Kleele T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5827; Loreto A, 2015, CELL REP, V13, P2539, DOI 10.1016/j.celrep.2015.11.032; Ma N, 2016, BIOMED OPT EXPRESS, V7, P2441, DOI 10.1364/BOE.7.002441; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Mahamdeh M, 2018, J MICROSC-OXFORD, V272, P60, DOI 10.1111/jmi.12744; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yu QR, 2009, J PHOTOCH PHOTOBIO B, V95, P46, DOI 10.1016/j.jphotobiol.2008.12.010; Zhu XH, 2015, P NATL ACAD SCI USA, V112, P2876, DOI 10.1073/pnas.1417921112	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220794	10.1371/journal.pone.0220794	http://dx.doi.org/10.1371/journal.pone.0220794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393939	Green Published, gold, Green Submitted			2022-12-27	WOS:000485002500063
J	Haridy, Y; Witzmann, F; Asbach, P; Reisz, RR				Haridy, Yara; Witzmann, Florian; Asbach, Patrick; Reisz, Robert R.			Permian metabolic bone disease revealed by microCT: Paget's disease-like pathology in vertebrae of an early amniote	PLOS ONE			English	Article							OSTEITIS DEFORMANS; VARANOPID SYNAPSIDA; RICHARDS SPUR; UPDATE; SPINE; EUPELYCOSAURIA	Bone remodeling is an essential physiological process in growth and healing. In modern systems deviations from normal bone physiology in the form of pathologies aid in the understanding of normal bone metabolism. Here we use external morphology and X-ray microtomography to diagnose and describe a metabolic bone disease in an amniote from the early Permian. The specimen consists of two fused tail vertebrae of a small varanopid from early Permian (289 million years old) cave deposits near Richards Spur, Oklahoma, USA. Inspection of the outer morphology reveals that the fusion encompasses the vertebral centra, zygopophyses and haemal arches, with the fusion zones distinctly swollen on the left side of the specimen. With visualization of its internal structure by microCT, this specimen is diagnosed as a complex metabolic bone disease. The radiological imaging suggests a pathologically high bone turnover rate, as shown by abnormal bone formation in some areas and increased bone resorption in others. This supports that the varanopid suffered from a metabolic bone disease similar to Paget's disease of bone as seen in humans today, which is linked to both genetic and viral factors. This finding extends the occurrence of Paget-like disease to the early Permian, and-provided a viral component was present-would also be by far the oldest evidence of viral infection in the fossil record.	[Haridy, Yara; Witzmann, Florian] Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany; [Asbach, Patrick] Charite Univ Med Berlin, Inst Radiol, Berlin, Germany; [Reisz, Robert R.] Jilin Univ, Int Ctr Future Sci, Dinosaur Evolut Res Ctr, Changchun, Jilin, Peoples R China; [Reisz, Robert R.] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada	Leibniz Institut fur Evolutions und Biodiversitatsforschung; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Jilin University; University of Toronto; University Toronto Mississauga	Haridy, Y (corresponding author), Leibniz Inst Evolut & Biodiversitatsforsch, Museum Nat Kunde, Berlin, Germany.	yara.haridy@mfn.belin	haridy, yara/AAT-3129-2021	haridy, yara/0000-0002-6908-5749; Asbach, Patrick/0000-0002-6885-3283	NSERC Discovery Grant; Deutsche Forschungsgemeinschaft (DFG); Open Access Fund of the Leibniz Association	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Fund of the Leibniz Association	This project was supported by funding from NSERC Discovery Grant to R.R.R., and the Deutsche Forschungsgemeinschaft (DFG) to FW. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2014, FIBROUS DYSPLASIA RE, V5; Anderson JS, 2004, J VERTEBR PALEONTOL, V24, P173, DOI 10.1671/1940-13; Antinoff N, 1997, OSTEOMYELITIS REPTIL, V4; Benton MJ, 2015, PALAEONTOLOGY, V58, P1003, DOI 10.1111/pala.12191; Berman DS, 1982, RESTUDY MYCTEROSAURU; Boriani S, 1997, SPINE, V22, P1036, DOI 10.1097/00007632-199705010-00020; Brickley M., 2010, BIOARCHAEOLOGY METAB; Brink KS, 2019, SCI NAT-HEIDELBERG, V106, DOI 10.1007/s00114-018-1598-1; Brocklehurst N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156810; Campione NE, 2011, ACTA PALAEONTOL POL, V56, P739, DOI 10.4202/app.2010.0071; Cundy T, 2008, TRENDS ENDOCRIN MET, V19, P246, DOI 10.1016/j.tem.2008.06.001; Cundy T, 2018, METABOLISM, V80, P5, DOI 10.1016/j.metabol.2017.06.010; Dell'Atti C, 2007, SKELETAL RADIOL, V36, P609, DOI 10.1007/s00256-006-0270-6; DiCaprio MR, 2005, J BONE JOINT SURG AM, V87A, P1848, DOI 10.2106/JBJS.D.02942; Evans DC, 2009, PALAEONTOLOGY, V52, P219, DOI 10.1111/j.1475-4983.2008.00837.x; Ford DP, 2019, PAP PALAEONTOL, V5, P197, DOI 10.1002/spp2.1236; FRYE FL, 1974, VET MED SM ANIM CLIN, V69, P186; Frye FL, 2000, P ASS REPTILIAN AMPH, V19; Galiova M, 2010, ANAL BIOANAL CHEM, V398, P1095, DOI 10.1007/s00216-010-3976-1; Gennari L, 2018, EXPERT OPIN ORPHAN D, V6, P485, DOI 10.1080/21678707.2018.1500691; Haridy Y, 2019, JAMA ONCOL, V5, P425, DOI 10.1001/jamaoncol.2018.6766; HOLDSWORTH F, 1970, J BONE JOINT SURG AM, VA 52, P1534, DOI 10.2106/00004623-197052080-00002; HUGHES HC, 1971, VET PATHOL, V8, P414, DOI 10.1177/0300985871008005-00603; KASTERT J, 1952, Beitr Klin Tuberk Spezif Tuberkuloseforsch, V106, P455, DOI 10.1007/BF02144554; Khan MA, 2002, ANN INTERN MED, V136, P896, DOI 10.7326/0003-4819-136-12-200206180-00011; Kiel J.L., 1983, American Association of Zoo Veterinarians Annual Proceedings, V1983, P201; Kurihara N, 2011, CELL METAB, V13, P23, DOI 10.1016/j.cmet.2010.12.002; LANDER P, 1991, SPINE, V16, P46, DOI 10.1097/00007632-199101000-00009; MacDougall M. J., 2017, THESIS; Maddin HC, 2006, J VERTEBR PALEONTOL, V26, P957, DOI 10.1671/0272-4634(2006)26[957:AEPVVS]2.0.CO;2; McKean D, 2016, BJR CASE REP, V2, DOI 10.1259/bjrcr.20150405; Menendez-Bueyes LR, 2017, REUMATOL CLIN, V13, P66, DOI [10.1016/j.reuma.2016.02.008, 10.1016/j.reumae.2016.02.009]; PAAJANEN H, 1989, SKELETAL RADIOL, V18, P523, DOI 10.1007/BF00351753; Pelletier V, 2014, VERTEBR PALEOBIOL PA, P53, DOI 10.1007/978-94-007-6841-3_4; Prescher A, 1998, EUR J RADIOL, V27, P181, DOI 10.1016/S0720-048X(97)00165-4; Preziosi R, 2007, VET J, V174, P669, DOI 10.1016/j.tvjl.2006.11.012; Reisz R.R., 1997, OKLA GEOL NOTES, V57, P160; Reisz RR, 2007, J VERTEBR PALEONTOL, V27, P734, DOI 10.1671/0272-4634(2007)27[734:HSFTPO]2.0.CO;2; Roches E, 2002, INT J OSTEOARCHAEOL, V12, P229, DOI 10.1002/oa.617; Rothschild BM, 2006, B NEW MEXICO MUSEUM, V33; Rothschild BM, 1998, J ZOO WILDLIFE MED, V7; Singer FR, 2011, CELL METAB, V13, P5, DOI 10.1016/j.cmet.2010.12.014; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Walters B, 2012, COMPLETE DINOSAUR; White G, 2013, TRAUMA, V27, P254, DOI DOI 10.1016/J.MP0RTH.2013.07.001; Witzmann F, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1080719; Witzmann F, 2011, CURR BIOL, V21, pR647, DOI 10.1016/j.cub.2011.08.006; Yamada K, 1999, J VET MED SCI, V61, P1055, DOI 10.1292/jvms.61.1055; ZLATKIN MB, 1986, RADIOLOGY, V160, P155, DOI 10.1148/radiology.160.1.2940618	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0219662	10.1371/journal.pone.0219662	http://dx.doi.org/10.1371/journal.pone.0219662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390345	Green Submitted, Green Published, gold			2022-12-27	WOS:000484999400007
J	Montroni, D; Zhang, XL; Leonard, J; Kaya, M; Amemiya, C; Falini, G; Rolandi, M				Montroni, Devis; Zhang, Xiaolin; Leonard, Janet; Kaya, Murat; Amemiya, Chris; Falini, Giuseppe; Rolandi, Marco			Structural characterization of the buccal mass of Ariolimax californicus (Gastropoda; Stylommatophora)	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; RADULA TEETH; BETA-CHITIN; BIOMINERALIZATION; PLEUROBRANCHAEA; PLASTICITY; MORPHOLOGY; MOVEMENTS; APPARATUS; PATTERNS	Biological materials such as chiton tooth, squid beak, and byssal threads of bivalves have inspired the development of new technologies. To this end, we have characterized the acellular components in the buccal mass of the terrestrial slug Ariolimax californicus (banana slug). These components are the radula, the jaw, and the odontophore. In the radula, calcium-rich denticles are tightly interlocked one to the other on top of a nanofibrous chitin membrane. The jaw has a nanostructured morphology made of chitin to achieve compression resistance and is directly linked to the foregut cuticle, which has a protective nanofibrous structure. Finally, in the odontophore, we observed a structurally elastic microstructure that interfaces soft tissues with a highly stressed radula membrane. Based on those observations, we discuss the interaction between these components and highlight how the materials in these task-specific components have evolved. This structure-properties-function study of the A. californicus' buccal mass may aid in the design and fabrication of novel bioinspired materials.	[Montroni, Devis; Zhang, Xiaolin; Rolandi, Marco] Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA; [Montroni, Devis; Falini, Giuseppe] Univ Bologna, Dept Chem Giacomo Ciamician, Alma Mater Studiorum, Bologna, Italy; [Leonard, Janet] Univ Calif Santa Cruz, Inst Marine Sci, Joseph M Long Marine Lab, Santa Cruz, CA 95064 USA; [Kaya, Murat] Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, Aksaray, Turkey; [Amemiya, Chris] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Santa Cruz; University of Bologna; University of California System; University of California Santa Cruz; Aksaray University; University of California System; University of California Merced	Rolandi, M (corresponding author), Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA.	mrolandi@ucsc.edu	Kaya, Murat/AAA-7668-2020; Montroni, Devis/AAC-1893-2019	Montroni, Devis/0000-0003-1731-4578	Office of Naval Research Award [N000141410724]; University of California Santa Cruz; National Science Foundation [ECCS-1542152]	Office of Naval Research Award(Office of Naval Research); University of California Santa Cruz(University of California System); National Science Foundation(National Science Foundation (NSF))	This work is supported by the Office of Naval Research Award (N000141410724), and start-up funding at the University of California Santa Cruz. Part of this work was performed at the Stanford Nano Shared Facilities (SNSF), supported by the National Science Foundation under award ECCS-1542152.	Aldersey-Williams H, 2004, NAT MATER, V3, P277, DOI 10.1038/nmat1119; Alvim J, 2014, J MOLLUS STUD, V80, P604, DOI 10.1093/mollus/eyu063; Amini S, 2015, NAT MATER, V14, P943, DOI [10.1038/NMAT4309, 10.1038/nmat4309]; Binney WG, 1874, ACAD NAT SCI, V26, P33; Binney WG, 1876, P ACAD NAT SCI PHILA, V28, P183; Binney WG, 1875, JAW LINGUAL MEMBRANE, V27, P140; CARRIKER MR, 1974, MAR BIOL, V25, P63, DOI 10.1007/BF00395108; Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7; EVANS LA, 1992, CALCIFIED TISSUE INT, V51, P78, DOI 10.1007/BF00296222; Fabritius HO, 2012, Z KRIST-CRYST MATER, V227, P766, DOI 10.1524/zkri.2012.1532; Falini G, 2013, J STRUCT BIOL, V183, P226, DOI 10.1016/j.jsb.2013.05.001; Gao XZ, 2013, INT J BIO-INSPIR COM, V5, P336, DOI 10.1504/IJBIC.2013.058911; Gervais JA, 1998, AM MIDL NAT, V140, P103, DOI 10.1674/0003-0031(1998)140[0103:TPFSDB]2.0.CO;2; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; GRAHAM A, 1973, J ZOOL, V169, P317; Gu ZZ, 2003, ANGEW CHEM INT EDIT, V42, P894, DOI 10.1002/anie.200390235; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1309, DOI 10.1152/jn.1996.75.4.1309; Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20176; Kawamura T, 2001, FISHERIES SCI, V67, P596, DOI 10.1046/j.1444-2906.2001.00295.x; Kinoshita S., 2002, FORMA, V17, P103; Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI [10.1146/annurev-matsci-070909-104427, 10.1146/annurev-matsci-070909-10442]; Leonard JL, 2002, INVERTEBR REPROD DEV, V41, P83, DOI 10.1080/07924259.2002.9652738; MACKENSTEDT U, 1987, ZOOMORPHOLOGY, V107, P209, DOI 10.1007/BF00312262; Mackenstedt U, 2001, BIOL TERRESTRIAL MOL; MCCLELLAN AD, 1982, J EXP BIOL, V98, P195; Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117; Montroni D, 2019, CARBOHYD POLYM, V207, P26, DOI 10.1016/j.carbpol.2018.11.069; Montroni D, 2018, ACS BIOMATER SCI ENG, V4, P57, DOI 10.1021/acsbiomaterials.7b00743; Montroni D, 2017, RSC ADV, V7, P36605, DOI 10.1039/c7ra06664c; Onelli OD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01496-8; Onitsuka T, 2004, J SHELLFISH RES, V23, P1079; Padilla DK, 1998, VELIGER, V41, P201; Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152; PEARSON FG, 1960, J POLYM SCI, V43, P101, DOI 10.1002/pol.1960.1204314109; Reid DG, 1999, J MOLLUS STUD, V65, P355, DOI 10.1093/mollus/65.3.355; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; ROLLO CD, 1983, RES POPUL ECOL, V25, P20, DOI 10.1007/BF02528782; RUDALL KM, 1973, BIOL REV, V48, P597, DOI 10.1111/j.1469-185X.1973.tb01570.x; Runham N. W., 1997, Scientia Marina, V61, P67; Saunders M, 2009, J STRUCT BIOL, V167, P55, DOI 10.1016/j.jsb.2009.03.003; Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343; Senseman D. M, 1976, THESIS; SENSEMAN DM, 1977, J CHEM ECOL, V3, P707, DOI 10.1007/BF00988069; Sone ED, 2007, J STRUCT BIOL, V158, P428, DOI 10.1016/j.jsb.2007.01.001; VANDERWAL P, 1989, J ULTRA MOL STRUCT R, V102, P147, DOI 10.1016/0889-1605(89)90052-9; Vortsepneva E, 2013, ZOOMORPHOLOGY, V132, P359, DOI 10.1007/s00435-013-0199-y; Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764; Weaver JC, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70016-X; WOLTER K, 1992, J MOLLUS STUD, V58, P245, DOI 10.1093/mollus/58.3.245	49	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0212249	10.1371/journal.pone.0212249	http://dx.doi.org/10.1371/journal.pone.0212249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390363	Green Published, gold, Green Submitted			2022-12-27	WOS:000484999400001
J	Berg, M; Linnebjerg, JF; Taylor, G; Ismar-Rebitz, SMH; Bell, M; Gaskin, CP; Akesson, S; Rayner, MJ				Berg, Martin; Linnebjerg, Jannie F.; Taylor, Graeme; Ismar-Rebitz, Stefanie M. H.; Bell, Mike; Gaskin, Chris P.; Akesson, Susanne; Rayner, Matt J.			Year-round distribution, activity patterns and habitat use of a poorly studied pelagic seabird, the fluttering shearwater Puffinus gavia	PLOS ONE			English	Article							WANDERING ALBATROSSES; SEXUAL-DIMORPHISM; RISSA-TRIDACTYLA; SARDINOPS-SAGAX; MIGRATION; ECOLOGY; DISPERSAL; AUSTRALIA; REVEALS; CLIMATE	We present the first study to examine the year-round distribution, activity patterns, and habitat use of one of New Zealand's most common seabirds, the fluttering shearwater (Puffinus gavia). Seven adults from Burgess Island, in the Hauraki Gulf, and one individual from Long Island, in the Marlborough Sounds, were successfully tracked with combined light-saltwater immersion loggers for one to three years. Our tracking data confirms that fluttering shearwaters employ different overwintering dispersal strategies, where three out of eight individuals, for at least one of the three years when they were being tracked, crossed the Tasman Sea to forage over coastal waters along eastern Tasmania and southeastern Australia. Resident birds stayed confined to waters of northern and central New Zealand year-round. Although birds frequently foraged over pelagic shelf waters, the majority of tracking locations were found over shallow waters close to the coast. All birds foraged predominantly in daylight and frequently visited the colony at night throughout the year. We found no significant inter-seasonal differences in the activity patterns, or between migratory and resident individuals. Although further studies of inter-colony variation in different age groups will be necessary, this study presents novel insights into year-round distribution, activity patterns and habitat use of the fluttering shearwater, which provide valuable baseline information for conservation as well as for further ecological studies.	[Berg, Martin; Linnebjerg, Jannie F.; Akesson, Susanne] Lund Univ, Ctr Anim Movement Res, Dept Biol, Lund, Sweden; [Linnebjerg, Jannie F.] Aarhus Univ, Dept Biosci, Roskilde, Denmark; [Taylor, Graeme] New Zealand Dept Conservat, Wellington, New Zealand; [Ismar-Rebitz, Stefanie M. H.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Expt Ecol Benthos Ecol, Kiel, Germany; [Ismar-Rebitz, Stefanie M. H.; Rayner, Matt J.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Bell, Mike] Wildlife Management Int Ltd, Wellington, New Zealand; [Gaskin, Chris P.] Northern New Zealand Seabird Trust, Warkworth, New Zealand; [Rayner, Matt J.] Auckland Museum, Auckland, New Zealand	Lund University; Aarhus University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Auckland	Berg, M; Akesson, S (corresponding author), Lund Univ, Ctr Anim Movement Res, Dept Biol, Lund, Sweden.	martin.berg20@gmail.com; Susanne.Akesson@biol.lu.se	Linnebjerg, Jannie/AAI-4571-2020	Linnebjerg, Jannie Fries/0000-0003-4043-0606	Auckland Zoo Research Grant; Lund University Student Research Grant; ERASMUS+ Grant; Carlsberg Foundation; Linnaeus grant from the Swedish Research Council [349-2007-8690]; Lund University	Auckland Zoo Research Grant; Lund University Student Research Grant; ERASMUS+ Grant; Carlsberg Foundation(Carlsberg Foundation); Linnaeus grant from the Swedish Research Council; Lund University	This research was made possible by the Auckland Zoo Research Grant and by the Lund University Student Research Grant. Martin Berg was further supported by the ERASMUS+ Grant. Jannie F. Linnebjerg was funded by the Carlsberg Foundation. Jannie F. Linnebjerg and Susanne Akesson are supported by a Linnaeus grant to the Centre for Animal Movement Research (CAnMove) at Lund University from the Swedish Research Council (349-2007-8690) and Lund University. The funder provided support in the form of salaries for authors [JFL, GT, SMHI, MBELL, CPG, SA, MJR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section in the manuscript.; We thank Ngati Rehua for supporting this study on Pokohinu and Jim Foye at Maritime New Zealand for permission to use their facilities for accommodation. We are grateful for the hard work and dedication of many field assistants, particularly Jonas Kotlarz, Jesper Wadstain, Kajsa Svensson, Leon Berard and Jemma Welch. We also thank James Ross and Piers Barney for logistic support and transport to the island in variable weather conditions. Thanks to Northern New Zealand Seabird Trust and Auckland Museum for support with field equipment. We are also grateful to two anonymous reviewers for helpful comments on the submitted version of this paper. This is a report from the Centre for Animal Movement Research (CAnMove) at Lund University.	[Anonymous], 2021, LANG ENV STAT COMP; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Berg M, 2018, EMU, V118, P173, DOI 10.1080/01584197.2017.1366831; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; BRADFORD JM, 1982, DEEP-SEA RES, V29, P1501, DOI 10.1016/0198-0149(82)90039-5; Brummelen V, 2013, HEAVENLY MATH FORGOT; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Catry P, 2013, ECOLOGY, V94, P1230, DOI 10.1890/12-2177.1; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chastel O, 1995, AUK, V112, P964, DOI 10.2307/4089027; Cornell Lab of Ornithology, 2016, EBIRD BAS DAT VERS E; Crossland J, 1981, FISH EGGS LARVAE HAU; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Daunt F, 2014, ECOLOGY, V95, P2077, DOI 10.1890/13-1797.1; Dias MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049376; FLETCHER WJ, 1992, AUST J MAR FRESH RES, V43, P1437; Frederiksen M, 2004, GLOBAL CHANGE BIOL, V10, P1214, DOI 10.1111/j.1529-8817.2003.00794.x; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gaskin CP., 2013, SEABIRDS HAURAKI GUL; Goldsworthy SD, 2013, ECOL MODEL, V255, P38, DOI 10.1016/j.ecolmodel.2013.01.006; Gonzalez-Solis J, 2000, OIKOS, V90, P390, DOI 10.1034/j.1600-0706.2000.900220.x; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Gutowsky SE, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0023-4; Hauraki Gulf Forum, 2014, STAT OUR GULF 2014; Hoedt FE, 1995, MAR FRESHWATER RES, V46, P1085, DOI 10.1071/MF9951085; Hope RM, 2013, RMISC RMISC RYAN MIS; Mackley EK, 2010, MAR ECOL PROG SER, V406, P291, DOI 10.3354/meps08532; McKnight A, 2011, MAR ECOL PROG SER, V442, P241, DOI 10.3354/meps09373; Miskelly C, 2012, RENA OIL SPILL NZ SE; Mitchell GW, 2012, J ANIM ECOL, V81, P1024, DOI 10.1111/j.1365-2656.2012.01978.x; Neira FJ, 1999, AUST J ZOOL, V47, P37, DOI 10.1071/ZO98068; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Onley D., 2007, ALBATROSSES PETRELS; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinet P, 2011, MAR ECOL PROG SER, V423, P291, DOI 10.3354/meps08971; Ramos R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23447; Rayner MJ, 2016, MAR ECOL PROG SER, V549, P217, DOI 10.3354/meps11707; Rayner MJ, 2008, MAR ECOL PROG SER, V370, P271, DOI 10.3354/meps07660; Rayner MJ, 2011, J AVIAN BIOL, V42, P266, DOI 10.1111/j.1600-048X.2010.05238.x; Rayner MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1330; Reid TA, 2002, BIRDS AUSTR MONOGRAP, V4; Robertson C.J.R., 1984, International Council for Bird Preservation Technical Publication, P573; Sarkar D, 2008, USE R, P1; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Taylor GA, 2000, THREATENED SPECIES O, V17; Ward EJ, 2015, ECOL APPL, V25, P2198, DOI 10.1890/15-0051.1.sm; Ward T, 2002, FISH RES, V56, P37, DOI 10.1016/S0165-7836(01)00314-9; Waugh SM, 2003, TUHINGA, V24, P159; Weimerskirch H, 2006, J AVIAN BIOL, V37, P23, DOI 10.1111/j.2006.0908-8857.03675.x; Weimerskirch H, 2016, SCIENCE, V353, P74, DOI 10.1126/science.aaf4374; Whiteway T, 2009, DATABASE AUSTR BATHY; Wickham H., 2016, DPLYR GRAMMAR DATA M; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zeldis JR, 2015, NEW ZEAL J MAR FRESH, V49, P69, DOI 10.1080/00288330.2014.955806	59	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219986	10.1371/journal.pone.0219986	http://dx.doi.org/10.1371/journal.pone.0219986			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386672	Green Published, Green Accepted, gold			2022-12-27	WOS:000484997100013
J	Schwinger, C; Golden, MH; Grellety, E; Roberfroid, D; Guesdon, B				Schwinger, Catherine; Golden, Michael H.; Grellety, Emmanuel; Roberfroid, Dominique; Guesdon, Benjamin			Severe acute malnutrition and mortality in children in the community: Comparison of indicators in a multi-country pooled analysis	PLOS ONE			English	Article							UPPER ARM CIRCUMFERENCE; WEIGHT-FOR-HEIGHT; HOSPITALIZED CHILDREN; DEVELOPING-COUNTRIES; UNDERLYING CAUSE; HIGH-RISK; MUAC; UNDERNUTRITION; SUFFICIENT; PNEUMONIA	Objectives This study aims to describe the mortality risk of children in the community who had severe acute malnutrition (SAM) defined by either a mid-upper arm circumference (MUAC) <115mm, a low weight-for-height Z-score (WHZ) <-3 or both criteria. Methods We pooled individual-level data from children aged 6-59 months enrolled in 3 community-based studies in the Democratic Republic of the Congo (DRC), Senegal and Nepal. We estimate the mortality hazard using Cox proportional hazard models in groups defined by either anthropometric indicator. Results In total, we had 49,001 time points provided by 15,060 children available for analysis, summing to a total of 143,512 person-months. We found an increasing death rate with a deteriorating nutritional status for all anthropometrical indicators. Children identified as SAM only by a low MUAC (<115mm) and those identified only by a low WHZ (Z-score <-3) had a similar mortality hazard which was about 4 times higher than those without an anthropometric deficit. Having both a low MUAC and a low WHZ was associated with an 8 times higher hazard of dying compared to children within the normal range. The 2 indicators identified a different set of children; the proportion of children identified by both indicators independently ranged from 7% in the DRC cohort, to 35% and 37% in the Senegal and the Nepal cohort respectively. Conclusion In the light of an increasing popularity of using MUAC as the sole indicator to identify SAM children, we show that children who have a low WHZ, but a MUAC above the cut-off would be omitted from diagnosis and treatment despite having a similar risk of death.	[Schwinger, Catherine] Univ Bergen, Ctr Int Hlth, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway; [Golden, Michael H.] Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland; [Grellety, Emmanuel] Univ Libre Bruxelles, Sch Publ Hlth, Res Ctr Hlth Policy & Syst Int Hlth, Brussels, Belgium; [Roberfroid, Dominique] Belgian Hlth Care Knowledge Ctr KCE, Brussels, Belgium; [Guesdon, Benjamin] Act Against Hunger, Paris, France	University of Bergen; University of Aberdeen; Universite Libre de Bruxelles	Schwinger, C (corresponding author), Univ Bergen, Ctr Int Hlth, Ctr Intervent Sci Maternal & Child Hlth, Bergen, Norway.	c.schwinger@uib.no	Golden, Michael/AAB-8989-2020	Golden, Michael/0000-0002-4039-7538; Guesdon, Benjamin/0000-0002-2876-0533; Grellety Bosviel, Emmanuel/0000-0001-9736-414X; Schwinger, Catherine/0000-0003-3457-3379	Centre de Developpement Integrale-Bwamanda; Flemish Inter-University Council (Vlaamse Interuniversitaire Raad); Belgian Administration for Development Cooperation; Nutricia Research Foundation; Research Council of Norway through its Centres of Excellence funding scheme, the University of Bergen (UiB), Norway [223269]	Centre de Developpement Integrale-Bwamanda; Flemish Inter-University Council (Vlaamse Interuniversitaire Raad); Belgian Administration for Development Cooperation; Nutricia Research Foundation(Danone Nutricia); Research Council of Norway through its Centres of Excellence funding scheme, the University of Bergen (UiB), Norway	We would like to acknowledge the principal investigators of the original studies: Jan Van den Broeck for the DRC cohort, Michel Garenne for the Senegal cohort, and Keith West for the Nepal cohort. The DRC study was supported by the Centre de Developpement Integrale-Bwamanda, and funding was provided by the Flemish Inter-University Council (Vlaamse Interuniversitaire Raad), the Belgian Administration for Development Cooperation, and the Nutricia Research Foundation. Catherine Schwinger is affiliated to the Centre for Intervention Science in Maternal and Child Health (CISMAC), which is funded by the Research Council of Norway through its Centres of Excellence funding scheme (project number 223269), the University of Bergen (UiB), Norway.	Ali E, 2013, T ROY SOC TROP MED H, V107, P319, DOI 10.1093/trstmh/trt018; Alexandre MAA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003743; ARCHIE JP, 1981, ANN SURG, V193, P296, DOI 10.1097/00000658-198103000-00008; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Bilukha O, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0232-0; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Briend A., 2016, BMC NUTR, V2, P63, DOI [10.1186/s40795-016-0101-7, DOI 10.1186/S40795-016-0101-7, 10.1186/s40795-016, DOI 10.1186/S40795-016]; Briend A, 2015, FOOD NUTR BULL, V36, pS15, DOI 10.1177/15648265150361S103; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; CHEN LC, 1980, AM J CLIN NUTR, V33, P1836, DOI 10.1093/ajcn/33.8.1836; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Custodio E, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0213-3; Dasgupta R, 2013, INDIAN PEDIATR, V50, P154, DOI 10.1007/s13312-013-0032-1; Davis AP, 1996, LANCET, V348, P868, DOI 10.1016/S0140-6736(96)02134-4; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Fernandez MAL, 2010, PEDIATRICS, V126, pE195, DOI 10.1542/peds.2009-2175; Garenne M, 1987, RISQUES DECES ASS DI; Garenne M, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12736; Goossens S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049320; Grellety E., 2016, BMC NUTR, V2, P1173, DOI [10.1038/ng.3097, DOI 10.1038/NG.3097, DOI 10.1186/S40795-016-0049-7]; Grellety E, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0382-6; Grellety E, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0383-5; Grellety E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168585; Grellety E, 2015, PUBLIC HEALTH NUTR, V18, P2575, DOI 10.1017/S1368980015000737; Grijalva-Eternod CS, 2015, AM J CLIN NUTR, V102, P593, DOI 10.3945/ajcn.114.106419; Isanaka S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137606; KATZ J, 1989, AM J EPIDEMIOL, V130, P1219, DOI 10.1093/oxfordjournals.aje.a115450; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Laillou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101159; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Oldenburg CE, 2018, CLIN INFECT DIS, V67, P1027, DOI 10.1093/cid/ciy207; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; PELLETIER DL, 1994, J NUTR, V124, pS2047; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; Roberfroid D, 2013, UTILIZATION MIDUPPER; Roberfroid D, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0074-4; Sachdeva S, 2016, PUBLIC HEALTH NUTR, V19, P2513, DOI 10.1017/S1368980016000719; Tu YK, 2004, J DENT, V32, P133, DOI 10.1016/j.jdent.2003.10.001; Tu YK, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-2; UNHCR, 2011, GUIDELINES FOR SELEC; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development/The World Bank, 2021, LEVELS TRENDS CHILD; Van den Broeck J., 1994, THESIS; VANDENBROECK J, 1993, LANCET, V341, P1491, DOI 10.1016/0140-6736(93)90632-Q; Walters T, 2012, MID UPPER ARM CIRCUM; WEST KP, 1991, LANCET, V338, P67, DOI 10.1016/0140-6736(91)90070-6; WHO, 2019, SUPPL FOODS MAN MOD; Wieringa FT, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060786; World Health Organization, 2006, WHO CHILD GROWTH STA; World Health Organization, 2013, GUID UPD MAN SEV AC; Young H., 2009, REV NUTR MORTALITY I, P78	51	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0219745	10.1371/journal.pone.0219745	http://dx.doi.org/10.1371/journal.pone.0219745			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386678	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100008
J	Adams, WM; Adams, JD; Karras, EM; Rysanek, E				Adams, William M.; Adams, J. D.; Karras, Eleni M.; Rysanek, Erin			Validity of temperature, duration, and vessel seal on 24-hour urinary hydration markers	PLOS ONE			English	Article							BIOMARKERS; VOLUME	The purpose of this study was to examine the effect of storage temperature, duration, and storage vessel seal on 24 h urinary hydration markers. Twenty-one males (n = 8) and females (n = 13) (mean +/- SD; age, 24 +/- 5 y; body mass, 68.9 +/- 24.2 kg; height, 160.2 +/- 32.1 cm) without a history of renal disease or currently taking any medications or supplements known to affect the accuracy of urinary hydration markers were enrolled in this study. Participants provided a 24 h urine sample in a clean container with each urine sample being separate into four separate containers, two in each of the following temperatures: 7 degrees C and 22 degrees C. One specimen container at each temperature was either sealed using the manufacturers cap (single sealed) or the manufacturers cap plus laboratory wrapping film (double sealed). Each sample was analyzed after 1, 2, 3, 7 and 10 days. Urine samples were assessed for urine osmolality (U-OSMO), urine specific gravity (U-SG) and urine color (U-COL). U-OSMO was stable at 7 degrees C for two days (mean difference [95% CI]; +1 mmol.kg(-1) [0+3], p>0.05) and three days (+1 mmol.kg(-1) [0, +3], p>0.05) for single sealed and double sealed containers, respectively. U-SG measures were stable for singled sealed and double sealed for up to ten days when stored at 22 degrees C. U-COL measures were maintained for up to three days in all storage methods (p>0.05). In conclusion, if immediate analysis is unavailable, such as in the case of field based or longitudinal research, it is recommended that 24 h urine samples are stored in a refrigerated environment and hydration markers (U-OSMO and U-COL) be assessed within 48 h.	[Adams, William M.; Karras, Eleni M.; Rysanek, Erin] Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC 27412 USA; [Adams, J. D.] Mayo Clin, Div Endocrinol Diabet & Metab, Rochester, MN USA	University of North Carolina; University of North Carolina Greensboro; Mayo Clinic	Adams, WM (corresponding author), Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC 27412 USA.	emadams@uncg.edu	; Adams, William/K-3312-2014	Adams, J.D./0000-0002-0738-5826; Adams, William/0000-0001-7372-8455	Safrit Measurement in Research Fund; Department if Kinesiology at the University of North Carolina at Greensboro	Safrit Measurement in Research Fund; Department if Kinesiology at the University of North Carolina at Greensboro	This study was funded by the Safrit Measurement in Research Fund and was awarded by the Department if Kinesiology at the University of North Carolina at Greensboro.	Adams Heather M, 2015, Asian J Sports Med, V6, pe24041, DOI 10.5812/asjsm.24041; Adams JD, 2017, INT J SPORT NUTR EXE, V27, P18, DOI 10.1123/ijsnem.2016-0098; Armstrong LE, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121928; Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265; Bezuidenhout K, 2016, ANN CLIN BIOCHEM, V53, P452, DOI 10.1177/0004563215602028; Borghi L, 1999, NEPHRON, V81, P31, DOI 10.1159/000046296; Cheuvront SN, 2010, AM J CLIN NUTR, V92, P565, DOI 10.3945/ajcn.2010.29490; Clark WF, 2011, CLIN J AM SOC NEPHRO, V6, P2634, DOI 10.2215/CJN.01990211; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Ellis LA, 2016, INT J SPORT NUTR EXE, V26, P356, DOI 10.1123/ijsnem.2015-0244; Gunter EW, 1997, CHEMOSPHERE, V34, P1945, DOI 10.1016/S0045-6535(97)00056-8; Halim, 2009, URINALYSIS APPROVED; Hunt A., 2011, J HLTH SAF ENV, V27, P139; Padrao P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111272; Perrier E, 2013, EUR J CLIN NUTR, V67, P939, DOI 10.1038/ejcn.2013.93; Perrier E, 2013, BRIT J NUTR, V109, P1678, DOI 10.1017/S0007114512003601; Perrier ET, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/231063; Slawson M, 1980, RN, V43, P40	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220724	10.1371/journal.pone.0220724	http://dx.doi.org/10.1371/journal.pone.0220724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381592	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600030
J	Sonda, TB; Horumpende, PG; Kumburu, HH; van Zwetselaar, M; Mshana, SE; Alifrangis, M; Lund, O; Aarestrup, FM; Chilongola, JO; Mmbaga, BT; Kibiki, GS				Sonda, Tolbert B.; Horumpende, Pius G.; Kumburu, Happiness H.; van Zwetselaar, Marco; Mshana, Stephen E.; Alifrangis, Michael; Lund, Ole; Aarestrup, Frank M.; Chilongola, Jaffu O.; Mmbaga, Blandina T.; Kibiki, Gibson S.			Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: A need for a hospital antibiotic stewardship programme	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; INFECTIONS; CEPHALOSPORINS; MANAGEMENT; CHILDREN; STRAINS	Excessive use of antibiotics, especially watch group antibiotics such as ceftriaxone leads to emergence and spread of antimicrobial resistance (AMR). In low and middle-income countries (LMICs), antibiotics are overused but data on consumption is scarcely available. We aimed at determining the extent and predictors of ceftriaxone use in a tertiary care university teaching hospital in Kilimanjaro, Tanzania. A hospital-based cross-sectional study was conducted from August 2013 through August 2015. Patients admitted in the medical, surgical wards and their respective intensive care units, receiving antimicrobials and other medications for various ailments were enrolled. Socio-demographic and clinical data were recorded in a structured questionnaire from patients' files and logistic regression was performed to determine the predictors for ceftriaxone use. Out of the 630 patients included in this study, 322 (51.1%) patients were on ceftriaxone during their time of hospitalization. Twenty-two patients out of 320 (6.9%) had been on ceftriaxone treatment without evidence of infection. Ceftriaxone use for surgical prophylaxis was 44 (40.7%), of which 32 (72.7%) and 9 (20.5%) received ceftriaxone prophylaxis before and after surgery, respectively. Three (6.8%) received ceftriaxone prophylaxis during surgery. Predicting factors for that the health facility administered ceftriaxone were identified as history of any medication use before referral to hospital [OR = 3.4, 95% CI (1.0-11.4), p = 0.047], bacterial infection [OR = 18.0, 95% CI (1.4-225.7, p = 0.025)], surgical ward [OR = 2.9, 95% CI (0.9-9.4), p = 0.078] and medical wards [OR = 5.0, 95% CI (0.9-28.3), p = 0.070]. Overall, a high ceftriaxone use at KCMC hospital was observed. Antimicrobial stewardship programs are highly needed to monitor and regulate hospital antimicrobial consumption, which in turn could help in halting the rising crisis of antimicrobial resistance.	[Sonda, Tolbert B.; Horumpende, Pius G.; Kumburu, Happiness H.; van Zwetselaar, Marco; Chilongola, Jaffu O.; Mmbaga, Blandina T.] Kilimanjaro Clin Res Inst, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Horumpende, Pius G.; Chilongola, Jaffu O.; Mmbaga, Blandina T.] Kilimanjaro Christian Med Univ Coll, Dept Biochem & Mol Biol, Moshi, Tanzania; [Horumpende, Pius G.] Lugalo Gen Mil Hosp, Mil Coll Med Sci, Dar Es Salaam, Tanzania; [Mshana, Stephen E.] Catholic Univ Hlth & Allied Sci, Mwanza, Tanzania; [Alifrangis, Michael] Copenhagen Univ Hosp, Ctr Med Parasitol, Copenhagen, Denmark; [Lund, Ole] Tech Univ Denmark, Ctr Biol Sequence Anal, Copenhagen, Denmark; [Aarestrup, Frank M.] Tech Univ Denmark, Ctr Genom Epidemiol, Copenhagen, Denmark; [Kibiki, Gibson S.] East Africa Hlth Res Commiss, Bujumbura, Burundi	Kilimanjaro Christian Medical Centre; University of Copenhagen; Technical University of Denmark; Technical University of Denmark	Horumpende, PG (corresponding author), Kilimanjaro Clin Res Inst, Kilimanjaro Christian Med Ctr, Moshi, Tanzania.; Horumpende, PG (corresponding author), Kilimanjaro Christian Med Univ Coll, Dept Biochem & Mol Biol, Moshi, Tanzania.; Horumpende, PG (corresponding author), Lugalo Gen Mil Hosp, Mil Coll Med Sci, Dar Es Salaam, Tanzania.	p.horumpende@kcri.ac.tz	Lund, Ole/F-4437-2014; Mmbaga, Blandina Theophil/AAR-8707-2021; Mshana, Stephen/AAE-1900-2022; Chilongola, Jaffu/K-9552-2017; van Zwetselaar, Marco/AAJ-6241-2020; Horumpende, Pius/AAS-2712-2020	Lund, Ole/0000-0003-1108-0491; Mmbaga, Blandina Theophil/0000-0002-5550-1916; Chilongola, Jaffu/0000-0003-2997-6747; van Zwetselaar, Marco/0000-0002-5953-0060; Horumpende, Pius/0000-0003-1241-6997; Aarestrup, Frank/0000-0002-7116-2723; Alifrangis, Michael/0000-0002-3835-3333	DANIDA through Danida Fellowship Centre [12-007DTU]	DANIDA through Danida Fellowship Centre	This study was supported by DANIDA through Danida Fellowship Centre award number DFC No. 12-007DTU.	Ampaire L, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i1.432; Argaw Nitsuh Alemayehu, 2017, BMC Res Notes, V10, P160, DOI 10.1186/s13104-017-2475-2; Arwyn-Jones J., 2019, SURGERY, V37, P9, DOI [10.1016/j.mpsur.2018.11.006, DOI 10.1016/J.MPSUR.2018.11.006]; Ayele AA, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.383; Ayinalem GA, 2017, INT J BASIC CLIN PHA; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Chiotos K, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-015-0510-9; Christopher A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-27; Dasaraju PV, 1996, MED MICROBIOLOGY; Egbuchulam N, 2018, J HOSP ADM, V7, P36, DOI [10.5430/jha.v7n2p36, DOI 10.5430/JHA.V7N2P36]; ELTAHAWY ATAE, 1988, CHEMIOTERAPIA, V7, P75; Garraffo A, 2014, MED MALADIES INFECT, V44, P63, DOI 10.1016/j.medmal.2013.12.002; Halawi Ezaedin, 2018, BMC Res Notes, V11, P538, DOI 10.1186/s13104-018-3643-8; Hurst AL, 2017, J PEDIAT INF DIS SOC, V6, P57, DOI 10.1093/jpids/piv082; Iddi Z., 2013, THESIS; JACOBSON KL, 1995, CLIN INFECT DIS, V21, P1107, DOI 10.1093/clinids/21.5.1107; Jroundi I, 2013, ANTIBIOTICS-BASEL, V2, P450, DOI 10.3390/antibiotics2040450; Kemigisha E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205316; Kiguba R, 2016, J ANTIMICROB CHEMOTH, V71, P1697, DOI 10.1093/jac/dkw025; Kumburu HH, 2017, TROP MED INT HEALTH, V22, P454, DOI 10.1111/tmi.12836; Lee Hyuck, 2009, Korean Journal of Internal Medicine, V24, P374, DOI 10.3904/kjim.2009.24.4.374; Lin HA, 2016, J MICROBIOL IMMUNOL, V49, P237, DOI 10.1016/j.jmii.2014.12.010; Lo D, 2015, DRAFT GLOBAL AMR ACT; Mascellino MT, 2017, DRUG DES DEV THER, V11, P2209, DOI 10.2147/DDDT.S136240; Masinde A, 2009, Tanzan J Health Res, V11, P154; Moremi N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2082-1; Muller A, 2004, J ANTIMICROB CHEMOTH, V54, P173, DOI 10.1093/jac/dkh282; Mushi MF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303104; Newman RE, 2012, PEDIATRICS, V129, pE597, DOI 10.1542/peds.2011-1533; Nimmich Elizabeth B, 2017, Hosp Pharm, V52, P691, DOI 10.1177/0018578717720506; Ntirenganya C, 2015, AM J TROP MED HYG, V92, P865, DOI 10.4269/ajtmh.14-0607; Nyongole O, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.226.6253; Pereira LMP, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-59; Shimels Tariku, 2015, J Pharm Policy Pract, V8, P26, DOI 10.1186/s40545-015-0047-1; Sileshi A, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0057-x; Thriemer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055495; Velickovic-Radovanovic R, 2015, J CLIN PHARM THER, P31, DOI [10.5633/amm.2015.0205, DOI 10.5633/AMM.2015.0205]	37	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220261	10.1371/journal.pone.0220261	http://dx.doi.org/10.1371/journal.pone.0220261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381579	Green Published, gold, Green Submitted			2022-12-27	WOS:000484993600013
J	Zhou, C; Jiao, Y; Browder, J				Zhou, Can; Jiao, Yan; Browder, Joan			How much do we know about seabird bycatch in pelagic longline fisheries? A simulation study on the potential bias caused by the usually unobserved portion of seabird bycatch	PLOS ONE			English	Article							MORTALITY; MODEL	Not much is known about the fleet level total seabird bycatch from pelagic longlines of United States vessels in the western North Atlantic or other fleets of the Atlantic or other oceans. Onboard observers generally only record seabird bycatch during line hauling. Seabirds are predominantly caught during the line setting stage, and, due to predation or mechanical action, those caught prior to the haul can drop off the hook and be lost to the onboard observer. We developed a model to gauge the size of this bycatch loss problem and provide a first approximation of its impact on estimates of total fleet bycatch. We started with a traditional loss-free bycatch model, which assumes that birds recorded were the only birds captured, and integrated into it two crucial components of the bycatch process: capture origin (set or haul) and bycatch loss of set-captures. We extracted count data on seabird bycatch loss and bycatch mortality from the literature on other longline fisheries and used these data to simulate potential total seabird bycatch in the western North Atlantic. Simulations revealed the shortcomings of both the traditional bycatch model and the current haul-only observer protocol, each of which contributed to biologically significant underestimation of total bycatch and estimation uncertainty. Based on our results, we recommend a loss-corrected modeling approach to provide a more accurate estimate of seabird mortalities in pelagic longline fisheries. Where possible, fishery-specific seabird bycatch loss rates need to be ascertained via specific set and haul observing protocols. But, even where fishery-specific estimates for a region are not available, the methodology developed here is applicable to other pelagic longline fisheries to approximate fleet-level loss-corrected bycatch.	[Zhou, Can; Jiao, Yan] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Browder, Joan] NOAA, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL USA	Virginia Polytechnic Institute & State University; National Oceanic Atmospheric Admin (NOAA) - USA	Zhou, C (corresponding author), Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.	eidotog@gmail.com	Zhou, Can/AAZ-9771-2020	Zhou, Can/0000-0003-4533-5333; Jiao, Yan/0000-0002-8804-5005	National Oceanic and Atmospheric Administration National Marine Fisheries Service, Southeast Fisheries Science Center [WC133F15SE1858]; National Oceanic and Atmospheric Administration Fisheries' National Seabird Program; National Seabird Program	National Oceanic and Atmospheric Administration National Marine Fisheries Service, Southeast Fisheries Science Center; National Oceanic and Atmospheric Administration Fisheries' National Seabird Program; National Seabird Program	This work received funding from the National Oceanic and Atmospheric Administration National Marine Fisheries Service, Southeast Fisheries Science Center, grant number WC133F15SE1858 (https://www.sefsc.noaa.gov/) to YJ, and funding from National Oceanic and Atmospheric Administration Fisheries' National Seabird Program (https://www.st.nmfs.noaa.gov/national-seabird-program/) to JB and to the Southeast Fisheries Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The second grant from the National Seabird Program was an internal one, and it doesn't have a grant number.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Babcock E. A, 2003, MUCH OBSERVER COVERA; Beerkircher L.R., 2002, MAR FISH REV, V64, P40, DOI DOI 10.1037/0003-066x.59.1.29; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Brothers N, 2016, ACAP 7 M SEAB BYC WO; Brothers N.P., 1999, INCIDENTAL CATCH SEA; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; Burnham K P, 2003, MODEL SELECT MULTIMO; Camphuysen C.J., 1995, CONSUMPTION DISCARDS; Croxall JP, 1998, POPULATION CHANGES A; Debski I., 2016, OBSERVER COVERAGE MO; Diaz G.A., 2009, COLLECTIVE VOLUME SC, V64, P2415; Gales R, 1998, BIOL CONSERV, V86, P37, DOI 10.1016/S0006-3207(98)00011-1; Gilman E, 2003, OCEAN COAST MANAGE, V46, P985, DOI 10.1016/j.ocecoaman.2003.12.001; Gilman EL, 2009, MINIMIZING BYCATCH S; Gilman E, 2007, FISHERIES SCI, V73, P208, DOI 10.1111/j.1444-2906.2007.01321.x; Gilman E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155477; Hata D, 2006, UNPUB; Huin Nicolas, 1996, Marine Ornithology, V24, P19; Kadane JB, 2006, BAYESIAN ANAL, V1, P363, DOI 10.1214/06-BA113; Lawson T., 2006, SCI ASPECTS OBSERVER; Lee David S., 1999, Journal of the Elisha Mitchell Scientific Society, V115, P294; Li Y, 2015, ESTIMATED SEABIRD BY; Li Y, 2014, ESTIMATED SEABIRD BY; Li Y, 2016, ICES J MAR SCI, V73, P2687, DOI 10.1093/icesjms/fsw088; Li Y, 2013, ECOL MODEL, V260, P36, DOI 10.1016/j.ecolmodel.2013.03.021; Lord D, 2008, ACCIDENT ANAL PREV, V40, P1123, DOI 10.1016/j.aap.2007.12.003; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M., 2002, J R STAT SOC B, V64, P620, DOI [10.1111/1467-9868.00353., DOI 10.1111/1467-9868.00353]; R Development Core Team, 2016, R LANG ENV STAT COMP; Rodriguez A, FUTURE DIRECTIONS CO; Shmueli G, 2005, J ROY STAT SOC C-APP, V54, P127, DOI 10.1111/j.1467-9876.2005.00474.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tennyson A., 1990, Forest & Bird (Wellington), V21, P23; Vega R, 2009, FISH RES, V98, P22, DOI 10.1016/j.fishres.2009.03.010; Vucetich JA, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P35, DOI 10.1007/978-0-387-85952-1_3; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; Winter A, 2011, WATERBIRDS, V34, P289, DOI 10.1675/063.034.0304; Zhou C., 2017, ESTIMATED SEABIRD BY; Zhou Can, 2019, Ecological Modelling, V407, DOI 10.1016/j.ecolmodel.2019.108726; Zhou C, 2019, AQUAT CONSERV, V29, P1324, DOI 10.1002/aqc.3066; Zuur Alain F., 2009, P1	42	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0220797	10.1371/journal.pone.0220797	http://dx.doi.org/10.1371/journal.pone.0220797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381613	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600036
J	Appel, JM; Fullerton, K; Hennessy, E; Korn, AR; Tovar, A; Allender, S; Hovmand, PS; Kasman, M; Swinburn, BA; Hammond, RA; Economos, CD				Appel, Julia M.; Fullerton, Karen; Hennessy, Erin; Korn, Ariella R.; Tovar, Alison; Allender, Steven; Hovmand, Peter S.; Kasman, Matt; Swinburn, Boyd A.; Hammond, Ross A.; Economos, Christina D.			Design and methods of Shape Up Under 5: Integration of systems science and community-engaged research to prevent early childhood obesity	PLOS ONE			English	Article							INTERVENTIONS; DISPARITIES; DIFFUSION; NUTRITION; CHILDREN; WHOLE	Shape Up Under 5 (SUU5) was a two-year early childhood obesity prevention pilot study in Somerville, Massachusetts (2015-2017) designed to test a novel conceptual framework called Stakeholder-driven Community Diffusion. For whole-of-community interventions, this framework posits that diffusion of stakeholders' knowledge about and engagement with childhood obesity prevention efforts through their social networks will improve the implementation of health-promoting policy and practice changes intended to reduce obesity risk. SUU5 used systems science methods (agent-based modeling, group model building, social network analysis) to design, facilitate, and evaluate the work of 16 multisector stakeholders ('the Committee'). In this paper, we describe the design and methods of SUU5 using the conceptual framework: the approach to data collection, and methods and rationale for study inputs, activities and evaluation, which together may further our understanding of the hypothesized processes within Stakeholder-driven Community Diffusion. We also present a generalizable conceptual framework for addressing childhood obesity and similar complex public health issues through whole-of-community interventions.	[Appel, Julia M.; Fullerton, Karen; Hennessy, Erin; Korn, Ariella R.; Economos, Christina D.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Tovar, Alison] Univ Rhode Isl, Dept Nutr & Food Sci, South Kingston, RI USA; [Allender, Steven; Swinburn, Boyd A.] Deakin Univ, Global Obes Ctr GLOBE, Ctr Populat Hlth Res, Geelong, Vic, Australia; [Hovmand, Peter S.] Washington Univ, George Warren Brown Sch Social Work, Social Syst Design Lab, St Louis, MO 63130 USA; [Kasman, Matt; Hammond, Ross A.] Brookings Inst, Ctr Social Dynam & Policy, Washington, DC 20036 USA; [Swinburn, Boyd A.] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand	Tufts University; University of Rhode Island; Deakin University; Washington University (WUSTL); Brookings Institution; University of Auckland	Economos, CD (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	christina.economos@tufts.edu		Allender, Steven/0000-0002-4842-3294	National Institutes of Health (NIH) from the National Heart, Lung and Blood Institute (NHLBI) [1R01HL115485]; Office for Behavioral and Social Sciences Research (OBSSR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Heart, Lung and Blood Institute (NHLBI); Office for Behavioral and Social Sciences Research (OBSSR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	COMPACT and Shape Up Under 5 were funded by National Institutes of Health (NIH, https://www.nih.gov/), grant #1R01HL115485 from the National Heart, Lung and Blood Institute (NHLBI, https://www.nhlbi.nih.gov/) and the Office for Behavioral and Social Sciences Research (OBSSR, https://obssr.od.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski T, 2018, CHILD OBES, V14, P1, DOI 10.1089/chi.2017.0303; Benjamin SE, 2007, J NUTR EDUC BEHAV, V39, P142, DOI 10.1016/j.jneb.2006.08.027; Boelsen-Robinson T, 2015, OBES REV, V16, P806, DOI 10.1111/obr.12297; Bosse T, 2013, AUTON AGENT MULTI-AG, V27, P52, DOI 10.1007/s10458-012-9201-1; Cowan R, 2004, J ECON DYN CONTROL, V28, P1557, DOI 10.1016/j.jedc.2003.04.002; Dearing JW, 2008, J PUBLIC HEALTH MAN, V14, P99, DOI 10.1097/01.PHH.0000311886.98627.b7; Economos CD, 2007, OBESITY, V15, P1325, DOI 10.1038/oby.2007.155; Economos CD, 2017, OBESITY, V25, P1155, DOI 10.1002/oby.21893; Friedkin NE, 1999, ADV GROUP, V16, P1; Gillman MW, 2008, OBESITY, V16, P1651, DOI 10.1038/oby.2008.260; Gillman MW, 2016, JAMA PEDIATR, V170, P9, DOI 10.1001/jamapediatrics.2015.2786; Hammond RA, 2009, PREV CHRONIC DIS, V6; Henderson KE, 2011, J AM DIET ASSOC, V111, P1306, DOI 10.1016/j.jada.2011.06.011; Hovmand PS, 2011, INT C SYST DYN 2011; Huang TT, 2009, PREV CHRONIC DIS, V6; Institute of Medicine, 2012, 9780309221542 I MED; Ip EH, 2013, HEALTH EDUC BEHAV, V40, p123S, DOI 10.1177/1090198113493911; Korn AR, 2018, CHILD OBES, V14, P537, DOI 10.1089/chi.2018.0032; Korn AR, 2018, BMC PUBLIC HEALTH, V18, DOI [10.1186/s12889-018-5588-1, 10.1186/S12889-018-5588-1]; Luke DA, 2012, ANNU REV PUBL HEALTH, V33, P357, DOI 10.1146/annurev-publhealth-031210-101222; Mezirow J., 1991, TRANSFORMATIVE DIMEN, DOI DOI 10.1002/ACE.7401; Pan LP, 2012, JAMA-J AM MED ASSOC, V308, P2563, DOI 10.1001/jama.2012.108099; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; Shoham David A, 2015, Curr Epidemiol Rep, V2, P71; Taveras EM, 2017, OBESITY, V25, P1159, DOI 10.1002/oby.21866; Taveras EM, 2015, CHILD OBES, V11, P11, DOI 10.1089/chi.2014.0031; Taveras EM, 2013, JAMA PEDIATR, V167, P731, DOI 10.1001/jamapediatrics.2013.85; Terrell LG, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-0725, 10.1542/peds.2018-1916, 10.1542/peds.2017-3459]; Thompson AL, 2013, SOC SCI MED, V97, P288, DOI 10.1016/j.socscimed.2012.12.007; Wolfenden L, 2014, PREV MED, V62, P193, DOI 10.1016/j.ypmed.2014.01.031	30	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220169	10.1371/journal.pone.0220169	http://dx.doi.org/10.1371/journal.pone.0220169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369570	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900032
J	Ramalho, SHR; Cipriano, G; Vieira, PJC; Nakano, EY; Winkelmann, ER; Callegaro, CC; Chiappa, GR				Rodolpho Ramalho, Sergio Henrique; Cipriano Junior, Gerson; Cardoso Vieira, Paulo Jose; Nakano, Eduardo Yoshio; Winkelmann, Eliane R.; Callegaro, Carine C.; Chiappa, Gaspar Rogerio			Inspiratory muscle strength and six-minute walking distance in heart failure: Prognostic utility in a 10 years follow up cohort study	PLOS ONE			English	Article							REFERENCE VALUES; EXERCISE; MORTALITY; WEAKNESS; TESTS	Background Maximal inspiratory pressure (PImax) and 6-minutes walk distance test (6MWD) may be more available and feasible alternatives for prognostic assessment than cardiopulmonary testing. We hypothesized that the PImax and 6MWD combination could improve their individual accuracy as risk predictors. We aimed to evaluate PImax ability as a mortality predictor in HF and whether the combination to 6MWD could improve risk stratification. Methods Prospective cohort from HF Clinics of three University Hospitals. PImax, 6MWD and pVO(2) were obtained at baseline. The end point was all cause mortality. Results Consecutive 256 individuals (50% woman, 57.4 +/- 10.4years) with low ejection fraction (LVEF) (31.8 +/- 8.6%) were followed up to 10years. During a median follow-up of 34.7 (IQR 37) months, 110 participants died. Mean +/- SD values were: pVO(2) 14.9 +/- 5.1mL/kg/min, PImax 5.5 +/- 1.3kPa and 6MWD 372 +/- 118m. In multivariate Cox regression, pVO(2), PImax, 6MWD and LVEF were independent mortality predictors. The pVO(2) showed gold standard accuracy, followed by PImax (AUC = 0.84) and 6MWD (AUC = 0.74). Kaplan-Meier mean survival time (MST +/- SE) for lower (<= 5.0kPa) and higher (>6.0kPa) PImax tertiles, were 37.9 +/- 2.8months and 105.0 +/- 5.2months respectively, and addition of 6MWD did not restratified risk. For intermediate PImax tertile, MST was 81.5 +/- 5.5months, but adding 6MWD, MST was lower (53.3 +/- 7.6months) if distance was <= 350m and higher (103.1 +/- 5.7months) for longer distances. Conclusion PImax is an independent mortality predictor in HF, more accurate than 6MWD and LVEF. Addition of 6MWD empowers risk stratification only for intermediate PImax tertile. Although less accurate than pVO(2), this simpler approach could be a feasible alternative as a prognostic assessment.	[Rodolpho Ramalho, Sergio Henrique; Cipriano Junior, Gerson; Chiappa, Gaspar Rogerio] Univ Brasilia, Hlth Sci & Technol Program, Brasilia, DF, Brazil; [Cipriano Junior, Gerson] Univ Brasilia, Rehabil Sci Program, Brasilia, DF, Brazil; [Cardoso Vieira, Paulo Jose] Hosp Cristo Redentor, Intens Care Unit, Porto Alegre, RS, Brazil; [Nakano, Eduardo Yoshio] Univ Brasilia, Dept Stat, Brasilia, DF, Brazil; [Winkelmann, Eliane R.] Univ Reg Noroeste Estado Rio Grande do Sul UNIJUI, Ijui, Brazil; [Callegaro, Carine C.] Univ Fed Santa Maria, Dept Physiotherapy, Santa Maria, RS, Brazil; [Chiappa, Gaspar Rogerio] Fac Integradas Uniao Educ Planalto Cent, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; Universidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUI; Universidade Federal de Santa Maria (UFSM)	Ramalho, SHR (corresponding author), Univ Brasilia, Hlth Sci & Technol Program, Brasilia, DF, Brazil.	shrramalho@gmail.com	Nakano, Eduardo Y/G-1660-2011; Ramalho, Sergio/AAE-2098-2019; Cipriano Jr., Gerson/K-6317-2014; Londoner, Kenneth L/AAD-2222-2019	Nakano, Eduardo Y/0000-0002-9071-8512; Ramalho, Sergio/0000-0001-8444-2655; Cipriano Jr., Gerson/0000-0001-6323-7003; Londoner, Kenneth L/0000-0001-9085-3813; Technologies, BioSig/0000-0001-8277-164X; Callegaro, Carine/0000-0001-9482-5457; Winkelmann, Eliane Roseli/0000-0002-4922-6516	Brazilian Government agencies for this research: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [407527/2013-3]; Coordenacao de Aperfeic oamento de Pessoal de Nivel Superior (CAPES) [53001010088P8]	Brazilian Government agencies for this research: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeic oamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	GRC was supported by Brazilian Government agencies for this research: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 407527/2013-3 and Coordenacao de Aperfeic oamento de Pessoal de Nivel Superior (CAPES; 53001010088P8). The authors declare no potential conflicts of interest with respect to the research, authorship or publication of this article.	Adsett J, 2011, EUR J CARDIOV PREV R, V18, P601, DOI 10.1177/1741826710389403; Arena Ross, 2012, Congest Heart Fail, V18, P302, DOI 10.1111/j.1751-7133.2012.00296.x; Billebeau G, 2017, EUR J PREV CARDIOL, V24, P1127, DOI 10.1177/2047487317705488; Cacciatore F, 2012, EUR J PREV CARDIOL, V19, P1401, DOI 10.1177/1741826711422991; Cahalin LP, 2013, EXPERT REV CARDIOVAS, V11, P161, DOI [10.1586/erc.12.191, 10.1586/ERC.12.191]; Chase PJ, 2013, JACC-HEART FAIL, V1, P427, DOI 10.1016/j.jchf.2013.05.008; Coats AJS, 1996, J MOL CELL CARDIOL, V28, P2255, DOI 10.1006/jmcc.1996.0218; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dall'Ago P, 2006, J AM COLL CARDIOL, V47, P757, DOI 10.1016/j.jacc.2005.09.052; Frankenstein L, 2008, EUR J CARDIOV PREV R, V15, P156, DOI 10.1097/HJR.0b013e3282f0d6ea; Frankenstein L, 2009, EUR J CARDIOV PREV R, V16, P424, DOI 10.1097/HJR.0b013e3283030a7e; Gilstrap LG, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008789; Goldberg LR, 2007, CIRCULATION, V116, P360, DOI 10.1161/CIRCULATIONAHA.107.713735; Guazzi M, 2012, EUR HEART J, V33, P2917, DOI 10.1093/eurheartj/ehs221; Iliou MC, 2017, EUR J PREV CARDIOL, V24, P1274, DOI 10.1177/2047487317712601; Kelley RC, 2017, HEART FAIL REV, V22, P191, DOI 10.1007/s10741-016-9549-4; Keteyian SJ, 2016, J AM COLL CARDIOL, V67, P780, DOI 10.1016/j.jacc.2015.11.050; Komajda M, 2017, EUR J HEART FAIL, V19, P1495, DOI 10.1002/ejhf.876; Meyer FJ, 2001, CIRCULATION, V103, P2153; Meyer T, 2001, INT J SPORTS MED, V22, P593, DOI 10.1055/s-2001-18523; Montemezzo D, 2014, ARCH PHYS MED REHAB, V95, P1398, DOI 10.1016/j.apmr.2014.02.022; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Palau P, 2019, REV ESP CARDIOL, V72, P288, DOI 10.1016/j.rec.2018.01.010; Piepoli MF, 2011, EUR J HEART FAIL, V13, P347, DOI 10.1093/eurjhf/hfr017; Ribeiro Jorge P, 2009, Curr Heart Fail Rep, V6, P95; Rodrigues A, 2017, CHEST, V152, P32, DOI 10.1016/j.chest.2016.11.045; Rostagno C, 2003, EUR J HEART FAIL, V5, P247, DOI 10.1016/S1388-9842(02)00244-1; Savarese G, 2018, EUR J HEART FAIL, V20, P284; Smart NA, 2013, INT J CARDIOL, V167, P1502, DOI 10.1016/j.ijcard.2012.04.029; Tikunov B, 1997, CIRCULATION, V95, P910; van der Palen J, 2004, THORAX, V59, P1063, DOI 10.1136/thx.2004.021915; Verissimo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118218; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220638	10.1371/journal.pone.0220638	http://dx.doi.org/10.1371/journal.pone.0220638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369636	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900073
J	McAvoy, KM; Soit, HR; Marsh, G; Peterson, M; Reynolds, TL; Gagnon, J; Geisler, S; Leach, P; Roberts, C; Cahir-McFarland, E; Ransohoff, RM; Crotti, A				McAvoy, Kathleen M.; Soit, Hameetha Rajamohamed; Marsh, Galina; Peterson, Michael; Reynolds, Taylor L.; Gagnon, Jake; Geisler, Sarah; Leach, Prescott; Roberts, Chris; Cahir-McFarland, Ellen; Ransohoff, Richard M.; Crotti, Andrea			Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; CANCER SUPPRESSION; PROTEIN EXPRESSION; C-FOS; ACTIVATION; BRAIN; GENE; BAR; NEURODEGENERATION; IDENTIFICATION	BIN1 is the most important risk locus for Late Onset Alzheimer's Disease (LOAD), after ApoE. BIN1 AD-associated SNPs correlate with Tau deposition as well as with brain atrophy. Furthermore, the level of neuronal-specific BIN1 isoform 1 protein is decreased in sporadic AD cases in parallel with neuronal loss, despite an overall increase in BIN1 total mRNA. To address the relationship between reduction of BIN1 and neuronal cell loss in the context of Tau pathology, we knocked-down endogenous murine Bin1 via stereotaxic injection of AAV-Bin1 shRNA in the hippocampus of mice expressing Tau P301S (PS19). We observed a statistically significant reduction in the number of neurons in the hippocampus of mice injected with AAV-Bin1 shRNA in comparison with mice injected with AAV control. To investigate whether neuronal loss is due to deletion of Bin1 selectively in neurons in presence Tau P301S, we bred Bin1(flox/flox) with Thy1-Cre and subsequently with PS19 mice. Mice lacking neuronal Bin1 and expressing Tau P301S showed increased mortality, without increased neuropathology, when compared to neuronal Bin1 and Tau P301S-expressing mice. The loss of Bin1 isoform 1 resulted in reduced excitability in primary neurons in vitro, reduced neuronal c-fos expression as well as in altered microglia transcriptome in vivo. Taken together, our data suggest that the contribution of genetic variation in BIN1 locus to AD risk could result from a cell-autonomous reduction of neuronal excitability due to Bin1 decrease, exacerbated by the presence of aggregated Tau, coupled with a non-cell autonomous microglia activation.	[McAvoy, Kathleen M.; Soit, Hameetha Rajamohamed; Marsh, Galina; Peterson, Michael; Reynolds, Taylor L.; Gagnon, Jake; Geisler, Sarah; Leach, Prescott; Roberts, Chris; Cahir-McFarland, Ellen; Crotti, Andrea] Biogen, Cambridge, MA 02142 USA; [Ransohoff, Richard M.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Crotti, Andrea] Astellas Innovat Management, Cambridge, MA 02138 USA	Biogen; Harvard University; Harvard Medical School	Crotti, A (corresponding author), Biogen, Cambridge, MA 02142 USA.; Crotti, A (corresponding author), Astellas Innovat Management, Cambridge, MA 02138 USA.	andrea.crotti@astellas.com			Biogen	Biogen(Biogen)	Funding for this work had been provided by Biogen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SL, 2016, J NEUROPATH EXP NEUR, V75, P779, DOI 10.1093/jnen/nlw056; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; [Anonymous], [No title captured]; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Bungenberg J, 2016, NEUROBIOL DIS, V86, P121, DOI 10.1016/j.nbd.2015.11.011; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Cruz FC, 2015, BRAIN RES, V1628, P157, DOI 10.1016/j.brainres.2014.11.005; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Cruz JC, 2006, J NEUROSCI, V26, P10536, DOI 10.1523/JNEUROSCI.3133-06.2006; De Rossi P, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0124-1; Dewachter I, 2002, J NEUROSCI, V22, P3445; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Drager NM, 2017, EMBO REP, V18, P2051, DOI 10.15252/embr.201744137; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Glennon EBC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078806; Hargis KE, 2017, BEHAV BRAIN RES, V322, P311, DOI 10.1016/j.bbr.2016.05.007; Holler CJ, 2014, J ALZHEIMERS DIS, V42, P1221, DOI 10.3233/JAD-132450; Holtmaat A, 2016, NAT NEUROSCI, V19, P1553, DOI 10.1038/nn.4418; Hong TT, 2017, PHYSIOL REV, V97, P227, DOI 10.1152/physrev.00037.2015; Huser S, 2013, BIOCHEM J, V450, P73, DOI 10.1042/BJ20121373; Jasnow AM, 2013, J NEUROSCI, V33, P10396, DOI 10.1523/JNEUROSCI.5539-12.2013; Joo JY, 2016, NAT NEUROSCI, V19, P75, DOI 10.1038/nn.4170; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Mandhane SN, 2007, SEIZURE-EUR J EPILEP, V16, P636, DOI 10.1016/j.seizure.2007.05.005; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; McCullough KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13149; Montaguti E, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00441; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Munoz W, 2014, CELL REP, V9, P2304, DOI 10.1016/j.celrep.2014.11.042; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Prendergast GC, 2009, BBA-REV CANCER, V1795, P25, DOI 10.1016/j.bbcan.2008.09.001; Ramalingam A, 2007, CELL CYCLE, V6, P1914, DOI 10.4161/cc.6.15.4514; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; REPRESA A, 1995, J NEUROBIOL, V26, P413, DOI 10.1002/neu.480260313; Scharfman HE, 2012, FUTUR NEUROL, V7, P177, DOI 10.2217/FNL.12.8; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Sottejeau Y, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0237-8; Vossel KA, 2017, LANCET NEUROL, V16, P311, DOI 10.1016/S1474-4422(17)30044-3; Wang HF, 2016, J ALZHEIMERS DIS, V52, P179, DOI 10.3233/JAD-150972; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Woerman AL, 2017, JAMA NEUROL, V74, P1464, DOI 10.1001/jamaneurol.2017.2822; Ye H, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0399-8; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang XL, 2015, NEUROPSYCHOPHARMACOL, V40, P1794, DOI 10.1038/npp.2015.30; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099665	57	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220125	10.1371/journal.pone.0220125	http://dx.doi.org/10.1371/journal.pone.0220125			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408457	gold, Green Submitted, Green Published			2022-12-27	WOS:000485009500008
J	Janssen, S; Heijs, JJA; van der Meijs, W; Nonnekes, J; Bittner, M; Dorresteijn, LDA; Bloem, BR; van Wezel, RJA; Heida, T				Janssen, S.; Heijs, J. J. A.; van der Meijs, W.; Nonnekes, J.; Bittner, M.; Dorresteijn, L. D. A.; Bloem, B. R.; van Wezel, R. J. A.; Heida, T.			Validation of the Auditory Stroop Task to increase cognitive load in walking tasks in healthy elderly and persons with Parkinson's disease	PLOS ONE			English	Article							OBJECTIVE MEASURES; ATTENTIONAL COST; DUAL-TASKING; GAIT; PEOPLE; INTERFERENCE; STRATEGY; POSTURE; IMPACT; CUES	Background The development of treatments for freezing of gait (FOG) in Parkinson's disease (PD) requires experimental study set-ups in which FOG is likely to occur, and is amenable to therapeutic interventions. We explore whether the 'Auditory Stroop Task' (AST) can be used to increase cognitive load (and thereby elicit FOG), simultaneously with visual cues (as a therapeutic intervention for FOG). We additionally examined how these two contrasting effects might interact in affecting gait and FOG parameters. Objectives We investigated whether: (1) the 'Auditory Stroop Task' (AST) influences gait in healthy elderly and persons with PD who experience FOG, and increases the frequency of FOG events among PD patients; (2) the AST and visual cues interact; and (3) different versions of the AST exert different cognitive loads. Methods In 'Experiment 1', 19 healthy elderly subjects performed a walking task while performing a high and low load version of the AST. Walking with a random numbers task, and walking without cognitive load served as control conditions. In 'Experiment 2', 20 PD patients with FOG and 18 healthy controls performed a walking task with the AST, and no additional cognitive load as control condition. Both experiments were performed with and without visual cues. Velocity, cadence, stride length, and stride time were measured in all subjects. FOG severity was measured in patients. Results Compared to the control conditions, the AST negatively affected all gait parameters in both patients and controls. The AST did not increase the occurrence of FOG in patients. Visual cues reduced the decline in stride length induced by cognitive load in both groups. Both versions of the AST exerted similar effects on gait parameters in controls. Conclusions The AST is well-suited to simulate the effects of cognitive load on gait parameters, but not FOG severity, in gait experiments in persons with PD and FOG.	[Janssen, S.; Heijs, J. J. A.; Bittner, M.; van Wezel, R. J. A.; Heida, T.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Biomed Signals & Syst Grp, Enschede, Netherlands; [Janssen, S.; Bloem, B. R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands; [van der Meijs, W.; van Wezel, R. J. A.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Biophys, Nijmegen, Netherlands; [Nonnekes, J.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Rehabil, Nijmegen, Netherlands; [Dorresteijn, L. D. A.] Med Spectrum Twente, Dept Neurol, Enschede, Netherlands	University of Twente; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Medical Spectrum Twente	Janssen, S (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Biomed Signals & Syst Grp, Enschede, Netherlands.; Janssen, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands.	s.janssen-2@utwente.nl	van der Meijs, Wijnand/Y-8642-2019; Nonnekes, Jorik/P-6648-2015; van Wezel, Richard R J/G-4455-2011; Bloem, Bastiaan/H-8013-2014; Janssen, Sabine/F-2917-2016	van Wezel, Richard R J/0000-0001-5753-7069; Bloem, Bastiaan/0000-0002-6371-3337; Heida, Tjitske/0000-0002-8382-6291; Janssen, Sabine/0000-0001-8470-3050; Nonnekes, Jorik/0000-0003-2434-1427; Heijs, Janne/0000-0001-5354-881X	Netherlands Organization for Scientific Research [058-14-001]; Netherlands Organization for Health Research and Development (ZonMw); National Initiative Brain & Cognition (NIHC)	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); National Initiative Brain & Cognition (NIHC)	This work is funded by a research grant (058-14-001) under the Light, Cognition, Behaviour and Health call, a joint initiative of the Netherlands Organization for Scientific Research, the Netherlands Organization for Health Research and Development (ZonMw) and the National Initiative Brain & Cognition (NIHC). The funder provided support in the form of salaries for authors [SJ, MB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Amri M, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18030719; Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Amboni M, 2008, MOVEMENT DISORD, V23, P395, DOI 10.1002/mds.21850; Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Baker K, 2007, ARCH PHYS MED REHAB, V88, P1593, DOI 10.1016/j.apmr.2007.07.026; Beck EN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144986; Bekkers EMJ, 2018, NEUROREHAB NEURAL RE, V32, P166, DOI 10.1177/1545968318761121; Beyea J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040934; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; Christensen TA, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00236; Fortaleza ACD, 2017, GAIT POSTURE, V56, P76, DOI 10.1016/j.gaitpost.2017.05.006; Ekker MS, 2016, PARKINSONISM RELAT D, V22, pS73, DOI 10.1016/j.parkreldis.2015.08.031; Ginis P, 2018, ANN PHYS REHABIL MED, V61, P407, DOI 10.1016/j.rehab.2017.08.002; GREEN EJ, 1981, PERCEPT PSYCHOPHYS, V30, P459, DOI 10.3758/BF03204842; Janssen S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00279; Karatsidis  A., 2016, SENSORS, V17, P1; Kelly VE, 2012, PARKINSONS DIS-US, V2012, DOI [10.1155/2012/918719, 10.1073/pnas.1207553109]; Knight S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00230; Lohnes CA, 2011, GAIT POSTURE, V33, P478, DOI 10.1016/j.gaitpost.2010.12.029; Mancini M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31156-4; Mazaheri M, 2015, EXP BRAIN RES, V233, P3467, DOI 10.1007/s00221-015-4407-5; Morris TR, 2012, PARKINSONISM RELAT D, V18, P572, DOI 10.1016/j.parkreldis.2012.03.001; Nanhoe-Mahabier W, 2012, MOVEMENT DISORD, V27, P574, DOI 10.1002/mds.24935; Nieuwboer A, 2007, J NEUROL NEUROSUR PS, V78, P134, DOI 10.1136/jnnp.200X.097923; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Paulich M, 2018, CISC VIS NETW IND GL; Rochester L, 2007, J NEURAL TRANSM, V114, P1243, DOI 10.1007/s00702-007-0756-y; Roetenberg D., 2009, TECHNICAL REPORT; SHOR RE, 1975, J GEN PSYCHOL, V93, P281; Skog I, 2010, IEEE T BIOMED ENG, V57; Strouwen C, 2016, PARKINSONISM RELAT D, V23, P23, DOI 10.1016/j.parkreldis.2015.11.020; Virmani T, 2018, GAIT POSTURE, V65, P100, DOI 10.1016/j.gaitpost.2018.07.167; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zhao Y, 2016, J NEUROL, V263, P1156, DOI 10.1007/s00415-016-8115-2	35	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220735	10.1371/journal.pone.0220735	http://dx.doi.org/10.1371/journal.pone.0220735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5CU	31386695	Green Published, Green Submitted, gold			2022-12-27	WOS:000484997100035
J	Xu, PP; Dong, N; Wong, SC; Huang, HL				Xu, Pengpeng; Dong, Ni; Wong, S. C.; Huang, Helai			Cyclists injured in traffic crashes in Hong Kong: A call for action	PLOS ONE			English	Article							SIGNALIZED INTERSECTIONS; SAFETY; RISK; EXPOSURE; PEDESTRIANS; SEVERITY; NUMBERS; MODELS; RATES	Background Perceived as a minor transportation mode mainly for recreation, cycling and its related safety issues have not been treated as a citywide concern in Hong Kong and have thus received inadequate research efforts. Our study aimed to illuminate the safety challenges faced by cyclists in Hong Kong. Methods We examined the police crash records from 1998 to 2017 and developed a Bayesian Poisson state space model to evaluate the longitudinal change in traffic injuries to cyclists. We then used quasi-induced exposure to measure the annual relative risk of crash involvement for cycling. Based on an officially published travel characteristics survey, we further measured the risk of injury for cycling per minutes cycled. Results Between 1998 and 2017, Hong Kong witnessed a more than twofold increase in the number of cyclist injuries, with an average annual increase rate of 5.18% (95% CI: 0.53%-12.77%). By 2017, cyclists were 2.21 (1.82-2.69) times more likely to be involved in traffic crashes than in 1998. Per 10 million minutes, the injury rates for cycling were 28.64 (27.43-29.70) and 42.54 (41.07-44.02) on weekdays during 2001-2003 and 2010-2012. After adjusting for sex and age groups, cyclists were 1.95 (1.43-2.61) times more likely to be injured in 2010-2012 than in 2001-2003. Per minutes traveled, cyclists also sustained significantly higher risks of fatality and injury than pedestrians, private car drivers and passengers, taxi passengers, public bus passengers, and minibus passengers. A comparison of Hong Kong with other regions suggests that Hong Kong is among the most dangerous areas for cycling in terms of fatality rate per minutes cycled. Conclusions Cyclist injuries have become a substantial public health burden in Hong Kong. A range of countermeasures with proven effectiveness should be promptly implemented to improve the safety of these vulnerable road users.	[Xu, Pengpeng; Wong, S. C.] Univ Hong Kong, Dept Civil Engn, Hong Kong, Peoples R China; [Dong, Ni] Southwest Jiaotong Univ, Sch Transportat & Logist, Chengdu, Sichuan, Peoples R China; [Huang, Helai] Cent South Univ, Sch Traff & Transportat Engn, Changsha, Hunan, Peoples R China	University of Hong Kong; Southwest Jiaotong University; Central South University	Wong, SC (corresponding author), Univ Hong Kong, Dept Civil Engn, Hong Kong, Peoples R China.	hhecwsc@hku.hk	Dong, Ni/AAP-5112-2020; Xu, Pengpeng/W-7868-2019; Wong, S.C./A-7258-2008	Wong, S.C./0000-0003-1169-7045; Xu, Pengpeng/0000-0001-9826-4212	Joint Research Scheme of National Nature Science Foundation of China/Research Grants Council of Hong Kong [71561167001, N_HKU707/15]; Natural Science Foundation of China [71601163, 71671100]; University of Hong Kong	Joint Research Scheme of National Nature Science Foundation of China/Research Grants Council of Hong Kong; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of Hong Kong(University of Hong Kong)	This work was supported by grants from the Joint Research Scheme of National Nature Science Foundation of China/Research Grants Council of Hong Kong (Project Nos. 71561167001 and N_HKU707/15) and the Natural Science Foundation of China (Project No. 71601163; 71671100). SCW and PX were respectively supported by the Francis S Y Bong Professorship in Engineering and a Research Postgraduate Studentship from the University of Hong Kong. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, HONG KONG TRANSP DEP; Bergel R, 2012, TRANSPORT REV, V32, P653, DOI 10.1080/01441647.2012.695407; Blaizot S, 2013, ACCIDENT ANAL PREV, V58, P35, DOI 10.1016/j.aap.2013.04.018; Bouaoun L, 2015, ACCIDENT ANAL PREV, V75, P217, DOI 10.1016/j.aap.2014.10.025; Brown V, 2017, J TRANSP HEALTH, V7, P23, DOI 10.1016/j.jth.2017.02.011; Chandraratna S, 2009, ACCIDENT ANAL PREV, V41, P308, DOI 10.1016/j.aap.2008.12.005; Cheng W, 2018, ACCIDENT ANAL PREV, V112, P84, DOI 10.1016/j.aap.2017.12.020; Chieng M, 2017, J TRANSP HEALTH, V6, P23, DOI 10.1016/j.jth.2017.02.008; Chin HC, 2018, ACCIDENT ANAL PREV, V112, P50, DOI 10.1016/j.aap.2017.12.024; Commandeur JJF, 2013, ACCIDENT ANAL PREV, V60, P424, DOI 10.1016/j.aap.2012.11.006; Congdon P., 2014, APPL BAYESIAN MODELL; Constant A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000228; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gotschi T, 2016, TRANSPORT REV, V36, P45, DOI 10.1080/01441647.2015.1057877; Guo Q, 2017, ACCIDENT ANAL PREV, V99, P114, DOI 10.1016/j.aap.2016.11.002; Hong Kong Transport Department, 2014, TRAV CHAR SURV 2011; Hong Kong Transport Department, 2017, ROAD TRAFF ACC STAT; Jiang XG, 2010, ACCIDENT ANAL PREV, V42, P1352, DOI 10.1016/j.aap.2010.02.016; Keall M, 2009, TRAFFIC INJ PREV, V10, P30, DOI 10.1080/15389580802383117; Kim JH, 2016, INT J EPIDEMIOL, V45, P1668, DOI 10.1093/ije/dyw172; Loo BPY, 2007, INJURY PREV, V13, P186, DOI 10.1136/ip.2006.013458; Loo BPY, 2010, ACCIDENT ANAL PREV, V42, P1902, DOI 10.1016/j.aap.2010.05.011; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Lusk AC, 2011, INJURY PREV, V17, P131, DOI 10.1136/ip.2010.028696; Ma XX, 2017, ANAL METHODS ACCID R, V15, P29, DOI 10.1016/j.amar.2017.06.001; Maibach E, 2009, PREV MED, V49, P326, DOI 10.1016/j.ypmed.2009.06.028; Mandic S, 2018, J TRANSP HEALTH, V8, P271, DOI 10.1016/j.jth.2017.12.010; McAndrews C., 2001, INJURY PREV, V17, P204; McAndrews C, 2013, ACCIDENT ANAL PREV, V60, P103, DOI 10.1016/j.aap.2013.08.005; Mindell JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050606; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw360, 10.1093/ije/dyw153]; Pedroso FE, 2016, AM J PUBLIC HEALTH, V106, P2171, DOI 10.2105/AJPH.2016.303454; Prati G, 2017, TRANSPORT RES F-TRAF, V47, P34, DOI 10.1016/j.trf.2017.04.008; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Pulugurtha SS, 2015, ACCIDENT ANAL PREV, V76, P34, DOI 10.1016/j.aap.2014.12.020; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Santamarina-Rubio E, 2014, ACCIDENT ANAL PREV, V65, P1, DOI 10.1016/j.aap.2013.11.015; Schneider RJ, 2017, ACCIDENT ANAL PREV, V106, P82, DOI 10.1016/j.aap.2017.04.018; Short J, 2014, TRANSPORT POLICY, V33, P154, DOI 10.1016/j.tranpol.2014.03.003; Sze NN, 2019, ACCIDENT ANAL PREV, V128, P17, DOI 10.1016/j.aap.2019.03.017; Sze NN, 2011, HONG KONG J EMERG ME, V18, P136, DOI 10.1177/102490791101800302; Thornley SJ, 2008, INJURY PREV, V14, P11, DOI 10.1136/ip.2007.016675; Tin ST, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-655; To DKB, 2005, TRANSPORTMETRICA, V1, P247, DOI 10.1080/18128600508685650; Vanparijs J, 2015, ACCIDENT ANAL PREV, V84, P9, DOI 10.1016/j.aap.2015.08.007; Xie SQ, 2018, ACCIDENT ANAL PREV, V121, P285, DOI 10.1016/j.aap.2018.09.030; Xu PP, 2019, INJURY PREV, V25, P20, DOI 10.1136/injuryprev-2017-042469; Xu PP, 2017, ACCIDENT ANAL PREV, V98, P330, DOI 10.1016/j.aap.2016.10.015; Xu XC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181544; Xu XC, 2016, J ADV TRANSPORT, V50, P2015, DOI 10.1002/atr.1442; Yao S, 2016, INJURY PREV, V22, P379, DOI 10.1136/injuryprev-2016-041964; Yeung JHH, 2009, INJURY, V40, P555, DOI 10.1016/j.injury.2008.08.015	53	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220785	10.1371/journal.pone.0220785	http://dx.doi.org/10.1371/journal.pone.0220785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5FL	31398211	Green Submitted, Green Published, gold			2022-12-27	WOS:000485004000020
J	Altamura, C; Paolucci, M; Brunelli, N; Rizzo, AC; Cecchi, G; Assenza, F; Silvestrini, M; Vernieri, F				Altamura, Claudia; Paolucci, Matteo; Brunelli, Nicoletta; Rizzo, Angelo Cascio; Cecchi, Gianluca; Assenza, Federica; Silvestrini, Mauro; Vernieri, Fabrizio			Right-to-left shunts and hormonal therapy influence cerebral vasomotor reactivity in patients with migraine with aura	PLOS ONE			English	Article							TRANSCRANIAL DOPPLER; STROKE; RISK; SUPERSENSITIVITY; HEMODYNAMICS; INFARCTS	Patent Foramen Ovale and impaired cerebral hemodynamics were proposed among the pathophysiological mechanisms explaining the increased risk for stroke in patients with Migraine with Aura (MA). Our study aimed at comparing the vasomotor reactivity (VMR) of the anterior and the posterior cerebral circulation in patients with Migraine with Aura, in patients with acute vascular ischemic accidents, and in controls. We hypothesized that VMR in MA patients is preserved in the anterior circulation and reduced in the posterior circulation. We prospectively assessed with Transcranial Doppler the vasomotor reactivity to breath holding of the Middle and Posterior Cerebral Arteries (MCA, PCA) in MA patients, in acute vascular patients and healthy controls. We also evaluated the possible effect of clinical characteristics of MA (attack frequency, aura length or type, disease history), vascular factors and the presence of right-to-left shunt on VMR. Diverging from our hypothesis, MA patients displayed a higher breath-holding index (BHI) than controls in the MCA (1.84 +/- 0.47%/s vs 1.53 +/- 0.47%/s, p = .001) as well as in the PCA (1.87 +/- 0.65%/s vs 1.47 +/- 0.44%/s, p<.001). In MA patients, MCA BHI was higher in those with large right-to-left shunts (2.09 +/- 0.42 vs 1.79 +/- 0.47, p=.046) and lower in those taking estrogens (1.30 +/- 0.30%/s vs 1.9 +/- 0.45%/s, p = .009). We did not observe an effect of MA characteristics on BHI. The increased BHI in MA patients with large right-to-left shunts could be explained by the vasoactive effect in the cerebral circulation of substances bypassing the deactivating pulmonary filters or by a constitutional trait of the vascular system associating persistent right-to-left shunts and hyper-reactive hemodynamics. Our results discourage the hypothesis that altered hemodynamics contribute to increasing the stroke risk in all MA patients. However, estrogens can lower VMR, curtailing the hemodynamic resources of MA patients.	[Altamura, Claudia; Paolucci, Matteo; Brunelli, Nicoletta; Rizzo, Angelo Cascio; Cecchi, Gianluca; Assenza, Federica; Vernieri, Fabrizio] Campus Biomed Univ Rome, Clin Neurol Headache & Neurosonol Unit, Rome, Italy; [Silvestrini, Mauro] Marche Polytech Univ, Dept Expt & Clin Med, Neurol Clin, Ancona, Italy	University Campus Bio-Medico - Rome Italy; Marche Polytechnic University	Altamura, C (corresponding author), Campus Biomed Univ Rome, Clin Neurol Headache & Neurosonol Unit, Rome, Italy.	c.altamura@unicampus.it	Silvestrini, Mauro/AAB-3838-2019; Paolucci, Matteo/AAE-2722-2019; Brunelli, Nicoletta/ABE-1864-2020; Altamura, Claudia/J-1156-2019	Paolucci, Matteo/0000-0002-5347-378X; Altamura, Claudia/0000-0002-5934-5535; Cascio Rizzo, Angelo/0000-0002-3258-5061; Brunelli, Nicoletta/0000-0002-8590-9015				Altamura C, 2018, NEUROL SCI, V39, pS101, DOI 10.1007/s10072-018-3354-x; Altamura C, 2018, NEUROL SCI, V39, pS87, DOI 10.1007/s10072-018-3351-0; Androulakis XM, 2016, NEUROLOGY, V87, P2527, DOI 10.1212/WNL.0000000000003428; Bartolini M, 2005, FUNCT NEUROL, V20, P209; Buratti L, 2016, J CEREBR BLOOD F MET, V36, P1804, DOI 10.1177/0271678X15613526; Diomedi M, 2001, J NEUROL SCI, V185, P49, DOI 10.1016/S0022-510X(01)00462-2; Fiermonte G, 1999, CEPHALALGIA, V19, P492, DOI 10.1046/j.1468-2982.1999.019005492.x; Frederiksen SD, 2019, J CEREBR BLOOD F MET, V39, P610, DOI 10.1177/0271678X17747188; Gaist D, 2016, BRAIN, V139, P2015, DOI 10.1093/brain/aww099; Goadsby Peter J, 2013, Handb Clin Neurol, V117, P193, DOI 10.1016/B978-0-444-53491-0.00016-X; Gollion C, 2019, CEPHALALGIA, V39, P635, DOI 10.1177/0333102418806861; Grimsrud KW, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0716-2; Guo ZN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104849; Hodkinson DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137971; Homma S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2015.86; Jauss M, 2000, CEREBROVASC DIS, V10, P490, DOI 10.1159/000016119; Jiang XH, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-018-1022-7; Kruit MC, 2005, BRAIN, V128, P2068, DOI 10.1093/brain/awh542; Li LX, 2015, NEUROLOGY, V85, P1444, DOI 10.1212/WNL.0000000000002059; Lokkegaard E, 2017, STROKE, V48, P2266, DOI 10.1161/STROKEAHA.117.017132; MacClellan LR, 2007, STROKE, V38, P2438, DOI 10.1161/STROKEAHA.107.488395; Magalhaes JE, 2018, HEADACHE, V58, P1277, DOI 10.1111/head.13378; Mahmoud AN, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020498; Mawet J, 2015, NEUROLOGY, V85, P1945, DOI 10.1212/WNL.0000000000002166; Miller VM, 2008, PHARMACOL REV, V60, P210, DOI 10.1124/pr.107.08002; OLESEN J, 1993, NEUROREPORT, V4, P1027, DOI 10.1097/00001756-199308000-00008; Park TH, 2013, J STROKE CEREBROVASC, V22, P482, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.006; Perko D, 2011, ACTA NEUROL SCAND, V124, P269, DOI 10.1111/j.1600-0404.2010.01468.x; Pezzini A, 2018, STROKE, V49, P573, DOI 10.1161/STROKEAHA.118.020554; Rajan R, 2015, J NEUROL NEUROSUR PS, V86, P1253, DOI 10.1136/jnnp-2014-309571; Reinhard M, 2014, NEUROLOGY, V83, P1424, DOI 10.1212/WNL.0000000000000888; Rivera-Lara L, 2017, ANESTHESIOLOGY, V126, P1187, DOI 10.1097/ALN.0000000000001625; Sacco S, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0815-1; Sacco S, 2012, J HEADACHE PAIN, V13, P177, DOI 10.1007/s10194-012-0424-y; Schulte LH, 2016, BRAIN, V139, P1987, DOI 10.1093/brain/aww097; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Silvestrini M, 2004, HEADACHE, V44, P29, DOI 10.1111/j.1526-4610.2004.04006.x; THOMSEN LL, 1995, CEPHALALGIA, V15, P211, DOI 10.1046/j.1468-2982.1995.015003211.x; THOMSEN LL, 1995, CLIN AUTON RES, V5, P243, DOI 10.1007/BF01818887; THOMSEN LL, 1993, CEPHALALGIA, V13, P395, DOI 10.1046/j.1468-2982.1993.1306395.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Vernieri F, 2008, CEPHALALGIA, V28, P689, DOI 10.1111/j.1468-2982.2008.01579.x; Vernieri F, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-18	43	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220637	10.1371/journal.pone.0220637	http://dx.doi.org/10.1371/journal.pone.0220637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369637	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900072
J	Huang, YS; Xu, DC; Kan, JM; Li, WB				Huang, Yongsheng; Xu, Daochun; Kan, Jiangming; Li, Wenbin			Study on field experiments of forest soil thermoelectric power generation devices	PLOS ONE			English	Article							WASTE HEAT; ELECTRICITY; ENERGY; PERFORMANCE; STOVE	As a new strategy to power forest wireless sensors in remote areas, an environmental microenergy collection device has been improved, and field experiments were carried out under natural conditions for the first time. The thermoelectric power generation devices used a gravity-assisted heat pipe to transmit heat from shallow soil to ground level, and a thermoelectric generator (TEG) was employed to generate electric power from the temperature difference between soil and air. Over the 6-month experimental period at two natural sites, approximately 128.74 J of energy could be harvested in a single day, and 5 209.92 J of energy could be harvested in a generation cycle. The results showed the feasibility of using this green energy to power wireless sensors in remote forests or other environments, This work is relevant to the current acute energy shortages and environmental pollution problems.	[Huang, Yongsheng; Xu, Daochun; Kan, Jiangming; Li, Wenbin] Beijing Forestry Univ, Sch Technol, Key Lab State Forestry Adm Forestry Equipment & A, Beijing, Peoples R China; [Huang, Yongsheng] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS	Li, WB (corresponding author), Beijing Forestry Univ, Sch Technol, Key Lab State Forestry Adm Forestry Equipment & A, Beijing, Peoples R China.	leewb@bjfu.edu.cn			National Natural Science Foundation of China [31670716]; China Postdoctoral Science Special Foundation [2016T90044]; China Postdoctoral Science Foundation [2015M570945]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Special Foundation; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Thsi work was supported by the National Natural Science Foundation of China(31670716)-No to WL; the China Postdoctoral Science Special Foundation (2016T90044)-No to DX and China Postdoctoral Science Foundation (2015M570945)-No to DX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouhacina B, 2015, APPL THERM ENG, V79, P153, DOI 10.1016/j.applthermaleng.2015.01.027; Chen J, 2016, IEEE T NUCL SCI, V63, P2738, DOI 10.1109/TNS.2016.2606090; Chiwaki N, 2018, J MICROMECH MICROENG, V28, P1; Ga LaTai, 2018, Journal of Forestry Engineering, V3, P136; Hao ZB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136639; Huang Y, J FOREST ENV, V38, P84; Jang JY, 2013, APPL THERM ENG, V51, P677, DOI 10.1016/j.applthermaleng.2012.10.024; Lawrence EE, 2002, XXI INTERNATIONAL CONFERENCE ON THERMOELECTRICS, PROCEEDINGS ICT '02, P446, DOI 10.1109/ICT.2002.1190357; Liu TJ, 2017, J ELECTRON MATER, V46, P3137, DOI 10.1007/s11664-016-5223-9; Lopez-Lapena O, 2018, IEEE T IND ELECTRON, V65, P9668, DOI 10.1109/TIE.2018.2821622; Luo X, 2018, IEEE T IND INFORM, V14, P4963, DOI 10.1109/TII.2018.2854549; Maixner MR, 2009, ENERG CONVERS MANAGE, V50, P2361, DOI 10.1016/j.enconman.2009.05.019; Najjar YSH, 2017, RENEW SUST ENERG REV, V69, P854, DOI 10.1016/j.rser.2016.07.041; Nie BC, 2018, RENEW ENERG, V128, P391, DOI 10.1016/j.renene.2018.05.081; Nuwayhid RY, 2005, ENERG CONVERS MANAGE, V46, P1631, DOI 10.1016/j.enconman.2004.07.006; Nuwayhid RY, 2003, RENEW ENERG, V28, P205, DOI 10.1016/S0960-1481(02)00024-1; Orr B, 2017, APPL THERM ENG, V126, P1185, DOI 10.1016/j.applthermaleng.2016.11.019; Qi D, 2016, APPL THERM ENG, V106, P1023, DOI 10.1016/j.applthermaleng.2016.06.048; Remeli MF, 2015, ENERG CONVERS MANAGE, V91, P110, DOI 10.1016/j.enconman.2014.12.001; Stevens JW, 2013, ENERG CONVERS MANAGE, V68, P114, DOI 10.1016/j.enconman.2012.12.029; Thielen M, 2017, ENERG CONVERS MANAGE, V131, P44, DOI 10.1016/j.enconman.2016.11.005; TYRRELL HJV, 1956, NATURE, V177, P668, DOI 10.1038/177668b0; Wang N., 2017, ACTA TECH CSAV CESKO, V6, P1; Zhang Z, 2016, ENERG CONVERS MANAGE, V127, P301, DOI 10.1016/j.enconman.2016.09.023; Zhang Z, 2015, ENERG CONVERS MANAGE, V97, P178, DOI 10.1016/j.enconman.2015.03.060; Zou SG, 2018, SCI TOTAL ENVIRON, V635, P1215, DOI 10.1016/j.scitotenv.2018.04.201	26	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0221019	10.1371/journal.pone.0221019	http://dx.doi.org/10.1371/journal.pone.0221019			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398217	Green Published, Green Submitted, gold			2022-12-27	WOS:000485004000041
J	Yeh, ML; Huang, CF; Huang, CI; Dai, CY; Lin, IH; Liang, PC; Hsieh, MH; Lin, ZY; Chen, SC; Huang, JF; Chen, JJ; Yu, ML; Chuang, WL				Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Dai, Chia-Yen; Lin, I-Hung; Liang, Po-Cheng; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Chen, Shinn-Chern; Huang, Jee-Fu; Chen, Jyh-Jou; Yu, Ming-Lung; Chuang, Wan-Long			Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients	PLOS ONE			English	Article							MAC-2 BINDING-PROTEIN; SIMPLE NONINVASIVE INDEX; HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; SERUM WFA(+)-M2BP; VIRUS INFECTION; BIOPSY; GUIDELINES; ENTECAVIR; CIRRHOSIS	Background Wisteria floribunda agglutinin-positive Mac-2-binding protein (WFA(+)-M2BP) was a novel marker of liver fibrosis. We aimed to investigate WFA(+)-M2BP level in assessing liver fibrosis in patients with chronic hepatitis B (CHB) infection. Methods A total of 160 CHB patients, who received a liver biopsy, were consecutively recruited. Serum WFA(+)-M2BP level was quantified at the time point of biopsy. The results were compared with histopathological manifestations and clinical characteristics of the patients. Results The median WFA(+)-M2BP level, aspartate aminotransferase-to-platelet ratio (APRI) and Fibrosis-4 (FIB-4) index were 1.20 COI, 1.19, and 1.63, respectively. Fifty-one (31.9%) patients had advanced fibrosis. There was a significant increase of WFA(+)-M2BP levels in parallel to necroinflammation/fibrosis stages. The areas under the receiver operating characteristic curve (AUROC) of WFA(+)-M2BP level for predicting fibrosis stages were 0.780 of F2, 0.785 of F3, and 0.769 of F4, respectively (all p < 0.001). The multivariate analysis identified age (Odds ratio [OR] 1.05, 95% confidence interval [CI]: 1.010-1.092, p = 0.014), platelet (OR: 0.99, 95% CI: 0.980-0.998, p = 0.013), and WFA(+)-M2BP level (OR: 1.97, 95% CI: 1.299-2.984, p = 0.001) as independent factors associated with advanced fibrosis. Combination of age, platelet and WFA(+)-M2BP level achieved a better diagnostic performance for advanced fibrosis (AUROC: 0.732, accuracy: 81.3%) than APRI (AUROC: 0.577, accuracy: 63.8%) or FIB-4 index (AUROC: 0.691, accuracy: 75.6%). Conclusion WFA(+)-M2BP had a good performance indistinguishing liver fibrosis in CHB patients. The combination of age, platelet, and WFA(+)-M2BPaddressed more accuracy in identifying patients with advanced fibrosis.	[Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Dai, Chia-Yen; Lin, I-Hung; Liang, Po-Cheng; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Chen, Shinn-Chern; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-I; Dai, Chia-Yen; Lin, I-Hung; Liang, Po-Cheng; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Chen, Shinn-Chern; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Huang, Chung-Feng; Dai, Chia-Yen; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan; [Dai, Chia-Yen; Hsieh, Meng-Hsuan] Kaohsiung Med Univ Hosp, Hlth Management Ctr, Kaohsiung, Taiwan; [Chen, Jyh-Jou] Chi Mei Med Ctr, Div Gastroenterol & Hepatol, Liouying, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chi Mei Hospital	Huang, JF (corresponding author), Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan.; Huang, JF (corresponding author), Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan.; Huang, JF (corresponding author), Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan.; Chen, JJ (corresponding author), Chi Mei Med Ctr, Div Gastroenterol & Hepatol, Liouying, Taiwan.	jf71218@gmail.com; jjchen@mail.chimei.org.tw	Hsieh, Meng Hsuan/AAY-7973-2021; Chuang, Wan-Long/ABF-7427-2021; Huang, Jee-Fu/AAX-4622-2020; Yu, Ming-Lung/AAZ-4306-2020	Chuang, Wan-Long/0000-0002-2376-421X; Huang, Jee-Fu/0000-0002-2752-7051; Yu, Ming-Lung/0000-0001-8145-1900; Yeh, Ming-Lun/0000-0003-3728-7618; Hsieh, Meng-Hsuen/0000-0001-9739-3901	Kaohsiung Medical University Hospital [KMUH102-2R05, KMUH105-5R04, 105CM-KMU-09, KMUH104-4T02, KMUH105-5R03]	Kaohsiung Medical University Hospital	This study was supported partly by grants from Kaohsiung Medical University Hospital - grant number KMUH102-2R05, KMUH105-5R04, 105CM-KMU-09 for the author Jee-Fu Huang and KMUH104-4T02, KMUH105-5R03 for the author Ming-Lun Yeh. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Akay S, 2007, DIGEST DIS SCI, V52, P579, DOI 10.1007/s10620-006-9493-6; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Castera L, 2015, DIGEST DIS, V33, P498, DOI 10.1159/000374097; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Germani G, 2011, SEMIN LIVER DIS, V31, P82, DOI 10.1055/s-0031-1272836; Hasegawa K, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091500; Heo JY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003328; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Huang JF, 2007, GUT, V56, P736, DOI 10.1136/gut.2006.115410; Jekarl DW, 2018, ANN LAB MED, V38, P348, DOI 10.3343/alm.2018.38.4.348; Kuno A, 2013, PROTEOM CLIN APPL, V7, P642, DOI 10.1002/prca.201300010; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Lin D, 2016, ALIMENT PHARM THER, V44, P846, DOI 10.1111/apt.13774; LIN TM, 1991, ANTICANCER RES, V11, P2063; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Myers RP, 2008, LIVER INT, V28, P705, DOI 10.1111/j.1478-3231.2008.01691.x; Nishikawa H, 2017, HEPATOL RES, V47, pE74, DOI 10.1111/hepr.12724; Nishikawa H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004679; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Sasaki R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129053; Sato S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122143; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Toyoda H, 2016, LIVER INT, V36, P293, DOI 10.1111/liv.12907; Ura K, 2016, ALIMENT PHARM THER, V43, P114, DOI 10.1111/apt.13431; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Xiao GQ, 2015, HEPATOLOGY, V61, P292, DOI 10.1002/hep.27382; Xu HQ, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0618-5; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Zou X, 2017, LIVER INT, V37, P35, DOI 10.1111/liv.13188	35	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220663	10.1371/journal.pone.0220663	http://dx.doi.org/10.1371/journal.pone.0220663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393964	gold, Green Published, Green Submitted			2022-12-27	WOS:000485002500049
J	Bailey, NW; Freedman, G; Raj, K; Sullivan, CM; Rogasch, NC; Chung, SW; Hoy, KE; Chambers, R; Hassed, C; Van Dam, NT; Koenig, T; Fitzgerald, PB				Bailey, Neil W.; Freedman, Gabrielle; Raj, Kavya; Sullivan, Caley M.; Rogasch, Nigel C.; Chung, Sung W.; Hoy, Kate E.; Chambers, Richard; Hassed, Craig; Van Dam, Nicholas T.; Koenig, Thomas; Fitzgerald, Paul B.			Mindfulness meditators show altered distributions of early and late neural activity markers of attention in a response inhibition task	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; COGNITIVE THERAPY; VISUAL-ATTENTION; PARIETAL CORTEX; ERP; MECHANISMS; CONFLICT; ALPHA; EEG; PERFORMANCE	Attention is vital for optimal behavioural performance in every-day life. Mindfulness meditation has been shown to enhance attention. However, the components of attention altered by meditation and the related neural activities are underexplored. In particular, the contributions of inhibitory processes and sustained attention are not well understood. To address these points, 34 meditators were compared to 28 age and gender matched controls during electroencephalography (EEG) recordings of neural activity during a Go/Nogo response inhibition task. This task generates a P3 event related potential, which is related to response inhibition processes in Nogo trials, and attention processes across both trial types. Compared with controls, meditators were more accurate at responding to Go and Nogo trials. Meditators showed a more frontally distributed P3 to both Go and Nogo trials, suggesting more frontal involvement in sustained attention rather than activity specific to response inhibition. Unexpectedly, meditators also showed increased positivity over the right parietal cortex prior to visual information reaching the occipital cortex (during the pre-C1 window). Both results were positively related to increased accuracy across both groups. The results suggest that meditators show altered engagement of neural regions related to attention, including both higher order processes generated by frontal regions, and sensory anticipation processes generated by poster regions. This activity may reflect an increased capacity to modulate a range of neural processes in order to meet task requirements. This increased capacity may underlie the improved attentional function observed in mindfulness meditators.	[Bailey, Neil W.; Freedman, Gabrielle; Raj, Kavya; Sullivan, Caley M.; Chung, Sung W.; Hoy, Kate E.; Fitzgerald, Paul B.] Monash Univ, Monash Alfred Psychiat Res Ctr, Cent Clin Sch, Melbourne, Vic, Australia; [Bailey, Neil W.; Fitzgerald, Paul B.] Epworth Healthcare, Epworth Ctr Innovat Mental Hlth, Epworth Clin, Camberwell, Vic, Australia; [Raj, Kavya; Rogasch, Nigel C.] Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, Brain & Mental Hlth Res Hub, Clayton, Vic, Australia; [Raj, Kavya; Rogasch, Nigel C.] Monash Univ, Monash Biomed Imaging, Clayton, Vic, Australia; [Chambers, Richard] Monash Univ, Campus Community Div, Melbourne, Vic, Australia; [Hassed, Craig] Monash Univ, Dept Gen Practice, Melbourne, Vic, Australia; [Van Dam, Nicholas T.] Univ Melbourne, Sch Psychol Sci, Parkville, Vic, Australia; [Van Dam, Nicholas T.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Koenig, Thomas] Univ Bern, Univ Hosp Psychiat, Translat Res Ctr, Bern, Switzerland	Monash University; Monash University; Monash University; Monash University; Monash University; University of Melbourne; Icahn School of Medicine at Mount Sinai; University of Bern; University Hospital of Bern	Bailey, NW (corresponding author), Monash Univ, Monash Alfred Psychiat Res Ctr, Cent Clin Sch, Melbourne, Vic, Australia.; Bailey, NW (corresponding author), Epworth Healthcare, Epworth Ctr Innovat Mental Hlth, Epworth Clin, Camberwell, Vic, Australia.	neil.bailey@monash.edu	Bailey, Neil/AAB-2741-2021; Koenig, Thomas/ABD-2278-2020; Van Dam, Nicholas Thomas/G-2799-2010	Koenig, Thomas/0000-0002-1472-4638; Van Dam, Nicholas Thomas/0000-0002-1131-0739; Chung, Sung Wook/0000-0001-8022-8037; Bailey, Neil/0000-0002-8483-1068; Rogasch, Nigel/0000-0002-4484-1069; Hoy, Kate/0000-0003-0694-9674	Neuronetics; Cervel Neurotech; National Health and Medical Research Council of Australia [6069070, 1082894, 1072057]	Neuronetics; Cervel Neurotech; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	PBF has received equipment for research from MagVenture A/S, Medtronic Ltd, Cervel Neurotech and Brainsway Ltd and funding for research from Neuronetics and Cervel Neurotech. PBF is supported by a National Health and Medical Research Council of Australia Practitioner Fellowship (6069070). KEH is supported by a National Health and Medical Research Council of Australia Career Development Fellowship (1082894). NCR is supported by a National Health and Medical Research Council of Australia Fellowship (1072057). These funders supported the researchers for other projects but no funding contribution was made to this specific project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PBF has received equipment for research from MagVenture A/S, Medtronic Ltd, Cervel Neurotech and Brainsway Ltd and funding for research from Neuronetics and Cervel Neurotech. PBF is on the scientific advisory board for Bionomics Ltd. All other authors have no conflicts to report. PBF is supported by a National Health and Medical Research Council of Australia Practitioner Fellowship (6069070). KEH is supported by a National Health and Medical Research Council of Australia Career Development Fellowship (1082894). NCR is supported by a National Health and Medical Research Council of Australia Fellowship (1072057). This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Andreu CI, 2017, MINDFULNESS, V8, P1603, DOI 10.1007/s12671-017-0732-z; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; BAILEY N, 2018, MINDFULNESS, P1; Bailey NW, 2014, PSYCHIAT RES-NEUROIM, V224, P324, DOI 10.1016/j.pscychresns.2014.09.008; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Beck A.T., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Benikos N, 2013, INT J PSYCHOPHYSIOL, V87, P262, DOI 10.1016/j.ijpsycho.2012.08.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Chambers R, 2008, COGNITIVE THER RES, V32, P303, DOI 10.1007/s10608-007-9119-0; Cheng KS, 2017, PEERJ, V5, DOI 10.7717/peerj.3857; Cramer AOJ, 2016, PSYCHON B REV, V23, P640, DOI 10.3758/s13423-015-0913-5; Crane RS, 2017, PSYCHOL MED, V47, P990, DOI 10.1017/S0033291716003317; Datta A, 2007, COMPUTATIONAL INTELL, V2007; Davidson RJ, 2015, AM PSYCHOL, V70, P581, DOI 10.1037/a0039512; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Eldar S, 2010, BIOL PSYCHOL, V85, P252, DOI 10.1016/j.biopsycho.2010.07.010; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Falkenstein M, 2006, CLIN NEUROPHYSIOL, V117, P1638, DOI 10.1016/j.clinph.2006.05.002; Fox KCR, 2014, NEUROSCI BIOBEHAV R, V43, P48, DOI 10.1016/j.neubiorev.2014.03.016; Foxe JJ, 2002, EXP BRAIN RES, V142, P139, DOI 10.1007/s00221-001-0906-7; Foxe JJ, 2005, EXP BRAIN RES, V166, P370, DOI 10.1007/s00221-005-2378-7; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Fu SM, 2005, COGNITIVE BRAIN RES, V23, P341, DOI 10.1016/j.cogbrainres.2004.11.014; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Hartmann L, 2016, BRAIN STRUCT FUNCT, V221, P3835, DOI 10.1007/s00429-015-1131-7; Holzel BK, 2011, PERSPECT PSYCHOL SCI, V6, P537, DOI 10.1177/1745691611419671; Hong XF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08807-z; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Junior R.D.M., 2014, PSYCHOL NEUROSCI, V7, P503, DOI [10.3922/j.psns.2014.4.09, DOI 10.3922/J.PSNS.2014.4.09]; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; Keil A, 2007, NEUROIMAGE, V36, P472, DOI 10.1016/j.neuroimage.2007.02.048; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Kerr CE, 2011, BRAIN RES BULL, V85, P96, DOI 10.1016/j.brainresbull.2011.03.026; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Koenig T., 2011, COMPUT INTEL NEUROSC, V2011, P4; Koenig T, 2014, BRAIN TOPOGR, V27, P72, DOI 10.1007/s10548-013-0310-1; Krompinger JW, 2009, BIOL PSYCHOL, V81, P153, DOI 10.1016/j.biopsycho.2009.03.007; Lao SA, 2016, CONSCIOUS COGN, V45, P109, DOI 10.1016/j.concog.2016.08.017; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LEHMANN D, 1987, ELECTROEN CLIN NEURO, V67, P271, DOI 10.1016/0013-4694(87)90025-3; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Malinowski P, 2017, MINDFULNESS, V8, P78, DOI 10.1007/s12671-015-0482-8; Malinowski P, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00008; Manna A, 2010, BRAIN RES BULL, V82, P46, DOI 10.1016/j.brainresbull.2010.03.001; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Moore A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00018; Moore A, 2009, CONSCIOUS COGN, V18, P176, DOI 10.1016/j.concog.2008.12.008; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nieuwenhuis S, 2004, PSYCHOPHYSIOLOGY, V41, P157, DOI 10.1046/j.1469-8986.2003.00128.x; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Palmer JA, 2008, AC SPEECH SIGN PROC; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Posner MI, 2015, CURR OPIN BEHAV SCI, V4, P1, DOI 10.1016/j.cobeha.2014.12.008; Quaglia JT, 2016, J PERS, V84, P393, DOI 10.1111/jopy.12167; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; Sandra BK, 2011, EMOTION, V11, P299, DOI 10.1037/a0022764; Sanger KL, 2016, TRENDS NEUROSCI EDUC, V5, P1, DOI 10.1016/j.tine.2016.01.001; Schoenberg PLA, 2015, COGN NEURODYNAMICS, V9, P13, DOI 10.1007/s11571-014-9308-y; Schoenberg PLA, 2014, COGN NEURODYNAMICS, V8, P373, DOI 10.1007/s11571-014-9294-0; Schoenberg PLA, 2014, CLIN NEUROPHYSIOL, V125, P1407, DOI 10.1016/j.clinph.2013.11.031; Schroeder CE, 2001, FRONT BIOSCI-LANDMRK, V6, pD672, DOI 10.2741/Schroed; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Slagter HA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00017; Slagter HA, 2009, J COGNITIVE NEUROSCI, V21, P1536, DOI 10.1162/jocn.2009.21125; Steer RA., 1997, BECK ANXIETY INVENTO; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tang YY, 2015, NAT REV NEUROSCI, V16, P213, DOI 10.1038/nrn3916; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; Valentine E.R., 1999, MENTAL HLTH RELIG CU, V2, P59, DOI DOI 10.1080/13674679908406332; Van der Lubbe RHJ, 2005, J COGNITIVE NEUROSCI, V17, P1829, DOI 10.1162/089892905775008634; van Leeuwen S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00133; Vogel EK, 2005, J COGNITIVE NEUROSCI, V17, P1907, DOI 10.1162/089892905775008599; Walach H, 2006, PERS INDIV DIFFER, V40, P1543, DOI 10.1016/j.paid.2005.11.025; Wessel JR, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.12871; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207; Worden MS, 2000, J NEUROSCI, V20	93	14	14	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0203096	10.1371/journal.pone.0203096	http://dx.doi.org/10.1371/journal.pone.0203096			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5CU	31386663	Green Published, gold, Green Submitted			2022-12-27	WOS:000484997100001
J	Anand, G; Chhajed, D; Shah, S; Atkins, S; Diwan, V				Anand, Gopesh; Chhajed, Dilip; Shah, Shailja; Atkins, Salla; Diwan, Vishal			Do qualifications matter? A qualitative study of how villagers decide their health care providers in a developing economy	PLOS ONE			English	Article							RURAL INDIA; ACCESS; URBAN	Introduction The National Rural Health Mission (NRHM) was launched in India in 2005 to address the health needs of under-served populations in rural areas, and to support universal access to care. Despite this initiative, unaccredited informal providers (IPs) often remain patients' first point of contact, which has led to inconsistencies in treatment, and has compromised the quality of care. Aim To explore the factors that influence patients' decisions about healthcare providers in rural areas of central India. Methods Nine focus group discussions (FGDs) were held in nine villages in central India. Framework analysis using an inductive approach was used to analyse the data. Results The crosscutting theme across the discussions was not choice but need-the need for affordable and accessible health care regardless of the provider's qualification. Results highlighted that IPs play a pivotal role in villagers' lives. Formal healthcare services were accessed infrequently, and mainly when a condition was judged severe or possibly even fatal. Even then, affordability was carefully weighed. Villagers' distance from formal providers contributed to high cost and low preference of formal providers. When opting for IPs, familiarity and trust were more important to villagers than qualifications. IPs have operated in rural communities in India for a long time and have adapted their services to meet the needs, preferences, social norms, and economic conditions of villagers. Conclusion IPs have captured a niche and are often the first contact point in rural settings even when patients ultimately are diagnosed and treated by trained doctors. Merely tackling the under-supply of qualified doctors is not effective or sufficient to impact on the rural healthcare system: the strong and prevalent influence of IPs needs to be addressed also.	[Anand, Gopesh; Chhajed, Dilip] Univ Illinois, Gies Coll Business, Dept Business Adm, Urbana, IL USA; [Shah, Shailja] Indian Inst Publ Hlth, Gandhinagar, India; [Atkins, Salla] Univ Tampere, Fac Social Sci, New Social Res & Hlth Sci, Tampere, Finland; [Atkins, Salla; Diwan, Vishal] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Diwan, Vishal] RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India; [Diwan, Vishal] Ujjain Charitable Trust Hosp & Res Ctr, Int Ctr Hlth Res, Ujjain, Madhya Pradesh, India	University of Illinois System; University of Illinois Urbana-Champaign; Tampere University; Karolinska Institutet	Diwan, V (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Diwan, V (corresponding author), RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India.; Diwan, V (corresponding author), Ujjain Charitable Trust Hosp & Res Ctr, Int Ctr Hlth Res, Ujjain, Madhya Pradesh, India.	vishal.diwan@ki.se	Atkins, Salla/ABH-1071-2021	Anand, Gopesh/0000-0002-5387-2027; Atkins, Salla/0000-0002-4116-893X; Diwan, Vishal/0000-0001-7948-8579				Abhijit Banerjee, 2004, Economic and Political Weekly, V39, P944; [Anonymous], 2012, INDIAN EXPRESS; [Anonymous], 2013, ANN HLTH SURV B 2012; Bajpai N, 2010, IMPROVING ACCESS EFF; Cross J, 2009, IDS WORK PAP, P1, DOI [DOI 10.1111/J.2040-0209.2009.00334_2.X, 10.1111/j.2040-0209.2009.00334_2.x]; Das J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7384; Das J, 2016, HEALTH AFFAIR, V35, P1764, DOI 10.1377/hlthaff.2016.0558; Das J, 2012, HEALTH AFFAIR, V31, P2774, DOI 10.1377/hlthaff.2011.1356; Gautham M, 2014, HEALTH POLICY PLANN, V29, pI20, DOI 10.1093/heapol/czt050; Gautham Meenakshi, 2011, Indian J Med Res, V134, P627, DOI 10.4103/0971-5916.90987; George A, 2013, SOC SCI MED, V96, P297, DOI 10.1016/j.socscimed.2013.01.022; Gupta A, 2017, J PHARM PRACTICE COM, V3, P92; Kane Sumit, 2015, Indian J Med Ethics, V12, P157; Kohnke EJ, 2017, PROD OPER MANAG, V26, P1092, DOI 10.1111/poms.12705; May C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-182; Mor N, 2014, HINDU; Natonal Bank for Agriculture and Rural Development, 2016, POT LINK PLAN 2016 1; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pulla P, 2015, SCROLL; Ranga V, 2016, GEOJOURNAL, V81, P267, DOI 10.1007/s10708-014-9618-y; Rao P. H., 2005, Health and Population - Perspectives and Issues, V28, P40; Ritchie J., 2002, ANAL QUALITATIVE DAT, P187; Rohde J, 1994, Health Millions, V2, P13; Russell S, 2005, SOC SCI MED, V61, P1396, DOI 10.1016/j.socscimed.2004.11.077; Saurman E, 2016, J HEALTH SERV RES PO, V21, P36, DOI 10.1177/1355819615600001; Sengupta A, 2013, UNIVERSAL HLTH CAREI; Sieverding M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1780-0; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Sumit G, 2013, UNIVERSAL HLTH COVER; Yadav Kapil, 2009, Indian J Community Med, V34, P3, DOI 10.4103/0970-0218.45368	30	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220316	10.1371/journal.pone.0220316	http://dx.doi.org/10.1371/journal.pone.0220316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369610	Green Published, gold, Green Submitted			2022-12-27	WOS:000484987900042
J	Zhang, LL; Jing, XD; Chen, W; Bai, JL; Vasseur, L; He, WY; You, MS				Zhang, Lingling; Jing, Xiaodong; Chen, Wei; Bai, Jianlin; Vasseur, Liette; He, Weiyi; You, Minsheng			Selection of reference genes for expression analysis of plant-derived microRNAs in Plutella xylostella using qRT-PCR and ddPCR	PLOS ONE			English	Article							DROPLET-DIGITAL PCR; DIAMONDBACK MOTH; QUANTIFICATION; LEPIDOPTERA; NORMALIZATION; MANAGEMENT; MECHANISM; ECOLOGY; RNAS; TOOL	The establishment of an expression quantification system that can be easily applied for the comparison of microRNAs (miRNAs) from biological samples is an important step toward understanding functional mechanisms in organisms. However, there is lack of attention on the selection of reference genes for miRNA expression profiling in insect herbivores. Here, we explored the candidate reference genes in a notorious pest of cruciferous crops, Plutella xylostella, for normalization of miRNA expression in developmental stages and tissues and in response to a change of food source from artificial diet to host plant Arabidopsis thaliana. We first compared the expression levels and stability of eight small RNAs using qRT-PCR, and found that miR11 was the most suitable reference gene for expression quantification of the miRNAs. We then confirmed this finding using digital droplet PCR and further validated with a well-studied cross-kingdom miRNA derived from A. thaliana (ath-miR159a). However, none of the reference genes was applicable for all experimental conditions, and multiple reference genes were sometimes required within the same experiment. Our work provides a method for the selection of reference genes for quantification of plant-derived miRNAs, which paves the way for unveiling their roles in the insect-plant coevolution.	[Zhang, Lingling; Jing, Xiaodong; Chen, Wei; Bai, Jianlin; Vasseur, Liette; He, Weiyi; You, Minsheng] Fujian Agr & Forestry Univ, Inst Appl Ecol, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China; [Zhang, Lingling; Jing, Xiaodong; Chen, Wei; Bai, Jianlin; Vasseur, Liette; He, Weiyi; You, Minsheng] Fujian Agr & Forestry Univ, Int Joint Res Lab Ecol Pest Control, Minist Educ, Fuzhou, Fujian, Peoples R China; [Vasseur, Liette] Brock Univ, Dept Biol Sci, St Catharines, ON, Canada	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Brock University	He, WY; You, MS (corresponding author), Fujian Agr & Forestry Univ, Inst Appl Ecol, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China.; He, WY; You, MS (corresponding author), Fujian Agr & Forestry Univ, Int Joint Res Lab Ecol Pest Control, Minist Educ, Fuzhou, Fujian, Peoples R China.	wy.he@fafu.edu.cn; msyou@fafu.edu.cn	zhang, lingling/HDM-2189-2022; He, Weiyi/N-6148-2017	He, Weiyi/0000-0001-8659-3123; Chen, Wei/0000-0001-9570-3662	National Key R&D Program of China [2017YFD0200400]; Fujian Provincial Science and Technology Major Project [2018NZ0002-1]; Natural Science Foundation of Fujian Province [2019J01369]	National Key R&D Program of China; Fujian Provincial Science and Technology Major Project; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This study was funded by the National Key R&D Program of China (grant number 2017YFD0200400 awarded to Assoc. Prof. Weiyi He), the Fujian Provincial Science and Technology Major Project (grant number 2018NZ0002-1 awarded to Prof. Minsheng You), and the Natural Science Foundation of Fujian Province (grant number 2019J01369 awarded to Assoc. Prof. Weiyi He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boehme P, 2015, HUM GENE THER METHOD, V26, P25, DOI 10.1089/hgtb.2014.138; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Chang YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181862; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Dai TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173821; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; Feng Bing, 2014, Acta Entomologica Sinica, V57, P286; Fu W, 2013, INT J BIOL SCI, V9, P792, DOI 10.7150/ijbs.5862; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Kiseleva Y. Y., 2016, Biomeditsinskaya Khimiya, V62, P403, DOI 10.18097/PBMC20166204403; Li RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061619; Li ZY, 2016, ANNU REV ENTOMOL, V61, P277, DOI 10.1146/annurev-ento-010715-023622; Lim QE, 2011, NEUROSCIENCE, V199, P32, DOI 10.1016/j.neuroscience.2011.10.024; Lukasik A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010009; Mangolini A, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0037-0; Meuer MS, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-18840-4, DOI 10.1007/978-3-642-18840-4]; Miotto E, 2014, CANCER EPIDEM BIOMAR, V23, P2638, DOI 10.1158/1055-9965.EPI-14-0503; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Sarfraz M, 2005, BIOCONTROL SCI TECHN, V15, P763, DOI 10.1080/09583150500136956; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sokol Nicholas S., 2008, V420, P319, DOI 10.1007/978-1-59745-583-1_20; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Winde I, 2011, PHYTOCHEMISTRY, V72, P1566, DOI 10.1016/j.phytochem.2011.01.016; Xiang MQ, 2014, BIOCHEM BIOPH RES CO, V454, P210, DOI 10.1016/j.bbrc.2014.10.064; Xie FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026980; Yang YH, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex007; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130	43	10	11	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220475	10.1371/journal.pone.0220475	http://dx.doi.org/10.1371/journal.pone.0220475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369618	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900054
J	Rubio, E; Zboromyrska, Y; Bosch, J; Fernandez-Pittol, MJ; Fidalgo, BI; Fasanella, A; Mons, A; Romn, A; Casals-Pascual, C; Vila, J				Rubio, Elisa; Zboromyrska, Yuliya; Bosch, Jordi; Fernandez-Pittol, Mariana J.; Fidalgo, Berta, I; Fasanella, Assumpta; Mons, Anna; Romn, Angely; Casals-Pascual, Climent; Vila, Jordi			Evaluation of flow cytometry for the detection of bacteria in biological fluids	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; URINARY-TRACT PATHOGENS; SYSMEX UF-1000I; DIRECT IDENTIFICATION; SAMPLES; DIAGNOSIS; PERFORMANCE; CULTURE	Objectives Conventional microbiological procedures for the isolation of bacteria from biological fluids consist of culture on solid media and enrichment broth. However, these methods can delay the microbiological identification for up to 4 days. The aim of this study was to evaluate the analytical performance of Sysmex UF500i (Sysmex, Kobe, Japan) as a screening method for the detection of bacteria in different biological fluids in comparison with direct Gram staining and the conventional culture on solid media and enrichment broth. Methods A total of 479 biological fluid samples were included in the study (180 ascitic, 131 amniotic, 56 synovial, 40 cerebrospinal, 36 pleural, 24 peritoneal, 9 bile and 3 pericardial fluids). All samples were processed by conventional culture methods and analyzed by flow cytometry. Direct Gram staining was performed in 339 samples. The amount of growth on culture was recorded for positive samples. Results Bacterial and white blood cell count by flow cytometry was significantly higher among culture positive samples and samples with a positive direct Gram stain compared to culture negative samples. Bacterial count directly correlated with the amount of growth on culture (Kruskall-Wallis H chi(2) (3) = 11.577, p = 0.009). The best specificity (95%) for bacterial count to predict culture positivity was achieved applying a cut-off value of 240 bacteria/mu L. Conclusions Bacterial and white blood cell counts obtained with flow cytometry correlate with culture results in biological fluids. Bacterial count can be used as a complementary method along with the direct Gram stain to promptly detect positive samples and perform other diagnostic techniques in order to accelerate the bacterial detection and identification.	[Rubio, Elisa; Bosch, Jordi; Fernandez-Pittol, Mariana J.; Fidalgo, Berta, I; Fasanella, Assumpta; Mons, Anna; Romn, Angely; Casals-Pascual, Climent; Vila, Jordi] Univ Barcelona, Hosp Clin, BDC, Dept Microbiol, Barcelona, Spain; [Zboromyrska, Yuliya] Consorci Lab Intercomarcal Alt Penedes Anoia & Ga, Barcelona, Spain; [Bosch, Jordi; Casals-Pascual, Climent; Vila, Jordi] Inst Global Hlth, ISGlobal, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; ISGlobal	Rubio, E (corresponding author), Univ Barcelona, Hosp Clin, BDC, Dept Microbiol, Barcelona, Spain.	elrubio@clinic.cat	Casals-Pascual, Climent/N-7692-2018	Casals-Pascual, Climent/0000-0002-0867-8954; Rubio Garcia, Elisa/0000-0002-2556-8837; Poliakova Mazneva, Yuliya/0000-0003-2716-4729	Sysmex Espana S.L.	Sysmex Espana S.L.	The authors received no specific funding for this work. However, Sysmex Espana S.L. financially supported the study providing reagents and equipment. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altun O, 2015, J CLIN MICROBIOL, V53, P710, DOI 10.1128/JCM.03434-14; Alvarez-Barrientos A, 2000, CLIN MICROBIOL REV, V13, P167, DOI 10.1128/CMR.13.2.167-195.2000; Buoro S, 2012, CLIN BIOCHEM, V45, P1263, DOI 10.1016/j.clinbiochem.2012.05.005; Buoro S, 2014, J MED BIOCHEM, V33, P191, DOI 10.2478/jomb-2013-0034; de Frutos-Serna M, 2014, ENFERM INFEC MICR CL, V32, P147, DOI 10.1016/j.eimc.2013.02.015; De Rosa R, 2010, CLIN CHIM ACTA, V411, P1137, DOI 10.1016/j.cca.2010.03.027; Dever JB, 2015, ALIMENT PHARM THER, V41, P1116, DOI 10.1111/apt.13172; Ferreira L, 2010, J CLIN MICROBIOL, V48, P2110, DOI 10.1128/JCM.02215-09; Fuller DD, 1997, DIAGN MICR INFEC DIS, V29, P219, DOI 10.1016/S0732-8893(97)00164-8; Inigo M, 2016, J CLIN MICROBIOL, V54, P988, DOI 10.1128/JCM.02832-15; Johnson CT, 2017, FRONT PHARMACOL, V8, P1, DOI [10.3389/fphar.2017.00001, DOI 10.3389/FPHAR.2017.00001]; Jolkkonen S, 2010, J CLIN MICROBIOL, V48, P3117, DOI 10.1128/JCM.00617-10; Khan MMT, 2010, APPL ENVIRON MICROB, V76, P5088, DOI 10.1128/AEM.02932-09; Landry ML, 2011, MANUAL CLIN MICROBIO, V10th, P228; Le ZA, 2016, J INFECT CHEMOTHER, V22, P377, DOI 10.1016/j.jiac.2016.02.009; Rossello GAM, 2014, APMIS, V122, P790, DOI 10.1111/apm.12208; March-Rossello G.A., 2016, REV LAB CLIN, V9, P3, DOI [DOI 10.1016/J.LABCLI.2015.12.001, 10.1016/j.labcli.2015.12.001]; Martin-gutierrez G, 2014, ENFERM INFEC MICR CL, P10, DOI [10.1016/S0213-005X(14)70169-7, DOI 10.1016/S0213-005X(14)70169-7]; Monsen T, 2017, EUR J CLIN MICROBIOL, V36, P1691, DOI 10.1007/s10096-017-2964-1; Nanos NE, 2008, CLIN CHIM ACTA, V392, P30, DOI 10.1016/j.cca.2008.02.020; Oviano M, 2017, J ANTIMICROB CHEMOTH, V72, P1350, DOI 10.1093/jac/dkw579; Penders J, 2004, NEPHROL DIAL TRANSPL, V19, P463, DOI 10.1093/ndt/gfg552; Proulx N, 2005, QJM-INT J MED, V98, P291, DOI 10.1093/qjmed/hci047; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839, DOI 10.1016/0002-9378(93)90014-A; Saito Takashi, 2005, Journal of Infection and Chemotherapy, V11, P220, DOI 10.1007/s10156-005-0399-6; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; Stirling P, 2014, INT J MICROBIOL, DOI [10.1155/2014/830857, DOI 10.1155/2014/830857]; Van Acker JT, 2001, CLIN CHEM, V47, P556; van der Zwet WC, 2010, CLIN CHEM LAB MED, V48, P1765, DOI 10.1515/CCLM.2010.342; Zboromyrska Y, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.01.025	30	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2019	14	8							e0220307	10.1371/journal.pone.0220307	http://dx.doi.org/10.1371/journal.pone.0220307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5DR	31390352	Green Published, gold, Green Submitted			2022-12-27	WOS:000484999400015
J	Nukui, Y; Yamana, T; Masuo, M; Tateishi, T; Kishino, M; Tateishi, U; Tomita, M; Hasegawa, T; Aritsu, T; Miyazaki, Y				Nukui, Yoshihisa; Yamana, Takashi; Masuo, Masahiro; Tateishi, Tomoya; Kishino, Mitsuhiro; Tateishi, Ukihide; Tomita, Makoto; Hasegawa, Takehiro; Aritsu, Takashi; Miyazaki, Yasunari			Serum CXCL9 and CCL17 as biomarkers of declining pulmonary function in chronic bird-related hypersensitivity pneumonitis	PLOS ONE			English	Article							AVIAN ANTIGEN; CHEMOKINE; FIBROSIS; KL-6; EXPRESSION; PREDICTS; CXCR3; LUNG	The clinical course of chronic hypersensitivity pneumonitis (HP) with fibrosis is similar to that of idiopathic pulmonary fibrosis (IPF). Current research is expected to identify biomarkers effective in predicting the deterioration of lung function in a clinical setting. Our group analyzed the relationships between the following parameters in chronic bird-related HP: patient characteristics, serum markers, lung function, HRCT findings, BALF profiles, and the worsening of lung function. We also analyzed serum levels of CXCL9, CCL17, and Krebs von den Lungen 6 (KL-6) as serum markers. Patients showing declines in vital capacity (VC) of over 5% at 6 months after first admission were categorized as the "decline group"; the others were categorized as the "stable group." The serum level of CCL17 and the percentage of BALF macrophages were significantly higher in the decline group compared to the stable group. Serum levels of CXCL9 and CCL17 were significant variables in a multivariate logistic regression analysis of factors associated with VC decline. Patients with a chemokine profile combining lower serum CXCL9 and higher serum CCL17 exhibited significantly larger VC decline in a cluster analysis. Higher serum CCL17 and lower serum CXCL9 were important predictors of worsening lung function in patients with chronic bird-related HP.	[Nukui, Yoshihisa; Yamana, Takashi; Masuo, Masahiro; Tateishi, Tomoya; Miyazaki, Yasunari] Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo, Japan; [Kishino, Mitsuhiro; Tateishi, Ukihide] Tokyo Med & Dent Univ, Dept Diagnost Radiol, Bunkyo Ku, Tokyo, Japan; [Tomita, Makoto] Tokyo Med & Dent Univ, Dept Clin Res Ctr, Bunkyo Ku, Tokyo, Japan; [Hasegawa, Takehiro; Aritsu, Takashi] Sysmex Corp, Nishi Ku, Kobe, Hyogo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Sysmex Corporation	Miyazaki, Y (corresponding author), Tokyo Med & Dent Univ, Dept Resp Med, Bunkyo Ku, Tokyo, Japan.	miyazaki.pilm@tmd.ac.jp	; MIYAZAKI, YASUNARI/B-7847-2015	Tateishi, Tomoya/0000-0001-5402-3185; MIYAZAKI, YASUNARI/0000-0002-9073-9815; Yamana, Takashi/0000-0001-8833-2322; Hasegawa, Takehiro/0000-0002-4635-4942	Sysmex Corp.	Sysmex Corp.	Y. M. received funding from from the Sysmex Corp. T. H. and T. A. are employees of Sysmex Corporation. T. H. contributed to the analysis and interpretation of the data. T. H. and T. A. contributed to the measurement of CXCL9, CCL17, and KL-6.; Serum levels of CXCL9, CCL17, and KL-6 were measured by Sysmex Corp. Funding from the Sysmex Corp. is gratefully acknowledged.	Agostini C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-20; Belperio JA, 2004, J IMMUNOL, V173, P4692, DOI 10.4049/jimmunol.173.7.4692; Chiba S, 2016, CHEST, V149, P1473, DOI 10.1016/j.chest.2015.12.030; FINK JN, 1984, J ALLERGY CLIN IMMUN, V74, P1, DOI 10.1016/0091-6749(84)90077-0; Ishizuka M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137978; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Kishi M, 2008, THORAX, V63, P810, DOI 10.1136/thx.2007.086074; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Miyazaki Y, 2016, EXPERT REV CLIN IMMU, V12, P953, DOI 10.1080/1744666X.2016.1182426; Miyazaki Y, 2008, CHEST, V134, P1265, DOI 10.1378/chest.08-0866; Nance S, 2005, EUR J IMMUNOL, V35, P1928, DOI 10.1002/eji.200425762; Nance S, 2004, EUR J IMMUNOL, V34, P677, DOI 10.1002/eji.200324634; O'Beirne SL, 2015, J IMMUNOL, V195, P2788, DOI 10.4049/jimmunol.1402008; Ohnishi H, 2003, THORAX, V58, P872, DOI 10.1136/thorax.58.10.872; Ohtani Y, 2000, CHEST, V118, P1382, DOI 10.1378/chest.118.5.1382; Ohtani Y, 2005, THORAX, V60, P665, DOI 10.1136/thx.2004.027326; Okamoto T, 2015, RESP MED, V109, P1576, DOI 10.1016/j.rmed.2015.10.005; Pechkovsky DV, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-75; Pignatti P, 2006, AM J RESP CRIT CARE, V173, P310, DOI 10.1164/rccm.200502-244OC; ROLAND M, 2011, AM J RESP CRIT CARE, V184, P1382; Salisbury ML, 2017, AM J RESP CRIT CARE, V196, P690, DOI 10.1164/rccm.201608-1675PP; Sekiya T, 2000, J IMMUNOL, V165, P2205, DOI 10.4049/jimmunol.165.4.2205; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Sema M, 2018, IMMUN INFLAMM DIS, V6, P154, DOI 10.1002/iid3.202; Shinoda H, 2009, RESPIRATION, V78, P285, DOI 10.1159/000207617; Tateishi T, 2011, J COMPUT ASSIST TOMO, V35, P272, DOI 10.1097/RCT.0b013e318209c5a6; Tsutsui T, 2015, ANN AM THORAC SOC, V12, P1013, DOI 10.1513/AnnalsATS.201412-569OC; Walsh SLF, 2014, THORAX, V69, P216, DOI 10.1136/thoraxjnl-2013-203843; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Yokoyama A, 1998, AM J RESP CRIT CARE, V158, P1680, DOI 10.1164/ajrccm.158.5.9803115; Yoshizawa Y, 1999, J ALLERGY CLIN IMMUN, V103, P315, DOI 10.1016/S0091-6749(99)70507-5; Zappala CJ, 2010, EUR RESPIR J, V35, P830, DOI 10.1183/09031936.00155108	34	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0220462	10.1371/journal.pone.0220462	http://dx.doi.org/10.1371/journal.pone.0220462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW4ZH	31369605	Green Published, Green Submitted, gold			2022-12-27	WOS:000484987900052
J	Singh, S; Bermudez-Contreras, E; Nazari, M; Sutherland, RJ; Mohajerani, MH				Singh, Surjeet; Bermudez-Contreras, Edgar; Nazari, Mojtaba; Sutherland, Robert J.; Mohajerani, Majid H.			Low-cost solution for rodent home-cage behaviour monitoring	PLOS ONE			English	Article							TRANSGENIC MOUSE MODELS; SLEEP-WAKE BEHAVIOR; MICE; TRACKING; IDENTIFICATION; HUNTINGTONS; RESOLUTION; DISEASE; SIGNALS; SYSTEM	In the current research on measuring complex behaviours/phenotyping in rodents, most of the experimental design requires the experimenter to remove the animal from its homecage environment and place it in an unfamiliar apparatus (novel environment). This interaction may influence behaviour, general well-being, and the metabolism of the animal, affecting the phenotypic outcome even if the data collection method is automated. Most of the commercially available solutions for home-cage monitoring are expensive and usually lack the flexibility to be incorporated with existing home-cages. Here we present a low-cost solution for monitoring home-cage behaviour of rodents that can be easily incorporated to practically any available rodent home-cage. To demonstrate the use of our system, we reliably predict the sleep/wake state of mice in their home-cage using only video. We validate these results using hippocampal local field potential (LFP) and electromyography (EMG) data. Our approach provides a low-cost flexible methodology for high-throughput studies of sleep, circadian rhythm and rodent behaviour with minimal experimenter interference.	[Singh, Surjeet; Bermudez-Contreras, Edgar; Nazari, Mojtaba; Sutherland, Robert J.; Mohajerani, Majid H.] Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB, Canada	University of Lethbridge	Sutherland, RJ; Mohajerani, MH (corresponding author), Univ Lethbridge, Dept Neurosci, Canadian Ctr Behav Neurosci, Lethbridge, AB, Canada.	robert.sutherland@uleth.ca; mohajerani@uleth.ca	singh, surjeet/AAI-3872-2020; Contreras, Edgar Bermudez/AAB-2566-2019	singh, surjeet/0000-0002-4646-2089; Contreras, Edgar Bermudez/0000-0002-4937-1780; Mohajerani, Majid H./0000-0003-0964-2977	Natural Sciences and Engineering Research Council of Canada (NSERC) [40352, RGPIN-2017-03857]; Campus Alberta for Innovation Program Chair; Alberta Alzheimer Research Program; Alzheimer Society of Canada; NSERC Discovery Grant; Alberta Neuroscience Program Grant	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Campus Alberta for Innovation Program Chair; Alberta Alzheimer Research Program; Alzheimer Society of Canada; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Neuroscience Program Grant	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant #40352 and #RGPIN-2017-03857 (MHM), Campus Alberta for Innovation Program Chair, Alberta Alzheimer Research Program, Alzheimer Society of Canada (MHM), NSERC Discovery Grant and Alberta Neuroscience Program Grant (RJS). Some of the authors (EBC, MHM, and RJS) have a financial interest in the company "NeuroCage Systems Inc." that is developing a product "Homecage Monitoring System" whose initial design was inspired by the results presented in this work. The funders and this company had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant #40352 and #RGPIN-2017-03857 (MHM), Campus Alberta for Innovation Program Chair, Alberta Alzheimer Research Program, Alzheimer Society of Canada (MHM), NSERC Discovery Grant and Alberta Neuroscience Program Grant (RJS).	Aoki R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01371-0; Bains RS, 2018, J NEUROSCI METH, V300, P37, DOI 10.1016/j.jneumeth.2017.04.014; Bains RS, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00106; Bermudez-Contreras E, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.2.025005; Bourel M, 2014, COMPUT STAT DATA AN, V79, P149, DOI 10.1016/j.csda.2014.05.004; Brown L, 2016, COMPASS CONTINUOUS O; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dandan S, 2016, 2016 3RD INTERNATION; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Eckel-Mahan Kristin, 2015, Curr Protoc Mouse Biol, V5, P271, DOI 10.1002/9780470942390.mo140229; Elder GA, 2010, MT SINAI J MED, V77, P69, DOI 10.1002/msj.20159; Fisher SP, 2012, J BIOL RHYTHM, V27, P48, DOI 10.1177/0748730411431550; Flores AE, 2007, IEEE T BIO-MED ENG, V54, P225, DOI 10.1109/TBME.2006.886938; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Godbehere AB, 2012, P AMER CONTR CONF, P4305; Goodman S, 2002, NATURE, V417, P684, DOI 10.1038/417684a; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hawkins P, 2002, LAB ANIM-UK, V36, P378, DOI 10.1258/002367702320389044; Hong WZ, 2015, P NATL ACAD SCI USA, V112, pE5351, DOI 10.1073/pnas.1515982112; Howerton CL, 2012, J NEUROSCI METH, V209, P74, DOI 10.1016/j.jneumeth.2012.06.001; Jafari Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09799-6; Jaliy Udesang K., 2014, INT J INNOVATIVE RES, V2; Janus C, 2001, PHYSIOL BEHAV, V73, P873, DOI 10.1016/S0031-9384(01)00524-8; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Jones D, 2017, PICAMERA PURE PYTHON; KaewTraKulPong P, 2002, VIDEO-BASED SURVEILLANCE SYSTEMS: COMPUTER VISION AND DISTRIBUTED PROCESSING, P135; Lee JQ, 2017, HIPPOCAMPUS, V27, P951, DOI 10.1002/hipo.22759; Littin K, 2008, P ROY SOC B-BIOL SCI, V275, P1865, DOI 10.1098/rspb.2008.0388; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; McShane BB, 2012, SLEEP, V35, P433, DOI 10.5665/sleep.1712; Mehla J, 2018, J ALZHEIMERS DIS, V61, P283, DOI 10.3233/JAD-170635; Melchior S, RASPICAM DOCUMENTATI; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Murphy TH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11611; Noorshams O, 2017, AUTOMATED SYSTEMS AS; Pack AI, 2007, PHYSIOL GENOMICS, V28, P232, DOI 10.1152/physiolgenomics.00139.2006; Perez-Escudero A, 2014, NAT METHODS, V11, P743, DOI [10.1038/NMETH.2994, 10.1038/nmeth.2994]; Poddar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083171; Redfern WS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181068; Richter H, 2008, BEHAV BRAIN RES, V190, P74, DOI 10.1016/j.bbr.2008.02.005; Salem GH, 2015, BEHAV RES METHODS, V47, P235, DOI 10.3758/s13428-014-0451-5; Singh S, 2016, BEHAV BRAIN RES, V299, P141, DOI 10.1016/j.bbr.2015.11.023; Spruijt Berry M, 2006, Drug Discov Today Technol, V3, P231, DOI 10.1016/j.ddtec.2006.06.010; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Storch C, 2004, J NEUROSCI METH, V133, P173, DOI 10.1016/j.jneumeth.2003.10.008; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Vecchio Laura M, 2018, Brain Plast, V4, P17, DOI 10.3233/BPL-180069; Weissbrod A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3018; Whishaw IQ, 2017, EXP BRAIN RES, V235, P1919, DOI 10.1007/s00221-017-4925-4; Winter Y, 2011, J NEUROSCI METH, V196, P276, DOI 10.1016/j.jneumeth.2011.01.017; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zivkovic Z, 2006, PATTERN RECOGN LETT, V27, P773, DOI 10.1016/j.patrec.2005.11.005; Zivkovic Z, 2004, INT C PATT RECOG, P28, DOI 10.1109/ICPR.2004.1333992	57	24	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220751	10.1371/journal.pone.0220751	http://dx.doi.org/10.1371/journal.pone.0220751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5AR	31374097	gold, Green Published, Green Submitted			2022-12-27	WOS:000484991500031
J	de Rassenfosse, G; Jaffe, A; Raiteri, E				de Rassenfosse, Gaetan; Jaffe, Adam; Raiteri, Emilio			The procurement of innovation by the US government	PLOS ONE			English	Article							SCIENCE; IMPACT	The U.S. government invests more than $50 billion per year in R&D procurement but we know little about the outcomes of these investments. We have traced all the patents arising from government funding since the year 2000. About 1.5 percent of all R&D procurement contracts have led to at least one patent for a total of about 13,000 patents. However, contracts connected to patents account for 36 per cent of overall contract value. The gestation lag from the signing date of the contract to the patent filing is on average 33 months and does not depend on the type of R&D performed. Patents that are produced faster also seem to be more valuable. We find strong decreasing returns to contract size. Conditional on generating at least one patent, a 1-percent increase in the size of an R&D contract is associated with 0.12 percent more patents.	[de Rassenfosse, Gaetan; Raiteri, Emilio] Ecole Polytech Fed Lausanne, Coll Management Technol, Chair Innovat & IP Policy, Lausanne, Switzerland; [Jaffe, Adam] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Jaffe, Adam] Brandeis Univ, Waltham, MA USA; [Jaffe, Adam] Motu Econ & Publ Policy Res, Wellington, New Zealand; [Jaffe, Adam] Queensland Univ Technol, Brisbane, Qld, Australia; [Raiteri, Emilio] Eindhoven Univ Technol, Sch Innovat Sci, Eindhoven, Netherlands	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Massachusetts Institute of Technology (MIT); Brandeis University; Queensland University of Technology (QUT); Eindhoven University of Technology	de Rassenfosse, G (corresponding author), Ecole Polytech Fed Lausanne, Coll Management Technol, Chair Innovat & IP Policy, Lausanne, Switzerland.	gaetan.derassenfosse@epfl.ch	Jaffe, Adam/R-8313-2019	Jaffe, Adam/0000-0003-1337-1751; de Rassenfosse, Gaetan/0000-0002-7862-0918; raiteri, emilio/0000-0002-2769-1660	Marie Sklodowska-Curie program [665667]	Marie Sklodowska-Curie program	E.R. was supported by Marie Sklodowska-Curie program for the project "Innovative Public Procurement as Innovation Policy" (Action: H2020-MSCA COFUND-2015, Grant Agreement Number: 665667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A., 2005, ANN EC STAT, V79, P91, DOI [10.2307/20777571, DOI 10.2307/20777571]; Azoulay P, 2015, PUBLIC R D INVESTMEN; de Rassenfosse G, 2018, EUR ECON REV, V101, P625, DOI 10.1016/j.euroecorev.2017.11.005; GEROSKI P. A., 1990, INT REV APPL EC, V4, P182, DOI DOI 10.1080/758523673; Jacob BA, 2011, J PUBLIC ECON, V95, P1168, DOI 10.1016/j.jpubeco.2011.05.005; Jaffe AB, 2017, J ASSOC INF SCI TECH, V68, P1360, DOI 10.1002/asi.23731; Lane J, 2011, SCIENCE, V331, P678, DOI 10.1126/science.1201865; Lane J, 2010, NATURE, V464, P488, DOI 10.1038/464488a; Li D, 2017, SCIENCE, V356, P78, DOI 10.1126/science.aal0010; LICHTENBERG FR, 1988, AM ECON REV, V78, P550; Link AN, 2009, ECON INNOV NEW TECH, V18, P381, DOI 10.1080/10438590802208166; Mowery D. C., 2011, ACCELERATING ENERGY, P159; Raiteri E, 2018, RES POLICY, V47, P936, DOI 10.1016/j.respol.2018.02.017; Sampat BN, 2012, RES POLICY, V41, P1729, DOI 10.1016/j.respol.2012.05.013; Toole AA, 2007, J ECON BEHAV ORGAN, V63, P716, DOI 10.1016/j.jebo.2006.05.011	15	3	3	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2019	14	8							e0218927	10.1371/journal.pone.0218927	http://dx.doi.org/10.1371/journal.pone.0218927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5GN	31404070	Green Published, gold, Green Submitted			2022-12-27	WOS:000485006800006
J	Radder, B; Prange-Lasonder, GB; Kottink, AIR; Holmberg, J; Sletta, K; van Dijk, M; Meyer, T; Melendez-Calderon, A; Buurke, JH; Rietman, JS				Radder, Bob; Prange-Lasonder, Gerdienke B.; Kottink, Anke I. R.; Holmberg, Johnny; Sletta, Kristin; van Dijk, Manon; Meyer, Thomas; Melendez-Calderon, Alejandro; Buurke, Jaap H.; Rietman, Johan S.			Home rehabilitation supported by a wearable soft-robotic device for improving hand function in older adults: A pilot randomized controlled trial	PLOS ONE			English	Article							ELDERLY-PEOPLE; BLOCK TEST; STROKE; GLOVE; SARCOPENIA; THERAPY; AGE; BOX	Background New developments, based on the concept of wearable soft-robotic devices, make it possible to support impaired hand function during the performance of daily activities and intensive task-specific training. The wearable soft-robotic ironHand glove is such a system that supports grip strength during the performance of daily activities and hand training exercises at home. Design This pilot randomized controlled clinical study explored the effect of prolonged use of the assistive ironHand glove during daily activities at home, in comparison to its use as a trainings tool at home, on functional performance of the hand. Methods In total, 91 older adults with self-perceived decline of hand function participated in this study. They were randomly assigned to a 4-weeks intervention of either assistive or therapeutic ironHand use, or control group (received no additional exercise or treatment). All participants performed a maximal pinch grip test, Box and Blocks test (BBT), Jebsen-Taylor Hand Function Test (JTHFT) at baseline and after 4-weeks of intervention. Only participants of the assistive and therapeutic group completed the System Usability Scale (SUS) after the intervention period. Results Participants of the assistive and therapeutic group reported high scores on the SUS (mean = 73, SEM = 2). The therapeutic group showed improvements in unsupported handgrip strength (mean Delta = 3) and pinch strength (mean Delta = 0.5) after 4 weeks of ironHand use (p <= 0.039). Scores on the BBT and JTHFT improved not only after 4 weeks of ironHand use (assistive and therapeutic), but also in the control group. Only handgrip strength improved more in the therapeutic group compared to the assistive and control group. No significant correlations were found between changes in performance and assistive or therapeutic ironHand use (p >= 0.062). Conclusion This study showed that support of the wearable soft-robotic ironHand system either as assistive device or as training tool may be a promising way to counter functional hand function decline associated with ageing.	[Radder, Bob; Prange-Lasonder, Gerdienke B.; Kottink, Anke I. R.; Buurke, Jaap H.; Rietman, Johan S.] Roessingh Res & Dev, Enschede, Netherlands; [Radder, Bob; Prange-Lasonder, Gerdienke B.; Rietman, Johan S.] Univ Twente, Dept Biomech Engn, Enschede, Netherlands; [Kottink, Anke I. R.; Buurke, Jaap H.] Univ Twente, Dept Biosyst & Signals, Enschede, Netherlands; [Holmberg, Johnny; Sletta, Kristin] Eskilstuna Kommun Vard & Omsorgsforvaltningen, Eskilstuna, Sweden; [van Dijk, Manon] Natl Fdn Elderly, Bunnik, Netherlands; [Meyer, Thomas] terzStiftung, Berlingen, Switzerland; [Melendez-Calderon, Alejandro; Buurke, Jaap H.; Rietman, Johan S.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Melendez-Calderon, Alejandro] Cereneo Adv Rehabil Inst, Vitznau, Switzerland	University of Twente; University of Twente; Northwestern University	Radder, B (corresponding author), Roessingh Res & Dev, Enschede, Netherlands.; Radder, B (corresponding author), Univ Twente, Dept Biomech Engn, Enschede, Netherlands.	b.radder@rrd.nl		Melendez-Calderon, Alejandro/0000-0002-7922-1345	Active and Assisted Living joint programme via ZonMw (the Netherlands) [AAL-2013-6-134]; Vinnova (Sweden); State Secretariat for Education, Research and Innovation (Switzerland)	Active and Assisted Living joint programme via ZonMw (the Netherlands); Vinnova (Sweden)(Vinnova); State Secretariat for Education, Research and Innovation (Switzerland)	This work is partly funded by the Active and Assisted Living joint programme (http://www.aal-europe.eu/, grant AAL-2013-6-134) via ZonMw (the Netherlands), Vinnova (Sweden) and the State Secretariat for Education, Research and Innovation (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, STESASERA390 UN; Balasubramanian S, 2010, CURR OPIN NEUROL, V23, P661, DOI 10.1097/WCO.0b013e32833e99a4; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Bangor A, 2009, J USABILITY STUD, V4, P114; Basteris A, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-111; Bautmans I, 2009, ACTA CLIN BELG, V64, P303, DOI 10.1179/acb.2009.048; Bos RA, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0168-z; Brooke J., 1996, USABILITY EVALUATION, DOI 10.1201/9781498710411-35; Carmeli E, 2003, J GERONTOL A-BIOL, V58, P146, DOI 10.1093/gerona/58.2.M146; Covinsky KE, 2008, J AM GERIATR SOC, V56, P23, DOI 10.1111/j.1532-5415.2007.01511.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; Desrosiers J, 1999, EXP GERONTOL, V34, P393, DOI 10.1016/S0531-5565(99)00018-2; Diftler M, 2014, INT C ROB AUT ICRA; Fess E. E., 1992, GRIP STRENGTH; HACKEL ME, 1992, PHYS THER, V72, P373, DOI 10.1093/ptj/72.5.373; Hunter S., 2002, REV CLIN GERONTOL, V12, P68, DOI DOI 10.1017/S0959259802012194; In H, 2015, IEEE ROBOT AUTOM MAG, V22, P97, DOI 10.1109/MRA.2014.2362863; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; Kadowaki Y, 2011, J ROBOT MECHATRON, V23, P281, DOI 10.20965/jrm.2011.p0281; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Lum Peter S, 2012, Am J Phys Med Rehabil, V91, pS242, DOI 10.1097/PHM.0b013e31826bcedb; Maciejasz P, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-3; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; Mehrholz J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006876.pub4; Nijenhuis SM, 2017, CLIN REHABIL, V31, P207, DOI 10.1177/0269215516629722; Nijenhuis SM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0080-y; Nijenhuis SM, 2016, 8 INT C EHEALTH TEL; ORNE MT, 1962, AM PSYCHOL, V17, P776, DOI 10.1037/h0043424; Osteras N, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010388.pub2; Polygerinos P, 2015, ROB AUT ICRA 2015 IE; Polygerinos P, 2015, REH ROB ICORR 2015 I; Polygerinos P, 2015, ROBOT AUTON SYST, V73, P135, DOI 10.1016/j.robot.2014.08.014; Popov D, 2017, IEEE-ASME T MECH, V22, P865, DOI 10.1109/TMECH.2016.2641932; Prange GB, 2006, J REHABIL RES DEV, V43, P171, DOI 10.1682/JRRD.2005.04.0076; Radder B, 2017, BIOSYST BIOROBOT, V15, P1251, DOI 10.1007/978-3-319-46669-9_204; Radder B, 2017, BIOSYST BIOROBOT, V15, P1245, DOI 10.1007/978-3-319-46669-9_203; Radder Bob, 2016, J Rehabil Assist Technol Eng, V3, p2055668316670553, DOI 10.1177/2055668316670553; Radder B, 2020, ASSIST TECHNOL, V32, P9, DOI 10.1080/10400435.2018.1453888; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Timmermans AAA, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-1; Vanoglio F, 2017, CLIN REHABIL, V31, P351, DOI 10.1177/0269215516642606; Veerbeek JM, 2016, NEUROREHABILITATION; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33; Wittmann F, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0182-1; Xiloyannis M, 2016, BIOM ROB BIOM BIOROB; Yun Y, 2017, ROB AUT ICRA 2017 IE	48	18	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2019	14	8							e0220544	10.1371/journal.pone.0220544	http://dx.doi.org/10.1371/journal.pone.0220544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5CU	31386685	Green Published, gold			2022-12-27	WOS:000484997100023
J	dos Reis, MC; Bagatini, IL; Vidal, LD; Bonnet, MP; Marques, DD; Sarmento, H				dos Reis, Mariana Camara; Bagatini, Inessa Lacativa; Vidal, Luciana de Oliveira; Bonnet, Marie-Paule; Marques, David da Motta; Sarmento, Hugo			Spatial heterogeneity and hydrological fluctuations drive bacterioplankton community composition in an Amazon floodplain system	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; DIVERSITY; REVEALS; CARBON; BIOGEOGRAPHY; DYNAMICS; PATTERNS; RIVER	Amazonian floodplains form complex hydrological networks that play relevant roles in global biogeochemical cycles, and bacterial degradation of the organic matter in these systems is key for regional carbon budget. The Amazon undergoes extreme seasonal variations in water level, which produces changes in landscape and diversifies sources of organic inputs into floodplain systems. Although these changes should affect bacterioplankton community composition (BCC), little is known about which factors drive spatial and temporal patterns of bacterioplankton in these Amazonian floodplains. We used high-throughput sequencing (Illumina MiSeq) of the V3-V4 region of the 16S rRNA gene to investigate spatial and temporal patterns of BCC of two size fractions, and their correlation with environmental variables in an Amazon floodplain lake (Lago Grande do Curuai). We found a high degree of novelty in bacterioplankton, as more than half of operational taxonomic units (OTUs) could not be classified at genus level. Spatial habitat heterogeneity and the flood pulse were the main factors shaping free-living (FL) BCC. The gradient of organic matter from transition zone lake -Amazon River was the main driver for particle-attached (PA) BCC. The BCC reflected the complexity of the system, with more variation in space than in time, although both factors were important drivers of the BCC in this Amazon floodplain system.	[dos Reis, Mariana Camara; Sarmento, Hugo] Univ Fed Sao Carlos, Lab Microbial Proc & Biodivers, Dept Hidrobiol, Sao Carlos, SP, Brazil; [dos Reis, Mariana Camara] Univ Fed Sao Carlos, Programa Posgrad Ecol & Recursos Nat, Sao Carlos, SP, Brazil; [Bagatini, Inessa Lacativa] Univ Fed Sao Carlos, Lab Ficol, Dept Bot, Sao Carlos, SP, Brazil; [Vidal, Luciana de Oliveira] Univ Estadual Norte Fluminense, Lab Ciencias Ambientais, Ctr Biociencias & Biotecnol, Campos Dos Goytacazes, RJ, Brazil; [Bonnet, Marie-Paule] Inst Res Dev, UMR Espace DEV 228, Montpellier, France; [Bonnet, Marie-Paule] Univ Brasilia, Inst Res Dev, Int Joint Lab, LMI OCE, Brasilia, DF, Brazil; [Marques, David da Motta] Univ Fed Rio Grande do Sul, Inst Hydraul Res, Porto Alegre, RS, Brazil; [dos Reis, Mariana Camara] Sorbonne Univ, CNRS, UMR 7144, Adaptat & Divers Milieu Marin,Stn Biol Roscoff, Pl Georges Teissier, Roscoff, France	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade Estadual do Norte Fluminense; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidade de Brasilia; Universidade Federal do Rio Grande do Sul; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	dos Reis, MC (corresponding author), Univ Fed Sao Carlos, Lab Microbial Proc & Biodivers, Dept Hidrobiol, Sao Carlos, SP, Brazil.; dos Reis, MC (corresponding author), Univ Fed Sao Carlos, Programa Posgrad Ecol & Recursos Nat, Sao Carlos, SP, Brazil.; dos Reis, MC (corresponding author), Sorbonne Univ, CNRS, UMR 7144, Adaptat & Divers Milieu Marin,Stn Biol Roscoff, Pl Georges Teissier, Roscoff, France.	maricamarareis@gmail.com	Bagatini, I.L./H-9960-2017; Bonnet, Marie-Paule/J-6888-2016; Sarmento, Hugo/W-3805-2019; Reis, Mariana Câmara dos/AAC-4225-2021; Vidal, Luciana O/V-4819-2019	Bagatini, I.L./0000-0002-5549-2255; Bonnet, Marie-Paule/0000-0002-3950-4041; Sarmento, Hugo/0000-0001-5220-7992; Reis, Mariana Câmara dos/0000-0003-4887-5351; Vidal, Luciana/0000-0001-5065-0835; da Motta Marques, David/0000-0002-3809-8053	Conselho nacional de desenvolvimento cientifico e tecnologico [132749/2015-7, 490634/2013-3, 309514/2017-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/18083-0, 2014/13139-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [AUXPE-PNPD 2837/2010]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil) [490634/2013-3]; IRD (Institut de Recherche pour le Developpement); international research program Clim-FABIAM - FRB (Fondation pour la Recherche sur la Biodiversite); International Joint Laboratory, LMI OCE (IRD/Universidade de Brasilia); European Union's Horizon 2020 Research and innovation program under the Marie Sklodowska-Curie grant [691053]; INCT [16-2014]; CNPq; Capes; Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)	Conselho nacional de desenvolvimento cientifico e tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); IRD (Institut de Recherche pour le Developpement); international research program Clim-FABIAM - FRB (Fondation pour la Recherche sur la Biodiversite); International Joint Laboratory, LMI OCE (IRD/Universidade de Brasilia); European Union's Horizon 2020 Research and innovation program under the Marie Sklodowska-Curie grant; INCT; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	MCDR received a grant from Conselho nacional de desenvolvimento cientifico e tecnologico (grant process 132749/2015-7). ILB received a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2013/18083-0). LOV received a grant from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (grant process AUXPE-PNPD 2837/2010). DMM received a grant from Conselho nacional de desenvolvimento cientifico e tecnologico (490634/2013-3). HS received a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2014/13139-3) and Conselho nacional de desenvolvimento cientifico e tecnologico (309514/2017-7). This research was done under the auspices of CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil grant number 490634/2013-3), IRD (Institut de Recherche pour le Developpement), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2014/13139-3) and an international research program Clim-FABIAM (coordinated by MPB), which was funded by FRB (Fondation pour la Recherche sur la Biodiversite). The work also received funding from the International Joint Laboratory, LMI OCE (IRD/Universidade de Brasilia), from the European Union's Horizon 2020 Research and innovation program under the Marie Sklodowska-Curie grant (No. 691053 H2020-MSCA-RISE-2015 ODYSSEA project) and is part of the activities of the INCT no 16-2014 ODISSEIA, with funding from CNPq, Capes and Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF). The funders URLs are: http://www.cnpq.br/; http://www.fapesp.br/; http://www.capes.gov.br; https://www.ird.fr/; https://ec.europa.eu/programmes/horizon2020/; http://www.fap.df.gov.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2014, NATURE, V505, P395, DOI 10.1038/nature12797; Amaral JHF, 2018, SCI TOTAL ENVIRON, V630, P1381, DOI 10.1016/j.scitotenv.2018.02.331; Anderson M.J., 2005, PERMUTATIONAL MULTIV; APHA AWWA WEF, 2012, STANDARD METHODS EXA, P541; Bizic-Ionescu M, 2015, ENVIRON MICROBIOL, V17, P3500, DOI 10.1111/1462-2920.12466; Bonnet MP, 2008, J HYDROL, V349, P18, DOI 10.1016/j.jhydrol.2007.10.055; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Cai HY, 2013, MICROB ECOL, V66, P73, DOI 10.1007/s00248-013-0224-1; Carney RL, 2015, AQUAT MICROB ECOL, V75, P187, DOI 10.3354/ame01758; de Melo ML, 2019, FRESHWATER BIOL, V64, P108, DOI 10.1111/fwb.13198; Doherty M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00882; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Dvorak P, 2014, MOL ECOL, V23, P5538, DOI 10.1111/mec.12948; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ghai R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023785; Ghylin TW, 2014, ISME J, V8, P2503, DOI 10.1038/ismej.2014.135; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Ji Y, 2016, ENVIRON MICROBIOL, V18, P5082, DOI 10.1111/1462-2920.13491; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; LEWIS WM, 1976, SCIENCE, V192, P885, DOI 10.1126/science.192.4242.885; Liu LM, 2015, ISME J, V9, P2068, DOI 10.1038/ismej.2015.29; Lliros M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116145; Logares R, 2014, ENVIRON MICROBIOL, V16, P2659, DOI 10.1111/1462-2920.12250; Luef B, 2007, FRESHWATER BIOL, V52, P1043, DOI 10.1111/j.1365-2427.2007.01752.x; Lynch MDJ, 2015, NAT REV MICROBIOL, V13, P217, DOI 10.1038/nrmicro3400; Mackereth J., 1979, Q REV BIOL, V54, P203, DOI [DOI 10.1002/IROH.19790640404, 10.1086/411247, DOI 10.1086/411247]; Maurice Bourgoin L, 2007, J HYDROL, V335, P140, DOI 10.1016/j.jhydrol.2006.11.023; Melack JM, 2016, ECOL STUD-ANAL SYNTH, V227, P119, DOI 10.1007/978-3-662-49902-3_7; Mestre M, 2017, ISME J, V11, P999, DOI 10.1038/ismej.2016.166; Mohit V, 2014, APPL ENVIRON MICROB, V80, P2071, DOI 10.1128/AEM.02916-13; Moreira-Turcq P, 2013, GLOBAL BIOGEOCHEM CY, V27, P119, DOI 10.1002/gbc.20022; Mortillaro JM, 2016, LIMNOLOGICA, V59, P90, DOI 10.1016/j.limno.2016.03.008; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oksanen J., 2019, R PACKAGE VERSION, DOI DOI 10.4135/9781412971874.N145; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Pedros-Alio C, 2012, ANNU REV MAR SCI, V4, P449, DOI 10.1146/annurev-marine-120710-100948; Perez MAP, 2011, CHEM GEOL, V286, P158, DOI 10.1016/j.chemgeo.2011.05.004; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2009, R LANG ENV STAT COMP; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Read DS, 2015, ISME J, V9, P516, DOI 10.1038/ismej.2014.166; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; RICHEY JE, 1990, LIMNOL OCEANOGR, V35, P352, DOI 10.4319/lo.1990.35.2.0352; Roberts D., 2007, LABDSV ORDINATION MU; Ruiz-Gonzalez C, 2015, GLOBAL ECOL BIOGEOGR, V24, P1487, DOI 10.1111/geb.12356; Ruiz-Gonzalez C, 2015, ECOL LETT, V18, P1198, DOI 10.1111/ele.12499; Salcher MM, 2014, J LIMNOL, V73, P74, DOI 10.4081/jlimnol.2014.813; Sarmento H, 2008, FRESHWATER BIOL, V53, P756, DOI 10.1111/j.1365-2427.2007.01939.x; Sarmento H, 2012, HYDROBIOLOGIA, V686, P1, DOI 10.1007/s10750-012-1011-6; Satinsky BM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0099-0; Savio D, 2015, ENVIRON MICROBIOL, V17, P4994, DOI 10.1111/1462-2920.12886; Schmidt ML, 2016, ENVIRON MICROBIOL, V18, P1212, DOI 10.1111/1462-2920.13143; Schneegurt Mark A., 2003, Current Issues in Molecular Biology, V5, P1; Silva TSF, 2009, WETLANDS, V29, P747, DOI 10.1672/08-107.1; Sioli H, 1984, AMAZON LIMNOLOGY LAN, P127, DOI [DOI 10.1007/978-94-009-6542-3_5, 10.1007/978-94-009-6542-3_5]; Staley C, 2015, SCI TOTAL ENVIRON, V505, P435, DOI 10.1016/j.scitotenv.2014.10.012; Tessler M, 2016, MICROB ECOL, V73, P1, DOI [10.1007/s00248-016-0827-4, DOI 10.1007/S00248-016-0827-4]; Wiens JJ, 2011, ECOL LETT, V14, P643, DOI 10.1111/j.1461-0248.2011.01625.x; Woodhouse JN, 2016, ISME J, V10, P1337, DOI 10.1038/ismej.2015.218; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	63	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2019	14	8							e0220695	10.1371/journal.pone.0220695	http://dx.doi.org/10.1371/journal.pone.0220695			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5FL	31398199	gold, Green Published, Green Submitted			2022-12-27	WOS:000485004000013
J	Rujimongkon, K; Mungthin, M; Tummatorn, J; Ampawong, S; Adisakwattana, P; Boonyuen, U; Reamtong, O				Rujimongkon, Kitiya; Mungthin, Mathirut; Tummatorn, Jumreang; Ampawong, Sumate; Adisakwattana, Poom; Boonyuen, Usa; Reamtong, Onrapak			Proteomic analysis of Plasmodium falciparum response to isocryptolepine derivative	PLOS ONE			English	Article							TOPOISOMERASE-II; MALARIA PARASITES; PROTEIN; INHIBITION; CRYPTOLEPINE; CYCLE; MEFLOQUINE; ALKALOIDS; ANALOGS; TARGETS	Drug-resistant strains of malaria parasites have emerged for most of antimalarial medications. A new chemotherapeutic compound is needed for malarial therapy. Antimalarial activity against both drug-sensitive and drug-resistant P. falciparum has been reported for an isocryptolepine derivative, 8-bromo-2-fluoro-5-methyl-5H-indolo[3,2-c]quinoline (ICL-M), which also showed less toxicity to human cells. ICL-M has indoloquinoline as a core structure and its mode of action remains unclear. Here, we explored the mechanisms of ICL-M in P. falciparum by assessing the stage-specific activity, time-dependent effect, a proteomic analysis and morphology. Since human topo II activity inhibition has been reported as a function of isocryptolepine derivatives, malarial topo II activity inhibition of ICL-M was also examined in this study. The ICL-M exhibited antimalarial activity against both the ring and trophozoite stages of P. falciparum. Our proteomics analysis revealed that a total of 112 P. falciparum proteins were differentially expressed after ICL-M exposure; among these, 58 and 54 proteins were upregulated and downregulated, respectively. Proteins localized in the food vacuole, nucleus, and cytoplasm showed quantitative alterations after ICL-M treatment. A bioinformatic analysis revealed that pathways associated with ribosomes, proteasomes, metabolic pathways, amino acid biosynthesis, oxidative phosphorylation, and carbon metabolism were significantly different in P. falciparum treated with ICL-M. Moreover, a loss of ribosomes was clearly observed by transmission electron microscopy in the ICL-M-treated P. falciparum. This finding is in agreement with the proteomics data, which revealed downregulated levels of ribosomal proteins following ICL-M treatment. Our results provide important information about the mechanisms by which ICL-M affects the malaria parasite, which may facilitate the drug development of isocryptolepine derivatives.	[Rujimongkon, Kitiya; Boonyuen, Usa; Reamtong, Onrapak] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Mungthin, Mathirut] Phramongkutklao Coll Med, Dept Pharmacol, Bangkok, Thailand; [Tummatorn, Jumreang] Chulabhorn Grad Inst, Minist Educ, Ctr Excellence Environm Hlth & Toxicol, Program Chem Biol, Bangkok, Thailand; [Tummatorn, Jumreang] Chulabhorn Res Inst, Lab Med Chem, Bangkok, Thailand; [Ampawong, Sumate] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand; [Adisakwattana, Poom] Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok, Thailand	Mahidol University; Phramongkutklao College of Medicine; Chulabhorn Graduate Institute; Chulabhorn Research Institute; Mahidol University; Mahidol University	Reamtong, O (corresponding author), Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand.	onrapak.rea@mahidol.ac.th	Boonyuen, Usa/AAX-7128-2020	Boonyuen, Usa/0000-0003-0640-6215; AMPAWONG, Sumate/0000-0002-5378-2996; Tummatorn, Jumreang/0000-0002-1662-151X; Adisakwattana, Poom/0000-0002-0313-9900	FTM2013 of Faculty of Tropical Medicine, Mahidol university; Thailand Toray Science Foundation	FTM2013 of Faculty of Tropical Medicine, Mahidol university; Thailand Toray Science Foundation	This study was supported by FTM2013 of Faculty of Tropical Medicine, Mahidol university and Thailand Toray Science Foundation.	Aly NSM, 2007, PARASITOL RES, V100, P1119, DOI 10.1007/s00436-007-0460-8; Ampawong S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33372-4; Aroonkit P, 2015, EUR J MED CHEM, V94, P56, DOI 10.1016/j.ejmech.2015.02.047; BELL A, 1994, BIOCHEM PHARMACOL, V48, P495, DOI 10.1016/0006-2952(94)90279-8; Bertin GI, 2016, SCI REP-UK, V6, DOI 10.1038/srep26773; Bhaumik P, 2011, BIOCHEMISTRY-US, V50, P8862, DOI 10.1021/bi201118z; Bonjean K, 1998, BIOCHEMISTRY-US, V37, P5136, DOI 10.1021/bi972927q; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141; Chen BJ, 2014, CANCER LETT, V354, P378, DOI 10.1016/j.canlet.2014.08.045; Cromm PM, 2017, ACS CENTRAL SCI, V3, P830, DOI 10.1021/acscentsci.7b00252; Dassonneville L, 1999, BIOCHEMISTRY-US, V38, P7719, DOI 10.1021/bi990094t; de Almeida-Bizzo JH, 2014, EXP PARASITOL, V147, P60, DOI 10.1016/j.exppara.2014.08.015; Devi SB, 2019, MED HYPOTHESES, V125, P119, DOI 10.1016/j.mehy.2019.01.006; EPPING RJ, 1988, MOL BIOCHEM PARASIT, V28, P1, DOI 10.1016/0166-6851(88)90173-9; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Ghosh P, 2014, RSC ADV, V4, P22442, DOI 10.1039/c4ra03650f; Grellier P, 1996, PHYTOTHER RES, V10, P317, DOI 10.1002/(SICI)1099-1573(199606)10:4&lt;317::AID-PTR858&gt;3.0.CO;2-0; Guo XY, 2011, J CELL MOL MED, V15, P296, DOI 10.1111/j.1582-4934.2009.00969.x; IBRAHIM ES, 1988, EUR J MED CHEM, V23, P183, DOI 10.1016/0223-5234(88)90192-4; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ismail HM, 2016, P NATL ACAD SCI USA, V113, P2080, DOI 10.1073/pnas.1600459113; Jenner L, 2013, P NATL ACAD SCI USA, V110, P3812, DOI 10.1073/pnas.1216691110; Kassa FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026495; Kumar S, 2007, LIFE SCI, V80, P813, DOI 10.1016/j.lfs.2006.11.008; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Lavrado J, 2011, J MED CHEM, V54, P734, DOI 10.1021/jm101383f; Le Manach C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-424; Makanga M, 2005, PROTEOMICS, V5, P1849, DOI 10.1002/pmic.200401076; MARQUEZ VE, 1972, J MED CHEM, V15, P36, DOI 10.1021/jm00271a010; Morita M, 2012, J PROTEOME RES, V11, P5704, DOI 10.1021/pr3005315; Moura PA, 2009, ANTIMICROB AGENTS CH, V53, P4968, DOI 10.1128/AAC.00882-09; Mudeppa DG, 2015, J BIOL CHEM, V290, P20313, DOI 10.1074/jbc.M115.639039; Mukherjee A, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02309-17, 10.1128/aac.02309-17]; Ng CL, 2017, TRENDS PARASITOL, V33, P731, DOI 10.1016/j.pt.2017.05.009; Nirmalan N, 2004, MOL MICROBIOL, V52, P1187, DOI 10.1111/j.1365-2958.2004.04049.x; Pal HC, 2016, MOLECULES, V21, DOI 10.3390/molecules21121758; Pelchovich G, 2014, FEBS J, V281, P3701, DOI 10.1111/febs.12892; Prieto JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004098; Ray S, 2012, J PROTEOMICS, V75, P3063, DOI 10.1016/j.jprot.2011.10.018; Reamtong O, 2015, INT J MASS SPECTROM, V391, P82, DOI 10.1016/j.ijms.2015.09.009; Reiter K, 2013, J BIOL CHEM, V288, P27724, DOI 10.1074/jbc.M113.498410; RIOU JF, 1991, MOL PHARMACOL, V40, P699; Sachanonta N, 2011, ULTRASTRUCT PATHOL, V35, P214, DOI 10.3109/01913123.2011.601405; Segura C, 2014, BIOMEDICA, V34, P237, DOI [10.7705/biomedica.v34i2.1700, 10.1590/S0120-41572014000200010]; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Skinner TS, 1996, INT J PARASITOL, V26, P519, DOI 10.1016/0020-7519(96)89380-5; Sun J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129626; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Uchuskin MG, 2012, ORG BIOMOL CHEM, V10, P7262, DOI 10.1039/c2ob25836f; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Van Miert S, 2005, J NAT PROD, V68, P674, DOI 10.1021/np0496284; Voss TS, 2002, J BIOL CHEM, V277, P17493, DOI 10.1074/jbc.M200100200; Wang N, 2014, BIOORGAN MED CHEM, V22, P2629, DOI 10.1016/j.bmc.2014.03.030; Whittell LR, 2011, BIOORGAN MED CHEM, V19, P7519, DOI 10.1016/j.bmc.2011.10.037; Willcox ML, 2004, BMJ-BRIT MED J, V329, P1156, DOI 10.1136/bmj.329.7475.1156; Wong W, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.31; World Health Organization, 2018, WORLD MAL REP 2018; Yang KS, 2013, ANGEW CHEM INT EDIT, V52, P10593, DOI 10.1002/anie.201304096	61	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2019	14	8							e0220871	10.1371/journal.pone.0220871	http://dx.doi.org/10.1371/journal.pone.0220871			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5EW	31393938	Green Submitted, Green Published, gold			2022-12-27	WOS:000485002500075
J	Margulis, AV; Hernandez-Diaz, S; McElrath, T; Rothman, KJ; Plana, E; Almqvist, C; D'Onofrio, BM; Oberg, AS				Margulis, Andrea, V; Hernandez-Diaz, Sonia; McElrath, Thomas; Rothman, Kenneth J.; Plana, Estel; Almqvist, Catarina; D'Onofrio, Brian M.; Oberg, Anna Sara			Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth	PLOS ONE			English	Article							INTRAUTERINE GROWTH; FETAL-GROWTH; MATERNAL USE; EPILEPSY; DELIVERY; OUTCOMES; RISK; MALFORMATIONS; ASSOCIATION; POPULATION	Background The associations of individual antiepileptic drugs (AEDs) with pregnancy duration and size at birth, and potential dose relations, are not well characterized. Methods This cohort study used nationwide Swedish register data (1996-2013). Adjusting for smoking, epilepsy and other AED indications, we used linear and quantile regression to explore associations with pregnancy duration, and birth weight, length, and head circumference (the last three operationalized as z-scores). We used logistic regression for preterm delivery, small for gestational age, and microcephaly. Lamotrigine was the reference drug. Results 6,720 infants were exposed to AEDs in utero; AED exposure increased over the study period. Relative to lamotrigine-exposed infants, carbamazepine-exposed infants were born, on average, 1.3 days earlier (mean [95% confidence interval]: -1.3 [-2.3 to 0.3]); were 0.1 standard deviations (SDs) lighter (-0.1 [-0.2 to 0.0]); and had a head circumference that was 0.2 SDs smaller (-0.2 [-0.3 to 0.1]). Pregabalin-exposed infants were born, on average, 1.1 days earlier (-1.1 [-3.0 to 0.8]); were 0.1 SDs lighter (-0.1 [-0.3 to 0.0]); and had the same head circumference as lamotrigine-exposed infants. Levetiracetam-exposed infants were born, on average, 0.5 days earlier (-0.5 [-2.6 to 1.6]); were 0.1 SDs lighter (-0.1 [-0.3 to 0.0]); and had a head circumference 0.1 SDs smaller (-0.1 [-0.3 to 0.1]). Valproic acid-exposed infants had, on average, the same duration of gestation and birth weight z-score as lamotrigine-exposed infants, but had a head circumference 0.2 SDs smaller (-0.2 [-0.2 to 0.1]). Associations between carbamazepine exposure and pregnancy duration and between valproic acid exposure and pregnancy duration and birth weight z-score were more negative at the left than at the right tails of the outcome distributions. Effect-measure modification and dose-response relations were noted for some of the associations. Conclusions Relative to lamotrigine, valproic acid and carbamazepine were associated with smaller head circumference.	[Margulis, Andrea, V; Plana, Estel] RTI Hlth Solut, Barcelona, Spain; [Hernandez-Diaz, Sonia; Oberg, Anna Sara] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [McElrath, Thomas] Harvard Med Sch, Brigham & Womens Hosp, Div Maternal Fetal Med, Boston, MA 02115 USA; [Rothman, Kenneth J.] RTI Hlth Solut, Waltham, MA USA; [Almqvist, Catarina; D'Onofrio, Brian M.; Oberg, Anna Sara] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [D'Onofrio, Brian M.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Research Triangle Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Research Triangle Institute; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Indiana University System; Indiana University Bloomington	Margulis, AV (corresponding author), RTI Hlth Solut, Barcelona, Spain.	amargulis@rti.org	Oberg, Anna Sara/AAH-1078-2021; Margulis, Andrea/G-2833-2013	Oberg, Anna Sara/0000-0001-6638-1895; Margulis, Andrea/0000-0001-7388-6082; Plana, Estel/0000-0001-8675-7503	Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) [340-2013-5867]	Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM)	ASO, CA and BMD received funds from the Swedish Research Council through the Swedish Initiative for Research on Microdata in the Social And Medical Sciences (SIMSAM) framework grant no. 340-2013-5867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For AVM, KJR, and EP: this project was internally funded. TM received no specific funding for this work.	Abrahamsson K., 2018, SWEDISH REGISTER ED; Almgren M, 2009, SEIZURE-EUR J EPILEP, V18, P672, DOI 10.1016/j.seizure.2009.09.002; Artama M, 2013, DRUG SAFETY, V36, P359, DOI 10.1007/s40264-013-0052-8; Battino D, 1999, EPILEPSY RES, V36, P53, DOI 10.1016/S0920-1211(99)00020-0; Bromley RL, 2017, JAMA-J AM MED ASSOC, V318, P1700, DOI 10.1001/jama.2017.14485; Bromley RL, 2017, SEIZURE-EUR J EPILEP, V44, P225, DOI 10.1016/j.seizure.2016.10.006; Bruckner TA, 2017, EPIDEMIOLOGY, V28, P580, DOI 10.1097/EDE.0000000000000661; de Jong Josta, 2016, Drugs Real World Outcomes, V3, P131; Elkjaer LS, 2018, JAMA NEUROL, V75, P663, DOI 10.1001/jamaneurol.2017.5035; EMA, 2008, ANN 2 SCI CONCL GROU; EMA, 2016, PUBL SUMM OP ORPH DE; EMA, 2018, NEW MEAS AV VALPR EX; EMA, 2017, LAM SUMM PROD CHAR; European Commission, 2019, PUBL HLTH UN REG MED; Foch C, 2018, INT J PEDIATR OTORHI, V113, P192, DOI 10.1016/j.ijporl.2018.07.035; Gerard EE, 2015, J PEDIATR GENET, V4, P94, DOI 10.1055/s-0035-1556741; Hagenfeldt K., 1998, ROUTINE ULTRASOUND E; Hao L, 2007, QUANTILE REGRESSION; Hernandez-Diaz S, 2017, ANN NEUROL, V82, P457, DOI 10.1002/ana.25031; Hernandez-Diaz S, 2014, OBSTET GYNECOL, V123, P21, DOI 10.1097/AOG.0000000000000018; HIILESMAA VK, 1981, LANCET, V2, P165; Hvas CL, 2000, BRIT J OBSTET GYNAEC, V107, P896, DOI 10.1111/j.1471-0528.2000.tb11089.x; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Kallen B., 2003, SWEDISH MED BIRTH RE; Kilic D, 2014, EPILEPSIA, V55, P1714, DOI 10.1111/epi.12758; Kolstad E, 2016, EPILEPSIA, V57, P1849, DOI 10.1111/epi.13573; Koren G, 2018, PEDIATR DRUGS, V20, P331, DOI 10.1007/s40272-018-0294-0; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Margulis AV, 2017, PHARMACOEPIDEM DR S, V26, P408; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McInerney KA, 2018, BJOG; Mostacci B, 2018, J NEUROL NEUROSUR PS, V89, pE1, DOI 10.1136/jnnp-2017-316143corr1; Niklasson A, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-8; Pariente G, 2017, CNS DRUGS, V31, P451, DOI 10.1007/s40263-017-0439-7; Pariente G, 2017, CNS DRUGS, V31, P439, DOI 10.1007/s40263-017-0433-0; Patorno E, 2017, NEUROLOGY, V88, P2020, DOI [10.1212/wnl.0000000000003959, 10.1212/WNL.0000000000003959]; Pennell PB, 2012, EPILEPSY BEHAV, V24, P449, DOI 10.1016/j.yebeh.2012.05.010; Petersen MR, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-9; Petersen MR, 2006, AM J EPIDEMIOL, V163, P1158, DOI 10.1093/aje/kwj162; Raguideau F, 2016, EXPOSITION ACIDE VAL; Raguideau F, 2017, EXPOSITION IN UTERO; Shorvon SD, 2009, EPILEPSIA, V50, P93, DOI 10.1111/j.1528-1167.2009.02042.x; Tomson T, 2018, LANCET NEUROL, V17, P530, DOI 10.1016/S1474-4422(18)30107-8; Vajda FJE, 2018, ACTA NEUROL SCAND, V138, P115, DOI 10.1111/ane.12965; Vajda FJ, 2013, NEUROLOGY, V81, P999, DOI 10.1212/WNL.0b013e3182a43e81; Veiby G, 2014, J NEUROL, V261, P579, DOI 10.1007/s00415-013-7239-x; Veiby G, 2009, EPILEPSIA, V50, P2130, DOI 10.1111/j.1528-1167.2009.02147.x; Veroniki AA, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017248; Veroniki AA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0845-1; Viale L, 2015, LANCET, V386, P1845, DOI 10.1016/S0140-6736(15)00045-8; Wen XR, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1190-7; Weston J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010224.pub2; WHO Collaborating Center for Drug Statistics Methodology, 2009, DEF DAIL DOS DEF GEN; Wide K, 2000, EPILEPSIA, V41, P854, DOI 10.1111/j.1528-1157.2000.tb00253.x; Winterfeld U, 2016, NEUROLOGY, V86, P2251, DOI 10.1212/WNL.0000000000002767	56	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2019	14	8							e0214180	10.1371/journal.pone.0214180	http://dx.doi.org/10.1371/journal.pone.0214180			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5BL	31381574	Green Published, Green Submitted, gold			2022-12-27	WOS:000484993600002
J	Shtar, G; Rokach, L; Shapira, B				Shtar, Guy; Rokach, Lior; Shapira, Bracha			Detecting drug-drug interactions using artificial neural networks and classic graph similarity measures	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS	Drug-drug interactions are preventable causes of medical injuries and often result in doctor and emergency room visits. Computational techniques can be used to predict potential drug-drug interactions. We approach the drug-drug interaction prediction problem as a link prediction problem and present two novel methods for drug-drug interaction prediction based on artificial neural networks and factor propagation over graph nodes: adjacency matrix factorization (AMF) and adjacency matrix factorization with propagation (AMFP). We conduct a retrospective analysis by training our models on a previous release of the DrugBank database with 1,141 drugs and 45,296 drug-drug interactions and evaluate the results on a later version of DrugBank with 1,440 drugs and 248,146 drug-drug interactions. Additionally, we perform a holdout analysis using DrugBank. We report an area under the receiver operating characteristic curve score of 0.807 and 0.990 for the retrospective and holdout analyses respectively. Finally, we create an ensemble-based classifier using AMF, AMFP, and existing link prediction methods and obtain an area under the receiver operating characteristic curve of 0.814 and 0.991 for the retrospective and the holdout analyses. We demonstrate that AMF and AMFP provide state of the art results compared to existing methods and that the ensemble-based classifier improves the performance by combining various predictors. Additionally, we compare our methods with multi-source data-based predictors using cross-validation. In the multi-source data comparison, our methods outperform various ensembles created using 29 different predictors based on several data sources. These results suggest that AMF, AMFP, and the proposed ensemble-based classifier can provide important information during drug development and regarding drug prescription given only partial or noisy data. Additionally, the results indicate that the interaction network (known DDIs) is the most useful data source for identifying potential DDIs and that our methods take advantage of it better than the other methods investigated. The methods we present can also be used to solve other link prediction problems. Drug embeddings (compressed representations) created when training our models using the interaction network have been made public.	[Shtar, Guy; Rokach, Lior; Shapira, Bracha] Ben Gurion Univ Negev, Dept Software & Informat Syst Engn, Beer Sheva, Israel	Ben Gurion University	Shtar, G (corresponding author), Ben Gurion Univ Negev, Dept Software & Informat Syst Engn, Beer Sheva, Israel.	Shtar@post.bgu.ac.il	Rokach, Lior/F-8247-2010	Shapira, Bracha/0000-0003-4943-9324				Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Corrigan OP, 2002, SOC SCI MED, V55, P497, DOI 10.1016/S0277-9536(01)00183-6; Cukierski W, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1237, DOI 10.1109/IJCNN.2011.6033365; Diederik P.K., 2015, INT C LEARNING REPRE; Fan JC, 2018, NEURAL NETWORKS, V98, P34, DOI 10.1016/j.neunet.2017.10.007; Fire M, 2013, ACM T INTEL SYST TEC, V5, DOI 10.1145/2542182.2542192; Glorot X., 2010, P 13 INT C ARTIFICIA, V9, P249, DOI DOI 10.1.1/207.2059; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; Hagberg A., 2008, P 7 PYTH SCI C SCIPY; He XN, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P173, DOI 10.1145/3038912.3052569; Huang Z, 2005, ACM-IEEE J CONF DIG, P141, DOI 10.1145/1065385.1065415; Ickowicz E, 2012, J AM GERIATR SOC, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Lim S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190926; Park K, 2015, PLOS ONE, V10, P1; Qato DM, 2016, JAMA INTERN MED, V176, P473, DOI 10.1001/jamainternmed.2015.8581; Raschetti R, 1999, EUR J CLIN PHARMACOL, V54, P959, DOI 10.1007/s002280050582; Ryu JY, 2018, P NATL ACAD SCI USA, V115, pE4304, DOI 10.1073/pnas.1803294115; Shi JY, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2379-8; Sun X, 2014, IEEE SIGNAL PROC LET, V21, P1389, DOI 10.1109/LSP.2014.2337313; Sun Y, 2018, COMPLEXITY, DOI 10.1155/2018/8645793; Vilar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058321; Vilar S, 2012, J AM MED INFORM ASSN, V19, P1066, DOI 10.1136/amiajnl-2012-000935; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Wu H, 2018, KNOWL-BASED SYST, V145, P46, DOI 10.1016/j.knosys.2018.01.003; Yang Y, 2015, KNOWL INF SYST, V45, P751, DOI 10.1007/s10115-014-0789-0; Zhang PW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13501; Zhang W, 2019, INFORM SCIENCES, V497, P189, DOI 10.1016/j.ins.2019.05.017; Zhang W, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1415-9	31	29	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 1	2019	14	8							e0219796	10.1371/journal.pone.0219796	http://dx.doi.org/10.1371/journal.pone.0219796			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW4ZH	31369568	Green Submitted, gold, Green Published			2022-12-27	WOS:000484987900018
J	Ogundeji, YK; Akomolafe, B; Ohiri, K; Butawa, NN				Ogundeji, Yewande Kofoworola; Akomolafe, Babatunde; Ohiri, Kelechi; Butawa, Nuhu Natie			Factors influencing willingness and ability to pay for social health insurance in Nigeria	PLOS ONE			English	Article							TO-PAY; EXPENDITURE; GHANA	Background Many low and middle-income countries are increasingly cognisant of the need to offer financial protection to its citizens through pre-payment schemes in order to curb high out of pocket expenditure and catastrophic spending on healthcare. However, there is limited rigorous contextual evidence to make decisions regarding optimal design of such schemes. This study assesses the willingness-to-pay (WTP) for the recently introduced state contributory health insurance scheme (SHIS) in Nigeria. Methods The study took place in 6 local government areas in Kaduna state, North-west Nigeria. Data were collected from a household survey using a three-stage cluster sampling approach, with each household having the same probability of being selected. Interviews were conducted with 4000 individuals in 1020 households. Contingent valuation was used to elicit the willing to pay (WTP) for the household using the bidding game technique. The relationship between socioeconomic status and WTP was also examined using logistic regression models. Findings About 82% of the household heads were willing to pay insurance premiums for their households, which came to an average of 513 Naira (1.68 USD) per month per person. The average amount individuals were willing to pay was lower in rural areas (611 Naira) compared to urban areas (463 Naira). These results were influenced by household size, level of education, occupation and household income. In addition, only 65% of the households had the ability to pay the average premium. Conclusion Socioeconomic factors influence individuals' WTP for contributory health insurance schemes. It is important to create awareness about the benefits of the insurance scheme, especially in rural areas, and in both the formal and informal sectors in Nigeria. WTP information can inform the amount of insurance premiums. However, it is important to consider differences between the WTP and the cost of benefits package to be offered, as the premium amount may need to be subsidized with public financing.	[Ogundeji, Yewande Kofoworola; Akomolafe, Babatunde; Ohiri, Kelechi] HSDF, Dept Hlth Financing, Abuja, Nigeria; [Butawa, Nuhu Natie] Minist Hlth, Dept Planning Res & Stat, Kaduna, Nigeria		Ogundeji, YK (corresponding author), HSDF, Dept Hlth Financing, Abuja, Nigeria.	yewande.ogundeji@hsdf.org.ng						Ahmed S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148211; Asenso-Okyere WK, 1997, HEALTH POLICY, V42, P223, DOI 10.1016/S0168-8510(97)00069-9; Asfaw A, 2004, HEALTH POLICY, V70, P97, DOI 10.1016/j.healthpol.2004.02.005; Asfaw A, 2008, AIID, V1, P22; Asgary Ali, 2004, Eur J Health Econ, V5, P209, DOI 10.1007/s10198-004-0233-6; Ataguba JE, 2008, COMMUNITY HLTH INSUR; Babatunde O., 2012, INT REV SOCIAL SCI H, V2, P133; Barton T, 1995, P DISS SEM EC UG; Dong HJ, 2003, HEALTH ECON, V12, P849, DOI 10.1002/hec.771; Dong HJ, 2005, HEALTH POLICY, V72, P149, DOI 10.1016/j.healthpol.2004.02.014; Federal Ministry of Health, 2016, GUID ADM DISB MON FU, P69; Federal Ministry of Health, 2016, NAT HLTH ACC; Hester V, 2009, FISCAL SPACE POLICY; HUBER JH, 1993, SOC SCI MED, V36, P485, DOI 10.1016/0277-9536(93)90410-6; Jakovljevic M., 2014, SERBIAN J EXPT CLIN, V15, P139, DOI 10.2478/sjecr-2014-0018; Jakovljevic M, 2017, HEALTH ECON, V26, P844, DOI 10.1002/hec.3406; Jakovljevic M, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00002; Lwambo N. J., 2005, HLTH RES B, V7, P149; Maumita G, 2013, IOSR J HUMANIT SOC S, V12, P41; McIntyre D, 2008, B WORLD HEALTH ORGAN, V86, P871, DOI 10.2471/BLT.08.053413; Mtei G, 2007, IFAKARA HLTH RES DEV, P1; OECD, 2014, MEAS FIN PROT ACC SE; Onwujekwe O., 2006, FEASIBILITY VOLUNTAR; Onwujekwe O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040811; Onwujekwe O, 2010, HEALTH POLICY PLANN, V25, P155, DOI 10.1093/heapol/czp046; Pejcic AV, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00052; Peterson L, 2015, EXTENDING HLTH INSUR; Rancic N., 2016, E EUR BUS EC J, V2, P2; Rebecca T, 2015, J CHEM INF MODEL, V1, P1, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Toonen J, 1995, COMMUNITY FINANCING; WHO, 2009, REG HLTH FOR WHO S E; WHO, 2014, FISC SPAC PUBL FIN M; WHO, 2007, SOC HLTH PROT; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	34	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2019	14	8							e0220558	10.1371/journal.pone.0220558	http://dx.doi.org/10.1371/journal.pone.0220558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	IW5AR	31374083	Green Published, Green Submitted, gold			2022-12-27	WOS:000484991500019
J	Raben, D; Sullivan, AK; Mocroft, A; Kutsyna, G; Hadziosmanovic, V; Vassilenko, A; Chkhartisvili, N; Mitsura, V; Pedersen, C; Anderson, J; Begovac, J; Dragsted, UB; Bertisch, B; Grzeszczuk, A; Minton, J; Necsoi, VC; Kitchen, M; Ajana, F; Sokhan, A; Comi, L; Farazmand, P; Pesut, D; De Wit, S; Gate, JM; Gazzard, B; Monforte, AD; Rockstroh, JK; Yazdanpanah, Y; Champenois, K; Jakobsen, ML; Lundgren, JD; Clumeck, N; Gatell, J; Gazzard, B; Lundgren, J; Monforte, AD; Rockstroh, J; Mocroft, A; Yazdanpanah, Y; Zangerle, R; Kitchen, M; Vassilenko, A; Necsoi, C; Genotte, AF; Pedersen, C; Redder, L; Caby, F; Bouvet, E; Khuong, MA; Caldato, S; Morlat, P; Coban, D; Arvieux, C; Cabie, A; Chkhartishvili, N; Gerdes, S; Sambatakou, H; Sthoeger, ZM; Elbirt, D; Comi, L; Bini, T; Celesia, BM; Gussio, M; Brinkman, K; Grzeszczuk, A; Rosca, EC; Pesut, D; Sanchez, MAG; Estrada, VP; Gonzalez, EO; Ocampo, A; Masia, M; Agusti, C; Sonnerborg, A; Vernazza, P; Sullivan, A; Rayment, M; Rae, C; Foxton, M; Morris, S; Palfreeman, A; Calderwood, J; Ong, ELC; Mummery, D; Kuznetsova, A; Sullivan, A; Champenois, K; Raben, D; Jakobsen, ML; Hansen, EW				Raben, Dorthe; Sullivan, Ann Kathleen; Mocroft, Amanda; Kutsyna, Galyna; Hadziosmanovic, Vesna; Vassilenko, Anna; Chkhartisvili, Nikoloz; Mitsura, Viktar; Pedersen, Court; Anderson, Jane; Begovac, Josip; Dragsted, Ulrik Bak; Bertisch, Barbara; Grzeszczuk, Anna; Minton, Jane; Necsoi, Valentina Coca; Kitchen, Maria; Ajana, Faiza; Sokhan, Anton; Comi, Laura; Farazmand, Paymaneh; Pesut, Dragica; De Wit, Stephane; Maria Gate, Jose; Gazzard, Brian; Monforte, Antonella d'Arminio; Rockstroh, Juergen Kurt; Yazdanpanah, Yazdan; Champenois, Karen; Jakobsen, Marie Louise; Lundgren, Jens Dilling; Clumeck, N.; Gatell, J.; Gazzard, B.; Lundgren, J.; Monforte, A. d'Arminio; Rockstroh, J.; Mocroft, A.; Yazdanpanah, Y.; Zangerle, R.; Kitchen, M.; Vassilenko, A.; Necsoi, C.; Genotte, A. F.; Pedersen, C.; Redder, L.; Caby, F.; Bouvet, E.; Khuong, M. A.; Caldato, S.; Morlat, P.; Coban, D.; Arvieux, C.; Cabie, A.; Chkhartishvili, N.; Gerdes, S.; Sambatakou, H.; Sthoeger, Z. M.; Elbirt, D.; Comi, L.; Bini, T.; Celesia, B. M.; Gussio, M.; Brinkman, K.; Grzeszczuk, A.; Rosca, E. C.; Pesut, D.; Goenaga Sanchez, M. A.; Estrada, V. P.; Ortega Gonzalez, E.; Ocampo, A.; Masia, M.; Agusti, C.; Sonnerborg, A.; Vernazza, P.; Sullivan, A.; Rayment, M.; Rae, C.; Foxton, Matt; Morris, S.; Palfreeman, A.; Calderwood, J.; Ong, E. L. C.; Mummery, D.; Kuznetsova, A.; Sullivan, Ann; Champenois, K.; Raben, D.; Jakobsen, M. L.; Hansen, E. Wiuff		HIDES Study Grp	Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study-2012-2015	PLOS ONE			English	Article							CARE	Background It is cost-effective to perform an HIV test in people with specific indicator conditions (IC) with an undiagnosed HIV prevalence of at least 0.1%. Our aim was to determine the HIV prevalence for 14 different conditions across 20 European countries. Methods Individuals aged 18-65 years presenting for care with one of 14 ICs between January 2012 and June 2014 were included and routinely offered an HIV test. Logistic regression assessed factors associated with testing HIV positive. Patients presenting with infectious mononucleosis-like syndrome (IMS) were recruited up until September 2015. Results Of 10,877 patients presenting with an IC and included in the analysis, 303 tested positive (2.8%; 95% CI 2.5-3.1%). People presenting with an IC in Southern and Eastern Europe were more likely to test HIV positive as were people presenting with IMS, lymphadenopathy and leukocytopenia/thrombocytopenia. One third of people diagnosed with HIV after presenting with IMS reported a negative HIV test in the preceding 12 months. Of patients newly diagnosed with HIV where data was available, 92.6% were promptly linked to care; of these 10.4% were reported lost to follow up or dead 12 months after diagnosis. Conclusion The study showed that 10 conditions had HIV prevalences > 0.1%. These 10 ICs should be adopted into HIV testing and IC specialty guidelines. As IMS presentation can mimic acute HIV sero-conversion and has the highest positivity rate, this IC in particular affords opportunities for earlier diagnosis and public health benefit.	[Raben, Dorthe; Jakobsen, Marie Louise; Lundgren, Jens Dilling] Rigshosp, Ctr Hlth & Infect Dis Res, Copenhagen, Denmark; [Sullivan, Ann Kathleen; Gazzard, Brian; Sullivan, Ann] NHS Fdn Trust, Chelsea & Westminster Hosp, London, England; [Mocroft, Amanda] UCL, London, England; [Kutsyna, Galyna] Luhansk AIDS Ctr, Lugansk, Ukraine; [Hadziosmanovic, Vesna] Univ Sarajevo, Infect Dis Clin, Clin Ctr, Sarajevo, Bosnia & Herceg; [Vassilenko, Anna] Belarusian State Med Univ, Minsk, BELARUS; [Chkhartisvili, Nikoloz] AIDS & Clin Immunol Res Ctr, Tiblisi, Georgia; [Mitsura, Viktar] Gomel State Med Univ, Gomel, BELARUS; [Pedersen, Court] Odense Univ Hosp, Odense, Denmark; [Anderson, Jane] Homerton Univ Hosp, London, England; [Begovac, Josip] Univ Hosp Infect Dis, Zagreb, Croatia; [Dragsted, Ulrik Bak] Zealand Univ Hosp, Roskilde, Region Zealand, Denmark; [Bertisch, Barbara; Vernazza, P.] Kantonsspital, St Gallen, Switzerland; [Grzeszczuk, Anna] Med Univ Bialystok, Bialystok, Poland; [Minton, Jane; Palfreeman, A.; Calderwood, J.] St James Univ Hosp, Leeds, W Yorkshire, England; [Necsoi, Valentina Coca; De Wit, Stephane] Univ Libre Bruxelles, St Pierre Univ Hosp, Brussels, Belgium; [Kitchen, Maria] Univ Hosp Innsbruck, Innsbruck, Austria; [Ajana, Faiza] Ctr Hosp Tourcoing, Tourcoing, France; [Sokhan, Anton] Kharkiv Natl Med Univ, Kharkov, Ukraine; [Comi, Laura] ASST Papa Giovanni XXIII, Osped Bergamo, Bergamo, Italy; [Farazmand, Paymaneh] Huddersfield Royal Infirm, Huddersfield, W Yorkshire, England; [Pesut, Dragica; Clumeck, N.] Univ Belgrade, Clin Ctr Serbia, Sch Med, Belgrade, Serbia; [Maria Gate, Jose; Gatell, J.] Univ Barcelona, Hosp Clin Barcelona IDIBAPS, Barcelona, Spain; [Monforte, Antonella d'Arminio; Rockstroh, Juergen Kurt; Gazzard, B.; Comi, L.; Bini, T.] San Paolo Hosp, Unit Infect Dis, Milan, Italy; [Rockstroh, Juergen Kurt; Monforte, A. d'Arminio] Univ Bonn, HIV Outpatient Clin, Bonn, Germany; [Yazdanpanah, Yazdan; Rockstroh, J.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Yazdanpanah, Yazdan; Champenois, Karen; Mocroft, A.] Hop Bichat Claude Bernard, Paris, France; [Clumeck, N.; Necsoi, C.; Genotte, A. F.] St Pierre Univ Hosp, Brussels, Belgium; [Gatell, J.] Hosp Clin Barcelona, Barcelona, Spain; [Gazzard, B.; Sullivan, A.; Rae, C.] Chelsea & Westminster Hosp, London, England; [Monforte, A. d'Arminio] Univ Milan, San Paolo Hosp, Unit Infect Dis, Milan, Italy; [Rockstroh, J.] Univ Bonn, Dept Med, Bonn, Germany; [Mocroft, A.] UCL, Med Sch, London, England; [Yazdanpanah, Y.; Bouvet, E.] Hop Bichat Claude Bernard, Paris, France; [Zangerle, R.; Kitchen, M.] Univ Hosp Innsbruck, Dept Dermatol & Venereol, Innsbruck, Austria; [Vassilenko, A.] Minsk Municipal Infect Dis Hosp, Minsk, BELARUS; [Pedersen, C.; Redder, L.] Odense Univ Hosp, UB Dragsted, Roskilde Hosp, Odense, Denmark; [Caby, F.] Hop La Pitie Salpetriere, Paris, France; [Khuong, M. A.] Hop Delafontaine, St Denis, Reunion, France; [Khuong, M. A.] Ctr Hosp Rene Dubois, Pontoise, France; [Caldato, S.; Morlat, P.] Hop St Andre, Bordeaux, France; [Coban, D.] CHU Clermont Ferrand, Clermont Ferrand, France; [Arvieux, C.] Hop Pontchaillou, Rennes, France; [Cabie, A.] CHU Ft de France, Fort De France, Martinique, France; [Chkhartishvili, N.] Infect Dis AIDS & Clin Immunol Res Ctr, Tbilisi, Georgia; [Yazdanpanah, Yazdan; Rockstroh, J.] Univ Bonn, Dept Med, Immunol Ambulanz, Bonn, Germany; [Gerdes, S.] Univ Hautklin Kiel, Kiel, Germany; [Sambatakou, H.] Hippokrateion Hosp, Athens, Greece; [Sthoeger, Z. M.; Elbirt, D.] Ben Ari Inst Clin Immunol, Rehovot, Israel; [Celesia, B. M.; Gussio, M.] Univ Catania, Unit Infect Dis, Catania, Italy; [Brinkman, K.] Onze Lieve Vrouw Hosp, Internal Med, Amsterdam, Netherlands; [Brinkman, K.; Grzeszczuk, A.] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland; [Rosca, E. C.] Univ Med & Farm Timisoara, Clin Emergency Cty Hosp, Timisoara, Romania; [Pesut, D.] Univ Belgrade, Sch Med, Clin Ctr Serbia, Teaching Hosp Pulmonol, Belgrade, Serbia; [Goenaga Sanchez, M. A.] Hosp Donostia, San Sebastian, Spain; [Estrada, V. P.] Hosp Univ San Carlos, Madrid, Spain; [Ortega Gonzalez, E.] Consorcio Hosp Gen Univ Valencia, Valencia, Spain; [Ocampo, A.] Complexo Xeral Cies Vigo, Vigo, Spain; [Masia, M.] Hosp Univ Elche, Elche, Spain; [Agusti, C.] CEEISCAT, Badalona, Spain; [Sonnerborg, A.] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Sullivan, A.; Rayment, M.; Rae, C.; Foxton, Matt] Chelsea & Westminster Hosp NHS Fdn Trust, London, England; [Morris, S.] Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Ong, E. L. C.] Newcastle Upon Tyne Hosp, Newcastle, England; [Mummery, D.] North End Med Ctr, London, England; [Kuznetsova, A.] Kharkov Reg Clin Infect Dis, Kharkov, Ukraine; [Champenois, K.] Inserm UMR1137, IAME, Paris, France; [Raben, D.; Jakobsen, M. L.; Hansen, E. Wiuff] Rigshosp, CHIP, Copenhagen, Denmark; [Lundgren, J.] Rigshosp, Copenhagen, Denmark; [Lundgren, J.] Univ Copenhagen, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Imperial College London; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; University of Sarajevo; Belarusian State Medical University; Gomel State Medical University; University of Southern Denmark; Odense University Hospital; University of London; Queen Mary University London; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Medical University of Bialystok; Saint James's University Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Medical University of Innsbruck; Kharkiv National Medical University; ASST Papa Giovanni XXIII; Clinical Centre of Serbia; University of Belgrade; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; San Paolo-Polo Universitaria Hospital; University of Bonn; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of Barcelona; Hospital Clinic de Barcelona; Imperial College London; San Paolo-Polo Universitaria Hospital; University of Milan; University of Bonn; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Medical University of Innsbruck; University of Southern Denmark; Odense University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre Hospitalier Rene Dubos, Pontoise; CHU Bordeaux; CHU Clermont Ferrand; CHU Rennes; CHU Martinique; University of Bonn; University of Kiel; Schleswig Holstein University Hospital; Hippokration General Hospital; University of Catania; Onze Lieve Vrouwe Gasthuis Hospital; Medical University of Bialystok; Victor Babes University of Medicine & Pharmacy, Timisoara; Clinical Centre of Serbia; University of Belgrade; University Hospital Donostia; Karolinska Institutet; Karolinska University Hospital; Imperial College London; University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Jakobsen, ML (corresponding author), Rigshosp, Ctr Hlth & Infect Dis Res, Copenhagen, Denmark.	marie.louise.jakobsen@regionh.dk	Lundgren, Jens/AAE-6876-2019; Mitsura, Viktar/G-2457-2017; Gatell, Jose M/ABC-3607-2020; Redder, Louise/ABI-1987-2020; Sokhan, Anton/Q-2373-2016; Rosca, Elena Cecilia/C-5543-2012; Vassilenko, Anna/AAB-4152-2021; Kitchen, Maria/AAN-4964-2020; Begovac, Josip/AAI-5672-2021; Malagon-Rojas, Jeadran N/AAS-4687-2021; Arvieux, Catherine/AAQ-3128-2021; Rosca, Elena Cecilia/AAE-6234-2021; Gerdes, Sascha/J-4308-2017	Mitsura, Viktar/0000-0002-0449-5026; Redder, Louise/0000-0003-3965-2025; Sokhan, Anton/0000-0003-1860-3099; Rosca, Elena Cecilia/0000-0003-2412-1942; Kitchen, Maria/0000-0003-1391-0532; Begovac, Josip/0000-0003-2641-4327; Malagon-Rojas, Jeadran N/0000-0001-5801-936X; Rosca, Elena Cecilia/0000-0003-2412-1942; Gerdes, Sascha/0000-0002-6667-7757; , IIS Galicia Sur/0000-0003-3812-7413; Anna, Vassilenko/0000-0003-1907-2322	HIV in Europe initiative from Gilead Sciences; ViiV Healthcare; Merck; Tibotec; Pfizer; Schering-Plough; Abbott; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; European Commission under the 2nd Health Programme; Danish National Research Foundation [DNRF126]	HIV in Europe initiative from Gilead Sciences; ViiV Healthcare; Merck(Merck & Company); Tibotec; Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); European Commission under the 2nd Health Programme; Danish National Research Foundation(Danmarks Grundforskningsfond)	The HIDES study was funded by the HIV in Europe initiative which has received unrestricted funding from Gilead Sciences, ViiV Healthcare, Merck, Tibotec, Pfizer, Schering-Plough, Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, and the European Commission under the 2nd Health Programme. The study is also supported by a grant [grant number DNRF126] from the Danish National Research Foundation. The operational procedures within the initiative include the following to maintain the autonomy of the initiative. The Steering Committee is the governing body and sponsors do not have representation on the Steering Committee. Furthermore, data, records, reports, Intellectual Property Rights and Know How generated as result of the initiative shall be deemed vested in and the property of the Steering Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankiersztejn-Bartczak M, 2015, HIV MED, V16, P88, DOI 10.1111/hiv.12175; [Anonymous], 2012, HIV INDICATOR CONDIT; Bert F, 2018, HEALTH POLICY, V122, P533, DOI 10.1016/j.healthpol.2018.03.007; Croxford S, 2018, EUROSURVEILLANCE; Gazzard B, 2008, HIV MED, V9, P34, DOI 10.1111/j.1468-1293.2008.00592.x; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Lord E, 2017, HIV MED, V18, P300, DOI 10.1111/hiv.12430; Menacho I, 2013, HIV MED, V14, P33, DOI 10.1111/hiv.12064; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Raben D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140845; Rayment M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039530; Rothman RE, 2012, ACAD EMERG MED, V19, P497, DOI 10.1111/j.1553-2712.2012.01351.x; Sullivan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052845; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132	14	13	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2019	14	8							e0220108	10.1371/journal.pone.0220108	http://dx.doi.org/10.1371/journal.pone.0220108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IW5HO	31408476	gold, Green Published, Green Submitted			2022-12-27	WOS:000485009500007
